PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schuster, MA; Osherov, A; Chung, PJ				Schuster, Mark A.; Osherov, Artem; Chung, Paul J.			Why Counting Black Lives Matters - The 2020 Census	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schuster, Mark A.; Osherov, Artem; Chung, Paul J.] Kaiser Permanente Bernard J Tyson Sch Med, Pasadena, CA 91101 USA	Kaiser Permanente	Schuster, MA (corresponding author), Kaiser Permanente Bernard J Tyson Sch Med, Pasadena, CA 91101 USA.							Elliott Diana, 2019, ASSESSING MISCOUNTS; O'Hare WP, 2019, SPRINGERBRIEF POPUL, P39, DOI 10.1007/978-3-030-10973-8_4; Seeskin Z, 2018, BALANCING 2020 3 CEN; Sherman A, 2018, BUDGET DEAL POLICY M	5	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2020	383	9								10.1056/NEJMp2022162	http://dx.doi.org/10.1056/NEJMp2022162			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2NK	32780572	Bronze			2022-12-28	WOS:000563821400004
J	Alwan, NA				Alwan, Nisreen A.			A negative COVID-19 test does not mean recovery	NATURE			English	Editorial Material									[Alwan, Nisreen A.] Univ Southampton, Publ Hlth, Southampton, Hants, England	University of Southampton	Alwan, NA (corresponding author), Univ Southampton, Publ Hlth, Southampton, Hants, England.	n.a.alwan@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463					0	29	30	3	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					170	170		10.1038/d41586-020-02335-z	http://dx.doi.org/10.1038/d41586-020-02335-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ0LC	32782377	Bronze			2022-12-28	WOS:000558814100001
J	Ferris, ST; Durai, V; Wu, R; Theisen, DJ; Ward, JP; Bern, MD; Davidson, JT; Bagadia, P; Liu, TT; Briseno, CG; Li, LJ; Gillanders, WE; Wu, GF; Yokoyama, WM; Murphy, TL; Schreiber, RD; Murphy, KM				Ferris, Stephen T.; Durai, Vivek; Wu, Renee; Theisen, Derek J.; Ward, Jeffrey P.; Bern, Michael D.; Davidson, Jesse T.; Bagadia, Prachi; Liu, Tiantian; Briseno, Carlos G.; Li, Lijin; Gillanders, William E.; Wu, Gregory F.; Yokoyama, Wayne M.; Murphy, Theresa L.; Schreiber, Robert D.; Murphy, Kenneth M.			cDC1 prime and are licensed by CD4(+)T cells to induce anti-tumour immunity	NATURE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; CD8(+) T-CELLS; ANTIGEN UPTAKE; HELP; ACTIVATION; REVEALS; MEMORY; MACROPHAGES; EXPRESSION; RESPONSES	Conventional type 1 dendritic cells perform antigen processing and priming of CD4(+)and CD8(+)T cells against tumour antigens, orchestrating their cross-talk to effect anti-tumour immunity. Conventional type 1 dendritic cells (cDC1)(1)are thought to perform antigen cross-presentation, which is required to prime CD8(+)T cells(2,3), whereas cDC2 are specialized for priming CD4(+)T cells(4,5). CD4(+)T cells are also considered to help CD8(+)T cell responses through a variety of mechanisms(6-11), including a process whereby CD4(+)T cells 'license' cDC1 for CD8(+)T cell priming(12). However, this model has not been directly tested in vivo or in the setting of help-dependent tumour rejection. Here we generated anXcr1(Cre)mouse strain to evaluate the cellular interactions that mediate tumour rejection in a model requiring CD4(+)and CD8(+)T cells. As expected, tumour rejection required cDC1 and CD8(+)T cell priming required the expression of major histocompatibility class I molecules by cDC1. Unexpectedly, early priming of CD4(+)T cells against tumour-derived antigens also required cDC1, and this was not simply because they transport antigens to lymph nodes for processing by cDC2, as selective deletion of major histocompatibility class II molecules in cDC1 also prevented early CD4(+)T cell priming. Furthermore, deletion of either major histocompatibility class II or CD40 in cDC1 impaired tumour rejection, consistent with a role for cognate CD4(+)T cell interactions and CD40 signalling in cDC1 licensing. Finally, CD40 signalling in cDC1 was critical not only for CD8(+)T cell priming, but also for initial CD4(+)T cell activation. Thus, in the setting of tumour-derived antigens, cDC1 function as an autonomous platform capable of antigen processing and priming for both CD4(+)and CD8(+)T cells and of the direct orchestration of their cross-talk that is required for optimal anti-tumour immunity.	[Ferris, Stephen T.; Durai, Vivek; Wu, Renee; Theisen, Derek J.; Ward, Jeffrey P.; Davidson, Jesse T.; Bagadia, Prachi; Liu, Tiantian; Briseno, Carlos G.; Wu, Gregory F.; Murphy, Theresa L.; Schreiber, Robert D.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ward, Jeffrey P.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Bern, Michael D.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Div Rheumatol, St Louis, MO USA; [Davidson, Jesse T.; Li, Lijin; Gillanders, William E.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Gillanders, William E.] Alvin J Siteman Canc Ctr Barnes Jewish Hosp, St Louis, MO USA; [Gillanders, William E.] Washington Univ, Sch Med, St Louis, MO USA; [Wu, Gregory F.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Schreiber, Robert D.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA; [Schreiber, Robert D.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Durai, Vivek] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of California System; University of California San Francisco	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	kmurphy@wustl.edu		Ferris, Stephen/0000-0003-3340-2607; Schreiber, Robert/0000-0003-1590-2341; Ward, Jeffrey/0000-0002-9707-895X	Howard Hughes Medical Institute; US National Institutes of Health [R01AI150297]; National Institutes of Health [R01NS106289, T32 AI007163, T32CA009621, R01CA190700, R01AI129545, F30DK112466, F30DK108498, T32CA95473]; Stand Up To Cancer-Lustgarden Foundation Pancreatic Cancer Foundation Convergence Team Translational Research Grant; US National Science Foundation [DGE-1143954]; Cancer Center Support Grant from the US National Cancer Institute [P30 CA91842]; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the US National Center for Research Resources [UL1 TR000448]; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs; Alvin J. Siteman Comprehensive Cancer Center; National Cancer Institute of the National Institutes of Health Cancer Center Support Grant [P30CA91842]; Washington University Rheumatic Diseases Research Resource-based Center Grant [P30AR073752]; Parker Institute for Cancer Immunotherapy	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer-Lustgarden Foundation Pancreatic Cancer Foundation Convergence Team Translational Research Grant; US National Science Foundation(National Science Foundation (NSF)); Cancer Center Support Grant from the US National Cancer Institute; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the US National Center for Research Resources; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs; Alvin J. Siteman Comprehensive Cancer Center; National Cancer Institute of the National Institutes of Health Cancer Center Support Grant; Washington University Rheumatic Diseases Research Resource-based Center Grant; Parker Institute for Cancer Immunotherapy	K.M.M. was supported by the Howard Hughes Medical Institute and the US National Institutes of Health (R01AI150297); R.D.S. by grants from the National Institutes of Health (R01CA190700) and The Parker Institute for Cancer Immunotherapy, and a Stand Up To Cancer-Lustgarden Foundation Pancreatic Cancer Foundation Convergence Team Translational Research Grant; W.M.Y. by a grant from the National Institutes of Health (R01AI129545); M.D.B. and V.D. by fellowship grants from the National Institutes of Health (F30DK112466 and F30DK108498, respectively); S.T.F. by a postdoctoral training grant from the National Institutes of Health (T32CA95473); G.F.W., D.J.T. and J.T.D. by the National Institutes of Health (R01NS106289, T32 AI007163 and T32CA009621, respectively); and P.B. by the US National Science Foundation (DGE-1143954). We thank the Genome Technology Access Center, Department of Genetics, Washington University School of Medicine in St Louis, for help with genomic analysis. The Center is supported by Cancer Center Support Grant P30 CA91842 from the US National Cancer Institute and by Institute of Clinical and Translational Sciences/Clinical and Translational Science Award UL1 TR000448 from the US National Center for Research Resources. Aspects of studies including tetramer production were performed with assistance by the Immunomonitoring Laboratory, which is supported by the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs and the Alvin J. Siteman Comprehensive Cancer Center that, in turn, is supported by the National Cancer Institute of the National Institutes of Health Cancer Center Support Grant (P30CA91842) and the Washington University Rheumatic Diseases Research Resource-based Center Grant (P30AR073752).	Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Bern MD, 2019, J EXP MED, V216, P99, DOI 10.1084/jem.20181076; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cancel JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00009; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Lehmann CHK, 2017, J EXP MED, V214, P1509, DOI 10.1084/jem.20160951; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Pasqual G, 2018, NATURE, V553, P496, DOI 10.1038/nature25442; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Theisen DJ, 2019, CANCER IMMUNOL RES, V7, P29, DOI 10.1158/2326-6066.CIR-18-0138; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wu XD, 2016, J EXP MED, V213, P2553, DOI 10.1084/jem.20160600; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	50	125	126	7	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					624	+		10.1038/s41586-020-2611-3	http://dx.doi.org/10.1038/s41586-020-2611-3		AUG 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF3UH	32788723	Green Accepted			2022-12-28	WOS:000559369600003
J	Paul, JD; Cifu, AS				Paul, Jonathan D.; Cifu, Adam S.			Management of Acute Pulmonary Embolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VENOUS THROMBOEMBOLISM	This JAMA Clinical Guidelines Synopsis summarizes the European Society of Cardiology's 2019 guidelines for diagnosis and management of acute pulmonary embolism.	[Paul, Jonathan D.; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Hoeper MM, 2014, LANCET RESP MED, V2, P573, DOI 10.1016/S2213-2600(14)70089-X; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Marti C, 2015, EUR HEART J, V36, P605, DOI 10.1093/eurheartj/ehu218; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Rogers MAM, 2012, CIRCULATION, V125, P2092, DOI 10.1161/CIRCULATIONAHA.111.084467; Tritschler T, 2018, JAMA-J AM MED ASSOC, V320, P1583, DOI 10.1001/jama.2018.14346; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485	7	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					597	598		10.1001/jama.2020.3905	http://dx.doi.org/10.1001/jama.2020.3905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780129				2022-12-28	WOS:000562845100023
J	Grajales-Reyes, GE; Colonna, M				Grajales-Reyes, Gary E.; Colonna, Marco			Interferon responses in viral pneumonias	SCIENCE			English	Editorial Material							SUPPRESSION		[Grajales-Reyes, Gary E.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Grajales-Reyes, GE (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	garygrajalesreyes@wustl.edu; mcolonna@wustl.edu						Andreakos E, 2019, CURR OPIN IMMUNOL, V56, P67, DOI 10.1016/j.coi.2018.10.007; Bimonte S, 2020, IN VIVO, V34, P1597, DOI 10.21873/invivo.11949; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Planet PJ, 2016, MBIO, V7, DOI 10.1128/mBio.01939-15; Porta C, 2005, ONCOGENE, V24, P605, DOI 10.1038/sj.onc.1208204; Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850	12	14	14	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					626	+		10.1126/science.abd2208	http://dx.doi.org/10.1126/science.abd2208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764056				2022-12-28	WOS:000559184400025
J	Li, H; Limenitakis, JP; Greiff, V; Yilmaz, B; Scharen, O; Urbaniak, C; Zund, M; Lawson, MAE; Young, ID; Rupp, S; Heikenwalder, M; McCoy, KD; Hapfelmeier, S; Ganal-Vonarburg, SC; Macpherson, AJ				Li, Hai; Limenitakis, Julien P.; Greiff, Victor; Yilmaz, Bahtiyar; Scharen, Olivier; Urbaniak, Camilla; Zund, Mirjam; Lawson, Melissa A. E.; Young, Ian D.; Rupp, Sandra; Heikenwalder, Mathias; McCoy, Kathy D.; Hapfelmeier, Siegfried; Ganal-Vonarburg, Stephanie C.; Macpherson, Andrew J.			Mucosal or systemic microbiota exposures shape the B cell repertoire	NATURE			English	Article							IGA RESPONSES; ANTIBODIES; DIVERSITY; COMPLEMENT; REVEALS; PACKAGE; INNATE; DRIVES	Colonization by the microbiota causes a marked stimulation of B cells and induction of immunoglobulin, but mammals colonized with many taxa have highly complex and individualized immunoglobulin repertoires(1,2). Here we use a simplified model of defined transient exposures to different microbial taxa in germ-free mice(3)to deconstruct how the microbiota shapes the B cell pool and its functional responsiveness. We followed the development of the immunoglobulin repertoire in B cell populations, as well as single cells by deep sequencing. Microbial exposures at the intestinal mucosa generated oligoclonal responses that differed from those of germ-free mice, and from the diverse repertoire that was generated after intravenous systemic exposure to microbiota. The IgA repertoire-predominantly to cell-surface antigens-did not expand after dose escalation, whereas increased systemic exposure broadened the IgG repertoire to both microbial cytoplasmic and cell-surface antigens. These microbial exposures induced characteristic immunoglobulin heavy-chain repertoires in B cells, mainly at memory and plasma cell stages. Whereas sequential systemic exposure to different microbial taxa diversified the IgG repertoire and facilitated alternative specific responses, sequential mucosal exposure produced limited overlapping repertoires and the attrition of initial IgA binding specificities. This shows a contrast between a flexible response to systemic exposure with the need to avoid fatal sepsis, and a restricted response to mucosal exposure that reflects the generic nature of host-microbial mutualism in the mucosa. A mouse model of systemic versus mucosal exposure to microbial taxa reveals that the former provokes a flexible B cell response with a diverse immunoglobulin repertoire, whereas the latter generates a more-restricted response.	[Li, Hai; Limenitakis, Julien P.; Yilmaz, Bahtiyar; Zund, Mirjam; Lawson, Melissa A. E.; Young, Ian D.; Rupp, Sandra; McCoy, Kathy D.; Ganal-Vonarburg, Stephanie C.; Macpherson, Andrew J.] Univ Bern, Univ Klin Viszerale Chirurg & Med, Inselspital, Maurice Muller Labs DBMR, Bern, Switzerland; [Greiff, Victor] Univ Oslo, Dept Immunol, Oslo, Norway; [Scharen, Olivier; Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Urbaniak, Camilla] McMaster Univ, Med Ctr, Hamilton, ON, Canada; [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany	University of Bern; University Hospital of Bern; University of Oslo; University of Bern; McMaster University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ganal-Vonarburg, SC; Macpherson, AJ (corresponding author), Univ Bern, Univ Klin Viszerale Chirurg & Med, Inselspital, Maurice Muller Labs DBMR, Bern, Switzerland.	stephanie.ganal@dbmr.unibe.ch; andrew.macpherson@dbmr.unibe.ch	Li, Hai/AAI-9163-2021; Urbaniak, Camilla/AAX-4845-2021; McCoy, Kathy/ABD-5814-2021; Hapfelmeier, Siegfried/B-6005-2011; Ganal-Vonarburg, Stephanie C./AAE-5705-2019	Hapfelmeier, Siegfried/0000-0002-6913-7932; Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; Greiff, Victor/0000-0003-2622-5032; Young, Ian/0000-0001-6250-9820; Yilmaz, Bahtiyar/0000-0003-1888-9226; Li, Hai/0000-0002-4762-9362; Lawson, Melissa/0000-0001-9882-8663; Zund, Mirjam/0000-0003-2443-9328; Limenitakis, Julien/0000-0002-6785-3492	Genaxen Foundation; Inselspital; University of Bern; Swiss National Science Foundation [SNSF CRSII5_177164, SNSF 310030_179479]; European Research Council [742195]; European Molecular Biology Organization [627206]; Stiftung Experimentelle Biomedizin; UiO:LifeSciences Convergence Environment Immunolingo; EU [825821]; SNSF [169791]; ERC [StG 281904, StG 281785]; ERC CoG (HepatoMetaboPath); SystemsX Transition Postdoc Fellowship [TPdF2013/139]	Genaxen Foundation; Inselspital; University of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Stiftung Experimentelle Biomedizin; UiO:LifeSciences Convergence Environment Immunolingo; EU(European Commission); SNSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); ERC CoG (HepatoMetaboPath); SystemsX Transition Postdoc Fellowship	We thank M. Gomez de Aguero, T. Leeb, P. Nicholson, M. Geuking and D. Candinas. The Clean Mouse Facility is supported by the Genaxen Foundation, Inselspital and the University of Bern. This work was funded by the Swiss National Science Foundation (SNSF CRSII5_177164, SNSF 310030_179479) and the European Research Council (H2020 ERC2016-ADG HHMM_Neonates, Grant Agreement: 742195) to A.J.M. S.C.G.-V. was funded by a Marie Curie Intra-European Fellowship (FP7-PEOPLE-2013-IEF project no. 627206), a long-term fellowship from the European Molecular Biology Organization and the Peter Hans Hofschneider Endowed Professorship by Stiftung Experimentelle Biomedizin. V.G. acknowledges the support of UiO:LifeSciences Convergence Environment Immunolingo and EU H2020 iReceptorplus (no. 825821). S.H. was funded by SNSF grant 169791 and ERC StG 281904. K.D.M. was funded by the ERC StG 281785. M.H. was funded by an ERC CoG (HepatoMetaboPath). J.P.L. was supported by a SystemsX Transition Postdoc Fellowship (TPdF2013/139).	Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Boursier L, 1999, IMMUNOLOGY, V97, P558; Bunker JJ, 2017, SCIENCE, V358, DOI 10.1126/science.aan6619; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chen YZ, 2018, J EXP MED, V215, P1397, DOI 10.1084/jem.20171761; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; DunnWalters DK, 1997, EUR J IMMUNOL, V27, P2959, DOI 10.1002/eji.1830271131; ESPINOZAJURADO J, 2015, COLD SPRING HARB PRO, V2015, DOI DOI 10.1101/PDB.PROT081331; Greiff V, 2017, CELL REP, V19, P1467, DOI 10.1016/j.celrep.2017.04.054; Greiff V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0040-5; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Khan TA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501371; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Menzel U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096727; Miho E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09278-8; Mowat AM, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P487, DOI 10.1016/B978-012491543-5/50031-0; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Pfister SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15891-9; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Valdezi Y, 2014, TRENDS IMMUNOL, V35, P526, DOI 10.1016/j.it.2014.07.003; van der Loo MPJ, 2014, R J, V6, P111; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Wilmore JR, 2018, CELL HOST MICROBE, V23, P302, DOI 10.1016/j.chom.2018.01.005; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006	42	69	70	2	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					274	+		10.1038/s41586-020-2564-6	http://dx.doi.org/10.1038/s41586-020-2564-6		AUG 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32760003	Green Accepted			2022-12-28	WOS:000556239400005
J	Mahase, E				Mahase, Elisabeth			Covid-19: Where are we on immunity and vaccines?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, CANSINO BIOL RECOMBI; Barnes JE. C.I.A., 2020, NEW YORK TIMES; CanSino Biologics, REC NOV COR VACC; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Kramer AE., 2020, NEW YORK TIMES; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2612; Sewell HF, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3018; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6	8	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m3096	10.1136/bmj.m3096	http://dx.doi.org/10.1136/bmj.m3096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759299	Bronze			2022-12-28	WOS:000556139400009
J	Seok, H; Lee, H; Lee, S; Ahn, SH; Lee, HS; Kim, GWD; Peak, J; Park, J; Cho, YK; Jeong, Y; Gu, D; Jeong, Y; Eom, S; Jang, ES; Chi, SW				Seok, Heeyoung; Lee, Haejeong; Lee, Sohyun; Ahn, Seung Hyun; Lee, Hye-Sook; Kim, Geun-Woo D.; Peak, Jongjin; Park, Jongyeun; Cho, You Kyung; Jeong, Yeojin; Gu, Dowoon; Jeong, Yeahji; Eom, Sangkyeong; Jang, Eun-Sook; Chi, Sung Wook			Position-specific oxidation of miR-1 encodes cardiac hypertrophy	NATURE			English	Article							MUSCLE-SPECIFIC MICRORNA; INSERTION	The 8-oxoguanine modification of the microRNA miR-1 results in redirected recognition and silencing of target genes and leads to cardiac hypertrophy in mice. In pathophysiology, reactive oxygen species oxidize biomolecules that contribute to disease phenotypes(1). One such modification, 8-oxoguanine(2)(o(8)G), is abundant in RNA(3)but its epitranscriptional role has not been investigated for microRNAs (miRNAs). Here we specifically sequence oxidized miRNAs in a rat model of the redox-associated condition cardiac hypertrophy(4). We find that position-specific o(8)G modifications are generated in seed regions (positions 2-8) of selective miRNAs, and function to regulate other mRNAs through o(8)G center dot A base pairing. o(8)G is induced predominantly at position 7 of miR-1 (7o(8)G-miR-1) by treatment with an adrenergic agonist. Introducing 7o(8)G-miR-1 or 7U-miR-1 (in which G at position 7 is substituted with U) alone is sufficient to cause cardiac hypertrophy in mice, and the mRNA targets of o(8)G-miR-1 function in affected phenotypes; the specific inhibition of 7o(8)G-miR-1 in mouse cardiomyocytes was found to attenuate cardiac hypertrophy. o(8)G-miR-1 is also implicated in patients with cardiomyopathy. Our findings show that the position-specific oxidation of miRNAs could serve as an epitranscriptional mechanism to coordinate pathophysiological redox-mediated gene expression.	[Seok, Heeyoung; Lee, Haejeong; Lee, Sohyun; Ahn, Seung Hyun; Lee, Hye-Sook; Kim, Geun-Woo D.; Peak, Jongjin; Park, Jongyeun; Cho, You Kyung; Gu, Dowoon; Jeong, Yeahji; Eom, Sangkyeong; Jang, Eun-Sook; Chi, Sung Wook] Korea Univ, Dept Life Sci, Seoul, South Korea; [Lee, Haejeong; Kim, Geun-Woo D.; Jeong, Yeojin; Chi, Sung Wook] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea	Korea University; Korea University	Chi, SW (corresponding author), Korea Univ, Dept Life Sci, Seoul, South Korea.; Chi, SW (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea.	chi13@korea.ac.kr	seok, heeyoung/ABC-3957-2020	Lee, Haejeong/0000-0001-5243-7595; Park, Jongyeun/0000-0001-7394-5361; SEOK, HEEYOUNG/0000-0003-2699-9935; Jeong, Yeahji/0000-0003-0464-1422	Samsung Research Funding and Incubation Center of Samsung Electronics [SRFC-MA1801-10]; Korea University Grant	Samsung Research Funding and Incubation Center of Samsung Electronics(Samsung); Korea University Grant	We thank all members of the Chi laboratory for help and discussions. We thank in particular M.-H. Chung for sharing research experiences with H. Kasai and S. Nishimura, which inspired us to initiate this project; the late S.-D. Yoo for scientific discussions; the late Y.-S. Lee for initial help on this work; D.-Z. Wang for providing the pJG/ALPHA MHC vector; J. Han, H.-W. Lee and W. J. Park for providing AC16 cells and Y. W. Chung for H9c2 cells, which were used for preliminary studies; Samsung Medical Center for echocardiograms; J. Im and J. W. Park for initial help with the HPLC analysis to confirm the o8G immunoprecipitation; E. S. Cho for help in analysing sequence conservation of miR-1 oxo sites; D. H. Lee and W. Lee for initial help with the project; and the staff of Gyerim Experimental Animal Resource Center for animal care and technical assistance. This work was supported by Samsung Research Funding and Incubation Center of Samsung Electronics under project number SRFC-MA1801-10 and Korea University Grant.	Alenko A, 2017, BIOCHEMISTRY-US, V56, P5053, DOI 10.1021/acs.biochem.7b00730; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002849; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Choi YS, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx091; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Kim SK, 2004, J BIOCHEM MOL BIOL, V37, P657; Lee HS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10154; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Nunomura A, 1999, J NEUROSCI, V19, P1959; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Park S, 2018, NUCLEIC ACIDS RES, V46, P11153, DOI 10.1093/nar/gky917; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Seok H, 2016, MOL CELLS, V39, P375, DOI 10.14348/molcells.2016.0013; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Simms CL, 2016, CELL MOL LIFE SCI, V73, P3639, DOI 10.1007/s00018-016-2261-7; Spengler RM, 2016, NUCLEIC ACIDS RES, V44, P7120, DOI 10.1093/nar/gkw640; Stark K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001167; Su XM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46259; Wang JX, 2015, MOL CELL, V59, P50, DOI 10.1016/j.molcel.2015.05.003; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Ying XY, 2016, HYPERTENSION, V68, P1160, DOI 10.1161/HYPERTENSIONAHA.116.07562; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	35	43	42	5	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					279	+		10.1038/s41586-020-2586-0	http://dx.doi.org/10.1038/s41586-020-2586-0		AUG 2020	31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32760005				2022-12-28	WOS:000556239400004
J	Cousins, S				Cousins, Sophie			COVID-19 has "devastating" effect on women and girls	LANCET			English	Editorial Material																			0	69	70	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					301	302						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0RO	32738942	Green Published, Bronze			2022-12-28	WOS:000561615700008
J	Low, JG; Ng, JHJ; Ong, EZ; Kalimuddin, S; Wijaya, L; Chan, YFZ; Ng, DHL; Tan, HC; Baglody, A; Chionh, YH; Lee, DCP; Budigi, Y; Sasisekharan, R; Ooi, EE				Low, Jenny G.; Ng, Justin H. J.; Ong, Eugenia Z.; Kalimuddin, Shirin; Wijaya, Limin; Chan, Yvonne F. Z.; Ng, Dorothy H. L.; Tan, Hwee-Cheng; Baglody, Anjali; Chionh, Yok-Hian; Lee, Debbie C. P.; Budigi, Yadunanda; Sasisekharan, Ram; Ooi, Eng-Eong			Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINATION; POTENT	BackgroundInsufficient vaccine doses and the lack of therapeutic agents for yellow fever put global health at risk, should this virus emerge from sub-Saharan Africa and South America. MethodsIn phase 1a of this clinical trial, we assessed the safety, side-effect profile, and pharmacokinetics of TY014, a fully human IgG1 anti-yellow fever virus monoclonal antibody. In a double-blind, phase 1b clinical trial, we assessed the efficacy of TY014, as compared with placebo, in abrogating viremia related to the administration of live yellow fever vaccine (YF17D-204; Stamaril). The primary safety outcomes were adverse events reported 1 hour after the infusion and throughout the trial. The primary efficacy outcome was the dose of TY014 at which 100% of the participants tested negative for viremia within 48 hours after infusion. ResultsA total of 27 healthy participants were enrolled in phase 1a, and 10 participants in phase 1b. During phase 1a, TY014 dose escalation to a maximum of 20 mg per kilogram of body weight occurred in 22 participants. During phases 1a and 1b, adverse events within 1 hour after infusion occurred in 1 of 27 participants who received TY014 and in none of the 10 participants who received placebo. At least one adverse event occurred during the trial in 22 participants who received TY014 and in 8 who received placebo. The mean half-life of TY014 was approximately 12.8 days. At 48 hours after the infusion, none of the 5 participants who received the starting dose of TY014 of 2 mg per kilogram had detectable YF17D-204 viremia; these participants remained aviremic throughout the trial. Viremia was observed at 48 hours after the infusion in 2 of 5 participants who received placebo and at 72 hours in 2 more placebo recipients. Symptoms associated with yellow fever vaccine were less frequent in the TY014 group than in the placebo group. ConclusionsThis phase 1 trial of TY014 did not identify worrisome safety signals and suggested potential clinical benefit, which requires further assessment in a phase 2 trial. (Funded by Tysana; ClinicalTrials.gov number, NCT03776786.) A phase 1a-1b trial of TY014, an IgG1 anti-yellow fever virus monoclonal antibody, did not identify worrisome safety signals. Ten participants were randomly assigned to receive TY014 or placebo 24 hours after live yellow fever vaccination (YF17D-204). YF17D-204 viremia was detectable in no participants in the TY014 group and in four in the placebo group, providing preliminary evidence of potential efficacy.	[Low, Jenny G.; Ong, Eugenia Z.; Tan, Hwee-Cheng; Ooi, Eng-Eong] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore; [Low, Jenny G.; Kalimuddin, Shirin; Wijaya, Limin; Chan, Yvonne F. Z.; Ng, Dorothy H. L.] Singapore Gen Hosp, Singapore, Singapore; [Ng, Justin H. J.; Baglody, Anjali; Chionh, Yok-Hian; Lee, Debbie C. P.; Budigi, Yadunanda] Tysana, Singapore, Singapore; [Sasisekharan, Ram; Ooi, Eng-Eong] Singapore MIT Massachusetts Inst Technol Alliance, Singapore, Singapore; [Sasisekharan, Ram] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	National University of Singapore; Singapore General Hospital; Massachusetts Institute of Technology (MIT)	Ooi, EE (corresponding author), 8 Coll Rd, Singapore 169857, Singapore.	engeong.ooi@duke-nus.edu.sg			Tysana	Tysana	Funded by Tysana; ClinicalTrials.gov number, NCT03776786.	[Anonymous], 2017, LANCET HIV, V2, pe115; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Basler CF, 2017, SEMIN IMMUNOPATHOL, V39, P551, DOI 10.1007/s00281-017-0637-x; Chan KR, 2019, NAT MED, V25, P1218, DOI 10.1038/s41591-019-0510-7; Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.164, 10.1038/NMICROBIOL.2016.164]; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12; Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012; Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131; Gershman MD, 2017, MMWR-MORBID MORTAL W, V66, P457, DOI 10.15585/mmwr.mm6617e2; Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818; Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; MI NI, 2018, MED MYCOLOGY ISHAM, V56, pS1; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030; Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]; Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026; Ng KH, 2019, CELL HOST MICROBE, V26, P601, DOI 10.1016/j.chom.2019.10.005; Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172; Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X; Song R, 2018, EMERG INFECT DIS, V24, P1383, DOI 10.3201/eid2407.171868; Tharakaraman K, 2018, CELL HOST MICROBE, V23, P618, DOI 10.1016/j.chom.2018.04.004	23	9	9	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					452	459		10.1056/NEJMoa2000226	http://dx.doi.org/10.1056/NEJMoa2000226			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW2GI	32726531	Bronze, Green Published			2022-12-28	WOS:000556861800012
J	Slomski, A				Slomski, Anita			Telehealth Reduces Excess Weight Gain in Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					327	327		10.1001/jama.2020.11670	http://dx.doi.org/10.1001/jama.2020.11670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721002				2022-12-28	WOS:000562851000007
J	Dyer, C				Dyer, Clare			Former Manchester City doctor can return to work after suspension for ordering drugs under patient's name	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2996	10.1136/bmj.m2996	http://dx.doi.org/10.1136/bmj.m2996			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32718939				2022-12-28	WOS:000554458200004
J	Burmester, GR; Buttgereit, F; Bernasconi, C; Alvaro-Gracia, JM; Castro, N; Dougados, M; Gabay, C; van Laar, JM; Nebesky, JM; Pethoe-Schramm, A; Salvarani, C; Donath, MY; John, MR				Burmester, Gerd R.; Buttgereit, Frank; Bernasconi, Corrado; Alvaro-Gracia, Jose M.; Castro, Nidia; Dougados, Maxime; Gabay, Cem; van Laar, Jacob M.; Nebesky, Jan Michael; Pethoe-Schramm, Attila; Salvarani, Carlo; Donath, Marc Y.; John, Markus R.		SEMIRA Collaborators	Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; POLYMYALGIA-RHEUMATICA; EULAR RECOMMENDATIONS; ORAL CORTICOSTEROIDS; TOCILIZUMAB; METHOTREXATE; MANAGEMENT; CLASSIFICATION; PREDNISOLONE; REDUCTION	Background Patients with inflammatory diseases, such as rheumatoid arthritis, often receive glucocorticoids, but long-term use can produce adverse effects. Evidence from randomised controlled trials to guide tapering of oral glucocorticoids is scarce. We investigated a scheme for tapering oral glucocorticoids compared with continuing low-dose oral glucocorticoids in patients with rheumatoid arthritis. Methods The Steroid EliMination In Rheumatoid Arthritis (SEMIRA) trial was a double-blind, multicentre, two parallel-arm, randomised controlled trial done at 39 centres from six countries (France, Germany, Italy, Russia, Serbia, and Tunisia). Adult patients with rheumatoid arthritis receiving tocilizumab and glucocorticoids 5-15 mg per day for 24 weeks or more were eligible for inclusion if they had received prednisone 5 mg per day for 4 weeks or more and had stable low disease activaity, confirmed by a Disease Activity Score for 28 joints-erythrocyte sedimentation rate (DAS 28-ESR) of 3.2 or less 4-6 weeks before and on the day of randomisation. Patients were randomly assigned 1:1 to either continue masked prednisone 5 mg per day for 24 weeks or to taper masked prednisone reaching 0 mg per day at week 16. All patients received tocilizumab (162 mg subcutaneously every week or 8 mg/kg intravenously every 4 weeks) with or without csDMARDs maintained at stable doses during the entire 24-week study. The primary outcome was the difference in mean DAS 28-E SR change from baseline to week 24, with a difference of more than 0.6 defined as clinically relevant between the continued-prednisone group and the tapered-prednisone group. The trial is registered with ClinicalTrials.gov , NCTO 2573012. Findings Between Oct 21, 2015, and June 9, 2017, 421 patients were screened and 259 (200 [77%] women and 59 [23%] men) were recruited onto the trial. In all 128 patients assigned to the continued-prednisone regimen, disease activity control was superior to that in all 131 patients assigned to the tapered-prednisone regimen; the estimated mean change in DAS 28-ESR from baseline to week 24 was 0.54 (95% CI 0.35-0.73) with tapered prednisone and -0.08 (-0.27 to 0.12) with continued prednisone (difference 0.61 [0.35-0.88]; p<0.0001), favouring continuing prednisone 5 mg per day for 24 weeks. Treatment was regarded as successful (defined as low disease activity at week 24, plus absence of rheumatoid arthritis flare for 24 weeks and no confirmed adrenal insufficiency) in 99 (77%) patients in the continued-prednisone group versus 85 (65%) patients in the tapered-prednisone group (relative risk 0.83; 95% CI 0.71-0.97). Serious adverse events occurred in seven (5%) patients in the tapered-prednisone group and four (3%) patients in the continued-prednisone group; no patients had symptomatic adrenal insufficiency. Interpretation In patients who achieved low disease activity with tocilizumab and at least 24 weeks of glucocorticoid treatment, continuing glucocorticoids at 5 mg per day for 24 weeks provided safe and better disease control than tapering glucocorticoids, although two-thirds of patients were able to safely taper their glucocorticoid dose. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Burmester, Gerd R.; Buttgereit, Frank] Free Univ, Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Burmester, Gerd R.; Buttgereit, Frank] Humboldt Univ, D-10117 Berlin, Germany; [Bernasconi, Corrado; Castro, Nidia; Nebesky, Jan Michael; Pethoe-Schramm, Attila; John, Markus R.] F Hoffmann La Roche, Pharmaceut Div, Basel, Switzerland; [Alvaro-Gracia, Jose M.] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Dougados, Maxime] Univ Paris 05, Rheumatol Serv, Paris, France; [Gabay, Cem] Geneva Univ Hosp, Hop Cochin, Dept Rheumatol, Geneva, Switzerland; [Gabay, Cem] Geneva Sch Med, Geneva, Switzerland; [van Laar, Jacob M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Salvarani, Carlo] Univ Modena & Reggio Emilia, Dept Rheumatol & Clin Immunol, Reggio Emilia, Italy; [Salvarani, Carlo] IRCCS Reggio Emilia, Azienda Unita Sanit Locale, Reggio Emilia, Italy; [Donath, Marc Y.] Univ Hosp Basel, Dept Rheumatol, Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Roche Holding; Complutense University of Madrid; General University Gregorio Maranon Hospital; UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Geneva; Utrecht University; Utrecht University Medical Center; Universita di Modena e Reggio Emilia; University of Basel	Burmester, GR (corresponding author), Free Univ, Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany.; Burmester, GR (corresponding author), Humboldt Univ, D-10117 Berlin, Germany.	gerd.burmester@charite.de	Salvarani, Carlo/K-2431-2018	Buttgereit, Frank/0000-0003-2534-550X; Bernasconi, Corrado/0000-0002-1019-5468	F Hoffmann-La Roche	F Hoffmann-La Roche(Hoffmann-La Roche)	F Hoffmann-La Roche.	Albrecht K, 2015, RHEUMATOL INT, V35, P1377, DOI 10.1007/s00296-015-3229-x; Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Black RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166468; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Borresen SW, 2017, EUR J ENDOCRINOL, V177, P287, DOI 10.1530/EJE-17-0251; Buckley L, 2018, NEW ENGL J MED, V379, P2547, DOI 10.1056/NEJMcp1800214; Buttgereit F, 2016, JAMA-J AM MED ASSOC, V315, P2442, DOI 10.1001/jama.2016.5444; Buttgereit F, 2013, ANN RHEUM DIS, V72, P204, DOI 10.1136/annrheumdis-2011-201067; Bykerk VP, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000225; Caporali R, 2015, NEUROIMMUNOMODULAT, V22, P104, DOI 10.1159/000362730; Choy E, 2019, RHEUMATOLOGY, V58, P1056, DOI 10.1093/rheumatology/key393; Dejaco C, 2015, ANN RHEUM DIS, V74, P1799, DOI 10.1136/annrheumdis-2015-207492; Dougados M, 2015, ARTHRIT CARE RES, V67, P1762, DOI 10.1002/acr.22633; Dougados M, 2013, ANN RHEUM DIS, V72, P43, DOI 10.1136/annrheumdis-2011-201282; Fortunet C, 2015, RHEUMATOLOGY, V54, P672, DOI 10.1093/rheumatology/keu339; Overman RA, 2013, ARTHRIT CARE RES, V65, P294, DOI 10.1002/acr.21796; Pazianas M, 2015, TRENDS ENDOCRIN MET, V26, P111, DOI 10.1016/j.tem.2015.01.004; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ribbens C, 2014, ANN RHEUM DIS, V73, P495, DOI 10.1136/annrheumdis-2014-eular.1992; Roubille C, 2017, ANN RHEUM DIS, V76, P1797, DOI 10.1136/annrheumdis-2016-210135; Saraux A, 2016, CLIN EXP RHEUMATOL, V34, P303; Schuetz P, 2015, EUR J ENDOCRINOL, V173, P19, DOI 10.1530/EJE-15-0182; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; van Staa TP, 2000, QJM-MON J ASSOC PHYS, V93, P105, DOI 10.1093/qjmed/93.2.105; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P249, DOI 10.1007/s00223-008-9124-7; Volkmann ER, 2013, J RHEUMATOL, V40, P1646, DOI 10.3899/jrheum.130019; Wilson JC, 2019, ARTHRIT CARE RES, V71, P498, DOI 10.1002/acr.23611; YAGIZ B, 2018, ARTHRITIS RHEUMAT S9, V70	33	40	40	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					267	276						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK8ZY	32711802				2022-12-28	WOS:000567020100017
J	Mateus, J; Grifoni, A; Tarke, A; Sidney, J; Ramirez, SI; Dan, JM; Burger, ZC; Rawlings, SA; Smith, DM; Phillips, E; Mallal, S; Lammers, M; Rubiro, P; Quiambao, L; Sutherland, A; Yu, EDW; Antunes, RD; Greenbaum, J; Frazier, A; Markmann, AJ; Premkumar, L; de Silva, A; Peters, B; Crotty, S; Sette, A; Weiskopf, D				Mateus, Jose; Grifoni, Alba; Tarke, Alison; Sidney, John; Ramirez, Sydney, I; Dan, Jennifer M.; Burger, Zoe C.; Rawlings, Stephen A.; Smith, Davey M.; Phillips, Elizabeth; Mallal, Simon; Lammers, Marshall; Rubiro, Paul; Quiambao, Lorenzo; Sutherland, Aaron; Yu, Esther Dawen; Antunes, Ricardo da Silva; Greenbaum, Jason; Frazier, April; Markmann, Alena J.; Premkumar, Lakshmanane; de Silva, Aravinda; Peters, Bjoern; Crotty, Shane; Sette, Alessandro; Weiskopf, Daniela			Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans	SCIENCE			English	Article							FOLLICULAR HELPER-CELLS; HUMAN CORONAVIRUSES; RECOGNITION	Many unknowns exist about human immune responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2-reactive CD4(+) T cells have been reported in unexposed individuals, suggesting preexisting cross-reactive T cell memory in 20 to 50% of people. However, the source of those T cells has been speculative. Using human blood samples derived before the SARS-CoV-2 virus was discovered in 2019, we mapped 142 T cell epitopes across the SARS-CoV-2 genome to facilitate precise interrogation of the SARS-CoV-2-specific CD4(+) T cell repertoire. We demonstrate a range of preexisting memory CD4(+) T cells that are cross-reactive with comparable affinity to SARS-CoV-2 and the common cold coronaviruses human coronavirus (HCoV)-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1. Thus, variegated T cell memory to coronaviruses that cause the common cold may underlie at least some of the extensive heterogeneity observed in coronavirus disease 2019 (COVID-19) disease.	[Mateus, Jose; Grifoni, Alba; Tarke, Alison; Sidney, John; Ramirez, Sydney, I; Dan, Jennifer M.; Lammers, Marshall; Rubiro, Paul; Quiambao, Lorenzo; Sutherland, Aaron; Yu, Esther Dawen; Antunes, Ricardo da Silva; Greenbaum, Jason; Frazier, April; Peters, Bjoern; Crotty, Shane; Sette, Alessandro; Weiskopf, Daniela] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA; [Phillips, Elizabeth; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA 6150, Australia; [Ramirez, Sydney, I; Dan, Jennifer M.; Burger, Zoe C.; Rawlings, Stephen A.; Smith, Davey M.; Peters, Bjoern; Crotty, Shane; Sette, Alessandro] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA; [Markmann, Alena J.] Univ N Carolina, Dept Med, Div Infect Dis, Sch Med, Chapel Hill, NC 27599 USA; [Premkumar, Lakshmanane; de Silva, Aravinda] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA	La Jolla Institute for Immunology; Murdoch University; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sette, A; Weiskopf, D (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA.; Sette, A (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA.	alex@lji.org; daniela@lji.org	Sette, Alessandro/AFO-8916-2022; Grifoni, Alba/AAS-7620-2021; Mallal, Simon Alexander/HDM-9561-2022; Rawlings, Stephen/ABA-6797-2020; Yu, Dawen/AAE-6444-2019	Grifoni, Alba/0000-0002-2209-5966; Mallal, Simon Alexander/0000-0002-7036-1309; Rawlings, Stephen/0000-0003-3637-1447; Yu, Dawen/0000-0002-3970-3753; Quiambao, Lorenzo/0000-0002-3684-8009; Burger, Zoe/0000-0002-6842-0760; Ramirez, Sydney/0000-0002-7166-5195; Markmann, Alena J./0000-0003-3656-9322; Dan, Jennifer/0000-0002-1672-0657; Tarke, Alison/0000-0002-2464-6549	National Institute of Health (NIH) (NIAID) [AI42742, AI135078]; National Institute of Health (NIH) (NIH) [75N9301900065, U19 AI118626]; UCSD (Infectious Diseases Division) [AI007036, AI007384]; John and Mary Tu Foundation	National Institute of Health (NIH) (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health (NIH) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD (Infectious Diseases Division); John and Mary Tu Foundation	This work was funded by the National Institutes of Health (NIH) (NIAID award no. AI42742 from the Cooperative Centers for Human Immunology to S.C. and A.S.; NIH contract no. 75N9301900065 to A.S. and D.W.; grant no. U19 AI118626 to A.S. and B.P.; NIAID K08 award no. AI135078 to J.M.D.); by the UCSD (T32 grant nos. AI007036 and AI007384 from the Infectious Diseases Division to S.I.R. and S.A.R.); and by the John and Mary Tu Foundation (D.M.S).	Alba Grifoni, 2020, BIORXIV PREPRINT, DOI [10.1101/2020.02.12.946087, DOI 10.1101/2020.02.12.946087]; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Antunes RDS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169086; Arlehamn CSL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005760; Bancroft T, 2016, CELL IMMUNOL, V304, P35, DOI 10.1016/j.cellimm.2016.05.002; Braun J., 2020, PRESENCE SARS COV 2, DOI [DOI 10.1101/2020.04.17.20061440, 10.1101/2020.04.17.20061440]; Pro SC, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/763461; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; -Cervantes L. Kuri, 2020, 2020051841011 BIORXI; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, J VIROL, V94, DOI 10.1128/JVI.00089-20; Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309; Havenar-Daughton C, 2016, J IMMUNOL, V197, P994, DOI 10.4049/jimmunol.1600320; HENSEN EJ, 1979, NATURE, V277, P223, DOI 10.1038/277223a0; Hinz D, 2016, CLIN EXP ALLERGY, V46, P705, DOI 10.1111/cea.12692; Hinz D, 2015, CLIN EXP ALLERGY, V45, P1601, DOI 10.1111/cea.12507; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kadkhoda K, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00344-20; Killerby ME, 2018, J CLIN VIROL, V101, P52, DOI 10.1016/j.jcv.2018.01.019; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kuri-Cervantes L., 2020, BIORXIV; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Meckiff Benjamin J, 2020, SSRN, P3641939, DOI [10.1101/2020.06.12.148916, 10.2139/ssrn.3641939]; Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006; Nickbakhsh S, 2020, J INFECT DIS, DOI [10.1093/infdis/jiaa185, DOI 10.1093/INFDIS/JIAA185]; Nickbakhsh S, 2020, J INFECT DIS, V222, P17, DOI 10.1093/infdis/jiaa185; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Peng Y., 2020, BIORXIV; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Rodriguez L, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100078; Sallusto F, 2000, CURR TOP MICROBIOL, V251, P167; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008; Voic H., 2020, BIORXIV, DOI [10.1101/2020.07.29.227082, DOI 10.1101/2020.07.29.227082]; Walsh EE, 2013, J INFECT DIS, V208, P1634, DOI 10.1093/infdis/jit393; Wec A. Z., 2020, SCIENCE; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309; Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289; Wen A. Z., 2020, SCIENCE; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269	50	523	531	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2020	370	6512			SI		89	+		10.1126/science.abd3871	http://dx.doi.org/10.1126/science.abd3871			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OC5AM	32753554	Green Published			2022-12-28	WOS:000579169000049
J	Arunachalam, PS; Wimmers, F; Mok, CKP; Perera, RAPM; Scott, M; Hagan, T; Sigal, N; Feng, YP; Bristow, L; Tsang, OTY; Wagh, D; Coller, J; Pellegrini, KL; Kazmin, D; Alaaeddine, G; Leung, WS; Chan, JMC; Chik, TSH; Choi, CYC; Huerta, C; McCullough, MP; Lv, HB; Anderson, E; Edupuganti, S; Upadhyay, AA; Bosinger, SE; Maecker, HT; Khatri, P; Rouphael, N; Peiris, M; Pulendran, B				Arunachalam, Prabhu S.; Wimmers, Florian; Mok, Chris Ka Pun; Perera, Ranawaka A. P. M.; Scott, Madeleine; Hagan, Thomas; Sigal, Natalia; Feng, Yupeng; Bristow, Laurel; Tsang, Owen Tak-Yin; Wagh, Dhananjay; Coller, John; Pellegrini, Kathryn L.; Kazmin, Dmitri; Alaaeddine, Ghina; Leung, Wai Shing; Chan, Jacky Man Chun; Chik, Thomas Shiu Hong; Choi, Chris Yau Chung; Huerta, Christopher; McCullough, Michele Paine; Lv, Huibin; Anderson, Evan; Edupuganti, Srilatha; Upadhyay, Amit A.; Bosinger, Steve E.; Maecker, Holden Terry; Khatri, Purvesh; Rouphael, Nadine; Peiris, Malik; Pulendran, Bali			Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans	SCIENCE			English	Article							I INTERFERON; SEPSIS; CYTOKINE; RECEPTOR; DISEASE	Coronavirus disease 2019 (COVID-19) represents a global crisis, yet major knowledge gaps remain about human immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We analyzed immune responses in 76 COVID-19 patients and 69 healthy individuals from Hong Kong and Atlanta, Georgia, United States. In the peripheral blood mononuclear cells (PBMCs) of COVID-19 patients, we observed reduced expression of human leukocyte antigen class DR (HLA-DR) and proinflammatory cytokines by myeloid cells as well as impaired mammalian target of rapamycin (mTOR) signaling and interferon-alpha (IFN-alpha) production by plasmacytoid dendritic cells. By contrast, we detected enhanced plasma levels of inflammatory mediators-including EN-RAGE, TNFSF14, and oncostatin M-which correlated with disease severity and increased bacterial products in plasma. Single-cell transcriptomics revealed a lack of type I IFNs, reduced HLA-DR in the myeloid cells of patients with severe COVID-19, and transient expression of IFN-stimulated genes. This was consistent with bulk PBMC transcriptomics and transient, low IFN-alpha levels in plasma during infection. These results reveal mechanisms and potential therapeutic targets for COVID-19.	[Arunachalam, Prabhu S.; Wimmers, Florian; Scott, Madeleine; Hagan, Thomas; Sigal, Natalia; Feng, Yupeng; Kazmin, Dmitri; Maecker, Holden Terry; Khatri, Purvesh; Pulendran, Bali] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA; [Mok, Chris Ka Pun; Lv, Huibin; Peiris, Malik] Univ Hong Kong HKU, HKU Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China; [Perera, Ranawaka A. P. M.; Peiris, Malik] HKU, Ctr Influenza Res, Sch Publ Hlth, HKU Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Scott, Madeleine; Khatri, Purvesh] Stanford Univ, Ctr Biomed Informat, Dept Med, Sch Med, Stanford, CA 94305 USA; [Bristow, Laurel; Alaaeddine, Ghina; Huerta, Christopher; McCullough, Michele Paine; Edupuganti, Srilatha; Rouphael, Nadine] Emory Univ, Hope Clin Emory Vaccine Ctr, Dept Med, Div Infect Dis,Sch Med, Decatur, GA 30030 USA; [Tsang, Owen Tak-Yin; Leung, Wai Shing; Chan, Jacky Man Chun; Chik, Thomas Shiu Hong; Choi, Chris Yau Chung] Hosp Author Hong Kong, Princess Margaret Hosp, Infect Dis Ctr, Hong Kong, Peoples R China; [Wagh, Dhananjay; Coller, John] Stanford Univ, Sch Med, Stanford Funct Genom Facil, Stanford, CA 94305 USA; [Pellegrini, Kathryn L.; Upadhyay, Amit A.; Bosinger, Steve E.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Anderson, Evan] Emory Univ, Dept Pediat, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA; [Bosinger, Steve E.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30329 USA; [Pulendran, Bali] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Pulendran, Bali] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; University of Hong Kong; University of Hong Kong; Stanford University; Emory University; Stanford University; Emory University; Emory University; Emory University; Stanford University; Stanford University	Pulendran, B (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	bpulend@stanford.edu	Upadhyay, Amit/R-5056-2019; Perera, Dr. Ranawaka A.P.M Perera/N-8263-2015; Mok, Chris Ka Pun/ABD-2667-2021; Alaaeddine, Ghina/HHN-7143-2022; Pulendran, Bali/AAW-9550-2021	Upadhyay, Amit/0000-0002-0952-4164; Perera, Dr. Ranawaka A.P.M Perera/0000-0003-3936-1535; Bristow, Laurel/0000-0001-9050-0057; S ARUNACHALAM, PRABHU/0000-0003-0090-5689; Lv, Huibin/0000-0003-2218-0076; Pulendran, Bali/0000-0001-6517-4333; Khatri, Purvesh/0000-0002-4143-4708	NIH [S10 OD 026799, HIPC U19AI090023, U19AI057266, U24AI120134, P51 OD 011132]; Sean Parker Cancer Institute; Soffer endowment; Violetta Horton endowment; Calmette and Yersin scholarship from the Pasteur International Network Association; National Natural Science Foundation of China (NSFC)-Research Grants Council (RGC) Joint Research Scheme [N_HKU737/18]; Guangzhou Medical University High-level University Innovation Team Training Program [Guangzhou Medical University] [159]; U.S. NIH [HHSN272201400006C]; RGC of the Hong Kong Special Administrative Region, China [T11-712/19-N]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sean Parker Cancer Institute; Soffer endowment; Violetta Horton endowment; Calmette and Yersin scholarship from the Pasteur International Network Association; National Natural Science Foundation of China (NSFC)-Research Grants Council (RGC) Joint Research Scheme; Guangzhou Medical University High-level University Innovation Team Training Program [Guangzhou Medical University]; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RGC of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This work was supported by NIH grants HIPC U19AI090023 (to B.P.), U19AI057266 (to B.P. and principal investigator R. Ahmed from Emory University), and U24AI120134 (to S.E.B.); the Sean Parker Cancer Institute; the Soffer endowment (to B.P.); the Violetta Horton endowment (to B.P.); a Calmette and Yersin scholarship from the Pasteur International Network Association (to H.L.); the National Natural Science Foundation of China (NSFC)-Research Grants Council (RGC) Joint Research Scheme (N_HKU737/18) (to C.K.P.M. and M.P.); the Guangzhou Medical University High-level University Innovation Team Training Program [Guangzhou Medical University released (2017) no. 159] (to C.K.P.M. and M.P.); the U.S. NIH (contract no. HHSN272201400006C) (to M.P.); and the RGC of the Hong Kong Special Administrative Region, China (project no. T11-712/19-N) (to M.P.). Next-generation sequencing services were provided by the Yerkes NHP Genomics Core, which is supported in part by NIH P51 OD 011132, and the data were acquired on a NovaSeq 6000 funded by NIH S10 OD 026799.	Anhe FF, 2020, NAT METAB, V2, P233, DOI 10.1038/s42255-020-0178-9; Arif A, 2019, MOL CELL, V73, P446, DOI 10.1016/j.molcel.2018.11.017; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; da Silva Antunes R, 2018, FRONT IMMUNOL, V9, P576, DOI DOI 10.3389/fimmu.2018.00576; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dunning J, 2018, NAT IMMUNOL, V19, P625, DOI 10.1038/s41590-018-0111-5; Fernandez Rosemary, 2015, Bio Protoc, V5; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Li J., 2009, BATCH EFFECTS NOISE, P141; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mudd P. A., 2020, TARGETED IMMUNOSUPPR, DOI [10.1101/2020.05.28.20115667, DOI 10.1101/2020.05.28.20115667.]; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Oczypok EA, 2017, PAEDIATR RESPIR REV, V23, P40, DOI 10.1016/j.prrv.2017.03.012; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Pena OM, 2014, EBIOMEDICINE, V1, P64, DOI 10.1016/j.ebiom.2014.10.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Watanabe N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202049; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang ZN, 2020, MOL IMMUNOL, V122, P38, DOI 10.1016/j.molimm.2020.03.022; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	43	516	517	22	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2020	369	6508			SI		1210	+		10.1126/science.abc6261	http://dx.doi.org/10.1126/science.abc6261			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NL6LT	32788292	Green Published			2022-12-28	WOS:000567525400047
J	Clairfeuille, T; Buchholz, KR; Li, QL; Verschueren, E; Liu, P; Sangaraju, D; Park, S; Noland, CL; Storek, KM; Nickerson, NN; Martin, L; Dela Vega, T; Miu, A; Reeder, J; Ruiz-Gonzalez, M; Swem, D; Han, GH; DePonte, DP; Hunter, MS; Gati, C; Shahidi-Latham, S; Xu, M; Skelton, N; Sellers, BD; Skippington, E; Sandoval, W; Hanan, EJ; Payandeh, J; Rutherford, ST				Clairfeuille, Thomas; Buchholz, Kerry R.; Li, Qingling; Verschueren, Erik; Liu, Peter; Sangaraju, Dewakar; Park, Summer; Noland, Cameron L.; Storek, Kelly M.; Nickerson, Nicholas N.; Martin, Lynn; Dela Vega, Trisha; Anh Miu; Reeder, Janina; Ruiz-Gonzalez, Maria; Swem, Danielle; Han, Guanghui; DePonte, Daniel P.; Hunter, Mark S.; Gati, Cornelius; Shahidi-Latham, Sheerin; Xu, Min; Skelton, Nicholas; Sellers, Benjamin D.; Skippington, Elizabeth; Sandoval, Wendy; Hanan, Emily J.; Payandeh, Jian; Rutherford, Steven T.			Structure of the essential inner membrane lipopolysaccharide-PbgA complex	NATURE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; MUTANT LH530; BIOSYNTHESIS; BINDING; TRANSFERASE; RECOGNITION; MECHANISMS	Lipopolysaccharide (LPS) resides in the outer membrane of Gram-negative bacteria where it is responsible for barrier function(1,2). LPS can cause death as a result of septic shock, and its lipid A core is the target of polymyxin antibiotics(3,4). Despite the clinical importance of polymyxins and the emergence of multidrug resistant strains(5), our understanding of the bacterial factors that regulate LPS biogenesis is incomplete. Here we characterize the inner membrane protein PbgA and report that its depletion attenuates the virulence ofEscherichia coliby reducing levels of LPS and outer membrane integrity. In contrast to previous claims that PbgA functions as a cardiolipin transporter(6-9), our structural analyses and physiological studies identify a lipid A-binding motif along the periplasmic leaflet of the inner membrane. Synthetic PbgA-derived peptides selectively bind to LPS in vitro and inhibit the growth of diverse Gram-negative bacteria, including polymyxin-resistant strains. Proteomic, genetic and pharmacological experiments uncover a model in which direct periplasmic sensing of LPS by PbgA coordinates the biosynthesis of lipid A by regulating the stability of LpxC, a key cytoplasmic biosynthetic enzyme(10-12). In summary, we find that PbgA has an unexpected but essential role in the regulation of LPS biogenesis, presents a new structural basis for the selective recognition of lipids, and provides opportunities for future antibiotic discovery. Structural and physiological studies show that the inner membrane protein PbgA is a crucial sensor of lipopolysaccharide (LPS) and regulates the activity of the LPS biosynthesis enzyme LpxC.	[Clairfeuille, Thomas; Noland, Cameron L.; Payandeh, Jian] Genentech Inc, Struct Biol, San Francisco, CA 94080 USA; [Buchholz, Kerry R.; Storek, Kelly M.; Nickerson, Nicholas N.; Swem, Danielle; Payandeh, Jian; Rutherford, Steven T.] Genentech Inc, Infect Dis, San Francisco, CA 94080 USA; [Li, Qingling; Verschueren, Erik; Liu, Peter; Han, Guanghui; Sandoval, Wendy] Genentech Inc, Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Sangaraju, Dewakar; Shahidi-Latham, Sheerin] Genentech Inc, Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Park, Summer; Xu, Min] Genentech Inc, Translat Immunol, San Francisco, CA 94080 USA; [Martin, Lynn; Dela Vega, Trisha] Genentech Inc, BioMol Resources, San Francisco, CA 94080 USA; [Anh Miu] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Reeder, Janina; Skippington, Elizabeth] Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Ruiz-Gonzalez, Maria; Skelton, Nicholas; Sellers, Benjamin D.; Hanan, Emily J.] Genentech Inc, Discovery Chem Dept, San Francisco, CA 94080 USA; [DePonte, Daniel P.; Hunter, Mark S.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA USA; [Gati, Cornelius] SLAC Natl Accelerator Lab, Biosci Div, Menlo Pk, CA USA; [Gati, Cornelius] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University	Payandeh, J (corresponding author), Genentech Inc, Struct Biol, San Francisco, CA 94080 USA.; Payandeh, J; Rutherford, ST (corresponding author), Genentech Inc, Infect Dis, San Francisco, CA 94080 USA.; Hanan, EJ (corresponding author), Genentech Inc, Discovery Chem Dept, San Francisco, CA 94080 USA.	hanan.emily@gene.com; payandeh.jian@gene.com; rutherford.steven@gene.com	Han, Guanghui/N-8573-2013	Han, Guanghui/0000-0002-9893-9168; Storek, Kelly/0000-0002-2289-0214; Buchholz, Kerry/0000-0001-9419-0076	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; SLAC National Accelerator Laboratory; Stanford University through a Panofsky Fellowship	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); SLAC National Accelerator Laboratory(Stanford UniversityUnited States Department of Energy (DOE)); Stanford University through a Panofsky Fellowship	We thank our Genentech colleagues for their support, in particular, A. Song, I. Kekessie, J. Toms, E. Hecht, C. Peng, A. Liu, P. Smith, A. Estevez, C. Ciferri, H. Ho, E. Castellanos, A. K. Katakam, I. Zilberleyb, M. Reichelt, M.-W. Tan, J. Kiefer, Y. Franke, C. Koth, E. Brown and S. Hymowitz. We thank D. Cawley for antibody generation and Smartox Biotechnology for peptide synthesis. Use of the Linac Coherent Light Source (LCLS) and the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, are supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. C.G. appreciates support from the SLAC National Accelerator Laboratory and Stanford University through a Panofsky Fellowship. All reagents are available under a materials transfer agreement with Genentech.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander MK, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01142-18, 10.1128/aac.01142-18]; Anandan A, 2017, P NATL ACAD SCI USA, V114, P2218, DOI 10.1073/pnas.1612927114; [Anonymous], PYMOL MOL GRAPHICS S; [Anonymous], 2017, SCHRODINGER RELEASE; Arunmanee W, 2016, P NATL ACAD SCI USA, V113, pE5034, DOI 10.1073/pnas.1602382113; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cian M, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00758-19; Dalebroux ZD, 2015, CELL HOST MICROBE, V17, P441, DOI 10.1016/j.chom.2015.03.003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay NR, 2008, GENETICS, V178, P1327, DOI 10.1534/genetics.107.081836; DIEDERICH L, 1992, PLASMID, V28, P14, DOI 10.1016/0147-619X(92)90032-6; Dong H, 2016, SCI REP, V6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JP, 2020, MBIO, V11, DOI 10.1128/mBio.03277-19; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fivenson EM, 2020, MBIO, V11, DOI 10.1128/mBio.00939-20; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Gabale U., 2020, NEW FUNCTIONAL IDENT, DOI [10.1101/2020.02.13.947838v1, DOI 10.1101/2020.02.13.947838V1]; Guest RL, 2020, MBIO, V11, DOI 10.1128/mBio.00598-20; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Hankins Jessica V, 2013, Methods Mol Biol, V966, P239, DOI 10.1007/978-1-62703-245-2_15; Hirvas L, 1997, MICROBIOL-UK, V143, P73, DOI 10.1099/00221287-143-1-73; Ho H, 2018, NATURE, V557, P196, DOI 10.1038/s41586-018-0083-5; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2014, J BIOL CHEM, V289, P14829, DOI 10.1074/jbc.M113.539494; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li YY, 2019, NATURE, V567, P486, DOI 10.1038/s41586-019-1025-6; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Ma G, 2016, SCI REP, V6; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi W, 2017, NATURE, V549, P233, DOI 10.1038/nature23649; Mohammad MM, 2011, J BIOL CHEM, V286, P8000, DOI 10.1074/jbc.M110.197723; Nguyen D, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00303-20; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; Noland CL, 2017, P NATL ACAD SCI USA, V114, pE6044, DOI 10.1073/pnas.1707813114; Nurminen M, 1997, MICROBIOL-UK, V143, P1533, DOI 10.1099/00221287-143-5-1533; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens TW, 2019, NATURE, V567, P550, DOI 10.1038/s41586-019-1039-0; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Qiu N, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00340-19; Rossi RM, 2017, MBIO, V8, DOI 10.1128/mBio.01199-17; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Shrivastava R, 2019, J BIOL CHEM, V294, P14175, DOI 10.1074/jbc.AW119.008139; Sorensen PG, 1996, J BIOL CHEM, V271, P25898, DOI 10.1074/jbc.271.42.25898; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; White TA, 2016, J APPL CRYSTALLOGR, V49, P680, DOI 10.1107/S1600576716004751; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yoshimura M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-69	75	36	36	3	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					479	+		10.1038/s41586-020-2597-x	http://dx.doi.org/10.1038/s41586-020-2597-x		AUG 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32788728	Green Submitted			2022-12-28	WOS:000559369600001
J	Guo, XJ; Yu, QQ; Chen, DF; Wei, JN; Yang, PC; Yu, J; Wang, XH; Kang, L				Guo, Xiaojiao; Yu, Qiaoqiao; Chen, Dafeng; Wei, Jianing; Yang, Pengcheng; Yu, Jia; Wang, Xianhui; Kang, Le			4-Vinylanisole is an aggregation pheromone in locusts	NATURE			English	Article							SCHISTOCERCA-GREGARIA ORTHOPTERA; ODORANT RECEPTOR; DESERT LOCUST; MIGRATORIA; VOLATILES; SENSILLA; REVEAL; FAMILY	Locust plagues threaten agricultural and environmental safety throughout the world(1,2). Aggregation pheromones have a crucial role in the transition of locusts from a solitary form to the devastating gregarious form and the formation of large-scale swarms(3,4). However, none of the candidate compounds reported(5-7)meet all the criteria for a locust aggregation pheromone. Here, using behavioural assays, electrophysiological recording, olfactory receptor characterization and field experiments, we demonstrate that 4-vinylanisole (4VA) (also known as 4-methoxystyrene) is an aggregation pheromone of the migratory locust (Locusta migratoria). Both gregarious and solitary locusts are strongly attracted to 4VA, regardless of age and sex. Although it is emitted specifically by gregarious locusts, 4VA production can be triggered by aggregation of four to five solitary locusts. It elicits responses specifically from basiconic sensilla on locust antennae. We also identified OR35 as a specific olfactory receptor of 4VA. Knockout of OR35 using CRISPR-Cas9 markedly reduced the electrophysiological responses of the antennae and impaired 4VA behavioural attractiveness. Finally, field trapping experiments verified the attractiveness of 4VA to experimental and wild populations. These findings identify a locust aggregation pheromone and provide insights for the development of novel control strategies for locusts. 4-Vinylanisole, which is emitted by gregarious locusts or as a result of aggregation of solitary locusts, is identified as an aggregation pheromone that strongly attracts both solitary and gregarious locusts, acting via the olfactory receptor OR35.	[Guo, Xiaojiao; Yu, Qiaoqiao; Chen, Dafeng; Wei, Jianing; Yu, Jia; Wang, Xianhui; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Guo, Xiaojiao; Yu, Qiaoqiao; Wang, Xianhui; Kang, Le] Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing, Peoples R China; [Yang, Pengcheng; Kang, Le] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Kang, Le] Hebei Univ, Coll Life Sci, Baoding, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Hebei University	Wang, XH; Kang, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.; Wang, XH; Kang, L (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing, Peoples R China.; Kang, L (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China.; Kang, L (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Peoples R China.	wangxh@ioz.ac.cn; lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Yang, Pengcheng/N-1037-2014	Kang, Le/0000-0003-4262-2329; Yang, Pengcheng/0000-0001-5496-8357; Wei, Jianing/0000-0002-8517-2164	National Natural Science Foundation of China [31920103004, 31872303, 31930012]; Chinese Academy of Sciences [152111KYSB20180036, QYZDY-SSW-SMC009, XDB11010200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank C. Z. Wang for his technical assistance on olfactory receptor identification; X. H. Li for assistance on analysing the field data; J. Yang for assistance on graphic presentation using R platform; F. C. Tang for sharing Software Origin and SPSS. We thank North Dagang Waterland Reserve for field trapping experiments. This research is supported by the National Natural Science Foundation of China (grant nos. 31920103004, 31872303 and 31930012) and grants from Chinese Academy of Sciences (nos. 152111KYSB20180036, QYZDY-SSW-SMC009 and XDB11010200).	de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; FUZEAUBRAESCH S, 1988, J CHEM ECOL, V14, P1023, DOI 10.1007/BF01018790; Guo XJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03437-z; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hassanali A, 2005, ANNU REV ENTOMOL, V50, P223, DOI 10.1146/annurev.ento.50.071803.130345; Ignell R, 2001, BRAIN BEHAV EVOLUT, V57, P1, DOI 10.1159/000047222; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Milet-Pinheiro P, 2017, FLORA, V231, P1, DOI 10.1016/j.flora.2017.03.006; Niassy A, 1999, J CHEM ECOL, V25, P1029, DOI 10.1023/A:1020873623852; NOLTE DJ, 1973, J INSECT PHYSIOL, V19, P1547, DOI 10.1016/0022-1910(73)90084-X; OBENGOFORI D, 1994, J CHEM ECOL, V20, P2077, DOI 10.1007/BF02066244; Ochieng SA, 1998, CELL TISSUE RES, V291, P525, DOI 10.1007/s004410051022; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Pregitzer P, 2017, INT J BIOL SCI, V13, P911, DOI 10.7150/ijbs.18402; Song Hojun, 2005, Journal of Orthoptera Research, V14, P235, DOI 10.1665/1082-6467(2005)14[235:PPOTEO]2.0.CO;2; Stige LC, 2007, P NATL ACAD SCI USA, V104, P16188, DOI 10.1073/pnas.0706813104; Tong XW, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008675; Uvarov BP., 1966, GRASSHOPPERS LOCUSTS, V1; Wang QB, 2006, FOOD CHEM, V98, P52, DOI 10.1016/j.foodchem.2005.04.033; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang XH, 2014, ANNU REV ENTOMOL, V59, P225, DOI 10.1146/annurev-ento-011613-162019; Wang YD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003102; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; Wei JN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5495; Wei JN, 2017, INSECT SCI, V24, P60, DOI 10.1111/1744-7917.12396; You YW, 2016, INSECT BIOCHEM MOLEC, V79, P66, DOI 10.1016/j.ibmb.2016.10.008; Zhang L, 2019, ANNU REV ENTOMOL, V64, P15, DOI 10.1146/annurev-ento-011118-112500	29	50	64	79	348	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					584	+		10.1038/s41586-020-2610-4	http://dx.doi.org/10.1038/s41586-020-2610-4		AUG 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF2RN	32788724				2022-12-28	WOS:000559369600002
J	Rimmer, A				Rimmer, Abi			Overseas doctors stranded by cancelled exams can stay in UK without extra visa costs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Home Office, 2020, COR COVID 19 ADV UK; Rimmer A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2576	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3177	10.1136/bmj.m3177	http://dx.doi.org/10.1136/bmj.m3177			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784202				2022-12-28	WOS:000560307500001
J	McCann, MC				McCann, Maureen C.			Chimeric plants-the best of both worlds	SCIENCE			English	Editorial Material									[McCann, Maureen C.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	McCann, MC (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.							Carpita N. C., 2015, BIOCH MOL BIOL PLANT; Haroldsen VM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00039; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Melnyk CW, 2017, REGENERATION, V4, P3, DOI 10.1002/reg2.71; Notaguchi M, 2020, SCIENCE, V369, P698, DOI 10.1126/science.abc3710; Scheiner SM, 2020, EVOL APPL, V13, P388, DOI 10.1111/eva.12876; Song GQ, 2015, J AM SOC HORTIC SCI, V140, P203, DOI 10.21273/JASHS.140.3.203; Thompson & Morgan, 2 IN 1 CROPP VEG; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114	9	5	6	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					618	619		10.1126/science.abd1641	http://dx.doi.org/10.1126/science.abd1641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764051				2022-12-28	WOS:000559184400020
J	Winn, RT; Leech, S				Winn, Remus T.; Leech, Suzy			Acute onset rash in a limited distribution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Winn, Remus T.; Leech, Suzy] Royal Victoria Infirm, Dermatol Dept, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Winn, RT (corresponding author), Royal Victoria Infirm, Dermatol Dept, Newcastle Upon Tyne, Tyne & Wear, England.	Remuswinn@googlemail.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m2626	10.1136/bmj.m2626	http://dx.doi.org/10.1136/bmj.m2626			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NZ0NS	32763923				2022-12-28	WOS:000576789200001
J	Rimmer, A				Rimmer, Abi			Government to get CQC-style ratings for its performance on health and social care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m3090	10.1136/bmj.m3090	http://dx.doi.org/10.1136/bmj.m3090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759282				2022-12-28	WOS:000556139400008
J	Lapinaite, A; Knott, GJ; Palumbo, CM; Lin-Shiao, E; Richter, MF; Zhao, KT; Beal, PA; Liu, DR; Doudna, JA				Lapinaite, Audrone; Knott, Gavin J.; Palumbo, Cody M.; Lin-Shiao, Enrique; Richter, Michelle F.; Zhao, Kevin T.; Beal, Peter A.; Liu, David R.; Doudna, Jennifer A.			DNA capture by a CRISPR-Cas9-guided adenine base editor	SCIENCE			English	Article							ADENOSINE-DEAMINASE; CRYO-EM; GENOMIC DNA; RNA; ENDONUCLEASE; TARGET; TADA; COMPLEX	CRISPR-Cas-guided base editors convert A center dot T to G center dot C, or C center dot G to T center dot A, in cellular DNA for precision genome editing. To understand the molecular basis for DNA adenosine deamination by adenine base editors (ABEs), we determined a 3.2-angstrom resolution cryo-electron microscopy structure of ABE8e in a substrate-bound state in which the deaminase domain engages DNA exposed within the CRISPR-Cas9 R-loop complex. Kinetic and structural data suggest that ABE8e catalyzes DNA deamination up to similar to 1100-fold faster than earlier ABEs because of mutations that stabilize DNA substrates in a constrained, transfer RNA-like conformation. Furthermore, ABE8e's accelerated DNA deamination suggests a previously unobserved transient DNA melting that may occur during double-stranded DNA surveillance by CRISPR-Cas9. These results explain ABE8e-mediated base-editing outcomes and inform the future design of base editors.	[Lapinaite, Audrone; Knott, Gavin J.; Lin-Shiao, Enrique; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Knott, Gavin J.] Monash Univ, Dept Biochem & Mol Biol, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Palumbo, Cody M.; Beal, Peter A.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Richter, Michelle F.; Zhao, Kevin T.; Liu, David R.] Broad Inst Harvard & MIT, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02141 USA; [Richter, Michelle F.; Zhao, Kevin T.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Richter, Michelle F.; Zhao, Kevin T.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Gladstone Inst, Gladstone Inst Data Sci & Biotechnol, San Francisco, CA 94158 USA; [Lapinaite, Audrone] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85281 USA	University of California System; University of California Berkeley; Monash University; University of California System; University of California Davis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; Arizona State University; Arizona State University-Tempe	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Gladstone Inst, Gladstone Inst Data Sci & Biotechnol, San Francisco, CA 94158 USA.	doudna@berkeley.edu	Liu, David R./HCH-3132-2022	Knott, Gavin J./0000-0002-9007-6273; Zhao, Kevin/0000-0003-3440-2094; Palumbo, Cody/0000-0002-2083-0517; Lin Shiao, Enrique/0000-0001-5396-9614; Lapinaite, Audrone/0000-0002-9427-9342	Centers for Excellence in Genomic Science of the National Institutes of Health [RM1HG009490]; Office of the Director, National Institutes of Health (OD) [U01AI142817-02]; William M. Keck Foundation; National Multiple Sclerosis Society; Paul Allen Frontiers Group; Howard Hughes Medical Institute; National Science Foundation [1817593]; NHMRC [1175568]; American Australian Association; Paul G. Allen Frontiers Group; NIH [R01GM061115, T32GM113770, U01 AI142756, RM1 HG009490, R01 EB022376, R35 GM118062]; St. Jude Collaborative Research Consortium; Bill and Melinda Gates Foundation; HHMI; Harvard Chemical Biology Training Grant [T32 GM095450]	Centers for Excellence in Genomic Science of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William M. Keck Foundation(W.M. Keck Foundation); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Paul Allen Frontiers Group; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); American Australian Association; Paul G. Allen Frontiers Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Jude Collaborative Research Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); HHMI(Howard Hughes Medical Institute); Harvard Chemical Biology Training Grant	Research reported in this publication was supported by the Centers for Excellence in Genomic Science of the National Institutes of Health under award no. RM1HG009490 and the Somatic Cell Genome Editing Program of the Office of the Director, National Institutes of Health (OD), under award no. U01AI142817-02. J.A.D. receives funding from the William M. Keck Foundation, the National Multiple Sclerosis Society, the Paul Allen Frontiers Group, and the Howard Hughes Medical Institute. This material is based upon work supported by the National Science Foundation under award no. 1817593. A.L. was supported by the Centers for Excellence in Genomic Science of the National Institutes of Health under award no. RM1HG009490. G.J.K. was supported by an NHMRC Investigator Grant (EL1, 1175568) and previously by an American Australian Association Fellowship. E.L.-S. was supported by the Paul G. Allen Frontiers Group. P.A.B. was supported by NIH grant no. R01GM061115. C.M.P. was supported by NIH Predoctoral Training Grant no. T32GM113770. D.R.L. was supported by NIH grant nos. U01 AI142756, RM1 HG009490, R01 EB022376, and R35 GM118062; the St. Jude Collaborative Research Consortium; the Bill and Melinda Gates Foundation; and the Howard Hughes Medical Institute. M.F.R. was supported by an HHMI Hanna Gray Fellowship. K.T.Z. was supported by Harvard Chemical Biology Training Grant no. T32 GM095450.	Adams P.D., 2012, INT TABLES CRYSTALLO, P539, DOI 10.1107/97809553602060000865; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Chen C., 2019, 754564 BIORXIV, DOI [10.1101/754564, DOI 10.1101/754564]; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaudelli NM, 2020, NAT BIOTECHNOL, V38, P892, DOI 10.1038/s41587-020-0491-6; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Grunewald J, 2019, NAT BIOTECHNOL, V37, P1041, DOI 10.1038/s41587-019-0236-6; Haudenschild BL, 2004, J AM CHEM SOC, V126, P11213, DOI 10.1021/ja0472073; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim J, 2006, BIOCHEMISTRY-US, V45, P6407, DOI 10.1021/bi0522394; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Levy JM, 2020, NAT BIOMED ENG, V4, P97, DOI 10.1038/s41551-019-0501-5; Liang PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07988-z; Liang PP, 2018, PROTEIN CELL, V9, P808, DOI 10.1007/s13238-018-0566-z; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Ma YW, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0047-9; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qin W, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0609-1; Rallapalli KL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2309; Rees HA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5717; Richter MF, 2020, NAT BIOTECHNOL, V38, P883, DOI 10.1038/s41587-020-0453-z; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Song CQ, 2020, NAT BIOMED ENG, V4, P125, DOI 10.1038/s41551-019-0357-8; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Veliz EA, 2003, J AM CHEM SOC, V125, P10867, DOI 10.1021/ja029742d; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Yang L, 2019, PROTEIN CELL, V10, P700, DOI 10.1007/s13238-019-0631-2; YAO M, 1994, J BIOL CHEM, V269, P16260; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	42	46	50	24	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					566	+		10.1126/science.abb1390	http://dx.doi.org/10.1126/science.abb1390			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732424	Green Accepted			2022-12-28	WOS:000556568100046
J	Molyneux, M				Molyneux, Malcolm			Ombudsman's report for 2019	LANCET			English	Editorial Material									[Molyneux, Malcolm] The Lancet, London EC2Y 5AS, England		Molyneux, M (corresponding author), The Lancet, London EC2Y 5AS, England.	ombudsman@lancet.com						Molyneux M, 2017, LANCET, V389, P783, DOI 10.1016/S0140-6736(17)30400-2; Molyneux M, 2016, LANCET, V387, P210, DOI 10.1016/S0140-6736(16)00034-9	2	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					224	225						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711783				2022-12-28	WOS:000567020100010
J	[Anonymous]				[Anonymous]			Summary for Patients: Obesity and Risk for Adverse Outcomes Among Patients Diagnosed With COVID-19	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2020	173	10					I14	I14		10.7326/P20-0011	http://dx.doi.org/10.7326/P20-0011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OU5XD	32783683	Green Published			2022-12-28	WOS:000591600700002
J	Watanabe, R; Buschauer, R; Bohning, J; Audagnotto, M; Lasker, K; Lu, TW; Boassa, D; Taylor, S; Villa, E				Watanabe, Reika; Buschauer, Robert; Bohning, Jan; Audagnotto, Martina; Lasker, Keren; Lu, Tsan-Wen; Boassa, Daniela; Taylor, Susan; Villa, Elizabeth			The In Situ Structure of Parkinson's Disease-Linked LRRK2	CELL			English	Article							GTP-BINDING; KINASE-ACTIVITY; SWISS-MODEL; ROC DOMAIN; VISUALIZATION; REVEALS; ARCHITECTURE; INHIBITOR; MUTATIONS; VARIANT	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of familial Parkinson's disease. LRRK2 is a multi-domain protein containing a kinase and GTPase. Using correlative light and electron microscopy, in situ cryo-electron tomography, and subtomogram analysis, we reveal a 14-A degrees structure of LRRK2 bearing a pathogenic mutation that oligomerizes as a right-handed double helix around microtubules, which are left-handed. Using integrative modeling, we determine the architecture of LRRK2, showing that the GTPase and kinase are in close proximity, with the GTPase closer to the microtubule surface, whereas the kinase is exposed to the cytoplasm. We identify two oligomerization interfaces mediated by non-catalytic domains. Mutation of one of these abolishes LRRK2 microtubule-association. Our work demonstrates the power of cryo-electron tomography to generate models of previously unsolved structures in their cellular environment.	[Watanabe, Reika; Buschauer, Robert; Bohning, Jan; Audagnotto, Martina; Villa, Elizabeth] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lasker, Keren] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Lu, Tsan-Wen; Taylor, Susan] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Boassa, Daniela] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA; [Taylor, Susan] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Watanabe, Reika] La Jolla Inst Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA; [Buschauer, Robert] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Bohning, Jan] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Audagnotto, Martina] AstraZeneca, Med Chem Res & Early Dev, Resp & Immunol, BioPharmaceut R&D, S-43150 Molndal, Sweden	University of California System; University of California San Diego; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; La Jolla Institute for Immunology; University of Munich; University of Oxford; AstraZeneca	Villa, E (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	evilla@ucsd.edu	Villa, Elizabeth/D-1811-2010	Villa, Elizabeth/0000-0003-4677-9809; Boehning, Jan/0000-0002-6242-1041; Buschauer, Robert/0000-0002-5794-4841	NIH Director's New Innovator Award [1DP2GM123494-01]; Michael J. Fox Foundation [11425]; NIH NIGMS [R01GM086197]; Branfman Family Foundation; Visible Molecular Cell Consortium at UC San Diego; Taiwan MOE fellowship; National Science Foundation [ECCS-1542148]; NIH National Center for Microscopy and Imaging Research [P41GM103412]	NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Branfman Family Foundation; Visible Molecular Cell Consortium at UC San Diego; Taiwan MOE fellowship; National Science Foundation(National Science Foundation (NSF)); NIH National Center for Microscopy and Imaging Research	We thank Daniel Castano Diez and Paula Perez Navarro for assistance with Dynamo and Guillaume Castillon, Alexis Rohou, Junru Hu, and members of the Villa lab for stimulating discussions and technical support. This work was supported by an NIH Director's New Innovator Award (1DP2GM123494-01 to E.V.), a Michael J. Fox Foundation grant (11425 to E.V., S.T., and D.B.), an NIH NIGMS (R01GM086197) and a Branfman Family Foundation award (to D.B). M.A. was supported by a postdoctoral fellowship from the Visible Molecular Cell Consortium at UC San Diego. T.-W.L. is supported by a Taiwan MOE fellowship. We acknowledge the use of the UC San Diego cryo-Electron Microscopy Facility (partially supported by a gift from the Agouron Institute to UC San Diego) with special thanks to Tim Booth, the NIH National Center for Microscopy and Imaging Research (P41GM103412), and the San Diego Nanotechnology Infrastructure (SDNI) of UC San Diego, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the National Science Foundation (ECCS-1542148), with special thanks to Jeff Wu and Bernd Fruhberger.	Albert S, 2020, P NATL ACAD SCI USA, V117, P1069, DOI 10.1073/pnas.1905641117; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bepler T., 2020, BIORXIV, DOI DOI 10.1101/838920; Bharat T.A.M., 2019, CORRELATIVE IMAGING, P137; Bharat TAM, 2016, NAT PROTOC, V11, P9, DOI 10.1038/nprot.2016.124; Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Ramirez MB, 2017, HUM MOL GENET, V26, P2747, DOI 10.1093/hmg/ddx161; Bohning J, 2021, PROG BIOPHYS MOL BIO, V160, P97, DOI 10.1016/j.pbiomolbio.2020.05.010; Bouchet-Marquis C, 2007, BIOL CELL, V99, P45, DOI 10.1042/BC20060081; Buckley G, 2020, J STRUCT BIOL, V210, DOI 10.1016/j.jsb.2020.107488; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Chaaban S, 2017, MOL BIOL CELL, V28, P2924, DOI 10.1091/mbc.E16-05-0271; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Dahlberg PD, 2020, P NATL ACAD SCI USA, V117, P13937, DOI 10.1073/pnas.2001849117; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Deyaert E, 2019, BIOCHEM J, V476, P51, DOI 10.1042/BCJ20180803; Di Maio R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5429; Eguchi T, 2018, P NATL ACAD SCI USA, V115, pE9115, DOI 10.1073/pnas.1812196115; Eisenstein F, 2019, J STRUCT BIOL, V208, P107, DOI 10.1016/j.jsb.2019.08.006; Fell MJ, 2015, J PHARMACOL EXP THER, V355, P397, DOI 10.1124/jpet.115.227587; Flory P.J., 1953, MOL CELL PROTEOMICS, V9, P1666; Fung HC, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-47; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Gorelick S, 2019, ELIFE, V8, DOI 10.7554/eLife.45919; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guaitoli G, 2016, P NATL ACAD SCI USA, V113, pE4357, DOI 10.1073/pnas.1523708113; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x; Himes BA, 2018, NAT METHODS, V15, P955, DOI 10.1038/s41592-018-0167-z; Hoffman DP, 2020, SCIENCE, V367, P265, DOI 10.1126/science.aaz5357; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jasnin M, 2013, P NATL ACAD SCI USA, V110, P20521, DOI 10.1073/pnas.1320155110; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; Kovtun O, 2018, NATURE, V561, P561, DOI 10.1038/s41586-018-0526-z; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuba J, 2021, J MICROSC-OXFORD, V281, P112, DOI 10.1111/jmi.12939; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lasker K, 2009, J MOL BIOL, V388, P180, DOI 10.1016/j.jmb.2009.02.031; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Martinez-Sanchez A, 2020, NAT METHODS, V17, P209, DOI 10.1038/s41592-019-0675-5; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Moser F, 2019, P NATL ACAD SCI USA, V116, P4804, DOI 10.1073/pnas.1810690116; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rickgauer JP, 2017, ELIFE, V6, DOI 10.7554/eLife.25648; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roosen DA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0140-1; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Schaffer M, 2019, NAT METHODS, V16, P757, DOI 10.1038/s41592-019-0497-5; Schaffer M, 2017, J STRUCT BIOL, V197, P73, DOI 10.1016/j.jsb.2016.07.010; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt SH, 2019, P NATL ACAD SCI USA, V116, P14979, DOI 10.1073/pnas.1900289116; Scott JD, 2017, J MED CHEM, V60, P2983, DOI 10.1021/acs.jmedchem.7b00045; Sejwal K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09126-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song KK, 2020, NAT METHODS, V17, P201, DOI 10.1038/s41592-019-0651-0; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Tan EK, 2006, ANN ACAD MED SINGAP, V35, P840; Tegunov D., 2020, BIOCHEM SOC T, DOI 10.1101/2020.06.05.136341; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Toro-Nahuelpan M, 2020, NAT METHODS, V17, P50, DOI 10.1038/s41592-019-0630-5; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Wagner FR, 2020, NAT PROTOC, V15, P2041, DOI 10.1038/s41596-020-0320-x; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Williamson DS, 2017, J MED CHEM, V60, P8945, DOI 10.1021/acs.jmedchem.7b01186; Wu G, 2020, BIORXIV; Xu M, 2019, STRUCTURE, V27, P679, DOI 10.1016/j.str.2019.01.005; Zachs T, 2020, ELIFE, V9, DOI 10.7554/eLife.52286; Zens B., 2020, BIORXIV; Zhang PF, 2019, P NATL ACAD SCI USA, V116, P1579, DOI 10.1073/pnas.1817889116; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	86	74	75	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2020	182	6					1508	+		10.1016/j.cell.2020.08.004	http://dx.doi.org/10.1016/j.cell.2020.08.004			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NR3DQ	32783917	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000571443300014
J	Xia, SL; Duan, K; Zhang, YT; Zhao, DY; Zhang, HJ; Xie, ZQ; Li, XG; Peng, C; Zhang, YB; Zhang, W; Yang, YK; Chen, W; Gao, XX; You, WY; Wang, XW; Wang, ZJ; Shi, ZL; Wang, YX; Yang, XQ; Zhang, LH; Huang, LL; Wang, Q; Lu, J; Yang, YL; Guo, J; Zhou, W; Wan, X; Wu, C; Wang, WH; Huang, SH; Du, JH; Meng, ZY; Pan, A; Yuan, ZM; Shen, S; Guo, WS; Yang, XM				Xia, Shengli; Duan, Kai; Zhang, Yuntao; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Yanbo; Zhang, Wei; Yang, Yunkai; Chen, Wei; Gao, Xiaoxiao; You, Wangyang; Wang, Xuewei; Wang, Zejun; Shi, Zhengli; Wang, Yanxia; Yang, Xuqin; Zhang, Lianghao; Huang, Lili; Wang, Qian; Lu, Jia; Yang, Yongli; Guo, Jing; Zhou, Wei; Wan, Xin; Wu, Cong; Wang, Wenhui; Huang, Shihe; Du, Jianhui; Meng, Ziyan; Pan, An; Yuan, Zhiming; Shen, Shuo; Guo, Wanshen; Yang, Xiaoming			Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONAVIRUS; VIRUS	This interim analysis of 2 randomized trials compares adverse reactions and neutralizing antibody responses to inactivated coronavirus disease 2019 (COVID-19) vs adjuvant-only control vaccination, and compares the outcomes at varying vaccine doses among healthy adults in China. Question What are the safety and immunogenicity of an inactivated vaccine against coronavirus disease 2019 (COVID-19)? Findings This was an interim analysis of 2 randomized placebo-controlled trials. In 96 healthy adults in a phase 1 trial of patients randomized to aluminum hydroxide (alum) only and low, medium, and high vaccine doses on days 0, 28, and 56, 7-day adverse reactions occurred in 12.5%, 20.8%, 16.7%, and 25.0%, respectively; geometric mean titers of neutralizing antibodies at day 14 after the third injection were 316, 206 and 297 in the low-, medium-, and high-dose groups, respectively. In 224 healthy adults randomized to the medium dose, 7-day adverse reactions occurred in 6.0% and 14.3% of the participants who received injections on days 0 and 14 vs alum only, and 19.0% and 17.9% who received injections on days 0 and 21 vs alum only, respectively; geometric mean titers of neutralizing antibodies in the vaccine groups at day 14 after the second injection were 121 vs 247, respectively. Meaning This inactivated COVID-19 vaccine had a low rate of adverse reactions and demonstrated immunogenicity, but longer-term assessment of safety and efficacy will require phase 3 trials. Importance A vaccine against coronavirus disease 2019 (COVID-19) is urgently needed. Objective To evaluate the safety and immunogenicity of an investigational inactivated whole-virus COVID-19 vaccine in China. Interventions In the phase 1 trial, 96 participants were assigned to 1 of the 3 dose groups (2.5, 5, and 10 mu g/dose) and an aluminum hydroxide (alum) adjuvant-only group (n = 24 in each group), and received 3 intramuscular injections at days 0, 28, and 56. In the phase 2 trial, 224 adults were randomized to 5 mu g/dose in 2 schedule groups (injections on days 0 and 14 [n = 84] vs alum only [n = 28], and days 0 and 21 [n = 84] vs alum only [n = 28]). Design, Setting, and Participants Interim analysis of ongoing randomized, double-blind, placebo-controlled, phase 1 and 2 clinical trials to assess an inactivated COVID-19 vaccine. The trials were conducted in Henan Province, China, among 96 (phase 1) and 224 (phase 2) healthy adults aged between 18 and 59 years. Study enrollment began on April 12, 2020. The interim analysis was conducted on June 16, 2020, and updated on July 27, 2020. Main Outcomes and Measures The primary safety outcome was the combined adverse reactions 7 days after each injection, and the primary immunogenicity outcome was neutralizing antibody response 14 days after the whole-course vaccination, which was measured by a 50% plaque reduction neutralization test against live severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Results Among 320 patients who were randomized (mean age, 42.8 years; 200 women [62.5%]), all completed the trial up to 28 days after the whole-course vaccination. The 7-day adverse reactions occurred in 3 (12.5%), 5 (20.8%), 4 (16.7%), and 6 (25.0%) patients in the alum only, low-dose, medium-dose, and high-dose groups, respectively, in the phase 1 trial; and in 5 (6.0%) and 4 (14.3%) patients who received injections on days 0 and 14 for vaccine and alum only, and 16 (19.0%) and 5 (17.9%) patients who received injections on days 0 and 21 for vaccine and alum only, respectively, in the phase 2 trial. The most common adverse reaction was injection site pain, followed by fever, which were mild and self-limiting; no serious adverse reactions were noted. The geometric mean titers of neutralizing antibodies in the low-, medium-, and high-dose groups at day 14 after 3 injections were 316 (95% CI, 218-457), 206 (95% CI, 123-343), and 297 (95% CI, 208-424), respectively, in the phase 1 trial, and were 121 (95% CI, 95-154) and 247 (95% CI, 176-345) at day 14 after 2 injections in participants receiving vaccine on days 0 and 14 and on days 0 and 21, respectively, in the phase 2 trial. There were no detectable antibody responses in all alum-only groups. Conclusions and Relevance In this interim report of the phase 1 and phase 2 trials of an inactivated COVID-19 vaccine, patients had a low rate of adverse reactions and demonstrated immunogenicity; the study is ongoing. Efficacy and longer-term adverse event assessment will require phase 3 trials.	[Xia, Shengli; Zhao, Dongyang; Xie, Zhiqiang; Zhang, Wei; You, Wangyang; Wang, Yanxia; Huang, Lili; Guo, Wanshen] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Duan, Kai; Li, Xinguo; Chen, Wei; Wang, Zejun; Zhang, Lianghao; Lu, Jia; Guo, Jing; Zhou, Wei; Wan, Xin; Wu, Cong; Wang, Wenhui; Huang, Shihe; Du, Jianhui; Meng, Ziyan; Shen, Shuo; Yang, Xiaoming] Wuhan Inst Biol Prod Co Ltd, Natl Engn Technol Res Ctr Combined Vaccines, Wuhan, Hubei, Peoples R China; [Zhang, Yuntao; Yang, Yunkai; Wang, Xuewei; Yang, Xuqin; Wang, Qian; Yang, Xiaoming] China Natl Biotec Grp Co Ltd, 4 Hui Xin E St, Beijing, Peoples R China; [Zhang, Huajun; Peng, Cheng; Gao, Xiaoxiao; Shi, Zhengli; Yuan, Zhiming] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens, Ctr Biosafety Mega Sci, Wuhan, Hubei, Peoples R China; [Zhang, Yanbo; Pan, An] Huazhong Univ Sci & Technol, Key Lab Environm & Hlth, Dept Epidemiol & Biostat, Minist Educ, Wuhan, Hubei, Peoples R China; [Zhang, Yanbo; Pan, An] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Yang, Yongli] Zhengzhou Univ, Dept Epidemiol & Biostat, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Pan, An] Huazhong Univ Sci & Technol, Natl Med Ctr Major Publ Hlth Events, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Zhengzhou University; Huazhong University of Science & Technology	Pan, A (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, 13 Hangkong Rd, Wuhan, Peoples R China.; Yang, XM (corresponding author), China Natl Biotec Grp Co Ltd, 4 Hui Xin E St, Beijing, Peoples R China.	panan@hust.edu.cn; yangxiaoming@sinopharm.com	Pan, An/C-5572-2011	Pan, An/0000-0002-1089-7945; Zhang, Yan-Bo/0000-0003-1054-9657	National Program on Key Research Project of China [2020YFC0842100]; Major Science and Technology Project of the National New Drug Development of China [2018ZX09734-004]; China National Biotec Group Co Ltd; Wuhan Institute of Biological Products Co Ltd.	National Program on Key Research Project of China; Major Science and Technology Project of the National New Drug Development of China; China National Biotec Group Co Ltd; Wuhan Institute of Biological Products Co Ltd.	This study was supported by the National Program on Key Research Project of China (2020YFC0842100) and Major Science and Technology Project of the National New Drug Development of China (2018ZX09734-004). The vaccine was developed and the study was sponsored by the China National Biotec Group Co Ltd and the Wuhan Institute of Biological Products Co Ltd.	[Anonymous], 2020, NAT MED 0618; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Eroshenko N, 2020, NAT BIOTECHNOL, V38, P789, DOI 10.1038/s41587-020-0577-1; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Hotez PJ, 2020, NAT REV IMMUNOL, V20, P399, DOI 10.1038/s41577-020-0358-6; Hotez PJ, 2020, NAT REV IMMUNOL, V20, P347, DOI 10.1038/s41577-020-0323-4; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lin JT, 2007, ANTIVIR THER, V12, P1107; Liu T, 2020, PREVALENCE IGG ANTIB, DOI [DOI 10.1101/2020.06.13.20130252, 10.1101/2020.06.13.20130252]; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Mulligan MJ, 2020, PHASE 1 2 STUDY DESC, DOI [10.1038/s41586-020-2639-4, 10.1101/2020.06.30.20142570]; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Sahin U, 2020, CONCURRENT HUMAN ANT, DOI [10.1101/2020.07.17.20140533, DOI 10.1101/2020.07.17.20140533]; Stern PL, 2020, ANN ALLERG ASTHMA IM, V125, P17, DOI 10.1016/j.anai.2020.01.025; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Wang XT, 2020, CLIN INFECT DIS, V71, P844, DOI 10.1093/cid/ciaa200; WHO, DRAFT LANDSC COVID 1; World Health Organization, WHO COR DIS COVID 19; Wu F., 2020, NEUTRALIZING ANTIBOD, DOI [10.1101/2020.03.30.20047365, DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Zhao J, 2020, CLIN INFECT DIS, DOI 10.1101/2020.03.11.20031096; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	34	390	439	8	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					951	960		10.1001/jama.2020.15543	http://dx.doi.org/10.1001/jama.2020.15543			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32789505	Bronze, Green Published			2022-12-28	WOS:000571867000018
J	Abbasi, J				Abbasi, Jennifer			Regulatory T Cells Tested in Patients With COVID-19 ARDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					539	539		10.1001/jama.2020.13765	http://dx.doi.org/10.1001/jama.2020.13765			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780125	Bronze			2022-12-28	WOS:000562845100005
J	Bisseling, T; Geurts, R				Bisseling, Ton; Geurts, Rene			Specificity in legume nodule symbiosis	SCIENCE			English	Editorial Material							RECEPTOR		[Bisseling, Ton] Beijing Univ Agr, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing 102206, Peoples R China; [Bisseling, Ton; Geurts, Rene] Wageningen Univ, Cluster Plant Dev Biol, Lab Mol Biol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands	Beijing University of Agriculture; Wageningen University & Research	Bisseling, T (corresponding author), Beijing Univ Agr, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing 102206, Peoples R China.; Bisseling, T (corresponding author), Wageningen Univ, Cluster Plant Dev Biol, Lab Mol Biol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	ton.bisseling@vvur.nl; rene.geurts@wur.nl						Bozsoki Z, 2020, SCIENCE, V369, P663, DOI 10.1126/science.abb3377; Bozsoki Z, 2017, P NATL ACAD SCI USA, V114, pE8118, DOI 10.1073/pnas.1706795114; Cope KR, 2019, PLANT CELL, V31, P2386, DOI 10.1105/tpc.18.00676; De Mita S, 2014, NEW PHYTOL, V201, P961, DOI 10.1111/nph.12549; Feng F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12999-5; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gibelin-Viala C, 2019, NEW PHYTOL, V223, P1516, DOI 10.1111/nph.15891; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Remigi P, 2016, TRENDS MICROBIOL, V24, P63, DOI 10.1016/j.tim.2015.10.007; Rutten L, 2020, PLANT PHYSIOL, V184, P1004, DOI 10.1104/pp.19.01420; Nguyen TV, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3140-1; van Velzen R, 2019, TRENDS PLANT SCI, V24, P49, DOI 10.1016/j.tplants.2018.10.005; Zipfel C, 2017, NATURE, V543, P328, DOI 10.1038/nature22009	14	5	7	4	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					620	621		10.1126/science.abd3857	http://dx.doi.org/10.1126/science.abd3857			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764052				2022-12-28	WOS:000559184400021
J	Becker, HN; Alexander, JW; Atreya, SK; Bolton, SJ; Brennan, MJ; Brown, ST; Guillaume, A; Guillot, T; Ingersoll, AP; Levin, SM; Lunine, JI; Aglyamov, YS; Steffes, PG				Becker, Heidi N.; Alexander, James W.; Atreya, Sushil K.; Bolton, Scott J.; Brennan, Martin J.; Brown, Shannon T.; Guillaume, Alexandre; Guillot, Tristan; Ingersoll, Andrew P.; Levin, Steven M.; Lunine, Jonathan, I; Aglyamov, Yury S.; Steffes, Paul G.			Small lightning flashes from shallow electrical storms on Jupiter	NATURE			English	Article							MOIST CONVECTION; GALILEO IMAGES; ATMOSPHERE; PERFORMANCE; CLOUDS	Small lightning flashes detected on Jupiter by Juno have shallow origins above the 2-bar level of Jupiter's atmosphere where temperatures are too low for liquid water to exist. Lightning flashes have been observed by a number of missions that visited or flew by Jupiter over the past several decades. Imagery led to a flash rate estimate of about 4 x 10(-3)flashes per square kilometre per year (refs.(1,2)). The spatial extent of Voyager flashes was estimated to be about 30 kilometres (half-width at half-maximum intensity, HWHM), but the camera was unlikely to have detected the dim outer edges of the flashes, given its weak response to the brightest spectral line of Jovian lightning emission, the 656.3-nanometre H alpha line of atomic hydrogen(1,3-6). The spatial resolution of some cameras allowed investigators to confirm 22 flashes with HWHM greater than 42 kilometres, and to estimate one with an HWHM of 37 to 45 kilometres (refs.(1,7-9)). These flashes, with optical energies comparable to terrestrial 'superbolts'-of (0.02-1.6) x 10(10) joules-have been interpreted as tracers of moist convection originating near the 5-bar level of Jupiter's atmosphere (assuming photon scattering from points beneath the clouds)(1-3,7,8,10-12). Previous observations of lightning have been limited by camera sensitivity, distance from Jupiter and long exposures (about 680 milliseconds to 85 seconds), meaning that some measurements were probably superimposed flashes reported as one(1,2,7,9,10,13). Here we report optical observations of lightning flashes by the Juno spacecraft with energies of approximately 10(5)-10(8) joules, flash durations as short as 5.4 milliseconds and inter-flash separations of tens of milliseconds, with typical terrestrial energies. The flash rate is about 6.1 x 10(-2)flashes per square kilometre per year, more than an order of magnitude greater than hitherto seen. Several flashes are of such small spatial extent that they must originate above the 2-bar level, where there is no liquid water(14,15). This implies that multiple mechanisms for generating lightning on Jupiter need to be considered for a full understanding of the planet's atmospheric convection and composition.	[Becker, Heidi N.; Alexander, James W.; Brennan, Martin J.; Brown, Shannon T.; Guillaume, Alexandre; Levin, Steven M.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91125 USA; [Atreya, Sushil K.] Univ Michigan, Dept Climate & Space Sci & Engn, Ann Arbor, MI 48109 USA; [Bolton, Scott J.] Southwest Res Inst, San Antonio, TX USA; [Guillot, Tristan] Univ Cote dAzur, Observ Cote dAzur, Lab Lagrange, CNRS, Nice, France; [Ingersoll, Andrew P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lunine, Jonathan, I; Aglyamov, Yury S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Steffes, Paul G.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; Southwest Research Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; California Institute of Technology; Cornell University; University System of Georgia; Georgia Institute of Technology	Becker, HN (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91125 USA.	Heidi.N.Becker@jpl.nasa.gov	; Brennan, Martin/AAG-9917-2020	Guillot, Tristan/0000-0002-7188-8428; Levin, Steven/0000-0003-2242-5459; Brennan, Martin/0000-0003-0796-4251; Becker, Heidi N/0000-0001-5777-9850; Lunine, Jonathan/0000-0003-2279-4131				Acton CH, 1996, PLANET SPACE SCI, V44, P65, DOI 10.1016/0032-0633(95)00107-7; [Anonymous], 2019, NAIF PLAN DAT SYST N; Baines KH, 2007, SCIENCE, V318, P226, DOI 10.1126/science.1147912; Becker HN, 2017, SPACE SCI REV, V213, P507, DOI 10.1007/s11214-017-0345-9; Bolton SJ, 2017, SCIENCE, V356, P821, DOI 10.1126/science.aal2108; Borucki WJ, 1996, ICARUS, V123, P336, DOI 10.1006/icar.1996.0162; BORUCKI WJ, 1986, J GEOPHYS RES-ATMOS, V91, P9893, DOI 10.1029/JD091iD09p09893; BORUCKI WJ, 1982, ICARUS, V52, P492, DOI 10.1016/0019-1035(82)90009-4; BORUCKI WJ, 1992, ICARUS, V96, P1, DOI 10.1016/0019-1035(92)90002-O; Brown S, 2018, NATURE, V558, P87, DOI 10.1038/s41586-018-0156-5; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; DANIELSON GE, 1981, J GEOPHYS RES-SPACE, V86, P8683, DOI 10.1029/JA086iA10p08683; DEPATER I, 1986, ICARUS, V68, P344, DOI 10.1016/0019-1035(86)90027-8; Dye JE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007550; Dye JE, 2019, J GEOPHYS RES-ATMOS, V124, P1021, DOI 10.1029/2018JD029130; Dyudina UA, 2004, ICARUS, V172, P24, DOI 10.1016/j.icarus.2004.07.014; Dyudina UA, 2002, ICARUS, V160, P336, DOI 10.1006/icar.2002.6977; Guillot T, 2020, J GEOPHYS RES-PLANET, V125, DOI 10.1029/2020JE006403; Holzworth RH, 2019, J GEOPHYS RES-ATMOS, V124, P9996, DOI 10.1029/2019JD030975; Janssen MA, 2017, SPACE SCI REV, V213, P139, DOI 10.1007/s11214-017-0349-5; Klaasen KP, 1997, OPT ENG, V36, P3001, DOI 10.1117/1.601525; Kuhlman KM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036650; LEWIS JS, 1969, ICARUS, V10, P365, DOI 10.1016/0019-1035(69)90091-8; Li C, 2017, GEOPHYS RES LETT, V44, P5317, DOI 10.1002/2017GL073159; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; Mathworks Help Centre, 2019, DEC DEBL IM US L RIC; Nelson J, 2003, ATMOS CHEM PHYS, V3, P1237, DOI 10.5194/acp-3-1237-2003; Oshea D.C., 1985, ELEMENTS MODERN OPTI; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; RINNERT K, 1985, J GEOPHYS RES-ATMOS, V90, P6225, DOI 10.1029/JD090iD04p06225; Seiff A, 1998, J GEOPHYS RES-PLANET, V103, P22857, DOI 10.1029/98JE01766; SMITH BA, 1977, SPACE SCI REV, V21, P103, DOI 10.1007/BF00200847; STOKER CR, 1986, ICARUS, V67, P106, DOI 10.1016/0019-1035(86)90179-X; TURMAN BN, 1977, J GEOPHYS RES-OC ATM, V82, P2566, DOI 10.1029/JC082i018p02566; WEIDENSCHILLING SJ, 1973, ICARUS, V20, P465, DOI 10.1016/0019-1035(73)90019-5; YAIR Y, 1995, ICARUS, V114, P278, DOI 10.1006/icar.1995.1062; YAIR Y, 1995, ICARUS, V115, P421, DOI 10.1006/icar.1995.1108; Yair Y, 1998, J GEOPHYS RES-ATMOS, V103, P14157, DOI 10.1029/98JD00310	40	13	14	3	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					55	+		10.1038/s41586-020-2532-1	http://dx.doi.org/10.1038/s41586-020-2532-1			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32760043	Green Published			2022-12-28	WOS:000560290400014
J	Dyer, C				Dyer, Clare			Covid-19: 150m pound worth of masks bought without tender by government are unusable	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3147	10.1136/bmj.m3147	http://dx.doi.org/10.1136/bmj.m3147			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32763894	Bronze			2022-12-28	WOS:000560719800001
J	Duffett, L; Castellucci, LA; Forgie, MA				Duffett, Lisa; Castellucci, Lana A.; Forgie, Melissa A.			Pulmonary embolism: update on management and controversies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEMATOLOGY 2018 GUIDELINES; VENOUS THROMBOEMBOLISM PROPHYLAXIS; CATHETER-DIRECTED THROMBOLYSIS; EMERGENCY-DEPARTMENT PATIENTS; CLINICAL DECISION RULE; DEEP-VEIN THROMBOSIS; AMERICAN SOCIETY; D-DIMER; LOW-RISK; COMPUTED-TOMOGRAPHY	Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be promptly diagnosed and treated. The diagnosis, risk assessment, and management of pulmonary embolism have evolved with a better understanding of efficient use of diagnostic and therapeutic options. The use of either clinical probability adjusted or age adjusted D-dimer interpretation has led to a reduction in diagnostic imaging to exclude pulmonary embolism. Direct oral anticoagulation therapies are safe, effective, and convenient treatments for most patients with acute venous thromboembolism, with a lower risk of bleeding than vitamin K antagonists. These oral therapeutic options have opened up opportunities for safe outpatient management of pulmonary embolism in selected patients. Recent clinical trials exploring the use of systemic thrombolysis in intermediate to high risk pulmonary embolism suggest that this therapy should be reserved for patients with evidence of hemodynamic compromise. The role of low dose systemic or catheter directed thrombolysis in other patient subgroups is uncertain. After a diagnosis of pulmonary embolism, all patients should be assessed for risk of recurrent venous thromboembolism to guide duration of anticoagulation. Patients with a venous thromboembolism associated with a strong, transient, provoking risk factor can safely discontinue anticoagulation after three months of treatment. Patients with an ongoing strong risk factor, such as cancer, or unprovoked events are at increased risk of recurrent events and should be considered for extended treatment. The use of a risk prediction score can help to identify patients with unprovoked venous thromboembolism who can benefit from extended duration therapy. Despite major advances in the management of pulmonary embolism, up to half of patients report chronic functional limitations. Such patients should be screened for chronic thromboembolic pulmonary hypertension, but only a small proportion will have this as the explanation of their symptoms. In the remaining patients, future studies are needed to understand the pathophysiology and explore interventions to improve quality of life.	[Duffett, Lisa; Castellucci, Lana A.] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Duffett, Lisa; Castellucci, Lana A.; Forgie, Melissa A.] Univ Ottawa, Fac Med, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Castellucci, LA (corresponding author), Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada.; Castellucci, LA (corresponding author), Univ Ottawa, Fac Med, Dept Med, Ottawa, ON, Canada.	lcastellucci@toh.ca			Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research [CDT-142654]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	LAC is supported by Heart and Stroke Foundation of Canada National New Investigator and Ontario Clinician Scientist Phase I award. LD, LAC, and MAF are investigators of the Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network; the Network receives grant funding from the Canadian Institutes of Health Research (Funding Reference: CDT-142654). CanVECTOR's Patient Partners platform provided support for patient engagement activities..	Ageno W, 2013, J THROMB HAEMOST, V11, P1597, DOI 10.1111/jth.12301; Agnelli G, 2020, NEW ENGL J MED, V382, P1599, DOI 10.1056/NEJMoa1915103; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Al-Horani RA, 2020, EXPERT OPIN THER PAT, V30, P39, DOI 10.1080/13543776.2020.1705783; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; [Anonymous], 2019, SIGN 50 GUID DEV HDB; [Anonymous], 2020, ASH CLIN PRACTICE GU; Vilchez JA, 2014, THER ADV DRUG SAF, V5, P8, DOI 10.1177/2042098613507945; Aujesky D, 2006, ARCH INTERN MED, V166, P169, DOI 10.1001/archinte.166.2.169; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Avgerinos ED, 2018, J VASC SURG-VENOUS L, V6, P530, DOI 10.1016/j.jvsv.2018.03.010; Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116; Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Barco S, 2020, EUR HEART J, V41, P509, DOI 10.1093/eurheartj/ehz367; Barco S, 2020, LANCET RESP MED, V8, P277, DOI 10.1016/S2213-2600(19)30354-6; Bariteau A, 2018, ACAD EMERG MED, V25, P828, DOI 10.1111/acem.13399; BARRITT DW, 1960, LANCET, V1, P1309; Bates SM, 2018, BLOOD ADV, V2, P3317, DOI 10.1182/bloodadvances.2018024802; Bauer KA, 2020, JAMA-J AM MED ASSOC, V323, P121, DOI 10.1001/jama.2019.20783; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2019, J THROMB HAEMOST, V17, P1217, DOI 10.1111/jth.14477; Belohlavek J, 2013, EXP CLIN CARDIOL, V18, P129; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Brenner B, 2019, THROMB J, V17, DOI 10.1186/s12959-019-0196-6; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Carrier M, 2018, CURR ONCOL, V25, P329, DOI 10.3747/co.25.4266; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Carrier M, 2017, HEMATOL-AM SOC HEMAT, P237, DOI 10.1182/asheducation-2017.1.237; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Castellucci LA, 2018, RES PRACT THROMB HAE, V2, P529, DOI 10.1002/rth2.12121; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chai-Adisaksopha C, 2015, J THROMB HAEMOST, V13, P2012, DOI 10.1111/jth.13139; Choi JH, 2020, ANN THORAC SURG, V110, P1072, DOI 10.1016/j.athoracsur.2020.01.075; Claeys M, 2019, JACC-CARDIOVASC IMAG, V12, P1444, DOI 10.1016/j.jcmg.2018.07.021; Cohn DM, 2008, J THROMB HAEMOST, V6, P1099, DOI 10.1111/j.1538-7836.2008.03005.x; Conget F, 2008, THROMB HAEMOSTASIS, V100, P937, DOI 10.1160/TH08-02-0065; Connors JM, 2017, NEW ENGL J MED, V377, P1177, DOI 10.1056/NEJMra1700365; Coppens M, 2008, J THROMB HAEMOST, V6, P1474, DOI 10.1111/j.1538-7836.2008.03055.x; Coutance G, 2011, CRIT CARE, V15, DOI 10.1186/cc10119; Couturaud F, 2014, BLOOD, V124, P2124, DOI 10.1182/blood-2014-03-559757; Couturaud F, 2009, CHEST, V136, P1537, DOI 10.1378/chest.09-0757; Cuker A, 2018, BLOOD ADV, V2, P3360, DOI 10.1182/bloodadvances.2018024489; Darwish OS, 2018, J HOSP MED, V13, P706, DOI 10.12788/jhm.2961; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; DeLoughery EP, 2019, SEMIN THROMB HEMOST, V45, P502, DOI 10.1055/s-0039-1692439; den Exter PL, 2016, AM J RESP CRIT CARE, V194, P998, DOI 10.1164/rccm.201512-2494OC; den Exter PL, 2015, THROMB HAEMOSTASIS, V114, P26, DOI 10.1160/TH14-10-0842; Donadini MP, 2009, THROMB HAEMOSTASIS, V102, P1287, DOI 10.1160/TH09-05-0301; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Douma RA, 2010, THROMB RES, V126, pE271, DOI 10.1016/j.thromres.2010.07.008; Duffett L, 2017, J THROMB HAEMOST, V15, P3, DOI 10.1111/jth.13564; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Elias A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010324; Ende-Verhaar YM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01792-2016; Etchegary H, 2008, THROMB RES, V122, P491, DOI 10.1016/j.thromres.2007.12.001; Fernandes A, 2019, NEW ENGL J MED, V381, P1171, DOI 10.1056/NEJMclde1907665; Fernandes T, 2018, THROMB RES, V164, P145, DOI 10.1016/j.thromres.2018.01.012; Freund Y, 2018, JAMA-J AM MED ASSOC, V319, P559, DOI 10.1001/jama.2017.21904; Garcia D, 2013, BLOOD, V122, P817, DOI 10.1182/blood-2013-04-496257; Garcia-Fuster MJ, 2005, PATHOPHYSIOL HAEMO T, V34, P6, DOI 10.1159/000088541; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Gogarten W, 2010, EUR J ANAESTH, V27, P999, DOI 10.1097/EJA.0b013e32833f6f6f; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grobman WA, 2018, NEW ENGL J MED, V379, P513, DOI 10.1056/NEJMoa1800566; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hamadah A, 2011, J THROMB HAEMOST, V9, P2406, DOI 10.1111/j.1538-7836.2011.04533.x; Hao QK, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004437.pub5; Hayashino Y, 2005, RADIOLOGY, V234, P740, DOI 10.1148/radiol.2343031009; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; HENRY JW, 1995, CHEST, V107, P1375, DOI 10.1378/chest.107.5.1375; Heshka J, 2008, J Genet Couns, V17, P288, DOI 10.1007/s10897-008-9148-1; Ho WK, 2018, PATHOLOGY, V50, P580, DOI 10.1016/j.pathol.2017.12.344; Horlocker TT, 2018, REGION ANESTH PAIN M, V43, P263, DOI 10.1097/AAP.0000000000000763; Hunter R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024805; Jimenez D, 2018, THORAX, V73, P464, DOI 10.1136/thoraxjnl-2017-210040; Jimenez D, 2016, J AM COLL CARDIOL, V67, P162, DOI 10.1016/j.jacc.2015.10.060; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Kahn SR, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.03.033; Kahn SR, 2017, CHEST, V151, P1058, DOI 10.1016/j.chest.2016.11.030; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Keller K, 2019, THROMB RES, V178, P173, DOI 10.1016/j.thromres.2019.04.020; Khan F, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4363; Kline JA, 2018, JAMA-J AM MED ASSOC, V319, P551, DOI 10.1001/jama.2017.21901; Klok FA, 2014, BLOOD REV, V28, P221, DOI 10.1016/j.blre.2014.07.003; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01647-2019; Konstantinides SV, 2017, J AM COLL CARDIOL, V69, P1536, DOI 10.1016/j.jacc.2016.12.039; Kraaijpoel Noemie, 2019, J Clin Oncol, V37, P1713, DOI 10.1200/JCO.18.01977; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2014, CIRCULATION, V129, P479, DOI 10.1161/CIRCULATIONAHA.113.005544; Langlois E, 2019, J THROMB HAEMOST, V17, P1329, DOI 10.1111/jth.14483; Langlois NJ, 2003, THROMB HAEMOSTASIS, V90, P17, DOI 10.1055/s-0037-1613594; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2006, ARCH INTERN MED, V166, P176, DOI 10.1001/archinte.166.2.176; Le Gal G, 2009, J THROMB HAEMOST, V7, P752, DOI 10.1111/j.1538-7836.2009.03324.x; Lim W, 2018, BLOOD ADV, V2, P3226, DOI 10.1182/bloodadvances.2018024828; Linkins LA, 2017, INT J LAB HEMATOL, V39, P98, DOI 10.1111/ijlh.12665; Lloyd AJ, 2018, VALUE HEALTH, V21, P449, DOI 10.1016/j.jval.2017.09.015; Louzada ML, 2011, THROMB RES, V128, P530, DOI 10.1016/j.thromres.2011.05.024; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351; Ma KA, 2018, RES PRACT THROMB HAE, V2, P670, DOI 10.1002/rth2.12123; McBane RD, 2020, J THROMB HAEMOST, V18, P411, DOI 10.1111/jth.14662; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Mismetti P, 2015, JAMA-J AM MED ASSOC, V313, P1627, DOI 10.1001/jama.2015.3780; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Monagle P, 2018, BLOOD ADV, V2, P3292, DOI 10.1182/bloodadvances.2018024786; Mos ICM, 2009, J THROMB HAEMOST, V7, P1491, DOI 10.1111/j.1538-7836.2009.03518.x; Mos ICM, 2014, THROMB RES, V133, P1039, DOI 10.1016/j.thromres.2014.03.050; Nijkeuter M, 2006, CHEST, V129, P192, DOI 10.1378/chest.129.1.192; Ordi-Ros J, 2019, ANN INTERN MED, V171, P685, DOI 10.7326/M19-0291; Palareti G, 2014, BLOOD, V124, P196, DOI 10.1182/blood-2014-01-548065; Peacock WF, 2018, ACAD EMERG MED, V25, P995, DOI 10.1111/acem.13451; Pengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333; Piazza G, 2015, JACC-CARDIOVASC INTE, V8, P1382, DOI 10.1016/j.jcin.2015.04.020; Prins MH, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-21; Rai V, 2019, REV CARDIOVASC MED, V20, P245, DOI 10.31083/j.rcm.2019.04.56; Raskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Righini M, 2018, ANN INTERN MED, V169, P766, DOI 10.7326/M18-1670; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Robert-Ebadi H, 2017, J THROMB HAEMOST, V15, P1764, DOI 10.1111/jth.13770; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Rodger MA, 2018, THROMB RES, V169, P82, DOI 10.1016/j.thromres.2018.07.020; Rodger MA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1065; Rodger MA, 2018, HEMATOL-AM SOC HEMAT, P426, DOI 10.1182/asheducation-2018.1.426; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Schunemann HJ, 2018, BLOOD ADV, V2, P3198, DOI 10.1182/bloodadvances.2018022954; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sista AK, 2018, THROMB RES, V164, P157, DOI 10.1016/j.thromres.2017.06.017; Smith SB, 2016, CHEST, V150, P35, DOI 10.1016/j.chest.2016.02.638; Sorensen HT, 2011, J THROMB HAEMOST, V9, P320, DOI 10.1111/j.1538-7836.2010.04129.x; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Stein PD, 2012, THROMB RES, V130, P841, DOI 10.1016/j.thromres.2012.07.011; Stein PD, 2010, CLIN CHEST MED, V31, P611, DOI 10.1016/j.ccm.2010.07.001; Stein PD, 2004, ARCH INTERN MED, V164, P2260, DOI 10.1001/archinte.164.20.2260; Stein PD, 2004, ARCH INTERN MED, V164, P1541, DOI 10.1001/archinte.164.14.1541; Tanabe Y, 2018, AM J CARDIOL, V122, P1079, DOI 10.1016/j.amjcard.2018.05.042; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x; Tritschler T, 2018, JAMA-J AM MED ASSOC, V320, P1583, DOI 10.1001/jama.2018.14346; van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1; van der Pol LM, 2019, NEW ENGL J MED, V380, P1139, DOI 10.1056/NEJMoa1813865; van Es N, 2016, ANN INTERN MED, V165, P253, DOI 10.7326/M16-0031; van Mens TE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011053.pub2; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wartski M, 2000, J NUCL MED, V41, P1043; Weinberg A, 2017, SEMIN RESP CRIT CARE, V38, P66, DOI 10.1055/s-0036-1597559; Weitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518; Weitz JI, 2020, JAMA-J AM MED ASSOC, V323, P130, DOI 10.1001/jama.2019.20687; Wells PS, 2018, ANN INTERN MED, V168, P131, DOI 10.7326/M17-0291; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wendelboe AM, 2015, J THROMB HAEMOST, V13, P1365, DOI 10.1111/jth.13031; Wendelboe AM, 2016, CIRC RES, V118, P1340, DOI 10.1161/CIRCRESAHA.115.306841; Wicki J, 2000, THROMB HAEMOSTASIS, V84, P548, DOI 10.1055/s-0037-1614065; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Witt DM, 2018, BLOOD ADV, V2, P3257, DOI 10.1182/bloodadvances.2018024893; Young Annie M, 2018, J Clin Oncol, V36, P2017, DOI 10.1200/JCO.2018.78.8034; Young T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006212.pub3; Zondag W, 2013, THROMB HAEMOSTASIS, V109, P47, DOI 10.1160/TH12-07-0466; 2012, NEW ENGL J MED, V366, P1287, DOI [DOI 10.1056/NEJMoa1113572, 10.1056/NEJMoa1113572, DOI 10.1056/NEJMOA1113572]	171	40	44	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m2177	10.1136/bmj.m2177	http://dx.doi.org/10.1136/bmj.m2177			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759284				2022-12-28	WOS:000556139400004
J	Nakkazi, E				Nakkazi, Esther			Fighting malaria with genetically modified mosquitoes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												estanakkazi@gmail.com						Evans BR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49660-6; Target Malaria, 2019, TARGET MALARIA PROCE; WHO, 2019, WORLD MALARIA REPORT	3	2	2	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2020	370								m2172	10.1136/bmj.m2172	http://dx.doi.org/10.1136/bmj.m2172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RK	32753476				2022-12-28	WOS:000556140300002
J	Griffin, S				Griffin, Shaun			Coca-Cola's work with academics was a "low point in history of public health"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Serodio P, 2020, PUBLIC HEALTH NUTR, V23, P2647, DOI 10.1017/S1368980020002098	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2020	370								m3075	10.1136/bmj.m3075	http://dx.doi.org/10.1136/bmj.m3075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1QV	32747432				2022-12-28	WOS:000556138700001
J	Hanada, Y; Wang, KK				Hanada, Yuri; Wang, Kenneth K.			Screening for Barrett's oesophagus: is now the time?	LANCET			English	Editorial Material									[Hanada, Yuri; Wang, Kenneth K.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Wang, KK (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	wang.kenneth@mayo.edu			eNose (Zupten, Netherlands)	eNose (Zupten, Netherlands)(Netherlands Government)	KKW reports receiving research funding from eNose (Zupten, Netherlands) for research on a device used in a screening study of Barrett's oesophagus, and declares no financial interests in the device. YH declares no competing interests.	Calman K, 1994, J MED SCREEN, V1, P101; Fitzgerald RC, 2020, LANCET, V396, P333, DOI 10.1016/S0140-6736(20)31099-0; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Kadri SR, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4372; Ross-Innes CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001780; Sikora K, 2020, MEDICINE, V48, P132	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					292	293						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0RO	32738941	hybrid, Green Published			2022-12-28	WOS:000561615700004
J	O'Reilly, FJ; Xue, L; Graziadei, A; Sinn, L; Lenz, S; Tegunov, D; Blotz, C; Singh, N; Hagen, WJH; Cramer, P; Stulke, J; Mahamid, J; Rappsilber, J				O'Reilly, Francis J.; Xue, Liang; Graziadei, Andrea; Sinn, Ludwig; Lenz, Swantje; Tegunov, Dimitry; Bloetz, Cedric; Singh, Neil; Hagen, Wim J. H.; Cramer, Patrick; Stuelke, Jobrg; Mahamid, Julia; Rappsilber, Juri			In-cell architecture of an actively transcribing-translating expressome	SCIENCE			English	Article							RNA-POLYMERASE; CRYOELECTRON TOMOGRAPHY; CROSS-LINKING; CRYO-EM; STRUCTURAL BASIS; ALPHA-SUBUNIT; TRANSCRIPTION; VISUALIZATION; COMPLEX; RIBOSOME	Structural biology studies performed inside cells can capture molecular machines in action within their native context. In this work, we developed an integrative in-cell structural approach using the genome-reduced human pathogen Mycoplasma pneumoniae. We combined whole-cell cross-linking mass spectrometry, cellular cryo-electron tomography, and integrative modeling to determine an in-cell architecture of a transcribing and translating expressome at subnanometer resolution. The expressome comprises RNA polymerase (RNAP), the ribosome, and the transcription elongation factors NusG and NusA. We pinpointed NusA at the interface between a NusG-bound elongating RNAP and the ribosome and propose that it can mediate transcription-translation coupling. Translation inhibition dissociated the expressome, whereas transcription inhibition stalled and rearranged it. Thus, the active expressome architecture requires both translation and transcription elongation within the cell.	[O'Reilly, Francis J.; Graziadei, Andrea; Sinn, Ludwig; Lenz, Swantje; Rappsilber, Juri] Tech Univ Berlin, Inst Biotechnol, Bioanalyt Unit, D-13355 Berlin, Germany; [Xue, Liang; Hagen, Wim J. H.; Mahamid, Julia] European Mol Biol Lab EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Xue, Liang] Collaborat Joint PhD Degree EMBL & Heidelberg Uni, Fac Biosci, D-69120 Heidelberg, Germany; [Tegunov, Dimitry; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; [Bloetz, Cedric; Singh, Neil; Stuelke, Jobrg] Georg August Univ Gottingen, GZMB, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Rappsilber, Juri] Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland	Technical University of Berlin; European Molecular Biology Laboratory (EMBL); Max Planck Society; University of Gottingen; University of Edinburgh	Rappsilber, J (corresponding author), Tech Univ Berlin, Inst Biotechnol, Bioanalyt Unit, D-13355 Berlin, Germany.; Mahamid, J (corresponding author), European Mol Biol Lab EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; Rappsilber, J (corresponding author), Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland.	julia.mahamid@embl.de; juri.rappsilber@tu-berlin.de	Xue, Liang/HCH-3547-2022; Stülke, Jörg/AAD-1600-2021; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Tegunov, Dimitry/D-7834-2015	Xue, Liang/0000-0003-4368-2526; Rappsilber, Juri/0000-0001-5999-1310; Hagen, Wim/0000-0001-6229-2692; Singh, Neil/0000-0001-7256-003X; Graziadei, Andrea/0000-0001-7709-6002; Stulke, Jorg/0000-0001-5881-5390; Tegunov, Dimitry/0000-0001-7019-3221; O'Reilly, Francis J/0000-0001-9258-0150; Lenz, Swantje/0000-0002-8839-5371; Sinn, Ludwig/0000-0003-4692-0681	Bundesministerium for Bildung und Forschung [FKZ031L0012]; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC2008/1 - 390540038, 426290502, 392923329]; Wellcome Trust [103139, 203149]; EMBL; European Research Council [760067, 693023]	Bundesministerium for Bildung und Forschung; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBL; European Research Council(European Research Council (ERC)European Commission)	This project received funding from the Bundesministerium for Bildung und Forschung Grant FKZ031L0012 to J.S.; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy EXC2008/1 - 390540038, project no. 426290502 and 392923329, the Wellcome Trust Senior Research Fellowship (103139) to JR; and EMBL and the European Research Council to J.M (760067) and P.C.(693023). The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust (203149).	Abdelkareem M, 2019, MOL CELL, V75, P298, DOI 10.1016/j.molcel.2019.04.029; Bartesaghi A, 2012, STRUCTURE, V20, P2003, DOI 10.1016/j.str.2012.10.016; Beck M, 2016, TRENDS CELL BIOL, V26, P825, DOI 10.1016/j.tcb.2016.08.006; Beuth B, 2005, EMBO J, V24, P3576, DOI 10.1038/sj.emboj.7600829; Bharat TAM, 2016, NAT PROTOC, V11, P9, DOI 10.1038/nprot.2016.124; Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026; Bnlot A. F., 2013, P NATL ACAD SCI USA, V110, P20994; Bonomi M, 2019, STRUCTURE, V27, P175, DOI 10.1016/j.str.2018.09.011; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Brilot AF, 2013, P NATL ACAD SCI USA, V110, P20994, DOI 10.1073/pnas.1311423110; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen J, 2017, MOL CELL, V68, P388, DOI 10.1016/j.molcel.2017.09.006; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Conn AB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102595; Dauden MI, 2017, EMBO REP, V18, P264, DOI 10.15252/embr.201643353; Demo G, 2017, ELIFE, V6, DOI 10.7554/eLife.28560; Demo G, 2014, J STRUCT BIOL, V187, P174, DOI 10.1016/j.jsb.2014.06.001; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Fischer L, 2017, ANAL CHEM, V89, P3829, DOI 10.1021/acs.analchem.6b03745; Fukuda Y, 2015, J STRUCT BIOL, V190, P143, DOI 10.1016/j.jsb.2015.03.004; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grosjean H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004363; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Guo XY, 2018, MOL CELL, V69, P816, DOI 10.1016/j.molcel.2018.02.008; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Halbedel S, 2004, J BACTERIOL, V186, P7936, DOI 10.1128/JB.186.23.7936-7943.2004; Hertig S, 2015, BIOPHYS J, V108, P2097, DOI 10.1016/j.bpj.2015.03.051; Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011; Himes BA, 2018, NAT METHODS, V15, P955, DOI 10.1038/s41592-018-0167-z; Hrabe T, 2012, J STRUCT BIOL, V178, P177, DOI 10.1016/j.jsb.2011.12.003; Kang JY, 2018, CELL, V173, P1650, DOI 10.1016/j.cell.2018.05.017; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kastritis PL, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167412; Kohler R, 2017, SCIENCE, V356, P194, DOI 10.1126/science.aal3059; Kolbowski L, 2017, ANAL CHEM, V89, P5311, DOI 10.1021/acs.analchem.6b04935; Kosinski J, 2015, J STRUCT BIOL, V189, P177, DOI 10.1016/j.jsb.2015.01.014; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krupp F, 2019, MOL CELL, V74, P143, DOI 10.1016/j.molcel.2019.01.016; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lamour V, 2009, J STRUCT BIOL, V168, P352, DOI 10.1016/j.jsb.2009.07.001; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Ling C, 2016, WIRES RNA, V7, P620, DOI 10.1002/wrna.1354; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Maffioli SI, 2017, CELL, V169, P1240, DOI 10.1016/j.cell.2017.05.042; Mah TF, 2000, GENE DEV, V14, P2664, DOI 10.1101/gad.822900; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McGary K, 2013, CURR OPIN MICROBIOL, V16, P112, DOI 10.1016/j.mib.2013.01.010; Mendes ML, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20198994; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Naydenova K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00782-3; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; O'Reilly FJ, 2018, NAT STRUCT MOL BIOL, V25, P1000, DOI 10.1038/s41594-018-0147-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinero-Lambea C, 2020, ACS SYNTH BIOL, V9, P1693, DOI 10.1021/acssynbio.0c00022; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Sohmen D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7941; Stagno JR, 2011, NUCLEIC ACIDS RES, V39, P7803, DOI 10.1093/nar/gkr418; Stieger CE, 2019, J PROTEOME RES, V18, P1363, DOI 10.1021/acs.jproteome.8b00947; Svetlov MS, 2019, RNA, V25, P600, DOI 10.1261/rna.069260.118; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Turtola M, 2016, ELIFE, V5, DOI 10.7554/eLife.18096; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Viswanath S, 2017, BIOPHYS J, V113, P2344, DOI 10.1016/j.bpj.2017.10.005; Wang C., 2020, 972380 BIORXIV, DOI [10.1101/2020.03.01.972380vl, DOI 10.1101/2020.03.01.972380V1]; Wang L., 2013, ARXIV13075824MATHNA; Washburn R. S., 2019, 871962 BIORXIV, DOI [10.1101/871962v1, DOI 10.1101/871962V1]; Washburn RL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020246; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Webster M. W., 2020, 971028 BIORXIV, DOI [10.1101/2020.03.01.971028vl, DOI 10.1101/2020.03.01.971028V1]; Weiss A, 2015, FEMS MICROBIOL REV, V39, P541, DOI 10.1093/femsre/fuv005; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; Yus E, 2019, CELL SYST, V9, P143, DOI 10.1016/j.cels.2019.07.001; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	92	90	90	10	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					554	+		10.1126/science.abb3758	http://dx.doi.org/10.1126/science.abb3758			76	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732422	Green Accepted, Green Submitted			2022-12-28	WOS:000556568100043
J	Veronig, AM				Veronig, Astrid M.			Can we predict solar flares?	SCIENCE			English	Editorial Material									[Veronig, Astrid M.] Karl Franzens Univ Graz, Inst Phys, Graz, Austria; [Veronig, Astrid M.] Karl Franzens Univ Graz, Kanzelhohe Observ Solar & Environm Res, Graz, Austria	University of Graz; University of Graz	Veronig, AM (corresponding author), Karl Franzens Univ Graz, Inst Phys, Graz, Austria.; Veronig, AM (corresponding author), Karl Franzens Univ Graz, Kanzelhohe Observ Solar & Environm Res, Graz, Austria.	astrid.veronig@uni-graz.at	Veronig, Astrid/B-8422-2009	Veronig, Astrid/0000-0003-2073-002X	 [P27292-N20];  [I4555-N]	; 	A.M.V. acknowledges theAustrian Science Fund (FWF): P27292-N20 and I4555-N.	Amari T, 2014, NATURE, V514, P465, DOI 10.1038/nature13815; Carrington R. C., 1859, MONTHLY NOTICES ROY, V20, P13, DOI [10.1093/mnras/20.1.13, DOI 10.1093/MNRAS/20.1.13]; Green LM, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-017-0462-5; Hodgson R., 1859, MONTHLY NOTICES ROY, V20, P15, DOI [10.1093/mnras/20.1.15, DOI 10.1093/MNRAS/20.1.15]; Ishiguro N, 2017, ASTROPHYS J, V843, DOI 10.3847/1538-4357/aa799b; Kusano K, 2020, SCIENCE, V369, P587, DOI 10.1126/science.aaz2511; Leka KD, 2019, ASTROPHYS J SUPPL S, V243, DOI 10.3847/1538-4365/ab2e12; Priest ER, 2002, ASTRON ASTROPHYS REV, V10, P313, DOI 10.1007/s001590100013; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Schrijver CJ, 2008, ASTROPHYS J, V675, P1637, DOI 10.1086/527413; Schrijver CJ, 2007, ASTROPHYS J, V655, pL117, DOI 10.1086/511857; Su Y, 2013, NAT PHYS, V9, P489, DOI [10.1038/nphys2675, 10.1038/NPHYS2675]; Thalmann JK, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L23; Torok T, 2005, ASTROPHYS J, V630, pL97, DOI 10.1086/462412; Yashiro S, 2006, ASTROPHYS J, V650, pL143, DOI 10.1086/508876	15	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					504	505		10.1126/science.abb6150	http://dx.doi.org/10.1126/science.abb6150			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732409				2022-12-28	WOS:000556568100024
J	Mahase, E				Mahase, Elisabeth			Covid-19: Campaigners demand to see contracts for 10bn pound track and trace services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, WE DES SEE TEST TRAC; IACOBUCCI G, 2020, BMJ-BRIT MED J, V370, DOI DOI 10.1136/BMJ.M2805	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3037	10.1136/bmj.m3037	http://dx.doi.org/10.1136/bmj.m3037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732189	Bronze			2022-12-28	WOS:000556139900008
J	Wu, SE; Hashimoto-Hill, S; Woo, V; Eshleman, EM; Whitt, J; Engleman, L; Karns, R; Denson, LA; Haslam, DB; Alenghat, T				Wu, Shu-en; Hashimoto-Hill, Seika; Woo, Vivienne; Eshleman, Emily M.; Whitt, Jordan; Engleman, Laura; Karns, Rebekah; Denson, Lee A.; Haslam, David B.; Alenghat, Theresa			Microbiota-derived metabolite promotes HDAC3 activity in the gut	NATURE			English	Article							HISTONE DEACETYLASE 3; NUCLEAR RECEPTOR COREPRESSOR; TOLL-LIKE RECEPTORS; EXPRESSION; PHYTATE; COMPLEX; CELLS; CRYPT	The coevolution of mammalian hosts and their beneficial commensal microbes has led to development of symbiotic host-microbiota relationships(1). Epigenetic machinery permits mammalian cells to integrate environmental signals(2); however, how these pathways are fine-tuned by diverse cues from commensal bacteria is not well understood. Here we reveal a highly selective pathway through which microbiota-derived inositol phosphate regulates histone deacetylase 3 (HDAC3) activity in the intestine. Despite the abundant presence of HDAC inhibitors such as butyrate in the intestine, we found that HDAC3 activity was sharply increased in intestinal epithelial cells of microbiota-replete mice compared with germ-free mice. This divergence was reconciled by the finding that commensal bacteria, includingEscherichia coli, stimulated HDAC activity through metabolism of phytate and production of inositol-1,4,5-trisphosphate (InsP(3)). Both intestinal exposure to InsP(3)and phytate ingestion promoted recovery following intestinal damage. Of note, InsP(3)also induced growth of intestinal organoids derived from human tissue, stimulated HDAC3-dependent proliferation and countered butyrate inhibition of colonic growth. Collectively, these results show that InsP(3)is a microbiota-derived metabolite that activates a mammalian histone deacetylase to promote epithelial repair. Thus, HDAC3 represents a convergent epigenetic sensor of distinct metabolites that calibrates host responses to diverse microbial signals. Phytate metabolism and production of inositol trisphosphate by commensal bacteria activates epithelial histone deacetylase 3 and promotes intestinal repair.	[Wu, Shu-en; Hashimoto-Hill, Seika; Woo, Vivienne; Eshleman, Emily M.; Whitt, Jordan; Engleman, Laura; Alenghat, Theresa] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Karns, Rebekah; Denson, Lee A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Denson, Lee A.; Haslam, David B.; Alenghat, Theresa] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Haslam, David B.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Alenghat, Theresa] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Alenghat, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Alenghat, T (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.; Alenghat, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45229 USA.	theresa.alenghat@cchmc.org		Alenghat, Theresa/0000-0003-4514-3710	National Institutes of Health [DK114123, DK116868, DK098231, F32AI147591]; Pew Charitable Trust; Kenneth Rainin Foundation; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NIH [P30 DK078392]; CCHMC Trustee Award; Procter Scholar's Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trust; Kenneth Rainin Foundation; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCHMC Trustee Award; Procter Scholar's Program	We thank the Way, Qualls and Deshmukh laboratories for useful discussions; CCHMC Veterinary Services, Pathology Research Core, Research Flow Cytometry Core, NMR-based Metabolomics Core, and Confocal Imaging Core for services and technical assistance. This research is supported by the National Institutes of Health (DK114123 and DK116868 to T.A.; DK098231 to L.A.D.; and F32AI147591 to. E.M.E.), Pew Charitable Trust, and a Kenneth Rainin Foundation award to T.A. T.A. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. This project is supported in part by NIH P30 DK078392 and the CCHMC Trustee Award and Procter Scholar's Program.	Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Elliott EN, 2015, DEVELOPMENT, V142, P2163, DOI 10.1242/dev.117341; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hernandez-Chirlaque C, 2016, J CROHNS COLITIS, V10, P1324, DOI 10.1093/ecco-jcc/jjw096; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kartashov AV, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0720-3; Kim Eunha, 2016, Advances in Biological Regulation, V61, P25, DOI 10.1016/j.jbior.2015.11.005; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Kuang Z, 2019, SCIENCE, V365, P1428, DOI 10.1126/science.aaw3134; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim D, 2000, NAT STRUCT BIOL, V7, P108; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Navabi N, 2017, CELL REP, V19, P1165, DOI 10.1016/j.celrep.2017.04.046; Oksanen J., 2022, R PACKAGE VERSION; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sagar GDV, 2006, J CELL BIOCHEM, V98, P1543, DOI 10.1002/jcb.20870; Schell MJ, 2010, CELL MOL LIFE SCI, V67, P1755, DOI 10.1007/s00018-009-0238-5; Schlemmer U, 2009, MOL NUTR FOOD RES, V53, pS330, DOI 10.1002/mnfr.200900099; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Turgeon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073785; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Whitt J, 2018, GASTROENTEROLOGY, V155, P501, DOI 10.1053/j.gastro.2018.04.017; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; WISE A, 1982, APPL ENVIRON MICROB, V43, P753, DOI 10.1128/AEM.43.4.753-756.1982; Woo V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00928; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	66	68	7	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 1	2020	586	7827					108	+		10.1038/s41586-020-2604-2	http://dx.doi.org/10.1038/s41586-020-2604-2		JUL 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9IH	32731255	Green Accepted			2022-12-28	WOS:000572352600001
J	Dyer, C				Dyer, Clare			Trust was wrong to exclude parents from meeting about care of disabled child, says judge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m3019	10.1136/bmj.m3019	http://dx.doi.org/10.1136/bmj.m3019			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727714				2022-12-28	WOS:000554456000004
J	Turan, A; Essber, H; Saasouh, W; Hovsepyan, K; Makarova, N; Ayad, S; Cohen, B; Ruetzler, K; Soliman, LM; Maheshwari, K; Yang, DS; Mascha, EJ; Esa, WAS; Kessler, H; Delaney, CP; Sessler, DI				Turan, Alparslan; Essber, Hani; Saasouh, Wael; Hovsepyan, Karen; Makarova, Natalya; Ayad, Sabry; Cohen, Barak; Ruetzler, Kurt; Soliman, Loran Mounir; Maheshwari, Kamal; Yang, Dongsheng; Mascha, Edward J.; Esa, Wael Ali Sakr; Kessler, Herman; Delaney, Conor P.; Sessler, Daniel I.		FACTOR Study Grp	Effect of Intravenous Acetaminophen on Postoperative Hypoxemia After Abdominal Surgery The FACTOR Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINUTE VENTILATION; PAIN; PLACEBO; RELIABILITY; CONSUMPTION; VALIDITY; SCORE	IMPORTANCE Opioid-induced ventilatory depression and hypoxemia is common, severe, and often unrecognized in postoperative patients. To the extent that nonopioid analgesics reduce opioid consumption, they may decrease postoperative hypoxemia. OBJECTIVE To test the hypothesis that duration of hypoxemia is less in pat ents given intravenous acetaminophen than those given placebo. DESIGN, SETTING, AND PARTICIPANTS Randomized, placebo-controlled, double-blind trial conducted at 2 US academic hospitals among 570 patients who were undergoing abdominal surgery, enrolled from February 2015 through October 2018 and followed up until February 2019. INTERVENTIONS Participants were randomized to receive either intravenous acetaminophen, 1 g (n = 289), or normal saline placebo (n = 291) starting at the beginning of surgery and repeated every 6 hours until 48 postoperative hours or hospital discharge, whichever occurred first. MAIN OUTCOMES AND MEASURES The primary outcome WaS the total duration of hypoxemia (hemoglobin oxygen saturation [Spo(2)] <90%) per hour, with oxygen saturation measured continuously for 48 postoperative hours. Secondary outcomes were postoperative opioid consumption, pain (0-10-point scale; 0: no pain; 10: the most pain imaginable), nausea and vomiting, sedation, minimal alveolar concentration of volatile anesthetic, fatigue, active time, and respiratory function. RESULTS Among 580 patients randomized (mean age, 49 years; 48% women), 570 (98%) completed the trial. The primary outcome, median duration with Spo(2) of less than 90%, was 0.7 (interquartile range DOR], 0.1-5.1) minutes per hour among patients in the acetaminophen group and 1.1 (IQR, 0.1-6.6) minutes per hour among patients in the placebo group (P =.29), with an estimated median difference of-0.04 (95% CI,-0.18 to 0.11) minutes per hour. None of the 8 secondary end points differed significantly between the acetaminophen and placebo groups. Mean pain scores within initial 48 postoperative hours were 4.2 (SD, 1.8) in the acetaminophen group and 4.4 (SD, 1.8) in the placebo group (difference,-0.28; 95% CI,-0.71 to 0.15); median opioid use in morphine equivalents was 50 mg (IQR, 18-122 mg) and 58 mg (IQR, 24-151 mg), respectively, with a ratio of geometric means of 0.86 (95% CI, 0.61-1.21). CONCLUSIONS AND RELEVANCE Among patients who underwent abdominal surgery, use of postoperative intravenous acetaminophen, compared with placebo, did not significantly reduce the duration of postoperative hypoxemia over 48 hours. The study findings do not support the use of intravenous acetaminophen for this purpose.	[Turan, Alparslan; Ayad, Sabry; Cohen, Barak; Ruetzler, Kurt; Maheshwari, Kamal; Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA; [Turan, Alparslan; Essber, Hani; Saasouh, Wael; Hovsepyan, Karen; Makarova, Natalya; Ruetzler, Kurt; Soliman, Loran Mounir; Maheshwari, Kamal; Yang, Dongsheng; Mascha, Edward J.; Esa, Wael Ali Sakr] Cleveland Clin, Dept Gen Anesthesiol, Cleveland, OH 44106 USA; [Makarova, Natalya; Yang, Dongsheng; Mascha, Edward J.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Ayad, Sabry] Cleveland Clin, Anesthesiol Inst, Dept Reg Anesthesia, Cleveland, OH 44106 USA; [Cohen, Barak] Tel Aviv Univ, Div Anesthesiol Intens Care & Pain Management, Tel Aviv Med Ctr, Sackler Fac Med, Tel Aviv, Israel; [Kessler, Herman; Delaney, Conor P.] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Tel Aviv University; Sackler Faculty of Medicine; Cleveland Clinic Foundation	Turan, A (corresponding author), Cleveland Clin, Anesthesiol Inst, Dept Outcomes Res, 9500 Euclid Ave,P-77, Cleveland, OH 44195 USA.	turana@ccf.org	Ruetzler, Kurt/P-7101-2019; Ruetzler, Kurt/W-2596-2017; ayad, sabry/ABA-8262-2020	Ruetzler, Kurt/0000-0003-0467-1736; Ruetzler, Kurt/0000-0003-0467-1736; AYAD, SABRY/0000-0002-6728-9297	Mallinckrodt Pharmaceuticals	Mallinckrodt Pharmaceuticals	The study was funded by an investigator-initiated research grant from Mallinckrodt Pharmaceuticals. Sotera and Respiratory Motion provided devices and disposables.	Apfel CC, 1998, ACTA ANAESTH SCAND, V42, P495, DOI 10.1111/j.1399-6576.1998.tb05157.x; Banerjee U, 2018, J ANAESTH CLIN PHARM, V34, P465, DOI 10.4103/joacp.JOACP_276_17; Burbridge MA, 2019, CUREUS, V11, DOI 10.7759/cureus.3863; Cavalcante AN, 2018, J CLIN MONIT COMPUT, V32, P929, DOI 10.1007/s10877-017-0093-0; Crisp CC, 2017, FEMALE PELVIC MED RE, V23, P80, DOI 10.1097/SPV.0000000000000347; Hansen RN, 2017, CURR MED RES OPIN, V33, P943, DOI 10.1080/03007995.2017.1297702; Huang PS, 2018, J ARTHROPLASTY, V33, P1052, DOI 10.1016/j.arth.2017.10.054; Mendoza TR, 2004, CLIN J PAIN, V20, P357, DOI 10.1097/00002508-200409000-00011; Morwald EE, 2018, ANESTH ANALG, V127, P1221, DOI 10.1213/ANE.0000000000003344; Prescott L F, 2000, Am J Ther, V7, P143, DOI 10.1097/00045391-200007020-00011; Rindos NB, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2019.01.212; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Singla NK, 2012, PAIN PRACT, V12, P523, DOI 10.1111/j.1533-2500.2012.00556.x; Smith E, 2019, LARYNGOSCOPE INVEST, V4, P250, DOI 10.1002/lio2.254; Stark PA, 2013, ANESTHESIOLOGY, V118, P1332, DOI 10.1097/ALN.0b013e318289b84b; Stundner O, 2019, REGION ANESTH PAIN M, V44, P565, DOI 10.1136/rapm-2018-100145; Subramaniam B, 2019, JAMA-J AM MED ASSOC, V321, P686, DOI 10.1001/jama.2019.0234; Towers CV, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.203; Turan A, 2013, CLIN J PAIN, V29, P1050, DOI 10.1097/AJP.0b013e318287a258; Turner LC, 2019, OBSTET GYNECOL, V133, P492, DOI 10.1097/AOG.0000000000003102; Tyler MA, 2017, JAMA OTOLARYNGOL, V143, P788, DOI 10.1001/jamaoto.2017.0238; Voscopoulos C, 2013, ANESTH ANALG, V117, P91, DOI 10.1213/ANE.0b013e3182918098; Wang VC, 2018, J PAIN PALLIAT CARE, V32, P82, DOI 10.1080/15360288.2018.1513436; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wasserman I, 2018, ANESTHESIOLOGY, V129, P77, DOI 10.1097/ALN.0000000000002227; Weingarten TN, 2017, CURR OPIN ANESTHESIO, V30, P156, DOI 10.1097/ACO.0000000000000401	26	17	17	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					350	358		10.1001/jama.2020.10009	http://dx.doi.org/10.1001/jama.2020.10009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721009	Green Published, Bronze			2022-12-28	WOS:000562851000024
J	Anderson, MR; Geleris, J; Anderson, DR; Zucker, J; Nobel, YR; Freedberg, D; Small-Saunders, J; Rajagopalan, KN; Greendyk, R; Chae, SR; Natarajan, K; Roh, D; Edwin, E; Gallagher, D; Podolanczuk, A; Barr, RG; Ferrante, AW; Baldwin, MR				Anderson, Michaela R.; Geleris, Joshua; Anderson, David R.; Zucker, Jason; Nobel, Yael R.; Freedberg, Daniel; Small-Saunders, Jennifer; Rajagopalan, Kartik N.; Greendyk, Richard; Chae, Sae-Rom; Natarajan, Karthik; Roh, David; Edwin, Ethan; Gallagher, Dympna; Podolanczuk, Anna; Barr, R. Graham; Ferrante, Anthony W.; Baldwin, Matthew R.			Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE LUNG INJURY; NEW-YORK-CITY; SARCOPENIC OBESITY; ADIPOSE-TISSUE; MORTALITY; OUTCOMES; ASSOCIATION; FRAILTY; TRANSPLANTATION; PULMONARY	Objective: To determine whether obesity is associated with intubation or death, inflammation, cardiac injury, or fibrinolysis in coronavirus disease 2019 (COVID-19). Design: Retrospective cohort study. Setting: A quaternary academic medical center and community hospital in New York City. Participants: 2466 adults hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection over a 45-day period with at least 47 days of in-hospital observation. Measurements: Body mass index (BMI), admission biomarkers of inflammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (troponin level), and fibrinolysis (D-dimer level). The primary end point was a composite of intubation or death in time-to-event analysis. Results: Over a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) were intubated, 627 (25%) died, and 59 (2%) remained hospitalized. Compared with overweight patients, patients with obesity had higher risk for intubation or death, with the highest risk among those with class 3 obesity (hazard ratio, 1.6 [95% CI, 1.1 to 2.1]). This association was primarily observed among patients younger than 65 years and not in older patients (P for interaction by age = 0.042). Body mass index was not associated with admission levels of biomarkers of inflammation, cardiac injury, or fibrinolysis. Limitations: Body mass index was missing for 28% of patients. The primary analyses were conducted with multiple imputation for missing BMI. Upper bounding factor analysis suggested that the results are robust to possible selection bias. Conclusion: Obesity is associated with increased risk for intubation or death from COVID-19 in adults younger than 65 years, but not in adults aged 65 years or older.	[Anderson, Michaela R.; Geleris, Joshua; Zucker, Jason; Nobel, Yael R.; Freedberg, Daniel; Small-Saunders, Jennifer; Rajagopalan, Kartik N.; Chae, Sae-Rom; Natarajan, Karthik; Roh, David; Edwin, Ethan; Podolanczuk, Anna; Ferrante, Anthony W.; Baldwin, Matthew R.] Columbia Univ, Irving Med Ctr, 622 West 168th St,PH9-119, New York, NY 10032 USA; [Anderson, David R.] Villanova Univ, Villanova Sch Business, Villanova, PA 19085 USA; [Greendyk, Richard] NewYork Presbyterian Columbia Univ, Irving Med Ctr, New York, NY 10032 USA; [Gallagher, Dympna] Columbia Univ, Inst Human Nutr, Irving Med Ctr, New York, NY 10032 USA; [Barr, R. Graham] Columbia Univ, Irving Med Ctr, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Geleris, Joshua; Zucker, Jason; Natarajan, Karthik; Podolanczuk, Anna; Barr, R. Graham; Baldwin, Matthew R.] Columbia Univ, Irving Med Ctr, 622 West 168th St,PH8, New York, NY 10032 USA; [Anderson, David R.] Villanova Univ, Dept Management, Bartley Hall,800 Lancaster Ave, Villanova, PA 19085 USA; [Nobel, Yael R.; Freedberg, Daniel] Columbia Univ, Med Ctr, 630 West 168th St,P&S3-401, New York, NY 10032 USA; [Rajagopalan, Kartik N.] Columbia Univ, Med Ctr, 622 West 168th St,PH20-312, New York, NY 10032 USA; [Greendyk, Richard] NewYork Presbyterian Columbia Univ, Med Ctr, 177 Ft Washington,6C-12, New York, NY 10032 USA; [Chae, Sae-Rom] Columbia Univ, Med Ctr, 177 Ft Washington Ave,8MSK, New York, NY 10032 USA; [Roh, David] Columbia Univ, Med Ctr, 177 Ft Washington Ave,8GS-300, New York, NY 10032 USA; [Edwin, Ethan; Ferrante, Anthony W.] Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, Room 243,1150 St Nicholas Ave, New York, NY 10032 USA; [Gallagher, Dympna] Columbia Univ, Med Ctr, Body Composit Unit, 21 Audubon Ave,Suite SB 0172, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Villanova University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Villanova University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; Columbia University; Columbia University	Anderson, MR (corresponding author), Columbia Univ, Irving Med Ctr, 622 West 168th St,PH9-119, New York, NY 10032 USA.	mdr2140@cumc.columbia.edu	Ferrante, Anthony/AAC-7763-2019; Zucker, Jason/H-7241-2019; Baldwin, Matthew/GQY-7234-2022	Ferrante, Anthony/0000-0001-9272-2593; Zucker, Jason/0000-0001-6987-6412; Nobel, Yael/0000-0001-5759-3730; Small-Saunders, Jennifer/0000-0001-6064-2249; Chae, Sae-Rom/0000-0001-5404-7558	National Institutes of Health [K23-HL140199, R01-DK 066525, P30-DK026687, P30-DK063608, R01-LM006910, R01-HL077612, R01-HL093081, R01-HL121270, UL1 TR001873]; Stony Wold-Herbert Foundation; Parker B. Francis Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Wold-Herbert Foundation; Parker B. Francis Foundation	By National Institutes of Health grants K23-HL140199, R01-DK 066525, P30-DK026687, P30-DK063608, supported in part by R01-LM006910, R01-HL077612, R01-HL093081, R01-HL121270, and UL1 TR001873; the Stony Wold-Herbert Foundation; and the Parker B. Francis Foundation.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Afshar-Kharghan V, 2017, BLOOD, V129, P2214, DOI 10.1182/blood-2017-03-771501; [Anonymous], 2020, ANN INTERN MED, V173, P120, DOI [10.7326/M20-1632, DOI 10.7326/M20-1632, DOI 10.7326/M20-2730]; Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652; Baldwin MR, 2012, AM J TRANSPLANT, V12, P1256, DOI 10.1111/j.1600-6143.2011.03965.x; Baldwin MR, 2017, ANN AM THORAC SOC, V14, P1270, DOI 10.1513/AnnalsATS.201612-1008OC; Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419; Brandenberger C, 2018, AGING DIS, V9, P553, DOI 10.14336/AD.2017.0902; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brummel NE, 2017, AM J RESP CRIT CARE, V196, P64, DOI 10.1164/rccm.201605-0939OC; Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC; Cheng FW, 2016, OBESITY, V24, P2232, DOI 10.1002/oby.21612; Choy LN, 1996, OBES RES, V4, P521, DOI 10.1002/j.1550-8528.1996.tb00266.x; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]; Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Faust JS, 2020, JAMA INTERN MED, V180, P1045, DOI 10.1001/jamainternmed.2020.2306; Fernandez R, 2018, J THORAC CARDIOV SUR, V155, P1871, DOI 10.1016/j.jtcvs.2017.11.031; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Gries CJ, 2015, J HEART LUNG TRANSPL, V34, P241, DOI 10.1016/j.healun.2014.09.031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hajifathalian K, 2020, OBESITY, V28, P1606, DOI 10.1002/oby.22923; Hirani V, 2017, AGE AGEING, V46, P413, DOI 10.1093/ageing/afw214; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Johnson S, 1991, Proc Annu Symp Comput Appl Med Care, P381; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; King P, 2013, EUR RESPIR J, V41, P929, DOI 10.1183/09031936.00185211; Korakas E, 2020, AM J PHYSIOL-ENDOC M, V319, pE105, DOI 10.1152/ajpendo.00198.2020; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1016/j.jacc.2020.06.007, 10.1101/2020.04.20.20072702]; Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Magro CM, 2011, AM J CLIN PATHOL, V135, P599, DOI 10.1309/AJCP66QIMFARLZKI; Maurya R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02741; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; National Center for Immunization and Respiratory Diseases, COR DIS 2019 COVID 1; Nie W, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-61; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Oelsner EC, 2014, ANN INTERN MED, V161, P863, DOI 10.7326/M13-2570; Peng Y D, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P450, DOI 10.3760/cma.j.cn112148-20200220-00105; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Phung DT, 2013, OBES REV, V14, P839, DOI 10.1111/obr.12055; Ramsay J, PSPLINE PENALIZED SM; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Smith LH, 2019, EPIDEMIOLOGY, V30, P509, DOI 10.1097/EDE.0000000000001032; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Woolley C, 2019, J NUTR HEALTH AGING, V23, P558, DOI 10.1007/s12603-019-1206-x; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1038/s41591-020-0822-7, 10.1080/10408398.2020.1828813]; Zhi G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163677; Zhu ZZ, 2020, J ALLERGY CLIN IMMUN, V146, P327, DOI 10.1016/j.jaci.2020.06.001	73	105	109	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2020	173	10					782	+		10.7326/M20-3214	http://dx.doi.org/10.7326/M20-3214			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OU5XD	32726151	Green Published			2022-12-28	WOS:000591600700013
J	Chen, J; Malone, B; Llewellyn, E; Grasso, M; Shelton, PMM; Olinares, PDB; Maruthi, K; Eng, ET; Vatandaslar, H; Chait, BT; Kapoor, TM; Darst, SA; Campbell, EA				Chen, James; Malone, Brandon; Llewellyn, Eliza; Grasso, Michael; Shelton, Patrick M. M.; Olinares, Paul Dominic B.; Maruthi, Kashyap; Eng, Edward T.; Vatandaslar, Hasan; Chait, Brian T.; Kapoor, Tarun M.; Darst, Seth A.; Campbell, Elizabeth A.			Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex	CELL			English	Article							RNA-POLYMERASE; CRYO-EM; ARTERIVIRUS HELICASE; ENZYMATIC-ACTIVITIES; CORONAVIRUS; VIRUS; FIDELITY; PROTEIN; DNA; SARS	SARS-CoV-2 is the causative agent of the 2019-2020 pandemic. The SARS-CoV-2 genome is replicated and transcribed by the RNA-dependent RNA polymerase holoenzyme (subunits nsp7/nsp82/nsp12) along with a cast of accessory factors. One of these factors is the nsp13 helicase. Both the holo-RdRp and nsp13 are essential for viral replication and are targets for treating the disease COVID-19. Here we present cryoelectron microscopic structures of the SARS-CoV-2 holo-RdRp with an RNA template product in complex with two molecules of the nsp13 helicase. The Nidovirales order-specific N-terminal domains of each nsp13 interact with the N-terminal extension of each copy of nsp8. One nsp13 also contacts the nsp12 thumb. The structure places the nucleic acid-binding ATPase domains of the helicase directly in front of the replicating-transcribing holo-RdRp, constraining models for nsp13 function. We also observe ADP-Mg2+ bound in the nsp12 N-terminal nidovirus RdRp-associated nucleotidyltransferase domain, detailing a new pocket for anti-viral therapy development.	[Chen, James; Malone, Brandon; Llewellyn, Eliza; Darst, Seth A.; Campbell, Elizabeth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA; [Grasso, Michael; Shelton, Patrick M. M.; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Olinares, Paul Dominic B.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Maruthi, Kashyap; Eng, Edward T.] New York Struct Biol Ctr, Simons Electron Microscopy Ctr, Natl Resource Automated Mol Microscopy, New York, NY 10027 USA; [Vatandaslar, Hasan] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland	Rockefeller University; Rockefeller University; Rockefeller University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Darst, SA; Campbell, EA (corresponding author), Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA.	darst@rockefeller.edu; campbee@rockefeller.edu		Olinares, Paul Dominic/0000-0002-3429-6618; Chen, James/0000-0002-2311-003X; Malone, Brandon/0000-0001-7752-9824; Chait, Brian/0000-0003-3524-557X; Eng, Edward/0000-0002-8014-7269; Maruthi, Kashyap/0000-0001-5290-4413; Vatandaslar, Hasan/0000-0002-8405-9055	NIH National Institute of General Medical Sciences [P41 GM103310]; NYSTAR; Simons Foundation [SF349247]; NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy Program [U24 GM129539]; NY State Assembly Majority; Pels Family Center for Biochemistry and Structural Biology (The Rockefeller University); NIH [P41 GM109824, P41 GM103314, R35 GM130234, R35 GM118130, R01 GM114450]	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NYSTAR; Simons Foundation; NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NY State Assembly Majority; Pels Family Center for Biochemistry and Structural Biology (The Rockefeller University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Aher, J. Berger, R. Landick, and C. Rice for helpful discussions and suggestions; L. Urnavicius (Laboratory of Cell Biology and Laboratory of Chemistry and Cell Biology); M. Ebrahim (The Rockefeller University Evelyn Gruss Lipper Cryo-electron Microscopy Resource Center) and H. Kuang (New York Structural Biology Center [NYSBC]) for help with cryo-EM data collection; T. Tuschl for support; and members of the Chait, Darst/Campbell, and Kapoor laboratories for helpful discussions. We thank B.R. tenOever for SARS-CoV-2 RNA. Some of the work reported here was conducted at the Simons Electron Microscopy Center (SEMC) and the National Resource for Automated Molecular Microscopy (NRAMM) and National Center for CryoEM Access and Training (NCCAT) located at the NYSBC, supported by grants from the NIH National Institute of General Medical Sciences (P41 GM103310), NYSTAR, the Simons Foundation (SF349247), the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy Program (U24 GM129539), and NY State Assembly Majority. This work was supported by the Pels Family Center for Biochemistry and Structural Biology (The Rockefeller University) and NIH grants P41 GM109824 and P41 GM103314 (to B.T.C.), R35 GM130234 (to T.K.), R35 GM118130 (to S.A.D.), and R01 GM114450 (to E.A.C.).	Abdelkareem M, 2019, MOL CELL, V75, P298, DOI 10.1016/j.molcel.2019.04.029; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adedeji AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036521; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Alonso S, 2002, J VIROL, V76, P1293, DOI 10.1128/JVI.76.3.1293-1308.2002; Bautista EM, 2002, VIROLOGY, V298, P258, DOI 10.1006/viro.2002.1495; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Bouhaddou M, 2020, CELL, V182, P685, DOI 10.1016/j.cell.2020.06.034; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Chen J, 2019, J STRUCT BIOL-X, V1, DOI 10.1016/j.yjsbx.2019.100005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cupido T, 2019, NAT CHEM BIOL, V15, P444, DOI 10.1038/s41589-019-0225-6; D. E. Shaw Research, 2020, MOL DYN SIM REL SARS; de Groot R.J., 2012, FAMILY CORONAVIRIDAE, P806, DOI DOI 10.1016/B978-0-12-384684-6.00068-9; Deng ZQ, 2014, NUCLEIC ACIDS RES, V42, P3464, DOI 10.1093/nar/gkt1310; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Dulin D, 2017, CELL REP, V21, P1063, DOI 10.1016/j.celrep.2017.10.005; Dulin D, 2015, NUCLEIC ACIDS RES, V43, P10421, DOI 10.1093/nar/gkv1098; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Hao W, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006474; Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015; Hillen HS, 2020, NATURE, V584, P154, DOI 10.1038/s41586-020-2368-8; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Ivanov KA, 2004, J VIROL, V78, P7833, DOI 10.1128/JVI.78.14.7833-7838.2004; Jia ZH, 2019, NUCLEIC ACIDS RES, V47, P6538, DOI 10.1093/nar/gkz409; Kang JY, 2017, ELIFE, V6, DOI 10.7554/eLife.25478; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lee NR, 2010, NUCLEIC ACIDS RES, V38, P7626, DOI 10.1093/nar/gkq647; Lehmann KC, 2015, NUCLEIC ACIDS RES, V43, P8416, DOI 10.1093/nar/gkv838; Lehmann KC, 2015, VIRUS RES, V202, P12, DOI 10.1016/j.virusres.2014.12.001; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Mohni KN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003652; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Olinares PDB, 2020, METHODS MOL BIOL, V2062, P357, DOI 10.1007/978-1-4939-9822-7_17; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Pasternak AO, 2001, EMBO J, V20, P7220, DOI 10.1093/emboj/20.24.7220; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Pisa R, 2019, CELL CHEM BIOL, V26, P1263, DOI 10.1016/j.chembiol.2019.06.001; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reid DJ, 2019, J AM SOC MASS SPECTR, V30, P118, DOI 10.1007/s13361-018-1951-9; Saberi A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007314; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Seybert A, 2005, J VIROL, V79, P696, DOI 10.1128/JVI.79.2.696-704.2005; Shannon A, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104793; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith EC, 2014, ANNU REV VIROL, V1, P111, DOI 10.1146/annurev-virology-031413-085507; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tvarogova J, 2019, J VIROL, V93, DOI 10.1128/JVI.00291-19; US Food and Drug Administration, 2020, REMD EUA LETT AUTH R; van Dinten LC, 2000, J VIROL, V74, P5213, DOI 10.1128/JVI.74.11.5213-5223.2000; van Marle G, 1999, J VIROL, V73, P5274, DOI 10.1128/JVI.73.7.5274-5281.1999; vanDinten LC, 1996, J VIROL, V70, P6625, DOI 10.1128/JVI.70.10.6625-6633.1996; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Wang Q., 2020, CELL, V368, P1499; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xiao YB, 2012, J VIROL, V86, P4444, DOI 10.1128/JVI.06635-11; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Zhai YJ, 2005, NAT STRUCT MOL BIOL, V12, P980, DOI 10.1038/nsmb999; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang R, 2015, J VIROL, V89, P3598, DOI 10.1128/JVI.03535-14; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zuniga S, 2004, J VIROL, V78, P980, DOI 10.1128/JVI.78.2.980-994.2004	105	206	207	8	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2020	182	6					1560	+		10.1016/j.cell.2020.07.033	http://dx.doi.org/10.1016/j.cell.2020.07.033			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NR3DQ	32783916	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000571443300018
J	Wolff, G; Limpens, RWAL; Zevenhoven-Dobbe, JC; Laugks, U; Zheng, S; de Jong, AWM; Koning, RI; Agard, DA; Grunewald, K; Koster, AJ; Snijder, EJ; Barcena, M				Wolff, Georg; Limpens, Ronald W. A. L.; Zevenhoven-Dobbe, Jessika C.; Laugks, Ulrike; Zheng, Shawn; de Jong, Anja W. M.; Koning, Roman, I; Agard, David A.; Grunewald, Kay; Koster, Abraham J.; Snijder, Eric J.; Barcena, Montserrat			A molecular pore spans the double membrane of the coronavirus replication organelle	SCIENCE			English	Article							MOUSE HEPATITIS-VIRUS; CRYOELECTRON TOMOGRAPHY; NONSTRUCTURAL PROTEIN-3; NUCLEOCAPSID PROTEIN; SARS-CORONAVIRUS; RNA-SYNTHESIS; TOPOLOGY; IMPLEMENTATION; VISUALIZATION; INSIGHTS	Coronavirus genome replication is associated with virus-induced cytosolic double-membrane vesicles, which may provide a tailored microenvironment for viral RNA synthesis in the infected cell. However, it is unclear how newly synthesized genomes and messenger RNAs can travel from these sealed replication compartments to the cytosol to ensure their translation and the assembly of progeny virions. In this study, we used cellular cryo-electron microscopy to visualize a molecular pore complex that spans both membranes of the double-membrane vesicle and would allow export of RNA to the cytosol. A hexameric assembly of a large viral transmembrane protein was found to form the core of the crown-shaped complex. This coronavirus-specific structure likely plays a key role in coronavirus replication and thus constitutes a potential drug target.	[Wolff, Georg; Limpens, Ronald W. A. L.; de Jong, Anja W. M.; Koning, Roman, I; Koster, Abraham J.; Barcena, Montserrat] Leiden Univ, Dept Cell & Chem Biol, Sect Electron Microscopy, Med Ctr, NL-2333 ZC Leiden, Netherlands; [Zevenhoven-Dobbe, Jessika C.; Snijder, Eric J.] Leiden Univ, Dept Med Microbiol, Mol Virol Lab, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Laugks, Ulrike; Grunewald, Kay] Heinrich Pette Inst, Ctr Struct Syst Biol, Leibnitz Inst Expt Virol, Dept Struct Cell Biol Viruses, D-22607 Hamburg, Germany; [Zheng, Shawn] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Grunewald, Kay] Univ Hamburg, MIN Fac, Dept Chem, D-20146 Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Heinrich Pette Institute; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Hamburg	Barcena, M (corresponding author), Leiden Univ, Dept Cell & Chem Biol, Sect Electron Microscopy, Med Ctr, NL-2333 ZC Leiden, Netherlands.	m.barcena@lumc.nl	Grünewald, Kay/AAW-3652-2020; Snijder, Eric J./E-6073-2018; Barcena, Montserrat/B-5823-2012; Koster, Abraham/I-7665-2017	Grünewald, Kay/0000-0002-4788-2691; Snijder, Eric J./0000-0003-3297-2309; Barcena, Montserrat/0000-0002-7719-4443; Koster, Abraham/0000-0003-1717-2549; Limpens, Ronald/0000-0002-6243-6729; Wolff, Georg/0000-0002-1202-3344; Koning, Roman/0000-0001-6736-7147; Zheng, Shawn/0000-0001-9517-3075; Laugks, Ulrike/0000-0003-4175-4354; de Jong, Anja/0000-0001-8110-8520	Dutch Roadmap Grant NEMI (NWO grant) [184.034.014]; NIH [R35GM118099, U19 AI135990]; Howard Hughes Medical Institute; BMBF [05K18BHA]; DFG [EXC 2155, INST 152/772-1, INST 777-1 FUGG]; wakeuptocorona crowdfunding initiative of the Leiden University Fund (LUF); LUMC Bontius Foundation; SCORE project (European Union's Horizon 2020 research and innovation program) [101003627]	Dutch Roadmap Grant NEMI (NWO grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); wakeuptocorona crowdfunding initiative of the Leiden University Fund (LUF); LUMC Bontius Foundation; SCORE project (European Union's Horizon 2020 research and innovation program)	Access to NeCEN was made possible through financial support from the Dutch Roadmap Grant NEMI (NWO grant 184.034.014). D.A.A. was supported by NIH grants R35GM118099 and U19 AI135990. S.Z. was supported by the Howard Hughes Medical Institute. K.G. was supported by BMBF grant 05K18BHA and DFG grants EXC 2155, INST 152/772-1, and INST 777-1 FUGG. E.J.S. was supported by the #wakeuptocorona crowdfunding initiative of the Leiden University Fund (LUF) and LUMC Bontius Foundation and by the SCORE project (European Union's Horizon 2020 research and innovation program, grant 101003627).	Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811; Angelini MM, 2013, MBIO, V4, DOI 10.1128/mBio.00524-13; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106; Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Cong YY, 2020, J VIROL, V94, DOI 10.1128/JVI.01925-19; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; Ding K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10236-7; Ertel KJ, 2017, ELIFE, V6, DOI 10.7554/eLife.25940; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Freeman MC, 2014, J VIROL, V88, P5319, DOI 10.1128/JVI.00021-14; Gadlage MJ, 2010, J VIROL, V84, P280, DOI 10.1128/JVI.01772-09; Graham RL, 2006, ADV EXP MED BIOL, V581, P67; Gui M, 2017, PROTEIN CELL, V8, P219, DOI 10.1007/s13238-016-0352-8; Hagemeijer MC, 2014, VIROLOGY, V458, P125, DOI 10.1016/j.virol.2014.04.027; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hurst KR, 2013, J VIROL, V87, P9159, DOI 10.1128/JVI.01275-13; Kanjanahaluethai A, 2007, VIROLOGY, V361, P391, DOI 10.1016/j.virol.2006.12.009; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuo LL, 2016, VIROLOGY, V494, P100, DOI 10.1016/j.virol.2016.04.009; Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001; Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193; Maier HJ, 2013, MBIO, V4, DOI 10.1128/mBio.00801-13; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Neuman BW, 2016, ANTIVIR RES, V135, P97, DOI 10.1016/j.antiviral.2016.10.005; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; Oostra M, 2007, J VIROL, V81, P12323, DOI 10.1128/JVI.01506-07; Oostra M, 2008, J VIROL, V82, P12392, DOI 10.1128/JVI.01219-08; Oudshoorn D, 2017, MBIO, V8, DOI 10.1128/mBio.01658-17; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Serrano P, 2007, J VIROL, V81, P12049, DOI 10.1128/JVI.00969-07; Sevajol M, 2014, VIRUS RES, V194, P90, DOI 10.1016/j.virusres.2014.10.008; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Snijder EJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000715; Subissi L, 2014, ANTIVIR RES, V101, P122, DOI 10.1016/j.antiviral.2013.11.006; Ulasli M, 2010, CELL MICROBIOL, V12, P844, DOI 10.1111/j.1462-5822.2010.01437.x; V'kovski P, 2019, ELIFE, V8, DOI 10.7554/eLife.42037; Wolff G, 2019, J STRUCT BIOL, V208, DOI 10.1016/j.jsb.2019.09.006; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	50	177	181	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2020	369	6509			SI		1395	+		10.1126/science.abd3629	http://dx.doi.org/10.1126/science.abd3629			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO9YB	32763915	Green Published, Green Submitted			2022-12-28	WOS:000569840300058
J	Dias, JJ; Brealey, SD; Fairhurst, C; Amirfeyz, R; Bhowal, B; Blewitt, N; Brewster, M; Brown, D; Choudhary, S; Coapes, C; Cook, L; Costa, M; Davis, T; Di Mascio, L; Giddins, G; Hedley, H; Hewitt, C; Hinde, S; Hobby, J; Hodgson, S; Jefferson, L; Jeyapalan, K; Johnston, P; Jones, J; Keding, A; Leighton, P; Logan, A; Mason, W; McAndrew, A; McNab, I; Muir, L; Nicholl, J; Northgraves, M; Palmer, J; Poulter, R; Rahimtoola, Z; Rangan, A; Richards, S; Richardson, G; Stuart, P; Taub, N; Tavakkolizadeh, A; Tew, G; Thompson, J; Torgerson, D; Warwick, D				Dias, Joseph J.; Brealey, Stephen D.; Fairhurst, Caroline; Amirfeyz, Rouin; Bhowal, Bhaskar; Blewitt, Neil; Brewster, Mark; Brown, Daniel; Choudhary, Surabhi; Coapes, Christopher; Cook, Liz; Costa, Matthew; Davis, Tim; Di Mascio, Livio; Giddins, Grey; Hedley, Helen; Hewitt, Catherine; Hinde, Sebastian; Hobby, Jonathan; Hodgson, Stephen; Jefferson, Laura; Jeyapalan, Kanagaratnam; Johnston, Phillip; Jones, Jonathon; Keding, Ada; Leighton, Paul; Logan, Andrew; Mason, Will; McAndrew, Andrew; McNab, Ian; Muir, Lindsay; Nicholl, James; Northgraves, Matthew; Palmer, Jared; Poulter, Rob; Rahimtoola, Zulfi; Rangan, Amar; Richards, Simon; Richardson, Gerry; Stuart, Paul; Taub, Nicholas; Tavakkolizadeh, Adel; Tew, Garry; Thompson, John; Torgerson, David; Warwick, David			Surgery versus cast immobilisation for adults with a bicortical fracture of the scaphoid waist (SWIFFT): a pragmatic, multicentre, open-label, randomised superiority trial	LANCET			English	Article							PERCUTANEOUS SCREW FIXATION; CONSERVATIVE TREATMENT; FOLLOW-UP; EPIDEMIOLOGY	Background Scaphoid fractures account for 90% of carpal fractures and occur predominantly in young men. The use of immediate surgical fixation to manage this type of fracture has increased, despite insufficient evidence of improved outcomes over non-surgical management. The SWIFFT trial compared the clinical effectiveness of surgical fixation with cast immobilisation and early fixation of fractures that fail to unite in adults with scaphoid waist fractures displaced by 2 mm or less. Methods This pragmatic, parallel-group, multicentre, open-label, two-arm, randomised superiority trial included adults (aged 16 years or older) who presented to orthopaedic departments of 31 hospitals in England and Wales with a clear bicortical fracture of the scaphoid waist on radiographs. An independent remote randomisation service used a computer-generated allocation sequence with randomly varying block sizes to randomly assign participants (1:1) to receive either early surgical fixation (surgery group) or below-elbow cast immobilisation followed by immediate fixation if non-union of the fracture was confirmed (cast immobilisation group). Randomisation was stratified by whether or not there was displacement of either a step or a gap of 1-2 mm inclusive on any radiographic view. The primary outcome was the total patient-rated wrist evaluation (PRWE) score at 52 weeks after randomisation, and it was analysed on an available case intention-to-treat basis. This trial is registered with the ISRCTN registry, ISRCTN67901257, and is no longer recruiting, but long-term follow-up is ongoing. Findings Between July 23, 2013, and July 26, 2016, 439 (42%) of 1047 assessed patients (mean age 33 years; 363 [83%] men) were randomly assigned to the surgery group (n=219) or to the cast immobilisation group (n=220). Of these, 408 (93%) participants were included in the primary analysis (203 participants in the surgery group and 205 participants in the cast immobilisation group). 16 participants in the surgery group and 15 participants in the cast immobilisation group were excluded because of either withdrawal, no response, or no follow-up data at 6, 12, 26, or 52 weeks. There was no significant difference in mean PRWE scores at 52 weeks between the surgery group (adjusted mean 11 center dot 9 [95% CI 9 center dot 2-14 center dot 5]) and the cast immobilisation group (14 center dot 0 [11 center dot 3 to 16 center dot 6]; adjusted mean difference -2 center dot 1 [95% CI -5 center dot 8 to 1 center dot 6], p=0 center dot 27). More participants in the surgery group (31 [14%] of 219 participants) had a potentially serious complication from surgery than in the cast immobilisation group (three [1%] of 220 participants), but fewer participants in the surgery group (five [2%]) had cast-related complications than in the cast immobilisation group (40 [18%]). The number of participants who had a medical complication was similar between the two groups (four [2%] in the surgery group and five [2%] in the cast immobilisation group). Interpretation Adult patients with scaphoid waist fractures displaced by 2 mm or less should have initial cast immobilisation, and any suspected non-unions should be confirmed and immediately fixed with surgery. This treatment strategy will help to avoid the risks of surgery and mostly limit the use of surgery to fixing fractures that fail to unite. Copyright (c) 2020 Elsevier Ltd. All rights reserved.	[Dias, Joseph J.; Bhowal, Bhaskar; Jeyapalan, Kanagaratnam; Palmer, Jared] Univ Hosp Leicester Natl Hlth Serv NHS Trust, Leicester Gen Hosp, Leicester, Leics, England; [Brealey, Stephen D.; Fairhurst, Caroline; Cook, Liz; Hewitt, Catherine; Keding, Ada; Rangan, Amar; Torgerson, David] Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England; [Hinde, Sebastian; Richardson, Gerry] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Jefferson, Laura] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Amirfeyz, Rouin] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Infirm, Bristol, Avon, England; [Blewitt, Neil] Southmead Hosp, North Bristol NHS Trust, Bristol, Avon, England; [Brewster, Mark; Choudhary, Surabhi] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Brown, Daniel] Royal Liverpool Univ Hosp, Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Coapes, Christopher] James Cook Univ Hosp, South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England; [Costa, Matthew] John Radcliffe Hosp, Kadoorie Ctr, Oxford, England; [Davis, Tim] Nottingham Univ Hosp NHS Trust, Queens Med Ctr Campus, Nottingham, England; [Di Mascio, Livio] Royal London Hosp, Barts Hlth NHS Trust, London, England; [Giddins, Grey] Royal United Hosp Bath NHS Trust, Royal United Hosp, Bath, Avon, England; [Hedley, Helen] Univ Hosp Coventry & Warwickshire NHS Trust, Univ Hosp, Coventry, W Midlands, England; [Hobby, Jonathan] Hampshire Hosp NHS Fdn Trust, Basingstoke & North Hampshire Hosp, Basingstoke, Hants, England; [Hodgson, Stephen] Royal Bolton Hosp, Bolton NHS Fdn Trust, Bolton, England; [Johnston, Phillip] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Jones, Jonathon] Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Peterborough, England; [Leighton, Paul] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Logan, Andrew] Cardiff & Vale Univ Hlth Board, Univ Hosp Wales, Cardiff, Wales; [Mason, Will] Gloucestershire Hosp NHS Fdn Trust, Gloucestershire Royal Hosp, Gloucester, England; [McAndrew, Andrew; Rahimtoola, Zulfi] Royal Berkshire NHS Fdn Trust, Royal Berkshire Hosp, Reading, Berks, England; [McNab, Ian] Oxford Univ Hosp NHS Trust, Oxford, England; [Costa, Matthew; Rangan, Amar] Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Muir, Lindsay] Salford Royal Hosp NHS Fdn Trust, Salford, Lancs, England; [Nicholl, James] Maidstone & Tunbridge Wells NHS Trust, Tunbridge Wells, Kent, England; [Northgraves, Matthew] Univ Hull, Hull Hlth Trials Unit, Kingston Upon Hull, N Humberside, England; [Poulter, Rob] Royal Cornwall Hosp NHS Trust, Royal Cornwall Hosp, Truro, Cornwall, England; [Richards, Simon] Poole Hosp NHS Fdn Trust, Poole, Dorset, England; [Stuart, Paul] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Taub, Nicholas; Thompson, John] Univ Leicester, Dept Hlth Sci, George Davies Ctr, Leicester, Leics, England; [Tavakkolizadeh, Adel] Kings Coll Hosp NHS Fdn Trust, Kings Coll Hosp, London, England; [Tew, Garry] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England; [Warwick, David] Univ Hosp Southampton NHS Fdn Trust, Southampton Gen Hosp, Southampton, Hants, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of York - UK; University of York - UK; University of York - UK; Bristol Royal Infirmary; University of Bristol; North Bristol NHS Trust; Southmead Hospital; University of Birmingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; James Cook University Hospital; University of Oxford; Nottingham University Hospital NHS Trust; Barts Health NHS Trust; Royal London Hospital; University of Warwick; Royal Bolton Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; Cardiff University; Gloucestershire Hospitals NHS Foundation Trust; Gloucestershire Royal Hospital; Royal Berkshire Hospital; Oxford University Hospitals NHS Foundation Trust; Nuffield Orthopaedic Centre; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Hull; Royal Cornwall Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Leicester; King's College Hospital NHS Foundation Trust; King's College Hospital; Northumbria University; University of Southampton; University Hospital Southampton NHS Foundation Trust	Dias, JJ (corresponding author), Univ Hosp Leicester NHSTrust, Leicester Gen Hosp, Leicester LE5 4PW, Leics, England.	jd96@le.ac.uk		Brown, Daniel John/0000-0002-0398-7053; Tew, Garry/0000-0002-8610-0613; Cook, Liz/0000-0001-6902-0235; Jefferson, Laura/0000-0003-2139-3555; Leighton, Paul/0000-0001-5208-0274; Hinde, Sebastian/0000-0002-7117-4142; Rangan, Amar/0000-0002-5452-8578; Northgraves, Matthew/0000-0001-9260-8643; brealey, stephen/0000-0001-9749-7014; Palmer, Jared/0000-0001-9667-8016; Muir, Lindsay/0000-0002-8949-9148; Hewitt, Catherine Elizabeth/0000-0002-0415-3536	National Institute for Health Research Health Technology Assessment Programme	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment Programme.	Adolfsson L, 2001, J HAND SURG-BRIT EUR, V26, P192, DOI 10.1054/jhsb.2001.0558; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arora R, 2007, ARCH ORTHOP TRAUM SU, V127, P39, DOI 10.1007/s00402-006-0229-z; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Bond CD, 2001, J BONE JOINT SURG AM, V83A, P483, DOI 10.2106/00004623-200104000-00001; CLAY NR, 1991, J BONE JOINT SURG BR, V73, P828, DOI 10.1302/0301-620X.73B5.1894676; Clementson M, 2015, J HAND SURG-AM, V40, P1341, DOI 10.1016/j.jhsa.2015.03.007; Dias JJ, 2008, J BONE JOINT SURG BR, V90B, P899, DOI 10.1302/0301-620X.90B7.20371; Dias JJ, 2011, J BONE JOINT SURG BR, V93B, P1433, DOI 10.1302/0301-620X.93B11.26934; Dias JJ, 2005, J BONE JOINT SURG AM, V87A, P2160, DOI 10.2106/JBJS.D.02305; Dias J, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1107-7; Dy Christopher J, 2018, HSS J, V14, P245, DOI 10.1007/s11420-018-9619-3; Garala K, 2016, BONE JOINT J, V98B, P654, DOI 10.1302/0301-620X.98B5.36938; Grewal R, 2009, J HAND SURG-AM, V34A, P732, DOI 10.1016/j.jhsa.2008.12.027; Hove LM, 1999, SCAND J PLAST RECONS, V33, P423, DOI 10.1080/02844319950159145; Ibrahim T, 2011, J HAND SURG-AM, V36A, P1759, DOI 10.1016/j.jhsa.2011.08.033; Li HY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013266; MacDermid J, 2007, PATIENT RATED WRIST; MACK GR, 1984, J BONE JOINT SURG AM, V66A, P504, DOI 10.2106/00004623-198466040-00003; McQueen MM, 2008, J BONE JOINT SURG BR, V90B, P66, DOI 10.1302/0301-620X.90B1.19767; Mehta SP, 2015, J ORTHOP SPORT PHYS, V45, P289, DOI 10.2519/jospt.2015.5236; Raittio LT, 2018, J HAND SURG-EUR VOL, V43, P402, DOI 10.1177/1753193417726051; Saeden B, 2001, J BONE JOINT SURG BR, V83B, P230, DOI 10.1302/0301-620X.83B2.11197; Shen LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125247; Singh HP, 2005, J HAND SURG-BRIT EUR, V30B, P440, DOI 10.1016/j.jhsb.2005.05.007; Sussman JB, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2073; ten Berg PWL, 2015, J HAND SURG-AM, V40, P67, DOI 10.1016/j.jhsa.2014.10.037; The NHS Information Centre, 2010, HOSP EP STAT ENGL IN; Vinnars B, 2008, J BONE JOINT SURG AM, V90A, P1176, DOI 10.2106/JBJS.G.00673; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	31	26	28	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					390	401						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0SW	32771106	Green Accepted, Green Submitted			2022-12-28	WOS:000561619100023
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			THE LONG HAUL	SCIENCE			English	Editorial Material																			0	12	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					614	617		10.1126/science.369.6504.614	http://dx.doi.org/10.1126/science.369.6504.614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764050				2022-12-28	WOS:000559184400019
J	Knops, RE; Nordkamp, LRAO; Delnoy, PPHM; Boersma, LVA; Kuschyk, J; El-Chami, MF; Bonnemeier, H; Behr, ER; Brouwer, TF; Kaab, S; Mittal, S; Quast, AFBE; Smeding, L; van der Stuijt, W; de Weger, A; de Wilde, KC; Bijsterveld, NR; Richter, S; Brouwer, MA; de Groot, JR; Kooiman, KM; Lambiase, PD; Neuzil, P; Vernooy, K; Alings, M; Betts, TR; Bracke, FALE; Burke, MC; de Jong, JSSG; Wright, DJ; Tijssen, JGP; Wilde, AAM				Knops, Reinoud E.; Nordkamp, Louise R. A. Olde; Delnoy, Peter-Paul H. M.; Boersma, Lucas V. A.; Kuschyk, Juergen; El-Chami, Mikhael F.; Bonnemeier, Hendrik; Behr, Elijah R.; Brouwer, Tom F.; Kaab, Stefan; Mittal, Suneet; Quast, Anne-Floor B. E.; Smeding, Lonneke; van der Stuijt, Willeke; de Weger, Anouk; de Wilde, Koen C.; Bijsterveld, Nick R.; Richter, Sergio; Brouwer, Marc A.; de Groot, Joris R.; Kooiman, Kirsten M.; Lambiase, Pier D.; Neuzil, Petr; Vernooy, Kevin; Alings, Marco; Betts, Tim R.; Bracke, Frank A. L. E.; Burke, Martin C.; de Jong, Jonas S. S. G.; Wright, David J.; Tijssen, Jan G. P.; Wilde, Arthur A. M.		PRAETORIAN Investigators	Subcutaneous or Transvenous Defibrillator Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SHOCKS; PREVENTION; EFFICACY; OUTCOMES; SAFETY	BACKGROUND The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based primarily on observational studies. METHODS We conducted a noninferiority trial in which patients with an indication for an ICD but no indication for pacing were assigned to receive a subcutaneous ICD or transvenous ICD. The primary end point was the composite of device-related complications and inappropriate shocks; the noninferiority margin for the upper boundary of the 95% confidence interval for the hazard ratio (subcutaneous ICD vs. transvenous ICD) was 1.45. A superiority analysis was prespecified if noninferiority was established. Secondary end points included death and appropriate shocks. RESULTS A total of 849 patients (426 in the subcutaneous ICD group and 423 in the transvenous ICD group) were included in the analyses. At a median follow-up of 49.1 months, a primary end-point event occurred in 68 patients in the subcutaneous ICD group and in 68 patients in the transvenous ICD group (48-month Kaplan-Meier estimated cumulative incidence, 15.1% and 15.7%, respectively; hazard ratio, 0.99; 95% confidence interval [CI], 0.71 to 1.39; P=0.01 for noninferiority; P=0.95 for superiority). Device-related complications occurred in 31 patients in the subcutaneous ICD group and in 44 in the transvenous ICD group (hazard ratio, 0.69; 95% CI, 0.44 to 1.09); inappropriate shocks occurred in 41 and 29 patients, respectively (hazard ratio, 1.43; 95% CI, 0.89 to 2.30). Death occurred in 83 patients in the subcutaneous ICD group and in 68 in the transvenous ICD group (hazard ratio, 1.23; 95% CI, 0.89 to 1.70); appropriate shocks occurred in 83 and 57 patients, respectively (hazard ratio, 1.52; 95% CI, 1.08 to 2.12). CONCLUSIONS In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to device-related complications and inappropriate shocks.	[Knops, Reinoud E.; Nordkamp, Louise R. A. Olde; Boersma, Lucas V. A.; Brouwer, Tom F.; Quast, Anne-Floor B. E.; Smeding, Lonneke; van der Stuijt, Willeke; de Weger, Anouk; de Wilde, Koen C.; de Groot, Joris R.; Kooiman, Kirsten M.; Burke, Martin C.; Tijssen, Jan G. P.; Wilde, Arthur A. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Cardiovasc Sci, Heart Ctr,Dept Clin & Expt Cardiol, Amsterdam, Netherlands; [Behr, Elijah R.; Lambiase, Pier D.; Wilde, Arthur A. M.] OLVG, ERN GUARD Heart, Amsterdam, Netherlands; [de Jong, Jonas S. S. G.] OLVG, Dept Cardiol, Amsterdam, Netherlands; [Delnoy, Peter-Paul H. M.] Isala Heart Ctr, Dept Cardiol, Zwolle, Netherlands; [Boersma, Lucas V. A.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Bijsterveld, Nick R.] Flevoziekenhuis, Dept Cardiol, Almere, Netherlands; [Brouwer, Marc A.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Vernooy, Kevin] Maastricht Univ, Med Ctr, Dept Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Alings, Marco] Amphia Hosp, Dept Cardiol, Breda, Netherlands; [Alings, Marco] Werkgrp Cardiol Ctr Nederland, Utrecht, Netherlands; [Bracke, Frank A. L. E.] Catharina Hosp, Dept Electrophysiol, Eindhoven, Netherlands; [Kuschyk, Juergen] Univ Med Ctr Mannheim, Dept Med Cardiol, Mannheim, Germany; [Kuschyk, Juergen] German Ctr Cardiovasc Res, Partner Site Heidelberg Mannheim, Mannheim, Germany; [Bonnemeier, Hendrik] Univ Klinikum Schleswig Holstein, Innere Med Klin 3, Schwerpunkt Kardiol & Angiol, Campus Kiel, Kiel, Germany; [Kaab, Stefan] Ludwig Maximilians Univ Hosp, Dept Med 1, Munich, Germany; [Kaab, Stefan] Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Richter, Sergio] Univ Leipzig, Dept Electrophysiol, Ctr Heart, Leipzig, Germany; [El-Chami, Mikhael F.] Emory Univ, Div Cardiol, Sect Electrophysiol, Atlanta, GA 30322 USA; [Behr, Elijah R.] St Georges Univ London, Cardiol Clin Acad Grp, London, England; [Behr, Elijah R.] St Georges Univ Hosp NHS Fdn Trust London, London, England; [Lambiase, Pier D.] UCL, Off Director Clin Electrophysiol Res, London, England; [Lambiase, Pier D.] UCL, Inherited Arrhythmia Specialist Serv, London, England; [Lambiase, Pier D.] Barts Heart Ctr, London, England; [Betts, Tim R.] Oxford Univ Hosp NHS Trust, Oxford Biomed Res Ctr, Oxford, England; [Wright, David J.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England; [Mittal, Suneet] Valley Hlth Syst, Ridgewood, NJ USA; [Neuzil, Petr] Homolka Hosp, Dept Cardiol, Prague, Czech Republic; [Burke, Martin C.] CorVita Sci Fdn, Chicago, IL USA	University of Amsterdam; St. Antonius Hospital Utrecht; Radboud University Nijmegen; Maastricht University; Amphia Hospital; Catharina Hospital; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; University of Kiel; Schleswig Holstein University Hospital; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Emory University; St Georges University London; University of London; University College London; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Liverpool Heart & Chest Hospital; Na Homolce Hospital	Knops, RE (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Clin & Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.e.knops@amsterdamumc.nl	Olde Nordkamp, Louise/GXM-6290-2022; Richter, Sergio/AAW-6105-2020; Nordbeck, Peter/D-4771-2018; Bracke, Frank/AAI-9237-2021; Brouwer, Marc A/B-1158-2014; van der Stuijt, Willeke/AAT-4801-2021; Knops, R/AAX-2027-2021	Nordbeck, Peter/0000-0002-2560-4068; Bracke, Frank/0000-0002-2726-4327; Boersma, Lucas/0000-0003-4591-4220; Smeding, Lonneke/0000-0002-7558-9011; van der Stuijt, Willeke/0000-0002-2236-3983; Vernooy, Kevin/0000-0002-8818-5964; Behr, Elijah/0000-0002-8731-2853; Lambiase, Pier/0000-0002-9055-9267	Boston Scientific	Boston Scientific(Boston Scientific)	Supported by Boston Scientific.	Al-Khatib SM, 2018, CIRCULATION, V138, P272; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bardy GH, 2010, NEW ENGL J MED, V363, P36, DOI 10.1056/NEJMoa0909545; Boersma LV, 2019, HEART RHYTHM, V16, P1636, DOI 10.1016/j.hrthm.2019.04.048; Brouwer TF, 2016, J AM COLL CARDIOL, V68, P2047, DOI 10.1016/j.jacc.2016.08.044; Burke MC, 2015, J AM COLL CARDIOL, V65, P1605, DOI 10.1016/j.jacc.2015.02.047; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Koneru JN, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007691; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Nordkamp LRAO, 2012, AM HEART J, V163, P753, DOI 10.1016/j.ahj.2012.02.012; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Quast AFBE, 2018, J CARDIOVASC ELECTR, V29, P1010, DOI 10.1111/jce.13498; Sears SF, 2018, HEART RHYTHM, V15, P734, DOI 10.1016/j.hrthm.2017.12.026; Theuns DAMJ, 2018, HEART RHYTHM, V15, P1515, DOI 10.1016/j.hrthm.2018.05.011; Weiss R, 2013, CIRCULATION, V128, P944, DOI 10.1161/CIRCULATIONAHA.113.003042; Wilkoff BL, 2008, J AM COLL CARDIOL, V52, P541, DOI 10.1016/j.jacc.2008.05.011	20	143	144	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					526	536		10.1056/NEJMoa1915932	http://dx.doi.org/10.1056/NEJMoa1915932			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	32757521	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000560438400015
J	Matheson, NJ; Lehner, PJ				Matheson, Nicholas J.; Lehner, Paul J.			How does SARS-CoV-2 cause COVID-19?	SCIENCE			English	Editorial Material							SPIKE; SARS		[Matheson, Nicholas J.; Lehner, Paul J.] Univ Cambridge, Dept Med, Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England; [Matheson, Nicholas J.] NHS Blood & Transplant, Cambridge, England	University of Cambridge	Matheson, NJ (corresponding author), Univ Cambridge, Dept Med, Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England.; Matheson, NJ (corresponding author), NHS Blood & Transplant, Cambridge, England.	njm25@cam.ac.uk; pjl30@cam.ac.uk		Matheson, Nicholas/0000-0002-3318-1851	Medical Research Council [CSF MR/P008801/1]; NHS Blood and Transplant [WPA15-02]; Wellcome Trust [PRF 210688/Z/18/Z]; MRC [MR/P008801/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS Blood and Transplant; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are supported by the Medical Research Council (CSF MR/P008801/1 to N.J.M.), NHS Blood and Transplant (WPA15-02 to N.J.M.), and the Wellcome Trust (PRF 210688/Z/18/Zto P.J.L.).	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Kuba K, 2006, J MOL MED, V84, P814, DOI 10.1007/s00109-006-0094-9; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	14	97	99	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					510	511		10.1126/science.abc6156	http://dx.doi.org/10.1126/science.abc6156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732413				2022-12-28	WOS:000556568100028
J	O'Dowd, A				O'Dowd, Adrian			Covid-19: Government failed to protect social care during pandemic, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Foundation, 2020, AD SOC CAR COVID 19; Health Foundation, 2020, AD SIC CAR COVID 19; O'Dowd A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3015	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3030	10.1136/bmj.m3030	http://dx.doi.org/10.1136/bmj.m3030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732321	Bronze			2022-12-28	WOS:000556139900011
J	Mahase, E				Mahase, Elisabeth			Doctors warned over "street benzos" linked to hospital admissions and deaths	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Medicines and Healthcare Products Regulatory Agency, 2020, EV HARM ILL FAK BENZ	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2995	10.1136/bmj.m2995	http://dx.doi.org/10.1136/bmj.m2995			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32718975				2022-12-28	WOS:000554458200001
J	Dyer, C				Dyer, Clare			Covid-19: Healthcare professional is referred to regulator for delaying a because of lack of PPE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2020	370								m3201	10.1136/bmj.m3201	http://dx.doi.org/10.1136/bmj.m3201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7NA	32788175	Bronze			2022-12-28	WOS:000560700100002
J	Wang, W; Withers, J; Li, H; Zwack, PJ; Rusnac, DV; Shi, H; Liu, LJ; Yan, SP; Hinds, TR; Guttman, M; Dong, XN; Zheng, N				Wang, Wei; Withers, John; Li, Heng; Zwack, Paul J.; Rusnac, Domnita-Valeria; Shi, Hui; Liu, Lijing; Yan, Shunping; Hinds, Thomas R.; Guttman, Mikelos; Dong, Xinnian; Zheng, Ning			Structural basis of salicylic acid perception byArabidopsisNPR proteins	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ARABIDOPSIS; NPR1; TOBACCO; SIGNAL; FAMILY	Structural determination of the salicylic-acid-binding core ofArabidopsisNPR4 sheds light on the mechanisms through which this plant hormone interacts with its receptors, providing insights that are of potential use in engineering enhanced immunity. Salicylic acid (SA) is a plant hormone that is critical for resistance to pathogens(1-3). The NPR proteins have previously been identified as SA receptors(4-10), although how they perceive SA and coordinate hormonal signalling remain unknown. Here we report the mapping of the SA-binding core ofArabidopsis thalianaNPR4 and its ligand-bound crystal structure. The SA-binding core domain of NPR4 refolded with SA adopts an alpha-helical fold that completely buries SA in its hydrophobic core. The lack of a ligand-entry pathway suggests that SA binding involves a major conformational remodelling of the SA-binding core of NPR4, which we validated using hydrogen-deuterium-exchange mass spectrometry analysis of the full-length protein and through SA-induced disruption of interactions between NPR1 and NPR4. We show that, despite the two proteins sharing nearly identical hormone-binding residues, NPR1 displays minimal SA-binding activity compared to NPR4. We further identify two surface residues of the SA-binding core, the mutation of which can alter the SA-binding ability of NPR4 and its interaction with NPR1. We also demonstrate that expressing a variant of NPR4 that is hypersensitive to SA could enhance SA-mediated basal immunity without compromising effector-triggered immunity, because the ability of this variant to re-associate with NPR1 at high levels of SA remains intact. By revealing the structural mechanisms of SA perception by NPR proteins, our work paves the way for future investigation of the specific roles of these proteins in SA signalling and their potential for engineering plant immunity.	[Wang, Wei; Li, Heng; Rusnac, Domnita-Valeria; Shi, Hui; Hinds, Thomas R.; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Wang, Wei] Henan Univ, Sch Life Sci, State Key Lab Crop Stress Adaptat & Improvement, Kaifeng, Peoples R China; [Withers, John; Zwack, Paul J.; Liu, Lijing; Yan, Shunping; Dong, Xinnian] Duke Univ, Howard Hughes Med Inst, Dept Biol, Durham, NC 27708 USA; [Guttman, Mikelos] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Li, Heng] Kronos Bio inc, Cambridge, MA USA; [Liu, Lijing] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Kant Dev & Environm Adaptat Biol, Qingdao, Peoples R China; [Yan, Shunping] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Henan University; Duke University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Shandong University; Huazhong Agricultural University	Zheng, N (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA.; Dong, XN (corresponding author), Duke Univ, Howard Hughes Med Inst, Dept Biol, Durham, NC 27708 USA.	xdong@duke.edu; nzheng@uw.edu	Yan, Shunping/AAD-8336-2021; Rusnac, Domnita-Valeria/V-8114-2019; Liu, Lijing/ADB-0506-2022; WANG, WEI/AEA-5010-2022	Yan, Shunping/0000-0002-3665-1310; Rusnac, Domnita-Valeria/0000-0001-8828-7701; WANG, WEI/0000-0002-4002-2648; liu, lijing/0000-0003-0260-8493	Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3032]; National Institutes of Health [2R01-GM069594-09, 5R35-GM118036]; Henan University; NRSA fellowship from NIGMS [1F32-GM122250-01A1]; Duke University Department of Biology Hargitt postdoctoral research fellowships	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henan University; NRSA fellowship from NIGMS; Duke University Department of Biology Hargitt postdoctoral research fellowships	We thank the beamline staff at ALS for help with data collection; T. Sun and Y. Zhang for advice on optimizing the radiolabelled ligand binding assay for NPR1; members of the N.Z., X.D. and W. Xu laboratories for discussion and help; Z. Mou for an NPR1 antibody; Y. Tada for the wheat-germ-based in vitro translation system; M. Mwimba for help with statistical analysis; and C. Sponsel for assisting with nucleic acid preparations for quantitative PCR and screening transgenic lines. This work is supported by the Howard Hughes Medical Institute to N.Z. and X.D., the Gordon and Betty Moore Foundation (GBMF3032) and the National Institutes of Health (2R01-GM069594-09 and 5R35-GM118036) to X.D., Henan University to W.W., an NRSA fellowship from NIGMS (1F32-GM122250-01A1) to P.J.Z., and Duke University Department of Biology HargittD postdoctoral research fellowships to J.W. and P.J.Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ding YL, 2018, CELL, V173, P1454, DOI 10.1016/j.cell.2018.03.044; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Hsu PL, 2018, CELL, V174, P1106, DOI 10.1016/j.cell.2018.06.038; Castello MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209835; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13099; Maier F, 2011, MOL PLANT PATHOL, V12, P73, DOI 10.1111/j.1364-3703.2010.00653.x; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Manohar M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00777; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skelly MJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47005; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Weigel RR, 2001, PLANT MOL BIOL, V46, P143, DOI 10.1023/A:1010652620115; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x	30	42	43	19	125	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2020	586	7828					311	+		10.1038/s41586-020-2596-y	http://dx.doi.org/10.1038/s41586-020-2596-y		AUG 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9PR	32788727	Green Accepted			2022-12-28	WOS:000559369600006
J	Buesseler, KO				Buesseler, Ken O.			Opening the floodgates at Fukushima	SCIENCE			English	Editorial Material							OCEAN		[Buesseler, Ken O.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu			Deerbrook Charitable Trust; Center for Marine and Environmental Radioactivity	Deerbrook Charitable Trust; Center for Marine and Environmental Radioactivity	This work was supported by the Deerbrook Charitable Trust and the Center for Marine and Environmental Radioactivity. Writing assistance by K. Kostel is also appreciated.	Buesseler K, 2017, ANNU REV MAR SCI, V9, P173, DOI 10.1146/annurev-marine-010816-060733; International Atomic Energy Agency (IAEA), 2004, SED DISTR COEFF CONC; International Commission on Radiological Protection (ICRP), 2010, INT COMM RAD PROT IC, V119; Oms PE, 2019, SCI TOTAL ENVIRON, V656, P1289, DOI 10.1016/j.scitotenv.2018.11.448; Sanial V, 2017, P NATL ACAD SCI USA, V114, P11092, DOI 10.1073/pnas.1708659114; TEPCO, TREAT WAT PORT SIT; TEPCO, 2020, DRAFT STUD RESP SUBC; TEPCO, 2020, DRAFT STUD RESP SUBC	8	34	35	9	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					621	+		10.1126/science.abc1507	http://dx.doi.org/10.1126/science.abc1507			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764053				2022-12-28	WOS:000559184400022
J	Miller, GJ				Miller, Gavin J.			Unifying the synthesis of nucleoside analogs	SCIENCE			English	Editorial Material									[Miller, Gavin J.] Keele Univ, Sch Chem & Phys Sci, Lennard Jones Lab, Keele ST5 5BG, Staffs, England	Keele University	Miller, GJ (corresponding author), Keele Univ, Sch Chem & Phys Sci, Lennard Jones Lab, Keele ST5 5BG, Staffs, England.	g.j.miller@keele.ac.uk	Miller, Gavin J/AAL-5783-2021	Miller, Gavin J/0000-0001-6533-3306				De Clercq E, 2016, J MED CHEM, V59, P2301, DOI 10.1021/acs.jmedchem.5b01157; Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489; Guinan M, 2020, MOLECULES, V25, DOI 10.3390/molecules25092050; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Meanwell M, 2020, SCIENCE, V369, P725, DOI 10.1126/science.abb3231; Nawrat CC, 2020, ORG LETT, V22, P2167, DOI 10.1021/acs.orglett.0c00239; Peifer M, 2014, J AM CHEM SOC, V136, P5900, DOI 10.1021/ja502205q; Romeo G, 2010, CHEM REV, V110, P3337, DOI 10.1021/cr800464r; Roy B, 2016, CHEM REV, V116, P7854, DOI 10.1021/acs.chemrev.6b00174; Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004; Yates MK, 2019, ANTIVIR RES, V162, P5, DOI 10.1016/j.antiviral.2018.11.016	11	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					623	623		10.1126/science.abd1283	http://dx.doi.org/10.1126/science.abd1283			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764054				2022-12-28	WOS:000559184400023
J	Berwick, DM; Cassel, CK				Berwick, Donald M.; Cassel, Christine K.			The NAM and the Quality of Health Care - Inflecting a Field	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								In 1999 and 2001, the Institute of Medicine published two landmark documents on health care quality and serious quality problems. Two decades later, focal progress in quality improvement is undeniable, but wholesale, systemic improvement has been hard to bring to scale.	[Berwick, Donald M.] Inst Healthcare Improvement, Boston, MA 02109 USA; [Cassel, Christine K.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Institute for Healthcare Improvement; University of California System; University of California San Francisco	Berwick, DM (corresponding author), Inst Healthcare Improvement, Boston, MA 02109 USA.							Berwick DM, 2016, JAMA-J AM MED ASSOC, V315, P1329, DOI 10.1001/jama.2016.1509; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Research Council, 1999, ENSURING QUALITY CAN	6	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					505	508		10.1056/NEJMp2005126	http://dx.doi.org/10.1056/NEJMp2005126			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32757519				2022-12-28	WOS:000560438400010
J	Yeung, K; Barthold, D; Dusetzina, SB; Basu, A				Yeung, Kai; Barthold, Douglas; Dusetzina, Stacie B.; Basu, Anirban			Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BackgroundSpecialty drugs are used to treat complex or life-threatening conditions, often at high financial costs to both patients and health plans. Three states - Delaware, Louisiana, and Maryland - passed legislation to cap out-of-pocket payments for specialty drugs at $150 per prescription. A concern is that these caps could shift costs to health plans, increasing insurance premiums. Estimates of the effect of the caps on patient and health-plan spending could inform future policies. MethodsWe analyzed a sample that included 27,161 persons under 65 years of age who had rheumatoid arthritis, multiple sclerosis, hepatitis C, psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis and who were in commercial health plans from 2011 through 2016 that were administered by three large nationwide insurers. The primary outcome was the change in out-of-pocket spending among specialty-drug users who were in the 95th percentile for spending on specialty drugs. Other outcomes were changes in mean out-of-pocket and health-plan spending for specialty drugs, nonspecialty drugs, and nondrug health care and utilization of specialty drugs. We compared outcomes in the three states that enacted caps with neighboring control states that did not, 3 years before and up to 3 years after enactment of the spending cap. ResultsCaps were associated with an adjusted change in out-of-pocket costs of -$351 (95% confidence interval, -554 to -148) per specialty-drug user per month, representing a 32% reduction in spending, among users in the 95th percentile of spending on specialty drugs. This finding was supported by multiple sensitivity analyses. Caps were not associated with changes in other outcomes. ConclusionsCaps for spending on specialty drugs were associated with substantial reductions in spending on specialty drugs among patients with the highest out-of-pocket costs, without detectable increases in health-plan spending, a proxy for future insurance premiums. (Funded by the Robert Wood Johnson Foundation Health Data for Action Program.) Treatments for diseases such as hepatitis C and rheumatoid arthritis are effective but expensive. Three states passed legislation to cap patients' out-of-pocket spending for specialty drugs at $150 per prescription. The caps were associated with reductions in out-of-pocket specialty-drug spending among patients with the highest costs, without an increase in overall plan spending.	[Yeung, Kai] Kaiser Permanente Washington Hlth Res Inst, Metropolitan Pk E,1730 Minor Ave,Rm 1600, Seattle, WA 98101 USA; [Yeung, Kai; Barthold, Douglas; Basu, Anirban] Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA; [Dusetzina, Stacie B.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Dusetzina, Stacie B.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Basu, Anirban] Natl Bur Econ Res, Cambridge, MA 02138 USA	Kaiser Permanente; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; National Bureau of Economic Research	Yeung, K (corresponding author), Kaiser Permanente Washington Hlth Res Inst, Metropolitan Pk E,1730 Minor Ave,Rm 1600, Seattle, WA 98101 USA.	kai.yeung@kp.org			Robert Wood Johnson Foundation Health Data for Action Program	Robert Wood Johnson Foundation Health Data for Action Program	Supported by a grant from the Robert Wood Johnson Foundation Health Data for Action Program.	Aitken M, 2019, MED USE SPENDING US; [Anonymous], 2018, HCCI COMM CLAIMS DAT; [Anonymous], 2015, MED D; Chernew ME, 2000, J HEALTH ECON, V19, P585, DOI 10.1016/S0167-6296(00)00061-8; Claxton G, 2018, PREEXISTING CONDITIO; Claxton G, 2009, HLTH BENEFITS 2009 A; Dusetzina SB, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2017.3598; Dusetzina SB, 2016, HEALTH AFFAIR, V35, P1241, DOI 10.1377/hlthaff.2015.1657; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Heckman JJ, 1997, REV ECON STUD, V64, P487, DOI 10.2307/2971729; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Starner CI, 2014, HEALTH AFFAIR, V33, P1761, DOI 10.1377/hlthaff.2014.0497; U.S. Labor Bureau of Labor Statistics, NTR	13	6	6	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					558	566		10.1056/NEJMsa1910366	http://dx.doi.org/10.1056/NEJMsa1910366			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32757524	Bronze			2022-12-28	WOS:000560438400018
J	Stormlund, S; Sopa, N; Zedeler, A; Bogstad, J; Praetorius, L; Nielsen, HS; Kitlinski, ML; Skouby, SO; Mikkelsen, AL; Spangmose, AL; Jeppesen, JV; Khatibi, A; Freiesleben, NL; Ziebe, S; Polyzos, NP; Bergh, C; Humaidan, P; Andersen, AN; Lossl, K; Pinborg, A				Stormlund, Sacha; Sopa, Negjyp; Zedeler, Anne; Bogstad, Jeanette; Praetorius, Lisbeth; Nielsen, Henriette Svarre; Kitlinski, Margaretha Laczna; Skouby, Sven O.; Mikkelsen, Anne Lis; Spangmose, Anne Laerke; Jeppesen, Janni Vikkelso; Khatibi, Ali; Freiesleben, Nina la Cour; Ziebe, Soren; Polyzos, Nikolaos P.; Bergh, Christina; Humaidan, Peter; Andersen, Anders Nyboe; Lossl, Kristine; Pinborg, Anja			Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation in women with regular menstrual cycles: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FROZEN EMBRYO-TRANSFER; OVARIAN STIMULATION; CRYOPRESERVATION; MATURATION; BORN	OBJECTIVE To compare the ongoing pregnancy rate between a freeze-all strategy and a fresh transfer strategy in assisted reproductive technology treatment. DESIGN Multicentre, randomised controlled superiority trial. SETTING Outpatient fertility clinics at eight public hospitals in Denmark, Sweden, and Spain. PARTICIPANTS 460 women aged 18-39 years with regular menstrual cycles starting their first, second, or third treatment cycle of in vitro fertilisation or intracytoplasmic sperm injection. INTERVENTIONS Women were randomised at baseline on cycle day 2 or 3 to one of two treatment groups: the freeze-all group (elective freezing of all embryos) who received gonadotropin releasing hormone agonist triggering and single frozen-thawed blastocyst transfer in a subsequent modified natural cycle; or the fresh transfer group who received human chorionic gonadotropin triggering and single blastocyst transfer in the fresh cycle. Women in the fresh transfer group with more than 18 follicles larger than 11 mm on the day of triggering had elective freezing of all embryos and postponement of transfer as a safety measure. MAIN OUTCOME MEASURES The primary outcome was the ongoing pregnancy rate defined as a detectable fetal heart beat after eight weeks of gestation. Secondary outcomes were live birth rate, positive human chorionic gonadotropin rate, time to pregnancy, and pregnancy related, obstetric, and neonatal complications. The primary analysis was performed according to the intention-to-treat principle. RESULTS Ongoing pregnancy rate did not differ significantly between the freeze-all and fresh transfer groups (27.8% (62/223) v 29.6% (68/230); risk ratio 0.98, 95% confidence interval 0.87 to 1.10, P=0.76). Additionally, no significant difference was found in the live birth rate (27.4% (61/223) for the freeze-all group and 28.7% (66/230) for the fresh transfer group; risk ratio 0.98, 95% confidence interval 0.87 to 1.10, P=0.83). No significant differences between groups were observed for positive human chorionic gonadotropin rate or pregnancy loss, and none of the women had severe ovarian hyperstimulation syndrome; only one hospital admission related to this condition occurred in the fresh transfer group. The risks of pregnancy related, obstetric, and neonatal complications did not differ between the two groups except for a higher mean birth weight after frozen blastocyst transfer and an increased risk of prematurity after fresh blastocyst transfer. Time to pregnancy was longer in the freeze-all group. CONCLUSIONS In women with regular menstrual cycles, a freeze-all strategy with gonadotropin releasing hormone agonist triggering for final oocyte maturation did not result in higher ongoing pregnancy and live birth rates than a fresh transfer strategy. The findings warrant caution in the indiscriminate application of a freeze-all strategy when no apparent risk of ovarian hyperstimulation syndrome is present.	[Stormlund, Sacha; Sopa, Negjyp; Zedeler, Anne; Praetorius, Lisbeth; Freiesleben, Nina la Cour; Pinborg, Anja] Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Fertil Clin, Kettegaard Alle 30, DK-2650 Copenhagen, Denmark; [Bogstad, Jeanette; Nielsen, Henriette Svarre; Spangmose, Anne Laerke; Jeppesen, Janni Vikkelso; Ziebe, Soren; Andersen, Anders Nyboe; Lossl, Kristine; Pinborg, Anja] Copenhagen Univ Hosp, Rigshosp, Fertil Clin, Copenhagen, Denmark; [Kitlinski, Margaretha Laczna] Skane Univ Hosp, Dept Reprod Med, Malmo, Sweden; [Skouby, Sven O.] Herlev Univ Hosp, Dept Obstet & Gynaecol, Fertil Clin, Copenhagen, Denmark; [Mikkelsen, Anne Lis] Holbaek Univ Hosp, Dept Obstet & Gynaecol, Fertil Clin, Holbaek, Denmark; [Khatibi, Ali; Bergh, Christina] Gothenburg Univ, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Obstet & Gynaecol,Inst Clin Sci,Reprod Med, Gothenburg, Sweden; [Polyzos, Nikolaos P.] Dexeus Univ Hosp, Dept Reprod Med, Barcelona, Spain; [Humaidan, Peter] Aarhus Univ, Skive Reg Hosp, Fertil Clin, Aarhus, Denmark; [Humaidan, Peter] Aarhus Univ, Fac Hlth, Aarhus, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Sahlgrenska University Hospital; University of Gothenburg; Aarhus University; Aarhus University	Stormlund, S (corresponding author), Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Fertil Clin, Kettegaard Alle 30, DK-2650 Copenhagen, Denmark.	sacha.stormlund.01@regionh.dk	; Nielsen, Henriette Svarre/E-3814-2014	Spangmose, Anne Laerke/0000-0001-7541-5858; Stormlund, Sacha/0000-0003-2352-1661; Zedeler, Anne/0000-0003-1394-9138; Freiesleben, Nina la Cour/0000-0002-5670-2015; Humaidan, Peter/0000-0001-6884-5366; Nielsen, Henriette Svarre/0000-0003-2106-8103	European Union	European Union(European Commission)	The study is part of the Reprounion collaborative study, cofinanced by the European Union, Interreg V OKS. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Aflatoonian A, 2013, J ASSIST REPROD GEN, V30, P1245, DOI 10.1007/s10815-013-0084-0; Aflatoonian A, 2010, J ASSIST REPROD GEN, V27, P357, DOI 10.1007/s10815-010-9412-9; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; Coates A, 2017, FERTIL STERIL, V107, P723, DOI [10.1016/.fertnstert.2016.12.022, 10.1016/j.fertnstert.2016.12.022]; Cobo A, 2012, FERTIL STERIL, V98, P1138, DOI 10.1016/j.fertnstert.2012.07.1107; De Geyter C, 2018, HUM REPROD, V33, P1586, DOI 10.1093/humrep/dey242; De Los SM, 2016, HUM REPROD, V31, P685, DOI DOI 10.1093/HUMREP/DEW016; Devroey P, 2011, HUM REPROD, V26, P2593, DOI 10.1093/humrep/der251; Ernstad EG, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.03.010; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Griesinger G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149615; Humaidan P, 2011, HUM REPROD UPDATE, V17, P510, DOI 10.1093/humupd/dmr008; Kolibianakis E, 2002, FERTIL STERIL, V78, P1025, DOI 10.1016/S0015-0282(02)03323-X; Loutradi KE, 2008, FERTIL STERIL, V90, P186, DOI 10.1016/j.fertnstert.2007.06.010; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Orvieto R, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0187-6; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2014, HUM REPROD, V29, P618, DOI 10.1093/humrep/det440; Roque M, 2019, HUM REPROD UPDATE, V25, P2, DOI 10.1093/humupd/dmy033; Roque M, 2013, FERTIL STERIL, V99, P156, DOI 10.1016/j.fertnstert.2012.09.003; Shapiro BS, 2008, FERTIL STERIL, V89, P20, DOI 10.1016/j.fertnstert.2006.08.092; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; Shi YH, 2018, NEW ENGL J MED, V378, P126, DOI 10.1056/NEJMoa1705334; Stormlund S, 2019, HUM REPROD, V34, P679, DOI 10.1093/humrep/dez006; Stormlund S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016106; von Versen-Hoynck F, 2019, HYPERTENSION, V73, P640, DOI 10.1161/HYPERTENSIONAHA.118.12043; Vuong LN, 2018, NEW ENGL J MED, V378, P137, DOI 10.1056/NEJMoa1703768; Wei DM, 2019, LANCET, V393, P1310, DOI 10.1016/S0140-6736(18)32843-5; Youssef MAFM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008046.pub4	30	49	52	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m2519	10.1136/bmj.m2519	http://dx.doi.org/10.1136/bmj.m2519			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759285	hybrid, Green Published			2022-12-28	WOS:000556139400007
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK hospitals to get rapid tests from September	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, SUNDAY TIMES	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2020	370								m3087	10.1136/bmj.m3087	http://dx.doi.org/10.1136/bmj.m3087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RK	32753401	Bronze			2022-12-28	WOS:000556140300003
J	Ding, WN; Ree, RH; Spicer, RA; Xing, YW				Ding, Wen-Na; Ree, Richard H.; Spicer, Robert A.; Xing, Yao-Wu			Ancient orogenic and monsoon-driven assembly of the world's richest temperate alpine flora	SCIENCE			English	Article							APATITE FISSION-TRACK; NORTHERN TIBETAN PLATEAU; CENOZOIC TECTONIC EVOLUTION; MIDDLE MIOCENE REORGANIZATION; RIVER SHEAR ZONE; HENGDUAN MOUNTAINS; QILIAN SHAN; LATE-EOCENE; SOUTHERN TIBET; LUNPOLA BASIN	Understanding how alpine biotas formed in response to historical environmental change may improve our ability to predict and mitigate the threats to alpine species posed by global warming. In the world's richest temperate alpine flora, that of the Tibet-Himalaya-Hengduan region, phylogenetic reconstructions of biome and geographic range evolution show that extant lineages emerged by the early Oligocene and diversified first in the Hengduan Mountains. By the early to middle Miocene, accelerated diversification and colonization of adjacent regions were likely driven jointly by mountain building and intensification of the Asian monsoon. The alpine flora of the Hengduan Mountains has continuously existed far longer than any other alpine flora on Earth and illustrates how modern biotas have been shaped by past geological and climatic events.	[Ding, Wen-Na; Spicer, Robert A.; Xing, Yao-Wu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, CAS Key Lab Trop Forest Ecol, Mengla 666303, Yunnan, Peoples R China; [Ding, Wen-Na] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Ree, Richard H.] Field Museum, Negaunee Integrat Res Ctr, Chicago, IL 60605 USA; [Spicer, Robert A.; Xing, Yao-Wu] Chinese Acad Sci, Core Bot Gardens, Ctr Plant Ecol, Mengla 666303, Yunnan, Peoples R China; [Spicer, Robert A.] Open Univ, Sch Environm Earth & Ecosyst Sci, Milton Keynes MK7 6AA, Bucks, England	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Field Museum of Natural History (Chicago); Chinese Academy of Sciences; Open University - UK	Xing, YW (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, CAS Key Lab Trop Forest Ecol, Mengla 666303, Yunnan, Peoples R China.; Ree, RH (corresponding author), Field Museum, Negaunee Integrat Res Ctr, Chicago, IL 60605 USA.; Xing, YW (corresponding author), Chinese Acad Sci, Core Bot Gardens, Ctr Plant Ecol, Mengla 666303, Yunnan, Peoples R China.	rree@fieldmuseum.org; ywxing@xtbg.org.cn		Spicer, Robert/0000-0003-1076-2693; Xing, Yao-Wu/0000-0001-6709-4492; Ree, Richard/0000-0003-1898-3335; Ding, Wen-Na/0000-0002-0446-8431	National Natural Science Foundation of China [U1802242]; Chinese Academy of Sciences [XDB31000000]; National Key R&D Program of China [2017YFC0505200]; NERC-NSFC [NE/P013805/1]; Xishuangbanna Tropical Botanical Garden Fellowship for Visiting Scientists; China Scholarship Council [201804910698]; Grainger Bioinformatics Center at the Field Museum	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; NERC-NSFC; Xishuangbanna Tropical Botanical Garden Fellowship for Visiting Scientists; China Scholarship Council(China Scholarship Council); Grainger Bioinformatics Center at the Field Museum	This work was supported by the National Natural Science Foundation of China (U1802242), the Strategic Priority Research Program of Chinese Academy of Sciences (XDB31000000), and the National Key R&D Program of China (2017YFC0505200). R.A.S. was supported by NERC-NSFC joint project NE/P013805/1 and a Xishuangbanna Tropical Botanical Garden Fellowship for Visiting Scientists. W.-N.D. was supported by the China Scholarship Council (201804910698). R.H.R. was supported by the Grainger Bioinformatics Center at the Field Museum.	Ai KK, 2019, PALAEOGEOGR PALAEOCL, V515, P143, DOI 10.1016/j.palaeo.2018.04.017; Antonelli A, 2018, NAT GEOSCI, V11, P718, DOI 10.1038/s41561-018-0236-z; Antonelli A, 2018, P NATL ACAD SCI USA, V115, P6034, DOI 10.1073/pnas.1713819115; BILLINGS W D, 1974, Arctic and Alpine Research, V6, P129, DOI 10.2307/1550081; BLISS L. C., 1962, ARCTIC, V15, P117; Boucher LD, 2003, AM J BOT, V90, P1389, DOI 10.3732/ajb.90.9.1389; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boufford David E., 2014, Arnoldia (Jamaica Plain), V72, P24; Calvino CI, 2016, J BIOGEOGR, V43, P398, DOI 10.1111/jbi.12651; Cao K, 2019, TECTONICS, V38, P374, DOI 10.1029/2017TC004832; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Collinson M., 1983, PALAEONTOLOGICAL ASS, V1; COLLINSON ME, 1978, BOT J LINN SOC, V76, P195, DOI 10.1111/j.1095-8339.1978.tb02361.x; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Craddock W, 2011, LITHOSPHERE-US, V3, P420, DOI 10.1130/L159.1; Currie BS, 2005, GEOLOGY, V33, P181, DOI 10.1130/G21170.1; Dai JG, 2013, J GEOL SOC LONDON, V170, P917, DOI 10.1144/jgs2012-076; Dai JG, 2013, J GEOL, V121, P155, DOI 10.1086/669250; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; DeCelles PG, 2007, EARTH PLANET SC LETT, V253, P389, DOI 10.1016/j.epsl.2006.11.001; DeCelles PG, 2018, BASIN RES, V30, P228, DOI 10.1111/bre.12217; Deng T, 2019, CHIN SCI B-CHIN, V64, P2894, DOI 10.1360/TB-2019-0053; Deng T, 2015, NATL SCI REV, V2, P417, DOI 10.1093/nsr/nwv062; Deng T, 2012, P NATL ACAD SCI USA, V109, P7374, DOI 10.1073/pnas.1201052109; Ding L, 2017, GEOLOGY, V45, P215, DOI 10.1130/G38583.1; Ding L, 2014, EARTH PLANET SC LETT, V392, P250, DOI 10.1016/j.epsl.2014.01.045; Dorofeev P., 1963, TERTIARY FORAS W SIB; Duvall AR, 2013, TECTONICS, V32, P1190, DOI 10.1002/tect.20072; Eldrett JS, 2009, NATURE, V459, P969, DOI 10.1038/nature08069; Enkelmann E, 2006, GEOL SOC AM BULL, V118, P651, DOI 10.1130/B25805.1; Fang XM, 2007, EARTH PLANET SC LETT, V258, P293, DOI 10.1016/j.epsl.2007.03.042; Fang XM, 2003, EARTH PLANET SC LETT, V210, P545, DOI [10.1016/S0012-821X(03)00142-0, 10.1016/S0012-821X(03)-00142-0]; Farnsworth A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1697; Favre A, 2016, J BIOGEOGR, V43, P1967, DOI 10.1111/jbi.12840; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Freyman WA, 2019, SYST BIOL, V68, P505, DOI 10.1093/sysbio/syy078; Freyman WA, 2018, SYST BIOL, V67, P195, DOI 10.1093/sysbio/syx065; Friis E. M., 1979, B GEOL SOC DEN, V27, P117; Friis E. M., 2011, EARLY FOWERS ANGIOSP; Garzione CN, 2000, EARTH PLANET SC LETT, V183, P215, DOI 10.1016/S0012-821X(00)00252-1; Gebelin A, 2013, GEOLOGY, V41, P799, DOI 10.1130/G34331.1; Gehrke B, 2014, ALPINE BOT, V124, P165, DOI 10.1007/s00035-014-0132-0; George AD, 2001, GEOLOGY, V29, P939, DOI 10.1130/0091-7613(2001)029<0939:MCITNQ>2.0.CO;2; Godard V, 2009, TECTONICS, V28, DOI 10.1029/2008TC002407; Goldberg EE, 2012, EVOLUTION, V66, P3701, DOI 10.1111/j.1558-5646.2012.01730.x; Gourbet L, 2017, TECTONOPHYSICS, V700, P162, DOI 10.1016/j.tecto.2017.02.007; Han TS, 2020, NEW PHYTOL, V225, P571, DOI 10.1111/nph.16098; Hansen James, 2013, Philos Trans A Math Phys Eng Sci, V371, P20120294, DOI 10.1098/rsta.2012.0294; Heenan PB, 2013, NEW ZEAL J ECOL, V37, P105; Hermsen E. J., 2005, THESIS; Hermsen EJ, 2003, AM J BOT, V90, P1373, DOI 10.3732/ajb.90.9.1373; Hermsen EJ, 2013, BOT REV, V79, P1, DOI 10.1007/s12229-012-9114-3; Hohmann N, 2015, PLANT CELL, V27, P2770, DOI 10.1105/tpc.15.00482; Hohna S, 2016, SYST BIOL, V65, P726, DOI 10.1093/sysbio/syw021; Hoke GD, 2014, EARTH PLANET SC LETT, V394, P270, DOI 10.1016/j.epsl.2014.03.007; HOLTEN JI, 2003, ECOL STU AN, V167, P173; Huang J, 2020, SCI CHINA EARTH SCI, V63, P212, DOI 10.1007/s11430-019-9475-2; Hughes CE, 2015, NEW PHYTOL, V207, P275, DOI 10.1111/nph.13230; Hughes N. F., 1994, ENIGMA ANGIOSPERM OR, V1; Irving R. S., 1971, SW NAT, V16, P111, DOI [10.2307/3670101, DOI 10.2307/3670101]; Jia GD, 2015, GLOBAL PLANET CHANGE, V126, P14, DOI 10.1016/j.gloplacha.2014.12.007; Jiang XL, 2019, J BIOGEOGR, V46, P2203, DOI 10.1111/jbi.13654; Jiang XD, 2013, GEOLOGY, V41, P439, DOI 10.1130/G33890.1; Jing LZ, 2018, EARTH PLANET SC LETT, V490, P62, DOI 10.1016/j.epsl.2018.03.011; Jolivet M, 2001, TECTONOPHYSICS, V343, P111, DOI 10.1016/S0040-1951(01)00196-2; Jordan GJ, 2003, AM J BOT, V90, P761, DOI 10.3732/ajb.90.5.761; Kapp P, 2019, AM J SCI, V319, P159, DOI 10.2475/03.2019.01; Khan MA, 2014, GLOBAL PLANET CHANGE, V113, P1, DOI 10.1016/j.gloplacha.2013.12.003; Kirby E, 2002, TECTONICS, V21, DOI 10.1029/2000TC001246; Korner C., 2003, ALPINE PLANT LIFE FU, P9, DOI [DOI 10.1007/978-3-642-18970-8_2, 10.1007/978-3-642-18970-8_2]; Lai QZ, 2007, SCI CHINA SER D, V50, P172, DOI 10.1007/s11430-007-2048-7; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lease RO, 2012, GEOL SOC AM BULL, V124, P657, DOI 10.1130/B30524.1; Lease RO, 2011, GEOLOGY, V39, P359, DOI 10.1130/G31356.1; Leloup PH, 1995, TECTONOPHYSICS, V251, P3, DOI 10.1016/0040-1951(95)00070-4; Leloup PH, 2001, J GEOPHYS RES-SOL EA, V106, P6683, DOI 10.1029/2000JB900322; Li B.-Y., 1987, MT RES, V5, P12; Li BY., 1989, J MOUNTAIN RES, V7, P13; Li L, 2019, GEOL SOC AM BULL, V131, P831, DOI 10.1130/B32060.1; Li SH, 2020, EARTH PLANET SC LETT, V536, DOI 10.1016/j.epsl.2020.116144; Li XH, 2014, J SYST EVOL, V52, P280, DOI 10.1111/jse.12027; Li XH, 2017, PLANT DIVERSITY, V39, P37, DOI 10.1016/j.pld.2016.11.007; Lin TH, 2009, J ASIAN EARTH SCI, V34, P674, DOI 10.1016/j.jseaes.2008.10.009; Linder HP, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00038; Liu SF, 2013, BASIN RES, V25, P74, DOI 10.1111/j.1365-2117.2012.00548.x; Lu HJ, 2012, TECTONOPHYSICS, V580, P150, DOI 10.1016/j.tecto.2012.09.013; Lu HJ, 2009, EARTH PLANET SC LETT, V288, P539, DOI 10.1016/j.epsl.2009.10.016; Lu HY, 2004, SCI CHINA SER D, V47, P822, DOI 10.1360/03yd0315; Luo D, 2016, J BIOGEOGR, V43, P31, DOI 10.1111/jbi.12610; Madrinan Santiago, 2013, Frontiers in Genetics, V4, P192, DOI 10.3389/fgene.2013.00192; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Manchester SR, 2006, INT J PLANT SCI, V167, P897, DOI 10.1086/503918; Manish K, 2018, PEERJ, V6, DOI 10.7717/peerj.5919; McPhillips D, 2016, GEOPHYS RES LETT, V43, P101, DOI 10.1002/2015GL066780; Meng K, 2016, J ASIAN EARTH SCI, V115, P29, DOI 10.1016/j.jseaes.2015.09.020; Miao YF, 2016, GONDWANA RES, V31, P241, DOI 10.1016/j.gr.2015.01.007; Mosbrugger V., 2018, MOUNTAINS CLIMATE BI, V429, P448; Muellner-Riehl AN, 2019, J BIOGEOGR, V46, P2826, DOI 10.1111/jbi.13715; Nie JS, 2018, NAT GEOSCI, V11, P944, DOI 10.1038/s41561-018-0244-z; Nikitin V.P., 2006, PALEOKARPOLOGIYA STR; NIXON KC, 1993, AM J BOT, V80, P616, DOI 10.2307/2445430; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ouimet W, 2010, LITHOSPHERE-US, V2, P50, DOI 10.1130/L57.1; Pan BT, 2013, TERRA NOVA, V25, P431, DOI 10.1111/ter.12052; Rahbek C, 2019, SCIENCE, V365, P1114, DOI 10.1126/science.aax0151; Rahbek C, 2019, SCIENCE, V365, P1108, DOI 10.1126/science.aax0149; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rohrmann A, 2012, GEOLOGY, V40, P187, DOI 10.1130/G32530.1; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Saylor JE, 2009, AM J SCI, V309, P1, DOI 10.2475/01.2009.01; Searle MP, 1999, GEOL MAG, V136, P513, DOI 10.1017/S0016756899002885; Shen XM, 2016, TECTONOPHYSICS, V687, P223, DOI 10.1016/j.tecto.2016.08.006; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Su T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2189; Su T, 2019, NATL SCI REV, V6, P495, DOI 10.1093/nsr/nwy062; Sun JM, 2014, PALAEOGEOGR PALAEOCL, V399, P21, DOI 10.1016/j.palaeo.2014.02.004; Sun JM, 2005, EARTH PLANET SC LETT, V235, P641, DOI 10.1016/j.epsl.2005.04.034; Tang MY, 2017, TECTONOPHYSICS, V712, P170, DOI 10.1016/j.tecto.2017.05.018; TAPPONNIER P, 1990, NATURE, V343, P431, DOI 10.1038/343431a0; VANDERBURGH J, 1987, REV PALAEOBOT PALYNO, V52, P299, DOI 10.1016/0034-6667(87)90064-9; Vannay JC, 2004, TECTONICS, V23, DOI 10.1029/2002TC001429; Vargas P, 2003, TAXON, V52, P463, DOI 10.2307/3647446; Wang E, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001877; Wang E, 2012, NAT GEOSCI, V5, P640, DOI [10.1038/ngeo1538, 10.1038/NGEO1538]; Wang N, 2012, SCI CHINA EARTH SCI, V55, P714, DOI 10.1007/s11430-012-4368-5; Wang SF, 2009, INT GEOL REV, V51, P1121, DOI 10.1080/00206810902945132; Wang XM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0893; Wang Y, 2006, GEOLOGY, V34, P309, DOI 10.1130/G22254.1; WOLFE JA, 1987, ANN MO BOT GARD, V74, P785, DOI 10.2307/2399450; Wu FX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00928-9; Wu L, 2019, GEOL SOC AM BULL, V131, P1157, DOI 10.1130/B31875.1; Xiao GQ, 2012, EARTH PLANET SC LETT, V317, P185, DOI 10.1016/j.epsl.2011.11.008; Xing YW, 2017, P NATL ACAD SCI USA, V114, pE3444, DOI 10.1073/pnas.1616063114; Xing YW, 2016, INT J PLANT SCI, V177, P371, DOI 10.1086/685388; Xu B, 2014, J SYST EVOL, V52, P271, DOI 10.1111/jse.12037; Xu Q, 2013, EARTH PLANET SC LETT, V362, P31, DOI 10.1016/j.epsl.2012.11.058; Ye XY, 2019, J BIOGEOGR, V46, P2678, DOI 10.1111/jbi.13723; Yin A, 2008, GEOL SOC AM BULL, V120, P847, DOI 10.1130/B26232.1; Yin A, 2008, GEOL SOC AM BULL, V120, P813, DOI 10.1130/B26180.1; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang B, 2010, J STRUCT GEOL, V32, P445, DOI 10.1016/j.jsg.2010.02.001; Zhang ML, 2015, BIOCHEM SYST ECOL, V63, P80, DOI 10.1016/j.bse.2015.09.017; Zhang YZ, 2017, EARTH PLANET SC LETT, V465, P1, DOI 10.1016/j.epsl.2017.02.025; Zhang YZ, 2015, TECTONICS, V34, P1219, DOI 10.1002/2014TC003671; Zheng DW, 2006, EARTH PLANET SC LETT, V248, P198, DOI 10.1016/j.epsl.2006.05.023; Zheng DW, 2010, GEOSPHERE, V6, P937, DOI 10.1130/GES00523.1; Zheng HB, 2013, P NATL ACAD SCI USA, V110, P7556, DOI 10.1073/pnas.1216241110	149	114	132	48	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					578	+		10.1126/science.abb4484	http://dx.doi.org/10.1126/science.abb4484			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732426				2022-12-28	WOS:000556568100049
J	Snyder, MP; Gingeras, TR; Moore, JE; Weng, ZP; Gerstein, MB; Ren, B; Hardison, RC; Stamatoyannopoulos, JA; Graveley, BR; Feingold, EA; Pazin, MJ; Pagan, M; Gilchrist, DA; Hitz, BC; Cherry, JM; Bernstein, BE; Mendenhall, EM; Zerbino, DR; Frankish, A; Flicek, P; Myers, RM				Snyder, Michael P.; Gingeras, Thomas R.; Moore, Jill E.; Weng, Zhiping; Gerstein, Mark B.; Ren, Bing; Hardison, Ross C.; Stamatoyannopoulos, John A.; Graveley, Brenton R.; Feingold, Elise A.; Pazin, Michael J.; Pagan, Michael; Gilchrist, Daniel A.; Hitz, Benjamin C.; Cherry, J. Michael; Bernstein, Bradley E.; Mendenhall, Eric M.; Zerbino, Daniel R.; Frankish, Adam; Flicek, Paul; Myers, Richard M.		ENCODE Project Consortium	Perspectives on ENCODE	NATURE			English	Article							DNA ELEMENTS; REGULATORY INFORMATION; TRANSCRIPTION FACTORS; FUNCTIONAL ELEMENTS; HUMAN GENOME; MOUSE; IDENTIFICATION; ENCYCLOPEDIA; PRINCIPLES; DROSOPHILA	The Encylopedia of DNA Elements (ENCODE) Project launched in 2003 with the long-term goal of developing a comprehensive map of functional elements in the human genome. These included genes, biochemical regions associated with gene regulation (for example, transcription factor binding sites, open chromatin, and histone marks) and transcript isoforms. The marks serve as sites for candidatecis-regulatory elements (cCREs) that may serve functional roles in regulating gene expression(1). The project has been extended to model organisms, particularly the mouse. In the third phase of ENCODE, nearly a million and more than 300,000 cCRE annotations have been generated for human and mouse, respectively, and these have provided a valuable resource for the scientific community. The authors summarize the history of the ENCODE Project, the achievements of ENCODE 1 and ENCODE 2, and how the new data generated and analysed in ENCODE 3 complement the previous phases.	[Snyder, Michael P.; Hitz, Benjamin C.; Cherry, J. Michael] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; [Snyder, Michael P.] Stanford Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Gingeras, Thomas R.] Cold Spring Harbor Lab, Funct Genom, POB 100, Cold Spring Harbor, NY 11724 USA; [Moore, Jill E.; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Weng, Zhiping] Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg,Clin Translat Res Ctr, Shanghai, Peoples R China; [Weng, Zhiping] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Gerstein, Mark B.] Yale Univ, New Haven, CT USA; [Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA USA; [Ren, Bing] Univ Calif San Diego, Ctr Epigenom, La Jolla, CA 92103 USA; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA USA; [Graveley, Brenton R.] UConn Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT USA; [Feingold, Elise A.; Pazin, Michael J.; Pagan, Michael; Gilchrist, Daniel A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Broad Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02115 USA; [Mendenhall, Eric M.] Univ Alabama, Biol Sci, Huntsville, AL 35899 USA; [Mendenhall, Eric M.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Zerbino, Daniel R.; Frankish, Adam; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England	Stanford University; Stanford University; Cold Spring Harbor Laboratory; University of Massachusetts System; University of Massachusetts Worcester; Tongji University; Boston University; Yale University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Huntsville; HudsonAlpha Institute for Biotechnology; European Molecular Biology Laboratory (EMBL)	Snyder, MP (corresponding author), Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA.; Snyder, MP (corresponding author), Stanford Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Ecker, Joseph R/B-9144-2008; Rodriguez, Jose/AAS-4147-2021; Boyle, Alan/I-1848-2014; Johnson, Rory/ABE-2503-2021; Uszczynska-Ratajczak, Barbara/G-9814-2015; Hardison, Ross C/G-1142-2010; Kellis, Manolis/ABE-7385-2020; Barozzi, Iros/GLQ-8907-2022; He, Peng/AAT-3673-2021; Qin, Qian/AAI-7894-2020; Chen, Jia-Yu/J-6798-2013; Savic, Daniel/N-5525-2018; Lagarde, Julien/AAI-1686-2020; Zhang, Xiao-Ou/J-6229-2014; Hubbard, Tim @timjph/C-2567-2008; choudhary, jyoti/S-1232-2017; Visel, Axel/A-9398-2009; Zang, Chongzhi/D-1445-2011	Ecker, Joseph R/0000-0001-5799-5895; Rodriguez, Jose/0000-0002-9948-5073; Boyle, Alan/0000-0002-2081-1105; Johnson, Rory/0000-0003-4607-2782; Uszczynska-Ratajczak, Barbara/0000-0003-0150-3841; Hardison, Ross C/0000-0003-4084-7516; Kellis, Manolis/0000-0001-7113-9630; Barozzi, Iros/0000-0003-0690-3473; He, Peng/0000-0002-2457-3554; Qin, Qian/0000-0002-2119-6263; Chen, Jia-Yu/0000-0001-9449-9321; Savic, Daniel/0000-0002-6693-0265; Lagarde, Julien/0000-0002-0290-7445; Tsuji, Junko/0000-0003-0139-3750; Dickel, Diane/0000-0001-5497-6824; Yu, Tianxiong/0000-0003-1151-4624; Zhang, Qi/0000-0001-6197-0973; Zhang, Xiao-Ou/0000-0002-2027-1313; Barrell, Daniel/0000-0002-0977-0963; Cherry, J. Michael/0000-0001-9163-5180; Martin, Fergal/0000-0002-1672-050X; Flicek, Paul/0000-0002-3897-7955; Epstein, Charles B./0000-0001-8358-8345; Zhou, Xiao-Qiao/0000-0002-0724-5153; Wright, James/0000-0001-6950-4328; Nguyen, Thai Bao/0000-0001-8450-2988; Harrow, Jennifer/0000-0003-0338-3070; Beer, Michael A/0000-0001-9955-3809; Kundaje, Anshul/0000-0003-3084-2287; Sisu, Cristina/0000-0001-9371-0797; Ren, Bing/0000-0002-5435-1127; Hubbard, Tim @timjph/0000-0002-1767-9318; Chan, Esther/0000-0002-2406-2623; Mendenhall, Eric/0000-0002-7395-6295; Tress, Michael/0000-0001-9046-6370; Snyder, Michael/0000-0003-0784-7987; choudhary, jyoti/0000-0003-0881-5477; Rivera-Mulia, Juan Carlos/0000-0002-7566-3875; DANYKO, CASSIDY/0000-0001-7803-783X; Schlaffner, Christoph/0000-0003-2717-3406; Izuogu, Osagie/0000-0003-3116-2558; Nelson, Jemma/0000-0003-2846-2007; Donaldson, Sarah/0000-0002-2576-3173; Bignell, alexandra/0000-0002-5926-7020; Loveland, Jane/0000-0002-7669-2934; Lee, Donghoon/0000-0003-0453-6059; Zerbino, Daniel/0000-0001-5350-3056; Pennacchio, Len/0000-0002-8748-3732; Visel, Axel/0000-0002-4130-7784; Hunt, Toby/0000-0001-8377-0841; Zang, Chongzhi/0000-0003-4812-3627; Whitaker, John W./0000-0002-0585-9119; Reymond, Alexandre/0000-0003-1030-8327; Kay, Mike/0000-0002-3282-0834; Liu, Jason/0000-0001-7197-7319; Pan, Xinghua (Victor)/0000-0002-7421-8155; Sundararaman, Balaji/0000-0001-8559-1660; Xiao, Rui/0000-0002-9477-1054; Garcia Giron, Carlos/0000-0002-0935-7271; Mudge, Jonathan/0000-0003-4789-7495; Frankish, Adam/0000-0002-4333-628X; Moore, Jill/0000-0002-3023-0806; Bennett, Esther Ruth/0000-0002-9009-4607; Pagan, Michael/0000-0002-7638-531X; Chee, Sora/0000-0003-2687-7786; Kaul, Rajinder/0000-0002-7895-9284; Dobin, Alexander/0000-0002-4115-9128; Blue, Steven/0000-0003-0279-6690; Yeo, Eugene/0000-0002-0799-6037; Yee, Brian/0000-0001-5615-8550	NCI NIH HHS [P30 CA045508, P30 CA008748, P01 CA155258] Funding Source: Medline; NHGRI NIH HHS [U54 HG007004, U01 HG007033, U54 HG006996, F32 HG006993, U54 HG006991, UM1 HG009442, U24 HG009397, U54 HG006998, U41 HG007000, U54 HG006997, U54 HG006994, U54 HG007010, U01 HG007019, T32 HG000044, U01 HG007036, U41 HG006992, U41 HG007234, U54 HG007002, U54 HG007005, U01 HG007037] Funding Source: Medline; NIDDK NIH HHS [R37 DK050107, R01 DK068634, R24 DK106766, R01 DK050107] Funding Source: Medline; NIGMS NIH HHS [R01 GM083337, T32 GM087237] Funding Source: Medline; NIH HHS [U41HG006996, U41HG007003, U41HG006994, U41HG006995, U41HG007001, U41HG006998, U41HG006993, U41HG007002, U41HG006999, U41HG006997, U41HG007000] Funding Source: Medline; BBSRC [BB/I025360/1] Funding Source: UKRI	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Breschi A., 2020, PREPRINT, DOI [10.1101/857169, DOI 10.1101/857169]; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ENCODE Project Consortium, 2004, SCIENCE, V306, P636; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gorkin DU, 2020, NATURE, V583, P744, DOI 10.1038/s41586-020-2093-3; Grubert F, 2020, NATURE, V583, P737, DOI 10.1038/s41586-020-2151-x; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; He P, 2020, NATURE, V583, P760, DOI 10.1038/s41586-020-2536-x; He YP, 2020, NATURE, V583, P752, DOI 10.1038/s41586-020-2119-x; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Keilwagen J, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1614-y; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Klein JC, 2018, ACS CHEM BIOL, V13, P326, DOI 10.1021/acschembio.7b00778; Kudron MM, 2018, GENETICS, V208, P937, DOI 10.1534/genetics.117.300657; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meuleman W, 2020, NATURE, V584, P244, DOI 10.1038/s41586-020-2559-3; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Partridge EC, 2020, NATURE, V583, P720, DOI 10.1038/s41586-020-2023-4; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Snyder MP, 2019, NATURE, V574, P187, DOI 10.1038/s41586-019-1629-x; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Vierstra J, 2020, NATURE, V583, P729, DOI 10.1038/s41586-020-2528-x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	43	62	63	6	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					693	+		10.1038/s41586-020-2449-8	http://dx.doi.org/10.1038/s41586-020-2449-8			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728248	Green Published			2022-12-28	WOS:000554831500019
J	Griffin, S				Griffin, Shaun			Author retracts article from Nature after raising concerns about sponsorship	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Retraction Watch, 2010, AUTH RETR NAT COMM S; Witwer K., 2020, NATURE	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m3017	10.1136/bmj.m3017	http://dx.doi.org/10.1136/bmj.m3017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727718				2022-12-28	WOS:000554456000007
J	O'Dowd, A				O'Dowd, Adrian			Covid-19: Social care was "thrown to the wolves" by government, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Public Accounts Committee, 2020, READ NHS SOC CAR COV	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m3015	10.1136/bmj.m3015	http://dx.doi.org/10.1136/bmj.m3015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727717	Bronze			2022-12-28	WOS:000554456000002
J	Ferry, G				Ferry, Georgina			A woman's place Kesaveloo Goonaruthnum Naidoo: anti-apartheid campaigner	LANCET			English	Editorial Material												mgf@georginaferry.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					231	231						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711787				2022-12-28	WOS:000567020100015
J	Spiegel, HML				Spiegel, Hans M. L.			DISCOVER: much accomplished, but not yet for all	LANCET			English	Editorial Material							PREEXPOSURE PROPHYLAXIS; PREVENTION		[Spiegel, Hans M. L.] NIAID, Kelly Govt Solut, NIH, Dept Hlth & Human Serv, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Spiegel, HML (corresponding author), NIAID, Kelly Govt Solut, NIH, Dept Hlth & Human Serv, Rockville, MD 20852 USA.	hans.spiegel@nih.gov						Anderson PL, 2020, C RETR OPP INF BOST; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Gill K, 2017, 9 INT AIDS SOC C HIV; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hosek S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21107; Mayer KH, 2020, LANCET, V396, P239, DOI 10.1016/S0140-6736(20)31065-5; Onyema O, 2020, C RETR OPP INF BOST; Tanner MR, 2020, MMWR RECOMM REP, V69, P1, DOI 10.15585/mmwr.rr6903a1; UNAIDS, 2020, WEV GOT POWE WOM AD	9	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					214	215		10.1016/S0140-6736(20)31530-0	http://dx.doi.org/10.1016/S0140-6736(20)31530-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711780	Green Published, Bronze			2022-12-28	WOS:000567020100005
J	Einav, T; Gentles, LE; Bloom, JD				Einav, Tal; Gentles, Lauren E.; Bloom, Jesse D.			SnapShot: Influenza by the Numbers	CELL			English	Editorial Material									[Einav, Tal] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Einav, T (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.								0	2	2	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					532	+		10.1016/j.cell.2020.05.004	http://dx.doi.org/10.1016/j.cell.2020.05.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32707094				2022-12-28	WOS:000552745000020
J	Rasmussen, SA; Jamieson, DJ				Rasmussen, Sonja A.; Jamieson, Denise J.			Public Health Decision Making during Covid-19-Fulfilling the CDC Pledge to the American People	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Pressure placed on the CDC raises concern that in responding to the most critical public health emergency of our lifetimes, guidelines regarding the safety of U.S. schoolchildren could be based not on the best scientific data available, but on political considerations.	[Rasmussen, Sonja A.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA; [Rasmussen, Sonja A.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Rasmussen, Sonja A.] Coll Med, Gainesville, FL 32611 USA; [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University	Rasmussen, SA (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.; Rasmussen, SA (corresponding author), Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.; Rasmussen, SA (corresponding author), Coll Med, Gainesville, FL 32611 USA.							Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Esposito S, 2020, JAMA PEDIAT; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Park YJ, 2020, EMERGING INFECT DIS; Shekerdemian LS, 2020, JAMA PEDIAT	5	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2020	383	10					901	903		10.1056/NEJMp2026045	http://dx.doi.org/10.1056/NEJMp2026045			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NO9YO	32726524	Bronze			2022-12-28	WOS:000569841600008
J	Bae, JA; Curtis, LH; Hernandez, AF				Bae, Jonathan A.; Curtis, Lesley H.; Hernandez, Adrian F.			National Hospital Quality Rankings Improving the Value of Information in Hospital Rating Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; MORTALITY		[Bae, Jonathan A.; Hernandez, Adrian F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Bae, Jonathan A.] Duke Univ Hlth Syst, Durham, NC USA; [Curtis, Lesley H.] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA; [Curtis, Lesley H.; Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Hernandez, AF (corresponding author), 200 Morris St, Durham, NC 27701 USA.	Adrian.hernandez@duke.edu						[Anonymous], 2019, US NEWS WORLD R 0729; Arias E, 2019, NATL VITAL STAT SYST, V68, P1; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cunningham TJ, 2017, MMWR-MORBID MORTAL W, V66, P444, DOI 10.15585/mmwr.mm6617e1; Harder B, 2015, JAMA-J AM MED ASSOC, V313, P1903, DOI 10.1001/jama.2015.4566; Hota B, 2020, AM J MED QUAL, V35, P222, DOI 10.1177/1062860619860250; National Center for Health Statistics, 2018, US SMALL AR LIF EXP; Rosenberg BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166762; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					839	840		10.1001/jama.2020.11165	http://dx.doi.org/10.1001/jama.2020.11165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32730574				2022-12-28	WOS:000570094600010
J	Hawkes, S; Allotey, P; Elhadj, AS; Clark, J; Horton, R				Hawkes, Sarah; Allotey, Pascale; Elhadj, As Sy; Clark, Jocalyn; Horton, Richard			The Lancet Commission on Gender and Global Health	LANCET			English	Editorial Material									[Hawkes, Sarah] UCL, Inst Global Hlth, London WC1N 1EH, England; [Allotey, Pascale] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Elhadj, As Sy] Kofi Annan Fdn, Geneva, Switzerland; [Clark, Jocalyn; Horton, Richard] The Lancet, London, England	University of London; University College London	Hawkes, S (corresponding author), UCL, Inst Global Hlth, London WC1N 1EH, England.	s.hawkes@ucl.ac.uk		Clark, Jocalyn/0000-0002-8014-3989				[Anonymous], 2019, LANCET, V393, P493, DOI 10.1016/S0140-6736(19)30239-9; [Anonymous], 2020, GLOBAL HLTH 50 50 AN; Barker G, 2010, GLOB PUBLIC HEALTH, V5, P539, DOI 10.1080/17441690902942464; Clark J, 2019, LANCET, V393, P2367, DOI 10.1016/S0140-6736(19)30986-9; Collin Parkes, 2015, DEATH BEREAVEMENT CU, P9; CONNELL RW, 1990, THEOR SOC, V19, P507, DOI 10.1007/BF00147025; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; Gupta GR, 2019, LANCET, V393, P2550, DOI 10.1016/S0140-6736(19)30651-8; Hawkes S., 2020, OXFORD HDB GLOBAL HL, P237; Hay K, 2019, LANCET, V393, P2535, DOI 10.1016/S0140-6736(19)30648-8; Pruitt AS, 2018, GENDER WORK ORGAN, V25, P144, DOI 10.1111/gwao.12203; Springer KW, 2012, SOC SCI MED, V74, P1661, DOI 10.1016/j.socscimed.2012.03.001; UN, 2019, SUST DEV GOALS REP; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2	14	16	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2020	396	10250					521	522		10.1016/S0140-6736(20)31547-6	http://dx.doi.org/10.1016/S0140-6736(20)31547-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OC4LV	32763153	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000579130500006
J	Dyer, O				Dyer, Owen			Beirut's battered hospitals struggle in aftermath of explosion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3171	10.1136/bmj.m3171	http://dx.doi.org/10.1136/bmj.m3171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784204				2022-12-28	WOS:000560307500004
J	Pouchot, J; Couprie, A				Pouchot, Jacques; Couprie, Anne			A wandering spleen, splenomegaly, hypersplenism, and iron deficiency anaemia	LANCET			English	Editorial Material									[Pouchot, Jacques; Couprie, Anne] Hop Europeen Georges Pompidou, AP HP, Med Interne, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Pouchot, J (corresponding author), Hop Europeen Georges Pompidou, AP HP, Med Interne, F-75015 Paris, France.	jacques.pouchot@aphp.fr							0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					412	412						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0SW	32771108				2022-12-28	WOS:000561619100025
J	Hong, YL; Liu, ZB; Wang, L; Zhou, TY; Ma, W; Xu, C; Feng, S; Chen, L; Chen, ML; Sun, DM; Chen, XQ; Cheng, HM; Ren, WC				Hong, Yi-Lun; Liu, Zhibo; Wang, Lei; Zhou, Tianya; Ma, Wei; Xu, Chuan; Feng, Shun; Chen, Long; Chen, Mao-Lin; Sun, Dong-Ming; Chen, Xing-Qiu; Cheng, Hui-Ming; Ren, Wencai			Chemical vapor deposition of layered two-dimensional MoSi2N4 materials	SCIENCE			English	Article							TOTAL-ENERGY CALCULATIONS; ELASTIC PROPERTIES; MECHANICAL-PROPERTIES; YOUNGS MODULUS; HIGH-QUALITY; GRAPHENE; STRENGTH; MOBILITY	Identifying two-dimensional layered materials in the monolayer limit has led to discoveries of numerous new phenomena and unusual properties. We introduced elemental silicon during chemical vapor deposition growth of nonlayered molybdenum nitride to passivate its surface, which enabled the growth of centimeter-scale monolayer films of MoSi2N4. This monolayer was built up by septuple atomic layers of N-Si-N-Mo-N-Si-N, which can be viewed as a MoN2 layer sandwiched between two Si-N bilayers. This material exhibited semiconducting behavior (bandgap similar to 1.94 electron volts), high strength (similar to 66 gigapascals), and excellent ambient stability. Density functional theory calculations predict a large family of such monolayer structured two-dimensional layered materials, including semiconductors, metals, and magnetic half-metals.	[Hong, Yi-Lun; Liu, Zhibo; Wang, Lei; Zhou, Tianya; Ma, Wei; Xu, Chuan; Feng, Shun; Chen, Long; Chen, Mao-Lin; Sun, Dong-Ming; Chen, Xing-Qiu; Cheng, Hui-Ming; Ren, Wencai] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Hong, Yi-Lun; Wang, Lei; Zhou, Tianya; Ma, Wei; Chen, Mao-Lin; Sun, Dong-Ming; Chen, Xing-Qiu; Cheng, Hui-Ming; Ren, Wencai] Univ Sci & Technol China, Sch Mat Sci & Engn, Shenyang 110016, Peoples R China; [Feng, Shun] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 200031, Peoples R China; [Cheng, Hui-Ming] Tsinghua Univ, Shenzhen Geim Graphene Ctr, Tsinghua Berkeley Shenzhen Inst, Shenzhen 518055, Peoples R China; [Cheng, Hui-Ming] Univ Surrey, Adv Technol Inst, Guildford GU2 7XH, Surrey, England	Chinese Academy of Sciences; Institute of Metal Research, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; ShanghaiTech University; Tsinghua University; University of Surrey	Ren, WC (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.; Ren, WC (corresponding author), Univ Sci & Technol China, Sch Mat Sci & Engn, Shenyang 110016, Peoples R China.	wcren@limr.ac.cn	Wang, Lei/HHS-8535-2022; Cheng, Hui-Ming/B-8682-2012	Wang, Lei/0000-0002-0537-1105; Sun, Dongming/0000-0003-1552-7940; Chen, Long/0000-0002-8451-1419; Ma, Wei/0000-0001-8034-1865; Liu, Zhibo/0000-0002-9944-2129; Chen, Long/0000-0002-2966-1772	National Natural Science Foundation of China [51325205, 51725103, 51290273, 51521091, 51671193]; Key Research Program of Frontier Sciences of the Chinese Academy of Sciences [ZDBS-LY-JSC027]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB30000000]; National Key R&D Program of the Ministry of Science and Technology of China [2016YFA0200101]; LiaoNing Revitalization Talents Program [XLYC1808013]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Development and Reform Commission of Shenzhen Municipality	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences of the Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of the Ministry of Science and Technology of China; LiaoNing Revitalization Talents Program; Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Development and Reform Commission of Shenzhen Municipality	Supported by the National Natural Science Foundation of China (nos. 51325205, 51725103, 51290273, 51521091, and 51671193), the Key Research Program of Frontier Sciences of the Chinese Academy of Sciences (no. ZDBS-LY-JSC027), the Strategic Priority Research Program of the Chinese Academy of Sciences (no. XDB30000000), the National Key R&D Program of the Ministry of Science and Technology of China (no. 2016YFA0200101), LiaoNing Revitalization Talents Program (no. XLYC1808013), the Program for Guangdong Introducing Innovative and Entrepreneurial Teams, and the Development and Reform Commission of Shenzhen Municipality for the development of the "Low-Dimensional Materials and Devices" discipline.	Anasori B., 2019, 2D METAL CARBIDES NI; Anasori B, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.98; Arutt CN, 2017, SEMICOND SCI TECH, V32, DOI [10.1088/1361-6641/32/1/013005, 10.1038/ncomms15815]; BARDEEN J, 1950, PHYS REV, V80, P72, DOI 10.1103/PhysRev.80.72; Bertolazzi S, 2011, ACS NANO, V5, P9703, DOI 10.1021/nn203879f; Bruls RJ, 2001, J EUR CERAM SOC, V21, P263, DOI 10.1016/S0955-2219(00)00210-7; Cadelano E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.235502; Cai YQ, 2014, J AM CHEM SOC, V136, P6269, DOI 10.1021/ja4109787; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/2/025001; Castellanos-Gomez A, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-233; Cooper RC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035423; Ganin AY, 2006, J SOLID STATE CHEM, V179, P2339, DOI 10.1016/j.jssc.2006.05.025; Gao J, 2016, ADV MATER, V28, P9735, DOI 10.1002/adma.201601104; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Heyd J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2204597; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Kanoun MB, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.134109; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lee C, 2009, PHYS STATUS SOLIDI B, V246, P2562, DOI 10.1002/pssb.200982329; Lee GH, 2013, SCIENCE, V340, P1073, DOI 10.1126/science.1235126; Li JW, 2013, J PHYS CHEM C, V117, P15842, DOI 10.1021/jp403986v; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lin L, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8337; Lipatov A, 2020, ADV ELECTRON MATER, V6, DOI 10.1002/aelm.201901382; Lipatov A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0491; Liu F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064120; Naguib M, 2014, ADV MATER, V26, P992, DOI 10.1002/adma.201304138; Naguib M, 2011, ADV MATER, V23, P4248, DOI 10.1002/adma.201102306; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Najafi L, 2018, ACS NANO, V12, P10736, DOI 10.1021/acsnano.8b05514; Ni ZH, 2010, PHYSICA B, V405, P1301, DOI 10.1016/j.physb.2009.11.071; Oyama S. T., 1996, CHEM TRANSITION META, P1; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Politano A, 2015, NANO RES, V8, P1847, DOI 10.1007/s12274-014-0691-9; Reddy CD, 2006, NANOTECHNOLOGY, V17, P864, DOI 10.1088/0957-4484/17/3/042; Roundy D, 1999, PHYS REV LETT, V82, P2713, DOI 10.1103/PhysRevLett.82.2713; Toth V. L. E., 1971, TRANSITION METAL CAR; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; Wang H, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902663; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Wang ZX, 2017, ADV MATER, V29, DOI 10.1002/adma.201700364; Xi JY, 2012, NANOSCALE, V4, P4348, DOI 10.1039/c2nr30585b; Xu C, 2015, NAT MATER, V14, P1135, DOI [10.1038/NMAT4374, 10.1038/nmat4374]; Zhao H, 2009, NANO LETT, V9, P3012, DOI 10.1021/nl901448z; Zheng YP, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/40/405701	49	269	267	156	712	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					670	+		10.1126/science.abb7023	http://dx.doi.org/10.1126/science.abb7023			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764066				2022-12-28	WOS:000559184400041
J	Pascalau, R; Kuruvilla, R				Pascalau, Raluca; Kuruvilla, Rejji			A Hairy End to a Chilling Event	CELL			English	Editorial Material							STEM-CELLS; SKIN	In the skin, sympathetic nerves, arrector pili muscles, and hair follicles form a tri-lineage unit to cause piloerection or goosebumps. In this issue of Cell, Schwartz et al. report that, beyond goosebumps, muscle-anchored nerves form ``synapse-like'' connections with hair follicle stem cells to promote hair regeneration in response to cold.	[Pascalau, Raluca; Kuruvilla, Rejji] Johns Hopkins Univ, Dept Biol, 3400 N Charles St,227 Mudd Hall, Baltimore, MD 21218 USA	Johns Hopkins University	Kuruvilla, R (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St,227 Mudd Hall, Baltimore, MD 21218 USA.	rkuruvilla@jhu.edu		Pascalau, Raluca/0000-0002-7059-6896				Botchkarev VA, 1999, J INVEST DERMATOL, V113, P878, DOI 10.1046/j.1523-1747.1999.00791.x; Fan SMY, 2018, P NATL ACAD SCI USA, V115, pE6880, DOI 10.1073/pnas.1719548115; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Furlan A, 2016, NAT NEUROSCI, V19, P1331, DOI 10.1038/nn.4376; Gonzales KAU, 2017, DEV CELL, V43, P387, DOI 10.1016/j.devcel.2017.10.001; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Shwartz Y, 2020, CELL, V182, P578, DOI 10.1016/j.cell.2020.06.031; Zhang B, 2020, NATURE, V577, P676, DOI 10.1038/s41586-020-1935-3	9	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					539	541		10.1016/j.cell.2020.07.004	http://dx.doi.org/10.1016/j.cell.2020.07.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32763185	Bronze			2022-12-28	WOS:000558649000003
J	Hernansanz-Agustin, P; Choya-Foces, C; Carregal-Romero, S; Ramos, E; Oliva, T; Villa-Pina, T; Moreno, L; Izquierdo-alvarez, A; Cabrera-Garcia, JD; Cortes, A; Lechuga-Vieco, AV; Jadiya, P; Navarro, E; Parada, E; Palomino-Antolin, A; Tello, D; Acin-Perez, R; Rodriguez-Aguilera, JC; Navas, P; Cogolludo, A; Lopez-Montero, I; Martinez-del-Pozo, A; Egea, J; Lopez, MG; Elrod, JW; Ruiz-Cabello, J; Bogdanova, A; Enriquez, JA; Martinez-Ruiz, A				Hernansanz-Agustin, Pablo; Choya-Foces, Carmen; Carregal-Romero, Susana; Ramos, Elena; Oliva, Tamara; Villa-Pina, Tamara; Moreno, Laura; Izquierdo-alvarez, Alicia; Cabrera-Garcia, J. Daniel; Cortes, Ana; Lechuga-Vieco, Ana Victoria; Jadiya, Pooja; Navarro, Elisa; Parada, Esther; Palomino-Antolin, Alejandra; Tello, Daniel; Acin-Perez, Rebeca; Rodriguez-Aguilera, Juan Carlos; Navas, Placido; Cogolludo, Angel; Lopez-Montero, Ivan; Martinez-del-Pozo, Alvaro; Egea, Javier; Lopez, Manuela G.; Elrod, John W.; Ruiz-Cabello, Jesus; Bogdanova, Anna; Enriquez, Jose Antonio; Martinez-Ruiz, Antonio			Na(+)controls hypoxic signalling by the mitochondrial respiratory chain	NATURE			English	Article							ELECTRON-TRANSPORT; COMPLEX-III; PULMONARY VASOCONSTRICTION; OXIDATIVE-PHOSPHORYLATION; CYTOCHROME-C; ALPHA-SARCIN; CA2+; CALCIUM; CELLS; ACCUMULATION	All metazoans depend on the consumption of O(2)by the mitochondrial oxidative phosphorylation system (OXPHOS) to produce energy. In addition, the OXPHOS uses O(2)to produce reactive oxygen species that can drive cell adaptations(1-4), a phenomenon that occurs in hypoxia(4-8)and whose precise mechanism remains unknown. Ca(2+)is the best known ion that acts as a second messenger(9), yet the role ascribed to Na(+)is to serve as a mere mediator of membrane potential(10). Here we show that Na(+)acts as a second messenger that regulates OXPHOS function and the production of reactive oxygen species by modulating the fluidity of the inner mitochondrial membrane. A conformational shift in mitochondrial complex I during acute hypoxia(11)drives acidification of the matrix and the release of free Ca(2+)from calcium phosphate (CaP) precipitates. The concomitant activation of the mitochondrial Na+/Ca(2+)exchanger promotes the import of Na(+)into the matrix. Na(+)interacts with phospholipids, reducing inner mitochondrial membrane fluidity and the mobility of free ubiquinone between complex II and complex III, but not inside supercomplexes. As a consequence, superoxide is produced at complex III. The inhibition of Na(+)import through the Na+/Ca(2+)exchanger is sufficient to block this pathway, preventing adaptation to hypoxia. These results reveal that Na(+)controls OXPHOS function and redox signalling through an unexpected interaction with phospholipids, with profound consequences for cellular metabolism. Na(+)controls the function of the mitochondrial oxidative phosphorylation system and hypoxic redox signalling through an unexpected interaction with phospholipids.	[Hernansanz-Agustin, Pablo; Choya-Foces, Carmen; Oliva, Tamara; Cabrera-Garcia, J. Daniel; Parada, Esther; Palomino-Antolin, Alejandra; Tello, Daniel; Egea, Javier; Martinez-Ruiz, Antonio] Hosp Univ Santa Cristina, Inst Invest Sanitaria Princesa IIS IP, Unidad Invest, Madrid, Spain; [Hernansanz-Agustin, Pablo; Lechuga-Vieco, Ana Victoria; Acin-Perez, Rebeca; Enriquez, Jose Antonio] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Carregal-Romero, Susana; Ruiz-Cabello, Jesus] Basque Res & Technol Alliance BRTA, Ctr Cooperat Res Biomat CIC BiomaGUNE, Donostia San Sebastian, Spain; [Carregal-Romero, Susana; Moreno, Laura; Cogolludo, Angel; Ruiz-Cabello, Jesus] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Ramos, Elena; Villa-Pina, Tamara; Izquierdo-alvarez, Alicia] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP, Serv Inmunol, Madrid, Spain; [Moreno, Laura; Elrod, John W.] Univ Complutense Madrid UCM, Inst Invest Sanitaria Gregorio Maranon IISGM, Dept Farmacol & Toxicol, Fac Med, Madrid, Spain; [Cortes, Ana; Rodriguez-Aguilera, Juan Carlos; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Cortes, Ana; Rodriguez-Aguilera, Juan Carlos; Navas, Placido] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Jadiya, Pooja] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Navarro, Elisa; Parada, Esther; Palomino-Antolin, Alejandra; Egea, Javier; Lopez, Manuela G.] Univ Autonoma Madrid UAM, Inst Invest Sanitaria Princesa IIS IP, Dept Farmacol & Terapeut, Fac Med,Inst Teofilo Hernando, Madrid, Spain; [Lopez-Montero, Ivan] Univ Complutense Madrid, Inst Invest Sanitaria, Hosp 12 Octubre Imas12, Dept Quim Fis, Madrid, Spain; [Martinez-del-Pozo, Alvaro; Martinez-Ruiz, Antonio] Univ Complutense Madrid UCM, Dept Bioquim & Biol Mol, Madrid, Spain; [Ruiz-Cabello, Jesus] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Ruiz-Cabello, Jesus] Univ Complutense Madrid UCMM, Fac Farm, Dept Quim Ciencias Farmaceut, Madrid, Spain; [Bogdanova, Anna] Univ Zurich, Vetsuisse Fac, Inst Vet Physiol, Red Blood Cell Grp, Zurich, Switzerland; [Bogdanova, Anna] Univ Zurich, ZIHP, Zurich, Switzerland; [Enriquez, Jose Antonio] Ctr Invest Biomed Red Fragilidad Envejecimiento S, Madrid, Spain; [Martinez-Ruiz, Antonio] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Acin-Perez, Rebeca] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Acin-Perez, Rebeca] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIC biomaGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Basque Foundation for Science; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Martinez-Ruiz, A (corresponding author), Hosp Univ Santa Cristina, Inst Invest Sanitaria Princesa IIS IP, Unidad Invest, Madrid, Spain.; Enriquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Martinez-Ruiz, A (corresponding author), Univ Complutense Madrid UCM, Dept Bioquim & Biol Mol, Madrid, Spain.; Enriquez, JA (corresponding author), Ctr Invest Biomed Red Fragilidad Envejecimiento S, Madrid, Spain.; Martinez-Ruiz, A (corresponding author), Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.	jaenriquez@cnic.es; amartinezruiz@salud.madrid.org	Carregal-Romero, Susana/K-6493-2019; Martínez-Ruiz, Antonio/A-5672-2009; Cogolludo, Angel/A-6129-2011; Ruiz-Cabello, Jesus/A-9570-2012; NAVAS, PLACIDO/R-5943-2019; Hernansanz-Agustín, Pablo/AAA-5348-2020; Carregal-Romero, Susana/I-7946-2014; Martinez-del-Pozo, Alvaro/L-8556-2014; Moreno, Laura/A-9433-2010; Enríquez, J.A./M-8468-2016; Bogdanova, Anna/M-1977-2017; Acin-Perez, Rebeca/H-6160-2015	Martínez-Ruiz, Antonio/0000-0001-5394-9824; Ruiz-Cabello, Jesus/0000-0001-8681-5056; NAVAS, PLACIDO/0000-0002-4115-7966; Hernansanz-Agustín, Pablo/0000-0003-2935-207X; Carregal-Romero, Susana/0000-0003-1444-6268; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Moreno, Laura/0000-0001-9028-2299; Enríquez, J.A./0000-0002-3671-2961; Bogdanova, Anna/0000-0003-0502-5381; Acin-Perez, Rebeca/0000-0001-9553-8337; Elrod, John/0000-0003-3925-2224	Spanish Government [CP14/00008, CPII19/00005, PI16/00735, SAF2016-77222-R, PI17/01286, SAF2015-65633-R, RTI2018-099357-B-I00, CB16/10/00282, RTI2018-095793-B-I00, SAF2017-84494-2-R, SEV-2015-0505]; European Union FEDER/ERDF; European Union [ITN GA317433, MC-CIG GA304217]; Comunidad de Madrid [B2017/BMD-3727, B2017/BMD-3827]; Fundacion Domingo Martinez; Human Frontier Science Program [HFSP-RGP0016/2018]; Fundacion BBVA; UCM-Banco Santander [PR75/18-21561]; Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion [2018-CIEN-000058-01]; Basque Government under the ELKARTEK Program [KK-2019/bmG19]; Swiss National Science Foundation (SNF) [310030_124970/1]; IIS-IP; COST actions [TD0901, BM1203]; Pro-CNIC Foundation; Universidad Autonoma de Madrid (UAM); I3SNS;  [CSD2007-00020];  [CP07/00143];  [PS09/00101];  [PI12/00875];  [PI15/00107];  [RTI2018-094203-B-I00];  [CP12/03304];  [PI15/01100]	Spanish Government(Spanish GovernmentEuropean Commission); European Union FEDER/ERDF; European Union(European Commission); Comunidad de Madrid(Comunidad de Madrid); Fundacion Domingo Martinez; Human Frontier Science Program(Human Frontier Science Program); Fundacion BBVA(BBVA Foundation); UCM-Banco Santander; Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion; Basque Government under the ELKARTEK Program(Basque Government); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); IIS-IP; COST actions(European Cooperation in Science and Technology (COST)); Pro-CNIC Foundation; Universidad Autonoma de Madrid (UAM); I3SNS; ; ; ; ; ; ; ; 	We thank M. Kowalewski (Institute of Veterinary Anatomy, UZH) for allowing us the use of the microscope for live-cell imaging; A. Alfuzzi, J. Prieto, A. Mellado (IIS-IP) and B. Barreira (CIBERES) for collaboration in experiments; E. Fuertes-Yebra (IIS-IP) for technical assistance; M. E. Soriano and F. Caicci (University of Padova) for performing electron microscopy; R. Rizzuto and D. De Stefani (University of Padova) for MCU KO and control cell lines; M. T. Alonso (IBGM, University of Valladolid and CSIC) for the pcDNA3-erGAP3 plasmid; J. Langer from CIC biomaGUNE for fruitful discussion and support with the IR spectroscopy measurements; I. Sekler (Ben-Gurion University), C. Rueda and J. Satrustegui (CMBSO, UAM-CSIC) for providing plasmids and other material and for helpful discussions; M. Cano and A. G. Garcia (IIS-IP and UAM), M. Murphy (MRC and University of Cambridge), I. Wittig (Goethe Universitat), J. Miguel Mancheno (IQFR, CSIC), A. Pascual and J. Lopez-Barneo (IBIS, US-CSIC) for helpful discussions; and L. del Peso (UAM) and F. Sanchez-Madrid (IIS-IP and UAM) for their support. This research has been financed by Spanish Government grants (ISCIII and AEI agencies, partially funded by the European Union FEDER/ERDF) CSD2007-00020 (RosasNet, Consolider-Ingenio 2010 programme to A.M.-R. and J.A.E.); CP07/00143, PS09/00101, PI12/00875, PI15/00107 and RTI2018-094203-B-I00 (to A.M.-R.); CP12/03304 and PI15/01100 (to L.M.); CP14/00008, CPII19/00005 and PI16/00735 (to J.E.); SAF2016-77222-R (to A. Cogolludo); PI17/01286 (to P.N.); SAF2015-65633-R, RTI2018-099357-B-I00 and CB16/10/00282 (to J.A.E.); RTI2018-095793-B-I00 (to M.G.L.); and SAF2017-84494-2-R (to J.R.-C.), by the European Union (ITN GA317433 to J.A.E. and MC-CIG GA304217 to R.A.-P.), by grants from the Comunidad de Madrid B2017/BMD-3727 (to A. Cogolludo) and B2017/BMD-3827 (to M.G.L.), by a grant from the Fundacion Domingo Martinez (to M.G.L. and A.M.-R.), by the Human Frontier Science Program grant HFSP-RGP0016/2018 (to J.A.E.), by grants from the Fundacion BBVA (to R.A.-P. and J.R.-C.), by the UCM-Banco Santander grant PR75/18-21561 (to A.M.-d.-P.), by the Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion 2018-CIEN-000058-01 (to J.R.-C.) and from the Basque Government under the ELKARTEK Program (grant no. KK-2019/bmG19 to J.R.-C.), by the Swiss National Science Foundation (SNF) grant 310030_124970/1 (to A.B.), by a travel grant from the IIS-IP (to P.H.-A.) and by the COST actions TD0901 (HypoxiaNet) and BM1203 (EU-ROS). The CNIC is supported by the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (Spanish Government award SEV-2015-0505). CIC biomaGUNE is supported by the Maria de Maeztu Units of Excellence Program from the Spanish Government (MDM-2017-0720). P.H.-A. was a recipient of a predoctoral FPU fellowship from the Spanish Government. E.N. is a recipient of a predoctoral FPI fellowship from the Universidad Autonoma de Madrid (UAM). A.M.-R., L.M. and J.E. are supported by the I3SNS or 'Miguel Servet' programmes (ISCIII, Spanish Government; partially funded by the FEDER/ERDF).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Babot M, 2014, BBA-BIOENERGETICS, V1837, P1083, DOI 10.1016/j.bbabio.2014.02.018; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Rodriguez-Aguilera JC, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030027; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Connolly MJ, 2013, J PHYSIOL-LONDON, V591, P4473, DOI 10.1113/jphysiol.2013.253682; Cordomi A, 2008, J PHYS CHEM B, V112, P1397, DOI 10.1021/jp073897w; COX DA, 1993, J BIOL CHEM, V268, P938; Desireddi JR, 2010, ANTIOXID REDOX SIGN, V12, P595, DOI 10.1089/ars.2009.2862; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Gallet PF, 1997, BIOCHEM J, V324, P627, DOI 10.1042/bj3240627; GASSET M, 1989, BIOCHEM J, V258, P569, DOI 10.1042/bj2580569; GREENAWALT JW, 1964, J CELL BIOL, V23, P21, DOI 10.1083/jcb.23.1.21; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hernansanz-Agustin P, 2017, REDOX BIOL, V12, P1040, DOI 10.1016/j.redox.2017.04.025; Hernansanz-Agustin P, 2014, FREE RADICAL BIO MED, V71, P146, DOI 10.1016/j.freeradbiomed.2014.03.011; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lenaz G, 2009, BBA-BIOENERGETICS, V1787, P563, DOI 10.1016/j.bbabio.2009.02.019; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Martinez-Ruiz A, 2001, METHODS ENZYMOL, V341, P335, DOI 10.1016/S0076-6879(01)41162-1; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Michelakis EV, 2004, J MOL CELL CARDIOL, V37, P1119, DOI 10.1016/j.yjmcc.2004.09.007; Moreno L, 2014, ANTIOXID REDOX SIGN, V20, P1, DOI 10.1089/ars.2012.4752; Munoz C, 1996, J IMMUNOL, V157, P3587; Navarro-Antolin J, 2000, J BIOL CHEM, V275, P3075, DOI 10.1074/jbc.275.5.3075; Pabst G, 2007, BIOPHYS J, V93, P2688, DOI 10.1529/biophysj.107.112615; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; STONE TJ, 1965, P NATL ACAD SCI USA, V54, P1010, DOI 10.1073/pnas.54.4.1010; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Alonso MT, 2017, BBA-MOL CELL RES, V1864, P894, DOI 10.1016/j.bbamcr.2016.12.003; Wolf SG, 2017, ELIFE, V6, DOI 10.7554/eLife.29929; Yubero D, 2016, MITOCHONDRION, V30, P51, DOI 10.1016/j.mito.2016.06.007; Zhang HW, 2017, METHODS MOL BIOL, V1522, P17, DOI 10.1007/978-1-4939-6591-5_2; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	54	76	76	9	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2020	586	7828					287	+		10.1038/s41586-020-2551-y	http://dx.doi.org/10.1038/s41586-020-2551-y		JUL 2020	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9PR	32728214	Green Published, Green Accepted			2022-12-28	WOS:000554511600005
J	Sahin, U; Oehm, P; Derhovanessian, E; Jabulowsky, RA; Vormehr, M; Gold, M; Maurus, D; Schwarck-Kokarakis, D; Kuhn, AN; Omokoko, T; Kranz, LM; Diken, M; Kreiter, S; Haas, H; Attig, S; Rae, R; Cuk, K; Kemmer-Bruck, A; Breitkreuz, A; Tolliver, C; Caspar, J; Quinkhardt, J; Hebich, L; Stein, M; Hohberger, A; Vogler, I; Liebig, I; Renken, S; Sikorski, J; Leierer, M; Muller, V; Mitzel-Rink, H; Miederer, M; Huber, C; Grabbe, S; Utikal, J; Pinter, A; Kaufmann, R; Hassel, JC; Loquai, C; Tureci, O				Sahin, Ugur; Oehm, Petra; Derhovanessian, Evelyna; Jabulowsky, Robert A.; Vormehr, Mathias; Gold, Maike; Maurus, Daniel; Schwarck-Kokarakis, Doreen; Kuhn, Andreas N.; Omokoko, Tana; Kranz, Lena M.; Diken, Mustafa; Kreiter, Sebastian; Haas, Heinrich; Attig, Sebastian; Rae, Richard; Cuk, Katarina; Kemmer-Brueck, Alexandra; Breitkreuz, Andrea; Tolliver, Claudia; Caspar, Janina; Quinkhardt, Juliane; Hebich, Lisa; Stein, Malte; Hohberger, Alexander; Vogler, Isabel; Liebig, Inga; Renken, Stephanie; Sikorski, Julian; Leierer, Melanie; Mueller, Verena; Mitzel-Rink, Heidrun; Miederer, Matthias; Huber, Christoph; Grabbe, Stephan; Utikal, Jochen; Pinter, Andreas; Kaufmann, Roland; Hassel, Jessica C.; Loquai, Carmen; Tuereci, Oezlem			An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma	NATURE			English	Article							CANCER-IMMUNOTHERAPY; ANTIGENS; LIPOSOMES; HIERARCHY; ALIGNMENT	Treating patients who have cancer with vaccines that stimulate a targeted immune response is conceptually appealing, but cancer vaccine trials have not been successful in late-stage patients with treatment-refractory tumours(1,2). We are testing melanoma FixVac (BNT111)-an intravenously administered liposomal RNA (RNA-LPX) vaccine, which targets four non-mutated, tumour-associated antigens that are prevalent in melanoma-in an ongoing, first-in-human, dose-escalation phase I trial in patients with advanced melanoma (Lipo-MERIT trial, ClinicalTrials.gov identifier NCT02410733). We report here data from an exploratory interim analysis that show that melanoma FixVac, alone or in combination with blockade of the checkpoint inhibitor PD1, mediates durable objective responses in checkpoint-inhibitor (CPI)-experienced patients with unresectable melanoma. Clinical responses are accompanied by the induction of strong CD4(+)and CD8(+)T cell immunity against the vaccine antigens. The antigen-specific cytotoxic T-cell responses in some responders reach magnitudes typically reported for adoptive T-cell therapy, and are durable. Our findings indicate that RNA-LPX vaccination is a potent immunotherapy in patients with CPI-experienced melanoma, and suggest the general utility of non-mutant shared tumour antigens as targets for cancer vaccination. Results of an exploratory interim analysis from a phase I trial show that an RNA vaccine targeted towards four melanoma-associated antigens produces durable objective responses in patients with melanoma that are accompanied by strong CD4(+)and CD8(+)T-cell immunity.	[Sahin, Ugur; Oehm, Petra; Derhovanessian, Evelyna; Jabulowsky, Robert A.; Vormehr, Mathias; Gold, Maike; Maurus, Daniel; Schwarck-Kokarakis, Doreen; Kuhn, Andreas N.; Omokoko, Tana; Kranz, Lena M.; Diken, Mustafa; Kreiter, Sebastian; Haas, Heinrich; Cuk, Katarina; Kemmer-Brueck, Alexandra; Breitkreuz, Andrea; Tolliver, Claudia; Caspar, Janina; Quinkhardt, Juliane; Hebich, Lisa; Stein, Malte; Vogler, Isabel; Liebig, Inga; Renken, Stephanie; Sikorski, Julian; Huber, Christoph; Tuereci, Oezlem] BioNTech, Mainz, Germany; [Sahin, Ugur; Diken, Mustafa; Kreiter, Sebastian; Attig, Sebastian; Rae, Richard; Hohberger, Alexander; Huber, Christoph] Johannes Gutenberg Univ Mainz gGmbH, Translat Oncol Univ Med Ctr, TRON, Mainz, Germany; [Sahin, Ugur; Attig, Sebastian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany; [Sahin, Ugur; Tuereci, Oezlem] Helmholtz Inst Translat Oncol Mainz, HI TRON, Mainz, Germany; [Leierer, Melanie; Hassel, Jessica C.] Heidelberg Univ Hosp, Dept Dermatol, Heidelberg, Germany; [Leierer, Melanie; Hassel, Jessica C.] Heidelberg Univ Hosp, Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Mueller, Verena; Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Mueller, Verena; Utikal, Jochen] Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Mitzel-Rink, Heidrun; Grabbe, Stephan; Loquai, Carmen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Mainz, Germany; [Miederer, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Nucl Med, Mainz, Germany; [Pinter, Andreas; Kaufmann, Roland] Univ Hosp Frankfurt Main, Dept Dermatol Venereol & Allergol, Frankfurt, Germany	BioNTech SE; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sahin, U (corresponding author), BioNTech, Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz gGmbH, Translat Oncol Univ Med Ctr, TRON, Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany.; Sahin, U (corresponding author), Helmholtz Inst Translat Oncol Mainz, HI TRON, Mainz, Germany.	ugur.sahin@biontech.de	Grabe, Stephan/AAJ-4578-2021; Loquai, Carmen/AAW-9241-2020; Miederer, Matthias/ABA-5988-2020; Vormehr, Mathias/AAJ-7808-2021	Grabe, Stephan/0000-0002-6863-8719; Miederer, Matthias/0000-0001-5075-5995; Vormehr, Mathias/0000-0001-7788-3380; Kranz, Lena/0000-0003-1943-3431; Oehm, Petra/0000-0002-1086-2726				Barichello JM, 2010, METHODS MOL BIOL, V605, P461, DOI 10.1007/978-1-60327-360-2_32; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; de Vries J, 2016, NATURE, V534, P329, DOI 10.1038/nature18443; Grabbe S, 2016, NANOMEDICINE-UK, V11, P2723, DOI 10.2217/nnm-2016-0275; Grunwitz C, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1629259; Hanagiri T, 2006, CANCER IMMUNOL IMMUN, V55, P178, DOI 10.1007/s00262-005-0063-0; Hofbauer GFL, 1998, J CUTAN PATHOL, V25, P204, DOI 10.1111/j.1600-0560.1998.tb01720.x; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hu YN, 2014, CANCER IMMUNOL IMMUN, V63, P779, DOI 10.1007/s00262-014-1551-x; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jackson H, 2006, J IMMUNOL, V176, P5908, DOI 10.4049/jimmunol.176.10.5908; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Nishino M, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-17; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pektor S, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0435-z; Pektor S, 2016, NUCL MED BIOL, V43, P651, DOI 10.1016/j.nucmedbio.2016.07.004; Reinhard K, 2020, SCIENCE, V367, P446, DOI 10.1126/science.aay5967; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Romero P, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf0685; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Simon P, 2014, CANCER IMMUNOL RES, V2, P1230, DOI 10.1158/2326-6066.CIR-14-0108; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; von Niessen AGO, 2019, MOL THER, V27, P824, DOI 10.1016/j.ymthe.2018.12.011	36	240	245	43	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2020	585	7823					107	+		10.1038/s41586-020-2537-9	http://dx.doi.org/10.1038/s41586-020-2537-9		JUL 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NJ1LP	32728218				2022-12-28	WOS:000554511600004
J	Riva, L; Yuan, SF; Yin, X; Martin-Sancho, L; Matsunaga, N; Pache, L; Burgstaller-Muehlbacher, S; De Jesus, PD; Teriete, P; Hull, MV; Chang, MW; Chan, JFW; Cao, JL; Poon, VKM; Herbert, KM; Cheng, KY; Nguyen, TTH; Rubanov, A; Pu, Y; Nguyen, C; Choi, A; Rathnasinghe, R; Schotsaert, M; Miorin, L; Dejosez, M; Zwaka, TP; Sit, KY; Martinez-Sobrido, L; Liu, WC; White, KM; Chapman, ME; Lendy, EK; Glynne, RJ; Albrecht, R; Ruppin, E; Mesecar, AD; Johnson, JR; Benner, C; Sun, R; Schultz, PG; Su, AI; Garcia-Sastre, A; Chatterjee, AK; Yuen, KY; Chanda, SK				Riva, Laura; Yuan, Shuofeng; Yin, Xin; Martin-Sancho, Laura; Matsunaga, Naoko; Pache, Lars; Burgstaller-Muehlbacher, Sebastian; De Jesus, Paul D.; Teriete, Peter; Hull, Mitchell V.; Chang, Max W.; Chan, Jasper Fuk-Woo; Cao, Jianli; Poon, Vincent Kwok-Man; Herbert, Kristina M.; Cheng, Kuoyuan; Nguyen, Tu-Trinh H.; Rubanov, Andrey; Pu, Yuan; Nguyen, Courtney; Choi, Angela; Rathnasinghe, Raveen; Schotsaert, Michael; Miorin, Lisa; Dejosez, Marion; Zwaka, Thomas P.; Sit, Ko-Yung; Martinez-Sobrido, Luis; Liu, Wen-Chun; White, Kris M.; Chapman, Mackenzie E.; Lendy, Emma K.; Glynne, Richard J.; Albrecht, Randy; Ruppin, Eytan; Mesecar, Andrew D.; Johnson, Jeffrey R.; Benner, Christopher; Sun, Ren; Schultz, Peter G.; Su, Andrew I.; Garcia-Sastre, Adolfo; Chatterjee, Arnab K.; Yuen, Kwok-Yung; Chanda, Sumit K.			Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing	NATURE			English	Article							EBOLA-VIRUS; CATHEPSIN-L; POSTMENOPAUSAL OSTEOPOROSIS; IL-12/IL-23 INHIBITOR; REPLICATION; EFFICACY; APILIMOD; PIKFYVE; ONO-5334; KINASE	The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019 has triggered an ongoing global pandemic of the severe pneumonia-like disease coronavirus disease 2019 (COVID-19)(1). The development of a vaccine is likely to take at least 12-18 months, and the typical timeline for approval of a new antiviral therapeutic agent can exceed 10 years. Thus, repurposing of known drugs could substantially accelerate the deployment of new therapies for COVID-19. Here we profiled a library of drugs encompassing approximately 12,000 clinical-stage or Food and Drug Administration (FDA)-approved small molecules to identify candidate therapeutic drugs for COVID-19. We report the identification of 100 molecules that inhibit viral replication of SARS-CoV-2, including 21 drugs that exhibit dose-response relationships. Of these, thirteen were found to harbour effective concentrations commensurate with probable achievable therapeutic doses in patients, including the PIKfyve kinase inhibitor apilimod(2-4)and the cysteine protease inhibitors MDL-28170, Z LVG CHN2, VBY-825 and ONO 5334. Notably, MDL-28170, ONO 5334 and apilimod were found to antagonize viral replication in human pneumocyte-like cells derived from induced pluripotent stem cells, and apilimod also demonstrated antiviral efficacy in a primary human lung explant model. Since most of the molecules identified in this study have already advanced into the clinic, their known pharmacological and human safety profiles will enable accelerated preclinical and clinical evaluation of these drugs for the treatment of COVID-19. A screen of the ReFRAME library of approximately 12,000 known drugs for antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) identified several candidate compounds with suitable activities and pharmacological profiles, which could potentially expedite the deployment of therapies for coronavirus disease 2019 (COVID-19).	[Riva, Laura; Yin, Xin; Martin-Sancho, Laura; Matsunaga, Naoko; Pache, Lars; De Jesus, Paul D.; Teriete, Peter; Herbert, Kristina M.; Rubanov, Andrey; Pu, Yuan; Nguyen, Courtney; Chanda, Sumit K.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, Immun & Pathogenesis Program, La Jolla, CA 92037 USA; [Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Cao, Jianli; Poon, Vincent Kwok-Man; Yuen, Kwok-Yung] Univ Hong Kong Hong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China; [Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Cao, Jianli; Poon, Vincent Kwok-Man; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China; [Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Cao, Jianli; Poon, Vincent Kwok-Man; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Burgstaller-Muehlbacher, Sebastian] Univ Vienna, Max Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria; [Burgstaller-Muehlbacher, Sebastian] Med Univ Vienna, Vienna, Austria; [Hull, Mitchell V.; Nguyen, Tu-Trinh H.; Schultz, Peter G.; Chatterjee, Arnab K.] Calibr Scripps Res, La Jolla, CA 92037 USA; [Chang, Max W.; Benner, Christopher] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cheng, Kuoyuan; Ruppin, Eytan] NCI, Canc Data Sci Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Cheng, Kuoyuan] Univ Maryland, Biol Sci Grad Program, College Pk, MD USA; [Choi, Angela; Rathnasinghe, Raveen; Schotsaert, Michael; Miorin, Lisa; Liu, Wen-Chun; White, Kris M.; Albrecht, Randy; Johnson, Jeffrey R.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Choi, Angela; Rathnasinghe, Raveen; Schotsaert, Michael; Miorin, Lisa; Liu, Wen-Chun; White, Kris M.; Albrecht, Randy; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Choi, Angela; Rathnasinghe, Raveen] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Dejosez, Marion; Zwaka, Thomas P.] Icahn Sch Med Mt Sinai, Ctr Cell Based Res Parkinsons Dis, Dept Cell Regenerat & Dev Biol, Black Family Stem Cell Inst,Huffington Fdn, New York, NY 10029 USA; [Sit, Ko-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Peoples R China; [Martinez-Sobrido, Luis] Texas Biomed Res Inst, San Antonio, TX USA; [Chapman, Mackenzie E.; Mesecar, Andrew D.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Lendy, Emma K.; Mesecar, Andrew D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Glynne, Richard J.] Incept Therapeut, San Diego, CA USA; [Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Su, Andrew I.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Hong Kong; University of Hong Kong; University of Hong Kong; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Hong Kong; Texas Biomedical Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Los Angeles; Scripps Research Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chanda, SK (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, Immun & Pathogenesis Program, La Jolla, CA 92037 USA.; Yuen, KY (corresponding author), Univ Hong Kong Hong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Li Ka Shing Fac Med, Hong Kong, Peoples R China.; Chatterjee, AK (corresponding author), Calibr Scripps Res, La Jolla, CA 92037 USA.	achatterjee@scripps.edu; kyyuen@hku.hk; schanda@sbpdiscovery.org	Chan, Jasper F. W./D-8007-2013; YIN, XIN/B-5862-2018; Liu, Wen-Chun/AAU-3193-2021; LIU, WEN-CHUN/ABC-8722-2020	Chan, Jasper F. W./0000-0001-6336-6657; YIN, XIN/0000-0003-2357-6718; Liu, Wen-Chun/0000-0003-0344-4371; Burgstaller-Muehlbacher, Sebastian/0000-0003-4640-3510; Albrecht, Randy/0000-0003-4008-503X; Pu, Yuan/0000-0002-7049-8452; Cheng, Kuoyuan/0000-0001-8118-5243; Rathnasinghe, Raveen/0000-0002-1260-2493; Yuan, Shuofeng/0000-0001-7996-1119; Poon, Vincent kwok-man/0000-0002-7737-8912; Hull, Mitchell/0000-0002-9364-1901; Martinez-Sobrido, Luis/0000-0001-7084-0804; Rubanov, Andrey/0000-0002-5007-0360; Cao, Jianli/0000-0003-1464-7377; Chang, Max/0000-0002-4526-489X	Sanford Burnham Prebys Medical Discovery Institute: DoD [W81XWH-20-1-0270]; DHIPC [U19 AI118610]; Fluomics/NOSI [U19 AI135972]; Health and Medical Research Fund [COVID190121]; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; National Program on Key Research Project of China [2020YFA0707500, 2020YFA0707504]; Theme-Based Research Scheme of the Research Grants Council [T11/707/15]; Hong Kong Special Administrative Region; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201700060C]; NIH/NIGMS T32 Training Grant for Structural Biology and Biophysics [GM132024]; Huffington Foundation; Bill and Melinda Gates Foundation; CRIP (Center for Research for Influenza Pathogenesis); NIAID [HHSN272201400008C]; JPB Foundation; Open Philanthropy Project [2020-215611 (5384)]; NIAID grant [U19AI135972, U19AI142733]; DoD [W81XWH-20-1-0270]; DARPA grant [HR0011-19-2-0020]	Sanford Burnham Prebys Medical Discovery Institute: DoD; DHIPC; Fluomics/NOSI; Health and Medical Research Fund; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; National Program on Key Research Project of China; Theme-Based Research Scheme of the Research Grants Council; Hong Kong Special Administrative Region; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS T32 Training Grant for Structural Biology and Biophysics; Huffington Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CRIP (Center for Research for Influenza Pathogenesis); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); JPB Foundation; Open Philanthropy Project; NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DoD(United States Department of Defense); DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281. The authors thank A. Embry for guidance in securing reagents; S. Yoh for scientific input; H. Nymark-McMahon for manuscript editing; T. Marathe for copy editing; S. Blondelle and L. Adelman for facilities and biosafety support; M. Chacon for administrative assistance; W. Thienphrapa and H. Curry for literature research support; R. Eaden for shipping and delivery assistance; O. Harismendy for advice on data analysis; and B. Anson and A. Hamdani in the Mesecar laboratory for providing samples of SARS-CoV-2 Mpro. This work was supported by the following grants to the Sanford Burnham Prebys Medical Discovery Institute: DoD: W81XWH-20-1-0270; DHIPC: U19 AI118610; Fluomics/NOSI: U19 AI135972, as well as generous philanthropic donations from D. Ruch and S. Blair and J. Blair. The work at the University of Hong Kong was partly supported by the donations of R. Yu and C. Yu, the Shaw Foundation of Hong Kong, M. S.-K. Tong and M. T. M. M. Yin; and funding from the Health and Medical Research Fund (grant no. COVID190121), the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; the National Program on Key Research Project of China (grant no. 2020YFA0707500 and 2020YFA0707504); and the Theme-Based Research Scheme (T11/707/15) of the Research Grants Council and Hong Kong Special Administrative Region. Viral protease studies have been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201700060C to A.D.M. M.E.C. is supported by an NIH/NIGMS T32 Training Grant for Structural Biology and Biophysics (GM132024). The work on iPCS-derived pneumocytes was partly supported by the Huffington Foundation. The work at Calibr at Scripps Research was supported by the Bill and Melinda Gates Foundation. This research was also partly funded by CRIP (Center for Research for Influenza Pathogenesis), a NIAID supported Center of Excellence for Influenza Research and Surveillance (CEIRS, contract no. HHSN272201400008C), by DARPA grant HR0011-19-2-0020, by an administrative supplement to NIAID grant U19AI142733, and by the generous support of the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611 (5384)) and anonymous donors to A.G.-S. and by supplements to NIAID grant U19AI135972 and DoD grant W81XWH-20-1-0270 to S.K.C. and A.G.-S. The funding sources had no role in the study design, data collection, analysis, interpretation or writing of the report. Finally, we wish to thank the late Ananda Mohan Chakrabarty for his generous and inspiring mentorship and advice.	Baez-Santos YM, 2014, J MED CHEM, V57, P2393, DOI 10.1021/jm401712t; Billich A, 2007, IDRUGS, V10, P53; BJORCK L, 1990, J VIROL, V64, P941; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bollong MJ, 2017, P NATL ACAD SCI USA, V114, P4679, DOI 10.1073/pnas.1702750114; Butler D. J., 2020, HOST VIRAL ENVIRONME, DOI [10.1101/2020.04.20.048066, DOI 10.1101/2020.04.20.048066]; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chapman M.E., 2020, BROAD SPECTRUM INHIB, DOI [10.21203/RS.3.RS-26344/V1, DOI 10.21203/RS.3.RS-26344/V1]; Chen H, 2020, 1 CLIN STUDY USING H, DOI [10.1101/2020.03.22.20034041, DOI 10.1101/2020.03.22.20034041]; Chen WH, 2020, CURR TROP MED REP, V7, P61, DOI 10.1007/s40475-020-00201-6; Choudhary S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01664; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Cihlar T, 2016, CURR OPIN VIROL, V18, P50, DOI 10.1016/j.coviro.2016.03.004; D'Alessandro S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010085; Deprez M, 2020, AM J RESP CRIT CARE, V202, P1636, DOI 10.1164/rccm.201911-2199OC; DEWIT S, 1992, ANTIMICROB AGENTS CH, V36, P2661, DOI 10.1128/AAC.36.12.2661; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eastell R, 2014, J BONE MINER RES, V29, P458, DOI 10.1002/jbmr.2047; Eastell R, 2011, J BONE MINER RES, V26, P1303, DOI 10.1002/jbmr.341; Ferenci P, 2017, LANCET INFECT DIS, V17, P1008, DOI 10.1016/S1473-3099(17)30486-3; GARRELTS JC, 1991, DICP ANN PHARMAC, V25, P525, DOI 10.1177/106002809102500513; Gayle S, 2017, BLOOD, V129, P1768, DOI 10.1182/blood-2016-09-736892; Ghaedi M, 2013, J CLIN INVEST, V123, P4950, DOI 10.1172/JCI68793; Ghosh AK, 2008, BIOORG MED CHEM LETT, V18, P5684, DOI 10.1016/j.bmcl.2008.08.082; Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112; Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096; Jacob A, 2019, NAT PROTOC, V14, P3303, DOI 10.1038/s41596-019-0220-0; Janes J, 2018, P NATL ACAD SCI USA, V115, P10750, DOI 10.1073/pnas.1810137115; Kapoor Aditya, 2020, Indian Pacing Electrophysiol J, V20, P117, DOI 10.1016/j.ipej.2020.04.003; Kim YJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104558; Kujawski SA, 2020, MEDRXIV, DOI 10.1101/2020.03.09.20032896; Kwan CY, 2002, ACTA PHARMACOL SIN, V23, P1057; Li YY, 2012, GENOME MED, V4, DOI 10.1186/gm326; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005373; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Marzi A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001923; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Matthew AN, 2018, BIOCHEMISTRY-US, V57, P481, DOI 10.1021/acs.biochem.7b01160; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07; Nelson EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005540; Park WB, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e84; Qiu S, 2018, VIROLOGY, V513, P17, DOI 10.1016/j.virol.2017.09.028; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Sbrissa D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204532; Schneider M, 2012, J VIROL, V86, P10112, DOI 10.1128/JVI.01001-12; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sultana F, 2020, J CELL BIOCHEM, V121, P2927, DOI 10.1002/jcb.29534; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; US Food and Drug Administration, 2020, FDA ISS EM US AUTH P; Wang SQ, 2007, AMINO ACIDS, V33, P129, DOI 10.1007/s00726-006-0403-1; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; WHITE EL, 1991, ANTIVIR RES, V16, P257, DOI 10.1016/0166-3542(91)90005-C; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; World Health Organization, 2020, COR DIS COVID 19 PAN; Xu Z, 2020, DROPPED REF, DOI [10.26434/chemrxiv.12039888.v1, DOI 10.26434/CHEMRXIV.12039888.V1]; Yamamoto N, 2004, BIOCHEM BIOPH RES CO, V318, P719, DOI 10.1016/j.bbrc.2004.04.083; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yuan SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08015-x; Zhou YC, 2012, EXPERT REV ANTI-INFE, V10, P1129, DOI [10.1586/ERI.12.104, 10.1586/eri.12.104]; ZHOU YY, 2019, NAT COMMUN, V10, DOI [10.1038/S41467-019-09234-6, DOI 10.1038/s41587-020-0546-8, DOI 10.1038/S41467-019-09234-6]	67	407	413	15	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 1	2020	586	7827					113	+		10.1038/s41586-020-2577-1	http://dx.doi.org/10.1038/s41586-020-2577-1		JUL 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9IH	32707573	Green Accepted, Bronze			2022-12-28	WOS:000572353000001
J	Obasi, AI				Obasi, Angela I.			Equity in excellence or just another tax on Black skin?	LANCET			English	Editorial Material									[Obasi, Angela I.] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Obasi, Angela I.] Liverpool Univ Hosp NHS Fdn Trust, AXESS Sexual Hlth, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Obasi, AI (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.; Obasi, AI (corresponding author), Liverpool Univ Hosp NHS Fdn Trust, AXESS Sexual Hlth, Liverpool, Merseyside, England.	angela.obasi@lstmed.ac.uk	Obasi, Angela/AAK-4395-2021	Obasi, Angela/0000-0001-6801-8889				Advance HE, 2019, EQ HIGH ED STAFF STA; [Anonymous], 2020, LANCET, V395, P1813, DOI 10.1016/S0140-6736(20)31353-2; Aston J., 2006, EXPERIENCE CLAIMANTS; Diaz T, 2020, TEACH LEARN MED, V32, P110, DOI 10.1080/10401334.2019.1670665; Gewin V, 2020, NATURE, V583, P479, DOI 10.1038/d41586-020-01920-6; Khan MS, 2019, LANCET, V393, P594, DOI 10.1016/S0140-6736(18)32609-6; Knight M, 2018, SAVING LIVES IMPROVI; McNeilly M D, 1996, Ethn Dis, V6, P154; Mercer SH, 2011, J COUNS PSYCHOL, V58, P457, DOI 10.1037/a0024937; Nature, 2019, NATURE, V574, P5; Phelan JC, 2015, ANNU REV SOCIOL, V41, P311, DOI 10.1146/annurev-soc-073014-112305; Renton D., 2013, CULTURE DISBELIEF WH; Research Excellence Framework, 2021, REF 2021 EQ DIV ADV; Research Excellence Framework, 2019, 201901 REF; Rodriguez JE, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0290-9	15	5	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2020	396	10252					651	653		10.1016/S0140-6736(20)31536-1	http://dx.doi.org/10.1016/S0140-6736(20)31536-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OC4OX	32711686	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000579138700006
J	Schurch, CM; Bhate, SS; Barlow, GL; Phillips, DJ; Noti, L; Zlobec, I; Chu, P; Black, S; Demeter, J; McIlwain, DR; Samusik, N; Goltsev, Y; Nolan, GP				Schurch, Christian M.; Bhate, Salil S.; Barlow, Graham L.; Phillips, Darci J.; Noti, Luca; Zlobec, Inti; Chu, Pauline; Black, Sarah; Demeter, Janos; McIlwain, David R.; Samusik, Nikolay; Goltsev, Yury; Nolan, Garry P.			Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front	CELL			English	Article							TERTIARY LYMPHOID STRUCTURES; PROGNOSTIC VALUE; T-CELLS; TUMOR; IMMUNOTHERAPY; TISSUE; CYTOMETRY; RESPONSES	Antitumoral immunity requires organized, spatially nuanced interactions between components of the immune tumor microenvironment (iTME). Understanding this coordinated behavior in effective versus ineffective tumor control will advance immunotherapies. We re-engineered co-detection by indexing (CODEX) for paraffin-embedded tissue microarrays, enabling simultaneous profiling of 140 tissue regions from 35 advanced-stage colorectal cancer (CRC) patients with 56 protein markers. We identified nine conserved, distinct cellular neighborhoods (CNs)-a collection of components characteristic of the CRC iTME. Enrichment of PD-1(+)CD4(+) T cells only within a granulocyte CN positively correlated with survival in a high-risk patient subset. Coupling of tumor and immune CNs, fragmentation of T cell and macrophage CNs, and disruption of inter-CN communication was associated with inferior outcomes. This study provides a framework for interrogating how complex biological processes, such as antitumoral immunity, occur through concerted actions of cells and spatial domains.	[Schurch, Christian M.; Bhate, Salil S.; Barlow, Graham L.; Phillips, Darci J.; Chu, Pauline; Black, Sarah; Demeter, Janos; McIlwain, David R.; Samusik, Nikolay; Goltsev, Yury; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Schurch, Christian M.; Bhate, Salil S.; Barlow, Graham L.; Phillips, Darci J.; Chu, Pauline; Black, Sarah; McIlwain, David R.; Goltsev, Yury; Nolan, Garry P.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Bhate, Salil S.] Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA; [Phillips, Darci J.] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Noti, Luca; Zlobec, Inti] Univ Bern, Inst Pathol, CH-3008 Bern, Switzerland	Stanford University; Stanford University; Stanford University; Stanford University; University of Bern	Schurch, CM; Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Schurch, CM; Nolan, GP (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	christian.m.schuerch@gmail.com; gnolan@stanford.edu	Schürch, Christian/L-6188-2019	Schürch, Christian/0000-0002-1792-1768; Barlow, Graham/0000-0001-9335-5414; Noti, Luca/0000-0002-2737-2870; McIlwain, David/0000-0002-2537-0273; Nolan, Garry/0000-0002-8862-9043; Demeter, Janos/0000-0002-7301-8055; Bhate, Salil/0000-0002-2057-9182; Phillips, Darci/0000-0002-0804-3342	NIH [2U19AI057229-16, 5P01HL10879707, 5R01GM10983604, 5R33CA18365403, 5U01AI101984-07, 5UH2AR06767604, 5R01CA19665703, 5U54CA20997103, 5F99CA212231-02, 1F32CA233203-01, 5U01AI140498-02, 1U54HG010426-01, 5U19AI100627-07, 1R01HL120724-01A1, R33CA183692, R01HL128173-04, 5P01AI131374-02, 5UG3DK114937-02, 1U19AI135976-01, IDIQ17X149, 1U2CCA233238-01, 1U2CCA233195-01]; DOD [W81XWH-14-1-0180, W81XWH-12-1-0591]; FDA [HHSF223201610018C, DSTL/AGR/00980/01]; Cancer Research UK [C27165/A29073]; Bill and Melinda Gates Foundation [OPP1113682]; Cancer Research Institute; Parker Institute for Cancer Immunotherapy; Kenneth Rainin Foundation [2018-575]; Silicon Valley Community Foundation [2017-175329, 2017-177799-5022]; Beckman Center for Molecular and Genetic Medicine; Juno Therapeutics [122401]; Pfizer [123214]; Celgene [133826, 134073]; Rachford & Carlotta A. Harris Endowed Chair; Swiss National Science Foundation [P300PB_171189, P400PM_183915]; Lady Tata Memorial Trust (London, UK); NIH T32 fellowship through the Stanford Department of Epithelial Biology [AR007422]; NIH F32 fellowship [CA233203]; Stanford Dean's postdoctoral fellowship; Stanford Dermatology Department; Stanford Bio-X interdisciplinary graduate fellowship; Stanford Bioengineering Department; NIH T32 fellowship through the Stanford Molecular and Cellular Immunobiology Program [5T32AI007290-34]; Vaxart [137364]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); FDA(United States Department of Health & Human Services); Cancer Research UK(Cancer Research UK); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Cancer Research Institute; Parker Institute for Cancer Immunotherapy; Kenneth Rainin Foundation; Silicon Valley Community Foundation; Beckman Center for Molecular and Genetic Medicine; Juno Therapeutics; Pfizer(Pfizer); Celgene(Bristol-Myers SquibbCelgene Corporation); Rachford & Carlotta A. Harris Endowed Chair; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lady Tata Memorial Trust (London, UK); NIH T32 fellowship through the Stanford Department of Epithelial Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F32 fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Dean's postdoctoral fellowship; Stanford Dermatology Department; Stanford Bio-X interdisciplinary graduate fellowship; Stanford Bioengineering Department; NIH T32 fellowship through the Stanford Molecular and Cellular Immunobiology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vaxart	We thank Angelica Trejo, Han Chen, Kenyi Donoso, Nilanjan Mukherjee, Vishal Venkataraaman, and Gustavo Vazquez (Stanford University) for excellent technical assistance and Sandrine Ruppen, Carmen Cardozo, and Dr. Jose ' Galva ' n (University of Bern) for help with creating the TMAs. We are grateful to Dr. Anna Seigal (University of Oxford, UK) for helpful discussions regarding tensor decomposition, Dr. Julian Schardt (University Hospital Bern, Switzerland) for helping obtain patient clinical information, and Prof. Paul Bollyky (Stanford University) for providing the biotinylated VG1 hyaluronan detection reagent. We thank the patients for consent to use their tissues for research. We would like to extend our gratitude to Dr. Sizun Jiang and Dr. Xavier Rovira-Clave ' (Stanford University) for critical comments on the manuscript. This work was supported by the NIH (2U19AI057229-16, 5P01HL10879707, 5R01GM10983604, 5R33CA18365403, 5U01AI101984-07, 5UH2AR06767604, 5R01CA19665703, 5U54CA20997103, 5F99CA212231-02, 1F32CA233203-01, 5U01AI140498-02, 1U54HG010426-01, 5U19AI100627-07, 1R01HL120724-01A1, R33CA183692, R01HL128173-04, 5P01AI131374-02, 5UG3DK114937-02, 1U19AI135976-01, IDIQ17X149, 1U2CCA233238-01, and 1U2CCA233195-01); the DOD (W81XWH-14-1-0180 and W81XWH-12-1-0591); the FDA (HHSF223201610018C and DSTL/AGR/00980/01); Cancer Research UK (C27165/A29073); the Bill and Melinda Gates Foundation (OPP1113682); the Cancer Research Institute; the Parker Institute for Cancer Immunotherapy; the Kenneth Rainin Foundation (2018-575); the Silicon Valley Community Foundation (2017-175329 and 2017-177799-5022); the Beckman Center for Molecular and Genetic Medicine; Juno Therapeutics (122401); Pfizer (123214); Celgene (133826 and 134073); Vaxart (137364); and the Rachford & Carlotta A. Harris Endowed Chair (to G.P.N.). C.M.S. was supported by an advanced postdoctoral mobility fellowship from the Swiss National Science Foundation (P300PB_171189 and P400PM_183915) and an international award for research in leukemia from the Lady Tata Memorial Trust (London, UK). D.J.P. was supported by an NIH T32 fellowship through the Stanford Department of Epithelial Biology (AR007422), an NIH F32 fellowship (CA233203), a Stanford Dean's postdoctoral fellowship, and the Stanford Dermatology Department. S.S.B. was supported by a Stanford Bio-X interdisciplinary graduate fellowship and the Stanford Bioengineering Department. G.L.B was supported by an NIH T32 fellowship through the Stanford Molecular and Cellular Immunobiology Program(5T32AI007290-34).	Agasti SS, 2017, CHEM SCI, V8, P3080, DOI 10.1039/c6sc05420j; Ali HR, 2020, NAT CANCER, V1, P163, DOI 10.1038/s43018-020-0026-6; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Arnol D, 2019, CELL REP, V29, P202, DOI 10.1016/j.celrep.2019.08.077; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bjornson-Hooper Z.B., 2019, BIORXIV, DOI [10.1101/574160, 10.1101/574160V1]; Breheny P., 2013, VISUALIZATION REGRES, P1, DOI DOI 10.32614/RJ-2017-046; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Clark SJ, 2011, INVEST OPHTH VIS SCI, V52, P6511, DOI 10.1167/iovs.11-7909; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Dieu-Nosjean MC, 2016, IMMUNOL REV, V271, P260, DOI 10.1111/imr.12405; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Friedman J., 2010, TECHNICAL REPORT; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; GRAHAM DM, 1990, MODERN PATHOL, V3, P332; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gut G, 2018, SCIENCE, V361, DOI 10.1126/science.aar7042; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardoon DR, 2004, NEURAL COMPUT, V16, P2639, DOI 10.1162/0899766042321814; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hmeljaki J, 2018, CANCER DISCOV, V8, P1548, DOI 10.1158/2159-8290.CD-18-0804; Hore V, 2016, NAT GENET, V48, P1094, DOI 10.1038/ng.3624; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Jackson HW, 2020, NATURE, V578, P615, DOI 10.1038/s41586-019-1876-x; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kather JN, 2018, ELIFE, V7, DOI 10.7554/eLife.36967; Kather JN, 2017, CANCER RES, V77, P6442, DOI 10.1158/0008-5472.CAN-17-2006; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kim Y. J., 2007, IEEE C COMP VIS PATT, P1, DOI [DOI 10.1109/CVPR.2007.383405, DOI 10.1061/40927(243)477]; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Kossaifi J, 2019, J MACH LEARN RES, V20; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Laurin C, 2016, STAT APPL GENET MOL, V15, P305, DOI 10.1515/sagmb-2015-0043; Lin JR, 2018, ELIFE, V7, DOI 10.7554/eLife.31657; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; Munn DH, 2016, CURR OPIN IMMUNOL, V39, P1, DOI 10.1016/j.coi.2015.10.009; Newell EW, 2018, CANCER IMMUNOL RES, V6, P2, DOI 10.1158/2326-6066.CIR-17-0519; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Saka SK, 2019, NAT BIOTECHNOL, V37, P1080, DOI 10.1038/s41587-019-0207-y; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Schapiro D, 2017, NAT METHODS, V14, P873, DOI [10.1038/NMETH.4391, 10.1038/nmeth.4391]; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Seabold S., 2010, 9 PYTH SCI C, P6, DOI DOI 10.25080/MAJORA-92BF1922-011; Shah W, 2011, CELL MOL IMMUNOL, V8, P59, DOI 10.1038/cmi.2010.56; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stoltzfus CR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107523; Therneau T., 2015, PACKAGE SURVIVAL ANA; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang K, 2017, HUM PATHOL, V69, P110, DOI 10.1016/j.humpath.2017.09.012; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Wang Y, 2017, NANO LETT, V17, P6131, DOI 10.1021/acs.nanolett.7b02716; Wei L, 2017, NATURE, V544, P465, DOI 10.1038/nature22051; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Zhu Q, 2018, NAT BIOTECHNOL, V36, P1183, DOI 10.1038/nbt.4260	64	167	167	11	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2020	182	5					1341	+		10.1016/j.cell.2020.07.005	http://dx.doi.org/10.1016/j.cell.2020.07.005			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NR3DG	32763154	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000571442200021
J	Palmqvist, S; Janelidze, S; Quiroz, YT; Zetterberg, H; Lopera, F; Stomrud, E; Su, Y; Chen, YH; Serrano, GE; Leuzy, A; Mattsson-Carlgren, N; Strandberg, O; Smith, R; Villegas, A; Sepulveda-Falla, D; Chai, XY; Proctor, NK; Beach, TG; Blennow, K; Dage, JL; Reiman, EM; Hansson, O				Palmqvist, Sebastian; Janelidze, Shorena; Quiroz, Yakeel T.; Zetterberg, Henrik; Lopera, Francisco; Stomrud, Erik; Su, Yi; Chen, Yinghua; Serrano, Geidy E.; Leuzy, Antoine; Mattsson-Carlgren, Niklas; Strandberg, Olof; Smith, Ruben; Villegas, Andres; Sepulveda-Falla, Diego; Chai, Xiyun; Proctor, Nicholas K.; Beach, Thomas G.; Blennow, Kaj; Dage, Jeffrey L.; Reiman, Eric M.; Hansson, Oskar			Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEUROFILAMENT LIGHT-CHAIN; TAU; ASSOCIATION; CONSORTIUM; ESTABLISH; KINETICS; REGISTRY; CERAD	Key PointsQuestionWhat is the discriminative accuracy of plasma phospho-tau217 (P-tau217) for differentiating Alzheimer disease from other neurodegenerative disorders? FindingsIn this cross-sectional study that included 1402 participants from 3 selected cohorts, plasma P-tau217 discriminated Alzheimer disease from other neurodegenerative diseases (area under the receiver operating characteristic curve of 0.89 in a neuropathologically defined cohort and 0.96 in a clinically defined cohort), with performance that was significantly better than established Alzheimer disease plasma- and MRI-based biomarkers but not significantly different from key CSF- or PET-based biomarkers. MeaningAlthough plasma P-tau217 was able to discriminate Alzheimer disease from other neurodegenerative diseases, further research is needed to validate the findings in unselected and diverse populations, optimize the assay, and determine its potential role in clinical care. ImportanceThere are limitations in current diagnostic testing approaches for Alzheimer disease (AD). ObjectiveTo examine plasma tau phosphorylated at threonine 217 (P-tau217) as a diagnostic biomarker for AD. Design, Setting, and ParticipantsThree cross-sectional cohorts: an Arizona-based neuropathology cohort (cohort 1), including 34 participants with AD and 47 without AD (dates of enrollment, May 2007-January 2019); the Swedish BioFINDER-2 cohort (cohort 2), including cognitively unimpaired participants (n=301) and clinically diagnosed patients with mild cognitive impairment (MCI) (n=178), AD dementia (n=121), and other neurodegenerative diseases (n=99) (April 2017-September 2019); and a Colombian autosomal-dominant AD kindred (cohort 3), including 365 PSEN1 E280A mutation carriers and 257 mutation noncarriers (December 2013-February 2017). ExposuresPlasma P-tau217. Main Outcomes and MeasuresPrimary outcome was the discriminative accuracy of plasma P-tau217 for AD (clinical or neuropathological diagnosis). Secondary outcome was the association with tau pathology (determined using neuropathology or positron emission tomography [PET]). ResultsMean age was 83.5 (SD, 8.5) years in cohort 1, 69.1 (SD, 10.3) years in cohort 2, and 35.8 (SD, 10.7) years in cohort 3; 38% were women in cohort 1, 51% in cohort 2, and 57% in cohort 3. In cohort 1, antemortem plasma P-tau217 differentiated neuropathologically defined AD from non-AD (area under the curve [AUC], 0.89 [95% CI, 0.81-0.97]) with significantly higher accuracy than plasma P-tau181 and neurofilament light chain (NfL) (AUC range, 0.50-0.72; P<.05). The discriminative accuracy of plasma P-tau217 in cohort 2 for clinical AD dementia vs other neurodegenerative diseases (AUC, 0.96 [95% CI, 0.93-0.98]) was significantly higher than plasma P-tau181, plasma NfL, and MRI measures (AUC range, 0.50-0.81; P<.001) but not significantly different compared with cerebrospinal fluid (CSF) P-tau217, CSF P-tau181, and tau-PET (AUC range, 0.90-0.99; P>.15). In cohort 3, plasma P-tau217 levels were significantly greater among PSEN1 mutation carriers, compared with noncarriers, from approximately 25 years and older, which is 20 years prior to estimated onset of MCI among mutation carriers. Plasma P-tau217 levels correlated with tau tangles in participants with (Spearman rho =0.64; P<.001), but not without (Spearman <rho>=0.15; P=.33), beta -amyloid plaques in cohort 1. In cohort 2, plasma P-tau217 discriminated abnormal vs normal tau-PET scans (AUC, 0.93 [95% CI, 0.91-0.96]) with significantly higher accuracy than plasma P-tau181, plasma NfL, CSF P-tau181, CSF A beta 42:A beta 40 ratio, and MRI measures (AUC range, 0.67-0.90; P<.05), but its performance was not significantly different compared with CSF P-tau217 (AUC, 0.96; P=.22). Conclusions and RelevanceAmong 1402 participants from 3 selected cohorts, plasma P-tau217 discriminated AD from other neurodegenerative diseases, with significantly higher accuracy than established plasma- and MRI-based biomarkers, and its performance was not significantly different from key CSF- or PET-based measures. Further research is needed to optimize the assay, validate the findings in unselected and diverse populations, and determine its potential role in clinical care. This cross-sectional study compares the accuracy of plasma tau phosphorylated at threonine 217 (P-tau217) levels vs other plasma-, MRI-, CSF-, and PET-based markers for distinguishing Alzheimer from other neurodegenerative diseases in 3 cohorts in Arizona, Sweden, and Columbia with or at risk for dementia.	[Palmqvist, Sebastian; Janelidze, Shorena; Stomrud, Erik; Leuzy, Antoine; Mattsson-Carlgren, Niklas; Strandberg, Olof; Smith, Ruben; Hansson, Oskar] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [Palmqvist, Sebastian; Stomrud, Erik; Hansson, Oskar] Skane Univ Hosp, Memory Clin, SE-20502 Malmo, Sweden; [Quiroz, Yakeel T.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Quiroz, Yakeel T.; Lopera, Francisco; Villegas, Andres; Sepulveda-Falla, Diego] Univ Antioquia, Grp Neurociencias Antioquia, Medellin, Colombia; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Su, Yi; Chen, Yinghua; Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Serrano, Geidy E.; Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Mattsson-Carlgren, Niklas] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Mattsson-Carlgren, Niklas; Smith, Ruben] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Sepulveda-Falla, Diego] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Mol Neuropathol Alzheimers Dis MoNeA, Hamburg, Germany; [Chai, Xiyun; Proctor, Nicholas K.; Dage, Jeffrey L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Reiman, Eric M.] Univ Arizona, Phoenix, AZ USA; [Reiman, Eric M.] Arizona State Univ, Phoenix, AZ USA; [Reiman, Eric M.] Translat Genom Res Inst, Phoenix, AZ USA	Lund University; Lund University; Skane University Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidad de Antioquia; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Lund University; Lund University; Skane University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eli Lilly; University of Arizona; Arizona State University; Arizona State University-Downtown Phoenix; Translational Genomics Research Institute	Hansson, O (corresponding author), Skane Univ Hosp, Memory Clin, SE-20502 Malmo, Sweden.	Oskar.Hansson@med.lu.se	Palmqvist, Sebastian/AFQ-9019-2022; Hansson, Oskar/A-7134-2013; chen, ying/HHS-8254-2022; Mattsson-Carlgren, Niklas/H-7597-2019; Palmqvist, Sebastian/AAU-1148-2021; LOPERA, FRANCISCO/AAR-5968-2021; Sepulveda-Falla, Diego/GLU-9062-2022	Palmqvist, Sebastian/0000-0002-9267-1930; Hansson, Oskar/0000-0001-8467-7286; Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Sepulveda-Falla, Diego/0000-0003-0176-2042; Dage, Jeffrey/0000-0002-2192-1699	Swedish Research Council; Knut and AliceWallenberg Foundation; Region Skane; Marianne and MarcusWallenberg Foundation; Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Swedish Alzheimer Foundation; Swedish Brain Foundation; Parkinson Foundation of Sweden; Parkinson Research Foundation; Skane University Hospital Foundation; Greta and Johan Kock Foundation; Swedish federal government under the ALF agreement; Massachusetts General Hospital Executive Committee on Research; National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services; Michael J. Fox Foundation for Parkinson's Research; Banner Alzheimer's Foundation; Sun Health Foundation; State of Arizona; Eli Lilly and Company; NIH Office of the Director; Alzheimer's Association	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and AliceWallenberg Foundation(Knut & Alice Wallenberg Foundation); Region Skane; Marianne and MarcusWallenberg Foundation; Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Swedish Alzheimer Foundation; Swedish Brain Foundation; Parkinson Foundation of Sweden; Parkinson Research Foundation; Skane University Hospital Foundation; Greta and Johan Kock Foundation; Swedish federal government under the ALF agreement; Massachusetts General Hospital Executive Committee on Research; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Michael J. Fox Foundation for Parkinson's Research; Banner Alzheimer's Foundation; Sun Health Foundation; State of Arizona; Eli Lilly and Company(Eli Lilly); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association)	Work at the authors' research centers was supported by the Swedish Research Council, the Knut and AliceWallenberg Foundation, Region Skane, the Marianne and MarcusWallenberg Foundation, the Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University, the Swedish Alzheimer Foundation, the Swedish Brain Foundation, The Parkinson Foundation of Sweden, The Parkinson Research Foundation, the Skane University Hospital Foundation, the Greta and Johan Kock Foundation, the Swedish federal government under the ALF agreement, the NIH Office of the Director, the Alzheimer's Association, the Massachusetts General Hospital Executive Committee on Research, the National Institute of Neurological Disorders and Stroke (U24 NS072026), National Institute on Aging (P30 AG19610), the Arizona Department of Health Services, the Michael J. Fox Foundation for Parkinson's Research, Banner Alzheimer's Foundation, Sun Health Foundation, the State of Arizona, and Eli Lilly and Company. Eli Lilly and Company provided material support for P-tau217 sample analysis and salary for Dr Chai, Mr Proctor, and Dr Dage. The precursor of 18F-flutemetamol was provided by GE Healthcare and the precursor of 18F-RO948 was provided by Roche.	ABBASI J, 2018, JAMA-J AM MED ASSOC, V320, P965, DOI DOI 10.1001/JAMA.2018.13027; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barthelemy NR, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00596-4; Barthelemy NR, 2020, NAT MED, V26, P398, DOI 10.1038/s41591-020-0781-z; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Chatterjee P, 2018, J ALZHEIMERS DIS, V63, P479, DOI 10.3233/JAD-180025; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duits FH, 2016, ALZHEIMERS DEMENT, V12, P154, DOI 10.1016/j.jalz.2015.08.003; Gordon BA, 2019, BRAIN, V142, P1063, DOI 10.1093/brain/awz019; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Janelidze S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15436-0; Janelidze S, 2020, NAT MED, V26, P379, DOI 10.1038/s41591-020-0755-1; Kuhlmann J, 2017, CLIN CHIM ACTA, V467, P27, DOI 10.1016/j.cca.2016.05.014; Leuzy A, 2020, JAMA NEUROL, V77, P955, DOI 10.1001/jamaneurol.2020.0989; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mattsson-Carlgren N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2387; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P989, DOI 10.1016/j.jalz.2018.02.013; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Palmqvist S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201911170; Palmqvist S, 2019, JAMA NEUROL, V76, P1060, DOI 10.1001/jamaneurol.2019.1632; Palmqvist S, 2019, ALZHEIMERS DEMENT, V15, P194, DOI 10.1016/j.jalz.2018.08.014; Quiroz YT, 2020, LANCET NEUROL, V19, P513, DOI 10.1016/S1474-4422(20)30137-X; Quiroz YT, 2018, JAMA NEUROL, V75, P548, DOI 10.1001/jamaneurol.2017.4907; Rabinovici GD, 2019, JAMA-J AM MED ASSOC, V321, P1286, DOI 10.1001/jama.2019.2000; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Tariot Pierre N, 2018, Alzheimers Dement (N Y), V4, P150, DOI 10.1016/j.trci.2018.02.002; Thijssen EH, 2020, NAT MED, V26, P387, DOI 10.1038/s41591-020-0762-2; World Health Organization, 2017, GLOB ACT PLAN PUBL H; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zhou WJ, 2017, NEUROSCI LETT, V650, P60, DOI 10.1016/j.neulet.2017.04.027	39	311	322	12	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					772	781		10.1001/jama.2020.12134	http://dx.doi.org/10.1001/jama.2020.12134			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32722745	Bronze, Green Published			2022-12-28	WOS:000568230000023
J	Amunts, K; Mohlberg, H; Bludau, S; Zilles, K				Amunts, Katrin; Mohlberg, Hartmut; Bludau, Sebastian; Zilles, Karl			Julich-Brain: A 3D probabilistic atlas of the human brain's cytoarchitecture	SCIENCE			English	Article							AUDITORY-CORTEX; ORGANIZATION; PROVENANCE; MODEL; MAP	Cytoarchitecture is a basic principle of microstructural brain parcellation. We introduce Julich-Brain, a three-dimensional atlas containing cytoarchitectonic maps of cortical areas and subcortical nuclei. The atlas is probabilistic, which enables it to account for variations between individual brains. Building such an atlas was highly data- and labor-intensive and required the development of nested, interdependent workflows for detecting borders between brain areas, data processing, provenance tracking, and flexible execution of processing chains to handle large amounts of data at different spatial scales. Full cortical coverage was achieved by the inclusion of gap maps to complement cortical maps. The atlas is dynamic and will be adapted as mapping progresses; it is openly available to support neuroimaging studies as well as modeling and simulation; and it is interoperable, enabling connection to other atlases and resources.	[Amunts, Katrin; Mohlberg, Hartmut; Bludau, Sebastian; Zilles, Karl] Res Ctr Julich, Inst Neurosci & Med INM 1, Julich, Germany; [Amunts, Katrin] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, C & O Vogt Inst Brain Res, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Amunts, K; Mohlberg, H (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM 1, Julich, Germany.; Amunts, K (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, C & O Vogt Inst Brain Res, Dusseldorf, Germany.	k.amunts@fz-juelich.de; h.mohlberg@fz-juelich.de	; Amunts, Katrin/I-3470-2013	Mohlberg, Hartmut/0000-0002-7040-3812; Amunts, Katrin/0000-0001-5828-0867	Portfolio Theme "Supercomputing and Modeling for the Human Brain" of the Helmholtz Association; European Union Seventh Framework Programme (FP7/2007-2013); European Union's Horizon 2020 Research and Innovation Programme [604102, 785907, 945539]	Portfolio Theme "Supercomputing and Modeling for the Human Brain" of the Helmholtz Association; European Union Seventh Framework Programme (FP7/2007-2013); European Union's Horizon 2020 Research and Innovation Programme	Supported by the Portfolio Theme "Supercomputing and Modeling for the Human Brain" of the Helmholtz Association, the European Union Seventh Framework Programme (FP7/2007-2013, HBP), and the European Union's Horizon 2020 Research and Innovation Programme, grant agreements 604102 (HBP SGA1), 785907 (HBP SGA2), and 945539 (HBP SGA3).	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Amunts K, 2007, J NEUROSCI, V27, P1356, DOI 10.1523/JNEUROSCI.4753-06.2007; Amunts K, 2015, NEURON, V88, P1086, DOI 10.1016/j.neuron.2015.12.001; Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Annese J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4122; Barequet G, 2004, GRAPH MODELS, V66, P245, DOI 10.1016/j.gmod.2004.05.001; Bjerke IE, 2018, EUR PSYCHIAT, V50, P70, DOI 10.1016/j.eurpsy.2018.02.004; Bludau S, 2018, BRAIN STRUCT FUNCT, V223, P2335, DOI 10.1007/s00429-018-1620-6; BRAAK H, 1977, ANAT EMBRYOL, V150, P229, DOI 10.1007/BF00316652; Brodmann K, 1909, VERGLEICHENDE LOKALI; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damasio H., 2005, HUMAN BRAIN ANATOMY, V2; Das S, 2016, NEUROIMAGE, V124, P1188, DOI 10.1016/j.neuroimage.2015.08.076; Delescluse M, 2012, J PHYSIOL-PARIS, V106, P159, DOI 10.1016/j.jphysparis.2011.09.011; Ding SL, 2016, J COMP NEUROL, V524, P3127, DOI 10.1002/cne.24080; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2018, NAT REV NEUROSCI, V19, P672, DOI 10.1038/s41583-018-0071-7; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Fischl B, 2018, NEUROIMAGE, V182, P219, DOI 10.1016/j.neuroimage.2018.01.036; Gibb M., 2012, INT C COMP METH SYS, P2; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Goebel R, 2012, NEUROIMAGE, V62, P748, DOI 10.1016/j.neuroimage.2012.01.083; Goulas A, 2018, TRENDS NEUROSCI, V41, P775, DOI 10.1016/j.tins.2018.06.003; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Homke L, 2006, NUMER LINEAR ALGEBR, V13, P215, DOI 10.1002/nla.477; MacKenzie-Graham AJ, 2008, NEUROIMAGE, V42, P178, DOI 10.1016/j.neuroimage.2008.04.186; Mai J.K., 2015, ATLAS HUMAN BRAIN, Vfourth; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McClatchey R., 2018, DATA PROVENANCE TRAC; Mohlberg Hartmut, 2016, Brain-Inspired Computing. Second International Workshop, BrainComp 2015. Revised Selected Papers: LNCS 10087, P15, DOI 10.1007/978-3-319-50862-7_2; Moreau L, 2011, FUTURE GENER COMP SY, V27, P743, DOI 10.1016/j.future.2010.07.005; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Nieuwenhuys R, 2017, BRAIN STRUCT FUNCT, V222, P465, DOI 10.1007/s00429-016-1228-7; Ono M., 1990, ATLAS CERBRAL SULCI; Operto G, 2008, NEUROIMAGE, V39, P127, DOI 10.1016/j.neuroimage.2007.08.039; Palomero-Gallagher N, 2015, NEUROIMAGE, V115, P177, DOI 10.1016/j.neuroimage.2015.04.053; Perrot M, 2011, MED IMAGE ANAL, V15, P529, DOI 10.1016/j.media.2011.02.008; Pichat J, 2018, MED IMAGE ANAL, V46, P73, DOI 10.1016/j.media.2018.02.004; Pinho AL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.105; Postelnicu G, 2009, IEEE T MED IMAGING, V28, P508, DOI 10.1109/TMI.2008.2004426; Proix T, 2017, BRAIN, V140, P641, DOI 10.1093/brain/awx004; Rosenke M, 2018, NEUROIMAGE, V170, P257, DOI 10.1016/j.neuroimage.2017.02.040; Roth JA, 2015, ANAT SCI EDUC, V8, P574, DOI 10.1002/ase.1529; Schleicher A, 2005, ANAT EMBRYOL, V210, P373, DOI 10.1007/s00429-005-0028-2; Spitzer H, 2018, LECT NOTES COMPUT SC, V11072, P663, DOI 10.1007/978-3-030-00931-1_76; Van Essen DC, 2019, P NATL ACAD SCI USA, V116, P26173, DOI 10.1073/pnas.1902299116; Van Horn JD, 2014, BRAIN IMAGING BEHAV, V8, P323, DOI 10.1007/s11682-013-9255-y; Vincent RD, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00035; Vogelstein JT, 2016, NEURON, V92, P622, DOI 10.1016/j.neuron.2016.10.033; von Economo C, 1925, CYTOARCHITEKTONIK HI; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zachlod D, 2020, CORTEX, V128, P1, DOI 10.1016/j.cortex.2020.02.021; Zehl L, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00026; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	56	94	95	10	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2020	369	6506			SI		988	+		10.1126/science.abb4588	http://dx.doi.org/10.1126/science.abb4588			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2OL	32732281				2022-12-28	WOS:000562436800050
J	Bates, SE				Bates, Susan E.			Epigenetic Therapies for Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							T-CELL LYMPHOMA; ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASES DNMT1; PHASE-II; MUTATIONAL LANDSCAPE; SYNTHETIC LETHALITY; TARGETING EZH2; TET2 MUTATIONS; MULTICENTER; INHIBITION	Cancer-cell biology is dictated by alterations in epigenetic regulation of gene expression. Mechanisms underlying these regulators are increasingly being elucidated, and agents that alter their function are being developed as treatments.	[Bates, Susan E.] Columbia Univ, Dept Med, Div Hematol Oncol, Irving Med Ctr, New York, NY 10027 USA; [Bates, Susan E.] James J Peters Vet Affairs Med Ctr, New York, NY 10468 USA	Columbia University; NewYork-Presbyterian Hospital	Bates, SE (corresponding author), Columbia Univ, Dept Med, Div Hematol Oncol, Irving Med Ctr, New York, NY 10027 USA.; Bates, SE (corresponding author), James J Peters Vet Affairs Med Ctr, New York, NY 10468 USA.		Bates, Susan/AFP-9514-2022					Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Alvarez MJ, 2018, NAT GENET, V50, P979, DOI 10.1038/s41588-018-0138-4; [Anonymous], 2017, CANCER DISCOV, V7, pOF12; Bates SE, 2015, BRIT J HAEMATOL, V170, P96, DOI 10.1111/bjh.13400; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Bewersdorf JP, 2019, THER ADV HEMATOL, V10, DOI 10.1177/2040620718816698; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan-Penebre E, 2017, MOL CANCER THER, V16, P850, DOI 10.1158/1535-7163.MCT-16-0678; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Choi J, 2015, NAT GENET, V47, P1011, DOI 10.1038/ng.3356; Coiffier B, 2012, J CLIN ONCOL, V30, P631, DOI 10.1200/JCO.2011.37.4223; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Daskalakis M, 2018, CELL CYCLE, V17, P811, DOI 10.1080/15384101.2018.1442623; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Ennishi D, 2019, CANCER DISCOV, V9, P546, DOI 10.1158/2159-8290.CD-18-1090; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghosh TK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54312-w; Ginder G D, 1983, Prog Clin Biol Res, V134, P501; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Griffith M, 2015, CELL SYST, V1, P210, DOI 10.1016/j.cels.2015.08.015; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Italiano A, 2018, LANCET ONCOL, V19, P649, DOI 10.1016/S1470-2045(18)30145-1; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Itzykson R, 2011, LEUKEMIA, V25, P1147, DOI 10.1038/leu.2011.71; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Janke C, 2017, CURR BIOL, V27, pR1287, DOI 10.1016/j.cub.2017.10.044; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kantarjian HM, 2017, LANCET ONCOL, V18, P1317, DOI 10.1016/S1470-2045(17)30576-4; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Klieser E, 2017, HUM PATHOL, V65, P41, DOI 10.1016/j.humpath.2017.02.009; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Krivtsov AV, 2019, CANCER CELL, V36, P660, DOI 10.1016/j.ccell.2019.11.001; Langer F, 2005, LEUKEMIA RES, V29, P325, DOI 10.1016/j.leukres.2004.08.004; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Linnekamp JF, 2017, CANCER TREAT REV, V54, P10, DOI 10.1016/j.ctrv.2017.01.004; Liu EMW, 2019, CELL SYST, V8, P446, DOI 10.1016/j.cels.2019.04.001; Liu MM, 2018, CANCER RES, V78, P5754, DOI 10.1158/0008-5472.CAN-17-3953; Lowery MA, 2019, LANCET GASTROENTEROL, V4, P711, DOI 10.1016/S2468-1253(19)30189-X; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Morschhauser F, 2019, ANN M AM SOC HEM ORL; O'Connor OA, 2019, BLOOD, V134, P1395, DOI 10.1182/blood.2019001285; O'Connor OA, 2015, J CLIN ONCOL, V33, P2492, DOI 10.1200/JCO.2014.59.2782; O'Connor OA, 2014, CLIN CANCER RES, V20, P5240, DOI 10.1158/1078-0432.CCR-14-2020; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Ogiwara H, 2016, CANCER DISCOV, V6, P430, DOI 10.1158/2159-8290.CD-15-0754; Okuda H, 2017, J CLIN INVEST, V127, P1918, DOI 10.1172/JCI91406; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Piha-Paul SA, 2019, JNCI CANC SPECTR, V4, ppkz093; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Ploen GG, 2014, BRIT J HAEMATOL, V167, P478, DOI 10.1111/bjh.13062; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Shen CX, 2013, J BIOL CHEM, V288, P30585, DOI 10.1074/jbc.M113.457135; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Spencer DH, 2017, CELL, V168, P801, DOI 10.1016/j.cell.2017.01.021; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Stein EM, 2019, BLOOD, V133, P676, DOI 10.1182/blood-2018-08-869008; Stein EM, 2018, BLOOD, V131, P2661, DOI 10.1182/blood-2017-12-818948; Suguitan Jr AL, 2011, PLOS ONE, V6; Tarakhovsky A, 2010, NAT IMMUNOL, V11, P565, DOI 10.1038/ni0710-565; Tiffen JC, 2015, ONCOTARGET, V6, P27023, DOI 10.18632/oncotarget.4809; Traina F, 2014, LEUKEMIA, V28, P78, DOI 10.1038/leu.2013.269; Valent P, 2017, EBIOMEDICINE, V26, P17, DOI 10.1016/j.ebiom.2017.11.024; Wang DL, 2016, NATURE, V538, P118, DOI 10.1038/nature19759; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; Yee AJ, 2018, ONCOLOGIST, V23, P516, DOI 10.1634/theoncologist.2017-0644; Yee AJ, 2016, LANCET ONCOL, V17, P1569, DOI 10.1016/S1470-2045(16)30375-8; 2019, CJEM, V21, pVI28	95	151	153	27	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					650	663		10.1056/NEJMra1805035	http://dx.doi.org/10.1056/NEJMra1805035			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32786190				2022-12-28	WOS:000562771200012
J	DiNardo, CD; Jonas, BA; Pullarkat, V; Thirman, MJ; Garcia, JS; Wei, AH; Konopleva, M; Dohner, H; Letai, A; Fenaux, P; Koller, E; Havelange, V; Leber, B; Esteve, J; Wang, J; Pejsa, V; Hajek, R; Porkka, K; Illes, A; Lavie, D; Lemoli, RM; Yamamoto, K; Yoon, SS; Jang, JH; Yeh, SP; Turgut, M; Hong, WJ; Zhou, Y; Potluri, J; Pratz, KW				DiNardo, C. D.; Jonas, B. A.; Pullarkat, V.; Thirman, M. J.; Garcia, J. S.; Wei, A. H.; Konopleva, M.; Doehner, H.; Letai, A.; Fenaux, P.; Koller, E.; Havelange, V.; Leber, B.; Esteve, J.; Wang, J.; Pejsa, V.; Hajek, R.; Porkka, K.; Illes, A.; Lavie, D.; Lemoli, R. M.; Yamamoto, K.; Yoon, S. -S.; Jang, J. -H.; Yeh, S. -P.; Turgut, M.; Hong, W. -J.; Zhou, Y.; Potluri, J.; Pratz, K. W.			Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVENTIONAL CARE REGIMENS; BCL-2 INHIBITION; ELDERLY-PATIENTS; SURVIVAL; ABT-199; RECOMMENDATIONS; DIAGNOSIS; ABT-737; PROTEIN; ADULTS	Background Older patients with acute myeloid leukemia (AML) have a dismal prognosis, even after treatment with a hypomethylating agent. Azacitidine added to venetoclax had promising efficacy in a previous phase 1b study. Methods We randomly assigned previously untreated patients with confirmed AML who were ineligible for standard induction therapy because of coexisting conditions, because they were 75 years of age or older, or both to azacitidine plus either venetoclax or placebo. All patients received a standard dose of azacitidine (75 mg per square meter of body-surface area subcutaneously or intravenously on days 1 through 7 every 28-day cycle); venetoclax (target dose, 400 mg) or matching placebo was administered orally, once daily, in 28-day cycles. The primary end point was overall survival. Results The intention-to-treat population included 431 patients (286 in the azacitidine-venetoclax group and 145 in the azacitidine-placebo [control] group). The median age was 76 years in both groups (range, 49 to 91). At a median follow-up of 20.5 months, the median overall survival was 14.7 months in the azacitidine-venetoclax group and 9.6 months in the control group (hazard ratio for death, 0.66; 95% confidence interval, 0.52 to 0.85; P<0.001). The incidence of complete remission was higher with azacitidine-venetoclax than with the control regimen (36.7% vs. 17.9%; P<0.001), as was the composite complete remission (complete remission or complete remission with incomplete hematologic recovery) (66.4% vs. 28.3%; P<0.001). Key adverse events included nausea of any grade (in 44% of the patients in the azacitidine-venetoclax group and 35% of those in the control group) and grade 3 or higher thrombocytopenia (in 45% and 38%, respectively), neutropenia (in 42% and 29%), and febrile neutropenia (in 42% and 19%). Infections of any grade occurred in 85% of the patients in the azacitidine-venetoclax group and 67% of those in the control group, and serious adverse events occurred in 83% and 73%, respectively. Conclusions In previously untreated patients who were ineligible for intensive chemotherapy, overall survival was longer and the incidence of remission was higher among patients who received azacitidine plus venetoclax than among those who received azacitidine alone. The incidence of febrile neutropenia was higher in the venetoclax-azacitidine group than in the control group. (Funded by AbbVie and Genentech; VIALE-A ClinicalTrials.gov number,.) In more than 400 older patients with AML who could not receive myeloablative therapy, the incidence of composite complete remission was higher (66.4% vs. 28.3) and the median overall survival was longer (14.7 vs. 9.6 months) among patients who received azacitidine plus venetoclax (a B-cell lymphoma 2 antagonist) than among those who received azacitidine alone.	[DiNardo, C. D.; Konopleva, M.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Leukemia, Houston, TX 77030 USA; [Jonas, B. A.] Univ Calif Davis, Sch Med, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA; [Pullarkat, V.] City Hope Comprehens Canc Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Pullarkat, V.] City Hope Comprehens Canc Ctr, Gehr Family Ctr Leukemia Res, Duarte, CA USA; [Hong, W. -J.] Genentech Inc, San Francisco, CA USA; [Thirman, M. J.] Univ Chicago, Univ Chicago Med, Dept Med, Sect Hematol & Oncol, Chicago, IL USA; [Zhou, Y.; Potluri, J.] AbbVie, N Chicago, IL USA; [Garcia, J. S.; Letai, A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wei, A. H.] Alfred Hosp, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Wei, A. H.] Monash Univ, Melbourne, Vic, Australia; [Doehner, H.] Ulm Univ Hosp, Dept Internal Med 3, Ulm, Germany; [Fenaux, P.] Hop St Louis, AP HP, Paris, France; [Fenaux, P.] Univ Paris, Paris, France; [Koller, E.] Hanusch Hosp, Med Dept Hematol & Oncol, Vienna, Austria; [Havelange, V.] Clin Univ St Luc, Dept Hematol, Brussels, Belgium; [Leber, B.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Esteve, J.] August Pi i Sunyer Biomed Res Inst, Hosp Clin, Dept Hematol, Barcelona, Spain; [Wang, J.] Chinese Acad Med Sci, Inst Hematol & Hosp Blood Dis, Peking Union Med Coll, Tianjin, Peoples R China; [Pejsa, V.] Univ Zagreb, Sch Med, Univ Hosp Dubrava, Dept Hematol, Zagreb, Croatia; [Hajek, R.] Univ Hosp Ostrava Poruba, Dept Clin Subjects, Ostrava, Czech Republic; [Porkka, K.] Univ Helsinki, Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland; [Illes, A.] Univ Debrecen, Dept Hematol, Fac Med, Debrecen, Hungary; [Lavie, D.] Hadassah Med Ctr, Jerusalem, Israel; [Lemoli, R. M.] Univ Genoa, Dept Internal Med, Clin Hematol, Genoa, Italy; [Lemoli, R. M.] San Martino Hosp IRCCS, Genoa, Italy; [Yamamoto, K.] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi, Japan; [Yoon, S. -S.] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Jang, J. -H.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hematol Oncol, Seoul, South Korea; [Yeh, S. -P.] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Turgut, M.] Ondokuz Mayis Univ, Div Hematol, Dept Internal Med, Fac Med, Samsun, Turkey; [Pratz, K. W.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; City of Hope; City of Hope; Roche Holding; Genentech; University of Chicago; AbbVie; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Florey Institute of Neuroscience & Mental Health; Monash University; Ulm University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; WGKK - Hanusch Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; McMaster University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; University of Zagreb; University of Helsinki; Helsinki University Central Hospital; University of Debrecen; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Aichi Cancer Center; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; Ondokuz Mayis University; University of Pennsylvania; Pennsylvania Medicine	DiNardo, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 428, Houston, TX 77030 USA.	cdinardo@mdanderson.org	LEMOLI, ROBERTO/AAC-2370-2022; Jonas, Brian/AAS-3639-2020; Hajek, Roman/I-6639-2017; Porkka, Kimmo/O-2323-2016	LEMOLI, ROBERTO/0000-0001-9000-562X; Jonas, Brian/0000-0002-4921-5809; Hajek, Roman/0000-0001-6955-6267; Porkka, Kimmo/0000-0003-4112-5902; Wei, Andrew/0000-0002-7514-3298	AbbVie; Genentech	AbbVie(AbbVie); Genentech(Roche HoldingGenentech)	Supported by AbbVie and Genentech.	Adams CM, 2019, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00636; Bogenberger JM, 2015, LEUKEMIA LYMPHOMA, V56, P226, DOI 10.3109/10428194.2014.910657; CAMPOS L, 1993, BLOOD, V81, P3091; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cortes JE, 2019, LEUKEMIA, V33, P379, DOI 10.1038/s41375-018-0312-9; DiNardo CD, 2020, BLOOD, V135, P85, DOI 10.1182/blood.2019001239; DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752; DiNardo CL, 2018, LANCET ONCOL, V19, P216, DOI 10.1016/S1470-2045(18)30010-X; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Howlader N, 2019, NIH, V1; Jin S, 2020, CLIN CANCER RES, V26, P3371, DOI 10.1158/1078-0432.CCR-19-1900; Jonas BA, 2019, LEUKEMIA, V33, P2795, DOI 10.1038/s41375-019-0612-8; Karakas T, 2002, LEUKEMIA, V16, P846, DOI 10.1038/sj.leu.2402434; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Konopleva M, 2016, CANCER DISCOV, V6, P1106, DOI 10.1158/2159-8290.CD-16-0313; Krauss AC, 2019, CLIN CANCER RES, V25, P2685, DOI 10.1158/1078-0432.CCR-18-2990; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Mehta SV, 2013, NEOPLASMA, V60, P666, DOI 10.4149/neo_2013_085; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pollyea DA, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117179; Richard-Carpentier G, 2019, THER ADV HEMATOL, V10, DOI 10.1177/2040620719882822; Schuurhuis GJ, 2018, BLOOD, V131, P1275, DOI 10.1182/blood-2017-09-801498; Song XL, 2018, ACTA HAEMATOL-BASEL, V139, P115, DOI 10.1159/000486228; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048	28	707	715	19	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					617	629		10.1056/NEJMoa2012971	http://dx.doi.org/10.1056/NEJMoa2012971			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32786187	Bronze			2022-12-28	WOS:000562771200009
J	Gradinaru, V				Gradinaru, Viviana			Expanding the brain researcher's toolkit	SCIENCE			English	Editorial Material							STRATEGIES; DISEASE; TISSUE		[Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	viviana@caltech.edu			NIH; NIH BRAIN Grants	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH BRAIN Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research described in this essay was funded mainly by the NIH Director's New Innovator and Pioneer Awards and NIH BRAIN Grants to V.G. The author is a cofounder and board member of Capsida Biotherapeutics.	[Anonymous], 2019, SCIENCE, DOI DOI 10.1126/SCIENCE.AAX4236; Bedbrook CN, 2019, NAT METHODS, V16, P1176, DOI 10.1038/s41592-019-0583-8; Bedbrook CN, 2018, ANNU REV NEUROSCI, V41, P323, DOI 10.1146/annurev-neuro-080317-062048; Bedbrook CN, 2017, P NATL ACAD SCI USA, V114, pE2624, DOI 10.1073/pnas.1700269114; Borghammer P, 2019, J PARKINSON DIS, V9, pS281, DOI 10.3233/JPD-191721; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Challis C, 2020, NAT NEUROSCI, V23, P327, DOI 10.1038/s41593-020-0589-7; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Godinho-Silva C, 2019, ANNU REV IMMUNOL, V37, P19, DOI 10.1146/annurev-immunol-042718-041812; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2018, ANNU REV BIOPHYS, V47, P355, DOI 10.1146/annurev-biophys-070317-032905; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Kumar SR, 2020, NAT METHODS, V17, P541, DOI 10.1038/s41592-020-0799-7; Sung HY, 2014, J MOV DISORD, V7, P7, DOI 10.14802/jmd.14002; Xiao C, 2016, NEURON, V90, P333, DOI 10.1016/j.neuron.2016.03.028; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	22	2	2	5	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					637	+		10.1126/science.abd2660	http://dx.doi.org/10.1126/science.abd2660			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764063	Bronze			2022-12-28	WOS:000559184400034
J	Dyer, C				Dyer, Clare			Coroner warns about poor drug reviews after patient dies from tramadol overdose	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m3101	10.1136/bmj.m3101	http://dx.doi.org/10.1136/bmj.m3101			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759281				2022-12-28	WOS:000556139400006
J	Wang, H; Park, M; Dong, R; Kim, J; Cho, YK; Tlusty, T; Granick, S				Wang, Huan; Park, Myeonggon; Dong, Ruoyu; Kim, Junyoung; Cho, Yoon-Kyoung; Tlusty, Tsvi; Granick, Steve			Boosted molecular mobility during common chemical reactions	SCIENCE			English	Article							CLICK CHEMISTRY; RING-CLOSURE; DIFFUSION; AZIDE; CYCLOADDITIONS; ACTIVATION; ENTHALPY; ENTROPY; BIOLOGY; DFT	Mobility of reactants and nearby solvent is more rapid than Brownian diffusion during several common chemical reactions when the energy release rate exceeds a threshold. Screening a family of 15 organic chemical reactions, we demonstrate the largest boost for catalyzed bimolecular reactions, click chemistry, ring-opening metathesis polymerization, and Sonogashira coupling. Boosted diffusion is also observed but to lesser extent for the uncatalyzed Diels-Alder reaction, but not for substitution reactions S(N)1 and S(N)2 within instrumental resolution. Diffusion coefficient increases as measured by pulsed-field gradient nuclear magnetic resonance, whereas in microfluidics experiments, molecules in reaction gradients migrate "uphill" in the direction of lesser diffusivity. This microscopic consumption of energy by chemical reactions transduced into mechanical motion presents a form of active matter.	[Wang, Huan; Park, Myeonggon; Dong, Ruoyu; Kim, Junyoung; Cho, Yoon-Kyoung; Tlusty, Tsvi; Granick, Steve] Inst Basic Sci IBS, Ctr Soft & Living Matter, Ulsan 44919, South Korea; [Park, Myeonggon; Tlusty, Tsvi] Ulsan Natl Inst Sci & Technol UNIST, Dept Phys, Ulsan 44919, South Korea; [Kim, Junyoung; Cho, Yoon-Kyoung] UNIST, Dept Biomed Engn, Ulsan 44919, South Korea; [Granick, Steve] UNIST, Dept Chem, Ulsan 44919, South Korea	Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Granick, S (corresponding author), Inst Basic Sci IBS, Ctr Soft & Living Matter, Ulsan 44919, South Korea.; Granick, S (corresponding author), UNIST, Dept Chem, Ulsan 44919, South Korea.	sgranick@gmail.com	Cho, Yoon-Kyoung/ABF-9355-2021; Tlusty, Tsvi/A-9880-2008; Cho, Yoon-Kyoung/E-9082-2010	Cho, Yoon-Kyoung/0000-0001-6423-1834; Tlusty, Tsvi/0000-0002-9662-3725; Cho, Yoon-Kyoung/0000-0001-6423-1834; Kim, Junyoung/0000-0002-3574-6908; Granick, Steve/0000-0003-4775-2202; WANG, HUAN/0000-0002-2542-936X	Institute for Basic Science [IBS-R020-D1]	Institute for Basic Science	This work was supported by the taxpayers of South Korea through the Institute for Basic Science, project code IBS-R020-D1.	Agudo-Canalejo J, 2018, NANO LETT, V18, P2711, DOI 10.1021/acs.nanolett.8b00717; Alabugin IV, 2011, J AM CHEM SOC, V133, P12608, DOI 10.1021/ja203191f; ASANO T, 1978, CHEM REV, V78, P407, DOI 10.1021/cr60314a004; Bechinger C, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.045006; Boutelle RC, 2011, J ORG CHEM, V76, P7994, DOI 10.1021/jo201606z; Coskun A, 2012, CHEM SOC REV, V41, P19, DOI 10.1039/c1cs15262a; Feng MD, 2020, ANNU REV BIOPHYS, V49, P87, DOI 10.1146/annurev-biophys-121219-081535; Fernandez E, 2019, J AM CHEM SOC, V141, P1928, DOI 10.1021/jacs.8b07884; FUCHS R, 1973, J AM CHEM SOC, V95, P3194, DOI 10.1021/ja00791a021; Garcia-Lopez V, 2017, NATURE, V548, P567, DOI 10.1038/nature23657; Golestanian R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.108102; Haddon RC, 2016, J ORG CHEM, V81, P3648, DOI 10.1021/acs.joc.6b00298; Haldon E, 2015, ORG BIOMOL CHEM, V13, P9528, DOI 10.1039/c5ob01457c; Hillier IH, 2011, DALTON T, V40, P1061, DOI 10.1039/c0dt01314e; Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525; Jee A.-Y., 2018, P NATL ACAD SCI USA, V115, pE10812, DOI DOI 10.1073/PNAS; Jee AY, 2018, P NATL ACAD SCI USA, V115, pE10812, DOI 10.1073/pnas.1814180115; Jee AY, 2018, P NATL ACAD SCI USA, V115, P14, DOI 10.1073/pnas.1717844115; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jones GO, 2008, J ORG CHEM, V73, P1333, DOI 10.1021/jo702295d; Kanazawa K, 2020, NATURE, V579, P364, DOI 10.1038/s41586-020-2086-2; Kapral R, 2016, PHYSICA D, V318, P100, DOI 10.1016/j.physd.2015.10.024; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kozuch S, 2012, ACS CATAL, V2, P2787, DOI 10.1021/cs3005264; Li JX, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aam6431; Liebchen B, 2018, ACCOUNTS CHEM RES, V51, P2982, DOI 10.1021/acs.accounts.8b00215; Lightstone FC, 1998, BIOORG CHEM, V26, P193, DOI 10.1006/bioo.1998.1096; MacDonald T. S., 2019, ANGEW CHEM INT EDIT, V131, P19040, DOI DOI 10.1002/ANGE.201910968; MacDonald T. S. C., 2019, ANGEW CHEM INT EDIT, V131, P19040; MacDonald TSC, 2019, CHEMPHYSCHEM, V20, P926, DOI 10.1002/cphc.201900150; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Morehead A, 1998, CHEM COMMUN, P275; Naumov S, 2008, J PHYS ORG CHEM, V21, P963, DOI 10.1002/poc.1407; Nedd S, 2015, PHYS CHEM CHEM PHYS, V17, P1347, DOI 10.1039/c4cp03418j; Ni BB, 2013, CHEM COMMUN, V49, P10130, DOI 10.1039/c3cc46153j; Ogba OM, 2018, CHEM SOC REV, V47, P4510, DOI 10.1039/c8cs00027a; Presolski Stanislav I, 2011, Curr Protoc Chem Biol, V3, P153; Ramaswamy S, 2017, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aa6bc5; Rulisek L, 2005, J ORG CHEM, V70, P6295, DOI 10.1021/jo050759z; Schnitzer M. J., 1990, S SOC GEN MICROBIOL, V46, P15; Sengupta S, 2013, J AM CHEM SOC, V135, P1406, DOI 10.1021/ja3091615; Shelley MJ, 2016, ANNU REV FLUID MECH, V48, P487, DOI 10.1146/annurev-fluid-010814-013639; Sikk L, 2012, J MOL MODEL, V18, P3025, DOI 10.1007/s00894-011-1311-1; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Swan I, 2015, J MAGN RESON, V252, P120, DOI 10.1016/j.jmr.2014.12.006; Thirumurugan P, 2013, CHEM REV, V113, P4905, DOI 10.1021/cr200409f; Tuba R, 2013, POLYM CHEM-UK, V4, P3959, DOI 10.1039/c3py00584d; Tupper PF, 2012, P ROY SOC A-MATH PHY, V468, P3864, DOI 10.1098/rspa.2012.0259; Unaleroglu C, 2001, SYN REACT INORG MET, V31, P1531, DOI 10.1081/SIM-100107700; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; van der Eide EF, 2010, NAT CHEM, V2, P571, DOI [10.1038/nchem.653, 10.1038/NCHEM.653]; Webb A., 2002, ANN REP NMR SPECTR, V45, P1, DOI DOI 10.1016/S0066-4103(02)45009-0; WINSTEIN S, 1957, J AM CHEM SOC, V79, P5937, DOI 10.1021/ja01579a027; Worrell BT, 2013, SCIENCE, V340, P457, DOI 10.1126/science.1229506; Yasir M, 2019, NAT CHEM, V11, P488, DOI 10.1038/s41557-019-0239-4	55	42	43	15	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					537	+		10.1126/science.aba8425	http://dx.doi.org/10.1126/science.aba8425			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732420				2022-12-28	WOS:000556568100039
J	Balkwill, FR				Balkwill, Frances R.			A Darker Side to Retinoic Acid Revealed by Sarcomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A recent study of mouse models and human sarcoma tissue implicates retinoic acid, produced by the tumor cells of sarcomas, in blunting antitumor immune mechanisms.	[Balkwill, Frances R.] Queen Mary Univ London, Barts Canc Inst, London, England	University of London; Queen Mary University London	Balkwill, FR (corresponding author), Queen Mary Univ London, Barts Canc Inst, London, England.							Burnett AK, 2015, LANCET ONCOL, V16, P1295, DOI 10.1016/S1470-2045(15)00193-X; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Devalaraja S, 2020, CELL, V180, P1098, DOI 10.1016/j.cell.2020.02.042; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Ponzetta A, 2019, CELL, V178, P346, DOI 10.1016/j.cell.2019.05.047	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					491	493		10.1056/NEJMcibr2005538	http://dx.doi.org/10.1056/NEJMcibr2005538			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32726538				2022-12-28	WOS:000556861800019
J	Grubert, F; Srivas, R; Spacek, DV; Kasowski, M; Ruiz-Velasco, M; Sinnott-Armstrong, N; Greenside, P; Narasimha, A; Liu, Q; Geller, B; Sanghi, A; Kulik, M; Sa, SL; Rabinovitch, M; Kundaje, A; Dalton, S; Zaugg, JB; Snyder, M				Grubert, Fabian; Srivas, Rohith; Spacek, Damek, V; Kasowski, Maya; Ruiz-Velasco, Mariana; Sinnott-Armstrong, Nasa; Greenside, Peyton; Narasimha, Anil; Liu, Qing; Geller, Benjamin; Sanghi, Akshay; Kulik, Michael; Sa, Silin; Rabinovitch, Marlene; Kundaje, Anshul; Dalton, Stephen; Zaugg, Judith B.; Snyder, Michael			Landscape of cohesin-mediated chromatin loops in the human genome	NATURE			English	Article							WIDE ASSOCIATION; TRANSCRIPTION FACTORS; INTEGRATIVE ANALYSIS; GENE-EXPRESSION; CONTACT MAPS; DOMAINS; ARCHITECTURE; STEM; DISRUPTION; ACTIVATION	Physical interactions between distal regulatory elements have a key role in regulating gene expression, but the extent to which these interactions vary between cell types and contribute to cell-type-specific gene expression remains unclear. Here, to address these questions as part of phase III of the Encyclopedia of DNA Elements (ENCODE), we mapped cohesin-mediated chromatin loops, using chromatin interaction analysis by paired-end tag sequencing (ChIA-PET), and analysed gene expression in 24 diverse human cell types, including core ENCODE cell lines. Twenty-eight per cent of all chromatin loops vary across cell types; these variations modestly correlate with changes in gene expression and are effective at grouping cell types according to their tissue of origin. The connectivity of genes corresponds to different functional classes, with housekeeping genes having few contacts, and dosage-sensitive genes being more connected to enhancer elements. This atlas of chromatin loops complements the diverse maps of regulatory architecture that comprise the ENCODE Encyclopedia, and will help to support emerging analyses of genome structure and function. A map of cohesin-mediated chromatin loops in 24 types of human cells identifies loops that show cell-type-specific variation, indicating that chromatin loops may help to specify cell-specific gene expression programs and functions.	[Grubert, Fabian; Srivas, Rohith; Spacek, Damek, V; Kasowski, Maya; Sinnott-Armstrong, Nasa; Narasimha, Anil; Liu, Qing; Geller, Benjamin; Sanghi, Akshay; Kundaje, Anshul; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; [Grubert, Fabian; Kasowski, Maya] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Ruiz-Velasco, Mariana; Zaugg, Judith B.] European Mol Biol Lab, Struct & Computat Biol, Heidelberg, Germany; [Greenside, Peyton] Stanford Univ, Sch Med, Biomed Informat Grad Training Program, Stanford, CA 94305 USA; [Kulik, Michael; Dalton, Stephen] Univ Georgia, Ctr Mol Med, Athens, GA 30602 USA; [Kulik, Michael; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Sa, Silin; Rabinovitch, Marlene] Stanford Univ, Sch Med, Vera Moulton Wall Ctr Pulm Vasc Dis, Palo Alto, CA 94304 USA; [Sa, Silin; Rabinovitch, Marlene] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA; [Sa, Silin; Rabinovitch, Marlene] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; European Molecular Biology Laboratory (EMBL); Stanford University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Stanford University; Stanford University; Stanford University; Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA.	mpsnyder@stanford.edu		Snyder, Michael/0000-0003-0784-7987; Kundaje, Anshul/0000-0003-3084-2287; Dalton, Stephen/0000-0002-3450-1263	NHGRI NIH HHS [U01 HG009431, T32 HG000044] Funding Source: Medline; NHLBI NIH HHS [R24 HL123767, R01 HL074186, R01 HL122887] Funding Source: Medline; NIGMS NIH HHS [P01 GM085354] Funding Source: Medline; NIH HHS [S10 OD020141, 5P5OHG00773504, 5U01 HL10739302, 3U54HG006999504S1] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cruz-Molina S, 2017, CELL STEM CELL, V20, P689, DOI 10.1016/j.stem.2017.02.004; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Reshef YA, 2018, NAT GENET, V50, P1483, DOI 10.1038/s41588-018-0196-7; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Ruiz-Velasco M, 2017, CELL SYST, V5, P628, DOI 10.1016/j.cels.2017.10.018; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tung PY, 2013, STEM CELLS, V31, P2330, DOI 10.1002/stem.1526; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064237	80	53	53	8	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					737	+		10.1038/s41586-020-2151-x	http://dx.doi.org/10.1038/s41586-020-2151-x			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728247	hybrid, Green Published			2022-12-28	WOS:000554831500024
J	Dyer, C				Dyer, Clare			Surgeon who was suspended for performing wrong knee surgery can practise again	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5384	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2020	370								m3002	10.1136/bmj.m3002	http://dx.doi.org/10.1136/bmj.m3002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MT1NQ	32723729				2022-12-28	WOS:000554735400001
J	Kuehn, BM				Kuehn, Bridget M.			More Than 1 in 3 US Adults Use Disinfectants Unsafely	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					328	328		10.1001/jama.2020.12600	http://dx.doi.org/10.1001/jama.2020.12600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721014				2022-12-28	WOS:000562851000012
J	Shah, A				Shah, Amar			How to move beyond quality improvement projects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shah, Amar] East London NHS Fdn Trust, London E1 8DE, England		Shah, A (corresponding author), East London NHS Fdn Trust, London E1 8DE, England.	amarshah@nhs.net						Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Boaden R, 2008, QUALITY IMPROVEMENT; Call L, 2011, MLC TOPICAL BRIEF US; Goldstone J, 1998, J VASC SURG, V28, P378, DOI 10.1016/S0741-5214(98)70180-6; Healthcare Improvement Scotland, 2018, QUAL MAN SYST 90 DAY; Juran J., 1970, QUALITY PLANNING ANA; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Scoville, 2016, SUSTAINING IMPROVEME; Shah A, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l189	9	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2319	10.1136/bmj.m2319	http://dx.doi.org/10.1136/bmj.m2319			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32718988				2022-12-28	WOS:000554458200007
J	Volkmann, ER				Volkmann, Elizabeth R.			Tapering glucocorticoids in rheumatoid arthritis	LANCET			English	Editorial Material							RECOMMENDATIONS		[Volkmann, Elizabeth R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Volkmann, ER (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	evolkmann@mednet.ucla.edu			NHLBI NIH HHS [K23 HL150237] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burmester GR, 2020, LANCET, V396, P267, DOI 10.1016/S0140-6736(20)30636-X; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Strehl C, 2016, ANN RHEUM DIS, V75, P952, DOI 10.1136/annrheumdis-2015-208916; Tong JJ, 2020, CLIN RHEUMATOL, V39, P357, DOI 10.1007/s10067-019-04787-9; Volkmann ER, 2013, J RHEUMATOL, V40, P1646, DOI 10.3899/jrheum.130019; Wallace BI, 2019, ANN RHEUM DIS, V78, P1733, DOI 10.1136/annrheumdis-2019-216009; Wasko MC, 2016, ARTHRIT CARE RES, V68, P706, DOI 10.1002/acr.22722	9	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					218	219						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711782	Green Accepted			2022-12-28	WOS:000567020100007
J	Horn, DM; Haas, JS				Horn, Daniel M.; Haas, Jennifer S.			Covid-19 and the Mandate to Redefine Preventive Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANNUAL WELLNESS VISIT	As we define the new normal for ambulatory care in the Covid era, we need a new approach to providing routine preventive care. Failure to advance alternative systems for promoting evidence-based prevention could worsen the health disparities underscored by the pandemic.	[Horn, Daniel M.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Horn, DM (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.							Ganguli I, 2019, HEALTH AFFAIR, V38, P1927, DOI 10.1377/hlthaff.2019.00304; Ganguli I, 2017, JAMA-J AM MED ASSOC, V317, P2233, DOI 10.1001/jama.2017.4342; Mehrotra A, 2015, NEW ENGL J MED, V373, P1485, DOI 10.1056/NEJMp1507485; Nelson HD, 2020, ANN INTERN MED, V172, P258, DOI 10.7326/M19-3199; Sepucha KR, 2016, HEALTH AFFAIR, V35, P630, DOI 10.1377/hlthaff.2015.1376	5	12	12	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2020	383	16					1505	1507		10.1056/NEJMp2018749	http://dx.doi.org/10.1056/NEJMp2018749			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OE4ES	32786183	Bronze			2022-12-28	WOS:000580486200006
J	Studdert, DM; Hall, MA; Mello, MM				Studdert, David M.; Hall, Mark A.; Mello, Michelle M.			Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Studdert, David M.; Mello, Michelle M.] Stanford Univ, Stanford Law Sch & Stanford Hlth Policy, Stanford, CA 94305 USA; [Studdert, David M.; Mello, Michelle M.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Hall, Mark A.] Wake Forest Univ, Sch Law, Wake Forest, NC USA; [Hall, Mark A.] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest, NC USA	Stanford University; Stanford University; Wake Forest University; Wake Forest University	Studdert, DM (corresponding author), Stanford Univ, Stanford Law Sch & Stanford Hlth Policy, Stanford, CA 94305 USA.; Studdert, DM (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Hall, Mark A./0000-0001-6277-144X; Mello, Michelle/0000-0003-2877-4270				Roberts SA, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa059	1	11	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2020	383	13							e83	10.1056/NEJMp2024274	http://dx.doi.org/10.1056/NEJMp2024274			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NX2KQ	32757517	Bronze			2022-12-28	WOS:000575544000001
J	Sokol, J				Sokol, Joshua			LUCKY STRIKE	SCIENCE			English	Editorial Material																			0	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					760	765		10.1126/science.369.6505.760	http://dx.doi.org/10.1126/science.369.6505.760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792379				2022-12-28	WOS:000559731300015
J	Vishik, I				Vishik, Inna			A coexistence that CuO2 planes can see	SCIENCE			English	Editorial Material									[Vishik, Inna] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA	University of California System; University of California Davis	Vishik, I (corresponding author), Univ Calif Davis, Dept Phys, Davis, CA 95616 USA.	ivishik@ucdavis.edu	Vishik, Inna/AGU-2119-2022	Vishik, Inna/0000-0002-8534-9329				Fradkin E, 2015, REV MOD PHYS, V87, P457, DOI 10.1103/RevModPhys.87.457; Hashimoto M, 2014, NAT PHYS, V10, P483, DOI [10.1038/NPHYS3009, 10.1038/nphys3009]; Homes CC, 2004, NATURE, V430, P539, DOI 10.1038/nature02673; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; Iyo A, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.094711; Kunisada S, 2020, SCIENCE, V369, P833, DOI 10.1126/science.aay7311; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383	7	0	0	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					775	776		10.1126/science.aba9482	http://dx.doi.org/10.1126/science.aba9482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792386				2022-12-28	WOS:000559731300022
J	Yousuf, MS; Price, TJ				Yousuf, Muhammad Saad; Price, Theodore J.			The importins of pain	SCIENCE			English	Editorial Material									[Yousuf, Muhammad Saad; Price, Theodore J.] Univ Texas Dallas, Ctr Adv Pain Studies, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Yousuf, MS (corresponding author), Univ Texas Dallas, Ctr Adv Pain Studies, Richardson, TX 75083 USA.	yousuf.muhammadsaad@utdallas.edu; theodore.price@utdallas.edu	Yousuf, Muhammad Saad/AAW-1533-2020		NIH [NS065926]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are supported by NIH grant NS065926.	Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Haroutounian S, 2014, PAIN, V155, P1272, DOI 10.1016/j.pain.2014.03.022; Marvaldi L, 2020, SCIENCE, V369, P842, DOI 10.1126/science.aaz5875; Melemedjian O, 2014, J PAIN, V15, pS45, DOI 10.1016/j.jpain.2014.01.187; North RY, 2019, BRAIN, V142, P1215, DOI 10.1093/brain/awz063; Price TJ, 2018, NAT REV NEUROSCI, V19, P383, DOI 10.1038/s41583-018-0012-5; Serra J, 2012, PAIN, V153, P42, DOI 10.1016/j.pain.2011.08.015; Terenzio M, 2018, SCIENCE, V359, P1416, DOI 10.1126/science.aan1053; Vaso A, 2014, PAIN, V155, P1384, DOI 10.1016/j.pain.2014.04.018	10	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					774	775		10.1126/science.abd4196	http://dx.doi.org/10.1126/science.abd4196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792385				2022-12-28	WOS:000559731300021
J	Yang, ZH; Bethge, C; Tian, H; Tomczyk, S; Morton, R; Del Zanna, G; McIntosh, SW; Karak, BB; Gibson, S; Samanta, T; He, JS; Chen, YJ; Wang, LH				Yang, Zihao; Bethge, Christian; Tian, Hui; Tomczyk, Steven; Morton, Richard; Del Zanna, Giulio; McIntosh, Scott W.; Karak, Bidya Binay; Gibson, Sarah; Samanta, Tanmoy; He, Jiansen; Chen, Yajie; Wang, Linghua			Global maps of the magnetic field in the solar corona	SCIENCE			English	Article							SUFFICIENT ENERGY; WAVE-PROPAGATION; ALFVENIC WAVES; POWER; SEISMOLOGY; FLUX	Understanding many physical processes in the solar atmosphere requires determination of the magnetic field in each atmospheric layer. However, direct measurements of the magnetic field in the Sun's corona are difficult to obtain. Using observations with the Corona! Multi-channel Polarimeter, we have determined the spatial distribution of the plasma density in the corona and the phase speed of the prevailing transverse magnetohydrodynamic waves within the plasma. We combined these measurements to map the plane-of-sky component of the global coronal magnetic field. The derived field strengths in the corona, from 1.05 to 1.35 solar radii, are mostly 1 to 4 gauss. Our results demonstrate the capability of imaging spectroscopy in coronal magnetic field diagnostics.	[Yang, Zihao; Tian, Hui; He, Jiansen; Chen, Yajie; Wang, Linghua] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Bethge, Christian] Univ Space Res Assoc, Huntsville, AL 35805 USA; [Bethge, Christian; Tomczyk, Steven; McIntosh, Scott W.; Gibson, Sarah] Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA; [Tian, Hui] Chinese Acad Sci, Natl Astron Observ, Key Lab Solar Act, Beijing 100012, Peoples R China; [Morton, Richard] Northumbria Univ, Dept Math Phys & Elect Engn, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Del Zanna, Giulio] Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Karak, Bidya Binay] Banaras Hindu Univ, Indian Inst Technol, Dept Phys, Varanasi 221005, Uttar Pradesh, India; [Samanta, Tanmoy] George Mason Univ, Dept Phys & Astron, Fairfax, VA 22030 USA; [Samanta, Tanmoy] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Chen, Yajie] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany	Peking University; Universities Space Research Association (USRA); National Center Atmospheric Research (NCAR) - USA; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Northumbria University; University of Cambridge; Banaras Hindu University (BHU); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT BHU) - Varanasi; George Mason University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Max Planck Society	Tian, H (corresponding author), Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China.; Tomczyk, S (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.; Tian, H (corresponding author), Chinese Acad Sci, Natl Astron Observ, Key Lab Solar Act, Beijing 100012, Peoples R China.	huitian@pku.edu.cn; tomczyk@ucar.edu	He, Jiansen/B-1808-2012; Wang, Linghua/C-4938-2014; Morton, Richard/K-3915-2012	He, Jiansen/0000-0001-8179-417X; Wang, Linghua/0000-0001-7309-4325; Morton, Richard/0000-0001-5678-9002; Tian, Hui/0000-0002-1369-1758; Samanta, Tanmoy/0000-0002-9667-6392; Yang, Zihao/0000-0002-4973-0018; Karak, Bidya Binay/0000-0002-8883-3562; McIntosh, Scott/0000-0002-7369-1776	NSFC [11825301, 11790304(11790300), 41421003, 41774183, 41861134033, 41874200]; Strategic Priority Research Program of CAS [XDA17040507]; Max Planck Partner Group program; STFC (UK) [ST/P000665/1, ST/T000481/1]; Department of Science and Technology (SERB/DST) through the Ramanujan Fellowship [SB/S2/RJN-017/2018]; STFC [ST/T000481/1, ST/P000665/1, ST/T000384/1, ST/R000743/1] Funding Source: UKRI	NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; Max Planck Partner Group program(Max Planck Society); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Department of Science and Technology (SERB/DST) through the Ramanujan Fellowship(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by NSFC grants 11825301, 11790304(11790300), 41421003, 41774183, 41861134033, and 41874200; the Strategic Priority Research Program of CAS (grant no. XDA17040507), the Max Planck Partner Group program, STFC (UK) through consolidated grants to the atomic astrophysics group at DAMTP at the University of Cambridge (ST/P000665/1 and ST/T000481/1); and the Department of Science and Technology (SERB/DST) through the Ramanujan Fellowship (project no. SB/S2/RJN-017/2018).	Andretta V, 2012, SOL PHYS, V279, P53, DOI 10.1007/s11207-012-9974-z; Aschwanden MJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/102; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Chen F, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201526237; Chen Y, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/147; De Moortel I, 2009, ASTROPHYS J LETT, V699, pL72, DOI 10.1088/0004-637X/699/2/L72; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; Del Zanna G, 2018, ASTROPHYS J, V865, DOI 10.3847/1538-4357/aadcf1; Del Zanna G, 2018, ASTROPHYS J, V852, DOI 10.3847/1538-4357/aa9edf; Dere KP, 2019, ASTROPHYS J SUPPL S, V241, DOI 10.3847/1538-4365/ab05cf; Dere KP, 1997, ASTRON ASTROPHYS SUP, V125, P149, DOI 10.1051/aas:1997368; EDWIN PM, 1983, SOL PHYS, V88, P179, DOI 10.1007/BF00196186; Fleishman GD, 2020, SCIENCE, V367, P278, DOI 10.1126/science.aax6874; Gibson SE, 2016, FRONT ASTRON SPACE, V3, DOI 10.3389/fspas.2016.00008; Gibson SE, 1999, J GEOPHYS RES-SPACE, V104, P9691, DOI 10.1029/98JA02681; Goossens M, 2009, ASTRON ASTROPHYS, V503, P213, DOI 10.1051/0004-6361/200912399; Gopalswamy N, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/72; HOUSE LL, 1972, SOL PHYS, V23, P103, DOI 10.1007/BF00153894; Kumari A, 2019, ASTROPHYS J, V881, DOI 10.3847/1538-4357/ab2adf; Kuridze D, 2019, ASTROPHYS J, V874, DOI 10.3847/1538-4357/ab08e9; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Lin H, 2004, ASTROPHYS J, V613, pL177, DOI 10.1086/425217; Lin HS, 2000, ASTROPHYS J, V541, pL83, DOI 10.1086/312900; Liu JJ, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/7; Liu W, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/1/L13; Long DM, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201730413; Magyar N, 2018, ASTROPHYS J, V856, DOI 10.3847/1538-4357/aab42c; Mancuso S, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322645; McIntosh SW, 2008, SOL PHYS, V252, P321, DOI 10.1007/s11207-008-9257-x; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; Morton RJ, 2019, NAT ASTRON, V3, P223, DOI 10.1038/s41550-018-0668-9; Morton RJ, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/2/89; Morton RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8813; Nakariakov VM, 2001, ASTRON ASTROPHYS, V372, pL53, DOI 10.1051/0004-6361:20010607; Ofman L, 2015, ASTRON ASTROPHYS, V582, DOI 10.1051/0004-6361/201425054; Priest E. R, 1982, SOLAR MAGNETOHYDRODY; SCHATTEN KH, 1969, SOL PHYS, V6, P442, DOI 10.1007/BF00146478; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Schmieder B, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201423922; Schrijver CJ, 2003, SOL PHYS, V212, P165, DOI 10.1023/A:1022908504100; Threlfall J, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321782; Tian H, 2013, SOL PHYS, V288, P637, DOI 10.1007/s11207-013-0317-5; Tian H, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/144; Tiwari AK, 2019, ASTROPHYS J, V876, DOI 10.3847/1538-4357/ab164b; Tomczyk S, 2008, SOL PHYS, V247, P411, DOI 10.1007/s11207-007-9103-6; Tomczyk S, 2007, SCIENCE, V317, P1192, DOI 10.1126/science.1143304; Tomczyk S., 2015, MEASUREMENT ERRORS C; Tomczyk S, 2009, ASTROPHYS J, V697, P1384, DOI 10.1088/0004-637X/697/2/1384; Ulrich RK, 2006, SOL PHYS, V235, P17, DOI 10.1007/s11207-006-0041-5; Van Vleck JH, 1925, P NATL ACAD SCI USA, V11, P612; Wiegelmann T, 2014, ASTRON ASTROPHYS REV, V22, DOI 10.1007/s00159-014-0078-7; Yu XX, 2018, ASTROPHYS J, V866, DOI 10.3847/1538-4357/aadfdd	52	46	48	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					694	+		10.1126/science.abb4462	http://dx.doi.org/10.1126/science.abb4462			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764071	Green Accepted, Green Submitted			2022-12-28	WOS:000559184400046
J	Rimmer, A				Rimmer, Abi			Breaking the menopause taboo: more must be done to support doctors, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, CHALL CULT MEN WORK	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3107	10.1136/bmj.m3107	http://dx.doi.org/10.1136/bmj.m3107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32764030				2022-12-28	WOS:000560719800005
J	Wang, H; Zhang, YT; Huang, BY; Deng, W; Quan, YR; Wang, WL; Xu, WB; Zhao, YX; Li, N; Zhang, J; Liang, HY; Bao, LL; Xu, YF; Ding, L; Zhou, WM; Gao, H; Liu, JN; Niu, PH; Zhao, L; Zhen, W; Fu, H; Yu, SZ; Zhang, ZL; Xu, GX; Li, CG; Lou, ZY; Xu, M; Qin, C; Wu, GZ; Gao, GF; Tan, WJ; Yang, XM				Wang, Hui; Zhang, Yuntao; Huang, Baoying; Deng, Wei; Quan, Yaru; Wang, Wenling; Xu, Wenbo; Zhao, Yuxiu; Li, Na; Zhang, Jin; Liang, Hongyang; Bao, Linlin; Xu, Yanfeng; Ding, Ling; Zhou, Weimin; Gao, Hong; Liu, Jiangning; Niu, Peihua; Zhao, Li; Zhen, Wei; Fu, Hui; Yu, Shouzhi; Zhang, Zhengli; Xu, Guangxue; Li, Changgui; Lou, Zhiyong; Xu, Miao; Qin, Chuan; Wu, Guizhen; Gao, George Fu; Tan, Wenjie; Yang, Xiaoming			Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2	CELL			English	Article							CORONAVIRUS; OUTBREAK	The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The development of a vaccine is urgently needed for the prevention and control of COVID-19. Here, we report the pilot-scale production of an inactivated SARS-CoV-2 vaccine candidate (BBIBP-CorV) that induces high levels of neutralizing antibodies titers in mice, rats, guinea pigs, rabbits, and nonhuman primates (cynomolgus monkeys and rhesus macaques) to provide protection against SARS-CoV-2. Two-dose immunizations using 2 mg/dose of BBIBP-CorV provided highly efficient protection against SARS-CoV-2 intratracheal challenge in rhesus macaques, without detectable antibodydependent enhancement of infection. In addition, BBIBP-CorV exhibits efficient productivity and good genetic stability for vaccine manufacture. These results support the further evaluation of BBIBP-CorV in a clinical trial.	[Wang, Hui; Zhang, Yuntao; Zhao, Yuxiu; Li, Na; Zhang, Jin; Liang, Hongyang; Ding, Ling; Fu, Hui; Yu, Shouzhi; Zhang, Zhengli; Yang, Xiaoming] Beijing Inst Biol Prod Co Ltd, Beijing, Peoples R China; [Huang, Baoying; Wang, Wenling; Xu, Wenbo; Zhou, Weimin; Niu, Peihua; Zhao, Li; Zhen, Wei; Wu, Guizhen; Gao, George Fu; Tan, Wenjie] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Deng, Wei; Bao, Linlin; Xu, Yanfeng; Gao, Hong; Liu, Jiangning; Qin, Chuan] Chinese Acad Med Sci, NHC Key Lab Human Dis Comparat Med, Natl Anim Models Human Dis Resources Ctr, Inst Lab Anim Sci,Beijing Key Lab Anim Models Eme, Beijing, Peoples R China; [Deng, Wei; Bao, Linlin; Xu, Yanfeng; Gao, Hong; Liu, Jiangning; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Quan, Yaru; Li, Changgui; Xu, Miao] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Xu, Guangxue; Lou, Zhiyong] Tsinghua Univ, MOE Key Lab Prot Sci, Sch Med, Beijing, Peoples R China; [Xu, Guangxue; Lou, Zhiyong] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Sch Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China; Tsinghua University; Tsinghua University	Yang, XM (corresponding author), Beijing Inst Biol Prod Co Ltd, Beijing, Peoples R China.; Wu, GZ; Gao, GF; Tan, WJ (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.; Qin, C (corresponding author), Chinese Acad Med Sci, NHC Key Lab Human Dis Comparat Med, Natl Anim Models Human Dis Resources Ctr, Inst Lab Anim Sci,Beijing Key Lab Anim Models Eme, Beijing, Peoples R China.; Qin, C (corresponding author), Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China.; Li, CG; Xu, M (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.; Lou, ZY (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Sch Med, Beijing, Peoples R China.; Lou, ZY (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Sch Med, Beijing, Peoples R China.	changguili@aliyun.com; louzy@mail.tsinghua.edu.cn; xumiaobj@126.com; qinchuan@pumc.edu.cn; wugz@ivdc.chinacdc.cn; gaofu@chinacdc.cn; tanwj@ivdc.chinacdc.cn; yangxiaoming@sinopharm.com	Yu, Shouzhi/HGE-6750-2022; Deng, Wei/GWC-9207-2022; Gao, George Fu/ABD-5229-2021; qin, chuan/ABG-4508-2020	Xu, Guangxue/0000-0001-8491-1087	National Program on Key Research Project of China [2020YFA0707500, 2016YFD0500301, 2017YFC0840300, 2020YFC0842100]; National Natural Science Foundation of China (NSFC) [31971126]; CAMS Initiative for Innovative Medicine of China [2016I2M-2-006]; Beijing Science and Technology Plan [Z201100005420014]; National Mega Projects of China for Major Infectious Diseases [2017ZX10304402, 2016ZX10004001-003]	National Program on Key Research Project of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine of China; Beijing Science and Technology Plan; National Mega Projects of China for Major Infectious Diseases	We thank Dr. Taijiao Jiang for his assistance to prepare the phylogenic tree. This work was supported by the National Program on Key Research Project of China (2020YFA0707500, 2016YFD0500301, 2017YFC0840300, and 2020YFC0842100), the National Natural Science Foundation of China (NSFC) (31971126), CAMS Initiative for Innovative Medicine of China (2016I2M-2-006), National Mega Projects of China for Major Infectious Diseases (2017ZX10304402 and 2016ZX10004001-003), and Beijing Science and Technology Plan (Z201100005420014).	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gary EN, 2020, CURR OPIN IMMUNOL, V65, P21, DOI 10.1016/j.coi.2020.01.006; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Shan C, 2020, RES SQUARE, DOI [10.21203/rs.2.25200/v1, DOI 10.21203/RS.2.25200/V1]; Stern PL, 2020, ANN ALLERG ASTHMA IM, V125, P17, DOI 10.1016/j.anai.2020.01.025; Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang QD, 2016, ACS INFECT DIS, V2, P361, DOI 10.1021/acsinfecdis.6b00006; Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Yu P, 2020, ANIM MODEL EXP MED, V3, P93, DOI 10.1002/ame2.12108; Zhang C, 2016, HUM VACC IMMUNOTHER, V12, P2064, DOI 10.1080/21645515.2016.1165908; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	24	437	471	21	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					713	+		10.1016/j.cell.2020.06.008	http://dx.doi.org/10.1016/j.cell.2020.06.008			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32778225	Green Published, Bronze			2022-12-28	WOS:000558649000015
J	[Anonymous]				[Anonymous]			Seven days in medicine: 29 July to 4 August 2020 Covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2020, VIS CAR HOM COR; Mitchell J, 2020, ANAESTHESIA, V75, P1482, DOI 10.1111/anae.15179; National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID AR; National Institute for Health and Care Excellence, 2020, CHRON PAIN ASS MAN D; UK Parliament, 2020, WORKF BURN RES NHS S	5	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3076	10.1136/bmj.m3076	http://dx.doi.org/10.1136/bmj.m3076			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32763905				2022-12-28	WOS:000560719800006
J	Voelker, R				Voelker, Rebecca			First-in-Class HIV Drug Is Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					433	433		10.1001/jama.2020.13103	http://dx.doi.org/10.1001/jama.2020.13103			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2KY	32749476				2022-12-28	WOS:000595463700001
J	Voelker, R				Voelker, Rebecca			Breast Cancer Drug Can Be Given at Home or in the Clinic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					433	433		10.1001/jama.2020.13100	http://dx.doi.org/10.1001/jama.2020.13100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2KY	32749475				2022-12-28	WOS:000595463700002
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: US needs a national plan to fight rising infections, experts say	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Eban K, 2020, VANITY FAIR	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2020	370								m3072	10.1136/bmj.m3072	http://dx.doi.org/10.1136/bmj.m3072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1QV	32747346	Bronze			2022-12-28	WOS:000556138700002
J	Marselis, D; Hordijk, L				Marselis, Daan; Hordijk, Lucien			From blockbuster to "nichebuster": how a flawed legislation helped create a new profit model for the drug industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Marselis, Daan; Hordijk, Lucien] Invest Desk, Amsterdam, Netherlands		Marselis, D (corresponding author), Invest Desk, Amsterdam, Netherlands.	marselis@investigativedesk.com			Dutch Journalism Fund; Dutch government; Open Society Initiative for Europe (part of Open Society Foundations); Dutch Cancer Society; Dutch Fund for In-depth Journalism; EU Journalism Fund; Bath University; Merck Sharp Dohme; Bristol-Myers Squibb	Dutch Journalism Fund; Dutch government; Open Society Initiative for Europe (part of Open Society Foundations); Dutch Cancer Society(KWF Kankerbestrijding); Dutch Fund for In-depth Journalism; EU Journalism Fund; Bath University; Merck Sharp Dohme(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb)	Competing interests: We have read and understood BMJ policy on declaration of interests and declare the following: LH declares: I am a freelance journalist, but my main client is the pharmaceuticals desk team of The Investigative Desk, a non-profit organisation for investigative journalism. The Investigative Desk is a foundation. Our work is currently financed by the Dutch Journalism Fund (in turn funded by the Dutch government), the Open Society Initiative for Europe (part of Open Society Foundations), the Dutch Cancer Society, the Dutch Fund for In-depth Journalism, EU Journalism Fund, Bath University, and fees for sold articles in different media outlets. In 2019, I spoke at an in-service training by and for hospital pharmacists about high priced medicines, reimbursement, and industry strategies to fend off competition from generic or biosimilar companies. I received _350 for this service, paid for by Farma Actueel, a small magazine for pharmacists. In 2019, I was invited to talk at Pfizer Netherlands Medical Day about how an investigative journalist looks at the pharmaceutical industry and to debate on statements about the industry. I could say what I wanted, and I denied payment for this day, but Pfizer compensated me for my travelling expenses ((sic)18.90). At the end of the day, I received a bottle of wine and a cheese. DM: I am a freelance journalist, working for The Investigative Desk and for the Dutch commercial radio station BNR Nieuwsradio. My husband (FJ Borm) is employed as a thoracic oncologist at Leiden University Medical Hospital and is currently a PhD student at NKI-AVL (Netherlands Cancer Institute). His research project is partly funded by Merck Sharp & Dohme and Bristol-Myers Squibb.	[Anonymous], 2008, GUIDELINE ASPECTS AP, V8; Commission of the European Communities, 1998, PROP REG EUR PARL CO; Council of the European Union, 2016, COUNC CONCL STRENGTH; Deticek A, 2018, VALUE HEALTH, V21, P553, DOI 10.1016/j.jval.2018.01.007; European Commission. Pharmaceutical Committee, 2020, EV ORPH PAED REG; European Foundation for the Advancement of Medicine. European Commission, 1998, WORKSH RAR DIS ORPH; European Medicines Agency Management Board, 2017, HIGHL OCT 2017 M; Grossetete F., 1999, RECOMMENDATION 2 REA	8	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m2983	10.1136/bmj.m2983	http://dx.doi.org/10.1136/bmj.m2983			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727745				2022-12-28	WOS:000554456000001
J	Mahase, E				Mahase, Elisabeth			Covid-19: GPs raise workload concerns as government extends flu vaccination programme	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2020	370								m2990	10.1136/bmj.m2990	http://dx.doi.org/10.1136/bmj.m2990			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7IG	32709623	Bronze			2022-12-28	WOS:000554448500005
J	Corbett, KS; Edwards, DK; Leist, SR; Abiona, OM; Boyoglu-Barnum, S; Gillespie, RA; Himansu, S; Schafer, A; Ziwawo, CT; DiPiazza, AT; Dinnon, KH; Elbashir, SM; Shaw, CA; Woods, A; Fritch, EJ; Martinez, DR; Bock, KW; Minai, M; Nagata, BM; Hutchinson, GB; Wu, K; Henry, C; Bahl, K; Garcia-Dominguez, D; Ma, LZ; Renzi, I; Kong, WP; Schmidt, SD; Wang, LS; Zhang, Y; Phung, E; Chang, LA; Loomis, RJ; Altaras, NE; Narayanan, E; Metkar, M; Presnyak, V; Liu, C; Louder, MK; Shi, W; Leung, K; Yang, ES; West, A; Gully, KL; West, A; Gully, KL; Wang, NS; Wrapp, D; Doria-Rose, NA; Stewart-Jones, G; Bennett, H; Alvarado, GS; Nason, MC; Ruckwardt, TJ; McLellan, JS; Denison, MR; Chappell, JD; Moore, IN; Morabito, KM; Mascola, JR; Baric, RS; Carfi, A; Graham, BS				Corbett, Kizzmekia S.; Edwards, Darin K.; Leist, Sarah R.; Abiona, Olubukola M.; Boyoglu-Barnum, Seyhan; Gillespie, Rebecca A.; Himansu, Sunny; Schafer, Alexandra; Ziwawo, Cynthia T.; DiPiazza, Anthony T.; Dinnon, Kenneth H.; Elbashir, Sayda M.; Shaw, Christine A.; Woods, Angela; Fritch, Ethan J.; Martinez, David R.; Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Hutchinson, Geoffrey B.; Wu, Kai; Henry, Carole; Bahl, Kapil; Garcia-Dominguez, Dario; Ma, LingZhi; Renzi, Isabella; Kong, Wing-Pui; Schmidt, Stephen D.; Wang, Lingshu; Zhang, Yi; Phung, Emily; Chang, Lauren A.; Loomis, Rebecca J.; Altaras, Nedim Emil; Narayanan, Elisabeth; Metkar, Mihir; Presnyak, Vlad; Liu, Cuiping; Louder, Mark K.; Shi, Wei; Leung, Kwanyee; Yang, Eun Sung; West, Ande; Gully, Kendra L.; Stevens, Laura J.; Gully, Kendra L.; Wang, Nianshuang; Wrapp, Daniel; Doria-Rose, Nicole A.; Stewart-Jones, Guillaume; Bennett, Hamilton; Alvarado, Gabriela S.; Nason, Martha C.; Ruckwardt, Tracy J.; McLellan, Jason S.; Denison, Mark R.; Chappell, James D.; Moore, Ian N.; Morabito, Kaitlyn M.; Mascola, John R.; Baric, Ralph S.; Carfi, Andrea; Graham, Barney S.			SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness	NATURE			English	Article							MERS-COV; SPIKE; INFLUENZA; IMMUNOGENICITY; PROTECTION; VIRUS; RSV	A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have led to the development of mutations that stabilize Betacoronavirus spike proteins in the prefusion state, improving their expression and increasing immunogenicity(1). This principle has been applied to design mRNA-1273, an mRNA vaccine that encodes a SARS-CoV-2 spike protein that is stabilized in the prefusion conformation. Here we show that mRNA-1273 induces potent neutralizing antibody responses to both wild-type (D614) and D614G mutant(2) SARS-CoV-2 as well as CD8(+) T cell responses, and protects against SARS-CoV-2 infection in the lungs and noses of mice without evidence of immunopathology. mRNA-1273 is currently in a phase III trial to evaluate its efficacy.	[Corbett, Kizzmekia S.; Abiona, Olubukola M.; Boyoglu-Barnum, Seyhan; Gillespie, Rebecca A.; Ziwawo, Cynthia T.; DiPiazza, Anthony T.; Hutchinson, Geoffrey B.; Kong, Wing-Pui; Schmidt, Stephen D.; Wang, Lingshu; Zhang, Yi; Phung, Emily; Chang, Lauren A.; Loomis, Rebecca J.; Liu, Cuiping; Louder, Mark K.; Shi, Wei; Leung, Kwanyee; Yang, Eun Sung; Doria-Rose, Nicole A.; Alvarado, Gabriela S.; Ruckwardt, Tracy J.; Morabito, Kaitlyn M.; Mascola, John R.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Edwards, Darin K.; Himansu, Sunny; Elbashir, Sayda M.; Shaw, Christine A.; Woods, Angela; Wu, Kai; Henry, Carole; Garcia-Dominguez, Dario; Ma, LingZhi; Renzi, Isabella; Altaras, Nedim Emil; Narayanan, Elisabeth; Metkar, Mihir; Presnyak, Vlad; Stewart-Jones, Guillaume; Bennett, Hamilton; Carfi, Andrea] Moderna Inc, Cambridge, MA USA; [Leist, Sarah R.; Schafer, Alexandra; Dinnon, Kenneth H.; Martinez, David R.; West, Ande; Gully, Kendra L.; Baric, Ralph S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Fritch, Ethan J.; Baric, Ralph S.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Moore, Ian N.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Phung, Emily] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Stevens, Laura J.; Denison, Mark R.; Chappell, James D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Wang, Nianshuang; Wrapp, Daniel; McLellan, Jason S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University; Vanderbilt University; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Carfi, A (corresponding author), Moderna Inc, Cambridge, MA USA.	andrea.carfi@modernatx.com; bgraham@nih.gov	Mascola, John/AAI-7193-2021; martinez, david/GQI-0849-2022; Wrapp, Daniel/HCH-3481-2022; Wang, Nianshuang/C-1463-2010	Wrapp, Daniel/0000-0002-0538-9647; Wang, Nianshuang/0000-0002-7569-011X; Wang, Lingshu/0000-0002-8404-4910; Fritch, Ethan/0000-0003-1096-8958; Humphris-Narayanan, Elisabeth/0000-0001-8836-181X	Intramural Research Program of the VRC; Division of Intramural Research, NIAID, NIH; NIH NIAID [R01-AI127521, T32-AI007151]; NIH [AI149644, AI100625, HHSN261200800001E, HHSN272201700036I, 75N93019F00132, 5494549]; Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority [75A50120C00034]; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award	Intramural Research Program of the VRC; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund)	We thank K. Bok, K. Carlton, M. Kanekiyo, R. Seder and other members of all included laboratories for critical discussions, advice and review of the manuscript; J. Stein for technology transfer; M. Young for administrative support; members of the NIH NIAID VRC Translational Research Program for technical assistance with mouse experiments; B. Hartman for assistance with graphics; H. Mu and M. Farzan for the ACE2-overexpressing 293 cells; and M. Whitt for support on VSV-based pseudovirus production. This work was supported by the Intramural Research Program of the VRC and the Division of Intramural Research, NIAID, NIH (B.S.G.), NIH NIAID grant R01-AI127521 (J.S.M.), and NIH grants AI149644 and AI100625 (R.S.B.). mRNA-1273 has been funded in part with Federal funds from the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under contract 75A50120C00034. PRNT assays were funded under NIH contract HHSN261200800001E agreement 17x198 (to J.D.C.), furnished through Leidos Biomedical Research. MERS-CoV mRNA mouse challenge studies were funded under NIH contract HHSN272201700036I task order no. 75N93019F00132 requisition no. 5494549 (to R.S.B.). K.S.C.'s research fellowship was partially funded by the Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH. D.R.M. was funded by NIH NIAID grant T32-AI007151 and a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award.	Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226; Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033; Czub M, 2005, VACCINE, V23, P2273, DOI 10.1016/j.vaccine.2005.01.033; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Douglas MG, 2018, VIROLOGY, V517, P98, DOI 10.1016/j.virol.2017.12.006; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Freeman Brandi, 2020, bioRxiv, DOI 10.1101/2020.04.24.057323; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Graham BS, 2020, J CLIN INVEST, V130, P3348, DOI 10.1172/JCI139601; Graham BS, 2019, ANNU REV MED, V70, P91, DOI 10.1146/annurev-med-121217-094234; Graham BS, 2018, JAMA-J AM MED ASSOC, V319, P1431, DOI 10.1001/jama.2018.0345; Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9; Hassett KJ, 2019, MOL THER-NUCL ACIDS, V15, P1, DOI 10.1016/j.omtn.2019.01.013; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Jackson L. A., 2020, N ENGL J MED MOA; John S, 2018, VACCINE, V36, P1689, DOI 10.1016/j.vaccine.2018.01.029; Keni R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00216; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Klumpp-Thomas Carleen, 2020, medRxiv, DOI 10.1101/2020.05.21.20109280; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Mauger DM, 2019, P NATL ACAD SCI USA, V116, P24075, DOI 10.1073/pnas.1908052116; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Nelson J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6893; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Vogel AB, 2018, MOL THER, V26, P446, DOI 10.1016/j.ymthe.2017.11.017; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]	43	184	185	24	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2020	586	7830					567	+		10.1038/s41586-020-2622-0	http://dx.doi.org/10.1038/s41586-020-2622-0			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP6FG	32756549	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000623930000001
J	Powe, NR				Powe, Neil R.			Black Kidney Function Matters Use or Misuse of Race?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANCESTRY		[Powe, Neil R.] Univ Calif San Francisco, Priscilla Chan & Mark Zuckerberg San Francisco Ge, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Powe, NR (corresponding author), Priscilla Chan & Mark Zuckerberg San Francisco Ge, 1001 Potrero Ave,Room 5F40, San Francisco, CA 94110 USA.	neil.powe@ucsf.edu						Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; CDC Chronic Disease Surveillance System, TRACK KIDN DIS US; Eneanya ND, 2019, JAMA-J AM MED ASSOC, V322, P113, DOI 10.1001/jama.2019.5774; Fox ER, 2016, JAMA CARDIOL, V1, P15, DOI 10.1001/jamacardio.2015.0300; Levey AS, 2020, CLIN J AM SOC NEPHRO, V15, P1203, DOI 10.2215/CJN.12791019; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Powe NR, 2008, J AM SOC NEPHROL, V19, P1271, DOI 10.1681/ASN.2008040358; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Udler MS, 2015, J AM SOC NEPHROL, V26, P1682, DOI 10.1681/ASN.2014050474	9	69	69	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					737	738		10.1001/jama.2020.13378	http://dx.doi.org/10.1001/jama.2020.13378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32761164				2022-12-28	WOS:000568230000014
J	Rimmer, A				Rimmer, Abi			Disabled doctors are not getting the workplace adjustments they need, research finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, DIS MED PROF	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2020	370								m3189	10.1136/bmj.m3189	http://dx.doi.org/10.1136/bmj.m3189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7NA	32788158				2022-12-28	WOS:000560700100001
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Should the UK be aiming for elimination?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BBC NEWS; Cooney C., 2020, SUN; HABIB H, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2376; Independent Scientific Advisory Group for Emergencies, 2020, 7 IND SAGE; Office for National Statistics, 2020, COMP ALL CAUS MORT E; Torjesen I, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2874	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2020	370								m3071	10.1136/bmj.m3071	http://dx.doi.org/10.1136/bmj.m3071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1QV	32747404	Bronze			2022-12-28	WOS:000556138700005
J	Kusano, K; Iju, T; Bamba, Y; Inoue, S				Kusano, Kanya; Iju, Tomoya; Bamba, Yumi; Inoue, Satoshi			A physics-based method that can predict imminent large solar flares	SCIENCE			English	Article							TRIGGER MECHANISM; KINK INSTABILITY; SPACE-WEATHER	Solar flares are highly energetic events in the Sun's corona that affect Earth's space weather. The mechanism that drives the onset of solar flares is unknown, hampering efforts to forecast them, which mostly rely on empirical methods. We present the k-scheme, a physics-based model to predict large solar flares through a critical condition of magnetohydrodynamic instability, triggered by magnetic reconnection. Analysis of the largest (X-class) flares from 2008 to 2019 (during solar cycle 24) shows that the k-scheme predicts most imminent large solar flares, with a small number of exceptions for confined flares. We conclude that magnetic twist flux density, close to a magnetic polarity inversion line on the solar surface, determines when and where solar flares may occur and how large they can be.	[Kusano, Kanya; Bamba, Yumi; Inoue, Satoshi] Nagoya Univ, Inst Space Earth Environm Res, Nagoya, Aichi 4648601, Japan; [Iju, Tomoya] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Bamba, Yumi] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Nagoya University	Kusano, K (corresponding author), Nagoya Univ, Inst Space Earth Environm Res, Nagoya, Aichi 4648601, Japan.	kusano@nagoya-u.jp		Iju, Tomoya/0000-0001-9084-2946; Bamba, Yumi/0000-0001-8385-8990	MEXT/JSPS KAKENHI [JP15H05814]; MEXT; JAMSTEC	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JAMSTEC	This work was supported by MEXT/JSPS KAKENHI JP15H05814, MEXT as "Exploratory Challenge on Post-K computer," and JAMSTEC.	Barnes G, 2016, ASTROPHYS J, V829, DOI 10.3847/0004-637X/829/2/89; Bobra MG, 2014, SOL PHYS, V289, P3549, DOI 10.1007/s11207-014-0529-3; Canfield RC, 1999, GEOPHYS RES LETT, V26, P627, DOI 10.1029/1999GL900105; Chen PF, 2000, ASTROPHYS J, V545, P524, DOI 10.1086/317803; Chintzoglou G, 2019, ASTROPHYS J, V871, DOI 10.3847/1538-4357/aaef30; Duan AY, 2019, ASTROPHYS J, V884, DOI 10.3847/1538-4357/ab3e33; HOOD AW, 1979, SOL PHYS, V64, P303, DOI 10.1007/BF00151441; Inoue S, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/101; Ishiguro N, 2017, ASTROPHYS J, V843, DOI 10.3847/1538-4357/aa799b; Jing J, 2018, ASTROPHYS J, V864, DOI 10.3847/1538-4357/aad6e4; Kliem B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255002; Kusano K, 2004, ASTROPHYS J, V610, P537, DOI 10.1086/421547; Kusano K, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/31; Leka KD, 2019, ASTROPHYS J SUPPL S, V243, DOI 10.3847/1538-4365/ab2e12; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Machol J, 2016, GOES XRAY SENSOR XRS; Moore RL, 2001, ASTROPHYS J, V552, P833, DOI 10.1086/320559; Park SH, 2020, ASTROPHYS J, V890, DOI 10.3847/1538-4357/ab65f0; Rust DM, 1996, ASTROPHYS J, V464, pL199, DOI 10.1086/310118; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Schrijver CJ, 2015, SPACE WEATHER, V13, P524, DOI 10.1002/2015SW001252; Shibata K, 2011, LIVING REV SOL PHYS, V8, DOI 10.12942/lrsp-2011-6; Sun XD, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/2/L28; Svestka Z., 1992, LECT NOTE PHYS, V399, P1, DOI DOI 10.1007/3-540-55246-4_70; Thalmann JK, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L23; Torok T, 2004, ASTRON ASTROPHYS, V413, pL27, DOI 10.1051/0004-6361:20031691; Wang HM, 2015, RES ASTRON ASTROPHYS, V15, P145, DOI 10.1088/1674-4527/15/2/001; Welsch BT, 2018, SOL PHYS, V293, DOI 10.1007/s11207-018-1329-y; Yang SH, 2017, ASTROPHYS J LETT, V849, DOI 10.3847/2041-8213/aa9476; Zhang J, 2006, ASTROPHYS J, V649, P1100, DOI 10.1086/506903	30	36	36	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					587	591		10.1126/science.aaz2511	http://dx.doi.org/10.1126/science.aaz2511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY1FK	32732427				2022-12-28	WOS:000576143800001
J	Mercado, NB; Zahn, R; Wegmann, F; Loos, C; Chandrashekar, A; Yu, JY; Liu, JY; Peter, L; McMahan, K; Tostanoski, LH; He, X; Martinez, DR; Rutten, L; Bos, R; van Manen, D; Vellinga, J; Custers, J; Langedijk, JP; Kwaks, T; Bakkers, MJG; Zuijdgeest, D; Huber, SKR; Atyeo, C; Fischinger, S; Burke, JS; Feldman, J; Hauser, BM; Caradonna, TM; Bondzie, EA; Dagotto, G; Gebre, MS; Hoffman, E; Jacob-Dolan, C; Kirilova, M; Li, ZF; Lin, ZJ; Mahrokhian, SH; Maxfield, LF; Nampanya, F; Nityanandam, R; Nkolola, JP; Patel, S; Ventura, JD; Verrington, K; Wan, HH; Pessaint, L; Van Ry, A; Blade, K; Strasbaugh, A; Cabus, M; Brown, R; Cook, A; Zouantchangadou, S; Teow, E; Andersen, H; Lewis, MG; Cai, YF; Chen, B; Schmidt, AG; Reeves, RK; Baric, RS; Lauffenburger, DA; Alter, G; Stoffels, P; Mammen, M; Van Hoof, J; Schuitemaker, H; Barouch, DH				Mercado, Noe B.; Zahn, Roland; Wegmann, Frank; Loos, Carolin; Chandrashekar, Abishek; Yu, Jingyou; Liu, Jinyan; Peter, Lauren; McMahan, Katherine; Tostanoski, Lisa H.; He, Xuan; Martinez, David R.; Rutten, Lucy; Bos, Rinke; van Manen, Danielle; Vellinga, Jort; Custers, Jerome; Langedijk, Johannes P.; Kwaks, Ted; Bakkers, Mark J. G.; Zuijdgeest, David; Rosendahl Huber, Sietske K.; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; Hoffman, Emily; Jacob-Dolan, Catherine; Kirilova, Marinela; Li, Zhenfeng; Lin, Zijin; Mahrokhian, Shant H.; Maxfield, Lori F.; Nampanya, Felix; Nityanandam, Ramya; Nkolola, Joseph P.; Patel, Shivani; Ventura, John D.; Verrington, Kaylee; Wan, Huahua; Pessaint, Laurent; Van Ry, Alex; Blade, Kelvin; Strasbaugh, Amanda; Cabus, Mehtap; Brown, Renita; Cook, Anthony; Zouantchangadou, Serge; Teow, Elyse; Andersen, Hanne; Lewis, Mark G.; Cai, Yongfei; Chen, Bing; Schmidt, Aaron G.; Reeves, R. Keith; Baric, Ralph S.; Lauffenburger, Douglas A.; Alter, Galit; Stoffels, Paul; Mammen, Mathai; Van Hoof, Johan; Schuitemaker, Hanneke; Barouch, Dan H.			Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques	NATURE			English	Article							LENGTH INFECTIOUS CDNA; REVERSE GENETICS; CORONAVIRUS; IMMUNOGENICITY; SPIKE; ANTIBODIES; EFFICACY; IMMUNITY	A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic(1-8). For global deployment and pandemic control, a vaccine that requires only a single immunization would be optimal. Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in non-human primates. Fifty-two rhesus macaques (Macaca mulatta) were immunized with Ad26 vectors that encoded S variants or sham control, and then challenged with SARS-CoV-2 by the intranasal and intratracheal routes(9,10). The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs after SARS-CoV-2 challenge. Titres of vaccine-elicited neutralizing antibodies correlated with protective efficacy, suggesting an immune correlate of protection. These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in non-human primates. The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials. The protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccine expressing the SARS-CoV-2 spike protein in non-human primates is demonstrated.	[Mercado, Noe B.; Chandrashekar, Abishek; Yu, Jingyou; Liu, Jinyan; Peter, Lauren; McMahan, Katherine; Tostanoski, Lisa H.; He, Xuan; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; Hoffman, Emily; Jacob-Dolan, Catherine; Kirilova, Marinela; Li, Zhenfeng; Lin, Zijin; Mahrokhian, Shant H.; Maxfield, Lori F.; Nampanya, Felix; Nityanandam, Ramya; Nkolola, Joseph P.; Patel, Shivani; Ventura, John D.; Verrington, Kaylee; Wan, Huahua; Reeves, R. Keith; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Zahn, Roland; Wegmann, Frank; Rutten, Lucy; Bos, Rinke; van Manen, Danielle; Vellinga, Jort; Custers, Jerome; Langedijk, Johannes P.; Kwaks, Ted; Bakkers, Mark J. G.; Zuijdgeest, David; Rosendahl Huber, Sietske K.; Stoffels, Paul; Mammen, Mathai; Van Hoof, Johan; Schuitemaker, Hanneke] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Loos, Carolin; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Loos, Carolin; Lauffenburger, Douglas A.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Martinez, David R.; Baric, Ralph S.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Atyeo, Caroline; Fischinger, Stephanie; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Dagotto, Gabriel; Gebre, Makda S.; Jacob-Dolan, Catherine; Schmidt, Aaron G.; Barouch, Dan H.] Harvard Med Sch, Boston, MA 02115 USA; [Pessaint, Laurent; Van Ry, Alex; Blade, Kelvin; Strasbaugh, Amanda; Cabus, Mehtap; Brown, Renita; Cook, Anthony; Zouantchangadou, Serge; Teow, Elyse; Andersen, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD USA; [Cai, Yongfei; Chen, Bing] Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA; [Chen, Bing; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; BIOQUAL Inc.; Harvard University; Boston Children's Hospital	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Barouch, DH (corresponding author), Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA.	dbarouch@bidmc.harvard.edu	Zahn, Roland/ABE-8779-2021; martinez, david/GQI-0849-2022; Cai, Yongfei/ABI-7748-2020; Chandrashekar, Abishek/P-2610-2019; Mercado, Noe/ABE-8247-2020	Cai, Yongfei/0000-0002-3628-3802; Chandrashekar, Abishek/0000-0001-7821-5552; Lin, Zijin/0000-0002-6706-5410; Tostanoski, Lisa/0000-0001-9255-5684; Gebre, Makda/0000-0001-8520-2178; Hauser, Blake/0000-0002-0100-1684; Nampanya, Felix/0000-0003-4102-1265; Mercado, Noe/0000-0001-7769-7326; Mahrokhian, Shant/0000-0003-4094-8739; Caradonna, Timothy/0000-0001-7138-4441; Jacob-Dolan, Catherine/0000-0001-6641-0342; Ventura, John/0000-0002-4373-3242	Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) [HHS0100201700018C]; Janssen Vaccines Prevention BV; Ragon Institute of MGH, MIT, and Harvard; Mark and Lisa Schwartz Foundation; National Institutes of Health [OD024917, AI129797, AI124377, AI128751, AI126603, AI007151, AI152296, AI146779, 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197]; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award; Massachusetts Consortium on Pathogen Readiness (MassCPR)	Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA); Janssen Vaccines Prevention BV; Ragon Institute of MGH, MIT, and Harvard; Mark and Lisa Schwartz Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund); Massachusetts Consortium on Pathogen Readiness (MassCPR)	We thank S. Blokland, Y. Choi, K. de Boer, I. de los Rios Oakes, E. van der Helm, D. Spek, I. Swart, M. Koning, A. Brandjes, N. van Dijk, A. de Wilde, M. Navis, R. van Schie, J. Verhagen, R. Vogels, R. van der Vlugt, A. Roos Broekhuijsen, B. Bart, J. Velasco, B. Finneyfrock, C. Shaver, J. Yalley-Ogunro, D. Wesemann, N. Kordana, M. Lifton, E. Borducchi, M. Silva, A. Richardson and C. Caron for advice, assistance and reagents. This project was funded in part by the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) under contract HHS0100201700018C. We also acknowledge support from Janssen Vaccines & Prevention BV, the Ragon Institute of MGH, MIT, and Harvard, Mark and Lisa Schwartz Foundation, Massachusetts Consortium on Pathogen Readiness (MassCPR), and the National Institutes of Health (OD024917, AI129797, AI124377, AI128751, AI126603 to D.H.B.; AI007151 and AI152296 to D.R.M.; AI146779 to A.G.S.; 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197 to R.S.B.). We also acknowledge a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award to D.R.M.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032; Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/s0140-6736(18)31364-3, 10.1016/S0140-6736(18)31364-3]; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	33	497	513	8	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2020	586	7830					583	+		10.1038/s41586-020-2607-z	http://dx.doi.org/10.1038/s41586-020-2607-z		JUL 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OE6NR	32731257	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-28	WOS:000577298500002
J	Rimmer, A				Rimmer, Abi			RCP: Voluntary appointments must reflect diversity of medical workforce	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Physicians, 2020, 2020 VIS IND REP DIV	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3051	10.1136/bmj.m3051	http://dx.doi.org/10.1136/bmj.m3051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732253				2022-12-28	WOS:000556139900003
J	Rimmer, A				Rimmer, Abi			Covid-19: Trust leaders express concern over levels of fatigue and anxiety among staff	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Confederation, 2020, NHS COV 19 VIEWS TRU	1	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m3004	10.1136/bmj.m3004	http://dx.doi.org/10.1136/bmj.m3004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727856	Bronze			2022-12-28	WOS:000554456000006
J	Kurian, AW; Bernhisel, R; Stefanick, ML				Kurian, Allison W.; Bernhisel, Ryan; Stefanick, Marcia L.			Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kurian, Allison W.; Stefanick, Marcia L.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Bernhisel, Ryan] Myriad Genet Inc, Salt Lake City, UT USA	Stanford University; Myriad Genetics, Inc	Kurian, AW (corresponding author), Stanford Univ, Dept Med, Sch Med, 150 Governors Ln,HRP Redwood Bldg,Room T254A, Stanford, CA 94305 USA.	akurian@stanford.edu	Kurian, Allison/A-4560-2019	Kurian, Allison/0000-0002-6175-9470				Daly MB, 2020, J NATL COMPR CANC NE, V18, P380, DOI 10.6004/jnccn.2020.0017; Kurian AW, 2020, JAMA-J AM MED ASSOC, V323, P995, DOI 10.1001/jama.2020.0229; LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40; Shimelis H, 2018, JNCI-J NATL CANCER I, V110, P855, DOI 10.1093/jnci/djy106; Tung N, 2016, J CLIN ONCOL, V34, P1460, DOI 10.1200/JCO.2015.65.0747	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					397	398		10.1001/jama.2020.7999	http://dx.doi.org/10.1001/jama.2020.7999			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721001				2022-12-28	WOS:000562851000035
J	Eaton, L				Eaton, Lynn			Unwanted pregnancies fall worldwide but women in poorer countries remain disadvantaged, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bearak J, 2020, LANCET GLOB HEALTH, V8, pE1152, DOI 10.1016/S2214-109X(20)30315-6	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2020	370								m2985	10.1136/bmj.m2985	http://dx.doi.org/10.1136/bmj.m2985			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7IG	32709616				2022-12-28	WOS:000554448500004
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: US cases are greatly underestimated, seroprevalence studies suggest	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Brown TS, 2020, JAMA INT MED; Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, 2020, COV 19 DASHB; Havers FP, 2020, JAMA INT MED	3	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2020	370								m2988	10.1136/bmj.m2988	http://dx.doi.org/10.1136/bmj.m2988			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7IG	32709608	Bronze			2022-12-28	WOS:000554448500001
J	Gu, HJ; Chen, Q; Yang, G; He, L; Fan, H; Deng, YQ; Wang, YX; Teng, Y; Zhao, ZP; Cui, YJ; Li, YC; Li, XF; Li, JF; Zhang, NN; Yang, XL; Chen, SL; Guo, Y; Zhao, GY; Wang, XL; Luo, DY; Wang, H; Yang, X; Li, Y; Han, GC; He, YX; Zhou, XJ; Geng, SS; Sheng, XL; Jiang, SB; Sun, SH; Qin, CF; Zhou, YS				Gu, Hongjing; Chen, Qi; Yang, Guan; He, Lei; Fan, Hang; Deng, Yong-Qiang; Wang, Yanxiao; Teng, Yue; Zhao, Zhongpeng; Cui, Yujun; Li, Yuchang; Li, Xiao-Feng; Li, Jiangfan; Zhang, Na-Na; Yang, Xiaolan; Chen, Shaolong; Guo, Yan; Zhao, Guangyu; Wang, Xiliang; Luo, De-Yan; Wang, Hui; Yang, Xiao; Li, Yan; Han, Gencheng; He, Yuxian; Zhou, Xiaojun; Geng, Shusheng; Sheng, Xiaoli; Jiang, Shibo; Sun, Shihui; Qin, Cheng-Feng; Zhou, Yusen			Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy	SCIENCE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; SARS-COV; TARGET	The ongoing coronavirus disease 2019 (COVID-19) pandemic has prioritized the development of small-animal models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the respiratory tract of aged BALB/c mice. The resulting mouse-adapted strain at passage 6 (called MASCp6) showed increased infectivity in mouse lung and led to interstitial pneumonia and inflammatory responses in both young and aged mice after intranasal inoculation. Deep sequencing revealed a panel of adaptive mutations potentially associated with the increased virulence. In particular, the N501Y mutation is located at the receptor binding domain (RBD) of the spike protein. The protective efficacy of a recombinant RBD vaccine candidate was validated by using this model. Thus, this mouse-adapted strain and associated challenge model should be of value in evaluating vaccines and antivirals against SARS-CoV-2.	[Gu, Hongjing; Chen, Qi; He, Lei; Fan, Hang; Deng, Yong-Qiang; Teng, Yue; Zhao, Zhongpeng; Cui, Yujun; Li, Yuchang; Li, Xiao-Feng; Li, Jiangfan; Zhang, Na-Na; Yang, Xiaolan; Chen, Shaolong; Guo, Yan; Zhao, Guangyu; Wang, Xiliang; Luo, De-Yan; Wang, Hui; Sun, Shihui; Qin, Cheng-Feng; Zhou, Yusen] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Yang, Guan; Wang, Yanxiao; Yang, Xiao] Beijing Inst Life, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China; [Li, Yan; Han, Gencheng] Inst Mil Cognit & Brain Sci, Beijing 100850, Peoples R China; [He, Yuxian] Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Zhou, Xiaojun] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China; [Geng, Shusheng; Sheng, Xiaoli] Beijing JOINN Biol Co, Beijing 100176, Peoples R China; [Jiang, Shibo] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China	Academy of Military Medical Sciences - China; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China; Fudan University	Sun, SH; Qin, CF (corresponding author), Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Jiang, SB (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.	shibojiang@fudan.edu.cn; sunsh01@163.com; qincf@bml.ac.cn	Qin, Cheng-Feng/I-6839-2019; Fan, Hang/AAA-8489-2022; li, xiao/GSN-6181-2022; XIAO, YANG/GPW-5529-2022; li, xiaofeng/GXF-9442-2022	Qin, Cheng-Feng/0000-0002-0632-2807; Cui, Yujun/0000-0001-7236-2412; Fan, Hang/0000-0002-7927-1684; zhongpeng, zhao/0000-0002-9147-6252; Yang, Xiao/0000-0002-0298-9831; Shibo, Jiang/0000-0001-8283-7135	National Key Plan for Scientific Research and Development of China [2016YFD0500304, 2016YFD0500306, 2020YFA0707801]; National Natural Science Foundation of China [82041006, 82041025]; National Science and Technology Major Project of China [2018ZX09711003, 2017ZX10304402003]; Beijing Municipal Science and Technology Project [Z201100001020004]; National Science Fund for Distinguished Young Scholar [81925025]; Innovative Research Group from the NSFC [81621005]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5-049]	National Key Plan for Scientific Research and Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Beijing Municipal Science and Technology Project; National Science Fund for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovative Research Group from the NSFC; CAMS Innovation Fund for Medical Sciences	This work was supported by the National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, and 2020YFA0707801), the National Natural Science Foundation of China (82041006 and 82041025), the National Science and Technology Major Project of China (2018ZX09711003 and 2017ZX10304402003), and Beijing Municipal Science and Technology Project (Z201100001020004). C.-F.Q. was supported by the National Science Fund for Distinguished Young Scholar (81925025), the Innovative Research Group (81621005) from the NSFC, and the CAMS Innovation Fund for Medical Sciences (2019-I2M-5-049).	Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; Deng W., 2020, SCIENCE; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Dinnon K. H., 2020, 081497 BIORXIV, DOI DOI 10.1101/2020.05.06.081497; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Li K, 2020, METHODS MOL BIOL, V2099, P161, DOI 10.1007/978-1-0716-0211-9_13; Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3; Petersen E., 2020, LANCET INFECT DIS; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Wang C., 2020, RES SQUARE, DOI 10.21203/rs.3.rs-19346/v1; Wang CF, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102833; Wang YJ, 2020, P NATL ACAD SCI USA, V117, P13967, DOI 10.1073/pnas.2008209117; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yi CY, 2020, CELL MOL IMMUNOL, V17, P621, DOI 10.1038/s41423-020-0458-z; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	33	401	417	7	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2020	369	6511					1603	+		10.1126/science.abc4730	http://dx.doi.org/10.1126/science.abc4730			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9TD	32732280	Green Published			2022-12-28	WOS:000574653300030
J	Henderson, MC				Henderson, Mark C.			Non Sei Solo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Henderson, Mark C.] UC Davis Med Ctr, Dept Internal Med, 4150 V St,Ste 3100, Sacramento, CA 95817 USA	University of California System; University of California Davis	Henderson, MC (corresponding author), UC Davis Med Ctr, Dept Internal Med, 4150 V St,Ste 3100, Sacramento, CA 95817 USA.	mchenderson@ucdavis.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					843	844		10.1001/jama.2020.14420	http://dx.doi.org/10.1001/jama.2020.14420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32761163				2022-12-28	WOS:000570094600012
J	Moudgil, A; Wilkinson, MN; Chen, XH; He, J; Cammack, AJ; Vasek, MJ; Lagunas, T; Qi, ZT; Lalli, MA; Guo, C; Morris, SA; Dougherty, JD; Mitra, RD				Moudgil, Arnav; Wilkinson, Michael N.; Chen, Xuhua; He, June; Cammack, Alexander J.; Vasek, Michael J.; Lagunas, Tomas; Qi, Zongtai; Lalli, Matthew A.; Guo, Chuner; Morris, Samantha A.; Dougherty, Joseph D.; Mitra, Robi D.			Self-Reporting Transposons Enable Simultaneous Readout of Gene Expression and Transcription Factor Binding in Single Cells	CELL			English	Article							PIGGYBAC TRANSPOSON; IN-VIVO; SLEEPING-BEAUTY; CALLING CARDS; SELECTIVE-INHIBITION; CHROMATIN STATES; DNA INTERACTIONS; SUPER-ENHANCERS; SITE SELECTION; RNA-SEQ	Cellular heterogeneity confounds in situ assays of transcription factor (TF) binding. Single-cell RNA sequencing (scRNA-seq) deconvolves cell types from gene expression, but no technology links cell identity to TF binding sites (TFBS) in those cell types. We present self-reporting transposons (SRTs) and use them in single-cell calling cards (scCC), a novel assay for simultaneously measuring gene expression and mapping TFBS in single cells. The genomic locations of SRTs are recovered from mRNA, and SRTs deposited by exogenous, TF-transposase fusions can be used to map TFBS. We then present scCC, which map SRTs from scRNA-seq libraries, simultaneously identifying cell types and TFBS in those same cells. We benchmark multiple TFs with this technique. Next, we use scCC to discover BRD4-mediated cell-state transitions in K562 cells. Finally, we map BRD4 binding sites in the mouse cortex at single-cell resolution, establishing a new method for studying TF biology in situ.	[Moudgil, Arnav; Wilkinson, Michael N.; Chen, Xuhua; He, June; Vasek, Michael J.; Lagunas, Tomas; Qi, Zongtai; Lalli, Matthew A.; Guo, Chuner; Morris, Samantha A.; Dougherty, Joseph D.; Mitra, Robi D.] Washington Univ, Dept Genet, Sch Med St Louis, St Louis, MO 63110 USA; [Moudgil, Arnav; Wilkinson, Michael N.; Chen, Xuhua; He, June; Qi, Zongtai; Mitra, Robi D.] Washington Univ, Edison Family Ctr Genome Sci & Syst Biol, Sch Med St Louis, St Louis, MO 63110 USA; [Moudgil, Arnav; Guo, Chuner] Washington Univ, Med Scientist Training Program, Sch Med St Louis, St Louis, MO 63110 USA; [Cammack, Alexander J.] Washington Univ, Dept Neurol, Sch Med St Louis, St Louis, MO 63110 USA; [Vasek, Michael J.; Lagunas, Tomas; Dougherty, Joseph D.] Washington Univ, Dept Psychiat, Sch Med St Louis, St Louis, MO 63110 USA; [Guo, Chuner; Morris, Samantha A.] Washington Univ, Dept Dev Biol, Sch Med St Louis, St Louis, MO 63110 USA; [Morris, Samantha A.] Washington Univ, Ctr Regenerat Med, Sch Med St Louis, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Mitra, RD (corresponding author), Washington Univ, Dept Genet, Sch Med St Louis, St Louis, MO 63110 USA.; Mitra, RD (corresponding author), Washington Univ, Edison Family Ctr Genome Sci & Syst Biol, Sch Med St Louis, St Louis, MO 63110 USA.	rmitra@wustl.edu		Moudgil, Arnav/0000-0002-0544-3463; Guo, Chuner/0000-0003-4202-9285; Lalli, Matthew/0000-0003-0419-1206; Qi, Zongtai/0000-0002-0762-4209; Wilkinson, Michael/0000-0003-3004-6811	NCI Cancer Center Support Grant [P30 CA91842]; ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 TR000448]; NIH Roadmap for Medical Research; Hope Center Viral Vectors Core; P30 Neuroscience Blueprint Interdisciplinary Center Core award [P30 NS057105]; NIH [R21 HG009750, R01 GM126112, U01 MH109133, RF1 MH117070, T32 GM007200, T32 HG000045, F30 HG009986, T32 GM008151, F32 NS105363, T32 HL125241, T32 GM007067]; Children's Discovery Institute [MC-II-2016-533]; Allen Distinguished Investigator Award (through the Paul G. Allen Frontiers Group); Vallee Scholar Award; Sloan Research Fellowship	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Center Viral Vectors Core; P30 Neuroscience Blueprint Interdisciplinary Center Core award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; Allen Distinguished Investigator Award (through the Paul G. Allen Frontiers Group); Vallee Scholar Award; Sloan Research Fellowship(Alfred P. Sloan Foundation)	We thank Jessica Hoisington-Lopez and MariaLynn Crosby from the DNA Sequencing Innovation Lab at The Edison Family Center for Genome Sciences and Systems Biology for their sequencing expertise. Additional sequencing was performed by the Genome Technology Access Center (GTAC) in the Department of Genetics at Washington University School of Medicine. Flow cytometry was conducted and analyzed at Siteman Flow Cytometry Core at the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO. Both GTAC and the Flow Cytometry Core are supported by NCI Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center. GTAC is further supported by ICTS/CTSA Grant UL1 TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This work was supported by the Hope Center Viral Vectors Core and a P30 Neuroscience Blueprint Interdisciplinary Center Core award to Washington University (P30 NS057105). This work was also supported by NIH grants R21 HG009750 (R.D.M. and S.A.M.), R01 GM126112 (S.A.M.), U01 MH109133 (J.D.D. and R.D.M.), and RF1 MH117070 (J.D.D. and R.D.M.) and a grant from the Children's Discovery Institute (#MC-II-2016-533, R.D.M.). S.A.M. was supported by an Allen Distinguished Investigator Award (through the Paul G. Allen Frontiers Group), a Vallee Scholar Award, and a Sloan Research Fellowship. A.M. was supported by NIH grants T32 GM007200, T32 HG000045, and F30 HG009986, A.J.C by NIH T32 GM008151; M.J.V. by NIH F32 NS105363; M.A.L. by NIH T32 HL125241; and T.L. by NIH T32 GM007067. We thank Donald Conrad and Ben Humphreys for their advice and constructive feedback during this project, and Shirley McKinney for laboratory support. Last, we thank the three anonymous reviewers for their feedback and suggestions. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NIH.	Ai SS, 2019, NAT CELL BIOL, V21, P1164, DOI 10.1038/s41556-019-0383-5; Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728; [Anonymous], [No title captured], DOI DOI 10.1007/s00367-011-0258-7; Avey D, 2018, CELL REP, V24, P3619, DOI 10.1016/j.celrep.2018.08.080; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Cammack AJ, 2020, P NATL ACAD SCI USA, V117, P10003, DOI 10.1073/pnas.1918241117; Campagne A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08255-x; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Cao JY, 2018, SCIENCE, V361, P1380, DOI 10.1126/science.aau0730; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Carter B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11559-1; Castillo-Hair SM, 2016, ACS SYNTH BIOL, V5, P774, DOI 10.1021/acssynbio.5b00284; Chen W, 2017, GENOM PROTEOM BIOINF, V15, P287, DOI 10.1016/j.gpb.2017.06.001; Chiu AC, 2018, MOL CELL, V69, P648, DOI 10.1016/j.molcel.2018.01.006; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Clark SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03149-4; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129; Di Micco R, 2014, CELL REP, V9, P234, DOI 10.1016/j.celrep.2014.08.055; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Folkerts H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1648-4; Fournier M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34962; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia-Carpizo V, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0197-x; Gasperini M, 2019, CELL, V176, P377, DOI 10.1016/j.cell.2018.11.029; Gogol-Doring A, 2016, MOL THER, V24, P592, DOI 10.1038/mt.2016.11; Gonen N, 2018, SCIENCE, V360, P1469, DOI 10.1126/science.aas9408; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Grosselin K, 2019, NAT GENET, V51, P1060, DOI 10.1038/s41588-019-0424-9; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gurdon JB, 2016, CURR TOP DEV BIOL, V116, P445, DOI 10.1016/bs.ctdb.2015.10.005; Hafler BP, 2012, P NATL ACAD SCI USA, V109, P7882, DOI 10.1073/pnas.1203138109; Hainer SJ, 2019, CELL, V177, P1319, DOI 10.1016/j.cell.2019.03.014; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Harada A, 2019, NAT CELL BIOL, V21, P287, DOI 10.1038/s41556-018-0248-3; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hwang B, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0071-8; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kalhor R, 2018, SCIENCE, V361, P893, DOI 10.1126/science.aat9804; Karaiskos N, 2017, SCIENCE, V358, P194, DOI 10.1126/science.aan3235; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Kfoury N., 2017, BIORXIV, DOI [10.1101/199059, DOI 10.1101/199059]; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kvon EZ, 2016, CELL, V167, P633, DOI 10.1016/j.cell.2016.09.028; Lalli Matthew A, 2020, Genome Res, V30, P1317, DOI 10.1101/gr.262295.120; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Litzenburger UM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1133-7; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martins AL, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1053; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Najafova Z, 2017, NUCLEIC ACIDS RES, V45, P127, DOI 10.1093/nar/gkw826; Oliphant T.E., 2015, GUIDE NUMPY, Vsecond; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Ponnaluri VKC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1247-6; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Price-Whelan AM, 2018, ASTRON J, V156, DOI 10.3847/1538-3881/aabc4f; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Qi ZT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1290; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raff T, 1997, BIOTECHNIQUES, V23, P456, DOI 10.2144/97233st02; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Robitaille TP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322068; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Rooijers K, 2019, NAT BIOTECHNOL, V37, P766, DOI 10.1038/s41587-019-0150-y; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Rouillard A.D., 2016, DATABASE-OXFORD, V2016; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Scargle JD, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/167; Scheiber IF, 2013, NEUROCHEM INT, V62, P556, DOI 10.1016/j.neuint.2012.08.017; Schuster DJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00042; Sdelci S, 2019, NAT GENET, V51, P990, DOI 10.1038/s41588-019-0413-z; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shema E, 2019, NAT GENET, V51, P19, DOI 10.1038/s41588-018-0290-x; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Stroud H, 2017, CELL, V171, P1151, DOI 10.1016/j.cell.2017.09.047; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Svensson V, 2018, NAT PROTOC, V13, P599, DOI 10.1038/nprot.2017.149; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang HY, 2007, GENOME RES, V17, P1202, DOI 10.1101/gr.6510207; Wang HY, 2012, GENETICS, V190, P941, DOI 10.1534/genetics.111.137315; Wang HY, 2011, GENOME RES, V21, P748, DOI 10.1101/gr.114850.110; Wang QH, 2019, MOL CELL, V76, P206, DOI 10.1016/j.molcel.2019.07.015; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Yen M, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0424-0; Yoshida J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43613; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng DH, 2016, RNA, V22, P1631, DOI 10.1261/rna.057075.116; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhu XQ, 2012, DEVELOPMENT, V139, P2299, DOI 10.1242/dev.078873; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	158	22	23	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					992	+		10.1016/j.cell.2020.06.037	http://dx.doi.org/10.1016/j.cell.2020.06.037			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32710817	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000561488500018
J	Abbott, A				Abbott, Alison			WHAT ANIMALS REALLY THINK	NATURE			English	News Item						Neuroscience	DYNAMICS; STATES	Neuroscientists are scrutinizing huge piles of data to learn how brains create emotions and other internal states such as aggression and desire.										Allen WE, 2019, SCIENCE, V364, P253, DOI 10.1126/science.aav3932; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Calhoun AJ, 2019, NAT NEUROSCI, V22, P2040, DOI 10.1038/s41593-019-0533-x; Cermak N, 2020, ELIFE, V9, DOI 10.7554/eLife.57093; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Grundemann J, 2019, SCIENCE, V364, P254, DOI 10.1126/science.aav8736; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Jung Y, 2020, NEURON, V105, P322, DOI 10.1016/j.neuron.2019.10.028; Marques JC, 2020, NATURE, V577, P239, DOI 10.1038/s41586-019-1858-z; Musall S, 2019, NAT NEUROSCI, V22, P1677, DOI 10.1038/s41593-019-0502-4; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893	11	4	4	5	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					182	185		10.1038/d41586-020-02337-x	http://dx.doi.org/10.1038/d41586-020-02337-x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ0LC	32782378				2022-12-28	WOS:000558814100010
J	McWilliams, SF; Broere, DLJ; Halliday, CJV; Bhutto, SM; Mercado, BQ; Holland, PL				McWilliams, Sean F.; Broere, Daniel L. J.; Halliday, Connor J. V.; Bhutto, Samuel M.; Mercado, Brandon Q.; Holland, Patrick L.			Coupling dinitrogen and hydrocarbons through aryl migration	NATURE			English	Article							C BOND FORMATION; CATALYTIC SILYLATION; IRON; CONVERSION; N-2; ACTIVATION; REDUCTION; CHEMISTRY; CLEAVAGE; COMPLEX	The activation of abundant molecules such as hydrocarbons and atmospheric nitrogen (N-2) remains a challenge because these molecules are often inert. The formation of carbon-nitrogen bonds from N(2)typically has required reactive organic precursors that are incompatible with the reducing conditions that promote N(2)reactivity(1), which has prevented catalysis. Here we report a diketiminate-supported iron system that sequentially activates benzene and N(2)to form aniline derivatives. The key to this coupling reaction is the partial silylation of a reduced iron-dinitrogen complex, followed by migration of a benzene-derived aryl group to the nitrogen. Further reduction releases N-2-derived aniline, and the resulting iron species can re-enter the cyclic pathway. Specifically, we show that an easily prepared diketiminate iron bromide complex(2)mediates the one-pot conversion of several petroleum-derived arenes into the corresponding silylated aniline derivatives, by using a mixture of sodium powder, crown ether, trimethylsilyl bromide and N(2)as the nitrogen source. Numerous compounds along the cyclic pathway are isolated and crystallographically characterized, and their reactivity supports a mechanism for sequential hydrocarbon activation and N(2)functionalization. This strategy couples nitrogen atoms from N(2)with abundant hydrocarbons, and maps a route towards future catalytic systems. An iron complex sequentially activates N(2)and C-H bonds in benzene to form aniline, with coupling achieved through partial silylation of a reduced iron-nitrogen complex and phenyl migration.	[McWilliams, Sean F.; Broere, Daniel L. J.; Bhutto, Samuel M.; Mercado, Brandon Q.; Holland, Patrick L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Broere, Daniel L. J.; Halliday, Connor J. V.] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland; [Broere, Daniel L. J.] Univ Utrecht, Debye Inst Nanomat Sci, Utrecht, Netherlands	Yale University; University of Edinburgh; Utrecht University	Holland, PL (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	patrick.holland@yale.edu		Broere, Daniel L. J./0000-0002-6641-4092; Mercado, Brandon/0000-0002-1940-3497; Bhutto, Samuel/0000-0002-6464-3385	NIGMS NIH HHS [F31 GM116463, R01 GM065313] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andino JG, 2013, ANGEW CHEM INT EDIT, V52, P4726, DOI 10.1002/anie.201209168; Bernskoetter WH, 2006, J AM CHEM SOC, V128, P10696, DOI 10.1021/ja064163k; Betley TA, 2003, J AM CHEM SOC, V125, P10782, DOI 10.1021/ja036687f; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Chalkley MJ, 2017, ACS CENTRAL SCI, V3, P217, DOI 10.1021/acscentsci.7b00014; Chen JG, 2018, SCIENCE, V360, DOI 10.1126/science.aar6611; Curley JJ, 2011, DALTON T, V40, P2429, DOI 10.1039/c0dt01326a; Davies HML, 2011, CHEM SOC REV, V40, P1855, DOI 10.1039/c1cs90010b; Deegan MM, 2018, CHEM SCI, V9, P6264, DOI 10.1039/c8sc02380h; Ferreira RB, 2018, ACS CATAL, V8, P7208, DOI 10.1021/acscatal.8b02021; Figueroa JS, 2006, J AM CHEM SOC, V128, P940, DOI 10.1021/ja056408j; Gomez-Gallego M, 2011, CHEM REV, V111, P4857, DOI 10.1021/cr100436k; Hickey AK, 2017, CHEM COMMUN, V53, P1245, DOI 10.1039/c6cc09244f; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Holland PL, 2008, ACCOUNTS CHEM RES, V41, P905, DOI 10.1021/ar700267b; Jacobs BP, 2017, J AM CHEM SOC, V139, P12145, DOI 10.1021/jacs.7b06960; Kakiuchi F, 2003, ADV SYNTH CATAL, V345, P1077, DOI 10.1002/adsc.200303094; Kalman SE, 2013, ORGANOMETALLICS, V32, P1797, DOI 10.1021/om301219t; Keane AJ, 2015, ANGEW CHEM INT EDIT, V54, P10220, DOI 10.1002/anie.201502293; Kim S, 2020, CHEM REV, V120, P5637, DOI 10.1021/acs.chemrev.9b00705; Klopsch I, 2016, ANGEW CHEM INT EDIT, V55, P4786, DOI 10.1002/anie.201600790; Knobloch DJ, 2010, NAT CHEM, V2, P30, DOI [10.1038/nchem.477, 10.1038/NCHEM.477]; Lee Y, 2010, NAT CHEM, V2, P558, DOI [10.1038/NCHEM.660, 10.1038/nchem.660]; Liao Q, 2016, ANGEW CHEM INT EDIT, V55, P11212, DOI 10.1002/anie.201604812; Liao Q, 2015, ACS CATAL, V5, P6902, DOI 10.1021/acscatal.5b01626; MacKay BA, 2004, CHEM REV, V104, P385, DOI 10.1021/cr020610c; MacLeod KC, 2016, J AM CHEM SOC, V138, P11185, DOI 10.1021/jacs.6b04984; McWilliams SF, 2018, J AM CHEM SOC, V140, P8586, DOI 10.1021/jacs.8b04828; Morello L, 2004, J AM CHEM SOC, V126, P9480, DOI 10.1021/ja049490b; Moret ME, 2011, J AM CHEM SOC, V133, P18118, DOI 10.1021/ja208675p; Mori M, 2004, J ORGANOMET CHEM, V689, P4210, DOI 10.1016/j.jorganchem.2004.05.053; Nishibayashi Y, 2018, DALTON T, V47, P11290, DOI 10.1039/c8dt02572j; Nishibayashi Y, 2015, INORG CHEM, V54, P9234, DOI 10.1021/acs.inorgchem.5b00881; Piascik AD, 2018, J AM CHEM SOC, V140, P10691, DOI 10.1021/jacs.8b06999; Prokopchuk DE, 2017, J AM CHEM SOC, V139, P9291, DOI 10.1021/jacs.7b04552; Schlogl R., 2008, HDB HETEROGENEOUS CA, V5, P2501; Schrock RR, 2005, ACCOUNTS CHEM RES, V38, P955, DOI 10.1021/ar0501121; Sellmann D., 1978, ANGEW CHEM, V90, P295; Sellmann D., 1977, ANGEW CHEM, V89, P918; Siedschlag RB, 2015, J AM CHEM SOC, V137, P4638, DOI 10.1021/jacs.5b01445; Smith JM, 2006, J AM CHEM SOC, V128, P756, DOI 10.1021/ja052707x; Suzuki T, 2018, ACS CATAL, V8, P3011, DOI 10.1021/acscatal.7b04351; Tanabe Y, 2019, COORDIN CHEM REV, V389, P73, DOI 10.1016/j.ccr.2019.03.004; Tanaka H, 2011, J AM CHEM SOC, V133, P3498, DOI 10.1021/ja109181n; Yu Y, 2007, ORGANOMETALLICS, V26, P3217, DOI 10.1021/om7003805; Yuki M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2264	47	38	39	3	86	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					221	+		10.1038/s41586-020-2565-5	http://dx.doi.org/10.1038/s41586-020-2565-5			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788733	Green Submitted, Green Accepted			2022-12-28	WOS:000559831500013
J	Vitek, L; Tiribelli, C				Vitek, Libor; Tiribelli, Claudio			Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Hans Fischer, who won the Nobel Prize in Chemistry in 1930 and whose work led to the synthesis of bilirubin, would be astounded by the properties of bilirubin that have since emerged and are evident in preclinical studies of inflammatory bowel disease and pancreatitis.	[Vitek, Libor] Charles Univ Prague, Fac Gen Hosp, Prague, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Tiribelli, Claudio] Fdn Italiana Fegato, Trieste, Italy	Charles University Prague; General University Hospital Prague; Charles University Prague	Vitek, L (corresponding author), Charles Univ Prague, Fac Gen Hosp, Prague, Czech Republic.; Vitek, L (corresponding author), Charles Univ Prague, Fac Med 1, Prague, Czech Republic.		Vitek, Libor/A-2645-2008; Tiribelli, Claudio/A-4716-2014	Vitek, Libor/0000-0002-5318-0151; Tiribelli, Claudio/0000-0001-6596-7595				Jangi S, 2013, INT J BIOCHEM CELL B, V45, P2843, DOI 10.1016/j.biocel.2013.09.014; Lee Y, 2020, NAT MATER, V19, P118, DOI 10.1038/s41563-019-0462-9; Longhi MS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92791; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Vitek L, 2020, MED RES REV, V40, P1335, DOI 10.1002/med.21660; Vitek L, 2019, CLIN PHARMACOL THER, V106, P568, DOI 10.1002/cpt.1341; Yao Q, 2020, J CONTROL RELEASE, V322, P312, DOI 10.1016/j.jconrel.2020.03.034; 2013, SURG OBES RELAT DIS, V9, pE1003	8	16	16	6	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					684	686		10.1056/NEJMcibr2013250	http://dx.doi.org/10.1056/NEJMcibr2013250			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32786195				2022-12-28	WOS:000562771200018
J	Greenhalgh, T; Knight, M; A'Court, C; Buxton, M; Husain, L				Greenhalgh, Trisha; Knight, Matthew; A'Court, Christine; Buxton, Maria; Husain, Laiba			Management of post-acute covid-19 in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; REHABILITATION; INTERVENTIONS		[Greenhalgh, Trisha; A'Court, Christine; Husain, Laiba] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Knight, Matthew] West Hertfordshire Hosp NHS Trust, Watford, England; [Buxton, Maria] Cent London Community Healthcare, West Hertfordshire Resp Serv, London, England	University of Oxford	Greenhalgh, T (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	trish.greenhalgh@phc.ox.ac.uk	Greenhalgh, Trisha/B-1825-2015; , Matthew/AAZ-4939-2020; , Matthew/AAO-9856-2020	Greenhalgh, Trisha/0000-0003-2369-8088; , Matthew/0000-0001-5390-8723; Knight, Matthew/0000-0003-1761-0115	ESRC [ES/V010069/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Andrenelli E, 2020, EUR J PHYS REHAB MED, V56, P508, DOI [10.23736/S1973-9087.20.06435-7, 10.23736/S1973-9087.20.06378-9]; Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006; Assaf G., 2020, PATIENT LED RES; Balbi B, 2020, REPORT ADHOC INT TAS; Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596; British Thoracic Society, 2020, BTS GUID VEN THROMB; British Thoracic Society, 2020, BRIT THOR SOC GUID R; Callard F., 2020, SOMATOSPHERE; Carfi A, 2020, JAMA-J AM MED ASSOC; Charon Rita, 2008, NARRATIVE MED HONORI; Cilloniz Catia, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020035; ClinicalTrials.gov, 2020, LONG TERM IMP INF NO; Colafrancesco S, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102573; Collins JA, 2015, BREATHE, V11, P195, DOI 10.1183/20734735.001415; Connolly B, 2016, THORAX, V71, P881, DOI 10.1136/thoraxjnl-2015-208273; COVID Symptom Study, 2020, LONG DOES COVID 19 L; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16; Dasgupta A, 2020, J PAK MED ASSOC, V70, pS131, DOI 10.5455/JPMA.32; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Elliott N, 2020, BRIT J SPORT MED, V54, P1174, DOI 10.1136/bjsports-2020-102637; Finch D., 2020, ARE CHANGES EMPLOYME; Forte G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114151; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Garner P., 2020, BMJ OPINION; Geddes L, 2020, NEW SCI, V27; Gemelli Against COVID-19 Post-Acute Care Study Group, 2020, AGING CLIN EXP RES; George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V323, P2007, DOI 10.1001/jama.2020.4686; Greenhalgh T., 2020, WHAT IS EFFICACY SAF; Hoffman GJ, 2020, J AGING SOC POLICY, V32, P450, DOI 10.1080/08959420.2020.1771239; Homerton University Hospital, 2020, POSTCOVID 19 PATIENT; Hosseiny M, 2020, AM J ROENTGENOL, V214, P1078, DOI 10.2214/AJR.20.22969; Hui DSC, 2009, HONG KONG MED J, V15, P21; Hull JH, 2020, LANCET RESP MED, V8, P666, DOI 10.1016/S2213-2600(20)30246-0; ISRCTN Registry, 2020, ISRCTN10980107; Jiang HJ, 2020, ASIAN PAC J TROP MED, V13, P252, DOI 10.4103/1995-7645.281614; Kemp HI, 2020, BRIT J ANAESTH, V125, P436, DOI 10.1016/j.bja.2020.05.021; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Klok FA, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00189-2020; Knight M, 2020, HLTH SERVICE J; Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479; Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384; Larun L, 2017, COCHRANE DB SYST REV, V4; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37; Mukaino M, 2020, AM J PHYS MED REHAB, V99, P478, DOI 10.1097/PHM.0000000000001441; National Institute for Health and Care Excellence, 2020, MYALG ENC ENC CHRON; National Institute for Health and Care Excellence, 2018, CHRONIC HEART FAILUR; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS DIAGN; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; NHS England, 2020, YOUR COVID REC; NHS England, 2021, PULS OX DET EARL DET; NHS England, 2020, AFT CAR NEEDS INP RE; NHS England and NHS Improvement, 2020, REM MON COVID 19 DIA; NHS England and NHS Improvement, 2020, PULS OX DET EARL DET; O'Driscoll BR, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2016-209729; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Pan-American Health Organisation World Health Organisation, 2020, REH CONS COVID 19 OU; Pelliccia A, 2019, EUR HEART J, V40, P19, DOI 10.1093/eurheartj/ehy730; Public Health England, 2020, DISP RISK OUTC COVID; Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rose Nikolas, 2020, Wellcome Open Res, V5, P166, DOI 10.12688/wellcomeopenres.16123.1; Royal College of Occupational Therapists, 2020, CONS YOUR EN PRACT A; Sheehy Lisa Mary, 2020, JMIR Public Health Surveill, V6, pe19462, DOI 10.2196/19462; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Tarassenko L, 2020, SHOULD SMARTPHONE AP; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; The European Society for Cardiology, 2020, ESC GUID DIAGN MAN C; Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP; Varatharaj Aravinthan, 2020, Lancet Psychiatry, V7, P875, DOI 10.1016/S2215-0366(20)30287-X; Walton K., 2020, BRIT SOC REHABILITAT; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; Watt G., 2020, 36 U GLASG; World Health Organization, 2020, MENTAL HLTH PSYCHOSO; Wu F., 2020, NEUTRALIZING ANTIBOD, DOI [10.1101/2020.03.30.20047365, DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Yancy CW, 2020, JAMA CARDIOL, V5, P1216, DOI 10.1001/jamacardio.2020.3575; Zhang T, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P496, DOI 10.3760/cma.j.cn112147-20200311-00312; Zhao HM, 2020, CHINESE MED J-PEKING, V133, P1595, DOI 10.1097/CM9.0000000000000848	82	601	620	7	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3026	10.1136/bmj.m3026	http://dx.doi.org/10.1136/bmj.m3026			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784198	Bronze			2022-12-28	WOS:000560307500007
J	Vinter, N; Huang, QX; Fenger-Gron, M; Frost, L; Benjamin, EJ; Trinquart, L				Vinter, Nicklas; Huang, Qiuxi; Fenger-Gron, Morten; Frost, Lars; Benjamin, Emelia J.; Trinquart, Ludovic			Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICARE BENEFICIARIES; ORAL ANTICOAGULANTS; NATIONAL TRENDS; GLOBAL BURDEN; RISK-FACTORS; PREVALENCE; HOSPITALIZATION; EPIDEMIOLOGY; METAANALYSIS; PROJECTIONS	OBJECTIVE To assess temporal trends in the association between newly diagnosed atrial fibrillation and death. DESIGN Community based cohort study. SETTING Framingham Heart Study cohort, in 1972-85, 1986-2000, and 2001-15 (periods 1-3, respectively), in Framingham, MA, USA. PARTICIPANTS Participants with no atrial fibrillation, aged 45-95 in each time period, and identified with newly diagnosed atrial fibrillation (or atrial flutter) during each time period. MAIN OUTCOME MEASURES The main outcome was all cause mortality. Hazard ratios for the association between time varying atrial fibrillation and all cause mortality were calculated with adjustment for time varying confounding factors. The difference in restricted mean survival times, adjusted for confounders, between participants with atrial fibrillation and matched referents at 10 years after a diagnosis of atrial fibrillation was estimated. Meta-regression was used to test for linear trends in hazard ratios and restricted mean survival times over the different time periods. RESULTS 5671 participants were selected in time period 1, 6177 in period 2, and 6174 in period 3. Adjusted hazard ratios for all cause mortality between participants with and without atrial fibrillation were 1.9 (95% confidence interval 1.7 to 2.2) in time period 1, 1.4 (1.3 to 1.6) in period 2, and 1.7 (1.5 to 2.0) in period 3 (P-trend=0.70). Ten years after diagnosis of atrial fibrillation, the adjusted difference in restricted mean survival times between participants with atrial fibrillation and matched referents decreased by 31%, from -2.9 years (95% confidence interval -3.2 to -2.5) in period 1, to -2.1 years (-2.4 to -1.8) in period 2, to -2.0 years (-2.3 to -1.7) in period 3 (P-trend=0.03). CONCLUSIONS No evidence of a temporal trend in hazard ratios for the association between atrial fibrillation and all cause mortality was found. The mean number of life years lost to atrial fibrillation at 10 years had improved significantly, but a two year gap compared with individuals without atrial fibrillation still remained.	[Vinter, Nicklas; Frost, Lars] Silkeborg Reg Hosp, Diagnost Ctr, Univ Res Clin Innovat Patient Pathways, Silkeborg, Denmark; [Vinter, Nicklas; Frost, Lars] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Vinter, Nicklas] Aalborg Univ, Danish Ctr Clin Hlth Serv Res, Dept Clin Med, Aalborg, Denmark; [Huang, Qiuxi; Trinquart, Ludovic] Boston Univ, Dept Biostat, Sch Publ Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA; [Fenger-Gron, Morten] Res Unit Gen Practice, Aarhus, Denmark; [Benjamin, Emelia J.] Boston Univ, Dept Med, Sch Med, Boston, MA 02215 USA; [Benjamin, Emelia J.] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02215 USA; [Benjamin, Emelia J.; Trinquart, Ludovic] NHLBI, Framingham, MA 01702 USA; [Benjamin, Emelia J.; Trinquart, Ludovic] Boston Univ, Framingham Heart Study, Framingham, MA 01702 USA	Aarhus University; Silkeborg Central Hospital; Aarhus University; Aalborg University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study	Trinquart, L (corresponding author), Boston Univ, Dept Biostat, Sch Publ Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA.; Trinquart, L (corresponding author), NHLBI, Framingham, MA 01702 USA.; Trinquart, L (corresponding author), Boston Univ, Framingham Heart Study, Framingham, MA 01702 USA.	ludovic@bu.edu	Trinquart, Ludovic/H-4961-2019; Benjamin, Emelia/E-7103-2011; Frost, Lars/V-3982-2017	Trinquart, Ludovic/0000-0002-3028-4900; Benjamin, Emelia/0000-0003-4076-2336; Frost, Lars/0000-0001-9215-9796; Huang, Qiuxi/0000-0001-6113-8247; Vinter, Nicklas/0000-0003-0558-8483	National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [HHSN268201500001I]; Boston University School of Medicine; American Heart Association [18SFRN34110082, 18SFRN34150007, 1RC1HL101056]; NIH/NHLBI [R01 HL128914, R01 HL092577, R01 HL126136];  [75N92019D00031]	National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University School of Medicine; American Heart Association(American Heart Association); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); 	This work was supported by the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI), Framingham Heart Study (NHLBI/NIH contract No HHSN268201500001I), and the Boston University School of Medicine. This work was also supported by the American Heart Association (18SFRN34110082, 18SFRN34150007, and 1RC1HL101056) and the NIH/NHLBI (R01 HL128914, R01 HL092577, and R01 HL126136). The Framingham Heart Study is supported by 75N92019D00031. The funding sources had no role in the design, analysis, and reporting of the study.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Chamberlain AM, 2017, AM HEART J, V185, P74, DOI 10.1016/j.ahj.2016.11.008; Chang SH, 2017, JAMA CARDIOL, V2, P863, DOI 10.1001/jamacardio.2017.1855; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Conner SC, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013011; Conner SC, 2019, STAT MED, V38, P3832, DOI 10.1002/sim.8206; Emdin CA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h7013; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Freeman JV, 2017, CIRCULATION, V135, P1227, DOI 10.1161/CIRCULATIONAHA.116.022388; Frost L, 2005, INT J CARDIOL, V103, P78, DOI 10.1016/j.ijcard.2004.08.024; Gadsboll K, 2017, EUR HEART J, V38, P899, DOI 10.1093/eurheartj/ehw658; Greenland S., 2008, MODERN EPIDEMIOLOGY; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Katz DF, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003476; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Lane DA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005155; Lubitz SA, 2015, CIRCULATION, V131, P1648, DOI 10.1161/CIRCULATIONAHA.114.014058; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Magnussen C, 2017, CIRCULATION, V136, P1588, DOI [10.1161/CIRCULATIONAHA.117.028981, 10.1161/circulationaha.117.028981]; Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587; Martinez C, 2015, HEART, V101, P1748, DOI 10.1136/heartjnl-2015-307808; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nevalainen J, 2009, STAT MED, V28, P3657, DOI 10.1002/sim.3731; Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Poole C, 2017, EPIDEMIOLOGY, V28, P6, DOI 10.1097/EDE.0000000000000577; Poole C, 2010, EPIDEMIOLOGY, V21, P3, DOI 10.1097/EDE.0b013e3181c30eba; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rowan SB, 2007, J AM COLL CARDIOL, V49, P1561, DOI 10.1016/j.jacc.2006.11.045; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schmidt M, 2016, INT J CARDIOL, V225, P30, DOI 10.1016/j.ijcard.2016.09.071; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Spiegelman D, 2017, AM J PUBLIC HEALTH, V107, P1087, DOI 10.2105/AJPH.2017.303810; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Staerk L, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.119.005918; Staerk L, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1453; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174; 2001, CIRCULATION, V104, P2118	45	19	19	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m2724	10.1136/bmj.m2724	http://dx.doi.org/10.1136/bmj.m2724			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784208	Green Published, hybrid			2022-12-28	WOS:000560307500003
J	Notaguchi, M; Kurotani, K; Sato, Y; Tabata, R; Kawakatsu, Y; Okayasu, K; Sawai, Y; Okada, R; Asahina, M; Ichihashi, Y; Shirasu, K; Suzuki, T; Niwa, M; Higashiyama, T				Notaguchi, Michitaka; Kurotani, Ken-ichi; Sato, Yoshikatsu; Tabata, Ryo; Kawakatsu, Yaichi; Okayasu, Koji; Sawai, Yu; Okada, Ryo; Asahina, Masashi; Ichihashi, Yasunori; Shirasu, Ken; Suzuki, Takamasa; Niwa, Masaki; Higashiyama, Tetsuya			Cell-cell adhesion in plant grafting is facilitated by beta-1,4-glucanases	SCIENCE			English	Article							HORMONAL RESPONSES; MESSENGER-RNA; GENES; TRANSFORMATION; CONSTRUCTION; REVEALS	Plant grafting is conducted for fruit and vegetable propagation, whereby a piece of living tissue is attached to another through cell-cell adhesion. However, graft compatibility limits combinations to closely related species, and the mechanism is poorly understood. We found that Nicotiana is capable of graft adhesion with a diverse range of angiosperms. Comparative transcriptomic analyses on graft combinations indicated that a subclade of beta-1,4-glucanases secreted into the extracellular region facilitates cell wall reconstruction near the graft interface. Grafting was promoted by overexpression of the beta-1,4-glucanase. Using Nicotiana stem as an interscion, we produced tomato fruits on rootstocks from other plant families. These findings demonstrate that the process of cell -cell adhesion is a potential target to enhance plant grafting techniques.	[Notaguchi, Michitaka; Kurotani, Ken-ichi] Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Notaguchi, Michitaka; Tabata, Ryo; Kawakatsu, Yaichi; Okayasu, Koji; Sawai, Yu; Okada, Ryo; Niwa, Masaki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Notaguchi, Michitaka; Sato, Yoshikatsu; Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Notaguchi, Michitaka; Sawai, Yu; Niwa, Masaki] Nagoya Univ, Incubat Facil, GRA&GREEN Inc, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Sato, Yoshikatsu; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Asahina, Masashi] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Ichihashi, Yasunori; Shirasu, Ken] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ichihashi, Yasunori] RIKEN BioResource Res Ctr, Tsukuba, Ibaraki 3050074, Japan; [Shirasu, Ken; Higashiyama, Tetsuya] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Suzuki, Takamasa] Chubu Univ, Coll Biosci & Biotechnol, Matsumoto Cho, Kasugai, Aichi 4878501, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Teikyo University; RIKEN; RIKEN; University of Tokyo; Chubu University	Notaguchi, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.; Notaguchi, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.; Notaguchi, M (corresponding author), Nagoya Univ, Inst Transformat Biomol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.; Notaguchi, M (corresponding author), Nagoya Univ, Incubat Facil, GRA&GREEN Inc, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	notaguchi.michitaka@b.mbox.nagoya-u.ac.jp	Notaguchi, Michitaka/GVS-9676-2022; Shirasu, Ken/A-4455-2010; Sato, Yoshikatsu/I-6129-2014; Tabata, Ryo/ABI-7295-2020; Asahina, Masashi/HHZ-0634-2022; Notaguchi, Michitaka/AAL-8676-2021; Shirasu, Ken/ABF-5306-2020	Shirasu, Ken/0000-0002-0349-3870; Asahina, Masashi/0000-0002-1828-0966; Shirasu, Ken/0000-0002-0349-3870; Notaguchi, Michitaka/0000-0003-0831-2108; Kawakatsu, Yaichi/0000-0001-8470-706X; Sato, Yoshikatsu/0000-0002-4967-2698	Japan Society for the Promotion of Science [18KT0040, 18H03950, 19H05361, JP16H06280, 19H05364, 15H05959, 17H06172]; Canon Foundation [R17-0070]; Project of the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology) [28001A, 28001AB]; Japan Science and Technology Agency [ERATO JPMJER1004, START15657559, PRESTO15665754]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canon Foundation(Canon Foundation); Project of the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Supported by grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (18KT0040, 18H03950, and 19H05361 to M.No.; JP16H06280 and 19H05364 to Y.Sat.; 15H05959 and 17H06172 to K.S.), the Canon Foundation (R17-0070), the Project of the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology 28001A and 28001AB) to M.No., and the Japan Science and Technology Agency (ERATO JPMJER1004 to T.H.; START15657559 and PRESTO15665754 to M.No.).	Andres P. K., 1993, Horticultural Reviews, V15, P183; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Gallois P, 1995, Methods Mol Biol, V49, P39; Gaut BS, 2019, ANNU REV GENET, V53, P195, DOI 10.1146/annurev-genet-112618-043545; Goldschmidt EE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00727; Hartmann H. T., 1975, PLANT PROPAGATION PR, P314; Ichihashi Y, 2018, METHODS MOL BIOL, V1830, P163, DOI 10.1007/978-1-4939-8657-6_11; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; KOLLMANN R, 1985, PROTOPLASMA, V124, P224, DOI 10.1007/BF01290774; Lee JungMyung, 2003, Horticultural Reviews, V28, P61, DOI 10.1002/9780470650851.ch2; Lewis DR, 2013, PLANT CELL, V25, P3329, DOI 10.1105/tpc.113.114868; Matsuoka K, 2018, PLANT MOL BIOL, V96, P531, DOI 10.1007/s11103-018-0702-4; Matsuoka K, 2016, PLANT CELL PHYSIOL, V57, P2620, DOI 10.1093/pcp/pcw177; Melnyk CW, 2018, P NATL ACAD SCI USA, V115, pE2447, DOI 10.1073/pnas.1718263115; Melnyk CW, 2017, REGENERATION, V4, P3, DOI 10.1002/reg2.71; MOORE R, 1981, AM J BOT, V68, P831, DOI 10.2307/2443189; Mudge K., 2009, Horticultural Reviews, V35, P437; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; NICKELL LG, 1948, SCIENCE, V108, P389, DOI 10.1126/science.108.2806.389; Notaguchi M, 2015, PLANT CELL PHYSIOL, V56, P311, DOI 10.1093/pcp/pcu210; Notaguchi M, 2009, J PLANT RES, V122, P201, DOI 10.1007/s10265-008-0209-1; Otagaki S, 2011, EPIGENETICS-US, V6, P681, DOI 10.4161/epi.6.6.16214; Ren Y, 2018, PLANT PHYSIOL BIOCH, V129, P368, DOI 10.1016/j.plaphy.2018.06.021; Roodt D, 2019, GENOME BIOL EVOL, V11, P1986, DOI 10.1093/gbe/evz115; SIMON S. V., 1930, JAHRB WISS BOT [LEIPZIG], V72, P160; Townsley BT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00366; Tsutsui H, 2020, PLANT J, V103, P918, DOI 10.1111/tpj.14768; Tsutsui H, 2017, PLANT CELL PHYSIOL, V58, P1291, DOI 10.1093/pcp/pcx098; Tsutsui H, 2017, PLANT CELL PHYSIOL, V58, P46, DOI 10.1093/pcp/pcw191; Urbanowicz BR, 2007, PLANT PHYSIOL, V144, P1693, DOI 10.1104/pp.107.102574; Wang J, 2017, NEW PHYTOL, V214, P56, DOI 10.1111/nph.14383; Xie LL, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1976-7	37	56	62	21	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					698	+		10.1126/science.abc3710	http://dx.doi.org/10.1126/science.abc3710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764072	Green Submitted			2022-12-28	WOS:000559184400047
J	Risa, GT; Hurtig, F; Bray, S; Hafner, AE; Harker-Kirschneck, L; Faull, P; Davis, C; Papatziamou, D; Mutavchiev, DR; Fan, C; Meneguello, L; Pulschen, AA; Dey, G; Culley, S; Kilkenny, M; Souza, DP; Pellegrini, L; de Bruin, RAM; Henriques, R; Snijders, AP; Saric, A; Lindas, AC; Robinson, NP; Baum, B				Risa, Gabriel Tarrason; Hurtig, Fredrik; Bray, Sian; Hafner, Anne E.; Harker-Kirschneck, Lena; Faull, Peter; Davis, Colin; Papatziamou, Dimitra; Mutavchiev, Delyan R.; Fan, Catherine; Meneguello, Leticia; Pulschen, Andre Arashiro; Dey, Gautam; Culley, Sian; Kilkenny, Mairi; Souza, Diorge P.; Pellegrini, Luca; de Bruin, Robertus A. M.; Henriques, Ricardo; Snijders, Ambrosius P.; Saric, Andela; Lindas, Ann-Christin; Robinson, Nicholas P.; Baum, Buzz			The proteasome controls ESCRT-III-mediated cell division in an archaeon	SCIENCE			English	Article							SULFOLOBUS; DNA; REPLICATION; ASSEMBLIES; ASSIGNMENT; BORTEZOMIB; INHIBITORS; INITIATION; PLATFORM; CYCLE	Sulfolobus acidocaldarius is the closest experimentally tractable archaeal relative of eukaryotes and, despite lacking obvious cyclin-dependent kinase and cyclin homologs, has an ordered eukaryote-like cell cycle with distinct phases of DNA replication and division. Here, in exploring the mechanism of cell division in S. acidocaldarius, we identify a role for the archaeal proteasome in regulating the transition from the end of one cell cycle to the beginning of the next. Further, we identify the archaeal ESCRT-III homolog, CdvB, as a key target of the proteasome and show that its degradation triggers division by allowing constriction of the CdvB1:CdvB2 ESCRT-III division ring. These findings offer a minimal mechanism for ESCRT-III-mediated membrane remodeling and point to a conserved role for the proteasome in eukaryotic and archaeal cell cycle control.	[Risa, Gabriel Tarrason; Hafner, Anne E.; Harker-Kirschneck, Lena; Mutavchiev, Delyan R.; Fan, Catherine; Meneguello, Leticia; Pulschen, Andre Arashiro; Dey, Gautam; Culley, Sian; Souza, Diorge P.; de Bruin, Robertus A. M.; Henriques, Ricardo; Saric, Andela; Baum, Buzz] Univ Coll London UCL, MRC Lab Mol Cell Biol, London, England; [Hurtig, Fredrik; Lindas, Ann-Christin] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Bray, Sian; Kilkenny, Mairi; Pellegrini, Luca] Univ Cambridge, Biochem Dept, Cambridge, England; [Hafner, Anne E.; Harker-Kirschneck, Lena; Saric, Andela; Baum, Buzz] UCL, Inst Phys Living Syst, London, England; [Hafner, Anne E.; Harker-Kirschneck, Lena; Saric, Andela] UCL, Dept Phys & Astron, London, England; [Faull, Peter; Davis, Colin; Snijders, Ambrosius P.] Francis Crick Inst, Prote Platform, London, England; [Papatziamou, Dimitra; Robinson, Nicholas P.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	MRC Laboratory Molecular Biology; University of London; University College London; Stockholm University; University of Cambridge; University of London; University College London; University of London; University College London; Francis Crick Institute; Lancaster University	Baum, B (corresponding author), Univ Coll London UCL, MRC Lab Mol Cell Biol, London, England.; Baum, B (corresponding author), UCL, Inst Phys Living Syst, London, England.; Robinson, NP (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	n.robinson2@lancaster.ac.uk; b.baum@ucl.ac.uk	Dey, Gautam/GON-6083-2022; Pellegrini, Luca/AAE-2312-2022; Dey, Gautam/AAQ-8917-2020; Saric, Andela/F-2013-2014; Henriques, Ricardo/T-4004-2018	Dey, Gautam/0000-0003-1416-6223; Pellegrini, Luca/0000-0002-9300-497X; Dey, Gautam/0000-0003-1416-6223; Bray, Sian/0000-0001-5411-8248; Saric, Andela/0000-0002-7854-2139; Hurtig, Fredrik/0000-0003-2461-0877; Henriques, Ricardo/0000-0002-2043-5234; Baum, Buzz/0000-0002-9201-6186; Harker-Kirschneck, Lena/0000-0001-6092-6591; Hafner, Anne Elisabeth/0000-0003-2495-7061; Meneguello, Leticia/0000-0002-8201-5841; Culley, Sian/0000-0003-2112-0143; Robinson, Nick/0000-0002-6094-1924; Snijders, Bram/0000-0002-5416-8592; Faull, Peter/0000-0001-8491-8086; Tarrason Risa, Gabriel/0000-0002-3846-3284; Souza, Diorge/0000-0003-1303-1765	MRC [1621658, MC_CF12266]; Vetenskapsradet [621-2013-4685]; HFSP [LT001027/2019]; Wellcome Trust; BBSRC [BB/K009001/1, RG53842]; Cancer Research UK [FC001999, C33246/A20147]; Francis Crick Institute; UK Medical Research Council [FC001999]; Biotechnology and Biological Sciences Research Council [BB/M009513/1]; European Research Council [802960]; Engineering and Physical Sciences Research Council [EP/R011818/1]; Division of Biomedical and Life Sciences (Lancaster University); Wellcome Trust [FC001999, 203276/Z/16/Z]; Isaac Newton Trust Research Grant (Trinity College); Isaac Newton Trust Research Grant (Department of Biochemistry, Cambridge); BBSRC [BB/P001440/1] Funding Source: UKRI; MRC [MR/K015826/1, MC_UP_1201/27] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Vetenskapsradet(Swedish Research Council); HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Francis Crick Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division of Biomedical and Life Sciences (Lancaster University); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust Research Grant (Trinity College); Isaac Newton Trust Research Grant (Department of Biochemistry, Cambridge); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Baum, Henriques, and de Bruin labs received support from the MRC (MC_CF12266). G.T.R. was supported by MRC (1621658). F.H. was supported by Vetenskapsradet (621-2013-4685) and A.A.P. by the HFSP (LT001027/2019 fellowship). A collaborative grant from the Wellcome Trust supported A.A.P., D.P.S., G.D., S.C., and the Baum, Lindas, and Henriques labs (203276/Z/16/Z). D.R.M. was supported by a BBSRC grant awarded to B.B. (BB/K009001/1). L.M. and R.A.M.d.B. were supported by Cancer Research UK (C33246/A20147). P.F., C.D., and A.P.S. were supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001999), the UK Medical Research Council (FC001999), and the Wellcome Trust (FC001999). L.H.-K. was supported by the Biotechnology and Biological Sciences Research Council (BB/M009513/1). A.S. and A.E.H. were supported by the European Research Council (802960) and the Engineering and Physical Sciences Research Council (EP/R011818/1). N.P.R. was supported by the Isaac Newton Trust Research Grant (Trinity College and Department of Biochemistry, Cambridge) and start-up funds from the Division of Biomedical and Life Sciences (Lancaster University) and received a BBSRC Doctoral Training Grant (RG53842) for S.B.	Adams J, 1999, CANCER RES, V59, P2615; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anjum RS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9163; Ausiannikava D, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020056; Bernander R, 2007, MOL MICROBIOL, V66, P557, DOI 10.1111/j.1365-2958.2007.05917.x; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Caillat C, 2019, BIOCHEM SOC T, V47, P441, DOI 10.1042/BST20180026; Caspi Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00174; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dobro MJ, 2013, MOL BIOL CELL, V24, P2319, DOI 10.1091/mbc.E12-11-0785; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fu X, 2016, MBIO, V7, DOI 10.1128/mBio.00379-16; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1558, DOI 10.4161/cc.4.11.2145; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gristwood T, 2012, NUCLEIC ACIDS RES, V40, P5487, DOI 10.1093/nar/gks217; Groll M, 2003, J MOL BIOL, V327, P75, DOI 10.1016/S0022-2836(03)00080-9; Gustafsson N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12471; Harker-Kirschneck L, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0700-2; Hepowit NL, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00254-19; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kurosawa N, 2005, FEMS MICROBIOL LETT, V253, P141, DOI 10.1016/j.femsle.2005.09.031; Laine R. F., 2018, NANOJ HIGH PERFORMAN, DOI [10.1101/432674, DOI 10.1101/432674]; Lang SW, 2015, J BACTERIOL, V197, P3409, DOI 10.1128/JB.00496-15; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Liu JF, 2017, MOL MICROBIOL, V105, P540, DOI 10.1111/mmi.13716; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mierzwa BE, 2017, NAT CELL BIOL, V19, P787, DOI 10.1038/ncb3559; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Pfitzner A.K., 2019, BIORXIV2019718080, DOI [10.1101/718080, DOI 10.1101/718080]; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pulschen AA, 2020, CURR BIOL, V30, P2852, DOI 10.1016/j.cub.2020.05.021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samson RY, 2011, MOL CELL, V41, P186, DOI 10.1016/j.molcel.2010.12.018; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; WOLD S, 1994, EMBO J, V13, P2097, DOI 10.1002/j.1460-2075.1994.tb06485.x; Yang N, 2014, EXTREMOPHILES, V18, P331, DOI 10.1007/s00792-013-0618-5; York AG, 2013, NAT METHODS, V10, P1122, DOI [10.1038/NMETH.2687, 10.1038/nmeth.2687]; Yuan HY, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011905; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	53	23	24	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					642	+		10.1126/science.aaz2532	http://dx.doi.org/10.1126/science.aaz2532			63	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764038	Green Accepted, Green Submitted			2022-12-28	WOS:000559184400036
J	Griffin, S				Griffin, Shaun			Covid-19: England had worst excess mortality in Europe in April	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Office for National Statistics, 2020, COMP ALL CAUS MORT E	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2020	370								m3058	10.1136/bmj.m3058	http://dx.doi.org/10.1136/bmj.m3058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RD	32737032	Bronze			2022-12-28	WOS:000556139500005
J	Ensrud, KE; Schousboe, JT				Ensrud, Kristine E.; Schousboe, John T.			Delayed Denosumab Injections and Fracture Risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WOMEN		[Ensrud, Kristine E.; Schousboe, John T.] Univ Minnesota, Minneapolis, MN USA; [Ensrud, Kristine E.] VA Hlth Care Syst, Minneapolis, MN USA; [Schousboe, John T.] HealthPartners Inst, Minneapolis, MN USA; [Ensrud, Kristine E.] Minneapolis VA Hlth Care Syst, Ctr Care Delivery & Outcomes Res, 1110 One Vet Dr, Minneapolis, MN 55417 USA; [Schousboe, John T.] HealthPartners Inst, 3311 Old Shakopee Rd, Bloomington, MN 55425 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; HealthPartners Institute for Education & Research	Ensrud, KE (corresponding author), Minneapolis VA Hlth Care Syst, Ctr Care Delivery & Outcomes Res, 1110 One Vet Dr, Minneapolis, MN 55417 USA.	ensru001@umn.edu		Ensrud, Kristine/0000-0002-9069-3036; Schousboe, John/0000-0002-9329-0750				Ban JK, 2019, OSTEOPOROSIS INT, V30, P1865, DOI 10.1007/s00198-019-05051-1; Bone HG, 2011, J CLIN ENDOCR METAB, V96, P972, DOI 10.1210/jc.2010-1502; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Hadji P, 2015, OSTEOPOROSIS INT, V26, P2479, DOI 10.1007/s00198-015-3164-4; Lyu HC, 2020, ANN INTERN MED, V173, P516, DOI 10.7326/M20-0882; Lyu HC, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz321; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Tripto-Shkolnik L, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115150; Yu EW, 2020, J BONE MINER RES, V35, P1009, DOI 10.1002/jbmr.4049	9	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					582	+		10.7326/M20-4802	http://dx.doi.org/10.7326/M20-4802			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX4GS	32716699				2022-12-28	WOS:000575671400019
J	Brubaker, L				Brubaker, Linda			Women Physicians and the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BURNOUT; CARE		[Brubaker, Linda] Univ Calif San Diego, 9500 Gilman Dr,MC 0971, La Jolla, CA 92075 USA	University of California System; University of California San Diego	Brubaker, L (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MC 0971, La Jolla, CA 92075 USA.	librubaker@ucsd.edu						[Anonymous], ACT COLL CLIN WELL B; Berwick DM, 2020, JAMA-J AM MED ASSOC, V323, P1708, DOI 10.1001/jama.2020.2984; Danhauer SC, 2020, JAMA SURG, V155, P721, DOI 10.1001/jamasurg.2020.1345; Dzau VJ, 2018, NEW ENGL J MED, V378, P312, DOI 10.1056/NEJMp1715127; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Ly DP, 2018, MAYO CLIN PROC, V93, P1484, DOI 10.1016/j.mayocp.2018.02.018; Myers SP, 2020, JAMA SURG, V155, P552, DOI 10.1001/jamasurg.2020.1127; Swartz TH, 2019, J INFECT DIS, V220, pS33, DOI 10.1093/infdis/jiz174; Wright AA, 2018, NEW ENGL J MED, V378, P309, DOI 10.1056/NEJMp1716845	9	66	67	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					835	836		10.1001/jama.2020.14797	http://dx.doi.org/10.1001/jama.2020.14797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32735329				2022-12-28	WOS:000570094600008
J	Moscola, J; Sembajwe, G; Jarrett, M; Farber, B; Chang, T; McGinn, T; Davidson, KW				Moscola, Joseph; Sembajwe, Grace; Jarrett, Mark; Farber, Bruce; Chang, Tylis; McGinn, Thomas; Davidson, Karina W.		Northwell Hlth Covid	Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Moscola, Joseph; Jarrett, Mark] Northwell Hlth, New Hyde Pk, NY USA; [Sembajwe, Grace; McGinn, Thomas; Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Farber, Bruce] Northwell Hlth, Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA; [Chang, Tylis] Northwell Hlth, Northwell Hlth Labs, Lake Success, NY USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health	Davidson, KW (corresponding author), Northwell Hlth, 130 E 59th St,Ste14C, New York, NY 10022 USA.	kdavidson2@northwell.edu	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X	NIA NIH HHS [R24 AG064191] Funding Source: Medline; NLM NIH HHS [R01 LM012836] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Association of Public Health Laboratories Council of State and Territorial Epidemiologists, 2020, PUBL HLTH CONS SER T; Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775; Rosenberg ES, 2020, ANN EPIDEMIOL, V48, P23, DOI 10.1016/j.annepidem.2020.06.004; Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160	6	165	168	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					893	895		10.1001/jama.2020.14765	http://dx.doi.org/10.1001/jama.2020.14765			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32780804	Green Published, Bronze			2022-12-28	WOS:000570094600020
J	Mao, JH; Milovanovic, SP; Andelkovic, M; Lai, XY; Cao, Y; Watanabe, K; Taniguchi, T; Covaci, L; Peeters, FM; Geim, AK; Jiang, YH; Andrei, EY				Mao, Jinhai; Milovanovic, Slavisa P.; Andelkovic, Misa; Lai, Xinyuan; Cao, Yang; Watanabe, Kenji; Taniguchi, Takashi; Covaci, Lucian; Peeters, Francois M.; Geim, Andre K.; Jiang, Yuhang; Andrei, Eva Y.			Evidence of flat bands and correlated states in buckled graphene superlattices	NATURE			English	Article							MAGIC-ANGLE; SUPERCONDUCTIVITY; FIELDS	Two-dimensional atomic crystals can radically change their properties in response to external influences, such as substrate orientation or strain, forming materials with novel electronic structure(1-5). An example is the creation of weakly dispersive, 'flat' bands in bilayer graphene for certain 'magic' angles of twist between the orientations of the two layers(6). The quenched kinetic energy in these flat bands promotes electron-electron interactions and facilitates the emergence of strongly correlated phases, such as superconductivity and correlated insulators. However, the very accurate fine-tuning required to obtain the magic angle in twisted-bilayer graphene poses challenges to fabrication and scalability. Here we present an alternative route to creating flat bands that does not involve fine-tuning. Using scanning tunnelling microscopy and spectroscopy, together with numerical simulations, we demonstrate that graphene monolayers placed on an atomically flat substrate can be forced to undergo a buckling transition(7-9), resulting in a periodically modulated pseudo-magnetic field(10-14), which in turn creates a 'post-graphene' material with flat electronic bands. When we introduce the Fermi level into these flat bands using electrostatic doping, we observe a pseudogap-like depletion in the density of states, which signals the emergence of a correlated state(15-17). This buckling of two-dimensional crystals offers a strategy for creating other superlattice systems and, in particular, for exploring interaction phenomena characteristic of flat bands. Buckled monolayer graphene superlattices are found to provide an alternative to twisted bilayer graphene for the study of flat bands and correlated states in a carbon-based material.	[Mao, Jinhai; Lai, Xinyuan; Jiang, Yuhang; Andrei, Eva Y.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Mao, Jinhai] Univ Chinese Acad Sci, Sch Phys Sci, Beijing, Peoples R China; [Mao, Jinhai] Univ Chinese Acad Sci, CAS Ctr Excellence Topol Quantum Computat, Beijing, Peoples R China; [Milovanovic, Slavisa P.; Andelkovic, Misa; Covaci, Lucian; Peeters, Francois M.] Univ Antwerp, Dept Fys, Antwerp, Belgium; [Cao, Yang; Geim, Andre K.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki, Japan; [Jiang, Yuhang] Univ Chinese Acad Sci, Coll Mat Sci & Optoelect Technol, Ctr Mat Sci & Optoelect Engn, Beijing, Peoples R China	Rutgers State University New Brunswick; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Antwerp; University of Manchester; National Institute for Materials Science; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, YH; Andrei, EY (corresponding author), Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA.; Jiang, YH (corresponding author), Univ Chinese Acad Sci, Coll Mat Sci & Optoelect Technol, Ctr Mat Sci & Optoelect Engn, Beijing, Peoples R China.	yuhangjiang@ucas.edu.cn; eandrei@physics.rutgers.edu	Anđelković, Miša/W-7698-2019; Watanabe, Kenji/ABB-2135-2021; Covaci, Lucian/B-6493-2009; Geim, Andre K/J-7888-2012	Anđelković, Miša/0000-0002-4117-5662; Watanabe, Kenji/0000-0003-3701-8119; Covaci, Lucian/0000-0001-9755-7443; Geim, Andre K/0000-0003-2861-8331; Milovanovic, Slavisa/0000-0002-6415-6456				Amorim B, 2016, PHYS REP, V617, P1, DOI 10.1016/j.physrep.2015.12.006; Andelkovic M, 2018, PHYS REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.034004; Andrei EY, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/5/056501; ANDREI EY, 1988, PHYS REV LETT, V60, P2765, DOI 10.1103/PhysRevLett.60.2765; Bao WZ, 2009, NAT NANOTECHNOL, V4, P562, DOI [10.1038/nnano.2009.191, 10.1038/NNANO.2009.191]; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; Cai S, 2011, J MECH PHYS SOLIDS, V59, P1094, DOI 10.1016/j.jmps.2011.02.001; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Carrillo-Bastos R, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.125422; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Georgi A, 2017, NANO LETT, V17, P2240, DOI 10.1021/acs.nanolett.6b04870; Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803; Gomes KK, 2012, NATURE, V483, P306, DOI 10.1038/nature10941; Guinea F, 2010, NAT PHYS, V6, P30, DOI 10.1038/NPHYS1420; Jiang YH, 2019, NATURE, V573, P91, DOI 10.1038/s41586-019-1460-4; Jiang YH, 2017, NANO LETT, V17, P2839, DOI 10.1021/acs.nanolett.6b05228; Kauppila VJ, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.214505; Kerelsky A, 2019, NATURE, V572, P95, DOI 10.1038/s41586-019-1431-9; Kopnin NB, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.220503; Levy N, 2010, SCIENCE, V329, P544, DOI 10.1126/science.1191700; Li G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3633943; Luican A, 2009, SOLID STATE COMMUN, V149, P1151, DOI 10.1016/j.ssc.2009.02.059; Masir MR, 2013, SOLID STATE COMMUN, V175, P76, DOI 10.1016/j.ssc.2013.04.001; Milovanovi S. P., 2019, PREPRINT; Moldovan D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035446; Neek-Amal M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115428; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Palacios-Berraquero C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15093; Schneider M, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.161407; Settnes M, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.035456; Tang E, 2014, NAT PHYS, V10, P964, DOI [10.1038/NPHYS3109, 10.1038/nphys3109]; Weisse A, 2006, REV MOD PHYS, V78, P275, DOI 10.1103/RevModPhys.78.275; Xie YL, 2019, NATURE, V572, P101, DOI 10.1038/s41586-019-1422-x; Zhang ZZ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235411	40	64	66	20	205	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					215	+		10.1038/s41586-020-2567-3	http://dx.doi.org/10.1038/s41586-020-2567-3			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788735	Green Submitted			2022-12-28	WOS:000559831500012
J	Albert, H				Albert, Helen			What will it take for Germany to embrace digital health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												scicom.hla@gmail.com						Barker T, 2020, GERMANYS ANGST IS KI; Bertelsmann Stiftung, DIG HLTH IND; Deutsche Arzt AG, 7 MILL MIN MED HILF; Devins S, 2017, HANDELSBLATT TO 0210; EIT Health, EIT HLTH GERM THINK; Elteste U, 2020, COVINGTON DIGITAL HL; Healthcare industry BW, EHR PHR DIG REC GERM; Lomas N., 2020, TECHCRUNCH	8	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m2828	10.1136/bmj.m2828	http://dx.doi.org/10.1136/bmj.m2828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QD5YJ	32784199				2022-12-28	WOS:000615593000001
J	Banerjee, A; Shah, SR				Banerjee, Abhirup; Shah, Sudeep R.			Necrolytic Migratory Erythema Associated with a Glucagonoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Banerjee, Abhirup; Shah, Sudeep R.] PD Hinduja Natl Hosp & Med Res Ctr, Mumbai, Maharashtra, India		Banerjee, A (corresponding author), PD Hinduja Natl Hosp & Med Res Ctr, Mumbai, Maharashtra, India.	drabhirupbanerjee@gmail.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6							e39	10.1056/NEJMicm1915564	http://dx.doi.org/10.1056/NEJMicm1915564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32757527				2022-12-28	WOS:000560438400005
J	Porciello, J; Tufan, HA; Njuki, J; Winters, P; Mabaya, E; Coffman, R				Porciello, Jaron; Tufan, Hale Ann; Njuki, Jemimah; Winters, Paul; Mabaya, Edward; Coffman, Ronnie			Averting hunger in sub-Saharan Africa requires data and synthesis	NATURE			English	Editorial Material						Agriculture; Developing world; Research data; SARS-CoV-2		As the United Nations warns of famine on a scale not seen in 50 years, researchers must help to build agile, inclusive data collection and analysis to inform agricultural policy. As the United Nations warns of famine on a scale not seen in 50 years, researchers must help to build agile, inclusive data collection and analysis to inform agricultural policy.	[Porciello, Jaron; Tufan, Hale Ann; Mabaya, Edward] Cornell Univ, Dept Global Dev, Ithaca, NY 14850 USA; [Njuki, Jemimah] Int Dev Res Ctr, Ottawa, ON, Canada; [Winters, Paul] Univ Notre Dame, Global Affairs, South Bend, IN USA; [Coffman, Ronnie] Cornell Univ, Coll Agr & Life Sci, Plant Breeding & Genet, Ithaca, NY USA	Cornell University; University of Notre Dame; Cornell University	Porciello, J (corresponding author), Cornell Univ, Dept Global Dev, Ithaca, NY 14850 USA.	jat264@cornell.edu		Porciello, Jaron/0000-0002-3179-1971; Winters, Paul/0000-0001-9976-4534				[Anonymous], 2019, CONNECTED WOMEN MOBI; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Korkoyah D, 2015, EBOLA IMPACT REVEALE; Lobell DB, 2020, AM J AGR ECON, V102, P202, DOI 10.1093/ajae/aaz051; Quisumbing AR., 2020, WOMENS EMPOWERMENT A; Stewart R, 2019, PALGR COMMUN, V5, DOI 10.1057/s41599-019-0303-0; Teeken B, 2018, ECON BOT, V72, P263, DOI 10.1007/s12231-018-9421-7; Tsan M., 2019, DIGITALISATION AFRIC	8	3	3	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					37	40		10.1038/d41586-020-02281-w	http://dx.doi.org/10.1038/d41586-020-02281-w			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB1QU	32760042				2022-12-28	WOS:000560290400008
J	Lin, WJ				Lin, Wen-Jing			My womb is my business	SCIENCE			English	Editorial Material									[Lin, Wen-Jing] Univ Tokyo, Tokyo, Japan	University of Tokyo	Lin, WJ (corresponding author), Univ Tokyo, Tokyo, Japan.								0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					594	594		10.1126/science.369.6503.594	http://dx.doi.org/10.1126/science.369.6503.594			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732428				2022-12-28	WOS:000556568100051
J	Zhang, SW; Zhang, HW; Zhou, YF; Qiao, M; Zhao, SM; Kozlova, A; Shi, JX; Sanders, AR; Wang, G; Luo, KX; Sengupta, S; West, S; Qian, S; Streit, M; Avramopoulos, D; Cowan, CA; Chen, MJ; Pang, ZPP; Gejman, PV; He, X; Duan, JB				Zhang, Siwei; Zhang, Hanwen; Zhou, Yifan; Qiao, Min; Zhao, Siming; Kozlova, Alena; Shi, Jianxin; Sanders, Alan R.; Wang, Gao; Luo, Kaixuan; Sengupta, Subhajit; West, Siobhan; Qian, Sheng; Streit, Michael; Avramopoulos, Dimitrios; Cowan, Chad A.; Chen, Mengjie; Pang, Zhiping P.; Gejman, Pablo V.; He, Xin; Duan, Jubao			Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ARCHITECTURE; ENHANCER ACTIVITY; COMMON VARIANTS; RISK VARIANTS; STEM-CELLS; LOCI; IDENTIFICATION; INSIGHTS; TRANSCRIPTOME	Most neuropsychiatric disease risk variants are in noncoding sequences and lack functional interpretation. Because regulatory sequences often reside in open chromatin, we reasoned that neuropsychiatric disease risk variants may affect chromatin accessibility during neurodevelopment. Using human induced pluripotent stem cell (iPSC)-derived neurons that model developing brains, we identified thousands of genetic variants exhibiting allele-specific open chromatin (ASoC). These neuronal ASoCs were partially driven by altered transcription factor binding, overrepresented in brain gene enhancers and expression quantitative trait loci, and frequently associated with distal genes through chromatin contacts. ASoCs were enriched for genetic variants associated with brain disorders, enabling identification of functional schizophrenia risk variants and their cis-target genes. This study highlights ASoC as a functional mechanism of noncoding neuropsychiatric risk variants, providing a powerful framework for identifying disease causal variants and genes.	[Zhang, Siwei; Zhang, Hanwen; Kozlova, Alena; Sanders, Alan R.; Sengupta, Subhajit; West, Siobhan; Streit, Michael; Gejman, Pablo V.; Duan, Jubao] NorthShore Univ HealthSyst, Ctr Psychiat Genet, Evanston, IL 60201 USA; [Zhou, Yifan; Qiao, Min; Zhao, Siming; Wang, Gao; Luo, Kaixuan; Qian, Sheng; He, Xin] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Zhou, Yifan] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Qiao, Min] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Sanders, Alan R.; Gejman, Pablo V.; Duan, Jubao] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Avramopoulos, Dimitrios] Johns Hopkins Univ, Dept Genet Med & Psychiat, Baltimore, MD 21205 USA; [Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chen, Mengjie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Pang, Zhiping P.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, Dept Neurosci & Cell Biol, New Brunswick, NJ 08901 USA; [He, Xin] Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA	NorthShore University Health System; University of Chicago; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Johns Hopkins University; Harvard University; University of Chicago; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Chicago	Duan, JB (corresponding author), NorthShore Univ HealthSyst, Ctr Psychiat Genet, Evanston, IL 60201 USA.; He, X (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.; Duan, JB (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.; He, X (corresponding author), Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA.	xinhe@uchicago.edu; jduan@uchicago.edu	Zhang, Siwei/AAM-7361-2021	Zhang, Siwei/0000-0002-1646-063X; Zhou, Yifan/0000-0002-3768-9353; Qiao, Min/0000-0002-5823-4892; Zhang, Hanwen/0000-0001-8490-918X; Sanders, Alan/0000-0001-6629-4011	NIH [R01AA023797, R01MH113215, R01MH110531, R01MH106575, R01MH116281, R01AG063175]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH grants R01AA023797 (to Z.P.P.); R01MH113215 (to D.A.); R01MH110531 (to X.H.); and R01MH106575, R01MH116281, and R01AG063175 (to J.D.).	Amiri A, 2018, SCIENCE, V362, P1268, DOI 10.1126/science.aat6720; [Anonymous], 2020, BENCHLING; Barretto N, 2020, J NEUROSCI METH, V334, DOI 10.1016/j.jneumeth.2019.108548; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bryois J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05379-y; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Forrest MP, 2017, CELL STEM CELL, V21, P305, DOI 10.1016/j.stem.2017.07.008; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Fullard JF, 2018, GENOME RES, V28, P1243, DOI 10.1101/gr.232488.117; Gonzalez R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01463; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gusmao EG, 2016, NAT METHODS, V13, P303, DOI [10.1038/nmeth.3772, 10.1038/NMETH.3772]; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Haslinger D, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0239-z; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffman GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02330-5; Iwaki H, 2019, MOVEMENT DISORD, V34, P1839, DOI 10.1002/mds.27845; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Marballi KK, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00023; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7; Ng B, 2017, NAT NEUROSCI, V20, P1418, DOI 10.1038/nn.4632; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Onuchic V, 2018, SCIENCE, V361, P1354, DOI 10.1126/science.aar3146; Park SM, 2016, EXP NEUROBIOL, V25, P33, DOI 10.5607/en.2016.25.1.33; Rajarajan P, 2018, SCIENCE, V362, P1269, DOI 10.1126/science.aat4311; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/nmeth.4612, 10.1038/NMETH.4612]; Song M, 2019, NAT GENET, V51, P1252, DOI 10.1038/s41588-019-0472-1; Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Takata A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14519; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Ugur B, 2017, CELL REP, V21, P3794, DOI 10.1016/j.celrep.2017.12.005; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Vidal C, 2019, ALZH DEMENT-TRCI, V5, P27, DOI 10.1016/j.trci.2018.12.003; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wagih O., 2018, ALLELE SPECIFIC TRAN, DOI [10.1101/253427, DOI 10.1101/253427]; Wagih O., 253427 BIORXIV; Wang G., 2018, BIORXIV, DOI [10.1101/501114, DOI 10.1101/501114]; Weissbein U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12144; Wen XQ, 2016, ANN APPL STAT, V10, P1619, DOI 10.1214/16-AOAS952; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; Xu J, 2017, NAT GENET, V49, P377, DOI 10.1038/ng.3769; Yeo NC, 2018, NAT METHODS, V15, P611, DOI 10.1038/s41592-018-0048-5; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	86	33	33	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					561	+		10.1126/science.aay3983	http://dx.doi.org/10.1126/science.aay3983			97	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732423	Green Accepted			2022-12-28	WOS:000556568100045
J	Andrade, RD				Andrade, Rodrigo de Oliveira			Covid-19 is causing the collapse of Brazil's national health service	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rodrigo.oliandrade@gmail.com	de Oliveira Andrade, Rodrigo/AAC-3184-2020					Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Biernath A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m537; DYER O, 2018, BMJ-BRIT MED J, V363, P82747, DOI DOI 10.1136/BMJ.K5027; Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829; Neves RG, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300008, 10.5123/s1679-49742018000300008]; Phillips D., 2020, GUARDIAN; Phillips Tom, 2020, GUARDIAN; The Commonwealth Fund, 2020, INT HLTH CAR SYST PR	9	26	27	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3032	10.1136/bmj.m3032	http://dx.doi.org/10.1136/bmj.m3032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QD5VQ	32732376	Bronze			2022-12-28	WOS:000615585900001
J	Hall, S				Hall, Shannon			Pluto's dark side spills its secrets - including hints of a hidden ocean	NATURE			English	News Item						Planetary science; Astronomy and astrophysics		Images of the dwarf planet's far side are revealing possible signs of liquid water, mysterious shards of ice and new theories for the frigid world's birth. Images of the dwarf planet's far side are revealing possible signs of liquid water, mysterious shards of ice and new theories for the frigid world's birth.										Bertrand T, 2019, ICARUS, V329, P148, DOI 10.1016/j.icarus.2019.02.007; Cruikshank DP, 2019, ASTROBIOLOGY, V19, P831, DOI 10.1089/ast.2018.1927; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Moore JM, 2018, ICARUS, V300, P129, DOI 10.1016/j.icarus.2017.08.031; Nimmo F, 2016, NATURE, V540, P94, DOI 10.1038/nature20148; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494	6	1	1	3	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					674	678		10.1038/d41586-020-02082-1	http://dx.doi.org/10.1038/d41586-020-02082-1			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728264	Bronze			2022-12-28	WOS:000554831500016
J	Partridge, EC; Chhetri, SB; Prokop, JW; Ramaker, RC; Jansen, CS; Goh, ST; Mackiewicz, M; Newberry, KM; Brandsmeier, LA; Meadows, SK; Messer, CL; Hardigan, AA; Coppola, CJ; Dean, EC; Jiang, S; Savic, D; Mortazavi, A; Wold, BJ; Myers, RM; Mendenhall, EM				Partridge, E. Christopher; Chhetri, Surya B.; Prokop, Jeremy W.; Ramaker, Ryne C.; Jansen, Camden S.; Goh, Say-Tar; Mackiewicz, Mark; Newberry, Kimberly M.; Brandsmeier, Laurel A.; Meadows, Sarah K.; Messer, C. Luke; Hardigan, Andrew A.; Coppola, Candice J.; Dean, Emma C.; Jiang, Shan; Savic, Daniel; Mortazavi, Ali; Wold, Barbara J.; Myers, Richard M.; Mendenhall, Eric M.			Occupancy maps of 208 chromatin-associated proteins in one human cell type	NATURE			English	Article							PIONEER TRANSCRIPTION FACTORS; CHIP-SEQ; FACTOR-BINDING; WEB SERVER; GENOME; NETWORK; ARCHITECTURE; SPECIFICITY; EXPRESSION; PROMOTERS	Transcription factors are DNA-binding proteins that have key roles in gene regulation(1,2). Genome-wide occupancy maps of transcriptional regulators are important for understanding gene regulation and its effects on diverse biological processes(3-6). However, only a minority of the more than 1,600 transcription factors encoded in the human genome has been assayed. Here we present, as part of the ENCODE (Encyclopedia of DNA Elements) project, data and analyses from chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) experiments using the human HepG2 cell line for 208 chromatin-associated proteins (CAPs). These comprise 171 transcription factors and 37 transcriptional cofactors and chromatin regulator proteins, and represent nearly one-quarter of CAPs expressed in HepG2 cells. The binding profiles of these CAPs form major groups associated predominantly with promoters or enhancers, or with both. We confirm and expand the current catalogue of DNA sequence motifs for transcription factors, and describe motifs that correspond to other transcription factors that are co-enriched with the primary ChIP target. For example, FOX family motifs are enriched in ChIP-seq peaks of 37 other CAPs. We show that motif content and occupancy patterns can distinguish between promoters and enhancers. This catalogue reveals high-occupancy target regions at which many CAPs associate, although each contains motifs for only a minority of the numerous associated transcription factors. These analyses provide a more complete overview of the gene regulatory networks that define this cell type, and demonstrate the usefulness of the large-scale production efforts of the ENCODE Consortium. ChIP-seq and CETCh-seq data are used to analyse binding maps for 208 transcription factors and other chromatin-associated proteins in a single human cell type, providing a comprehensive catalogue of the transcription factor landscape and gene regulatory networks in these cells.	[Partridge, E. Christopher; Chhetri, Surya B.; Prokop, Jeremy W.; Ramaker, Ryne C.; Mackiewicz, Mark; Newberry, Kimberly M.; Brandsmeier, Laurel A.; Meadows, Sarah K.; Messer, C. Luke; Hardigan, Andrew A.; Dean, Emma C.; Myers, Richard M.; Mendenhall, Eric M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Chhetri, Surya B.; Coppola, Candice J.; Mendenhall, Eric M.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Prokop, Jeremy W.] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, Grand Rapids, MI USA; [Ramaker, Ryne C.; Hardigan, Andrew A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Jansen, Camden S.; Jiang, Shan; Mortazavi, Ali] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Goh, Say-Tar; Wold, Barbara J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dean, Emma C.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Savic, Daniel] St Jude Childrens Res Hosp, Pharmaceut Sci Dept, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chhetri, Surya B.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MA USA	HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Huntsville; Michigan State University; Michigan State University College of Human Medicine; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine; California Institute of Technology; University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; Johns Hopkins University	Myers, RM; Mendenhall, EM (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.; Mendenhall, EM (corresponding author), Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA.	rmyers@hudsonalpha.org; eric.mendenhall@uah.edu	Savic, Daniel/N-5525-2018	Savic, Daniel/0000-0002-6693-0265; Mendenhall, Eric/0000-0002-7395-6295				Akaike H., 1973, SELECTED PAPERS HIRO, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Andersson R, 2015, TRENDS GENET, V31, P426, DOI 10.1016/j.tig.2015.05.007; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Choi WI, 2014, J BIOL CHEM, V289, P18641, DOI 10.1074/jbc.M113.538777; CONACCISORRELL M, 2014, CSH PERSPECT MED, V4, DOI DOI 10.1101/CSHPERSPECT.A014357; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dao LTM, 2017, NAT GENET, V49, P1073, DOI 10.1038/ng.3884; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; Faherty N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28210; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghandi M, 2016, BIOINFORMATICS, V32, P2205, DOI 10.1093/bioinformatics/btw203; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hunt RW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0412-4; Hunt RW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-472; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang ZW, 2017, ELIFE, V6, DOI 10.7554/eLife.22767; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Morgunova E, 2017, CURR OPIN STRUC BIOL, V47, P1, DOI 10.1016/j.sbi.2017.03.006; Mortazavi A, 2013, GENOME RES, V23, P2136, DOI 10.1101/gr.158261.113; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Partridge EC, 2016, BIOESSAYS, V38, P801, DOI 10.1002/bies.201600028; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shin Hyunjin, 2013, Quant Biol, V1, P54; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teng MX, 2017, GENOME RES, V27, P1930, DOI 10.1101/gr.220673.117; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wei B, 2018, NAT BIOTECHNOL, V36, P521, DOI 10.1038/nbt.4138; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Wreczycka K, 2019, NUCLEIC ACIDS RES, V47, P5735, DOI 10.1093/nar/gkz460; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 2016, NUCLEIC ACIDS RES, V44, P6721, DOI 10.1093/nar/gkw278	77	32	32	3	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					720	+		10.1038/s41586-020-2023-4	http://dx.doi.org/10.1038/s41586-020-2023-4			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728244	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000554831500022
J	Looi, MK				Looi, Mun-Keat			Covid-19: Deaths in Yemen are five times global average as healthcare collapses	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for International Development Foreign & Commonwealth Office Cleverly J, 2020, UK CALLS DRAST ACT Y; Medecins Sans Frontieres, 2020, COR COVID 19 SPREADS; MedGlobal, 2020, TIPP POINT YEM HLTH; Wadvalla BA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2830; WHO Africa, 2020, 10000 HLTH WORK AFR; World Health Organization, YEM	6	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2997	10.1136/bmj.m2997	http://dx.doi.org/10.1136/bmj.m2997			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32719047	Bronze			2022-12-28	WOS:000554458200008
J	Mantzari, E; Rubin, GJ; Marteau, TM				Mantzari, Eleni; Rubin, G. James; Marteau, Theresa M.			Is risk compensation threatening public health in the covid-19 pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA TRANSMISSION; NONPHARMACEUTICAL INTERVENTIONS; RESPIRATORY-INFECTIONS; PREVENT TRANSMISSION; FACE MASKS; FACEMASKS; HELMETS; REDUCE		[Mantzari, Eleni; Marteau, Theresa M.] Univ Cambridge, Behav & Heath Res Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Rubin, G. James] Kings Coll London, Dept Psychol Med, London, England	University of Cambridge; University of London; King's College London	Marteau, TM (corresponding author), Univ Cambridge, Behav & Heath Res Unit, Dept Publ Hlth & Primary Care, Cambridge, England.	tm388@cam.ac.uk			National Institute for Health Research (NIHR); NIHR Health Protection Research Unit in Emergency Preparedness and Response	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Health Protection Research Unit in Emergency Preparedness and Response	We have read and understood BMJ policy on declaration of interests and declare EM is funded by a National Institute for Health Research (NIHR) senior investigator award held by TMM. GJR was funded by the NIHR Health Protection Research Unit in Emergency Preparedness and Response, a partnership between Public Health England, King's College London, and the University of East Anglia. The views expressed are those of the authors and not necessarily those of the NIHR, Public Health England, or the Department of Health and Social Care.	Aggarwal N, 2020, INDIAN J PUBLIC HLTH, V64, P192, DOI 10.4103/ijph.IJPH_470_20; Aiello AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029744; Alfelali M., 2019, FACEMASK VERSUS NO F; Barasheed O, 2016, INT J INFECT DIS, V47, P105, DOI 10.1016/j.ijid.2016.03.023; bin-Reza F, 2012, INFLUENZA OTHER RESP, V6, P257, DOI 10.1111/j.1750-2659.2011.00307.x; Brauner J.M., 2020, EFFECTIVENESS 8 NONP, DOI [10.1101/2020.05.28.2011612, DOI 10.1101/2020.05.28.2011612]; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Deiss V, 2020, FOURRAGES, P25; Esmaeilikia M, 2019, TRANSPORT RES F-TRAF, V60, P299, DOI 10.1016/j.trf.2018.10.026; European Centre for Disease Prevention and Control, 2020, US FAC MASKS COMM RE; Goeijenbier M, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw078; Greenhalgh T, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1435; Hagger M.S., 2020, HDB BEHAV CHANGE, DOI [10.1017/9781108677318, DOI 10.1017/9781108677318, https://doi.org/10.1017/9781108677318]; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; Hendrix MJ, 2020, MMWR-MORBID MORTAL W, V69, P930, DOI 10.15585/mmwr.mm6928e2; Howard JR, 2020, SUNY Series Afr Amer, P1; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Juneau CE., 2020, EVIDENCE BASED COST, DOI 10.1101/2020.04.20.20054726; Kasting ML, 2016, HUM VACC IMMUNOTHER, V12, P1435, DOI 10.1080/21645515.2016.1141158; Lam W, 2015, J CLIN NURS, V24, P891, DOI 10.1111/jocn.12646; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lazzarino AI, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2003; Liang MM, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101751; Long YL, 2020, J EVID-BASED MED, V13, P93, DOI 10.1111/jebm.12381; MacIntyre CR, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103629; Maclntyre CR, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h694; Marasinghe KM, 2020, SYSTEMATIC REV INVES, DOI [10.21203/rs.3.rs-16701/v2, DOI 10.21203/RS.3.RS-16710/V1]; Marchiori M., 2020, ARXIV; Michie, 2020, QEIOS, DOI [10.32388/1SC5L4, DOI 10.32388/1SC5L4]; Mitze T, 2020, P NATL ACAD SCI USA, V117, P32293, DOI 10.1073/pnas.2015954117; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2203, DOI 10.1001/jama.2019.6390; Payne DCS-JS, 2020, SARS COV 2 INFECT SE; PELTZMAN S, 1975, J POLIT ECON, V83, P677, DOI 10.1086/260352; Pless B, 2016, SAFETY, V2, DOI 10.3390/safety2030016; Royal Society British Academy, 2020, FAC MASKS COV GEN PU; SAGE, 2020, SPI B RET SAGE US FA; Saunders-Hastings P, 2017, EPIDEMICS-NETH, V20, P1, DOI 10.1016/j.epidem.2017.04.003; Seres G., 2020, DISCUSSION PAPERS RE, DOI 10.2139/ssrn.3641367; Seres Gyula, 2020, FACE MASKS INCREASE; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Smith SMS, 2015, RESPIROLOGY, V20, P896, DOI 10.1111/resp.12541; Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182; Weiss HA, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000390708.66136.f4; WHO, 2020, ADV US MASKS CONT CO; Xiao JY, 2020, EMERG INFECT DIS, V26, P967, DOI 10.3201/eid2605.190994	51	44	44	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2020	370								m2913	10.1136/bmj.m2913	http://dx.doi.org/10.1136/bmj.m2913			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QD5VG	32713835	Green Submitted, Bronze			2022-12-28	WOS:000615584900001
J	Guglani, S				Guglani, Sam			The Notes Sorrow	LANCET			English	Editorial Material									[Guglani, Sam] Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2019	394	10215					2145	2145		10.1016/S0140-6736(19)33053-3	http://dx.doi.org/10.1016/S0140-6736(19)33053-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JV7MT	32738959				2022-12-28	WOS:000502546300014
J	Keane, P; Topol, E				Keane, Pearse; Topol, Eric			Digital medicine Reinventing the eye exam	LANCET			English	Editorial Material									[Keane, Pearse] Moorfields Eye Hosp NHS Fdn Trust, London EC1V 2PD, England; [Topol, Eric] Scripps Res Translat Inst, La Jolla, CA USA	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Keane, P (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, London EC1V 2PD, England.	pearse.keane@moorfields.nhs.uk		Topol, Eric/0000-0002-1478-4729; Keane, Pearse/0000-0002-9239-745X	Department of Health [CS-2014-14-023] Funding Source: Medline	Department of Health			0	5	5	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2019	394	10215					2141	2141		10.1016/S0140-6736(19)33051-X	http://dx.doi.org/10.1016/S0140-6736(19)33051-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JV7MT	32738957				2022-12-28	WOS:000502546300012
J	Luo, L; Liu, D; Liao, XL; Wu, XB; Jing, QL; Zheng, JZ; Liu, FH; Yang, SG; Bi, H; Li, ZH; Liu, JP; Song, WQ; Zhu, W; Wang, ZH; Zhang, XR; Huang, QM; Chen, PL; Liu, HM; Cheng, X; Cai, MC; Yang, P; Yang, XF; Han, ZG; Tang, JL; Ma, Y; Mao, C				Luo, Lei; Liu, Dan; Liao, Xinlong; Wu, Xianbo; Jing, Qinlong; Zheng, Jiazhen; Liu, Fanghua; Yang, Shigui; Bi, Hua; Li, Zhihao; Liu, Jianping; Song, Weiqi; Zhu, Wei; Wang, Zhenghe; Zhang, Xiru; Huang, Qingmei; Chen, Peiliang; Liu, Huamin; Cheng, Xin; Cai, Miaochun; Yang, Pei; Yang, Xingfen; Han, Zhigang; Tang, Jinling; Ma, Yu; Mao, Chen			Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China A Prospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							EPIDEMIOLOGY	Background: Risk for transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to close contacts of infected persons has not been well estimated. Objective: To evaluate the risk for transmission of SARS-CoV-2 to close contacts in different settings. Design: Prospective cohort study. Setting: Close contacts of persons infected with SARS-CoV-2 in Guangzhou, China. Participants: 3410 close contacts of 391 index cases were traced between 13 January and 6 March 2020. Data on the setting of the exposure, reverse transcriptase polymerase chain reaction testing, and clinical characteristics of index and secondary cases were collected. Measurement: Coronavirus disease 2019 (COVID-19) cases were confirmed by guidelines issued by China. Secondary attack rates in different settings were calculated. Results: Among 3410 close contacts, 127 (3.7% [95% CI, 3.1% to 4.4%]) were secondarily infected. Of these 127 persons, 8 (6.3% [CI, 2.1% to 10.5%]) were asymptomatic. Of the 119 symptomatic cases, 20 (16.8%) were defined as mild, 87 (73.1%) as moderate, and 12 (10.1%) as severe or critical. Compared with the household setting (10.3%), the secondary attack rate was lower for exposures in health care settings (1.0%; odds ratio [OR], 0.09 [CI, 0.04 to 0.20]) and on public transportation (0.1%; OR, 0.01 [CI, 0.00 to 0.08]). The secondary attack rate increased with the severity of index cases, from 0.3% (CI, 0.0% to 1.0%) for asymptomatic to 3.3% (CI, 1.8% to 4.8%) for mild, 5.6% (CI, 4.4% to 6.8%) for moderate, and 6.2% (CI, 3.2% to 9.1%) for severe or critical cases. Index cases with expectoration were associated with higher risk for secondary infection (13.6% vs. 3.0% for index cases without expectoration; OR, 4.81 [CI, 3.35 to 6.93]). Limitation: There was potential recall bias regarding symptom onset among patients with COVID-19, and the symptoms and severity of index cases were not assessed at the time of exposure to contacts. Conclusion: Household contact was the main setting for transmission of SARS-CoV-2, and the risk for transmission of SARS-CoV-2 among close contacts increased with the severity of index cases.	[Luo, Lei; Liao, Xinlong; Jing, Qinlong; Liu, Fanghua; Bi, Hua; Liu, Jianping; Zhu, Wei; Han, Zhigang; Ma, Yu] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Guangdong, Peoples R China; [Liu, Dan; Wu, Xianbo; Zheng, Jiazhen; Li, Zhihao; Song, Weiqi; Wang, Zhenghe; Zhang, Xiru; Huang, Qingmei; Chen, Peiliang; Liu, Huamin; Cheng, Xin; Cai, Miaochun; Yang, Pei; Yang, Xingfen; Mao, Chen] Southern Med Univ, Sch Publ Hlth, Guangzhou 510515, Guangdong, Peoples R China; [Yang, Shigui] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou 310003, Zhejiang, Peoples R China; [Tang, Jinling] Guangzhou Med Univ, Clin Data Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Tang, Jinling] Guangzhou Med Univ, Guangdong Prov Childrens Med Res Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China	Southern Medical University - China; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Guangzhou Medical University; Guangzhou Medical University	Han, ZG; Ma, Y (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Guangdong, Peoples R China.; Mao, C (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou 510515, Guangdong, Peoples R China.; Tang, JL (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.	zhiganghan616@163.com; jltang@cuhk.edu.hk; freedomsky_220@163.com; maochen9@smu.edu.cn	刘, 芳华/H-7907-2014; Tang, Jin-Ling/AAJ-4090-2021; Li, Zhi-Hao/AAX-2941-2020; Mao, Chen/AAW-2742-2020; Wu, Xianbo/AAL-2948-2020; Li, Zhi-Hao/GVU-9321-2022	刘, 芳华/0000-0002-1934-3674; Mao, Chen/0000-0002-6537-6215; Li, Zhi-Hao/0000-0002-1597-2676; Zhenghe, Wang/0000-0003-4585-677X; Liu, Dan/0000-0002-5581-4605	Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme; National Natural Science Foundation of China; Construction of High-level University of Guangdong; Zhejiang University Special Scientific Research Fund for COVID-19 Prevention and Control	Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Construction of High-level University of Guangdong; Zhejiang University Special Scientific Research Fund for COVID-19 Prevention and Control	By the Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme, the National Natural Science Foundation of China, the Construction of High-level University of Guangdong, and the Zhejiang University Special Scientific Research Fund for COVID-19 Prevention and Control.	Arashiro T, 2020, EMERG INFECT DIS, V26, P1346, DOI 10.3201/eid2606.200452; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chinese Center for Disease Control and Prevention, 2020, GUID INV MAN CLOS CO, DOI DOI 10.46234/CCDCW2020.084; Cowling BJ, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.6.2000110; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; National Health Commission of the People's Republic of China, 2020, PROT PREV CONTR COVI, DOI DOI 10.46234/CCDCW2020.082; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Park SY, 2020, EMERG INFECT DIS, V26, P1666, DOI 10.3201/eid2608.201274; Romaniuk H, 2014, AM J EPIDEMIOL, V180, P920, DOI 10.1093/aje/kwu224; WHO, 2020, WHO COR COVID 19 DAS; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, 2020, 82 WHO; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu TM, 2020, INT J INFECT DIS, V94, P68, DOI 10.1016/j.ijid.2020.03.022; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	24	104	109	8	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2020	173	11					879	+		10.7326/M20-2671	http://dx.doi.org/10.7326/M20-2671			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OZ7ZT	32790510	Green Published			2022-12-28	WOS:000595140400008
J	Shaffer, SM; Emert, BL; Hueros, RAR; Cote, C; Harmange, G; Schaff, DL; Sizemore, AE; Gupte, R; Torre, E; Singh, A; Bassett, DS; Raj, A				Shaffer, Sydney M.; Emert, Benjamin L.; Hueros, Raul A. Reyes; Cote, Christopher; Harmange, Guillaume; Schaff, Dylan L.; Sizemore, Ann E.; Gupte, Rohit; Torre, Eduardo; Singh, Abhyudai; Bassett, Danielle S.; Raj, Arjun			Memory Sequencing Reveals Heritable Single-Cell Gene Expression Programs Associated with Distinct Cellular Behaviors	CELL			English	Article							BREAST-CANCER; VARIABILITY; SENSITIVITY; COLLECTION; TRANSITION; STATE; LINES	Non-genetic factors can cause individual cells to fluctuate substantially in gene expression levels over time. It remains unclear whether these fluctuations can persist for much longer than the time of one cell division. Current methods for measuring gene expression in single cells mostly rely on single time point measurements, making the duration of gene expression fluctuations or cellular memory difficult to measure. Here, we combined Luria and Delbrack's fluctuation analysis with population-based RNA sequencing (MemorySeq) for identifying genes transcriptome-wide whose fluctuations persist for several divisions. MemorySeq revealed multiple gene modules that expressed together in rare cells within otherwise homogeneous clonal populations. These rare cell subpopulations were associated with biologically distinct behaviors like proliferation in the face of anti-cancer therapeutics. The identification of non-genetic, multigenerational fluctuations can reveal new forms of biological memory in single cells and suggests that non-genetic heritability of cellular state may be a quantitative property.	[Shaffer, Sydney M.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Shaffer, Sydney M.; Cote, Christopher; Schaff, Dylan L.; Sizemore, Ann E.; Gupte, Rohit; Bassett, Danielle S.; Raj, Arjun] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Emert, Benjamin L.; Hueros, Raul A. Reyes; Harmange, Guillaume; Torre, Eduardo] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hueros, Raul A. Reyes; Torre, Eduardo] Univ Penn, Perelman Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Harmange, Guillaume] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Singh, Abhyudai] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Bassett, Danielle S.] Univ Penn, Dept Phys & Astron, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Sch Engn & Appl Sci, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Cote, Christopher; Raj, Arjun] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Delaware; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; The Santa Fe Institute; University of Pennsylvania; Pennsylvania Medicine	Raj, A (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.; Raj, A (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	arjunrajlab@gmail.com		Singh, Abhyudai/0000-0002-1451-2838; Reyes Hueros, Raul/0000-0001-7554-051X; Schaff, Dylan/0000-0002-3367-9270; Cote, Christopher J./0000-0003-1119-5109; Shaffer, Sydney/0000-0003-3539-9886; Harmange, Guillaume/0000-0002-3157-5355	NIH [F30 AI114475, DP5 OD028144, F30 CA236129, T32 GM007170, T32 HG000046, 5R01GM124446, 5R01GM126557, P30 CA016520, U01 CA227550, TR01 GM137425, R01 CA232256]; NSF Graduate Research Fellowship [DGE-1845298]; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; ISI Foundation; NIH/NCI PSOC [U54 CA193417]; NSF [CAREER 1350601]; SPORE [P50 CA174523]; NIH 4DN [U01 HL129998]; NIH Center for Photogenomics [RM1 HG007743]; Tara Miller Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); ISI Foundation; NIH/NCI PSOC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); SPORE; NIH 4DN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Photogenomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tara Miller Foundation	We thank Siyu Feng, David Brown, and Bo Huang for constructs pSFFV_mNG2(1-10) and Christian Meyer for discussions about sort-relaxation experiments. We thank Caroline Bartman, Yogesh Goyal, Rodrigo Gier, Margaret Dunagin and other members of the Raj and Shaffer labs for many useful suggestions. We thank the Flow Cytometry Core Laboratory at the Children's Hospital of Philadelphia Research Institute for assistance in designing and performing FACS. S.M.S. acknowledges support from NIH (F30 AI114475 and DP5 OD028144). B.L.E. acknowledges support from NIH (F30 CA236129, T32 GM007170, and T32 HG000046). R.A.R.H. acknowledges support from the NSF Graduate Research Fellowship (DGE-1845298). A.S. acknowledges support by NIH (5R01GM124446 and 5R01GM126557). A.E.S. and D.S.B. acknowledge support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, and the ISI Foundation. A.R. acknowledges NIH/NCI PSOC (U54 CA193417), NSF (CAREER 1350601), SPORE (P50 CA174523), NIH (P30 CA016520, U01 CA227550, TR01 GM137425, and R01 CA232256), NIH 4DN (U01 HL129998), NIH Center for Photogenomics (RM1 HG007743), and the Tara Miller Foundation.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aomatsu N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-400; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Ben-David U, 2018, NATURE, V560, P325, DOI 10.1038/s41586-018-0409-3; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Buonato JM, 2014, CANCER RES, V74, P309, DOI 10.1158/0008-5472.CAN-12-4721; Castel SE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12817; Chao H.X., 2018, BIORXIV, DOI [10.1101/283614., DOI 10.1101/283614]; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fallahi-Sichani M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20166796; Feng SY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00494-8; Franco HL, 2018, GENOME RES, V28, P159, DOI 10.1101/gr.226019.117; Gao RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00244-w; Garrison E., 2012, ARXIV12073907; Giusti C, 2015, P NATL ACAD SCI USA, V112, P13455, DOI 10.1073/pnas.1506407112; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hormoz S, 2016, CELL SYST, V3, P419, DOI 10.1016/j.cels.2016.10.015; Jiang L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1010-4; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Krepler C, 2017, CELL REP, V21, P1953, DOI 10.1016/j.celrep.2017.10.021; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luria SE, 1943, GENETICS, V28, P491; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Meir Z, 2020, NAT GENET, V52, P709, DOI 10.1038/s41588-020-0645-y; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Phillips NE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09189-8; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rieck B, 2018, IEEE T VIS COMPUT GR, V24, P822, DOI 10.1109/TVCG.2017.2744321; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Singh A, 2010, PHILOS T R SOC A, V368, P4995, DOI 10.1098/rsta.2010.0211; Span PN, 2003, BRIT J CANCER, V89, P271, DOI 10.1038/sj.bjc.6601122; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Symmons O, 2016, MOL CELL, V62, P788, DOI 10.1016/j.molcel.2016.05.023; TLSTY TD, 1989, P NATL ACAD SCI USA, V86, P9441, DOI 10.1073/pnas.86.23.9441; Torre E.A., 2019, BIORXIV, DOI [10.1101/638809, DOI 10.1101/638809]; Torre E, 2018, CELL SYST, V6, P171, DOI 10.1016/j.cels.2018.01.014; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Xi YX, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4533-0	55	51	51	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					947	+		10.1016/j.cell.2020.07.003	http://dx.doi.org/10.1016/j.cell.2020.07.003			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32735851	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000561488500015
J	Grossman, DC; Larson, EB; Sox, HC				Grossman, David C.; Larson, Eric B.; Sox, Harold C.			Integrating Personalized Medicine With Population Health Management The Path Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses genome-wide sequencing (GWS) as a potential pathway not only to personalized medicine but also to population health, and proposes 5 dimensions health care organizations might consider when deciding on markers to screen for as they move toward genomic approaches to caring for their patient populations.	[Grossman, David C.; Larson, Eric B.] Kaiser Permanente, Washington Hlth Res Inst, 601 Union,Ste 3100, Seattle, WA 98101 USA; [Grossman, David C.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Sox, Harold C.] Patient Ctr Outcomes Res Inst, Washington, DC USA	Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Grossman, DC (corresponding author), Kaiser Permanente, Washington Hlth Res Inst, 601 Union,Ste 3100, Seattle, WA 98101 USA.	david.c.grossman@kp.org						Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kaiser Permanente, RES PROGR GEN ENV HL; Luirink IK, 2019, NEW ENGL J MED, V381, P1547, DOI 10.1056/NEJMoa1816454; National Cancer Institute, PERSONALIZED MED; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P652, DOI 10.1001/jama.2019.10987; Phillips KA, 2017, GENET MED, V19, P1, DOI 10.1038/gim.2017.21; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701	9	3	3	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2020	324	7					631	632		10.1001/jama.2020.1406	http://dx.doi.org/10.1001/jama.2020.1406			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NG9GI	32761169				2022-12-28	WOS:000564288700005
J	Grimm, A; Frattini, NE; Puri, S; Mundhada, SO; Touzard, S; Mirrahimi, M; Girvin, SM; Shankar, S; Devoret, MH				Grimm, A.; Frattini, N. E.; Puri, S.; Mundhada, S. O.; Touzard, S.; Mirrahimi, M.; Girvin, S. M.; Shankar, S.; Devoret, M. H.			Stabilization and operation of a Kerr-cat qubit	NATURE			English	Article							ERROR-CORRECTION; QUANTUM; DECOHERENCE	Quantum superpositions of macroscopically distinct classical states-so-called Schrodinger cat states-are a resource for quantum metrology, quantum communication and quantum computation. In particular, the superpositions of two opposite-phase coherent states in an oscillator encode a qubit protected against phase-flip errors(1,2). However, several challenges have to be overcome for this concept to become a practical way to encode and manipulate error-protected quantum information. The protection must be maintained by stabilizing these highly excited states and, at the same time, the system has to be compatible with fast gates on the encoded qubit and a quantum non-demolition readout of the encoded information. Here we experimentally demonstrate a method for the generation and stabilization of Schrodinger cat states based on the interplay between Kerr nonlinearity and single-mode squeezing(1,3)in a superconducting microwave resonator(4). We show an increase in the transverse relaxation time of the stabilized, error-protected qubit of more than one order of magnitude compared with the single-photon Fock-state encoding. We perform all single-qubit gate operations on timescales more than sixty times faster than the shortest coherence time and demonstrate single-shot readout of the protected qubit under stabilization. Our results showcase the combination of fast quantum control and robustness against errors, which is intrinsic to stabilized macroscopic states, as well as the potential of of these states as resources in quantum information processing(5-8). A qubit generated and stabilized in a superconducting microwave resonator by encoding it into Schrodinger cat states produced by Kerr nonlinearity and single-mode squeezing shows intrinsic robustness to phase-flip errors.	[Grimm, A.; Frattini, N. E.; Mundhada, S. O.; Touzard, S.; Shankar, S.; Devoret, M. H.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Puri, S.; Girvin, S. M.] Yale Univ, Dept Phys, New Haven, CT USA; [Mirrahimi, M.] Inria Paris, QUANTIC Team, Paris, France; [Grimm, A.] Paul Scherrer Inst, Photon Sci Div, Villigen, Switzerland; [Shankar, S.] Univ Texas Austin, Elect & Comp Engn, Austin, TX 78712 USA	Yale University; Yale University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Texas System; University of Texas Austin	Grimm, A; Devoret, MH (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.; Grimm, A (corresponding author), Paul Scherrer Inst, Photon Sci Div, Villigen, Switzerland.	alexander.grimm@psi.ch; michel.devoret@yale.edu	Touzard, Steven/GNP-0888-2022; Shankar, Shyam/K-5127-2013	Touzard, Steven/0000-0002-3475-2839; Shankar, Shyam/0000-0002-1311-9508; Mirrahimi, Mazyar/0000-0001-9471-6031				Aliferis P, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.052331; Campagne-Ibarcq P, 2020, NATURE, V584, P368, DOI 10.1038/s41586-020-2603-3; Cochrane PT, 1999, PHYS REV A, V59, P2631, DOI 10.1103/PhysRevA.59.2631; Dykman MI, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.195444; Dykman MI, 1998, PHYS REV E, V57, P5202, DOI 10.1103/PhysRevE.57.5202; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Frattini NE, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4984142; Goto H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21686; Guillaud J, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.041053; Haroche S., 2006, EXPLORING QUANTUM; Hu L, 2019, NAT PHYS, V15, P503, DOI 10.1038/s41567-018-0414-3; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Lescanne R, 2020, NAT PHYS, V16, P509, DOI 10.1038/s41567-020-0824-x; Lescanne R, 2019, PHYS REV APPL, V11, DOI 10.1103/PhysRevApplied.11.014030; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Marandi A, 2014, NAT PHOTONICS, V8, P937, DOI [10.1038/nphoton.2014.249, 10.1038/NPHOTON.2014.249]; MILBURN GJ, 1991, PHYS REV A, V44, P4704, DOI 10.1103/PhysRevA.44.4704; Munro WJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023819; Ofek N, 2016, NATURE, V536, P441, DOI 10.1038/nature18949; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Puri S., 2019, SCI ADV; Puri S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15785; Puri S, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0019-1; Sank D, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.190503; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Siddiqi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.027005; Touzard S, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021005; Tuckett DK, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.050505; Vuillot C, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.032344; Wang ZY, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021049; Wilson CM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.233907; Wustmann W, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.184501; YURKE B, 1988, PHYSICA B & C, V151, P298, DOI 10.1016/0378-4363(88)90181-7; Zhang Y N, 2017, J HEALTHCARE ENG, V2017, P2017; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	41	98	99	2	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					205	+		10.1038/s41586-020-2587-z	http://dx.doi.org/10.1038/s41586-020-2587-z			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788737	Green Accepted			2022-12-28	WOS:000559831500010
J	Howlader, N; Forjaz, G; Mooradian, MJ; Meza, R; Kong, CY; Cronin, KA; Mariotto, AB; Lowy, DR; Feuer, EJ				Howlader, Nadia; Forjaz, Goncalo; Mooradian, Meghan J.; Meza, Rafael; Kong, Chung Yin; Cronin, Kathleen A.; Mariotto, Angela B.; Lowy, Douglas R.; Feuer, Eric J.			The Effect of Advances in Lung-Cancer Treatment on Population Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-HODGKIN-LYMPHOMA; OPEN-LABEL; PROSTATE-CANCER; PHASE-III; TRENDS; DOCETAXEL; NIVOLUMAB; ADENOCARCINOMA; MULTICENTER; SMOKING	Lung-cancer incidence has been decreasing in part because of a decrease in smoking. However, the decline in population-based mortality from non-small-cell lung cancer has been greater than can be accounted for by cancer screening and a decrease in cancer incidence. Evidence indicates that advances in treatment account for the acceleration in decreased mortality. Background Lung cancer is made up of distinct subtypes, including non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Although overall mortality from lung cancer has been declining in the United States, little is known about mortality trends according to cancer subtype at the population level because death certificates do not record subtype information. Methods Using data from Surveillance, Epidemiology, and End Results (SEER) areas, we assessed lung-cancer mortality and linked deaths from lung cancer to incident cases in SEER cancer registries. This allowed us to evaluate population-level mortality trends attributed to specific subtypes (incidence-based mortality). We also evaluated lung-cancer incidence and survival according to cancer subtype, sex, and calendar year. Joinpoint software was used to assess changes in incidence and trends in incidence-based mortality. Results Mortality from NSCLC decreased even faster than the incidence of this subtype, and this decrease was associated with a substantial improvement in survival over time that corresponded to the timing of approval of targeted therapy. Among men, incidence-based mortality from NSCLC decreased 6.3% annually from 2013 through 2016, whereas the incidence decreased 3.1% annually from 2008 through 2016. Corresponding lung cancer-specific survival improved from 26% among men with NSCLC that was diagnosed in 2001 to 35% among those in whom it was diagnosed in 2014. This improvement in survival was found across all races and ethnic groups. Similar patterns were found among women with NSCLC. In contrast, mortality from SCLC declined almost entirely as a result of declining incidence, with no improvement in survival. This result correlates with limited treatment advances for SCLC in the time frame we examined. Conclusions Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, and survival after diagnosis improved substantially. Our analysis suggests that a reduction in incidence along with treatment advances - particularly approvals for and use of targeted therapies - is likely to explain the reduction in mortality observed during this period.	[Howlader, Nadia; Forjaz, Goncalo; Cronin, Kathleen A.; Mariotto, Angela B.; Feuer, Eric J.] NCI, Surveillance Res Program, Div Canc Control & Populat Sci, 9609 Med Ctr Dr,Rm 4E532, Bethesda, MD 20892 USA; [Lowy, Douglas R.] NCI, Off Director, Bethesda, MD 20892 USA; [Mooradian, Meghan J.; Kong, Chung Yin] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Meza, Rafael] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Michigan System; University of Michigan	Howlader, N (corresponding author), NCI, Surveillance Res Program, Div Canc Control & Populat Sci, 9609 Med Ctr Dr,Rm 4E532, Bethesda, MD 20892 USA.	howladern@mail.nih.gov						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], HPR1882 DTSQ; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Blom EF, 2020, ANN AM THORAC SOC, V17, P186, DOI 10.1513/AnnalsATS.201901-094OC; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brenner H, 2014, J CLIN EPIDEMIOL, V67, P184, DOI 10.1016/j.jclinepi.2013.08.017; CHU KC, 1994, J CLIN EPIDEMIOL, V47, P1451, DOI 10.1016/0895-4356(94)90089-2; Clegg LX, 2002, J NATL CANCER I, V94, P1537; Feuer EJ, 1999, JNCI-J NATL CANCER I, V91, P1025, DOI 10.1093/jnci/91.12.1025; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Horn L, 2018, NEW ENGL J MED, V379, P2220, DOI 10.1056/NEJMoa1809064; Horn L, 2017, J CLIN ONCOL, V35, P3924, DOI 10.1200/JCO.2017.74.3062; Howlader N, 2018, SEER CANC STAT REV 1; Howlader N, 2016, CANCER EPIDEM BIOMAR, V25, P1289, DOI 10.1158/1055-9965.EPI-16-0273; Howlader N, 2016, CANCER EPIDEM BIOMAR, V25, P174, DOI 10.1158/1055-9965.EPI-15-0921; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Jemal A, 2017, JAMA ONCOL, V3, P1278, DOI 10.1001/jamaoncol.2016.6416; Jeon J, 2018, ANN INTERN MED, V169, P684, DOI [10.7326/M18-1250, 10.7326/m18-1250]; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Li YL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209709; Mariotto Angela B, 2014, J Natl Cancer Inst Monogr, V2014, P145, DOI 10.1093/jncimonographs/lgu024; Meza R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121323; Nabi J, 2019, HLTH AFFAIRS BLOG; Phipps AI, 2012, AM J PUBLIC HEALTH, V102, P1791, DOI 10.2105/AJPH.2011.300393; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2016, NEW ENGL J MED, V374, P54, DOI 10.1056/NEJMoa1508887; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Travis WD, 2015, J THORAC ONCOL, V10, P1240, DOI 10.1097/JTO.0000000000000663; Wachtel MS, 2013, PROSTATE, V73, P1365, DOI 10.1002/pros.22680; Ward EM, 2019, JNCI-J NATL CANCER I, V111, P1279, DOI 10.1093/jnci/djz106; Yu MD, 2014, CANCER EPIDEM BIOMAR, V23, P1546, DOI 10.1158/1055-9965.EPI-14-0130	38	419	427	26	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					640	649		10.1056/NEJMoa1916623	http://dx.doi.org/10.1056/NEJMoa1916623			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32786189	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000562771200011
J	Diaz-Urrutia, C; Ott, T				Diaz-Urrutia, Christian; Ott, Timo			Response to Comment on "Activation of methane to CH3+: A selective industrial route to methanesulfonic acid"	SCIENCE			English	Editorial Material							ETHANE; FUNCTIONALIZATION; OXIDATION; ALKANES	Roytman and Singleton argue that our proposed electrophilic mechanism for the sulfonation of methane in superacid conditions is "not plausible." We clarify certain terms that might have caused misinterpretation of our proposed mechanism and supplement the discussion. We reaffirm that an electrophilic mechanism may be operative under our reaction conditions.	[Diaz-Urrutia, Christian; Ott, Timo] Grillo Werke AG, R&D Dept, Chem Div, D-47169 Duisburg, Germany		Ott, T (corresponding author), Grillo Werke AG, R&D Dept, Chem Div, D-47169 Duisburg, Germany.	t.ott@grillo.de		Ott, Timo/0000-0002-3408-0956	Grillo-Werke AG	Grillo-Werke AG	This work was solely supported by Grillo-Werke AG.	Basickes N, 1996, J AM CHEM SOC, V118, P13111, DOI 10.1021/ja9632365; Diaz-Urrutia C, 2019, SCIENCE, V363, P1326, DOI 10.1126/science.aav0177; Fuller JT, 2016, ACS CATAL, V6, P4312, DOI 10.1021/acscatal.6b00226; Gunsalus NJ, 2017, CHEM REV, V117, P8521, DOI 10.1021/acs.chemrev.6b00739; Konnick MM, 2014, J AM CHEM SOC, V136, P10085, DOI 10.1021/ja504368r; Mukhopadhyay S, 2003, ORG PROCESS RES DEV, V7, P161, DOI 10.1021/op020079n; Olah G.A., 2009, SUPERACID CHEM, V2; OLAH GA, 1977, J AM CHEM SOC, V99, P483, DOI 10.1021/ja00444a027; ROBINSON EA, 1966, CAN J CHEMISTRY, V44, P1437, DOI 10.1139/v66-212; Roytman VA, 2019, SCIENCE, V364, DOI 10.1126/science.aax7083; Schuth F, 2019, SCIENCE, V363, P1282, DOI 10.1126/science.aaw7738; SEN A, 1994, J AM CHEM SOC, V116, P998, DOI 10.1021/ja00082a022; Shi HC, 2006, J MOL CATAL A-CHEM, V258, P35, DOI 10.1016/j.molcata.2006.05.017; WALRAFEN GE, 1960, T FARADAY SOC, V56, P1419, DOI 10.1039/tf9605601419	14	1	1	3	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504							eaax9966	10.1126/science.aax9966	http://dx.doi.org/10.1126/science.aax9966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764039				2022-12-28	WOS:000559184400001
J	Maxmen, A; Tollefson, J				Maxmen, Amy; Tollefson, Jeff			THE PROBLEM WITH PANDEMIC PLANNING	NATURE			English	News Item						SARS-CoV-2; Epidemiology; Politics		Two decades of war-game scenarios foresaw leaky travel bans, a scramble for vaccines and disputes between state and federal leaders. But none predicted Donald Trump.											0	11	11	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					26	29		10.1038/d41586-020-02277-6	http://dx.doi.org/10.1038/d41586-020-02277-6			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU9KG	32753759				2022-12-28	WOS:000555983600010
J	Oliver, D				Oliver, David			David Oliver: The medical examiner role could transform our approach to handling death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Department of Health and Social Care, CONS OUTC DEATH CERT; NHS, 2020, COR ACT EXC DEATH PR; Oliver D., 2020, INDEPENDENT     0514; Royal College of Pathologists, SETT MED EX SYST; Royal College of Physicians, 2019, RCPS NAT MORT CAS RE; Welsh Government, 2018, INTR MED EX WAL CONS	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3050	10.1136/bmj.m3035	http://dx.doi.org/10.1136/bmj.m3035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32764076	Bronze			2022-12-28	WOS:000560719800002
J	Wise, J				Wise, Jacqui			Leicester lockdown: could better data have prevented it?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Bird S., 2020, SIGNIFICANCE; Halliday J, 2020, GUARDIAN; Hancock M, 2020, COMMUNICATION   0629; Leicester City Council, 2020, COV 19 LEIC; Leicester City Council, 2020, MEAS COV 19 LEIC; Rapid Investigation Team, 2020, PREL INV COV 19 EXC	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m3028	10.1136/bmj.m3028	http://dx.doi.org/10.1136/bmj.m3028			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759327	Bronze			2022-12-28	WOS:000556139400010
J	Mahase, E				Mahase, Elisabeth			Four in 10 dementia cases could be prevented or delayed by targeting risk factors, report says	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2020	370								m3050	10.1136/bmj.m3050	http://dx.doi.org/10.1136/bmj.m3050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1QV	32747331				2022-12-28	WOS:000556138700008
J	Mahase, E				Mahase, Elisabeth			Sixty seconds on ... waves	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centre for Evidence-Based Medicine, 2020, COVID 19 EP WAV	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2020	370								m3074	10.1136/bmj.m3074	http://dx.doi.org/10.1136/bmj.m3074			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1QV	32747338	Bronze			2022-12-28	WOS:000556138700007
J	Griffin, MP; Yuan, Y; Takas, T; Domachowske, JB; Madhi, SA; Manzoni, P; Simoes, EAF; Esser, MT; Khan, AA; Dubovsky, F; Villafana, T; DeVincenzo, JP				Griffin, M. Pamela; Yuan, Yuan; Takas, Therese; Domachowske, Joseph B.; Madhi, Shabir A.; Manzoni, Paolo; Simoes, Eric A. F.; Esser, Mark T.; Khan, Anis A.; Dubovsky, Filip; Villafana, Tonya; DeVincenzo, John P.		Nirsevimab Study Grp	Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL-ANTIBODY; YOUNG-CHILDREN; DISEASE; MOTAVIZUMAB; BURDEN; PALIVIZUMAB; PROPHYLAXIS; HOSPITALIZATION; BRONCHIOLITIS	BackgroundRespiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants, and a need exists for prevention of RSV in healthy infants. Nirsevimab is a monoclonal antibody with an extended half-life that is being developed to protect infants for an entire RSV season with a single intramuscular dose. MethodsIn this trial conducted in both northern and southern hemispheres, we evaluated nirsevimab for the prevention of RSV-associated lower respiratory tract infection in healthy infants who had been born preterm (29 weeks 0 days to 34 weeks 6 days of gestation). We randomly assigned the infants in a 2:1 ratio to receive nirsevimab, at a dose of 50 mg in a single intramuscular injection, or placebo at the start of an RSV season. The primary end point was medically attended RSV-associated lower respiratory tract infection through 150 days after administration of the dose. The secondary efficacy end point was hospitalization for RSV-associated lower respiratory tract infection through 150 days after administration of the dose. ResultsFrom November 2016 through November 2017, a total of 1453 infants were randomly assigned to receive nirsevimab (969 infants) or placebo (484 infants) at the start of the RSV season. The incidence of medically attended RSV-associated lower respiratory tract infection was 70.1% lower (95% confidence interval [CI], 52.3 to 81.2) with nirsevimab prophylaxis than with placebo (2.6% [25 infants] vs. 9.5% [46 infants]; P<0.001) and the incidence of hospitalization for RSV-associated lower respiratory tract infection was 78.4% lower (95% CI, 51.9 to 90.3) with nirsevimab than with placebo (0.8% [8 infants] vs. 4.1% [20 infants]; P<0.001). These differences were consistent throughout the 150-day period after the dose was administered and across geographic locations and RSV subtypes. Adverse events were similar in the two trial groups, with no notable hypersensitivity reactions. ConclusionsA single injection of nirsevimab resulted in fewer medically attended RSV-associated lower respiratory tract infections and hospitalizations than placebo throughout the RSV season in healthy preterm infants. (Funded by AstraZeneca and Sanofi Pasteur; ClinicalTrials.gov number, NCT02878330.) Nirsevimab, a monoclonal antibody with an extended half-life, is designed to protect infants from respiratory syncytial virus disease after a single intramuscular dose. This placebo-controlled trial involving 1447 preterm infants at 164 sites in 23 countries assessed the effectiveness of nirsevimab over 150 days after the dose was administered.	[Griffin, M. Pamela; Yuan, Yuan; Takas, Therese; Esser, Mark T.; Khan, Anis A.; Dubovsky, Filip; Villafana, Tonya] AstraZeneca, Gaithersburg, MD USA; [Domachowske, Joseph B.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Natl Res Fdn, Dept Sci & Technol,South African Res Chair, Johannesburg, South Africa; [Manzoni, Paolo] St Anna Hosp, AOU Citta Salute & Sci, Nuovo Osped Infermi Biella & Neonatol & NICU, Dept Maternal Neonatal & Infant Med,Div Pediat &, Turin, Italy; [Simoes, Eric A. F.] Univ Colorado, Sch Med, Aurora, CO USA; [DeVincenzo, John P.] Le Bonheur Childrens Hosp, Childrens Fdn, Res Inst, Memphis, TN USA	AstraZeneca; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna; University of Colorado System; University of Colorado Anschutz Medical Campus	Villafana, T (corresponding author), AstraZeneca, R&D Biopharmaceut, 1 MedImmune Way, Gaithersburg, MD 20878 USA.	tonya.villafana@astrazeneca.com	Richmond, Peter C/G-3379-2012; Papenburg, Jesse/I-7847-2019; Biban, Paolo/ABD-1352-2020; Martinon-Torres, Federico/E-4982-2016; Yuan, Yuan/H-4007-2013; Perrett, Kirsten/P-8813-2019; Faust, Saul/J-9779-2014	Richmond, Peter C/0000-0001-7562-7228; Papenburg, Jesse/0000-0003-4232-871X; Martinon-Torres, Federico/0000-0002-9023-581X; Madhi, Shabir/0000-0002-7629-0636; Yuan, Yuan/0000-0003-4706-7897; Perrett, Kirsten/0000-0002-5683-996X; Faust, Saul/0000-0003-3410-7642	AstraZeneca; Sanofi Pasteur; Regeneron; GlaxoSmithKline; Merck; Bill & Melinda Gates Foundation; Sanofi; Roche; AbbVie; Alere; Johnson Johnson; Novavax; University of Tennessee; Reviral - AstraZeneca	AstraZeneca(AstraZeneca); Sanofi Pasteur; Regeneron(Regeneron); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Sanofi; Roche(Roche Holding); AbbVie(AbbVie); Alere; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Novavax; University of Tennessee; Reviral - AstraZeneca(AstraZeneca)	Supported by AstraZeneca and Sanofi Pasteur.; Dr. Griffin reports being employed by and owning stock in AstraZeneca; Dr. Yuan, being employed by and owning stock in AstraZeneca; Ms. Takas, being employed by and owning stock in AstraZeneca; Dr. Domachowske, receiving fees for clinical trial activities, paid to his institution, from Regeneron, GlaxoSmithKline, and Merck; Dr. Madhi, receiving grant support, paid to his institution, and advisory board fees from the Bill & Melinda Gates Foundation, and grant support, paid to his institution, from Pfizer, GlaxoSmithKline, Minervax, and Sanofi; Dr. Manzoni, receiving advisory board fees from AstraZeneca; Dr. Simoes, receiving grant support, paid to his institution, consulting fees, and travel support from AstraZeneca, Merck, Regeneron, Pfizer, and Roche, consulting fees, lecture fees, fees for serving on a data and safety monitoring board, and travel support from AbbVie, consulting fees from Alere, fees for serving on a data and safety monitoring board from GlaxoSmithKline, grant support, paid to his institution, from Johnson & Johnson, and grant support, paid to his institution, and travel support from Novavax; Dr. Esser, being employed by and owning stock in AstraZeneca; Dr. Khan, being employed by and owning stock in AstraZeneca and holding pending patent US 62/840,701 on dosage regimens for and compositions including Anti-RSV Antibodies, licensed to Sanofi, for which royalties are received; Dr. Dubovsky, being employed by and owning stock in AstraZeneca; Dr. Villafana, being employed by and owning stock options in AstraZeneca; and Dr. DeVincenzo, receiving advisory fees from Vir Biotechnology, Gilead, Adma Biologics, Pfizer, Enanta, GlaxoSmithKline, and Janssen, grant support, paid to the University of Tennessee, and advisory fees from ArkBio, owning stock options in ArkBio, and receiving grant support, paid to the University of Tennessee, and advisory fees from Reviral and Pulmocide. No other potential conflict of interest relevant to this article was reported.; We thank the trial investigators, trial participants, participants' families, and the nirsevimab study team; Vadryn Pierre, Ph.D., for conducting the noncompartmental analysis of the pharmacokinetic data; Michael McCarthy, Ph.D., for assistance with manuscript preparation; and Ruvini Jayasinghe, Ph.D., of Oxford PharmaGenesis, for medical writing support of an earlier version of the manuscript, funded by AstraZeneca. JK Associates, a member of the Fishawack Group of Companies, provided additional medical writing assistance, which was funded by AstraZeneca. Nirsevimab is being developed in partnership between AstraZeneca and Sanofi Pasteur.	Anderson EJ, 2020, AM J PERINAT, V37, P421, DOI 10.1055/s-0039-1681014; [Anonymous], 2010, JOINT COMMITTEE VACC; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 2017, SYN PAL HIGHL PRESCR; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Carbonell-Estrany X, 2010, PEDIATRICS, V125, pE35, DOI 10.1542/peds.2008-1036; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Chu HY, 2017, J CLIN VIROL, V95, P90, DOI 10.1016/j.jcv.2017.08.017; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Feltes TF, 2011, PEDIATR RES, V70, P186, DOI 10.1203/PDR.0b013e318220a553; Giersing BK, 2019, VACCINE, V37, P7355, DOI 10.1016/j.vaccine.2017.02.068; Griffin MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01714-16, 10.1128/aac.01714-16]; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Hall C, 2009, TXB PEDIAT INFECT DI, P2462; Hall Caroline Breese, 2012, Infectious Disorders - Drug Targets, V12, P92; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Karron RA, 2018, LANCET RESP MED, V6, P65, DOI 10.1016/S2213-2600(17)30303-X; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Mazur NI, 2018, LANCET INFECT DIS, V18, pE295, DOI 10.1016/S1473-3099(18)30292-5; Miller EK, 2013, PEDIATR INFECT DIS J, V32, P950, DOI 10.1097/INF.0b013e31829b7e43; Munoz FM, 2019, 27 ANN M EUR SOC PAE; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; O'Brien KL, 2015, LANCET INFECT DIS, V15, P1398, DOI 10.1016/S1473-3099(15)00247-9; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Robbie GJ, 2012, ANTIMICROB AGENTS CH, V56, P4927, DOI 10.1128/AAC.06446-11; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Simoes EAF, 2015, J INFECT DIS, V211, pS1, DOI 10.1093/infdis/jiu828; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Villafana T, 2017, EXPERT REV VACCINES, V16, P737, DOI 10.1080/14760584.2017.1333425; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	150	159	10	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					415	425		10.1056/NEJMoa1913556	http://dx.doi.org/10.1056/NEJMoa1913556			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW2GI	32726528	Bronze			2022-12-28	WOS:000556861800009
J	He, YP; Hariharan, M; Gorkin, DU; Dickel, DE; Luo, CY; Castanon, RG; Nery, JR; Lee, AY; Zhao, Y; Huang, H; Williams, BA; Trout, D; Amrhein, H; Fang, RX; Chen, HM; Li, B; Visel, A; Pennacchio, LA; Ren, B; Ecker, JR				He, Yupeng; Hariharan, Manoj; Gorkin, David U.; Dickel, Diane E.; Luo, Chongyuan; Castanon, Rosa G.; Nery, Joseph R.; Lee, Ah Young; Zhao, Yuan; Huang, Hui; Williams, Brian A.; Trout, Diane; Amrhein, Henry; Fang, Rongxin; Chen, Huaming; Li, Bin; Visel, Axel; Pennacchio, Len A.; Ren, Bing; Ecker, Joseph R.			Spatiotemporal DNA methylome dynamics of the developing mouse fetus	NATURE			English	Article							TRANSCRIPTION FACTORS; STEM-CELLS; METHYLATION LANDSCAPE; SUPER-ENHANCERS; WEB SERVER; CHROMATIN; BINDING; BASE; IDENTITY; NEURONS	Cytosine DNA methylation is essential for mammalian development but understanding of its spatiotemporal distribution in the developing embryo remains limited(1,2). Here, as part of the mouse Encyclopedia of DNA Elements (ENCODE) project, we profiled 168 methylomes from 12 mouse tissues or organs at 9 developmental stages from embryogenesis to adulthood. We identified 1,808,810 genomic regions that showed variations in CG methylation by comparing the methylomes of different tissues or organs from different developmental stages. These DNA elements predominantly lose CG methylation during fetal development, whereas the trend is reversed after birth. During late stages of fetal development, non-CG methylation accumulated within the bodies of key developmental transcription factor genes, coinciding with their transcriptional repression. Integration of genome-wide DNA methylation, histone modification and chromatin accessibility data enabled us to predict 461,141 putative developmental tissue-specific enhancers, the human orthologues of which were enriched for disease-associated genetic variants. These spatiotemporal epigenome maps provide a resource for studies of gene regulation during tissue or organ progression, and a starting point for investigating regulatory elements that are involved in human developmental disorders. Analysis of 168 methylomes from 12 mouse tissues at 9 developmental stages sheds light on the epigenetic and regulatory landscape during mammalian fetal development.	[He, Yupeng; Hariharan, Manoj; Luo, Chongyuan; Castanon, Rosa G.; Nery, Joseph R.; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [He, Yupeng; Zhao, Yuan; Fang, Rongxin] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Gorkin, David U.; Lee, Ah Young; Zhao, Yuan; Huang, Hui; Fang, Rongxin; Li, Bin; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dickel, Diane E.; Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA; [Huang, Hui] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Williams, Brian A.; Trout, Diane; Amrhein, Henry] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, US DOE, Joint Genome Inst, Berkeley, CA USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Diego; California Institute of Technology; United States Department of Energy (DOE); Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California Merced; University of California System; University of California Berkeley; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Visel, Axel/A-9398-2009	Ecker, Joseph R/0000-0001-5799-5895; Visel, Axel/0000-0002-4130-7784; Pennacchio, Len/0000-0002-8748-3732; Chen, Huaming/0000-0001-5289-7882; Fang, Rongxin/0000-0003-0107-7504; Dickel, Diane/0000-0001-5497-6824; Ren, Bing/0000-0002-5435-1127				1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Bembom O., 2016, SEQLOGO SEQUENCE LOG; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanovic O, 2016, NAT GENET, V48, P417, DOI 10.1038/ng.3522; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17186; Gorkin DU, 2020, NATURE, V583, P744, DOI 10.1038/s41586-020-2093-3; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; He Peng, 2020, Nature, V583, P760, DOI 10.1038/s41586-020-2536-x; He YP, 2017, P NATL ACAD SCI USA, V114, pE1633, DOI 10.1073/pnas.1618353114; He YP, 2015, ANNU REV GENOM HUM G, V16, P55, DOI 10.1146/annurev-genom-090413-025437; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Jones K. L., 2005, RECOGNIZABLE PATTERN; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Stroud H, 2017, CELL, V171, P1151, DOI 10.1016/j.cell.2017.09.047; Svendsen CN, 2001, NAT REV NEUROSCI, V2, P831, DOI 10.1038/35097581; Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu H, 2016, NAT REV GENET, V17, P551, DOI 10.1038/nrg.2016.83; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	79	40	40	8	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					752	+		10.1038/s41586-020-2119-x	http://dx.doi.org/10.1038/s41586-020-2119-x			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728242	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000554831500026
J	Chlebowski, RT; Anderson, GL; Aragaki, AK; Manson, JE; Stefanick, ML; Pan, K; Barrington, W; Kuller, LH; Simon, MS; Lane, D; Johnson, KC; Rohan, TE; Gass, MLS; Cauley, JA; Paskett, ED; Sattari, M; Prentice, RL				Chlebowski, Rowan T.; Anderson, Garnet L.; Aragaki, Aaron K.; Manson, JoAnn E.; Stefanick, Marcia L.; Pan, Kathy; Barrington, Wendy; Kuller, Lewis H.; Simon, Michael S.; Lane, Dorothy; Johnson, Karen C.; Rohan, Thomas E.; Gass, Margery L. S.; Cauley, Jane A.; Paskett, Electra D.; Sattari, Maryam; Prentice, Ross L.			Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; SYMPTOM EXPERIENCE; EQUINE ESTROGEN; TAMOXIFEN; HYSTERECTOMY; PREVENTION; OUTCOMES; RISK	IMPORTANCE The influence of menopausal hormone therapy on breast cancer remains unsettled with discordant findings from observational studies and randomized clinical trials. OBJECTIVE To assess the association of prior randomized use of estrogen plus progestin or prior randomized use of estrogen alone with breast cancer incidence and mortality in the Women's Health Initiative clinical trials. DESIGN, SETTING, AND PARTICIPANTS Long-term follow-up of 2 placebo-controlled randomized clinical trials that involved 27347 postmenopausal women aged 50 through 79 years with no prior breast cancer and negative baseline screening mammogram. Women were enrolled at 40 US centers from 1993 to 1998 with follow-up through December 31, 2017. INTERVENTIONS In the trial involving 16 608 women with a uterus, 8506 were randomized to receive 0.625 mg/d of conjugated equine estrogen (CEE) plus 2.5 mg/d of medroxyprogesterone acetate (MPA) and 8102, placebo. In the trial involving 10 739 women with prior hysterectomy, 5310 were randomized to receive 0.625 mg/d of CEE alone and 5429, placebo. The CEE-plus-MPA trial was stopped in 2002 after 5.6 years' median intervention duration, and the CEE-only trial was stopped in 2004 after 7.2 years' median intervention duration. MAIN OUTCOMES AND MEASURES The primary outcome was breast cancer incidence (protocol prespecified primary monitoring outcome for harm) and secondary outcomes were deaths from breast cancer and deaths after breast cancer. RESULTS Among 27 347 postmenopausal women who were randomized in both trials (baseline mean [SD] age, 63.4 years [7.2 years]), after more than 20 years of median cumulative follow-up, mortality information was available for more than 98%. CEE alone compared with placebo among 10 739 women with a prior hysterectomy was associated with statistically significantly lower breast cancer incidence with 238 cases (annualized rate, 0.30%) vs 296 cases (annualized rate, 0.37%; hazard ratio [HR], 0.78; 95% CI, 0.65-0.93; P =.005) and was associated with statistically significantly lower breast cancer mortality w th 30 deaths (annualized mortality rate, 0.031%) vs 46 deaths (annualized mortality rate, 0.046%; HR, 0.60; 95% CI, 0.37-0.97; P =.04). In contrast, CEE plus MPA compared with placebo among 16 608 women with a uterus was associated with statistically significantly higher breast cancer incidence with 584 cases (annualized rate, 0.45%) vs 447 cases (annualized rate, 0.36%; HR, 1.28; 95% CI, 1.13-1.45; P <.001) and no significant difference in breast cancer mortality with 71 deaths (annualized mortality rate, 0.045%) vs 53 deaths (annualized mortality rate, 0.035%; HR, 1.35; 95% CI, 0.94-1.95; P=.11). CONCLUSIONS AND RELEVANCE In this long-term follow-up study of 2 randomized trials, prior randomized use of CEE alone, compared with placebo, among women who had a previous hysterectomy, was significantly associated with lower breast cancer incidence and lower breast cancer mortality, whereas prior randomized use of CEE plus MPA, compared with placebo, among women who had an intact uterus, was significantly associated with a higher breast cancer incidence but no significant difference in breast cancer mortality.	[Chlebowski, Rowan T.; Pan, Kathy] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, 1124 W Carson St,Bldg N-18, Torrance, CA 90502 USA; [Anderson, Garnet L.; Aragaki, Aaron K.; Gass, Margery L. S.; Prentice, Ross L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Manson, JoAnn E.] Harvard Med Sch, Brigham & Womens Hosp, Div Publ Hlth Sci, Boston, MA 02115 USA; [Stefanick, Marcia L.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Barrington, Wendy] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kuller, Lewis H.; Cauley, Jane A.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Simon, Michael S.] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA; [Lane, Dorothy] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN 38163 USA; [Rohan, Thomas E.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Paskett, Electra D.] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Sattari, Maryam] Univ Florida Hlth Internal Med, Div Gen Internal Med, Gainesville, FL USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Barbara Ann Karmanos Cancer Institute; Wayne State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Health Science Center; Yeshiva University; Albert Einstein College of Medicine; University System of Ohio; Ohio State University	Chlebowski, RT (corresponding author), Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, 1124 W Carson St,Bldg N-18, Torrance, CA 90502 USA.	rowanchlebowski@gmail.com			NHLBI, National Institutes of Health, Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]	NHLBI, National Institutes of Health, Department of Health and Human Services	The Women's Health Initiative program is supported by the NHLBI, National Institutes of Health, Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221.	Abderrahman B, 2016, EXPERT REV ENDOCRINO, V11, P81, DOI 10.1586/17446651.2016.1128324; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bennett RL, 2007, J MED SCREEN, V14, P200, DOI 10.1258/096914107782912068; Beral V, 2019, LANCET, V394, P1139, DOI [10.1016/S0140-6736(19)32033-4, 10.1016/S0140-6736(19)32033-1]; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Brunner RL, 2010, MENOPAUSE, V17, P946, DOI 10.1097/gme.0b013e3181d76953; Centers for Disease Control and Prevention, WOMENS REPROD HLTH; Chlebowski RT, 2017, MENOPAUSE, V24, P133, DOI 10.1097/GME.0000000000000733; Chlebowski RT, 2015, JAMA ONCOL, V1, P296, DOI 10.1001/jamaoncol.2015.0494; Chlebowski RT, 2015, LANCET ONCOL, V16, P7, DOI 10.1016/S1470-2045(14)71184-2; Chlebowski RT, 2012, JNCI-J NATL CANCER I, V104, P517, DOI 10.1093/jnci/djs014; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Howell A, 2012, LANCET ONCOL, V13, P437, DOI 10.1016/S1470-2045(12)70110-9; Hulley SB, 2004, JAMA-J AM MED ASSOC, V291, P1769, DOI 10.1001/jama.291.14.1769; Joffe MM, 2001, EPIDEMIOLOGY, V12, P429, DOI 10.1097/00001648-200107000-00013; Jordan VC, 2008, J CLIN ONCOL, V26, P3073, DOI 10.1200/JCO.2008.17.5190; Joshi PA, 2015, JAMA ONCOL, V1, P283, DOI 10.1001/jamaoncol.2015.0512; Kim S, 2018, BREAST CANCER RES TR, V170, P667, DOI 10.1007/s10549-018-4782-2; Manson JE, 2019, ANN INTERN MED, V171, P406, DOI 10.7326/M19-0274; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; McTiernan A, 2009, J CLIN ONCOL, V27, P6135, DOI 10.1200/JCO.2008.21.7166; Ockene JK, 2005, JAMA-J AM MED ASSOC, V294, P183, DOI 10.1001/jama.294.2.183; Pocock S, 1999, LANCET, V353, P943, DOI 10.1016/S0140-6736(98)00379-1; Prentice RL, 2005, BIOMETRICS, V61, P899, DOI 10.1111/j.0006-341X.2005.454_1.x; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2019, CLIMACTERIC, V22, P3, DOI 10.1080/13697137.2017.1388364; Stefanick Marcia L, 2005, Am J Med, V118 Suppl 12B, P64, DOI 10.1016/j.amjmed.2005.09.059; Visvanathan K, 2019, J CLIN ONCOL, V37, P3152, DOI 10.1200/JCO.19.01472; 2019, LANCET, V394, P1159, DOI DOI 10.1016/S0140-6736(19)31709-X1016/S0140-6736(19)32033-1	39	110	113	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					369	380		10.1001/jama.2020.9482	http://dx.doi.org/10.1001/jama.2020.9482			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721007	Green Published, Bronze			2022-12-28	WOS:000562851000026
J	Fore, HH; Dongyu, Q; Beasley, DM; Ghebreyesus, TA				Fore, Henrietta H.; Qu Dongyu; Beasley, David M.; Ghebreyesus, Tedros A.			Child malnutrition and COVID-19: the time to act is now	LANCET			English	Editorial Material									[Fore, Henrietta H.] United Nations Childrens Fund, New York, NY 10017 USA; [Qu Dongyu] Food & Agr Org United Nations, Rome, Italy; [Beasley, David M.] World Food Programme, Rome, Italy; [Ghebreyesus, Tedros A.] WHO, Geneva, Switzerland	UNICEF; Food & Agriculture Organization of the United Nations (FAO); World Health Organization	Fore, HH (corresponding author), United Nations Childrens Fund, New York, NY 10017 USA.	hfore@unicef.org			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Headey D, 2020, LANCET, V396, P519, DOI 10.1016/S0140-6736(20)31647-0; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; UNICEF, 2020, SITUATION TRACKING F; UNICEF WHO World Bank Group, 2020, JOINT MALNUTRITION E; United Nations, 2020, THE IMPACT OF COVID; WHO, 2020, SCIENTIFIC BRIEF	6	63	63	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2020	396	10250					517	518		10.1016/S0140-6736(20)31648-2	http://dx.doi.org/10.1016/S0140-6736(20)31648-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OC4LV	32730742	Bronze, Green Published			2022-12-28	WOS:000579130500004
J	Baicker, K; Chandra, A				Baicker, Katherine; Chandra, Amitabh			Do We Spend Too Much on Health Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Health system reforms - such as changes in insurance design, patient cost sharing, payment reform, or price regulation - should be judged by whether they move us toward higher-value use of resources, rather than by whether they reduce spending.	[Baicker, Katherine] Univ Chicago, Chicago, IL 60637 USA; [Baicker, Katherine; Chandra, Amitabh] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Chandra, Amitabh] Harvard Univ, Cambridge, MA 02138 USA	University of Chicago; National Bureau of Economic Research; Harvard University	Baicker, K (corresponding author), Univ Chicago, Chicago, IL 60637 USA.; Baicker, K (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.							Acemoglu D, 2013, REV ECON STAT, V95, P1079, DOI 10.1162/REST_a_00306; Brot-Goldberg ZC, 2017, Q J ECON, V132, P1261, DOI 10.1093/qje/qjx013; Centers for Medicare Medicaid Services, 2020, NAT HLTH EXP DAT; Hartman M, 2020, HEALTH AFFAIR, V39, P8, DOI 10.1377/hlthaff.2019.01451	4	4	4	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					605	608		10.1056/NEJMp2006099	http://dx.doi.org/10.1056/NEJMp2006099			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE7HD	32786184				2022-12-28	WOS:000562771200005
J	Notman, N; Woolston, C				Notman, Nina; Woolston, Chris			LOOK BEYOND METRICS	NATURE			English	Editorial Material						Careers; Institutions; Publishing		Survey finds that standard metrics of success can't completely explain why some candidates get offers and others don't. Survey finds that standard metrics of success can't completely explain why some candidates get offers and others don't.										Fernandes J. D., 2020, ELIFE, V9, DOI 10.7554/eLife.540977360372	1	2	2	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					315	315		10.1038/d41586-020-02224-5	http://dx.doi.org/10.1038/d41586-020-02224-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW4DT	32710005				2022-12-28	WOS:000556990400001
J	Chambers, HF; Bayer, AS				Chambers, Henry F.; Bayer, Arnold S.			Native-Valve Infective Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; DUKE CRITERIA; EARLY SURGERY; DIAGNOSIS; THERAPY; ECHOCARDIOGRAPHY; GENTAMICIN; MANAGEMENT; DAPTOMYCIN; VANCOMYCIN	Native-Valve Infective Endocarditis The modified Duke criteria, which are based on findings on physical examination, echocardiography, microbiologic studies, and computed tomographic and magnetic resonance imaging of target organs, are sensitive and specific for the clinical diagnosis of infective endocarditis. Transesophageal echocardiography, which is more sensitive than transthoracic echocardiography (TTE) for identifying valvular vegetations and periannular complications of infective endocarditis, is indicated when TTE is negative or nondiagnostic. Beta-lactam antibiotics are recommended over vancomycin or daptomycin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. In older patients with infective endocarditis caused by Enterococcus faecalis, especially those with underlying renal disease or those receiving other nephrotoxic agents, ampicillin plus ceftriaxone is preferred over aminoglycoside-containing regimens. Early surgery for uncontrolled infection, congestive heart failure caused by valvular dysfunction, or prevention of central nervous system embolization is associated with improved outcomes. A transition to an oral step-down regimen after an initial intravenous course of therapy may be considered in selected patients. The diagnosis of infectious endocarditis is based on modified Duke criteria, according to findings on physical examination, echocardiography, microbiologic studies, and imaging of target organs. The selection and duration of antibiotic treatment depend on culture results. Early surgery is indicated in some patients.	[Chambers, Henry F.] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA; [Bayer, Arnold S.] Harbor UCLA Univ Calif Los Angeles Med Ctr, Div Infect Dis, Los Angeles, CA USA; [Bayer, Arnold S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bayer, Arnold S.] Lundquist Inst, Torrance, CA USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chambers, HF (corresponding author), Univ Calif San Francisco, Div HIV Infect Dis & Global Med, Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA.	henry.chambers@ucsf.edu	Rosca, Ovidiu/AAN-1781-2021					Afonso L, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0928-9; Ambrosioni J, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0574-9; [Anonymous], 2017, MEDICINE, V96, pe6504; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bai AD, 2017, J AM SOC ECHOCARDIOG, V30, P639, DOI 10.1016/j.echo.2017.03.007; Beganovic M, 2018, CLIN INFECT DIS, V67, P303, DOI 10.1093/cid/ciy064; Bin Abdulhak AA, 2014, GLOB HEART, V9, P131, DOI 10.1016/j.gheart.2014.01.002; Bundgaard H, 2019, NEW ENGL J MED, V380, P1373, DOI 10.1056/NEJMc1902096; Cahill TJ, 2016, LANCET, V387, P882, DOI 10.1016/S0140-6736(15)00067-7; Cosgrove SE, 2009, CLIN INFECT DIS, V48, P713, DOI 10.1086/597031; Dahl A, 2013, CIRCULATION, V127, P1810, DOI 10.1161/CIRCULATIONAHA.112.001170; Escola-Verge L, 2019, REV ESP CARDIOL; Fernandez-Hidalgo N, 2013, CLIN INFECT DIS, V56, P1261, DOI 10.1093/cid/cit052; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Gatti G, 2019, SCAND CARDIOVASC J, V53, P117, DOI 10.1080/14017431.2019.1610188; Geriak M, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02483-18, 10.1128/aac.02483-18]; Gomes A, 2017, LANCET INFECT DIS, V17, pE1, DOI 10.1016/S1473-3099(16)30141-4; Gritsenko D, 2017, CLIN THER, V39, P212, DOI 10.1016/j.clinthera.2016.12.005; Habib G, 1999, J AM COLL CARDIOL, V33, P2023, DOI 10.1016/S0735-1097(99)00116-3; Habib G, 2019, EUR HEART J, V40, P3222, DOI 10.1093/eurheartj/ehz620; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2010, EUR J ECHOCARDIOGR, V11, P202, DOI 10.1093/ejechocard/jeq004; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Holubar M, 2016, INFECT DIS CLIN N AM, V30, P491, DOI 10.1016/j.idc.2016.02.009; Iversen K, 2019, NEW ENGL J MED, V380, P415, DOI 10.1056/NEJMoa1808312; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Liang FX, 2016, INTERACT CARDIOV TH, V22, P336, DOI 10.1093/icvts/ivv368; Liesman RM, 2017, J CLIN MICROBIOL, V55, P2599, DOI [10.1128/JCM.00635-17, 10.1128/jcm.00635-17]; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Nakatani S, 2019, CIRC J, V83, P1767, DOI 10.1253/circj.CJ-19-0549; Nannini EC, 2009, ANTIMICROB AGENTS CH, V53, P3437, DOI 10.1128/AAC.00317-09; Narayanan MA, 2016, HEART, V102, P950, DOI 10.1136/heartjnl-2015-308589; Olaison L, 2002, CLIN INFECT DIS, V34, P159, DOI 10.1086/338233; Pericas JM, 2017, REV ESP CARDIOL, V70, P451, DOI [10.1016/j.rec.2016.10.013, 10.1016/j.recesp.2016.09.055]; Pettersson GB, 2014, J THORAC CARDIOV SUR, V147, P1142, DOI 10.1016/j.jtcvs.2013.11.031; Pettersson GB, 2017, J THORAC CARDIOV SUR, V153, P1241, DOI 10.1016/j.jtcvs.2016.09.093; Prendergast BD, 2004, HEART, V90, P611, DOI 10.1136/hrt.2003.029850; Spellberg B, 2020, JAMA INT MED; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Thwaites GE, 2018, LANCET, V391, P668, DOI 10.1016/S0140-6736(17)32456-X; Tong SYC, 2020, JAMA-J AM MED ASSOC, V323, P527, DOI 10.1001/jama.2020.0103; Venn RA, 2019, AM HEART J, V216, P102, DOI 10.1016/j.ahj.2019.07.011; Weis S, 2019, CLIN MICROBIOL INFEC, V25, P818, DOI 10.1016/j.cmi.2019.03.010; Wong D, 2016, AM J CARDIOL, V118, P1410, DOI 10.1016/j.amjcard.2016.07.053	45	30	33	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					567	576		10.1056/NEJMcp2000400	http://dx.doi.org/10.1056/NEJMcp2000400			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	32757525				2022-12-28	WOS:000560438400019
J	Galvez-Cardenas, KM; Varela, DC				Galvez-Cardenas, Kenny M.; Varela, Diana-Cristina			Uvula Amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Galvez-Cardenas, Kenny M.] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Varela, Diana-Cristina] Univ Pontificia Bolivariana, Medellin, Colombia	Universidad Pontificia Bolivariana	Varela, DC (corresponding author), Univ Pontificia Bolivariana, Medellin, Colombia.	dianacristinavarela@gmail.com		Varela Tabares, Diana-Cristina/0000-0002-6935-9615					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					577	577		10.1056/NEJMicm1915258	http://dx.doi.org/10.1056/NEJMicm1915258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32757526				2022-12-28	WOS:000560438400020
J	Liu, Z				Liu, Zhong			Errors in Trial of Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Liu, Zhong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, 26 Huacai Rd, Chengdu 610052, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Peking Union Medical College	Liu, Z (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, 26 Huacai Rd, Chengdu 610052, Sichuan, Peoples R China.	liuz@ibt.pumc.edu.cn	Liu, Zhong/ABH-8584-2020	liu, zhong/0000-0001-8173-9656				Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044	1	4	4	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					518	519		10.1001/jama.2020.12607	http://dx.doi.org/10.1001/jama.2020.12607			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749486				2022-12-28	WOS:000561261900033
J	Pelayo, R; Mourrain, P				Pelayo, Rafael; Mourrain, Philippe			William C. Dement (1928-2020)	SCIENCE			English	Editorial Material									[Pelayo, Rafael; Mourrain, Philippe] Stanford Univ, Sch Med, Sleep Med Div, Stanford, CA 94305 USA	Stanford University	Pelayo, R (corresponding author), Stanford Univ, Sch Med, Sleep Med Div, Stanford, CA 94305 USA.	pelayo@stanford.edu							0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					512	512		10.1126/science.abd6855	http://dx.doi.org/10.1126/science.abd6855			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732414				2022-12-28	WOS:000556568100029
J	Rimmer, A				Rimmer, Abi			NHS England workforce plan fails to tackle staff shortages, say health leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M464; MAHASE E, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L4019; NHS England, 2020, WE AR NHS PEOPL PLAN	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2020	370								m3057	10.1136/bmj.m3057	http://dx.doi.org/10.1136/bmj.m3057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RD	32737053				2022-12-28	WOS:000556139500007
J	Day, M				Day, Michael			Covid-19: Eight day quarantine is as good as 14 for returning travellers, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Clifford S, 2020, STRATEGIES REDUCE RI, DOI [10.1101/2020.07.24.20161281, DOI 10.1101/2020.07.24.20161281]	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3047	10.1136/bmj.m3047	http://dx.doi.org/10.1136/bmj.m3047			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732429	Bronze			2022-12-28	WOS:000556139900006
J	Evans, MK				Evans, Michele K.			Covid's Color Line - Infectious Disease, Inequity, and Racial Justice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The disproportionate effect of the Covid-19 pandemic on African Americans, Latinx Americans, and Native Americans is not unforeseen. Inequities in health, health care access, and quality of care are ingrained in our health care system, and they must be addressed now.	[Evans, Michele K.] NIA, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Evans, MK (corresponding author), NIA, Baltimore, MD 21224 USA.			Evans, Michele/0000-0002-8546-2831				Abdala N, 2016, AIDS BEHAV, V20, P512, DOI 10.1007/s10461-015-1043-9; Davis K, 2014, MIRROR WALL 2014 UPD; Espinosa M, 2014, SOC SCI HIST, V38, P437, DOI 10.1017/ssh.2015.20; Gamble VN, 2010, PUBLIC HEALTH REP, V125, P114; Grief SN, 2017, PRIMARY CARE, V44, P67, DOI 10.1016/j.pop.2016.09.011	5	58	58	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					408	410		10.1056/NEJMp2019445	http://dx.doi.org/10.1056/NEJMp2019445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32726526	Bronze			2022-12-28	WOS:000556861800007
J	Kuzmenko, A; Oguienko, A; Esyunina, D; Yudin, D; Petrova, M; Kudinova, A; Maslova, O; Ninova, M; Ryazansky, S; Leach, D; Aravin, AA; Kulbachinskiy, A				Kuzmenko, Anton; Oguienko, Anastasiya; Esyunina, Daria; Yudin, Denis; Petrova, Mayya; Kudinova, Alina; Maslova, Olga; Ninova, Maria; Ryazansky, Sergei; Leach, David; Aravin, Alexei A.; Kulbachinskiy, Andrey			DNA targeting and interference by a bacterial Argonaute nuclease	NATURE			English	Article							RECBCD ENZYME; REPAIR; BREAK	Members of the conserved Argonaute protein family use small RNA guides to locate their mRNA targets and regulate gene expression and suppress mobile genetic elements in eukaryotes(1,2). Argonautes are also present in many bacterial and archaeal species(3-5). Unlike eukaryotic proteins, several prokaryotic Argonaute proteins use small DNA guides to cleave DNA, a process known as DNA interference(6-10). However, the natural functions and targets of DNA interference are poorly understood, and the mechanisms of DNA guide generation and target discrimination remain unknown. Here we analyse the activity of a bacterial Argonaute nuclease fromClostridium butyricum(CbAgo) in vivo. We show thatCbAgo targets multicopy genetic elements and suppresses the propagation of plasmids and infection by phages.CbAgo induces DNA interference between homologous sequences and triggers DNA degradation at double-strand breaks in the target DNA. The loading ofCbAgo with locus-specific small DNA guides depends on both its intrinsic endonuclease activity and the cellular double-strand break repair machinery. A similar interaction was reported for the acquisition of new spacers during CRISPR adaptation, and prokaryotic genomes that encode Ago nucleases are enriched in CRISPR-Cas systems. These results identify molecular mechanisms that generate guides for DNA interference and suggest that the recognition of foreign nucleic acids by prokaryotic defence systems involves common principles. Argonaute protein from the bacteriumC. butyricumtargets multicopy genetic elements and functions in the suppression of plasmid and phage propagation, and there appears to be a DNA-mediated immunity pathway in prokaryotes.	[Kuzmenko, Anton; Oguienko, Anastasiya; Esyunina, Daria; Yudin, Denis; Petrova, Mayya; Kudinova, Alina; Maslova, Olga; Ryazansky, Sergei; Aravin, Alexei A.; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Kuzmenko, Anton; Ninova, Maria; Aravin, Alexei A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Leach, David] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Esyunina, Daria] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland	Russian Academy of Sciences; California Institute of Technology; University of Edinburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kuzmenko, A; Aravin, AA; Kulbachinskiy, A (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.; Kuzmenko, A; Aravin, AA (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	dr.ant.kuz@gmail.com; aaa@caltech.edu; avkulb@yandex.ru	Ryazansky, Sergei/K-3692-2016; Leach, David R/H-7159-2012; Kulbachinskiy, Andrey/P-5401-2016; Maslova, Olga A./D-3327-2019; Kudinova, Alina/ABC-7359-2021; Ninova, Maria/AAG-9476-2021	Ryazansky, Sergei/0000-0002-3171-2997; Leach, David R/0000-0003-4964-6913; Kulbachinskiy, Andrey/0000-0002-2292-6424; Maslova, Olga A./0000-0002-4301-8783; Ninova, Maria/0000-0001-5051-5502; Oguienko, Anastasiya/0000-0002-8473-6378; Kuzmenko, Anton/0000-0001-7169-0561; Yudin, Denis/0000-0002-4103-0543	Ministry of Science and Higher Education of the Russian Federation [14.W03.31.0007]; Russian Science Foundation [19-14-00359]; Russian Foundation for Basic Research [18-29-07086]; HHMI Faculty Scholar Award; MRC (UK) [MR/M019160/1]; MRC [MR/M019160/1] Funding Source: UKRI	Ministry of Science and Higher Education of the Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); HHMI Faculty Scholar Award; MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. A. White for strains with engineered I-SceI sites, G. Smith for RecBCD antibodies, S. Lysenkov for the help with statistical analysis and A. Olina for the help with the phage experiments. D.Y. would like to thank M. Kolesnik for discussions. The project was in part supported by the Ministry of Science and Higher Education of the Russian Federation (14.W03.31.0007), Russian Science Foundation (19-14-00359, analysis of DSB formation), Russian Foundation for Basic Research (18-29-07086). A.A.A. is supported by an HHMI Faculty Scholar Award. D.L. is supported by grant MR/M019160/1 from the MRC (UK).	Bernheim A, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0088; Bobay LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003825; Bohn C, 2004, MOL MICROBIOL, V52, P427, DOI 10.1111/j.1365-2958.2004.03985.x; CAPALDO FN, 1975, J MOL BIOL, V91, P53, DOI 10.1016/0022-2836(75)90371-X; CHAUDHURY AM, 1984, J BACTERIOL, V160, P788, DOI 10.1128/JB.160.2.788-791.1984; Couvin D, 2018, NUCLEIC ACIDS RES, V46, pW246, DOI 10.1093/nar/gky425; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Gebert D, 2015, WIRES RNA, V6, P687, DOI 10.1002/wrna.1310; He F, 2011, BIO-PROTOCOL, V101, pE97, DOI [10.21769/BioProtoc.97, DOI 10.21769/BI0PR0T0C.97]; Hegge JW, 2019, NUCLEIC ACIDS RES, V47, P5809, DOI 10.1093/nar/gkz306; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Jolly SM, 2020, CELL, V182, P1545, DOI 10.1016/j.cell.2020.07.036; Kaya E, 2016, P NATL ACAD SCI USA, V113, P4057, DOI 10.1073/pnas.1524385113; Koonin EV, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0177-2; Kuzmenko A, 2019, NUCLEIC ACIDS RES, V47, P5822, DOI 10.1093/nar/gkz379; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Lisitskaya L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07449-7; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Ofir G, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0051-0; Olina A, 2020, RNA BIOL, V17, P677, DOI 10.1080/15476286.2020.1724716; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Ryazansky S, 2018, MBIO, V9, DOI 10.1128/mBio.01935-18; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Sinha AK, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007256; Sinha AK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006895; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; Swarts DC, 2017, MOL CELL, V65, P985, DOI 10.1016/j.molcel.2017.01.033; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; White MA, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008473; White MA, 2018, NUCLEIC ACIDS RES, V46, P6670, DOI 10.1093/nar/gky463; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Willkomm S, 2018, FEMS MICROBIOL REV, V42, P376, DOI 10.1093/femsre/fuy010; Willkomm S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.35; Zander A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.34	46	40	42	6	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2020	587	7835					632	+		10.1038/s41586-020-2605-1	http://dx.doi.org/10.1038/s41586-020-2605-1		JUL 2020	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL3XR	32731256	Green Accepted			2022-12-28	WOS:000576135400001
J	Aragona, M; Sifrim, A; Malfait, M; Song, Y; Van Herck, J; Dekoninck, S; Gargouri, S; Lapouge, G; Swedlund, B; Dubois, C; Baatsen, P; Vints, K; Han, S; Tissir, F; Voet, T; Simons, BD; Blanpain, C				Aragona, Mariaceleste; Sifrim, Alejandro; Malfait, Milan; Song, Yura; Van Herck, Jens; Dekoninck, Sophie; Gargouri, Souhir; Lapouge, Gaelle; Swedlund, Benjamin; Dubois, Christine; Baatsen, Pieter; Vints, Katlijn; Han, Seungmin; Tissir, Fadel; Voet, Thierry; Simons, Benjamin D.; Blanpain, Cedric			Mechanisms of stretch-mediated skin expansion at single-cell resolution	NATURE			English	Article							SERUM RESPONSE FACTOR; READ ALIGNMENT; ALPHA-CATENIN; STEM; GROWTH; ACTIN; YAP; DIFFERENTIATION; MECHANOBIOLOGY; PROLIFERATION	The ability of the skin to grow in response to stretching has been exploited in reconstructive surgery(1). Although the response of epidermal cells to stretching has been studied in vitro(2,3), it remains unclear how mechanical forces affect their behaviour in vivo. Here we develop a mouse model in which the consequences of stretching on skin epidermis can be studied at single-cell resolution. Using a multidisciplinary approach that combines clonal analysis with quantitative modelling and single-cell RNA sequencing, we show that stretching induces skin expansion by creating a transient bias in the renewal activity of epidermal stem cells, while a second subpopulation of basal progenitors remains committed to differentiation. Transcriptional and chromatin profiling identifies how cell states and gene-regulatory networks are modulated by stretching. Using pharmacological inhibitors and mouse mutants, we define the step-by-step mechanisms that control stretch-mediated tissue expansion at single-cell resolution in vivo. Single-cell analysis in a mouse model of skin stretching shows that stretching causes a transient expansion bias in a population of epidermal stem cells, which is associated with chromatin remodelling and changes in transcriptional profiles.	[Aragona, Mariaceleste; Malfait, Milan; Song, Yura; Dekoninck, Sophie; Gargouri, Souhir; Lapouge, Gaelle; Swedlund, Benjamin; Dubois, Christine; Blanpain, Cedric] Univ Libre Bruxelles, Lab Stem Cells & Canc, Brussels, Belgium; [Sifrim, Alejandro; Van Herck, Jens; Voet, Thierry] Univ Leuven, Dept Human Genet, KU Leuven, Leuven, Belgium; [Sifrim, Alejandro; Van Herck, Jens; Voet, Thierry] Wellcome Trust Sanger Inst, Sanger Inst, EBI Single Cell Genom Ctr, Hinxton, England; [Baatsen, Pieter; Vints, Katlijn] Electron Microscopy Platform VIB Bio Imaging Core, Leuven, Belgium; [Han, Seungmin; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Han, Seungmin; Simons, Benjamin D.] Univ Cambridge, Stem Cell Inst, MRC, Wellcome Trust, Cambridge, England; [Tissir, Fadel] Catholic Univ Louvain, Inst Neurosci, Dev Neurobiol, Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge, England; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, Brussels, Belgium	Universite Libre de Bruxelles; KU Leuven; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Universite Catholique Louvain; University of Cambridge; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, Lab Stem Cells & Canc, Brussels, Belgium.; Simons, BD (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.; Simons, BD (corresponding author), Univ Cambridge, Stem Cell Inst, MRC, Wellcome Trust, Cambridge, England.; Simons, BD (corresponding author), Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge, England.; Blanpain, C (corresponding author), Univ Libre Bruxelles, WELBIO, Brussels, Belgium.	bds10@cam.ac.uk; cedric.blanpain@ulb.ac.be	Voet, Thierry/E-8877-2017; Simons, Benjamin/AAY-8920-2020; Aragona, Mariaceleste/AAB-7307-2021; Blanpain, Cedric/ABD-8392-2021; Malfait, Milan/AAW-1397-2020; Sifrim, Alejandro/AAY-2019-2021	Voet, Thierry/0000-0003-1204-9963; Simons, Benjamin/0000-0002-3875-7071; Aragona, Mariaceleste/0000-0002-2239-3541; Malfait, Milan/0000-0001-9144-3701; Sifrim, Alejandro/0000-0001-8247-4020; Song, Yura/0000-0002-1173-9172; Swedlund, Benjamin/0000-0002-8264-9342; Van Herck, Jens/0000-0002-1291-4462	HFSPO [LT000092/2016-L, LT000380/2015-L]; FNRS fellowship; Royal Society EP Abraham Research Professorship; Wellcome Trust [098357/Z/12/Z, 092096]; CRUK [C6946/A14492]; KU Leuven SymBioSys; FWO [12W7318N, 12O5617N]; FNRS; TELEVIE; PAI programme; Fondation Contre le Cancer; ULB foundation; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council (ERC-EXPAND) [616333]; Stiching Tegen Kanker; MRC [MC_PC_17230] Funding Source: UKRI	HFSPO(Human Frontier Science Program); FNRS fellowship(Fonds de la Recherche Scientifique - FNRS); Royal Society EP Abraham Research Professorship; Wellcome Trust(Wellcome Trust); CRUK(Cancer Research UK); KU Leuven SymBioSys(KU Leuven); FWO(FWO); FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; PAI programme; Fondation Contre le Cancer; ULB foundation; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council (ERC-EXPAND); Stiching Tegen Kanker; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the animal facility at ULB (Erasme campus), the ULB genomic core facility (F. Libert and A. Lefort), J.-M. Vanderwinden and LiMiF for the help with confocal microscopy, T. Van Brussel for help with 10X genomics, B. Gilbert, W. Declercq and P. Vieugue for helping with the TEWL assay, A. De Groote for performing mice perfusion, and colleagues who provided reagents mentioned in the text. scRNA-seq was performed at the Brussels Interuniversity Genomics High Throughput core and the Genomics Core Leuven. C.B. is an investigator of WELBIO. M.A. is supported by a long-term postdoctoral fellowship of the HFSPO (LT000380/2015-L) and an FNRS fellowship. B.D.S. is supported by a Royal Society EP Abraham Research Professorship and a Wellcome Trust Senior Investigator Award (098357/Z/12/Z). S.H. is supported by a long-term fellowship of the HFSPO (LT000092/2016-L). B.D.S and S.H. acknowledge core funding to the Gurdon Institute from the Wellcome Trust (092096) and CRUK (C6946/A14492). A.S., J.V.H. and T.V. are supported by KU Leuven SymBioSys, Stiching Tegen Kanker, FWO postdoctoral fellowship number 12W7318N and Marie Sklodowska-Curie fellowship number 12O5617N. F.T. is a research director at the FNRS. This work was supported by the FNRS, TELEVIE, the PAI programme, a research grant from the Fondation Contre le Cancer, the ULB foundation, the foundation Bettencourt Schueller, the foundation Baillet Latour and a consolidator grant of the European Research Council (ERC-EXPAND, 616333).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aragona M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14684; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Botchkarev VA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015248; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Damiani D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13509; Duda M, 2019, DEV CELL, V48, P245, DOI 10.1016/j.devcel.2018.12.020; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ellis SJ, 2019, NATURE, V569, P497, DOI 10.1038/s41586-019-1199-y; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirata H, 2015, EMBO REP, V16, P250, DOI 10.15252/embr.201439140; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Joost S, 2018, CELL REP, V25, P585, DOI 10.1016/j.celrep.2018.09.059; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Kirby TJ, 2018, NAT CELL BIOL, V20, P373, DOI 10.1038/s41556-018-0038-y; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeGoff L, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019232; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Mamidi A, 2018, NATURE, V564, P114, DOI 10.1038/s41586-018-0762-2; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mesa KR, 2018, CELL STEM CELL, V23, P677, DOI 10.1016/j.stem.2018.09.005; Miroshnikova YA, 2018, NAT CELL BIOL, V20, P69, DOI 10.1038/s41556-017-0005-z; Moreno E, 2019, CURR BIOL, V29, P23, DOI 10.1016/j.cub.2018.11.007; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nava MM, 2020, CELL, V181, P800, DOI 10.1016/j.cell.2020.03.052; Obdeijn MC, 2009, J PLAST RECONSTR AES, V62, P1219, DOI 10.1016/j.bjps.2007.12.088; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rognoni E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050411; Rompolas P, 2016, SCIENCE, V352, P1471, DOI 10.1126/science.aaf7012; Rottner K, 2017, J CELL SCI, V130, P3427, DOI 10.1242/jcs.206433; Sanchez-Danes A, 2016, NATURE, V536, P298, DOI 10.1038/nature19069; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tepole AB, 2016, ANN BIOMED ENG, V44, P1734, DOI 10.1007/s10439-015-1467-4; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vining KH, 2017, NAT REV MOL CELL BIO, V18, P728, DOI 10.1038/nrm.2017.108; Whitson RJ, 2018, NAT MED, V24, P271, DOI 10.1038/nm.4476; Wickstrom SA, 2018, CURR OPIN CELL BIOL, V54, P89, DOI 10.1016/j.ceb.2018.05.003; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yang KX, 2016, J ORTHOP RES, V34, P1121, DOI 10.1002/jor.23138; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zollner AM, 2013, J MECH BEHAV BIOMED, V28, P495, DOI 10.1016/j.jmbbm.2013.03.018	62	62	62	7	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					268	+		10.1038/s41586-020-2555-7	http://dx.doi.org/10.1038/s41586-020-2555-7		JUL 2020	33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32728211	Green Submitted, Green Accepted			2022-12-28	WOS:000553758900001
J	Kadosh, E; Snir-Alkalay, I; Venkatachalam, A; May, S; Lasry, A; Elyada, E; Zinger, A; Shaham, M; Vaalani, G; Mernberger, M; Stiewe, T; Pikarsky, E; Oren, M; Ben-Neriah, Y				Kadosh, Eliran; Snir-Alkalay, Irit; Venkatachalam, Avanthika; May, Shahaf; Lasry, Audrey; Elyada, Ela; Zinger, Adar; Shaham, Maya; Vaalani, Gitit; Mernberger, Marco; Stiewe, Thorsten; Pikarsky, Eli; Oren, Moshe; Ben-Neriah, Yinon			The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic	NATURE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; GAIN; MOUSE; TUMORIGENESIS; PROGRESSION; SENESCENCE; MUTATIONS; ABLATION; MODEL	In two mouse models of intestinal cancer, mutant p53 has an oncogenic effect in the distal gut but a tumour-suppressive effect in the proximal gut, and these opposing properties are determined by the gut microbiome. Somatic mutations in p53, which inactivate the tumour-suppressor function of p53 and often confer oncogenic gain-of-function properties, are very common in cancer(1,2). Here we studied the effects of hotspot gain-of-function mutations inTrp53(the gene that encodes p53 in mice) in mouse models of WNT-driven intestinal cancer caused byCsnk1a1deletion(3,4)orApc(Min)mutation(5). Cancer in these models is known to be facilitated by loss of p53(3,6). We found that mutant versions of p53 had contrasting effects in different segments of the gut: in the distal gut, mutant p53 had the expected oncogenic effect; however, in the proximal gut and in tumour organoids it had a pronounced tumour-suppressive effect. In the tumour-suppressive mode, mutant p53 eliminated dysplasia and tumorigenesis inCsnk1a1-deficient andApc(Min/+)mice, and promoted normal growth and differentiation of tumour organoids derived from these mice. In these settings, mutant p53 was more effective than wild-type p53 at inhibiting tumour formation. Mechanistically, the tumour-suppressive effects of mutant p53 were driven by disruption of the WNT pathway, through preventing the binding of TCF4 to chromatin. Notably, this tumour-suppressive effect was completely abolished by the gut microbiome. Moreover, a single metabolite derived from the gut microbiota-gallic acid-could reproduce the entire effect of the microbiome. Supplementing gut-sterilized p53-mutant mice and p53-mutant organoids with gallic acid reinstated the TCF4-chromatin interaction and the hyperactivation of WNT, thus conferring a malignant phenotype to the organoids and throughout the gut. Our study demonstrates the substantial plasticity of a cancer mutation and highlights the role of the microenvironment in determining its functional outcome.	[Kadosh, Eliran; Snir-Alkalay, Irit; Venkatachalam, Avanthika; May, Shahaf; Lasry, Audrey; Elyada, Ela; Zinger, Adar; Shaham, Maya; Vaalani, Gitit; Pikarsky, Eli; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel; [Mernberger, Marco; Stiewe, Thorsten] Philipps Univ Marburg, Genom Core Facil, Inst Mol Oncol, Marburg, Germany; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Lasry, Audrey] NYU, Sch Med, Dept Pathol, New York, NY USA; [Elyada, Ela] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	Hebrew University of Jerusalem; Philipps University Marburg; Weizmann Institute of Science; New York University; Cold Spring Harbor Laboratory	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel.	yinonb@ekmd.huji.ac.il	pikarsky, eli/GXV-7099-2022	Stiewe, Thorsten/0000-0003-0134-7826	Israel Science Foundation (ISF) Centers of Excellence [2084/15]; ISF within the Israel Precision Medicine Program [3165/19]; European Research Council [294390 PICHO, 281738 LIVERMICROENV]; Israel Cancer Research Fund Professorship	Israel Science Foundation (ISF) Centers of Excellence; ISF within the Israel Precision Medicine Program; European Research Council(European Research Council (ERC)European Commission); Israel Cancer Research Fund Professorship	We thank N. Cohen-Saban and N. Amsalem for assistance with mouse models; M. Biton for project discussions in the initial phase of this study; the Mass Spectrometry Unit of the Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem (HUJI) for MS analysis; and the Genomic Applications Laboratory, Core Research Facility and Faculty of Medicine at HUJI and I. Plaschkes (Bioinformatics Unit, The Robert H. Smith Faculty of Agriculture, Food and Environment at HUJI) for assistance with 16S rRNA sequence analysis. This work was supported by the Israel Science Foundation (ISF) Centers of Excellence (2084/15) to Y.B.-N., M.O. and E.P., the ISF (3165/19) within the Israel Precision Medicine Program to Y.B.-N., the European Research Council within the FP-7 to Y.B.-N. (294390 PICHO) and E.P (281738 LIVERMICROENV) and the Israel Cancer Research Fund Professorship to Y.B.-N.	Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Diaz-Quiroz DC, 2018, J ENZYM INHIB MED CH, V33, P397, DOI 10.1080/14756366.2017.1422125; Chen HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051001; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Huang Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22030353; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00162-16; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muir RM, 2011, PLANT MOL BIOL, V75, P555, DOI 10.1007/s11103-011-9739-3; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schulz-Heddergott R, 2018, CANCER CELL, V34, P298, DOI 10.1016/j.ccell.2018.07.004; Sklarz M., 2018, NEATSEQ FLOW LIGHTWE, DOI [10.1101/173005v3., DOI 10.1101/173005V3]; Stiewe T, 2018, DRUG RESIST UPDATE, V38, P27, DOI 10.1016/j.drup.2018.05.001; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yizhak K, 2019, SCIENCE, V364, P970, DOI 10.1126/science.aaw0726; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x	38	126	129	14	123	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 1	2020	586	7827					133	+		10.1038/s41586-020-2541-0	http://dx.doi.org/10.1038/s41586-020-2541-0		JUL 2020	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9IH	32728212	Green Accepted			2022-12-28	WOS:000554511600001
J	Dyer, O				Dyer, Owen			Covid-19: US states are not reporting vital data, says former CDC chief	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, TRACKING COVID 19 US; Centers for Disease Control and Prevention, CAS US	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2993	10.1136/bmj.m2993	http://dx.doi.org/10.1136/bmj.m2993			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32719009	Bronze			2022-12-28	WOS:000554458200002
J	Ball, P				Ball, Philip			The art of medicine How to get smarter about medical intervention	LANCET			English	Editorial Material									[Ball, Philip] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School								Ablin R., 2010, NY TIMES; Chaudhury A, 2017, P NATL ACAD SCI USA, V114, P12344, DOI 10.1073/pnas.1709228114; Hwang B, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0071-8; Louis DN, 2014, ARCH PATHOL LAB MED, V138, P1133, DOI 10.5858/arpa.2014-0034-ED; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Yang JH, 2019, CELL, V177	6	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2019	394	10215					2146	2147		10.1016/S0140-6736(19)33054-5	http://dx.doi.org/10.1016/S0140-6736(19)33054-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JV7MT	32738960				2022-12-28	WOS:000502546300015
J	Lyu, HC; Yoshida, K; Zhao, SS; Wei, J; Zeng, C; Tedeschi, SK; Leder, BZ; Lei, GH; Tang, PF; Solomon, DH				Lyu, Houchen; Yoshida, Kazuki; Zhao, Sizheng S.; Wei, Jie; Zeng, Chao; Tedeschi, Sara K.; Leder, Benjamin Z.; Lei, Guanghua; Tang, Peifu; Solomon, Daniel H.			Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; TARGET TRIAL; COLORECTAL-CANCER; DISCONTINUATION; DATABASE; THERAPY; METAANALYSIS; VALIDATION; PREVENTION	Background: Denosumab is effective for osteoporosis, but discontinuation leads to rapid reversal of its therapeutic effect. Objective: To estimate the risk for fracture among users of denosumab who delayed subsequent doses compared with users who received doses on time. Design: Population-based cohort study. Setting: The Health Improvement Network U.K. primary care database, 2010 to 2019. Patients: Persons aged 45 years or older who initiated denosumab therapy for osteoporosis. Measurements: Observational data were used to emulate an analysis of a hypothetical trial with 3 dosing intervals: subsequent denosumab injection given within 4 weeks after the recommended date ("on time"), delay by 4 to 16 weeks ("short delay"), and delay by more than 16 weeks ("long delay"). The primary outcome was a composite of all fracture types at 6 months after the recommended date. Secondary outcomes were major osteoporotic fracture, vertebral fracture, hip fracture, and nonvertebral fracture. Results: Investigators identified 2594 patients initiating denosumab therapy. The risk for composite fracture over 6 months was 27.3 in 1000 for on-time dosing, 32.2 in 1000 for short delay, and 42.4 in 1000 for long delay. Compared with on-time injections, short delay had a hazard ratio (HR) for composite fracture of 1.03 (95% CI, 0.63 to 1.69) and long delay an HR of 1.44 (CI, 0.96 to 2.17) (P for trend = 0.093). For vertebral fractures, short delay had an HR of 1.48 (CI, 0.58 to 3.79) and long delay an HR of 3.91 (CI, 1.62 to 9.45). Limitation: Dosing schedules were not randomly assigned. Conclusion: Although delayed administration of subsequent denosumab doses by more than 16 weeks is associated with increased risk for vertebral fracture compared with on-time dosing, evidence is insufficient to conclude that fracture risk is increased at other anatomical sites with long delay.	[Lyu, Houchen; Tang, Peifu] Gen Hosp Chinese PLA, Natl Clin Res Ctr Orthoped Sports Med & Rehabil, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Yoshida, Kazuki; Tedeschi, Sara K.; Solomon, Daniel H.] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, 60 Fenwood Rd, Boston, MA 02115 USA; [Zhao, Sizheng S.] Univ Liverpool, Inst Life Course & Med Sci, 3rd Floor Clin Sci Ctr, Liverpool L7 8TX, Merseyside, England; [Wei, Jie] Cent South Univ, Xiangya Hosp, Hlth Management Ctr, 87 Xiangya Rd, Changsha 410008, Peoples R China; [Zeng, Chao; Lei, Guanghua] Cent South Univ, Xiangya Hosp, Dept Orthopaed, 87 Xiangya Rd, Changsha 410008, Peoples R China; [Leder, Benjamin Z.] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, 50 Blossom St,THR 1051, Boston, MA 02114 USA; [Leder, Benjamin Z.] Harvard Med Sch, 50 Blossom St,THR 1051, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; University of Liverpool; Central South University; Central South University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lei, GH (corresponding author), Cent South Univ, Xiangya Hosp, Dept Orthopaed, 87 Xiangya Rd, Changsha 410008, Peoples R China.; Solomon, DH (corresponding author), Brigham & Womens Hosp, Div Rheumatol, 60 Fenwood Rd, Boston, MA 02115 USA.; Tang, PF (corresponding author), Gen Hosp Chinese PLA, Natl Clin Resh Ctr Orthoped Sports Med & Rehabil, 28 Fuxing Rd, Beijing 100853, Peoples R China.	lei_guanghua@csu.edu.cn; pftang301@126.com; dsolomon@bwh.harvard.edu	Wei, Jie/ACR-8087-2022	Wei, Jie/0000-0003-3510-8241; Lyu, Houchen/0000-0002-0128-0062; Zhao, Sizheng Steven/0000-0002-3558-7353; Yoshida, Kazuki/0000-0002-2030-3549	National Institutes of Health [NIH-P30-AR072577]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By grant NIH-P30-AR072577 from the National Institutes of Health and by internal resources from the National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation (Beijing) and Xiangya Hospital, Central South University.	Anastasilakis AD, 2016, OSTEOPOROSIS INT, V27, P1929, DOI 10.1007/s00198-015-3459-5; Anastasilakis AD, 2017, J BONE MINER RES, V32, P1291, DOI 10.1002/jbmr.3110; Aubry-Rozier B, 2016, OSTEOPOROSIS INT, V27, P1923, DOI 10.1007/s00198-015-3380-y; Baker R, 2016, INJURY PREV, V22, P59, DOI 10.1136/injuryprev-2015-041561; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bone HG, 2011, J CLIN ENDOCR METAB, V96, P972, DOI 10.1210/jc.2010-1502; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cain LE, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1212; Cooper C, 2010, OSTEOPOROSIS INT, V21, P569, DOI 10.1007/s00198-009-1003-1; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Danaei G, 2018, J CLIN EPIDEMIOL, V96, P12, DOI 10.1016/j.jclinepi.2017.11.021; Dickerman BA, 2019, NAT MED, V25, P1601, DOI 10.1038/s41591-019-0597-x; Eastell R, 2019, J CLIN ENDOCR METAB, V104, P1595, DOI 10.1210/jc.2019-00221; Emilsson L, 2018, JAMA ONCOL, V4, P63, DOI 10.1001/jamaoncol.2017.2752; Fahrleitner-Pammer A, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0351-2; Garcia-Albeniz X, 2017, EUR J EPIDEMIOL, V32, P495, DOI 10.1007/s10654-017-0287-2; Garcia-Albeniz X, 2017, ANN INTERN MED, V166, P18, DOI 10.7326/M16-0758; Hadji P, 2015, OSTEOPOROSIS INT, V26, P2479, DOI 10.1007/s00198-015-3164-4; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k182; Hernan MA, 2017, NEW ENGL J MED, V377, P1391, DOI 10.1056/NEJMsm1605385; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hippisley-Cox J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3427; Khalid S, 2018, CLIN EPIDEMIOL, V10, P1417, DOI 10.2147/CLEP.S164112; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Labrecque JA, 2017, EUR J EPIDEMIOL, V32, P473, DOI 10.1007/s10654-017-0293-4; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lyu HC, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz321; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Ogdie A, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210441; Orellana L, 2010, MAIN CONTENT INT J 1, V6, P8, DOI DOI 10.2202/1557-4679.1200; Orellana L, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1242; Popp AW, 2016, OSTEOPOROSIS INT, V27, P1917, DOI 10.1007/s00198-015-3458-6; Prieto-Alhambra D, 2011, ARTHRITIS RHEUM-US, V63, P992, DOI 10.1002/art.30214; Schlienger RG, 2004, JAMA-J AM MED ASSOC, V292, P1326, DOI 10.1001/jama.292.11.1326; Schneeweiss S, 2019, ANN INTERN MED, V170, P398, DOI 10.7326/M18-3079; Sutjandra L, 2011, CLIN PHARMACOKINET, V50, P793, DOI 10.2165/11594240-000000000-00000; Torgerson DJ, 1998, ANN RHEUM DIS, V57, P378, DOI 10.1136/ard.57.6.378; Tripto-Shkolnik L, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115150; Tsourdi E, 2017, BONE, V105, P11, DOI 10.1016/j.bone.2017.08.003; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Zhang Yi, 2014, Med Care, V52 Suppl 3, pS132, DOI 10.1097/MLR.0b013e3182a53ca8	45	30	32	4	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					516	+		10.7326/M20-0882	http://dx.doi.org/10.7326/M20-0882			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX4GS	32716706				2022-12-28	WOS:000575671400007
J	Katzenelenbogen, Y; Sheban, F; Yalin, A; Yofe, I; Svetlichnyy, D; Jaitin, DA; Bornstein, C; Moshe, A; Keren-Shaul, H; Cohen, M; Wang, SY; Li, BG; David, E; Salame, TM; Weiner, A; Amit, I				Katzenelenbogen, Yonatan; Sheban, Fadi; Yalin, Adam; Yofe, Ido; Svetlichnyy, Dmitry; Jaitin, Diego Adhemar; Bornstein, Chamutal; Moshe, Adi; Keren-Shaul, Hadas; Cohen, Merav; Wang, Shuang-Yin; Li, Baoguo; David, Eyal; Salame, Tomer-Meir; Weiner, Assaf; Amit, Ido			Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer	CELL			English	Article							SUPPRESSOR-CELLS; T-CELLS; LINEAGE COMMITMENT; EXPRESSION; QUANTIFICATION; REGULATORS; HEALTH; ID2	Cell function and activity are regulated through integration of signaling, epigenetic, transcriptional, and metabolic pathways. Here, we introduce INs-seq, an integrated technology for massively parallel recording of single-cell RNA sequencing (scRNA-seq) and intracellular protein activity. We demonstrate the broad utility of INs-seq for discovering new immune subsets by profiling different intracellular signatures of immune signaling, transcription factor combinations, and metabolic activity. Comprehensive mapping of Arginase 1-expressing cells within tumor models, a metabolic immune signature of suppressive activity, discovers novel Arg1(+) Trem2(+) regulatory myeloid (Mreg) cells and identifies markers, metabolic activity, and pathways associated with these cells. Genetic ablation of Trem2 in mice inhibits accumulation of intra-tumoral Mreg cells, leading to a marked decrease in dysfunctional CD8(+) T cells and reduced tumor growth. This study establishes INs-seq as a broadly applicable technology for elucidating integrated transcriptional and intracellular maps and identifies the molecular signature of myeloid suppressive cells in tumors.	[Katzenelenbogen, Yonatan; Sheban, Fadi; Yalin, Adam; Yofe, Ido; Svetlichnyy, Dmitry; Jaitin, Diego Adhemar; Bornstein, Chamutal; Moshe, Adi; Keren-Shaul, Hadas; Cohen, Merav; Wang, Shuang-Yin; Li, Baoguo; David, Eyal; Weiner, Assaf; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Salame, Tomer-Meir] Weizmann Inst Sci, Flow Cytometry Unit, Life Sci Core Facil, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Weiner, A; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	assaf.weiner@weizmann.ac.il; ido.amit@weizmann.ac.il		Wang, Shuang-Yin/0000-0001-9683-4103	Merck KGaA (Darmstadt, Germany); Chan Zuckerberg Initiative (CZI); HHMI international scholar award; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; Wolfson Foundation; Family Charitable Trust; Thompson Family Foundation; MRA Established Investigator Award [509044]; D. Dan and Betty Kahn Foundation; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel Award for Innovative Investigation; NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance [NMSS PA-1604 08459]; Adelis Foundation; Israeli Council for Higher Education	Merck KGaA (Darmstadt, Germany); Chan Zuckerberg Initiative (CZI); HHMI international scholar award(Howard Hughes Medical Institute); European Research Council Consolidator Grant (ERC-COG); Wolfson Foundation; Family Charitable Trust; Thompson Family Foundation; MRA Established Investigator Award; D. Dan and Betty Kahn Foundation; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel Award for Innovative Investigation; NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance; Adelis Foundation; Israeli Council for Higher Education	We thank Dr. A. Giladi and Dr. A. Deczkowska for reviewing the manuscript, N. David and T. Wiesel from the Scientific Illustration unit of the Weizmann Institute for artwork, Dr. M. Kedmi from the Advanced Sequencing Technologies unit, and members of the Amit laboratory for discussions. I.A. is an Eden and Steven Romick Professorial Chair and is supported by Merck KGaA (Darmstadt, Germany); the Chan Zuckerberg Initiative (CZI); an HHMI international scholar award; European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0; an SCA award from the Wolfson Foundation and Family Charitable Trust; the Thompson Family Foundation; MRA Established Investigator Award 509044; D. Dan and Betty Kahn Foundation; the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; the Helen and Martin Kimmel Award for Innovative Investigation; a NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance/NMSS PA-1604 08459; and an Adelis Foundation grant. F.S. is a recipient of the Israeli Council for Higher Education MSc and PhD fellowships.	Alles J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0383-5; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Arlauckas SP, 2018, THERANOSTICS, V8, P5842, DOI 10.7150/thno.26888; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Caldwell RW, 2018, PHYSIOL REV, V98, P641, DOI 10.1152/physrev.00037.2016; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chen X, 2011, INT IMMUNOPHARMACOL, V11, P1489, DOI 10.1016/j.intimp.2011.05.018; Deczkowska A, 2020, CELL, V181, P1207, DOI 10.1016/j.cell.2020.05.003; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerlach JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37977-7; Gervois P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01668; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Griffiths JA, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178046; Held W, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay6863; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Kratchmarov R, 2018, BLOOD ADV, V2, P1685, DOI 10.1182/bloodadvances.2018016279; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Linde N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02481-5; Magnuson AM, 2018, P NATL ACAD SCI USA, V115, pE10672, DOI 10.1073/pnas.1810580115; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schlepckow K, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911227; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang WQ, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-018-0115-x; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Tong AA, 2019, IMMUNOL CELL BIOL, V97, P787, DOI 10.1111/imcb.12276; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Yamada H, 2010, BIOCHEM BIOPH RES CO, V397, P425, DOI 10.1016/j.bbrc.2010.05.112; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang XJ, 2018, HUM PATHOL, V72, P91, DOI 10.1016/j.humpath.2017.10.026; Zheng HH, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00395; Zhong L, 2017, J EXP MED, V214, P597, DOI 10.1084/jem.20160844; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	62	146	148	8	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					872	+		10.1016/j.cell.2020.06.032	http://dx.doi.org/10.1016/j.cell.2020.06.032			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32783915	Bronze			2022-12-28	WOS:000561488500010
J	Dore, GJ; Trooskin, S				Dore, Gregory J.; Trooskin, Stacey			People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								To reduce the burden of HCV, it will be important to expand harm reduction for people who inject drugs. One model comes from Australia, where high treatment uptake has reduced the prevalence of active infection in this population.	[Dore, Gregory J.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Dore, Gregory J.] St Vincents Hosp, Sydney, NSW, Australia; [Trooskin, Stacey] Univ Penn, Philadelphia FIGHT Community Hlth Ctr, Philadelphia, PA 19104 USA; [Trooskin, Stacey] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dore, GJ (corresponding author), UNSW Sydney, Kirby Inst, Sydney, NSW, Australia.; Dore, GJ (corresponding author), St Vincents Hosp, Sydney, NSW, Australia.		Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622				Grebely J, 2019, ADDICTION, V114, P150, DOI 10.1111/add.14393; Hajarizadeh B, 2018, J VIRAL HEPATITIS, V25, P640, DOI 10.1111/jvh.12852; Moon S, 2019, NEW ENGL J MED, V380, P607, DOI 10.1056/NEJMp1813728; National Academies of Sciences Engineering and Medicine 2020, 2020, OPP IMPR OP US DIS I; World Health Organization, 2016, GLOB HLTH SECT STRAT	5	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					608	611		10.1056/NEJMp2002126	http://dx.doi.org/10.1056/NEJMp2002126			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE7HD	32786185				2022-12-28	WOS:000562771200006
J	Rizzo, F; Vegetti, S; Powell, D; Fraternali, F; McKean, JP; Stacey, HR; White, SDM				Rizzo, F.; Vegetti, S.; Powell, D.; Fraternali, F.; McKean, J. P.; Stacey, H. R.; White, S. D. M.			A dynamically cold disk galaxy in the early Universe	NATURE			English	Article							STAR-FORMING GALAXIES; TO-LIGHT RATIO; C II EMISSION; ATLAS(3D) PROJECT; ANGULAR-MOMENTUM; MOLECULAR GAS; DARK-MATTER; SCALING RELATIONS; EVOLUTION; KINEMATICS	The extreme astrophysical processes and conditions that characterize the early Universe are expected to result in young galaxies that are dynamically different from those observed today(1-5). This is because the strong effects associated with galaxy mergers and supernova explosions would lead to most young star-forming galaxies being dynamically hot, chaotic and strongly unstable(1,2). Here we report the presence of a dynamically cold, but highly star-forming, rotating disk in a galaxy at redshift(6)z = 4.2, when the Universe was just 1.4 billion years old. Galaxy SPT-S J041839-4751.9 is strongly gravitationally lensed by a foreground galaxy atz = 0.263, and it is a typical dusty starburst, with global star-forming(7)and dust properties(8)that are in agreement with current numerical simulations(9)and observations(10). Interferometric imaging at a spatial resolution of about 60 parsecs reveals a ratio of rotational to random motions of 9.7 +/- 0.4, which is at least four times larger than that expected from any galaxy evolution model at this epoch(1-5)but similar to the ratios of spiral galaxies in the local Universe(11). We derive a rotation curve with the typical shape of nearby massive spiral galaxies, which demonstrates that at least some young galaxies are dynamically akin to those observed in the local Universe, and only weakly affected by extreme physical processes. A strongly lensed galaxy at redshift 4.2 appears to be a dynamically cold disk galaxy, similar to spiral galaxies in the local neighbourhood and weakly affected by extreme physical processes.	[Rizzo, F.; Vegetti, S.; Powell, D.; Stacey, H. R.; White, S. D. M.] Max Planck Inst Astrophys, Garching, Germany; [Fraternali, F.; McKean, J. P.; Stacey, H. R.] Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands; [McKean, J. P.; Stacey, H. R.] Netherlands Inst Radio Astron, ASTRON, Dwingeloo, Netherlands	Max Planck Society; University of Groningen	Rizzo, F (corresponding author), Max Planck Inst Astrophys, Garching, Germany.	frizzo@mpa-garching.mpg.de	Rizzo, Francesca/GXB-2844-2022; White, Simon/Y-2399-2019; Fraternali, Filippo/F-6647-2014	White, Simon/0000-0002-1061-6154; Powell, Devon/0000-0002-4912-9943; Rizzo, Francesca/0000-0001-9705-2461; Fraternali, Filippo/0000-0002-0447-3230; RIZZO, Francesca/0000-0001-5809-0684	European Research Council Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Aravena M, 2016, MON NOT R ASTRON SOC, V457, P4406, DOI 10.1093/mnras/stw275; Barnabe M, 2009, MON NOT R ASTRON SOC, V399, P21, DOI 10.1111/j.1365-2966.2009.14941.x; Barro G, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/52; Bird JC, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/43; Cappellari M, 2013, MON NOT R ASTRON SOC, V432, P1709, DOI 10.1093/mnras/stt562; Cappellari M, 2013, MON NOT R ASTRON SOC, V432, P1862, DOI 10.1093/mnras/stt644; Cappellari M, 2011, MON NOT R ASTRON SOC, V413, P813, DOI 10.1111/j.1365-2966.2010.18174.x; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Carlstrom JE, 2011, PUBL ASTRON SOC PAC, V123, P568, DOI 10.1086/659879; Chen CC, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/194; De Breuck C, 2019, ASTRON ASTROPHYS, V631, DOI 10.1051/0004-6361/201936169; Dekel A, 2014, MON NOT R ASTRON SOC, V438, P1870, DOI 10.1093/mnras/stt2331; Di Teodoro EM, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201628315; Di Teodoro EM, 2015, MON NOT R ASTRON SOC, V451, P3021, DOI 10.1093/mnras/stv1213; Dutton AA, 2014, MON NOT R ASTRON SOC, V441, P3359, DOI 10.1093/mnras/stu742; Emsellem E, 2011, MON NOT R ASTRON SOC, V414, P888, DOI 10.1111/j.1365-2966.2011.18496.x; Feroz F, 2019, OPEN J ASTR, V2, P10, DOI [10.21105/astro.1306.2144, DOI 10.21105/ASTRO.1306.2144, 10.21105/ASTRO.1306.2144]; Girard M, 2019, ASTRON ASTROPHYS, V631, DOI 10.1051/0004-6361/201935896; Gullberg B, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aabe8c; Gullberg B, 2015, MON NOT R ASTRON SOC, V449, P2883, DOI 10.1093/mnras/stv372; Harrison CM, 2017, MON NOT R ASTRON SOC, V467, P1965, DOI 10.1093/mnras/stx217; Hayward CC, 2017, MON NOT R ASTRON SOC, V465, P1682, DOI 10.1093/mnras/stw2888; Hodge JA, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L18; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15, P417; Hung CL, 2019, MON NOT R ASTRON SOC, V482, P5125, DOI 10.1093/mnras/sty2970; Iorio G, 2017, MON NOT R ASTRON SOC, V466, P4159, DOI 10.1093/mnras/stw3285; Jones GC, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa8df2; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Koopmans LVE, 2006, ASTROPHYS J, V649, P599, DOI 10.1086/505696; Krajnovic D, 2013, MON NOT R ASTRON SOC, V432, P1768, DOI 10.1093/mnras/sts315; Krumholz MR, 2018, MON NOT R ASTRON SOC, V477, P2716, DOI 10.1093/mnras/sty852; Lang P, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/11; Lelli F, 2018, MON NOT R ASTRON SOC, V479, P5440, DOI 10.1093/mnras/sty1795; Lelli F, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/6/157; Lelli F, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201322657; Martizzi D, 2020, MON NOT R ASTRON SOC, V492, P79, DOI 10.1093/mnras/stz3419; McAlpine S, 2019, MON NOT R ASTRON SOC, V488, P2440, DOI 10.1093/mnras/stz1692; McDermid RM, 2015, MON NOT R ASTRON SOC, V448, P3484, DOI 10.1093/mnras/stv105; McMullin JP, 2007, ASTR SOC P, V376, P127; Naab T, 2009, ASTROPHYS J LETT, V699, pL178, DOI 10.1088/0004-637X/699/2/L178; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Neto GBL, 1999, MON NOT R ASTRON SOC, V309, P481, DOI 10.1046/j.1365-8711.1999.02849.x; Pillepich A, 2019, MON NOT R ASTRON SOC, V490, P3196, DOI 10.1093/mnras/stz2338; Powell D., 2020, PREPRINT; Rafelski M, 2016, ASTROPHYS J, V825, DOI 10.3847/0004-637X/825/2/87; Rizzo F, 2018, MON NOT R ASTRON SOC, V481, P5606, DOI 10.1093/mnras/sty2594; Smit R, 2018, NATURE, V553, P178, DOI 10.1038/nature24631; Speagle J. S, 2019, PREPRINT; Spilker JS, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/112; Stacey GJ, 2010, ASTROPHYS J, V724, P957, DOI 10.1088/0004-637X/724/2/957; Swinbank AM, 2017, MON NOT R ASTRON SOC, V467, P3140, DOI 10.1093/mnras/stx201; Tamburro D, 2009, ASTRON J, V137, P4424, DOI 10.1088/0004-6256/137/5/4424; Teklu AF, 2018, ASTROPHYS J LETT, V854, DOI 10.3847/2041-8213/aaaeb4; Terzic B, 2005, MON NOT R ASTRON SOC, V362, P197, DOI 10.1111/j.1365-2966.2005.09269.x; Toft S, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/68; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Turner OJ, 2017, MON NOT R ASTRON SOC, V471, P1280, DOI 10.1093/mnras/stx1366; Ubler H, 2019, ASTROPHYS J, V880, DOI 10.3847/1538-4357/ab27cc; Ubler H, 2018, ASTROPHYS J LETT, V854, DOI 10.3847/2041-8213/aaacfa; Utomo D, 2019, ASTROPHYS J, V871, DOI 10.3847/1538-4357/aaf582; Vegetti S, 2009, MON NOT R ASTRON SOC, V392, P945, DOI 10.1111/j.1365-2966.2008.14005.x; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Weiss A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/88; Wisnioski E, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/209; Zanella A, 2018, MON NOT R ASTRON SOC, V481, P1976, DOI 10.1093/mnras/sty2394; Zolotov A, 2015, MON NOT R ASTRON SOC, V450, P2327, DOI 10.1093/mnras/stv740	70	38	38	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					201	+		10.1038/s41586-020-2572-6	http://dx.doi.org/10.1038/s41586-020-2572-6			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788739	Green Published, Green Submitted			2022-12-28	WOS:000559831500009
J	Li, DN; Rooney, MR; Burmeister, LA; Basta, NE; Lutsey, PL				Li, Danni; Rooney, Mary R.; Burmeister, Lynn A.; Basta, Nicole E.; Lutsey, Pamela L.			Trends in Daily Use of Biotin Supplements Among US Adults, 1999-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This pharmacoepidemiology study uses NHANES data to characterize the prevalence and trends in use of high-dosage biotin supplementation among US adults between 1999 and 2016.	[Li, Danni] Univ Minnesota, Dept Lab Med & Pathol, 420 Delaware St SE,MMC 609, Minneapolis, MN 55455 USA; [Rooney, Mary R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Burmeister, Lynn A.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Basta, Nicole E.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lutsey, Pamela L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Minnesota System; University of Minnesota Twin Cities	Li, DN (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, 420 Delaware St SE,MMC 609, Minneapolis, MN 55455 USA.	dannili@umn.edu		Lutsey, Pamela/0000-0002-1572-1340; Burmeister, Lynn/0000-0003-4795-2546; Li, Danni/0000-0002-0608-2831	National Heart, Lung, and Blood Institute [T32HL007779]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Rooney was support by training grant T32HL007779 from the National Heart, Lung, and Blood Institute.	Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; [Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; [Anonymous], 2017, FDA WARNS BIOTIN MAY; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; Li D, 2017, JAMA-J AM MED ASSOC, V318, P1150, DOI 10.1001/jama.2017.13705	5	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					605	607		10.1001/jama.2020.8144	http://dx.doi.org/10.1001/jama.2020.8144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780133	Green Published			2022-12-28	WOS:000562845100027
J	Mahase, E				Mahase, Elisabeth			Mortality rates are lower with higher continuity of care, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Baker R, 2020, BR J GEN PRACT; Murphy M, 2020, BR J GEN PRACT	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3184	10.1136/bmj.m3184	http://dx.doi.org/10.1136/bmj.m3184			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784197				2022-12-28	WOS:000560307500008
J	Rhim, JW; Kim, K; Yang, BJ				Rhim, Jun-Won; Kim, Kyoo; Yang, Bohm-Jung			Quantum distance and anomalous Landau levels of flat bands	NATURE			English	Article							TOTAL-ENERGY CALCULATIONS; BERRYS PHASE; METALS	Semiclassical quantization of electronic states under a magnetic field, as proposed by Onsager, describes not only the Landau level spectrum but also the geometric responses of metals under a magnetic field(1-5). Even in graphene with relativistic energy dispersion, Onsager's rule correctly describes the pi Berry phase, as well as the unusual Landau level spectrum of Dirac particles(6,7). However, it is unclear whether this semiclassical idea is valid in dispersionless flat-band systems, in which an infinite number of degenerate semiclassical orbits are allowed. Here we show that the semiclassical quantization rule breaks down for a class of dispersionless flat bands called 'singular flat bands'(8). The singular flat band has a band crossing with another dispersive band that is enforced by the band-flatness condition, and shows anomalous magnetic responses. The Landau levels of a singular flat band develop in the empty region in which no electronic states exist in the absence of a magnetic field, and exhibit an unusual 1/ndependence on the Landau level indexn, which results in diverging orbital magnetic susceptibility. The total energy spread of the Landau levels of a singular flat band is determined by the quantum geometry of the relevant Bloch states, which is characterized by their Hilbert-Schmidt quantum distance. We show that there is a universal and simple relationship between the total Landau level spread of a flat band and the maximum Hilbert-Schmidt quantum distance, which can be verified in various candidate materials. The results indicate that the anomalous Landau level spectrum of flat bands is promising for the direct measurement of the quantum geometry of wavefunctions in condensed matter. The semiclassical quantization rule breaks down for a class of dispersionless flat bands, and their anomalous Landau level spectrum is characterized by their Hilbert-Schmidt quantum distance.	[Rhim, Jun-Won; Yang, Bohm-Jung] Inst Basic Sci IBS, Ctr Correlated Electron Syst, Seoul, South Korea; [Rhim, Jun-Won; Yang, Bohm-Jung] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Kim, Kyoo] Korea Atom Energy Res Inst, Daejeon, South Korea; [Yang, Bohm-Jung] Seoul Natl Univ, Ctr Theoret Phys CTP, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Korea Atomic Energy Research Institute (KAERI); Seoul National University (SNU)	Yang, BJ (corresponding author), Inst Basic Sci IBS, Ctr Correlated Electron Syst, Seoul, South Korea.; Yang, BJ (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.; Yang, BJ (corresponding author), Seoul Natl Univ, Ctr Theoret Phys CTP, Seoul, South Korea.	bjyang@snu.ac.kr	Yang, Bohm-Jung/B-3645-2013	Rhim, Jun-Won/0000-0001-9094-0650; Kim, Kyoo/0000-0002-7305-8786				Berry M. V, 1989, GEOMETRIC PHASES PHY, P7; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Buzek V, 1996, PHYS REV A, V54, P1844, DOI 10.1103/PhysRevA.54.1844; Chen YP, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.035135; Dodonov VV, 2000, J MOD OPTIC, V47, P633, DOI 10.1080/09500340008233385; Dudarev SL, 1998, PHYS REV B, V57, P1505, DOI 10.1103/PhysRevB.57.1505; Fuchs JN, 2018, SCIPOST PHYS, V4, DOI 10.21468/SciPostPhys.4.5.024; Gao Y, 2017, P NATL ACAD SCI USA, V114, P7295, DOI 10.1073/pnas.1702595114; Gianfrate A, 2020, NATURE, V578, P381, DOI 10.1038/s41586-020-1989-2; Haldane F.D.M., 2010, DIRAC POINT MODELS H; Hanaguri T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081305; Ihn T., 2010, SEMICONDUCTOR NANOST; Kang M., 2020, PREPRINT; Kang MG, 2020, NAT MATER, V19, P163, DOI 10.1038/s41563-019-0531-0; Kopnin NB, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.220503; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee JM, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.137002; Li Z, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4511; Lin ZY, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.096401; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Mikitik GP, 1999, PHYS REV LETT, V82, P2147, DOI 10.1103/PhysRevLett.82.2147; Min H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165310; Neupert T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245103; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; ONSAGER L, 1952, PHILOS MAG, V43, P1006; Ozawa T, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.201117; Park S, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.125127; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Piechon F, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.134423; Po HC, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.195455; Ramachandran A, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.161104; Rhim JW, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.045107; ROTH LM, 1966, PHYS REV, V145, P434, DOI 10.1103/PhysRev.145.434; Sadowski ML, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266405; Stoner EC, 1933, PHILOS MAG, V15, P1018; Terashima TT, 2017, J PHYS SOC JPN, V86, DOI 10.7566/JPSJ.86.054710; Xiao Y, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104505; Yamada MG, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.081102; Yang BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5898; Ye LD, 2018, NATURE, V555, P638, DOI 10.1038/nature25987; Yin JX, 2019, NAT PHYS, V15, P443, DOI 10.1038/s41567-019-0426-7; You J-Y, 2019, SCI REP, V2019, P9; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	45	35	35	9	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					59	+		10.1038/s41586-020-2540-1	http://dx.doi.org/10.1038/s41586-020-2540-1			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32760047				2022-12-28	WOS:000560290400015
J	Okereke, OI; Reynolds, CF; Mischoulon, D; Chang, G; Vyas, CM; Cook, NR; Weinberg, A; Bubes, V; Copeland, T; Friedenberg, G; Lee, IM; Buring, JE; Manson, JE				Okereke, Olivia I.; Reynolds, Charles F., III; Mischoulon, David; Chang, Grace; Vyas, Chirag M.; Cook, Nancy R.; Weinberg, Alison; Bubes, Vadim; Copeland, Trisha; Friedenberg, Georgina; Lee, I-Min; Buring, Julie E.; Manson, JoAnn E.			Effect of Long-term Vitamin D-3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENTION; OVERWEIGHT; MODEL	Importance Low levels of 25-hydroxyvitamin D have been associated with higher risk for depression later in life, but there have been few long-term, high-dose large-scale trials. Objective To test the effects of vitamin D-3 supplementation on late-life depression risk and mood scores. Design, Setting, and Participants There were 18 353 men and women aged 50 years or older in the VITAL-DEP (Vitamin D and Omega-3 Trial-Depression Endpoint Prevention) ancillary study to VITAL, a randomized clinical trial of cardiovascular disease and cancer prevention among 25 871 adults in the US. There were 16 657 at risk for incident depression (ie, no depression history) and 1696 at risk for recurrent depression (ie, depression history but no treatment for depression within the past 2 years). Randomization occurred from November 2011 through March 2014; randomized treatment ended on December 31, 2017, and this was the final date of follow-up. Intervention Randomized assignment in a 2 x 2 factorial design to vitamin D-3 (2000 IU/d of cholecalciferol) and fish oil or placebo; 9181 were randomized to vitamin D-3 and 9172 were randomized to matching placebo. Main Outcomes and Measures The primary outcomes were the risk of depression or clinically relevant depressive symptoms (total of incident and recurrent cases) and the mean difference in mood scores (8-item Patient Health Questionnaire depression scale [PHQ-8]; score range, 0 points [least symptoms] to 24 points [most symptoms]; the minimal clinically important difference for change in scores was 0.5 points). Results Among the 18 353 randomized participants (mean age, 67.5 [SD, 7.1] years; 49.2% women), the median treatment duration was 5.3 years and 90.5% completed the trial (93.5% among those alive at the end of the trial). Risk of depression or clinically relevant depressive symptoms was not significantly different between the vitamin D-3 group (609 depression or clinically relevant depressive symptom events; 12.9/1000 person-years) and the placebo group (625 depression or clinically relevant depressive symptom events; 13.3/1000 person-years) (hazard ratio, 0.97 [95% CI, 0.87 to 1.09]; P = .62); there were no significant differences between groups in depression incidence or recurrence. No significant differences were observed between treatment groups for change in mood scores over time; mean change in PHQ-8 score was not significantly different from zero (mean difference for change in mood scores, 0.01 points [95% CI, -0.04 to 0.05 points]). Conclusions and Relevance Among adults aged 50 years or older without clinically relevant depressive symptoms at baseline, treatment with vitamin D-3 compared with placebo did not result in a statistically significant difference in the incidence and recurrence of depression or clinically relevant depressive symptoms or for change in mood scores over a median follow-up of 5.3 years. These findings do not support the use of vitamin D-3 in adults to prevent depression.	[Okereke, Olivia I.; Mischoulon, David; Vyas, Chirag M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Okereke, Olivia I.; Mischoulon, David; Vyas, Chirag M.; Cook, Nancy R.; Weinberg, Alison; Bubes, Vadim; Copeland, Trisha; Friedenberg, Georgina; Lee, I-Min; Buring, Julie E.; Manson, JoAnn E.] Harvard Med Sch, Boston, MA 02115 USA; [Okereke, Olivia I.; Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Okereke, Olivia I.; Cook, Nancy R.; Lee, I-Min; Buring, Julie E.; Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Reynolds, Charles F., III] UPMC, Dept Psychiat, Pittsburgh, PA USA; [Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Chang, Grace] VA Boston Healthcare Syst, Dept Psychiat, Brockton, MA USA; [Cook, Nancy R.; Weinberg, Alison; Bubes, Vadim; Copeland, Trisha; Friedenberg, Georgina; Lee, I-Min; Buring, Julie E.; Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Okereke, OI (corresponding author), Massachusetts Gen Hosp, One Bowdoin Sq,7th Floor, Boston, MA 02114 USA.	olivia.okereke@mgh.harvard.edu	Lee, I-Min/ABD-5409-2021; Okereke, Olivia/AAF-7031-2021; Okereke, Olivia I/R-9934-2016		National Institute of Mental Health [R01 MH091448, P30 MH090333]; National Cancer Institute [U01 CA138962, R01 CA138962]; National Heart, Lung, and Blood Institute; Office of Dietary Supplements; National Institute of Neurological Disorders and Stroke; National Center for Complementary and Integrative Health; National Institute of Diabetes and Digestive and Kidney Diseases [DK088078, R01 DK088762]; National Heart, Lung, and Blood Institute [R01 HL101932, R01 HL102122]; National Institute on Aging [R01 AG036755]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR059086, R01 AR060574]; University of Pittsburgh Medical Center Endowment in Geriatric Psychiatry	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Complementary and Integrative Health; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Pittsburgh Medical Center Endowment in Geriatric Psychiatry	Pharmavite LLC (vitamin D3) and Pronova BioPharma/BASF (Omacor fish oil) donated the study agents, matching placebos, and packaging in the form of calendar packs. VITAL-DEP was supported by grant R01 MH091448 from the National Institute of Mental Health. VITAL was supported by grants U01 CA138962 and R01 CA138962 from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the Office of Dietary Supplements, the National Institute of Neurological Disorders and Stroke, and the National Center for Complementary and Integrative Health. The VITAL ancillary studies and the Clinical and Translational Science Center component were supported by grants DK088078 and R01 DK088762 from the National Institute of Diabetes and Digestive and Kidney Diseases, grants R01 HL101932 and R01 HL102122 from the National Heart, Lung, and Blood Institute, grant R01 AG036755 from the National Institute on Aging, grants R01 AR059086 and R01 AR060574 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and grant R01 MH091448 from the National Institute of Mental Health. Dr Reynolds' participation also received support from grant P30 MH090333 from the National Institute of Mental Health and funding from the University of Pittsburgh Medical Center Endowment in Geriatric Psychiatry.	Beekman ATF, 2002, ARCH GEN PSYCHIAT, V59, P605, DOI 10.1001/archpsyc.59.7.605; Bot M, 2019, JAMA-J AM MED ASSOC, V321, P858, DOI 10.1001/jama.2019.0556; Committee on Prevention of Mental Disorders, 1994, REDUCING RISKS MENTA; Cuijpers P, 2003, AM J PSYCHIAT, V160, P1385, DOI 10.1176/appi.ajp.160.8.1385; de Koning EJ, 2019, AM J CLIN NUTR, V110, P1119, DOI 10.1093/ajcn/nqz141; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Dumville JC, 2006, J NUTR HEALTH AGING, V10, P151; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN, P103; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Jorde R, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2018.19; Kim SM, 2017, CURR CARDIOVASC RISK, V11, DOI 10.1007/s12170-017-0528-7; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Li HB, 2019, AM J GERIAT PSYCHIAT, V27, P1192, DOI 10.1016/j.jagp.2019.05.022; Libuda L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051085; Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Milaneschi Y, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0554-y; Okereke OI, 2018, CONTEMP CLIN TRIALS, V68, P133, DOI 10.1016/j.cct.2018.02.017; Okereke OI, 2016, J AFFECT DISORDERS, V198, P1, DOI 10.1016/j.jad.2016.03.022; Pan A, 2012, INT J OBESITY, V36, P595, DOI 10.1038/ijo.2011.111; Reynolds CF, 2012, ANNU REV PUBL HEALTH, V33, P123, DOI 10.1146/annurev-publhealth-031811-124544; Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544; Stewart AE, 2014, MED HYPOTHESES, V83, P517, DOI 10.1016/j.mehy.2014.09.010; Unutzer J, 2000, J AM GERIATR SOC, V48, P871	26	52	53	3	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					471	480		10.1001/jama.2020.10224	http://dx.doi.org/10.1001/jama.2020.10224			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NC5NN	32749491	Green Published, Bronze			2022-12-28	WOS:000561261900018
J	Fitzgerald, RC; di Pietro, M; O'Donovan, M; Maroni, R; Muldrew, B; Debiram-Beecham, I; Gehrung, M; Offman, J; Tripathi, M; Smith, SG; Aigret, B; Walter, FM; Rubin, G; Sasieni, P				Fitzgerald, Rebecca C.; di Pietro, Massimiliano; O'Donovan, Maria; Maroni, Roberta; Muldrew, Beth; Debiram-Beecham, Irene; Gehrung, Marcel; Offman, Judith; Tripathi, Monika; Smith, Samuel G.; Aigret, Benoit; Walter, Fiona M.; Rubin, Greg; Sasieni, Peter		BEST3 Trial Team	Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial	LANCET			English	Article							HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX; RADIOFREQUENCY ABLATION; COST-EFFECTIVENESS; ADENOCARCINOMA; MANAGEMENT; PREVALENCE; DIAGNOSIS	Background Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is unclear. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett's oesophagus. The aim of this study was to investigate whether offering this test to patients on medication for gastro-oesophageal reflux would increase the detection of Barrett's oesophagus compared with standard management. Methods This multicentre, pragmatic, randomised controlled trial was done in 109 socio-demographically diverse general practice clinics in England. Randomisation was done both at the general practice clinic level (cluster randomisation) and at the individual patient level, and the results for each type of randomisation were analysed separately before being combined. Patients were eligible if they were aged 50 years or older, had been taking acid-suppressants for symptoms of gastro-oesophageal reflux for more than 6 months, and had not undergone an endoscopy procedure within the past 5 years. General practice clinics were selected by the local clinical research network and invited to participate in the trial. For cluster randomisation, clinics were randomly assigned (1:1) by the trial statistician using a computer-generated randomisation sequence; for individual patient-level randomisation, patients were randomly assigned (1:1) by the general practice clinics using a centrally prepared computer-generated randomisation sequence. After randomisation, participants received either standard management of gastro-oesophageal reflux (usual care group), in which participants only received an endoscopy if required by their general practitioner, or usual care plus an offer of the Cytosponge-TFF3 procedure, with a subsequent endoscopy if the procedure identified TFF3-positive cells (intervention group). The primary outcome was the diagnosis of Barrett's oesophagus at 12 months after enrolment, expressed as a rate per 1000 person-years, in all participants in the intervention group (regardless of whether they had accepted the offer of the Cytosponge-TFF3 procedure) compared with all participants in the usual care group. Analyses were intention-to-treat. The trial is registered with the ISRCTN registry, ISRCTN68382401, and is completed. Findings Between March 20, 2017, and March 21, 2019, 113 general practice clinics were enrolled, but four clinics dropped out shortly after randomisation. Using an automated search of the electronic prescribing records of the remaining 109 clinics, we identified 13 657 eligible patients who were sent an introductory letter with 14 days to opt out. 13 514 of these patients were randomly assigned (per practice or at the individual patient level) to the usual care group (n=6531) or the intervention group (n=6983). Following randomisation, 149 (2%) of 6983 participants in the intervention group and 143 (2%) of 6531 participants in the usual care group, on further scrutiny, did not meet all eligibility criteria or withdrew from the study. Of the remaining 6834 participants in the intervention group, 2679 (39%) expressed an interest in undergoing the Cytosponge-TFF3 procedure. Of these, 1750 (65%) met all of the eligibility criteria on telephone screening and underwent the procedure. Most of these participants (1654 [95%]; median age 69 years) swallowed the Cytosponge successfully and produced a sample. 231 (3%) of 6834 participants had a positive Cytosponge-TFF3 result and were referred for an endoscopy. Patients who declined the offer of the Cytosponge-TFF3 procedure and all participants in the usual care group only had an endoscopy if deemed necessary by their general practitioner. During an average of 12 months of follow-up, 140 (2%) of 6834 participants in the intervention group and 13 (<1%) of 6388 participants in the usual care group were diagnosed with Barrett's oesophagus (absolute difference 18.3 per 1000 person-years [95% CI 14.8-21.8]; rate ratio adjusted for cluster randomisation 10.6 [95% CI 6.0-18.8], p<0.0001). Nine (<1%) of 6834 participants were diagnosed with dysplastic Barrett's oesophagus (n=4) or stage I oesophago-gastric cancer (n=5) in the intervention group, whereas no participants were diagnosed with dysplastic Barrett's oesophagus or stage I gastro-oesophageal junction cancer in the usual care group. Among 1654 participants in the intervention group who swallowed the Cytosponge device successfully, 221 (13%) underwent endoscopy after testing positive for TFF3 and 131 (8%, corresponding to 59% of those having an endoscopy) were diagnosed with Barrett's oesophagus or cancer. One patient had a detachment of the Cytosponge from the thread requiring endoscopic removal, and the most common side-effect was a sore throat in 63 (4%) of 1654 participants. Interpretation In patients with gastro-oesophageal reflux, the offer of Cytosponge-TFF3 testing results in improved detection of Barrett's oesophagus. Cytosponge-TFF3 testing could also lead to the diagnosis of treatable dysplasia and early cancer. This strategy will lead to additional endoscopies with some false positive results.	[Fitzgerald, Rebecca C.; di Pietro, Massimiliano; O'Donovan, Maria; Debiram-Beecham, Irene; Tripathi, Monika] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge CB2 0XZ, England; [Walter, Fiona M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Unit, Cambridge, England; [Fitzgerald, Rebecca C.; di Pietro, Massimiliano; O'Donovan, Maria; Tripathi, Monika] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge, England; [Maroni, Roberta; Muldrew, Beth; Aigret, Benoit; Sasieni, Peter] Kings Coll London, Canc Res UK, Sch Canc & Pharmaceut Sci, London, England; [Sasieni, Peter] Kings Coll London, Canc Prevent Trials Unit, Sch Canc & Pharmaceut Sci, London, England; [Offman, Judith] Kings Coll London, Canc Prevent Grp, Sch Canc & Pharmaceut Sci, London, England; [Gehrung, Marcel] Univ Cambridge, Res UK Cambridge Inst, Cambridge, England; [Smith, Samuel G.] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Rubin, Greg] Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst, Inst Populat Hlth Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Cambridge; University of Cambridge; Cancer Research UK; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Cambridge; University of Leeds; Newcastle University - UK	Fitzgerald, RC (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge CB2 0XZ, England.	rcf29@mrc-cu.cam.ac.uk	Walter, Fiona/F-3054-2014; Walter, Fiona/GYR-1347-2022; Bowers, Ben/AAR-7022-2020; Bowers, Ben/C-4128-2016; Maroni, Roberta/K-7044-2019; Lovat, Laurence/C-1986-2009	Bowers, Ben/0000-0001-6772-2620; Bowers, Ben/0000-0001-6772-2620; Maroni, Roberta/0000-0001-6420-2881; Walter, Fiona/0000-0002-7191-6476; Sasieni, Peter/0000-0003-1509-8744; Lydon, Anne/0000-0003-3132-4801; Moore, Patrick/0000-0001-8279-6724; Rubin, Greg/0000-0002-4967-0297; Lovat, Laurence/0000-0003-4542-3915; Fitzgerald, Rebecca/0000-0002-3434-3568; bhandari, pradeep/0000-0002-1241-2083; Larcombe, James/0000-0002-3111-7346	Cancer Research UK; National Institute for Health Research; UK National Health Service; Medtronic; Medical Research Council; MRC [MC_UU_12022/2] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); UK National Health Service; Medtronic(Medtronic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK, National Institute for Health Research, the UK National Health Service, Medtronic, and the Medical Research Council.	Arnold M, 2019, LANCET ONCOL, V20, P1493, DOI 10.1016/S1470-2045(19)30456-5; Banks M, 2019, GUT, V68, P1545, DOI 10.1136/gutjnl-2018-318126; Benaglia T, 2013, GASTROENTEROLOGY, V144, P62, DOI 10.1053/j.gastro.2012.09.060; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; El-Serag HB, 2016, GUT, V65, P1252, DOI 10.1136/gutjnl-2014-308865; Everhart JE, 2009, GASTROENTEROLOGY, V136, P376, DOI 10.1053/j.gastro.2008.12.015; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Gupta S, 2020, GASTROENTEROLOGY, V158, P693, DOI 10.1053/j.gastro.2019.12.003; Heberle CR, 2017, CLIN GASTROENTEROL H, V15, P1397, DOI 10.1016/j.cgh.2017.02.017; Januszewicz W, 2019, CLIN GASTROENTEROL H, V17, P647, DOI 10.1016/j.cgh.2018.07.043; Kadri SR, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4372; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; NICE, 2014, CHRON KIDN DIS AD AS; Offman J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4664-3; Paterson AL, 2020, DIAGN CYTOPATHOL, V48, P253, DOI 10.1002/dc.24354; Pech O, 2014, GASTROENTEROLOGY, V146, P652, DOI 10.1053/j.gastro.2013.11.006; Phoa KN, 2014, JAMA-J AM MED ASSOC, V311, P1209, DOI 10.1001/jama.2014.2511; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Ross-Innes CS, 2017, LANCET GASTROENTEROL, V2, P23, DOI 10.1016/S2468-1253(16)30118-2; Ross-Innes CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001780; Shaheen NJ, 2016, AM J GASTROENTEROL, V111, P30, DOI 10.1038/ajg.2015.322; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Sharma P, 2020, GASTROENTEROLOGY, V158, P760, DOI 10.1053/j.gastro.2019.09.051; Sharma P, 2020, GASTROENTEROLOGY, V158, P9, DOI 10.1053/j.gastro.2019.09.048; Shawihdi M, 2014, GUT, V63, P250, DOI 10.1136/gutjnl-2012-304202; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Vaughan TL, 2015, NAT REV GASTRO HEPAT, V12, P243, DOI 10.1038/nrgastro.2015.24; Visrodia K, 2016, ALIMENT PHARM THER, V44, P775, DOI 10.1111/apt.13783; Wani S, 2012, CLIN GASTROENTEROL H, V10, P704, DOI 10.1016/j.cgh.2012.03.030	30	69	72	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					333	344						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0RO	32738955	Green Published, hybrid			2022-12-28	WOS:000561615700001
J	Laborde, D; Martin, W; Swinnen, J; Vos, R				Laborde, David; Martin, Will; Swinnen, Johan; Vos, Rob			COVID-19 risks to global food security	SCIENCE			English	Editorial Material									[Laborde, David; Martin, Will; Swinnen, Johan; Vos, Rob] Int Food Policy Res Inst, Washington, DC 20036 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Vos, R (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	r.vos@cgiar.org	Swinnen, Johan/AAC-1736-2021	Swinnen, Johan/0000-0002-8650-1978				Abate G., 2020, ETHIOPIA STRATEGY SU; Anderson K., 2014, EC FOOD PRICE VOLATI; Bhalla N., 2020, NO BED ROSES E AFRIC; Bouet A, 2012, REV WORLD ECON, V148, P209, DOI 10.1007/s10290-011-0108-8; Committee onWorldFood Security (CFS), 2009, CFS20092; Food Security Portal, HARD WHEAT EXC FOOD; Food Security Portal, RIC EXC FOOD PRIC VA; Gentilini U., 2020, SOCIAL PROTECTION JO; HeadeyRuel D.M., 2020, IFPRI COVID 19 BLOG; Hidrobo Melissa., 2020, GENDER SENSITIVE SOC; IFPRI, COVID 19 FOOD TRAD P; IMF, 2020, WORLD EC OUTL UPD CR; International Organization for Migration (IOM), 2020, MIGR GLOB FOOD SUPPL; Laborde D., 2020, ESTIMATING POVERTY I; McAuliffe S., 2020, BMJ NUTR PREVENT HLT, DOI [10.1136/ bmjnph-2020-000100, DOI 10.1136/BMJNPH-2020-000100]; Tamru S., 2020, IFPRI COVID 19 BLOG	16	371	381	34	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					500	502		10.1126/science.abc4765	http://dx.doi.org/10.1126/science.abc4765			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732407				2022-12-28	WOS:000556568100022
J	Mueller, NS; Okamura, Y; Vieira, BGM; Juergensen, S; Lange, H; Barros, EB; Schulz, F; Reich, S				Mueller, Niclas S.; Okamura, Yu; Vieira, Bruno G. M.; Juergensen, Sabrina; Lange, Holger; Barros, Eduardo B.; Schulz, Florian; Reich, Stephanie			Deep strong light-matter coupling in plasmonic nanoparticle crystals	NATURE			English	Article							OPTICAL-PROPERTIES	Photons and plasmons hybridize into polaritons in three-dimensional crystals of plasmonic nanoparticles, leading to deep strong light-matter coupling and the breakdown of the Purcell effect. In the regime of deep strong light-matter coupling, the coupling strength exceeds the transition energies of the material(1-3), fundamentally changing its properties(4,5); for example, the ground state of the system contains virtual photons and the internal electromagnetic field gets redistributed by photon self-interaction(1,6). So far, no electronic excitation of a material has shown such strong coupling to free-space photons. Here we show that three-dimensional crystals of plasmonic nanoparticles can realize deep strong coupling under ambient conditions, if the particles are ten times larger than the interparticle gaps. The experimental Rabi frequencies (1.9 to 3.3 electronvolts) of face-centred cubic crystals of gold nanoparticles with diameters between 25 and 60 nanometres exceed their plasmon energy by up to 180 per cent. We show that the continuum of photons and plasmons hybridizes into polaritons that violate the rotating-wave approximation. The coupling leads to a breakdown of the Purcell effect-the increase of radiative damping through light-matter coupling-and increases the radiative polariton lifetime. The results indicate that metallic and semiconducting nanoparticles can be used as building blocks for an entire class of materials with extreme light-matter interaction, which will find application in nonlinear optics, the search for cooperative effects and ground states, polariton chemistry and quantum technology(4,5).	[Mueller, Niclas S.; Okamura, Yu; Vieira, Bruno G. M.; Juergensen, Sabrina; Reich, Stephanie] Free Univ Berlin, Dept Phys, Berlin, Germany; [Vieira, Bruno G. M.; Barros, Eduardo B.] Univ Fed Ceara, Dept Phys, Fortaleza, Ceara, Brazil; [Lange, Holger; Schulz, Florian] Univ Hamburg, Inst Phys Chem, Hamburg, Germany	Free University of Berlin; Universidade Federal do Ceara; University of Hamburg	Reich, S (corresponding author), Free Univ Berlin, Dept Phys, Berlin, Germany.	reich@physik.fu-berlin.de	Schulz, Florian/F-4059-2015; BARROS, EDUARDO B/A-4555-2013; Lange, Holger/J-8189-2016; Reich, Stephanie/S-1811-2016; Gondim de Melo Vieira, Bruno/J-1184-2014	Schulz, Florian/0000-0003-4440-3680; Lange, Holger/0000-0002-4236-2806; Reich, Stephanie/0000-0002-2391-0256; Okamura, Yu/0000-0001-5464-9559; Barros, Eduardo Bede/0000-0001-9210-9166; Gondim de Melo Vieira, Bruno/0000-0002-8563-6504; Juergensen, Sabrina/0000-0001-6528-4954				ARTONI M, 1991, PHYS REV B, V44, P3736, DOI 10.1103/PhysRevB.44.3736; Askenazi B, 2017, ACS PHOTONICS, V4, P2550, DOI 10.1021/acsphotonics.7b00838; Baranov DG, 2018, ACS PHOTONICS, V5, P24, DOI 10.1021/acsphotonics.7b00674; Bastus NG, 2011, LANGMUIR, V27, P11098, DOI 10.1021/la201938u; Bayer A, 2017, NANO LETT, V17, P6340, DOI 10.1021/acs.nanolett.7b03103; Chen PY, 2012, ADV MATER, V24, pOP281, DOI 10.1002/adma.201202624; Ciuti C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115303; Ciuti C, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.033811; De Liberato S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01504-5; De Liberato S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.016401; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; Forn-Diaz P, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.025005; Forn-Diaz P, 2017, NAT PHYS, V13, P39, DOI [10.1038/nphys3905, 10.1038/NPHYS3905]; Garziano L, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.043601; Gunter G, 2009, NATURE, V458, P178, DOI 10.1038/nature07838; Halas NJ, 2011, CHEM REV, V111, P3913, DOI 10.1021/cr200061k; Hanske C, 2017, J PHYS CHEM C, V121, P10899, DOI 10.1021/acs.jpcc.6b12161; HOPFIELD JJ, 1958, PHYS REV, V112, P1555, DOI 10.1103/PhysRev.112.1555; Huang CP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016402; Hutchison JA, 2012, ANGEW CHEM INT EDIT, V51, P1592, DOI 10.1002/anie.201107033; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Kockum AF, 2019, NAT REV PHYS, V1, P295, DOI 10.1038/s42254-019-0046-2; Kockum AF, 2019, NAT REV PHYS, V1, P19, DOI 10.1038/s42254-018-0006-2; Kockum AF, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.063849; Lamowski S, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.125409; Lau CY, 2011, LANGMUIR, V27, P3355, DOI 10.1021/la104786z; Li XW, 2018, NAT PHOTONICS, V12, P324, DOI 10.1038/s41566-018-0153-0; Liu N, 2008, NAT MATER, V7, P31, DOI 10.1038/nmat2072; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Matricardi C, 2018, ACS NANO, V12, P8531, DOI 10.1021/acsnano.8b04073; Mihailovic M, 2009, OPT MATER, V31, P532, DOI 10.1016/j.optmat.2007.10.023; Mueller NS, 2019, FARADAY DISCUSS, V214, P159, DOI 10.1039/c8fd00149a; Mueller NS, 2018, ACS PHOTONICS, V5, P3962, DOI 10.1021/acsphotonics.8b00898; Nataf P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190402; NICOLSON AM, 1970, IEEE T INSTRUM MEAS, VIM19, P377, DOI 10.1109/TIM.1970.4313932; Olmon RL, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235147; Park DJ, 2015, P NATL ACAD SCI USA, V112, P977, DOI 10.1073/pnas.1422649112; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; RAKIC AD, 1995, APPL OPTICS, V34, P4755, DOI 10.1364/AO.34.004755; Rivera N, 2016, SCIENCE, V353, P263, DOI 10.1126/science.aaf6308; Romero G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120501; Ross MB, 2015, NAT NANOTECHNOL, V10, P453, DOI [10.1038/nnano.2015.68, 10.1038/NNANO.2015.68]; Rossatto DZ, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.013849; Schulz F, 2017, LANGMUIR, V33, P14437, DOI 10.1021/acs.langmuir.7b03600; Sun L, 2018, P NATL ACAD SCI USA, V115, P7242, DOI 10.1073/pnas.1800106115; Yannopapas V, 1999, PHYS REV B, V60, P5359, DOI 10.1103/PhysRevB.60.5359; Ye XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10052; Yoshihara F, 2017, NAT PHYS, V13, P44, DOI [10.1038/NPHYS3906, 10.1038/nphys3906]; Yu P., 1996, FUNDAMENTALS SEMICON; Zheng YQ, 2014, PART PART SYST CHAR, V31, P266, DOI 10.1002/ppsc.201300256	50	79	78	40	222	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					780	+		10.1038/s41586-020-2508-1	http://dx.doi.org/10.1038/s41586-020-2508-1			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728238	Green Submitted			2022-12-28	WOS:000554831500031
J	Banik, SM; Pedram, K; Wisnovsky, S; Ahn, G; Riley, NM; Bertozzi, CR				Banik, Steven M.; Pedram, Kayvon; Wisnovsky, Simon; Ahn, Green; Riley, Nicholas M.; Bertozzi, Carolyn R.			Lysosome-targeting chimaeras for degradation of extracellular proteins	NATURE			English	Article							MANNOSE 6-PHOSPHATE; COMPUTATIONAL PLATFORM; RECEPTOR; ANTIBODY; CONJUGATION; STRATEGY; AFFINITY; DISEASE	The majority of therapies that target individual proteins rely on specific activity-modulating interactions with the target protein-for example, enzyme inhibition or ligand blocking. However, several major classes of therapeutically relevant proteins have unknown or inaccessible activity profiles and so cannot be targeted by such strategies. Protein-degradation platforms such as proteolysis-targeting chimaeras (PROTACs)(1,2)and others (for example, dTAGs(3), Trim-Away(4), chaperone-mediated autophagy targeting(5)and SNIPERs(6)) have been developed for proteins that are typically difficult to target; however, these methods involve the manipulation of intracellular protein degradation machinery and are therefore fundamentally limited to proteins that contain cytosolic domains to which ligands can bind and recruit the requisite cellular components. Extracellular and membrane-associated proteins-the products of 40% of all protein-encoding genes(7)-are key agents in cancer, ageing-related diseases and autoimmune disorders(8), and so a general strategy to selectively degrade these proteins has the potential to improve human health. Here we establish the targeted degradation of extracellular and membrane-associated proteins using conjugates that bind both a cell-surface lysosome-shuttling receptor and the extracellular domain of a target protein. These initial lysosome-targeting chimaeras, which we term LYTACs, consist of a small molecule or antibody fused to chemically synthesized glycopeptide ligands that are agonists of the cation-independent mannose-6-phosphate receptor (CI-M6PR). We use LYTACs to develop a CRISPR interference screen that reveals the biochemical pathway for CI-M6PR-mediated cargo internalization in cell lines, and uncover the exocyst complex as a previously unidentified-but essential-component of this pathway. We demonstrate the scope of this platform through the degradation of therapeutically relevant proteins, including apolipoprotein E4, epidermal growth factor receptor, CD71 and programmed death-ligand 1. Our results establish a modular strategy for directing secreted and membrane proteins for lysosomal degradation, with broad implications for biochemical research and for therapeutics. Lysosome-targeting chimaeras-in which a small molecule or antibody is connected to a glycopeptide ligand to form a conjugate that can bind a cell-surface lysosome-shuttling receptor and a protein target-are used to achieve the targeted degradation of extracellular and membrane proteins.	[Banik, Steven M.; Pedram, Kayvon; Wisnovsky, Simon; Ahn, Green; Riley, Nicholas M.; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute	Bertozzi, CR (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Bertozzi, CR (corresponding author), Howard Hughes Med Inst, Stanford, CA 94305 USA.	bertozzi@stanford.edu		Riley, Nicholas/0000-0002-1536-2966	National Institutes of Health (NIH) [P30CA124435]; NIH [R01CA227942, K00CA21245403]; National Institute of General Medical Sciences F32 Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship; Stanford Graduate Fellowship; Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program; Banting Postdoctoral Fellowship from the Canadian Institutes of Health	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences F32 Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program; Banting Postdoctoral Fellowship from the Canadian Institutes of Health	We thank M. Bassik for the CRISPRi library and dCas9-KRAB-expressing cell lines; T. Waldmann for a gift of the HDLM-2 cell line and E. Appel for use of aqueous gel permeation chromatography equipment. This work was supported in part by National Institutes of Health (NIH) grant P30CA124435 using the Stanford Cancer Institute Proteomics/Mass Spectrometry Shared Resource and by NIH grant R01CA227942 to C.R.B. S.M.B was supported by a National Institute of General Medical Sciences F32 Postdoctoral Fellowship. K.P. was supported by a National Science Foundation Graduate Research Fellowship, a Stanford Graduate Fellowship, and the Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program. S.W. was supported by a Banting Postdoctoral Fellowship from the Canadian Institutes of Health. G.A. was supported by a National Science Foundation Graduate Research Fellowship. N.M.R. was supported by NIH grant K00CA21245403.	ALON R, 1993, J IMMUNOL METHODS, V165, P127, DOI 10.1016/0022-1759(93)90114-M; Beljaars L, 1999, HEPATOLOGY, V29, P1486, DOI 10.1002/hep.510290526; Berkowitz DB, 2004, ORG LETT, V6, P4921, DOI 10.1021/ol0479444; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Clift D, 2017, CELL, V171, P1692, DOI 10.1016/j.cell.2017.10.033; Coutinho MF, 2012, MOL GENET METAB, V107, P257, DOI 10.1016/j.ymgme.2012.07.012; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Das S, 2016, ACS MACRO LETT, V5, P809, DOI 10.1021/acsmacrolett.6b00297; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fan XL, 2014, NAT NEUROSCI, V17, P471, DOI 10.1038/nn.3637; Gary-Bobo M, 2007, CURR MED CHEM, V14, P2945, DOI 10.2174/092986707782794005; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hebert AS, 2018, ANAL CHEM, V90, P2333, DOI 10.1021/acs.analchem.7b04808; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Igawa T, 2016, IMMUNOL REV, V270, P132, DOI 10.1111/imr.12392; Jeanjean A, 2006, BIOORGAN MED CHEM, V14, P3575, DOI 10.1016/j.bmc.2006.01.024; Jeanjean A, 2008, BIOORG MED CHEM LETT, V18, P6240, DOI 10.1016/j.bmcl.2008.09.101; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kramer JR, 2015, P NATL ACAD SCI USA, V112, P12574, DOI 10.1073/pnas.1516127112; Li JY, 2016, CANCER CELL, V29, P117, DOI 10.1016/j.ccell.2015.12.008; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu L, 2017, MOL THER-METH CLIN D, V5, P59, DOI 10.1016/j.omtm.2017.03.006; Nabet B, 2018, NAT CHEM BIOL, V14, P431, DOI 10.1038/s41589-018-0021-8; Naito Mikihiko, 2019, Drug Discov Today Technol, V31, P35, DOI 10.1016/j.ddtec.2018.12.002; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; RITTER TE, 1995, P NATL ACAD SCI USA, V92, P3824, DOI 10.1073/pnas.92.9.3824; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Shen Y, 2018, AM J CANCER RES, V8, P916; Sly WS, 2006, P NATL ACAD SCI USA, V103, P15172, DOI 10.1073/pnas.0607053103; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vidal S, 2002, PHOSPHORUS SULFUR, V177, P2363, DOI 10.1080/10426500214297; WEISSMAN AM, 1986, J CELL BIOL, V102, P951, DOI 10.1083/jcb.102.3.951; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yamazaki Y, 2016, CNS DRUGS, V30, P773, DOI 10.1007/s40263-016-0361-4; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105; Zhu YX, 2004, J BIOL CHEM, V279, P50336, DOI 10.1074/jbc.M409676200	46	198	203	120	424	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					291	+		10.1038/s41586-020-2545-9	http://dx.doi.org/10.1038/s41586-020-2545-9		JUL 2020	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32728216	Green Accepted			2022-12-28	WOS:000554511600003
J	Carvelli, J; Demaria, O; Vely, F; Batista, L; Benmansour, NC; Fares, J; Carpentier, S; Thibult, ML; Morel, A; Remark, R; Andre, P; Represa, A; Piperoglou, C; Cordier, PY; Le Dault, E; Guervilly, C; Simeone, P; Gainnier, M; Morel, Y; Ebbo, M; Schleinitz, N; Vivier, E				Carvelli, Julien; Demaria, Olivier; Vely, Frederic; Batista, Luciana; Benmansour, Nassima Chouaki; Fares, Joanna; Carpentier, Sabrina; Thibult, Marie-Laure; Morel, Ariane; Remark, Romain; Andre, Pascale; Represa, Agnes; Piperoglou, Christelle; Cordier, Pierre Yves; Le Dault, Erwan; Guervilly, Christophe; Simeone, Pierre; Gainnier, Marc; Morel, Yannis; Ebbo, Mikael; Schleinitz, Nicolas; Vivier, Eric		Explore COVID-19 IPH Grp; Explore COVID-19 Marseille Immunop	Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis	NATURE			English	Article							ACUTE LUNG INJURY; COMPLEMENT ACTIVATION; C5A; EXPRESSION; INFECTION; PROTEIN	Blockade of the C5a-C5aR1 axis using anti-C5aR1 monoclonal antibodies prevented inflammation associated with COVID-19. Coronavirus disease 2019 (COVID-19) is a disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in a pandemic(1). The C5a complement factor and its receptor C5aR1 (also known as CD88) have a key role in the initiation and maintenance of several inflammatory responses by recruiting and activating neutrophils and monocytes(1). Here we provide a longitudinal analysis of immune responses, including phenotypic analyses of immune cells and assessments of the soluble factors that are present in the blood and bronchoalveolar lavage fluid of patients at various stages of COVID-19 severity, including those who were paucisymptomatic or had pneumonia or acute respiratory distress syndrome. The levels of soluble C5a were increased in proportion to the severity of COVID-19 and high expression levels of C5aR1 receptors were found in blood and pulmonary myeloid cells, which supports a role for the C5a-C5aR1 axis in the pathophysiology of acute respiratory distress syndrome. Anti-C5aR1 therapeutic monoclonal antibodies prevented the C5a-mediated recruitment and activation of human myeloid cells, and inhibited acute lung injury in human C5aR1 knock-in mice. These results suggest that blockade of the C5a-C5aR1 axis could be used to limit the infiltration of myeloid cells in damaged organs and prevent the excessive lung inflammation and endothelialitis that are associated with acute respiratory distress syndrome in patients with COVID-19.	[Carvelli, Julien; Gainnier, Marc] Hop La Timone, Assistance Publ Hop Marseille, Reanimat Urgences, Marseilles, France; [Carvelli, Julien; Guervilly, Christophe; Simeone, Pierre; Gainnier, Marc] Aix Marseille Univ, Marseilles, France; [Demaria, Olivier; Batista, Luciana; Fares, Joanna; Carpentier, Sabrina; Thibult, Marie-Laure; Morel, Ariane; Remark, Romain; Andre, Pascale; Represa, Agnes; Morel, Yannis; Vivier, Eric] Innate Pharma, Marseilles, France; [Vely, Frederic; Piperoglou, Christelle; Ebbo, Mikael; Schleinitz, Nicolas; Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, CIML, Marseilles, France; [Vely, Frederic; Piperoglou, Christelle; Vivier, Eric] Hop La Timone, Assistance Publ Hop Marseille, Immunol, Marseille Immunopole, Marseilles, France; [Benmansour, Nassima Chouaki; Cordier, Pierre Yves; Le Dault, Erwan] Hop Instruct Armees Laveran, Marseilles, France; [Benmansour, Nassima Chouaki] Assistance Publ Hop Marseille, Marseilles, France; [Guervilly, Christophe] Aix Marseille Univ, Hop Nord, Assistance Publ Hop Marseille, Reanimat Detresses Resp & Infect Severes, Marseilles, France; [Simeone, Pierre] Aix Marseille Univ, Hop Timone, Assistance Publ Hop Marseille, Reanimat Polyvalente, Marseilles, France; [Ebbo, Mikael; Schleinitz, Nicolas] Hop La Timone, Assistance Publ Hop Marseille, Internal Med, Marseilles, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Innate Pharma, Marseilles, France.; Vivier, E (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseilles, France.; Vivier, E (corresponding author), Hop La Timone, Assistance Publ Hop Marseille, Immunol, Marseille Immunopole, Marseilles, France.	vivier@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010; Vély, Frédéric/HHM-3894-2022; Simeone, Pierre/AAW-4347-2021; guervilly, christophe/C-1083-2016; daniel, laurent/R-2826-2016	Vivier, Eric/0000-0001-7022-8287; Guervilly, Christophe/0000-0001-9066-6591; daniel, laurent/0000-0002-7539-0109; Girard-Madoux, Mathilde/0000-0002-8840-2623; Simeone, Pierre/0000-0002-0682-9405; pastorino, boris/0000-0001-5233-5193	European Research Council (ERC) under the European Union [694502, 875102]; Agence Nationale de la Recherche including the PIONEER Project [ANR-17-RHUS-0007]; MSDAvenir; Innate Pharma	European Research Council (ERC) under the European Union(European Research Council (ERC)); Agence Nationale de la Recherche including the PIONEER Project(French National Research Agency (ANR)); MSDAvenir; Innate Pharma	We thank all of the healthcare workers involved in the analysis, diagnosis and treatment of patients at AP-HM and Hopital Laveran, especially Elise Kaspi, Eric Garnotel, Corinne Surcouf, Francois Xavier Le Flem (Bataillon des Marins Pompiers Marseille). We thank all our patients, supporters and families for their confidence in our work. The E.V. laboratory at CIML and Assistance-Publique des Hopitaux de Marseille is supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC, grant agreement number 694502 and MInfla-TILC, grant agreement number 875102 - MInfla-Tilc), the Agence Nationale de la Recherche including the PIONEER Project (ANR-17-RHUS-0007), MSDAvenir, Innate Pharma and institutional grants awarded to the CIML (INSERM, CNRS, and Aix-Marseille University) and Marseille Immunopole.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Amrane S, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101632; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Copin MC, 2020, INTENS CARE MED, V46, P1124, DOI 10.1007/s00134-020-06057-8; Cugno M, 2020, J ALLERGY CLIN IMMUN, V146, P215, DOI 10.1016/j.jaci.2020.05.006; Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Foley JH, 2016, THROMB RES, V141, pS50, DOI 10.1016/S0049-3848(16)30365-6; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hatcher, 2020, NAT MED, V29, P1, DOI [10.1101/2020.03.18.20038018, DOI 10.1101/2020.03.18.20038018, 10.3389/fmolb.2020.604252, DOI 10.1038/S41591-020-0897-1]; Jayne DRW, 2017, J AM SOC NEPHROL, V28, P2756, DOI 10.1681/ASN.2016111179; Jiang YT, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0063-8; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lee H, 2006, NAT BIOTECHNOL, V24, P1279, DOI 10.1038/nbt1248; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5; Ramlall V, 2020, NAT MED, V26, P1609, DOI 10.1038/s41591-020-1021-2; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Russkamp NF, 2015, FASEB J, V29, P3762, DOI 10.1096/fj.15-271635; Sun SH, 2015, CLIN INFECT DIS, V60, P586, DOI 10.1093/cid/ciu887; Sun SH, 2013, AM J RESP CELL MOL, V49, P221, DOI 10.1165/rcmb.2012-0428OC; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Thomson TM, 2020, BRIT J HAEMATOL, V190, P520, DOI 10.1111/bjh.16938; Trujillo G, 2011, MOL IMMUNOL, V49, P495, DOI 10.1016/j.molimm.2011.09.024; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang RX, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.28; Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363	39	240	246	7	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2020	588	7836					146	+		10.1038/s41586-020-2600-6	http://dx.doi.org/10.1038/s41586-020-2600-6		JUL 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA7WA	32726800	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000580948400001
J	Kinderknecht, K; Harris, C; Jones-Smith, J				Kinderknecht, Kelsey; Harris, Cristen; Jones-Smith, Jessica			Association of the Healthy, Hunger-Free Kids Act With Dietary Quality Among Children in the US National School Lunch Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE The Healthy, Hunger-Free Kids Act of 2010, implemented nationwide in 2012, was intended to improve the nutritional quality of meals served in the National School Lunch Program (NSLP). OBJECTIVE To assess whether there was an assoc at on between the Healthy, Hunger-Free Kids Act of 2010 and dietary quality of lunch for students participating in the NSLP, stratified by income. DESIGN, SETTING, PARTICIPANTS Serial cross-sectional study design, using National Health and Nutrition Examination Survey (NHANES) data from 2007-2008, 2009-2010, 2013-2014, and 2015-2016, of students who were surveyed in the NHANES and were attending schools participating in the NSLP. Individuals who were aged 5 to 18 years, in kindergarten through 12th grade, enrolled in a school that served school lunch, and had a reliable weekday dietary recall were included. EXPOSURES The Healthy, Hunger-Free Kids Act of 2010 (prepolicy period: 2007-2010; postpolicy period: 2013-2016), with participation in the NSLP estimated based on an algorithm. MAIN OUTCOMES AND MEASURES The primary outcome was dietary quality of intake for lunch, measured by the Healthy Eating Index-2010 (HEI-2010) score (range, 0-100; 0 indicates a diet with no adherence to the 2010 Dietary Guidelines for Americans and 100 indicates a diet with complete adherence to the guidelines). RESULTS Among 6389 students included in the surveys (mean age, 11.7 [95% CI, 11.6-11.9] years; 3145 [50%] female students; 1880 [56%] were non-Hispanic white), 32% were low-income, 12% were low-middle-income, and 56% were middle-high-income students. A total of 2472 (39%) were participants in the NSLP. Among low-income students, the adjusted mean prepolicy HEI-2010 score was 42.7 and the postpolicy score was 54.6 among NSLP participants and the adjusted mean prepolicy score was 34.8 and postpolicy score was 34.1among NSLP nonparticipants (difference in differences, 12.6 [95% CI, 8.9-16.3]). Among low-middle-income students, the adjusted mean prepolicy HEI-2010 score was 40.4 and postpolicy score was 54.8 among NSLP participants and the adjusted mean prepolicy score was 34.2 and postpolicy score was 36.1among NSLP nonparticipants (difference in differences, 12.4 [95% CI, 4.9-19.9]). Among middle-high-income students, the adjusted mean HEI-2010 prepolicy score was 42.7 and postpolicy score 55.5 for NSLP participants and the adjusted mean prepolicy score was 38.9 and prepolicy score was 43.6 for NSLP nonparticipants (difference in differences, 8.1[95% CI, 4.2-12.0]). CONCLUSIONS AND RELEVANCE In a serial cross-sectional study of students, the Healthy, Hunger-Free Kids Act of 2010 was associated with better changes in dietary quality for lunch among presumed low-income, low-middle-income, and middle-high-income participants in the NSLP compared with nonparticipants.	[Kinderknecht, Kelsey] Univ Washington, Nutr Sci Program, Sch Publ Hlth, Seattle, WA 98195 USA; [Harris, Cristen] Univ Washington, Dept Epidemiol, Nutr Sci Program, Sch Publ Hlth, Seattle, WA 98195 USA; [Jones-Smith, Jessica] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98195 USA; [Jones-Smith, Jessica] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kinderknecht, K (corresponding author), Univ Washington, UW Nutr Sci Program, 305 Raitt Hall,POB 353410, Seattle, WA 98195 USA.	kkinder3@uw.edu			Health Resources and Services Administration of the US Department of Health and Human Services [T79MC00013]	Health Resources and Services Administration of the US Department of Health and Human Services	Ms Kinderknecht and Dr Harris were supported in this project by the Health Resources and Services Administration of the US Department of Health and Human Services under grant number T79MC00013 (Partners in Excellence for Training in MCH Nutrition).	[Anonymous], 2019, AMPM USDA AUT MULT P; Au LE, 2020, J NUTR EDUC BEHAV, V52, P249, DOI 10.1016/j.jneb.2019.10.016; Bornhorst C, 2014, CLIN NUTR, V33, P79, DOI 10.1016/j.clnu.2013.03.018; Condon J, 2020, INT J AGING HUM DEV, V91, P340, DOI 10.1177/0091415019882005; Cullen Karen Weber, 2017, Prev Med Rep, V5, P82; Food and Nutrition Service, 2018, CHILD NUTR PROGR FLE; Food and Nutrition Service, 2020, SIMPL MEAL SERV MON; Food and Nutrition Service (FNS) USDA, 2012, Fed Regist, V77, P4088; Fox MK, 2019, SCH NUTR MEAL COST S; Gearan EC, 2020, J ACAD NUTR DIET, V120, P363, DOI 10.1016/j.jand.2019.10.022; Guerrero AD, 2016, J ACAD NUTR DIET, V116, P439, DOI 10.1016/j.jand.2015.08.019; Hanson KL, 2013, J NUTR, V143, P714, DOI 10.3945/jn.112.170548; Kirkpatrick SI, 2018, J ACAD NUTR DIET, V118, P1603, DOI 10.1016/j.jand.2018.05.020; Liu JX, 2020, JAMA-J AM MED ASSOC, V323, P1161, DOI 10.1001/jama.2020.0878; Liu Yibin, 2019, J Acad Nutr Diet, V119, P1703, DOI 10.1016/j.jand.2019.02.015; Moshfegh A., 2014, FOOD PATTERNS EQUIVA; Ralston K, 2008, NATL SCH LUNCH PROGR; Tester JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3557; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; Zhang FF, 2015, J PEDIATR GASTR NUTR, V61, P499, DOI 10.1097/MPG.0000000000000826; Zimmer MC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112607	22	27	27	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					359	368		10.1001/jama.2020.9517	http://dx.doi.org/10.1001/jama.2020.9517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721008	Green Published, Bronze			2022-12-28	WOS:000562851000025
J	Slomski, A				Slomski, Anita			Intervention Improves Kids' Attitudes About Mental Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					327	327		10.1001/jama.2020.12591	http://dx.doi.org/10.1001/jama.2020.12591			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE8JP	32721004				2022-12-28	WOS:000562851000008
J	Oliver, G; Kipnis, J; Randolph, GJ; Harvey, NL				Oliver, Guillermo; Kipnis, Jonathan; Randolph, Gwendalyn J.; Harvey, Natasha L.			The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease	CELL			English	Review							GROWTH-FACTOR-C; PRIMARY CONGENITAL GLAUCOMA; INFLAMMATORY-BOWEL-DISEASE; HIGH-DENSITY-LIPOPROTEINS; SCHLEMMS CANAL INTEGRITY; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; HEREDITARY LYMPHEDEMA; TRANSCRIPTION FACTOR; CARDIAC LYMPHATICS	Mammals have two specialized vascular circulatory systems: the blood vasculature and the lymphatic vasculature. The lymphatic vasculature is a unidirectional conduit that returns filtered interstitial arterial fluid and tissue metabolites to the blood circulation. It also plays major roles in immune cell trafficking and lipid absorption. As we discuss in this review, the molecular characterization of lymphatic vascular development and our understanding of this vasculature's role in pathophysiological conditions has greatly improved in recent years, changing conventional views about the roles of the lymphatic vasculature in health and disease. Morphological or functional defects in the lymphatic vasculature have now been uncovered in several pathological conditions. We propose that subtle asymptomatic alterations in lymphatic vascular function could underlie the variability seen in the body's response to a wide range of human diseases.	[Oliver, Guillermo] Northwestern Univ, Ctr Vasc & Dev Biol, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Kipnis, Jonathan] Univ Virginia, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA; [Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Randolph, Gwendalyn J.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Harvey, Natasha L.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Harvey, Natasha L.] SA Pathol, Adelaide, SA, Australia	Northwestern University; Feinberg School of Medicine; University of Virginia; University of Virginia; Washington University (WUSTL); Centre for Cancer Biology; University of South Australia; SA Pathology	Oliver, G (corresponding author), Northwestern Univ, Ctr Vasc & Dev Biol, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA.	guillermo.oliver@northwestern.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X; Harvey, Natasha/0000-0001-9839-8966	NIH [RO1HL073402-16, RF1 AG 057496, R37 AI 049653, DP1 DK109668, R01DK119147]; Rainin Foundation Synergy Award; NHMRC [APP1146800, APP1146352]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rainin Foundation Synergy Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We want to thank Justin Rustenhoven, Kelly Betterman, and Nozomu Takata for help with some of the drawings included in the figures. This work was partially supported by NIH RO1HL073402-16 (to G.O.); NIH RF1 AG 057496 (to J.K.); NIH R37 AI 049653, DP1 DK109668, and R01DK119147 and a Rainin Foundation Synergy Award (to G.J.R.), and NHMRC APP1146800 and APP1146352 (to N.L.H.).	ADAIR TH, 1982, AM J PHYSIOL, V243, pH351, DOI 10.1152/ajpheart.1982.243.3.H351; Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Alders M, 2013, MOL SYNDROMOL, V4, P107, DOI [10.1159/000342486, 10.1159/000354097]; Alders M, 2014, HUM GENET, V133, P1161, DOI 10.1007/s00439-014-1456-y; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Alexander JS, 2010, ANN NY ACAD SCI, V1207, pE75, DOI 10.1111/j.1749-6632.2010.05757.x; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Arngrim N, 2013, INT J OBESITY, V37, P748, DOI 10.1038/ijo.2012.98; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Aspelund A, 2014, J CLIN INVEST, V124, P3975, DOI 10.1172/JCI75395; Au AC, 2010, AM J HUM GENET, V87, P436, DOI 10.1016/j.ajhg.2010.08.008; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bazigou E, 2013, CELL MOL LIFE SCI, V70, P1055, DOI 10.1007/s00018-012-1110-6; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Becker F, 2015, INFLAMM BOWEL DIS, V21, P1282, DOI 10.1097/MIB.0000000000000371; Bernier-Latmani J, 2017, NAT REV GASTRO HEPAT, V14, P510, DOI 10.1038/nrgastro.2017.79; Berta J, 2014, ONCOTARGET, V5, P4426, DOI 10.18632/oncotarget.2032; Berton M, 2015, J AM ACAD DERMATOL, V72, P333, DOI 10.1016/j.jaad.2014.10.033; Betterman KL, 2020, J CLIN INVEST, V130, P3315, DOI 10.1172/JCI99027; Blum KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094713; Bogoslowski A, 2018, P NATL ACAD SCI USA, V115, P2449, DOI 10.1073/pnas.1715756115; Bolte AC., 2019, MENINGEAL LYMPHALIC, P817023, DOI [10.1101/817023, DOI 10.1101/817023]; Boone PM, 2020, AM J MED GENET A, V182, P189, DOI 10.1002/ajmg.a.61392; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bouvree K, 2012, CIRC RES, V111, P437, DOI 10.1161/CIRCRESAHA.112.269316; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Boyages J, 2015, ANN SURG ONCOL, V22, pS1263, DOI 10.1245/s10434-015-4700-3; Bradham R R, 1973, Ann Thorac Surg, V15, P526; Brakenhielm E, 2019, NAT REV CARDIOL, V16, P56, DOI 10.1038/s41569-018-0087-8; Brent L, 1997, HUM IMMUNOL, V52, P75, DOI 10.1016/S0198-8859(96)00289-3; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Broggi MAS, 2019, J EXP MED, V216, P1091, DOI 10.1084/jem.20181618; Brorson H, 2003, Scand J Surg, V92, P287; Brorson H, 2010, PHLEBOLOGY, V25, P52, DOI 10.1258/phleb.2010.010s08; Brorson H, 2016, J RECONSTR MICROSURG, V32, P56, DOI 10.1055/s-0035-1549158; Brouillard P, 2017, HUM MOL GENET, V26, P4095, DOI 10.1093/hmg/ddx297; Brouillard P, 2014, J CLIN INVEST, V124, P898, DOI 10.1172/JCI71614; Bui HM, 2016, J CLIN INVEST, V126, P2167, DOI 10.1172/JCI83967; Butler MG, 2007, AM J MED GENET A, V143A, P1212, DOI 10.1002/ajmg.a.31703; Butler MG, 2009, BIRTH DEFECTS RES C, V87, P222, DOI 10.1002/bdrc.20155; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Cha B, 2018, CELL REP, V25, P571, DOI 10.1016/j.celrep.2018.09.049; Cha B, 2016, GENE DEV, V30, P1454, DOI 10.1101/gad.282400.116; Chen JY, 2019, DEV CELL, V49, P697, DOI 10.1016/j.devcel.2019.03.022; Choi D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125068; Choi D, 2017, CIRC RES, V120, P1426, DOI 10.1161/CIRCRESAHA.116.309548; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cifarelli V, 2019, CELL MOL GASTROENTER, V7, P503, DOI 10.1016/j.jcmgh.2018.12.002; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Coxam B, 2014, CELL REP, V7, P623, DOI 10.1016/j.celrep.2014.03.063; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Czepielewski RS, 2018, J EXP MED, V215, P2699, DOI 10.1084/jem.20181898; D'Alessio S, 2015, ONCOTARGET, V6, P34047, DOI 10.18632/oncotarget.6026; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Da Mesquita S, 2018, NEURON, V100, P375, DOI 10.1016/j.neuron.2018.09.022; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Dagenais SL, 2004, GENE EXPR PATTERNS, V4, P611, DOI 10.1016/j.modgep.2004.07.004; Dai TY, 2006, EUR J PHARMACOL, V553, P222, DOI 10.1016/j.ejphar.2006.09.034; Davis RB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92465; Dayan JH, 2018, ANNU REV MED, V69, P263, DOI 10.1146/annurev-med-060116-022900; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Dellinger MT, 2014, BONE, V63, P47, DOI 10.1016/j.bone.2014.02.011; DELUISE VP, 1983, SURV OPHTHALMOL, V28, P1, DOI 10.1016/0039-6257(83)90174-1; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dixon JB, 2010, ANN NY ACAD SCI, V1207, pE52, DOI 10.1111/j.1749-6632.2010.05716.x; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Drewry LL, 2019, NAT MICROBIOL, V4, P1951, DOI 10.1038/s41564-019-0504-8; Escobedo N, 2017, CELL METAB, V26, P598, DOI 10.1016/j.cmet.2017.07.020; Escobedo N, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85096; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; FALLS H F, 1964, Trans Am Ophthalmol Soc, V62, P248; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fankhauser M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4712; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Finegold DN, 2001, HUM MOL GENET, V10, P1185, DOI 10.1093/hmg/10.11.1185; Flaht-Zabost A, 2014, ANAT REC, V297, P1115, DOI 10.1002/ar.22912; Fotiou E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9085; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Frye M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03959-6; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gancz D., 2019, COLD SPRING HARB PER, V12; Gauvrit S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05039-1; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geng X, 2017, DIS MODEL MECH, V10, P1273, DOI 10.1242/dmm.030825; Geng X, 2016, DEV BIOL, V409, P218, DOI 10.1016/j.ydbio.2015.10.022; Gerner MY, 2017, J EXP MED, V214, P3105, DOI 10.1084/jem.20170335; Gerster R, 2015, CELL MOL GASTROENTER, V1, P171, DOI 10.1016/j.jcmgh.2014.12.006; Ghalamkarpour A, 2009, J PEDIATR-US, V155, P90, DOI 10.1016/j.jpeds.2009.02.023; Gibbons C, 2007, MOL ENDOCRINOL, V21, P783, DOI 10.1210/me.2006-0156; GORDON AS, 2020, J MED GENET, DOI DOI 10.1136/JMEDGENET-2019-106084; Greiwe L, 2016, ACTA PHYSIOL, V217, P61, DOI 10.1111/apha.12633; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Gur-Cohen S, 2019, SCIENCE, V366, P1218, DOI 10.1126/science.aay4509; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; HAMANAKA T, 1992, EXP EYE RES, V55, P479, DOI 10.1016/0014-4835(92)90121-8; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; HENNEKAM RCM, 1989, AM J MED GENET, V34, P593, DOI 10.1002/ajmg.1320340429; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Hespe GE, 2016, J PHYSIOL-LONDON, V594, P4267, DOI 10.1113/JP271757; Heyde A, 2019, P NATL ACAD SCI USA, V116, P14129, DOI 10.1073/pnas.1819408116; Hiraoka N, 2015, BRIT J CANCER, V112, P1782, DOI 10.1038/bjc.2015.145; Hogan BM, 2017, DEV CELL, V42, P567, DOI 10.1016/j.devcel.2017.08.015; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Howard R, 2020, NAT REV NEUROL, V16, P63, DOI 10.1038/s41582-019-0295-9; Hu XT, 2020, CELL RES, V30, P229, DOI 10.1038/s41422-020-0287-8; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huang LH, 2019, CELL METAB, V29, P475, DOI 10.1016/j.cmet.2018.10.006; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Huntington GS, 1910, AM J ANAT, V10, P177, DOI 10.1002/aja.1000100108; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Ishikawa Y, 2007, HISTOPATHOLOGY, V51, P345, DOI 10.1111/j.1365-2559.2007.02785.x; Jacob L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12568-w; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Jha SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04982-1; Jiang XG, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01402; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Jones GE, 2017, CLIN MED, V17, P552, DOI 10.7861/clinmedicine.17-6-552; Jurisic G, 2013, INFLAMM BOWEL DIS, V19, P1983, DOI 10.1097/MIB.0b013e31829292f7; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Kagemann L, 2014, INVEST OPHTH VIS SCI, V55, P1805, DOI 10.1167/iovs.13-13264; Kagemann L, 2010, INVEST OPHTH VIS SCI, V51, P4054, DOI 10.1167/iovs.09-4559; Kahari L, 2019, J CLIN INVEST, V129, P3086, DOI 10.1172/JCI125740; Kampmeier O.F, 1969, EVOLUTION COMP MORPH; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpinich NO, 2014, ARTERIOSCL THROM VAS, V34, P239, DOI 10.1161/ATVBAHA.113.302905; Kazenwadel J, 2018, CURR OPIN IMMUNOL, V53, P81, DOI 10.1016/j.coi.2018.04.012; Kazenwadel J, 2015, J CLIN INVEST, V125, P2979, DOI 10.1172/JCI78888; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Kim J, 2017, J CLIN INVEST, V127, P3877, DOI 10.1172/JCI94668; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kizhatil K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001912; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Lee CK, 2019, SCIENCE, V363, P644, DOI 10.1126/science.aav0173; Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Lioux G, 2020, DEV CELL, V52, P350, DOI 10.1016/j.devcel.2019.12.006; Liu X, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158261; Logovinsky V, 2016, ALZHEIMERS RES THER, V8, DOI [10.1016/j.trci.2016.01.001, 10.1186/s13195-016-0181-2]; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lund AW, 2016, J CLIN INVEST, V126, P3389, DOI 10.1172/JCI79434; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Lyons O, 2017, J EXP MED, V214, P2437, DOI 10.1084/jem.20160875; Ma GC, 2008, PRENATAL DIAG, V28, P1057, DOI 10.1002/pd.2130; Ma QL, 2019, J EXP MED, V216, P2492, DOI 10.1084/jem.20190351; Mackie DI, 2018, J EXP MED, V215, P2339, DOI 10.1084/jem.20180528; Mao R, 2019, INFLAMM BOWEL DIS, V25, P421, DOI 10.1093/ibd/izy331; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; Martens R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14921-w; Martin-Almedina S, 2016, J CLIN INVEST, V126, P3080, DOI 10.1172/JCI85794; Martinez-Corral I, 2015, CIRC RES, V116, P1649, DOI 10.1161/CIRCRESAHA.116.306170; Maruyama K, 2019, DEV BIOL, V452, P134, DOI 10.1016/j.ydbio.2019.05.002; McDonald DM, 2018, SCIENCE, V361, P551, DOI 10.1126/science.aau5583; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Meige H., 1898, PRESSE MED, V6, P341; Milasan A, 2019, ATHEROSCLEROSIS, V283, P106, DOI 10.1016/j.atherosclerosis.2019.01.031; Milasan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27862; Miller LS, 2018, P NATL ACAD SCI USA, V115, P2272, DOI 10.1073/pnas.1800448115; Milroy W.F., 1892, ANNU REV NEUROSCI; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Muthuchamy M, 2008, ANN NY ACAD SCI, V1131, P89, DOI 10.1196/annals.1413.008; Nakamura K, 2008, INT J CARDIOL, V129, P309, DOI 10.1016/j.ijcard.2008.02.007; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Naxerova K, 2017, SCIENCE, V357, P55, DOI 10.1126/science.aai8515; Neel J., 1954, HUM HERED, P41; Nitti MD, 2016, J PHYSIOL-LONDON, V594, P7073, DOI 10.1113/JP273061; Nonomura K, 2018, P NATL ACAD SCI USA, V115, P12817, DOI 10.1073/pnas.1817070115; Nores GDG, 2016, INT J OBESITY, V40, P1582, DOI 10.1038/ijo.2016.96; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; Outeda P, 2014, CELL REP, V7, P634, DOI 10.1016/j.celrep.2014.03.064; Overby DR, 2014, P NATL ACAD SCI USA, V111, P13876, DOI 10.1073/pnas.1410602111; Park DY, 2014, J CLIN INVEST, V124, P3960, DOI 10.1172/JCI75392; Patel TK, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0312-x; Pena-Jimenez D, 2019, EMBO J, V38, DOI 10.15252/embj.2019101688; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Perry LP, 2012, J AAPOS, V16, P565, DOI 10.1016/j.jaapos.2012.06.012; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Petrova TV, 2018, J EXP MED, V215, P35, DOI 10.1084/jem.20171868; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Pfarr KM, 2009, PARASITE IMMUNOL, V31, P664, DOI 10.1111/j.1365-3024.2009.01133.x; Pichol-Thievend C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160184; Planas-Paz L, 2012, EMBO J, V31, P788, DOI 10.1038/emboj.2011.456; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Pujol F, 2017, ARTERIOSCL THROM VAS, V37, P1732, DOI 10.1161/ATVBAHA.117.309818; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rademakers T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45263; Rahier JF, 2013, INFLAMM BOWEL DIS, V19, P2084, DOI 10.1097/MIB.0b013e3182971cec; Ramos RF, 2007, J GLAUCOMA, V16, P391, DOI 10.1097/IJG.0b013e3180654ac6; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Randolph GJ, 2017, ANNU REV IMMUNOL, V35, P31, DOI 10.1146/annurev-immunol-041015-055354; Randolph GJ, 2016, AM J PATHOL, V186, P3066, DOI 10.1016/j.ajpath.2016.07.026; Randolph GJ, 2014, J CLIN INVEST, V124, P929, DOI 10.1172/JCI71610; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Rockson SG, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123775; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Rustenhoven J, 2019, SCIENCE, V366, P1448, DOI 10.1126/science.aay0479; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Sabine A, 2016, ANTIOXID REDOX SIGN, V25, P451, DOI 10.1089/ars.2016.6685; Sabine A, 2015, J CLIN INVEST, V125, P3861, DOI 10.1172/JCI80454; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; Savetsky IL, 2014, AM J PHYSIOL-HEART C, V307, pH165, DOI 10.1152/ajpheart.00244.2014; Sawane M, 2013, DIABETES, V62, P1970, DOI 10.2337/db12-0604; Schlemm F., 1830, THEORETISCH PRAKTISC, P331; Schneider M, 2005, NAT GENET, V37, P1023, DOI 10.1038/ng1005-1023; Sevigny J, 2017, NATURE, V546, P564, DOI 10.1038/nature22809; Shi GP, 2015, NAT REV CARDIOL, V12, P643, DOI 10.1038/nrcardio.2015.117; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; SHIMADA T, 1989, ACTA ANAT, V136, P16; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x; Souma T, 2016, J CLIN INVEST, V126, P2575, DOI 10.1172/JCI85830; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2014, GENE DEV, V28, P2175, DOI 10.1101/gad.216226.113; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; St John AL, 2014, IMMUNITY, V41, P440, DOI 10.1016/j.immuni.2014.07.013; Stanczuk L, 2015, CELL REP, V10, P1708, DOI 10.1016/j.celrep.2015.02.026; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Steinskog ESS, 2016, ONCOTARGET, V7, P45789, DOI 10.18632/oncotarget.9953; Stone OA, 2019, DEV CELL, V50, P247, DOI 10.1016/j.devcel.2019.04.034; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Sweet DT, 2015, J CLIN INVEST, V125, P2995, DOI 10.1172/JCI79386; Swenson KK, 2009, ONCOL NURS FORUM, V36, P185, DOI 10.1188/09.ONF.185-193; Takeda A, 2019, IMMUNITY, V51, P561, DOI 10.1016/j.immuni.2019.06.027; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tatin F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93887; Tatin F, 2013, DEV CELL, V26, P31, DOI 10.1016/j.devcel.2013.05.015; Tavakkolizadeh A, 2001, BRIT J PLAST SURG, V54, P367, DOI 10.1054/bjps.2001.3572; Thackaberry EA, 2019, INVEST OPHTH VIS SCI, V60, P4097, DOI 10.1167/iovs.18-26349; Thomson BR, 2017, J CLIN INVEST, V127, P4421, DOI 10.1172/JCI95545; Thomson BR, 2014, J CLIN INVEST, V124, P4320, DOI 10.1172/JCI77162; Tian W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3920; Torrisi JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19817; Triacca V, 2017, CIRC RES, V120, P1440, DOI 10.1161/CIRCRESAHA.116.309828; Trincot CE, 2019, CIRC RES, V124, P101, DOI 10.1161/CIRCRESAHA.118.313835; Truong TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098245; UPTON ML, 1985, J NEUROSURG, V63, P867, DOI 10.3171/jns.1985.63.6.0867; Van Balkom IDC, 2002, AM J MED GENET, V112, P412, DOI 10.1002/ajmg.10707; Van Kruiningen HJ, 2008, GUT, V57, P1; van Steensel MAM, 2009, HUM MUTAT, V30, pE1002, DOI 10.1002/humu.21127; van Zwam M, 2009, J PATHOL, V217, P543, DOI 10.1002/path.2476; VANDERPUTTE SCJ, 1975, ACTA MORPHOL NEER SC, V13, P245; Vieira JM, 2018, J CLIN INVEST, V128, P3402, DOI 10.1172/JCI97192; Vignes S, 2007, ACTA ONCOL, V46, P1138, DOI 10.1080/02841860701403020; von der Weid PY, 2011, CURR OPIN GASTROEN, V27, P335, DOI 10.1097/MOG.0b013e3283476e8f; Vuorio T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34770-4; Vuorio T, 2017, TRENDS ENDOCRIN MET, V28, P285, DOI 10.1016/j.tem.2016.12.002; Vuorio T, 2014, ARTERIOSCL THROM VAS, V34, P1162, DOI 10.1161/ATVBAHA.114.302528; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wang YX, 2017, DEVELOPMENT, V144, P3590, DOI 10.1242/dev.147967; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Witte MH, 2001, MICROSC RES TECHNIQ, V55, P122, DOI 10.1002/jemt.1163; Wong BW, 2017, NATURE, V542, P49, DOI 10.1038/nature21028; Wynd S, 2007, B WORLD HEALTH ORGAN, V85, P493, DOI 10.2471/BLT.06.031047; Yanev P, 2020, J CEREBR BLOOD F MET, V40, P263, DOI 10.1177/0271678X18822921; Yang CW, 2013, J EXP MED, V210, P375, DOI 10.1084/jem.20122183; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yoon SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220341; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zhang F, 2018, SCIENCE, V361, P599, DOI 10.1126/science.aap9331; Zou WY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0147-y	314	165	168	15	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					270	296		10.1016/j.cell.2020.06.039	http://dx.doi.org/10.1016/j.cell.2020.06.039			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32707093	Bronze, Green Accepted			2022-12-28	WOS:000552745000004
J	Corbett, KS; Flynn, B; Foulds, KE; Francica, JR; Boyoglu-Barnum, S; Werner, AP; Flach, B; O'Connell, S; Bock, KW; Minai, M; Nagata, BM; Andersen, H; Martinez, DR; Noe, AT; Douek, N; Donaldson, MM; Nji, NN; Alvarado, GS; Edwards, DK; Flebbe, DR; Lamb, E; Doria-Rose, NA; Lin, BC; Louder, MK; O'Dell, S; Schmidt, SD; Phung, E; Chang, LA; Yap, C; Todd, JPM; Pessaint, L; Van Ry, A; Browne, S; Greenhouse, J; Putman-Taylor, T; Strasbaugh, A; Campbell, TA; Cook, A; Dodson, A; Steingrebe, K; Shi, W; Zhang, Y; Abiona, OM; Wang, LS; Pegu, A; Yang, ES; Leung, K; Zhou, T; Teng, IT; Widge, A; Gordon, I; Novik, L; Gillespie, RA; Loomis, RJ; Moliva, JI; Stewart-Jones, G; Himansu, S; Kong, WP; Nason, MC; Morabito, KM; Ruckwardt, TJ; Ledgerwood, JE; Gaudinski, MR; Kwong, PD; Mascola, JR; Carfi, A; Lewis, MG; Baric, RS; McDermott, A; Moore, IN; Sullivan, NJ; Roederer, M; Seder, RA; Graham, BS				Corbett, Kizzmekia S.; Flynn, Barbara; Foulds, Kathryn E.; Francica, Joseph R.; Boyoglu-Barnum, Seyhan; Werner, Anne P.; Flach, Britta; O'Connell, Sarah; Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Andersen, Hanne; Martinez, David R.; Noe, Amy T.; Douek, Naomi; Donaldson, Mitzi M.; Nji, Nadesh N.; Alvarado, Gabriela S.; Edwards, Darin K.; Flebbe, Dillon R.; Lamb, Evan; Doria-Rose, Nicole A.; Lin, Bob C.; Louder, Mark K.; O'Dell, Sijy; Schmidt, Stephen D.; Phung, Emily; Chang, Lauren A.; Yap, Christina; Todd, John-Paul M.; Pessaint, Laurent; Van Ry, Alex; Browne, Shanai; Greenhouse, Jack; Putman-Taylor, Tammy; Strasbaugh, Amanda; Campbell, Tracey-Ann; Cook, Anthony; Dodson, Alan; Steingrebe, Katelyn; Shi, Wei; Zhang, Yi; Abiona, Olubukola M.; Wang, Lingshu; Pegu, Amarendra; Yang, Eun Sung; Leung, Kwanyee; Zhou, Tongqing; Teng, I-Ting; Widge, Alicia; Gordon, Ingelise; Novik, Laura; Gillespie, Rebecca A.; Loomis, Rebecca J.; Moliva, Juan I.; Stewart-Jones, Guillaume; Himansu, Sunny; Kong, Wing-Pui; Nason, Martha C.; Morabito, Kaitlyn M.; Ruckwardt, Tracy J.; Ledgerwood, Julie E.; Gaudinski, Martin R.; Kwong, Peter D.; Mascola, John R.; Carfi, Andrea; Lewis, Mark G.; Baric, Ralph S.; McDermott, Adrian; Moore, Ian N.; Sullivan, Nancy J.; Roederer, Mario; Seder, Robert A.; Graham, Barney S.			Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LENGTH INFECTIOUS CDNA; REVERSE GENETICS; SPIKE; MERS; IMMUNOGENICITY	BackgroundVaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed. The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on viral replication in both upper and lower airways is important to evaluate in nonhuman primates. MethodsNonhuman primates received 10 or 100 mu g of mRNA-1273, a vaccine encoding the prefusion-stabilized spike protein of SARS-CoV-2, or no vaccine. Antibody and T-cell responses were assessed before upper- and lower-airway challenge with SARS-CoV-2. Active viral replication and viral genomes in bronchoalveolar-lavage (BAL) fluid and nasal swab specimens were assessed by polymerase chain reaction, and histopathological analysis and viral quantification were performed on lung-tissue specimens. ResultsThe mRNA-1273 vaccine candidate induced antibody levels exceeding those in human convalescent-phase serum, with live-virus reciprocal 50% inhibitory dilution (ID50) geometric mean titers of 501 in the 10-mu g dose group and 3481 in the 100-mu g dose group. Vaccination induced type 1 helper T-cell (Th1)-biased CD4 T-cell responses and low or undetectable Th2 or CD8 T-cell responses. Viral replication was not detectable in BAL fluid by day 2 after challenge in seven of eight animals in both vaccinated groups. No viral replication was detectable in the nose of any of the eight animals in the 100-mu g dose group by day 2 after challenge, and limited inflammation or detectable viral genome or antigen was noted in lungs of animals in either vaccine group. ConclusionsVaccination of nonhuman primates with mRNA-1273 induced robust SARS-CoV-2 neutralizing activity, rapid protection in the upper and lower airways, and no pathologic changes in the lung. (Funded by the National Institutes of Health and others.) Two injections of an mRNA-based vaccine encoding the SARS-CoV-2 spike protein elicited high levels of neutralizing antibody and Th1 CD4 T-cell responses in rhesus macaques. Two days after challenge of vaccinated animals with intranasal and intratracheal virus, viral replication was undetectable in bronchoalveolar-lavage fluid and nasal secretions.	[Corbett, Kizzmekia S.; Flynn, Barbara; Foulds, Kathryn E.; Francica, Joseph R.; Boyoglu-Barnum, Seyhan; Werner, Anne P.; Flach, Britta; O'Connell, Sarah; Noe, Amy T.; Douek, Naomi; Donaldson, Mitzi M.; Nji, Nadesh N.; Alvarado, Gabriela S.; Flebbe, Dillon R.; Lamb, Evan; Doria-Rose, Nicole A.; Lin, Bob C.; Louder, Mark K.; O'Dell, Sijy; Schmidt, Stephen D.; Phung, Emily; Chang, Lauren A.; Yap, Christina; Todd, John-Paul M.; Shi, Wei; Zhang, Yi; Abiona, Olubukola M.; Wang, Lingshu; Pegu, Amarendra; Yang, Eun Sung; Leung, Kwanyee; Zhou, Tongqing; Teng, I-Ting; Widge, Alicia; Gordon, Ingelise; Novik, Laura; Gillespie, Rebecca A.; Loomis, Rebecca J.; Moliva, Juan I.; Kong, Wing-Pui; Morabito, Kaitlyn M.; Ruckwardt, Tracy J.; Ledgerwood, Julie E.; Gaudinski, Martin R.; Kwong, Peter D.; Mascola, John R.; McDermott, Adrian; Sullivan, Nancy J.; Roederer, Mario; Seder, Robert A.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA; [Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Lewis, Mark G.] NIAID, Infect Dis Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Andersen, Hanne; Pessaint, Laurent; Van Ry, Alex; Browne, Shanai; Greenhouse, Jack; Putman-Taylor, Tammy; Strasbaugh, Amanda; Campbell, Tracey-Ann; Cook, Anthony; Dodson, Alan; Steingrebe, Katelyn; Moore, Ian N.] Bioqual, Rockville, MD USA; [Gaudinski, Martin R.] Public Hlth Serv Commissioned Corps, Rockville, MD USA; [Martinez, David R.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Edwards, Darin K.; Stewart-Jones, Guillaume; Himansu, Sunny; Carfi, Andrea] Moderna, Cambridge, MA USA; [Phung, Emily] George Washington Univ, Inst Biomed Sci, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); BIOQUAL Inc.; University of North Carolina; University of North Carolina Chapel Hill; George Washington University	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.	rseder@mail.nih.gov	Mascola, John/AAI-7193-2021; McDermott, Adrian B/E-7306-2011; martinez, david/GQI-0849-2022; Roederer, Mario/G-1887-2011	Elyard, Hanne/0000-0003-1103-9608; Himansu, Sunny/0000-0002-7954-9674; Gaudinski, Martin/0000-0002-3743-5281; McDermott, Adrian/0000-0003-0616-9117; Werner, Anne/0000-0003-2322-6830; Wang, Lingshu/0000-0002-8404-4910; Chang, Lauren/0000-0002-3287-3987	Intramural Research Program of the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Department of Health and Human Services [75A50120C00034]; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; NIAID [T32-AI007151, F32 AI152296]; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award	Intramural Research Program of the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Department of Health and Human Services; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund)	Supported by the Intramural Research Program of the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); and the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Department of Health and Human Services (contract 75A50120C00034). Dr. Corbett is the recipient of a research fellowship that was partially funded by the Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH. Dr. Martinez was funded by grants from the NIAID (T32-AI007151 and F32 AI152296) and a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award.	Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035; Callaway E, 2020, NATURE, V579, P482, DOI 10.1038/d41586-020-00758-2; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chen WH, 2020, CURR TROP MED REP, V7, P61, DOI 10.1007/s40475-020-00201-6; CHEN Y, 2017, WORLD CONSTRUCTION, V5, P6; Chuang GY, 2017, J VIROL, V91, DOI 10.1128/JVI.02268-16; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1101/2020.06.11.145920, 10.1038/s41586-020-2622-0]; Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Donaldson MM, 2019, CYTOM PART A, V95A, P261, DOI 10.1002/cyto.a.23670; Edridge AWD, 2020, PREPRINT, DOI [10.1101/2020.05.11.20086439v2, DOI 10.1101/2020.05.11.20086439V2]; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Graham BS, 2019, ANNU REV MED, V70, P91, DOI 10.1146/annurev-med-121217-094234; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hassett KJ, 2019, MOL THER-NUCL ACIDS, V15, P1, DOI 10.1016/j.omtn.2019.01.013; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HEALTH, V5, pe86; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Killikelly AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34108; Long QQ, 2020, REPROD BIOL ENDOCRIN, V18, DOI 10.1186/s12958-020-00600-4; Loomis RJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00842; Meckiff Benjamin J, 2020, SSRN, P3641939, DOI [10.1101/2020.06.12.148916, 10.2139/ssrn.3641939]; Mulligan MJ, 2020, PHASE 1 2 STUDY DESC, DOI [10.1038/s41586-020-2639-4, 10.1101/2020.06.30.20142570]; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Neidleman Jason, 2020, bioRxiv, DOI 10.1101/2020.06.08.138826; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Sekine T., 2020, CELL, DOI [10.1016/j.cell.2020.08.017, 10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017]; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; Stewart-Jones GBE, 2018, P NATL ACAD SCI USA, V115, P12265, DOI 10.1073/pnas.1811980115; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Wang L, 2018, J VIROL, V92, pe02002; Wang N, 2019, CELL REP, V28; Wang WL, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.114; Widjaja I, 2019, EMERG MICROBES INFEC, V8, P516, DOI 10.1080/22221751.2019.1597644; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	54	588	609	14	118	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2020	383	16					1544	1555		10.1056/NEJMoa2024671	http://dx.doi.org/10.1056/NEJMoa2024671			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OE4ES	32722908	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000580486200011
J	Vinogradova, EV; Zhang, XY; Remillard, D; Lazar, DC; Suciu, RM; Wang, YJ; Bianco, G; Yamashita, Y; Crowley, VM; Schafroth, MA; Yokoyama, M; Konrad, DB; Lum, KM; Simon, GM; Kemper, EK; Lazear, MR; Yin, SF; Blewett, MM; Dix, MM; Nguyen, N; Shokhirev, MN; Chin, EN; Lairson, LL; Melillo, B; Schreiber, SL; Forli, S; Teijaro, JR; Cravatt, BF				Vinogradova, Ekaterina V.; Zhang, Xiaoyu; Remillard, David; Lazar, Daniel C.; Suciu, Radu M.; Wang, Yujia; Bianco, Giulia; Yamashita, Yu; Crowley, Vincent M.; Schafroth, Michael A.; Yokoyama, Minoru; Konrad, David B.; Lum, Kenneth M.; Simon, Gabriel M.; Kemper, Esther K.; Lazear, Michael R.; Yin, Sifei; Blewett, Megan M.; Dix, Melissa M.; Nhan Nguyen; Shokhirev, Maxim N.; Chin, Emily N.; Lairson, Luke L.; Melillo, Bruno; Schreiber, Stuart L.; Forli, Stefano; Teijaro, John R.; Cravatt, Benjamin F.			An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells	CELL			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; SENSITIVE CYSTEINES; DRUG DISCOVERY; ACTIVATION; INHIBITOR; APOPTOSIS; DIFFERENTIATION; UBIQUITINATION; DEGRADATION	Electrophilic compounds originating from nature or chemical synthesis have profound effects on immune cells. These compounds are thought to act by cysteine modification to alter the functions of immune-relevant proteins; however, our understanding of electrophile-sensitive cysteines in the human immune proteome remains limited. Here, we present a global map of cysteines in primary human T cells that are susceptible to covalent modification by electrophilic small molecules. More than 3,000 covalently liganded cysteines were found on functionally and structurally diverse proteins, including many that play fundamental roles in immunology. We further show that electrophilic compounds can impair T cell activation by distinct mechanisms involving the direct functional perturbation and/or degradation of proteins. Our findings reveal a rich content of ligandable cysteines in human T cells and point to electrophilic small molecules as a fertile source for chemical probes and ultimately therapeutics that modulate immunological processes and their associated disorders.	[Vinogradova, Ekaterina V.; Zhang, Xiaoyu; Remillard, David; Suciu, Radu M.; Wang, Yujia; Yamashita, Yu; Crowley, Vincent M.; Schafroth, Michael A.; Yokoyama, Minoru; Konrad, David B.; Lum, Kenneth M.; Kemper, Esther K.; Lazear, Michael R.; Yin, Sifei; Blewett, Megan M.; Dix, Melissa M.; Chin, Emily N.; Lairson, Luke L.; Melillo, Bruno; Cravatt, Benjamin F.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Lazar, Daniel C.; Nhan Nguyen; Teijaro, John R.] Scripps Res Inst, Dept Immunol & Infect Dis, La Jolla, CA 92037 USA; [Bianco, Giulia; Forli, Stefano] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Yamashita, Yu] Otsuka Pharmaceut Co Ltd, New Drug Res Div, Med Chem Res Labs, 463-10 Kawauchi Cho, Tokushima 7710192, Japan; [Simon, Gabriel M.] Vivid Therapeut, 5820 Nancy Ridge Dr, San Diego, CA 92121 USA; [Shokhirev, Maxim N.] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Melillo, Bruno; Schreiber, Stuart L.] Broad Inst, Chem Biol & Therapeut Sci Program, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Otsuka Pharmaceutical; Salk Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Vinogradova, EV; Cravatt, BF (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.; Teijaro, JR (corresponding author), Scripps Res Inst, Dept Immunol & Infect Dis, La Jolla, CA 92037 USA.	vinograd@scripps.edu; teijaro@scripps.edu; cravatt@scripps.edu	Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; Bianco, Giulia/0000-0001-9558-6339; Konrad, David/0000-0001-5718-8081; Lazear, Michael/0000-0001-5313-4262; Wang, Yujia/0000-0002-7099-6283; Zhang, Xiaoyu/0000-0002-0951-9664; Lazar, Daniel/0000-0002-1130-4590	NIH [CA231991]; NIH-NCI [K99CA248715, CA212467, CA211526, GM069832]; Clinical Translational Science Award [UL1 TR001114]; Damon Runyon Cancer Research Foundation [DRG-2341-18]; Life Sciences Research Foundation; NIH-NCI CCSG [P30 014195, R01 GM102491-07]; Helmsley Trust; European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020); Vividion Therapeutics	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical Translational Science Award; Damon Runyon Cancer Research Foundation; Life Sciences Research Foundation; NIH-NCI CCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Helmsley Trust; European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020); Vividion Therapeutics	We thank D. Tallman for technical assistance, B. Lu for help with Table S4, and M. Niphakis for helpful discussions. This work was supported by NIH (CA231991 to B.F.C.), NIH-NCI (K99CA248715 to X.Z., CA212467 to V.M.C., CA211526 to M.M.D., and GM069832 to S.F.), a Clinical Translational Science Award (UL1 TR001114), Damon Runyon Cancer Research Foundation (DRG-2341-18 to X.Z.), the Life Sciences Research Foundation (to E.V.V.), and Vividion Therapeutics. M.N.S. was supported by funding from NIH-NCI CCSG (P30 014195 and R01 GM102491-07), and the Helmsley Trust. D.B.K. received funding from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020).	Abbad MM, 2009, INT J EMERG TECHNOL, V4, P4, DOI 10.3991/ijet.v4i4.928; Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002; Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; Baillie TA, 2016, ANGEW CHEM INT EDIT, V55, P13408, DOI 10.1002/anie.201601091; Bar-Peled L, 2017, CELL, V171, P696, DOI 10.1016/j.cell.2017.08.051; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianco G, 2016, PROTEIN SCI, V25, P295, DOI 10.1002/pro.2733; Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Blewett MM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7694; Buckley DL, 2015, ACS CHEM BIOL, V10, P1831, DOI 10.1021/acschembio.5b00442; Burslem GM, 2018, CELL CHEM BIOL, V25, P67, DOI 10.1016/j.chembiol.2017.09.009; Cai Q, 2011, J MED CHEM, V54, P2714, DOI 10.1021/jm101505d; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chen Q, 2006, J BIOL CHEM, V281, P19985, DOI 10.1074/jbc.M601629200; Chylek LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104240; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Franchina DG, 2018, TRENDS IMMUNOL, V39, P489, DOI 10.1016/j.it.2018.01.005; Gao DW, 2018, J AM CHEM SOC, V140, P8069, DOI 10.1021/jacs.8b03704; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Haines JD, 2015, NAT NEUROSCI, V18, P511, DOI 10.1038/nn.3953; Han XM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1806-6; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hiemer S., 2019, BIORXIV, DOI [10.1101/635789, DOI 10.1101/635789]; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Ishida H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40662; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; Jones LH, 2018, CELL CHEM BIOL, V25, P30, DOI 10.1016/j.chembiol.2017.10.011; Jung ID, 2009, INT J IMMUNOPATH PH, V22, P501, DOI 10.1177/039463200902200227; Klopfenstein DV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28948-z; Kumar P, 2017, AM J PHYSIOL-RENAL, V313, pF781, DOI 10.1152/ajprenal.00166.2017; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lian GJ, 2018, ELIFE, V7, DOI 10.7554/eLife.36158; Lucherini OM, 2018, CLIN EXP RHEUMATOL, V36, pS3; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Martell J, 2016, CELL CHEM BIOL, V23, P955, DOI 10.1016/j.chembiol.2016.06.015; Maurais AJ, 2019, CURR OPIN CHEM BIOL, V50, P29, DOI 10.1016/j.cbpa.2019.02.010; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mortenson DE, 2018, J AM CHEM SOC, V140, P200, DOI 10.1021/jacs.7b08366; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Oestreich KJ, 2012, CURR OPIN IMMUNOL, V24, P191, DOI 10.1016/j.coi.2011.12.004; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qinheng Z., 2019, SLEEPING BEAUTY PHEN, DOI [10.26434/chemrxiv.7842020.v1, DOI 10.26434/CHEMRXIV.7842020.V1]; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Ravindranath PA, 2016, BIOINFORMATICS, V32, P3142, DOI 10.1093/bioinformatics/btw367; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Rip J, 2018, CRIT REV IMMUNOL, V38, P91, DOI 10.1615/CritRevImmunol.2018025184; Roberts AM, 2017, CURR OPIN BIOTECH, V43, P25, DOI 10.1016/j.copbio.2016.08.003; Saidu NEB, 2019, MED RES REV, V39, P1923, DOI 10.1002/med.21567; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Suarez-Fueyo A, 2016, CURR OPIN IMMUNOL, V43, P32, DOI 10.1016/j.coi.2016.09.001; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Telliez JB, 2016, ACS CHEM BIOL, V11, P3442, DOI 10.1021/acschembio.6b00677; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Tovell H, 2019, ACS CHEM BIOL, V14, P882, DOI 10.1021/acschembio.8b01016; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Voisinne G, 2019, NAT IMMUNOL, V20, P1530, DOI 10.1038/s41590-019-0489-8; Wagner T, 2015, ONCOTARGET, V6, P7123, DOI 10.18632/oncotarget.3344; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wang XY, 2020, EUR J MED CHEM, V187, DOI 10.1016/j.ejmech.2019.111918; Wang YJ, 2019, NAT CHEM, V11, P1113, DOI 10.1038/s41557-019-0351-5; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Xu H, 2019, ACS CHEM BIOL, V14, P1235, DOI 10.1021/acschembio.9b00188; Yang JH, 2019, J BIOL CHEM, V294, P8161, DOI 10.1074/jbc.RA118.006325; Yang YB, 2016, CANCER CELL, V29, P494, DOI 10.1016/j.ccell.2016.03.006; Zapf CW, 2012, J MED CHEM, V55, P10047, DOI 10.1021/jm301190s; Zaro BW, 2019, J IMMUNOL, V202, P2737, DOI 10.4049/jimmunol.1801627; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114	100	63	64	8	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					1009	+		10.1016/j.cell.2020.07.001	http://dx.doi.org/10.1016/j.cell.2020.07.001			47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32730809	Bronze, Green Accepted			2022-12-28	WOS:000561488500019
J	Bowman, D; Williamson, G; Yebra, M; Lizundia-Loiola, J; Pettinari, ML; Shah, S; Bradstock, R; Chuvieco, E				Bowman, David; Williamson, Grant; Yebra, Marta; Lizundia-Loiola, Joshua; Pettinari, Maria Lucrecia; Shah, Sami; Bradstock, Ross; Chuvieco, Emilio			Wildfires: Australia needs national monitoring agency	NATURE			English	Editorial Material						Environmental sciences; Climate change; Policy; Society			[Bowman, David] Univ Tasmania, Sch Nat Sci, Pyrogeog & fire Sci, Hobart, Tas, Australia; [Williamson, Grant] Univ Tasmania, Sch Nat Sci, Hobart, Tas, Australia; [Yebra, Marta] Australian Natl Univ, Environm & Engn, Canberra, ACT, Australia; [Lizundia-Loiola, Joshua; Pettinari, Maria Lucrecia] Univ Alcala, Dept Geol Geog & Environm, Alcala De Henares, Spain; [Shah, Sami] Australian Natl Univ, Canberra, ACT, Australia; [Bradstock, Ross] Univ Wollongong, Ctr Environm Risk Management Bushfires, Wollongong, NSW, Australia; [Chuvieco, Emilio] Univ Alcala, Dept Geol Geog & Environm, Geog, Alcala De Henares, Spain	University of Tasmania; University of Tasmania; Australian National University; Universidad de Alcala; Australian National University; University of Wollongong; Universidad de Alcala	Bowman, D (corresponding author), Univ Tasmania, Sch Nat Sci, Pyrogeog & fire Sci, Hobart, Tas, Australia.	david.bowman@utas.edu.au	; Bowman, David/A-2930-2011	Pettinari, M. Lucrecia/0000-0002-7472-4373; Bowman, David/0000-0001-8075-124X; Williamson, Grant/0000-0002-3469-7550				Adams MA, 2020, GLOBAL CHANGE BIOL, V26, P3756, DOI 10.1111/gcb.15125; Arriagada NB, 2020, MED J AUSTRALIA, V213, P282, DOI [10.5694/mja2.50545, 10.5694.mja2.50545]; Bradstock RA, 2020, GLOBAL CHANGE BIOL, V26, pE8, DOI 10.1111/gcb.15111; Bryant C., 2008, DELIBERATELY LIT VEG; Bryant C., 2008, UNDERSTANDING BUSHFI; Ellis S, 2004, NATL INQUIRY BUSHFIR; Fox-Hughes P, 2014, INT J WILDLAND FIRE, V23, P309, DOI 10.1071/WF13126; Gammage B., 2012, BIGGEST ESTATE EARTH; Harris RMB, 2018, NAT CLIM CHANGE, V8, P579, DOI 10.1038/s41558-018-0187-9; King AD, 2020, NAT CLIM CHANGE, V10, P177, DOI 10.1038/s41558-020-0718-z; Lewis SC, 2020, B AM METEOROL SOC, V101, pS115, DOI 10.1175/BAMS-D-19-0144.1; Lindenmayer DB, 2020, NAT ECOL EVOL, V4, P898, DOI 10.1038/s41559-020-1195-5; Lizundia-Loiola J, 2020, REMOTE SENS ENVIRON, V236, DOI 10.1016/j.rse.2019.111493; Roxburgh S., 2014, NATIVE FOREST WILDFI; Sharples JJ, 2016, CLIMATIC CHANGE, V139, P85, DOI 10.1007/s10584-016-1811-1; Steffensen V., 2020, FIRE COUNTRY INDIGEN, P240; Stephenson C, 2013, ENVIRON HAZARDS-UK, V12, P93, DOI 10.1080/17477891.2012.703490; Surawski NC, 2015, ATMOS CHEM PHYS, V15, P5259, DOI 10.5194/acp-15-5259-2015; Vardoulakis S, 2020, MED J AUSTRALIA, V212, P349, DOI 10.5694/mja2.50511; Volkova L, 2014, INT J WILDLAND FIRE, V23, P771, DOI 10.1071/WF14009; Ward M, 2020, NAT ECOL EVOL, V4, P1321, DOI 10.1038/s41559-020-1251-1; Williams R.J., 2009, INTERACTIONS CLIMATE	22	50	53	5	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					188	191		10.1038/d41586-020-02306-4	http://dx.doi.org/10.1038/d41586-020-02306-4			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA5BI	32788729				2022-12-28	WOS:000559831500007
J	Nottingham, AT; Meir, P; Velasquez, E; Turner, BL				Nottingham, Andrew T.; Meir, Patrick; Velasquez, Esther; Turner, Benjamin L.			Soil carbon loss by experimental warming in a tropical forest	NATURE			English	Article							TEMPERATURE SENSITIVITY; CLIMATE-CHANGE; ELEVATION GRADIENT; EXTRACTION METHOD; RAIN-FOREST; BIOMASS; RESPIRATION; DECOMPOSITION; EFFICIENCY; DYNAMICS	When tropical forest soils are warmed in situ, they release more CO(2)than predicted by theory, creating a potentially substantial positive feedback to climate change. Tropical soils contain one-third of the carbon stored in soils globally(1), so destabilization of soil organic matter caused by the warming predicted for tropical regions this century(2)could accelerate climate change by releasing additional carbon dioxide (CO2) to the atmosphere(3-6). Theory predicts that warming should cause only modest carbon loss from tropical soils relative to those at higher latitudes(5,7), but there have been no warming experiments in tropical forests to test this(8). Here we show that in situ experimental warming of a lowland tropical forest soil on Barro Colorado Island, Panama, caused an unexpectedly large increase in soil CO(2)emissions. Two years of warming of the whole soil profile by four degrees Celsius increased CO(2)emissions by 55 per cent compared to soils at ambient temperature. The additional CO(2)originated from heterotrophic rather than autotrophic sources, and equated to a loss of 8.2 +/- 4.2 (one standard error) tonnes of carbon per hectare per year from the breakdown of soil organic matter. During this time, we detected no acclimation of respiration rates, no thermal compensation or change in the temperature sensitivity of enzyme activities, and no change in microbial carbon-use efficiency. These results demonstrate that soil carbon in tropical forests is highly sensitive to warming, creating a potentially substantial positive feedback to climate change.	[Nottingham, Andrew T.; Meir, Patrick] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Nottingham, Andrew T.; Velasquez, Esther; Turner, Benjamin L.] Smithsonian Trop Res Inst, Panama City, Panama; [Meir, Patrick] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of Edinburgh; Smithsonian Institution; Smithsonian Tropical Research Institute; Australian National University	Nottingham, AT (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.; Nottingham, AT (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	Andrew.Nottingham@ed.ac.uk	Turner, Benjamin L/E-5940-2011; Turner, Benjamin/AAZ-1465-2021	Turner, Benjamin L/0000-0002-6585-0722; Turner, Benjamin/0000-0002-6585-0722	NERC [NE/K016369/1, NE/K016253/1, NE/M017508/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson-Teixeira KJ, 2016, GLOBAL CHANGE BIOL, V22, P1690, DOI 10.1111/gcb.13226; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bradford MA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00333; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Carey JC, 2016, P NATL ACAD SCI USA, V113, P13797, DOI 10.1073/pnas.1605365113; CAVELIER J, 1992, PLANT SOIL, V142, P187, DOI 10.1007/BF00010965; Chambers JQ, 2004, ECOL APPL, V14, pS72; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Ciais P., 2013, CLIMATE CHANGE 2013, P465, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CBO9781107415324.015]; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Dacal M, 2019, NAT ECOL EVOL, V3, P232, DOI 10.1038/s41559-018-0770-5; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Frey SD, 2013, NAT CLIM CHANGE, V3, P395, DOI [10.1038/nclimate1796, 10.1038/NCLIMATE1796]; Hanson PJ, 2011, GLOBAL CHANGE BIOL, V17, P1083, DOI 10.1111/j.1365-2486.2010.02221.x; HENDERSHOT WH, 1986, SOIL SCI SOC AM J, V50, P605, DOI 10.2136/sssaj1986.03615995005000030013x; Jackson RB, 2017, ANNU REV ECOL EVOL S, V48, P419, DOI 10.1146/annurev-ecolsys-112414-054234; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; KOUNO K, 1995, SOIL BIOL BIOCHEM, V27, P1353, DOI 10.1016/0038-0717(95)00057-L; Leigh EG, 1999, TROPICAL FOREST ECOL; Liu JJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam5690; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Masson-Delmotte V., 2018, GLOBAL WARMING 1 5 C; Melillo JM, 2017, SCIENCE, V358, P101, DOI 10.1126/science.aan2874; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Nottingham AT, 2015, BIOGEOSCIENCES, V12, P6071, DOI 10.5194/bg-12-6071-2015; Nottingham AT, 2019, ECOL LETT, V22, P1889, DOI 10.1111/ele.13379; Nottingham AT, 2016, BIOGEOCHEMISTRY, V127, P217, DOI 10.1007/s10533-015-0176-2; Nottingham AT, 2015, BIOSCIENCE, V65, P906, DOI 10.1093/biosci/biv109; Nottingham AT, 2010, NEW PHYTOL, V186, P957, DOI 10.1111/j.1469-8137.2010.03226.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pries CEH, 2017, SCIENCE, V355, P1420, DOI 10.1126/science.aal1319; Romero-Olivares AL, 2017, SOIL BIOL BIOCHEM, V107, P32, DOI 10.1016/j.soilbio.2016.12.026; Rubio VE, 2017, ECOL EVOL, V7, P7104, DOI 10.1002/ece3.3267; Sanchez P.A., 1992, MYTHS SCI SOILS TROP, V29, P35; Sinsabaugh RL, 2016, ECOL MONOGR, V86, P172, DOI 10.1890/15-2110.1; Steidinger BS, 2019, NATURE, V569, P404, DOI 10.1038/s41586-019-1128-0; Tang JW, 2019, ECOSYSTEM CONSEQUENCES OF SOIL WARMING: MICROBES, VEGETATION, FAUNA, AND SOIL BIOGEOCHEMISTRY, P175, DOI 10.1016/B978-0-12-813493-1.00009-0; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Turner BL, 2009, SOIL SCI SOC AM J, V73, P1972, DOI 10.2136/sssaj2008.0407; van Gestel N, 2018, NATURE, V554, pE4, DOI 10.1038/nature25745; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; WIEDER RK, 1995, ECOLOGY, V76, P1971, DOI 10.2307/1940727; Wood TE, 2019, ECOSYSTEM CONSEQUENCES OF SOIL WARMING: MICROBES, VEGETATION, FAUNA, AND SOIL BIOGEOCHEMISTRY, P385, DOI 10.1016/B978-0-12-813493-1.00015-6; Woodring WP, 1958, MISC COLLECT, V135, P1; Zuur A.F., 2007, MIXED EFFECTS MODELS, V1st, DOI [10.1007/978-0-387-87458-6, DOI 10.1007/978-0-387-87458-6]	48	68	71	58	319	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					234	+		10.1038/s41586-020-2566-4	http://dx.doi.org/10.1038/s41586-020-2566-4			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788738	Green Accepted			2022-12-28	WOS:000559831500015
J	Khalyavin, DD; Johnson, RD; Orlandi, F; Radaelli, PG; Manuel, P; Belik, AA				Khalyavin, Dmitry D.; Johnson, Roger D.; Orlandi, Fabio; Radaelli, Paolo G.; Manuel, Pascal; Belik, Alexei A.			Emergent helical texture of electric dipoles	SCIENCE			English	Article							MAGNETIC-STRUCTURES; CRYSTAL-STRUCTURE; DIFFRACTION; TRANSITIONS; DISTORTION; ROUTE	Long-range ordering of magnetic dipoles in bulk materials gives rise to a broad range of magnetic structures, from simple collinear ferromagnets and antiferromagnets, to complex magnetic helicoidal textures stabilized by competing exchange interactions. In contrast, dipolar order in dielectric crystals is typically limited to parallel (ferroelectric) and antiparallel (antiferroelectric) collinear alignments of electric dipoles. Here, we report an observation of incommensurate helical ordering of electric dipoles by light hole doping of the quadruple perovskite BiMn7O12. In analogy with magnetism, the electric dipole helicoidal texture is stabilized by competing instabilities. Specifically, orbital ordering and lone electron pair stereochemical activity compete, giving rise to phase transitions from a nonchiral cubic structure to an incommensurate electric dipole and orbital helix via an intermediate density wave.	[Khalyavin, Dmitry D.; Orlandi, Fabio; Manuel, Pascal] Rutherford Appleton Lab, ISIS Facil, Harwell Campus, Didcot OX11 0QX, Oxon, England; [Johnson, Roger D.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Johnson, Roger D.; Radaelli, Paolo G.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Belik, Alexei A.] Natl Inst Mat Sci NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; University College London; University of Oxford; National Institute for Materials Science	Khalyavin, DD (corresponding author), Rutherford Appleton Lab, ISIS Facil, Harwell Campus, Didcot OX11 0QX, Oxon, England.	dmitry.khalyavin@stfc.ac.uk	Radaelli, Paolo G/C-2952-2011; Orlandi, Fabio/R-6403-2016; Belik, Alexei/H-2938-2011; Khalyavin, Dmitry/E-4335-2017	Radaelli, Paolo G/0000-0002-6717-035X; Orlandi, Fabio/0000-0001-6333-521X; Belik, Alexei/0000-0001-9031-2355; Johnson, Roger/0000-0001-7241-792X; Khalyavin, Dmitry/0000-0002-6724-7695; Manuel, Pascal/0000-0002-8845-6576	Royal Society University Research Fellowship [JPJ004596]; EPSRC [EP/M020517/1] Funding Source: UKRI	Royal Society University Research Fellowship(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	R.D.J. acknowledges support from a Royal Society University Research Fellowship. A.A.B. acknowledges partial support from grant JPJ004596 (ATLA, Japan).	Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029; Belik AA, 2006, CHEM MATER, V18, P798, DOI 10.1021/cm052334z; Belik AA, 2017, INORG CHEM, V56, P12272, DOI 10.1021/acs.inorgchem.7b01723; Belik AA, 2017, ANGEW CHEM INT EDIT, V56, P10423, DOI 10.1002/anie.201704798; Campbell BJ, 2006, J APPL CRYSTALLOGR, V39, P607, DOI 10.1107/S0021889806014075; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Chapon Laurent C., 2011, NEUTRON NEWS, V22, P22; Chauleau JY, 2020, NAT MATER, V19, P386, DOI 10.1038/s41563-019-0516-z; Cherifi-Hertel S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15768; Das S, 2019, NATURE, V568, P368, DOI 10.1038/s41586-019-1092-8; Goodenough J.B., 1963, MAGNETISM CHEM BOND; Hearmon AJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237201; Jia CL, 2011, SCIENCE, V331, P1420, DOI 10.1126/science.1200605; Johnson RD, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.257202; Johnson RD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.067201; Johnson RD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137205; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Khalyavin D. D., 2020, ZENODO, DOI [10.5281/zenodo.3749292., DOI 10.5281/ZENODO.3749292]; Khalyavin D. D., 2020, ZENODO, DOI [10.5281/zenodo.3749292., DOI 10.5281/ZENODO.3749292.]; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; KITTEL C, 1951, PHYS REV, V82, P729, DOI 10.1103/PhysRev.82.729; KOEHLER WC, 1966, PHYS REV, V151, P414, DOI 10.1103/PhysRev.151.414; KOEHLER WC, 1961, J APPL PHYS, V32, pS20, DOI 10.1063/1.2000405; Lodahl P, 2017, NATURE, V541, P473, DOI 10.1038/nature21037; MEYER RB, 1975, J PHYS LETT-PARIS, V36, pL69, DOI 10.1051/jphyslet:0197500360306900; Mezzadri F, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100106; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Neaton JB, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014113; NEEL L, 1948, ANN PHYS-PARIS, V3, P137; Palewicz A, 2010, ACTA PHYS POL A, V117, P296, DOI 10.12693/APhysPolA.117.296; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; Perks NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2294; Petricek V, 2014, Z KRIST-CRYST MATER, V229, P345, DOI 10.1515/zkri-2014-1737; Rabe KA, 2007, TOP APPL PHYS, V105, P1; Rodriguez-Carvajal J, 1998, PHYS REV B, V57, pR3189, DOI 10.1103/PhysRevB.57.R3189; Salamon MB, 2001, REV MOD PHYS, V73, P583, DOI 10.1103/RevModPhys.73.583; SAWAGUCHI E, 1951, PHYS REV, V83, P1078, DOI 10.1103/PhysRev.83.1078; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Seshadri R, 2001, CHEM MATER, V13, P2892, DOI 10.1021/cm010090m; SHULL CG, 1949, PHYS REV, V76, P1256, DOI 10.1103/PhysRev.76.1256.2; Slawinski WA, 2017, ACTA CRYSTALLOGR B, V73, P313, DOI 10.1107/S2052520617000725; Stokes H. T., ISOTROPY SOFTWARE SU; Suchomel MR, 2006, CHEM MATER, V18, P4987, DOI 10.1021/cm061085r; Takagi R, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau3402; Tanaka M, 2013, J CERAM SOC JPN, V121, P287, DOI 10.2109/jcersj2.121.287; Tokura Y, 2006, REP PROG PHYS, V69, P797, DOI 10.1088/0034-4885/69/3/R06; Valasek J, 1922, PHYS REV, V19, P478, DOI 10.1103/PhysRev.19.478; Yadav AK, 2016, NATURE, V530, P198, DOI 10.1038/nature16463; YOSHIMORI A, 1959, J PHYS SOC JPN, V14, P807, DOI 10.1143/JPSJ.14.807	50	18	18	9	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					680	+		10.1126/science.aay7356	http://dx.doi.org/10.1126/science.aay7356			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764068	Green Submitted, Green Published			2022-12-28	WOS:000559184400043
J	Yu, RF				Yu, Ruofan			Building bridges	SCIENCE			English	Editorial Material									[Yu, Ruofan] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Yu, RF (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					738	738						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764074				2022-12-28	WOS:000559184400054
J	Kosar, CM; Loomer, L; Thomas, KS; White, EM; Panagiotou, OA; Rahman, M				Kosar, Cyrus M.; Loomer, Lacey; Thomas, Kali S.; White, Elizabeth M.; Panagiotou, Orestis A.; Rahman, Momotazur			Association of Diagnosis Coding With Differences in Risk-Adjusted Short-term Mortality Between Critical Access and Non-Critical Access Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; REDUCTION; OUTCOMES; RATES	Question Are differences in risk-adjusted mortality rates between critical access hospitals (CAHs) and non-CAHs related to differences in diagnosis coding practices? Findings In this serial cross-sectional study of 4 & x202f;094 & x202f;720 rural Medicare beneficiaries hospitalized from 2007 to 2017, combined in-hospital and 30-day postdischarge mortality rates were higher for CAHs than non-CAHs when risk adjustment included both preexisting conditions and in-hospital comorbidity measures, but were not significantly different for CAHs vs non-CAHs when adjusting only for preexisting conditions. Meaning The findings suggest that short-term mortality outcomes at CAHs may not differ from those of non-CAHs when risk adjustment is based on preexisting conditions that are not influenced by coding practices for in-hospital comorbidities. Importance Critical access hospitals (CAHs) provide care to rural communities. Increasing mortality rates have been reported for CAHs relative to non-CAHs. Because Medicare reimburses CAHs at cost, CAHs may report fewer diagnoses than non-CAHs, which may affect risk-adjusted comparisons of outcomes. Objective To assess serial differences in risk-adjusted mortality rates between CAHs and non-CAHs after accounting for differences in diagnosis coding. Design, Setting, and Participants Serial cross-sectional study of rural Medicare Fee-for-Service beneficiaries admitted to US CAHs and non-CAHs for pneumonia, heart failure, chronic obstructive pulmonary disease, arrhythmia, urinary tract infection, septicemia, and stroke from 2007 to 2017. The final date of follow-up was December 31, 2017. Exposure Admission to a CAH vs non-CAH. Main Outcomes and Measures Discharge diagnosis count including trends from 2010 to 2011 when Medicare expanded the allowable number of billing codes for hospitalizations, and combined in-hospital and 30-day postdischarge mortality adjusted for demographics, primary diagnosis, preexisting conditions, and with vs without further adjustment for Hierarchical Condition Category (HCC) score to understand the contribution of in-hospital secondary diagnoses. Results There were 4 & x202f;094 & x202f;720 hospitalizations (17% CAH) for 2 & x202f;850 & x202f;194 unique Medicare beneficiaries (mean [SD] age, 76.3 [11.7] years; 55.5% women). Patients in CAHs were older (median age, 80.1 vs 76.8 years) and more likely to be female (58% vs 55%). In 2010, the adjusted mean discharge diagnosis count was 7.52 for CAHs vs 8.53 for non-CAHs (difference, -0.99 [95% CI, -1.08 to -0.90]; P < .001). In 2011, the CAH vs non-CAH difference in diagnoses coded increased (P < .001 for interaction between CAH and year) to 9.27 vs 12.23 (difference, -2.96 [95% CI, -3.19 to -2.73]; P < .001). Adjusted mortality rates from the model with HCC were 13.52% for CAHs vs 11.44% for non-CAHs (percentage point difference, 2.08 [95% CI, 1.74 to 2.42]; P < .001) in 2007 and increased to 15.97% vs 12.46% (difference, 3.52 [95% CI, 3.09 to 3.94]; P < .001) in 2017 (P < .001 for interaction). Adjusted mortality rates from the model without HCC were not significantly different between CAHs and non-CAHs in all years except 2007 (12.19% vs 11.74%; difference, 0.45 [95% CI, 0.12 to 0.79]; P = .008) and 2010 (12.71% vs 12.28%; difference, 0.42 [95% CI, 0.07 to 0.77]; P = .02). Conclusions and Relevance For rural Medicare beneficiaries hospitalized from 2007 to 2017, CAHs submitted significantly fewer hospital diagnosis codes than non-CAHs, and short-term mortality rates adjusted for preexisting conditions but not in-hospital comorbidity measures were not significantly different by hospital type in most years. The findings suggest that short-term mortality outcomes at CAHs may not differ from those of non-CAHs after accounting for different coding practices for in-hospital comorbidities. This study uses Medicare data to estimate mortality differences for common medical conditions (pneumonia, heart failure, chronic obstructive pulmonary disease, urinary tract infection, others) at US critical access vs non-critical access hospitals between 2007 and 2017 with vs without adjustment for discharge diagnosis counts to assess the extent to which coding practices rather than illness severity might account for observed mortality differences.	[Kosar, Cyrus M.; Loomer, Lacey; Thomas, Kali S.; White, Elizabeth M.; Panagiotou, Orestis A.; Rahman, Momotazur] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Kosar, Cyrus M.; Loomer, Lacey; Thomas, Kali S.; White, Elizabeth M.; Panagiotou, Orestis A.; Rahman, Momotazur] Brown Univ, Ctr Gerontol & Healthcare Res, Providence, RI 02912 USA; [Thomas, Kali S.] Dept Veteran Affairs Med Ctr, Providence, RI USA	Brown University; Brown University	Kosar, CM (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02901 USA.	cyrus_kosar@brown.edu	Panagiotou, Orestis/AAI-1268-2021	Loomer, Lacey/0000-0001-8177-6043; Kosar, Cyrus/0000-0003-0533-7529	NIA [5R21AG053712-02, P01AG027296, 5R03AG054687-02]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the NIA (grants 5R21AG053712-02, P01AG027296, and 5R03AG054687-02).	Ayalon L, 2011, AGING MENT HEALTH, V15, P376, DOI 10.1080/13607863.2010.519323; Barnett ML, 2015, JAMA INTERN MED, V175, P1803, DOI 10.1001/jamainternmed.2015.4660; Basu J, 2000, J RURAL HEALTH, V16, P129, DOI 10.1111/j.1748-0361.2000.tb00446.x; Carroll CE, 2019, AM SOC HLTH EC ANN M; Centers for Medicare and Medicaid Services, REOP FAC NON NON COV; Dharmarajan K, 2017, JAMA-J AM MED ASSOC, V318, P270, DOI 10.1001/jama.2017.8444; Geruso M, 2020, J POLIT ECON, V128, P984, DOI 10.1086/704756; Gowrisankaran G, 2016, 22873 NBER, DOI [10.3386/w22873, DOI 10.3386/W22873]; Ibrahim AM, 2018, ANN SURG, V267, P473, DOI 10.1097/SLA.0000000000002216; Ibrahim AM, 2018, JAMA INTERN MED, V178, P290, DOI 10.1001/jamainternmed.2017.6148; Ibrahim AM, 2016, JAMA-J AM MED ASSOC, V315, P2095, DOI 10.1001/jama.2016.5618; Ioannidis JPA, 2013, JAMA-J AM MED ASSOC, V309, P1410, DOI 10.1001/jama.2013.3150; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P1379, DOI 10.1001/jama.2013.2366; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Kaufman BG, 2016, J RURAL HEALTH, V32, P35, DOI 10.1111/jrh.12128; Lichtman JH, 2012, STROKE, V43, P2741, DOI 10.1161/STROKEAHA.112.665646; Liu JX, 2007, J RURAL HEALTH, V23, P17, DOI 10.1111/j.1748-0361.2006.00063.x; Meit M, 2014, 2014 UPDATE RURAL UR; Moscovice IS, 2011, JAMA-J AM MED ASSOC, V306, P1653, DOI 10.1001/jama.2011.1487; Newhart C, 2011, EVALUATION CMS HCC R; Roberts ET, 2018, JAMA INTERN MED, V178, P1498, DOI 10.1001/jamainternmed.2018.4481; Rural Health Research Gateway, RUR COMM AG INC HLTH; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Sloan FA, 2010, AM J PUBLIC HEALTH, V100, P357, DOI 10.2105/AJPH.2008.158188; The Dartmouth Atlas of Health Care, RES METHODS; Tsugawa Y, 2019, JAMA INTERN MED, V179, P1287, DOI 10.1001/jamainternmed.2019.1005; US Department of Agriculture, TREATM MAN; Wadhera RK, 2018, JAMA-J AM MED ASSOC, V320, P2542, DOI 10.1001/jama.2018.19232; Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation, 2013, 2013 MEAS UPD SPEC A	29	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					481	487		10.1001/jama.2020.9935	http://dx.doi.org/10.1001/jama.2020.9935			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NC5NN	32749490	Bronze, Green Published			2022-12-28	WOS:000561261900019
J	Griffin, S				Griffin, Shaun			Covid-19: Lack of action on government statistics is unacceptable, says expert	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					GOV.UK, 2020, COR COVID 19 UK; Office for National Statistics, 2020, DEATHS REG WEEKL ENG	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m3025	10.1136/bmj.m3025	http://dx.doi.org/10.1136/bmj.m3025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727713	Bronze			2022-12-28	WOS:000554456000003
J	Griffin, S				Griffin, Shaun			Covid-19: Former civil service head criticises government's response to crisis	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022						0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2992	10.1136/bmj.m2992	http://dx.doi.org/10.1136/bmj.m2992			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32718918	Bronze			2022-12-28	WOS:000554458200011
J	Mahase, E				Mahase, Elisabeth			National registry will record patient outcomes from devices implanted during vascular surgery	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		MAHASE E, 2020, BMJ-BRIT MED J, V370, DOI DOI 10.1136/BMJ.M2726	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2020	370								m2981	10.1136/bmj.m2981	http://dx.doi.org/10.1136/bmj.m2981			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7IG	32709607				2022-12-28	WOS:000554448500006
J	Vahidy, FS; Drews, AL; Masud, FN; Schwartz, RL; Askary, B; Boom, ML; Phillips, RA				Vahidy, Farhaan S.; Drews, Ashley L.; Masud, Faisal N.; Schwartz, Roberta L.; Askary, Belimat Billy; Boom, Marc L.; Phillips, Robert A.			Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study examined the sociodemographic and clinical characteristics of patients, as well as their clinical outcomes, during a surge in COVID-19 disease in Houston, Texas.	[Vahidy, Farhaan S.; Phillips, Robert A.] Houston Methodist Res Inst, Ctr Outcomes Res, Houston, TX USA; [Drews, Ashley L.; Boom, Marc L.] Houston Methodist, Dept Med, Houston, TX USA; [Masud, Faisal N.] Houston Methodist, Dept Anesthesiol & Crit Care, Houston, TX USA; [Schwartz, Roberta L.] Houston Methodist, Houston Methodist Acad Inst, Houston, TX USA; [Askary, Belimat Billy] Houston Methodist, Syst Qual & Patient Safety, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Phillips, RA (corresponding author), Houston Methodist, 6565 Fannin St,Dunn 200, Houston, TX 77030 USA.	raphillips@houstonmethodist.org						Office of the Texas Governor, 2020, GOV STRIK FORC OP TE; Tittle S., NEJM CAT INN CAR DEL, DOI [10.1056/cat.20.0287, DOI 10.1056/CAT.20.0287]; Vahidy FS, 2020, RACIAL ETHNIC DISPAR, DOI [10.1101/2020.04.24.20073148, DOI 10.1101/2020.04.24.20073148]	3	65	65	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					998	1000		10.1001/jama.2020.15301	http://dx.doi.org/10.1001/jama.2020.15301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32789492	Green Published, Bronze			2022-12-28	WOS:000571867000024
J	Hebert-Magee, S				Hebert-Magee, Shantel			What Is Liberty? Addressing Undeserved Suffering in Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hebert-Magee, Shantel] Louisiana Off Publ Hlth, Baton Rouge, LA 70802 USA		Hebert-Magee, S (corresponding author), Louisiana Off Publ Hlth, Baton Rouge, LA 70802 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2020	383	8							e58	10.1056/NEJMpv2024567	http://dx.doi.org/10.1056/NEJMpv2024567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2MJ	32767892	Bronze			2022-12-28	WOS:000563818700001
J	Califf, RM; Hernandez, AF; Landray, M				Califf, Robert M.; Hernandez, Adrian F.; Landray, Martin			Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments Observational Cacophony, Randomized Harmony	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the role of observational study designs and data in the rapid stand-up of an evidence base for managing the COVID-19 pandemic, proposing ways to position observational research as a foundation for rapid follow-on randomized evaluation without premature overinterpretation of its findings.	[Califf, Robert M.] Verily Life Sci Alphabet, San Francisco, CA USA; [Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC USA; [Hernandez, Adrian F.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Landray, Martin] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	Duke University; Duke University; University of Oxford	Califf, RM (corresponding author), Verily Life Sci, 269 E Grand Ave, San Francisco, CA 94080 USA.	robertcaliff@verily.com		Landray, Martin/0000-0001-6646-827X	Health Data Research UK; NIHR Oxford Biomedical Research Centre; Medical Research Council Population Health Research Unit; MRC [MC_UU_12026/4, MC_PC_18033, MC_U137686860] Funding Source: UKRI	Health Data Research UK; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council Population Health Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr Landray is supported by Health Data Research UK, the NIHR Oxford Biomedical Research Centre, and the Medical Research Council Population Health Research Unit.	Collins R, 2020, NEW ENGL J MED, V382, P674, DOI 10.1056/NEJMsb1901642; Corrigan-Curay J, 2018, JAMA-J AM MED ASSOC, V320, P867, DOI 10.1001/jama.2018.10136; Halpern SD, 2020, JAMA; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273, 10.1101/2020.06.22.20137273v1, DOI 10.1101/2020.07.15.20151852]; Horby P., 2020, PREPRINT, DOI [10.1101/2020.07.15.20151852, DOI 10.1101/2020.07.15.20151852V1]; Joyner MJ, 2020, MAYO CLIN PROC, DOI 10.1016/j.mayocp.2020.06.028; Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742; London AJ, 2020, SCIENCE, V368, P476, DOI 10.1126/science.abc1731; Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]; World Health Organization (WHO), 2020, Q A HYDR COVID 19	10	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2020	324	7					625	626		10.1001/jama.2020.13319	http://dx.doi.org/10.1001/jama.2020.13319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NG9GI	32735313	Bronze			2022-12-28	WOS:000564288700002
J	Sullivan, SMP; Rains, MC; Rodewald, AD; Buzbee, WW; Rosemond, AD				Sullivan, S. Mazeika Patricio; Rains, Mark C.; Rodewald, Amanda D.; Buzbee, William W.; Rosemond, Amy D.			Distorting science, putting water at risk	SCIENCE			English	Editorial Material							FISH		[Sullivan, S. Mazeika Patricio] Ohio State Univ, Sch Environm & Nat Resources, Schiermeier Olentangy River Wetland Res Pk, Columbus, OH 43210 USA; [Rains, Mark C.] Univ S Florida, Sch Geosci, Tampa, FL 33620 USA; [Rodewald, Amanda D.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Rodewald, Amanda D.] Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA; [Buzbee, William W.] Georgetown Univ, Law Ctr, Washington, DC USA; [Rosemond, Amy D.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Ohio; Ohio State University; State University System of Florida; University of South Florida; Cornell University; Cornell University; Georgetown University; University System of Georgia; University of Georgia	Sullivan, SMP (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Schiermeier Olentangy River Wetland Res Pk, Columbus, OH 43210 USA.	sullivan.191@osu.edu	Rodewald, Amanda D/I-6308-2016; Sulliván, Mažeika Patricio/C-8261-2012	Rodewald, Amanda D/0000-0002-6719-6306; Sulliván, Mažeika Patricio/0000-0003-2341-5316; Rains, Mark/0000-0002-8103-475X				[Anonymous], 2013, STATE CONSTRAINTS ST; Colvin SAR, 2019, FISHERIES, V44, P73, DOI 10.1002/fsh.10229; Creed IF, 2017, NAT GEOSCI, V10, P809, DOI 10.1038/ngeo3041; Meyer R., 2020, NAVIGABLE WATERS PRO; Milly PCD, 2020, SCIENCE, V367, P1252, DOI 10.1126/science.aay9187; Perkin JS, 2017, P NATL ACAD SCI USA, V114, P7373, DOI 10.1073/pnas.1618936114; Sullivan SMP, 2019, P NATL ACAD SCI USA, V116, P11558, DOI 10.1073/pnas.1907489116; U.S. Department of Defense and U.S. Environmental Protection Agency, 2020, FED REGISTER, V85, P22250; U.S. Environmental Protection Agency, 2014, COMMUNICATION   1017; U.S. Environmental Protection Agency and Department of the Army, 2020, EC AN NAV WAT PROT R; U.S. EPA, 2020, EPASAB20002 US EPA; United States Environment Protection Agency ( U.S. EPA) and United States Army Corps of Engineers (U.S ACE), 2015, FED REGISTER; US Environmental Protection Agency, 2015, EPA600R14475F US EPA	13	11	11	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					766	768		10.1126/science.abb6899	http://dx.doi.org/10.1126/science.abb6899			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792380				2022-12-28	WOS:000559731300016
J	Shi, YM; Xu, SG; Yang, YP; Slizovskiy, S; Morozov, SV; Son, SK; Ozdemir, S; Mullan, C; Barrier, J; Yin, J; Berdyugin, AI; Piot, BA; Taniguchi, T; Watanabe, K; Fal'ko, VI; Novoselov, KS; Geim, AK; Mishchenko, A				Shi, Yanmeng; Xu, Shuigang; Yang, Yaping; Slizovskiy, Sergey; Morozov, Sergey V.; Son, Seok-Kyun; Ozdemir, Servet; Mullan, Ciaran; Barrier, Julien; Yin, Jun; Berdyugin, Alexey I.; Piot, Benjamin A.; Taniguchi, Takashi; Watanabe, Kenji; Fal'ko, Vladimir I.; Novoselov, Kostya S.; Geim, A. K.; Mishchenko, Artem			Electronic phase separation in multilayer rhombohedral graphite	NATURE			English	Article							BAND-STRUCTURE; GRAPHENE; INSULATOR	Of the two stable forms of graphite, hexagonal and rhombohedral, the former is more common and has been studied extensively. The latter is less stable, which has so far precluded its detailed investigation, despite many theoretical predictions about the abundance of exotic interaction-induced physics(1-6). Advances in van der Waals heterostructure technology(7)have now allowed us to make high-quality rhombohedral graphite films up to 50 graphene layers thick and study their transport properties. Here we show that the bulk electronic states in such rhombohedral graphite are gapped(8)and, at low temperatures, electron transport is dominated by surface states. Because of their proposed topological nature, the surface states are of sufficiently high quality to observe the quantum Hall effect, whereby rhombohedral graphite exhibits phase transitions between a gapless semimetallic phase and a gapped quantum spin Hall phase with giant Berry curvature. We find that an energy gap can also be opened in the surface states by breaking their inversion symmetry by applying a perpendicular electric field. Moreover, in rhombohedral graphite thinner than four nanometres, a gap is present even without an external electric field. This spontaneous gap opening shows pronounced hysteresis and other signatures characteristic of electronic phase separation, which we attribute to emergence of strongly correlated electronic surface states. High-quality rhombohedral graphite films are found to offer an alternative to twisted bilayer graphene as a platform for studying correlated physics in carbon materials.	[Shi, Yanmeng; Yang, Yaping; Slizovskiy, Sergey; Son, Seok-Kyun; Ozdemir, Servet; Mullan, Ciaran; Barrier, Julien; Yin, Jun; Berdyugin, Alexey I.; Fal'ko, Vladimir I.; Novoselov, Kostya S.; Geim, A. K.; Mishchenko, Artem] Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England; [Xu, Shuigang; Yang, Yaping; Slizovskiy, Sergey; Son, Seok-Kyun; Barrier, Julien; Yin, Jun; Fal'ko, Vladimir I.; Novoselov, Kostya S.; Geim, A. K.; Mishchenko, Artem] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Morozov, Sergey V.] Russian Acad Sci, Inst Microelect Technol & High Pur Mat, Chernogolovka, Russia; [Piot, Benjamin A.] Univ Grenoble Alpes, Lab Natl Champs Magnet Intenses, UPS INSA EMFL CNRS LNCMI, Grenoble, France; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Fal'ko, Vladimir I.] Henry Royce Inst Adv Mat, Manchester, Lancs, England; [Novoselov, Kostya S.] Natl Univ Singapore, Ctr Adv 2D Mat, Singapore, Singapore; [Novoselov, Kostya S.] Chongqing 2D Mat Inst, Chongqing, Peoples R China; [Son, Seok-Kyun] Mokpo Natl Univ, Dept Phys, Muan, South Korea	University of Manchester; University of Manchester; Russian Academy of Sciences; Institute of Microelectronics Technology & High-Purity Materials, RAS; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Institute for Materials Science; National University of Singapore; Mokpo National University	Mishchenko, A (corresponding author), Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England.; Mishchenko, A (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England.	artem.mishchenko@gmail.com	Mishchenko, Artem/C-7561-2011; Novoselov, Kostya S/G-9581-2014; Morozov, Sergey V/H-3171-2014; Geim, Andre K/J-7888-2012; Barrier, Julien/AFE-8867-2022	Mishchenko, Artem/0000-0002-0427-5664; Novoselov, Kostya S/0000-0003-4972-5371; Morozov, Sergey V/0000-0003-3075-7787; Geim, Andre K/0000-0003-2861-8331; Barrier, Julien/0000-0002-6484-2157; Yang, Yaping/0000-0002-4335-8518; Son, Seok-Kyun/0000-0002-9530-2639; Slizovskiy, Sergey/0000-0003-0131-0775; Fal'ko, Vladimir/0000-0003-0828-0310; Xu, Shuigang/0000-0002-0589-5291; Mullan, Ciaran/0000-0001-6319-3135	EPSRC [EP/K005014/1, EP/N01085X/1, 2109254, EP/P025021/1, EP/N007131/1, EP/S019367/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Cai S, 2018, NPJ QUANTUM MATER, V3, DOI 10.1038/s41535-018-0134-z; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI [10.1080/00018730110113644, 10.1080/00018738100101367]; Garcia-Ruiz A, 2019, NANO LETT, V19, P6152, DOI 10.1021/acs.nanolett.9b02196; HAERING RR, 1958, CAN J PHYS, V36, P352, DOI 10.1139/p58-036; Henck H, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.245421; Henni Y, 2016, NANO LETT, V16, P3710, DOI 10.1021/acs.nanolett.6b01041; Ho CH, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.075437; Kharitonov M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195435; Kharitonov M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.046803; Kopnin NB, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.140503; Lee Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6656; Lee YCG, 2019, PREPRINT; Lemonik Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245451; MCCLURE JW, 1969, CARBON, V7, P425, DOI 10.1016/0008-6223(69)90073-6; Min HK, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155416; Munoz WA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134509; Myhro K, 2018, 2D MATER, V5, DOI 10.1088/2053-1583/aad2f2; Nakasuga T, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.085404; Neupane M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4841; Otani M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161403; Pamuk B, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.075422; Ran S, 2017, P NATL ACAD SCI USA, V114, P9826, DOI 10.1073/pnas.1710192114; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Shi YM, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.096802; Slizovskiy S, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0268-8; Velasco J, 2012, NAT NANOTECHNOL, V7, P156, DOI [10.1038/nnano.2011.251, 10.1038/NNANO.2011.251]; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Xiao RJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165404; Xu DH, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.201404; Yang YP, 2019, NANO LETT, V19, P8526, DOI 10.1021/acs.nanolett.9b03014; Yin J, 2019, NAT PHYS, V15, P437, DOI 10.1038/s41567-019-0427-6; Zhang F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.186804; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Zhang Y, 2010, NAT PHYS, V6, P584, DOI 10.1038/NPHYS1689	41	42	42	20	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					210	+		10.1038/s41586-020-2568-2	http://dx.doi.org/10.1038/s41586-020-2568-2			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788736	Green Submitted			2022-12-28	WOS:000559831500011
J	Minneci, PC; Hade, EM; Lawrence, AE; Sebastiao, YV; Saito, JM; Mak, GZ; Fox, C; Hirschl, RB; Gadepalli, S; Helmrath, MA; Kohler, JE; Leys, CM; Sato, TT; Lal, DR; Landman, MP; Kabre, R; Fallat, ME; Cooper, JN; Deans, KJ				Minneci, Peter C.; Hade, Erinn M.; Lawrence, Amy E.; Sebastiao, Yuri V.; Saito, Jacqueline M.; Mak, Grace Z.; Fox, Christa; Hirschl, Ronald B.; Gadepalli, Samir; Helmrath, Michael A.; Kohler, Jonathan E.; Leys, Charles M.; Sato, Thomas T.; Lal, Dave R.; Landman, Matthew P.; Kabre, Rashmi; Fallat, Mary E.; Cooper, Jennifer N.; Deans, Katherine J.		Midwest Pediat Surg Consortium	Association of Nonoperative Management Using Antibiotic Therapy vs Laparoscopic Appendectomy With Treatment Success and Disability Days in Children With Uncomplicated Appendicitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; GENERIC CORE SCALES; QUALITY-OF-LIFE; PROPENSITY SCORE; PEDSQL(TM); RELIABILITY; OUTCOMES; SURGERY	Importance Nonoperative management with antibiotics alone has the potential to treat uncomplicated pediatric appendicitis with fewer disability days than surgery. Objective To determine the success rate of nonoperative management and compare differences in treatment-related disability, satisfaction, health-related quality of life, and complications between nonoperative management and surgery in children with uncomplicated appendicitis. Design, Setting, and Participants Multi-institutional nonrandomized controlled intervention study of 1068 children aged 7 through 17 years with uncomplicated appendicitis treated at 10 tertiary children's hospitals across 7 US states between May 2015 and October 2018 with 1-year follow-up through October 2019. Of the 1209 eligible patients approached, 1068 enrolled in the study. Interventions Patient and family selection of nonoperative management with antibiotics alone (nonoperative group, n = 370) or urgent (<= 12 hours of admission) laparoscopic appendectomy (surgery group, n = 698). Main Outcomes and Measures The 2 primary outcomes assessed at 1 year were disability days, defined as the total number of days the child was not able to participate in all of his/her normal activities secondary to appendicitis-related care (expected difference, 5 days), and success rate of nonoperative management, defined as the proportion of patients initially managed nonoperatively who did not undergo appendectomy by 1 year (lowest acceptable success rate, >= 70%). Inverse probability of treatment weighting (IPTW) was used to adjust for differences between treatment groups for all outcome assessments. Results Among 1068 patients who were enrolled (median age, 12.4 years; 38% girls), 370 (35%) chose nonoperative management and 698 (65%) chose surgery. A total of 806 (75%) had complete follow-up: 284 (77%) in the nonoperative group; 522 (75%) in the surgery group. Patients in the nonoperative group were more often younger (median age, 12.3 years vs 12.5 years), Black (9.6% vs 4.9%) or other race (14.6% vs 8.7%), had caregivers with a bachelor's degree (29.8% vs 23.5%), and underwent diagnostic ultrasound (79.7% vs 74.5%). After IPTW, the success rate of nonoperative management at 1 year was 67.1% (96% CI, 61.5%-72.31%; P = .86). Nonoperative management was associated with significantly fewer patient disability days at 1 year than did surgery (adjusted mean, 6.6 vs 10.9 days; mean difference, -4.3 days (99% CI, -6.17 to -2.43; P < .001). Of 16 other prespecified secondary end points, 10 showed no significant difference. Conclusion and Relevance Among children with uncomplicated appendicitis, an initial nonoperative management strategy with antibiotics alone had a success rate of 67.1% and, compared with urgent surgery, was associated with statistically significantly fewer disability days at 1 year. However, there was substantial loss to follow-up, the comparison with the prespecified threshold for an acceptable success rate of nonoperative management was not statistically significant, and the hypothesized difference in disability days was not met.	[Minneci, Peter C.; Lawrence, Amy E.; Sebastiao, Yuri V.; Cooper, Jennifer N.; Deans, Katherine J.] Ohio State Univ, Coll Med, Ctr Surg Outcomes Res, Abigail Wexner Res Inst,Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Minneci, Peter C.; Lawrence, Amy E.; Deans, Katherine J.] Nationwide Childrens Hosp, Dept Pediat Surg, Columbus, OH USA; [Hade, Erinn M.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Hade, Erinn M.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Saito, Jacqueline M.] Washington Univ, Sch Med, Dept Surg, Div Pediat Surg, St Louis, MO 63110 USA; [Mak, Grace Z.; Fox, Christa] Univ Chicago, Dept Surg, Pediat Surg Sect, Med & Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Hirschl, Ronald B.; Gadepalli, Samir] Univ Michigan, Sch Med, Dept Surg, Div Pediat Surg, Ann Arbor, MI USA; [Helmrath, Michael A.] Univ Cincinnati, Coll Med, Dept Surg, Div Pediat Surg, Cincinnati, OH USA; [Kohler, Jonathan E.; Leys, Charles M.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Pediat Surg, Madison, WI USA; [Sato, Thomas T.; Lal, Dave R.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Landman, Matthew P.] Indiana Univ Sch Med, Dept Surg, Div Pediat Surg, Indianapolis, IN 46202 USA; [Kabre, Rashmi] Northwestern Univ, Feinberg Sch Med, Div Pediat Surg, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Fallat, Mary E.] Univ Louisville, Sch Med, Dept Surg, Div Pediat Surg, Louisville, KY 40292 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL); University of Chicago; University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Indiana University System; Indiana University Bloomington; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Louisville	Minneci, PC (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Surg Outcomes Res, 700 Childrens Dr,FB 3A-3, Columbus, OH 43205 USA.	peter.minneci@nationwidechildrens.org		Fallat, Mary/0000-0002-0808-6713; Sebastiao, Yuri Vanda/0000-0002-4268-3095; Sato, Thomas/0000-0001-6547-6403; Gadepalli, Samir/0000-0001-8268-8723	PCORI, an independent, nonprofit organization [CER-1507-31325]; National Center for Advancing Translational Sciences [UL1TR001070]	PCORI, an independent, nonprofit organization; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is funded by award CER-1507-31325 from PCORI, an independent, nonprofit organization authorized by the US Congress in 2010. This project is also supported by grant UL1TR001070 from the National Center for Advancing Translational Sciences.	Abes M, 2007, J PEDIATR SURG, V42, P1439, DOI 10.1016/j.jpedsurg.2007.03.049; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Cash CL, 2012, J AM COLL SURGEONS, V215, P101, DOI 10.1016/j.jamcollsurg.2012.02.024; Chan KS, 2005, MED CARE, V43, P256, DOI 10.1097/00005650-200503000-00008; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Davidson GH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016117; de Vries BBLP, 2016, STAT METHODS MED RES, V25, P3066, DOI 10.1177/0962280216674296; Fitzmaurice GJ, 2011, CAN J SURG, V54, P307, DOI 10.1503/cjs.006610; Georgiou R, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3003; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kocatas A, 2013, ULUS TRAVMA ACIL CER, V19, P200, DOI 10.5505/tjtes.2013.58234; Kozak LJ, 1998, AMBULATORY INPATIENT; Kyaw L, 2020, EUR J PEDIATR, V179, P735, DOI 10.1007/s00431-019-03555-w; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee SL, 2018, J PEDIATR SURG, V53, P42, DOI 10.1016/j.jpedsurg.2017.10.014; Little RJA, 1996, BIOMETRICS, V52, P98, DOI 10.2307/2533148; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; McCaig L F, 2001, Adv Data, P1; Minneci PC, 2019, CONTEMP CLIN TRIALS, V83, P10, DOI 10.1016/j.cct.2019.06.013; Minneci PC, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5009; Minneci PC, 2016, JAMA SURG, V151, P408, DOI 10.1001/jamasurg.2015.4534; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Salminen P, 2018, JAMA-J AM MED ASSOC, V320, P1259, DOI 10.1001/jama.2018.13201; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Svensson JF, 2015, ANN SURG, V261, P67, DOI 10.1097/SLA.0000000000000835; Talan DA, 2017, ANN EMERG MED, V70, P1, DOI 10.1016/j.annemergmed.2016.08.446; Tanaka Y, 2015, J PEDIATR SURG, V50, P1893, DOI 10.1016/j.jpedsurg.2015.07.008; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812; Wills Celia E, 2003, Health Expect, V6, P149, DOI 10.1046/j.1369-6513.2003.00220.x	37	41	40	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					581	593		10.1001/jama.2020.10888	http://dx.doi.org/10.1001/jama.2020.10888			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32730561	Bronze, Green Published			2022-12-28	WOS:000562845100020
J	Walker, D				Walker, Darren			The Work of Philanthropy in Responding to COVID-19 and Addressing Inequality A New Foundation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this Viewpoint the president of the Ford Foundation calls on philanthropic and other wealthy organizations to make creative and generous grants to less well-endowed counterpart institutions and communities to redress the racial and socioeconomic disparities exposed by the COVID-19 pandemic and continued killings of Black Americans.	[Walker, Darren] Ford Fdn, 320 E 43rd St, New York, NY 10017 USA		Walker, D (corresponding author), Ford Fdn, 320 E 43rd St, New York, NY 10017 USA.	d.walker@fordfoundation.org						amfAR, 2020, COVID 19 RAC DISP US; APM Research Lab, 2020, FOC BLACK AM; Armour S., 2020, WALL STREET J; Berwick DM, 2020, JAMA-J AM MED ASSOC, V323, P2125, DOI 10.1001/jama.2020.6949; Carnegie A., 2017, THE GOSPEL OF WEALTH; Fernandes D, 2020, BOSTON GLOBE; Santhanam L., 2020, PBS NEWS HOUR; Walker D, 2019, PENSIONS INVESTMENTS	8	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					541	542		10.1001/jama.2020.12904	http://dx.doi.org/10.1001/jama.2020.12904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32722747	Bronze			2022-12-28	WOS:000562845100009
J	Livingston, G; Huntley, J; Sommerlad, A; Ames, D; Ballard, C; Banerjee, S; Brayne, C; Burns, A; Cohen-Mansfield, J; Cooper, C; Costafreda, SG; Dias, A; Fox, N; Gitlin, LN; Howard, R; Kales, HC; Kivimaki, M; Larson, EB; Ogunniyi, A; Orgeta, V; Ritchie, K; Rockwood, K; Sampson, EL; Samus, Q; Schneider, LS; Selbaek, G; Teri, L; Mukadam, N				Livingston, Gill; Huntley, Jonathan; Sommerlad, Andrew; Ames, David; Ballard, Clive; Banerjee, Sube; Brayne, Carol; Burns, Alistair; Cohen-Mansfield, Jiska; Cooper, Claudia; Costafreda, Sergi G.; Dias, Amit; Fox, Nick; Gitlin, Laura N.; Howard, Robert; Kales, Helen C.; Kivimaki, Mika; Larson, Eric B.; Ogunniyi, Adesola; Orgeta, Vasiliki; Ritchie, Karen; Rockwood, Kenneth; Sampson, Elizabeth L.; Samus, Quincy; Schneider, Lon S.; Selbaek, Geir; Teri, Linda; Mukadam, Naaheed			Dementia prevention, intervention, and care: 2020 report of the Lancet Commission	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; LIFE-STYLE INTERVENTION; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; INCIDENT DEMENTIA; NEUROFILAMENT LIGHT; ALCOHOL-CONSUMPTION; OLDER-ADULTS		[Livingston, Gill; Huntley, Jonathan; Sommerlad, Andrew; Cooper, Claudia; Costafreda, Sergi G.; Howard, Robert; Orgeta, Vasiliki; Sampson, Elizabeth L.; Mukadam, Naaheed] UCL, Div Psychiat, London W1T 7NF, England; [Fox, Nick] UCL, Dementia Res Ctr, UK Dementia Res Inst, London, England; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Livingston, Gill; Huntley, Jonathan; Sommerlad, Andrew; Cooper, Claudia; Costafreda, Sergi G.; Howard, Robert; Mukadam, Naaheed] Camden & Islington NHS Fdn Trust, London, England; [Sampson, Elizabeth L.] Barnet Enfield & Haringey Mental Hlth Trust, London, England; [Ames, David] Univ Melbourne, Royal Melbourne Hosp, Natl Ageing Res Inst, Parkville, Vic, Australia; [Ames, David] Univ Melbourne, Royal Melbourne Hosp, Acad Unit Psychiat Old Age, Parkville, Vic, Australia; [Ballard, Clive] Univ Exeter, Exeter, Devon, England; [Banerjee, Sube] Univ Plymouth, Fac Hlth Med Dent & Human Sci, Plymouth, Devon, England; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Burns, Alistair] Univ Manchester, Dept Old Age Psychiat, Manchester, Lancs, England; [Cohen-Mansfield, Jiska] Tel Aviv Univ, Dept Hlth Promot, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Cohen-Mansfield, Jiska] Tel Aviv Univ, Heczeg Inst Aging, Tel Aviv, Israel; [Cohen-Mansfield, Jiska] Tel Aviv Univ, Minerva Ctr Interdisciplinary Study End Life, Tel Aviv, Israel; [Dias, Amit] Goa Med Coll, Dept Prevent & Social Med, Bambolim, Goa, India; [Fox, Nick] Univ Coll London Hosp NHS Fdn Trust, Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Gitlin, Laura N.] Johns Hopkins Univ, Ctr Innovat Care Aging, Baltimore, MA USA; [Samus, Quincy] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MA USA; [Kales, Helen C.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sch Med, Sacramento, CA 95817 USA; [Larson, Eric B.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Ogunniyi, Adesola] Univ Coll Hosp, Ibadan, Nigeria; [Ritchie, Karen] Univ Montpellier, INSERM, Unit 1061, Neuropsychiat Epidemiol & Clin Res,La Colombiere, Montpellier, France; [Ritchie, Karen] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Rockwood, Kenneth] Dalhousie Univ, Ctr Hlth Care Elderly People, Geriatr Med, Halifax, NS, Canada; [Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Leonard Davis Sch Gerontol, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA; [Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Leonard Davis Sch Gerontol, Dept Neurol, Los Angeles, CA 90007 USA; [Selbaek, Geir] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Selbaek, Geir] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Selbaek, Geir] Oslo Univ Hosp, Dept Geriatr, Oslo, Norway; [Teri, Linda] Univ Washington, Sch Nursing, Dept Psychosocial & Community Hlth, Seattle, WA 98195 USA	University of London; University College London; University of London; University College London; University of London; University College London; National Ageing Research Institute; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Exeter; University of Plymouth; University of Cambridge; University of Manchester; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Goa Medical College & Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Davis; Kaiser Permanente; University of Ibadan; University College Hospital, Ibadan; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Edinburgh; Dalhousie University; University of Southern California; University of Southern California; University of Oslo; University of Oslo; University of Washington; University of Washington Seattle	Livingston, G (corresponding author), UCL, Div Psychiat, London W1T 7NF, England.	g.livingston@ucl.ac.uk	Kivimaki, Mika/B-3607-2012; Fox, Nick C/B-1319-2009; Sampson, Elizabeth L/B-8647-2009; cohen-mansfield, jiska/AFS-8589-2022; Cooper, Claudia/C-1556-2008	Kivimaki, Mika/0000-0002-4699-5627; Fox, Nick C/0000-0002-6660-657X; Sampson, Elizabeth L/0000-0001-8929-7362; cohen-mansfield, jiska/0000-0003-0209-7304; Ballard, Clive/0000-0003-0022-5632; Cooper, Claudia/0000-0002-2777-7616; Livingston, Gill/0000-0001-6741-5516; Orgeta, Vasiliki/0000-0001-8643-5061; Banerjee, Sube/0000-0002-8083-7649; Huntley, Jonathan/0000-0001-6304-6231; Brayne, Carol/0000-0001-5307-663X; Costafreda Gonzalez, Sergi/0000-0001-6914-086X; Howard, Robert/0000-0002-3071-2338; Selbaek, Geir/0000-0001-6511-8219	University College London (UCL); Alzheimer's Society, UK; Economic and Social Research Council; Alzheimer's Research UK; University College London Hospitals National Institute for Health Research Biomedical Research Centre; MRC [MR/R024227/1, UKDRI-1001, MR/S011676/1, G0802594, G9901400, G0601022] Funding Source: UKRI	University College London (UCL); Alzheimer's Society, UK; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); University College London Hospitals National Institute for Health Research Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are partnered by University College London (UCL), the Alzheimer's Society, UK, the Economic and Social Research Council, and Alzheimer's Research UK, and would like to thank them for financial help. These organisations funded the fares, accommodation, and food for the Commission meeting but had no role in the writing of the manuscript or the decision to submit it for publication. We would like to thank Bernadette Courtney, Jacques Gianino, and Nuj Monowari, from UCL, London, UK, for their administrative help, including managing finances, booking rooms and food, and setting up a website supported by the University College London Hospitals National Institute for Health Research Biomedical Research Centre. We would like thank Henrik Zetterberg for advice on biomarkers and dementia.	Abell JG, 2018, EUR HEART J, V39, P3119, DOI 10.1093/eurheartj/ehy288; Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Agar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181020; Ahmadi-Abhari S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2856; Akbaraly TN, 2019, JAMA-J AM MED ASSOC, V321, P957, DOI 10.1001/jama.2019.1432; Albanese Emiliano, 2017, Alzheimers Dement (Amst), V8, P165, DOI 10.1016/j.dadm.2017.05.007; Almeida OP, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.90; Altman D.G., 1991, PRACTICAL STAT MED R; American Psychiatric Association, 1996, DSM 4 SOURCEBOOK; American Psychiatric Association, 2013, DSM 5 TASK FORC DIAG; Amieva H, 2018, J GERONTOL A-BIOL, V73, P1383, DOI 10.1093/gerona/glx250; Andrews M, 2018, NEUROL THER, V7, P51, DOI 10.1007/s40120-018-0095-y; Ankhili A, 2018, MATERIALS, V11, DOI 10.3390/ma11020256; Anstey KJ, 2019, J ALZHEIMERS DIS, V70, pS165, DOI 10.3233/JAD-190181; Arenaza-Urquijo EM, 2019, BRAIN, V142, P1134, DOI 10.1093/brain/awz037; Sastre AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003804.pub2; Armstrong NM, 2019, JAMA OTOLARYNGOL, V145, P794, DOI 10.1001/jamaoto.2019.1610; Aworinde J, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1930-5; Bahar-Fuchs A, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013069.pub2; Ballard C, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002500; Banerjee S, 2017, INT J GERIATR PSYCH, V32, P68, DOI 10.1002/gps.4602; Barbateskovic M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024562; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P71, DOI 10.1016/j.yfrne.2017.04.002; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barreto PD, 2018, J GERONTOL A-BIOL, V73, P1504, DOI 10.1093/gerona/glx234; Bartels C, 2018, AM J PSYCHIAT, V175, P232, DOI 10.1176/appi.ajp.2017.17040404; Bauer K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-10; Bennett HQ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1105-8; Birks JS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001190.pub3; Blacker D, 2018, JAMA PSYCHIAT, V75, P703, DOI 10.1001/jamapsychiatry.2018.0656; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Bowe B, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15834; Boyle PA, 2019, ANN NEUROL, V85, P114, DOI 10.1002/ana.25380; Boyle PA, 2018, ANN NEUROL, V83, P74, DOI 10.1002/ana.25123; Brazil K, 2018, PALLIATIVE MED, V32, P603, DOI 10.1177/0269216317722413; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Bronskill SE, 2018, J AM GERIATR SOC, V66, P1963, DOI 10.1111/jgs.15519; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P981, DOI 10.1016/j.jalz.2018.03.005; Browne J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012546; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bubu OM, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw032; Bunn F, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0909-2; Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4; Burry L, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005594.pub3; Butler M, 2018, ANN INTERN MED, V168, P63, DOI 10.7326/M17-1531; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; CarePort Health, 2020, COVID 19 REP; Carey IM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022404; Chan D, 2018, NEUROBIOL AGING, V70, P180, DOI 10.1016/j.neurobiolaging.2018.06.012; Chandler MJ, 2016, NEUROPSYCHOL REV, V26, P225, DOI 10.1007/s11065-016-9330-4; Chang CCH, 2012, ALZ DIS ASSOC DIS, V26, P300, DOI 10.1097/WAD.0b013e3182420b6e; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Chen H, 2017, ENVIRON INT, V108, P271, DOI 10.1016/j.envint.2017.08.020; Chen H, 2017, LANCET, V389, P718, DOI 10.1016/S0140-6736(16)32399-6; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00085; Choi D, 2018, ANN CLIN TRANSL NEUR, V5, P1192, DOI 10.1002/acn3.633; Cholerton B, 2013, J ALZHEIMERS DIS, V36, P699, DOI 10.3233/JAD-130281; Chu SF, 2016, ASIA-PAC J PUBLIC HE, V28, P519, DOI 10.1177/1010539516662956; Clare L, 2019, HEALTH TECHNOL ASSES, V23, P1, DOI 10.3310/hta23100; Clouston SAP, 2017, SOC SCI MED, V178, P78, DOI 10.1016/j.socscimed.2017.01.019; Cohen-Mansfield J, 2018, DEMENT GERIATR COGN, V46, P100, DOI 10.1159/000491746; Cohen-Mansfield J, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0357-z; Comas-Herrera A, 2020, LTCCOVIDORG INT LONG, DOI DOI 10.1038/nrclinonc.2015.201; Cooper C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193399; Cooper C, 2017, AGE AGEING, V46, P393, DOI 10.1093/ageing/afw208; Cossette B, 2019, J AM MED DIR ASSOC; D'Cunha NM, 2018, BRIT J NUTR, V119, P280, DOI [10.1017/S0007114517003452, 10.1017/s0007114517003452]; Dang C, 2018, J ALZHEIMERS DIS, V65, P1313, DOI 10.3233/JAD-180507; Davis DHJ, 2017, JAMA PSYCHIAT, V74, P244, DOI 10.1001/jamapsychiatry.2016.3423; de Graaf MNS, 2019, APL BIOENG, V3, DOI 10.1063/1.5090986; Debanne SM, 2007, J ALZHEIMERS DIS, V11, P313; Delgado J, 2018, JAMA INTERN MED, V178, P93, DOI 10.1001/jamainternmed.2017.7023; Denier N, 2017, ADV LIFE COURSE RES, V31, P11, DOI 10.1016/j.alcr.2016.10.004; Dening KH, 2017, INT J PALLIAT NURS, V23, P4, DOI 10.12968/ijpn.2017.23.1.4; Dening KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159056; Department of Health, 2012, US COMM QUAL INN CQU; Ding J, 2020, LANCET NEUROL, V19, P61, DOI 10.1016/S1474-4422(19)30393-X; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Donegan K, 2017, LANCET PUBLIC HEALTH, V2, pE149, DOI 10.1016/S2468-2667(17)30031-2; Dudas R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003944.pub2; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Ehrenberg AJ, 2018, J ALZHEIMERS DIS, V66, P115, DOI 10.3233/JAD-180688; Evans IEM, 2019, J ALZHEIMERS DIS, V70, pS119, DOI 10.3233/JAD-180501; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Farina N, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002854.pub5; Fereshtehnejad SM, 2018, ALZHEIMERS DEMENT, V14, P10, DOI 10.1016/j.jalz.2017.05.004; Fong TG, 2015, LANCET NEUROL, V14, P823, DOI 10.1016/S1474-4422(15)00101-5; Fowler NR, 2020, J AM GERIATR SOC, V68, P535, DOI 10.1111/jgs.16247; Fowler NR, 2018, CLIN INTERV AGING, V13, P1779, DOI 10.2147/CIA.S164957; Franzmeier N, 2018, BRAIN, V141, P1186, DOI 10.1093/brain/awy008; Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V318, P603, DOI 10.1001/jama.2017.10693; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gao SJ, 2019, J AM GERIATR SOC, V67, P1361, DOI 10.1111/jgs.16027; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gaster B, 2017, JAMA-J AM MED ASSOC, V318, P2175, DOI 10.1001/jama.2017.16473; Gates NJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012278.pub2; Gates NJ, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-55; Gavelin HM, 2020, NEUROPSYCHOL REV, V30, P167, DOI 10.1007/s11065-020-09434-8; Gitlin LN, 2018, J AM GERIATR SOC, V66, P339, DOI 10.1111/jgs.15194; Goldberg SE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4132; Golub JS, 2020, JAMA OTOLARYNGOL, V146, P57, DOI 10.1001/jamaoto.2019.3375; Grotz C, 2016, J NUTR HEALTH AGING, V20, P514, DOI 10.1007/s12603-015-0599-4; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Guterman EL, 2019, JAMA NEUROL, V76, P1166, DOI 10.1001/jamaneurol.2019.1820; Handing EP, 2015, J GERONTOL A-BIOL, V70, P1248, DOI 10.1093/gerona/glv038; Handley M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015257; Hanson LC, 2017, JAMA INTERN MED, V177, P24, DOI 10.1001/jamainternmed.2016.7031; Hersi M, 2017, NEUROTOXICOLOGY, V61, P143, DOI 10.1016/j.neuro.2017.03.006; Herukka SK, 2017, ALZHEIMERS DEMENT, V13, P285, DOI 10.1016/j.jalz.2016.09.009; Hill NTM, 2017, AM J PSYCHIAT, V174, P329, DOI 10.1176/appi.ajp.2016.16030360; Hoffman SJ, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2231; Horder H, 2018, NEUROLOGY, V90, pE1298, DOI 10.1212/WNL.0000000000005290; Hshieh TT, 2018, AM J GERIAT PSYCHIAT, V26, P1015, DOI 10.1016/j.jagp.2018.06.007; Huang CH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1187-0; Hussain S, 2018, NEUROSCI LETT, V671, P120, DOI 10.1016/j.neulet.2018.02.027; Ilomaki J, 2015, CURR CLIN PHARMACOL, V10, P204, DOI 10.2174/157488471003150820145539; Intrator O, 2004, J AM GERIATR SOC, V52, P1730, DOI 10.1111/j.1532-5415.2004.52469.x; Irwin MR, 2019, LANCET NEUROL, V18, P296, DOI 10.1016/S1474-4422(18)30450-2; Jack CR, 2019, JAMA-J AM MED ASSOC, V321, P2316, DOI 10.1001/jama.2019.7437; Jackson TA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002247; Jackson TA, 2016, AGE AGEING, V45, P493, DOI 10.1093/ageing/afw064; James BD, 2019, NEUROLOGY, V92, pe690, DOI 10.1212/WNL.0000000000006918; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Jarvenpaa T, 2005, EPIDEMIOLOGY, V16, P766, DOI 10.1097/01.ede.0000181307.30826.6c; Jia LF, 2020, LANCET NEUROL, V19, P81, DOI 10.1016/S1474-4422(19)30290-X; Kajitani S, 2017, AGEING SOC, V37, P1568, DOI 10.1017/S0144686X16000465; Kales HC, 2019, INT PSYCHOGERIATR, V31, P83, DOI 10.1017/S1041610218000534; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Kane RL, 2017, COMP EFFECT REV, DOI DOI 10.23970/AHRQEPCCER188; Kelly ME, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0632-2; Kingston A, 2018, LANCET PUBLIC HEALTH, V3, pE447, DOI 10.1016/S2468-2667(18)30118-X; Kinnunen KM, 2017, CURR OPIN PSYCHIATR, V30, P491, DOI 10.1097/YCO.0000000000000370; Kivimaki M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1495; Kivimaki M, 2018, ALZHEIMERS DEMENT, V14, P601, DOI 10.1016/j.jalz.2017.09.016; Koch M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10319; Kolanowski A, 2016, J AM GERIATR SOC, V64, P2424, DOI 10.1111/jgs.14511; Kremen WS, 2019, P NATL ACAD SCI USA, V116, P2021, DOI 10.1073/pnas.1811537116; Lamb SE, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1675; Lane CA, 2019, LANCET NEUROL, V18, P942, DOI 10.1016/S1474-4422(19)30228-5; Larsson SC, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5375; Latimer CS, 2017, J NEUROPATH EXP NEUR, V76, P458, DOI 10.1093/jnen/nlx030; Lau-Ng R, 2020, J AM GERIATR SOC, V68, P1895, DOI 10.1111/jgs.16669; Lawlor B, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002660; Lee ATC, 2018, JAMA PSYCHIAT, V75, P697, DOI 10.1001/jamapsychiatry.2018.0657; Li JL, 2018, J ALZHEIMERS DIS, V63, P1119, DOI [10.3233/JAD-170917, 10.3233/jad-170917]; Licher S, 2019, NAT MED, V25, P1364, DOI 10.1038/s41591-019-0547-7; Lichtwarck B, 2018, AM J GERIAT PSYCHIAT, V26, P25, DOI 10.1016/j.jagp.2017.05.015; Livingston G, 2020, COVID 19 DEMENTIA DI; Livingston G, 2020, BRIT J PSYCHIAT, V216, P35, DOI 10.1192/bjp.2019.160; Livingston G, 2019, LANCET PSYCHIAT, V6, P293, DOI 10.1016/S2215-0366(19)30045-8; Livingston G, 2019, INT PSYCHOGERIATR, V31, P251, DOI 10.1017/S1041610218000753; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Livingston G, 2017, BJPSYCH OPEN, V3, P171, DOI 10.1192/bjpo.bp.117.005181; Lonergan E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006379.pub3; Loughrey DG, 2018, JAMA OTOLARYNGOL, V144, P115, DOI 10.1001/jamaoto.2017.2513; Loughrey DG, 2017, ADV NUTR, V8, P571, DOI 10.3945/an.117.015495; Lourida I, 2019, JAMA-J AM MED ASSOC, V322, P430, DOI 10.1001/jama.2019.9879; Lu YK, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy143; Luckett T, 2017, INT PSYCHOGERIATR, V29, P1713, DOI 10.1017/S1041610217000977; Lutsey PL, 2018, ALZHEIMERS DEMENT, V14, P157, DOI 10.1016/j.jalz.2017.06.2269; Macedoa AC, 2017, J ALZHEIMERS DIS, V58, P993, DOI 10.3233/JAD-161287; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Maharani A, 2018, J AM GERIATR SOC, V66, P1130, DOI 10.1111/jgs.15363; Malone DC, 2009, AM J MANAG CARE, V15, P481; Martin-Garcia S, 2013, INT PSYCHOGERIATR, V25, P1077, DOI 10.1017/S1041610213000458; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Maust DT, 2017, AM J GERIAT PSYCHIAT, V25, P1074, DOI 10.1016/j.jagp.2017.02.025; McCleery J, VITAMIN MINERAL SUPP; McGrath ER, 2017, NEUROLOGY, V89, P2447, DOI 10.1212/WNL.0000000000004741; McGuinness B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub3; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; McMillan JM, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2018-000563; McNeil JJ, 2018, NEW ENGL J MED, V379, P1499, DOI 10.1056/NEJMoa1800722; Meeussen K, 2012, INT PSYCHOGERIATR, V24, P1581, DOI 10.1017/S1041610212000865; Melis RJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084014; Meng A, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0556-7; Moore KJ, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0523-3; Morris MC, 2018, NEUROLOGY, V90, pE214, DOI 10.1212/WNL.0000000000004815; Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9; Musiek ES, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.121; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; National Institute for Health and Care Excellence (UK), 2018, DEMENTIA ASSESSMENT; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Neitzel J, 2019, NEUROLOGY, V93, pE347, DOI 10.1212/WNL.0000000000007822; Nelson PT, 2019, BRAIN, V142, P1503, DOI 10.1093/brain/awz099; Neufeld KJ, 2016, J AM GERIATR SOC, V64, P705, DOI 10.1111/jgs.14076; NHS Digital, 2015, HLTH SURV ENGL 2014; Nicol GE, 2020, J AM GERIATR SOC, V68, P922, DOI 10.1111/jgs.16443; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Office for National Statistics, 2020, IMP COR CAR HOM ENGL; Ohara T, 2018, J AM GERIATR SOC, V66, P1911, DOI 10.1111/jgs.15446; Orgeta V, 2017, J ALZHEIMERS DIS, V58, P725, DOI 10.3233/JAD-161247; Oudin A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198283; Oudin A, 2016, ENVIRON HEALTH PERSP, V124, P306, DOI 10.1289/ehp.1408322; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Pan X, 2018, AM J EPIDEMIOL, V187, P911, DOI 10.1093/aje/kwx377; Panca M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211953; Parbo P, 2017, BRAIN, V140, P2002, DOI 10.1093/brain/awx120; Pase MP, 2016, STROKE, V47, P1201, DOI 10.1161/STROKEAHA.115.012608; Patnode C. D., 2020, SCREENING COGNITIVE, DOI DOI 10.1093/ndt/gfz051; Patterson C., 2018, ALZHEIMERS DIS INT W; Penninkilampi R, 2018, J ALZHEIMERS DIS, V66, P1619, DOI 10.3233/JAD-180439; Perneczky R, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1283-z; Peters R, 2020, NEUROLOGY, V94, pE267, DOI 10.1212/WNL.0000000000008732; Peters R, 2019, NEUROLOGY, V92, P1017, DOI 10.1212/WNL.0000000000007543; Peters R, 2019, J ALZHEIMERS DIS, V70, pS145, DOI 10.3233/JAD-180631; Phelan EA, 2015, MED CARE, V53, P207, DOI 10.1097/MLR.0000000000000294; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Pickett J, 2018, INT J GERIATR PSYCH, V33, P900, DOI 10.1002/gps.4868; Pistollato F, 2018, PHARMACOL RES, V131, P32, DOI 10.1016/j.phrs.2018.03.012; Piumatti G, 2018, J PUBLIC HEALTH-UK, V40, P304, DOI [10.1093/pubmed/fdy032, 10.1093/pubmed/fdx186]; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Power MC, 2016, NEUROTOXICOLOGY, V56, P235, DOI 10.1016/j.neuro.2016.06.004; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJA, 2014, DEMENTIA RISK REDUCT; Rabinovici GD, 2019, JAMA-J AM MED ASSOC, V321, P1286, DOI 10.1001/jama.2019.2000; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Radd-Vagenas S, 2018, AM J CLIN NUTR, V107, P389, DOI 10.1093/ajcn/nqx070; Rait G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3584; Ray J, 2018, JAMA OTOLARYNGOL, V144, P876, DOI 10.1001/jamaoto.2018.1656; Redelmeier DA, 2019, JAMA NEUROL, V76, P887, DOI 10.1001/jamaneurol.2019.1148; Rehm J, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0453-0; Rice L, 2017, EUR J RADIOL, V94, P16, DOI 10.1016/j.ejrad.2017.07.014; Richard E, 2019, LANCET DIGIT HEALTH, V1, pE424, DOI 10.1016/S2589-7500(19)30153-0; Richard E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010806; Richardson K, 2019, AM J EPIDEMIOL, V188, P1228, DOI 10.1093/aje/kwz073; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Ritchie K, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa069; Roberts RO, 2018, JAMA NEUROL, V75, P970, DOI 10.1001/jamaneurol.2018.0629; Rockwood K, 2019, NAT MED, V25, P1331, DOI 10.1038/s41591-019-0575-3; Rohwedder S, 2010, J ECON PERSPECT, V24, P119, DOI 10.1257/jep.24.1.119; Rosemond C, 2017, J PALLIAT MED, V20, P360, DOI 10.1089/jpm.2016.0271; Rosenberg A, 2018, ALZHEIMERS DEMENT, V14, P263, DOI 10.1016/j.jalz.2017.09.006; Rovner BW, 2018, JAMA NEUROL, V75, P1487, DOI 10.1001/jamaneurol.2018.2513; Ruthirakuhan MT, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012197.pub2; Rutjes AWS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011906.pub2; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Sabia S, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.14414; Sabia S, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2927; Sabia S, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2709; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Saint-Maurice PF, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0355; Saito T, 2018, J EPIDEMIOL COMMUN H, V72, P7, DOI 10.1136/jech-2017-209811; Sampson EL, 2018, PALLIATIVE MED, V32, P668, DOI 10.1177/0269216317726443; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Schwarzinger M, 2018, LANCET PUBLIC HEALTH, V3, pE124, DOI 10.1016/S2468-2667(18)30022-7; Scott I, 2019, INT J GERIATR PSYCH, V34, P1386, DOI 10.1002/gps.5127; Shah SM, 2016, INT J GERIATR PSYCH, V31, P929, DOI 10.1002/gps.4411; Sharma S, 2018, J AM MED DIR ASSOC, V19, P607, DOI 10.1016/j.jamda.2018.03.009; Shepherd H, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1369-7; Shi L, 2018, SLEEP MED REV, V40, P4, DOI 10.1016/j.smrv.2017.06.010; Shor E, 2017, SOC SCI MED, V186, P20, DOI 10.1016/j.socscimed.2017.05.049; Siddiqi N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub3; Sindi S, 2018, ALZHEIMERS DEMENT, V14, P1235, DOI 10.1016/j.jalz.2018.05.012; Singh-Manoux A, 2018, ALZHEIMERS DEMENT, V14, P178, DOI 10.1016/j.jalz.2017.06.2637; Singh-Manoux A, 2017, JAMA PSYCHIAT, V74, P712, DOI 10.1001/jamapsychiatry.2017.0660; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Soininen H, 2017, LANCET NEUROL, V16, P965, DOI 10.1016/S1474-4422(17)30332-0; Solomon A, 2018, JAMA NEUROL, V75, P462, DOI 10.1001/jamaneurol.2017.4365; Sommerlad A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002862; Sommerlad A, 2018, ALZHEIMERS DEMENT, V14, P933, DOI 10.1016/j.jalz.2018.02.012; Sommerlad A, 2018, J NEUROL NEUROSUR PS, V89, P231, DOI 10.1136/jnnp-2017-316274; Song D, 2018, INT J NURS STUD, V79, P155, DOI 10.1016/j.ijnurstu.2018.01.002; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Staff RT, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4925; Stephen R, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0506-z; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Teri L, 2020, GERONTOLOGIST, V60, P548, DOI 10.1093/geront/gny122; Thyrian JR, 2017, JAMA PSYCHIAT, V74, P996, DOI 10.1001/jamapsychiatry.2017.2124; Tolppanen AM, 2017, ALZHEIMERS DEMENT, V13, P1371, DOI 10.1016/j.jalz.2017.04.010; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Troyer EA, 2020, BRAIN BEHAV IMMUN, V87, P34, DOI 10.1016/j.bbi.2020.04.027; Tully PJ, 2016, J HYPERTENS, V34, P1027, DOI 10.1097/HJH.0000000000000868; van der Lee SJ, 2018, ALZHEIMERS DEMENT, V14, P707, DOI 10.1016/j.jalz.2017.11.012; Van Leeuwen E, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007726.pub3, 10.1002/14651858.C.D007726.pub3]; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Veronese N, 2017, NEUROSCI BIOBEHAV R, V72, P87, DOI 10.1016/j.neubiorev.2016.11.017; Voytyuk I, 2018, BIOL PSYCHIAT, V83, P320, DOI 10.1016/j.biopsych.2017.08.001; Vroomen JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160908; Walker KA, 2019, JAMA-J AM MED ASSOC, V322, P535, DOI 10.1001/jama.2019.10575; Wallace Lindsay, 2018, Alzheimers Dement (Amst), V10, P394, DOI 10.1016/j.dadm.2018.05.002; Wallace LMK, 2019, LANCET NEUROL, V18, P177, DOI 10.1016/S1474-4422(18)30371-5; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Walsh S, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6930; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang HL, 2020, LANCET, V395, P1190, DOI 10.1016/S0140-6736(20)30755-8; White N, 2017, INT J GERIATR PSYCH, V32, P297, DOI 10.1002/gps.4463; Wilkinson T, 2018, ALZHEIMERS DEMENT, V14, P1038, DOI 10.1016/j.jalz.2018.02.016; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; World Health Organization, 2019, RISK RED COGN DECL D; Wu YC, 2019, JAMA PSYCHIAT, V76, P526, DOI 10.1001/jamapsychiatry.2018.4365; Wu YT, 2018, INT J EPIDEMIOL, V47, P709, DOI 10.1093/ije/dyy007; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Xu W, 2017, EUR J EPIDEMIOL, V32, P31, DOI 10.1007/s10654-017-0225-3; Xue BW, 2018, EUR J EPIDEMIOL, V33, P989, DOI 10.1007/s10654-017-0347-7; Yaffe K, 2019, JAMA-J AM MED ASSOC, V321, P548, DOI 10.1001/jama.2019.0008; Yaffe K, 2019, NEUROLOGY, V92, pE205, DOI 10.1212/WNL.0000000000006778; Yaffe K, 2014, LANCET NEUROL, V13, P1017, DOI 10.1016/S1474-4422(14)70172-3; Yu AL, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012494.pub2, 10.1002/14651858.0.0012494.pub2]; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108; Zhu CW, 2017, J ALZHEIMERS DIS, V57, P305, DOI 10.3233/JAD-161077; Zhu CW, 2015, INT J GERIATR PSYCH, V30, P833, DOI 10.1002/gps.4222; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zotcheva E, 2018, J ALZHEIMERS DIS, V66, P825, DOI 10.3233/JAD-180768	317	1200	1223	155	546	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					413	446		10.1016/S0140-6736(20)30367-6	http://dx.doi.org/10.1016/S0140-6736(20)30367-6			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0SW	32738937	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000561619100026
J	Camara-Leret, R; Frodin, DG; Adema, F; Anderson, C; Appelhans, MS; Argent, G; Guerrero, SA; Ashton, P; Baker, WJ; Barfod, AS; Barrington, D; Borosova, R; Bramley, GLC; Briggs, M; Buerki, S; Cahen, D; Callmander, MW; Cheek, M; Chen, CW; Conn, BJ; Coode, MJE; Darbyshire, I; Dawson, S; Dransfield, J; Drinkell, C; Duyfjes, B; Ebihara, A; Ezedin, Z; Fu, LF; Gideon, O; Girmansyah, D; Govaerts, R; Fortune-Hopkins, H; Hassemer, G; Hay, A; Heatubun, CD; Hind, DJN; Hoch, P; Homot, P; Hovenkamp, P; Hughes, M; Jebb, M; Jennings, L; Jimbo, T; Kessler, M; Kiew, R; Knapp, S; Lamei, P; Lehnert, M; Lewis, GP; Linder, HP; Lindsay, S; Low, YW; Lucas, E; Mancera, JP; Monro, AK; Moore, A; Middleton, DJ; Nagamasu, H; Newman, MF; Lughadha, EN; Melo, PHA; Ohlsen, DJ; Pannell, CM; Parris, B; Pearce, L; Penneys, DS; Perrie, LR; Petoe, P; Poulsen, AD; Prance, GT; Quakenbush, JP; Raes, N; Rodda, M; Rogers, ZS; Schuiteman, A; Schwartsburd, P; Scotland, RW; Simmons, MP; Simpson, DA; Stevens, P; Sundue, M; Testo, W; Trias-Blasi, A; Turner, I; Utteridge, T; Walsingham, L; Webber, BL; Wei, R; Weiblen, GD; Weigend, M; Weston, P; de Wilde, W; Wilkie, P; Wilmot-Dear, CM; Wilson, HP; Wood, JRI; Zhang, LB; van Welzen, PC				Camara-Leret, Rodrigo; Frodin, David G.; Adema, Frits; Anderson, Christiane; Appelhans, Marc S.; Argent, George; Guerrero, Susana Arias; Ashton, Peter; Baker, William J.; Barfod, Anders S.; Barrington, David; Borosova, Renata; Bramley, Gemma L. C.; Briggs, Marie; Buerki, Sven; Cahen, Daniel; Callmander, Martin W.; Cheek, Martin; Chen, Cheng-Wei; Conn, Barry J.; Coode, Mark J. E.; Darbyshire, Iain; Dawson, Sally; Dransfield, John; Drinkell, Clare; Duyfjes, Brigitta; Ebihara, Atsushi; Ezedin, Zacky; Fu, Long-Fei; Gideon, Osia; Girmansyah, Deden; Govaerts, Rafael; Fortune-Hopkins, Helen; Hassemer, Gustavo; Hay, Alistair; Heatubun, Charlie D.; Hind, D. J. Nicholas; Hoch, Peter; Homot, Peter; Hovenkamp, Peter; Hughes, Mark; Jebb, Matthew; Jennings, Laura; Jimbo, Tiberius; Kessler, Michael; Kiew, Ruth; Knapp, Sandra; Lamei, Penniel; Lehnert, Marcus; Lewis, Gwilym P.; Linder, Hans Peter; Lindsay, Stuart; Low, Yee Wen; Lucas, Eve; Mancera, Jeffrey P.; Monro, Alexandre K.; Moore, Alison; Middleton, David J.; Nagamasu, Hidetoshi; Newman, Mark F.; Lughadha, Eimear Nic; Melo, Pablo H. A.; Ohlsen, Daniel J.; Pannell, Caroline M.; Parris, Barbara; Pearce, Laura; Penneys, Darin S.; Perrie, Leon R.; Petoe, Peter; Poulsen, Axel Dalberg; Prance, Ghillean T.; Quakenbush, J. Peter; Raes, Niels; Rodda, Michele; Rogers, Zachary S.; Schuiteman, Andre; Schwartsburd, Pedro; Scotland, Robert W.; Simmons, Mark P.; Simpson, David A.; Stevens, Peter; Sundue, Michael; Testo, Weston; Trias-Blasi, Anna; Turner, Ian; Utteridge, Timothy; Walsingham, Lesley; Webber, Bruce L.; Wei, Ran; Weiblen, George D.; Weigend, Maximilian; Weston, Peter; de Wilde, Willem; Wilkie, Peter; Wilmot-Dear, Christine M.; Wilson, Hannah P.; Wood, John R., I; Zhang, Li-Bing; van Welzen, Peter C.			New Guinea has the world's richest island flora	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; CLASSIFICATION; HOTSPOTS; ENDEMISM	New Guinea is the world's largest tropical island and has fascinated naturalists for centuries(1,2). Home to some of the best-preserved ecosystems on the planet(3)and to intact ecological gradients-from mangroves to tropical alpine grasslands-that are unmatched in the Asia-Pacific region(4,5), it is a globally recognized centre of biological and cultural diversity(6,7). So far, however, there has been no attempt to critically catalogue the entire vascular plant diversity of New Guinea. Here we present the first, to our knowledge, expert-verified checklist of the vascular plants of mainland New Guinea and surrounding islands. Our publicly available checklist includes 13,634 species (68% endemic), 1,742 genera and 264 families-suggesting that New Guinea is the most floristically diverse island in the world. Expert knowledge is essential for building checklists in the digital era: reliance on online taxonomic resources alone would have inflated species counts by 22%. Species discovery shows no sign of levelling off, and we discuss steps to accelerate botanical research in the 'Last Unknown'(8). A catalogue of the vascular flora of New Guinea indicates that this island is the most floristically diverse in the world, and that 68% of the species identified are endemic to New Guinea.	[Camara-Leret, Rodrigo; Frodin, David G.; Ashton, Peter; Baker, William J.; Borosova, Renata; Bramley, Gemma L. C.; Briggs, Marie; Cahen, Daniel; Cheek, Martin; Coode, Mark J. E.; Darbyshire, Iain; Dawson, Sally; Dransfield, John; Drinkell, Clare; Govaerts, Rafael; Fortune-Hopkins, Helen; Heatubun, Charlie D.; Hind, D. J. Nicholas; Jennings, Laura; Lewis, Gwilym P.; Low, Yee Wen; Lucas, Eve; Monro, Alexandre K.; Moore, Alison; Middleton, David J.; Lughadha, Eimear Nic; Pannell, Caroline M.; Pearce, Laura; Petoe, Peter; Prance, Ghillean T.; Schuiteman, Andre; Simpson, David A.; Trias-Blasi, Anna; Turner, Ian; Utteridge, Timothy; Walsingham, Lesley; Wilmot-Dear, Christine M.; Wood, John R., I] Royal Bot Gardens, London, England; [Adema, Frits; Guerrero, Susana Arias; Duyfjes, Brigitta; Hovenkamp, Peter; Raes, Niels; de Wilde, Willem; van Welzen, Peter C.] Nat Biodivers Ctr, Leiden, Netherlands; [Anderson, Christiane] Univ Michigan Herbarium, Ann Arbor, MI USA; [Appelhans, Marc S.] Univ Gottingen, Dept Systemat Biodivers & Evolut Plants, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Argent, George; Hughes, Mark; Newman, Mark F.; Poulsen, Axel Dalberg; Wilkie, Peter; Wilson, Hannah P.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Barfod, Anders S.; Petoe, Peter] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Barrington, David; Sundue, Michael] Univ Vermont, Dept Plant Biol, Pringle Herbarium, Burlington, VT USA; [Buerki, Sven] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Callmander, Martin W.] Conservatoire & Jardin Bot Ville Geneve, Chambesy, Switzerland; [Conn, Barry J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Ezedin, Zacky; Weiblen, George D.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA; [Ezedin, Zacky] New Guinea Binatang Res Ctr, Madang, Papua N Guinea; [Fu, Long-Fei] Guangxi Zhuang Autonomous Reg & Chinese Acad Sci, Guangxi Key Lab Plant Conservat & Restorat Ecol K, Guangxi Inst Bot, Guilin, Peoples R China; [Gideon, Osia] Papua New Guinea Univ Technol, Lae, Papua N Guinea; [Girmansyah, Deden] Herbarium Bogoriense, Bogor, Indonesia; [Hassemer, Gustavo] Univ Fed Mato Grosso do Sul, Tres Lagoas Campus, Tres Lagoas, Brazil; [Hay, Alistair; Weston, Peter] Royal Bot Garden Sydney, Sydney, NSW, Australia; [Heatubun, Charlie D.] Univ Papua, Fak Kehutanan, Manokwari, Indonesia; [Heatubun, Charlie D.] Baden Penelitian & Pengembangan Daerah Prov Papua, Manokwari, Indonesia; [Hoch, Peter; Stevens, Peter; Zhang, Li-Bing] Missouri Bot Garden, St Louis, MO USA; [Homot, Peter; Jimbo, Tiberius; Lamei, Penniel] Papua New Guinea Forest Res Inst, Lae, Papua N Guinea; [Jebb, Matthew] Natl Bot Gardens Ireland, Glasnevin, Ireland; [Kessler, Michael; Linder, Hans Peter] Univ Zurich, Dept Systemat & Evolutionary Bot, Zurich, Switzerland; [Kiew, Ruth] Forest Res Inst Malaysia, Kepong, Malaysia; [Knapp, Sandra] Nat Hist Museum, Dept Life Sci, London, England; [Lehnert, Marcus; Weigend, Maximilian] Univ Bonn, Nees Inst Biodivers Plants, Bonn, Germany; [Lehnert, Marcus] Martin Luther Univ Halle Wittenberg, Inst Biol, Herbarium, Halle, Germany; [Lindsay, Stuart] Natl Pk Board, Nat Plants Ctr, Singapore, Singapore; [Low, Yee Wen; Rodda, Michele; Turner, Ian] Natl Pk Board, Singapore Bot Gardens, Singapore, Singapore; [Low, Yee Wen] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Mancera, Jeffrey P.] Univ Philippines Manila, Coll Arts & Sci, Dept Biol, Manila, Philippines; [Nagamasu, Hidetoshi] Kyoto Univ, Kyoto Univ Museum, Kyoto, Japan; [Melo, Pablo H. A.] Sao Paulo State Univ, Inst Biosci, Rio Claro, Brazil; [Ohlsen, Daniel J.; Pannell, Caroline M.; Scotland, Robert W.] Royal Bot Gardens Victoria, South Yarra, Vic, Australia; [Ohlsen, Daniel J.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Wood, John R., I] Univ Oxford, Dept Plant Sci, Oxford, England; [Pannell, Caroline M.] Queens Univ Belfast, Marine Lab, Portaferry, North Ireland; [Parris, Barbara] Fern Res Fdn, Kerikeri, New Zealand; [Penneys, Darin S.] Univ N Carolina, Wilmington, NC USA; [Perrie, Leon R.] Museum New Zealand Papa Tongarewa, Wellington, New Zealand; [Quakenbush, J. Peter] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Rogers, Zachary S.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA; [Schwartsburd, Pedro] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [Simmons, Mark P.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Simpson, David A.] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland; [Testo, Weston] Univ Florida, Dept Biol, Gainesville, FL USA; [Webber, Bruce L.] CSIRO Land & Water, Floreat, WA, Australia; [Webber, Bruce L.] Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia; [Wei, Ran] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Weiblen, George D.] Univ Minnesota, Bell Museum, St Paul, MN 55108 USA; [Wilson, Hannah P.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Zhang, Li-Bing] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [van Welzen, Peter C.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Camara-Leret, Rodrigo] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland	Royal Botanic Gardens, Kew; Naturalis Biodiversity Center; University of Michigan System; University of Michigan; University of Gottingen; Aarhus University; University of Vermont; Idaho; Boise State University; University of Sydney; National Museum of Nature and Science; University of Minnesota System; University of Minnesota Twin Cities; Research Center for LIPI; Universidade Federal de Mato Grosso do Sul; University of Papua; Missouri Botanical Gardens; University of Zurich; Institute Penyelidikan Perhutanan Malaysia; Natural History Museum London; University of Bonn; Martin Luther University Halle Wittenberg; University of Aberdeen; University of the Philippines System; University of the Philippines Manila; Kyoto University; Universidade Estadual Paulista; University of Melbourne; University of Oxford; Queens University Belfast; University of North Carolina; University of North Carolina Wilmington; Western Michigan University; New Mexico State University; Universidade Federal de Vicosa; Colorado State University; Trinity College Dublin; State University System of Florida; University of Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Chinese Academy of Sciences; Institute of Botany, CAS; University of Minnesota System; University of Minnesota Twin Cities; University of Glasgow; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Leiden University; Leiden University - Excl LUMC; University of Zurich	Camara-Leret, R (corresponding author), Royal Bot Gardens, London, England.	rodrigo.camaraleret@ieu.uzh.ch	Hassemer, Gustavo/C-2075-2015; Jimbo, Tiberius/AAA-2555-2021; Low, Yee Wen/GSE-4201-2022; Simmons, Mark Pitkin/F-7157-2013; Webber, Bruce/C-1057-2009; Raes, Niels/A-9645-2011; Kessler, Michael/A-3605-2009; Wei, ran/GXF-3452-2022; Low, Yee Wen/AGH-2791-2022; wei, wei/HHR-8613-2022; Parris, Barbara/AAV-7683-2021; Baker, William/B-1244-2011	Hassemer, Gustavo/0000-0003-4365-6934; Low, Yee Wen/0000-0002-0939-9068; Simmons, Mark Pitkin/0000-0003-3896-4633; Webber, Bruce/0000-0001-5934-6557; Raes, Niels/0000-0002-4329-4892; Kessler, Michael/0000-0003-4612-9937; Parris, Barbara/0000-0002-0478-627X; Mancera, Jeffrey/0000-0001-7431-8968; Cahen, Daniel/0000-0003-4549-7092; Sundue, Michael/0000-0003-1568-150X; Jennings, Laura/0000-0001-6777-2281; Buerki, Sven/0000-0002-8299-6539; Jimbo, Tiberius/0000-0003-0651-5307; Perrie, Leon/0000-0002-2118-3534; Hughes, Mark/0000-0002-2168-0514; Camara-Leret, Rodrigo/0000-0001-7705-0602; Lucas, Eve/0000-0002-7603-435X; Newman, Mark/0000-0003-4851-015X; Moore, Alison/0000-0002-8286-0359; Baker, William/0000-0001-6727-1831; Petoe, Peter/0000-0003-2985-9348	Royal Society International Exchanges [IE 170241]; Carlsberg Foundation; Danish Research Council; National Natural Science Foundation of China [31570307]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [153430/2018-4]; US National Science Foundation [DEB-1457366, DEB-1754667, DEB-0515678, DEB-0816749, DEB-0841885]; National Parks Board, Singapore; Deutsche Forschungsgemeinschaft [LE 1826/3-1]; Synthesys [GB-TAF-6305]; Sao Paulo Research Foundation - FAPESP [2015/13112-7, 2018/09379-6]; Edinburgh Botanic Garden (Sibbald) Trust; M. L. MacIntyre Begonia Trust; Scottish Government's Rural and Environmental Science and Analytical Services Division	Royal Society International Exchanges; Carlsberg Foundation(Carlsberg Foundation); Danish Research Council(Det Frie Forskningsrad (DFF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US National Science Foundation(National Science Foundation (NSF)); National Parks Board, Singapore; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Synthesys; Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Edinburgh Botanic Garden (Sibbald) Trust; M. L. MacIntyre Begonia Trust; Scottish Government's Rural and Environmental Science and Analytical Services Division	We thank the collectors, herbarium and database curators and colleagues at our institutions for support and discussions; J. Bascompte for feedback on a previous draft; and I. Camara Leret for the design of Fig. 3. R.C.-L. and P.C.v.W. received funding from the Royal Society International Exchanges (grant IE 170241, 'Building the New Guinea Research Team'); A.S.B. acknowledges financial support from the Carlsberg Foundation and the Danish Research Council; L.-F.F. acknowledges the National Natural Science Foundation of China (grant 31570307); G.H. acknowledges the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a post-doctoral fellowship (process 153430/2018-4); S.K. was supported by the US National Science Foundation (grant DEB-1457366); Y.W.L is funded by the National Parks Board, Singapore under a postgraduate research scholarship; M.L. received funding from the Deutsche Forschungsgemeinschaft (LE 1826/3-1) and Synthesys (GB-TAF-6305); P.H.A.M. acknowledges the Sao Paulo Research Foundation - FAPESP grant 2015/13112-7 and 2018/09379-6); D.S.P. received funding from the US National Science Foundation (grant DEB-1754667); the contributions of G.D.W. to the project were supported by the US National Science Foundation (grants DEB-0515678, DEB-0816749 and DEB-0841885); and M.H. and H.P.W. received funding from the Edinburgh Botanic Garden (Sibbald) Trust and the M. L. MacIntyre Begonia Trust. The Royal Botanic Garden Edinburgh is supported by the Scottish Government's Rural and Environmental Science and Analytical Services Division.	Backer C. A., 1968, FLORA JAVA, V1-3; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Camara-Leret R, 2019, NAT SUSTAIN, V2, P736, DOI 10.1038/s41893-019-0324-0; Camara-Leret R, 2019, FOR SOC, V3, P148, DOI 10.24259/fs.v3i1.6067; Cardoso D, 2017, P NATL ACAD SCI USA, V114, P10695, DOI 10.1073/pnas.1706756114; Christenhusz MJM, 2011, PHYTOTAXA, V19, P55, DOI 10.11646/phytotaxa.19.1.3; Conn B. J., 2019, TREES PAPUA NEW GUIN, V1-3; CONN BJ, 1994, INST BOT AC, P123; Coode M. J. E., 1997, CHECKLIST FLOWERING; Frodin D., 2007, ECOLOGY PAPUA 1, P87; Good R, 1960, B BR MUS NAT HIST, V2, P205; Goodwin ZA, 2015, CURR BIOL, V25, pR1066, DOI 10.1016/j.cub.2015.10.002; Goss A., 2011, FLORACRATS STATE SPO; Hijmans RJ, 2015, RASTER GEOGRAPHIC DA; Hoover JD, 2017, TROP ECOL, V58, P623; Lamanna C, 2014, P NATL ACAD SCI USA, V111, P13745, DOI 10.1073/pnas.1317722111; Loh J, 2005, ECOL INDIC, V5, P231, DOI 10.1016/j.ecolind.2005.02.005; MacArthur R, 1967, THEORY ISLAND BIOGEO; Madagascar Catalogue, CATALOGUE PLANTS MAD; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Newman M., 2017, TROPICAL PLANT COLLE, P177; Nickrent DL, COS DIGITAL FLORA PH; Paijmans K, 1976, NEW GUINEA VEGETATIO; QGIS Development Team, 2020, QGIS FREE OP SOURC G; R Development Core Team, 2009, R LANG ENV STAT COMP; Roos MC, 2004, J BIOGEOGR, V31, P1893, DOI 10.1111/j.1365-2699.2004.01154.x; Schuettpelz E, 2016, J SYST EVOL, V54, P563, DOI 10.1111/jse.12229; Souter Gavin, 1963, NEW GUINEA LAST UNKN; Steinbauer MJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P1097, DOI 10.1111/geb.12469; Supriatna J., 1999, IRIAN JAYA BIODIVERS; ter Steege H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29549; ter Steege H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40101-y; Ulloa CU, 2017, SCIENCE, V358, P1614, DOI 10.1126/science.aao0398; Van Steenis C. G. G. J., 1950, FLORA MALESIANA, V1, pXX, DOI DOI 10.1111/J.1365-2699.2011.02519.X; Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401; Webb CO, 2010, BIODIVERS CONSERV, V19, P955, DOI 10.1007/s10531-010-9817-x; Welzen P. C. van, 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P199	40	63	66	5	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					579	+		10.1038/s41586-020-2549-5	http://dx.doi.org/10.1038/s41586-020-2549-5		AUG 2020	13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF2RN	32760001				2022-12-28	WOS:000556239400007
J	Voelker, R				Voelker, Rebecca			Immunotherapy Is Now First-line Therapy for Some Colorectal Cancers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					433	433		10.1001/jama.2020.13299	http://dx.doi.org/10.1001/jama.2020.13299			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749477				2022-12-28	WOS:000561261900004
J	Colmer, J; Hardman, I; Shimshack, J; Voorheis, J				Colmer, Jonathan; Hardman, Ian; Shimshack, Jay; Voorheis, John			Disparities in PM2.5 air pollution in the United States	SCIENCE			English	Article							ENVIRONMENTAL JUSTICE; PARTICULATE MATTER; HEALTH; CONSEQUENCES; MORTALITY; BENEFITS; TRENDS; IMPACT	Air pollution at any given time is unequally distributed across locations. Average concentrations of fine particulate matter smaller than 2.5 micrometers in diameter (PM2.5) have fallen over time. However, we do not know how the spatial distribution of PM2.5 has evolved. Here, we provide early evidence. We combine 36 years of PM2.5 concentrations measured over similar to 8.6 million grid cells with geographic, economic, and demographic data from similar to 65,000 U.S. census tracts. We show that differences in PM2.5 between more and less polluted areas declined substantially between 1981 and 2016. However, the most polluted census tracts in 1981 remained the most polluted in 2016. The least polluted census tracts in 1981 remained the least polluted in 2016. The most exposed subpopulations in 1981 remained the most exposed in 2016. Overall, absolute disparities have fallen, but relative disparities persist.	[Colmer, Jonathan] Univ Virginia, Dept Econ, Charlottesville, VA 22908 USA; [Hardman, Ian] Stanford Univ, Program Energy & Sustainable Dev, Stanford, CA 94305 USA; [Shimshack, Jay] Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA USA; [Voorheis, John] US Bur Census, Washington, DC 20233 USA	University of Virginia; Stanford University; University of Virginia	Colmer, J (corresponding author), Univ Virginia, Dept Econ, Charlottesville, VA 22908 USA.	jonathan.colmer@virginia.edu		HARDMAN, IAN/0000-0002-1785-3240	ESRC [ES/M010341/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Agyeman J, 2016, ANNU REV ENV RESOUR, V41, P321, DOI 10.1146/annurev-environ-110615-090052; [Anonymous], 1999, THINKING INEQUALITY; [Anonymous], 1987, TOX WAST RAC US NAT; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; Auffhammer M, 2009, J ENVIRON ECON MANAG, V58, P15, DOI 10.1016/j.jeem.2008.12.004; Autor DH, 2013, AM ECON REV, V103, P2121, DOI 10.1257/aer.103.6.2121; Banzhaf S, 2008, AM ECON REV, V98, P843, DOI 10.1257/aer.98.3.843; Banzhaf S, 2019, J ECON PERSPECT, V33, P185, DOI 10.1257/jep.33.1.185; Bartik AW, 2019, AM ECON J-APPL ECON, V11, P105, DOI 10.1257/app.20170487; BEEN V, 1994, YALE LAW J, V103, P1383, DOI 10.2307/797089; Been V, 1997, ECOL LAW QUART, V24, P1; Bento A, 2015, REV ECON STAT, V97, P610, DOI 10.1162/REST_a_00493; Bolin Bob, 2005, RES HUMAN ECOLOGY, V12, P156; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115; Carlson C, 2000, J POLIT ECON, V108, P1292, DOI 10.1086/317681; Chay KY, 2005, J POLIT ECON, V113, P376, DOI 10.1086/427462; Chay KY, 2003, Q J ECON, V118, P1121, DOI 10.1162/00335530360698513; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Collins TW, 2009, APPL GEOGR, V29, P448, DOI 10.1016/j.apgeog.2008.10.005; Colmer J., 2020, REPLICATION DATA PM2, DOI [10.18130/V3/QLBNQJ., DOI 10.18130/V3/QLBNQJ]; Colmer J., 2020, REPLICATION DATA PM2, DOI [10.18130/V3/OLBNOJ., DOI 10.18130/V3/OLBNOJ]; Currie J, 2005, Q J ECON, V120, P1003, DOI 10.1093/qje/120.3.1003; Daniels Norman, 2013, INEQUALITIES HLTH CO, P178; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Fowlie M, 2019, AEA PAP P, V109, P283, DOI 10.1257/pandp.20191064; Fowlie M, 2012, AM ECON J-ECON POLIC, V4, P98, DOI 10.1257/pol.4.1.98; Fullerton D, 2006, EC POLLUTION HAVENS; Gamper-Rabindran S, 2011, AM ECON REV, V101, P620, DOI 10.1257/aer.101.3.620; Grainger C., 2018, DO REGULATORS UNPUB; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Hsiang S, 2019, REV ENV ECON POLICY, V13, P83, DOI 10.1093/reep/rey024; Isen A, 2017, J POLIT ECON, V125, P848, DOI 10.1086/691465; Jackson RB, 2014, ANNU REV ENV RESOUR, V39, P327, DOI 10.1146/annurev-environ-031113-144051; Logan JR, 2014, PROF GEOGR, V66, P412, DOI 10.1080/00330124.2014.905156; Mani M., 1998, J ENVIRON DEV, V7, P215, DOI [10.1177/107049659800700302, DOI 10.1177/107049659800700302]; Meng J, 2019, ENVIRON SCI TECHNOL, V53, P5071, DOI 10.1021/acs.est.8b06875; Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI 10.1146/annurev.environ.082508-094348; OATES WE, 1989, AM ECON REV, V79, P1233; Parrish DD, 2011, ATMOS ENVIRON, V45, P7015, DOI 10.1016/j.atmosenv.2011.09.039; Pierce JR, 2016, AM ECON REV, V106, P1632, DOI 10.1257/aer.20131578; Piketty T, 2018, Q J ECON, V133, P553, DOI 10.1093/qje/qjx043; Pinto JP, 2004, J AIR WASTE MANAGE, V54, P440, DOI 10.1080/10473289.2004.10470919; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Portney P., 1990, PUBLIC POLICIES ENV; Shapiro JS, 2018, AM ECON REV, V108, P3814, DOI 10.1257/aer.20151272; Sullivan D, 2018, 2018 RESILIENCE WEEK (RWS), P11; Temkin LS, 2003, ECON PHILOS, V19, P61, DOI 10.1017/S0266267103001020; U.S. Environmental Protection Agency (EPA), 2019, OUR NAT AIR STAT TRE; U.S. Government Accountability Office (GAO), 1983, RCED83168 GAO; Voorheis J., 2017, CARRAWP201704 US CEN; Zivin JG, 2012, AM ECON REV, V102, P3652, DOI 10.1257/aer.102.7.3652; Zou E., 2020, UNWATCHED POLL UNPUB	56	78	79	25	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					575	+		10.1126/science.aaz9353	http://dx.doi.org/10.1126/science.aaz9353			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732425				2022-12-28	WOS:000556568100048
J	Mahase, E				Mahase, Elisabeth			Covid-19: Tighter restrictions imposed in the north of England as cases spike	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2020	370								m3066	10.1136/bmj.m3066	http://dx.doi.org/10.1136/bmj.m3066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RD	32737025	Bronze			2022-12-28	WOS:000556139500012
J	Davies, J				Davies, Jane			Perspective: Care in the age of COVID-19	NATURE			English	Editorial Material						Health care; Diseases; Therapeutics; Information technology		Lockdowns have accelerated the drive towards telemedicine for people with cystic fibrosis - but the system needs critical appraisal. Lockdowns have accelerated the drive towards telemedicine for people with cystic fibrosis - but the system needs critical appraisal.				j.c.davies@imperial.ac.uk							0	8	8	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					S15	S15		10.1038/d41586-020-02112-y	http://dx.doi.org/10.1038/d41586-020-02112-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MT2XH	32728255	Bronze			2022-12-28	WOS:000554831500008
J	Wan, Z; Lewis, GF; Li, TS; Simpson, JD; Martell, SL; Zucker, DB; Mould, JR; Erkal, D; Pace, AB; Mackey, D; Ji, ADP; Koposov, SE; Kuehn, K; Shipp, N; Balbinot, E; Bland-Hawthorn, J; Casey, AR; Da Costa, GS; Kafle, P; Sharma, S; De Silva, GM				Wan, Zhen; Lewis, Geraint F.; Li, Ting S.; Simpson, Jeffrey D.; Martell, Sarah L.; Zucker, Daniel B.; Mould, Jeremy R.; Erkal, Denis; Pace, Andrew B.; Mackey, Dougal; Ji, Alexander P.; Koposov, Sergey E.; Kuehn, Kyler; Shipp, Nora; Balbinot, Eduardo; Bland-Hawthorn, Joss; Casey, Andrew R.; Da Costa, Gary S.; Kafle, Prajwal; Sharma, Sanjib; De Silva, Gayandhi M.			The tidal remnant of an unusually metal-poor globular cluster	NATURE			English	Article							MILKY-WAY; METALLICITY INDICATOR; GALAXY; MASS; EFFICIENT; TRIPLET; STREAMS; GAPS; II.	Globular clusters are some of the oldest bound stellar structures observed in the Universe(1). They are ubiquitous in large galaxies and are believed to trace intense star-formation events and the hierarchical build-up of structure(2,3). Observations of globular clusters in the Milky Way, and a wide variety of other galaxies, have found evidence for a'metallicity floor', whereby no globular clusters are found with chemical (metal) abundances below approximately 0.3 to 0.4 per cent of that of the Sun(4-6). The existence of this metallicity floor may reflect a minimum mass and a maximum redshift for surviving globular clusters to form-both critical components for understanding the build-up of mass in the Universe(7). Here we report measurements from the Southern Stellar Streams Spectroscopic Survey of the spatially thin, dynamically cold Phoenix stellar stream in the halo of the Milky Way. The properties of the Phoenix stream are consistent with it being the tidally disrupted remains of a globular cluster. However, its metal abundance ([Fe/H] = -2.7) is substantially below the empirical metallicity floor. The Phoenix stream thus represents the debris of the most metal-poor globular clusters discovered so far, and its progenitor is distinct from the present-day globular cluster population in the local Universe. Its existence implies that globular clusters below the metallicity floor have probably existed, but were destroyed during Galactic evolution. The Phoenix stream in the Milky Way halo is shown to be a tidally disrupted remnant of an unusually metal-poor globular cluster, which was possibly destroyed during Galactic evolution.	[Wan, Zhen; Lewis, Geraint F.; Bland-Hawthorn, Joss; Sharma, Sanjib] Univ Sydney, Sydney Inst Astron, Sch Phys, Sydney, NSW, Australia; [Li, Ting S.; Ji, Alexander P.] Observ Carnegie Inst Sci, Pasadena, CA USA; [Li, Ting S.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Li, Ting S.; Shipp, Nora] Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA; [Li, Ting S.; Shipp, Nora] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Simpson, Jeffrey D.; Martell, Sarah L.] Univ New South Wales, Sch Phys, Sydney, NSW, Australia; [Martell, Sarah L.; Bland-Hawthorn, Joss; Sharma, Sanjib; De Silva, Gayandhi M.] Ctr Excellence All Sky Astrophys Three Dimens AST, Sydney, NSW, Australia; [Zucker, Daniel B.] Macquarie Univ, Dept Phys & Astron, Sydney, NSW, Australia; [Zucker, Daniel B.] Macquarie Univ, Res Ctr Astron Astrophys & Astrophoton, Sydney, NSW, Australia; [Mould, Jeremy R.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Melbourne, Vic, Australia; [Erkal, Denis] Univ Surrey, Dept Phys, Guildford, Surrey, England; [Pace, Andrew B.; Koposov, Sergey E.] Carnegie Mellon Univ, McWilliams Ctr Cosmol, Pittsburgh, PA 15213 USA; [Mackey, Dougal; Da Costa, Gary S.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT, Australia; [Koposov, Sergey E.] Univ Cambridge, Inst Astron, Cambridge, England; [Kuehn, Kyler] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA; [Kuehn, Kyler; De Silva, Gayandhi M.] Macquarie Univ, Australian Astron Opt, Fac Sci & Engn, Sydney, NSW, Australia; [Shipp, Nora] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Balbinot, Eduardo] Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands; [Casey, Andrew R.] Monash Univ, Sch Phys & Astron, Melbourne, Vic, Australia; [Kafle, Prajwal] Univ Western Australia, Int Ctr Radio Astron Res ICRAR, Perth, WA, Australia	University of Sydney; Carnegie Institution for Science; Princeton University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; University of Chicago; University of New South Wales Sydney; Macquarie University; Macquarie University; Swinburne University of Technology; University of Surrey; Carnegie Mellon University; Australian National University; University of Cambridge; Macquarie University; University of Chicago; University of Groningen; Monash University; University of Western Australia	Lewis, GF (corresponding author), Univ Sydney, Sydney Inst Astron, Sch Phys, Sydney, NSW, Australia.	geraint.lewis@sydney.edu.au	Koposov, Sergey/F-2754-2012; Balbinot, Eduardo/ABE-5040-2020; bland-hawthorn, joss/ABE-7646-2020; Erkal, Denis/ABD-9303-2020; Lewis, Geraint/F-9069-2015	Koposov, Sergey/0000-0003-2644-135X; Balbinot, Eduardo/0000-0002-1322-3153; bland-hawthorn, joss/0000-0001-7516-4016; Erkal, Denis/0000-0002-8448-5505; Mould, Jeremy/0000-0003-3820-1740; Wan, Zhen/0000-0002-3105-3821; Martell, Sarah/0000-0002-3430-4163; Lewis, Geraint/0000-0003-3081-9319; Zucker, Daniel/0000-0003-1124-8477; Mackey, Dougal/0000-0002-6529-8093; Sharma, Sanjib/0000-0002-0920-809X; Simpson, Jeffrey/0000-0002-8165-2507				Abbott TMC, 2018, ASTROPHYS J SUPPL S, V239, DOI 10.3847/1538-4365/aae9f0; Amorisco NC, 2016, MON NOT R ASTRON SOC, V463, pL17, DOI 10.1093/mnrasl/slw148; Balbinot E, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/1/58; Banik N, 2019, MON NOT R ASTRON SOC, V484, P2009, DOI 10.1093/mnras/stz142; Beasley MA, 2019, MON NOT R ASTRON SOC, V487, P1986, DOI 10.1093/mnras/stz1349; Bland-Hawthorn J, 2016, ANNU REV ASTRON ASTR, V54, P529, DOI 10.1146/annurev-astro-081915-023441; Brodie JP, 2006, ANNU REV ASTRON ASTR, V44, P193, DOI 10.1146/annurev.astro.44.051905.092441; BROWN AGA, 2018, ASTRON ASTROPHYS, V616, DOI DOI 10.1051/0004-6361/201833051; Carlberg RG, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/2/135; Carrera R, 2013, MON NOT R ASTRON SOC, V434, P1681, DOI 10.1093/mnras/stt1126; Dehnen W, 1998, MON NOT R ASTRON SOC, V294, P429, DOI 10.1046/j.1365-8711.1998.01282.x; Erkal D, 2019, MON NOT R ASTRON SOC, V487, P2685, DOI 10.1093/mnras/stz1371; Erkal D, 2017, MON NOT R ASTRON SOC, V470, P60, DOI 10.1093/mnras/stx1208; Erkal D, 2016, MON NOT R ASTRON SOC, V461, P1590, DOI 10.1093/mnras/stw1400; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gibbons SLJ, 2014, MON NOT R ASTRON SOC, V445, P3788, DOI 10.1093/mnras/stu1986; Grillmair CJ, 2016, ASTROPHYS J LETT, V820, DOI 10.3847/2041-8205/820/2/L27; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; HARRIS WE, 1991, ANNU REV ASTRON ASTR, V29, P543, DOI 10.1146/annurev.aa.29.090191.002551; Helmi A, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201832698; Husser TO, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201219058; Iorio G, 2019, MON NOT R ASTRON SOC, V482, P3868, DOI 10.1093/mnras/sty2806; Koposov SE, 2019, MON NOT R ASTRON SOC, V485, P4726, DOI 10.1093/mnras/stz457; Koposov SE, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/146; Kruijssen JMD, 2019, MON NOT R ASTRON SOC, V486, pL20, DOI 10.1093/mnrasl/slz052; Kruijssen JMD, 2015, MON NOT R ASTRON SOC, V454, P1658, DOI 10.1093/mnras/stv2026; Larsen SS, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219895; Li TS, 2019, MON NOT R ASTRON SOC, V490, P3508, DOI 10.1093/mnras/stz2731; Li TS, 2018, ASTROPHYS J, V866, DOI 10.3847/1538-4357/aadf91; Mackey D, 2019, NATURE, V574, P69, DOI 10.1038/s41586-019-1597-1; Marigo P, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/1/77; McMillan PJ, 2017, MON NOT R ASTRON SOC, V465, P76, DOI 10.1093/mnras/stw2759; Pearson S, 2017, NAT ASTRON, V1, P633, DOI 10.1038/s41550-017-0220-3; Price-Whelan AM, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab4cef; Prusti T, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629272; Roederer IU, 2019, ASTROPHYS J, V883, DOI 10.3847/1538-4357/ab365c; Schonrich R, 2010, MON NOT R ASTRON SOC, V403, P1829, DOI 10.1111/j.1365-2966.2010.16253.x; Shipp N, 2019, ASTROPHYS J, V885, DOI 10.3847/1538-4357/ab44bf; Shipp N, 2018, ASTROPHYS J, V862, DOI 10.3847/1538-4357/aacdab; Simon JD, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aacdfb; Simpson JD, 2019, MON NOT R ASTRON SOC, V490, P741, DOI 10.1093/mnras/stz2611; Simpson JD, 2018, MON NOT R ASTRON SOC, V477, P4565, DOI 10.1093/mnras/sty847; Simpson Jeffrey D, 2020, EMPIRICAL RELATIONSH, DOI [10.5281/zenodo.3785756, DOI 10.5281/ZEN0D0.3785756]; Usher C, 2019, MON NOT R ASTRON SOC, V482, P1275, DOI 10.1093/mnras/sty2611; Vasiliev E, 2019, MON NOT R ASTRON SOC, V484, P2832, DOI 10.1093/mnras/stz171; Vasiliev E, 2019, MON NOT R ASTRON SOC, V482, P1525, DOI 10.1093/mnras/sty2672; Willman B, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/3/76	54	24	24	2	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					768	+		10.1038/s41586-020-2483-6	http://dx.doi.org/10.1038/s41586-020-2483-6			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728241	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000554831500028
J	Braun, J; Loyal, L; Frentsch, M; Wendisch, D; Georg, P; Kurth, F; Hippenstiel, S; Dingeldey, M; Kruse, B; Fauchere, F; Baysal, E; Mangold, M; Henze, L; Lauster, R; Mall, MA; Beyer, K; Rohmel, J; Voigt, S; Schmitz, J; Miltenyi, S; Demuth, I; Muller, MA; Hocke, A; Witzenrath, M; Suttorp, N; Kern, F; Reimer, U; Wenschuh, H; Drosten, C; Corman, VM; Giesecke-Thiel, C; Sander, LE; Thiel, A				Braun, Julian; Loyal, Lucie; Frentsch, Marco; Wendisch, Daniel; Georg, Philipp; Kurth, Florian; Hippenstiel, Stefan; Dingeldey, Manuela; Kruse, Beate; Fauchere, Florent; Baysal, Emre; Mangold, Maike; Henze, Larissa; Lauster, Roland; Mall, Marcus A.; Beyer, Kirsten; Roehmel, Jobst; Voigt, Sebastian; Schmitz, Juergen; Miltenyi, Stefan; Demuth, Ilja; Mueller, Marcel A.; Hocke, Andreas; Witzenrath, Martin; Suttorp, Norbert; Kern, Florian; Reimer, Ulf; Wenschuh, Holger; Drosten, Christian; Corman, Victor M.; Giesecke-Thiel, Claudia; Sander, Leif Erik; Thiel, Andreas			SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19	NATURE			English	Article							SARS CORONAVIRUS; IMMUNE-RESPONSE; PROTECTIVE IMMUNITY; EFFECTOR; NEUTRALIZATION; EPIDEMIOLOGY; INFECTION	A study of patients with COVID-19 and healthy donors found CD4(+)T cells that react to the spike protein of SARS-CoV-2 and human endemic coronaviruses; however, the effect of pre-existing SARS-CoV-2 cross-reactive T cells on clinical outcomes remains to be determined. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the rapidly unfolding coronavirus disease 2019 (COVID-19) pandemic(1,2). Clinical manifestations of COVID-19 vary, ranging from asymptomatic infection to respiratory failure. The mechanisms that determine such variable outcomes remain unresolved. Here we investigated CD4(+)T cells that are reactive against the spike glycoprotein of SARS-CoV-2 in the peripheral blood of patients with COVID-19 and SARS-CoV-2-unexposed healthy donors. We detected spike-reactive CD4(+)T cells not only in 83% of patients with COVID-19 but also in 35% of healthy donors. Spike-reactive CD4(+)T cells in healthy donors were primarily active against C-terminal epitopes in the spike protein, which show a higher homology to spike glycoproteins of human endemic coronaviruses, compared with N-terminal epitopes. Spike-protein-reactive T cell lines generated from SARS-CoV-2-naive healthy donors responded similarly to the C-terminal region of the spike proteins of the human endemic coronaviruses 229E and OC43, as well as that of SARS-CoV-2. This results indicate that spike-protein cross-reactive T cells are present, which were probably generated during previous encounters with endemic coronaviruses. The effect of pre-existing SARS-CoV-2 cross-reactive T cells on clinical outcomes remains to be determined in larger cohorts. However, the presence of spike-protein cross-reactive T cells in a considerable fraction of the general population may affect the dynamics of the current pandemic, and has important implications for the design and analysis of upcoming trials investigating COVID-19 vaccines.	[Braun, Julian; Loyal, Lucie; Dingeldey, Manuela; Kruse, Beate; Fauchere, Florent; Baysal, Emre; Mangold, Maike; Henze, Larissa; Lauster, Roland; Thiel, Andreas] Tech Univ Berlin, SiM Der Simulierte Mensch, Berlin, Germany; [Braun, Julian; Loyal, Lucie; Dingeldey, Manuela; Kruse, Beate; Fauchere, Florent; Baysal, Emre; Mangold, Maike; Henze, Larissa; Lauster, Roland; Thiel, Andreas] Charite Univ Med Berlin, Berlin, Germany; [Braun, Julian; Loyal, Lucie; Dingeldey, Manuela; Kruse, Beate; Fauchere, Florent; Baysal, Emre; Mangold, Maike; Henze, Larissa; Thiel, Andreas] Charite Univ Med Berlin, BIH Ctr Regenerat Therapies, Regenerat Immunol & Aging, Berlin, Germany; [Frentsch, Marco] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Frentsch, Marco; Mall, Marcus A.] Berlin Inst Hlth BIH, Berlin, Germany; [Wendisch, Daniel; Georg, Philipp; Kurth, Florian; Hippenstiel, Stefan; Hocke, Andreas; Witzenrath, Martin; Suttorp, Norbert; Sander, Leif Erik] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Kurth, Florian] Univ Med Ctr Hamburg Eppendorf, Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany; [Kurth, Florian] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Lauster, Roland] Tech Univ Berlin, Inst Biotechnol, Med Biotechnol, Berlin, Germany; [Mall, Marcus A.; Beyer, Kirsten; Roehmel, Jobst] Charite Univ Med Berlin, Dept Pediat Pulmonol Immunol & Crit Care Med, Berlin, Germany; [Voigt, Sebastian] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Schmitz, Juergen; Miltenyi, Stefan] Miltenyi Biotec, Bergisch Gladbach, Germany; [Demuth, Ilja] Charite Univ Med Berlin, Interdisciplinary Metab Ctr, Biol Aging BoA Grp, Berlin, Germany; [Mueller, Marcel A.; Drosten, Christian; Corman, Victor M.] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Kern, Florian] Brighton & Sussex Med Sch, Dept Clin & Expt Med, Brighton, E Sussex, England; [Kern, Florian; Reimer, Ulf; Wenschuh, Holger] JPT Peptide Technol, Berlin, Germany; [Giesecke-Thiel, Claudia] Max Planck Inst Mol Genet, Berlin, Germany	Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Miltenyi Biotec; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Brighton; University of Sussex; Max Planck Society	Thiel, A (corresponding author), Tech Univ Berlin, SiM Der Simulierte Mensch, Berlin, Germany.; Thiel, A (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Thiel, A (corresponding author), Charite Univ Med Berlin, BIH Ctr Regenerat Therapies, Regenerat Immunol & Aging, Berlin, Germany.; Sander, LE (corresponding author), Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany.; Giesecke-Thiel, C (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	giesecke@molgen.mpg.de; leif-erik.sander@charite.de; andreas.thiel@charite.de	Thiel, Andreas/AAC-3079-2021; Corman, Victor M/K-1319-2019; Mall, Marcus A./AAA-1498-2022; Demuth, Ilja/ABD-5352-2021; Müller, Marcel A./O-2425-2019; Kern, Florian/AAE-6784-2022; Loyal, Lucie/HCH-3710-2022	Thiel, Andreas/0000-0002-5515-4002; Corman, Victor M/0000-0002-3605-0136; Mall, Marcus A./0000-0002-4057-2199; Demuth, Ilja/0000-0002-4340-2523; Müller, Marcel A./0000-0003-2242-5117; Kern, Florian/0000-0002-0368-8408; Giesecke-Thiel, Claudia/0000-0002-5927-7018; Reimer, Ulf/0000-0002-3375-6889; Fauchere, Florent/0000-0002-1955-6362; Loyal, Lucie/0000-0001-5738-4437; Hippenstiel, Stefan/0000-0002-5146-1064; Henze, Larissa/0000-0002-6540-4263; Roehmel, Jobst/0000-0002-1535-8852; Kurth, Florian/0000-0002-3807-473X; Braun, Julian/0000-0002-7788-8154	German Research Foundation [KFO339, SFB-TR84]; German Federal Ministry of Education and Research (BMBF-RAPID); Federal Ministery of Health through a resolution of the German Bundestag; German Federal Ministry of Education and Research (BMBF-CAPSyS)	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF-RAPID); Federal Ministery of Health through a resolution of the German Bundestag; German Federal Ministry of Education and Research (BMBF-CAPSyS)	We thank U. Klein and H.-P. Herzel for discussion; T. Kaiser and J. Kirsch from the Flow Cytometry Core Facility (FCCF) of the DRFZ for technical help; and B. Timmerman from the Sequencing Core Facility of the Max Planck Institute for Molecular Genetics for discussion. This work was supported by the German Research Foundation (KFO339 to J.B. and F.F., SFB-TR84 projects A4 and B6 to S.H., B8 to M.M., C6 to M.W., C8 and C10 to L.E.S., and C9 to M.W. and N.S.) and by the German Federal Ministry of Education and Research (BMBF-RAPID to S.H. and C.D., and CAPSyS to M.W. and N.S.). This work was additionally funded by the Federal Ministery of Health through a resolution of the German Bundestag to A.T., J.B., L.H. and M.D.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306; Kurth F, 2020, INFECTION, V48, P619, DOI 10.1007/s15010-020-01464-x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Libraty DH, 2007, VIROLOGY, V368, P317, DOI 10.1016/j.virol.2007.07.015; LIDWELL OM, 1961, J HYG-CAMBRIDGE, V59, P309, DOI 10.1017/S0022172400038973; Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095; Meng T., 2020, INSERT SEQUENCE SARS, DOI 10.1101/2020.02.08.926006; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Schoenbrunn A, 2012, J IMMUNOL, V189, P5985, DOI 10.4049/jimmunol.1201090; Schulz AR, 2015, J IMMUNOL, V195, P4699, DOI 10.4049/jimmunol.1500598; Tyrrell D. A. J, 1965, J COMMON COLDS RELAT; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang BM, 2004, BLOOD, V104, P200, DOI 10.1182/blood-2003-11-4072; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yang JB, 2009, INT IMMUNOL, V21, P63, DOI 10.1093/intimm/dxn124; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104	38	679	689	6	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 12	2020	587	7833					270	+		10.1038/s41586-020-2598-9	http://dx.doi.org/10.1038/s41586-020-2598-9		JUL 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OQ5NQ	32726801	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000576135900002
J	Shin, D; Mukherjee, R; Grewe, D; Bojkova, D; Baek, K; Bhattacharya, A; Schulz, L; Widera, M; Mehdipour, AR; Tascher, G; Geurink, PP; Wilhelm, A; van Noort, GJV; Ovaa, H; Muller, S; Knobeloch, KP; Rajalingam, K; Schulman, BA; Cinatl, J; Hummer, G; Ciesek, S; Dikic, I				Shin, Donghyuk; Mukherjee, Rukmini; Grewe, Diana; Bojkova, Denisa; Baek, Kheewoong; Bhattacharya, Anshu; Schulz, Laura; Widera, Marek; Mehdipour, Ahmad Reza; Tascher, Georg; Geurink, Paul P.; Wilhelm, Alexander; van der Heden van Noort, Gerbrand J.; Ovaa, Huib; Mueller, Stefan; Knobeloch, Klaus-Peter; Rajalingam, Krishnaraj; Schulman, Brenda A.; Cinatl, Jindrich; Hummer, Gerhard; Ciesek, Sandra; Dikic, Ivan			Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity	NATURE			English	Article							CELL CARCINOMA ANTIGEN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; FORCE-FIELDS; UBIQUITIN; VIRUS; INHIBITORS; REVEAL; DOMAIN; IDENTIFICATION	Biochemical, structural and functional studies on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) papain-like protease PLpro reveal that it regulates host antiviral responses by preferentially cleaving the ubiquitin-like interferon-stimulated gene 15 protein (ISG15) and identify this protease as a potential therapeutic target for coronavirus disease 2019 (COVID-19). The papain-like protease PLpro is an essential coronavirus enzyme that is required for processing viral polyproteins to generate a functional replicase complex and enable viral spread(1,2). PLpro is also implicated in cleaving proteinaceous post-translational modifications on host proteins as an evasion mechanism against host antiviral immune responses(3-5). Here we perform biochemical, structural and functional characterization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PLpro (SCoV2-PLpro) and outline differences with SARS-CoV PLpro (SCoV-PLpro) in regulation of host interferon and NF-kappa B pathways. SCoV2-PLpro and SCoV-PLpro share 83% sequence identity but exhibit different host substrate preferences; SCoV2-PLpro preferentially cleaves the ubiquitin-like interferon-stimulated gene 15 protein (ISG15), whereas SCoV-PLpro predominantly targets ubiquitin chains. The crystal structure of SCoV2-PLpro in complex with ISG15 reveals distinctive interactions with the amino-terminal ubiquitin-like domain of ISG15, highlighting the high affinity and specificity of these interactions. Furthermore, upon infection, SCoV2-PLpro contributes to the cleavage of ISG15 from interferon responsive factor 3 (IRF3) and attenuates type I interferon responses. Notably, inhibition of SCoV2-PLpro with GRL-0617 impairs the virus-induced cytopathogenic effect, maintains the antiviral interferon pathway and reduces viral replication in infected cells. These results highlight a potential dual therapeutic strategy in which targeting of SCoV2-PLpro can suppress SARS-CoV-2 infection and promote antiviral immunity.	[Shin, Donghyuk; Mukherjee, Rukmini; Bhattacharya, Anshu; Tascher, Georg; Mueller, Stefan; Dikic, Ivan] Goethe Univ, Inst Biochem 2, Fac Med, Frankfurt, Germany; [Shin, Donghyuk; Mukherjee, Rukmini; Grewe, Diana; Bhattacharya, Anshu; Dikic, Ivan] Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Shin, Donghyuk; Dikic, Ivan] Max Planck Inst Biophys, Frankfurt, Germany; [Bojkova, Denisa; Widera, Marek; Wilhelm, Alexander; Cinatl, Jindrich; Ciesek, Sandra] Univ Hosp Frankfurt, Inst Med Virol, Frankfurt, Germany; [Baek, Kheewoong; Schulman, Brenda A.] Max Planck Inst Biochem, Dept Mol Machines & Signaling, Martinsried, Germany; [Schulz, Laura; Mehdipour, Ahmad Reza; Hummer, Gerhard] Max Planck Inst Biophys, Dept Theoret Biophys, Frankfurt, Germany; [Geurink, Paul P.; van der Heden van Noort, Gerbrand J.; Ovaa, Huib] Leiden Univ, Med Ctr, Oncode Inst, Leiden, Netherlands; [Geurink, Paul P.; van der Heden van Noort, Gerbrand J.; Ovaa, Huib] Leiden Univ, Med Ctr, Dept Chem, Immunol, Leiden, Netherlands; [Wilhelm, Alexander; Ciesek, Sandra] Goethe Univ, Inst Pharmaceut Biol, Frankfurt, Germany; [Knobeloch, Klaus-Peter] Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany; [Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Cell Biol Unit, Mainz, Germany; [Hummer, Gerhard] Goethe Univ Frankfurt, Inst Biophys, Frankfurt, Germany; [Ciesek, Sandra] Fraunhofer Inst Mol Biol & Appl Ecol IME, Branch Translat Med & Pharmacol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Goethe University Frankfurt; University of Freiburg; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Fraunhofer Gesellschaft	Dikic, I (corresponding author), Goethe Univ, Inst Biochem 2, Fac Med, Frankfurt, Germany.; Dikic, I (corresponding author), Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany.; Dikic, I (corresponding author), Max Planck Inst Biophys, Frankfurt, Germany.	dikic@biochem2.uni-frankfurt.de	van Noort, Gerbrand J van der Heden/J-4636-2017; Hummer, Gerhard/A-2546-2013; van Noort, Gerbrand van der Heden/AAZ-9848-2020; Widera, Marek/AAF-3691-2020; Mukherjee, Rukmini/GPX-7606-2022; Mehdipour, Ahmad Reza/AAY-5243-2021	van Noort, Gerbrand J van der Heden/0000-0001-5955-6431; Hummer, Gerhard/0000-0001-7768-746X; van Noort, Gerbrand van der Heden/0000-0001-5955-6431; Widera, Marek/0000-0001-5417-9307; Mukherjee, Rukmini/0000-0001-7955-6324; Muller, Stefan/0000-0002-8792-7700; Shin, Donghyuk/0000-0002-8272-6133; Tesmer, Laura/0000-0002-2403-7129; Wilhelm, Alexander/0000-0003-0904-3376; Tascher, Georg/0000-0002-5907-3947; Mehdipour, Ahmad Reza/0000-0002-0193-3334; Bhattacharya, Anshu/0000-0002-7383-3594	DFG [SFB 1177, LYSFOR2625]; Max Planck Society; NWO; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [789016]; Else Kroener Fresenius Stiftung; Dr. Rolf M. Schwiete Stiftung; internal IBC2 funds	DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Else Kroener Fresenius Stiftung; Dr. Rolf M. Schwiete Stiftung; internal IBC2 funds	We thank A. Gubas, C. Joazeiro, D. Hoeller and K. Koch for critical comments on the manuscript. We also thank Swiss Light Source (SLS) for providing special beam time for this project during the peak of the COVID-19 pandemic in Switzerland and W. Meitian and O. Vincent for providing on-site support during the data collection. We thank the Quantitative Proteomics Unit (IBCII, Goethe University Frankfurt) for support and expertise in sample preparation, LC-MS instrumentation and data analysis. This work was supported by the DFG-funded Collaborative Research Centre on Selective Autophagy (SFB 1177), by the Max Planck Society, by NWO (H.O. and G.J.v.d.H.v.N.) by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 789016Y) to B.A.S., LYSFOR2625 (DFG) to A.B. and (grant agreement no. 742720) to I.D., by the grants from Else Kroener Fresenius Stiftung, Dr. Rolf M. Schwiete Stiftung, and by internal IBC2 funds to I.D.	ABAD A, 1994, J CHEM SOC PERK T 1, P2987, DOI 10.1039/p19940002987; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anson B. J, 2020, PREPRINT, DOI [10.21203/rs.3.rs-26344/v1, DOI 10.21203/RS.3.RS-26344/V1]; Baek K, 2020, NATURE, V578, P461, DOI 10.1038/s41586-020-2000-y; Baez-Santos YM, 2014, J MED CHEM, V57, P2393, DOI 10.1021/jm401712t; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Basters A, 2017, NAT STRUCT MOL BIOL, V24, P270, DOI 10.1038/nsmb.3371; Basters A, 2014, FEBS J, V281, P1918, DOI 10.1111/febs.12754; Bekes M, 2016, MOL CELL, V62, P572, DOI 10.1016/j.molcel.2016.04.016; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, BIOPHYS J, V102, P1462, DOI 10.1016/j.bpj.2012.02.024; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7; Clasman JR, 2020, ANTIVIR RES, V174, DOI 10.1016/j.antiviral.2019.104661; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Daczkowski CM, 2017, J VIROL, V91, DOI 10.1128/JVI.01067-17; Daczkowski CM, 2017, J MOL BIOL, V429, P1661, DOI 10.1016/j.jmb.2017.04.011; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Flierman D, 2016, CELL CHEM BIOL, V23, P472, DOI 10.1016/j.chembiol.2016.03.009; Freitas BT, 2020, ACS INFECT DIS, V6, P2099, DOI 10.1021/acsinfecdis.0c00168; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Geurink PP, 2019, METHOD ENZYMOL, V618, P357, DOI 10.1016/bs.mie.2018.12.037; Ghosh AK, 2010, J MED CHEM, V53, P4968, DOI 10.1021/jm1004489; Ghosh AK, 2009, J MED CHEM, V52, P5228, DOI 10.1021/jm900611t; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kilianski A, 2014, ANTIVIR RES, V101, P105, DOI 10.1016/j.antiviral.2013.11.004; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Klann K, 2020, MOL CELL, V77, P913, DOI 10.1016/j.molcel.2019.11.010; Lim KP, 2000, J VIROL, V74, P1674, DOI 10.1128/JVI.74.4.1674-1685.2000; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lo H. S., 2020, SIMEPREVIR SUPPRESSE, DOI [10.1101/2020.05.26.116020, DOI 10.1101/2020.05.26.116020]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moll HP, 2011, CYTOKINE, V53, P52, DOI 10.1016/j.cyto.2010.09.006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Niemeyer D, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007296; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Onafuye H, 2019, BEILSTEIN J NANOTECH, V10, P1707, DOI 10.3762/bjnano.10.166; Ouellet M, 2005, J IMMUNOL, V174, P4120, DOI 10.4049/jimmunol.174.7.4120; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piana S, 2015, J PHYS CHEM B, V119, P5113, DOI 10.1021/jp508971m; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Rut Wioletta, 2020, bioRxiv, DOI 10.1101/2020.04.29.068890; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Shanker AKK, 2020, NEW J CHEM, V44, P9202, DOI 10.1039/d0nj00974a; Sheikh F, 2014, J LEUKOCYTE BIOL, V96, P591, DOI 10.1189/jlb.2A0414-191R; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Sommer S, 2013, BIOORGAN MED CHEM, V21, P2511, DOI 10.1016/j.bmc.2013.02.039; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; TAKEDA A, 1995, FEBS LETT, V359, P78, DOI 10.1016/0014-5793(94)01456-B; Toptan T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124396; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Willforss J, 2019, J PROTEOME RES, V18, P732, DOI 10.1021/acs.jproteome.8b00523; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	75	444	460	22	136	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2020	587	7835					657	+		10.1038/s41586-020-2601-5	http://dx.doi.org/10.1038/s41586-020-2601-5		JUL 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL3XR	32726803	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000576135900001
J	Trost, B; Engchuan, W; Nguyen, CM; Thiruvahindrapuram, B; Dolzhenko, E; Backstrom, I; Mirceta, M; Mojarad, BA; Yin, Y; Dov, A; Chandrakumar, I; Prasolava, T; Shum, N; Hamdan, O; Pellecchia, G; Howe, JL; Whitney, J; Klee, EW; Baheti, S; Amaral, DG; Anagnostou, E; Elsabbagh, M; Fernandez, BA; Hoang, N; Lewis, MES; Liu, XD; Sjaarda, C; Smith, IM; Szatmari, P; Zwaigenbaum, L; Glazer, D; Hartley, D; Stewart, AK; Eberle, MA; Sato, N; Pearson, CE; Scherer, SW; Yuen, RKC				Trost, Brett; Engchuan, Worrawat; Nguyen, Charlotte M.; Thiruvahindrapuram, Bhooma; Dolzhenko, Egor; Backstrom, Ian; Mirceta, Mila; Mojarad, Bahareh A.; Yin, Yue; Dov, Alona; Chandrakumar, Induja; Prasolava, Tanya; Shum, Natalie; Hamdan, Omar; Pellecchia, Giovanna; Howe, Jennifer L.; Whitney, Joseph; Klee, Eric W.; Baheti, Saurabh; Amaral, David G.; Anagnostou, Evdokia; Elsabbagh, Mayada; Fernandez, Bridget A.; Ny Hoang; Lewis, M. E. Suzanne; Liu, Xudong; Sjaarda, Calvin; Smith, Isabel M.; Szatmari, Peter; Zwaigenbaum, Lonnie; Glazer, David; Hartley, Dean; Stewart, A. Keith; Eberle, Michael A.; Sato, Nozomu; Pearson, Christopher E.; Scherer, Stephen W.; Yuen, Ryan K. C.			Genome-wide detection of tandem DNA repeats that are expanded in autism	NATURE			English	Article							TRANSMISSION RATIO DISTORTION; MENDELIAN TRANSMISSION; SPECTRUM DISORDERS; GENETIC RISK; ARCHITECTURE; VARIANTS; IDENTIFICATION; RESOURCE; INSIGHTS	Tandem DNA repeats vary in the size and sequence of each unit (motif). When expanded, these tandem DNA repeats have been associated with more than 40 monogenic disorders(1). Their involvement in disorders with complex genetics is largely unknown, as is the extent of their heterogeneity. Here we investigated the genome-wide characteristics of tandem repeats that had motifs with a length of 2-20 base pairs in 17,231 genomes of families containing individuals with autism spectrum disorder (ASD)(2,3)and population control individuals(4). We found extensive polymorphism in the size and sequence of motifs. Many of the tandem repeat loci that we detected correlated with cytogenetic fragile sites. At 2,588 loci, gene-associated expansions of tandem repeats that were rare among population control individuals were significantly more prevalent among individuals with ASD than their siblings without ASD, particularly in exons and near splice junctions, and in genes related to the development of the nervous system and cardiovascular system or muscle. Rare tandem repeat expansions had a prevalence of 23.3% in children with ASD compared with 20.7% in children without ASD, which suggests that tandem repeat expansions make a collective contribution to the risk of ASD of 2.6%. These rare tandem repeat expansions included previously undescribed ASD-linked expansions inDMPKandFXN, which are associated with neuromuscular conditions, and in previously unknown loci such asFGF14andCACNB1. Rare tandem repeat expansions were associated with lower IQ and adaptive ability. Our results show that tandem DNA repeat expansions contribute strongly to the genetic aetiology and phenotypic complexity of ASD. Genome-wide analysis of tandem DNA repeats in the genomes of individuals with autism spectrum disorder and control participants reveals a strong contribution of tandem repeat expansions to the genetic aetiology and phenotypic complexity of autism spectrum disorder.	[Trost, Brett; Engchuan, Worrawat; Nguyen, Charlotte M.; Thiruvahindrapuram, Bhooma; Backstrom, Ian; Mirceta, Mila; Mojarad, Bahareh A.; Yin, Yue; Dov, Alona; Chandrakumar, Induja; Prasolava, Tanya; Shum, Natalie; Hamdan, Omar; Pellecchia, Giovanna; Howe, Jennifer L.; Whitney, Joseph; Ny Hoang; Sato, Nozomu; Pearson, Christopher E.; Scherer, Stephen W.; Yuen, Ryan K. C.] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada; [Trost, Brett; Engchuan, Worrawat; Nguyen, Charlotte M.; Thiruvahindrapuram, Bhooma; Hamdan, Omar; Pellecchia, Giovanna; Howe, Jennifer L.; Whitney, Joseph; Scherer, Stephen W.; Yuen, Ryan K. C.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada; [Nguyen, Charlotte M.; Mirceta, Mila; Dov, Alona; Shum, Natalie; Ny Hoang; Pearson, Christopher E.; Yuen, Ryan K. C.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Dolzhenko, Egor; Eberle, Michael A.] Illumina, San Diego, CA USA; [Klee, Eric W.; Baheti, Saurabh] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Klee, Eric W.; Stewart, A. Keith] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Amaral, David G.] Univ Calif Davis, Sch Med, MIND Inst, Sacramento, CA 95817 USA; [Amaral, David G.] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA USA; [Anagnostou, Evdokia] Univ Toronto, Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Elsabbagh, Mayada] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Elsabbagh, Mayada] McGill Univ, Azrieli Ctr Autism Res, Montreal, PQ, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Lewis, M. E. Suzanne] Univ British Columbia UBC, Med Genet, Vancouver, BC, Canada; [Lewis, M. E. Suzanne] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Liu, Xudong; Sjaarda, Calvin] Queens Univ, Dept Psychiat, Kingston, ON, Canada; [Smith, Isabel M.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Smith, Isabel M.] IWK Hlth Ctr, Halifax, NS, Canada; [Szatmari, Peter] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Szatmari, Peter] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Szatmari, Peter] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Glazer, David] South San Francisco, VeriLy Life Sci, San Francisco, CA USA; [Hartley, Dean] Autism Speaks, New York, NY USA; [Stewart, A. Keith] Mayo Clin, Div Hematol, Rochester, MN USA; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Illumina; Mayo Clinic; Mayo Clinic; University of California System; University of California Davis; University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; McGill University; McGill University; Memorial University Newfoundland; University of British Columbia; Queens University - Canada; Dalhousie University; Dalhousie University; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; Mayo Clinic; University of Toronto	Yuen, RKC (corresponding author), Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada.; Yuen, RKC (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada.; Yuen, RKC (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	ryan.yuen@sickkids.ca	Scherer, Stephen W./B-3785-2013; Yuen, Ryan K. C./J-4876-2012; Trost, Brett/K-4127-2016	Scherer, Stephen W./0000-0002-8326-1999; Yuen, Ryan K. C./0000-0001-7273-4968; Smith, Isabel/0000-0001-5525-2123; Glazer, David/0000-0002-6407-8646; Elsabbagh, Mayada/0000-0002-7311-9059; Backstrom, Ian/0000-0003-2203-540X; Lewis, Suzanne/0000-0002-6300-5381; Engchuan, Worrawat/0000-0001-6138-1925; Trost, Brett/0000-0003-4863-7273	Autism Speaks; Canadian Institute for Advanced Research (CIFAR); KRG Children's Charitable Foundation; Petroff Family Fund; Kazman Family Fund; Marigold Foundation; Genome Canada; Canada Foundation for Innovation; Government of Ontario; Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC); Brain Canada; Province of Ontario Neurodevelopmental Disorders (POND) Network; Ontario Brain Institute (OBI); Hospital for Sick Children's Research Institute; SickKids Catalyst Scholar in Genetics, NARSAD Young Investigator award; University of Toronto McLaughlin Centre; Brain Canada Canadian Open Neuroscience Platform Research Scholar Award; Hospital for Sick Children; Ontario Graduate Scholarship; National Institute of Mental Health [1R01MH103371]; Stollery Children's Hospital Foundation Chair in Autism Research; Kids Brain Health Network; Nancy E.T. Fahrner Award; Canadian Institutes for Health Research Banting Postdoctoral Fellowship; BC Children's Hospital Research Institute; Genome British Columbia Strategic Initiative Grant; Dr. Stuart D. Sims Chair in Autism; Jamie Anderson Chair in Child and Youth Mental Health; Canada Research Chair in Disease-Associated Genome Instability; GlaxoSmithKline Chair in Genome Sciences at the University of Toronto	Autism Speaks; Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); KRG Children's Charitable Foundation; Petroff Family Fund; Kazman Family Fund; Marigold Foundation; Genome Canada(Genome Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Government of Ontario; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Brain Canada; Province of Ontario Neurodevelopmental Disorders (POND) Network; Ontario Brain Institute (OBI); Hospital for Sick Children's Research Institute; SickKids Catalyst Scholar in Genetics, NARSAD Young Investigator award; University of Toronto McLaughlin Centre; Brain Canada Canadian Open Neuroscience Platform Research Scholar Award; Hospital for Sick Children; Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stollery Children's Hospital Foundation Chair in Autism Research; Kids Brain Health Network; Nancy E.T. Fahrner Award; Canadian Institutes for Health Research Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Research Institute; Genome British Columbia Strategic Initiative Grant; Dr. Stuart D. Sims Chair in Autism; Jamie Anderson Chair in Child and Youth Mental Health; Canada Research Chair in Disease-Associated Genome Instability; GlaxoSmithKline Chair in Genome Sciences at the University of Toronto	We thank The Centre for Applied Genomics, especially J. Buchanan, B. Kellam, S. Lamoureux, T. Nalpathamkalam, R. Patel, W. Sung and Z. Wang. We also thank G. K. W. Wong, S. Walker and A. Paterson; the participating families in MSSNG (www.mss.ng), and Autism Speaks staff, M. Quirbach and V. Seifer, who manage the MSSNG and AGRE programs; the families at the participating SSC sites, and the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). Project funding is from Autism Speaks, the Canadian Institute for Advanced Research (CIFAR), the KRG Children's Charitable Foundation, The Petroff Family Fund, The Kazman Family Fund, The Marigold Foundation, Genome Canada, the Canada Foundation for Innovation, the Government of Ontario, Canadian Institutes for Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC), Brain Canada, Kids Brain Health Network, Province of Ontario Neurodevelopmental Disorders (POND) Network and the Ontario Brain Institute (OBI). R.K.C.Y. is supported by The Hospital for Sick Children's Research Institute, SickKids Catalyst Scholar in Genetics, NARSAD Young Investigator award, Dataset Analysis Grant from Autism Speaks, the University of Toronto McLaughlin Centre and the Nancy E.T. Fahrner Award. B. Trost was funded by the Canadian Institutes for Health Research Banting Postdoctoral Fellowship and the Brain Canada Canadian Open Neuroscience Platform Research Scholar Award. C.M.N. and B.A.M. were supported by the Restracomp Award from The Hospital for Sick Children, and M.M. by the Ontario Graduate Scholarship. M.E.S.L. is funded by an Investigator Grant Award Program (IGAP) salary award from BC Children's Hospital Research Institute and a Genome British Columbia Strategic Initiative Grant, D.G.A. by a National Institute of Mental Health Grant (1R01MH103371), E.A. by the Dr. Stuart D. Sims Chair in Autism, L.Z. by the Stollery Children's Hospital Foundation Chair in Autism Research, P.S. by the Patsy and Jamie Anderson Chair in Child and Youth Mental Health, C.E.P. by the Canada Research Chair in Disease-Associated Genome Instability and S.W.S. holds the GlaxoSmithKline Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; An JY, 2018, SCIENCE, V362, P1270, DOI 10.1126/science.aat6576; Bahlo Melanie, 2018, F1000Res, V7, DOI 10.12688/f1000research.13980.1; Bamshad MJ, 2019, AM J HUM GENET, V105, P448, DOI 10.1016/j.ajhg.2019.07.011; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cortese A, 2019, NAT GENET, V51, P649, DOI 10.1038/s41588-019-0372-4; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dean NL, 2006, EUR J HUM GENET, V14, P299, DOI 10.1038/sj.ejhg.5201559; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Dolzhenko E, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02017-z; Dolzhenko E, 2019, BIOINFORMATICS, V35, P4754, DOI 10.1093/bioinformatics/btz431; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Ekstrom AB, 2008, AM J MED GENET B, V147B, P918, DOI 10.1002/ajmg.b.30698; Ester M., 1996, P KDD 96, P1; Fernandez BA, 2017, DIALOGUES CLIN NEURO, V19, P353; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Hagerman RJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00564; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lagrue E, 2019, NEUROLOGY, V92, pE852, DOI 10.1212/WNL.0000000000006948; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Olson JE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032707; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafehi H, 2019, AM J HUM GENET, V105, P151, DOI 10.1016/j.ajhg.2019.05.016; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Risch N, 2014, AM J PSYCHIAT, V171, P1206, DOI 10.1176/appi.ajp.2014.13101359; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Shoubridge C, 2012, EUR J HUM GENET, V20, P1311, DOI 10.1038/ejhg.2012.61; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Trost B, 2018, AM J HUM GENET, V102, P142, DOI 10.1016/j.ajhg.2017.12.007; TSAI LY, 1983, BRIT J PSYCHIAT, V142, P373, DOI 10.1192/bjp.142.4.373; Vorstman JAS, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Werling DM, 2018, NAT GENET, V50, P727, DOI 10.1038/s41588-018-0107-y; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Yuen RKC, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.27; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004	64	67	68	2	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 1	2020	586	7827					80	+		10.1038/s41586-020-2579-z	http://dx.doi.org/10.1038/s41586-020-2579-z		JUL 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9IH	32717741	Green Accepted			2022-12-28	WOS:000567779600001
J	Kitamoto, S; Nagao-Kitamoto, H; Jiao, YZ; Gillilland, MG; Hayashi, A; Imai, J; Sugihara, K; Miyoshi, M; Brazil, JC; Kuffa, P; Hill, BD; Rizvi, SM; Wen, F; Bishu, S; Inohara, N; Eaton, KA; Nusrat, A; Lei, YL; Giannobile, WV; Kamada, N				Kitamoto, Sho; Nagao-Kitamoto, Hiroko; Jiao, Yizu; Gillilland, Merritt G., III; Hayashi, Atsushi; Imai, Jin; Sugihara, Kohei; Miyoshi, Mao; Brazil, Jennifer C.; Kuffa, Peter; Hill, Brett D.; Rizvi, Syed M.; Wen, Fei; Bishu, Shrinivas; Inohara, Naohiro; Eaton, Kathryn A.; Nusrat, Asma; Lei, Yu L.; Giannobile, William, V; Kamada, Nobuhiko			The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; GERM-FREE MICE; INTESTINAL INFLAMMATION; NLRP3 INFLAMMASOME; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; CROHNS-DISEASE; POTENTIAL ROLE; HELPER 17	The precise mechanism by which oral infection contributes to the pathogenesis of extra-oral diseases remains unclear. Here, we report that periodontal inflammation exacerbates gut inflammation in vivo. Periodontitis leads to expansion of oral pathobionts, including Klebsiella and Enterobacter species, in the oral cavity. Amassed oral pathobionts are ingested and translocate to the gut, where they activate the inflammasome in colonic mononuclear phagocytes, triggering inflammation, In parallel, periodontitis results in generation of oral pathobiont-reactive Th17 cells in the oral cavity. Oral pathobiont-reactive Th17 cells are imprinted with gut tropism and migrate to the inflamed gut. When in the gut, Th17 cells of oral origin can be activated by translocated oral pathobionts and cause development of colitis, but they are not activated by gut-resident microbes. Thus, oral inflammation, such as periodontitis, exacerbates gut inflammation by supplying the gut with both colitogenic pathobionts and pathogenic T cells.	[Kitamoto, Sho; Nagao-Kitamoto, Hiroko; Gillilland, Merritt G., III; Hayashi, Atsushi; Imai, Jin; Sugihara, Kohei; Miyoshi, Mao; Kuffa, Peter; Bishu, Shrinivas; Kamada, Nobuhiko] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Jiao, Yizu; Brazil, Jennifer C.; Inohara, Naohiro; Nusrat, Asma] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Eaton, Kathryn A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Hill, Brett D.; Rizvi, Syed M.; Wen, Fei] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Jiao, Yizu; Lei, Yu L.; Giannobile, William, V] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Hayashi, Atsushi] Miyarisan Pharmaceut Co Ltd, Res Lab, Tokyo, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kamada, N (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.	nkamada@umich.edu	Kamada, Nobuhiko/AAW-3299-2020; Lei, Yu Leo/ABF-1293-2020; Kitamoto, Sho/AAE-4549-2021	Kamada, Nobuhiko/0000-0002-1980-4178; Lei, Yu Leo/0000-0002-9868-9824; Kitamoto, Sho/0000-0003-3597-6647; Brazil, Jennifer/0000-0002-5013-5291; Bishu, Shrinivas/0000-0003-4823-5805	National Institutes of Health [DK108901, DK119219, AI142047, S10 OD020053, U01 DE029255]; Nation Science Foundation CAREER Award [1653611]; JSPS; Uehara Memorial Foundation; Crohn's and Colitis Foundation; University of Michigan Clinical and Translational Science Awards Program [UL1TR002240]; Prevent Cancer Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nation Science Foundation CAREER Award(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Crohn's and Colitis Foundation; University of Michigan Clinical and Translational Science Awards Program; Prevent Cancer Foundation	The authors thank the University of Michigan Center for Gastrointestinal Research (NIH 5P30DK034933), the Host Microbiome Initiative, the Germ-Free Animal Facility, the Advanced Genomics Core, the Microbial Systems Molecular Biology Laboratory, the CyTOF Core, and the Flow Cytometry Core for technical assistance and the In-Vivo Animal Core at the University of Michigan for histological evaluation. We also thank Meenal Mhaskar, Chithra K. Muraleedharan, Vicky Garcia-Hernandez, Miguel Quiros, Yoshiro Aoki, Yuping Zhang, Yasuyuki Hosono, Sergey S. Seregin, and Grace Y. Chen for experimental assistance. This work was supported by National Institutes of Health grants DK108901, DK119219, and AI142047 (to N.K.), S10 OD020053 (to F.W.), and U01 DE029255 (to Y.L.L.); Nation Science Foundation CAREER Award 1653611 (to F.W.); a JSPS Postdoctoral Fellowship for Research Abroad (to S.K., H.N.-K., and K.S.); an Uehara Memorial Foundation Postdoctoral Fellowship Award (to S.K. and K.S.); the Crohn's and Colitis Foundation (to H.N.-K., K.S., S.B., and N.I.); the University of Michigan Clinical and Translational Science Awards Program (UL1TR002240 to S.K.); and the Prevent Cancer Foundation (to S.K.).	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Arfi A, 2011, MOL GENET METAB, V103, P18, DOI 10.1016/j.ymgme.2011.01.015; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brandtzaeg P, 2001, ACTA ODONTOL SCAND, V59, P235, DOI 10.1080/00016350152509265; Briskin M, 1997, AM J PATHOL, V151, P97; Brito F, 2008, J CLIN PERIODONTOL, V35, P555, DOI 10.1111/j.1600-051X.2008.01231.x; Burr MD, 2006, MICROB ECOL, V51, P479, DOI 10.1007/s00248-006-9050-z; Calderon-Gomez E, 2016, GASTROENTEROLOGY, V151, P489, DOI 10.1053/j.gastro.2016.05.050; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Cheng WC, 2016, EUR J IMMUNOL, V46, P2211, DOI 10.1002/eji.201545871; COOPER HS, 1993, LAB INVEST, V69, P238; Curtis MM, 2014, CELL HOST MICROBE, V16, P759, DOI 10.1016/j.chom.2014.11.005; Dutzan N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0797; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ellett JD, 2009, LIVER TRANSPLANT, V15, P1101, DOI 10.1002/lt.21782; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hecht G, 2014, LAB ANIM-UK, V48, P292, DOI 10.1177/0023677214544728; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Juillerat P, 2012, ALIMENT PHARM THER, V36, P239, DOI 10.1111/j.1365-2036.2012.05173.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kitamoto S, 2020, NAT MICROBIOL, V5, P116, DOI 10.1038/s41564-019-0591-6; Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Lankarani KB, 2013, WORLD J GASTROENTERO, V19, P8571, DOI 10.3748/wjg.v19.i46.8571; Liu L, 2017, J CROHNS COLITIS, V11, P737, DOI 10.1093/ecco-jcc/jjw219; Lourenco SV, 2010, J EUR ACAD DERMATOL, V24, P204, DOI 10.1111/j.1468-3083.2009.03304.x; Lu XL, 2017, BIOMED PHARMACOTHER, V86, P645, DOI 10.1016/j.biopha.2016.11.075; Man SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45126; Marchesan J, 2018, NAT PROTOC, V13, P2247, DOI 10.1038/s41596-018-0035-4; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Moutsopoulos NM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007696; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Nagao-Kitamoto H, 2016, CELL MOL GASTROENTER, V2, P468, DOI 10.1016/j.jcmgh.2016.02.003; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Ono Y, 2012, GASTROENTEROLOGY, V143, P1288, DOI 10.1053/j.gastro.2012.07.108; Paik J, 2015, GUT MICROBES, V6, P255, DOI 10.1080/19490976.2015.1064576; Pakala SB, 2010, J BIOL CHEM, V285, P32787, DOI 10.1074/jbc.M110.151340; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Pietropaoli D, 2014, J PERIODONTOL, V85, P1799, DOI 10.1902/jop.2014.140316; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Reed M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12968-y; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sand J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0009-4; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schirmer M, 2018, CELL HOST MICROBE, V24, P600, DOI 10.1016/j.chom.2018.09.009; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt TSB, 2019, ELIFE, V8, DOI 10.7554/eLife.42693; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080; Shah R, 2017, DIGESTION, V95, P188, DOI 10.1159/000455008; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Takahashi K, 2005, J CLIN PERIODONTOL, V32, P369, DOI 10.1111/j.1600-051X.2005.00676.x; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; VANDYKE TE, 1986, INFECT IMMUN, V53, P671, DOI 10.1128/IAI.53.3.671-677.1986; Vavricka SR, 2013, INFLAMM BOWEL DIS, V19, P2768, DOI 10.1097/01.MIB.0000438356.84263.3b; Wang XC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2197-2; Watanabe T, 2009, MUTAT RES-GEN TOX EN, V673, P9, DOI 10.1016/j.mrgentox.2008.11.004; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	94	133	143	16	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					447	+		10.1016/j.cell.2020.05.048	http://dx.doi.org/10.1016/j.cell.2020.05.048			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32758418	Green Accepted, Bronze			2022-12-28	WOS:000552745000015
J	Stanley, KE; Giordano, J; Thorsten, V; Buchovecky, C; Thomas, A; Ganapathi, M; Liao, J; Dharmadhikari, AV; Revah-Politi, A; Ernst, M; Lippa, N; Holmes, H; Povysil, G; Hostyk, J; Parker, CB; Goldenberg, R; Saade, GR; Dudley, DJ; Pinar, H; Hogue, C; Reddy, UM; Silver, RM; Aggarwal, V; Allen, AS; Wapner, RJ; Goldstein, DB				Stanley, Kate E.; Giordano, Jessica; Thorsten, Vanessa; Buchovecky, Christie; Thomas, Amanda; Ganapathi, Mythily; Liao, Jun; Dharmadhikari, Avinash V.; Revah-Politi, Anya; Ernst, Michelle; Lippa, Natalie; Holmes, Halie; Povysil, Gundula; Hostyk, Joseph; Parker, Corette B.; Goldenberg, Robert; Saade, George R.; Dudley, Donald J.; Pinar, Halit; Hogue, Carol; Reddy, Uma M.; Silver, Robert M.; Aggarwal, Vimla; Allen, Andrew S.; Wapner, Ronald J.; Goldstein, David B.			Causal Genetic Variants in Stillbirth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXOME; MUTATIONS; DEATH; DIAGNOSIS; GENOMICS	BackgroundIn the majority of cases, the cause of stillbirth remains unknown despite detailed clinical and laboratory evaluation. Approximately 10 to 20% of stillbirths are attributed to chromosomal abnormalities. However, the causal nature of single-nucleotide variants and small insertions and deletions in exomes has been understudied. MethodsWe generated exome sequencing data for 246 stillborn cases and followed established guidelines to identify causal variants in disease-associated genes. These genes included those that have been associated with stillbirth and strong candidate genes. We also evaluated the contribution of 18,653 genes in case-control analyses stratified according to the degree of depletion of functional variation (described here as "intolerance" to variation). ResultsWe identified molecular diagnoses in 15 of 246 cases of stillbirth (6.1%) involving seven genes that have been implicated in stillbirth and six disease genes that are good candidates for phenotypic expansion. Among the cases we evaluated, we also found an enrichment of loss-of-function variants in genes that are intolerant to such variation in the human population (odds ratio, 2.15; 95% confidence interval [CI], 1.46 to 3.06). Loss-of-function variants in intolerant genes were concentrated in genes that have not been associated with human disease (odds ratio, 2.22; 95% CI, 1.41 to 3.34), findings that differ from those in two postnatal clinical populations that were also evaluated in this study. ConclusionsOur findings establish the diagnostic utility of clinical exome sequencing to evaluate the role of small genomic changes in stillbirth. The strength of the novel risk signal (as generated through the stratified analysis) was similar to that in known disease genes, which indicates that the genetic cause of stillbirth remains largely unknown. (Funded by the Institute for Genomic Medicine.) Little is known about the genetic causes of stillbirth. In this study, investigators used exome sequencing analysis to identify a genetic cause in a relatively small percentage of cases and to provide some interesting clues as to where to look for more genes that, when mutated, cause stillbirth. The article is accompanied by interactive tables and an illustrated glossary.	[Stanley, Kate E.; Giordano, Jessica; Revah-Politi, Anya; Ernst, Michelle; Lippa, Natalie; Holmes, Halie; Povysil, Gundula; Hostyk, Joseph; Aggarwal, Vimla; Wapner, Ronald J.; Goldstein, David B.] Columbia Univ, Irving Med Ctr, Vagelos Coll Phys & Surg, Inst Genom Med, New York, NY 10027 USA; [Giordano, Jessica; Goldenberg, Robert; Wapner, Ronald J.] Columbia Univ, Med Ctr, Dept Obstet & Gynaecol, New York, NY USA; [Buchovecky, Christie; Thomas, Amanda; Ganapathi, Mythily; Liao, Jun; Dharmadhikari, Avinash V.; Aggarwal, Vimla] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Thorsten, Vanessa; Parker, Corette B.] RTI Int, Res Triangle Pk, NC USA; [Allen, Andrew S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Saade, George R.] Univ Texas Med Branch, Dept Cell Biol, Galveston, TX 77555 USA; [Dudley, Donald J.] Univ Virginia, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Charlottesville, VA USA; [Pinar, Halit] Brown Univ, Women & Infants Hosp, Warren Alpert Sch Med, Div Perinatal & Pediat Pathol, Providence, RI USA; [Hogue, Carol] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Pregnancy & Perinatol Branch, Bethesda, MD USA; [Silver, Robert M.] Univ Utah, Salt Lake City, UT USA; [Silver, Robert M.] Intermt Healthcare, Salt Lake City, UT USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; Research Triangle Institute; Duke University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Virginia; Brown University; Women & Infants Hospital Rhode Island; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center	Goldstein, DB (corresponding author), Columbia Univ, Irving Med Ctr, Hammer Hlth Sci, Inst Genom Med, 701 W 168th St, New York, NY 10032 USA.	dbgoldstein@columbia.edu	Dharmadhikari, Avinash Vijay/AAA-1514-2021; Povysil, Gundula/AAN-8418-2021	Dharmadhikari, Avinash Vijay/0000-0003-4182-4543; Allen, Andrew/0000-0002-7232-2143; Thomas-Wilson, Amanda/0000-0001-5875-8349; Thorsten, Vanessa/0000-0003-4430-1473; Parker, Corette/0000-0002-6822-6845	Institute for Genomic Medicine [HD45925, HD45944, HD45952, HD45953, HD45954, HD45955]; NICHD	Institute for Genomic Medicine; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the Institute for Genomic Medicine with grants (HD45925, HD45944, HD45952, HD45953, HD45954, and HD45955) from the NICHD.	Allen AS, 2017, LANCET NEUROL, V16, P135, DOI 10.1016/S1474-4422(16)30359-3; [Anonymous], 2016, ANAL TOOL ANNOTATED, DOI DOI 10.1101/2020.06.08.136507V1.FULL; [Anonymous], 2017, J ONCOL PRACT, V13, pe353; Bagnall RD, 2016, ANN NEUROL, V79, P522, DOI 10.1002/ana.24596; Bartha I, 2018, NAT REV GENET, V19, P51, DOI 10.1038/nrg.2017.75; Brownstein C.A., 2018, SIDS SUDDEN INFANT E; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Crotti L, 2013, JAMA-J AM MED ASSOC, V309, P1473, DOI 10.1001/jama.2013.3219; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Fuller ZL, 2019, NAT GENET, V51, P772, DOI 10.1038/s41588-019-0383-1; Gelfman S, 2019, GENOME RES, V29, P809, DOI 10.1101/gr.243592.118; Gil-Rodriguez MC, 2015, HUM MUTAT, V36, P454, DOI 10.1002/humu.22761; Groopman EE, 2019, NEW ENGL J MED, V380, P142, DOI 10.1056/NEJMoa1806891; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Kasak L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45327; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2018, NAT METHODS, V15, P595, DOI 10.1038/s41592-018-0054-7; Liu ZH, 2014, J BIOL CHEM, V289, P29801, DOI 10.1074/jbc.M114.570416; Lord J, 2019, LANCET, V393, P747, DOI 10.1016/S0140-6736(18)31940-8; Mason-Suares H, 2017, EUR J HUM GENET, V25, P509, DOI 10.1038/ejhg.2016.202; Narula N, 2015, PEDIATR CARDIOL, V36, P768, DOI 10.1007/s00246-014-1082-4; Neubauer J, 2017, EUR J HUM GENET, V25, P404, DOI 10.1038/ejhg.2016.199; Park ES, 1998, AM J MED GENET, V78, P350, DOI 10.1002/(SICI)1096-8628(19980724)78:4<350::AID-AJMG9>3.3.CO;2-#; Petrovski S, 2019, LANCET, V393, P758, DOI 10.1016/S0140-6736(18)32042-7; Petrovski S, 2017, AM J RESP CRIT CARE, V196, P82, DOI [10.1164/rccm.201610-2088OC, 10.1164/rccm.201610-2088oc]; Reddy UM, 2012, NEW ENGL J MED, V367, P2185, DOI 10.1056/NEJMoa1201569; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sahlin E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210017; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shamseldin HE, 2018, GENET MED, V20, P420, DOI 10.1038/gim.2017.111; Splinter K, 2018, NEW ENGL J MED, V379, P2131, DOI 10.1056/NEJMoa1714458; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wapner RJ, 2002, SEMIN PERINATOL, V26, P70, DOI 10.1053/sper.2002.29853; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yates CL, 2017, GENET MED, V19, P1171, DOI 10.1038/gim.2017.31; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191; 2013, SURG OBES RELAT DIS, V9, pE1003; 2017, CELL, V171, pE1734	49	26	26	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2020	383	12					1107	1116		10.1056/NEJMoa1908753	http://dx.doi.org/10.1056/NEJMoa1908753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU8QD	32786180	Bronze, Green Accepted			2022-12-28	WOS:000573901600010
J	Douros, A; Lix, LM; Fralick, M; Dell'Aniello, S; Shah, BR; Ronksley, PE; Tremblay, E; Hu, NP; Alessi-Severini, S; Fisher, A; Bugden, SC; Ernst, P; Filion, KB				Douros, Antonios; Lix, Lisa M.; Fralick, Michael; Dell'Aniello, Sophie; Shah, Baiju R.; Ronksley, Paul E.; Tremblay, Eric; Hu, Nianping; Alessi-Severini, Silvia; Fisher, Anat; Bugden, Shawn C.; Ernst, Pierre; Filion, Kristian B.		Canadian Network Observational	Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis A Multicenter Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Sodium-glucose cotransporter-2 (SGLT-2) inhibitors could increase the risk for diabetic ketoacidosis (DKA). Objective: To assess whether SGLT-2 inhibitors, compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, are associated with an increased risk for DKA in patients with type 2 diabetes. Design: Population-based cohort study; prevalent new-user design between 2013 and 2018. (ClinicalTrials.gov: NCT04017221) Setting: Electronic health care databases from 7 Canadian provinces and the United Kingdom. Patients: 208 757 new users of SGLT-2 inhibitors were matched by using time-conditional propensity scores to 208 757 recipients of DPP-4 inhibitors. Measurements: Cox proportional hazards models estimated site-specific hazard ratios (HRs) with 95% CIs of DKA comparing receipt of SGLT-2 inhibitors with receipt of DPP-4 inhibitors, which were pooled by using random-effects models. Secondary analyses were stratified by molecule, age, sex, and prior receipt of insulin. Results: Overall, 521 patients were diagnosed with DKA during 370 454 person-years of follow-up (incidence rate per 1000 person-years, 1.40 [95% CI, 1.29 to 1.53]). Compared with DPP-4 inhibitors, SGLT-2 inhibitors were associated with an increased risk for DKA (incidence rate, 2.03 [CI, 1.83 to 2.25] versus 0.75 [CI, 0.63 to 0.89], respectively; HR, 2.85 [CI, 1.99 to 4.08]). Molecule-specific HRs were 1.86 (CI, 1.11 to 3.10) for dapagliflozin, 2.52 (CI, 1.23 to 5.14) for empagliflozin, and 3.58 (CI, 2.13 to 6.03) for canagliflozin. Age and sex did not modify the association; prior receipt of insulin appeared to decrease the risk. Limitations: There was unmeasured confounding and no laboratory data were available for the majority of patients, and molecule-specific analyses were conducted at a limited number of sites. Conclusion: SGLT-2 inhibitors were associated with an almost 3-fold increased risk for DKA, with molecule-specific analyses suggesting a class effect.	[Douros, Antonios; Dell'Aniello, Sophie; Ernst, Pierre; Filion, Kristian B.] Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote Ste Catherine Rd,Suite 492, Montreal, PQ H3T 1E2, Canada; [Lix, Lisa M.] Univ Manitoba, 753 McDermot Ave,Third Floor, Winnipeg, MB R3E 0T6, Canada; [Fralick, Michael] Sinai Hlth Syst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Shah, Baiju R.] Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,Room G106, Toronto, ON M4N 3M5, Canada; [Ronksley, Paul E.] Teaching Res & Wellness Bldg 3E18B, Calgary, AB T2N 4Z6, Canada; [Tremblay, Eric] Inst Natl Excellence Sante & Serv Sociaux, 2535 Blvd Laurier,Fifth Floor, Quebec City, PQ G1V 4M3, Canada; [Hu, Nianping] Hlth Qual Council, 241-111 Res Dr, Saskatoon, SK S7N 3R2, Canada; [Alessi-Severini, Silvia] Univ Manitoba, Rady Fac Hlth Sci, Coll Pharm, 750 McDermot Ave, Winnipeg, MB R3E 0T5, Canada; [Fisher, Anat] Univ British Columbia, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Bugden, Shawn C.] Mem Univ Newfoundland, Sch Pharm, 300 Prince Phillip Dr, St John, NF A1B 3V6, Canada	Lady Davis Institute; McGill University; University of Manitoba; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; University of British Columbia; Memorial University Newfoundland	Filion, KB (corresponding author), McGill Univ, Dept Med, 3755 Cote Ste Catherine Rd,Suite H410-1, Montreal, PQ, Canada.; Filion, KB (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 3755 Cote Ste Catherine Rd,Suite H410-1, Montreal, PQ, Canada.	kristian.filion@mcgill.ca	Douros, Antonios/C-9751-2017	Douros, Antonios/0000-0002-6005-4006; Fisher, Anat/0000-0001-9730-5107	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Tamez-Perez HE, 2015, WORLD J DIABETES, V6, P1073, DOI 10.4239/wjd.v6.i8.1073; Faillie JL, 2017, PHARMACOL RES, V118, P71, DOI 10.1016/j.phrs.2016.07.001; Ferrannini E, 2016, DIABETES, V65, P1190, DOI 10.2337/db15-1356; Fralick M, 2017, NEW ENGL J MED, V376, P2300, DOI 10.1056/NEJMc1701990; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Kim YG, 2018, DIABETES OBES METAB, V20, P1852, DOI 10.1111/dom.13297; Leslie BR, 2019, ANN INTERN MED, V171, P421, DOI 10.7326/M19-1463; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Newcomer JW, 2005, CNS DRUGS, V19, P1; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Suissa S, 2017, PHARMACOEPIDEM DR S, V26, P459, DOI 10.1002/pds.4107; Suissa Samy, 2012, Open Med, V6, pe134; Tahrani AA, 2013, LANCET DIABETES ENDO, V1, P140, DOI 10.1016/S2213-8587(13)70050-0; Ueda P, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4365; US Food and Drug Administration, 2015, FDA DRUG SAF COMM FD; Wang L, 2019, PHARMACOEPIDEM DR S, V28, P1620, DOI 10.1002/pds.4887; Wang YL, 2017, DIABETES RES CLIN PR, V128, P109, DOI 10.1016/j.diabres.2017.04.012; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	23	49	51	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2020	173	6					417	+		10.7326/M20-0289	http://dx.doi.org/10.7326/M20-0289			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX3SZ	32716707				2022-12-28	WOS:000575633300014
J	Li, QQ; Wu, JJ; Nie, JH; Zhang, L; Hao, H; Liu, S; Zhao, CY; Zhang, Q; Liu, H; Nie, LL; Qin, HY; Wang, M; Lu, Q; Li, XY; Sun, QY; Liu, JK; Zhang, LQ; Li, XG; Huang, WJ; Wang, YC				Li, Qianqian; Wu, Jiajing; Nie, Jianhui; Zhang, Li; Hao, Huan; Liu, Shuo; Zhao, Chenyan; Zhang, Qi; Liu, Huan; Nie, Lingling; Qin, Haiyang; Wang, Meng; Lu, Qiong; Li, Xiaoyu; Sun, Qiyu; Liu, Junkai; Zhang, Linqi; Li, Xuguang; Huang, Weijin; Wang, Youchun			The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	CELL			English	Article							SARS CORONAVIRUS; GLYCAN SHIELD; EBOLA-VIRUS; HIV-1 GP120; PROTEIN; GLYCOSYLATION; GLYCOPROTEIN; ANTIBODIES; 2019-NCOV; TARGET	The spike protein of SARS-CoV-2 has been undergoing mutations and is highly glycosylated. It is critically important to investigate the biological significance of these mutations. Here, we investigated 80 variants and 26 glycosylation site modifications for the infectivity and reactivity to a panel of neutralizing antibodies and sera from convalescent patients. D614G, along with several variants containing both D614G and another amino acid change, were significantly more infectious. Most variants with amino acid change at receptor binding domain were less infectious, but variants including A475V, L452R, V483A, and F490L became resistant to some neutralizing antibodies. Moreover, the majority of glycosylation deletions were less infectious, whereas deletion of both N331 and N343 glycosylation drastically reduced infectivity, revealing the importance of glycosylation for viral infectivity. Interestingly, N234Q was markedly resistant to neutralizing antibodies, whereas N165Q became more sensitive. These findings could be of value in the development of vaccine and therapeutic antibodies.	[Li, Qianqian; Wu, Jiajing; Nie, Jianhui; Zhang, Li; Hao, Huan; Liu, Shuo; Zhao, Chenyan; Liu, Huan; Nie, Lingling; Qin, Haiyang; Wang, Meng; Lu, Qiong; Li, Xiaoyu; Sun, Qiyu; Liu, Junkai; Huang, Weijin; Wang, Youchun] Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, 31 Huatuo St, Beijing 102629, Peoples R China; [Li, Qianqian; Wu, Jiajing; Nie, Jianhui; Zhang, Li; Hao, Huan; Liu, Shuo; Zhao, Chenyan; Liu, Huan; Nie, Lingling; Qin, Haiyang; Wang, Meng; Lu, Qiong; Li, Xiaoyu; Sun, Qiyu; Liu, Junkai; Huang, Weijin; Wang, Youchun] WHO Collaborating Ctr Standardizat & Evaluat Biol, 31 Huatuo St, Beijing 102629, Peoples R China; [Li, Qianqian; Wang, Youchun] Peking Union Med Coll, Grad Sch, 9 Dongdan Santiao, Beijing 100730, Peoples R China; [Zhang, Qi; Zhang, Linqi] Tsinghua Univ, Ctr Global Hlth & Infect Dis, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China; [Zhang, Qi; Zhang, Linqi] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Med, Beijing 100084, Peoples R China; [Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, HPFB, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0K9, Canada; [Li, Xuguang] WHO Collaborating Ctr Standardizat & Evaluat Biol, Ottawa, ON K1A 0K9, Canada	National Institute of Food & Drug Control - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Tsinghua University; Health Canada	Huang, WJ; Wang, YC (corresponding author), Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, 31 Huatuo St, Beijing 102629, Peoples R China.; Huang, WJ; Wang, YC (corresponding author), WHO Collaborating Ctr Standardizat & Evaluat Biol, 31 Huatuo St, Beijing 102629, Peoples R China.; Wang, YC (corresponding author), Peking Union Med Coll, Grad Sch, 9 Dongdan Santiao, Beijing 100730, Peoples R China.	huangweijin@nifdc.org.cn; wangyc@nifdc.org.cn	ZHANG, LIN/GYD-9123-2022; huang, weijin/AAY-5028-2020	huang, weijin/0000-0002-4246-8889	National Science and Technology Major Projects of Drug Discovery [2018ZX09101001]; National Science and Technology Major Projects of Infectious Disease [2017ZX10304402]; Bill and Melinda Gates Foundation [INV-006379]	National Science and Technology Major Projects of Drug Discovery; National Science and Technology Major Projects of Infectious Disease; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We would like to thank Prof. X. Sunney Xie of Peking University for providing mAb X593; Prof. JinghuaYan of the Institute of Microbiology, Chinese Academy of Sciences for mAbs CA1 and CB6; Dr. Liangzhi Xie from Sino Biological Company for mAbs H014 and H00S022 and the 293T-hACE2 cell line; Prof. Linqi Zhang of Tsinghua University for mAbs P2C-1F11, P2B-2F6, AB35, 261-262, 157, and 247; and Prof. Yan Wu of the Institute of Microbiology, Chinese Academy of Sciences for H4 and B38. We would like to thank Dr. Xiaoming Yang from China National Biotec Group Company Ltd. for providing convalescent sera (CS1, CS2, CS3, CS4, CS6, CS7, CS8, and CS10) and Ms. Fangyu Dong from China Biologic Products Holdings, Inc. for convalescent sera CS86 and CS87. This work was supported by the National Science and Technology Major Projects of Drug Discovery (2018ZX09101001), the National Science and Technology Major Projects of Infectious Disease (2017ZX10304402), and the Bill and Melinda Gates Foundation (INV-006379).	Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Dawood AA, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100673; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Francois KO, 2011, J BIOL CHEM, V286, P42900, DOI 10.1074/jbc.M111.274456; He YX, 2004, J IMMUNOL, V173, P4050, DOI 10.4049/jimmunol.173.6.4050; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Huang Y, 2020, J VIROL, V94, DOI 10.1128/JVI.01432-19; Hulswit RJG, 2016, ADV VIRUS RES, V96, P29, DOI 10.1016/bs.aivir.2016.08.004; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kumar Swatantra, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00571-5; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Lv M, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.15.2000125; Lv Z., 2020, BIORXIV, DOI [10.1101/2020.06.02.129098, DOI 10.1101/2020.06.02.129098]; Nie JH, 2020, EMERG MICROBES INFEC, V9, P680, DOI 10.1080/22221751.2020.1743767; Ning TT, 2019, J INFECT DIS, V219, P19, DOI 10.1093/infdis/jiy408; Petrie JG, 2019, J INFECT DIS, V219, P3, DOI 10.1093/infdis/jiy409; Saha P, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201312; Sheikh JA, 2020, INFECT GENET EVOL, V84, DOI 10.1016/j.meegid.2020.104330; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Vankadari N, 2020, EMERG MICROBES INFEC, V9, P601, DOI 10.1080/22221751.2020.1739565; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang WB, 2015, JAIDS-J ACQ IMM DEF, V69, P270, DOI 10.1097/QAI.0000000000000595; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yang XL, 2019, NAT MICROBIOL, V4, P390, DOI 10.1038/s41564-018-0328-y; Zhang XJ, 2015, J GEN VIROL, V96, P1248, DOI 10.1099/vir.0.000082	45	800	825	18	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2020	182	5					1284	+		10.1016/j.cell.2020.07.012	http://dx.doi.org/10.1016/j.cell.2020.07.012			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NR3DG	32730807	Green Published, Bronze			2022-12-28	WOS:000571442200017
J	Chakravarthy, U; Peto, T				Chakravarthy, Usha; Peto, Tunde			Current Perspective on Age-Related Macular Degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chakravarthy, Usha; Peto, Tunde] Queens Univ Belfast, Ctr Publ Hlth, Inst Clin Sci, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast	Chakravarthy, U (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Inst Clin Sci, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland.	u.chakravarthy@qub.ac.uk						Bakri SJ, 2019, OPHTHALMOLOGY, V126, P55, DOI 10.1016/j.ophtha.2018.07.028; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Broadhead GK, 2015, NUTR REV, V73, P448, DOI 10.1093/nutrit/nuv005; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Lambert NG, 2016, PROG RETIN EYE RES, V54, P64, DOI 10.1016/j.preteyeres.2016.04.003; Schultz R, 2018, INVEST OPHTH VIS SCI, V59	7	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					794	795		10.1001/jama.2020.5576	http://dx.doi.org/10.1001/jama.2020.5576			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32780786				2022-12-28	WOS:000568230000025
J	Stauffer, WM; Alpern, JD; Walker, PF				Stauffer, William M.; Alpern, Jonathan D.; Walker, Patricia F.			COVID-19 and Dexamethasone A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								Anticipating widespread global use of dexamethasone for COVID-19 in the wake of RECOVERY trial findings, this Viewpoint summarizes the theoretical risk of triggering Strongyloides hyperinfection/dissemination syndrome in people with asymptomatic strongyloidiasis, and proposes an algorithm to for assessing and managing the risk in outpatient and hospital settings.	[Stauffer, William M.] Univ Minnesota, Ctr Global Hlth & Social Responsibil, Minneapolis, MN USA; [Stauffer, William M.; Walker, Patricia F.] Univ Minnesota, Dept Med, Global Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Alpern, Jonathan D.; Walker, Patricia F.] HealthPartners Inst, Bloomington, MN USA; [Alpern, Jonathan D.] HealthPartners Travel & Trop Med Ctr, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research	Stauffer, WM (corresponding author), Univ Minnesota, Dept Med, 420 Delaware St SE,MMC 250, Minneapolis, MN 55455 USA.	stauf005@umn.edu						[Anonymous], PRES SCREEN STRONG I; [Anonymous], CORT INCL DEX; Asundi A, 2019, LANCET GLOB HEALTH, V7, pE236, DOI 10.1016/S2214-109X(18)30490-X; Boggild A K, 2016, Can Commun Dis Rep, V42, P12; Geri G, 2015, INFECTION, V43, P691, DOI 10.1007/s15010-015-0799-1; Krolewiecki A, 2019, INFECT DIS CLIN N AM, V33, P135, DOI 10.1016/j.idc.2018.10.006; Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013; Puthiyakunnon S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003018; Requena-Mendez A, 2017, AM J TROP MED HYG, V97, P645, DOI 10.4269/ajtmh.16-0923; The RECOVERY Collaborative Group, 2020, N ENGL J MED, DOI DOI 10.1056/NEJMOA2021436	10	56	56	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2020	324	7					623	624		10.1001/jama.2020.13170	http://dx.doi.org/10.1001/jama.2020.13170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NG9GI	32761166	Bronze			2022-12-28	WOS:000564288700001
J	Bullock, RM; Chen, JGG; Gagliardi, L; Chirik, PJ; Farha, OK; Hendon, CH; Jones, CW; Keith, JA; Klosin, J; Minteer, SD; Morris, RH; Radosevich, AT; Rauchfuss, TB; Strotman, NA; Vojvodic, A; Ward, TR; Yang, JY; Surendranath, Y				Bullock, R. Morris; Chen, Jingguang G.; Gagliardi, Laura; Chirik, Paul J.; Farha, Omar K.; Hendon, Christopher H.; Jones, Christopher W.; Keith, John A.; Klosin, Jerzy; Minteer, Shelley D.; Morris, Robert H.; Radosevich, Alexander T.; Rauchfuss, Thomas B.; Strotman, Neil A.; Vojvodic, Aleksandra; Ward, Thomas R.; Yang, Jenny Y.; Surendranath, Yogesh			Using nature's blueprint to expand catalysis with Earth-abundant metals	SCIENCE			English	Review							COUPLED ELECTRON-TRANSFER; DENSITY-FUNCTIONAL THEORY; H BOND FUNCTIONALIZATION; ACTIVE-SITE; ORGANIC FRAMEWORK; H-2 EVOLUTION; IRON-SULFUR; REDUCTION; ELECTROCATALYSTS; OXIDATION		[Bullock, R. Morris] Pacific Northwest Natl Lab, Ctr Mol Electrocatalysis, Richland, WA 99352 USA; [Chen, Jingguang G.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Chen, Jingguang G.] Brookhaven Natl Lab, Chem Div, Upton, NY 11973 USA; [Gagliardi, Laura] Univ Minnesota, Minnesota Supercomp Inst, Dept Chem, Minneapolis, MN 55455 USA; [Gagliardi, Laura] Univ Minnesota, Chem Theory Ctr, Minneapolis, MN 55455 USA; [Chirik, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Farha, Omar K.] Northwestern Univ, Dept Chem & Chem & Biol Engn, Evanston, IL 60208 USA; [Hendon, Christopher H.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Jones, Christopher W.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Keith, John A.] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Klosin, Jerzy] Dow Chem Co USA, Core R&D, Midland, MI 48674 USA; [Minteer, Shelley D.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Morris, Robert H.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Radosevich, Alexander T.; Surendranath, Yogesh] MIT, Dept Chem, Cambridge, MA 02139 USA; [Rauchfuss, Thomas B.] Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA; [Strotman, Neil A.] Merck & Co Inc, Proc Res & Dev, Rahway, NJ 07065 USA; [Vojvodic, Aleksandra] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Ward, Thomas R.] Univ Basel, Dept Chem, CH-4058 Basel, Switzerland; [Yang, Jenny Y.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Princeton University; Northwestern University; University of Oregon; University System of Georgia; Georgia Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dow Chemical Company; Utah System of Higher Education; University of Utah; University of Toronto; Massachusetts Institute of Technology (MIT); University of Illinois System; University of Illinois Urbana-Champaign; Merck & Company; University of Pennsylvania; University of Basel; University of California System; University of California Irvine	Bullock, RM (corresponding author), Pacific Northwest Natl Lab, Ctr Mol Electrocatalysis, Richland, WA 99352 USA.; Chen, JGG (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.; Chen, JGG (corresponding author), Brookhaven Natl Lab, Chem Div, Upton, NY 11973 USA.; Gagliardi, L (corresponding author), Univ Minnesota, Minnesota Supercomp Inst, Dept Chem, Minneapolis, MN 55455 USA.; Gagliardi, L (corresponding author), Univ Minnesota, Chem Theory Ctr, Minneapolis, MN 55455 USA.; Surendranath, Y (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	morris.bullock@pnnl.gov; jgchen@columbia.edu; gagliard@umn.edu; yogi@mit.edu	Morris, Robert H/R-8760-2016; Keith, John/K-7431-2013; Bullock, R. Morris/L-6802-2016; Farha, Omar/B-5512-2014; Vojvodic, Aleksandra/C-3383-2014; Minteer, Shelley/C-4751-2014	Morris, Robert H/0000-0002-7574-9388; Keith, John/0000-0002-6583-6322; Jones, Christopher/0000-0003-3255-5791; Surendranath, Yogesh/0000-0003-1016-3420; Bullock, R. Morris/0000-0001-6306-4851; Yang, Jenny/0000-0002-9680-8260; Klosin, Jerzy/0000-0002-9045-7308; Farha, Omar/0000-0002-9904-9845; Chirik, Paul/0000-0001-8473-2898; Vojvodic, Aleksandra/0000-0002-5584-6711; Minteer, Shelley/0000-0002-5788-2249	NIGMS NIH HHS [R01 GM061153] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2016, CRC HDB CHEM PHYS, V97; Asset T, 2020, JOULE, V4, P33, DOI 10.1016/j.joule.2019.12.002; Azcarate I, 2016, J AM CHEM SOC, V138, P16639, DOI 10.1021/jacs.6b07014; Baek J, 2018, J AM CHEM SOC, V140, P18208, DOI 10.1021/jacs.8b11525; Beyzavi MH, 2015, J AM CHEM SOC, V137, P13624, DOI [10.1021/jacs.5b08440, 10.1021/jacs.5b03440]; Bligaard T, 2016, ACS CATAL, V6, P2590, DOI 10.1021/acscatal.6b00183; Brandenberg OF, 2019, J AM CHEM SOC, V141, P8989, DOI 10.1021/jacs.9b02931; Brandenberg OF, 2017, CURR OPIN BIOTECH, V47, P102, DOI 10.1016/j.copbio.2017.06.005; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Carsch KM, 2019, SCIENCE, V365, P1138, DOI 10.1126/science.aax4423; Carter EA, 2008, SCIENCE, V321, P800, DOI 10.1126/science.1158009; Chantarojsiri T, 2018, CHEM SCI, V9, P2567, DOI 10.1039/c7sc04486k; Chaudhuri P, 1998, ANGEW CHEM INT EDIT, V37, P2217, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2217::AID-ANIE2217>3.0.CO;2-D; Chen JGG, 1996, CHEM REV, V96, P1477, DOI 10.1021/cr950232u; Chirik PJ, 2010, SCIENCE, V327, P794, DOI 10.1126/science.1183281; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Crockett MP, 2019, CHEM COMMUN, V55, P14426, DOI 10.1039/c9cc08229h; Darmon JM, 2012, J AM CHEM SOC, V134, P17125, DOI 10.1021/ja306526d; Davies HML, 2011, CHEM SOC REV, V40, P1857, DOI 10.1039/c0cs00217h; Dey S, 2014, J AM CHEM SOC, V136, P8847, DOI 10.1021/ja5021684; Dorel R, 2019, ANGEW CHEM INT EDIT, V58, P17118, DOI 10.1002/anie.201904795; Dou J, 2017, CHEM SOC REV, V46, P2001, DOI 10.1039/c6cs00931j; Egorova KS, 2017, ORGANOMETALLICS, V36, P4071, DOI 10.1021/acs.organomet.7b00605; Estes DP, 2011, ORGANOMETALLICS, V30, P3444, DOI 10.1021/om2001519; Falsig H, 2008, ANGEW CHEM INT EDIT, V47, P4835, DOI 10.1002/anie.200801479; Feng XY, 2020, J AM CHEM SOC, V142, P690, DOI 10.1021/jacs.9b12229; Ferreira RB, 2019, ACCOUNTS CHEM RES, V52, P447, DOI 10.1021/acs.accounts.8b00559; Ford CL, 2016, SCIENCE, V354, P741, DOI 10.1126/science.aah6886; Franke R, 2012, CHEM REV, V112, P5675, DOI 10.1021/cr3001803; Fried SD, 2014, SCIENCE, V346, P1510, DOI 10.1126/science.1259802; Friedfeld MR, 2018, SCIENCE, V360, P888, DOI 10.1126/science.aar6117; Gaggioli CA, 2019, ACS CATAL, V9, P8481, DOI 10.1021/acscatal.9b01775; Gagliardi L, 2017, ACCOUNTS CHEM RES, V50, P66, DOI 10.1021/acs.accounts.6b00471; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hartwig JF, 2016, ACS CENTRAL SCI, V2, P281, DOI 10.1021/acscentsci.6b00032; Hartwig JF, 2016, J AM CHEM SOC, V138, P2, DOI 10.1021/jacs.5b08707; Hayler JD, 2019, ORGANOMETALLICS, V38, P36, DOI 10.1021/acs.organomet.8b00566; Helm L, 2005, CHEM REV, V105, P1923, DOI 10.1021/cr030726o; Holland PL, 2015, ACCOUNTS CHEM RES, V48, P1696, DOI 10.1021/acs.accounts.5b00036; Horike S, 2008, J AM CHEM SOC, V130, P5854, DOI 10.1021/ja800669j; Horvath S, 2012, P NATL ACAD SCI USA, V109, P15663, DOI 10.1073/pnas.1118333109; Hsu CW, 2020, ANGEW CHEM INT EDIT, V59, P627, DOI 10.1002/anie.201906327; Huan TN, 2016, ENERG ENVIRON SCI, V9, P940, DOI 10.1039/c5ee02739j; Janet JP, 2020, ACS CENTRAL SCI, V6, P513, DOI 10.1021/acscentsci.0c00026; Jaouen F, 2011, ENERG ENVIRON SCI, V4, P114, DOI 10.1039/c0ee00011f; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Jimenez-Oses G, 2014, NAT CHEM BIOL, V10, P431, DOI 10.1038/nchembio.1503; Kaminsky CJ, 2019, ACS CATAL, V9, P3667, DOI 10.1021/acscatal.9b00404; Kas RK, 2020, CHEM SCI, V11, P1738, DOI 10.1039/c9sc05375a; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kibsgaard J, 2015, ENERG ENVIRON SCI, V8, P3022, DOI 10.1039/c5ee02179k; Kiernicki JJ, 2017, J AM CHEM SOC, V139, P18194, DOI 10.1021/jacs.7b11465; Kinauer M, 2018, CHEM SCI, V9, P4325, DOI 10.1039/c8sc01113c; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Klug CM, 2018, ACS CATAL, V8, P3286, DOI 10.1021/acscatal.7b04379; Lamoureux PS, 2019, CHEMCATCHEM, V11, P3579, DOI 10.1002/cctc.201900595; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; LEVER ABP, 1990, INORG CHEM, V29, P1271, DOI 10.1021/ic00331a030; LEVY RB, 1973, SCIENCE, V181, P547, DOI 10.1126/science.181.4099.547; Light KM, 2016, J BIOL INORG CHEM, V21, P715, DOI 10.1007/s00775-016-1378-3; Lin ZX, 2018, GREEN CHEM, V20, P2679, DOI 10.1039/c8gc00239h; Liu J, 2019, ACS CATAL, V9, P3198, DOI 10.1021/acscatal.8b04828; Liu J, 2014, CHEM REV, V114, P4366, DOI 10.1021/cr400479b; Liu TB, 2013, NAT CHEM, V5, P228, DOI [10.1038/nchem.1571, 10.1038/NCHEM.1571]; Loewen ND, 2017, ACCOUNTS CHEM RES, V50, P2362, DOI 10.1021/acs.accounts.7b00302; Lu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7567; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Lyaskovskyy V, 2012, ACS CATAL, V2, P270, DOI 10.1021/cs200660v; Marinkovic JM, 2019, IND ENG CHEM RES, V58, P2409, DOI 10.1021/acs.iecr.8b04010; Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551; Martin DJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz3318; McCrory CCL, 2013, J AM CHEM SOC, V135, P16977, DOI 10.1021/ja407115p; McCusker JK, 2019, SCIENCE, V363, P484, DOI 10.1126/science.aav9104; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Medford AJ, 2015, J CATAL, V328, P36, DOI 10.1016/j.jcat.2014.12.033; Meyer B, 2018, CHEM SCI, V9, P7069, DOI 10.1039/c8sc01949e; Nakajima T, 2019, J AM CHEM SOC, V141, P8732, DOI 10.1021/jacs.9b03532; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Nitopi S, 2019, CHEM REV, V119, P7610, DOI 10.1021/acs.chemrev.8b00705; Norskov JK, 2005, J ELECTROCHEM SOC, V152, pJ23, DOI 10.1149/1.1856988; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Nuss P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101298; Otake KI, 2018, J AM CHEM SOC, V140, P8652, DOI 10.1021/jacs.8b05107; Ott JC, 2018, J AM CHEM SOC, V140, P17413, DOI 10.1021/jacs.8b11330; PARKER VD, 1991, J AM CHEM SOC, V113, P7493, DOI 10.1021/ja00020a007; Pelletier JDA, 2016, ACCOUNTS CHEM RES, V49, P664, DOI 10.1021/acs.accounts.5b00518; Praneeth VKK, 2012, ANGEW CHEM INT EDIT, V51, P10228, DOI 10.1002/anie.201204100; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Romelt C, 2017, INORG CHEM, V56, P4745, DOI 10.1021/acs.inorgchem.7b00401; Saravanan K, 2017, J PHYS CHEM LETT, V8, P5002, DOI 10.1021/acs.jpclett.7b01974; Sattler JJHB, 2014, CHEM REV, V114, P10613, DOI 10.1021/cr5002436; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Seefeldt LC, 2018, ACCOUNTS CHEM RES, V51, P2179, DOI 10.1021/acs.accounts.8b00112; Seh ZW, 2017, SCIENCE, V355, DOI 10.1126/science.aad4998; Seh ZW, 2016, ACS ENERGY LETT, V1, P589, DOI 10.1021/acsenergylett.6b00247; Sharma S, 2014, NAT CHEM, V6, P927, DOI [10.1038/NCHEM.2041, 10.1038/nchem.2041]; Smalley RE, 2005, MRS BULL, V30, P412, DOI 10.1557/mrs2005.124; Solis BH, 2016, P NATL ACAD SCI USA, V113, P485, DOI 10.1073/pnas.1521834112; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Sun CY, 2018, J AM CHEM SOC, V140, P17394, DOI 10.1021/jacs.8b11085; Surendranath Y, 2012, J AM CHEM SOC, V134, P6326, DOI 10.1021/ja3000084; Swart M., 2016, SPIN STATES BIOCH IN; te Grotenhuis C, 2018, ANGEW CHEM INT EDIT, V57, P140, DOI 10.1002/anie.201711028; Thorseth MA, 2013, COORDIN CHEM REV, V257, P130, DOI 10.1016/j.ccr.2012.03.033; Toogood HS, 2018, ACS CATAL, V8, P3532, DOI 10.1021/acscatal.8b00624; Trotochaud L, 2014, J AM CHEM SOC, V136, P6744, DOI 10.1021/ja502379c; Ulissi ZW, 2017, ACS CATAL, V7, P6600, DOI 10.1021/acscatal.7b01648; van Leest NP, 2018, ADV ORGANOMET CHEM, V70, P71, DOI 10.1016/bs.adomc.2018.07.002; Vesborg PCK, 2012, RSC ADV, V2, P7933, DOI 10.1039/c2ra20839c; Wang Q, 2020, CHEM REV, V120, P1438, DOI 10.1021/acs.chemrev.9b00223; Wang VCC, 2017, CHEM REV, V117, P8574, DOI 10.1021/acs.chemrev.6b00624; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Watson LA, 2003, J AM CHEM SOC, V125, P8426, DOI 10.1021/ja035166p; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; Wikstrom M, 2018, CHEM REV, V118, P2469, DOI 10.1021/acs.chemrev.7b00664; Wu G, 2013, ACCOUNTS CHEM RES, V46, P1878, DOI 10.1021/ar400011z; Yan B, 2017, JOULE, V1, P600, DOI 10.1016/j.joule.2017.08.020; Yao CB, 2019, SCIENCE, V364, P764, DOI 10.1126/science.aaw3913; Zhang B, 2016, SCIENCE, V352, P333, DOI 10.1126/science.aaf1525; Zhang J, 2005, J AM CHEM SOC, V127, P15684, DOI 10.1021/ja0555724; Zhang RJK, 2019, NATURE, V565, P67, DOI 10.1038/s41586-018-0808-5; Zhang T, 2016, J AM CHEM SOC, V138, P3241, DOI 10.1021/jacs.6b00849; Zhong M, 2020, NATURE, V581, P178, DOI 10.1038/s41586-020-2242-8; Zhou YY, 2019, SCIENCE, V363, P857, DOI 10.1126/science.aau0364; Zhu YP, 2017, ACCOUNTS CHEM RES, V50, P915, DOI 10.1021/acs.accounts.6b00635; Zuo WW, 2013, SCIENCE, V342, P1080, DOI 10.1126/science.1244466	127	144	144	41	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					786	+	eabc3183	10.1126/science.abc3183	http://dx.doi.org/10.1126/science.abc3183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA3RX	32792370	Green Published, Green Accepted			2022-12-28	WOS:000559731300030
J	La Roca, P; Sade, M				La Roca, Paulo; Sade, Marcos			Designing a wider superelastic window	SCIENCE			English	Editorial Material									[La Roca, Paulo] Ctr Atom Bariloche CNEA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Sade, Marcos] Univ Nacl Cuyo, CONICET, CNEA, Inst Balseiro, San Carlos De Bariloche, Rio Negro, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	La Roca, P (corresponding author), Ctr Atom Bariloche CNEA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	paulo.laroca@cab.cnea.gov.ar		La Roca, Paulo Matias/0000-0003-0856-6052	ANPCyT [PICT 2017-2198, PICT 2017-4518]; CONICET [PIP 2017-0634]; U.N.Cuyo [06/C588]	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); U.N.Cuyo	Supported by ANPCyT (PICT 2017-2198 and PICT 2017-4518), CONICET(PIP 2017-0634),and U.N.Cuyo (06/C588).	Bubani FD, 2012, MAT SCI ENG A-STRUCT, V543, P88, DOI 10.1016/j.msea.2012.02.051; Jani JM, 2014, MATER DESIGN, V56, P1078, DOI 10.1016/j.matdes.2013.11.084; La Roca P, 2017, SHAPE MEM SUPERELAST, V3, P37, DOI 10.1007/s40830-016-0097-5; Omori T, 2011, SCIENCE, V333, P68, DOI 10.1126/science.1202232; Otsuka K., 1999, SHAPE MEMORY MAT; Sutou Y, 2009, ACTA MATER, V57, P5759, DOI 10.1016/j.actamat.2009.08.011; Xia J, 2020, SCIENCE, V369, P855, DOI 10.1126/science.abc1590	7	1	1	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					773	774		10.1126/science.abc8244	http://dx.doi.org/10.1126/science.abc8244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792384	Green Accepted			2022-12-28	WOS:000559731300020
J	Kuehn, BM				Kuehn, Bridget M.			Severe Hypoglycemia Linked With Over-the-Counter Supplement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					540	540		10.1001/jama.2020.12914	http://dx.doi.org/10.1001/jama.2020.12914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780142				2022-12-28	WOS:000562845100008
J	Akiyama, N				Akiyama, Nobumasa			Nuclear weapons: arms-control efforts need China	NATURE			English	Editorial Material						Nuclear physics; Society; History			[Akiyama, Nobumasa] Hitotsubashi Univ, Int Relat, Tokyo, Japan	Hitotsubashi University	Akiyama, N (corresponding author), Hitotsubashi Univ, Int Relat, Tokyo, Japan.	n.akiyama@r.hit-u.ac.jp						[Anonymous], 2020, SIPRI YB 2020, P354; [Anonymous], 2018, SEC OUR COMM FUT AG; Kaplan M. F., 1975, HUMAN JUDGMENT DECIS, P87; Krepinevich Jr A. F., 2019, FOREIGN AFFAIRS; Panda A, 2017, THE DIPLOMAT	5	0	0	2	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					40	42		10.1038/d41586-020-02282-9	http://dx.doi.org/10.1038/d41586-020-02282-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU9KG	32753758				2022-12-28	WOS:000555983600012
J	Mercer, J; Lee, JE; Saphire, EO; Freeman, SA				Mercer, Jason; Lee, Jeffrey E.; Saphire, Erica Ollmann; Freeman, Spencer A.			SnapShot: Enveloped Virus Entry	CELL			English	Editorial Material									[Mercer, Jason] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Mercer, Jason] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lee, Jeffrey E.; Freeman, Spencer A.] Univ Toronto, Toronto, ON, Canada; [Saphire, Erica Ollmann] La Jolla Inst Immunol, La Jolla, CA USA; [Freeman, Spencer A.] Hosp Sick Children, Toronto, ON, Canada	University of Birmingham; University of Birmingham; University of Toronto; La Jolla Institute for Immunology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Mercer, J (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Mercer, J (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.			Mercer, Jason/0000-0003-1466-9541				Benton DJ, 2020, NATURE, V583, P150, DOI 10.1038/s41586-020-2333-6; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Freeman SA, 2020, SCIENCE, V367, P301, DOI 10.1126/science.aaw9544; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Kilcher S, 2015, VIROLOGY, V479, P578, DOI 10.1016/j.virol.2015.01.024; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758	11	20	21	5	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					786	+		10.1016/j.cell.2020.06.033	http://dx.doi.org/10.1016/j.cell.2020.06.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32763187	Green Published, Bronze			2022-12-28	WOS:000558649000021
J	Burger, JA				Burger, Jan A.			Treatment of Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							B-CELL RECEPTOR; BRUTONS TYROSINE KINASE; PREVIOUSLY UNTREATED PATIENTS; HIGH-LEVEL EXPRESSION; GENE MUTATION STATUS; OPEN-LABEL; IBRUTINIB THERAPY; CLONAL EVOLUTION; INITIAL THERAPY; CD38 EXPRESSION	Treatment of CLL, the most common leukemia in the West, has undergone a revolution in the past few years with the development of agents that target signaling kinases and cell-survival mediators. Survival even among patients with a poor prognosis now exceeds 8 years.	[Burger, Jan A.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Unit 428, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Burger, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Unit 428, Houston, TX 77030 USA.	jaburger@mdanderson.org						Ahn IE, 2018, BLOOD, V131, P2357, DOI 10.1182/blood-2017-12-820910; Ahn IE, 2017, BLOOD, V129, P1469, DOI 10.1182/blood-2016-06-719294; [Anonymous], 2017, LANCET HIV, V2, pe115; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Blombery P, 2020, BLOOD, V135, P773, DOI 10.1182/blood.2019004205; Brown JR, 2019, BRIT J HAEMATOL, V184, P558, DOI 10.1111/bjh.15690; Brown JR, 2017, HAEMATOLOGICA, V102, P1796, DOI 10.3324/haematol.2017.171041; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Burger JA, 2015, NEW ENGL J MED, V373, P2425, DOI 10.1056/NEJMoa1509388; Burger JA, 2020, LEUKEMIA, V34, P787, DOI 10.1038/s41375-019-0602-x; Burger JA, 2019, BLOOD, V133, P1011, DOI 10.1182/blood-2018-10-879429; Burger JA, 2018, NAT REV CANCER, V18, P148, DOI 10.1038/nrc.2017.121; Burger JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11589; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Byrd JC, 2019, BLOOD, V135, P1204; Byrd JC, 2020, CLIN CANC RES; Byrd JC, 2016, NEW ENGL J MED, V374, P323, DOI 10.1056/NEJMoa1509981; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Compagno M, 2017, NATURE, V542, P489, DOI 10.1038/nature21406; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dartigeas C, 2018, LANCET HAEMATOL, V5, pE82, DOI 10.1016/S2352-3026(17)30235-1; Davids MS, 2019, LANCET HAEMATOL, V6, pE419, DOI 10.1016/S2352-3026(19)30104-8; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Eichhorst B, 2016, LANCET ONCOL, V17, P928, DOI 10.1016/S1470-2045(16)30051-1; Fischer K, 2019, NEW ENGL J MED, V380, P2225, DOI 10.1056/NEJMoa1815281; Fischer K, 2016, BLOOD, V127, P208, DOI 10.1182/blood-2015-06-651125; Fischer K, 2011, J CLIN ONCOL, V29, P3559, DOI 10.1200/JCO.2010.33.8061; Flinn IW, 2018, BLOOD, V132, P2446, DOI 10.1182/blood-2018-05-850461; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gauthier J, 2020, BLOOD, V135, P1650, DOI 10.1182/blood.2019002936; Ghia P, 2020, J CLIN ONCOL, V38; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2018, BLOOD, V131, P2745, DOI 10.1182/blood-2017-09-806398; Hallek M, 2016, LANCET ONCOL, V17, P779, DOI 10.1016/S1470-2045(16)30029-8; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; HANADA M, 1993, BLOOD, V82, P1820; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herndon TM, 2017, LEUKEMIA, V31, P1340, DOI 10.1038/leu.2017.11; Hillmen P, 2015, LANCET, V385, P1873, DOI 10.1016/S0140-6736(15)60027-7; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Hoogeboom R, 2013, J EXP MED, V210, P59, DOI 10.1084/jem.20121801; JAIN N, 2019, BLOOD S, V134, DOI DOI 10.1182/blood-2019-131939; Jain N, 2019, NEW ENGL J MED, V380, P2095, DOI 10.1056/NEJMoa1900574; Jones JA, 2018, LANCET ONCOL, V19, P65, DOI 10.1016/S1470-2045(17)30909-9; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kramer I, 2017, BLOOD, V130, P1477, DOI 10.1182/blood-2017-04-775841; Lampson BL, 2017, BLOOD, V129, P2581, DOI 10.1182/blood-2016-10-742437; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Maity PC, 2020, P NATL ACAD SCI USA, V117, P4320, DOI 10.1073/pnas.1913810117; Mato AR, 2018, HAEMATOLOGICA, V103, P874, DOI 10.3324/haematol.2017.182907; Morande PE, 2019, BLOOD, V133, P2056, DOI 10.1182/blood-2018-09-876292; Moreno C, 2019, LANCET ONCOL, V20, P43, DOI 10.1016/S1470-2045(18)30788-5; O'Brien S, 2018, BLOOD, V131, P1910, DOI 10.1182/blood-2017-10-810044; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Ponader S, 2014, J CLIN ONCOL, V32, P1830, DOI 10.1200/JCO.2013.53.1046; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Roberts AW, 2019, BLOOD, V134, P111, DOI 10.1182/blood.2018882555; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Ruchlemer R, 2019, MYCOSES, V62, P1140, DOI 10.1111/myc.13001; Seymour JF, 2018, NEW ENGL J MED, V378, P1107, DOI 10.1056/NEJMoa1713976; Shanafelt TD, 2019, NEW ENGL J MED, V381, P432, DOI 10.1056/NEJMoa1817073; Sharman JP, 2020, LANCET, V395, P1278, DOI 10.1016/S0140-6736(20)30262-2; Sharman JP, 2019, J CLIN ONCOL, V37, P1391, DOI 10.1200/JCO.18.01460; Smith CIE, 2017, ONCOGENE, V36, P2045, DOI 10.1038/onc.2016.343; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Stamatopoulos K, 2017, LEUKEMIA, V31, P282, DOI 10.1038/leu.2016.322; Strati P, 2014, BLOOD, V123, P3727, DOI 10.1182/blood-2013-11-538116; Tam CS, 2019, BLOOD, V134, P851, DOI 10.1182/blood.2019001160; ten Hacken E, 2016, J IMMUNOL, V197, P2522, DOI 10.4049/jimmunol.1600915; Thijssen R, 2019, CANCER CELL, V36, P341, DOI 10.1016/j.ccell.2019.09.008; Thompson PA, 2016, BLOOD, V127, P303, DOI 10.1182/blood-2015-09-667675; Thompson PA, 2015, CANCER-AM CANCER SOC, V121, P3612, DOI 10.1002/cncr.29566; Wodarz D, 2014, BLOOD, V123, P4132, DOI 10.1182/blood-2014-02-554220; Woyach JA, 2018, NEW ENGL J MED, V379, P2517, DOI 10.1056/NEJMoa1812836; Woyach JA, 2017, J CLIN ONCOL, V35, P1437, DOI 10.1200/JCO.2016.70.2282; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Woyach JA, 2014, BLOOD, V123, P1810, DOI 10.1182/blood-2013-09-527853	92	99	99	5	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					460	473		10.1056/NEJMra1908213	http://dx.doi.org/10.1056/NEJMra1908213			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW2GI	32726532				2022-12-28	WOS:000556861800013
J	Ma, B; Shang, ZH; Hu, Y; Hu, KL; Wang, YJ; Yang, X; Ashley, MCB; Hickson, P; Jiang, P				Ma, Bin; Shang, Zhaohui; Hu, Yi; Hu, Keliang; Wang, Yongjiang; Yang, Xu; Ashley, Michael C. B.; Hickson, Paul; Jiang, Peng			Night-time measurements of astronomical seeing at Dome A in Antarctica	NATURE			English	Article							DIFFERENTIAL IMAGE MOTION; BOUNDARY-LAYER; OPTICAL TURBULENCE; SURFACE-LAYER; SITE	Seeing-the angular size of stellar images blurred by atmospheric turbulence-is a critical parameter used to assess the quality of astronomical sites at optical/infrared wavelengths. Median values at the best mid-latitude sites are generally in the range of 0.6-0.8 arcseconds(1-3). Sites on the Antarctic plateau are characterized by comparatively weak turbulence in the free atmosphere above a strong but thin boundary layer(4-6). The median seeing at Dome C is estimated to be 0.23-0.36 arcseconds(7-10)above a boundary layer that has a typical height of 30 metres(10-12). At Domes A and F, the only previous seeing measurements have been made during daytime(13,14). Here we report measurements of night-time seeing at Dome A, using a differential image motion monitor(15). Located at a height of just 8 metres, it recorded seeing as low as 0.13 arcseconds, and provided seeing statistics that are comparable to those at a height of 20 metres at Dome C. This indicates that the boundary layer was below 8 metres for 31 per cent of the time, with median seeing of 0.31 arcseconds, consistent with free-atmosphere seeing. The seeing and boundary-layer thickness are found to be strongly correlated with the near-surface temperature gradient. The correlation confirms a median thickness of approximately 14 metres for the boundary layer at Dome A, as found from a sonic radar(16). The thinner boundary layer makes it less challenging to locate a telescope above it, thereby giving greater access to the free atmosphere. The night-time seeing (the extent to which a star's light is blurred by the atmosphere) at Dome A, the highest part on the Antarctic plateau, can be as good as 0.13 arcseconds above a height of only 8 metres.	[Ma, Bin; Shang, Zhaohui; Hu, Yi; Hu, Keliang; Wang, Yongjiang; Yang, Xu] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China; [Ma, Bin; Hickson, Paul] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Shang, Zhaohui] Tianjin Normal Univ, Tianjin Astrophys Ctr, Tianjin, Peoples R China; [Ashley, Michael C. B.] Univ New South Wales, Sch Phys, Sydney, NSW, Australia; [Jiang, Peng] Polar Res Inst China, Key Lab Polar Sci, MNR, Shanghai, Peoples R China	Chinese Academy of Sciences; National Astronomical Observatory, CAS; University of British Columbia; Tianjin Normal University; University of New South Wales Sydney; Polar Research Institute of China	Ma, B; Shang, ZH; Hu, Y (corresponding author), Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China.; Ma, B (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada.; Shang, ZH (corresponding author), Tianjin Normal Univ, Tianjin Astrophys Ctr, Tianjin, Peoples R China.	bma@nao.cas.cn; zshang@gmail.com; huyi.naoc@gmail.com		Ashley, Michael/0000-0003-1412-2028; Shang, Zhaohui/0000-0002-6796-124X; Wang, Yongjiang/0000-0002-9476-3011; Ma, Bin/0000-0002-6077-6287; hu, yi/0000-0003-3317-4771				Agabi A, 2006, PUBL ASTRON SOC PAC, V118, P344, DOI 10.1086/498728; Aristidi E, 2015, MON NOT R ASTRON SOC, V454, P4304, DOI 10.1093/mnras/stv2273; Aristidi E, 2009, ASTRON ASTROPHYS, V499, P955, DOI 10.1051/0004-6361/200810953; Ashley MCB, 1996, PUBL ASTRON SOC PAC, V108, P721, DOI 10.1086/133792; Ashley MCB, 2010, PROC SPIE, V7735, DOI 10.1117/12.857853; Baas P, 2019, Q J ROY METEOR SOC, V145, P930, DOI 10.1002/qj.3450; Bonner CS, 2010, PUBL ASTRON SOC PAC, V122, P1122, DOI 10.1086/656250; Gallee H, 2015, ATMOS CHEM PHYS, V15, P6225, DOI 10.5194/acp-15-6225-2015; Hickson P, 2019, MON NOT R ASTRON SOC, V485, P2532, DOI 10.1093/mnras/stz568; Hu Y, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/aae916; Hu Y, 2014, PUBL ASTRON SOC PAC, V126, P868, DOI 10.1086/678327; Lawrence JS, 2004, NATURE, V431, P278, DOI 10.1038/nature02929; Ma B, 2018, PROC SPIE, V10700, DOI 10.1117/12.2312563; Marks RD, 1999, ASTRON ASTROPHYS SUP, V134, P161, DOI 10.1051/aas:1999100; Okita H, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321937; Pei C., 2013, IAU S, V288, P296; Petenko I, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201323299; Petenko I, 2019, BOUND-LAY METEOROL, V171, P101, DOI 10.1007/s10546-018-0419-6; SARAZIN M, 1990, ASTRON ASTROPHYS, V227, P294; Saunders W, 2009, PUBL ASTRON SOC PAC, V121, P976, DOI 10.1086/605780; Shang ZH, 2018, PROC SPIE, V10700, DOI 10.1117/12.2312439; Skidmore W, 2009, PUBL ASTRON SOC PAC, V121, P1151, DOI 10.1086/644758; Swain MR, 2006, PUBL ASTRON SOC PAC, V118, P1190, DOI 10.1086/507153; Thomas-Osip J. E., 2011, PREPRINT; Tokovinin A, 2002, PUBL ASTRON SOC PAC, V114, P1156, DOI 10.1086/342683; Trinquet H, 2008, PUBL ASTRON SOC PAC, V120, P203, DOI 10.1086/528808; Ramio HV, 2012, PUBL ASTRON SOC PAC, V124, P868, DOI 10.1086/667599; Vernin J, 2002, ASTR SOC P, V266, P2; Vignon E, 2017, J GEOPHYS RES-ATMOS, V122, P6818, DOI 10.1002/2017JD026802; Vignon E, 2017, Q J ROY METEOR SOC, V143, P1241, DOI 10.1002/qj.2998; Xu J, 2020, RES ASTRON ASTROPHYS, V20, DOI 10.1088/1674-4527/20/6/87; Yang Y, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa73dc; Yuan X., 2013, ASTROPHYS ANTARCTICA, V288, P271; Zou H, 2010, ASTRON J, V140, P602, DOI 10.1088/0004-6256/140/2/602	34	19	22	9	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					771	+		10.1038/s41586-020-2489-0	http://dx.doi.org/10.1038/s41586-020-2489-0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728236	Green Submitted			2022-12-28	WOS:000554831500029
J	Slomski, A				Slomski, Anita			Novel Therapy Eradicates H pylori	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					327	327		10.1001/jama.2020.12592	http://dx.doi.org/10.1001/jama.2020.12592			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721005				2022-12-28	WOS:000562851000009
J	Devi, S				Devi, Sharmila			Ukrainian health authorities adopt hepatitis C project	LANCET			English	Editorial Material																			0	4	4	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					228	228						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711786	Green Published, Bronze			2022-12-28	WOS:000567020100013
J	Tartof, SY; Qian, L; Hong, V; Wei, R; Nadjafi, RF; Fischer, H; Li, ZX; Shaw, SF; Caparosa, SL; Nau, CL; Saxena, T; Rieg, GK; Ackerson, BK; Sharp, AL; Skarbinski, J; Naik, TK; Murali, SB				Tartof, Sara Y.; Qian, Lei; Hong, Vennis; Wei, Rong; Nadjafi, Ron F.; Fischer, Heidi; Li, Zhuoxin; Shaw, Sally F.; Caparosa, Susan L.; Nau, Claudia L.; Saxena, Tanmai; Rieg, Gunter K.; Ackerson, Bradley K.; Sharp, Adam L.; Skarbinski, Jacek; Naik, Tej K.; Murali, Sameer B.			Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization	ANNALS OF INTERNAL MEDICINE			English	Article							ADIPOSE-TISSUE; ANGIOTENSIN; ADIPONECTIN; HYPERTENSION	Background: Obesity, race/ethnicity, and other correlated characteristics have emerged as high-profile risk factors for adverse coronavirus disease 2019 (COVID-19)-associated outcomes, yet studies have not adequately disentangled their effects. Objective: To determine the adjusted effect of body mass index (BMI), associated comorbidities, time, neighborhood-level sociodemographic factors, and other factors on risk for death due to COVID-19. Design: Retrospective cohort study. Setting: Kaiser Permanente Southern California, a large integrated health care organization. Patients: Kaiser Permanente Southern California members diagnosed with COVID-19 from 13 February to 2 May 2020. Measurements: Multivariable Poisson regression estimated the adjusted effect of BMI and other factors on risk for death at 21 days; models were also stratified by age and sex. Results: Among 6916 patients with COVID-19, there was a J-shaped association between BMI and risk for death, even after adjustment for obesity-related comorbidities. Compared with patients with a BMI of 18.5 to 24 kg/m(2), those with BMIs of 40 to 44 kg/m(2) and greater than 45 kg/m(2) had relative risks of 2.68 (95% CI, 1.43 to 5.04) and 4.18 (CI, 2.12 to 8.26), respectively. This risk was most striking among those aged 60 years or younger and men. Increased risk for death associated with Black or Latino race/ethnicity or other sociodemographic characteristics was not detected. Limitation: Deaths occurring outside a health care setting and not captured in membership files may have been missed. Conclusion: Obesity plays a profound role in risk for death from COVID-19, particularly in male patients and younger populations. Our capitated system with more equalized health care access may explain the absence of effect of racial/ethnic and socioeconomic disparities on death. Our data highlight the leading role of severe obesity over correlated risk factors, providing a target for early intervention.	[Tartof, Sara Y.; Qian, Lei; Hong, Vennis; Wei, Rong; Fischer, Heidi; Li, Zhuoxin; Shaw, Sally F.; Caparosa, Susan L.; Nau, Claudia L.; Sharp, Adam L.] Kaiser Permanente Southern Calif, 100 South Los Robles,2nd Floor, Pasadena, CA 91101 USA; [Nadjafi, Ron F.] Kaiser Permanente Southern Calif Clin Informat, Pasadena, CA USA; [Saxena, Tanmai] Southern Calif Permanente Med Grp, Anaheim, CA USA; [Rieg, Gunter K.; Ackerson, Bradley K.] Southern Calif Permanente Med Grp, Harbor City, CA USA; [Sharp, Adam L.] Southern Calif Permanente Med Grp, Los Angeles, CA USA; [Skarbinski, Jacek] Permanente Med Grp Inc, Oakland, CA USA; [Naik, Tej K.] Southern Calif Permanente Med Grp, Ontario, CA USA; [Murali, Sameer B.] Southern Calif Permanente Med Grp, Fontana, CA USA	Kaiser Permanente; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups	Tartof, SY (corresponding author), Kaiser Permanente Southern Calif, 100 South Los Robles,2nd Floor, Pasadena, CA 91101 USA.	sara.y.tartof@kp.org; Lei.x.Qian@kp.org		Shaw, Sally/0000-0002-6553-1772; Hong, Vennis/0000-0002-6060-8419; Tartof, Sara/0000-0003-2336-8476; Wei, Rong/0000-0003-0204-4982	Roche-Genentech	Roche-Genentech(Roche HoldingGenentech)	By Roche-Genentech.	Anderson MR, 2020, ANN INTERN MED, V173, P782, DOI 10.7326/M20-3214; [Anonymous], 2020, ANN INTERN MED, V173, P120, DOI [10.7326/M20-1632, DOI 10.7326/M20-1632, DOI 10.7326/M20-2730]; [Anonymous], 2013, MAN OV OB AD SYST EV; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602; Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785; Diaz E, 2011, CHEST, V139, P382, DOI 10.1378/chest.10-1160; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Hanslik T, 2010, PLOS CURR, V2; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Jain S, 2011, CLIN INFECT DIS, V53, P422, DOI 10.1093/cid/cir448; Kalligeros M, 2020, OBESITY, V28, P1200, DOI 10.1002/oby.22859; Kass DA, 2020, LANCET, V395, P1544, DOI 10.1016/S0140-6736(20)31024-2; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Ni YN, 2019, AM J MED SCI, V357, P213, DOI 10.1016/j.amjms.2018.11.015; Ni YN, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1615-3; O'Brien JM, 2004, ANN INTERN MED, V140, P338, DOI 10.7326/0003-4819-140-5-200403020-00009; PALAIODIMOS L, 2020, METABOLISM, V108, DOI [10.1016/j.metabol.2020.154262, DOI 10.1016/J.METAB0L.2020.154262]; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Ran JM, 2006, METABOLISM, V55, P478, DOI 10.1016/j.metabol.2005.10.009; Rottoli M, 2020, EUR J ENDOCRINOL, V183, P389, DOI 10.1530/EJE-20-0541; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Sharma AM, 2004, HYPERTENSION, V44, P12, DOI 10.1161/01.HYP.0000132568.71409.a2; Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6; Thebault R., 2020, WASH POST; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Wu ZY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03015-0; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhi G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163677; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zorad S, 2006, EUR J PHARMACOL, V552, P112, DOI 10.1016/j.ejphar.2006.08.062	45	295	301	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2020	173	10					773	+		10.7326/M20-3742	http://dx.doi.org/10.7326/M20-3742			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OU5XD	32783686	Green Published			2022-12-28	WOS:000591600700012
J	Auger, KA; Shah, SS; Richardson, T; Hartley, D; Hall, M; Warniment, A; Timmons, K; Bosse, D; Ferris, SA; Brady, PW; Schondelmeyer, AC; Thomson, JE				Auger, Katherine A.; Shah, Samir S.; Richardson, Troy; Hartley, David; Hall, Matthew; Warniment, Amanda; Timmons, Kristen; Bosse, Dianna; Ferris, Sarah A.; Brady, Patrick W.; Schondelmeyer, Amanda C.; Thomson, Joanna E.			Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								This population epidemiology study estimates associations of school closures in the US and the timing of those closures in March 2020 with change in daily coronavirus disease 2019 (COVID-19) incidence and mortality through the first week of May, accounting for other contemporaneous public health interventions. Importance In the US, states enacted nonpharmaceutical interventions, including school closure, to reduce the spread of coronavirus disease 2019 (COVID-19). All 50 states closed schools in March 2020 despite uncertainty if school closure would be effective. Objective To determine if school closure and its timing were associated with decreased COVID-19 incidence and mortality. Design, Setting, and Participants US population-based observational study conducted between March 9, 2020, and May 7, 2020, using interrupted time series analyses incorporating a lag period to allow for potential policy-associated changes to occur. To isolate the association of school closure with outcomes, state-level nonpharmaceutical interventions and attributes were included in negative binomial regression models. States were examined in quartiles based on state-level COVID-19 cumulative incidence per 100000 residents at the time of school closure. Models were used to derive the estimated absolute differences between schools that closed and schools that remained open as well as the number of cases and deaths if states had closed schools when the cumulative incidence of COVID-19 was in the lowest quartile compared with the highest quartile. Exposures Closure of primary and secondary schools. Main Outcomes and Measures COVID-19 daily incidence and mortality per 100000 residents. Results COVID-19 cumulative incidence in states at the time of school closure ranged from 0 to 14.75 cases per 100000 population. School closure was associated with a significant decline in the incidence of COVID-19 (adjusted relative change per week, -62% [95% CI, -71% to -49%]) and mortality (adjusted relative change per week, -58% [95% CI, -68% to -46%]). Both of these associations were largest in states with low cumulative incidence of COVID-19 at the time of school closure. For example, states with the lowest incidence of COVID-19 had a -72% (95% CI, -79% to -62%) relative change in incidence compared with -49% (95% CI, -62% to -33%) for those states with the highest cumulative incidence. In a model derived from this analysis, it was estimated that closing schools when the cumulative incidence of COVID-19 was in the lowest quartile compared with the highest quartile was associated with 128.7 fewer cases per 100000 population over 26 days and with 1.5 fewer deaths per 100000 population over 16 days. Conclusions and Relevance Between March 9, 2020, and May 7, 2020, school closure in the US was temporally associated with decreased COVID-19 incidence and mortality; states that closed schools earlier, when cumulative incidence of COVID-19 was low, had the largest relative reduction in incidence and mortality. However, it remains possible that some of the reduction may have been related to other concurrent nonpharmaceutical interventions. Question Was statewide school closure associated with decreased incidence and mortality for coronavirus disease 2019 (COVID-19)? Findings In this US population-based time series analysis conducted between March 9, 2020, and May 7, 2020, school closure was associated with a significant decline in both incidence of COVID-19 (adjusted relative change per week, -62%) and mortality (adjusted relative change per week, -58%). In a model derived from this analysis, it was estimated that closing schools when the cumulative incidence of COVID-19 was in the lowest quartile compared with the highest quartile was associated with 128.7 fewer cases per 100000 population over 26 days and with 1.5 fewer deaths per 100000 population over 16 days. Meaning There was a temporal association between statewide school closure and lower COVID-19 incidence and mortality, although some of the reductions may have been related to other concurrent nonpharmaceutical interventions.	[Auger, Katherine A.; Shah, Samir S.; Warniment, Amanda; Timmons, Kristen; Bosse, Dianna; Ferris, Sarah A.; Brady, Patrick W.; Schondelmeyer, Amanda C.; Thomson, Joanna E.] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, 3333 Burnet Ave,ML 9016, Cincinnati, OH 45229 USA; [Auger, Katherine A.; Shah, Samir S.; Hartley, David; Brady, Patrick W.; Schondelmeyer, Amanda C.] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA; [Auger, Katherine A.; Shah, Samir S.; Hartley, David; Brady, Patrick W.; Schondelmeyer, Amanda C.; Thomson, Joanna E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Auger, Katherine A.; Shah, Samir S.; Richardson, Troy; Hall, Matthew; Brady, Patrick W.; Thomson, Joanna E.] Pediat Res Inpatient Settings Network, Cincinnati, OH USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Warniment, Amanda] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Auger, KA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, 3333 Burnet Ave,ML 9016, Cincinnati, OH 45229 USA.	katherine.auger@cchmc.org	Hall, Matt/AAT-1349-2021	Hall, Matt/0000-0001-7778-5887	Agency for Healthcare Research and Quality [KO8HS024735, K08HS023827, K08HS026763, K08HS025138, 5UL1TR001425-04]; National Center for Advancing Translational Sciences, National Institutes of Health	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this work was provided by Agency for Healthcare Research and Quality awards KO8HS024735 (Dr Auger), K08HS023827 (Dr Brady), K08HS026763 (Dr Schondelmeyer), and K08HS025138 (Dr Thomson) and award 5UL1TR001425-04 from the National Center for Advancing Translational Sciences, National Institutes of Health.	American Academy of Pediatrics, COVID 19 PLANN CONS; [Anonymous], **DATA OBJECT**; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Chu YH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013159; Colorado Department of Public Health and Environment, GET TEST; COVID Tracking Project, DAT API; De Luca G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2934-3; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Esposito S, 2020, JAMA PEDIATR, V174, P921, DOI 10.1001/jamapediatrics.2020.1892; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Georgia Department of Public Health, COVID 19; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]; Indiana State Department of Health, 2019 NOV COR COVID 1; Iowa Department of Public Health, NOV COR AC RESP DIS; Kaiser Family Foundation, TOT NUMB RES CERT NU; Koetsier J, 58 AM KNOWLEDGE WORK; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li Q, 2020, INFECT DIS THER, V9, P823, DOI 10.1007/s40121-020-00332-3; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Minnesota Department of Health, COR DIS 2019 COVID 1; Montana Department of Public Health and Human Services, 2019 NOV COR COVID 1; New Hampshire Department of Health and Human Services, NOV COR 2019 COVID 1; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Rosalsky G, COVID 19 FORCES MORE; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; South Carolina Department of Health and Environmental Control, COR DIS 2019 COVID 1; UN, POL BRIEF IMP COVID; US Census Bureau, AM COMMUNITY SURVEY; US Centers for Disease Control and Prevention, SOC VULN IND; US Centers for Disease Control and Prevention, SCH COVID 19 PAND; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Worby CJ, 2015, EPIDEMICS-NETH, V13, P10, DOI 10.1016/j.epidem.2015.04.003; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	38	194	199	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					859	870		10.1001/jama.2020.14348	http://dx.doi.org/10.1001/jama.2020.14348			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32745200	Green Published, Bronze			2022-12-28	WOS:000570094600015
J	Prescott, HC; Girard, TD				Prescott, Hallie C.; Girard, Timothy D.			Recovery From Severe COVID-19 Leveraging the Lessons of Survival From Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Prescott, Hallie C.] Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA; [Prescott, Hallie C.] VA Ctr Clin Management Res, Ann Arbor, MI USA; [Girard, Timothy D.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Girard, Timothy D.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prescott, HC (corresponding author), Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA.	hprescot@med.umich.edu		Girard, Timothy/0000-0002-9833-4871; Prescott, Hallie/0000-0002-8442-6724				Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Haines KJ, 2019, CRIT CARE MED, V47, P1194, DOI 10.1097/CCM.0000000000003818; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; McPeake J, 2019, ANN AM THORAC SOC, V16, P1304, DOI 10.1513/AnnalsATS.201903-248OC; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Prescott HC, 2015, JAMA-J AM MED ASSOC, V313, P1055, DOI 10.1001/jama.2015.1410; Schmidt K, 2016, JAMA-J AM MED ASSOC, V315, P2703, DOI 10.1001/jama.2016.7207; Taylor SP, 2020, ANN AM THORAC SOC, V17, P89, DOI 10.1513/AnnalsATS.201907-514OC	10	47	47	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					739	740		10.1001/jama.2020.14103	http://dx.doi.org/10.1001/jama.2020.14103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32777028	Bronze			2022-12-28	WOS:000568230000015
J	Saunders, SH; Tse, ECM; Yates, MD; Otero, FJ; Trammell, SA; Stemp, EDA; Barton, JK; Tender, LM; Newman, DK				Saunders, Scott H.; Tse, Edmund C. M.; Yates, Matthew D.; Otero, Fernanda Jimenez; Trammell, Scott A.; Stemp, Eric D. A.; Barton, Jacqueline K.; Tender, Leonard M.; Newman, Dianne K.			Extracellular DNA Promotes Efficient Extracellular Electron Transfer by Pyocyanin in Pseudomonas aeruginosa Biofilms	CELL			English	Article							CHARGE-TRANSPORT; MICROBIAL NANOWIRES; BACTERIAL BIOFILMS; MECHANISMS; DIFFUSION; EXOPOLYSACCHARIDE; CONDUCTIVITY; ANTIBIOTICS; PHENAZINES; FLAVINS	Redox cycling of extracellular electron shuttles can enable the metabolic activity of subpopulations within multicellular bacterial biofilms that lack direct access to electron acceptors or donors. How these shuttles catalyze extracellular electron transfer (EET) within biofilms without being lost to the environment has been a long-standing question. Here, we show that phenazines mediate efficient EET through interactions with extracellular DNA (eDNA) in Pseudomonas aeruginosa biofilms. Retention of pyocyanin (PYO) and phenazine carboxamide in the biofilm matrix is facilitated by eDNA binding. In vitro, different phenazines can exchange electrons in the presence or absence of DNA and can participate directly in redox reactions through DNA. In vivo, biofilm eDNA can also support rapid electron transfer between redox active intercalators. Together, these results establish that PYO:eDNA interactions support an efficient redox cycle with rapid EET that is faster than the rate of PYO loss from the biofilm.	[Saunders, Scott H.; Newman, Dianne K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Tse, Edmund C. M.; Barton, Jacqueline K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Tse, Edmund C. M.] Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China; [Yates, Matthew D.; Trammell, Scott A.; Tender, Leonard M.] Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Otero, Fernanda Jimenez] George Mason Univ, Fairfax, VA 22030 USA; [Stemp, Eric D. A.] Mt St Marys Univ, Dept Phys Sci, Los Angeles, CA USA; [Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; University of Hong Kong; United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; California Institute of Technology	Newman, DK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Barton, JK (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Tender, LM (corresponding author), Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.; Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	jkbarton@caltech.edu; leonard.tender@nrl.navy.mil; dkn@caltech.edu	Tse, Edmund Chun Ming/L-6841-2019; Tse, Edmund Chun Ming CM/E-5309-2019; Trammell, Scott A./ABB-7140-2020	Tse, Edmund Chun Ming/0000-0002-9313-1290; Tse, Edmund Chun Ming CM/0000-0002-9313-1290; Trammell, Scott A./0000-0002-7996-590X; Yates, Matthew/0000-0003-4373-3864; Jimenez Otero, Fernanda/0000-0003-1583-6495; Stemp, Eric/0000-0003-2098-4214	NIH [1R01AI127850-01A1, GM126904]; ARO [W911NF-17-1-0024]; ONR [N0001418WX00436]; Rosen Bioengineering Center at Caltech; Croucher Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARO; ONR(Office of Naval Research); Rosen Bioengineering Center at Caltech; Croucher Foundation	We thank Jeanyoung Jo, Lars Dietrich, and Matthew Parsek for providing strains and the Biological Imaging Center, GPS Division Analytical Facility, and Beckman Institute Laser Resource Center at Caltech for supporting confocal imaging, SEM imaging, and time resolved spectroscopy, respectively. We also thank three anonymous reviewers for their constructive comments. This work was supported by NIH (1R01AI127850-01A1 to D.K.N. and GM126904 to J.K.B.); ARO (W911NF-17-1-0024 to D.K.N.); ONR (N0001418WX00436 to M.D.Y., S.A.T., and L. M.T.); and Rosen Bioengineering Center at Caltech (to S.H.S., D.K. N., and J.K.B.). E.C.M.T. was supported by a Croucher Foundation Research Fellowship.	Akhoury A, 2013, J PHYS CHEM B, V117, P333, DOI 10.1021/jp302157g; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Allison DG, 2003, BIOFOULING, V19, P139, DOI 10.1038/nrmicro2415; [Anonymous], 2017, QDOAS VERSION 32 SO; Arkin MR, 1996, SCIENCE, V273, P475, DOI 10.1126/science.273.5274.475; Arkin MR, 1996, J AM CHEM SOC, V118, P2267, DOI 10.1021/ja9532998; Atlas RM., 2004, HDB MICROBIOLOGICAL; Bard A. J., 1980, ELECTROCHEMICAL METH; Bellin DL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10535; Bellin DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4256; Bergkessel M, 2019, MOL MICROBIOL, V112, P992, DOI 10.1111/mmi.14337; Boyd DA, 2015, BIOFILMS IN BIOELECTROCHEMICAL SYSTEMS: FROM LABORATORY PRACTICE TO DATA INTERPRETATION, P177; Chincholkar S., 2013, MICROBIAL PHENAZINES, DOI 10.1007/978-3-642-40573-0; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Cornelissen R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03044; Costa KC, 2017, SCIENCE, V355, P170, DOI 10.1126/science.aag3180; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DALTON EF, 1990, CHEM PHYS, V141, P143, DOI 10.1016/0301-0104(90)80026-T; Das T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08398; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Duvvuri H, 2018, BIOCHEMISTRY-US, V57, P2578, DOI 10.1021/acs.biochem.7b01264; Friedheim EAH, 1934, BIOCHEM J, V28, P173, DOI 10.1042/bj0280173; FRIEDMAN MS, 1990, DESIGN QUART, P2; Genereux JC, 2010, CHEM REV, V110, P1642, DOI 10.1021/cr900228f; Glasser NR, 2017, ANNU REV MICROBIOL, V71, P731, DOI 10.1146/annurev-micro-090816-093913; Glasser NR, 2017, J BIOL CHEM, V292, P5593, DOI 10.1074/jbc.M116.772848; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hernandez ME, 2004, APPL ENVIRON MICROB, V70, P921, DOI 10.1128/AEM.70.2.921-928.2004; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; HOLLSTEIN U, 1971, BIOCHEMISTRY-US, V10, P497, DOI 10.1021/bi00779a023; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; JERNAES MW, 1994, CYTOMETRY, V17, P302, DOI 10.1002/cyto.990170405; Jo J, 2017, ELIFE, V6, DOI [10.7554/eLife.30205, 10.7554/elife.30205]; Kahl L.J., 2019, BIORXIV, DOI [10.1101/797357., DOI 10.1101/797357]; Kahl LJ, 2016, FREE RADICAL BIO MED, V100, pS185, DOI 10.1016/j.freeradbiomed.2016.10.509; Kavanaugh JS, 2019, MBIO, V10, DOI 10.1128/mBio.01137-19; Kelley SO, 1997, BIOCONJUGATE CHEM, V8, P31, DOI 10.1021/bc960070o; Kempes CP, 2014, P NATL ACAD SCI USA, V111, P208, DOI 10.1073/pnas.1315521110; Light SH, 2018, NATURE, V562, P140, DOI 10.1038/s41586-018-0498-z; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Liu X, 2019, APPL MICROBIOL BIOT, V103, P1535, DOI 10.1007/s00253-018-9484-5; Lovric M, 2010, ELECTROANALYTICAL METHODS: GUIDE TO EXPERIMENTS AND APPLICATIONS, SECOND EDITION, P121, DOI 10.1007/978-3-642-02915-8_6; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Maruthupandy M, 2015, ADV NAT SCI-NANOSCI, V6, DOI 10.1088/2043-6262/6/4/045007; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Meirelles LA, 2018, MOL MICROBIOL, V110, P995, DOI 10.1111/mmi.14132; Muller K, 2018, HMS PRETTY TIME DAY; Nevin KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005628; Niesner R, 2000, J CHEM ENG DATA, V45, P1121, DOI 10.1021/je0000569; Okshevsky M, 2014, J MICROBIOL METH, V105, P102, DOI 10.1016/j.mimet.2014.07.010; Otero FJ, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00347-18; Pandit A, 2020, J APPL MICROBIOL, V129, P199, DOI 10.1111/jam.14609; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Robinson D., 2018, BROOM CONVERT STAT A; Rollefson JB, 2011, J BACTERIOL, V193, P1023, DOI 10.1128/JB.01092-10; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroth MN, 2018, J MED MICROBIOL, V67, P1191, DOI 10.1099/jmm.0.000758; Shi L, 2016, NAT REV MICROBIOL, V14, P651, DOI 10.1038/nrmicro.2016.93; Slinker JD, 2011, NAT CHEM, V3, P228, DOI 10.1038/NCHEM.982; Slinker JD, 2010, J AM CHEM SOC, V132, P2769, DOI 10.1021/ja909915m; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Stein R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11148; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; STEMP EDA, 1995, J AM CHEM SOC, V117, P2375, DOI 10.1021/ja00113a037; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Subramanian P, 2018, P NATL ACAD SCI USA, V115, pE3246, DOI 10.1073/pnas.1718810115; Team RC., 2013, R LANG ENV STAT COMP; Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159; Tse ECM, 2019, ACS CENTRAL SCI, V5, P65, DOI 10.1021/acscentsci.8b00566; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Wang FB, 2019, CELL, V177, P361, DOI 10.1016/j.cell.2019.03.029; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WHITE HS, 1982, J AM CHEM SOC, V104, P4811, DOI 10.1021/ja00382a013; Xu S, 2018, J AM CHEM SOC, V140, P10085, DOI 10.1021/jacs.8b05104; Xu S, 2016, ELECTROCHIM ACTA, V198, P49, DOI 10.1016/j.electacta.2016.03.074; Yates MD, 2015, PHYS CHEM CHEM PHYS, V17, P32564, DOI 10.1039/c5cp05152e	87	67	69	24	174	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					919	+		10.1016/j.cell.2020.07.006	http://dx.doi.org/10.1016/j.cell.2020.07.006			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32763156	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000561488500013
J	Ospina, ML; Tong, VT; Gonzalez, M; Valencia, D; Mercado, M; Gilboa, SM; Rodriguez, AJ; Tinker, SC; Rico, A; Winfield, CM; Pardo, L; Thomas, JD; Avila, G; Villanueva, JM; Gomez, S; Jamieson, DJ; Prieto, F; Meaney-Delman, D; Pacheco, O; Honein, MA				Ospina, Martha L.; Tong, Van T.; Gonzalez, Maritza; Valencia, Diana; Mercado, Marcela; Gilboa, Suzanne M.; Rodriguez, Andrea J.; Tinker, Sarah C.; Rico, Angelica; Winfield, Christina M.; Pardo, Lissethe; Thomas, Jennifer D.; Avila, Greace; Villanueva, Julie M.; Gomez, Sara; Jamieson, Denise J.; Prieto, Franklyn; Meaney-Delman, Dana; Pacheco, Oscar; Honein, Margaret A.			Zika Virus Disease and Pregnancy Outcomes in Colombia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-DEFECTS; INFECTION; INFANTS; TRANSMISSION; TERRITORIES; BRAZIL	BackgroundIn 2015 and 2016, Colombia had a widespread outbreak of Zika virus. Data from two national population-based surveillance systems for symptomatic Zika virus disease (ZVD) and birth defects provided complementary information on the effect of the Zika virus outbreak on pregnancies and infant outcomes. MethodsWe collected national surveillance data regarding cases of pregnant women with ZVD that were reported during the period from June 2015 through July 2016. The presence of Zika virus RNA was identified in a subgroup of these women on real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR) assay. Brain or eye defects in infants and fetuses and other adverse pregnancy outcomes were identified among the women who had laboratory-confirmed ZVD and for whom data were available regarding pregnancy outcomes. We compared the nationwide prevalence of brain and eye defects during the outbreak with the prevalence both before and after the outbreak period. ResultsOf 18,117 pregnant women with ZVD, the presence of Zika virus was confirmed in 5926 (33%) on rRT-PCR. Of the 5673 pregnancies with laboratory-confirmed ZVD for which outcomes had been reported, 93 infants or fetuses (2%) had brain or eye defects. The incidence of brain or eye defects was higher among pregnancies in which the mother had an onset of ZVD symptoms in the first trimester than in those with an onset during the second or third trimester (3% vs. 1%). A total of 172 of 5673 pregnancies (3%) resulted in pregnancy loss; after the exclusion of pregnancies affected by birth defects, 409 of 5426 (8%) resulted in preterm birth and 333 of 5426 (6%) in low birth weight. The prevalence of brain or eye defects during the outbreak was 13 per 10,000 live births, as compared with a prevalence of 8 per 10,000 live births before the outbreak and 11 per 10,000 live births after the outbreak. ConclusionsIn pregnant women with laboratory-confirmed ZVD, brain or eye defects in infants or fetuses were more common during the Zika virus outbreak than during the periods immediately before and after the outbreak. The frequency of such defects was increased among women with a symptom onset early in pregnancy. (Funded by the Colombian Instituto Nacional de Salud and the Centers for Disease Control and Prevention.) In an epidemiologic study of the Zika virus outbreak in Columbia in 2015 and 2016, brain or eye defects were diagnosed in 93 of 5673 infants or fetuses (2%) carried by women with laboratory-confirmed Zika virus disease.	[Ospina, Martha L.; Gonzalez, Maritza; Mercado, Marcela; Rodriguez, Andrea J.; Rico, Angelica; Pardo, Lissethe; Avila, Greace; Gomez, Sara; Prieto, Franklyn; Pacheco, Oscar] Inst Nacl Salud, Bogota, Colombia; [Tong, Van T.; Valencia, Diana; Gilboa, Suzanne M.; Tinker, Sarah C.; Winfield, Christina M.; Thomas, Jennifer D.; Villanueva, Julie M.; Meaney-Delman, Dana; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA	Instituto Nacional de Salud (Colombia); Centers for Disease Control & Prevention - USA; Emory University	Tong, VT (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.	vtong@cdc.gov		Tong, Van/0000-0002-3970-1440; PRIETO ALVARADO, FRANKLYN EDWIN/0000-0002-2079-7251	Colombian Instituto Nacional de Salud (INS); CDC; Office of Infectious Disease, Bureau for Global Health, U.S. Agency for International Development	Colombian Instituto Nacional de Salud (INS); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Infectious Disease, Bureau for Global Health, U.S. Agency for International Development(United States Agency for International Development (USAID))	Supported by the Colombian Instituto Nacional de Salud (INS) and the CDC under an interagency agreement with the Office of Infectious Disease, Bureau for Global Health, U.S. Agency for International Development.	Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Centers for Disease Control and Prevention, 2021, TRIOPL REAL TIM RT P; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Departamento Administrativo Nacional de Estadistica, 2014, NAC AR OC SEX SEG GR; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Honein MA, 2020, JAMA PEDIATR, V174, P237, DOI 10.1001/jamapediatrics.2019.5257; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Honein MA, 2016, NEW ENGL J MED, V375, P2393, DOI 10.1056/NEJMe1613368; Instituto Nacional de Salud, 2016, EP WEEK 30; Instituto Nacional de Salud, 2015, 0043 I NAC SAL; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3; Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1; Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204; Olson SM, 2019, BIRTH DEFECTS RES, V111, P938, DOI 10.1002/bdr2.1546; Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1; Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1	33	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					537	545		10.1056/NEJMoa1911023	http://dx.doi.org/10.1056/NEJMoa1911023			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	32757522	Bronze, Green Accepted			2022-12-28	WOS:000560438400016
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Medical Letter review describes how tafamidis prevents transthyretin protein complexes from disocciating into amyloid fibrils, and its recent approval in 2 different formulations (Vyndaqel and Vyndamax) for treatment of adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM).					Pflomm, Jean-Marie/HDO-0765-2022					Gertz MA, 2015, J AM COLL CARDIOL, V66, P2451, DOI 10.1016/j.jacc.2015.09.075; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; US Food and Drug Administration, FDA SUMM REV VYND TA	4	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					505	505		10.1001/jama.2020.0753	http://dx.doi.org/10.1001/jama.2020.0753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749489				2022-12-28	WOS:000561261900021
J	Yang, JY; Wang, W; Chen, ZM; Lu, SY; Yang, FL; Bi, ZF; Bao, LL; Mo, F; Li, X; Huang, Y; Hong, WQ; Yang, Y; Zhao, Y; Ye, F; Lin, S; Deng, W; Chen, H; Lei, H; Zhang, ZQ; Luo, M; Gao, H; Zheng, Y; Gong, YQ; Jiang, XH; Xu, YF; Lv, Q; Li, D; Wang, MN; Li, FD; Wang, SY; Wang, GP; Yu, P; Qu, YJ; Yang, L; Deng, HX; Tong, AP; Li, J; Wang, ZL; Yang, JL; Shen, GB; Zhao, ZW; Li, YH; Luo, JW; Liu, HQ; Yu, WH; Yang, ML; Xu, JW; Wang, JB; Li, HY; Wang, HX; Kuang, DX; Lin, PP; Hu, ZT; Guo, W; Cheng, W; He, YL; Song, XR; Chen, C; Xue, ZH; Yao, SH; Chen, L; Ma, XL; Chen, SY; Gou, ML; Huang, WJ; Wang, YC; Fan, CF; Tian, ZX; Shi, M; Wang, FS; Dai, LZ; Wu, M; Li, G; Wang, GY; Peng, Y; Qian, ZY; Huang, CH; Lau, JYN; Yang, ZL; Wei, YQ; Cen, XB; Peng, XZ; Qin, C; Zhang, K; Lu, GW; Wei, XW				Yang, Jingyun; Wang, Wei; Chen, Zimin; Lu, Shuaiyao; Yang, Fanli; Bi, Zhenfei; Bao, Linlin; Mo, Fei; Li, Xue; Huang, Yong; Hong, Weiqi; Yang, Yun; Zhao, Yuan; Ye, Fei; Lin, Sheng; Deng, Wei; Chen, Hua; Lei, Hong; Zhang, Ziqi; Luo, Min; Gao, Hong; Zheng, Yue; Gong, Yanqiu; Jiang, Xiaohua; Xu, Yanfeng; Lv, Qi; Li, Dan; Wang, Manni; Li, Fengdi; Wang, Shunyi; Wang, Guanpeng; Yu, Pin; Qu, Yajin; Yang, Li; Deng, Hongxin; Tong, Aiping; Li, Jiong; Wang, Zhenling; Yang, Jinliang; Shen, Guobo; Zhao, Zhiwei; Li, Yuhua; Luo, Jingwen; Liu, Hongqi; Yu, Wenhai; Yang, Mengli; Xu, Jingwen; Wang, Junbin; Li, Haiyan; Wang, Haixuan; Kuang, Dexuan; Lin, Panpan; Hu, Zhengtao; Guo, Wei; Cheng, Wei; He, Yanlin; Song, Xiangrong; Chen, Chong; Xue, Zhihong; Yao, Shaohua; Chen, Lu; Ma, Xuelei; Chen, Siyuan; Gou, Maling; Huang, Weijin; Wang, Youchun; Fan, Changfa; Tian, Zhixin; Shi, Ming; Wang, Fu-Sheng; Dai, Lunzhi; Wu, Min; Li, Gen; Wang, Guangyu; Peng, Yong; Qian, Zhiyong; Huang, Canhua; Lau, Johnson Yiu-Nam; Yang, Zhenglin; Wei, Yuquan; Cen, Xiaobo; Peng, Xiaozhong; Qin, Chuan; Zhang, Kang; Lu, Guangwen; Wei, Xiawei			A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity	NATURE			English	Article							RECEPTOR-BINDING DOMAIN; MERS-COV; CORONAVIRUS; SPIKE; NEUTRALIZATION; ANTIBODIES; MICE; RESPONSES; ALUMINUM; SUBUNIT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory disease called coronavirus disease 2019 (COVID-19), the spread of which has led to a pandemic. An effective preventive vaccine against this virus is urgently needed. As an essential step during infection, SARS-CoV-2 uses the receptor-binding domain (RBD) of the spike protein to engage with the receptor angiotensin-converting enzyme 2 (ACE2) on host cells(1,2). Here we show that a recombinant vaccine that comprises residues 319-545 of the RBD of the spike protein induces a potent functional antibody response in immunized mice, rabbits and non-human primates (Macaca mulatta) as early as 7 or 14 days after the injection of a single vaccine dose. The sera from the immunized animals blocked the binding of the RBD to ACE2, which is expressed on the cell surface, and neutralized infection with a SARS-CoV-2 pseudovirus and live SARS-CoV-2 in vitro. Notably, vaccination also provided protection in non-human primates to an in vivo challenge with SARS-CoV-2. We found increased levels of RBD-specific antibodies in the sera of patients with COVID-19. We show that several immune pathways and CD4 T lymphocytes are involved in the induction of the vaccine antibody response. Our findings highlight the importance of the RBD domain in the design of SARS-CoV-2 vaccines and provide a rationale for the development of a protective vaccine through the induction of antibodies against the RBD domain. A recombinant vaccine that targets the receptor-binding domain of the spike protein of SARS-CoV-2 induces a potent antibody response in immunized mice, rabbits and non-human primates, and protects primates from infection with the virus.	[Yang, Jingyun; Wang, Wei; Chen, Zimin; Yang, Fanli; Bi, Zhenfei; Mo, Fei; Li, Xue; Huang, Yong; Hong, Weiqi; Ye, Fei; Lin, Sheng; Chen, Hua; Lei, Hong; Zhang, Ziqi; Luo, Min; Zheng, Yue; Gong, Yanqiu; Jiang, Xiaohua; Li, Dan; Wang, Manni; Yang, Li; Deng, Hongxin; Tong, Aiping; Li, Jiong; Wang, Zhenling; Yang, Jinliang; Shen, Guobo; Zhao, Zhiwei; Luo, Jingwen; Lin, Panpan; Cheng, Wei; Song, Xiangrong; Chen, Chong; Xue, Zhihong; Yao, Shaohua; Chen, Lu; Ma, Xuelei; Chen, Siyuan; Gou, Maling; Dai, Lunzhi; Wu, Min; Peng, Yong; Qian, Zhiyong; Huang, Canhua; Wei, Yuquan; Cen, Xiaobo; Lu, Guangwen; Wei, Xiawei] Sichuan Univ, Lab Aging Res & Canc Drug Target, State Key Lab Biotherapy, Natl Clin Res Ctr Geriatr,West China Hosp, Chengdu, Peoples R China; [Yang, Jingyun; Wang, Wei; Chen, Zimin; Yang, Fanli; Bi, Zhenfei; Mo, Fei; Li, Xue; Huang, Yong; Hong, Weiqi; Ye, Fei; Lin, Sheng; Chen, Hua; Lei, Hong; Zhang, Ziqi; Luo, Min; Zheng, Yue; Gong, Yanqiu; Jiang, Xiaohua; Li, Dan; Wang, Manni; Yang, Li; Deng, Hongxin; Tong, Aiping; Li, Jiong; Wang, Zhenling; Yang, Jinliang; Shen, Guobo; Zhao, Zhiwei; Luo, Jingwen; Lin, Panpan; Cheng, Wei; Song, Xiangrong; Chen, Chong; Xue, Zhihong; Yao, Shaohua; Chen, Lu; Ma, Xuelei; Chen, Siyuan; Gou, Maling; Dai, Lunzhi; Wu, Min; Peng, Yong; Qian, Zhiyong; Huang, Canhua; Wei, Yuquan; Cen, Xiaobo; Lu, Guangwen; Wei, Xiawei] Sichuan Univ, Canc Ctr, Natl Clin Res Ctr Geriatr, West China Hosp, Chengdu, Peoples R China; [Lu, Shuaiyao; Yang, Yun; Zhao, Yuan; Liu, Hongqi; Yu, Wenhai; Yang, Mengli; Xu, Jingwen; Wang, Junbin; Li, Haiyan; Wang, Haixuan; Kuang, Dexuan; Peng, Xiaozhong] Chinese Acad Med Sci & Peking Union Med Coll, Natl Kunming Highlevel Biosafety Primate Res Ctr, Kunming, Yunnan, Peoples R China; [Bao, Linlin; Deng, Wei; Gao, Hong; Xu, Yanfeng; Lv, Qi; Li, Fengdi; Wang, Shunyi; Wang, Guanpeng; Yu, Pin; Qu, Yajin; Qin, Chuan] Chinese Acad Med Sci & Comparat Med Ctr, Peking Union Med Coll, Key Lab Human Dis Comparat Med,Inst Lab Anim Sci, Chinese Minist Hlth,Beijing Key Lab Anim Models E, Beijing, Peoples R China; [Li, Yuhua; Huang, Weijin; Wang, Youchun; Fan, Changfa] Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China; [Guo, Wei; He, Yanlin; Cen, Xiaobo] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Natl Chengdu Ctr Safety Evaluat Drugs, State Key Lab Biotherapy,West CHina Hosp, Chengdu, Peoples R China; [Guo, Wei; He, Yanlin; Cen, Xiaobo] Sichuan Univ, West China Hosp, Canc Ctr, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Hu, Zhengtao; Tian, Zhixin] Tongji Univ, Sch Chem Sci & Engn, Shanghai Key Lab Chem Assessment & Sustainabil, Shanghai, Peoples R China; [Shi, Ming; Wang, Fu-Sheng] Peoples Liberat Army Gen Hosp, Med Ctr 5, Treatment & Res Ctr Infect Dis, Natl Clin Res Ctr Infect Dis, Beijing, Peoples R China; [Li, Gen; Zhang, Kang] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China; [Wang, Guangyu] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Lau, Johnson Yiu-Nam] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Peoples R China; [Yang, Zhenglin] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Yang, Zhenglin] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Lab Med, Chengdu, Peoples R China; [Peng, Xiaozhong] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Lu, Guangwen] Sichuan Univ, West China Hosp, Emergency Dept, State Key Lab Biotherapy, Chengdu, Peoples R China	Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China; Sichuan University; Sichuan University; Tongji University; Chinese People's Liberation Army General Hospital; Macau University of Science & Technology; Tsinghua University; Hong Kong Polytechnic University; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University	Lu, GW; Wei, XW (corresponding author), Sichuan Univ, Lab Aging Res & Canc Drug Target, State Key Lab Biotherapy, Natl Clin Res Ctr Geriatr,West China Hosp, Chengdu, Peoples R China.; Lu, GW; Wei, XW (corresponding author), Sichuan Univ, Canc Ctr, Natl Clin Res Ctr Geriatr, West China Hosp, Chengdu, Peoples R China.; Zhang, K (corresponding author), Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China.; Lu, GW (corresponding author), Sichuan Univ, West China Hosp, Emergency Dept, State Key Lab Biotherapy, Chengdu, Peoples R China.	kang.zhang@gmail.com; lugw@scu.edu.cn; xiaweiwei@scu.edu.cn	qin, chuan/ABG-4508-2020; xu, jing/GRR-8698-2022; CHEN, SI/GZL-4800-2022; huang, weijin/AAY-5028-2020; Chen, Chong/AAR-4186-2021; zhang, ziqi/GPW-6618-2022; Zhang, Ziqi/HHN-7875-2022; Lu, Guangwen/HCH-9193-2022; yang, mengli/HGA-8986-2022; Deng, Wei/GWC-9207-2022; Zhang, Kang/Y-2740-2019; Li, yu/HHZ-5236-2022	huang, weijin/0000-0002-4246-8889; Chen, Chong/0000-0002-6787-0495; Zhang, Kang/0000-0002-4549-1697; Dai, Lunzhi/0000-0002-3003-8910; Xue, Zhihong/0000-0003-3568-2964; Wei, Yu-quan/0000-0002-6211-3217; Yao, Shaohua/0000-0002-0191-4889; Gong, Yanqiu/0000-0001-7890-5158	National Key Research and Development Program of China [2016YFA0201402]; National Natural Science Foundation Regional Innovation and Development [U19A2003]; National Major Scientific and Technological Special Project for 'Significant New Drugs Development' [2018ZX09733001]; Ministry of Science and Technology; National Health Commission; Ministry of Education of the People's Republic of China; National Key Research and Development Project of China [2016YFD0500304]; West China Hospital Sichuan University [HX-2019-nCoV-004)]; Macao Science and Technology Development Fund (FDCT);  [2020YFS0010]	National Key Research and Development Program of China; National Natural Science Foundation Regional Innovation and Development; National Major Scientific and Technological Special Project for 'Significant New Drugs Development'; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Commission; Ministry of Education of the People's Republic of China(Ministry of Education, China); National Key Research and Development Project of China; West China Hospital Sichuan University(Sichuan University); Macao Science and Technology Development Fund (FDCT); 	We thank Z. Li, G. Wei, Q. Chen, H. Yan, X. Zhou, X. Wu, F. Fu, H. Yang and X. Wu for assisting with the maintenance of the mouse facility, the collection of sera, and providing cell culture, ELISA assays and other technical support. This work was supported by the National Key Research and Development Program of China (2016YFA0201402), National Natural Science Foundation Regional Innovation and Development (U19A2003), the National Major Scientific and Technological Special Project for 'Significant New Drugs Development' (2018ZX09733001), the projects for the vaccine by the Ministry of Science and Technology, National Health Commission, Ministry of Education of the People's Republic of China, Sichuan province, National Key Research and Development Project of China (2016YFD0500304). The special research fund on COVID-19 of Sichuan province (2020YFS0010), the special research fund on COVID-19 of West China Hospital Sichuan University (HX-2019-nCoV-004) and Macao Science and Technology Development Fund (FDCT).	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Contreras-Gomez A, 2014, BIOTECHNOL PROGR, V30, P1, DOI 10.1002/btpr.1842; Cox MMJ, 2011, J INVERTEBR PATHOL, V107, pS31, DOI 10.1016/j.jip.2011.05.003; Dai LP, 2020, CELL, V182, P722, DOI 10.1016/j.cell.2020.06.035; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo YJ, 2005, DNA CELL BIOL, V24, P510, DOI 10.1089/dna.2005.24.510; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; He YX, 2006, J IMMUNOL, V176, P6085, DOI 10.4049/jimmunol.176.10.6085; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Liu MQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00535-2; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Luo M, 2017, CELL RES, V27, P586, DOI 10.1038/cr.2017.14; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Nie JH, 2020, EMERG MICROBES INFEC, V9, P680, DOI 10.1080/22221751.2020.1743767; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Stadlmann J, 2017, NATURE, V549, P538, DOI 10.1038/nature24015; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; Wang Y, 2020, J AM SOC MASS SPECTR, V31, P651, DOI 10.1021/jasms.9b00089; Wang Y, 2019, CHEM COMMUN, V55, P7934, DOI 10.1039/c9cc04114a; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Xiao KJ, 2019, J PROTEOME RES, V18, P2885, DOI 10.1021/acs.jproteome.9b00191; Xiao YH, 2013, VACCINE, V31, P319, DOI 10.1016/j.vaccine.2012.11.007; Yang WM, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188486; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	35	360	383	34	218	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2020	586	7830					572	+		10.1038/s41586-020-2599-8	http://dx.doi.org/10.1038/s41586-020-2599-8		JUL 2020	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OE6NR	32726802	Bronze			2022-12-28	WOS:000577299100001
J	Kuehn, BM				Kuehn, Bridget M.			Dramatic Increase in US Congenital Syphilis Cases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					328	328		10.1001/jama.2020.11652	http://dx.doi.org/10.1001/jama.2020.11652			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721013				2022-12-28	WOS:000562851000013
J	Swann, JB; Holland, SJ; Petersen, M; Pietsch, TW; Boehm, T				Swann, Jeremy B.; Holland, Stephen J.; Petersen, Malte; Pietsch, Theodore W.; Boehm, Thomas			The immunogenetics of sexual parasitism	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; PHYLOGENETIC SIGNAL; EVOLUTION; VERTEBRATE; TELEOSTEI; HOMOPLASY; HYPERMUTATION; ANGLERFISHES	Sexual parasitism has evolved as a distinctive mode of reproduction among deep-sea anglerfishes. The permanent attachment of males to host females observed in these species represents a form of anatomical joining, which is otherwise unknown in nature. Pronounced modifications to immune facilities are associated with this reproductive trait. The genomes of species with temporarily attaching males lack functional aicda genes that underpin affinity maturation of antibodies. Permanent attachment is associated with additional alterations, culminating in the loss of functional rag genes in some species, abolishing somatic diversification of antigen receptor genes, the hallmark of canonical adaptive immunity. In anglerfishes, coevolution of innate and adaptive immunity has been disentangled, implying that an alternative form of immunity supported the emergence of this evolutionarily successful group of vertebrates.	[Swann, Jeremy B.; Holland, Stephen J.; Petersen, Malte; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany; [Pietsch, Theodore W.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98105 USA	Max Planck Society; University of Washington; University of Washington Seattle	Swann, JB; Boehm, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany.	swann@ie-freiburg.mpg.de; boehm@ie-freburg.mpg.de		Pietsch, Theodore/0000-0002-5638-8468; Boehm, Thomas/0000-0001-5172-7478; Swann, Jeremy/0000-0003-2168-8994; Petersen, Malte/0000-0001-7601-9873	Max Planck Society; Ernst Jung Foundation for Science and Medicine; European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC grant [323126]; U.S. National Science Foundation [DEB 03-14637]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Ernst Jung Foundation for Science and Medicine; European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC grant; U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by the Max Planck Society, the Ernst Jung Foundation for Science and Medicine, the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement 323126, and U.S. National Science Foundation grant DEB 03-14637.	Alcover A, 2018, ANNU REV IMMUNOL, V36, P103, DOI 10.1146/annurev-immunol-042617-053429; ARCHIE JW, 1989, SYST ZOOL, V38, P253, DOI 10.2307/2992286; Beebe W., 1938, B NY ZOOL SOC, V41, P50; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boehm T, 2018, ANNU REV IMMUNOL, V36, P19, DOI 10.1146/annurev-immunol-042617-053028; Boehm T, 2014, ANNU REV ANIM BIOSCI, V2, P259, DOI 10.1146/annurev-animal-022513-114201; Boehm T, 2012, CURR BIOL, V22, pR722, DOI 10.1016/j.cub.2012.07.003; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carmona LM, 2016, GENE DEV, V30, P909, DOI 10.1101/gad.278432.116; Chhabra M, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03038; Colucci F, 2019, SCIENCE, V365, P862, DOI 10.1126/science.aaw1300; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Dong D, 2019, NATURE, V573, P546, DOI 10.1038/s41586-019-1537-0; Dubin A, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0594; Duquesnoy RJ, 2014, CURR OPIN ORGAN TRAN, V19, P428, DOI 10.1097/MOT.0000000000000100; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischer A, 2005, CURR OPIN ALLERGY CL, V5, P491, DOI 10.1097/01.all.0000191886.12645.79; Fischer A, 2018, SEMIN IMMUNOL, V36, P13, DOI 10.1016/j.smim.2017.12.001; Freeman MA, 2011, J FISH DIS, V34, P445, DOI 10.1111/j.1365-2761.2011.01255.x; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gold MR, 2019, ANNU REV IMMUNOL, V37, P97, DOI 10.1146/annurev-immunol-042718-041704; GOLOBOFF PA, 1991, CLADISTICS, V7, P215, DOI 10.1111/j.1096-0031.1991.tb00035.x; Grimholt Unni, 2016, Biology-Basel, V5, DOI 10.3390/biology5010006; Guselnikov SV, 2003, IMMUNOGENETICS, V55, P472, DOI 10.1007/s00251-003-0599-0; Haase D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0044; Hencken CG, 2012, NAT STRUCT MOL BIOL, V19, P834, DOI 10.1038/nsmb.2338; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hughes LC, 2018, P NATL ACAD SCI USA, V115, P6249, DOI 10.1073/pnas.1719358115; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Krishnan A, 2018, P NATL ACAD SCI USA, V115, pE3201, DOI 10.1073/pnas.1720897115; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Loupy A, 2018, NEW ENGL J MED, V379, P1150, DOI 10.1056/NEJMra1802677; Lunsford KE, 2011, CURR OPIN ORGAN TRAN, V16, P390, DOI 10.1097/MOT.0b013e328348b420; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MEIER R, 1991, SYST ZOOL, V40, P74, DOI 10.2307/2992223; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Morimoto R, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba0925; Munk O., 1983, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening, V144, P49; Munk O, 2000, ACTA ZOOL-STOCKHOLM, V81, P315, DOI 10.1046/j.1463-6395.2000.00062.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakanishi T, 2015, TRANSPLANTATION, V99, P1598, DOI 10.1097/TP.0000000000000688; NISBET NW, 1973, TRANSPLANT REV, V15, P123; Pietsch TW, 2007, COPEIA, P1; Pietsch TW, 2005, ICHTHYOL RES, V52, P207, DOI 10.1007/s10228-005-0286-2; PIETSCH TW, 1976, COPEIA, P781; Pietsch TW, 2009, OCEANIC ANGLERFISHES: EXTRAORDINARY DIVERSITY IN THE DEEP SEA, P1; Priyann A, 2019, MOL BIOL EVOL, V36, P2922, DOI 10.1093/molbev/msz185; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rangarajan S, 2014, CELL MOL LIFE SCI, V71, P3059, DOI 10.1007/s00018-014-1600-9; Regan CT, 1925, P R SOC LOND B-CONTA, V97, P386, DOI 10.1098/rspb.1925.0006; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Robinson O, 2016, MOL BIOL EVOL, V33, P2163, DOI 10.1093/molbev/msw080; Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x; Roth O, 2020, P NATL ACAD SCI USA, V117, P9431, DOI 10.1073/pnas.1916251117; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Teng G, 2015, ADV IMMUNOL, V128, P1, DOI 10.1016/bs.ai.2015.07.002; Tokunaga Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08000-2; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Watson CM, 2014, J EVOLUTION BIOL, V27, P2767, DOI 10.1111/jeb.12536; Watson W, 2004, REC AUST MUS, V56, P139, DOI 10.3853/j.0067-1975.56.2004.1429	79	10	10	5	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2020	369	6511					1608	+		10.1126/science.aaz9445	http://dx.doi.org/10.1126/science.aaz9445			94	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9TD	32732279				2022-12-28	WOS:000574653300031
J	Dibner, KA; Schweingruber, HA; Christakis, DA				Dibner, Kenne A.; Schweingruber, Heidi A.; Christakis, Dimitri A.			Reopening K-12 Schools During the COVID-19 Pandemic A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dibner, Kenne A.; Schweingruber, Heidi A.] Natl Acad Sci Engn & Med, 500 Fifth St NW, Washington, DC 20001 USA; [Christakis, Dimitri A.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Christakis, Dimitri A.] Seattle Childrens Hosp, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA	National Academies of Sciences, Engineering & Medicine; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Dibner, KA (corresponding author), Natl Acad Sci Engn & Med, 500 Fifth St NW, Washington, DC 20001 USA.	kdibner@nas.edu			Brady Education Foundation; Spencer Foundation	Brady Education Foundation; Spencer Foundation	The study was funded by the Brady Education Foundation and the Spencer Foundation.	National Academies of Sciences Engineering and Medicine, 2019, SHAP SUMM EXP OPP PR; National Academies of Sciences Engineering Medicine., 2020, REOP K 12 SCH COVID; National Research Council, 1998, PREVENTING READING D; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V324, P133, DOI 10.1001/jama.2020.10175; US Centers for Disease Control and Prevention, GUID SCH CHILD CAR P	5	30	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					833	834		10.1001/jama.2020.14745	http://dx.doi.org/10.1001/jama.2020.14745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32761241	Bronze			2022-12-28	WOS:000570094600007
J	[Anonymous]				[Anonymous]			Experts Discuss COVID-19-Remdesivir, Vaccines, and More	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					730	730		10.1001/jama.2020.15067	http://dx.doi.org/10.1001/jama.2020.15067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32777002	Bronze			2022-12-28	WOS:000568230000002
J	Paluck, EL; Clark, CS				Paluck, Elizabeth Levy; Clark, Chelsey S.			Can playing together help us live together?	SCIENCE			English	Editorial Material							FIELD EXPERIMENT; PREJUDICE		[Paluck, Elizabeth Levy; Clark, Chelsey S.] Princeton Univ, Sch Publ & Int Affairs, Dept Psychol & Policy, Princeton, NJ 08544 USA	Princeton University	Paluck, EL (corresponding author), Princeton Univ, Sch Publ & Int Affairs, Dept Psychol & Policy, Princeton, NJ 08544 USA.	epaluck@princeton.edu			Rita Allen Foundation	Rita Allen Foundation	The authors thank the Rita Allen Foundation for funding and R.Porat and D. Green for comments.	Allport G.W., 1954, NATURE PREJUDICE; [Anonymous], 1995, PRIVATE TRUTHS PUBLI; Cook S. W., 1978, J RES DEV EDUC, V55, P647; Dixon J, 2012, BEHAV BRAIN SCI, V35, P411, DOI 10.1017/S0140525X11002214; Mousa S, 2020, SCIENCE, V369, P866, DOI 10.1126/science.abb3153; Paluck EL., 2019, BEHAV PUBLIC POLICY, V3, P129, DOI 10.1017/bpp.2018.25; Paluck EL, 2009, J PERS SOC PSYCHOL, V96, P574, DOI 10.1037/a0011989; Scacco A, 2018, AM POLIT SCI REV, V112, P654, DOI 10.1017/S0003055418000151; Turner J. C, 1987, SELF CATEGORIZATION	9	5	5	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					769	770		10.1126/science.abb9990	http://dx.doi.org/10.1126/science.abb9990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792381				2022-12-28	WOS:000559731300017
J	Harris, C; Peacock, JL; Greenough, A				Harris, Christopher; Peacock, Janet L.; Greenough, Anne			Outcomes of the Neonatal Trial of High-Frequency Oscillation at 16 to 19 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Harris, Christopher; Greenough, Anne] Kings Coll London, London, England; [Peacock, Janet L.] Dartmouth Coll, Hanover, NH 03755 USA	University of London; King's College London; Dartmouth College	Greenough, A (corresponding author), Kings Coll London, London, England.	anne.greenough@kcl.ac.uk		Peacock, Janet/0000-0002-0310-2518; Bisquera, Alessandra/0000-0002-6639-2057; Greenough, Anne/0000-0002-8672-5349	National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London	National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London	Supported by the National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London.	Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; Zivanovic S, 2014, NEW ENGL J MED, V370, P1121, DOI 10.1056/NEJMoa1309220	2	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					689	691		10.1056/NEJMc2008677	http://dx.doi.org/10.1056/NEJMc2008677			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32786197	Bronze			2022-12-28	WOS:000562771200027
J	Khoury, P; Azar, E; Hitti, E				Khoury, Petra; Azar, Eid; Hitti, Eveline			COVID-19 Response in Lebanon Current Experience and Challenges in a Low-Resource Setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint describes the unique challenges faced by Lebanon, a small densely populated country with a fragmented health care system, in its response to the emerging COVID-19 pandemic, and it summarizes organizational, testing, and communications policies the nation has implemented that might be useful to other resource-limited countries and settings.	[Khoury, Petra] Amer Univ Beirut, Med Ctr, Qual Accreditat & Risk Management Dept, Beirut, Lebanon; [Azar, Eid] St George Univ, Med Ctr, Fac Med, Beirut, Lebanon; [Hitti, Eveline] Amer Univ Beirut, Dept Emergency Med, POB 11-0236, Beirut 11072020, Lebanon	American University of Beirut; American University of Beirut	Hitti, E (corresponding author), Amer Univ Beirut, Dept Emergency Med, POB 11-0236, Beirut 11072020, Lebanon.	eh16@aub.edu.lb						Abi-Rached J., 2020, SOCIOECONOMIC IMPACT; [Anonymous], 2020, MON COVID 19 INF LEB; Ma XY, 2020, J CRIT CARE, V58, P96, DOI 10.1016/j.jcrc.2020.04.012; Melki J., 2020, MITIGATING INFODEMIC; Park S, 2020, JAMA-J AM MED ASSOC, V323, P2129, DOI 10.1001/jama.2020.6602; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Roser M, 2020, WHY DID RENEWABLES B; United Nations High Commissioner for Refugees United Nations Children's Fund World Food Programme, 2019, VASYR 2019 VULN ASS; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151	9	32	32	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					548	549		10.1001/jama.2020.12695	http://dx.doi.org/10.1001/jama.2020.12695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32722763	Bronze			2022-12-28	WOS:000562845100012
J	Kuehn, BM				Kuehn, Bridget M.			Emerging Drug-Resistant Meningitis Detected in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					540	540		10.1001/jama.2020.13761	http://dx.doi.org/10.1001/jama.2020.13761			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780143				2022-12-28	WOS:000562845100007
J	Rogers, W				Rogers, Wendy			The art of medicine Moral responsibility in medicine: where are the boundaries?	LANCET			English	Editorial Material									[Rogers, Wendy] Macquarie Univ, Dept Philosophy, Sydney, NSW 2109, Australia; [Rogers, Wendy] Macquarie Univ, Dept Clin Med, Sydney, NSW 2109, Australia	Macquarie University; Macquarie University	Rogers, W (corresponding author), Macquarie Univ, Dept Philosophy, Sydney, NSW 2109, Australia.; Rogers, W (corresponding author), Macquarie Univ, Dept Clin Med, Sydney, NSW 2109, Australia.	wendy.rogers@mq.edu.au		Rogers, Wendy/0000-0001-9186-870X					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					373	374						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0SW	32771096				2022-12-28	WOS:000561619100016
J	Murphy, SP; Ibrahim, NE; Januzzi, JL				Murphy, Sean P.; Ibrahim, Nasrien E.; Januzzi, James L., Jr.			Heart Failure With Reduced Ejection Fraction A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONVERTING-ENZYME-INHIBITORS; CARDIAC-RESYNCHRONIZATION THERAPY; VENTRICULAR SYSTOLIC FUNCTION; ARTERY-BYPASS SURGERY; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; ATRIAL-FIBRILLATION; BETA-BLOCKERS; DEFIBRILLATOR IMPLANTATION; FERRIC CARBOXYMALTOSE	This narrative review summarizes the epidemiology, pathophysiology, diagnosis, management, and prognosis of heart failure with reduced ejection fraction. Importance Worldwide, the burden of heart failure has increased to an estimated 23 million people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF). Observations Heart failure is a clinical syndrome characterized by dyspnea or exertional limitation due to impairment of ventricular filling or ejection of blood or both. HFrEF occurs when the left ventricular ejection fraction (LVEF) is 40% or less and is accompanied by progressive left ventricular dilatation and adverse cardiac remodeling. Assessment for heart failure begins with obtaining a medical history and physical examination. Also central to diagnosis are elevated natriuretic peptides above age- and context-specific thresholds and identification of left ventricular systolic dysfunction with LVEF of 40% or less as measured by echocardiography. Treatment strategies include the use of diuretics to relieve symptoms and application of an expanding armamentarium of disease-modifying drug and device therapies. Unless there are specific contraindications, patients with HFrEF should be treated with a beta-blocker and one of an angiotensin receptor-neprilysin inhibitor, angiotensin-converting enzyme inhibitor, or angiotensin receptor blocker as foundational therapy, with addition of a mineralocorticoid receptor antagonist in patients with persistent symptoms. Ivabradine and hydralazine/isosorbide dinitrate also have a role in the care of certain patients with HFrEF. More recently, sodium-glucose cotransporter 2 (SGLT2) inhibitors have further improved disease outcomes, significantly reducing cardiovascular and all-cause mortality irrespective of diabetes status, and vericiguat, a soluble guanylate cyclase stimulator, reduces heart failure hospitalization in high-risk patients with HFrEF. Device therapies may be beneficial in specific subpopulations, such as cardiac resynchronization therapy in patients with interventricular dyssynchrony, transcatheter mitral valve repair in patients with severe secondary mitral regurgitation, and implantable cardiac defibrillators in patients with more severe left ventricular dysfunction particularly of ischemic etiology. Conclusions and Relevance HFrEF is a major public health concern with substantial morbidity and mortality. The management of HFrEF has seen significant scientific breakthrough in recent decades, and the ability to alter the natural history of the disease has never been better. Recent developments include SGLT2 inhibitors, vericiguat, and transcatheter mitral valve repair, all of which incrementally improve prognosis beyond foundational neurohormonal therapies. Disease morbidity and mortality remain high, with a 5-year survival rate of 25% after hospitalization for HFrEF.	[Murphy, Sean P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Ibrahim, Nasrien E.; Januzzi, James L., Jr.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Ibrahim, Nasrien E.; Januzzi, James L., Jr.] Harvard Med Sch, Boston, MA 02115 USA; [Januzzi, James L., Jr.] Baim Inst Clin Res, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Januzzi, JL (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	jjanuzzi@partners.org			Dennis and Marilyn Barry fund for cardiology research; Hutter Family Professorship	Dennis and Marilyn Barry fund for cardiology research; Hutter Family Professorship	Dr Ibrahim is supported in part by the Dennis and Marilyn Barry fund for cardiology research. Dr Januzzi is supported in part by the Hutter Family Professorship.	Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Armstrong PW, 2020, NEW ENGL J MED, V382, P1883, DOI 10.1056/NEJMoa1915928; Austin J, 2005, EUR J HEART FAIL, V7, P411, DOI 10.1016/j.ejheart.2004.10.004; BALL SG, 1993, LANCET, V342, P821; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Barker WH, 2006, CIRCULATION, V113, P799, DOI 10.1161/CIRCULATIONAHA.104.492033; Bayes-Genis A, 2005, J CARD FAIL, V11, pS3, DOI 10.1016/j.cardfail.2005.04.006; BRATER DC, 1986, AM J CARDIOL, V57, pA20; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Butler J, 2020, CIRCULATION, V142, P717, DOI 10.1161/CIRCULATIONAHA.120.047086; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Collins SP, 2006, ANN EMERG MED, V47, P13, DOI 10.1016/j.annemergmed.2005.04.003; Colvin M, 2015, J CARD FAIL, V21, P674, DOI 10.1016/j.cardfail.2015.05.013; Conrad N, 2018, LANCET, V391, P572, DOI 10.1016/S0140-6736(17)32520-5; Cosentino F., 2020, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/eurheartj/ehz486]; Das SR, 2018, J AM COLL CARDIOL, V72, P3200, DOI 10.1016/j.jacc.2018.09.020; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Dormans TPJ, 1996, J AM COLL CARDIOL, V28, P376, DOI 10.1016/0735-1097(96)00161-1; Dunlay SM, 2019, CIRCULATION, V140, pE294, DOI 10.1161/CIR.0000000000000691; Felker GM, 2020, J AM COLL CARDIOL, V75, P1178, DOI 10.1016/j.jacc.2019.12.059; Fitzgerald AA, 2011, J CARD FAIL, V17, P664, DOI 10.1016/j.cardfail.2011.04.011; Fiuzat M, 2012, J AM COLL CARDIOL, V60, P208, DOI 10.1016/j.jacc.2012.03.023; Gaasch WH, 2020, JAMA CARDIOL, V5, P476, DOI 10.1001/jamacardio.2019.5980; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Givertz MM, 2017, J AM COLL CARDIOL, V70, P1875, DOI 10.1016/j.jacc.2017.08.010; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Halliday BP, 2019, LANCET, V393, P61, DOI 10.1016/S0140-6736(18)32484-X; Hartupee J, 2017, NAT REV CARDIOL, V14, P30, DOI 10.1038/nrcardio.2016.163; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Ho JE, 2013, CIRC-HEART FAIL, V6, P279, DOI 10.1161/CIRCHEARTFAILURE.112.972828; Januzzi JL, 2018, J AM COLL CARDIOL, V71, P1191, DOI 10.1016/j.jacc.2018.01.021; Januzzi JL, 2019, JAMA-J AM MED ASSOC, V322, P1085, DOI 10.1001/jama.2019.12821; Januzzi JL, 2019, J AM COLL CARDIOL, V74, P1205, DOI 10.1016/j.jacc.2019.06.055; Jefferies JL, 2018, J AM COLL CARDIOL, V72, P367, DOI 10.1016/j.jacc.2018.05.023; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Kotecha D, 2017, J AM COLL CARDIOL, V69, P2885, DOI 10.1016/j.jacc.2017.04.001; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; Lechat P, 1999, LANCET, V353, P9; Lewis GD, 2017, JAMA-J AM MED ASSOC, V317, P1958, DOI 10.1001/jama.2017.5427; Lofman I, 2017, EUR J HEART FAIL, V19, P1606, DOI 10.1002/ejhf.821; Lytvyn Y, 2017, CIRCULATION, V136, P1643, DOI 10.1161/CIRCULATIONAHA.117.030012; Maggioni AP, 2013, EUR J HEART FAIL, V15, P808, DOI 10.1093/eurjhf/hft050; MAHDYOON H, 1989, AM J CARDIOL, V63, P625, DOI 10.1016/0002-9149(89)90912-0; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mamas MA, 2009, EUR J HEART FAIL, V11, P676, DOI 10.1093/eurjhf/hfp085; Margulies KB, 2016, JAMA-J AM MED ASSOC, V316, P500, DOI 10.1001/jama.2016.10260; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mentz RJ, 2018, J AM COLL CARDIOL, V72, P41, DOI 10.1016/j.jacc.2018.04.038; Morales DR, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0781-0; Morrow DA, 2019, CIRCULATION, V139, P2285, DOI 10.1161/CIRCULATIONAHA.118.039331; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mueller-Lenke N, 2006, HEART, V92, P695, DOI 10.1136/hrt.2005.074583; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Packer M, 2020, JAMA CARDIOL, V5, P469, DOI 10.1001/jamacardio.2019.5971; Packer M, 2017, JAMA CARDIOL, V2, P1025, DOI 10.1001/jamacardio.2017.2275; Pena LL, 2003, CIRCULATION, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40; Perera D, 2018, JACC-HEART FAIL, V6, P517, DOI 10.1016/j.jchf.2018.01.024; Petrie MC, 2020, JAMA-J AM MED ASSOC, V323, P1353, DOI 10.1001/jama.2020.1906; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ponikowski P, 2015, EUR HEART J, V36, P657, DOI 10.1093/eurheartj/ehu385; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Rangaswami J, 2019, CIRCULATION, V139, pE840, DOI 10.1161/CIR.0000000000000664; Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687; Savelieva I, 2008, DRUG SAFETY, V31, P95, DOI 10.2165/00002018-200831020-00001; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Selvaraj S, 2019, CIRCULATION, V140, P1369, DOI 10.1161/CIRCULATIONAHA.119.039920; Serenelli M, 2020, JACC-HEART FAIL, V8, P188, DOI 10.1016/j.jchf.2019.09.011; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Shi V, 2018, INT J CARDIOL, V264, P118, DOI 10.1016/j.ijcard.2018.03.121; Simpson J, 2020, JAMA CARDIOL, V5, P432, DOI 10.1001/jamacardio.2019.5850; Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655; Solomon SD, 2020, CIRCULATION, V141, P352, DOI 10.1161/CIRCULATIONAHA.119.044586; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640; SWEDBERG K, 1988, AM J CARDIOL, V62, pA60, DOI 10.1016/S0002-9149(88)80087-0; Swedberg K, 2010, REV PORT CARDIOL, V29, P1273, DOI 10.1016/S0140-6736(10)61198-1; Talajic M, 2010, J AM COLL CARDIOL, V55, P1796, DOI 10.1016/j.jacc.2010.01.023; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Thibodeau JT, 2014, JACC-HEART FAIL, V2, P24, DOI 10.1016/j.jchf.2013.07.009; Tsao CW, 2018, JACC-HEART FAIL, V6, P678, DOI 10.1016/j.jchf.2018.03.006; Velazquez EJ, 2019, NEW ENGL J MED, V380, P539, DOI 10.1056/NEJMoa1812851; Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Verma S, 2018, DIABETOLOGIA, V61, P2108, DOI 10.1007/s00125-018-4670-7; Wachter R, 2019, EUR J HEART FAIL, V21, P998, DOI 10.1002/ejhf.1498; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Yancy CW, 2018, J AM COLL CARDIOL, V71, P201, DOI 10.1016/j.jacc.2017.11.025; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yancy CW, 2005, AM J CARDIOL, V96, p3I, DOI 10.1016/j.amjcard.2005.07.028; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898	112	182	192	10	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					488	504		10.1001/jama.2020.10262	http://dx.doi.org/10.1001/jama.2020.10262			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749493				2022-12-28	WOS:000561261900020
J	Wouters, OJ; McKee, M; Luyten, J				Wouters, Olivier J.; McKee, Martin; Luyten, Jeroen			Research and Development Costs of New Drugs - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wouters, Olivier J.] London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England; [McKee, Martin] London Sch Econ & Polit Sci, Dept Hlth Serv Res & Policy, London, England; [Luyten, Jeroen] Leuven Inst Healthcare Policy, Dept Publ Hlth & Primary Care, Leuven, Belgium	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science	Wouters, OJ (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England.	o.j.wouters@lse.ac.uk	Wouters, Olivier/AAA-6345-2021	Wouters, Olivier/0000-0002-2514-476X; Luyten, Jeroen/0000-0001-6398-4025				Cutler DM, 2020, JAMA-J AM MED ASSOC, V323, P829, DOI 10.1001/jama.2020.0351; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Terry M., 2019, TOP 20 PHARMA CO MAR; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166	7	4	4	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					517	518		10.1001/jama.2020.8651	http://dx.doi.org/10.1001/jama.2020.8651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749488				2022-12-28	WOS:000561261900032
J	Dehay, C; Kennedy, H				Dehay, Colette; Kennedy, Henry			Evolution of the human brain	SCIENCE			English	Editorial Material							OUTER SUBVENTRICULAR ZONE; CORTEX		[Dehay, Colette; Kennedy, Henry] Univ Claude Bernard Lyon 1, Univ Lyon, Stem Cell & Brain Res Inst U1208, INSERM, F-69500 Bron, France; [Kennedy, Henry] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Key Lab Primate Neurobiol, Shanghai 200031, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Chinese Academy of Sciences	Dehay, C (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Stem Cell & Brain Res Inst U1208, INSERM, F-69500 Bron, France.	colette.dehay@inserm.fr; henry.kennedy@inserm.fr	Dehay, Colette/H-4437-2014; Kennedy, Henry/B-9636-2013	Dehay, Colette/0000-0002-5196-1464; Kennedy, Henry/0000-0002-2796-7663				Berg J., 2020, 20200331018820 BIORX; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Dennis MY, 2016, CURR OPIN GENET DEV, V41, P44, DOI 10.1016/j.gde.2016.08.001; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Heide M, 2020, SCIENCE, V369, P546, DOI 10.1126/science.abb2401; Kalebic N, 2018, ELIFE, V7, DOI 10.7554/eLife.41241; Namba T, 2020, NEURON, V105, P867, DOI 10.1016/j.neuron.2019.11.027; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Vezoli J., 2020, 20200408032706 BIORX; Won H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10248-3	15	3	3	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					506	507		10.1126/science.abd1840	http://dx.doi.org/10.1126/science.abd1840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732410	Green Submitted			2022-12-28	WOS:000556568100025
J	Miller, JFAP				Miller, Jacques F. A. P.			The function of the thymus and its impact on modern medicine	SCIENCE			English	Review							TO-CELL INTERACTION; HEMOLYSIN-FORMING CELLS; IMMUNE-RESPONSE; LYMPHOID ORGANS; IMMUNOLOGICAL FUNCTION; NEONATAL THYMECTOMY; CROSS-PRESENTATION; CROONIAN LECTURE; IRRADIATED MICE; BONE-MARROW	The lymphoid system is intimately involved in immunological processes. The small lymphocyte that circulates through blood into lymphoid tissues, then through the lymph and back to the blood through the thoracic duct, is able to initiate immune responses after appropriate stimulation by antigen. However, the lymphocytes found in the thymus are deficient in this ability despite the fact that the thymus plays a central role in lymphocyte production and in ensuring the normal development of immunological faculty. During embryogenesis, lymphocytes are present in the thymus before they can be identified in the circulation and in other lymphoid tissues. They become "educated" in the thymus to recognize a great diversity of peptide antigens bound to the body's own marker antigen, the major histocompatibility complex, but they are purged if they strongly react against their own self-components. Lymphocytes differentiate to become various T cell subsets and then exit through the bloodstream to populate certain areas of the lymphoid system as peripheral T lymphocytes with distinct markers and immune functions.	[Miller, Jacques F. A. P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Miller, Jacques F. A. P.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Miller, JFAP (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Miller, JFAP (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	miller@wehi.edu.au		Miller, Jacques/0000-0002-3848-5109				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ANDREASEN E, 1949, ANAT REC, V103, P401, DOI 10.1002/ar.1091030307; ARNASON BG, 1962, NATURE, V194, P99, DOI 10.1038/194099a0; Brayton H. W., 1919, BOSTON MED SURG J, V181, P740, DOI [10.1056/NEJM191912251812604, DOI 10.1056/NEJM191912251812604]; Burnet F.M., 1972, AUTOIMMUNITY AUTOIMM; BURNET M, 1962, SCI AM, V207, P50; CANTOR H, 1975, J EXP MED, V141, P1376, DOI 10.1084/jem.141.6.1376; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; CHEERS C, 1972, J EXP MED, V136, P1661, DOI 10.1084/jem.136.6.1661; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1968, AM J MED, V44, P499, DOI 10.1016/0002-9343(68)90051-X; CROSS AM, 1964, J EXP MED, V119, P837, DOI 10.1084/jem.119.5.837; Daley SR, 2017, IMMUNOL REV, V277, P9, DOI 10.1111/imr.12532; DALMASSO AP, 1962, P SOC EXP BIOL MED, V111, P143; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Di Pilato M, 2019, NATURE, V570, P112, DOI 10.1038/s41586-019-1215-2; FICHTELIUS K, 1961, ACTA PATHOL MIC SC, V51, P81; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Good R. A., 1969, IMMUNOLOGICAL TOLERA, P136; Gowans J. L., 1969, IMMUNOLOGICAL TOLERA, P164; GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; GRANT GA, 1965, NATURE, V205, P1124, DOI 10.1038/2051124a0; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; HOFMAN L, 1961, RADIAT RES, V15, P30, DOI 10.2307/3571064; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KENNEDY JC, 1965, P SOC EXP BIOL MED, V120, P868; KINCADE PW, 1970, P NATL ACAD SCI USA, V67, P1918, DOI 10.1073/pnas.67.4.1918; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; MARTINEZ C, 1962, P SOC EXP BIOL MED, V109, P193; Martinez C., 1964, THYMUS IMMUNOBIOLOGY, P465; MCINTIRE KR, 1964, NATURE, V204, P151, DOI 10.1038/204151a0; Medawar P. B., 1963, IMMUNOLOGICALLY COMP, P6; MEDAWAR PB, 1958, PROC R SOC SER B-BIO, V149, P145, DOI 10.1098/rspb.1958.0058; Metcalf D., 1964, THYMUS IMMUNOBIOLOGY, P150; Miller J. F., 1967, MODERN TRENDS PATHOL, P140; Miller JFAP, 2015, CANCER CELL, V27, P439, DOI 10.1016/j.ccell.2015.03.007; MILLER JF, 1961, LANCET, V2, P748; MILLER JF, 1961, NATURE, V191, P248, DOI 10.1038/191248a0; MILLER JFA, 1965, NATURE, V208, P1332, DOI 10.1038/2081332a0; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; MILLER JFA, 1959, NATURE, V184, P1809, DOI 10.1038/1841809a0; MILLER JFA, 1962, ANN NY ACAD SCI, V99, P340, DOI 10.1111/j.1749-6632.1962.tb45319.x; MILLER JFA, 1966, BRIT MED BULL, V22, P21, DOI 10.1093/oxfordjournals.bmb.a070431; MILLER JFA, 1963, NATURE, V199, P921, DOI 10.1038/199920a0; MILLER JFA, 1967, PHYSIOL REV, V47, P437, DOI 10.1152/physrev.1967.47.3.437; MILLER JFA, 1965, NATURE, V208, P1337, DOI 10.1038/2081337a0; MILLER JFA, 1962, NATURE, V195, P1318, DOI 10.1038/1951318a0; MILLER JFA, 1964, P SOC EXP BIOL MED, V116, P323; MILLER JFA, 1967, NATURE, V214, P992, DOI 10.1038/214992a0; MILLER JFAP, 1992, PHILOS T R SOC B, V337, P105, DOI 10.1098/rstb.1992.0087; MILLER JFAP, 1962, PROC R SOC SER B-BIO, V156, P415, DOI 10.1098/rspb.1962.0048; MILLER JFAP, 1971, NATURE-NEW BIOL, V230, P267, DOI 10.1038/newbio230267a0; MILLER JFAP, 1959, NATURE, V183, P1069, DOI 10.1038/1831069a0; MILLER JFAP, 1960, NATURE, V187, P703, DOI 10.1038/187703a0; Miller JFAP, 1998, IMMUNOL REV, V165, P267, DOI 10.1111/j.1600-065X.1998.tb01244.x; MILLER JFAP, 1963, P SOC EXP BIOL MED, V112, P785; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821; MOORE MAS, 1967, LANCET, V2, P658, DOI 10.1016/S0140-6736(67)90693-9; NAKAMURA K, 1961, BRIT J CANCER, V15, P306, DOI 10.1038/bjc.1961.38; OSMOND DG, 1986, IMMUNOL REV, V93, P103, DOI 10.1111/j.1600-065X.1986.tb01504.x; PAETKAU V, 1981, NATURE, V294, P689, DOI 10.1038/294689a0; Palmer S, 2018, P NATL ACAD SCI USA, V115, P1883, DOI 10.1073/pnas.1714478115; PANTELOURIS EM, 1971, IMMUNOLOGY, V20, P247; PARROTT DMV, 1966, J EXP MED, V123, P191, DOI 10.1084/jem.123.1.191; SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VOS O, 1959, J NATL CANCER I, V23, P53; WARNER NL, 1962, AUST J EXP BIOL MED, V43, P373; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; YOSHIKAI Y, 1984, NATURE, V312, P521, DOI 10.1038/312521a0; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	89	21	21	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					522	+	eaba2429	10.1126/science.aba2429	http://dx.doi.org/10.1126/science.aba2429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732394				2022-12-28	WOS:000556568100035
J	Rimmer, A				Rimmer, Abi			[Lack of] Diversity at the RCGP: five minutes with ... Naureen Bhatti	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m618	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2020	370								m3059	10.1136/bmj.m3059	http://dx.doi.org/10.1136/bmj.m3059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RD	32737056				2022-12-28	WOS:000556139500001
J	Wei, TR; Jin, M; Wang, YC; Chen, HY; Gao, ZQ; Zhao, KP; Qiu, PF; Shan, ZW; Jiang, J; Li, RB; Chen, LD; He, J; Shi, X				Wei, Tian-Ran; Jin, Min; Wang, Yuecun; Chen, Hongyi; Gao, Zhiqiang; Zhao, Kunpeng; Qiu, Pengfei; Shan, Zhiwei; Jiang, Jun; Li, Rongbin; Chen, Lidong; He, Jian; Shi, Xun			Exceptional plasticity in the bulk single-crystalline van der Waals semiconductor InSe	SCIENCE			English	Article							2-DIMENSIONAL MATERIALS; BRILLOUIN-SCATTERING; ELASTIC-CONSTANTS; GRAPHENE; COHP; GAS	Inorganic semiconductors are vital for a number of critical applications but are almost universally brittle. Here, we report the superplastic deformability of indium selenide (InSe). Bulk single-crystalline InSe can be compressed by orders of magnitude and morphed into a Mobius strip or a simple origami at room temperature. The exceptional plasticity of this two-dimensional van der Waals inorganic semiconductor is attributed to the interlayer gliding and cross-layer dislocation slip that are mediated by the long-range In-Se Coulomb interaction across the van der Waals gap and soft intralayer In-Se bonding. We propose a combinatory deformability indicator (Xi) to prescreen candidate bulk semiconductors for use in next-generation deformable or flexible electronics.	[Wei, Tian-Ran; Zhao, Kunpeng; Shi, Xun] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China; [Wei, Tian-Ran; Chen, Hongyi; Gao, Zhiqiang; Zhao, Kunpeng; Qiu, Pengfei; Chen, Lidong; Shi, Xun] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Jin, Min; Li, Rongbin] Shanghai Dianji Univ, Coll Mat, Shanghai 201306, Peoples R China; [Wang, Yuecun; Shan, Zhiwei] Xi An Jiao Tong Univ, Ctr Adv Mat Performance Nanoscale CAMP Nano, Xian 710049, Peoples R China; [Wang, Yuecun; Shan, Zhiwei] Xi An Jiao Tong Univ, Hysitron Appl Res Ctr China HARCC, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China; [Jiang, Jun] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Peoples R China; [He, Jian] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Shanghai Dianji University; Xi'an Jiaotong University; Xi'an Jiaotong University; Chinese Academy of Sciences; Ningbo Institute of Materials Technology and Engineering, CAS; Clemson University	Shi, X (corresponding author), Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.; Chen, LD; Shi, X (corresponding author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; He, J (corresponding author), Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA.	cld@mail.sic.ac.cn; jianhe@g.clemson.edu; xshi@sjtu.edu.cn	xjtu, campnano/Q-1904-2015; Chen, Lidong/F-2705-2010; wang, Yuecun/AAR-9167-2021; Jiang, Jun/ABC-3959-2020; He, Jian/C-5341-2011; Shi, Xun/A-1764-2019; jiang, jun/GWC-9329-2022; Wei, Tian-Ran/V-4957-2018	He, Jian/0000-0002-6377-3022; Shi, Xun/0000-0002-8086-6407; Wei, Tian-Ran/0000-0002-5011-0932; Shan, Zhiwei/0000-0002-4533-0869; gao, zhiqiang/0000-0002-2531-0844; Wang, Yuecun/0000-0002-1044-0160	National Key Research and Development Program of China [2018YFB0703600, 2017YFB0702001]; National Natural Science Foundation of China [51625205, 91963208, 51961135106, 51902249]; Nature Science Foundation of Shanghai [19ZR1419900]; Shanghai Engineering Research Center of Hot Manufacturing [18DZ2253400]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Engineering Research Center of Hot Manufacturing	This work is supported by the National Key Research and Development Program of China (2018YFB0703600 and 2017YFB0702001), the National Natural Science Foundation of China (51625205, 91963208, 51961135106, and 51902249), and the Nature Science Foundation of Shanghai (19ZR1419900). M.J. and R.L. acknowledge the support of the Shanghai Engineering Research Center of Hot Manufacturing (18DZ2253400).	Bandurin DA, 2017, NAT NANOTECHNOL, V12, P223, DOI [10.1038/nnano.2016.242, 10.1038/NNANO.2016.242]; Bertolazzi S, 2011, ACS NANO, V5, P9703, DOI 10.1021/nn203879f; Bhimanapati GR, 2015, ACS NANO, V9, P11509, DOI 10.1021/acsnano.5b05556; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bosak A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153408; CARLONE C, 1981, PHYS STATUS SOLIDI B, V103, P123, DOI 10.1002/pssb.2221030112; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Chen H, 2019, SCIENCE, V365, P1036, DOI 10.1126/science.aax7864; Das S, 2015, ANNU REV MATER RES, V45, P1, DOI 10.1146/annurev-matsci-070214-021034; Deringer VL, 2011, J PHYS CHEM A, V115, P5461, DOI 10.1021/jp202489s; DRONSKOWSKI R, 1993, J PHYS CHEM-US, V97, P8617, DOI 10.1021/j100135a014; FELDMAN JL, 1976, J PHYS CHEM SOLIDS, V37, P1141, DOI 10.1016/0022-3697(76)90143-8; Fiori G, 2014, NAT NANOTECHNOL, V9, P768, DOI [10.1038/nnano.2014.207, 10.1038/NNANO.2014.207]; GATULLE M, 1983, PHYS STATUS SOLIDI B, V119, P327, DOI 10.1002/pssb.2221190137; Green DJ, 1998, INTRO MECH PROPERTIE, P218; GRIMSDITCH MH, 1975, PHYS REV B, V11, P3139, DOI 10.1103/PhysRevB.11.3139; GURUSWAMY S, 1992, SEMICONDUCT SEMIMET, V37, P189; Han G, 2014, SMALL, V10, P2747, DOI 10.1002/smll.201400104; Han XD, 2007, ADV MATER, V19, P2112, DOI 10.1002/adma.200602705; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Kim SJ, 2015, ANNU REV MATER RES, V45, P63, DOI 10.1146/annurev-matsci-070214-020901; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lei SD, 2014, ACS NANO, V8, P1263, DOI 10.1021/nn405036u; Li GD, 2018, NPJ COMPUT MATER, V4, DOI 10.1038/s41524-018-0100-0; Li HF, 2019, JOULE, V3, P613, DOI 10.1016/j.joule.2019.01.013; Liang JS, 2019, ENERG ENVIRON SCI, V12, P2983, DOI 10.1039/c9ee01777a; Madelung O., 1996, SEMICONDUCTORS BASIC; Maintz S, 2016, J COMPUT CHEM, V37, P1030, DOI 10.1002/jcc.24300; Malloy K.J., 1992, MECH PROPERTIES SEMI, V37; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Mudd GW, 2013, ADV MATER, V25, P5714, DOI 10.1002/adma.201302616; Ormeci A, 2006, J PHYS CHEM A, V110, P1100, DOI 10.1021/jp054727r; Oshima Y, 2018, SCIENCE, V360, P772, DOI 10.1126/science.aar6035; Panella V, 1997, J PHYS-CONDENS MAT, V9, P5575, DOI 10.1088/0953-8984/9/26/006; Peng J, 2019, SCIENCE, V366, P690, DOI 10.1126/science.aaz5704; Peng L, 2017, ADV MATER, V29, DOI 10.1002/adma.201700589; POPOVIC S, 1979, J APPL CRYSTALLOGR, V12, P416, DOI 10.1107/S0021889879012863; Pyun SI, 1996, J POWER SOURCES, V63, P109, DOI 10.1016/S0378-7753(96)02457-3; RICE JR, 1992, J MECH PHYS SOLIDS, V40, P239, DOI 10.1016/S0022-5096(05)80012-2; RICE JR, 1974, PHILOS MAG, V29, P73, DOI 10.1080/14786437408213555; RIGOULT J, 1980, ACTA CRYSTALLOGR B, V36, P916, DOI 10.1107/S0567740880004840; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Seeger K., 2004, SEMICONDUCTOR PHYS I; Shen T, 2019, J AM CHEM SOC, V141, P3110, DOI 10.1021/jacs.8b12212; Shi X, 2018, NAT MATER, V17, P421, DOI 10.1038/s41563-018-0047-z; Tamalampudi SR, 2014, NANO LETT, V14, P2800, DOI 10.1021/nl500817g; Wang ZJ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681582; WIETING TJ, 1972, PHYS REV B, V5, P1473, DOI 10.1103/PhysRevB.5.1473	52	84	83	56	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					542	+		10.1126/science.aba9778	http://dx.doi.org/10.1126/science.aba9778			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732421				2022-12-28	WOS:000556568100040
J	Manyonda, I; Belli, AM; Lumsden, MA; Moss, J; McKinnon, W; Middleton, LJ; Cheed, V; Wu, O; Sirkeci, F; Daniels, JP; McPherson, K				Manyonda, Isaac; Belli, Anna-Maria; Lumsden, Mary-Ann; Moss, Jonathan; McKinnon, William; Middleton, Lee J.; Cheed, Versha; Wu, Olivia; Sirkeci, Fusun; Daniels, Jane P.; McPherson, Klim		FEMME Collaborative Grp	Uterine-Artery Embolization or Myomectomy for Uterine Fibroids	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; UFS-QOL; QUALITY; QUESTIONNAIRE; SURGERY	Background Uterine fibroids, the most common type of tumor among women of reproductive age, are associated with heavy menstrual bleeding, abdominal discomfort, subfertility, and a reduced quality of life. For women who wish to preserve their uterus and who have not had a response to medical treatment, myomectomy and uterine-artery embolization are therapeutic options. Methods We conducted a multicenter, randomized, open-label trial to evaluate myomectomy, as compared with uterine-artery embolization, in women who had symptomatic uterine fibroids and did not want to undergo hysterectomy. Procedural options included open abdominal, laparoscopic, or hysteroscopic myomectomy. The primary outcome was fibroid-related quality of life, as assessed by the score on the health-related quality-of-life domain of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire (scores range from 0 to 100, with higher scores indicating a better quality of life) at 2 years; adjustment was made for the baseline score. Results A total of 254 women, recruited at 29 hospitals in the United Kingdom, were randomly assigned: 127 to the myomectomy group (of whom 105 underwent myomectomy) and 127 to the uterine-artery embolization group (of whom 98 underwent embolization). Data on the primary outcome were available for 206 women (81%). In the intention-to-treat analysis, the mean (SD) score on the health-related quality-of-life domain of the UFS-QOL questionnaire at 2 years was 84.621.5 in the myomectomy group and 80.0 +/- 22.0 in the uterine-artery embolization group (mean adjusted difference with complete case analysis, 8.0 points; 95% confidence interval [CI], 1.8 to 14.1; P=0.01; mean adjusted difference with missing responses imputed, 6.5 points; 95% CI, 1.1 to 11.9). Perioperative and postoperative complications from all initial procedures, irrespective of adherence to the assigned procedure, occurred in 29% of the women in the myomectomy group and in 24% of the women in the uterine-artery embolization group. Conclusions Among women with symptomatic uterine fibroids, those who underwent myomectomy had a better fibroid-related quality of life at 2 years than those who underwent uterine-artery embolization. (Funded by the National Institute for Health Research Health Technology Assessment program; FEMME Current Controlled Trials number, ISRCTN70772394.)	[Manyonda, Isaac; Belli, Anna-Maria] St George Hosp, London, England; [Manyonda, Isaac; Belli, Anna-Maria] Med Sch, London, England; [Sirkeci, Fusun] Whipps Cross Hosp & Chest Clin, London, England; [Lumsden, Mary-Ann; Moss, Jonathan; Wu, Olivia] Univ Glasgow, Glasgow, Lanark, Scotland; [McKinnon, William; Middleton, Lee J.; Cheed, Versha] Univ Birmingham, Birmingham, W Midlands, England; [Daniels, Jane P.] Univ Nottingham, Nottingham, England; [McPherson, Klim] Univ Oxford, Oxford, England	St Georges University London; University of London; Queen Mary University London; University of Glasgow; University of Birmingham; University of Nottingham; University of Oxford	Daniels, JP (corresponding author), Univ Nottingham, Nottingham Clin Trials Unit, Univ Pk, Nottingham NG7 2RD, England.	jane.daniels@nottingham.ac.uk	moss, jon george/GWN-0387-2022	Cheed, Versha/0000-0002-6713-0913; Wu, Olivia/0000-0002-0570-6016; Middleton, Lee/0000-0003-4621-1922; Daniels, Jane/0000-0003-3324-6771	National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research Health Technology Assessment program; FEMME Current Controlled Trials number, ISRCTN70772394.	Borah BJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.017; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coyne KS, 2012, VALUE HEALTH, V15, P674, DOI 10.1016/j.jval.2012.03.1387; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; Drayer SM, 2015, INT J GYNECOL OBSTET, V131, P117, DOI 10.1016/j.ijgo.2015.04.051; Edwards RD, 2007, NEW ENGL J MED, V356, P360; El Shamy T, 2020, ACTA OBSTET GYN SCAN, V99, P16, DOI 10.1111/aogs.13698; Feng J, 2012, ARCH GYNECOL OBSTET, V285, P1407, DOI 10.1007/s00404-011-2065-9; Flyckt R, 2016, OBSTET GYNECOL INT, V2016, DOI 10.1155/2016/2789201; Fonseca MCM, 2017, CLIN THER, V39, P1438, DOI 10.1016/j.clinthera.2017.05.346; Goodwin SC, 2008, OBSTET GYNECOL, V111, P22, DOI 10.1097/01.AOG.0000296526.71749.c9; Harding G, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-99; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Little R. J. A., 2002, STAT ANAL MISSING DA; Lurie S, 2005, J Obstet Gynaecol, V25, P42, DOI 10.1080/01443610400024583; Manyonda IT, 2012, CARDIOVASC INTER RAD, V35, P530, DOI 10.1007/s00270-011-0228-5; Mara M, 2006, EUR J OBSTET GYN R B, V126, P226, DOI 10.1016/j.ejogrb.2005.10.008; Mara M, 2008, CARDIOVASC INTER RAD, V31, P73, DOI 10.1007/s00270-007-9195-2; McPherson K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-468; Metwally M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003857.pub3; Narayan A, 2010, J VASC INTERV RADIOL, V21, P1011, DOI 10.1016/j.jvir.2010.03.012; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Pritts EA, 2009, FERTIL STERIL, V91, P1215, DOI 10.1016/j.fertnstert.2008.01.051; Somigliana E, 2007, HUM REPROD UPDATE, V13, P465, DOI 10.1093/humupd/dmm013; Spies JB, 2002, OBSTET GYNECOL, V99, P290, DOI 10.1016/S0029-7844(01)01702-1; Stewart EA, 2017, BJOG-INT J OBSTET GY, V124, P1501, DOI 10.1111/1471-0528.14640; Sundermann AC, 2017, OBSTET GYNECOL, V130, P1065, DOI 10.1097/AOG.0000000000002313; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	30	43	46	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					440	451		10.1056/NEJMoa1914735	http://dx.doi.org/10.1056/NEJMoa1914735			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW2GI	32726530	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000556861800011
J	Svoboda, E				Svoboda, Elizabeth			Bacteria-eating viruses could provide a route to stability in cystic fibrosis	NATURE			English	Editorial Material						Infection; Diseases; Therapeutics; Medical research		Phage therapy is broadening the treatment landscape for people with drug-resistant infections. Phage therapy is broadening the treatment landscape for people with drug-resistant infections.										Dedrick RM, 2019, NAT MED, V25, P730, DOI 10.1038/s41591-019-0437-z; Djebara S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030265; Duplessis C. A. J., 2019, INTENSIVE CRIT CARE, V5, P11; Gibson SB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02537	4	4	4	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					S8	S9		10.1038/d41586-020-02109-7	http://dx.doi.org/10.1038/d41586-020-02109-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728257	Bronze			2022-12-28	WOS:000554831500005
J	Daniels, JP				Daniels, Joe Parkin			COVID-19 cases surge in Colombia	LANCET			English	Editorial Material																			0	1	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					227	227						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711785	Green Published, Bronze			2022-12-28	WOS:000567020100012
J	Shah, A; Marks, PW; Hahn, SM				Shah, Anand; Marks, Peter W.; Hahn, Stephen M.			Unwavering Regulatory Safeguards for COVID-19 Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint from the FDA reviews the minimum safety and efficacy standards COVID-19 vaccine candidates would need to meet to be considered for approval, and affirms its commitments to evaluating both in diverse populations and to postmarketing surveillance as means to ensure that approval will meet the highest safety and regulatory standards based on science and evidence, not politics.	[Shah, Anand; Marks, Peter W.; Hahn, Stephen M.] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Shah, A (corresponding author), US FDA, Med & Sci Affairs, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	anand.shah@fda.hhs.gov						[Anonymous], 2020, ASS PRESS; [Anonymous], 2011, ENS SAF VACC US; Collins FS, 2020, JAMA-J AM MED ASSOC, V323, P2455, DOI 10.1001/jama.2020.8920; O'Callaghan KP, 2020, JAMA-J AM MED ASSOC, V324, P437, DOI 10.1001/jama.2020.12190; U.S. Food & Drug Association, 2020, COVID 19 DEV DRUGS B; US Department of Health and Human Services,, 2020, FACT SHEET EXPL OP W; US Food and Drug Administration, 2020, DEV LIC VACC PREV CO	7	28	28	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					931	932		10.1001/jama.2020.15725	http://dx.doi.org/10.1001/jama.2020.15725			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32766736	Bronze			2022-12-28	WOS:000571867000009
J	Patra, S; Germann, M; Karr, JP; Haidar, M; Hilico, L; Korobov, VI; Cozijn, FMJ; Eikema, KSE; Ubachs, W; Koelemeij, JCJ				Patra, Sayan; Germann, M.; Karr, J-Ph; Haidar, M.; Hilico, L.; Korobov, V., I; Cozijn, F. M. J.; Eikema, K. S. E.; Ubachs, W.; Koelemeij, J. C. J.			Proton-electron mass ratio from laser spectroscopy of HD+ at the part-per-trillion level	SCIENCE			English	Article							CONSTANTS; HELIUM	Recent mass measurements of light atomic nuclei in Penning traps have indicated possible inconsistencies in closely related physical constants such as the proton-electron and deuteron-proton mass ratios. These quantities also influence the predicted vibrational spectrum of the deuterated molecular hydrogen ion (HD+) in its electronic ground state. We used Doppler-free two-photon laser spectroscopy to measure the frequency of the v = 0 -> 9 overtone transition (v, vibrational quantum number) of this spectrum with an uncertainty of 2.9 parts per trillion. By leveraging high-precision ab initio calculations, we converted our measurement to tight constraints on the proton-electron and deuteron-proton mass ratios, consistent with the most recent Penning trap determinations of these quantities. This results in a precision of 21 parts per trillion for the value of the proton-electron mass ratio.	[Patra, Sayan; Germann, M.; Cozijn, F. M. J.; Eikema, K. S. E.; Ubachs, W.; Koelemeij, J. C. J.] Vrije Univ Amsterdam, Dept Phys & Astron, LaserLaB, NL-1081 HV Amsterdam, Netherlands; [Karr, J-Ph; Haidar, M.; Hilico, L.] UPMC Sorbonne Univ, ENS PSL Res Univ, Coll France, CNRS,Lab Kastler Brossel, F-75005 Paris, France; [Karr, J-Ph; Hilico, L.] Univ Paris Saclay, Univ Evry Val dEssonne, Dept Phys, F-91000 Evry, France; [Korobov, V., I] Joint Inst Nucl Res, Bogolyubov Lab Theoret Phys, Dubna 141980, Russia; [Eikema, K. S. E.; Ubachs, W.] ARCNL Adv Res Ctr Nanolithog, NL-1098 XG Amsterdam, Netherlands; [Germann, M.] Umea Univ, Dept Phys, S-90187 Umea, Sweden	Vrije Universiteit Amsterdam; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Joint Institute for Nuclear Research - Russia; Umea University	Koelemeij, JCJ (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, LaserLaB, NL-1081 HV Amsterdam, Netherlands.	j.c.j.koelemeij@vu.nl	Patra, Sayan/AAX-2684-2020; Korobov, Vladimir/D-7849-2013; Ubachs, Wim/F-5649-2011	Patra, Sayan/0000-0002-2923-1561; Korobov, Vladimir/0000-0003-3724-0270; Cozijn, Frank/0000-0002-8169-5961; Ubachs, Wim/0000-0001-7840-3756; Haidar, Mohammad/0000-0003-2216-0702; Karr, Jean-Philippe/0000-0003-2082-0914; Koelemeij, Jeroen/0000-0003-1005-0231	Netherlands Organisation for Scientific Research (FOM Programs) [FOM 13PR3109, STW Vidi 12346]; European Research Council [AdG 670168, AdG 695677]; COST Action [CA17113]; Dutch-French bilateral Van Gogh program; Russian Foundation for Basic Research [19-02-00058-a]	Netherlands Organisation for Scientific Research (FOM Programs); European Research Council(European Research Council (ERC)European Commission); COST Action(European Cooperation in Science and Technology (COST)); Dutch-French bilateral Van Gogh program; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	We acknowledge support from the Netherlands Organisation for Scientific Research (FOM Programs "Broken Mirrors & Drifting Constants" and "The Mysterious Size of the Proton"; FOM 13PR3109, STW Vidi 12346), the European Research Council (AdG 670168 Ubachs, AdG 695677 Eikema), the COST Action CA17113 TIPICQA, and the Dutch-French bilateral Van Gogh program. J.-Ph.K. acknowledges support as a fellow of the Institut Universitaire de France. V.I.K. acknowledges support from the Russian Foundation for Basic Research under grant ~19-02-00058-a.	Alighanbari S, 2020, NATURE, V581, P152, DOI 10.1038/s41586-020-2261-5; Alighanbari S, 2018, NAT PHYS, V14, P555, DOI 10.1038/s41567-018-0074-3; Antognini A, 2013, SCIENCE, V339, P417, DOI 10.1126/science.1230016; Aznabayev DT, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.012501; Bakalov D, 2014, APPL PHYS B-LASERS O, V116, P777, DOI 10.1007/s00340-014-5902-2; Bakalov D, 2014, APPL PHYS B-LASERS O, V114, P213, DOI 10.1007/s00340-013-5703-z; Bakalov D, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/2/025003; Bakalov D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243001; Bergstrom I, 2002, PHYS SCRIPTA, V66, P201, DOI 10.1238/Physica.Regular.066a00201; Beyer A, 2017, SCIENCE, V358, P79, DOI 10.1126/science.aah6677; Bezginov N, 2019, SCIENCE, V365, P1007, DOI 10.1126/science.aau7807; Biesheuvel J, 2017, APPL PHYS B-LASERS O, V123, DOI 10.1007/s00340-016-6576-8; Biesheuvel J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10385; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; Fink DJ, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.013001; Fleurbaey H, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.183001; Haidar M, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.022501; Hamzeloui S, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.060501; HAPPER W, 1967, PHYS REV, V163, P12, DOI 10.1103/PhysRev.163.12; Heiss F, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.033001; Heisse F, 2019, PHYS REV A, V100, DOI 10.1103/PhysRevA.100.022518; Hori M, 2016, SCIENCE, V354, P610, DOI 10.1126/science.aaf6702; Karr JP, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.050501; Karr JP, 2014, J MOL SPECTROSC, V300, P37, DOI 10.1016/j.jms.2014.03.016; Koelemeij JCJ, 2012, APPL PHYS B-LASERS O, V107, P1075, DOI 10.1007/s00340-011-4802-y; Koelemeij JCJ, 2011, PHYS CHEM CHEM PHYS, V13, P18844, DOI 10.1039/c1cp21204d; Korobov VI, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.233001; Korobov VI, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.053003; LOW F, 1952, PHYS REV, V88, P53, DOI 10.1103/PhysRev.88.53; Mohr PJ, 2018, METROLOGIA, V55, P125, DOI 10.1088/1681-7575/aa99bc; Mohr PJ, 2016, J PHYS CHEM REF DATA, V45, DOI 10.1063/1.4954402; Mohr PJ, 2000, REV MOD PHYS, V72, P351, DOI 10.1103/RevModPhys.72.351; National Institute of Standards and Technology, 2019, CODATA INT REC 2018; Pachucki K, 1999, J PHYS B-AT MOL OPT, V32, P137, DOI 10.1088/0953-4075/32/1/014; Pachucki K, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.062511; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Patra S, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aa9b92; Patra Sayan, 2019, THESIS; Pohl R, 2016, SCIENCE, V353, P669, DOI 10.1126/science.aaf2468; Schiller S, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.052521; Solders A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012514; Telle HR, 2002, APPL PHYS B-LASERS O, V74, P1, DOI 10.1007/s003400100735; Udem T, 2019, ANN PHYS-BERLIN, V531, DOI 10.1002/andp.201900044; Van Dyck RS, 1999, AIP CONF PROC, V457, P101, DOI 10.1063/1.57450; Tran VQ, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033421; Xiong W, 2019, NATURE, V575, P147, DOI 10.1038/s41586-019-1721-2; Zafonte SL, 2015, METROLOGIA, V52, P280, DOI 10.1088/0026-1394/52/2/280	47	55	55	6	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2020	369	6508			SI		1238	+		10.1126/science.aba0453	http://dx.doi.org/10.1126/science.aba0453			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NL6LT	32732278	Green Submitted, Green Published			2022-12-28	WOS:000567525400051
J	Levinson, M; Cevik, M; Lipsitch, M				Levinson, Meira; Cevik, Muge; Lipsitch, Marc			Reopening Primary Schools during the Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Levinson, Meira] Harvard Grad Sch Educ, Cambridge, MA 02138 USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Lipsitch, Marc] Univ St Andrews, Div Infect & Global Hlth Res, Sch Med, St Andrews, Fife, Scotland	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University of St Andrews	Levinson, M (corresponding author), Harvard Grad Sch Educ, Cambridge, MA 02138 USA.			Lipsitch, Marc/0000-0003-1504-9213; Levinson, Meira/0000-0001-5645-7534; Cevik, Muge/0000-0003-1133-3874				American Academy of Pediatrics, 2020, AAP INT GUID SCH RE; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2020, DEATHS INV COVID 19; [Anonymous], 2020, PATH ZER SCH ACH PAN; Bailey J. P, 2020, CORONAVIRUS FAMILY I; Brighouse H., 2020, 20 HARV U SAFR CTR E; Camera L, 2020, US NEWS WORLD REPORT; Centers for Disease Control and Prevention, 2020, TEST HIGH DENS CRIT; Cevik M, 2020, Clin Microbiol Infect, V26, P842, DOI 10.1016/j.cmi.2020.04.023; Cohen P., 2020, NY TIMES; Couzin-Frankel J., 2020, SCH OPENINGS GLOBE S; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Education Week, 2020, SCH DISTR REOP PLANS; Faden R., 2020, ETHICS K 12 SCH REOP; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Finch WH, 2020, FRONTIERS SOCIOLOGY, DOI DOI 10.3389/FSOC.2020.00047/FULL; Goldstein D., 2020, NY TIMES; Goldstein E, 2020, EFFECT AGE TRANSMISS, DOI [10.1101/2020.07.19.20157362v1, DOI 10.1101/2020.07.19.20157362V1]; iek Slavoj., 2020, COVID 19 CORONAVIRUS; Koma W, 2020, LOW INCOME COMMUNITI; Levine R., 2020, CASE REOPENING SCH T; Levinson M., 2020, 17 HARV U SAFR CTR E; National Academies of Sciences Engineering Medicine., 2020, REOP K 12 SCH COVID; National Center for Educational Statistics, 2018, PRIV EL SEC SCH ENR; National Center for Educational Statistics, 2018, ENR PUBL EL SEC SCH; Novoa C, 2020, US CORONAVIRUS RESPO; Stanton Z, 2020, POLITICO; Strauss V, 2020, WASH POST; Taie S, 2020, 2020142 NCES; Van Buren A., 2016, MICHIGAN RADIO  0921; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Yglesias M., 2020, VOX             0708, DOI DOI 1314563/SCHOOL-REOPENING-TESTING-MONEY	32	83	83	3	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2020	383	10					981	985		10.1056/NEJMms2024920	http://dx.doi.org/10.1056/NEJMms2024920			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NO9YO	32726550	Bronze, Green Published			2022-12-28	WOS:000569841600020
J	Mbow, M; Lell, B; Jochems, SP; Cisse, B; Mboup, S; Dewals, BG; Jaye, A; Dieye, A; Yazdanbakhsh, M				Mbow, Moustapha; Lell, Bertrand; Jochems, Simon P.; Cisse, Badara; Mboup, Souleymane; Dewals, Benjamin G.; Jaye, Assan; Dieye, Alioune; Yazdanbakhsh, Maria			COVID-19 in Africa: Dampening the storm?	SCIENCE			English	Editorial Material							RESPONSES		[Mbow, Moustapha; Dieye, Alioune] Cheikh Anta Drop Univ Dakar, Dept Immunol, Fac Med Pharm & Odontol, Dakar, Senegal; [Lell, Bertrand] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Lell, Bertrand] Ctr Rech Med Lambarene, Lambarene, Gabon; [Jochems, Simon P.; Yazdanbakhsh, Maria] Leiden Univ, Ctr Infect Dis, Leiden, Netherlands; [Cisse, Badara] London Sch Hyg & Trop Med, London, England; [Mboup, Souleymane] Inst Hlth Res, Epidemiol Surveillance & Training, Dakar, Senegal; [Dewals, Benjamin G.] Univ Liege, FARAH, Lab Immunol Vaccinol, Liege, Belgium; [Jaye, Assan] London Sch Hyg & Trop Med, Med Res Council, Banjul, Gambia	Medical University of Vienna; Leiden University; Leiden University - Excl LUMC; University of London; London School of Hygiene & Tropical Medicine; University of Liege; University of London; London School of Hygiene & Tropical Medicine	Mbow, M (corresponding author), Cheikh Anta Drop Univ Dakar, Dept Immunol, Fac Med Pharm & Odontol, Dakar, Senegal.	moustapha2.mbow@ucad.edu.sn; m.yazdanbakhs@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Dewals, Benjamin G./AAL-5754-2021; Jochems, Simon/AAT-9156-2021	Yazdanbakhsh, Maria/0000-0002-7666-1441; Dewals, Benjamin G./0000-0003-1497-0799; Jochems, Simon/0000-0002-4835-1032				Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Li N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01551; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Martinez-Alvarez M, 2020, LANCET GLOB HEALTH, V8, pE631, DOI 10.1016/S2214-109X(20)30123-6; Mbow M, 2014, IMMUNOLOGY, V143, P569, DOI 10.1111/imm.12335; Mougeni F., 2020, MEDRXIV, DOI [10.1101/2020.05.19.20106914, DOI 10.1101/2020.05.19.20106914]; Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429; Ng K., 2020, BIORXIV, DOI [10.1101/2020.05.14.095414, DOI 10.1101/2020.05.14.095414]; Rolot M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06978-5; Smolen KK, 2014, J IMMUNOL, V193, P3003, DOI 10.4049/jimmunol.1400895; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	14	80	80	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					624	626		10.1126/science.abd3902	http://dx.doi.org/10.1126/science.abd3902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764055				2022-12-28	WOS:000559184400024
J	Fox, K				Fox, Keolu			The Illusion of Inclusion - The "All of Us" Research Program and Indigenous Peoples' DNA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The genomes of Indigenous peoples contain vast amounts of unexplored variation. But given the fraught history of genetic studies involving Indigenous peoples, tribal communities are sometimes reluctant to participate in genomics research.	[Fox, Keolu] Univ Calif San Diego, Dept Anthropol, Global Hlth Program, San Diego, CA 92103 USA; [Fox, Keolu] Univ Calif San Diego, Indigenous Futures Lab, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Fox, K (corresponding author), Univ Calif San Diego, Dept Anthropol, Global Hlth Program, San Diego, CA 92103 USA.; Fox, K (corresponding author), Univ Calif San Diego, Indigenous Futures Lab, San Diego, CA 92103 USA.							Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Garrison NA, 2019, ANNU REV GENOM HUM G, V20, P495, DOI 10.1146/annurev-genom-083118-015434; Hudson M, 2020, NAT REV GENET, V21, P377, DOI 10.1038/s41576-020-0228-x; Mills MC, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0261-x; Montasser ME, 2019, GENETIC FUNCTIONAL E	5	46	47	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					411	413		10.1056/NEJMp1915987	http://dx.doi.org/10.1056/NEJMp1915987			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32726527	Bronze			2022-12-28	WOS:000556861800008
J	Rochwerg, B; Agarwal, A; Zeng, LA; Leo, YS; Appiah, JA; Agoritsas, T; Bartoszko, J; Brignardello-Petersen, R; Ergan, B; Ge, L; Geduld, H; Gershengorn, HB; Manai, H; Huang, MH; Lamontagne, F; Kanda, S; Kawano-Dourado, L; Kurian, L; Kwizera, A; Murthy, S; Qadir, N; Siemieniuk, R; Silvestre, MA; Vandvik, PO; Ye, ZK; Zeraatkar, D; Guyatt, G				Rochwerg, Bram; Agarwal, Arnav; Zeng, Linan; Leo, Yee-Sin; Appiah, John Adabie; Agoritsas, Thomas; Bartoszko, Jessica; Brignardello-Petersen, Romina; Ergan, Begum; Ge, Long; Geduld, Heike; Gershengorn, Hayley B.; Manai, Hela; Huang, Minhua; Lamontagne, Francois; Kanda, Seema; Kawano-Dourado, Leticia; Kurian, Linda; Kwizera, Arthur; Murthy, Srinivas; Qadir, Nida; Siemieniuk, Reed; Silvestre, Maria Asuncion; Vandvik, Per Olav; Ye, Zhikang; Zeraatkar, Dena; Guyatt, Gordon			Remdesivir for severe covid-19: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; GRADE	CLINICAL QUESTION What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020. CURRENT PRACTICE Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. After rapid market approval in the US, remdesivir is already being used in clinical practice. RECOMMENDATIONS The guideline panel makes a weak recommendation for the use of remdesivir in severe covid-19 while recommending continuation of active enrolment of patients into ongoing randomised controlled trials examining remdesivir. HOW THIS GUIDELINE WAS CREATED An international panel of patients, clinicians, and methodologists produced these recommendations in adherence with standards for trustworthy guidelines using the GRADE approach. The recommendations are based on a linked systematic review and network meta-analysis. The panel considered an individual patient perspective and allowed contextual factors (such as resources) to be taken into account for countries and healthcare systems. THE EVIDENCE The linked systematic review (published 31 Jul 2020) identified two randomised trials with 1300 participants, showing low certainty evidence that remdesivir may be effective in reducing time to clinical improvement and may decrease mortality in patients with severe covid-19. Remdesivir probably has no important effect on need for invasive mechanical ventilation. Remdesivir may have little or no effect on hospital length of stay. UNDERSTANDING THE RECOMMENDATION Most patients with severe covid-19 would likely choose treatment with remdesivir given the potential reduction in time to clinical improvement. However, given the low certainty evidence for critical outcomes and the fact that different perspectives, values, and preferences may alter decisions regarding remdesivir, the panel issued a weak recommendation with strong support for continued recruitment in randomised trials.	[Rochwerg, Bram; Agarwal, Arnav; Zeng, Linan; Agoritsas, Thomas; Bartoszko, Jessica; Brignardello-Petersen, Romina; Ge, Long; Siemieniuk, Reed; Ye, Zhikang; Zeraatkar, Dena; Guyatt, Gordon] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Rochwerg, Bram] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Agarwal, Arnav] Univ Toronto, Dept Med, Toronto, ON, Canada; [Zeng, Linan] Sichuan Univ, West China Second Univ Hosp, Dept Pharm, Evidence Based Pharm Ctr, Chengdu, Peoples R China; [Leo, Yee-Sin] Natl Ctr Infect Dis, Singapore, Singapore; [Appiah, John Adabie] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Ergan, Begum] Dokuz Eylul Univ, Dept Pulm & Crit Care, Sch Med, Izmir, Turkey; [Ge, Long] Lanzhou Univ, Sch Publ Hlth, Evidence Based Social Sci Res Ctr, Lanzhou, Peoples R China; [Ge, Long] Lanzhou Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Lanzhou, Peoples R China; [Geduld, Heike] Stellenbosch Univ, Fac Med & Hlth Sci, Div Emergency Med, Cape Town, South Africa; [Gershengorn, Hayley B.; Guyatt, Gordon] Univ Miami, Miller Sch Med, Div Pulm Crit Care & Sleep Med, Miami, FL 33136 USA; [Gershengorn, Hayley B.] Albert Einstein Coll Med, Div Crit Care Med, Bronx, NY 10467 USA; [Manai, Hela] Emergency Med Serv, Fac Med, Tunis, Tunisia; [Huang, Minhua] Guangdong Kuaiwen Informat Technol Co LTD, Guangzhou, Guangdong, Peoples R China; [Lamontagne, Francois] CHU Sherbrooke, Ctr Rech, Dept Med, Sherbrooke, PQ, Canada; [Kanda, Seema] McMaster Univ Alumnus, Hamilton, ON, Canada; [Kawano-Dourado, Leticia] Univ Sao Paulo, Heart Inst InCor HCFMUSP, Div Pulm, Sch Med, Sao Paulo, Brazil; [Kawano-Dourado, Leticia] Hosp Coracao HCor, Res Inst, Sao Paulo, Brazil; [Kurian, Linda] Donald & Barbara Zucker Sch Med Hofstra Northwell, Div Hosp Med, Hempstead, NY USA; [Kwizera, Arthur] Makerere Univ, Coll Hlth Sci, Dept Anaesthesia & Crit Care, Kampala, Uganda; [Murthy, Srinivas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Qadir, Nida] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Silvestre, Maria Asuncion] Kalusugan Ng Mag Ina Hlth Mother & Child Inc, Quezon City, Philippines; [Silvestre, Maria Asuncion] Asia Pacific Ctr Evidence Based Healthcare, Manila, Philippines; [Vandvik, Per Olav] Univ Oslo, Inst Hlth & Soc, Dept Hlth Econ & Hlth Management, Oslo, Norway	McMaster University; McMaster University; University of Toronto; Sichuan University; National Centre for Infectious Diseases Singapore; Kwame Nkrumah University Science & Technology; University of Geneva; University of Geneva; Dokuz Eylul University; Lanzhou University; Lanzhou University; Stellenbosch University; University of Miami; Yeshiva University; Albert Einstein College of Medicine; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); University of Sherbrooke; Universidade de Sao Paulo; Hospital do Coracao - HCor; Makerere University; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oslo	Rochwerg, B (corresponding author), 711 Concess St, Hamilton, ON L8V 1C3, Canada.	rochwerg@mcmaster.ca	Agarwal, Arnav/J-1553-2014; ergan, begum/U-8276-2017; Zeraatkar, Dena/GNM-9600-2022; Agoritsas, Thomas/F-4321-2014	Agarwal, Arnav/0000-0002-0931-7851; ergan, begum/0000-0003-2920-9214; Agoritsas, Thomas/0000-0002-6182-9969; Lamontagne, Francois/0000-0002-0360-3427; Murthy, Srinivas/0000-0002-9476-839X				Alhazzani Waleed, 2020, Intensive Care Med, V46, P854, DOI [10.1007/s00134-020-06022-5, 10.1097/CCM.0000000000004363]; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2020, CORONAVIRUS DIS 2019; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bhimraj Adarsh, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa478; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Goldman JD, 2020, N ENGL J MED; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Infectious Diseases Data Observatory, 2020, LIV SYST REV COVID 1; Johns Hopkins University, 2020, COVID 19 DASHB; Maguire Brittany J, 2020, Wellcome Open Res, V5, P60, DOI 10.12688/wellcomeopenres.15821.1; National Institutes of Health, 2020, COVID 19 TREATM GUID; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; SIEMIENIUK RA, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I5191; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980; Vandvik PO, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5085; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Ye W, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01105; Ye ZK, 2020, CAN MED ASSOC J, V192, pE536, DOI 10.1503/cmaj.200648	22	73	74	3	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m2924	10.1136/bmj.m2924	http://dx.doi.org/10.1136/bmj.m2924			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732352	Green Published, Bronze			2022-12-28	WOS:000556139900013
J	Siemieniuk, RAC; Bartoszko, JJ; Ge, L; Zeraatkar, D; Izcovich, A; Pardo-Hernandez, H; Rochwerg, B; Lamontagne, F; Han, MA; Kum, E; Liu, Q; Agarwal, A; Agoritsas, T; Alexander, P; Chu, DK; Couban, R; Darzi, A; Devji, T; Fang, B; Fang, C; Flottorp, SA; Foroutan, F; Heels-Ansdell, D; Honarmand, K; Hou, LY; Hou, XR; Ibrahim, Q; Loeb, M; Marcucci, M; McLeod, SL; Motaghi, S; Murthy, S; Mustafa, RA; Neary, JD; Qasim, A; Rada, G; Bin Riaz, I; Sadeghirad, B; Sekercioglu, N; Sheng, LL; Switzer, C; Tendal, B; Thabane, L; Tomlinson, G; Turner, T; Vandvik, PO; Vernooij, RW; Viteri-Garcia, A; Wang, Y; Yao, L; Ye, ZK; Guyatt, GH; Brignardello-Peterson, R				Siemieniuk, Reed A. C.; Bartoszko, Jessica J.; Ge, Long; Zeraatkar, Dena; Izcovich, Ariel; Pardo-Hernandez, Hector; Rochwerg, Bram; Lamontagne, Francois; Han, Mi Ah; Kum, Elena; Liu, Qin; Agarwal, Arnav; Agoritsas, Thomas; Alexander, Paul; Chu, Derek K.; Couban, Rachel; Darzi, Andrea; Devji, Tahira; Fang, Bo; Fang, Carmen; Flottorp, Signe Agnes; Foroutan, Farid; Heels-Ansdell, Diane; Honarmand, Kimia; Hou, Liangying; Hou, Xiaorong; Ibrahim, Quazi; Loeb, Mark; Marcucci, Maura; McLeod, Shelley L.; Motaghi, Sharhzad; Murthy, Srinivas; Mustafa, Reem A.; Neary, John D.; Qasim, Anila; Rada, Gabriel; Bin Riaz, Irbaz; Sadeghirad, Behnam; Sekercioglu, Nigar; Sheng, Lulu; Switzer, Charlotte; Tendal, Britta; Thabane, Lehana; Tomlinson, George; Turner, Tari; Vandvik, Per O.; Vernooij, Robin Wm; Viteri-Garcia, Andres; Wang, Ying; Yao, Liang; Ye, Zhikang; Guyatt, Gordon H.; Brignardello-Peterson, Romina			Drug treatments for covid-19: living systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MULTICENTER	OBJECTIVE To compare the effects of treatments for coronavirus disease 2019 (covid-19). DESIGN Living systematic review and network meta-analysis. DATA SOURCES US Centers for Disease Control and Prevention COVID-19 Research Articles Downloadable Database, which includes 25 electronic databases and six additional Chinese databases to 20 July 2020. STUDY SELECTION Randomised clinical trials in which people with suspected, probable, or confirmed covid-19 were randomised to drug treatment or to standard care or placebo. Pairs of reviewers independently screened potentially eligible articles. METHODS After duplicate data abstraction, a bayesian random effects network meta-analysis was conducted. Risk of bias of the included studies was assessed using a modification of the Cochrane risk of bias 2.0 tool, and the certainty of the evidence using the grading of recommendations assessment, development and evaluation (GRADE) approach. For each outcome, interventions were classified in groups from the most to the least beneficial or harmful following GRADE guidance. RESULTS 23 randomised controlled trials were included in the analysis performed on 26 June 2020. The certainty of the evidence for most comparisons was very low because of risk of bias (lack of blinding) and serious imprecision. Glucocorticoids were the only intervention with evidence for a reduction in death compared with standard care (risk difference 37 fewer per 1000 patients, 95% credible interval 63 fewer to 11 fewer, moderate certainty) and mechanical ventilation (31 fewer per 1000 patients, 47 fewer to 9 fewer, moderate certainty). These estimates are based on direct evidence; network estimates for glucocorticoids compared with standard care were less precise because of network heterogeneity. Three drugs might reduce symptom duration compared with standard care: hydroxychloroquine (mean difference -4.5 days, low certainty), remdesivir (-2.6 days, moderate certainty), and lopinavir-ritonavir (-1.2 days, low certainty). Hydroxychloroquine might increase the risk of adverse events compared with the other interventions, and remdesivir probably does not substantially increase the risk of adverse effects leading to drug discontinuation. No other interventions included enough patients to meaningfully interpret adverse effects leading to drug discontinuation. CONCLUSION Glucocorticoids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care. The effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.	[Siemieniuk, Reed A. C.; Bartoszko, Jessica J.; Zeraatkar, Dena; Rochwerg, Bram; Kum, Elena; Agarwal, Arnav; Agoritsas, Thomas; Alexander, Paul; Darzi, Andrea; Devji, Tahira; Foroutan, Farid; Heels-Ansdell, Diane; Ibrahim, Quazi; Loeb, Mark; Marcucci, Maura; Motaghi, Sharhzad; Mustafa, Reem A.; Qasim, Anila; Sadeghirad, Behnam; Sekercioglu, Nigar; Switzer, Charlotte; Thabane, Lehana; Wang, Ying; Yao, Liang; Ye, Zhikang; Guyatt, Gordon H.; Brignardello-Peterson, Romina] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St W, Hamilton, ON L8S 4L8, Canada; [Ge, Long; Hou, Liangying] Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, Lanzhou, Gansu, Peoples R China; [Izcovich, Ariel; Honarmand, Kimia; Neary, John D.] Hosp Aleman, Serv Clin Med, Buenos Aires, DF, Argentina; [Pardo-Hernandez, Hector] St Pau Biomed Res Inst IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Pardo-Hernandez, Hector] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Rochwerg, Bram; Loeb, Mark; Marcucci, Maura; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lamontagne, Francois] CHU Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Lamontagne, Francois] CHU Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Han, Mi Ah] Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea; [Liu, Qin; Fang, Bo; Sheng, Lulu] Chongqing Med Univ, Cochrane China Network Affiliate, Chongqing, Peoples R China; [Liu, Qin; Fang, Bo; Sheng, Lulu] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Agarwal, Arnav] Univ Toronto, Dept Med, Toronto, ON, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Couban, Rachel; Sadeghirad, Behnam] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Fang, Carmen; Vandvik, Per O.] William Oster Hlth Network, Toronto, ON, Canada; [Flottorp, Signe Agnes] Norwegian Inst Publ Hlth, Oslo, Norway; [Chu, Derek K.; Flottorp, Signe Agnes] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Foroutan, Farid] Toronto Gen Hosp, Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Hou, Xiaorong] Chongqing Med Univ, Coll Med Informat, Chongqing, Peoples R China; [McLeod, Shelley L.] Sinai Hlth, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [McLeod, Shelley L.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Murthy, Srinivas] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada; [Mustafa, Reem A.] Univ Kansas, Med Ctr, Dept Med, Kansas City, MO USA; [Rada, Gabriel; Viteri-Garcia, Andres] Epistemonikos Fdn, Santiago, Chile; [Rada, Gabriel] Pontificia Univ Catolica Chile, Cochrane Chile Associated Ctr, UC Evidence Ctr, Santiago, Chile; [Bin Riaz, Irbaz] Mayo Clin Rochester, Hematol & Oncol, Rochester, MN USA; [Tendal, Britta; Turner, Tari] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia; [Tomlinson, George] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Vernooij, Robin Wm] Univ Med Ctr Utrecht, Dept Nephtol & Hypertens, Utrecht, Netherlands; [Vernooij, Robin Wm] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Viteri-Garcia, Andres] Univ UTE, Fac Ciencias Salud Eugenio Espejo, Ctr Invest Salud Publ & Epidemiol Clin CISPEQ, Quito, Ecuador	McMaster University; Lanzhou University; Hospital Aleman; University of Buenos Aires; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; McMaster University; University of Sherbrooke; University of Sherbrooke; Chosun University; Chongqing Medical University; Chongqing Medical University; University of Toronto; University of Geneva; University of Geneva; McMaster University; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Chongqing Medical University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of British Columbia; University of Kansas; Pontificia Universidad Catolica de Chile; Mayo Clinic; Monash University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.	reed.siemieniuk@medportal.ca	Sadeghirad, Behnam/A-1772-2009; Agoritsas, Thomas/F-4321-2014; SEKERCIOGLU, Nigar/AFR-0250-2022; Bin Riaz, Irbaz/ABB-3799-2020; Agarwal, Arnav/J-1553-2014; Vernooij, Robin/N-3652-2018; Zeraatkar, Dena/GNM-9600-2022; Couban, Rachel/AAV-1568-2021; McLeod, Shelley/AAE-9636-2019; Viteri-García, Andrés/AAA-4434-2021; T, E/HII-8943-2022; Tomlinson, George/L-5432-2016; Khamis, Assem/P-8992-2017	Sadeghirad, Behnam/0000-0001-9422-5232; Agoritsas, Thomas/0000-0002-6182-9969; SEKERCIOGLU, Nigar/0000-0001-6461-8801; Bin Riaz, Irbaz/0000-0003-4249-0311; Agarwal, Arnav/0000-0002-0931-7851; Vernooij, Robin/0000-0001-5734-4566; Couban, Rachel/0000-0001-8672-2845; McLeod, Shelley/0000-0003-2686-6307; Siemieniuk, Reed/0000-0002-3725-3031; Chu, Derek/0000-0001-8269-4496; Kum, Elena/0000-0002-6548-2632; Tomlinson, George/0000-0002-9328-6399; Wang, Ying/0000-0002-2296-1991; Qasim, Anila/0000-0001-9658-0078; Izcovich, Ariel/0000-0001-9053-4396; Lamontagne, Francois/0000-0002-0360-3427; Yao, Liang/0000-0003-4068-3136; Murthy, Srinivas/0000-0002-9476-839X; Guerin, Philippe/0000-0002-6008-2963; Viteri-Garcia, Andres/0000-0003-0393-2404; Khamis, Assem/0000-0002-5567-7065	Canadian Institutes of Health Research [CIHR-IRSC:0579001321]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (grant CIHR-IRSC:0579001321).	Amat-Santos IJ, 2020, J AM COLL CARDIOL, V76, P268, DOI 10.1016/j.jacc.2020.05.040; [Anonymous], 2020, GEMTC NETWORK META A; [Anonymous], COVIDENCE SYSTEMATIC; [Anonymous], 2020, R2JAGS USING R TO RU; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bi YB, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00080-8; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Borba MGS, 2020, CHLOROQUINE DIPHOSPH, DOI [10.1101/2020.04.07.20056424, 10.1101/ 2020.04.07.20056424., DOI 10.1101/2020.04.07.20056424]; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Boutron I, 2020, INTERVENTIONS FOR PR; Brignardello-Petersen R, 2020, GRADE APPROACH TO DR; Brignardello-Petersen R, 2019, J CLIN EPIDEMIOL, V108, P77, DOI 10.1016/j.jclinepi.2018.11.025; Brignardello-Petersen R, 2019, J CLIN EPIDEMIOL, V105, P60, DOI 10.1016/j.jclinepi.2018.08.022; Brignardello-Petersen R, 2018, J CLIN EPIDEMIOL, V93, P36, DOI 10.1016/j.jclinepi.2017.10.005; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cao Yang, 2020, J Allergy Clin Immunol, V146, P137, DOI 10.1016/j.jaci.2020.05.019; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chen C, 2020, MEDRXIV, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]; Chen CP, 2020, MEDRXIV PREPRINT 202, DOI [10.1101/2020.07.08.20148841, DOI 10.1101/2020.07.08.20148841]; Chen J, 2019, J ZHEJIANG U, V49, P215; Chen L., 2020, EFFICACY SAFETY CHLO, DOI [10.1101/2020.06.19.20136093, 10.1101/.20136093]; Chen Y-K, 2020, COMPARATIVE EFFECTIV; Corral L, 2020, MEDRXIV PREPRINT 202; Cytel, 2020, GLOBAL CORONAVIRUS C; Davoodi L, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13600; Davoudi-Monfared E, 2020, EFFICACY AND SAFETY; Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20; Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136; Djulbegovic B, 2020, J CLIN EPIDEMIOL, V126, P164, DOI 10.1016/j.jclinepi.2020.07.002; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; Friedrich JO, 2011, J CLIN EPIDEMIOL, V64, P556, DOI 10.1016/j.jclinepi.2010.09.016; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Guan Y., 2020, EXPLORATORY RANDOMIZ, V2020, DOI [10.1101/2020.03.19.20038984, DOI 10.1101/2020.03.19.20038984]; Guvenmez O, 2020, J POPUL THER CLIN PH, V27, pE5, DOI 10.15586/jptcp.v27iSP1.684; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273, 10.1101/2020.06.22.20137273v1, DOI 10.1101/2020.07.15.20151852]; Horby P, 2020, MEDRXIV PREPRINT 202; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huang MX, 2020, J MOL CELL BIOL, V12, P322, DOI 10.1093/jmcb/mjaa014; Hultcrantz M, 2017, J CLIN EPIDEMIOL, V87, P4, DOI 10.1016/j.jclinepi.2017.05.006; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium), 2020, COVID 19 REPORT 08 J; Juul S, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01371-0; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Li YP, 2020, MED-CAMBRIDGE, V1, P105, DOI 10.1016/j.medj.2020.04.001; Lou Y, 2020, CLIN OUTCOMES PLASMA, DOI [10.1101/2020.04.29.20085761, DOI 10.1101/2020.04.29.20085761]; Marshall IJ, 2018, RES SYNTH METHODS, V9, P602, DOI 10.1002/jrsm.1287; Mitja O, 2020, HYDROXYCHLOROQUINE A; Mitja O, 2021, CLIN INFECT DIS, V73, pE4073, DOI 10.1093/cid/ciaa1009; Niaee MS, 2021, ASIAN PAC J TROP MED, V14, P266, DOI 10.4103/1995-7645.318304; Norwegian Institute of Public Health, 2020, NIPH SYSTEMATIC AND; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rochwerg B, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2924; Rover C., 2017, ARXIV PREPRINT ARXIV; Schandelmaier S, 2020, CMAJ; SIEMIENIUK RA, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I5191; Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207; Spineli L, 2017, OBTAINING ABSOLUTE E; Tang W., 2020, HYDROXYCHLOROQUINE P, DOI [10.1101/2020.04.10.20060558, DOI 10.1101/2020.04.10.20060558]; Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849; The Stephen B. Thacker CDC Library, 2020, THACKER CDC LIBRARY; Turner RM, 2015, STAT MED, V34, P984, DOI 10.1002/sim.6381; van Valkenhoef G, 2016, RES SYNTH METHODS, V7, P80, DOI 10.1002/jrsm.1167; Vandvik PO, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0596-4; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO, 2020, RESP COMM SPREAD COV, DOI DOI 10.1017/DMP.2020.166; Yuan X., 2020, PULMONARY RADIOLOGIC, DOI [10.1101/2020.04.07.20054767, DOI 10.1101/2020.04.07.20054767]; Zhang, 2020, EFFICACY HYDROXYCHLO, P7, DOI [10.1101/.20040758, 10.1101/2020.03.22.20040758, DOI 10.1101/2020.03.22.20040758]; Zheng F., 2020, MEDRXIV, DOI [10.1101/2020.04.24.20077735, DOI 10.1101/2020.04.24.20077735]; Zhong M., 2020, RANDOMIZED SINGLE BL, DOI [10.1101/2020.04.15.20066266, DOI 10.1101/2020.04.15.20066266]; Zhou WaiMin, 2020, Chinese Journal of Virology, V36, P160, DOI 10.13242/j.cnki.bingduxuebao.003679	73	414	423	5	56	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m2980	10.1136/bmj.m2980	http://dx.doi.org/10.1136/bmj.m2980			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732190	Green Published, hybrid			2022-12-28	WOS:000556139900002
J	Rubin, R				Rubin, Rita			Higher Rate of Opioid-Related Stays in Urban Than Rural Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					326	326		10.1001/jama.2020.12645	http://dx.doi.org/10.1001/jama.2020.12645			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32720991				2022-12-28	WOS:000562851000005
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Trump shifts tone by endorsing masks and admitting US situation will worsen	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Clement C, 2020, WASHINGTON POST; McNeil DG, 2020, NY TIMES	2	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2020	370								n2989	10.1136/bmj.m2989	http://dx.doi.org/10.1136/bmj.m2989			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7IG	32709614	Bronze			2022-12-28	WOS:000554448500002
J	Cuneo, CN; Janeway, H				Cuneo, C. Nicholas; Janeway, Hannah			From Icebox to Tinderbox - A View from the Southern Border	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cuneo, C. Nicholas] Harvard Med Sch, Boston, MA 02115 USA; [Cuneo, C. Nicholas] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Cuneo, C. Nicholas] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Janeway, Hannah] Univ Calif Los Angeles, Dept Emergency Med, Los Angeles, CA USA; [Janeway, Hannah] Refugee Hlth Alliance, La Jolla, CA USA; [Janeway, Hannah] Refugee Hlth Alliance, Tijuana, Mexico	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles	Cuneo, CN (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Cuneo, CN (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Cuneo, CN (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.			Cuneo, Charles/0000-0002-5824-2243				HRW (Human Rights Watch), 2018, FREEZ AB COND WOM CH; Human Rights First, 2020, DEL DANG TRUMP ADM S; Peeler K, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMp1701684; Solis Gustavo, 2019, LOS ANGELES TIMES	4	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2020	383	13							e81	10.1056/NEJMp2009985	http://dx.doi.org/10.1056/NEJMp2009985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NX2KQ	32757518	Bronze			2022-12-28	WOS:000575544000005
J	Detsky, AS; Bogoch, II				Detsky, Allan S.; Bogoch, Isaac I.			COVID-19 in Canada Experience and Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Bogoch, Isaac I.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bogoch, Isaac I.] Univ Hlth Network, Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Detsky, AS (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	Allan.detsky@sinaihealth.ca						[Anonymous], 2020, COVID 19 GOING FORW; Apple, 2020, MOB TRENDS REP; Barrett K, 2020, CAN MED ASSOC J, V192, pE640, DOI 10.1503/cmaj.200715; Canadian Institute for Health Information, 2020, PAND EXP LONG TERM C; Google,, 2020, COVID 19 COMM MOB RE; Government of Canada,, 2020, INT J INFECT DIS; Park S, 2020, JAMA-J AM MED ASSOC, V323, P2129, DOI 10.1001/jama.2020.6602; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467; Worldometers, 2020, COR UPD	10	57	58	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					743	744		10.1001/jama.2020.14033	http://dx.doi.org/10.1001/jama.2020.14033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32790824	Bronze			2022-12-28	WOS:000568230000017
J	Stagkourakis, S; Smiley, KO; Williams, P; Kakadellis, S; Ziegler, K; Bakker, J; Brown, RSE; Harkany, T; Grattan, DR; Broberger, C				Stagkourakis, Stefanos; Smiley, Kristina O.; Williams, Paul; Kakadellis, Sarah; Ziegler, Katharina; Bakker, Joanne; Brown, Rosemary S. E.; Harkany, Tibor; Grattan, David R.; Broberger, Christian			A Neuro-hormonal Circuit for Paternal Behavior Controlled by a Hypothalamic Network Oscillation	CELL			English	Article							MEDIAL PREOPTIC AREA; TUBEROINFUNDIBULAR DOPAMINE NEURONS; PROLACTIN INDUCES PHOSPHORYLATION; RATS RATTUS-NORVEGICUS; MATERNAL-BEHAVIOR; PARENTAL BEHAVIOR; SERUM PROLACTIN; SEX-DIFFERENCES; IN-VIVO; NUCLEAR TRANSLOCATION	Parental behavior is pervasive throughout the animal kingdom and essential for species survival. However, the relative contribution of the father to offspring care differs markedly across animals, even between related species. The mechanisms that organize and control paternal behavior remain poorly understood. Using Sprague-Dawley rats and C57BL/6 mice, two species at opposite ends of the paternal spectrum, we identified that distinct electrical oscillation patterns in neuroendocrine dopamine neurons link to a chain of low dopamine release, high circulating prolactin, prolactin receptor-dependent activation of medial preoptic area galanin neurons, and paternal care behavior in male mice. In rats, the same parameters exhibit inverse profiles. Optogenetic manipulation of these rhythms in mice dramatically shifted serum prolactin and paternal behavior, whereas injecting prolactin into non-paternal rat sires triggered expression of parental care. These findings identify a frequency-tuned brain-endocrine-brain circuit that can act as a gain control system determining a species' parental strategy.	[Stagkourakis, Stefanos; Williams, Paul; Kakadellis, Sarah; Ziegler, Katharina; Bakker, Joanne; Harkany, Tibor; Broberger, Christian] Karolinska Inst, Dept Neurosci, Biomed B4, Solnavagen 9, S-17165 Stockholm, Sweden; [Smiley, Kristina O.; Brown, Rosemary S. E.; Grattan, David R.] Univ Otago, Ctr Neuroendocrinol, Sch Biomed Sci, Dunedin 9016, New Zealand; [Smiley, Kristina O.; Grattan, David R.] Univ Otago, Sch Biomed Sci, Dept Anat, Dunedin 9016, New Zealand; [Williams, Paul; Broberger, Christian] Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, S-10691 Stockholm, Sweden; [Brown, Rosemary S. E.] Univ Otago, Sch Biomed Sci, Dept Physiol, Dunedin 9016, New Zealand; [Harkany, Tibor] Med Univ Vienna, Ctr Brain Res, Dept Mol Neurosci, Spitalgasse 4, A-1090 Vienna, Austria; [Grattan, David R.] Univ Auckland, Maurice Wilkins Ctr, Auckland, New Zealand; [Stagkourakis, Stefanos] CALTECH, Dept Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA	Karolinska Institutet; University of Otago; University of Otago; Stockholm University; University of Otago; Medical University of Vienna; University of Auckland; California Institute of Technology	Stagkourakis, S; Broberger, C (corresponding author), Karolinska Inst, Dept Neurosci, Biomed B4, Solnavagen 9, S-17165 Stockholm, Sweden.; Broberger, C (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, S-10691 Stockholm, Sweden.; Stagkourakis, S (corresponding author), CALTECH, Dept Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	stefanos.stagkourakis@caltech.edu; christian.broberger@dbb.su.se	Stagkourakis, Stefanos/AGJ-9529-2022	Brown, Rosemary/0000-0001-6775-3072; Smiley, Kristina/0000-0003-0799-0441; Grattan, Dave/0000-0001-5606-2559; Ziegler, Katharina/0000-0003-2111-8916; Stagkourakis, Stefanos/0000-0003-1218-791X	European Research Council [261286-ENDOSWITCH, ERC-AdG-2015-695136]; Swedish Research Council [2018-02480]; Strategic Research Program in Diabetes at Karolinska Institutet; StratNeuro, Hjarnfonden (Swedish Brain Foundation); Novo Nordisk Fonden; Karolinska Institutet; EMBO ALTF [736-2018]	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Program in Diabetes at Karolinska Institutet; StratNeuro, Hjarnfonden (Swedish Brain Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Karolinska Institutet(Karolinska Institutet); EMBO ALTF	The authors thank Dr. G. Spigolon for advice regarding experiments and Dr. K. Ampatzis for advice regarding illustrations. Members of the Broberger laboratory are thanked for discussions during preparation of this manuscript and Drs. N.G. Larsson and O. Kiehn for sharing the DAT-Cre and floxed-tdTomato mice, respectively. This study was supported by grants from the European Research Council (261286-ENDOSWITCH to C.B. and ERC-AdG-2015-695136 to T.H.); the Swedish Research Council (2018-02480), Strategic Research Program in Diabetes at Karolinska Institutet and StratNeuro, Hjarnfonden (Swedish Brain Foundation), Novo Nordisk Fonden, and internal funds from Karolinska Institutet (to C.B.), and EMBO ALTF 736-2018 (to S.S.).	Ali S, 1998, J BIOL CHEM, V273, P7709, DOI 10.1074/jbc.273.13.7709; Aquino NSS, 2017, ENDOCRINOLOGY, V158, P1812, DOI 10.1210/en.2016-1855; ARITA J, 1986, ENDOCRINOLOGY, V119, P1666, DOI 10.1210/endo-119-4-1666; Banasikowski TJ, 2012, EUR NEUROPSYCHOPHARM, V22, P761, DOI 10.1016/j.euroneuro.2012.02.004; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Bendesky A, 2017, NATURE, V544, P434, DOI 10.1038/nature22074; BRIDGES RS, 1974, HORM BEHAV, V5, P219, DOI 10.1016/0018-506X(74)90030-0; BRIDGES RS, 1983, PSYCHONEUROENDOCRINO, V8, P109, DOI 10.1016/0306-4530(83)90047-1; Briffaud V, 2015, J NEUROSCI, V35, P4229, DOI 10.1523/JNEUROSCI.2633-14.2015; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Brown RSE, 2017, P NATL ACAD SCI USA, V114, P10779, DOI 10.1073/pnas.1708025114; Brown RSE, 2016, J NEUROSCI, V36, P9173, DOI 10.1523/JNEUROSCI.1471-16.2016; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Buntin JD, 2014, GEN COMP ENDOCR, V200, P1, DOI 10.1016/j.ygcen.2014.02.006; Capone F., 2005, CURR PROTOC TOXICOL, DOI DOI 10.1002/0471140856.TX1309S26; Cave BJ, 2005, NEUROREPORT, V16, P1423, DOI 10.1097/01.wnr.0000176516.19347.6f; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; Cox RL, 2003, PSYCHOL REP, V93, P59, DOI 10.2466/pr0.2003.93.1.59; DEMAREST KT, 1986, NEUROENDOCRINOLOGY, V43, P291, DOI 10.1159/000124543; DEMAREST KT, 1983, NEUROENDOCRINOLOGY, V36, P130, DOI 10.1159/000123449; DIXSON AF, 1982, NATURE, V299, P551, DOI 10.1038/299551a0; DUDLEY D, 1974, BEHAV BIOL, V11, P247, DOI 10.1016/S0091-6773(74)90433-7; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433, DOI 10.1113/jphysiol.1979.sp012781; EGID K, 1983, AM ZOOL, V23, P930; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ellis LD, 2007, J NEUROSCI, V27, P9491, DOI 10.1523/JNEUROSCI.1106-07.2007; Feldman R, 2015, TRENDS NEUROSCI, V38, P387, DOI 10.1016/j.tins.2015.04.004; Fleenor D, 2006, HORM RES, V66, P101, DOI 10.1159/000093667; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frantz A G, 1973, Front Neuroendocrinol, V0, P337; Frantz A G, 1973, Prog Brain Res, V39, P311; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Galende N, 2011, SOC DEV, V20, P845, DOI 10.1111/j.1467-9507.2011.00625.x; Geary DC, 2001, PARENT-SCI PRACT, V1, P5, DOI 10.1207/S15327922PAR011&2_2; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GONZALEZ DE, 1986, PHYSIOL BEHAV, V38, P789, DOI 10.1016/0031-9384(86)90044-2; Gonzalez-Iglesias AE, 2008, ENDOCRINOLOGY, V149, P1470, DOI 10.1210/en.2007-0980; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GREENBERG B, 1961, AM ZOOL, V1, P450; GREGORY I, 1958, AM J PSYCHIAT, V115, P432, DOI 10.1176/ajp.115.5.432; GUBERNICK DJ, 1989, HORM BEHAV, V23, P203, DOI 10.1016/0018-506X(89)90061-5; GUDELSKY GA, 1981, PSYCHONEUROENDOCRINO, V6, P3, DOI 10.1016/0306-4530(81)90044-5; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; HILLEGAART V, 1987, PHARMACOL TOXICOL, V60, P350, DOI 10.1111/j.1600-0773.1987.tb01525.x; HORNER BE, 1947, J MAMMAL, V28, P31, DOI 10.2307/1375492; HUNT RK, 1971, DEV BIOL, V26, P100, DOI 10.1016/0012-1606(71)90111-4; Ingram RE, 2000, J ABNORM PSYCHOL, V109, P588, DOI 10.1037//0021-843X.109.4.588; JAKUBOWSKI M, 1985, J COMP PSYCHOL, V99, P93, DOI 10.1037/0735-7036.99.1.93; Jaroenporn S, 2009, LIFE SCI, V85, P172, DOI 10.1016/j.lfs.2009.05.011; KETTERSON ED, 1994, ANNU REV ECOL SYST, V25, P601, DOI 10.1146/annurev.es.25.110194.003125; KEVERNE EB, 1988, PSYCHOPHARMACOLOGY, V96, pS30; Kohl J, 2018, NATURE, V556, P326, DOI 10.1038/s41586-018-0027-0; Kohl J, 2018, CURR OPIN NEUROBIOL, V49, P116, DOI 10.1016/j.conb.2018.02.002; KORANYI L, 1977, PHYSIOL BEHAV, V18, P287, DOI 10.1016/0031-9384(77)90135-4; Kuroda KO, 2014, NEUROSCI BULL, V30, P863, DOI 10.1007/s12264-014-1462-z; LEBOUCHER G, 1986, BIOL BEHAV, V11, P167; Lee AW, 2007, PHYSIOL BEHAV, V92, P617, DOI 10.1016/j.physbeh.2007.05.008; Lee AW, 2002, BEHAV NEUROSCI, V116, P968, DOI 10.1037//0735-7044.116.6.968; Lee G, 2015, JOVE-J VIS EXP, DOI 10.3791/52766; Lerant A, 2001, BRAIN RES, V904, P259, DOI 10.1016/S0006-8993(01)02470-2; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lyons DJ, 2010, NEURON, V65, P217, DOI 10.1016/j.neuron.2009.12.024; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Maki P, 2003, SOC PSYCH PSYCH EPID, V38, P354, DOI 10.1007/s00127-003-0642-3; MCCARTHY MM, 1986, PHYSIOL BEHAV, V36, P203, DOI 10.1016/0031-9384(86)90004-1; MCLEOD JD, 1991, J HEALTH SOC BEHAV, V32, P205, DOI 10.2307/2136804; McNamara JM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2752; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; MOFFITT TE, 1987, PSYCHIATRY, V50, P346, DOI 10.1080/00332747.1987.11024366; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; MORGAN DG, 1984, NEUROENDOCRINOLOGY, V38, P407, DOI 10.1159/000123926; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; NEILL J D, 1970, Endocrinology, V87, P1192; NUMAN M, 1977, J COMP PHYSIOL PSYCH, V91, P146, DOI 10.1037/h0077304; OLIVERAS D, 1986, ANIM BEHAV, V34, P519, DOI 10.1016/S0003-3472(86)80120-8; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; Perez CT, 2020, J NEUROSCI, V40, P3203, DOI 10.1523/JNEUROSCI.1553-18.2020; PRICE EO, 1977, BEHAV BIOL, V20, P60, DOI 10.1016/S0091-6773(77)90511-9; PRIESTNALL R, 1978, DEV PSYCHOBIOL, V11, P23, DOI 10.1002/dev.420110107; Rajendren G, 2000, NEUROENDOCRINOLOGY, V71, P27, DOI 10.1159/000054517; Rilling JK, 2013, NEUROPSYCHOLOGIA, V51, P731, DOI 10.1016/j.neuropsychologia.2012.12.017; Romano N, 2013, J NEUROSCI, V33, P4424, DOI 10.1523/JNEUROSCI.4415-12.2013; Ross CE, 1999, J MARRIAGE FAM, V61, P1034, DOI 10.2307/354022; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Sakaguchi K, 1996, NEUROENDOCRINOLOGY, V63, P559, DOI 10.1159/000127085; SAMUELS MH, 1981, ANAT REC, V199, pA222; Scott K, 2012, INT J PSYCHOL, V47, P233; Scott N, 2015, NATURE, V525, P519, DOI 10.1038/nature15378; SEGGIE JA, 1975, CAN J PHYSIOL PHARM, V53, P629, DOI 10.1139/y75-087; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Spitzer M, 1998, OBSTET GYNECOL, V91, P693, DOI 10.1016/S0029-7844(98)00066-0; Stagkourakis S, 2018, ELIFE, V7, DOI 10.7554/eLife.33144; SVARE B, 1977, HORM BEHAV, V8, P372, DOI 10.1016/0018-506X(77)90011-3; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Tang JR, 2009, NEURON, V63, P673, DOI 10.1016/j.neuron.2009.07.025; TERKEL J, 1968, J COMP PHYSIOL PSYCH, V65, P479, DOI 10.1037/h0025817; TERKEL J, 1979, BRAIN RES, V169, P369, DOI 10.1016/0006-8993(79)91037-0; Tsuneoka Y, 2015, EMBO J, V34, P2652, DOI 10.15252/embj.201591942; van der Pol LD, 2016, J CHILD FAM STUD, V25, P3367, DOI 10.1007/s10826-016-0490-x; Voloschin LM, 1998, BIOL REPROD, V59, P182, DOI 10.1095/biolreprod59.1.182; WANG HJ, 1993, ENDOCRINOLOGY, V133, P1657, DOI 10.1210/en.133.4.1657; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yen JC, 1999, J BIOMED SCI, V6, P418, DOI 10.1159/000025417; Yoo HI, 2006, PSYCHOPATHOLOGY, V39, P165, DOI 10.1159/000092677; ZARROW MX, 1971, HORM BEHAV, V2, P343, DOI 10.1016/0018-506X(71)90009-2; ZEVELOFF SI, 1980, EVOLUTION, V34, P973, DOI 10.1111/j.1558-5646.1980.tb04035.x; Zilkha N, 2017, ANNU REV NEUROSCI, V40, P273, DOI 10.1146/annurev-neuro-072116-031447	113	21	21	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					960	+		10.1016/j.cell.2020.07.007	http://dx.doi.org/10.1016/j.cell.2020.07.007			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32763155	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000561488500016
J	DiFiglia, M				DiFiglia, Marian			An early start to Huntington's disease	SCIENCE			English	Editorial Material							EXPRESSION; NEURONS		[DiFiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Lab Cellular Neurobiol, Charlestown, MA 02129 USA; [DiFiglia, Marian] Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	DiFiglia, M (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Lab Cellular Neurobiol, Charlestown, MA 02129 USA.; DiFiglia, M (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	difiglia@helix.mgh.harvard.edu			NINDS [1U01NS114098]; CHDI Foundation; Dake Family Fund	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CHDI Foundation; Dake Family Fund	The author is supported by NINDS 1U01NS114098, CHDI Foundation,and Dake Family Fund.	Ament SA, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20167435; Barnat M, 2020, SCIENCE, V369, P787, DOI 10.1126/science.aax3338; Bhide PG, 1996, J NEUROSCI, V16, P5523; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dubinsky JM, 2017, J HUNTINGTONS DIS, V6, P267, DOI 10.3233/JHD-170264; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Kovalenko M, 2018, J HUNTINGTONS DIS, V7, P17, DOI 10.3233/JHD-170282; Lee JK, 2012, NEUROLOGY, V79, P668, DOI 10.1212/WNL.0b013e3182648b65; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mehta SR, 2018, CELL REP, V25, P1081, DOI 10.1016/j.celrep.2018.09.076; Nguyen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064368; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6	15	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					771	772		10.1126/science.abd6215	http://dx.doi.org/10.1126/science.abd6215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792383				2022-12-28	WOS:000559731300019
J	Bisson, GP; Bastos, M; Campbell, JR; Bang, DD; Brust, JC; Isaakadis, P; Lange, C; Menzies, D; Migliori, GB; Pape, JW; Palmero, D; Baghei, P; Tabarsi, P; Viiklepp, P; Vilbrun, S; Walsh, J; Marks, SM				Bisson, Gregory P.; Bastos, Mayara; Campbell, Jonathon R.; Bang, Didi; Brust, James C.; Isaakadis, Petros; Lange, Christoph; Menzies, Dick; Migliori, Giovanni B.; Pape, Jean W.; Palmero, Domingo; Baghei, Parvaneh; Tabarsi, Payam; Viiklepp, Piret; Vilbrun, Stalz; Walsh, Jonathan; Marks, Suzanne M.			Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis	LANCET			English	Article							OUTCOMES; PREDICTORS; IMPUTATION	Background HIV-infection is associated with increased mortality during multidrug-resistant tuberculosis treatment, but the extent to which the use of antiretroviral therapy (ART) and anti-tuberculosis medications modify this risk are unclear. Our objective was to evaluate how use of these treatments altered mortality risk in HIV-positive adults with multidrug-resistant tuberculosis. Methods We did an individual patient data meta-analysis of adults 18 years or older with confirmed or presumed multidrug-resistant tuberculosis initiating tuberculosis treatment between 1993 and 2016. Data included ART use and anti-tuberculosis medications grouped according to WHO effectiveness categories. The primary analysis compared HIV-positive with HIV-negative patients in terms of death during multidrug-resistant tuberculosis treatment, excluding those lost to follow up, and was stratified by ART use. Analyses used logistic regression after exact matching on country World Bank income classification and drug resistance and propensity-score matching on age, sex, geographic site, year of multidrug-resistant tuberculosis treatment initiation, previous tuberculosis treatment, directly observed therapy, and acid-fast-bacilli smear-positivity to obtain adjusted odds ratios (aORs) and 95% CIs. Secondary analyses were conducted among those with HIV-infection. Findings We included 11 920 multidrug-resistant tuberculosis patients. 2997 (25%) were HIV-positive and on ART, 886 (7%) were HIV-positive and not on ART, and 1749 (15%) had extensively drug-resistant tuberculosis. By use of HIV-negative patients as reference, the aOR of death was 2 center dot 4 (95% CI 2 center dot 0-2 center dot 9) for all patients with HIV-infection, 1 center dot 8 (1 center dot 5-2 center dot 2) for HIV-positive patients on ART, and 4 center dot 2 (3 center dot 0-5 center dot 9) for HIV-positive patients with no or unknown ART. Among patients with HIV, use of at least one WHO Group A drug and specific use of moxifloxacin, levofloxacin, bedaquiline, or linezolid were associated with significantly decreased odds of death. Interpretation Use of ART and more effective anti-tuberculosis drugs is associated with lower odds of death among HIV-positive patients with multidrug-resistant tuberculosis. Access to these therapies should be urgently pursued. Copyright (c) 2020 Elsevier Ltd. All rights reserved.	[Bisson, Gregory P.; Walsh, Jonathan] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bisson, Gregory P.; Walsh, Jonathan] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bastos, Mayara] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Bastos, Mayara; Campbell, Jonathon R.; Menzies, Dick] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Bang, Didi] Statens Serum Inst, Virus & Microbiol Special Diagnost, Copenhagen, Denmark; [Brust, James C.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Isaakadis, Petros] Medecins Sans Frontieres, Cape Town, South Africa; [Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Migliori, Giovanni B.] Maugeri Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, Tradate, Italy; [Pape, Jean W.] Weill Cornell Med, New York, NY USA; [Palmero, Domingo] Hosp Muniz, Div Neumotisiol, Buenos Aires, DF, Argentina; [Baghei, Parvaneh; Tabarsi, Payam] Shahid Beheshti Univ Med Sci, Clin TB & Epidemiol Res Ctr, Natl Res Inst TB & Lung Dis, Tehran, Iran; [Viiklepp, Piret] Natl Inst Hlth Dev, Tallinn, Estonia; [Vilbrun, Stalz] Etud Sarcome Kaposi & Infect Opportunistes, Grp Haitien, Port Au Prince, Haiti; [Marks, Suzanne M.] Ctr Dis Control & Prevent, Atlanta, GA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Universidade do Estado do Rio de Janeiro; McGill University; Statens Serum Institut; Yeshiva University; Forschungszentrum Borstel; World Health Organization; Cornell University; University of Buenos Aires; Shahid Beheshti University Medical Sciences; National Institute for Health Development - Estonia; Centers for Disease Control & Prevention - USA	Bisson, GP (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Bisson, GP (corresponding author), Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA.	bisson@pennmedicine.upenn.edu	Campbell, Jonathon/AAN-4252-2021; Bang, Didi/GXV-1668-2022; Migliori, Giovanni Battista/AAB-8589-2020	Campbell, Jonathon/0000-0003-2341-2166; Bang, Didi/0000-0002-7490-5369; Migliori, Giovanni Battista/0000-0002-2597-574X; Isaakidis, Petros/0000-0002-7881-1554	American Thoracic Society; Canadian Institutes of Health Research; US Centers for Disease Control and Prevention; European Respiratory Society; Infectious Diseases Society of America	American Thoracic Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); European Respiratory Society; Infectious Diseases Society of America	American Thoracic Society, Canadian Institutes of Health Research, US Centers for Disease Control and Prevention, European Respiratory Society, Infectious Diseases Society of America.	AALEN OO, 1978, SCAND J STAT, V5, P141; [Anonymous], 2018, LANCET; Arentz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047370; Bastard M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193491; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Brust JCM, 2018, CLIN INFECT DIS, V66, P1246, DOI 10.1093/cid/cix1125; Chem ED, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4317-4; Chingonzoh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202469; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Efsen AMW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145380; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Gayoso R, 2018, BRAZ J INFECT DIS, V22, P305, DOI 10.1016/j.bjid.2018.07.002; Harausz EP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002591; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Mugabo P, 2015, AFRICAN J PHARM PHAR, V9, P875; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Rubin DB, 2004, MULTIPLE IMPUTATION; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Schnippel K, 2018, LANCET RESP MED, V6, P699, DOI 10.1016/S2213-2600(18)30235-2; The World Bank, 2019, WORLD DEV IND WDI; Umanah T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1214-3; UN General Assembly, 2018, POL DECL HIGH LEV M; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van der Walt M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144249; WHO, 2019, GLOB TUB REP 2019; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2019, WORLD MALARIA REPORT; World Health Organization, 2018, INT CLASS FUNCT DIS	35	29	32	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					402	411						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0SW	32771107	Green Accepted			2022-12-28	WOS:000561619100024
J	Roscioli, G; Taheri-Mousavi, SM; Tasan, CC				Roscioli, Gianluca; Taheri-Mousavi, Seyedeh Mohadeseh; Tasan, Cemal Cem			How hair deforms steel	SCIENCE			English	Article							STRAIGHT EDGE BLADES; CUTTING SOFT SOLIDS; LATH MARTENSITE; KNIFE SHARPNESS; FRACTURE CRITERION; CRYSTALLOGRAPHY; MICROSTRUCTURE; MORPHOLOGY; BOUNDARY; CRACKS	Steels for sharp edges or tools typically have martensitic microstructures, high carbide contents, and various coatings to exhibit high hardness and wear resistance. Yet they become practically unusable upon cutting much softer materials such as human hair, cheese, or potatoes. Despite this being an everyday observation, the underlying physical micromechanisms are poorly understood because of the structural complexity of the interacting materials and the complex boundary conditions of their co-deformation. To unravel this complexity, we carried out interrupted tests and in situ electron microscopy cutting experiments with two micromechanical testing setups. We investigated the findings analytically and numerically, revealing that the spatial variation of lath martensite structure plays the key role leading to a mixed-mode II-III cracking phenomenon before appreciable wear.	[Roscioli, Gianluca; Taheri-Mousavi, Seyedeh Mohadeseh; Tasan, Cemal Cem] MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Taheri-Mousavi, Seyedeh Mohadeseh] MIT, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tasan, CC (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tasan@mit.edu		Taheri-Mousavi, Seyedeh Mohadeseh/0000-0002-4124-3709	MIT	MIT	The research is partially supported by several seed grants at MIT, which are gratefully acknowledged.	ABAQUS/PRE, 1997, USERS MANUAL; [Anonymous], 1987, STRESS INTENSITY FAC; Arcona C, 1996, J MATER SCI, V31, P1327, DOI 10.1007/BF00353113; Ayatollahi MR, 2015, ENG FRACT MECH, V144, P32, DOI 10.1016/j.engfracmech.2015.06.070; Black D, 1985, BIOENGINEERING SKIN, V1, P111; Budinski K. G., 2007, SURFACE ENG WEAR RES; Budinski KG, 1997, J TEST EVAL, V25, P226, DOI 10.1520/JTE11483J; Cayron C, 2007, J APPL CRYSTALLOGR, V40, P1183, DOI 10.1107/S0021889807048777; Chang J, 2006, ENG FRACT MECH, V73, P1249, DOI 10.1016/j.engfracmech.2005.12.011; Chu JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52054-3; Claus O. H., 2015, Razor blades, Patent No. [U.S. 9,079,321B2, 9079321]; Claus O. H., U.S., Patent No. [9,079,321B2, 9079321]; Cline E.H., 2012, OXFORD HDB BRONZE AG; Clipstone C. J., 2004, U.S. Patent, Patent No. [6,684,513B1, 6684513]; ERDOGAN F, 1965, J APPL MECH, V32, P403, DOI 10.1115/1.3625814; Gregory GE, 2000, SURFACE ENG, V16, P373, DOI 10.1080/02670844.2000.11962915; HALLEN O, 1954, NATURE, V173, P958, DOI 10.1038/173958a0; Ikeda T, 1998, ENG FRACT MECH, V59, P725, DOI 10.1016/S0013-7944(97)00177-X; Jang JSC, 2015, INTERMETALLICS, V65, P56, DOI 10.1016/j.intermet.2015.06.012; Karltun J, 2016, APPL ERGON, V56, P92, DOI 10.1016/j.apergo.2016.03.010; Keturakis G, 2010, MATER SCI-MEDZG, V16, P205; Kinney CC, 2014, ACTA MATER, V69, P372, DOI 10.1016/j.actamat.2014.01.058; LaTorre, 2008, NANOTRIBOLOGY NANOME, P1325; Lerchbacher C, 2012, MICRON, V43, P818, DOI 10.1016/j.micron.2012.02.005; Marsot J, 2007, APPL ERGON, V38, P83, DOI 10.1016/j.apergo.2005.12.007; McCarthy CT, 2007, ENG FRACT MECH, V74, P2205, DOI 10.1016/j.engfracmech.2006.10.015; McCarthy CT, 2010, ENG FRACT MECH, V77, P437, DOI 10.1016/j.engfracmech.2009.10.003; McCarthy CT, 2005, KEY ENG MAT, V293-294, P769, DOI 10.4028/www.scientific.net/KEM.293-294.769; McGorry RW, 2005, APPL ERGON, V36, P71, DOI 10.1016/j.apergo.2004.08.002; McVeigh C, 2007, J MECH PHYS SOLIDS, V55, P225, DOI 10.1016/j.jmps.2006.08.002; Mendelson MI, 2001, CERAM ENG SCI PROC, V22, P293; Moore RL, 1995, THIN SOLID FILMS, V270, P331, DOI 10.1016/0040-6090(95)06703-5; Morito S, 2006, ACTA MATER, V54, P5323, DOI 10.1016/j.actamat.2006.07.009; Morito S, 2005, ISIJ INT, V45, P91, DOI 10.2355/isijinternational.45.91; Morito S, 2003, ACTA MATER, V51, P1789, DOI 10.1016/S1359-6454(02)00577-3; Morris JW, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/014208; Morsdorf L, 2016, ACTA MATER, V121, P202, DOI 10.1016/j.actamat.2016.09.006; Morsdorf L, 2015, ACTA MATER, V95, P366, DOI 10.1016/j.actamat.2015.05.023; Nissen W. I., 1966, U.S. Patent, Patent No. [3,461,616A, 3461616]; O'Keeffe SC, 2015, ACTA MATER, V82, P503, DOI 10.1016/j.actamat.2014.09.016; Ohmura T, 2004, J MATER RES, V19, P3626, DOI 10.1557/JMR.2004.0474; Ohmura T, 2001, SCRIPTA MATER, V45, P889, DOI 10.1016/S1359-6462(01)01121-6; Ozkan N, 2002, J FOOD SCI, V67, P1814, DOI 10.1111/j.1365-2621.2002.tb08728.x; Petersen D., 1997, J TEST EVAL, V25, P226; Qi L, 2014, ACTA MATER, V76, P23, DOI 10.1016/j.actamat.2014.04.038; RICE JR, 1965, J APPL MECH, V32, P418, DOI 10.1115/1.3625816; Sandvik, 2002, STAINL CHROM STEEL R; Sapiro D, 2016, JOM-US, V68, P3180, DOI 10.1007/s11837-016-2105-9; Schuldt S, 2016, J FOOD ENG, V188, P13, DOI 10.1016/j.jfoodeng.2016.04.022; Shibata A, 2010, MAT SCI ENG A-STRUCT, V527, P7538, DOI 10.1016/j.msea.2010.08.026; Shih C. F., 1991, FRACTURE ENG MAT STR, P41; SHIH CF, 1991, MAT SCI ENG A-STRUCT, V143, P77, DOI 10.1016/0921-5093(91)90727-5; Sih G.C., 1964, J APPL MECH-T ASME, V31, P477; Su ZH, 2019, IOP CONF SER-MAT SCI, V472, DOI 10.1088/1757-899X/472/1/012054; Tamaoki Tsukasa, 2013, Journal of the Japan Society for Precision Engineering, V79, P950; Thozhur SM, 2006, J MATER SCI, V41, P1109, DOI 10.1007/s10853-005-3648-2; U.S. Environmental Protection Agency (EPA), 1990, ENV CONS HDB; Vasquez N, 2018, J FOOD ENG, V219, P8, DOI 10.1016/j.jfoodeng.2017.09.008; Verhoeven JD, 2001, SCI AM, V284, P74, DOI 10.1038/scientificamerican0101-74; Yi J, 2015, ADV ENG MATER, V17, P620, DOI 10.1002/adem.201400209; Zhang JL, 2016, MATER CHARACT, V111, P137, DOI 10.1016/j.matchar.2015.11.019; Zhu QT, 2019, J MATER ENG PERFORM, V28, P4511, DOI 10.1007/s11665-019-04209-6	62	14	14	12	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					689	+		10.1126/science.aba9490	http://dx.doi.org/10.1126/science.aba9490			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764070				2022-12-28	WOS:000559184400045
J	Dighe, SU; Julia, F; Luridiana, A; Douglas, JJ; Leonori, D				Dighe, Shashikant U.; Julia, Fabio; Luridiana, Alberto; Douglas, James J.; Leonori, Daniele			A photochemical dehydrogenative strategy for aniline synthesis	NATURE			English	Article							PALLADIUM-CATALYZED ARYLATION; CASCADE REACTIONS; RADICAL CATIONS; CYCLOHEXANONES; ACTIVATION; AMINATION; ANALOGS	A dual cobalt and photocatalysis system provides a way to assemble anilines from cyclohexanones and amines by progressively dehydrating the intermediate imine. Chemical reactions that reliably join two molecular fragments together (cross-couplings) are essential to the discovery and manufacture of pharmaceuticals and agrochemicals(1,2). The introduction of amines onto functionalized aromatics at specific and pre-determined positions (orthoversusmetaversuspara) is currently achievable only in transition-metal-catalysed processes and requires halogen- or boron-containing substrates(3-6). The introduction of these groups around the aromatic unit is dictated by the intrinsic reactivity profile of the method (electrophilic halogenation or C-H borylation) so selective targeting of all positions is often not possible. Here we report a non-canonical cross-coupling approach for the construction of anilines, exploiting saturated cyclohexanones as aryl electrophile surrogates. Condensation between amines and carbonyls, a process that frequently occurs in nature and is often used by (bio-)organic chemists(7), enables a predetermined and site-selective carbon-nitrogen (C-N) bond formation, while a photoredox- and cobalt-based catalytic system progressively desaturates the cyclohexene ring en route to the aniline. Given that functionalized cyclohexanones are readily accessible with complete regiocontrol using the well established carbonyl reactivity, this approach bypasses some of the frequent selectivity issues of aromatic chemistry. We demonstrate the utility of this C-N coupling protocol by preparing commercial medicines and by the late-stage amination-aromatization of natural products, steroids and terpene feedstocks.	[Dighe, Shashikant U.; Julia, Fabio; Luridiana, Alberto; Leonori, Daniele] Univ Manchester, Dept Chem, Manchester, Lancs, England; [Douglas, James J.] AstraZeneca, R&D, Pharmaceut Sci, Early Chem Dev, Macclesfield, Cheshire, England	University of Manchester; AstraZeneca	Leonori, D (corresponding author), Univ Manchester, Dept Chem, Manchester, Lancs, England.	daniele.leonori@manchester.ac.uk	Luridiana, Alberto/ABA-6505-2021; Dighe, Shashi Uttam/M-7641-2016; Julia, Fabio/E-7414-2012	Dighe, Shashi Uttam/0000-0003-3482-502X; Douglas, James/0000-0002-9681-0459; Julia, Fabio/0000-0001-8903-4482; luridiana, alberto/0000-0002-7828-9866; Leonori, Daniele/0000-0002-7692-4504	EPSRC [EP/P004997/1] Funding Source: UKRI; European Research Council Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission)		Beletskaya IP, 2004, COORDIN CHEM REV, V248, P2337, DOI 10.1016/j.ccr.2004.09.014; Blakemore DC, 2018, NAT CHEM, V10, P383, DOI 10.1038/s41557-018-0021-z; Boursalian GB, 2016, NAT CHEM, V8, P810, DOI [10.1038/NCHEM.2529, 10.1038/nchem.2529]; Brusoe AT, 2015, J AM CHEM SOC, V137, P8460, DOI 10.1021/jacs.5b02512; Campos KR, 2019, SCIENCE, V363, P244, DOI 10.1126/science.aat0805; Cooke J., 2002, [No title captured], Patent No. [WO 02/066418, 02066418]; Crawley M. L., 2012, DRUG DISCOVERY DEV I; Dempsey JL, 2009, ACCOUNTS CHEM RES, V42, P1995, DOI 10.1021/ar900253e; Dobrikov GM, 2017, BIOORG MED CHEM LETT, V27, P4540, DOI 10.1016/j.bmcl.2017.08.056; Gridnev AA, 2001, CHEM REV, V101, P3611, DOI 10.1021/cr9901236; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Hartwig JF, 1998, ACCOUNTS CHEM RES, V31, P852, DOI 10.1021/ar970282g; Hartwig JF, 2008, NATURE, V455, P314, DOI 10.1038/nature07369; Hong WP, 2013, J AM CHEM SOC, V135, P13664, DOI 10.1021/ja4073172; Izawa Y, 2011, SCIENCE, V333, P209, DOI 10.1126/science.1204183; JOHNSSON K, 1993, NATURE, V365, P530, DOI 10.1038/365530a0; Koizumi Y, 2019, ANGEW CHEM INT EDIT, V58, P10893, DOI 10.1002/anie.201903841; Li Y, 2019, J ORG CHEM, V84, P12071, DOI 10.1021/acs.joc.9b02003; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Morris SA, 2016, ACCOUNTS CHEM RES, V49, P1957, DOI 10.1021/acs.accounts.6b00263; NICHOLAS AMD, 1982, CAN J CHEM, V60, P2165, DOI 10.1139/v82-310; Olah, 1963, FREIDEL CRAFTS REL, VI-IV; Park NH, 2015, ANGEW CHEM INT EDIT, V54, P8259, DOI 10.1002/anie.201502626; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Romero NA, 2015, SCIENCE, V349, P1326, DOI 10.1126/science.aac9895; Ruffoni A, 2019, NAT CHEM, V11, P426, DOI 10.1038/s41557-019-0254-5; Ruiz-Castillo P, 2016, CHEM REV, V116, P12564, DOI 10.1021/acs.chemrev.6b00512; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; See YY, 2014, EUR J ORG CHEM, V2014, P7405, DOI 10.1002/ejoc.201403054; Silvi M, 2018, NATURE, V554, P40, DOI 10.1038/nature25175; Sulur M, 2012, ORG PROCESS RES DEV, V16, P1746, DOI 10.1021/op300173z; Sun X, 2018, NAT CHEM, V10, P1229, DOI 10.1038/s41557-018-0142-4; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Weiss ME, 2011, ANGEW CHEM INT EDIT, V50, P11125, DOI 10.1002/anie.201105235; West JG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10093; West MJ, 2019, CHEM REV, V119, P12491, DOI 10.1021/acs.chemrev.9b00491; Zhao Y, 2011, ORG LETT, V13, P4308, DOI 10.1021/ol2016466	39	64	64	27	223	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					75	+		10.1038/s41586-020-2539-7	http://dx.doi.org/10.1038/s41586-020-2539-7			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32760044	Green Submitted			2022-12-28	WOS:000560290400017
J	Kritcher, AL; Swift, DC; Doppner, T; Bachmann, B; Benedict, LX; Collins, GW; DuBois, JL; Elsner, F; Fontaine, G; Gaffney, JA; Hamel, S; Lazicki, A; Johnson, WR; Kostinski, N; Kraus, D; MacDonald, MJ; Maddox, B; Martin, ME; Neumayer, P; Nikroo, A; Nilsen, J; Remington, BA; Saumon, D; Sterne, PA; Sweet, W; Correa, AA; Whitley, HD; Falcone, RW; Glenzer, SH				Kritcher, Andrea L.; Swift, Damian C.; Doppner, Tilo; Bachmann, Benjamin; Benedict, Lorin X.; Collins, Gilbert W.; DuBois, Jonathan L.; Elsner, Fred; Fontaine, Gilles; Gaffney, Jim A.; Hamel, Sebastien; Lazicki, Amy; Johnson, Walter R.; Kostinski, Natalie; Kraus, Dominik; MacDonald, Michael J.; Maddox, Brian; Martin, Madison E.; Neumayer, Paul; Nikroo, Abbas; Nilsen, Joseph; Remington, Bruce A.; Saumon, Didier; Sterne, Phillip A.; Sweet, Wendi; Correa, Alfredo A.; Whitley, Heather D.; Falcone, Roger W.; Glenzer, Siegfried H.			A measurement of the equation of state of carbon envelopes of white dwarfs	NATURE			English	Article							STARS	Researchers have measured the equation of state of hydrocarbon in a high-density regime, which is necessary for accurate modelling of the oscillations of white dwarf stars. White dwarfs represent the final state of evolution for most stars(1-3). Certain classes of white dwarfs pulsate(4,5), leading to observable brightness variations, and analysis of these variations with theoretical stellar models probes their internal structure. Modelling of these pulsating stars provides stringent tests of white dwarf models and a detailed picture of the outcome of the late stages of stellar evolution(6). However, the high-energy-density states that exist in white dwarfs are extremely difficult to reach and to measure in the laboratory, so theoretical predictions are largely untested at these conditions. Here we report measurements of the relationship between pressure and density along the principal shock Hugoniot (equations describing the state of the sample material before and after the passage of the shock derived from conservation laws) of hydrocarbon to within five per cent. The observed maximum compressibility is consistent with theoretical models that include detailed electronic structure. This is relevant for the equation of state of matter at pressures ranging from 100 million to 450 million atmospheres, where the understanding of white dwarf physics is sensitive to the equation of state and where models differ considerably. The measurements test these equation-of-state relations that are used in the modelling of white dwarfs and inertial confinement fusion experiments(7,8), and we predict an increase in compressibility due to ionization of the inner-core orbitals of carbon. We also find that a detailed treatment of the electronic structure and the electron degeneracy pressure is required to capture the measured shape of the pressure-density evolution for hydrocarbon before peak compression. Our results illuminate the equation of state of the white dwarf envelope (the region surrounding the stellar core that contains partially ionized and partially degenerate non-ideal plasmas), which is a weak link in the constitutive physics informing the structure and evolution of white dwarf stars(9).	[Kritcher, Andrea L.; Swift, Damian C.; Doppner, Tilo; Bachmann, Benjamin; Benedict, Lorin X.; Collins, Gilbert W.; DuBois, Jonathan L.; Gaffney, Jim A.; Hamel, Sebastien; Lazicki, Amy; Kostinski, Natalie; MacDonald, Michael J.; Maddox, Brian; Martin, Madison E.; Nikroo, Abbas; Nilsen, Joseph; Remington, Bruce A.; Sterne, Phillip A.; Correa, Alfredo A.; Whitley, Heather D.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Collins, Gilbert W.] Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA; [Collins, Gilbert W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Collins, Gilbert W.] Univ Rochester, Lab Laser Energet, Rochester, NY USA; [Elsner, Fred; Sweet, Wendi] Gen Atom, San Diego, CA USA; [Fontaine, Gilles] Univ Montreal, Montreal, PQ, Canada; [Johnson, Walter R.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Kraus, Dominik] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Kraus, Dominik] Tech Univ Dresden, Inst Solid State & Mat Phys, Dresden, Germany; [Neumayer, Paul] GSI Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Saumon, Didier] Los Alamos Natl Lab, Los Alamos, NM USA; [Falcone, Roger W.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Glenzer, Siegfried H.] SLAC Natl Accelerator, Menlo Pk, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Rochester; University of Rochester; University of Rochester; General Atomics & Affiliated Companies; Universite de Montreal; University of Notre Dame; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Kritcher, AL (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	kritcher2@llnl.gov	Whitley, Heather D./Q-7255-2019; Kraus, Dominik/H-3251-2011; Collins, Gilbert/ABH-2158-2020	Whitley, Heather D./0000-0002-2344-8698; Kraus, Dominik/0000-0002-6350-4180; Sterne, Philip/0000-0002-6398-3185; MacDonald, Michael/0000-0002-6295-6978; Bachmann, Benjamin/0000-0001-7992-0018; DuBois, Jonathan/0000-0003-3154-4273; Doppner, Tilo/0000-0002-5703-7125; Nikroo, Abbas/0000-0002-8855-0378				Bachmann B, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4891303; Barrios MA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3358144; Benedict LX, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.224109; Cauble R, 1998, PHYS REV LETT, V80, P1248, DOI 10.1103/PhysRevLett.80.1248; Clark DS, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3403293; Corsico AH, 2009, ASTRON ASTROPHYS, V506, P835, DOI 10.1051/0004-6361/200912481; Corsico AH, 2019, ASTRON ASTROPHYS REV, V27, DOI 10.1007/s00159-019-0118-4; Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872; Doppner T, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.025001; Dufour P, 2008, ASTROPHYS J, V683, P978, DOI 10.1086/589855; Dufour P, 2007, NATURE, V450, P522, DOI 10.1038/nature06318; Fontaine G, 2008, ASTRON ASTROPHYS, V483, pL1, DOI 10.1051/0004-6361:200809651; Fontaine G, 2012, ASTR SOC P, V462, P477; Fontaine G, 2001, PUBL ASTRON SOC PAC, V113, P409, DOI 10.1086/319535; FONTAINE G, 1976, ASTROPHYS J SUPPL S, V31, P467, DOI 10.1086/190388; Gaffney JA, 2018, HIGH ENERG DENS PHYS, V28, P7, DOI 10.1016/j.hedp.2018.08.001; Giammichele N, 2018, NATURE, V554, P73, DOI 10.1038/nature25136; Hamel S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094113; Hammel BA, 2010, HIGH ENERG DENS PHYS, V6, P171, DOI 10.1016/j.hedp.2009.12.005; Hinkel DE, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.225002; Hohenberger M, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890537; Hopkins LFB, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.175001; Hu SX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.063104; Hurricane OA, 2014, NATURE, V506, P343, DOI 10.1038/nature13008; Kerley G I, 2003, SAND20033613; Kraus D, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.011202; Kritcher AL, 2014, HIGH ENERG DENS PHYS, V10, P27, DOI 10.1016/j.hedp.2013.11.002; Lyon S., 1995, LAUR923407 LANL; Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740; Montgomery MH, 2008, ASTROPHYS J LETT, V678, pL51, DOI 10.1086/588286; Moses EI, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3116505; Ozaki N, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3152287; Parsons SG, 2020, NAT ASTRON, V4, P690, DOI 10.1038/s41550-020-1037-z; Scott HA, 2010, HIGH ENERG DENS PHYS, V6, P39, DOI 10.1016/j.hedp.2009.07.003; Smith RF, 2014, NATURE, V511, P330, DOI 10.1038/nature13526; Smith RF, 2018, NAT ASTRON, V2, P452, DOI 10.1038/s41550-018-0437-9; Sterne PA, 2016, J PHYS CONF SER, V717, DOI 10.1088/1742-6596/717/1/012082; Swift D. C., 2011, LLNLPROC492261; Swift D. C., 2020, PREPRINT; Swift DC, 2018, REV SCI INSTRUM, V89, DOI 10.1063/1.5032142; VLADIMIROV AS, 1984, JETP LETT+, V39, P82; Wilson B, 2006, J QUANT SPECTROSC RA, V99, P658, DOI 10.1016/j.jqsrt.2005.05.053; Winget DE, 2008, ANNU REV ASTRON ASTR, V46, P157, DOI 10.1146/annurev.astro.46.060407.145250; WINGET DE, 1987, ASTROPHYS J, V315, pL77, DOI 10.1086/184864; Zhang S, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5001208	45	40	40	2	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					51	+		10.1038/s41586-020-2535-y	http://dx.doi.org/10.1038/s41586-020-2535-y			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32760045	Green Submitted			2022-12-28	WOS:000560290400013
J	Shepherd, A				Shepherd, Alison			World's cameras focus on health	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m3078	10.1136/bmj.m3078	http://dx.doi.org/10.1136/bmj.m3078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759298				2022-12-28	WOS:000556139400013
J	Hampton, T				Hampton, Tracy			Virus Surveillance and Diagnosis With a CRISPR-Based Platform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					430	430		10.1001/jama.2020.12669	http://dx.doi.org/10.1001/jama.2020.12669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749473				2022-12-28	WOS:000561261900002
J	Wise, J				Wise, Jacqui			Covid-19: NHS Test and Trace must improve for schools to reopen safely, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; Panovska-Griffiths J, 2020, LANCET CHILD ADOLESC, V4, P817, DOI 10.1016/S2352-4642(20)30250-9	2	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2020	370								m3083	10.1136/bmj.m3083	http://dx.doi.org/10.1136/bmj.m3083			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RK	32753398	Bronze			2022-12-28	WOS:000556140300001
J	Limb, M				Limb, Matthew			Covid-19: Sandwell Council in West Midlands sets up contact tracing, citing failures of national scheme	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2020, NHS TEST TRAC WEEK 8	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2020	370								m3065	10.1136/bmj.m3065	http://dx.doi.org/10.1136/bmj.m3065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RD	32737052	Bronze			2022-12-28	WOS:000556139500013
J	Almeida, CC; Vaz, AM				Almeida, Catarina Cardoso; Vaz, Alexandra Mendonca			Ectopic Kidney	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 77-year-old man presented with nausea, vomiting, and diarrhea. During assessment, an incidental Bochdalek hernia containing the right kidney was identified.	[Almeida, Catarina Cardoso; Vaz, Alexandra Mendonca] Ctr Hosp Tondela Viseu, EPE, Viseu, Portugal		Almeida, CC (corresponding author), Ctr Hosp Tondela Viseu, EPE, Viseu, Portugal.	catarina.almeida.92@gmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					E30	E30		10.1056/NEJMicm1915200	http://dx.doi.org/10.1056/NEJMicm1915200			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32726534				2022-12-28	WOS:000556861800005
J	Bumpus, N				Bumpus, Namandje			White senior academics still resist recognizing racism	NATURE			English	Editorial Material						Society; Institutions		As a Black woman who is the chair of a university science department, people have questioned my right to exist at every stage. As a Black woman who is the chair of a university science department, people have questioned my right to exist at every stage.	[Bumpus, Namandje] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Bumpus, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA.	nbumpus1@jhmi.edu							0	13	13	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					661	661		10.1038/d41586-020-02203-w	http://dx.doi.org/10.1038/d41586-020-02203-w			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MQ7AZ	32724148	Bronze			2022-12-28	WOS:000553047000002
J	Dyer, O				Dyer, Owen			Covid-19: Excess deaths point to hidden toll in South Africa as cases surge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Parpia AS, 2016, EMERG INFECT DIS, V22, P433, DOI 10.3201/eid2203.150977; South African Medical Research Council, 2020, REP WEEK DEATHS S AF	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3038	10.1136/bmj.m3038	http://dx.doi.org/10.1136/bmj.m3038			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732246	Bronze			2022-12-28	WOS:000556139900012
J	Van Calster, B; Valentin, L; Froyman, W; Landolfo, C; Ceusters, J; Testa, AC; Wynants, L; Sladkevicius, P; Van Holsbeke, C; Domali, E; Fruscio, R; Epstein, E; Franchi, D; Kudla, MJ; Chiappa, V; Alcazar, JL; Leone, FPG; Buonomo, F; Coccia, ME; Guerriero, S; Deo, N; Jokubkiene, L; Savelli, L; Fischerova, D; Czekierdowski, A; Kaijser, J; Coosemans, A; Scambia, G; Vergote, I; Bourne, T; Timmerman, D				Van Calster, Ben; Valentin, Lil; Froyman, Wouter; Landolfo, Chiara; Ceusters, Jolien; Testa, Antonia C.; Wynants, Laure; Sladkevicius, Povilas; Van Holsbeke, Caroline; Domali, Ekaterini; Fruscio, Robert; Epstein, Elisabeth; Franchi, Dorella; Kudla, Marek J.; Chiappa, Valentina; Alcazar, Juan L.; Leone, Francesco P. G.; Buonomo, Francesca; Coccia, Maria Elisabetta; Guerriero, Stefano; Deo, Nandita; Jokubkiene, Ligita; Savelli, Luca; Fischerova, Daniela; Czekierdowski, Artur; Kaijser, Jeroen; Coosemans, An; Scambia, Giovanni; Vergote, Ignace; Bourne, Tom; Timmerman, Dirk			Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IOTA ADNEX MODEL; EXTERNAL VALIDATION; RISK MODELS; ULTRASOUND; MASSES; MALIGNANCY; SURGERY; PREDICTION; TUMORS; CALIBRATION	OBJECTIVE To evaluate the performance of diagnostic prediction models for ovarian malignancy in all patients with an ovarian mass managed surgically or conservatively. DESIGN Multicentre cohort study. SETTING 36 oncology referral centres (tertiary centres with a specific gynaecological oncology unit) or other types of centre. PARTICIPANTS Consecutive adult patients presenting with an adnexal mass between January 2012 and March 2015 and managed by surgery or follow-up. MAIN OUTCOME MEASURES Overall and centre specific discrimination, calibration, and clinical utility of six prediction models for ovarian malignancy (risk of malignancy index (RMI), logistic regression model 2 (LR2), simple rules, simple rules risk model (SRRisk), assessment of different neoplasias in the adnexa (ADNEX) with or without CA125). ADNEX allows the risk of malignancy to be subdivided into risks of a borderline, stage I primary, stage II-IV primary, or secondary metastatic malignancy. The outcome was based on histology if patients underwent surgery, or on results of clinical and ultrasound follow-up at 12 (+/- 2) months. Multiple imputation was used when outcome based on follow-up was uncertain. RESULTS The primary analysis included 17 centres that met strict quality criteria for surgical and follow-up data (5717 of all 8519 patients). 812 patients (14%) had a mass that was already in follow-up at study recruitment, therefore 4905 patients were included in the statistical analysis. The outcome was benign in 3441 (70%) patients and malignant in 978 (20%). Uncertain outcomes (486, 10%) were most often explained by limited follow-up information. The overall area under the receiver operating characteristic curve was highest for ADNEX with CA125 (0.94, 95% confidence interval 0.92 to 0.96), ADNEX without CA125 (0.94, 0.91 to 0.95) and SRRisk (0.94, 0.91 to 0.95), and lowest for RMI (0.89, 0.85 to 0.92). Calibration varied among centres for all models, however the ADNEX models and SRRisk were the best calibrated. Calibration of the estimated risks for the tumour subtypes was good for ADNEX irrespective of whether or not CA125 was included as a predictor. Overall clinical utility (net benefit) was highest for the ADNEX models and SRRisk, and lowest for RMI. For patients who received at least one follow-up scan (n=1958), overall area under the receiver operating characteristic curve ranged from 0.76 (95% confidence interval 0.66 to 0.84) for RMI to 0.89 (0.81 to 0.94) for ADNEX with CA125. CONCLUSIONS Our study found the ADNEX models and SRRisk are the best models to distinguish between benign and malignant masses in all patients presenting with an adnexal mass, including those managed conservatively.	[Van Calster, Ben; Froyman, Wouter; Landolfo, Chiara; Wynants, Laure; Bourne, Tom; Timmerman, Dirk] Katholieke Univ Leuven, Dept Dev & Regenerat, Herestr 49 Box 805, B-3000 Leuven, Belgium; [Van Calster, Ben] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Van Calster, Ben] Katholieke Univ Leuven, EPI Ctr, Leuven, Belgium; [Valentin, Lil; Sladkevicius, Povilas; Jokubkiene, Ligita] Skane Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden; [Valentin, Lil; Sladkevicius, Povilas; Jokubkiene, Ligita] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Froyman, Wouter; Coosemans, An; Vergote, Ignace; Bourne, Tom; Timmerman, Dirk] Univ Hosp Leuven, Dept Obstet & Gynaecol, Leuven, Belgium; [Landolfo, Chiara; Bourne, Tom] Imperial Coll, Queen Charlottes & Chelsea Hosp, London, England; [Ceusters, Jolien; Coosemans, An; Vergote, Ignace] Katholieke Univ Leuven, Dept Oncol, Lab Tumour Immunol & Immunotherapy, Leuven, Belgium; [Testa, Antonia C.; Scambia, Giovanni] Fdn Policlin Univ Agostino Gemelli, Ist Ricovero & Cura Carattere Sci, Dept Woman Child & Publ Hlth, Rome, Italy; [Testa, Antonia C.; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Life Sci & Publ Hlth, Rome, Italy; [Wynants, Laure] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Dept Epidemiol, Maastricht, Netherlands; [Van Holsbeke, Caroline] Ziekenhuis Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium; [Domali, Ekaterini] Natl & Kapodistrian Univ Athens, Alexandra Hosp, Med Sch, Dept Obstet & Gynaecol 1, Athens, Greece; [Fruscio, Robert] Univ Milano Bicocca, San Gerardo Hosp, Clin Obstet & Gynaecol, Monza, Italy; [Epstein, Elisabeth] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Epstein, Elisabeth] Soder Sjukhuset, Dept Obstet & Gynaecol, Stockholm, Sweden; [Franchi, Dorella] European Inst Oncol IRCCS, Div Gynaecol, Prevent Gynaecol Unit, Milan, Italy; [Kudla, Marek J.] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Perinatol & Ontol Gynaecol, Katowice, Poland; [Chiappa, Valentina] Natl Canc Inst, Dept Gynaecol Oncol, Milan, Italy; [Alcazar, Juan L.] Clin Univ Navarra, Sch Med, Dept Obstet & Gynaecol, Pamplona, Spain; [Leone, Francesco P. G.] Univ Milan, Biomed & Clin Sci Inst L Sacco, Dept Obstet & Gynaecol, Milan, Italy; [Buonomo, Francesca] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Coccia, Maria Elisabetta] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Guerriero, Stefano] Univ Cagliari, Policlin Univ Duilio Casula, Dept Obstet & Gynaecol, Cagliari, Italy; [Deo, Nandita] Whipps Cross Hosp & Chest Clin, Dept Obstet & Gynaecol, London, England; [Savelli, Luca] Univ Bologna, Dept Obstet & Gynaecol, Bologna, Italy; [Fischerova, Daniela] Charles Univ Prague, Fac Med 1, Dept Obstet & Gynaecol, Gynaecol Oncol Ctr, Prague, Czech Republic; [Fischerova, Daniela] Gen Univ Hosp, Prague, Czech Republic; [Czekierdowski, Artur] Med Univ Lublin, Dept Gynaecol Oncol & Gynaecol 1, Lublin, Poland; [Kaijser, Jeroen] Ikazia Hosp, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Coosemans, An; Vergote, Ignace] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium	KU Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; Lund University; Skane University Hospital; Lund University; KU Leuven; University Hospital Leuven; Imperial College London; KU Leuven; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Maastricht University; East Limburg Hospital; Alexandra Hospital; National & Kapodistrian University of Athens; San Gerardo Hospital; University of Milano-Bicocca; Karolinska Institutet; Sodersjukhuset Hospital; IRCCS European Institute of Oncology (IEO); Medical University Silesia; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Navarra; University of Milan; IRCCS Burlo Garofolo; University of Florence; University of Cagliari; University of London; Queen Mary University London; University of Bologna; Charles University Prague; General University Hospital Prague; Medical University of Lublin; Ikazia Hospital; KU Leuven; University Hospital Leuven	Timmerman, D (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Herestr 49 Box 805, B-3000 Leuven, Belgium.	dirk.timmerman@uzleuven.be	epstein, elisabeth/F-4586-2014; Sladkevicius, Povilas/L-8773-2019; Bourne, Tom/I-6478-2012; Epstein, Elisabeth/GRO-7235-2022; Van Calster, Ben/F-9150-2010; Buonomo, Francesca/I-2858-2018	epstein, elisabeth/0000-0003-2298-7785; Sladkevicius, Povilas/0000-0001-9563-8135; Bourne, Tom/0000-0003-1421-6059; Van Calster, Ben/0000-0003-1613-7450; Landolfo, Chiara/0000-0001-9808-7957; Ceusters, Jolien/0000-0001-5422-5668; Timmerman, Dirk/0000-0002-3707-6645; Kudla, Marek/0000-0003-0928-3433; Buonomo, Francesca/0000-0002-6587-2622; Wynants, Laure/0000-0002-3037-122X; Czekierdowski, Artur/0000-0001-6481-4271	Research Foundation Flanders (FWO) [G049312N, G0B4716N, 12F3114N]; Internal Funds KU Leuven [C24/15/037]; Linbury Trust [LIN 260]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust; Swedish Research Council [K2014-99X-22475-01-3, 2013-02282]; Avtal om lakarutbildning och forskning (ALF)-medel; Landstingsfinansierad Regional Forskning; Imperial College London	Research Foundation Flanders (FWO)(FWO); Internal Funds KU Leuven; Linbury Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust; Swedish Research Council(Swedish Research CouncilEuropean Commission); Avtal om lakarutbildning och forskning (ALF)-medel; Landstingsfinansierad Regional Forskning; Imperial College London(General Electric)	The IOTA5 study is supported by the Research Foundation Flanders (FWO) projects G049312N/G0B4716N/12F3114N, and Internal Funds KU Leuven (project C24/15/037). DT is a senior clinical investigator of FWO, LW is a postdoctoral fellow of FWO, and WF was a clinical fellow of FWO. CL was supported by Linbury Trust Grant LIN 260. TB is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust and Imperial College London. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health. LV is supported by the Swedish Research Council (grant K2014-99X-22475-01-3, Dnr 2013-02282), funds administered by Malmo University Hospital and Skane University Hospital, Allmanna Sjukhusets i Malmo Stiftelse for bekampande av cancer (the Malmo General Hospital Foundation for fighting against cancer), and two Swedish governmental grants (Avtal om lakarutbildning och forskning (ALF)-medel and Landstingsfinansierad Regional Forskning). The funders played no role in study design, data collection, data analysis, data interpretation, or reporting. The guarantors had full access to all the data in the study, take responsibility for the integrity of the data and the accuracy of the data analysis, and had final responsibility for the decision to submit for publication.	Andreotti RF, 2018, J AM COLL RADIOL, V15, P1415, DOI 10.1016/j.jacr.2018.07.004; Araujo KG, 2017, ULTRASOUND OBST GYN, V49, P778, DOI 10.1002/uog.15963; Bristow RE, 2013, OBSTET GYNECOL, V121, P1226, DOI 10.1097/AOG.0b013e3182922a17; Chen H, 2019, ULTRASOUND OBST GYN, V54, P815, DOI 10.1002/uog.20363; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; de Groot JAH, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4770; Demler OV, 2012, STAT MED, V31, P2577, DOI 10.1002/sim.5328; Earle CC, 2006, J NATL CANCER I, V98, P172, DOI 10.1093/jnci/djj019; Engelen MJA, 2006, CANCER-AM CANCER SOC, V106, P589, DOI 10.1002/cncr.21616; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Froyman W, 2019, LANCET ONCOL, V20, P448, DOI 10.1016/S1470-2045(18)30837-4; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Joyeux E, 2016, GYNECOL OBSTET FERTI, V44, P557, DOI 10.1016/j.gyobfe.2016.07.007; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Meys EMJ, 2017, ULTRASOUND OBST GYN, V49, P784, DOI 10.1002/uog.17225; Meys EMJ, 2016, EUR J CANCER, V58, P17, DOI 10.1016/j.ejca.2016.01.007; Moro F, 2017, ULTRASOUND OBST GYN, V50, P261, DOI 10.1002/uog.17222; Nunes N, 2018, ULTRASOUND OBST GYN, V51, P829, DOI 10.1002/uog.18918; Pereira PN, 2020, ABDOM RADIOL, V45, P3218, DOI 10.1007/s00261-019-02207-9; Sayasneh A, 2016, BRIT J CANCER, V115, P542, DOI 10.1038/bjc.2016.227; Sayasneh A, 2013, BRIT J CANCER, V108, P2448, DOI 10.1038/bjc.2013.224; Snell KIE, 2018, STAT METHODS MED RES, V27, P3505, DOI 10.1177/0962280217705678; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stukan M, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5629-x; Szubert S, 2016, GYNECOL ONCOL, V142, P490, DOI 10.1016/j.ygyno.2016.06.020; Testa A, 2014, BRIT J CANCER, V111, P680, DOI 10.1038/bjc.2014.333; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 2010, ULTRASOUND OBST GYN, V36, P226, DOI 10.1002/uog.7636; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Timmerman D, 2016, AM J OBSTET GYNECOL, V214, P424, DOI 10.1016/j.ajog.2016.01.007; Valentin L, 2004, BEST PRACT RES CL OB, V18, P71, DOI 10.1016/j.bpobgyn.2003.10.002; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; Van Calster B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5920; Van Calster B, 2012, EUR J EPIDEMIOL, V27, P761, DOI 10.1007/s10654-012-9733-3; Van Holsbeke C, 2012, CLIN CANCER RES, V18, P815, DOI 10.1158/1078-0432.CCR-11-0879; Van Hoorde K, 2014, STAT MED, V33, P2585, DOI 10.1002/sim.6114; Virgilio BA, 2019, ULTRASOUND OBST GYN, V54, P823, DOI 10.1002/uog.20277; Westwood M, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22440; Woo YL, 2012, GYNECOL ONCOL, V126, P286, DOI 10.1016/j.ygyno.2012.04.012; Wynants L, 2018, STAT MED, V37, P2034, DOI 10.1002/sim.7653; Wynants L, 2017, CLIN CANCER RES, V23, P5082, DOI 10.1158/1078-0432.CCR-16-3248	43	27	28	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m2614	10.1136/bmj.m2614	http://dx.doi.org/10.1136/bmj.m2614			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732303	Green Published, hybrid			2022-12-28	WOS:000556139900004
J	Meuleman, W; Muratov, A; Rynes, E; Halow, J; Lee, KS; Bates, D; Diegel, M; Dunn, D; Neri, F; Teodosiadis, A; Reynolds, A; Haugen, E; Nelson, J; Johnson, A; Frerker, M; Buckley, M; Sandstrom, R; Vierstra, J; Kaul, R; Stamatoyannopoulos, J				Meuleman, Wouter; Muratov, Alexander; Rynes, Eric; Halow, Jessica; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Dunn, Douglas; Neri, Fidencio; Teodosiadis, Athanasios; Reynolds, Alex; Haugen, Eric; Nelson, Jemma; Johnson, Audra; Frerker, Mark; Buckley, Michael; Sandstrom, Richard; Vierstra, Jeff; Kaul, Rajinder; Stamatoyannopoulos, John			Index and biological spectrum of human DNase I hypersensitive sites	NATURE			English	Article							REGULATORY ELEMENTS; PARTITIONING HERITABILITY; OPEN CHROMATIN; ASSOCIATION; MATRIX; GENES; DISCOVERY; DYNAMICS	DNase I hypersensitive sites (DHSs) are generic markers of regulatory DNA(1-5)and contain genetic variations associated with diseases and phenotypic traits(6-8). We created high-resolution maps of DHSs from 733 human biosamples encompassing 438 cell and tissue types and states, and integrated these to delineate and numerically index approximately 3.6 million DHSs within the human genome sequence, providing a common coordinate system for regulatory DNA. Here we show that these maps highly resolve thecis-regulatory compartment of the human genome, which encodes unexpectedly diverse cell- and tissue-selective regulatory programs at very high density. These programs can be captured comprehensively by a simple vocabulary that enables the assignment to each DHS of a regulatory barcode that encapsulates its tissue manifestations, and global annotation of protein-coding and non-coding RNA genes in a manner orthogonal to gene expression. Finally, we show that sharply resolved DHSs markedly enhance the genetic association and heritability signals of diseases and traits. Rather than being confined to a small number of distal elements or promoters, we find that genetic signals converge on congruently regulated sets of DHSs that decorate entire gene bodies. Together, our results create a universal, extensible coordinate system and vocabulary for human regulatory DNA marked by DHSs, and provide a new global perspective on the architecture of human gene regulation. High-resolution maps of DNase I hypersensitive sites from 733 human biosamples are used to identify and index regulatory DNA within the human genome.	[Meuleman, Wouter; Muratov, Alexander; Rynes, Eric; Halow, Jessica; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Dunn, Douglas; Neri, Fidencio; Teodosiadis, Athanasios; Reynolds, Alex; Haugen, Eric; Nelson, Jemma; Johnson, Audra; Frerker, Mark; Buckley, Michael; Sandstrom, Richard; Vierstra, Jeff; Kaul, Rajinder; Stamatoyannopoulos, John] Altius Inst Biomed Sci, Seattle, WA 98121 USA; [Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Meuleman, W; Stamatoyannopoulos, J (corresponding author), Altius Inst Biomed Sci, Seattle, WA 98121 USA.; Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA.	wouter@meuleman.org; jstam@altius.org	Halow, Jessica/GQO-7562-2022	Kaul, Rajinder/0000-0002-7895-9284; Nelson, Jemma/0000-0003-2846-2007	NIH [U54HG007010, UM1HG009444]; GlaxoSmithKline PLC	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline PLC(GlaxoSmithKline)	We thank R. Senarighi for expert assistance with scientific illustration and T. Mercer and C. Lundberg for figure layout consultation. This work was supported by NIH grants U54HG007010 and UM1HG009444 and a charitable contribution to the Altius Institute for Biomedical Sciences by GlaxoSmithKline PLC.	Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Boutsidis C, 2008, PATTERN RECOGN, V41, P1350, DOI 10.1016/j.patcog.2007.09.010; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Giansanti Valentina, 2020, F1000Res, V9, P199, DOI 10.12688/f1000research.22731.1; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; John Sam, 2013, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2127s103; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lachmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03751-6; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MCGHEE JD, 1981, CELL, V27, P45, DOI 10.1016/0092-8674(81)90359-7; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; MILLS FC, 1983, NATURE, V306, P809, DOI 10.1038/306809a0; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reshef YA, 2018, NAT GENET, V50, P1483, DOI 10.1038/s41588-018-0196-7; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; Sisu C, 2014, P NATL ACAD SCI USA, V111, P13361, DOI 10.1073/pnas.1407293111; Smit AF., 2018, REPEATMASKER; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Stein-O'Brien GL, 2018, TRENDS GENET, V34, P790, DOI 10.1016/j.tig.2018.07.003; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vierstra J, 2020, NATURE, V583, P729, DOI 10.1038/s41586-020-2528-x; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941	58	69	69	4	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					244	+		10.1038/s41586-020-2559-3	http://dx.doi.org/10.1038/s41586-020-2559-3		JUL 2020	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32728217	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000553758900002
J	Slomski, A				Slomski, Anita			Wellness Program Failed to Improve Employee Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					327	327		10.1001/jama.2020.12593	http://dx.doi.org/10.1001/jama.2020.12593			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721006				2022-12-28	WOS:000562851000010
J	Greer, DM; Shemie, SD; Lewis, A; Torrance, S; Varelas, P; Goldenberg, FD; Bernat, JL; Souter, M; Topcuoglu, MA; Alexandrov, AW; Baldisseri, M; Bleck, T; Citerio, G; Dawson, R; Hoppe, A; Jacobe, S; Manara, A; Nakagawa, TA; Pope, TM; Silvester, W; Thomson, D; Al Rahma, H; Badenes, R; Baker, AJ; Cerny, V; Chang, C; Chang, TR; Gnedovskaya, E; Han, MK; Honeybul, S; Jimenez, E; Kuroda, Y; Liu, G; Mallick, UK; Marquevich, V; Mejia-Mantilla, J; Piradov, M; Quayyum, S; Shrestha, GS; Su, YY; Timmons, SD; Teitelbaum, J; Videtta, W; Zirpe, K; Sung, GN				Greer, David M.; Shemie, Sam D.; Lewis, Ariane; Torrance, Sylvia; Varelas, Panayiotis; Goldenberg, Fernando D.; Bernat, James L.; Souter, Michael; Topcuoglu, Mehmet Akif; Alexandrov, Anne W.; Baldisseri, Marie; Bleck, Thomas; Citerio, Giuseppe; Dawson, Rosanne; Hoppe, Arnold; Jacobe, Stephen; Manara, Alex; Nakagawa, Thomas A.; Pope, Thaddeus Mason; Silvester, William; Thomson, David; Al Rahma, Hussain; Badenes, Rafael; Baker, Andrew J.; Cerny, Vladimir; Chang, Cherylee; Chang, Tiffany R.; Gnedovskaya, Elena; Han, Moon-Ku; Honeybul, Stephen; Jimenez, Edgar; Kuroda, Yasuhiro; Liu, Gang; Mallick, Uzzwal Kumar; Marquevich, Victoria; Mejia-Mantilla, Jorge; Piradov, Michael; Quayyum, Sarah; Shrestha, Gentle Sunder; Su, Ying-ying; Timmons, Shelly D.; Teitelbaum, Jeanne; Videtta, Walter; Zirpe, Kapil; Sung, Gene			Determination of Brain Death/Death by Neurologic Criteria The World Brain Death Project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; OF-LIFE CARE; TRANSCRANIAL DOPPLER; CONFIRMATORY TEST; EARLY-DIAGNOSIS; ORGAN SUPPORT; MIMICKING; CT; ARREST; RELIABILITY	IMPORTANCE There are inconsistencies in concept, criteria, practice, and documentation of brain death/death by neurologic criteria (BD/DNC) both internationally and within countries. OBJECTIVE To formulate a consensus statement of recommendations on determination of BD/DNC based on review of the literature and expert opinion of a large multidisciplinary, international panel. PROCESS Relevant international professional societies were recruited to develop recommendations regarding determination of BD/DNC. Literature searches of the Cochrane, Embase, and MEDLINE databases included January 1,1992, through April 2020 identified pertinent articles for review. Because of the lack of high-quality data from randomized clinical trials or large observational studies, recommendations were formulated based on consensus of contributors and medical societies that represented relevant disciplines, including critical care, neurology, and neurosurgery. EVIDENCE SYNTHESIS Based on review of the literature and consensus from a large multidisciplinary, international panel, minimum clinical criteria needed to determine BD/DNC in various circumstances were developed. RECOMMENDATIONS Prior to evaluating a patient for BD/DNC, the patient should have an established neurologic diagnosis that can lead to the complete and irreversible loss of all brain function, and conditions that may confound the clinical examination and diseases that may mimic BD/DNC should be excluded. Determination of BD/DNC can be done with a clinical examination that demonstrates coma, brainstem areflexia, and apnea. This is seen when (1) there is no evidence of arousal or awareness to maximal external stimulation, including noxious visual, auditory, and tactile stimulation; (2) pupils are fixed in a midsize or dilated position and are nonreactive to light; (3) corneal, oculocephalic, and oculovestibular reflexes are absent; (4) there is no facial movement to noxious stimulation; (5) the gag reflex is absent to bilateral posterior pharyngeal stimulation; (6) the cough reflex is absent to deep tracheal suctioning; (7) there is no brain-mediated motor response to noxious stimulation of the limbs; and (8) spontaneous respirations are not observed when apnea test targets reach pH <7.30 and PaCO2 >= 60 mm Hg. If the clinical examination cannot be completed, ancillary testing may be considered with blood flow studies or electrophysiologic testing. Special consideration is needed for children, for persons receiving extracorporeal membrane oxygenation, and for those receiving therapeutic hypothermia, as well as for factors such as religious, societal, and cultural perspectives; legal requirements; and resource availability. CONCLUSIONS AND RELEVANCE This report provides recommendations for the minimum clinical standards for determination of brain death/death by neurologic criteria in adults and children with clear guidance for various clinical circumstances. The recommendations have widespread international society endorsement and can serve to guide professional societies and countries in the revision or development of protocols and procedures for determination of brain death/death by neurologic criteria, leading to greater consistency within and between countries.	[Greer, David M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Shemie, Sam D.] McGill Univ, Montreal Childrens Hosp, Montreal, PQ, Canada; [Shemie, Sam D.; Torrance, Sylvia; Dawson, Rosanne] Canadian Blood Serv, Ottawa, ON, Canada; [Lewis, Ariane] NYU Langone Med Ctr, New York, NY USA; [Varelas, Panayiotis] Albany Med Coll, Albany, NY 12208 USA; [Goldenberg, Fernando D.] Univ Chicago, Chicago, IL 60637 USA; [Bernat, James L.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Souter, Michael] Univ Washington, Seattle, WA 98195 USA; [Topcuoglu, Mehmet Akif] Hacettepe Univ, Dept Neurol, Ankara, Turkey; [Alexandrov, Anne W.] Univ Tennessee, Ctr Hlth Sci, Coll Nursing, Memphis, TN 38163 USA; [Baldisseri, Marie] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Bleck, Thomas] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Citerio, Giuseppe] Univ Milano Bicocca, Milan, Italy; [Hoppe, Arnold] Univ Desarrollo, Clin Alemana, Santiago, Chile; [Jacobe, Stephen] Univ Sydney, Westmead, NSW, Australia; [Jacobe, Stephen] Childrens Hosp Westmead, Westmead, NSW, Australia; [Manara, Alex] Southmead Hosp, Bristol, Avon, England; [Nakagawa, Thomas A.] Univ Florida, Jacksonville, FL USA; [Pope, Thaddeus Mason] Mitchell Hamline Sch Law, St Paul, MN USA; [Silvester, William] Univ Melbourne, Melbourne, Vic, Australia; [Thomson, David] Univ Cape Town, Cape Town, South Africa; [Al Rahma, Hussain] Dubai Hosp, Dubai, U Arab Emirates; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ, Valencia, Spain; [Baker, Andrew J.] St Michaels Hosp, Unity Hlth Toronto, Toronto, ON, Canada; [Baker, Andrew J.; Quayyum, Sarah] Univ Toronto, Toronto, ON, Canada; [Cerny, Vladimir] Univ JE Purkyne, Masaryk Hosp, Usti Nad Labem, Czech Republic; [Chang, Cherylee] Queens Med Ctr, Honolulu, HI USA; [Chang, Tiffany R.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Gnedovskaya, Elena; Piradov, Michael] Res Ctr Neurol, Moscow, Russia; [Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea; [Honeybul, Stephen] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Jimenez, Edgar] Texas A&M, College Stn, TX USA; [Kuroda, Yasuhiro] Kagawa Univ, Takamatsu, Kagawa, Japan; [Liu, Gang; Su, Ying-ying] Capital Med Univ, Beijing, Peoples R China; [Mallick, Uzzwal Kumar] Natl Inst Neurosci & Hosp, Dhaka, Bangladesh; [Marquevich, Victoria] Hosp Univ Austral, Buenos Aires, DF, Argentina; [Mejia-Mantilla, Jorge] Fdn Valle Lili, Cali, Colombia; [Shrestha, Gentle Sunder] Tribhuvan Univ Teaching Hosp, Kathmandu, Nepal; [Timmons, Shelly D.] Indiana Univ, Indianapolis, IN 46204 USA; [Teitelbaum, Jeanne] Montreal Neurol Inst, Montreal, PQ, Canada; [Videtta, Walter] Natl Hosp, Buenos Aires, DF, Argentina; [Zirpe, Kapil] Ruby Hall Clin, Pune, Maharashtra, India; [Sung, Gene] Univ Southern Calif, 2051 Marengo St,IPT A4E111, Los Angeles, CA 90033 USA	Boston University; McGill University; Canadian Blood Services; NYU Langone Medical Center; Albany Medical College; University of Chicago; Dartmouth College; University of Washington; University of Washington Seattle; Hacettepe University; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; University of Milano-Bicocca; Clinica Alemana; Universidad del Desarrollo; University of Sydney; University of Sydney; Southmead Hospital; State University System of Florida; University of Florida; Mitchell Hamline School of Law; University of Melbourne; University of Cape Town; Dubai Hospital; Hospital Clinic Universitari de Valencia; University of Valencia; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Masaryk Hospital; University of Jan Evangelista Purkyne; The Queen's Medical Center; University of Texas System; University of Texas Health Science Center Houston; Research Center of Neurology; Seoul National University (SNU); Seoul National University Hospital; University of Western Australia; Texas A&M University System; Texas A&M University College Station; Kagawa University; Capital Medical University; Austral University; Hospital Universitario Austral; Fundacion Valle del Lili; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Indiana University System; Indiana University-Purdue University Indianapolis; McGill University; University of Southern California	Sung, GN (corresponding author), Univ Southern Calif, 2051 Marengo St,IPT A4E111, Los Angeles, CA 90033 USA.	gsung@usc.edu	Thomson, David/AAQ-9471-2021; Chang, Cherylee/ABG-2080-2020; Lewis, Ariane/AFK-4154-2022; Topcuoglu, Mehmet A./ABE-2655-2021; Badenes, Rafael/K-6628-2019; Gnedovskaya, Elena V/C-1891-2012	Thomson, David/0000-0003-2433-3611; Lewis, Ariane/0000-0002-0756-7320; Badenes, Rafael/0000-0001-7017-0150; Goldenberg, Fernando/0000-0003-1100-6830; Liu, Gang/0000-0001-6407-0188; HOPPE, ARNOLD/0000-0002-4236-0173				Academy of Medical Royal Colleges, 2008, COD PRACT DIAGN CONF; Academy of Medical Royal Colleges, COD PRACT DIAGN CONF; Albar M A, 1996, Saudi J Kidney Dis Transpl, V7, P109; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P97; [Anonymous], 1968, JAMA, V205, P337; [Anonymous], 1976, LANCET, V2, P1069; [Anonymous], 2013, ANZICS STATEMENT DEA, V2; Araki T, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1211-4; Australian and New Zealand Intensive Care Society, 2013, ANZICS STAT DEATH OR; Bakshi N, 1997, MUSCLE NERVE, V20, P1595, DOI 10.1002/(SICI)1097-4598(199712)20:12<1595::AID-MUS17>3.3.CO;2-8; Bernard V, 2010, ACTA NEUROL BELG, V110, P93; Bernat J L, 1992, J Clin Ethics, V3, P21; Berner D, 2012, CRIT CARE MED S, V40, P304; BLECK TP, 2012, AMINAOFFS ELECTRODIA, V6, P789; Bohatyrewicz R, 2010, TRANSPL P, V42, P3941, DOI 10.1016/j.transproceed.2010.09.143; Bosek Marcia Sue DeWolf, 2007, JONAS Healthc Law Ethics Regul, V9, P87; Braun M, 1997, NEURORADIOLOGY, V39, P400, DOI 10.1007/s002340050432; BRUCE EN, 1987, J APPL PHYSIOL, V62, P389, DOI 10.1152/jappl.1987.62.2.389; Burkle CM, 2015, SEMIN NEUROL, V35, P174, DOI 10.1055/s-0035-1547537; Campbell C., 1999, DEFINITION DEATH CON; Canadian Blood Services, NEUR DET DEATH; Chang JJ, 2016, AM J NEURORADIOL, V37, P408, DOI 10.3174/ajnr.A4548; Choong KA, 2018, HEC FORUM, V30, P71, DOI 10.1007/s10730-016-9307-y; Cleveland Clinic, DEATH NEUR CRIT COUR; Combes JC, 2007, TRANSPLANT P, V39, P16, DOI 10.1016/j.transproceed.2006.10.204; Cronberg T, 2013, RESUSCITATION, V84, P867, DOI 10.1016/j.resuscitation.2013.01.019; Dayal M, 2014, INDIAN J ANAESTH, V58, P458, DOI 10.4103/0019-5049.139008; Dupas B, 1998, AM J NEURORADIOL, V19, P641; Escudero D, 2015, ANAESTHESIA, V70, P1130, DOI 10.1111/anae.13065; FDA Drug Safety Communication, FDA WARNS GAD BAS CO; Felton D, 2014, CLIN TOXICOL, V52, P419; Da Silva IRF, 2015, JAMA NEUROL, V72, P112, DOI 10.1001/jamaneurol.2014.3083; FIELD DR, 1988, JAMA-J AM MED ASSOC, V260, P816, DOI 10.1001/jama.260.6.816; Flamm Anne Lederman, 2014, J Clin Ethics, V25, P222; Flowers WM, 1997, SOUTH MED J, V90, P1091, DOI 10.1097/00007611-199711000-00007; Frampas E, 2009, AM J NEURORADIOL, V30, P1566, DOI 10.3174/ajnr.A1614; Freund B, 2017, MUSCLE NERVE, V56, pE27, DOI 10.1002/mus.25689; Furton Edward J, 2002, Natl Cathol Bioeth Q, V2, P455; Garrett MP, 2018, J NEUROSURG, V128, P639, DOI 10.3171/2016.10.JNS161042; Geocadin RG, 2008, CURR OPIN CRIT CARE, V14, P261, DOI 10.1097/MCC.0b013e3282fd68ea; Gervais KG, 1987, REDEFINING DEATH; GILDER SSB, 1968, BRIT MED J, V3, P493, DOI 10.1136/bmj.3.5616.493; Greer DM, 2016, JAMA NEUROL, V73, P213, DOI 10.1001/jamaneurol.2015.3943; GRIGG MM, 1987, ARCH NEUROL-CHICAGO, V44, P948, DOI 10.1001/archneur.1987.00520210048018; HAAS JM, 2011, NATL CATHOL BIOETH Q, V11, P279; HANTSON P, 1993, EUR NEUROL, V33, P212, DOI 10.1159/000116939; In re Long Island Jewish Medical Center, 1996, WESTS N Y S, V641, P989; Ishii K, 1996, AM J NEURORADIOL, V17, P731; Jain S, 1995, BRAIN DEATH; Joffe AR, 2010, SPINAL CORD, V48, P2, DOI 10.1038/sc.2009.115; Joffe Ari R, 2010, J Intensive Care Med, V25, P53; John Joseph, 2008, Cases J, V1, P16, DOI 10.1186/1757-1626-1-16; Johnson LSM, 2016, J BIOETHIC INQ, V13, P105, DOI 10.1007/s11673-015-9683-z; Kahn PA, 2016, J RELIG HEALTH, V55, P1546, DOI 10.1007/s10943-015-0144-0; Karantanas AH, 2002, EUR RADIOL, V12, P2710, DOI 10.1007/s00330-002-1336-z; Kashkoush A, 2017, WORLD NEUROSURG, V108, P374, DOI 10.1016/j.wneu.2017.08.185; Khalid I, 2013, AM J HOSP PALLIAT ME, V30, P413, DOI 10.1177/1049909112452625; Krawiec C, 2019, NEUROPEDIATRICS, V50, P80, DOI 10.1055/s-0038-1676661; Kung NH, 2015, J NEUROL SCI, V352, P132, DOI 10.1016/j.jns.2015.03.045; Lanfermann H, 2016, ROFO-FORTSCHR RONTG, V188, P23, DOI 10.1055/s-0041-108202; Lang CJG, 2011, CRIT CARE MED, V39, P2205, DOI 10.1097/CCM.0b013e318222727c; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Leclerc X, 2006, J NEURORADIOLOGY, V33, P90, DOI 10.1016/S0150-9861(06)77237-6; Lee Seo-Young, 2017, Annals of Clinical Neurophysiology, V19, P118; Lewis A, 2020, NEUROLOGY, V95, pE299, DOI 10.1212/WNL.0000000000009888; Lewis A, 2017, CHEST, V152, P700, DOI 10.1016/j.chest.2017.05.030; Lewis A, 2017, CRIT CARE MED, V45, pE916, DOI 10.1097/CCM.0000000000002452; Lewis A, 2017, NAT REV NEUROL, V13, P505, DOI 10.1038/nrneurol.2017.72; Lewis A, 2017, NEUROCRIT CARE, V26, P446, DOI 10.1007/s12028-017-0375-x; Lewis A, 2016, NEUROLOGY, V87, P827, DOI 10.1212/WNL.0000000000003008; Liik M, 2012, BMJ; Lopez-Navidad A, 2000, TRANSPLANTATION, V70, P131; Luce JM, 2015, CHEST, V147, P1144, DOI 10.1378/chest.14-2227; Luchtmann M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03659; Lust RM, 2007, REFERENCE MODULE BIO; MacDonald D, 2018, J NEUROIMAGING, V28, P374, DOI 10.1111/jon.12516; MacDougall BJ, 2014, NEUROCRIT CARE, V21, P383, DOI 10.1007/s12028-014-9975-x; Marchand AJ, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0188-7; MARTIMASSO JF, 1993, J NEUROL SCI, V120, P115, DOI 10.1016/0022-510X(93)90034-V; Mathur M, 2008, PEDIATRICS, V121, P988, DOI 10.1542/peds.2007-1871; Mathur M, 2015, SEMIN NEUROL, V35, P116, DOI 10.1055/s-0035-1547540; Miller AC, 2014, CHEST, V146, P1092, DOI 10.1378/chest.14-0130; MITCHELL OC, 1962, J NEUROSURG, V19, P766, DOI 10.3171/jns.1962.19.9.0766; MOHANDAS A, 1971, J NEUROSURG, V35, P211, DOI 10.3171/jns.1971.35.2.0211; Mollaret P, 1959, REV NEUROL-FRANCE, V101, P3; Morrow SA, 2007, NEUROCRIT CARE, V6, P45, DOI 10.1385/NCC:6:1:45; Moussouttas M, 2004, NEUROCRIT CARE, V1, P469, DOI 10.1385/NCC:1:4:469; Nakagawa TA, 2012, ANN NEUROL, V71, P573, DOI 10.1002/ana.23552; Nakagawa TA, 2011, PEDIATRICS, V128, pE720, DOI 10.1542/peds.2011-1511; Neurocritical Care Society, BRAIN DEATH TOOLK; NHS Blood and Transplant, DIAGN DEATH US NEUR; Olick RS, 2009, J CLIN ETHIC, V20, P183; Orban JC, 2012, TRANSPLANTATION, V94, P585, DOI 10.1097/TP.0b013e3182612947; Padela AI, 2013, BIOETHICS, V27, P132, DOI 10.1111/j.1467-8519.2011.01935.x; Pandey Ashutosh, 2017, Neurosci J, V2017, P6017958, DOI 10.1155/2017/6017958; PAOLIN A, 1995, INTENS CARE MED, V21, P657, DOI 10.1007/BF01711544; Paris JJ, 2014, CAMB Q HEALTHC ETHIC, V23, P371, DOI 10.1017/S0963180114000048; Pontifical Academy of Sciences, 2007, SIGNS DEATH; Pope Thaddeus Mason, 2014, J Clin Ethics, V25, P245; President's Commission for the Study of Ethical Problems in Medicine and Biomedical Behavioral Research, 1981, DEF DEATH REP ED LEG; Puttinger G, 2016, EUR J NEUROL, V23, P165; Qazi F, 2013, THEOR MED BIOETH, V34, P117, DOI 10.1007/s11017-013-9250-8; Quesnel C, 2007, INTENS CARE MED, V33, P2129, DOI 10.1007/s00134-007-0789-6; Rady MY, 2013, J CARDIOTHOR VASC AN, V27, pE8, DOI 10.1053/j.jvca.2012.08.014; Ravikumar S, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00063; Rieke A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13261; Rigamonti A, 2009, J PERIPHER NERV SYST, V14, P316, DOI 10.1111/j.1529-8027.2009.00244.x; Rosner F., 1999, DEFINITION DEATH CON; Royal College of Paediatrics and Child Health, 2015, DIAGN DEATH NEUR CRI; Sahin H, 2015, DIAGN INTERV RADIOL, V21, P177, DOI 10.5152/dir.2014.14241; Sampson BG, 2017, CRIT CARE RESUSC, V19, P57; Sawicki M, 2015, ANN TRANSPL, V20, P449, DOI 10.12659/AOT.893808; Sawicki M, 2014, NEURORADIOLOGY, V56, P609, DOI 10.1007/s00234-014-1364-9; Schmidt JE, 2000, ANESTHESIOLOGY, V92, P1476, DOI 10.1097/00000542-200005000-00039; Setta SM, 2015, PHILOS ETHICS HUM ME, V10, DOI 10.1186/s13010-015-0025-x; SHANAWANI H, 2010, AM J RESP CRIT CARE, V181, DOI DOI 10.1164/AJRCCM-CONFERENCE.2010.181.1_MEETINGABSTRACTS.A6698; Shankar JJS, 2013, AM J NEURORADIOL, V34, P1175, DOI 10.3174/ajnr.A3376; Shappell CN, 2013, NEUROLOGY, V81, P2009, DOI 10.1212/01.wnl.0000436938.70528.4a; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Smith M, 2017, INTENS CARE MED, V43, P1383, DOI 10.1007/s00134-017-4676-5; Smith Martin L, 2011, Narrat Inq Bioeth, V1, P55, DOI 10.1353/nib.2011.0003; Sohn CH, 2012, KOREAN J RADIOL, V13, P541, DOI 10.3348/kjr.2012.13.5.541; Sprung CL, 2014, AM J RESP CRIT CARE, V190, P855, DOI 10.1164/rccm.201403-0593CC; Su YY, 2014, CHINESE MED J-PEKING, V127, P1272, DOI 10.3760/cma.j.issn.0366-6999.20133013; Szurhaj W, 2015, NEUROPHYSIOL CLIN, V45, P97, DOI 10.1016/j.neucli.2014.11.005; University of Cape Town, ORG DON DEATH LIF; University of Chicago, 2016, BRAIN DEATH SIM WORK; Vargas F, 2000, INTENS CARE MED, V26, P623, DOI 10.1007/s001340051213; VEITH FJ, 1977, JAMA-J AM MED ASSOC, V238, P1651, DOI 10.1001/jama.238.15.1651; Wahlster S, 2015, NEUROLOGY, V84, P1870, DOI 10.1212/WNL.0000000000001540; Wang MY, 2002, NEUROSURGERY, V51, P731, DOI 10.1227/01.NEU.0000024156.53597.IA; Webb AC, 2011, CRIT CARE MED, V39, P1538, DOI 10.1097/CCM.0b013e3182186687; Welschehold S, 2013, EUR J NEUROL, V20, P173, DOI 10.1111/j.1468-1331.2012.03826.x; Welschehold S, 2013, J TRAUMA ACUTE CARE, V74, P1279, DOI 10.1097/TA.0b013e31828c46ba; Welschehold S, 2012, DTSCH ARZTEBL INT, V109, P624, DOI 10.3238/arztebl.2012.0624; Welschehold Stefan, 2012, Acta Neurochir Suppl, V114, P311, DOI 10.1007/978-3-7091-0956-4_60; Wijdicks EFM, 2011, CRIT CARE MED, V39, P2204, DOI 10.1097/CCM.0b013e318222724e; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Young GB, 2003, CAN J NEUROL SCI, V30, P305, DOI 10.1017/S0317167100002997	142	109	115	7	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2020	324	11					1078	1097		10.1001/jama.2020.11586	http://dx.doi.org/10.1001/jama.2020.11586			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OF2XM	32761206				2022-12-28	WOS:000581077300022
J	Guan, DY; Xiong, Y; Trinh, TM; Xiao, Y; Hu, WX; Jiang, CJ; Dierickx, P; Jang, C; Rabinowitz, JD; Lazar, MA				Guan, Dongyin; Xiong, Ying; Trinh, Trang Minh; Xiao, Yang; Hu, Wenxiang; Jiang, Chunjie; Dierickx, Pieterjan; Jang, Cholsoon; Rabinowitz, Joshua D.; Lazar, Mitchell A.			The hepatocyte clock and feeding control chronophysiology of multiple liver cell types	SCIENCE			English	Article							REV-ERB-ALPHA; GENE-EXPRESSION; CIRCADIAN CLOCK; TRANSCRIPTION; METABOLISM; PROTEIN; DIFFERENTIATION; OSCILLATORS; PACEMAKER; COMPONENT	Most cells of the body contain molecular clocks, but the requirement of peripheral clocks for rhythmicity and their effects on physiology are not well understood. We show that deletion of core clock components REV-ERBa and REV-ERBIS in adult mouse hepatocytes disrupts diurnal rhythms of a subset of liver genes and alters the diurnal rhythm of de novo lipogenesis. Liver function is also influenced by nonhepatocytic cells, and the loss of hepatocyte REV-ERBs remodels the rhythmic transcriptomes and metabolomes of multiple cell types within the liver. Finally, alteration of food availability demonstrates the hierarchy of the cell-intrinsic hepatocyte clock mechanism and the feeding environment. Together, these studies reveal previously unsuspected roles of the hepatocyte clock in the physiological coordination of nutritional signals and cell-cell communication controlling rhythmic metabolism.	[Guan, Dongyin; Xiong, Ying; Trinh, Trang Minh; Xiao, Yang; Hu, Wenxiang; Jiang, Chunjie; Dierickx, Pieterjan; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Guan, Dongyin; Xiong, Ying; Trinh, Trang Minh; Xiao, Yang; Hu, Wenxiang; Jiang, Chunjie; Dierickx, Pieterjan; Lazar, Mitchell A.] Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jang, Cholsoon; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Jang, Cholsoon; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Jang, Cholsoon] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Irvine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	lazar@pennmedicine.upenn.edu	Rabinowitz, Joshua/GPP-4019-2022; Jiang, Chunjie/AAU-1775-2020; Lazar, Mitchell A/AAF-3738-2019; Dierickx, Pieterjan/ACC-1860-2022; Hu, Wenxiang/W-3737-2017	Rabinowitz, Joshua/0000-0002-1247-4727; Jiang, Chunjie/0000-0002-3033-092X; Dierickx, Pieterjan/0000-0002-1709-1477; Jang, Cholsoon/0000-0001-6651-4213; Xiao, Yang/0000-0002-9297-0973; Hu, Wenxiang/0000-0002-6754-5625; Guan, Dongyin/0000-0002-2641-3095	Penn Diabetes Research Center [P30 DK19525]; Penn DRC Metabolomics Core at Princeton [DK19525]; JPB Foundation; Cox Medical Research Institute; National Institutes of Health [R01-DK045586, F32DK116519]; American Diabetes Association [1-17-PDF-076, 1-18-PDF-132]; American Heart Association [20POST35210738]	Penn Diabetes Research Center; Penn DRC Metabolomics Core at Princeton; JPB Foundation; Cox Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association)	We thank the Functional Genomics Core and the Viral Vector Core of the Penn Diabetes Research Center (P30 DK19525) for next-generation sequencing and virus preparation, respectively. We also acknowledge the Penn DRC Metabolomics Core at Princeton (DK19525). This work was supported by the JPB Foundation (M.A.L.) and the Cox Medical Research Institute (M.A.L.), as well as by National Institutes of Health grants R01-DK045586 (M.A.L.) and F32DK116519 (D.G.). C.Ja. and W.H. were supported by American Diabetes Association Training Grants [1-17-PDF-076 (C.Ja.) and 1-18-PDF-132 (W.H.)]. P.D. was supported by a postdoctoral fellowship from the American Heart Association (20POST35210738).	Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Brocker CN, 2017, AM J PHYSIOL-GASTR L, V312, pG283, DOI 10.1152/ajpgi.00205.2016; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dierickx P, 2019, P NATL ACAD SCI USA, V116, P12147, DOI 10.1073/pnas.1904226116; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Geraud C, 2017, J CLIN INVEST, V127, P1099, DOI 10.1172/JCI90086; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Greenwell BJ, 2019, CELL REP, V27, P649, DOI 10.1016/j.celrep.2019.03.064; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; Guan DY, 2018, CELL, V174, P831, DOI 10.1016/j.cell.2018.06.031; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hughes ME, 2017, J BIOL RHYTHM, V32, P380, DOI 10.1177/0748730417728663; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Kalvisa A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006249; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Koronowski KB, 2019, CELL, V177, P1448, DOI 10.1016/j.cell.2019.04.025; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Madsen JGS, 2018, GENOME RES, V28, P243, DOI 10.1101/gr.227231.117; Mange F, 2017, GENOME RES, V27, P973, DOI 10.1101/gr.217521.116; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Ollinger R, 2014, J CELL SCI, V127, P4322, DOI 10.1242/jcs.156612; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Pope AJ, 2009, J BIOL CHEM, V284, P35338, DOI 10.1074/jbc.M109.037036; Quagliarini F, 2019, MOL CELL, V76, P531, DOI 10.1016/j.molcel.2019.10.007; Stapor P, 2014, J CELL SCI, V127, P4331, DOI 10.1242/jcs.153908; Su XY, 2017, ANAL CHEM, V89, P5941, DOI 10.1021/acs.analchem.7b00396; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Weng MP, 2017, BIOINFORMATICS, V33, P3505, DOI 10.1093/bioinformatics/btx426; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Xu M, 2019, CELL, V178, P1478, DOI 10.1016/j.cell.2019.07.021; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021; Zhang Z, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-019-10885-8, 10.1038/s41467-019-12533-7]; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094; Zucker SN, 2014, MOL CELL, V53, P916, DOI 10.1016/j.molcel.2014.01.033	60	43	44	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2020	369	6509			SI		1388	+		10.1126/science.aba8984	http://dx.doi.org/10.1126/science.aba8984			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO9YB	32732282	Green Accepted			2022-12-28	WOS:000569840300057
J	Bronselaer, B; Zanna, L				Bronselaer, Ben; Zanna, Laure			Heat and carbon coupling reveals ocean warming due to circulation changes	NATURE			English	Article							CLIMATE-CHANGE; GLOBAL OCEAN; SOUTHERN-OCEAN; ATLANTIC-OCEAN; NORTH-ATLANTIC; CO2; MODEL; FORMULATION; EMISSIONS; INCREASE	Anthropogenic global surface warming is proportional to cumulative carbon emissions(1-3); this relationship is partly determined by the uptake and storage of heat and carbon by the ocean(4). The rates and patterns of ocean heat and carbon storage are influenced by ocean transport, such as mixing and large-scale circulation(5-10). However, existing climate models do not accurately capture the observed patterns of ocean warming, with a large spread in their projections of ocean circulation and ocean heat uptake(8,11). Additionally, assessing the influence of ocean circulation changes (specifically, the redistribution of heat by resolved advection) on patterns of observed and simulated ocean warming remains a challenge. Here we establish a linear relationship between the heat and carbon uptake of the ocean in response to anthropogenic emissions. This relationship is determined mainly by intrinsic parameters of the Earth system-namely, the ocean carbon buffer capacity, the radiative forcing of carbon dioxide and the carbon inventory of the ocean. We use this relationship to reveal the effect of changes in ocean circulation from carbon dioxide forcing on patterns of ocean warming in both observations and global Earth system models from the Fifth Coupled Model Intercomparison Project (CMIP5). We show that historical patterns of ocean warming are shaped by ocean heat redistribution, which CMIP5 models simulate poorly. However, we find that projected patterns of heat storage are primarily dictated by the pre-industrial ocean circulation (and small changes in unresolved ocean processes)-that is, by the patterns of added heat owing to ocean uptake of excess atmospheric heat rather than ocean warming by circulation changes. Climate models show more skill in simulating ocean heat storage by the pre-industrial circulation compared to heat redistribution, indicating that warming patterns of the ocean may become more predictable as the climate warms. A linear relationship between the storage of heat and carbon in global oceans in response to anthropogenic emissions is used to reconstruct the effect of circulation changes on past and future ocean warming patterns.	[Bronselaer, Ben; Zanna, Laure] Univ Oxford, Atmospher Ocean & Planetary Phys, Oxford, England; [Bronselaer, Ben] Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Bronselaer, Ben] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Bronselaer, Ben] Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA; [Zanna, Laure] NYU, Courant Inst Math Sci, New York, NY USA	University of Oxford; National Oceanic Atmospheric Admin (NOAA) - USA; University of Arizona; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; New York University	Bronselaer, B (corresponding author), Univ Oxford, Atmospher Ocean & Planetary Phys, Oxford, England.; Bronselaer, B (corresponding author), Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA.; Bronselaer, B (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.; Bronselaer, B (corresponding author), Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA.	benjamin.bronselaer@cantab.net	Zanna, Laure/L-3169-2019	Zanna, Laure/0000-0002-8472-4828				Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Armour KC, 2016, NAT GEOSCI, V9, P549, DOI [10.1038/ngeo2731, 10.1038/NGEO2731]; Arora VK, 2013, J CLIMATE, V26, P5289, DOI 10.1175/JCLI-D-12-00494.1; Banks HT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025352; Bronselaer B, 2017, GEOPHYS RES LETT, V44, P12298, DOI 10.1002/2017GL074435; Bulwer BE, 2007, CONTEMP CARDIOL, P71, DOI 10.1007/978-1-59259-977-6_4; Caesar L, 2018, NATURE, V556, P191, DOI 10.1038/s41586-018-0006-5; Chemke R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15285-x; Cheng LJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601545; Cheng W, 2013, J CLIMATE, V26, P7187, DOI 10.1175/JCLI-D-12-00496.1; DeVries T, 2019, P NATL ACAD SCI USA, V116, P11646, DOI 10.1073/pnas.1900371116; DeVries T, 2017, NATURE, V542, P215, DOI 10.1038/nature21068; DeVries T, 2014, GLOBAL BIOGEOCHEM CY, V28, P631, DOI 10.1002/2013GB004739; Drijfhout S, 2012, J CLIMATE, V25, P8373, DOI 10.1175/JCLI-D-12-00490.1; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Dutkiewicz S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002342; Fay AR, 2013, GLOBAL BIOGEOCHEM CY, V27, P541, DOI 10.1002/gbc.20051; Fine RA, 2017, J GEOPHYS RES-OCEANS, V122, P3771, DOI 10.1002/2016JC012529; Fine RA, 2011, ANNU REV MAR SCI, V3, P173, DOI 10.1146/annurev.marine.010908.163933; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2014, J CLIMATE, V27, P511, DOI 10.1175/JCLI-D-12-00579.1; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Fu WW, 2016, BIOGEOSCIENCES, V13, P5151, DOI 10.5194/bg-13-5151-2016; Goodwin P, 2015, NAT GEOSCI, V8, P29, DOI [10.1038/NGEO2304, 10.1038/ngeo2304]; Gregory JM, 2016, GEOSCI MODEL DEV, V9, P3993, DOI 10.5194/gmd-9-3993-2016; Huber MB, 2017, GEOPHYS RES LETT, V44, P1402, DOI 10.1002/2016GL071587; IPCC, 2013, CLIMATE CHANGE 2022; Jones DC, 2014, GLOBAL BIOGEOCHEM CY, V28, P1163, DOI 10.1002/2014GB004813; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Key R.M., 2015, ORNLCDIAC162, DOI [10.3334/CDIAC/OTG.NDP093_GLODAPv2, DOI 10.3334/CDIAC/OTG.NDP093_GLODAPV2]; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Landschutzer P, 2016, GLOBAL BIOGEOCHEM CY, V30, P1396, DOI 10.1002/2015GB005359; Lauvset SK, 2016, EARTH SYST SCI DATA, V8, P325, DOI 10.5194/essd-8-325-2016; Levitus S, 1983, EOS T AM GEOPHYS UNI, V64, P962; Lovenduski NS, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002900; Marshall DP, 2014, J CLIMATE, V27, P8444, DOI 10.1175/JCLI-D-13-00344.1; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Olsen A, 2016, EARTH SYST SCI DATA, V8, P297, DOI 10.5194/essd-8-297-2016; Palter JB, 2018, GLOBAL BIOGEOCHEM CY, V32, P738, DOI 10.1002/2017GB005777; Rahmstorf S, 2015, NAT CLIM CHANGE, V5, P475, DOI [10.1038/nclimate2554, 10.1038/NCLIMATE2554]; Randerson JT, 2015, GLOBAL BIOGEOCHEM CY, V29, P744, DOI 10.1002/2014GB005079; REVELLE R, 1957, TELLUS, V9, P18, DOI 10.1111/j.2153-3490.1957.tb01849.x; Saenko OA, 2018, J CLIMATE, V31, P8589, DOI 10.1175/JCLI-D-18-0186.1; Sarmiento J. L., 2006, OCEAN BIOGEOCHEMICAL, pxii; Schwinger J, 2014, J CLIMATE, V27, P3869, DOI 10.1175/JCLI-D-13-00452.1; Sgubin G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14375; Smeed DA, 2018, GEOPHYS RES LETT, V45, P1527, DOI 10.1002/2017GL076350; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; Tjiputra JF, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.23083; Van Heuven, 2011, ORNLCDIAC105B USDA C; Williams RG, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003853; Wilson LJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P923, DOI 10.1111/geb.12456; Winton M, 2003, J CLIMATE, V16, P2875, DOI 10.1175/1520-0442(2003)016<2875:OTCIOO>2.0.CO;2; Winton M, 2013, J CLIMATE, V26, P2268, DOI 10.1175/JCLI-D-12-00296.1; Xie P, 2012, CLIM DYNAM, V38, P667, DOI 10.1007/s00382-011-1063-8; Zanna L, 2019, P NATL ACAD SCI USA, V116, P1126, DOI 10.1073/pnas.1808838115; Zickfeld K, 2009, P NATL ACAD SCI USA, V106, P16129, DOI 10.1073/pnas.0805800106	66	42	42	32	175	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					227	+		10.1038/s41586-020-2573-5	http://dx.doi.org/10.1038/s41586-020-2573-5			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32788734				2022-12-28	WOS:000559831500014
J	Iacobucci, G				Iacobucci, Gareth			Covid lockdown: England sees fewer cases of colds, flu, and bronchitis	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of General Practitioners, 2020, RSC COMM RESP DIS RE	1	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3182	10.1136/bmj.m3182	http://dx.doi.org/10.1136/bmj.m3182			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784206	Bronze			2022-12-28	WOS:000560307500006
J	Mahase, E				Mahase, Elisabeth			FACT CHECK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, SPI B INSIGHTS COMBI; [Anonymous], 2020, NBC NEWS; [Anonymous], 2020, 15 SAGE M COV 19 13; Michie S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2982	4	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2020	370								m3166	10.1136/bmj.m3166	http://dx.doi.org/10.1136/bmj.m3166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7QQ	32769080	Bronze			2022-12-28	WOS:000560709600009
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: How will we run flu clinics in a pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						[Anonymous], 2020, BBC NEWS; Boseley S, 2020, GUARDIAN; Cellan-Jones R., 2020, BBC NEWS; Financial Times, 2020, FINANCIAL TIMES; Merrick R., 2020, INDEPENDENT; Pearce C., 2020, PULSE; Sasse T, 2019, PROBATION OUTSOURCIN	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3033	10.1136/bmj.m3033	http://dx.doi.org/10.1136/bmj.m3033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732315	Bronze			2022-12-28	WOS:000556139900009
J	MPharm, HJS; Squires, P; Wilson, D; Lo-Ciganic, WH; Cook, RL; Park, H				MPharm, Hyun Jin Song; Squires, Patrick; Wilson, Debbie; Lo-Ciganic, Wei-Hsuan; Cook, Robert L.; Park, Haesuk			Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[MPharm, Hyun Jin Song; Squires, Patrick; Wilson, Debbie; Lo-Ciganic, Wei-Hsuan; Park, Haesuk] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, 1225 Ctr Dr,HPNP Bldg,Room 3325, Gainesville, FL 32610 USA; [Cook, Robert L.] Univ Florida, SHARC, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Park, H (corresponding author), Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, 1225 Ctr Dr,HPNP Bldg,Room 3325, Gainesville, FL 32610 USA.	hpark@cop.ufl.edu	Cook, Robert Lewis/ABI-4866-2020		National Institute on Drug Abuse of the National Institutes of Health [K01DA045618]; Southern HIV and Alcohol Research Consortium (SHARC) Administrative Core [U24AA022002]	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Southern HIV and Alcohol Research Consortium (SHARC) Administrative Core	Dr Park was supported in part by grant K01DA045618 from the National Institute on Drug Abuse of the National Institutes of Health. Dr Cook was supported in part by grant U24AA022002 from the Southern HIV and Alcohol Research Consortium (SHARC) Administrative Core.	Huang YLA, 2018, MMWR-MORBID MORTAL W, V67, P1147, DOI 10.15585/mmwr.mm6741a3; Liu TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165574; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2203, DOI 10.1001/jama.2019.6390; Silapaswan A, 2017, J GEN INTERN MED, V32, P192, DOI 10.1007/s11606-016-3899-4; Smith DK, 2018, ANN EPIDEMIOL, V28, P850, DOI 10.1016/j.annepidem.2018.05.003	5	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					395	397		10.1001/jama.2020.7312	http://dx.doi.org/10.1001/jama.2020.7312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32720996	Bronze, Green Published			2022-12-28	WOS:000562851000033
J	Weidinger, S; Schreiber, S				Weidinger, Stephan; Schreiber, Stefan			Abrocitinib for atopic dermatitis: a step forward	LANCET			English	Editorial Material							JAK INHIBITORS; DOUBLE-BLIND; MODERATE; PHASE-3; SAFETY		[Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, D-24105 Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med, D-24105 Kiel, Germany; [Weidinger, Stephan; Schreiber, Stefan] Excellence Cluster Precis Med Inflammat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Weidinger, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, D-24105 Kiel, Germany.; Weidinger, S (corresponding author), Excellence Cluster Precis Med Inflammat, Kiel, Germany.	sweidinger@dermatology.uni-kiel.de						Barbarot S, 2018, ALLERGY, V73, P1284, DOI 10.1111/all.13401; Gadina M, 2019, RHEUMATOLOGY, V58, P4, DOI 10.1093/rheumatology/key432; Hanauer S, 2019, CLIN GASTROENTEROL H, V17, P139, DOI 10.1016/j.cgh.2018.07.009; Heratizadeh A, 2020, J EUR ACAD DERMATOL, V34, P1263, DOI 10.1111/jdv.16078; Kleppe M, 2017, CELL STEM CELL, V21, P489, DOI 10.1016/j.stem.2017.08.011; Koride S, 2019, CPT-PHARMACOMET SYST, V8, P478, DOI 10.1002/psp4.12419; Nakagawa H, 2020, J AM ACAD DERMATOL, V82, P823, DOI 10.1016/j.jaad.2019.12.015; Scott IC, 2018, DRUG SAFETY, V41, P645, DOI 10.1007/s40264-018-0651-5; Simpson EL, 2020, LANCET, V396, P255, DOI 10.1016/S0140-6736(20)30732-7; Strowd LC, 2017, LANCET, V389, P2265, DOI 10.1016/S0140-6736(17)31192-3; US Food and Drug Administration, 2019, SAF TRIAL FINDS RISK; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Winthrop KL, 2017, NAT REV RHEUMATOL, V13, P234, DOI 10.1038/nrrheum.2017.23	13	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					215	217						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711781				2022-12-28	WOS:000567020100006
J	Anderson, RM; Hollingsworth, TD; Baggaley, RF; Maddren, R; Vegvari, C				Anderson, Roy M.; Hollingsworth, T. Deirdre; Baggaley, Rebecca F.; Maddren, Rosie; Vegvari, Carolin			COVID-19 spread in the UK: the end of the beginning?	LANCET			English	Editorial Material									[Anderson, Roy M.; Maddren, Rosie; Vegvari, Carolin] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, Med Res Council,Ctr Global Infect Dis Anal, London W2 1PG, England; [Hollingsworth, T. Deirdre] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England; [Baggaley, Rebecca F.] Univ Leicester, Dept Resp Sci, Leicester, Leics, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; University of Leicester	Anderson, RM (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, Med Res Council,Ctr Global Infect Dis Anal, London W2 1PG, England.	roy.anderson@imperial.ac.uk	Hollingsworth, Deirdre/D-2421-2009	Hollingsworth, Deirdre/0000-0001-5962-4238; Anderson, Roy/0000-0002-9528-3175; Baggaley, Rebecca/0000-0002-4688-3924	MRC [MR/R015600/1, MC_PC_19012] Funding Source: UKRI; Medical Research Council [MR/R015600/1, MC_PC_19012] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2020, CORONAVIRUS COVID 19; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.3, 10.12688/wellcomeopenres.15842.1]; European Commission, 2020, GUIDELINES ON COVID; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Gog J, 2020, PLUS MATHS; Gostic KM, 2020, PRACTICAL CONSIDERAT, DOI DOI 10.1101/2020.06.18.20134; Hardwick R., 2020, GITHUB; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Johns Hopkins University, 2020, COVID 19 MAP; Leclerc Quentin J, 2020, Wellcome Open Res, V5, P83, DOI [10.12688/wellcomeopenres.15889.1, 10.12688/wellcomeopenres.15889.2]; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315; Riley S., 2020, MEDRXIV, DOI [10.1101/2020.07.10.20150524, DOI 10.1101/2020.07.10.20150524]; STEIN M, 1987, TECHNOMETRICS, V29, P143, DOI 10.2307/1269769; The Academy of Medical Sciences, 2020, PREPARING FOR A CHAL; The Royal Society, 2020, FACE MASKS AND COVER; UK Government, 2020, GOVERNMENT PUBLISHES; UK Government, 2020, SENIOR CIVIL SERVANT; UK Government, 2020, CORONAVIRUS COVID 19; Vegvari C, 2020, GITHUB; Zhang YJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103705; Zheng J, 2018, CURR OPIN VIROL, V28, P43, DOI 10.1016/j.coviro.2017.11.002	26	36	37	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2020	396	10251					587	590		10.1016/S0140-6736(20)31689-5	http://dx.doi.org/10.1016/S0140-6736(20)31689-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OC4NF	32758428	Bronze, Green Published			2022-12-28	WOS:000579134100005
J	Mehta, A; Sperling, LS; Wells, BJ				Mehta, Anurag; Sperling, Laurence S.; Wells, Bryan J.			Postexercise Ankle-Brachial Index Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mehta, Anurag; Sperling, Laurence S.; Wells, Bryan J.] Emory Univ, Sch Med, Dept Med, Div Cardiol, 550 W Peachtree St NW,Sixth Floor, Atlanta, GA 30308 USA	Emory University	Wells, BJ (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, 550 W Peachtree St NW,Sixth Floor, Atlanta, GA 30308 USA.	bjwells@emory.edu						Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; [Anonymous], 2019, PHYS FEE SCHED SEARC; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE686, DOI 10.1161/CIR.0000000000000470; Hammad TA, 2015, JACC-CARDIOVASC INTE, V8, P1238, DOI 10.1016/j.jcin.2015.04.021; Loscalzo J., 2019, VASCULAR MED COMPANI, V3rd ed.; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; McPhail IR, 2001, J AM COLL CARDIOL, V37, P1381, DOI 10.1016/S0735-1097(01)01120-2; OURIEL K, 1982, SURGERY, V91, P686; Stein R, 2006, VASC MED, V11, P29, DOI 10.1191/1358863x06vm663oa; van Langen H, 2009, VASC MED, V14, P221, DOI 10.1177/1358863X08101017	10	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					796	797		10.1001/jama.2020.10164	http://dx.doi.org/10.1001/jama.2020.10164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32777001				2022-12-28	WOS:000568230000026
J	Lewis, D				Lewis, Dyani			Australia is cracking down on foreign interference in research. Is the system working?	NATURE			English	News Item						Institutions; Policy; Government		Pioneering guidelines aren't enough to prevent overseas militaries such as China's from co-opting the country's science, say some experts. Credit: Kevin Frayer/Getty Pioneering guidelines aren't enough to prevent overseas militaries such as China's from co-opting the country's science, say some experts.											0	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					178	179		10.1038/d41586-020-02188-6	http://dx.doi.org/10.1038/d41586-020-02188-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ0LC	32778707	Bronze			2022-12-28	WOS:000558814100008
J	Choi, CQ				Choi, Charles Q.			ASTRONOMY TAKES TO THE CLOUD	NATURE			English	Editorial Material						Astronomy and astrophysics; Astronomical instrumentation; Databases; Research data													0	0	0	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					159	160		10.1038/d41586-020-02284-7	http://dx.doi.org/10.1038/d41586-020-02284-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU9MN	32747778				2022-12-28	WOS:000555989500006
J	Villanueva, CJ				Villanueva, Claudio J.			Previews Finding a Needle in a Haystack: Identification of a Beige Fat Progenitor	CELL			English	Editorial Material							BROWN ADIPOSE-TISSUE; ADIPOCYTES; CELL	Oguri and colleagues use single-cell RNA sequencing to identify a beige adipocyte precursor cell that gives rise to thermogenic adipocytes in subcutaneous adipose tissue. These beige fat progenitors are marked by PDGFR alpha, Sca1, and CD81 and proliferate upon activation of FAK-signaling in response to the cold and irisin.	[Villanueva, Claudio J.] Univ Calif Los Angeles, David Geffen Sch Med, Mol Biol Inst, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Villanueva, CJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Mol Biol Inst, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	cvillanueva@ucla.edu			National Institutes of Health [R01DK103930]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.J.V. acknowledges support from the National Institutes of Health through funding of R01DK103930.	BOUILLAUD F, 1985, P NATL ACAD SCI USA, V82, P445, DOI 10.1073/pnas.82.2.445; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Oguri Y, 2020, CELL, V182, P563, DOI 10.1016/j.cell.2020.06.021; Pearson S, 2019, GENE DEV, V33, P747, DOI 10.1101/gad.321059.118; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	10	2	2	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					537	539		10.1016/j.cell.2020.07.014	http://dx.doi.org/10.1016/j.cell.2020.07.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32763184	Bronze			2022-12-28	WOS:000558649000002
J	Young, S; Chen, L; Palatnick, W; Wong, P; Wong, J				Young, Samantha; Chen, Luke; Palatnick, Wesley; Wong, Patrick; Wong, Justin			Led Astray	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEAD		[Young, Samantha] British Columbia Ctr Subst Use, 400-1045 Howe St, Vancouver, BC V6Z 2A9, Canada; [Young, Samantha] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Chen, Luke] Univ British Columbia, Div Hematol, Vancouver, BC, Canada; [Chen, Luke] Univ British Columbia, Ctr Hlth Educ Scholarship, Vancouver, BC, Canada; [Wong, Justin] Univ British Columbia, Div Crit Care, Vancouver, BC, Canada; [Palatnick, Wesley] Univ Manitoba, Dept Emergency Med, Winnipeg, MB, Canada; [Wong, Justin] Univ Manitoba, Dept Internal Med, Sect Crit Care, Winnipeg, MB, Canada; [Wong, Patrick] Richmond Gen Hosp, Dept Pathol & Lab Med, Richmond, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Manitoba; University of Manitoba	Young, S (corresponding author), British Columbia Ctr Subst Use, 400-1045 Howe St, Vancouver, BC V6Z 2A9, Canada.	samantha.young@alumni.ubc.ca	Chen, Luke Yu Chung/I-6027-2019	Chen, Luke Yu Chung/0000-0002-9551-2951; Young, Samantha/0000-0002-4064-0884				Abadin H, 2007, TOXICOLOGICAL PROFIL; Aghaee-Afshar Mahmoud, 2008, Arch Iran Med, V11, P553; [Anonymous], 2016, THE TOTAL AUDIENCE R; Fralick M, 2016, CAN MED ASSOC J, V188, pE521, DOI 10.1503/cmaj.160182; Ghane T, 2018, B WORLD HEALTH ORGAN, V96, P165, DOI 10.2471/BLT.17.196287; Gidlow DA, 2015, OCCUP MED-OXFORD, V65, P348, DOI 10.1093/occmed/kqv018; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Helmich F, 2018, NEW ENGL J MED, V379, pE35, DOI 10.1056/NEJMicm1801693; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; Law S, 2019, EMERG MED AUSTRALAS, V31, P144, DOI 10.1111/1742-6723.13224; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Shih RA, 2007, ENVIRON HEALTH PERSP, V115, P483, DOI 10.1289/ehp.9786; United Nations Office on Drugs and Crime, 2018, WORLD DRUG REPORT 20; Zamani N, 2018, NEW ENGL J MED, V379, P1861, DOI 10.1056/NEJMicm1807901	15	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					578	583		10.1056/NEJMcps1900799	http://dx.doi.org/10.1056/NEJMcps1900799			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32757528				2022-12-28	WOS:000560438400021
J	Hornberg, H; Perez-Garci, E; Schreiner, D; Hatstatt-Burkle, L; Magara, F; Baudouin, S; Matter, A; Nacro, K; Pecho-Vrieseling, E; Scheiffele, P				Hornberg, Hanna; Perez-Garci, Enrique; Schreiner, Dietmar; Hatstatt-Burkle, Laetitia; Magara, Fulvio; Baudouin, Stephane; Matter, Alex; Nacro, Kassoum; Pecho-Vrieseling, Eline; Scheiffele, Peter			Rescue of oxytocin response and social behaviour in a mouse model of autism	NATURE			English	Article							NEUROLIGIN-3; PROTEIN; TRANSLATION; MICE; PATHOPHYSIOLOGY; RECOGNITION; MODULATION; ACCURACY; DYNAMICS; DEFICITS	A fundamental challenge in developing treatments for autism spectrum disorders is the heterogeneity of the condition. More than one hundred genetic mutations confer high risk for autism, with each individual mutation accounting for only a small fraction of cases(1-3). Subsets of risk genes can be grouped into functionally related pathways, most prominently those involving synaptic proteins, translational regulation, and chromatin modifications. To attempt to minimize this genetic complexity, recent therapeutic strategies have focused on the neuropeptides oxytocin and vasopressin(4-6), which regulate aspects of social behaviour in mammals(7). However, it is unclear whether genetic risk factors predispose individuals to autism as a result of modifications to oxytocinergic signalling. Here we report that an autism-associated mutation in the synaptic adhesion moleculeNlgn3results in impaired oxytocin signalling in dopaminergic neurons and in altered behavioural responses to social novelty tests in mice. Notably, loss ofNlgn3is accompanied by a disruption of translation homeostasis in the ventral tegmental area. Treatment ofNlgn3-knockout mice with a new, highly specific, brain-penetrant inhibitor of MAP kinase-interacting kinases resets the translation of mRNA and restores oxytocin signalling and social novelty responses. Thus, this work identifies a convergence between the genetic autism risk factorNlgn3, regulation of translation, and oxytocinergic signalling. Focusing on such common core plasticity elements might provide a pragmatic approach to overcoming the heterogeneity of autism. Ultimately, this would enable mechanism-based stratification of patient populations to increase the success of therapeutic interventions. An autism-associated mutation inNlgn3results in impaired oxytocin signalling in dopaminergic neurons and altered social behavioural responses in mice, and treatment with an inhibitor of MAP kinase-interacting kinases rescues these phenotypes.	[Hornberg, Hanna; Schreiner, Dietmar; Hatstatt-Burkle, Laetitia; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland; [Perez-Garci, Enrique; Pecho-Vrieseling, Eline] Univ Basel, Dept Biomed, Basel, Switzerland; [Magara, Fulvio] Lausanne Univ Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Baudouin, Stephane] Cardiff Univ, Sch Biosci, Neurosci Div, Cardiff, Wales; [Matter, Alex; Nacro, Kassoum] Expt Drug Dev Ctr, Singapore, Singapore; [Baudouin, Stephane] Stalicla, Geneva, Switzerland	University of Basel; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Cardiff University; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC)	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	peter.scheiffele@unibas.ch		Nacro, Kassoum/0000-0002-3291-0215; Scheiffele, Peter/0000-0002-9516-9399; Hornberg, Hanna/0000-0001-9142-1932; Pecho-Vrieseling, Eline/0000-0001-6712-775X	Long-term Fellowship from the Human Frontiers Science Program; Swiss National Science Foundation; European Research Council; EU-AIMS; Innovative Medicines Initiatives from the European Commission; Innovative Medicines Initiative 2 Joint Undertaking [777394]; European Union; EFPIA; AUTISM SPEAKS; Autistica; SFARI; NCCR SYNAPSY; Biomedical Sciences Institutes (BMSI); Joint Council Office (JCO), Agency for Science, Technology and Research (A*STAR), Singapore [11 03 FG 07 05]	Long-term Fellowship from the Human Frontiers Science Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); EU-AIMS; Innovative Medicines Initiatives from the European Commission; Innovative Medicines Initiative 2 Joint Undertaking; European Union(European Commission); EFPIA; AUTISM SPEAKS; Autistica(Autistica); SFARI; NCCR SYNAPSY; Biomedical Sciences Institutes (BMSI); Joint Council Office (JCO), Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	We are grateful to A. Gomez, K. Tan, L. Traunmuller and F. Filice for comments on the manuscript and to members of the Scheiffele laboratory for discussions. We thank B. Boury Jamot for performing tests on Fmr1KO mice, F. Filice for experimental support, and A. Schmidt and the Biozentrum Proteomics Core Facility for conducting proteomics analysis. Funding: H.H. was supported by a Long-term Fellowship from the Human Frontiers Science Program. This work was supported by funds to P.S. from the Swiss National Science Foundation, a European Research Council Advanced Grant (SPLICECODE), EU-AIMS and AIMS-2-TRIALS which are supported by the Innovative Medicines Initiatives from the European Commission. The results leading to this publication has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777394. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The Scheiffele Laboratory is an associate member of the Swiss National Science Foundation's National Competence Centre for Research (NCCR) RNA and Disease. F.M. was supported by NCCR SYNAPSY. Discovery of ETC-168 was financially supported by Biomedical Sciences Institutes (BMSI) and Joint Council Office (JCO Project 11 03 FG 07 05), Agency for Science, Technology and Research (A*STAR), Singapore.	Ahrne E, 2016, J PROTEOME RES, V15, P2537, DOI 10.1021/acs.jproteome.6b00066; Asiminas A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aao0498; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAKKER CE, 1994, CELL, V78, P23; Bariselli S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05382-3; Barnes SA, 2015, J NEUROSCI, V35, P15073, DOI 10.1523/JNEUROSCI.1087-15.2015; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bolognani F, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat7838; Bowling H, 2016, NEUROPHARMACOLOGY, V100, P76, DOI 10.1016/j.neuropharm.2015.07.017; Bramham CR, 2016, TRENDS BIOCHEM SCI, V41, P847, DOI 10.1016/j.tibs.2016.07.008; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Cao W, 2018, NEURON, V97, P1253, DOI 10.1016/j.neuron.2018.02.001; Cataldo I, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00027; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; DiBenedictis BT, 2017, J COMP NEUROL, V525, P2549, DOI 10.1002/cne.24216; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gkogkas CG, 2014, CELL REP, V9, P1742, DOI 10.1016/j.celrep.2014.10.064; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hung LW, 2017, SCIENCE, V357, P1406, DOI 10.1126/science.aan4994; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jaramillo TC, 2018, AUTISM RES, V11, P234, DOI 10.1002/aur.1857; Lavallee-Adam M, 2014, J PROTEOME RES, V13, P5496, DOI 10.1021/pr500473n; McPartland JC, 2011, J AUTISM DEV DISORD, V41, P148, DOI 10.1007/s10803-010-1033-8; Mitre Mariela, 2018, Curr Top Behav Neurosci, V35, P31, DOI 10.1007/7854_2017_7; Modi B, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00513; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oettl LL, 2016, NEURON, V90, P609, DOI 10.1016/j.neuron.2016.03.033; Parker KJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau7356; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Richter JD, 2015, NAT REV NEUROSCI, V16, P595, DOI 10.1038/nrn4001; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sgritta M, 2019, NEURON, V101, P246, DOI 10.1016/j.neuron.2018.11.018; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Tom Dieck Susanne, 2012, Curr Protoc Cell Biol, VChapter 7, DOI 10.1002/0471143030.cb0711s56; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walum H, 2018, NAT REV NEUROSCI, V19, P643, DOI 10.1038/s41583-018-0072-6; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Xiao L, 2017, NEURON, V95, P368, DOI 10.1016/j.neuron.2017.06.003; Xu J, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00518; Xu YC, 2019, NAT MED, V25, P301, DOI 10.1038/s41591-018-0321-2; Yamasue H, 2019, CURR OPIN NEUROL, V32, P635, DOI 10.1097/WCO.0000000000000703; Yang H, 2018, J MED CHEM, V61, P4348, DOI 10.1021/acs.jmedchem.7b01714	63	46	48	4	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					252	+		10.1038/s41586-020-2563-7	http://dx.doi.org/10.1038/s41586-020-2563-7		AUG 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA5BI	32760004	Green Accepted, Green Published			2022-12-28	WOS:000556239400003
J	Schneider, EC				Schneider, Eric C.			Health Care as an Ongoing Policy Project	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The United States lags behind peer countries on key health outcomes, and the pandemic has highlighted weaknesses of U.S. health care. Though Americans have long struggled to bring about a high-performing, affordable health care system, additional reforms are needed.	[Schneider, Eric C.] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Schneider, EC (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Anderson GF, 2019, HEALTH AFFAIR, V38, P87, DOI 10.1377/hlthaff.2018.05144; [Anonymous], NAT HEALTHC QUAL DIS; Churchill Winston, 1939, RUSSIAN ENIGMA; Tikkanen RS, 2020, NEW ENGL J MED, V382, P885, DOI 10.1056/NEJMp1916585; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]	5	4	4	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					405	408		10.1056/NEJMp2021701	http://dx.doi.org/10.1056/NEJMp2021701			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32726525				2022-12-28	WOS:000556861800006
J	Mahase, E				Mahase, Elisabeth			Covid-19: Researchers investigating links with ethnicity receive 4.3m pound in funding	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2020	370								m3009	10.1136/bmj.m3009	http://dx.doi.org/10.1136/bmj.m3009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LD	32727715	Bronze			2022-12-28	WOS:000554456000005
J	Fandler-Hofler, S; Enzinger, C; Gattringer, T				Fandler-Hoefler, Simon; Enzinger, Christian; Gattringer, Thomas			Speechless from pain: migraine with prolonged aura	LANCET			English	Editorial Material									[Fandler-Hoefler, Simon; Enzinger, Christian; Gattringer, Thomas] Med Univ Graz, Dept Neurol, A-8036 Graz, Austria; [Enzinger, Christian; Gattringer, Thomas] Med Univ Graz, Div Neuroradiol Vasc & Intervent Radiol, Dept Radiol, Graz, Austria	Medical University of Graz; Medical University of Graz	Fandler-Hofler, S (corresponding author), Med Univ Graz, Dept Neurol, A-8036 Graz, Austria.	simon.fandler@medunigraz.at	Fandler-Höfler, Simon/AAL-9956-2020	Fandler-Höfler, Simon/0000-0001-9043-0378					0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					E11	E11		10.1016/S0140-6736(20)31551-8	http://dx.doi.org/10.1016/S0140-6736(20)31551-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711804				2022-12-28	WOS:000567020100003
J	Simpson, EL; Sinclair, R; Forman, S; Wollenberg, A; Aschoff, R; Cork, M; Bieber, T; Thyssen, JP; Yosipovitch, G; Flohr, C; Magnolo, N; Maari, C; Feeney, C; Biswas, P; Tatulych, S; Valdez, H; Rojo, R				Simpson, Eric L.; Sinclair, Rodney; Forman, Seth; Wollenberg, Andreas; Aschoff, Roland; Cork, Michael; Bieber, Thomas; Thyssen, Jacob P.; Yosipovitch, Gil; Flohr, Carsten; Magnolo, Nina; Maari, Catherine; Feeney, Claire; Biswas, Pinaki; Tatulych, Svitlana; Valdez, Hernan; Rojo, Ricardo			Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial	LANCET			English	Article							INITIAL VALIDATION; ECZEMA; INDEX; PATIENT; PREVALENCE; GUIDELINES; MECHANISMS; ASTHMA	Background Abrocitinib, an oral selective Janus kinase 1 inhibitor, was effective and well tolerated in adults with moderate-to-severe atopic dermatitis in a phase 2b trial. We aimed to assess the efficacy and safety of abrocitinib monotherapy in adolescents and adults with moderate-to-severe atopic dermatitis. Methods In this multicentre, double-blind, randomised phase 3 trial (JADE MONO-1), patients (aged >= 12 years) with moderate-to-severe atopic dermatitis (Investigator Global Assessment score >= 3, Eczema Area and Severity Index [EASI] score >= 16, percentage of body surface area affected >= 10%, and Peak Pruritus Numerical Rating Scale score >= 4) with a bodyweight of 40 kg or more, were enrolled at 69 sites in Australia, Canada, Europe, and the USA. Patients were randomly assigned (2:2:1) to oral abrocitinib 100 mg, abrocitinib 200 mg, or placebo once daily for 12 weeks. Randomisation was done using an interactive response technology system, stratified by baseline disease severity and age. Patients, investigators, and the funder of the study were masked to study treatment. The coprimary endpoints were the proportion of patients who had achieved an Investigator Global Assessment response (score of 0 [clear] or 1 [almost clear] with a >= 2-grade improvement from baseline), and the proportion of patients who achieved at least a 75% improvement in EASI score from baseline (EASI-75) score, both assessed at week 12. Efficacy was assessed in the full analysis set, which included all randomised patients who received at least one dose of study medication. Safety was assessed in all randomised patients. This study is registered with ClinicalTrials.gov, NCT03349060. Findings Between Dec 7, 2017, and March 26, 2019, 387 patients were enrolled: 156 were assigned to abrocitinib 100 mg, 154 to abrocitinib 200 mg, and 77 to placebo. All enrolled patients received at least one dose of study treatment and thus were evaluable for 12-week efficacy. Of the patients with available data for the coprimary endpoints at week 12, the proportion of patients who had achieved an Investigator Global Assessment response was significantly higher in the abrocitinib 100 mg group than in the placebo group (37 [24%] of 156 patients vs six [8%] of 76 patients; p=0.0037) and in the abrocitinib 200 mg group compared with the placebo group (67 [44%] of 153 patients vs six [8%] of 76 patients; p<0.0001). Of the patients with available data for the coprimary endpoints at week 12, compared with the placebo group, the proportion of patients who had achieved an EASI-75 response was significantly higher in the abrocitinib 100 mg group (62 [40%] of 156 patients vs nine [12%] of 76 patients; p<0.0001) and abrocitinib 200 mg group (96 [63%] of 153 patients vs nine [12%] of 76 patients; p<0.0001). Adverse events were reported in 108 (69%) of 156 patients in the abrocitinib 100 mg group, 120 (78%) of 154 patients in the abrocitinib 200 mg group, and 44 (57%) of 77 patients in the placebo group. Serious adverse events were reported in five (3%) of 156 patients in the abrocitinib 100 mg group, five (3%) of 154 patients in the abrocitinib 200 mg group, and three (4%) of 77 patients in the placebo group. No treatment-related deaths were reported. Interpretation Monotherapy with oral abrocitinib once daily was effective and well tolerated in adolescents and adults with moderate-to-severe atopic dermatitis. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Sinclair, Rodney] Sinclair Dermatol, Melbourne, Vic, Australia; [Forman, Seth] ForCare Clin Res, Tampa, FL USA; [Wollenberg, Andreas] Ludwig Maximilian Univ Munich, Dept Dermatol, Munich, Germany; [Aschoff, Roland] Univ Hosp Carl Gustav Carus, Dresden, Germany; [Cork, Michael] Univ Sheffield, Sheffield Dermatol Res, Dept Infect Immun & Cardiovasc Dis, Sheffield Childrens Hosp,Sheffield Teaching Hosp, Sheffield, S Yorkshire, England; [Bieber, Thomas] Univ Bonn, Dept Dermatol & Allergy, Univ Hosp, Bonn, Germany; [Thyssen, Jacob P.] Univ Copenhagen, Dept Dermatol & Allergy, Herlev Gentofte Hosp, Copenhagen, Denmark; [Yosipovitch, Gil] Univ Miami, Miller Sch Med, Miami Itch Ctr, Miami, FL 33136 USA; [Flohr, Carsten] Kings Coll London, Unit Populat Based Dermatol Res, St Johns Inst Dermatol, Guys & St Thomas NHS Fdn Trust, London, England; [Magnolo, Nina] Univ Hosp Munster, Munster, Germany; [Maari, Catherine] Innovaderm Res, Montreal, PQ, Canada; [Maari, Catherine] Univ Montreal Hosp Ctr, Montreal, PQ, Canada; [Feeney, Claire] Pfizer UK, Tadworth, Surrey, England; [Biswas, Pinaki; Valdez, Hernan] Pfizer, New York, NY USA; [Tatulych, Svitlana; Rojo, Ricardo] Pfizer, Groton, CT 06340 USA	Oregon Health & Science University; University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Bonn; University of Copenhagen; University of Miami; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Munster; Innovaderm Research Inc.; Universite de Montreal; Pfizer; Pfizer; Pfizer	Rojo, R (corresponding author), Pfizer, Groton, CT 06340 USA.	ricardo.rojo@pfizer.com	Thyssen, Jacob/ABD-8517-2020	Cork, Michael/0000-0003-4428-2428; Sinclair, Rodney/0000-0001-6751-1428	Pfizer; Lundbeck Foundation [R139-2012-12679] Funding Source: researchfish	Pfizer(Pfizer); Lundbeck Foundation(Lundbeckfonden)	Pfizer.	Akinlade B, 2019, BRIT J DERMATOL, V181, P459, DOI 10.1111/bjd.17869; Babon JJ, 2014, BIOCHEM J, V462, P1, DOI 10.1042/BJ20140712; Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137; Carroll CL, 2005, PEDIATR DERMATOL, V22, P192, DOI 10.1111/j.1525-1470.2005.22303.x; Center for Drug Evaluation and Research, 2017, CROSS DISC TEAM LEAD; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Colombel JF, 2018, INFLAMM BOWEL DIS, V24, P2173, DOI 10.1093/ibd/izy150; de Bruin-Weller M, 2018, BRIT J DERMATOL, V178, P1083, DOI 10.1111/bjd.16156; Dupixent, 2018, HIGHL PRESCR INF; Dupixent, 2017, ANN 1 SUMM PROD CHAR; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Fabbrocini G, 2018, DERMATOLOGY THER, V8, P527, DOI 10.1007/s13555-018-0258-x; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Gooderham MJ, 2019, JAMA DERMATOL, V155, P1371, DOI 10.1001/jamadermatol.2019.2855; Grozovsky R, 2015, CURR OPIN HEMATOL, V22, P445, DOI 10.1097/MOH.0000000000000170; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hendricks AJ, 2019, AM J CLIN DERMATOL, V20, P565, DOI 10.1007/s40257-019-00436-8; Lebwohl MG, 2018, G RAJK INT S AT DERM; LEWISJONES MS, 1995, BRIT J DERMATOL, V132, P942; Mollanazar NK, 2016, CLIN REV ALLERG IMMU, V51, P263, DOI 10.1007/s12016-015-8488-5; Ronnstad ATM, 2018, J AM ACAD DERMATOL, V79, P448, DOI 10.1016/j.jaad.2018.03.017; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P657, DOI 10.1111/jdv.14891; Xu YH, 2018, AM HEALTH DRUG BENEF, V11, P408; Yosipovitch G, 2019, BRIT J DERMATOL, V181, P761, DOI 10.1111/bjd.17744	31	128	131	4	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					255	266						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK8ZY	32711801	Green Accepted			2022-12-28	WOS:000567020100034
J	Walker, MA; Lareau, CA; Ludwig, LS; Karaa, A; Sankaran, VG; Regev, A; Mootha, VK				Walker, Melissa A.; Lareau, Caleb A.; Ludwig, Leif S.; Karaa, Amel; Sankaran, Vijay G.; Regev, Aviv; Mootha, Vamsi K.			Purifying Selection against Pathogenic Mitochondrial DNA in Human T Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-CELL; COMPLEX-I; MUTATION; MTDNA; MELAS; SEGREGATION; ENCEPHALOMYOPATHY; HETEROPLASMY; PHENOTYPE; FEATURES	Many mitochondrial diseases are caused by mutations in mitochondrial DNA (mtDNA). Patients' cells contain a mixture of mutant and nonmutant mtDNA (a phenomenon called heteroplasmy). The proportion of mutant mtDNA varies across patients and among tissues within a patient. We simultaneously assayed single-cell heteroplasmy and cell state in thousands of blood cells obtained from three unrelated patients who had A3243G-associated mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes. We observed a broad range of heteroplasmy across all cell types but also found markedly reduced heteroplasmy in T cells, a finding consistent with purifying selection within this lineage. We observed this pattern in six additional patients who had heteroplasmic A3243G without strokelike episodes. (Funded by the Marriott Foundation and others.) Most mitochondrial diseases are caused by mutations in mitochondrial DNA. A new type of genomic analysis provides evidence of selection against mutant mitochondria DNA in human T cells.	[Walker, Melissa A.; Mootha, Vamsi K.] Harvard Med Sch, Dept Mol Biol, Boston, MA 02115 USA; [Walker, Melissa A.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Karaa, Amel] Harvard Med Sch, Dept Pediat, Genet Unit, Boston, MA 02115 USA; [Walker, Melissa A.; Regev, Aviv; Mootha, Vamsi K.] Harvard Med Sch, Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lareau, Caleb A.; Ludwig, Leif S.; Sankaran, Vijay G.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, 1 Blackfan Cir,Karp 7211, Boston, MA 02115 USA; [Lareau, Caleb A.; Ludwig, Leif S.; Sankaran, Vijay G.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Walker, Melissa A.; Karaa, Amel] Harvard Med Sch, Boston, MA 02115 USA; [Ludwig, Leif S.; Regev, Aviv] MIT, Klarman Cell Observ, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Walker, Melissa A.; Lareau, Caleb A.; Sankaran, Vijay G.; Mootha, Vamsi K.] MIT, Broad Inst MIT & Harvard, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sankaran, Vijay G.] MIT, Harvard Stem Cell Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Regev, Aviv] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sankaran, VG (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, 1 Blackfan Cir,Karp 7211, Boston, MA 02115 USA.; Regev, A (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, 185 Cambridge St,6th Fl, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Med, 185 Cambridge St,6th Fl, Boston, MA 02114 USA.	sankaran@broadinstitute.org; vamsi@hms.harvard.edu	Lareau, Caleb/ABF-9490-2020; Ludwig, Leif S./A-1913-2015	Lareau, Caleb/0000-0003-4179-4807; Ludwig, Leif S./0000-0002-2916-2164; Mootha, Vamsi/0000-0001-9924-642X	Marriott Foundation; MacCurtain Family, the Tosteson Fund for Medical Discovery, the Massachusetts General Hospital Department of Neurology; New York Stem Cell Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Klarman Cell Observatory; National Human Genome Research Institute Center of Excellence in Genome Science; National Center for Advancing Translational Sciences (National Institutes of Health) [UL 1TR002541]	Marriott Foundation; MacCurtain Family, the Tosteson Fund for Medical Discovery, the Massachusetts General Hospital Department of Neurology; New York Stem Cell Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; National Human Genome Research Institute Center of Excellence in Genome Science; National Center for Advancing Translational Sciences (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by the Marriott Foundation (to Dr. Mootha), the MacCurtain Family, the Tosteson Fund for Medical Discovery, the Massachusetts General Hospital Department of Neurology (to Dr. Walker), the New York Stem Cell Foundation (to Dr. Sankaran), the National Institute of Diabetes and Digestive and Kidney Diseases and National Institutes of Health (to Dr. Sankaran), the Klarman Cell Observatory (to Dr. Regev), the National Human Genome Research Institute Center of Excellence in Genome Science (to Dr. Regev), and the National Center for Advancing Translational Sciences (National Institutes of Health Award, UL 1TR002541). Dr. Sankaran is a New York Stem Cell Foundation Robertson Investigator, and Drs. Regev and Mootha are Investigators of the Howard Hughes Medical Institute.	[Anonymous], 2010, NEPHROL THER, V6, pS27; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cabon L, 2018, CELL DEATH DIFFER, V25, P983, DOI 10.1038/s41418-017-0035-x; de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176; Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824; Gigarel N, 2005, MOL GENET METAB, V84, P289, DOI 10.1016/j.ymgme.2004.10.008; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262; Granja JM, 2019, NAT BIOTECHNOL, V37, P1458, DOI 10.1038/s41587-019-0332-7; Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099; HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526; Lareau CA, NAT BIOTECHNOL; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Ludwig LS, 2019, CELL REP, V27, P3228, DOI 10.1016/j.celrep.2019.05.046; Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022; Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z; Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703; NISHIZAWA M, 1987, J NEUROL SCI, V78, P189, DOI 10.1016/0022-510X(87)90060-8; Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532; Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; Ramstead AG, 2020, CELL REP, V30, P2889, DOI 10.1016/j.celrep.2020.02.042; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Simula L, 2018, CELL REP, V25, P3059, DOI 10.1016/j.celrep.2018.11.018; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; TANAKA M, 1987, J INHERIT METAB DIS, V10, P284, DOI 10.1007/BF01800083; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; Ulirsch JC, 2019, NAT GENET, V51, P683, DOI 10.1038/s41588-019-0362-6	40	25	25	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2020	383	16					1556	1563		10.1056/NEJMoa2001265	http://dx.doi.org/10.1056/NEJMoa2001265			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OE4ES	32786181	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000580486200012
J	Figueroa, JF; Wadhera, RK; Papanicolas, I; Riley, K; Zheng, J; Orav, EJ; Jha, AK				Figueroa, Jose F.; Wadhera, Rishi K.; Papanicolas, Irene; Riley, Kristen; Zheng, Jie; Orav, E. John; Jha, Ashish K.			Association of Nursing Home Ratings on Health Inspections, Quality of Care, and Nurse Staffing With COVID-19 Cases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Figueroa, Jose F.; Riley, Kristen; Zheng, Jie; Orav, E. John; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge Room 413, Boston, MA 02115 USA; [Wadhera, Rishi K.] Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res, Boston, MA 02215 USA; [Papanicolas, Irene] London Sch Econ, Dept Social & Hlth Policy, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; University of London; London School Economics & Political Science	Figueroa, JF (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge Room 413, Boston, MA 02115 USA.	jfigueroa@hsph.harvard.edu						Abbasi J, 2020, JAMA-J AM MED ASSOC, V324, P123, DOI 10.1001/jama.2020.10419; Centers for Medicare & Medicaid Services, DESIGN NURSING HOME; Chidambaram P., STATE REPORTING CASE; Davidson PM, 2020, J CLIN NURS, V29, P2758, DOI 10.1111/jocn.15297; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V324, P23, DOI 10.1001/jama.2020.8524; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V323, P2007, DOI 10.1001/jama.2020.4686	6	40	40	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2020	324	11					1103	1105		10.1001/jama.2020.14709	http://dx.doi.org/10.1001/jama.2020.14709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OF2XM	32790822	Green Published, Bronze			2022-12-28	WOS:000581077300025
J	Rodgers, GP; Collins, FS				Rodgers, Griffin P.; Collins, Francis S.			Precision Nutrition-the Answer to "What to Eat to Stay Healthy"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rodgers, Griffin P.; Collins, Francis S.] NIH, One Ctr Dr,Bldg 1,Room 126, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, One Ctr Dr,Bldg 1,Room 126, Bethesda, MD 20892 USA.	collinsf@od.nih.gov						Centers for Disease Control and Prevention, HLTH EC COSTS CHRON; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Shan ZL, 2019, JAMA-J AM MED ASSOC, V322, P1178, DOI 10.1001/jama.2019.13771; US Department of Health & Human Services; National Institutes of Health, 2020, 2020 2030 STRAT PLAN	4	71	76	8	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					735	736		10.1001/jama.2020.13601	http://dx.doi.org/10.1001/jama.2020.13601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32766768				2022-12-28	WOS:000568230000013
J	Molgora, M; Esaulova, E; Vermi, W; Hou, JC; Chen, Y; Luo, JQ; Brioschi, S; Bugatti, M; Omodei, AS; Ricci, B; Fronick, C; Panda, SK; Takeuchi, Y; Gubin, MM; Faccio, R; Cella, M; Gilfillan, S; Unanue, ER; Artyomov, MN; Schreiber, RD; Colonna, M				Molgora, Martina; Esaulova, Ekaterina; Vermi, William; Hou, Jinchao; Chen, Yun; Luo, Jingqin; Brioschi, Simone; Bugatti, Mattia; Omodei, Andrea Salvatore; Ricci, Biancamaria; Fronick, Catrina; Panda, Santosh K.; Takeuchi, Yoshiko; Gubin, Matthew M.; Faccio, Roberta; Cella, Marina; Gilfillan, Susan; Unanue, Emil R.; Artyomov, Maxim N.; Schreiber, Robert D.; Colonna, Marco			TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy	CELL			English	Article							IMMUNE CHECKPOINT BLOCKADE; MICROGLIAL RESPONSE; NITRIC-OXIDE; MACROPHAGES; CELLS; LYMPHOCYTES; ACTIVATION; EXPRESSION; RECEPTOR; DISEASE	Checkpoint immunotherapy unleashes T cell control of tumors, but is undermined by immunosuppressive myeloid cells. TREM2 is a myeloid receptor that transmits intracellular signals that sustain microglial responses during Alzheimer's disease. TREM2 is also expressed by tumor-infiltrating macrophages. Here, we found that Trem2(-/)(-) mice are more resistant to growth of various cancers than wild-type mice and are more responsive to anti-PD-1 immunotherapy. Furthermore, treatment with anti-TREM2 mAb curbed tumor growth and fostered regression when combined with anti-PD-1 scRNA-seq revealed that both TREM2 deletion and anti-TREM2 are associated with scant MRC1(+) and CX(3)CR1(+) macrophages in the tumor infiltrate, paralleled by expansion of myeloid subsets expressing immunostimulatory molecules that promote improved T cell responses. TREM2 was expressed in tumor macrophages in over 200 human cancer cases and inversely correlated with prolonged survival for two types of cancer. Thus, TREM2 might be targeted to modify tumor myeloid infiltrates and augment checkpoint immunotherapy.	[Molgora, Martina; Esaulova, Ekaterina; Vermi, William; Hou, Jinchao; Chen, Yun; Brioschi, Simone; Panda, Santosh K.; Takeuchi, Yoshiko; Cella, Marina; Gilfillan, Susan; Unanue, Emil R.; Artyomov, Maxim N.; Schreiber, Robert D.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Vermi, William; Bugatti, Mattia; Omodei, Andrea Salvatore] Univ Brescia, Dept Pathol, I-25123 Brescia, Italy; [Luo, Jingqin] Washington Univ, Siteman Canc Ctr, Sch Med, Div Publ Hlth Sci,Biostat Core, St Louis, MO 63110 USA; [Ricci, Biancamaria; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA; [Fronick, Catrina] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA; [Gubin, Matthew M.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Faccio, Roberta] Shriners Childrens Hosp St Louis, St Louis, MO 63110 USA; [Schreiber, Robert D.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	Washington University (WUSTL); University of Brescia; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu	Takeuchi, Yoshiko/ABA-5417-2020; Takeuchi, Yoshiko/GQP-2497-2022; Ricci, Biancamaria/AAT-9935-2021; Cella, Marina/ABA-8564-2020; Molgora, Martina/G-5591-2018	Takeuchi, Yoshiko/0000-0002-2637-7696; Gubin, Matthew/0000-0001-7443-2752; Schreiber, Robert/0000-0003-1590-2341; Omodei, Andrea Salvatore/0000-0002-4217-1698; Brioschi, Simone/0000-0002-3849-3926; Ricci, Biancamaria/0000-0003-1574-6043; Molgora, Martina/0000-0001-7328-2844; VERMI, WILLIAM/0000-0002-2291-2997; luo, jingqin/0000-0003-2759-3072	National Institutes of Health [R01 AR066551, R01 CA235096, RF1AG05148501, R21AG059176]; Cancer Research Institute-Lloyd J. Old Memorial Fellowship in Tumor Immunology; AIRC [IG23179]; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; CPRIT Scholar in Cancer Research Grant [RR190017]; National Cancer Institute of the National Institutes of Health [RO1CA190700]; Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Janssen Pharmaceutical Company of Johnson and Johnson; Prostate Cancer Foundation; Stand Up to Cancer-Lustgarten Foundation Pancreatic Cancer Foundation Convergence Dream Team translational research grant; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [AI114551, DK058177]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute-Lloyd J. Old Memorial Fellowship in Tumor Immunology; AIRC(Fondazione AIRC per la ricerca sul cancro); Parker Institute for Cancer Immunotherapy Bridge Scholar Award; CPRIT Scholar in Cancer Research Grant; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Janssen Pharmaceutical Company of Johnson and Johnson; Prostate Cancer Foundation; Stand Up to Cancer-Lustgarten Foundation Pancreatic Cancer Foundation Convergence Dream Team translational research grant; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the McDonnell Genome Institute at Washington University for sequencing, Ali Ellebedy, Aaron Schmitz, Daved Fremont, and Chris Nelson for advising in the generation of the recombinant antibody, David Holtzman for supporting antibody purification, and Erica Lantelme and the Flow Cytometry Core at Washington University for sorting. We also thank Wandy Beatty, director of the Molecular Microbiology Imaging Facility at Washington University, for valuable technical support. M. Colonna was supported by the National Institutes of Health (RF1AG05148501 and R21AG059176). M.M. is a recipient of the Cancer Research Institute-Lloyd J. Old Memorial Fellowship in Tumor Immunology. W.V. is supported by AIRC IG23179. R.F. was supported by grants from the National Institutes of Health (R01 AR066551 and R01 CA235096). M.M.G. was supported by a Parker Institute for Cancer Immunotherapy Bridge Scholar Award and a CPRIT Scholar in Cancer Research Grant (RR190017). R.D.S. was supported by grants from the National Cancer Institute of the National Institutes of Health (RO1CA190700), the Parker Institute for Cancer Immunotherapy, the Cancer Research Institute, Janssen Pharmaceutical Company of Johnson and Johnson, the Prostate Cancer Foundation, and a Stand Up to Cancer-Lustgarten Foundation Pancreatic Cancer Foundation Convergence Dream Team translational research grant. Stand Up to Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. E.R.U. received support from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (AI114551 and DK058177).	Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Arlauckas SP, 2018, THERANOSTICS, V8, P5842, DOI 10.7150/thno.26888; Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Broz ML, 2015, CANCER IMMUNOL RES, V3, P313, DOI 10.1158/2326-6066.CIR-15-0041; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Costa ML, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01357; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gubin MM, 2018, CELL, V175, P1443, DOI 10.1016/j.cell.2018.11.003; Harjunpaa H, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1445949; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; Hoves S, 2018, J EXP MED, V215, P859, DOI 10.1084/jem.20171440; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Iribarren C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25128-x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li XY, 2018, J CLIN INVEST, V128, P2613, DOI 10.1172/JCI98769; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Rashidian M, 2019, P NATL ACAD SCI USA, V116, P16971, DOI 10.1073/pnas.1905005116; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi FD, 2001, J IMMUNOL, V167, P3000, DOI 10.4049/jimmunol.167.5.3000; Song QQ, 2019, CANCER MED-US, V8, P3072, DOI 10.1002/cam4.2113; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Stadlbauer D, 2019, SCIENCE, V366, P499, DOI 10.1126/science.aay0678; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Su XM, 2016, CANCER RES, V76, P3484, DOI 10.1158/0008-5472.CAN-15-2663; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Veillette A, 2018, TRENDS IMMUNOL, V39, P173, DOI 10.1016/j.it.2017.12.005; Vermi W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4029; Wang ECE, 2019, CELL STEM CELL, V24, P654, DOI 10.1016/j.stem.2019.01.011; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wiehagen KR, 2017, CANCER IMMUNOL RES, V5, P1109, DOI 10.1158/2326-6066.CIR-17-0258; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Wu K, 2015, J EXP MED, V212, P681, DOI 10.1084/jem.20141732; Zhong L, 2017, J EXP MED, V214, P597, DOI 10.1084/jem.20160844	63	133	136	11	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					886	+		10.1016/j.cell.2020.07.013	http://dx.doi.org/10.1016/j.cell.2020.07.013			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32783918	Green Accepted, Bronze			2022-12-28	WOS:000561488500011
J	Chown, SL				Chown, Steven L.			Marine food webs destabilized	SCIENCE			English	Editorial Material									[Chown, Steven L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University	Chown, SL (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.	steven.chown@monash.edu	Chown, Steven/ABD-7646-2021					Hausfather Z, 2020, NATURE, V577, P618, DOI 10.1038/d41586-020-00177-3; Hicks CC, 2019, NATURE, V574, P95, DOI 10.1038/s41586-019-1592-6; Hindell MA, 2020, NATURE, V580, P87, DOI 10.1038/s41586-020-2126-y; Kroodsma DA, 2018, SCIENCE, V359, P904, DOI 10.1126/science.aao5646; Lotze HK, 2019, P NATL ACAD SCI USA, V116, P12907, DOI 10.1073/pnas.1900194116; Moore JK, 2018, SCIENCE, V359, P1139, DOI 10.1126/science.aao6379; Moss B, 2017, J EXP MAR BIOL ECOL, V492, P63, DOI 10.1016/j.jembe.2017.01.018; Nagelkerken I, 2020, SCIENCE, V369, P829, DOI 10.1126/science.aax0621; Pauly D, 2019, NATURE, V574, P41, DOI 10.1038/d41586-019-02810-2; Peck LS, 2018, OCEANOGR MAR BIOL, V56, P105; Stewart RIA, 2013, ADV ECOL RES, V48, P71, DOI 10.1016/B978-0-12-417199-2.00002-1; Watson RA, 2018, MAR POLICY, V93, P171, DOI 10.1016/j.marpol.2018.04.023	12	4	4	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					770	771		10.1126/science.abd5739	http://dx.doi.org/10.1126/science.abd5739			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA3RX	32792382				2022-12-28	WOS:000559731300018
J	Arezzo, F; Muzzupapa, G				Arezzo, Francesca; Muzzupapa, Giuseppe			Umbilical Cord Knot	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 36-year-old woman with a monochorionic, monoamniotic twin pregnancy underwent a cesarean section at 32 weeks of gestation. Complex knots in the umbilical cords were seen after delivery of twin girls.	[Arezzo, Francesca; Muzzupapa, Giuseppe] Univ Bari, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Arezzo, F (corresponding author), Univ Bari, Bari, Italy.	francescaarezzo@libero.it		Arezzo, Francesca/0000-0002-8914-9594					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					664	664		10.1056/NEJMicm1916811	http://dx.doi.org/10.1056/NEJMicm1916811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE7HD	32786191				2022-12-28	WOS:000562771200013
J	Khanna, S; Sengupta, T				Khanna, Sagar; Sengupta, Trina			Oral Metastasis of Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 60-year-old woman with colorectal cancer presented with a friable oral mass. A biopsy was performed, and a diagnosis of metastatic colorectal cancer was made.	[Khanna, Sagar] Mt Sinai Hlth Syst, New York, NY 10019 USA; [Sengupta, Trina] Jamaica Hosp Med Ctr, Jamaica, NY USA	Icahn School of Medicine at Mount Sinai	Khanna, S (corresponding author), Mt Sinai Hlth Syst, New York, NY 10019 USA.	docsagarkhanna@gmail.com							0	0	0	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7							e47	10.1056/NEJMicm1913118	http://dx.doi.org/10.1056/NEJMicm1913118			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE7HD	32786192				2022-12-28	WOS:000562771200003
J	Webb, E; Neeman, T; Bowden, FJ; Gaida, J; Mumford, V; Bissett, B				Webb, Elizabeth; Neeman, Teresa; Bowden, Francis J.; Gaida, Jamie; Mumford, Virginia; Bissett, Bernie			Compression Therapy to Prevent Recurrent Cellulitis of the Leg	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EDEMA; ERYSIPELAS; MANAGEMENT	Background Chronic edema of the leg is a risk factor for cellulitis. Daily use of compression garments on the leg has been recommended to prevent the recurrence of cellulitis, but there is limited evidence from trials regarding its effectiveness. Methods In this single-center, randomized, nonblinded trial, we assigned participants with chronic edema of the leg and recurrent cellulitis, in a 1:1 ratio, to receive leg compression therapy plus education on cellulitis prevention (compression group) or education alone (control group). Follow-up occurred every 6 months for up to 3 years or until 45 episodes of cellulitis had occurred in the trial. The primary outcome was the recurrence of cellulitis. Participants in the control group who had an episode of cellulitis crossed over to the compression group. Secondary outcomes included cellulitis-related hospital admission and quality-of-life assessments. Results A total of 183 patients were screened, and 84 were enrolled; 41 participants were assigned to the compression group, and 43 to the control group.At the time of a planned interim analysis, when 23 episodes of cellulitis had occurred, 6 participants (15%) in the compression group and 17 (40%) in the control group had had an episode of cellulitis (hazard ratio, 0.23; 95% confidence interval [CI], 0.09 to 0.59; P=0.002; relative risk [post hoc analysis], 0.37; 95% CI, 0.16 to 0.84; P=0.02), and the trial was stopped for efficacy.A total of 3 participants (7%) in the compression group and 6 (14%) in the control group were hospitalized for cellulitis (hazard ratio, 0.38; 95% CI, 0.09 to 1.59). Most quality-of-life outcomes did not differ between the two groups.No adverse events occurred during the trial. Conclusions In this small, single-center, nonblinded trial involving patients with chronic edema of the leg and cellulitis, compression therapy resulted in a lower incidence of recurrence of cellulitis than conservative treatment. (Funded by Calvary Public Hospital Bruce; Australian and New Zealand Clinical Trials Registry number,.) In a single-center, randomized, unblinded trial involving 84 participants with chronic edema of the leg and recurrent cellulitis, the incidences of cellulitis and hospitalizations among participants who received compression therapy were lower than those among participants who received only education about preventing cellulitis.	[Webb, Elizabeth] Calvary Publ Hosp Bruce, Physiotherapy Dept, 5 Mary Potter Cct, Bruce, ACT 2617, Australia; [Neeman, Teresa] Australian Natl Univ, Biol Data Sci Inst, Coll Sci, Canberra, ACT, Australia; [Neeman, Teresa] Australian Natl Univ, Biol Data Sci Inst, Coll Hlth, Canberra, ACT, Australia; [Neeman, Teresa] Australian Natl Univ, Biol Data Sci Inst, Coll Med, Canberra, ACT, Australia; [Bowden, Francis J.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Gaida, Jamie] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Webb, Elizabeth; Bissett, Bernie] Univ Canberra, Fac Hlth, Discipline Physiotherapy, Canberra, ACT, Australia; [Mumford, Virginia] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia	Australian National University; Australian National University; Australian National University; Australian National University; University of Canberra; University of Canberra; Macquarie University	Webb, E (corresponding author), Calvary Publ Hosp Bruce, Physiotherapy Dept, 5 Mary Potter Cct, Bruce, ACT 2617, Australia.	elizabeth.webb@calvary-act.com.au	Gaida, Jamie E/A-6062-2011; Mumford, Virginia/J-5267-2012	Gaida, Jamie E/0000-0002-4504-9188; Webb, Elizabeth/0000-0003-0602-4372; Mumford, Virginia/0000-0001-7915-0615	Calvary Public Hospital Bruce	Calvary Public Hospital Bruce	Supported by Calvary Public Hospital Bruce, which funded the clinician time to initiate and manage the trial.	Al-Niaimi F, 2009, J LYMPHOEDEMA, V4, P38; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2006, LYMPH FRAM TEMPL PRA; Arsenault K, 2011, REHABIL ONCOL, V29, P14, DOI 10.1097/01893697-201129030-00003; Australian Commission on Safety and Quality in Health Care, 2018, ANT STEW AUSTR HLTH; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; Chlebicki MP, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0422-0; Cox NH, 2006, BRIT J DERMATOL, V155, P947, DOI 10.1111/j.1365-2133.2006.07419.x; Cox NH, 1998, J ROY SOC MED, V91, P634, DOI 10.1177/014107689809101206; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; Elwell R, 2017, BR J NURS, V26, P468; Inghammar M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-270; Karppelin M, 2010, CLIN MICROBIOL INFEC, V16, P729, DOI 10.1111/j.1469-0691.2009.02906.x; Keeley V, 2010, J LYMPHOEDEMA, V5, P26; Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452; Ko LN, 2018, JAMA DERMATOL, V154, P529, DOI 10.1001/jamadermatol.2017.6196; Levell NJ, 2011, BRIT J DERMATOL, V164, P1326, DOI 10.1111/j.1365-2133.2011.10275.x; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Miteva M, 2010, DERMATOL THER, V23, P375, DOI 10.1111/j.1529-8019.2010.01338.x; Moffatt C, 2012, COMPRESSION THERAPY; Moffatt C, 2019, LYMPHAT RES BIOL, V17, P121, DOI 10.1089/lrb.2018.0085; Mortimer PS, 2004, CLIN MED, V4, P448, DOI 10.7861/clinmedicine.4-5-448; Nelson EA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002303.pub3; O'Meara S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000265.pub3; PAPPAS CJ, 1992, J VASC SURG, V16, P555, DOI 10.1016/0741-5214(92)90163-3; Pavlotsky Felix, 2004, J Dtsch Dermatol Ges, V2, P89, DOI 10.1046/j.1439-0353.2004.03028.x; R Core Team, 2020, R LANG ENV STAT COMP; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rathbun Suman W, 2007, Curr Treat Options Cardiovasc Med, V9, P115, DOI 10.1007/s11936-007-0005-6; Rich Anna, 2007, Br J Community Nurs, V12, pS6; Stephens M, 2018, CELL TISSUE RES, V371, P599, DOI 10.1007/s00441-017-2779-5; Swartz MN, 2004, NEW ENGL J MED, V350, P904, DOI 10.1056/NEJMcp031807; Thomas KS, 2017, BRIT J DERMATOL, V177, P541, DOI 10.1111/bjd.15634; Thomas KS, 2013, NEW ENGL J MED, V368, P1695, DOI 10.1056/NEJMoa1206300; Yasuhara H, 1996, INT ANGIOL, V15, P272	35	26	27	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					630	639		10.1056/NEJMoa1917197	http://dx.doi.org/10.1056/NEJMoa1917197			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32786188	Bronze			2022-12-28	WOS:000562771200010
J	Alarcon-Martinez, L; Villafranca-Baughman, D; Quintero, H; Kacerovsky, JB; Dotigny, F; Murai, KK; Prat, A; Drapeau, P; Di Polo, A				Alarcon-Martinez, Luis; Villafranca-Baughman, Deborah; Quintero, Heberto; Kacerovsky, J. Benjamin; Dotigny, Florence; Murai, Keith K.; Prat, Alexandre; Drapeau, Pierre; Di Polo, Adriana			Interpericyte tunnelling nanotubes regulate neurovascular coupling	NATURE			English	Article							CELLS; PERICYTES; CAPILLARIES; STRANDS; HEALTH	Signalling between cells of the neurovascular unit, or neurovascular coupling, is essential to match local blood flow with neuronal activity. Pericytes interact with endothelial cells and extend processes that wrap capillaries, covering up to 90% of their surface area(1,2). Pericytes are candidates to regulate microcirculatory blood flow because they are strategically positioned along capillaries, contain contractile proteins and respond rapidly to neuronal stimulation(3,4), but whether they synchronize microvascular dynamics and neurovascular coupling within a capillary network was unknown. Here we identify nanotube-like processes that connect two bona fide pericytes on separate capillary systems, forming a functional network in the mouse retina, which we named interpericyte tunnelling nanotubes (IP-TNTs). We provide evidence that these (i) have an open-ended proximal side and a closed-ended terminal (end-foot) that connects with distal pericyte processes via gap junctions, (ii) carry organelles including mitochondria, which can travel along these processes, and (iii) serve as a conduit for intercellular Ca(2+)waves, thus mediating communication between pericytes. Using two-photon microscope live imaging, we demonstrate that retinal pericytes rely on IP-TNTs to control local neurovascular coupling and coordinate light-evoked responses between adjacent capillaries. IP-TNT damage following ablation or ischaemia disrupts intercellular Ca2+ waves, impairing blood flow regulation and neurovascular coupling. Notably, pharmacological blockade of Ca(2+)influx preserves IP-TNTs, rescues light-evoked capillary responses and restores blood flow after reperfusion. Our study thus defines IP-TNTs and characterizes their critical role in regulating neurovascular coupling in the living retina under both physiological and pathological conditions. Retinal pericytes connect via interpericyte tunnelling nanotubes into functional syncytia that regulate microcirculatory blood flow to help to match local blood flow with neuronal activity.	[Alarcon-Martinez, Luis; Villafranca-Baughman, Deborah; Quintero, Heberto; Dotigny, Florence; Prat, Alexandre; Drapeau, Pierre; Di Polo, Adriana] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Alarcon-Martinez, Luis; Villafranca-Baughman, Deborah; Quintero, Heberto; Dotigny, Florence; Prat, Alexandre; Drapeau, Pierre; Di Polo, Adriana] Univ Montreal Hosp Res Ctr, Montreal, PQ, Canada; [Kacerovsky, J. Benjamin; Murai, Keith K.] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Ctr Res Neurosci,Dept Neurol & Neurosurg,Res Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Alarcon-Martinez, L; Di Polo, A (corresponding author), Univ Montreal, Dept Neurosci, Montreal, PQ, Canada.; Alarcon-Martinez, L; Di Polo, A (corresponding author), Univ Montreal Hosp Res Ctr, Montreal, PQ, Canada.	lalarcon@um.es; adriana.di.polo@umontreal.ca		Prat, Alexandre/0000-0001-6188-0580	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank T. Kennedy, N. Belforte, P. D'Onofrio, Y. Shiga, and R. Araya for comments on the manuscript; J. Mui and W. Leelapornpisit for assistance with sample preparation, microscope operation and data collection; and G. Seifert and C. Steinhauser for providing eyes from CX43-ECFP mice. Supported by grants from the Canadian Institutes of Health Research (A.D.P.).	Alarcon-Martinez L, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0761-z; Alarcon-Martinez L, 2018, ELIFE, V7, DOI 10.7554/eLife.34861; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Borysova L, 2013, CELL CALCIUM, V54, P163, DOI 10.1016/j.ceca.2013.06.001; CAMMERMEYER J, 1960, J COMP NEUROL, V114, P189, DOI 10.1002/cne.901140206; Cerletti U, 1910, HISTOL HISTOPATHOL A, V4, P1; Dalkara T, 2015, BRAIN RES, V1623, P3, DOI 10.1016/j.brainres.2015.03.047; Franco CA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002125; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Henle F, 1838, KORPER ARCH ANAT PHY, P103; Korenkova O, 2020, CELL STRESS, V4, P30, DOI 10.15698/cst2020.02.212; LEIBNITZ L, 1988, J HIRNFORSCH, V29, P367; Longden TA, 2017, NAT NEUROSCI, V20, P717, DOI 10.1038/nn.4533; Mendes-Jorge L, 2012, EXP EYE RES, V98, P79, DOI 10.1016/j.exer.2012.03.010; Mouton P.R., 2001, PRINCIPLES PRACTICES; Nilsson S.F., 2012, OCULAR BLOOD FLOW, P25, DOI [10.1007/978-3-540-69469-4_2, DOI 10.1007/978-3-540-69469-4_2]; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; REISSENWEBER NJ, 1971, ACTA ANAT, V78, P51; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sartori-Rupp A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08178-7; Takihara Y, 2015, P NATL ACAD SCI USA, V112, P10515, DOI 10.1073/pnas.1509879112; Theofilas P, 2017, J NEUROSCI RES, V95, P2182, DOI 10.1002/jnr.24055; Underly RG, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2378; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; WILLIAMSON JR, 1980, MICROVASC RES, V20, P233, DOI 10.1016/0026-2862(80)90010-2; Yu DY, 2019, PROG RETIN EYE RES, V70, P23, DOI 10.1016/j.preteyeres.2019.01.001; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	30	90	91	4	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2020	585	7823					91	+		10.1038/s41586-020-2589-x	http://dx.doi.org/10.1038/s41586-020-2589-x		AUG 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NJ1LP	32788726				2022-12-28	WOS:000559369600004
J	Budnitz, DS; Lovegrove, MC; Geller, RJ				Budnitz, Daniel S.; Lovegrove, Maribeth C.; Geller, Robert J.			Prevention of Unintentional Medication Overdose Among Children Time for the Promise of the Poison Prevention Packaging Act to Come to Fruition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXPOSURES	This Viewpoint discusses the success of US legislation to help prevent medication overdoses in children and suggests strategies to continue to reduce these overdoses, including changes to child-resistant packaging.	[Budnitz, Daniel S.; Lovegrove, Maribeth C.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop V18-4, Atlanta, GA 30329 USA; [Geller, Robert J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University	Budnitz, DS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop V18-4, Atlanta, GA 30329 USA.	dbudnitz@cdc.gov			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention (CDC).	Agarwal M, 2020, J PEDIATR-US, V219, P188, DOI 10.1016/j.jpeds.2019.12.027; Brass EP, 2018, J PEDIATR-US, V198, P254, DOI 10.1016/j.jpeds.2018.02.033; Department of Health and Human Services Food and Drug Administration, 2019, FED REGISTER, V84, P25283; Lovegrove MC, 2015, PEDIATRICS, V136, pE821, DOI 10.1542/peds.2015-2092; Neville K, 2015, PEDIATRICS, V135, P784, DOI 10.1542/peds.2015-0072; Wang GS, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-4232; Yin HS, 2014, PEDIATRICS, V134, pE354, DOI 10.1542/peds.2014-0395	7	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					550	551		10.1001/jama.2020.2152	http://dx.doi.org/10.1001/jama.2020.2152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32722746				2022-12-28	WOS:000562845100013
J	Ji, Z; Li, T; Yaghi, OM				Ji, Zhe; Li, Tong; Yaghi, Omar M.			Sequencing of metals in multivariate metal-organic frameworks	SCIENCE			English	Article							ATOM-PROBE; FUNCTIONAL-GROUPS; GAS-ADSORPTION; CARBON-DIOXIDE; ORDER; SURFACE; SITES	We mapped the metal sequences within crystals of metal-oxide rods in multivariate metal-organic framework-74 containing mixed combinations of cobalt (Co), cadmium (Cd), lead (Pb), and manganese (Mn). Atom probe tomography of these crystals revealed the presence of heterogeneous spatial sequences of metal ions that we describe, depending on the metal and synthesis temperature used, as random (Co, Cd, 120 degrees C), short duplicates (Co, Cd, 85 degrees C), long duplicates (Co, Pb, 85 C), and insertions (Co, Mn, 85 degrees C). Three crystals were examined for each sequence type, and the molar fraction of Co among all 12 samples was observed to vary from 0.4 to 0.9, without changing the sequence type. Compared with metal oxides, metal-organic frameworks have high tolerance for coexistence of different metal sizes in their rods and therefore assume various metal sequences.	[Ji, Zhe; Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ji, Zhe; Yaghi, Omar M.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Ji, Zhe; Yaghi, Omar M.] Kavli Energy NanoSci Inst Berkeley, Berkeley, CA 94720 USA; [Ji, Zhe; Yaghi, Omar M.] Berkeley Global Sci Inst, Berkeley, CA 94720 USA; [Li, Tong] Ruhr Univ Bochum, Inst Mat, Univ Str 150, D-44801 Bochum, Germany; [Yaghi, Omar M.] KACST, Univ Calif Berkeley King Abdulaziz City Sci & Tec, Riyadh 11442, Saudi Arabia	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Ruhr University Bochum	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Kavli Energy NanoSci Inst Berkeley, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Berkeley Global Sci Inst, Berkeley, CA 94720 USA.; Li, T (corresponding author), Ruhr Univ Bochum, Inst Mat, Univ Str 150, D-44801 Bochum, Germany.; Yaghi, OM (corresponding author), KACST, Univ Calif Berkeley King Abdulaziz City Sci & Tec, Riyadh 11442, Saudi Arabia.	tong.li@ruhr-uni-bochum.de; yaghi@berkeley.edu	Li, Tong/A-3182-2017	Li, Tong/0000-0001-5729-1839; Yaghi, Omar/0000-0002-5611-3325; Ji, Zhe/0000-0002-8532-333X	King Abdulaziz City for Science and Technology (Center of Excellence for Nanomaterials and Clean Energy Applications)	King Abdulaziz City for Science and Technology (Center of Excellence for Nanomaterials and Clean Energy Applications)	This research was supported by King Abdulaziz City for Science and Technology (Center of Excellence for Nanomaterials and Clean Energy Applications).	BAS P, 1995, APPL SURF SCI, V87-8, P298, DOI 10.1016/0169-4332(94)00561-3; Britt D, 2009, P NATL ACAD SCI USA, V106, P20637, DOI 10.1073/pnas.0909718106; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Castillo-Blas C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700773; Ceguerra AV, 2012, ACTA CRYSTALLOGR A, V68, P547, DOI 10.1107/S0108767312025706; Chen YS, 2017, SCIENCE, V355, P1196, DOI 10.1126/science.aal2418; Chen YS, 2020, SCIENCE, V367, P171, DOI 10.1126/science.aaz0122; Danoix F, 2007, ULTRAMICROSCOPY, V107, P734, DOI 10.1016/j.ultramic.2007.02.006; DEFONTAINE D, 1971, J APPL CRYSTALLOGR, V4, P15, DOI 10.1107/S0021889871006174; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; Devaraj A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9014; Dietzel PDC, 2008, CHEM COMMUN, P5125, DOI 10.1039/b810574j; Dong ZY, 2017, J AM CHEM SOC, V139, P14209, DOI 10.1021/jacs.7b07392; Fathieh F, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3198; Fracaroli AM, 2016, J AM CHEM SOC, V138, P8352, DOI 10.1021/jacs.6b04204; Furukawa H, 2015, ANGEW CHEM INT EDIT, V54, P3417, DOI 10.1002/anie.201410252; Gault B., 2012, ATOM PROBE MICROSCOP, V160; Gault B, 2012, MATER TODAY, V15, P378, DOI 10.1016/S1369-7021(12)70164-5; Hanikel N, 2019, ACS CENTRAL SCI, V5, P1699, DOI 10.1021/acscentsci.9b00745; Howe JD, 2017, J PHYS CHEM C, V121, P627, DOI 10.1021/acs.jpcc.6b11719; Hu YS, 2007, ADV FUNCT MATER, V17, P1873, DOI 10.1002/adfm.200601152; JOHNSON CA, 1974, TECHNOMETRICS, V16, P483, DOI 10.2307/1267599; Kong XQ, 2013, SCIENCE, V341, P882, DOI 10.1126/science.1238339; Kuzmina M, 2015, SCIENCE, V349, P1080, DOI 10.1126/science.aab2633; Li TT, 2018, MICROPOR MESOPOR MAT, V272, P101, DOI 10.1016/j.micromeso.2018.06.023; Lin S, 2015, SCIENCE, V349, P1208, DOI 10.1126/science.aac8343; Liu Q, 2016, J AM CHEM SOC, V138, P13822, DOI 10.1021/jacs.6b08724; Aguirre-Diaz LM, 2015, J AM CHEM SOC, V137, P6132, DOI 10.1021/jacs.5b02313; Pearson W. B., 1958, INT SERIES MONOGRAPH, V4; Pearson W.B., 1958, HDB LATTICE SPACINGS, V4; Perea DE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8589; Popp TMO, 2017, ACCOUNTS CHEM RES, V50, P532, DOI 10.1021/acs.accounts.6b00529; Porter J, 2009, P IEEE RAP SYST PROT, P3, DOI 10.1109/RSP.2009.32; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Scherrer B, 2020, CHEM MATER, V32, P1031, DOI 10.1021/acs.chemmater.9b03704; Schmidt JE, 2018, ANGEW CHEM INT EDIT, V57, P10422, DOI 10.1002/anie.201712952; Schrimpf W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04050-w; Urban A, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.176402; Vurpillot F, 2000, APPL PHYS LETT, V76, P3127, DOI 10.1063/1.126545; Wang LJ, 2014, INORG CHEM, V53, P5881, DOI 10.1021/ic500434a; Wang L, 2016, ACS APPL MATER INTER, V8, P16736, DOI 10.1021/acsami.6b05375; Xia QC, 2017, J AM CHEM SOC, V139, P8259, DOI 10.1021/jacs.7b03113; Yaghi O. M., 2019, INTRO RETICULAR CHEM; Zhang LQ, 2008, J POWER SOURCES, V185, P534, DOI 10.1016/j.jpowsour.2008.06.054; ZHANG X, 1991, J AM CERAM SOC, V74, P2846, DOI 10.1111/j.1151-2916.1991.tb06853.x; Zhang YB, 2015, J AM CHEM SOC, V137, P2641, DOI 10.1021/ja512311a; Zhu YH, 2017, NAT MATER, V16, P532, DOI [10.1038/nmat4852, 10.1038/NMAT4852]	47	93	92	52	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					674	+		10.1126/science.aaz4304	http://dx.doi.org/10.1126/science.aaz4304			89	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764067				2022-12-28	WOS:000559184400042
J	Meanwell, M; Silverman, SM; Lehmann, J; Adluri, B; Wang, Y; Cohen, R; Campeau, LC; Britton, R				Meanwell, Michael; Silverman, Steven M.; Lehmann, Johannes; Adluri, Bharanishashank; Wang, Yang; Cohen, Ryan; Campeau, Louis-Charles; Britton, Robert			A short de novo synthesis of nucleoside analogs	SCIENCE			English	Article							CHEMICAL-SHIFTS; NATURAL-PRODUCT; INHIBITOR; THYMIDINE; FLUORINE; PSI-6130; CANCER; TOOL	Nucleoside analogs are commonly used in the treatment of cancer and viral infections. Their syntheses benefit from decades of research but are often protracted, unamenable to diversification, and reliant on a limited pool of chiral carbohydrate starting materials. We present a process for rapidly constructing nucleoside analogs from simple achiral materials. Using only proline catalysis, heteroaryl-substituted acetaldehydes are fluorinated and then directly engaged in enantioselective aldol reactions in a one -pot reaction. A subsequent intramolecular fluoride displacement reaction provides a functionalized nucleoside analog. The versatility of this process is highlighted in multigram syntheses of D- or L-nucleoside analogs, locked nucleic acids, iminonucleosides, and C2'- and C4' -modified nucleoside analogs. This de novo synthesis creates opportunities for the preparation of diversity libraries and will support efforts in both drug discovery and development.	[Meanwell, Michael; Lehmann, Johannes; Adluri, Bharanishashank; Wang, Yang; Britton, Robert] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Silverman, Steven M.; Cohen, Ryan; Campeau, Louis-Charles] Merck & Co Inc, Dept Proc Res & Dev, Rahway, NJ 07065 USA	Simon Fraser University; Merck & Company	Britton, R (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	rbritton@sfu.ca		Meanwell, Michael/0000-0002-4217-8478; Adluri, Bharanishashank/0000-0003-3994-2321	Canadian Glycomics Network (Strategic Initiatives Grant) [CD-46]; Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN-201906468]; Merck Co., Inc.; NSERC CGSD2 scholarship; Deutsche Forschungsgemeinschaft (DFG)	Canadian Glycomics Network (Strategic Initiatives Grant); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Merck Co., Inc.(Merck & Company); NSERC CGSD2 scholarship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	R.B. acknowledges support from the Canadian Glycomics Network (Strategic Initiatives Grant, CD-46), the Natural Sciences and Engineering Research Council (NSERC) of Canada (Discovery Grant, RGPIN-201906468), and Merck & Co., Inc. M.M. was supported by an NSERC CGSD2 scholarship, and J.L. was supported by the Deutsche Forschungsgemeinschaft (DFG).	[Anonymous], 2019, SCHRODINGER RELEASE; Bergeron-Brlek M, 2013, ORG LETT, V15, P3554, DOI 10.1021/ol401370b; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P1, DOI 10.1039/9781847555380; Britton R, 2013, NAT PROD REP, V30, P227, DOI 10.1039/c2np20108a; Britton T. C., 1995, U.S. Patent, Patent No. [5,420,266A, 5420266]; Brodszki M, 2011, ORG PROCESS RES DEV, V15, P1027, DOI 10.1021/op200153s; Bruker, 2016, APEX3 SAINT SADABS; Campbell MA, 2011, CHEM SOC REV, V40, P5680, DOI 10.1039/c1cs15048k; Campos KR, 2019, SCIENCE, V363, P244, DOI 10.1126/science.aat0805; COOK AF, 1967, J AM CHEM SOC, V89, P2697, DOI 10.1021/ja00987a036; Cui HQ, 2012, J MED CHEM, V55, P10948, DOI 10.1021/jm301328h; Davis FA, 1997, J ORG CHEM, V62, P7546, DOI 10.1021/jo9714829; De Clercq E, 2016, J MED CHEM, V59, P2301, DOI 10.1021/acs.jmedchem.5b01157; De Clercq E, 2013, MED RES REV, V33, P1215, DOI 10.1002/med.21256; Downey AM, 2015, ORG LETT, V17, P4604, DOI 10.1021/acs.orglett.5b02332; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Grondal C, 2007, ADV SYNTH CATAL, V349, P694, DOI 10.1002/adsc.200600573; Gumina G, 2001, FEMS MICROBIOL LETT, V202, P9, DOI 10.1016/S0378-1097(01)00285-3; Hadj-Bouazza A, 2005, NUCLEOS NUCLEOT NUCL, V24, P1249, DOI 10.1081/NCN-200067423; Hubschle CB, 2011, J APPL CRYSTALLOGR, V44, P1281, DOI 10.1107/S0021889811043202; Hyde AM, 2019, ORG PROCESS RES DEV, V23, P1860, DOI 10.1021/acs.oprd.9b00187; Jenkinson SF, 2007, TETRAHEDRON LETT, V48, P4441, DOI 10.1016/j.tetlet.2007.04.105; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Lodewyk MW, 2012, CHEM REV, V112, P1839, DOI 10.1021/cr200106v; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; McLaughlin M, 2017, ORG LETT, V19, P926, DOI 10.1021/acs.orglett.7b00091; Mehellou Y, 2010, BIOORGAN MED CHEM, V18, P2439, DOI 10.1016/j.bmc.2010.02.059; Merino P., 2013, CHEM SYNTHESIS NUCLE; Moyroud E, 2000, TETRAHEDRON, V56, P1475, DOI 10.1016/S0040-4020(00)00046-6; Ni GC, 2019, RSC ADV, V9, P14302, DOI 10.1039/c9ra01399g; Ohrui H, 2006, CHEM REC, V6, P133, DOI 10.1002/tcr.20078; Peifer M, 2014, J AM CHEM SOC, V136, P5900, DOI 10.1021/ja502205q; Quintard A, 2017, ACS CATAL, V7, P5513, DOI 10.1021/acscatal.7b02353; Rablen PR, 1999, J PHYS CHEM A, V103, P7357, DOI 10.1021/jp9916889; Ren W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05702-7; Sanchez-Fernandez EM, 2012, CHEM-EUR J, V18, P8527, DOI 10.1002/chem.201200279; Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004; Seth P. P., 2008, U. S. Patent, Patent No. [8278283 B2, 8278283]; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shelton J, 2016, CHEM REV, V116, P14379, DOI 10.1021/acs.chemrev.6b00209; Steiner DD, 2005, ANGEW CHEM INT EDIT, V44, P3706, DOI 10.1002/anie.200500571; Teichert JS, 2019, ANGEW CHEM INT EDIT, V58, P9944, DOI 10.1002/anie.201903400; WITKOWSKI JT, 1972, J MED CHEM, V15, P1150, DOI 10.1021/jm00281a014; XU ZQ, 1995, J MED CHEM, V38, P875, DOI 10.1021/jm00006a004; Yamaguchi T, 2015, CHEM COMMUN, V51, P9737, DOI 10.1039/c5cc02024g; Yates MK, 2019, ANTIVIR RES, V162, P5, DOI 10.1016/j.antiviral.2018.11.016; Zeidler J, 2015, EUR J MED CHEM, V97, P409, DOI 10.1016/j.ejmech.2014.11.057	52	31	31	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					725	+		10.1126/science.abb3231	http://dx.doi.org/10.1126/science.abb3231			176	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764073				2022-12-28	WOS:000559184400052
J	Nunez-Mulder, L				Nunez-Mulder, Laura			Dress codes and skydiving: this year on Sharp Scratch	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nunez-Mulder, Laura] Univ Cambridge, Cambridge, England	University of Cambridge	Nunez-Mulder, L (corresponding author), Univ Cambridge, Cambridge, England.	laura.nunez-mulder@hotmail.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2020	370								m2479	10.1136/bmj.m2479	http://dx.doi.org/10.1136/bmj.m2479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7QQ	32769078				2022-12-28	WOS:000560709600010
J	Salas, RN				Salas, Renee N.			Lessons from the covid-19 pandemic provide a blueprint for the climate emergency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AGREEMENT		[Salas, Renee N.] Harvard Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA		Salas, RN (corresponding author), Harvard Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA.	rnsalas@mgh.harvard.edu						Dahlstrom MF, 2014, P NATL ACAD SCI USA, V111, P13614, DOI 10.1073/pnas.1320645111; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Karliner J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6878; Kickbusch I, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1336; Markandya A, 2018, LANCET PLANET HEALTH, V2, pE126, DOI [10.1016/S2542-5196(18)30029-9, 10.1016/s2542-5196(18)30029-9]; Milner J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6758; Patz JA, 2020, JAMA-J AM MED ASSOC, V323, P1247, DOI 10.1001/jama.2020.1313; Rutschman AS, HEALTH AFFAIR, DOI [10.1377/hblog20200309.826956, DOI 10.1377/HBLOG20200309.826956]; Salas RN, 2020, NEW ENGL J MED, V382, P589, DOI 10.1056/NEJMp2000331; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6	10	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3067	10.1136/bmj.m3067	http://dx.doi.org/10.1136/bmj.m3067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32763893	Bronze			2022-12-28	WOS:000560719800007
J	Limb, M				Limb, Matthew			Drug suppliers are told to replenish stockpiles for Brexit and further pandemic this winter	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons International Trade Committee, 2020, 1 HOUS COMM INT TRAD; IACOBUCCI G, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2283	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m3104	10.1136/bmj.m3104	http://dx.doi.org/10.1136/bmj.m3104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759279				2022-12-28	WOS:000556139400003
J	Pinto, PH; Kroupova, A; Schleiffer, A; Mechtler, K; Jinek, M; Weitzer, S; Martinez, J				Pinto, Paola H.; Kroupova, Alena; Schleiffer, Alexander; Mechtler, Karl; Jinek, Martin; Weitzer, Stefan; Martinez, Javier			ANGEL2 is a member of the CCR4 family of deadenylases with 2 ',3 '-cyclic phosphatase activity	SCIENCE			English	Article							XBP1 MESSENGER-RNA; STRUCTURE REFINEMENT; PROTEIN; PHOSPHODIESTERASE; LIGASE; REVEALS; COMPLEX; STRESS; IDENTIFICATION; ENDONUCLEASE	RNA molecules are frequently modified with a terminal 2',3'-cyclic phosphate group as a result of endonuclease cleavage, exonuclease trimming, or de novo synthesis. During pre-transfer RNA (tRNA) and unconventional messenger RNA (mRNA) splicing, 2',3'-cyclic phosphates are substrates of the tRNA ligase complex, and their removal is critical for recycling of tRNAs upon ribosome stalling. We identified the predicted deadenylase angel homolog 2 (ANGEL2) as a human phosphatase that converts 2',3'-cyclic phosphates into 2',3'-OH nucleotides. We analyzed ANGEL2's substrate preference, structure, and reaction mechanism. Perturbing ANGEL2 expression affected the efficiency of pre- tRNA processing, X-box-binding protein 1 (XBP1) mRNA splicing during the unfolded protein response, and tRNA nucleotidyltransferase 1 (TRNT1)-mediated CCA addition onto tRNAs. Our results indicate that ANGEL2 is involved in RNA pathways that rely on the ligation or hydrolysis of 2',3'-cyclic phosphates.	[Pinto, Paola H.; Weitzer, Stefan; Martinez, Javier] Med Univ Vienna, Vienna BioCtr, Max Perutz Labs, A-1030 Vienna, Austria; [Kroupova, Alena; Jinek, Martin] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Schleiffer, Alexander] Vienna BioCtr, Res Inst Mol Pathol, IMP IMBA Bioinformat Core Facil, A-1030 Vienna, Austria; [Mechtler, Karl] Vienna BioCtr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Mechtler, Karl] Austrian Acad Sci, Vienna BioCtr, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Zurich; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Weitzer, S; Martinez, J (corresponding author), Med Univ Vienna, Vienna BioCtr, Max Perutz Labs, A-1030 Vienna, Austria.	stefan.weitzer@meduniwien.ac.at; javier.martinez@meduniwien.ac.at	Mechtler, Karl/AAF-2717-2019; Jinek, Martin/E-6621-2011	Mechtler, Karl/0000-0002-3392-9946; Weitzer, Stefan/0000-0003-4172-9829; Kroupova, Alena/0000-0003-4166-1270; Schleiffer, Alexander/0000-0001-6251-2747; Martinez, Javier/0000-0001-9152-7323; Jinek, Martin/0000-0002-7601-210X	Medical University of Vienna; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) as Stand-Alone Projects [P29888, P32011]; Boehringer Ingelheim Fonds; FWF [SFB F3402, P24685, TRP 308-N15, I 3686]; Horizon 2020 EPIC-XS [P823839]	Medical University of Vienna; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) as Stand-Alone Projects(Austrian Science Fund (FWF)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); FWF(Austrian Science Fund (FWF)); Horizon 2020 EPIC-XS	Work at the Martinez lab was funded by the Medical University of Vienna and the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) as Stand-Alone Projects (P29888 and P32011) and through the RNA Biology Doctoral Program. A.K. is funded by the Boehringer Ingelheim Fonds PhD Fellowship. M.J. is an International Research Scholar of the Howard Hughes Medical Institute, Vallee Scholar of the Bert L. & N. Kuggie Vallee Foundation, and a member of the National Competence Center for Research (NCCR) RNA & Disease. Mass Spectrometry analysis was funded by FWF (SFB F3402; P24685, TRP 308-N15, and I 3686) and by Horizon 2020 EPIC-XS (P823839).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERNIER L, 1987, J NEUROSCI, V7, P2703; BORAH B, 1985, BIOCHEMISTRY-US, V24, P2058, DOI 10.1021/bi00329a038; Chakravarty AK, 2012, NUCLEIC ACIDS RES, V40, P8558, DOI 10.1093/nar/gks558; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Czech A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003767; Das U, 2013, NUCLEIC ACIDS RES, V41, P355, DOI 10.1093/nar/gks977; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doblmann J, 2019, J PROTEOME RES, V18, P535, DOI 10.1021/acs.jproteome.8b00113; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P1555, DOI 10.1080/00021369.1974.10861384; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; Godwin AR, 2013, BBA-GENE REGUL MECH, V1829, P571, DOI 10.1016/j.bbagrm.2012.12.004; Gosselin P, 2013, NUCLEIC ACIDS RES, V41, P7783, DOI 10.1093/nar/gkt569; Gradia SD, 2017, METHOD ENZYMOL, V592, P1, DOI 10.1016/bs.mie.2017.03.008; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Jurkin J, 2014, EMBO J, V33, P2922, DOI 10.15252/embj.201490332; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Kosmaczewski SG, 2014, EMBO REP, V15, P1278, DOI 10.15252/embr.201439531; Kuroha K, 2018, MOL CELL, V72, P286, DOI 10.1016/j.molcel.2018.08.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Martins A, 2004, J BIOL CHEM, V279, P18220, DOI 10.1074/jbc.M313386200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mroczek S, 2012, GENE DEV, V26, P1911, DOI 10.1101/gad.193169.112; Munir A, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00739-16; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Rendon OZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04564-3; Shchepachev V, 2012, CELL REP, V2, P855, DOI 10.1016/j.celrep.2012.08.031; Shigematsu M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008469; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tresaugues L, 2014, STRUCTURE, V22, P744, DOI 10.1016/j.str.2014.01.013; Unlu I, 2018, J BIOL CHEM, V293, P19365, DOI 10.1074/jbc.RA118.004872; Verma R, 2018, NATURE, V557, P446, DOI 10.1038/s41586-018-0022-5; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; WHITFELD PR, 1955, BIOCHEM J, V60, P15, DOI 10.1042/bj0600015; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood ER, 2015, J BIOL CHEM, V290, P19681, DOI 10.1074/jbc.M115.653113; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yi X, 2012, J BIOL CHEM, V287, P21045, DOI 10.1074/jbc.M112.355321; Yip MCJ, 2020, CELL REP, V30, P2106, DOI 10.1016/j.celrep.2020.01.082; Yip MCJ, 2019, NAT STRUCT MOL BIOL, V26, P343, DOI 10.1038/s41594-019-0211-4; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	61	12	12	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					524	+		10.1126/science.aba9763	http://dx.doi.org/10.1126/science.aba9763			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732418				2022-12-28	WOS:000556568100037
J	Whaley, CM; Arnold, DR; Gross, N; Jena, AB				Whaley, Christopher M.; Arnold, Daniel R.; Gross, Nate; Jena, Anupam B.			Practice composition and sex differences in physician income: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENDER-DIFFERENCES; EARNINGS; PRODUCTIVITY; DIVERSITY; SALARY; DISCRIMINATION; COMPENSATION; HARASSMENT; MEDICINE; TRENDS	OBJECTIVE To assess whether differences in income between male and female physicians vary according to the sex composition of physician practices. DESIGN Retrospective observational study. SETTING US national survey of physician salaries, 2014-18. PARTICIPANTS 18 802 physicians from 9848 group practices (categorized according to proportion of male physicians <= 50%, >50-75%, >75-90%, and >90%). MAIN OUTCOME MEASURES Sex differences in physician income in relation to the sex composition of physician practices after multivariable adjustment for physician specialty, years of experience, hours worked, measures of clinical workload, practice type, and geography. RESULTS Among 11 490 non-surgical specialists, the absolute adjusted sex difference in annual income (men versus women) was $36 604 (29 pound 663; (sic)32 621) (95% confidence interval $24 903 to $48 306; 11.7% relative difference) for practices with 50% or less of male physicians compared with $91 669 ($56 587 to $126 571; 19.9% relative difference) for practices with at least 90% of male physicians (P=0.03 for difference). Similar findings were observed among surgical specialists (n=3483), with absolute adjusted sex difference in annual income of $46 503 ($42 198 to $135 205; 10.2% relative difference) for practices with 50% or less of male physicians compared with $149 460 ($86 040 to $212 880; 26.9% relative difference) for practices with at least 90% of male physicians (P=0.06 for difference). Among primary care physicians (n=3829), sex differences in income were not related to the proportion of male physicians in a practice. CONCLUSIONS Among both non-surgical and surgical specialists, sex differences in income were largest in practices with the highest proportion of male physicians, even after detailed adjustment for factors that might explain sex differences in income.	[Whaley, Christopher M.] Rand, Santa Monica, CA USA; [Arnold, Daniel R.] Univ Calif Berkeley, Dept Hlth Policy & Management, Berkeley, CA 94720 USA; [Gross, Nate] Doximity, San Francisco, CA USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	RAND Corporation; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.; Jena, AB (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Jena, AB (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	jena@hcp.med.harvard.edu			Office of the Director, National Institutes of Health [1DP5OD017897]; National Institutes on Aging [1K01AG061274]; Nicholas C Petris Center on Health Care Markets and Consumer Welfare	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Nicholas C Petris Center on Health Care Markets and Consumer Welfare	ABJ was supported by the Office of the Director, National Institutes of Health (1DP5OD017897), CMW was supported by the National Institutes on Aging (1K01AG061274), and DRA was supported by the Nicholas C Petris Center on Health Care Markets and Consumer Welfare. The research conducted was independent of any involvement from the sponsors of the study. The study sponsors were not involved in study design, data interpretation, writing, or the decision to submit the article for publication.	Apaydin EA, 2018, J GEN INTERN MED, V33, P1574, DOI 10.1007/s11606-018-4462-2; Ash AS, 2004, ANN INTERN MED, V141, P205, DOI 10.7326/0003-4819-141-3-200408030-00009; Baker LC, 2018, MED CARE RES REV, V75, P88, DOI 10.1177/1077558716676018; Baker LC, 1996, NEW ENGL J MED, V334, P960, DOI 10.1056/NEJM199604113341506; Baumhakel M, 2009, EUR J HEART FAIL, V11, P299, DOI 10.1093/eurjhf/hfn041; Blumenthal DM, 2017, CIRCULATION, V135, P506, DOI 10.1161/CIRCULATIONAHA.116.023520; Butkus R, 2018, ANN INTERN MED, V168, P721, DOI 10.7326/M17-3438; Carr PL, 2000, ANN INTERN MED, V132, P889, DOI 10.7326/0003-4819-132-11-200006060-00007; Chattopadhyay P, 2004, ACAD MANAGE REV, V29, P180, DOI 10.2307/20159028; DesRoches CM, 2010, ACAD MED, V85, P631, DOI 10.1097/ACM.0b013e3181d2b095; Doximity, 2017, DOXIMITY REACHES 70; Doximity, 2019, CAREER NAVIGATOR SUR; Files JA, 2017, J WOMENS HEALTH, V26, P413, DOI 10.1089/jwh.2016.6044; Frintner MP, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3955; Garnero A, 2014, IND RELAT, V53, P430, DOI 10.1111/irel.12064; Gresenz CR, 2013, HEALTH SERV RES, V48, P696, DOI 10.1111/1475-6773.12029; Hamilton BH, 2012, ADV ECON ANAL PARTIC, V13, P99, DOI 10.1108/S0885-3339(2012)0000013009; Hoff TJ, 2004, INQUIRY-J HEALTH CAR, V41, P301, DOI 10.5034/inquiryjrnl_41.3.301; Jagsi R, 2016, JAMA-J AM MED ASSOC, V315, P2120, DOI 10.1001/jama.2016.2188; Jagsi R, 2013, ACAD MED, V88, P1689, DOI 10.1097/ACM.0b013e3182a71519; Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Joshi A, 2006, ACAD MANAGE J, V49, P459, DOI 10.2307/20159776; Khullar D, 2017, ANN INTERN MED, V167, P584, DOI 10.7326/M17-1304; Kim C, 2005, DIABETES CARE, V28, P1594, DOI 10.2337/diacare.28.7.1594; Lo Sasso AT, 2011, HEALTH AFFAIR, V30, P193, DOI 10.1377/hlthaff.2010.0597; LY DP, 2016, BMJ-BRIT MED J, V353, P2923, DOI DOI 10.1136/BMJ.I2923; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Ness RB, 2000, ANN INTERN MED, V133, P104, DOI 10.7326/0003-4819-133-2-200007180-00009; Oliveira DFM, 2019, JAMA-J AM MED ASSOC, V321, P898, DOI 10.1001/jama.2018.21944; Reisman AB, 2002, TEACH LEARN MED, V14, P236, DOI 10.1207/S15328015TLM1404_6; Rhodes KV, 2014, JAMA INTERN MED, V174, P861, DOI 10.1001/jamainternmed.2014.20; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Sarsons H., 2017, INTERPRETING SIGNALS; Seabury SA, 2013, JAMA INTERN MED, V173, P1748; Sege R, 2015, JAMA-J AM MED ASSOC, V314, P1175, DOI 10.1001/jama.2015.8517; Starmer AJ, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-2926; Le TAN, 2017, J AM DENT ASSOC, V148, P257, DOI 10.1016/j.adaj.2017.01.005; Tsugawa Y, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1797; Tsugawa Y, 2017, JAMA INTERN MED, V177, P675, DOI 10.1001/jamainternmed.2017.0059; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Weeks WB, 2009, HEALTH AFFAIR, V28, P557, DOI 10.1377/hlthaff.28.2.557; Wiler JL, 2019, ACAD EMERG MED, V26, P286, DOI 10.1111/acem.13694; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Yasaitis LC, 2016, HEALTH AFFAIR, V35, P1382, DOI 10.1377/hlthaff.2015.1635	46	16	16	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m2588	10.1136/bmj.m2588	http://dx.doi.org/10.1136/bmj.m2588			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MV1RG	32732322	hybrid, Green Published			2022-12-28	WOS:000556139900007
J	Lucas, C; Wong, P; Klein, J; Castro, TBR; Silva, J; Sundaram, M; Ellingson, MK; Mao, TY; Oh, JE; Israelow, B; Takahashi, T; Tokuyama, M; Lu, PW; Venkataraman, A; Park, A; Mohanty, S; Wang, HW; Wyllie, AL; Vogels, CBF; Earnest, R; Lapidus, S; Ott, IM; Moore, AJ; Muenker, MC; Fournier, JB; Campbell, M; Odio, CD; Casanovas-Massana, A; Herbst, R; Shaw, AC; Medzhitov, R; Schulz, WL; Grubaugh, ND; Dela Cruz, C; Farhadian, S; Ko, AI; Omer, SB; Iwasaki, A				Lucas, Carolina; Wong, Patrick; Klein, Jon; Castro, Tiago B. R.; Silva, Julio; Sundaram, Maria; Ellingson, Mallory K.; Mao, Tianyang; Oh, Ji Eun; Israelow, Benjamin; Takahashi, Takehiro; Tokuyama, Maria; Lu, Peiwen; Venkataraman, Arvind; Park, Annsea; Mohanty, Subhasis; Wang, Haowei; Wyllie, Anne L.; Vogels, Chantal B. F.; Earnest, Rebecca; Lapidus, Sarah; Ott, Isabel M.; Moore, Adam J.; Muenker, M. Catherine; Fournier, John B.; Campbell, Melissa; Odio, Camila D.; Casanovas-Massana, Arnau; Herbst, Roy; Shaw, Albert C.; Medzhitov, Ruslan; Schulz, Wade L.; Grubaugh, Nathan D.; Dela Cruz, Charles; Farhadian, Shelli; Ko, Albert, I; Omer, Saad B.; Iwasaki, Akiko		Yale IMPACT Team	Longitudinal analyses reveal immunological misfiring in severe COVID-19	NATURE			English	Article							RESPONSES; INNATE	Recent studies have provided insights into the pathogenesis of coronavirus disease 2019 (COVID-19)(1-4). However, the longitudinal immunological correlates of disease outcome remain unclear. Here we serially analysed immune responses in 113 patients with moderate or severe COVID-19. Immune profiling revealed an overall increase in innate cell lineages, with a concomitant reduction in T cell number. An early elevation in cytokine levels was associated with worse disease outcomes. Following an early increase in cytokines, patients with moderate COVID-19 displayed a progressive reduction in type 1 (antiviral) and type 3 (antifungal) responses. By contrast, patients with severe COVID-19 maintained these elevated responses throughout the course of the disease. Moreover, severe COVID-19 was accompanied by an increase in multiple type 2 (anti-helminths) effectors, including interleukin-5 (IL-5), IL-13, immunoglobulin E and eosinophils. Unsupervised clustering analysis identified four immune signatures, representing growth factors (A), type-2/3 cytokines (B), mixed type-1/2/3 cytokines (C), and chemokines (D) that correlated with three distinct disease trajectories. The immune profiles of patients who recovered from moderate COVID-19 were enriched in tissue reparative growth factor signature A, whereas the profiles of those with who developed severe disease had elevated levels of all four signatures. Thus, we have identified a maladapted immune response profile associated with severe COVID-19 and poor clinical outcome, as well as early immune signatures that correlate with divergent disease trajectories. A longitudinal analysis of immune responses in patients with moderate or severe COVID-19 identifies a maladapted immune response profile linked to severe disease.	[Lucas, Carolina; Wong, Patrick; Klein, Jon; Silva, Julio; Mao, Tianyang; Oh, Ji Eun; Israelow, Benjamin; Takahashi, Takehiro; Tokuyama, Maria; Lu, Peiwen; Venkataraman, Arvind; Park, Annsea; Medzhitov, Ruslan; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobior, New Haven, CT 06510 USA; [Castro, Tiago B. R.] Rockefeller Univ, Lab Mucosar Immunol, 1230 York Ave, New York, NY 10021 USA; [Sundaram, Maria; Ellingson, Mallory K.; Wyllie, Anne L.; Vogels, Chantal B. F.; Lapidus, Sarah; Ott, Isabel M.; Moore, Adam J.; Muenker, M. Catherine; Odio, Camila D.; Casanovas-Massana, Arnau; Grubaugh, Nathan D.; Ko, Albert, I; Omer, Saad B.] Yale Sch Publ Hearth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Israelow, Benjamin; Mohanty, Subhasis; Wang, Haowei; Earnest, Rebecca; Fournier, John B.; Campbell, Melissa; Shaw, Albert C.; Farhadian, Shelli; Ko, Albert, I; Omer, Saad B.] Yale Univ, Sch Med, Dept Med, Sect Infect Dis, New Haven, CT 06510 USA; [Herbst, Roy] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [Herbst, Roy] Yale Univ, Smirow Canc Hosp, New Haven, CT USA; [Medzhitov, Ruslan; Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Schulz, Wade L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Schulz, Wade L.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Dela Cruz, Charles] Yale Univ, Sch Med, Dept Med, Sect Pulm & Crit Care Med, New Haven, CT 06510 USA; [Omer, Saad B.] Yale Univ, Yale Inst Global Hearth, New Haven, CT USA	Yale University; Rockefeller University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobior, New Haven, CT 06510 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	akiko.iwasaki@yale.edu	Odio, Camila/CAF-7842-2022; Casanovas-Massana, Arnau/H-5806-2019; Ko, Albert/P-2343-2015; TBR, Castro/K-4014-2018; Shaw, Albert/AAD-2567-2021; Schulz, Wade/N-8029-2013	Odio, Camila/0000-0002-1730-4380; Casanovas-Massana, Arnau/0000-0002-3301-6143; Ko, Albert/0000-0001-9023-2339; TBR, Castro/0000-0002-0359-0611; Shaw, Albert/0000-0003-4970-7640; Lucas, Carolina/0000-0003-4590-2756; Rose, Kadi-Ann/0000-0003-4664-2757; Obaid, Abeer/0000-0002-9846-1045; Ott, Isabel/0000-0002-7134-0956; Velazquez, Sofia/0000-0001-5954-3518; Klein, Jonathan/0000-0002-3552-7684; Wyllie, Anne/0000-0001-6015-0279; Venkataraman, Arvind/0000-0003-1148-4402; Handoko, Ryan/0000-0002-8796-8238; Schulz, Wade/0000-0002-2048-4028; Mao, Tianyang/0000-0001-9251-8592; Sundaram, Maria/0000-0001-8056-3302; Vogels, Chantal/0000-0003-0027-6480; Martin, Anjelica/0000-0001-9669-8842; Nouws, Jessica/0000-0003-3347-3595; Muenker, M. Catherine/0000-0002-0450-0868; Valdez, Jordan/0000-0003-1313-190X; DeIuliis, Giuseppe/0000-0003-0841-8156	Women's Health Research at Yale Pilot Project Program; Emergent Ventures at the Mercatus Center; Ludwig Family Foundation; Department of Internal Medicine at the Yale School of Medicine; Mathers Foundation; Yale School of Public Health; Beatrice Kleinberg Neuwirth Fund; Yale COVID-19 Research Resource Fund; Gruber Foundation; NIAID [2T32AI007517-16]; NSF; NOW Rubicon [019.181EN.004]	Women's Health Research at Yale Pilot Project Program; Emergent Ventures at the Mercatus Center; Ludwig Family Foundation; Department of Internal Medicine at the Yale School of Medicine; Mathers Foundation; Yale School of Public Health; Beatrice Kleinberg Neuwirth Fund; Yale COVID-19 Research Resource Fund; Gruber Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF(National Science Foundation (NSF)); NOW Rubicon	We thank M. Linehan for technical and logistical assistance, and A. Wang, A. Ring, C. Wilen and D. Mucida for discussions. This work was supported by the Women's Health Research at Yale Pilot Project Program (A.I.), Fast Grant from Emergent Ventures at the Mercatus Center, Mathers Foundation, and the Ludwig Family Foundation, the Department of Internal Medicine at the Yale School of Medicine, Yale School of Public Health and the Beatrice Kleinberg Neuwirth Fund. IMPACT received support from the Yale COVID-19 Research Resource Fund. A.I. is an Investigator of the Howard Hughes Medical Institute. C.L. is a Pew Latin American Fellow. P.W. is supported by Gruber Foundation and the NSF. B.I. is supported by NIAID 2T32AI007517-16. C.B.F.V. is supported by NOW Rubicon 019.181EN.004.	Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2; Kalfaoglu B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.589380; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ostendorf L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02725; Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6; Wang DD, 2017, CELL MOL IMMUNOL, V14, P423, DOI 10.1038/cmi.2015.89; Wyllie A.L., 2020, SALIVA IS MORE SENSI, V8, P12, DOI [10.1101/2020.04.16.20067835, DOI 10.1101/2020.04.16.20067835]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yap JKY, 2020, J IMMUNOL, V205, P307, DOI 10.4049/jimmunol.2000513; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	26	904	922	15	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					463	+		10.1038/s41586-020-2588-y	http://dx.doi.org/10.1038/s41586-020-2588-y		JUL 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32717743	Bronze, Green Accepted			2022-12-28	WOS:000559369800001
J	Mahase, E				Mahase, Elisabeth			Covid-19: England's obesity strategy will fail without tackling social factors, warn doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Intensive Care National Audit and Research Centre, 2020, ICNARC REP COVID 19; NHS Digital, 2020, STAT OB PHYS ACT DIE; Public Health England, 2020, EXC WEIGHT COV 19; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	4	10	10	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2994	10.1136/bmj.m2994	http://dx.doi.org/10.1136/bmj.m2994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32718928	Bronze			2022-12-28	WOS:000554458200003
J	Sharma, A; Eisen, JE; Shepard, JAO; Bernheim, A; Little, BP				Sharma, Amita; Eisen, Jonathan E.; Shepard, Jo-Anne O.; Bernheim, Adam; Little, Brent P.			Case 25-2020: A 47-Year-Old Woman with a Lung Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSED HALO SIGN; ORGANIZING PNEUMONIA; CT; CLASSIFICATION; SOCIETY	A 47-year-old woman presented early during the Covid-19 pandemic with cough and shortness of breath. Radiography revealed a rounded mass in the right lower lobe. Computed tomography confirmed the presence of the mass and showed ground-glass attenuation and a reversed halo sign. An oncology consultation was requested, and a diagnosis was made.	[Sharma, Amita; Shepard, Jo-Anne O.; Little, Brent P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Eisen, Jonathan E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sharma, Amita; Shepard, Jo-Anne O.; Little, Brent P.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Eisen, Jonathan E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Bernheim, Adam] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Sharma, A (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Sharma, A (corresponding author), Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA.				Hummingbird Diagnostics	Hummingbird Diagnostics	Dr. Sharma reports receiving grant support from Hummingbird Diagnostics. No other potential conflict of interest relevant to this article was reported.	Ajlan AM, 2009, AM J ROENTGENOL, V193, P1494, DOI 10.2214/AJR.09.3625; [Anonymous], 2020, ACR REC US CHEST RAD; [Anonymous], 2020, N ENGL J MED, V382, P2354; [Anonymous], 1985, J THORAC IMAGING; Austin JHM, 2013, RADIOLOGY, V266, P62, DOI 10.1148/radiol.12120240; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]; Collins J, 1997, AM J ROENTGENOL, V169, P355, DOI 10.2214/ajr.169.2.9242736; Expert Panel on Thoracic Imaging:, 2018, J Am Coll Radiol, V15, pS240, DOI 10.1016/j.jacr.2018.09.012; Godoy MCB, 2012, BRIT J RADIOL, V85, P1226, DOI 10.1259/bjr/54532316; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe204002, DOI [10.1148/ryct.2020200110, 10.1148/ryct.2020204002]; Kim SJ, 2003, AM J ROENTGENOL, V180, P1251, DOI 10.2214/ajr.180.5.1801251; Miller WS, 1947, THE LUNG, V2nd; Prokop M, 2020, RADIOLOGY, V296, pE97, DOI 10.1148/radiol.2020201473; Remy-Jardin M, 1993, J Thorac Imaging, V8, P249, DOI 10.1097/00005382-199323000-00001; Revel M-P, 2020, EUR RADIOL; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1148/radiol.2020201365, 10.1016/j.chest.2020.04.003]; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; STR/ASER COVID-19 position statement, 2020, STRAS COVID 19 POS S; Toussie D, 2020, RADIOLOGY; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Voloudaki AE, 1996, ACTA RADIOL, V37, P889; WEBB WR, 1993, RADIOLOGY, V186, P117, DOI 10.1148/radiology.186.1.8416550; Wong HYF, 2019, RADIOLOGY; Yijiu X, 2020, CHINAS HUBEI REPORTS; Zompatori M, 1999, Radiol Med, V97, P308; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	27	6	6	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					665	674		10.1056/NEJMcpc2004977	http://dx.doi.org/10.1056/NEJMcpc2004977			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7HD	32730700	Bronze, Green Published			2022-12-28	WOS:000562771200014
J	Butler, AE; Misselbrook, D				Butler, Alexandra E.; Misselbrook, David			Distinguishing between type 1 and type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AUTOANTIBODIES; PROGRESSION; MELLITUS; HISTORY; ADULTS; HEALTH		[Butler, Alexandra E.] Hamad Bin Khalifa Univ, Qatar Fdn, Qatar Biomed Res Inst, Diabet Res Ctr, Doha, Qatar; [Misselbrook, David] Royal Coll Surg Ireland Bahrain, Dept Family Med, Adliya, Bahrain	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); Royal College of Surgeons - Ireland	Butler, AE (corresponding author), Hamad Bin Khalifa Univ, Qatar Fdn, Qatar Biomed Res Inst, Diabet Res Ctr, Doha, Qatar.	abutler@hbku.edu.qa		Butler, Alexandra/0000-0002-5762-3917				Barker JM, 2006, J CLIN ENDOCR METAB, V91, P1210, DOI 10.1210/jc.2005-1679; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Falorni A, 2005, BEST PRACT RES CL EN, V19, P119, DOI 10.1016/j.beem.2004.11.010; Graveling Alex J, 2015, Clin Diabetes Endocrinol, V1, P8, DOI 10.1186/s40842-015-0007-3; John WG, 2012, DIABETIC MED, V29, P1350, DOI 10.1111/j.1464-5491.2012.03762.x; Lebovitz HE, 2011, DIABETES CARE, V34, pS225, DOI 10.2337/dc11-s225; Leighton E, 2017, DIABETES THER, V8, P475, DOI 10.1007/s13300-017-0265-4; MOLBAK AG, 1994, DIABETIC MED, V11, P650, DOI 10.1111/j.1464-5491.1994.tb00327.x; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB AD DIAGN; O'Neal Katherine S, 2016, Diabetes Spectr, V29, P249; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Pozzilli P, 2018, ENDOCRINOL METAB, V33, P147, DOI 10.3803/EnM.2018.33.2.147; Ramtoola S, 2020, PRIM CARE DIABETES, V14, P349, DOI 10.1016/j.pcd.2019.09.009; Shields BM, 2018, DIABETES CARE, V41, P1486, DOI 10.2337/dc18-0465; Shields BM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009088; Skyler JS, 2017, DIABETES, V66, P241, DOI 10.2337/db16-0806; Sosenko JM, 2010, DIABETES, V59, P2386, DOI 10.2337/db10-0534; Sosenko JM, 2009, DIABETES CARE, V32, P1603, DOI 10.2337/dc08-2140; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Tsirogianni A, 2009, AUTOIMMUN REV, V8, P687, DOI 10.1016/j.autrev.2009.02.019; Valdez R, 2007, DIABETES CARE, V30, P2517, DOI 10.2337/dc07-0720; Wenzlau J, 2009, CURR DIABETES REP, V9, P105, DOI 10.1007/s11892-009-0019-4; World Health Organization, 2011, US GLYC HAEM HBA1C D; Wroblewski M, 1998, DIABETES CARE, V21, P250, DOI 10.2337/diacare.21.2.250	25	6	6	5	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m2998	10.1136/bmj.m2998	http://dx.doi.org/10.1136/bmj.m2998			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784223				2022-12-28	WOS:000560307500005
J	Bozsoki, Z; Gysel, K; Hansen, SB; Lironi, D; Kronauer, C; Feng, F; de Jong, N; Vinther, M; Kamble, M; Thygesen, MB; Engholm, E; Kofoed, C; Fort, S; Sullivan, JT; Ronson, CW; Jensen, KJ; Blaise, M; Oldroyd, G; Stougaard, J; Andersen, KR; Radutoiu, S				Bozsoki, Zoltan; Gysel, Kira; Hansen, Simon B.; Lironi, Damiano; Kronauer, Christina; Feng, Feng; de Jong, Noor; Vinther, Maria; Kamble, Manoj; Thygesen, Mikkel B.; Engholm, Ebbe; Kofoed, Christian; Fort, Sebastien; Sullivan, John T.; Ronson, Clive W.; Jensen, Knud J.; Blaise, Mickael; Oldroyd, Giles; Stougaard, Jens; Andersen, Kasper R.; Radutoiu, Simona			Ligand-recognizing motifs in plant LysM receptors are major determinants of specificity	SCIENCE			English	Article							INNATE IMMUNITY; CHITIN FRAGMENTS; KINASE GENE; PERCEPTION; LEGUME; RECOGNITION; RHIZOBIUM; ARABIDOPSIS; DEFENSE; CELLS	Plants evolved lysine motif (LysM) receptors to recognize and parse microbial elicitors and drive intracellular signaling to limit or facilitate microbial colonization. We investigated how chitin and nodulation (Nod) factor receptors of Lotus japonicas initiate differential signaling of immunity or root nodule symbiosis. Two motifs in the LysM1 domains of these receptors determine specific recognition of ligands and discriminate between their in planta functions. These motifs define the ligand-binding site and make up the most structurally divergent regions in cognate Nod factor receptors. An adjacent motif modulates the specificity for Nod factor recognition and determines the selection of compatible rhizobial symbionts in legumes. We also identified how binding specificities in LysM receptors can be altered to facilitate Nod factor recognition and signaling from a chitin receptor, advancing the prospects of engineering rhizobial symbiosis into nonlegumes.	[Bozsoki, Zoltan; Gysel, Kira; Hansen, Simon B.; Lironi, Damiano; Kronauer, Christina; de Jong, Noor; Vinther, Maria; Kamble, Manoj; Blaise, Mickael; Stougaard, Jens; Andersen, Kasper R.; Radutoiu, Simona] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Feng, Feng; Oldroyd, Giles] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England; [Thygesen, Mikkel B.; Engholm, Ebbe; Kofoed, Christian; Jensen, Knud J.] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg, Denmark; [Fort, Sebastien] Univ Grenoble Alpes, CERMAV, CNRS, F-38000 Grenoble, France; [Sullivan, John T.; Ronson, Clive W.] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Kofoed, Christian] Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA; [Blaise, Mickael] Univ Montpellier, Inst Rech Infectiol Montpellier, UMR 9004, CNRS, F-34293 Montpellier, France	Aarhus University; University of Cambridge; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Otago; Princeton University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Andersen, KR; Radutoiu, S (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	kra@mbg.au.dk; radutoiu@mbg.au.dk	Oldroyd, Giles/ABA-7501-2020; Fort, Sebastien/A-9906-2012; Oldroyd, Giles/ABD-8143-2021; Gysel, Kira/GZM-5751-2022; Thygesen, Mikkel B./F-4418-2014; Jensen, Knud/D-1145-2016	Fort, Sebastien/0000-0002-6133-9900; Oldroyd, Giles/0000-0002-5245-6355; Gysel, Kira/0000-0003-4245-9998; Hansen, Simon Boje/0000-0002-0843-3922; Blaise, Mickael/0000-0002-7860-3464; Bozsoki, Zoltan/0000-0002-4267-9969; Thygesen, Mikkel B./0000-0002-0158-2802; Kofoed, Christian/0000-0002-8258-5887; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Jensen, Knud/0000-0003-3525-5452; Kronauer, Christina/0000-0002-3172-5149	Bill and Melinda Gates Foundation; UK government's Department for International Development (DFID) through the Engineering Nitrogen Symbiosis for Africa project (ENSA) [OPP11772165]; Danish National Research Foundation [DNRF79]; Labex ARCANE; Glyco@Alps [ANR-15-IDEX-02]; PolyNat Carnot Institut [ANR-16-CARN-0025-01]; CBH-EUR-GS [ANR-17-EURE-0003]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK government's Department for International Development (DFID) through the Engineering Nitrogen Symbiosis for Africa project (ENSA); Danish National Research Foundation(Danmarks Grundforskningsfond); Labex ARCANE; Glyco@Alps; PolyNat Carnot Institut; CBH-EUR-GS	This work was supported by the Bill and Melinda Gates Foundation and the UK government's Department for International Development (DFID) through the Engineering Nitrogen Symbiosis for Africa project (ENSA; OPP11772165) and the Danish National Research Foundation grant DNRF79. S.F. received technical support from ICMG (FR 2607) mass spectrometry and NMR platforms and partial financial support from Labex ARCANE and CBH-EUR-GS (ANR-17-EURE-0003), Glyco@Alps (ANR-15-IDEX-02), and PolyNat Carnot Institut (ANR-16-CARN-0025-01).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bozsoki Z, 2017, P NATL ACAD SCI USA, V114, pE8118, DOI 10.1073/pnas.1706795114; Bressendorff S, 2016, PLANT CELL, V28, P1328, DOI 10.1105/tpc.15.00774; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; Buendia L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01531; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Carotenuto G, 2017, NEW PHYTOL, V214, P1440, DOI 10.1111/nph.14539; DENARIE J, 1993, CELL, V74, P951, DOI 10.1016/0092-8674(93)90717-5; Downie JA, 1999, CURR OPIN PLANT BIOL, V2, P483, DOI 10.1016/S1369-5266(99)00018-7; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Feng F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12999-5; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Hohmann U., 2020, BIORXIV 2020 02 18 9, DOI 10.1101/2020.02.18.954479; Hohmann U., 2020, CONSTITUTIVE ACTIVAT; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kawaharada Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14534; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami E, 2018, ELIFE, V7, DOI [10.7554/eLife.33506, 10.7554/elife.33506]; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Oldroyd GED, 2001, PLANT J, V28, P191, DOI 10.1046/j.1365-313X.2001.01149.x; R Core Team, 2019, R LANGUAGE ENV STAT; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Radutoiu S, 2005, LOTUS JAPONICUS HANDBOOK, P285, DOI 10.1007/1-4020-3735-X_28; Rodpothong P, 2009, MOL PLANT MICROBE IN, V22, P1546, DOI 10.1094/MPMI-22-12-1546; Sanchez-Vallet A, 2015, FEMS MICROBIOL REV, V39, P171, DOI 10.1093/femsre/fuu003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shinya T, 2012, PLANT CELL PHYSIOL, V53, P1696, DOI 10.1093/pcp/pcs113; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; Tsukada K, 2002, PHYSIOL PLANTARUM, V116, P373, DOI 10.1034/j.1399-3054.2002.1160313.x; Vander P, 1998, PLANT PHYSIOL, V118, P1353, DOI 10.1104/pp.118.4.1353; Villanueva RAM, 2019, MEAS-INTERDISCIP RES, V17, P160, DOI 10.1080/15366367.2019.1565254; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wang W, 2014, PLANT J, V78, P56, DOI 10.1111/tpj.12450; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zhukov V, 2008, MOL PLANT MICROBE IN, V21, P1600, DOI 10.1094/MPMI-21-12-1600	53	42	47	16	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					663	+		10.1126/science.abb3377	http://dx.doi.org/10.1126/science.abb3377			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764065	Green Submitted			2022-12-28	WOS:000559184400040
J	Donovan, PJ; Zaret, KS				Donovan, Peter J.; Zaret, Kenneth S.			John D. Gearhart (1943-2020)	SCIENCE			English	Biographical-Item									[Donovan, Peter J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Donovan, Peter J.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Donovan, Peter J.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Donovan, PJ (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA.; Donovan, PJ (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.; Donovan, PJ (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	pdonovan@uci.edu; zaret@pennmeclicine.upenn.edu						GEARHART JD, PUBLICATION LIST	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					628	628		10.1126/science.abd6915	http://dx.doi.org/10.1126/science.abd6915			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764057				2022-12-28	WOS:000559184400026
J	Bishop, D				Bishop, Dorothy			How scientists can stop fooling themselves	NATURE			English	Editorial Material						Research data; Research management			[Bishop, Dorothy] Univ Oxford, Oxford, England	University of Oxford	Bishop, D (corresponding author), Univ Oxford, Oxford, England.	dorothy.bishop@psy.ox.ac.uk						Jennings RC, 2004, SCI ENG ETHICS, V10, P639, DOI 10.1007/s11948-004-0044-2; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322	2	11	11	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					9	9		10.1038/d41586-020-02275-8	http://dx.doi.org/10.1038/d41586-020-02275-8			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU9MN	32747780				2022-12-28	WOS:000555989500001
J	Hauser, SL; Bar-Or, A; Cohen, JA; Comi, G; Correale, J; Coyle, PK; Cross, AH; de Seze, J; Leppert, D; Montalban, X; Selmaj, K; Wiendl, H; Kerloeguen, C; Willi, R; Li, B; Kakarieka, A; Tomic, D; Goodyear, A; Pingili, R; Haring, DA; Ramanathan, K; Merschhemke, M; Kappos, L				Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Leppert, David; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Kerloeguen, Cecile; Willi, Roman; Li, Bingbing; Kakarieka, Algirdas; Tomic, Davorka; Goodyear, Alexandra; Pingili, Ratnakar; Haring, Dieter A.; Ramanathan, Krishnan; Merschhemke, Martin; Kappos, Ludwig			Ofatumumab versus Teriflunomide in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL DEPLETION; INTERFERON BETA-1A; ORAL TERIFLUNOMIDE; OCRELIZUMAB; EFFICACY; PLACEBO; SAFETY	BackgroundOfatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-cell activation. The relative effects of these two drugs in patients with multiple sclerosis are not known. MethodsIn two double-blind, double-dummy, phase 3 trials, we randomly assigned patients with relapsing multiple sclerosis to receive subcutaneous ofatumumab (20 mg every 4 weeks after 20-mg loading doses at days 1, 7, and 14) or oral teriflunomide (14 mg daily) for up to 30 months. The primary end point was the annualized relapse rate. Secondary end points included disability worsening confirmed at 3 months or 6 months, disability improvement confirmed at 6 months, the number of gadolinium-enhancing lesions per T1-weighted magnetic resonance imaging (MRI) scan, the annualized rate of new or enlarging lesions on T2-weighted MRI, serum neurofilament light chain levels at month 3, and change in brain volume. ResultsOverall, 946 patients were assigned to receive ofatumumab and 936 to receive teriflunomide; the median follow-up was 1.6 years. The annualized relapse rates in the ofatumumab and teriflunomide groups were 0.11 and 0.22, respectively, in trial 1 (difference, -0.11; 95% confidence interval [CI], -0.16 to -0.06; P<0.001) and 0.10 and 0.25 in trial 2 (difference, -0.15; 95% CI, -0.20 to -0.09; P<0.001). In the pooled trials, the percentage of patients with disability worsening confirmed at 3 months was 10.9% with ofatumumab and 15.0% with teriflunomide (hazard ratio, 0.66; P=0.002); the percentage with disability worsening confirmed at 6 months was 8.1% and 12.0%, respectively (hazard ratio, 0.68; P=0.01); and the percentage with disability improvement confirmed at 6 months was 11.0% and 8.1% (hazard ratio, 1.35; P=0.09). The number of gadolinium-enhancing lesions per T1-weighted MRI scan, the annualized rate of lesions on T2-weighted MRI, and serum neurofilament light chain levels, but not the change in brain volume, were in the same direction as the primary end point. Injection-related reactions occurred in 20.2% in the ofatumumab group and in 15.0% in the teriflunomide group (placebo injections). Serious infections occurred in 2.5% and 1.8% of the patients in the respective groups. ConclusionsAmong patients with multiple sclerosis, ofatumumab was associated with lower annualized relapse rates than teriflunomide. (Funded by Novartis; ASCLEPIOS I and II ClinicalTrials.gov numbers, NCT02792218 and NCT02792231.) In two identical trials involving a total of 1882 patients with multiple sclerosis, the human anti-CD20 monoclonal antibody ofatumumab was associated with a lower annualized relapse rate than the pyrimidine-synthesis inhibitor teriflunomide, as well as fewer lesions on MRI.	[Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, 675 Nelson Rising Ln, San Francisco, CA 94158 USA; [Bar-Or, Amit] Univ Penn, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA; [Bar-Or, Amit] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cohen, Jeffrey A.] Cleveland Clin, Dept Neurol, Mellen Ctr Multiple Sclerosis, Neurol Inst, Cleveland, OH 44106 USA; [Comi, Giancarlo] Osped San Raffaele, Inst Expt Neurol, Milan, Italy; [Comi, Giancarlo] Osped San Raffaele, Multiple Sclerosis Ctr IRCCS, Milan, Italy; [Correale, Jorge] Fleni, Dept Neurol, Buenos Aires, DF, Argentina; [Coyle, Patricia K.] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA; [Cross, Anne H.] Washington Univ, Sch Med, St Louis, MO USA; [de Seze, Jerome] Univ Hosp Strasburg, Strasbourg, France; [de Seze, Jerome] INSERM 1434, Clin Invest Ctr, Strasbourg, France; [Leppert, David] Univ Hosp Basel, Basel, Switzerland; [Kerloeguen, Cecile; Willi, Roman; Kakarieka, Algirdas; Tomic, Davorka; Haring, Dieter A.; Ramanathan, Krishnan; Merschhemke, Martin] Novartis Pharmaceut, Basel, Switzerland; [Kappos, Ludwig] Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Hosp Basel, Neurol Clin & Policlin, Dept Clin Res, Petersgraben 4, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Petersgraben 4, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed Engn, Petersgraben 4, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Basel, Switzerland; [Montalban, Xavier] Hosp Univ Vall dHebron, Dept Neurol Neuroimmunol, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain; [Selmaj, Krzysztof] Univ Warmia & Mazury, Olsztyn, Poland; [Selmaj, Krzysztof] Ctr Neurol, Lodz, Poland; [Wiendl, Heinz] Univ Munster, Inst Translat Neurol, Dept Neurol, Munster, Germany; [Li, Bingbing; Goodyear, Alexandra; Pingili, Ratnakar] Novartis Pharmaceut, E Hanover, NJ USA	University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Basel; Novartis; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Hospital Universitari Vall d'Hebron; University of Warmia & Mazury; University of Munster; Novartis	Hauser, SL (corresponding author), Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.; Kappos, L (corresponding author), Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.; Kappos, L (corresponding author), Univ Hosp Basel, Neurol Clin & Policlin, Dept Clin Res, Petersgraben 4, CH-4031 Basel, Switzerland.; Kappos, L (corresponding author), Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Petersgraben 4, CH-4031 Basel, Switzerland.; Kappos, L (corresponding author), Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed Engn, Petersgraben 4, CH-4031 Basel, Switzerland.	stephen.hauser@ucsf.edu; kapposl-pa@usb.ch	Montalban, Xavier/J-5938-2016; Bar-Or, Amit/AIC-1416-2022; Wiendl, Heinz/AAX-6041-2021; Ozakbas, Serkan/V-6427-2019; Serrano-Castro, Pedro/A-7537-2008; van Oosten, Bob/I-7152-2012; Vecsei, Laszlo/B-2066-2010	Montalban, Xavier/0000-0002-0098-9918; Serrano-Castro, Pedro/0000-0002-3414-2707; Pingili, Ratnakar/0000-0002-4553-1871; Jasinska, Elzbieta/0000-0003-0016-9896; Cutter, Gary/0000-0002-8455-980X; Castillo-Trivino, Tamara/0000-0002-9249-3185; Willi, Roman/0000-0001-9612-9877; Reingold, Stephen/0000-0003-4485-8634; Derfuss, Tobias/0000-0001-8656-4250; Paz Soldan, M. Mateo/0000-0003-0521-7789; Laplaud, David/0000-0001-6113-6938; Pozzilli, Carlo/0000-0002-6360-4798; Meca-Lallana, Virginia/0000-0001-9418-4127; Pandit, Lekha/0000-0002-2269-5312; van Oosten, Bob/0000-0003-4536-6201; Liow, Kore/0000-0001-6452-9227; MARTINEZ YELAMOS, SERGIO/0000-0001-9889-2040; Reis, AlessanRSS/0000-0001-8486-7469; Turcani, Peter/0000-0002-4868-6836; Sevim, Serhan/0000-0002-0518-3374; Vecsei, Laszlo/0000-0001-8037-3672; Bartosik-Psujek, Halina/0000-0002-2860-6456; YUCEYAR, NUR/0000-0003-4590-6423	Novartis Pharma	Novartis Pharma	Supported by Novartis Pharma.	[Anonymous], 2016, ARZ AUT PRESCR INF; Bar-Or A, 2018, NEUROLOGY, V90, pE1805, DOI 10.1212/WNL.0000000000005516; Buron MD, 2019, NEUROLOGY, V92, pE1811, DOI 10.1212/WNL.0000000000007314; Cancer Institute N, 2017, COMMON TERMINOLOGY C; Confavreux C, 2014, LANCET NEUROL, V13, P247, DOI 10.1016/S1474-4422(13)70308-9; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Engelberts PJ, 2016, J IMMUNOL, V197, P4829, DOI 10.4049/jimmunol.1600811; Fogarty E, 2016, MULT SCLER RELAT DIS, V9, P23, DOI 10.1016/j.msard.2016.06.001; Genentech, 2020, OCR OCR PRESCR INF; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use, 2001, J Postgrad Med, V47, P45; Kahari L, 2019, J CLIN INVEST, V129, P3086, DOI 10.1172/JCI125740; Kalincik T, 2019, J NEUROL NEUROSUR PS, V90, P458, DOI 10.1136/jnnp-2018-319831; Kramer O, 2010, EVOL INTELL, V3, P51, DOI 10.1007/s12065-010-0035-y; Kurrasch R, 2013, J RHEUMATOL, V40, P1089, DOI 10.3899/jrheum.121118; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leppert D, 2017, COMP BCELL RECOVERY; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Roll P, 2006, ARTHRITIS RHEUM-US, V54, P2377, DOI 10.1002/art.22019; Schach S, 2007, MULT SCLER, V13, P509, DOI 10.1177/1352458506069537; Semple KM, 2019, CTS-CLIN TRANSL SCI, V12, P283, DOI 10.1111/cts.12613; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Sorensen PS, 2014, NEUROLOGY, V82, P573, DOI 10.1212/WNL.0000000000000125; Theil D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01340; Vermersch P, 2014, MULT SCLER J, V20, P705, DOI 10.1177/1352458513507821; World Medical Association, 2006, WMA DECL HELS ETH PR	30	173	177	7	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					546	557		10.1056/NEJMoa1917246	http://dx.doi.org/10.1056/NEJMoa1917246			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	32757523	Green Published, Bronze			2022-12-28	WOS:000560438400017
J	Shen, MH; Wu, MY				Shen, Meng-Han; Wu, Ming-Ying			Palatal Ulceration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 50-year-old woman presented with a large ulcer on her palate, intermittent fevers, and general malaise. Physical examination revealed a necrotic ulcer, and histopathological examination confirmed natural killer T-cell lymphoma.	[Shen, Meng-Han; Wu, Ming-Ying] Chang Gung Mem Hosp, Linkou, Taiwan	Chang Gung Memorial Hospital	Shen, MH (corresponding author), Chang Gung Mem Hosp, Linkou, Taiwan.	mp0541@cgmh.org.tw		Shen, Meng-Han/0000-0003-4714-424X					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					474	474		10.1056/NEJMicm1915191	http://dx.doi.org/10.1056/NEJMicm1915191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MW2GI	32726533				2022-12-28	WOS:000556861800014
J	Smith, DM; Scaife, AA; Eade, R; Athanasiadis, P; Bellucci, A; Bethke, I; Bilbao, R; Borchert, LF; Caron, LP; Counillon, F; Danabasoglu, G; Delworth, T; Doblas-Reyes, FJ; Dunstone, NJ; Estella-Perez, V; Flavoni, S; Hermanson, L; Keenlyside, N; Kharin, V; Kimoto, M; Merryfield, WJ; Mignot, J; Mochizuki, T; Modali, K; Monerie, PA; Muller, WA; Nicoli, D; Ortega, P; Pankatz, K; Pohlmann, H; Robson, J; Ruggieri, P; Sospedra-Alfonso, R; Swingedouw, D; Wang, Y; Wild, S; Yeager, S; Yang, X; Zhang, L				Smith, D. M.; Scaife, A. A.; Eade, R.; Athanasiadis, P.; Bellucci, A.; Bethke, I.; Bilbao, R.; Borchert, L. F.; Caron, L. -P.; Counillon, F.; Danabasoglu, G.; Delworth, T.; Doblas-Reyes, F. J.; Dunstone, N. J.; Estella-Perez, V.; Flavoni, S.; Hermanson, L.; Keenlyside, N.; Kharin, V.; Kimoto, M.; Merryfield, W. J.; Mignot, J.; Mochizuki, T.; Modali, K.; Monerie, P. -A.; Mueller, W. A.; Nicoli, D.; Ortega, P.; Pankatz, K.; Pohlmann, H.; Robson, J.; Ruggieri, P.; Sospedra-Alfonso, R.; Swingedouw, D.; Wang, Y.; Wild, S.; Yeager, S.; Yang, X.; Zhang, L.			North Atlantic climate far more predictable than models imply	NATURE			English	Article							SEASONAL PREDICTIONS; ATMOSPHERIC CIRCULATION; DECADAL PREDICTION; OSCILLATION; VARIABILITY; SKILL; CMIP5; NAO; INITIALIZATION; UNCERTAINTY	Current models are too noisy to predict climate usefully on decadal timescales, but two-stage post-processing of model outputs greatly improves predictions of decadal variations in North Atlantic winter climate. Quantifying signals and uncertainties in climate models is essential for the detection, attribution, prediction and projection of climate change(1-3). Although inter-model agreement is high for large-scale temperature signals, dynamical changes in atmospheric circulation are very uncertain(4). This leads to low confidence in regional projections, especially for precipitation, over the coming decades(5,6). The chaotic nature of the climate system(7-9)may also mean that signal uncertainties are largely irreducible. However, climate projections are difficult to verify until further observations become available. Here we assess retrospective climate model predictions of the past six decades and show that decadal variations in North Atlantic winter climate are highly predictable, despite a lack of agreement between individual model simulations and the poor predictive ability of raw model outputs. Crucially, current models underestimate the predictable signal (the predictable fraction of the total variability) of the North Atlantic Oscillation (the leading mode of variability in North Atlantic atmospheric circulation) by an order of magnitude. Consequently, compared to perfect models, 100 times as many ensemble members are needed in current models to extract this signal, and its effects on the climate are underestimated relative to other factors. To address these limitations, we implement a two-stage post-processing technique. We first adjust the variance of the ensemble-mean North Atlantic Oscillation forecast to match the observed variance of the predictable signal. We then select and use only the ensemble members with a North Atlantic Oscillation sufficiently close to the variance-adjusted ensemble-mean forecast North Atlantic Oscillation. This approach greatly improves decadal predictions of winter climate for Europe and eastern North America. Predictions of Atlantic multidecadal variability are also improved, suggesting that the North Atlantic Oscillation is not driven solely by Atlantic multidecadal variability. Our results highlight the need to understand why the signal-to-noise ratio is too small in current climate models(10), and the extent to which correcting this model error would reduce uncertainties in regional climate change projections on timescales beyond a decade.	[Smith, D. M.; Scaife, A. A.; Eade, R.; Dunstone, N. J.; Hermanson, L.] Met Off Hadley Ctr, Exeter, Devon, England; [Scaife, A. A.] Exeter Univ, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Athanasiadis, P.; Bellucci, A.; Nicoli, D.; Ruggieri, P.] Ctr Euro Mediterraneo Cambiamenti Climat, Bologna, Italy; [Bethke, I.; Counillon, F.; Keenlyside, N.] Univ Bergen, Geophys Inst, Bergen, Norway; [Bethke, I.; Counillon, F.; Keenlyside, N.] Bjerknes Ctr Climate Res, Bergen, Norway; [Bilbao, R.; Caron, L. -P.; Doblas-Reyes, F. J.; Ortega, P.; Wild, S.] Barcelona Supercomp Ctr, Barcelona, Spain; [Borchert, L. F.; Estella-Perez, V.; Flavoni, S.; Mignot, J.] Sorbonne Univ, Inst Pierre Simon Laplace IPSL, LOCEAN Lab, Paris, France; [Counillon, F.; Keenlyside, N.; Wang, Y.] Nansen Environm & Remote Sensing Ctr, Bergen, Norway; [Danabasoglu, G.; Yeager, S.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Delworth, T.; Yang, X.; Zhang, L.] Princeton Univ, Geophys Fluid Dynam Lab, Princeton, NJ 08544 USA; [Doblas-Reyes, F. J.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain; [Kharin, V.; Merryfield, W. J.; Sospedra-Alfonso, R.] Environm & Climate Change Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada; [Kimoto, M.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Mochizuki, T.] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka, Fukuoka, Japan; [Mochizuki, T.] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Modali, K.; Mueller, W. A.; Pohlmann, H.] Max Planck Inst Meteorol, Hamburg, Germany; [Monerie, P. -A.; Robson, J.] Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci, Reading, Berks, England; [Pankatz, K.; Pohlmann, H.] Deutsch Wetterdienst, Hamburg, Germany; [Swingedouw, D.] Univ Bordeaux, CNRS EPOC, Pessac, France; [Modali, K.] Univ Hamburg, Reg Comp Ctr, Hamburg, Germany	Met Office - UK; Hadley Centre; University of Exeter; University of Bergen; Bjerknes Centre for Climate Research; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Nansen Environmental & Remote Sensing Center (NERSC); National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; ICREA; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); University of Tokyo; Kyushu University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Max Planck Society; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Reading; UDICE-French Research Universities; Universite de Bordeaux; University of Hamburg	Smith, DM (corresponding author), Met Off Hadley Ctr, Exeter, Devon, England.	doug.smith@metoffice.gov.uk	Yang, Xiaosong/C-7260-2009; Borchert, Leonard/Y-2057-2019; Robson, Jon/A-7677-2012; Smith, Doug/ABD-5204-2021; Swingedouw, Didier/M-5471-2019; Wild, Simon/I-3673-2012; Estella Perez, Victor/GLV-6405-2022; Ruggieri, Paolo/X-6334-2018; Ortega, Pablo/ABE-7884-2020; Zhang, Liping/L-6480-2015; Keenlyside, Noel S/E-8303-2013	Yang, Xiaosong/0000-0003-3154-605X; Borchert, Leonard/0000-0002-3232-7409; Robson, Jon/0000-0002-3467-018X; Swingedouw, Didier/0000-0002-0583-0850; Wild, Simon/0000-0002-1089-5579; Estella Perez, Victor/0000-0003-3860-9121; Ruggieri, Paolo/0000-0003-1996-7206; Ortega, Pablo/0000-0002-4135-9621; Zhang, Liping/0000-0003-1122-8927; Keenlyside, Noel S/0000-0002-8708-6868; Danabasoglu, Gokhan/0000-0003-4676-2732; Wang, Yiguo/0000-0001-9544-8382; Counillon, Francois/0000-0002-6412-3806; Smith, Doug/0000-0001-5708-694X; Athanasiadis, Panos/0000-0003-1249-6624; Sospedra-Alfonso, Reinel/0000-0002-4472-5607; Nicoli, Dario/0000-0001-5890-9346; BELLUCCI, Alessio/0000-0003-3766-1921				Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Athanasiadis PJ, 2020, NPJ CLIM ATMOS SCI, V3, DOI 10.1038/s41612-020-0120-6; Baker AJ, 2019, J CLIMATE, V32, P7763, DOI 10.1175/JCLI-D-19-0054.1; Baker LH, 2018, GEOPHYS RES LETT, V45, P7808, DOI 10.1029/2018GL078838; Bindoff N. L., 2013, CLIM CHANG 2013 PHYS, DOI 10.1017/CBO9781107415324.022; Boer GJ, 2016, GEOSCI MODEL DEV, V9, P3751, DOI 10.5194/gmd-9-3751-2016; Borchert LF, 2019, GEOPHYS RES LETT, V46, P14042, DOI 10.1029/2019GL085385; Bracegirdle TJ, 2018, GEOPHYS RES LETT, V45, P7204, DOI 10.1029/2018GL078965; Cheung AH, 2017, J CLIMATE, V30, P4763, DOI [10.1175/JCLI-D-16-0712.1, 10.1175/jcli-d-16-0712.1]; Chikamoto Y, 2013, CLIM DYNAM, V40, P1201, DOI 10.1007/s00382-012-1351-y; Clement A, 2015, SCIENCE, V350, P320, DOI 10.1126/science.aab3980; Collins M., 2013, CLIMATE CHANGE 2013, P1029; Counillon F, 2016, TELLUS A, V68, DOI 10.3402/tellusa.v68.32437; Czaja A, 2019, CURR CLIM CHANGE REP, V5, P390, DOI 10.1007/s40641-019-00148-5; Deser C, 2017, CLIM DYNAM, V49, P3141, DOI 10.1007/s00382-016-3502-z; Doblas-Reyes FJ, 2009, Q J ROY METEOR SOC, V135, P1538, DOI 10.1002/qj.464; Doblas-Reyes F.J, 2018, ECMWF NEWSLETTER, P35, DOI [10.21957/fd9kz3, DOI 10.21957/FD9KZ3]; Dobrynin M, 2018, GEOPHYS RES LETT, V45, P3605, DOI 10.1002/2018GL077209; Dunstone N, 2018, GEOPHYS RES LETT, V45, P3246, DOI 10.1002/2017GL076337; Dunstone N, 2016, NAT GEOSCI, V9, P809, DOI 10.1038/ngeo2824; Eade R, 2014, GEOPHYS RES LETT, V41, P5620, DOI 10.1002/2014GL061146; Eden C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014069; Eden C, 2001, J CLIMATE, V14, P2266, DOI 10.1175/1520-0442(2001)014<2266:MOITDV>2.0.CO;2; Fereday D, 2018, J CLIMATE, V31, P963, DOI 10.1175/JCLI-D-17-0048.1; Gangsto R, 2013, CLIM RES, V55, P181, DOI 10.3354/cr01135; Goddard L, 2013, CLIM DYNAM, V40, P245, DOI 10.1007/s00382-012-1481-2; Greatbatch RJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017406; Haarsma R.J., 2020, GEOSCI MODEL DEV DIS, V2020, P1, DOI [10.5194/ gmd-2019-350, DOI 10.5194/GMD-2019-350, 10.5194/gmd-2019-350]; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hawkins E, 2016, CLIM DYNAM, V46, P3807, DOI 10.1007/s00382-015-2806-8; Hawkins E, 2011, CLIM DYNAM, V37, P407, DOI 10.1007/s00382-010-0810-6; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hodson DLR, 2008, CLIM DYNAM, V31, P973, DOI 10.1007/s00382-008-0372-z; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jin YH, 2018, CLIM DYNAM, V51, P2725, DOI 10.1007/s00382-017-4040-z; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Kharin VV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052647; Kim WM, 2018, GEOPHYS RES LETT, V45, P13449, DOI 10.1029/2018GL080474; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Kravtsov S, 2017, GEOPHYS RES LETT, V44, P5749, DOI 10.1002/2017GL074016; Krishnamurti TN, 1999, SCIENCE, V285, P1548, DOI 10.1126/science.285.5433.1548; Kug JS, 2008, ASIA-PAC J ATMOS SCI, V44, P259; Kumar A, 2018, CLIM DYNAM, V51, P2397, DOI 10.1007/s00382-017-4019-9; Marotzke J, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.563; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; Midgley, 2013, CLIMATE CHANGE 2013; Mochizuki T, 2012, J METEOROL SOC JPN, V90A, P373, DOI 10.2151/jmsj.2012-A22; Mori M, 2019, NAT CLIM CHANGE, V9, P123, DOI 10.1038/s41558-018-0379-3; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Muller WA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053326; O'Reilly CH, 2019, Q J ROY METEOR SOC, V145, P131, DOI 10.1002/qj.3413; Pohlmann H, 2019, GEOPHYS RES LETT, V46, P14118, DOI 10.1029/2019GL084878; Scaife AA, 2014, GEOPHYS RES LETT, V41, P2514, DOI 10.1002/2014GL059637; Scaife AA, 2009, CLIM DYNAM, V33, P603, DOI 10.1007/s00382-008-0451-1; Scaife AA, 2019, ATMOS SCI LETT, V20, DOI 10.1002/asl.922; Scaife AA, 2018, NPJ CLIM ATMOS SCI, V1, DOI 10.1038/s41612-018-0038-4; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Shepherd TG, 2014, NAT GEOSCI, V7, P703, DOI 10.1038/NGEO2253; Shin SI, 2011, CLIM DYNAM, V36, P1577, DOI 10.1007/s00382-009-0732-3; Siegert S, 2016, J CLIMATE, V29, P995, DOI 10.1175/JCLI-D-15-0196.1; Simpson IR, 2019, NAT GEOSCI, V12, P613, DOI 10.1038/s41561-019-0391-x; Smith DM, 2019, NPJ CLIM ATMOS SCI, V2, DOI 10.1038/s41612-019-0071-y; Smith DM, 2013, CLIM DYNAM, V41, P3325, DOI 10.1007/s00382-013-1683-2; Sospedra-Alfonso R, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL086361; Strommen K, 2019, Q J ROY METEOR SOC, V145, P147, DOI 10.1002/qj.3414; Swart NC, 2019, GEOSCI MODEL DEV, V12, P4823, DOI 10.5194/gmd-12-4823-2019; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Wang XF, 2017, J GEOPHYS RES-ATMOS, V122, P4202, DOI 10.1002/2016JD025979; Wang YG, 2017, OCEAN MODEL, V114, P33, DOI 10.1016/j.ocemod.2017.04.007; Weisheimer A, 2019, Q J ROY METEOR SOC, V145, P140, DOI 10.1002/qj.3446; Wilks D. S., 2019, STAT METHODS ATMOSPH; Williams KD, 2018, J ADV MODEL EARTH SY, V10, P357, DOI 10.1002/2017MS001115; Woollings T, 2010, PHILOS T R SOC A, V368, P3733, DOI 10.1098/rsta.2010.0040; Yang XS, 2013, J CLIMATE, V26, P650, DOI 10.1175/JCLI-D-12-00231.1; Yeager SG, 2018, B AM METEOROL SOC, V99, P1867, DOI 10.1175/BAMS-D-17-0098.1; Yeager SG, 2017, CURR CLIM CHANGE REP, V3, P112, DOI 10.1007/s40641-017-0064-z; Yun WT, 2003, J CLIMATE, V16, P3834, DOI 10.1175/1520-0442(2003)016<3834:IOTMST>2.0.CO;2; Zanardo S, 2019, GEOPHYS RES LETT, V46, P2563, DOI 10.1029/2019GL081956; Zappa G, 2017, J CLIMATE, V30, P6561, DOI 10.1175/JCLI-D-16-0807.1; Zhang W, 2019, GEOPHYS RES LETT, V46, P13308, DOI 10.1029/2019GL085159	83	88	89	11	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					796	+		10.1038/s41586-020-2525-0	http://dx.doi.org/10.1038/s41586-020-2525-0			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728237	Green Accepted, Green Submitted			2022-12-28	WOS:000554831500034
J	Van Nostrand, EL; Freese, P; Pratt, GA; Wang, XF; Wei, XT; Xiao, R; Blue, SM; Chen, JY; Cody, NAL; Dominguez, DI; Olson, S; Sundararaman, B; Zhan, LJ; Bazile, C; Bouvrette, LPB; Bergalet, J; Duff, MO; Garcia, KE; Gelboin-Burkhart, C; Hochman, M; Lambert, NJ; Li, HR; McGurk, MP; Nguyen, TB; Palden, T; Rabano, I; Sathe, S; Stanton, R; Su, A; Wang, R; Yee, BA; Zhou, B; Louie, AL; Aigner, S; Fu, XD; Lecuyer, E; Burge, CB; Graveley, BR; Yeo, GW				Van Nostrand, Eric L.; Freese, Peter; Pratt, Gabriel A.; Wang, Xiaofeng; Wei, Xintao; Xiao, Rui; Blue, Steven M.; Chen, Jia-Yu; Cody, Neal A. L.; Dominguez, Daniel; Olson, Sara; Sundararaman, Balaji; Zhan, Lijun; Bazile, Cassandra; Bouvrette, Louis Philip Benoit; Bergalet, Julie; Duff, Michael O.; Garcia, Keri E.; Gelboin-Burkhart, Chelsea; Hochman, Myles; Lambert, Nicole J.; Li, Hairi; McGurk, Michael P.; Nguyen, Thai B.; Palden, Tsultrim; Rabano, Ines; Sathe, Shashank; Stanton, Rebecca; Su, Amanda; Wang, Ruth; Yee, Brian A.; Zhou, Bing; Louie, Ashley L.; Aigner, Stefan; Fu, Xiang-Dong; Lecuyer, Eric; Burge, Christopher B.; Graveley, Brenton R.; Yeo, Gene W.			A large-scale binding and functional map of human RNA-binding proteins	NATURE			English	Article							NASCENT RNA; DISCOVERY; QUANTIFICATION; SEQUENCE; INSIGHTS; BIOLOGY; ROBUST; READ; SR	A combination of five assays is used to produce a catalogue of RNA elements to which RNA-binding proteins bind in human cells. Many proteins regulate the expression of genes by binding to specific regions encoded in the genome(1). Here we introduce a new data set of RNA elements in the human genome that are recognized by RNA-binding proteins (RBPs), generated as part of the Encyclopedia of DNA Elements (ENCODE) project phase III. This class of regulatory elements functions only when transcribed into RNA, as they serve as the binding sites for RBPs that control post-transcriptional processes such as splicing, cleavage and polyadenylation, and the editing, localization, stability and translation of mRNAs. We describe the mapping and characterization of RNA elements recognized by a large collection of human RBPs in K562 and HepG2 cells. Integrative analyses using five assays identify RBP binding sites on RNA and chromatin in vivo, the in vitro binding preferences of RBPs, the function of RBP binding sites and the subcellular localization of RBPs, producing 1,223 replicated data sets for 356 RBPs. We describe the spectrum of RBP binding throughout the transcriptome and the connections between these interactions and various aspects of RNA biology, including RNA stability, splicing regulation and RNA localization. These data expand the catalogue of functional elements encoded in the human genome by the addition of a large set of elements that function at the RNA level by interacting with RBPs.	[Van Nostrand, Eric L.; Pratt, Gabriel A.; Xiao, Rui; Blue, Steven M.; Chen, Jia-Yu; Sundararaman, Balaji; Garcia, Keri E.; Gelboin-Burkhart, Chelsea; Li, Hairi; Nguyen, Thai B.; Rabano, Ines; Sathe, Shashank; Stanton, Rebecca; Wang, Ruth; Yee, Brian A.; Zhou, Bing; Louie, Ashley L.; Aigner, Stefan; Fu, Xiang-Dong; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Van Nostrand, Eric L.; Pratt, Gabriel A.; Xiao, Rui; Blue, Steven M.; Chen, Jia-Yu; Sundararaman, Balaji; Garcia, Keri E.; Gelboin-Burkhart, Chelsea; Li, Hairi; Nguyen, Thai B.; Rabano, Ines; Sathe, Shashank; Stanton, Rebecca; Wang, Ruth; Yee, Brian A.; Zhou, Bing; Louie, Ashley L.; Aigner, Stefan; Fu, Xiang-Dong; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Freese, Peter; Burge, Christopher B.] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Pratt, Gabriel A.; Yeo, Gene W.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Wang, Xiaofeng; Cody, Neal A. L.; Bouvrette, Louis Philip Benoit; Bergalet, Julie; Lecuyer, Eric] Inst Rech Clin Montreal IRCM, Montreal, PQ, Canada; [Wei, Xintao; Olson, Sara; Zhan, Lijun; Duff, Michael O.; Graveley, Brenton R.] UConn Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA; [Xiao, Rui; Dominguez, Daniel] Wuhan Univ, Med Res Inst, Wuhan, Peoples R China; [Bazile, Cassandra; Hochman, Myles; Lambert, Nicole J.; McGurk, Michael P.; Palden, Tsultrim; Su, Amanda; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bouvrette, Louis Philip Benoit; Lecuyer, Eric] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada; [Palden, Tsultrim; Burge, Christopher B.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lecuyer, Eric] McGill Univ, Div Expt Med, Montreal, PQ, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Wuhan University; Massachusetts Institute of Technology (MIT); Universite de Montreal; Massachusetts Institute of Technology (MIT); McGill University	Fu, XD; Yeo, GW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Fu, XD; Yeo, GW (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.; Burge, CB (corresponding author), MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.; Lecuyer, E (corresponding author), Inst Rech Clin Montreal IRCM, Montreal, PQ, Canada.; Graveley, BR (corresponding author), UConn Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA.; Burge, CB (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Lecuyer, E (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada.; Burge, CB (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lecuyer, E (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ, Canada.	xdfu@ucsd.edu; eric.lecuyer@ircm.qc.ca; cburge@mit.edu; graveley@uchc.edu; geneyeo@ucsd.edu	Chen, Jia-Yu/J-6798-2013; Yeo, Gene/AAE-7676-2019; Sundararaman, Balaji/GWQ-5695-2022; Aigner, Stefan/D-1272-2017	Chen, Jia-Yu/0000-0001-9449-9321; Yeo, Gene/0000-0002-0799-6037; Sundararaman, Balaji/0000-0001-8559-1660; Aigner, Stefan/0000-0002-9511-3328; Van Nostrand, Eric/0000-0002-5188-0082; Nguyen, Thai Bao/0000-0001-8450-2988; Xiao, Rui/0000-0002-9477-1054; Yee, Brian/0000-0001-5615-8550; Blue, Steven/0000-0003-0279-6690	NCI NIH HHS [R01 CA226898] Funding Source: Medline; NHGRI NIH HHS [U41 HG009889, U54 HG007005, R01 HG004659] Funding Source: Medline; NIGMS NIH HHS [T32 GM087237] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afroz T, 2015, METHOD ENZYMOL, V558, P235, DOI 10.1016/bs.mie.2015.01.015; Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Attig J, 2018, CELL, V174, P1067, DOI 10.1016/j.cell.2018.07.001; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Brannan KW, 2016, MOL CELL, V64, P282, DOI 10.1016/j.molcel.2016.09.003; Brosseau JP, 2014, RNA, V20, P189, DOI 10.1261/rna.042168.113; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Conway AE, 2016, CELL REP, V15, P666, DOI 10.1016/j.celrep.2016.03.052; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Erkelenz S, 2013, RNA, V19, P96, DOI 10.1261/rna.037044.112; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hauer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8921; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kapeli K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12143; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Nussbacher JK, 2018, MOL CELL, V69, P1005, DOI 10.1016/j.molcel.2018.02.012; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Quinones-Valdez G, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0271-8; Ren F, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0827-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; SONENBERG N, 1979, NUCLEIC ACIDS RES, V7, P15, DOI 10.1093/nar/7.1.15; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tan LY, 2015, NUCLEIC ACIDS RES, V43, P5586, DOI 10.1093/nar/gkv429; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Wei CL, 2016, MOL CELL, V62, P875, DOI 10.1016/j.molcel.2016.04.013; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Yee BA, 2019, RNA, V25, P193, DOI 10.1261/rna.069237.118; Zhang F., 2018, HUM MOL GENET, V15, P3936	56	244	244	18	66	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					711	+		10.1038/s41586-020-2077-3	http://dx.doi.org/10.1038/s41586-020-2077-3			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728246	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000554831500021
J	Mayer, KH; Molina, JM; Thompson, MA; Anderson, PL; Mounzer, KC; De Wet, JJ; DeJesus, E; Jessen, H; Grant, RM; Ruane, PJ; Wong, P; Ebrahimi, R; Zhong, LJ; Mathias, A; Callebaut, C; Collins, SE; Das, M; McCallister, S; Brainard, DM; Brinson, C; Clarke, A; Coll, P; Post, FA; Hare, CB				Mayer, Kenneth H.; Molina, Jean-Michel; Thompson, Melanie A.; Anderson, Peter L.; Mounzer, Karam C.; De Wet, Joss J.; DeJesus, Edwin; Jessen, Heiko; Grant, Robert M.; Ruane, Peter J.; Wong, Pamela; Ebrahimi, Ramin; Zhong, Lijie; Mathias, Anita; Callebaut, Christian; Collins, Sean E.; Das, Moupali; McCallister, Scott; Brainard, Diana M.; Brinson, Cynthia; Clarke, Amanda; Coll, Pep; Post, Frank A.; Hare, C. Bradley			Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial	LANCET			English	Article							VIROLOGICALLY SUPPRESSED ADULTS; PEAK BONE MASS; INFECTION; SAFETY; MEN; ELVITEGRAVIR; COBICISTAT; EFFICACY; RISK; RILPIVIRINE	Background Tenofovir alafenamide shows high antiviral efficacy and improved renal and bone safety compared with tenofovir disoproxil fumarate when used for HIV treatment. Here, we report primary results from a blinded phase 3 study evaluating the efficacy and safety of pre-exposure prophylaxis (PrEP) with emtricitabine and tenofovir alafenamide versus emtricitabine and tenofovir disoproxil fumarate for HIV prevention. Methods This study is an ongoing, randomised, double-blind, multicentre, active-controlled, phase 3, noninferiority trial done at 94 community, public health, and hospital-associated clinics located in regions of Europe and North America, where there is a high incidence of HIV or prevalence of people living with HIV, or both. We enrolled adult cisgender men who have sex with men and transgender women who have sex with men, both with a high risk of acquiring HIV on the basis of their self-reported sexual behaviour in the past 12 weeks or their recent history (within 24 weeks of enrolment) of bacterial sexually transmitted infections. Participants with current or previous use of PrEP with emtricitabine and tenofovir disoproxil fumarate were not excluded. We used a computer-generated random allocation sequence to randomly assign (1:1) participants to receive either emtricitabine (200 mg) and tenofovir alafenamide (25 mg) tablets daily, with matched placebo tablets (emtricitabine and tenofovir alafenamide group), or emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg) tablets daily, with matched placebo tablets (emtricitabine and tenofovir disoproxil fumarate group). As such, all participants were given two tablets. The trial sponsor, investigators, participants, and the study staff who provided the study drugs, assessed the outcomes, and collected the data were masked to group assignment. The primary efficacy outcome was incident HIV infection, which was assessed when all participants had completed 48 weeks of followup and half of all participants had completed 96 weeks of follow-up. This full analysis set included all randomly assigned participants who had received at least one dose of the assigned study drug and had at least one post-baseline HIV test. Non-inferiority of emtricitabine and tenofovir alafenamide to emtricitabine and tenofovir disoproxil fumarate was established if the upper bound of the 95.003% CI of the HIV incidence rate ratio (IRR) was less than the prespecified non-inferiority margin of 1.62. We prespecified six secondary bone mineral density and renal biomarker safety endpoints to evaluate using the safety analysis set. This analysis set included all randomly assigned participants who had received at least one dose of the assigned study drug. This trial is registered with ClinicalTrials.gov, NCT02842086, and is no longer recruiting. Findings Between Sept 13, 2016, and June 30, 2017, 5387 (92%) of 5857 participants were randomly assigned and received emtricitabine and tenofovir alafenamide (n=2694) or emtricitabine and tenofovir disoproxil fumarate (n=2693). At the time of the primary efficacy analysis (ie, when all participants had completed 48 weeks and 50% had completed 96 weeks) emtricitabine and tenofovir alafenamide was non-inferior to emtricitabine and tenofovir disoproxil fumarate for HIV prevention, as the upper limit of the 95% CI of the IRR, was less than the prespecified non-inferiority margin of 1.62 (IRR 0.47 [95% CI 0.19-1.15]). After 8756 person-years of follow-up, 22 participants were diagnosed with HIV, seven participants in the emtricitabine and tenofovir alafenamide group (0.16 infections per 100 person-years [95% CI 0.06-0.33]), and 15 participants in the emtricitabine and tenofovir disoproxil fumarate group (0.34 infections per 100 person-years [0 49-0. 56]). Both regimens were well tolerated, with a low number of participants reporting adverse events that led to discontinuation of the study drug (36 [1%] of 2694 participants in the emtricitabine and tenofovir alafenamide group vs 49 [2%] of 2693 participants in the emtricitabine and tenofovir disoproxil fumarate group). Emtricitabine and tenofovir alafenamide was superior to emtricitabine and tenofovir disoproxil fumarate in all six prespecified bone mineral density and renal biomarker safety endpoints. Interpretation Daily emtricitabine and tenofovir alafenamide shows non-inferior efficacy to daily emtricitabine and tenofovir disoproxil fumarate for HIV prevention, and the number of adverse events for both regimens was low. Emtricitabine and tenofovir alafenamide had more favourable effects on bone mineral density and biomarkers of renal safety than emtricitabine and tenofovir disoproxil fumarate. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Molina, Jean-Michel] Univ Paris, Dept Infect Dis, Hop St Louis Lariboisiere, Paris, France; [Molina, Jean-Michel] INSERM U944, Paris, France; [Thompson, Melanie A.] AIDS Res Consortium Atlanta, Atlanta, GA USA; [Anderson, Peter L.] Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Mounzer, Karam C.] Philadelphia FIGHT, Philadelphia, PA USA; [De Wet, Joss J.] Spectrum Hlth, Vancouver, BC, Canada; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Jessen, Heiko] Praxis Jessen2 Kollegen, Berlin, Germany; [Grant, Robert M.] San Francisco AIDS Fdn, San Francisco, CA USA; [Grant, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ruane, Peter J.] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA; [Wong, Pamela; Ebrahimi, Ramin; Zhong, Lijie] Gilead Sci, Dept Biometr, Foster City, CA USA; [Mathias, Anita] Gilead Sci, Dept Clin Pharmacol, Foster City, CA USA; [Callebaut, Christian] Gilead Sci, Dept Virol, Foster City, CA USA; [Collins, Sean E.; Das, Moupali; McCallister, Scott; Brainard, Diana M.] Gilead Sci, Dept HIV & Emerging Viral Infect Clin Res, Foster City, CA 94404 USA; [Brinson, Cynthia] Cent Texas Clin Res, Austin, TX USA; [Clarke, Amanda] Brighton & Sussex Univ Hosp Natl Hlth Serv NHS Tr, Royal Sussex Cty Hosp, Brighton, E Sussex, England; [Coll, Pep] BCN Checkpoint & IrsiCaixa AIDS Res Inst, Barcelona, Spain; [Post, Frank A.] Kings Coll Hosp NHS Fdn Trust, Kings Coll Hosp, London, England; [Hare, C. Bradley] Kaiser Permanente San Francisco Med Ctr, Dept Adult & Family Med, San Francisco, CA USA	Fenway Health; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Anschutz Medical Campus; Orlando Immunology Center; University of California System; University of California San Francisco; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; University of Brighton; King's College Hospital NHS Foundation Trust; King's College Hospital; Kaiser Permanente	Das, M (corresponding author), Gilead Sci, Dept HIV & Emerging Viral Infect Clin Res, Foster City, CA 94404 USA.	moupali.as@gilead.com			Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	Agarwal K, 2018, J HEPATOL, V68, P672, DOI 10.1016/j.jhep.2017.11.039; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], GUID US ANT AG AD AD; Arribas JR, 2017, JAIDS-J ACQ IMM DEF, V75, P211, DOI 10.1097/qai.0000000000001350; AVAC, 2011, GOOD PART PRACT GUID, V2nd ed; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Becasen JS, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2018.304727; Borges AH, 2017, CLIN INFECT DIS, V64, P1413, DOI 10.1093/cid/cix167; Chan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3; Chen, 2018, OPEN FORUM INFECT S1, V5, pS396; Chou R, 2019, JAMA-J AM MED ASSOC, V321, P2214, DOI 10.1001/jama.2019.2591; DeJesus E, 2017, LANCET HIV, V4, pE205, DOI 10.1016/S2352-3018(17)30032-2; Elsesser SA, 2016, AIDS BEHAV, V20, P1400, DOI 10.1007/s10461-015-1238-0; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Gallant JE, 2016, LANCET HIV, V3, pE158, DOI 10.1016/S2352-3018(16)00024-2; Gilead Sciences, 2018, HIGHL PRESCR INF; Glidden DV, 2018, CLIN INFECT DIS, V67, P411, DOI 10.1093/cid/ciy083; Glidden DV, 2019, STAT COMMUN INFECT D, V11; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2018, LANCET HIV, V5, pE629, DOI 10.1016/S2352-3018(18)30215-7; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Gupta SK, 2019, AIDS, V33, P1455, DOI 10.1097/QAD.0000000000002223; Highleyman L., 2018, PREP SCALES HIV INCI; Hill A, 2019, 10 INT AIDS C HIV SC; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hodder S, 2018, JAIDS-J ACQ IMM DEF, V78, P209, DOI 10.1097/QAI.0000000000001663; Hoover, 2019, C RETR OPP INF MARCH; Huhn GD, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofz472; Kearney BP, 2009, PHARMACOTHERAPY, V29, P924, DOI 10.1592/phco.29.8.924; Landovitz RJ, 2020, CLIN INFECT DIS; LaVange LM, 2008, WILEY ENCY CLIN TRIA, P31; Littman AJ, 2013, INT J OBESITY, V37, P244, DOI 10.1038/ijo.2012.46; Malhotra R, 2013, OBESITY, V21, P1923, DOI 10.1002/oby.20318; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; Markowitz M, 2017, JAIDS-J ACQ IMM DEF, V76, pE104, DOI 10.1097/QAI.0000000000001534; Mary-Krause M, 2014, INT J EPIDEMIOL, V43, P1425, DOI 10.1093/ije/dyu002; Massud I, 2016, J INFECT DIS, V214, P1058, DOI 10.1093/infdis/jiw312; Mayer D, 2019, KNOWLEDGE, POLICY AND PRACTICE IN TEACHER EDUCATION: A CROSS-NATIONAL STUDY, P21; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mera R, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25433; Mills A, 2016, LANCET INFECT DIS, V16, P43, DOI 10.1016/S1473-3099(15)00348-5; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; Mullick C, 2020, J INFECT DIS, V221, P214, DOI 10.1093/infdis/jiz037; New York City Department of Health and Mental Hygiene, 2018, HIV SURV ANN REP 201; Nwokolo N, 2017, LANCET HIV, V4, pE153, DOI 10.1016/S2352-3018(17)30044-9; NYC Health, 2019, ON DEM DOS PREP GUID; Orkin C, 2017, LANCET HIV, V4, pE195, DOI 10.1016/S2352-3018(17)30031-0; Parikh UM, 2016, CURR OPIN HIV AIDS, V11, P49, DOI 10.1097/COH.0000000000000209; Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45; San Francisco Department of Public Health, 2019, IMP HIV PREV TREATM; San Francisco Department of Public Health Population Health Division, 2018, HIV EP ANN REP 2017; Santos JR, 2015, CLIN INFECT DIS, V61, P403, DOI 10.1093/cid/civ296; Sax PE, 2020, CLIN INFECT DIS, V71, P1379, DOI 10.1093/cid/ciz999; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Schwartz J, 2013, CERN REPORT, P21; Schwartz JL, 2018, HIV RES PREV C MADR; Spinner CD, DISCOVER STUDY HIV P; Sullivan PS., 2018, 22 INT AIDS C 23 27; Thaden JT, 2018, AIDS, V32, pF1, DOI 10.1097/QAD.0000000000001825; Tungsiripat M, 2010, AIDS, V24, P1781, DOI 10.1097/QAD.0b013e32833ad8b4; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; US CDC, 2015, 2015 SEX TRANSM DIS; US CDC, 2019, EFF PREV STRAT RED R; US CDC, 2018, HIV SURV REP DIAGN H; US CDC, 2018, HIV GAY BIS MEN; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Vuylsteke B, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25407; Walsh JS, 2009, OSTEOPOROSIS INT, V20, P355, DOI 10.1007/s00198-008-0672-5; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Wiens BL, 2005, J BIOPHARM STAT, V15, P929, DOI 10.1080/10543400500265660; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; World Health Organization, 2019, WHATS 2 1 1 EV DRIV	74	134	136	4	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					239	254						16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK8ZY	32711800	Green Published			2022-12-28	WOS:000567020100033
J	Dyer, C				Dyer, Clare			Cosmetic surgeon wins appeal against suspension from UK medical register	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6724	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2020	370								m2986	10.1136/bmj.m2986	http://dx.doi.org/10.1136/bmj.m2986			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7IG	32709615				2022-12-28	WOS:000554448500003
J	Headey, D; Heidkamp, R; Osendarp, S; Ruel, M; Scott, N; Black, R; Shekar, M; Bouis, H; Flory, A; Haddad, L; Walker, N				Headey, Derek; Heidkamp, Rebecca; Osendarp, Saskia; Ruel, Marie; Scott, Nick; Black, Robert; Shekar, Meera; Bouis, Howarth; Flory, Augustin; Haddad, Lawrence; Walker, Neff		Standing Together Nutr Consortium	Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality	LANCET			English	Editorial Material									[Headey, Derek; Ruel, Marie; Bouis, Howarth] Int Food Policy Res Inst IFPRI, Washington, DC USA; [Heidkamp, Rebecca; Black, Robert; Walker, Neff] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Osendarp, Saskia] Micronutrient Forum, Washington, DC 20005 USA; [Scott, Nick] Burnett Inst, Melbourne, Vic, Australia; [Shekar, Meera] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Flory, Augustin] Results Dev R4D, Washington, DC USA; [Haddad, Lawrence] Global Alliance Improved Nutr GAIN, Geneva, Switzerland	CGIAR; International Food Policy Research Institute (IFPRI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; The World Bank	Osendarp, S (corresponding author), Micronutrient Forum, Washington, DC 20005 USA.	saskia.osendarp@micronutrientforum.org		Ruel, Marie/0000-0002-9506-348X				Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171; Barden-OFallon J., 2015, PLOS CURR-TREE LIFE, DOI [10.1371/CURRENTS.OUTBREAKS.0B0BA06009DD091BC39DDB3C6D7B0826, DOI 10.1371/CURRENTS.OUTBREAKS.0B0BA06009DD091BC39DDB3C6D7B0826]; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Fore HH, 2020, LANCET, V396, P517, DOI 10.1016/S0140-6736(20)31648-2; Headey D, 2020, 01941 IFPRI; Laborde D., 2020, POVERTY FOOD INSECUR; Martorell R, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22952; Meera S, 2017, INVESTMENT FRAMEWORK; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; UNICEF, 2020, SIT TRACK COVID 19 S; UNICEF WHO World Bank Group, 2020, JOINT MALN EST; WFP (World Food Programme), 2020, COVID 19 WILL DOUBL	12	166	168	4	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2020	396	10250					519	521		10.1016/S0140-6736(20)31647-0	http://dx.doi.org/10.1016/S0140-6736(20)31647-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OC4LV	32730743	Green Published, Bronze			2022-12-28	WOS:000579130500005
J	Chen, FYH; Jung, HW; Tsuei, CY; Liao, JC				Chen, Frederic Y-H; Jung, Hsin-Wei; Tsuei, Chao-Yin; Liao, James C.			Converting Escherichia coli to a Synthetic Methylotroph Growing Solely on Methanol	CELL			English	Article							BACILLUS-METHANOLICUS; DNA; PATHWAY; CARBON; DEHYDROGENASE; BIOCONVERSION; ASSIMILATION; EXPRESSION; DELETION	Methanol, being electron rich and derivable from methane or CO2, is a potentially renewable one-carbon (C1) feedstock for microorganisms. Although the ribulose monophosphate (RuMP) cycle used by methylotrophs to assimilate methanol differs from the typical sugar metabolism by only three enzymes, turning a non-methylotrophic organism to a synthetic methylotroph that grows to a high cell density has been challenging. Here we reprogrammed E coli using metabolic robustness criteria followed by laboratory evolution to establish a strain that can efficiently utilize methanol as the sole carbon source. This synthetic methylotroph alleviated a so far uncharacterized hurdle, DNA-protein crosslinking (DPC), by insertion sequence (IS)-mediated copy number variations (CNVs) and balanced the metabolic flux by mutations. Being capable of growing at a rate comparable with natural methylotrophs in a wide range of methanol concentrations, this synthetic methylotrophic strain illustrates genome editing and evolution for microbial tropism changes and expands the scope of biological C1 conversion.	[Chen, Frederic Y-H; Jung, Hsin-Wei; Tsuei, Chao-Yin; Liao, James C.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chen, Frederic Y-H] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA	Academia Sinica - Taiwan; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	liaoj@gate.sinice.edu.tw	Chen, Frederic Y.H./AAP-3967-2021	Liao, James/0000-0002-4580-7276; Chen, Frederic Y.-H./0000-0002-7375-6103	Academia Sinica Core Facility and Innovative Instrument Project, Taiwan [AS-CFII-108-114, AS-CFII-108-107]	Academia Sinica Core Facility and Innovative Instrument Project, Taiwan	We thank the following colleagues from Academia Sinica, Taiwan: Dr. Meiyeh Jade Lu for fruitful discussions regarding genomics data analysis, Chia-che Lee for NGS data assistance, Dr. Shu-Jen Chou for digital PCR experiments, Dr. Sue-Ping Lee and Wen-Li Peng for TEM assistance, Dr. Shu-yu Lin and Dr. Yi-yun Chen for proteomics discussions, and Dr. Tzi-Yuan Wang for Nanopore sequencing. We thank the following previous UCLA Liao lab members: Dr. Tung-yun Wu for bioprospecting enzymes, Dr. Powei Chen for EMRA support, Dr. Chang-Ting Chen and Seunghwan Lee for methylotrophy work, and Aaron Baugh for CRISPR optimization efforts. We also thank the following core facilities at Academia Sinica: the NGS High Throughput Genomics Core Facility at the Biodiversity Research Center, the Imaging Core Facility at the Institute of Molecular Biology Center, the Genomic Technology Core at the Institute of Plant and Microbial Biology, and the Academia Sinica Common Mass Spectrometry Facilities for Proteomics and Protein Modification Analysis at the Institute of Biological Chemistry. The NGS Core Facility and mass spectrometry Facility are supported by the Academia Sinica Core Facility and Innovative Instrument Project, Taiwan (AS-CFII-108-114 and AS-CFII-108-107).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker S, 2005, ANAL BIOCHEM, V344, P204, DOI 10.1016/j.ab.2005.06.039; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Belkhelfa S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01313; Bennett RK, 2018, CURR OPIN BIOTECH, V50, P81, DOI 10.1016/j.copbio.2017.11.010; Bennett RK, 2018, METAB ENG, V45, P75, DOI 10.1016/j.ymben.2017.11.016; Bertau M., 2014, METHANOL BASIC CHEM; Bogorad IW, 2014, P NATL ACAD SCI USA, V111, P15928, DOI 10.1073/pnas.1413470111; Brautaset T, 2007, APPL MICROBIOL BIOT, V74, P22, DOI 10.1007/s00253-006-0757-z; Chen CT, 2018, METAB ENG, V49, P257, DOI 10.1016/j.ymben.2018.08.010; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Conrado RJ, 2014, SCIENCE, V343, P621, DOI 10.1126/science.1246929; Cotton CAR, 2020, CURR OPIN BIOTECH, V62, P168, DOI 10.1016/j.copbio.2019.10.002; De Meur Q, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02038-17; Gassler T, 2020, NAT BIOTECHNOL, V38, P210, DOI 10.1038/s41587-019-0363-0; Gleizer S, 2019, CELL, V179, P1255, DOI 10.1016/j.cell.2019.11.009; Gonzalez JE, 2018, METAB ENG, V45, P67, DOI 10.1016/j.ymben.2017.11.015; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Kim S, 2020, NAT CHEM BIOL, V16, P538, DOI 10.1038/s41589-020-0473-5; KOTLARZ D, 1975, BIOCHIM BIOPHYS ACTA, V381, P257, DOI 10.1016/0304-4165(75)90232-9; Kuk SK, 2017, ANGEW CHEM INT EDIT, V56, P3827, DOI 10.1002/anie.201611379; Lee Y, 2014, METAB ENG, V25, P63, DOI 10.1016/j.ymben.2014.06.006; Lin PP, 2018, P NATL ACAD SCI USA, V115, P3538, DOI 10.1073/pnas.1802191115; Meyer F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03937-y; Nayak DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107887; Noor R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1415-7; Patel SKS, 2019, ACS APPL MATER INTER, V11, P18968, DOI 10.1021/acsami.9b03420; Qiu HB, 2009, J PROTEOME RES, V8, P1983, DOI 10.1021/pr8009319; Rivera J.G.L., 2015, INTEGR BIOL CAMB, V7, P1; SERWER P, 1978, J ULTRA MOL STRUCT R, V65, P112, DOI 10.1016/S0022-5320(78)90049-7; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Stingele J, 2015, NAT REV MOL CELL BIO, V16, P455, DOI 10.1038/nrm4015; Tuyishime P, 2018, METAB ENG, V49, P220, DOI 10.1016/j.ymben.2018.07.011; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Woolston BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04795-4; Wu TY, 2016, APPL MICROBIOL BIOT, V100, P4969, DOI 10.1007/s00253-016-7320-3; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023	40	63	74	28	142	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					933	+		10.1016/j.cell.2020.07.010	http://dx.doi.org/10.1016/j.cell.2020.07.010			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32780992	Bronze			2022-12-28	WOS:000561488500014
J	Wu, W; Zhou, QP; Masubuchi, T; Shi, XS; Li, H; Xu, XY; Huang, M; Meng, L; He, X; Zhu, HY; Gao, SX; Zhang, N; Jing, RR; Sun, J; Wang, HP; Hui, EF; Wong, CC; Xu, CQ				Wu, Wei; Zhou, Qiuping; Masubuchi, Takeya; Shi, Xiaoshan; Li, Hua; Xu, Xinyi; Huang, Min; Meng, Li; He, Xing; Zhu, Hengyu; Gao, Shuaixin; Zhang, Nan; Jing, Ruirui; Sun, Jie; Wang, Haopeng; Hui, Enfu; Wong, Catherine Chiulan; Xu, Chenqi			Multiple Signaling Roles of CD3 epsilon and Its Application in CAR-T Cell Therapy	CELL			English	Article							PROLINE-RICH SEQUENCE; RECEPTOR ZETA; TYROSINE PHOSPHORYLATION; ABSOLUTE QUANTIFICATION; MEMBRANE ASSOCIATION; ACTIVATION MOTIFS; SUBUNIT CONTAINS; BINDING MOTIF; KINASE CSK; TCR-ZETA	A T cell receptor (TCR) mediates antigen-induced signaling through its associated CD3 epsilon, delta, gamma, and zeta, but the contributions of different CD3 chains remain elusive. Using quantitative mass spectrometry, we simultaneously quantitated the phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) of all CD3 chains upon TCR stimulation. A subpopulation of CD3 epsilon ITAMs was mono-phosphorylated, owing to Lck kinase selectivity, and specifically recruited the inhibitory Csk kinase to attenuate TCR signaling, suggesting that TCR is a self-restrained signaling machinery containing both activating and inhibitory motifs. Moreover, we found that incorporation of the CD3 epsilon cytoplasmic domain into a second-generation chimeric antigen receptor (CAR) improved antitumor activity of CAR-T cells. Mechanistically, the Csk-recruiting ITAM of CD3 epsilon reduced CAR-T cytokine production whereas the basic residue rich sequence (BRS) of CD3 epsilon promoted CAR-T persistence via p85 recruitment, Collectively, CD3 epsilon is a built-in multifunctional signal tuner, and increasing CD3 diversity represents a strategy to design next-generation CAR.	[Wu, Wei; Zhou, Qiuping; Shi, Xiaoshan; Li, Hua; Xu, Xinyi; Huang, Min; Meng, Li; He, Xing; Zhu, Hengyu; Wong, Catherine Chiulan; Xu, Chenqi] Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai 200031, Peoples R China; [Masubuchi, Takeya; Hui, Enfu] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Shi, Xiaoshan; Gao, Shuaixin; Zhang, Nan; Wong, Catherine Chiulan] Peking Univ, Hlth Sci Ctr, Hosp 1, Ctr Precis Med Multiom Res, Beijing 100191, Peoples R China; [Jing, Ruirui; Sun, Jie] Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Jing, Ruirui; Sun, Jie] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Jing, Ruirui; Sun, Jie] Zhejiang Univ, Inst Hematol, Hangzhou 310058, Zhejiang, Peoples R China; [Jing, Ruirui; Sun, Jie] Lab Stem Cell & Immunotherapy Engn, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Haopeng] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Wong, Catherine Chiulan] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Wong, Catherine Chiulan] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Xu, Chenqi] Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Zhejiang, Peoples R China; [Shi, Xiaoshan] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shi, Xiaoshan] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California San Diego; Peking University; Zhejiang University; Zhejiang University; Zhejiang University; ShanghaiTech University; Peking University; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wong, CC; Xu, CQ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai 200031, Peoples R China.; Hui, EF (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.; Wong, CC (corresponding author), Peking Univ, Hlth Sci Ctr, Hosp 1, Ctr Precis Med Multiom Res, Beijing 100191, Peoples R China.; Wong, CC (corresponding author), Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China.; Wong, CC (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Xu, CQ (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Zhejiang, Peoples R China.	enfuhui@ucsd.edu; catherine_wong@bjmu.edu.cn; cqxu@sibcb.ac.cn	Wu, Wei/AAY-3499-2020; Shi, Xiaoshan/AAH-7734-2021	Shi, Xiaoshan/0000-0001-7931-8684; Masubuchi, Takeya/0000-0001-6822-3049; Sun, Jie/0000-0002-5642-0560; Wang, Haopeng/0000-0002-4995-0838	Chinese Academy of Sciences (CAS) [XDB29000000, QYZDB-SSW-SMC048]; National Natural Science Foundation of China (NSFC) [31530022, 31861133009, 31621003]; National Key R&D Program of China [2019YFA0111001, 2018YFA0800702]; CAS grant (Outstanding Technology Talent Program); Double First-Class University grants of China [BMU2017YJ003, BMU2018XTZ002]; NSFC [31670919, 31670751]; Human Frontier Science Program postdoctoral fellowship	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; CAS grant (Outstanding Technology Talent Program); Double First-Class University grants of China; NSFC(National Natural Science Foundation of China (NSFC)); Human Frontier Science Program postdoctoral fellowship(Human Frontier Science Program)	We thank C. Yan, X. Xu, S. Rabat, and NCPSS NMR and MS departments for technical assistance. C.X. is funded by the Chinese Academy of Sciences (CAS) grants (XDB29000000, QYZDB-SSW-SMC048, Fountain-Valley Life Sciences Fund), the National Natural Science Foundation of China (NSFC) grants (31530022, 31861133009, 31621003), and the National Key R&D Program of China grant (2018YFA0800702). C.C.W. is funded by the CAS grant (Outstanding Technology Talent Program) and the Double First-Class University grants of China (BMU2017YJ003, BMU2018XTZ002). H.L. is funded by the NSFC grant (31670751). H.W. is funded by the National Key R&D Program of China (2019YFA0111001) and the NSFC grant (31670919). T.M. is supported by the Human Frontier Science Program postdoctoral fellowship. E.H. is a Searle Scholar and Pew Biomedical Scholar. CAR constructs used in Figures 6C-6G were adapted from an anti-CD19 CAR plasmid provided by W. Wong (Boston University).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alcover A, 2018, ANNU REV IMMUNOL, V36, P103, DOI 10.1146/annurev-immunol-042617-053429; Au-Yeung BB, 2018, ANNU REV IMMUNOL, V36, P127, DOI 10.1146/annurev-immunol-042617-053335; Ben Mkaddem S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00811; Bettini ML, 2017, J IMMUNOL, V199, P1555, DOI 10.4049/jimmunol.1700069; Bettini ML, 2014, J IMMUNOL, V193, P258, DOI 10.4049/jimmunol.1400322; Borroto A, 2014, J IMMUNOL, V192, P2042, DOI 10.4049/jimmunol.1203414; Brodeur JF, 2009, J IMMUNOL, V182, P4844, DOI 10.4049/jimmunol.0803679; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Cantin GT, 2007, ANAL CHEM, V79, P4666, DOI 10.1021/ac0618730; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Curran TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6924; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Davidson D, 2016, CELL REP, V17, P2776, DOI 10.1016/j.celrep.2016.11.035; deAos I, 1997, J BIOL CHEM, V272, P25310, DOI 10.1074/jbc.272.40.25310; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; DeFord-Watts LM, 2009, J IMMUNOL, V183, P1055, DOI 10.4049/jimmunol.0900404; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dong D, 2019, NATURE, V573, P546, DOI 10.1038/s41586-019-1537-0; Edelstein A.D., 2014, J BIOL METHODS, V1, pe10; Feucht J, 2019, NAT MED, V25, P82, DOI 10.1038/s41591-018-0290-5; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Goodfellow H.S., 2015, SCI SIGNAL, V8; Guedan S, 2020, J CLIN INVEST, V130, P3087, DOI 10.1172/JCI133215; Guirado M, 2002, BIOCHEM BIOPH RES CO, V291, P574, DOI 10.1006/bbrc.2002.6492; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Hwang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7982; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; James JR, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1088; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Li LY, 2017, P NATL ACAD SCI USA, V114, pE5891, DOI 10.1073/pnas.1701990114; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Manz BN, 2015, ELIFE, V4, DOI 10.7554/eLife.08088; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Morello A, 2016, CANCER DISCOV, V6, P133, DOI 10.1158/2159-8290.CD-15-0583; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; Pettinello R, 2017, DEV COMP IMMUNOL, V74, P125, DOI 10.1016/j.dci.2017.04.015; Reginald K, 2015, J IMMUNOL, V195, P5472, DOI 10.4049/jimmunol.1501300; Richter K, 2020, J BIOL CHEM, V295, P7849, DOI 10.1074/jbc.RA120.012788; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Shah NH, 2018, ELIFE, V7, DOI 10.7554/eLife.35190; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Sun J, 2010, MOL THER, V18, P2006, DOI 10.1038/mt.2010.185; SunderPlassmann R, 1997, EUR J IMMUNOL, V27, P2001, DOI 10.1002/eji.1830270826; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; Tanaka H, 2013, J BIOL CHEM, V288, P15240, DOI 10.1074/jbc.M112.439075; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	69	43	47	10	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					855	+		10.1016/j.cell.2020.07.018	http://dx.doi.org/10.1016/j.cell.2020.07.018			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32730808	Bronze			2022-12-28	WOS:000561488500009
J	Taylor, L				Taylor, Luke			Covid-19 misinformation sparks threats and violence against doctors in Latin America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lukestephentaylor@gmail.com						Amnistia Internacional, 2020, COVID 19 POS PART TH; [Anonymous], 2020, REUTERS; [Anonymous], 2020, EL ESPECTADOR; [Anonymous], 2020, JORNADA; Government of Mexico, 2020, OBS VIOL DER HUM DUR; International Committee of the Red Cross, 2020, HLTH CAR WORK SAV LI; Velasquez T., 2020, EL UNIVERSAL	7	23	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3088	10.1136/bmj.m3088	http://dx.doi.org/10.1136/bmj.m3088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QD5YJ	32784200	Bronze			2022-12-28	WOS:000615593000002
J	Mayanja-Kizza, H; Sekaggya-Wiltshire, C; Kassa, D				Mayanja-Kizza, Harriet; Sekaggya-Wiltshire, Christine; Kassa, Desta			Optimal therapy for multidrug-resistant tuberculosis and HIV	LANCET			English	Editorial Material							TB		[Mayanja-Kizza, Harriet; Sekaggya-Wiltshire, Christine] Makerere Univ, Dept Med, Kampala, Uganda; [Kassa, Desta] Ethiopian Publ Hlth Inst, HIV AIDS & TB Res Directorate, Addis Ababa, Ethiopia	Makerere University	Mayanja-Kizza, H (corresponding author), Makerere Univ, Dept Med, Kampala, Uganda.	hmk@chs.mak.ac.ug						Bisson GP, 2020, LANCET, V396, P402, DOI 10.1016/S0140-6736(20)31316-7; Cazabon Danielle, 2018, Gates Open Res, V2, P35, DOI 10.12688/gatesopenres.12842.2; Chem ED, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4317-4; Nakanwagi-Mukwaya A, 2013, PUBLIC HEALTH ACTION, V3, P149, DOI 10.5588/pha.12.0105; Saito S, 2012, JAIDS-J ACQ IMM DEF, V61, P216, DOI 10.1097/QAI.0b013e3182638ec7; Subbaraman R, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002754; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Udwadia Z, 2019, J CLIN TUBER OTH MYC, V16, DOI 10.1016/j.jctube.2019.100101; van Kampen S, 2013, TB CARE CORE PROJECT	9	0	1	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					363	365						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0SW	32771093				2022-12-28	WOS:000561619100010
J	Rushton, CH; Doerries, B; Greene, J; Geller, G				Rushton, Cynda H.; Doerries, Bryan; Greene, Jeremy; Geller, Gail			The art of medicine Dramatic interventions in the tragedy of the COVID-19 pandemic	LANCET			English	Editorial Material									[Rushton, Cynda H.; Geller, Gail] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Rushton, Cynda H.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [Rushton, Cynda H.; Geller, Gail] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Doerries, Bryan] Theater War Prod, New York, NY USA; [Greene, Jeremy] Johns Hopkins Univ, Sch Med, Ctr Med Humanities & Social Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Rushton, CH (corresponding author), Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.; Rushton, CH (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	crushto1@jhu.edu							0	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					305	306		10.1016/S0140-6736(20)31641-X	http://dx.doi.org/10.1016/S0140-6736(20)31641-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0RO	32711685	Green Published, Bronze			2022-12-28	WOS:000561615700010
J	Mahase, E				Mahase, Elisabeth			Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980	1	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								m3049	10.1136/bmj.m3049	http://dx.doi.org/10.1136/bmj.m3049			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732277	Bronze			2022-12-28	WOS:000556139900010
J	Chase, JM; Blowes, SA; Knight, TM; Gerstner, K; May, F				Chase, Jonathan M.; Blowes, Shane A.; Knight, Tiffany M.; Gerstner, Katharina; May, Felix			Ecosystem decay exacerbates biodiversity loss with habitat loss	NATURE			English	Article							SPECIES-AREA RELATIONSHIPS; GROUND BEETLES COLEOPTERA; AMAZONIAN FOREST FRAGMENTS; TROPICAL RAIN-FOREST; LAND-BRIDGE ISLANDS; ATLANTIC-FOREST; CONSERVATION VALUE; DISTRIBUTION PATTERNS; COMMUNITY STRUCTURE; EXTINCTION DEBT	Although habitat loss is the predominant factor leading to biodiversity loss in the Anthropocene(1,2), exactly how this loss manifests-and at which scales-remains a central debate(3-6). The 'passive sampling' hypothesis suggests that species are lost in proportion to their abundance and distribution in the natural habitat(7,8), whereas the 'ecosystem decay' hypothesis suggests that ecological processes change in smaller and more-isolated habitats such that more species are lost than would have been expected simply through loss of habitat alone(9,10). Generalizable tests of these hypotheses have been limited by heterogeneous sampling designs and a narrow focus on estimates of species richness that are strongly dependent on scale. Here we analyse 123 studies of assemblage-level abundances of focal taxa taken from multiple habitat fragments of varying size to evaluate the influence of passive sampling and ecosystem decay on biodiversity loss. We found overall support for the ecosystem decay hypothesis. Across all studies, ecosystems and taxa, biodiversity estimates from smaller habitat fragments-when controlled for sampling effort-contain fewer individuals, fewer species and less-even communities than expected from a sample of larger fragments. However, the diversity loss due to ecosystem decay in some studies (for example, those in which habitat loss took place more than 100 years ago) was less than expected from the overall pattern, as a result of compositional turnover by species that were not originally present in the intact habitats. We conclude that the incorporation of non-passive effects of habitat loss on biodiversity change will improve biodiversity scenarios under future land use, and planning for habitat protection and restoration. Analysis of 123 studies of assemblage-level abundances of focal taxa from fragmented habitats finds that increasing fragmentation has a disproportionately large effect on biodiversity loss, supporting the ecosystem decay hypothesis.	[Chase, Jonathan M.; Blowes, Shane A.; Knight, Tiffany M.; Gerstner, Katharina; May, Felix] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Chase, Jonathan M.; Blowes, Shane A.] Martin Luther Univ Halle Wittenberg, Inst Comp Sci, Halle, Saale, Germany; [Knight, Tiffany M.] Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Knight, Tiffany M.] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany; [May, Felix] Leuphana Univ, Luneburg, Germany; [May, Felix] Free Univ Berlin, Inst Biol, Theoret Ecol, Berlin, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leuphana University Luneburg; Free University of Berlin	Chase, JM (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.; Chase, JM (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Comp Sci, Halle, Saale, Germany.	jonathan.chase@idiv.de	B, A/AHB-5155-2022	Blowes, Shane/0000-0001-6310-3670; Chase, Jonathan/0000-0001-5580-4303; May, Felix/0000-0002-1106-8188; Knight, Tiffany/0000-0003-0318-1567	German Centre of Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation [FZT 118]; Helmholtz Association; Alexander von Humboldt Foundation	German Centre of Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation; Helmholtz Association(Helmholtz Association); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	All authors were supported by the German Centre of Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (funded by the German Research Foundation; FZT 118). The contribution of T.M.K. was also supported by the Helmholtz Association and by the Alexander von Humboldt Foundation. We thank the many authors who supplied the data that went into the core analyses of this paper, and A. Sagouis and M. Liebergesell for help with data acquisition, collation and harmonization. A. Sagouis helped with the preparation of the simulations in Extended Data Fig. 1, and Fig. 1 was created by F. Arndt (Formenorm.de) for the express use in this paper. Finally, we thank R. Colwell and J. Hortal for important comments and criticisms that helped us to improve the manuscript.	AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; Almeida-Gomes M, 2014, J HERPETOL, V48, P423, DOI 10.1670/12-187; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; Baldi A, 1999, ACTA OECOL, V20, P125, DOI 10.1016/S1146-609X(99)80025-3; Baselga A, 2013, METHODS ECOL EVOL, V4, P552, DOI 10.1111/2041-210X.12029; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Baz A, 1996, BIODIVERS CONSERV, V5, P493, DOI 10.1007/BF00056393; Bell KE, 2006, CONSERV BIOL, V20, P1750, DOI 10.1111/j.1523-1739.2006.00522.x; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Benitez-Malvido J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146461; Berg A, 1997, BIRD STUDY, V44, P355, DOI 10.1080/00063659709461071; Bernard E, 2007, BIOL CONSERV, V134, P332, DOI 10.1016/j.biocon.2006.07.021; Betts MG, 2019, SCIENCE, V366, P1236, DOI 10.1126/science.aax9387; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Bossart JL, 2016, BIOL CONSERV, V198, P122, DOI 10.1016/j.biocon.2016.03.029; Bossart JL, 2006, BIODIVERS CONSERV, V15, P333, DOI 10.1007/s10531-005-2574-6; Bragagnolo C, 2007, BIOL CONSERV, V139, P389, DOI 10.1016/j.biocon.2007.07.008; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Bueno AS, 2019, J BIOGEOGR, V46, P621, DOI 10.1111/jbi.13499; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Cabrera-Guzman E, 2012, BIODIVERS CONSERV, V21, P3243, DOI 10.1007/s10531-012-0312-4; Caceres NC, 2010, J NAT HIST, V44, P491, DOI 10.1080/00222930903477768; Cadotte MW, 2002, BIODIVERS CONSERV, V11, P1417, DOI 10.1023/A:1016282023542; Carneiro MS, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1500; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Cayuela L, 2006, J APPL ECOL, V43, P1172, DOI 10.1111/j.1365-2664.2006.01217.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chase J. M., 2019, FRONTIERS BIOGEOGRAP, V11, DOI [10.21425/F5FBG40844, DOI 10.21425/F5FBG40844]; Chase JM, 2019, ECOLOGY, V100; Chase JM, 2018, ECOL LETT, V21, P1737, DOI 10.1111/ele.13151; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Chisholm RA, 2018, ECOL LETT, V21, P804, DOI 10.1111/ele.12943; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cosson JF, 1999, BIOL CONSERV, V91, P213, DOI 10.1016/S0006-3207(99)00091-9; DAFONSECA GAB, 1990, BIOL CONSERV, V53, P265, DOI 10.1016/0006-3207(90)90097-9; Dami FD, 2013, AFR J ECOL, V51, P32, DOI 10.1111/aje.12028; Dauber J, 2006, CONSERV BIOL, V20, P1150, DOI 10.1111/j.1523-1739.2006.00373.x; Davies RG, 2003, J TROP ECOL, V19, P509, DOI 10.1017/S0266467403003560; de Aguiar WM, 2012, REV BRAS ENTOMOL, V56, P210, DOI 10.1590/S0085-56262012005000018; de la Sancha NU, 2014, MAMMALIA, V78, P437, DOI 10.1515/mammalia-2013-0100; de Lima MG, 1999, BIOL CONSERV, V91, P241, DOI 10.1016/S0006-3207(99)00084-1; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DESOUZA OFF, 1994, J TROP ECOL, V10, P197, DOI 10.1017/S0266467400007847; Diaz S, 2019, SCIENCE, V366, P1327, DOI 10.1126/science.aax3100; DICKMAN CR, 1987, J APPL ECOL, V24, P337, DOI 10.2307/2403879; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Ding ZF, 2013, J ANIM ECOL, V82, P781, DOI 10.1111/1365-2656.12046; Dixo M, 2009, ORYX, V43, P435, DOI 10.1017/S0030605309431508; Dominguez-Haydar Y, 2011, RESTOR ECOL, V19, P178, DOI 10.1111/j.1526-100X.2010.00735.x; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Estrada A, 2002, BIODIVERS CONSERV, V11, P1903, DOI 10.1023/A:1020896928578; Estrada A, 2002, BIOL CONSERV, V103, P237, DOI 10.1016/S0006-3207(01)00135-5; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2019, BIOL CONSERV, V230, P179, DOI 10.1016/j.biocon.2018.12.026; Fahrig L, 2017, ANNU REV ECOL EVOL S, V48, P1, DOI 10.1146/annurev-ecolsys-110316-022612; Fernandez IC, 2013, URBAN ECOSYST, V16, P377, DOI 10.1007/s11252-012-0272-1; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Fletcher RJ, 2018, BIOL CONSERV, V226, P9, DOI 10.1016/j.biocon.2018.07.022; Fujita A, 2008, ENTOMOL SCI, V11, P39, DOI 10.1111/j.1479-8298.2007.00243.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gavish Y, 2012, CONSERV BIOL, V26, P150, DOI 10.1111/j.1523-1739.2011.01799.x; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Giladi I, 2011, J VEG SCI, V22, P983, DOI 10.1111/j.1654-1103.2011.01309.x; Giraudo AR, 2008, BIODIVERS CONSERV, V17, P1251, DOI 10.1007/s10531-007-9309-9; Goncalves-Souza T, 2008, REV IBERICA ARACNOLO, V16, P35; Goodman SM, 2000, J ZOOL, V250, P193, DOI 10.1111/j.1469-7998.2000.tb01069.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guadagnin DL, 2005, WATERBIRDS, V28, P261, DOI 10.1675/1524-4695(2005)028[0261:SATPOW]2.0.CO;2; Gurevitch J, 2018, NATURE, V555, P175, DOI 10.1038/nature25753; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Halley JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12283; Halley JM, 2013, ANN NY ACAD SCI, V1286, P50, DOI 10.1111/nyas.12073; HALME E, 1993, ANN ZOOL FENN, V30, P17; Hanski I, 2013, P NATL ACAD SCI USA, V110, P12715, DOI 10.1073/pnas.1311491110; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Henry M, 2007, J ANIM ECOL, V76, P801, DOI 10.1111/j.1365-2656.2007.01258.x; Horvath R, 2009, AGR ECOSYST ENVIRON, V130, P16, DOI 10.1016/j.agee.2008.11.011; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hudson LN, 2017, ECOL EVOL, V7, P145, DOI 10.1002/ece3.2579; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jauker F, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2569; Jones IL, 2016, BIOL CONSERV, V199, P75, DOI 10.1016/j.biocon.2016.04.036; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jung JK, 2014, ECOL RES, V29, P877, DOI 10.1007/s11284-014-1175-9; Jyothi K. M., 2015, Journal of Threatened Taxa, V7, P8226; Kapoor V, 2008, J INSECT CONSERV, V12, P53, DOI 10.1007/s10841-006-9062-5; Kappes H, 2009, LANDSCAPE ECOL, V24, P685, DOI 10.1007/s10980-009-9342-z; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Knapp M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123052; Koh LP, 2010, J APPL ECOL, V47, P1063, DOI 10.1111/j.1365-2664.2010.01860.x; Lambert TD, 2003, J ZOOL, V260, P179, DOI 10.1017/S0952836903003637; Lasky JR, 2010, J TROP ECOL, V26, P67, DOI 10.1017/S0266467409990368; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lima JR, 2015, BIOTROPICA, V47, P369, DOI 10.1111/btp.12205; Lion MB, 2016, BIOTROPICA, V48, P265, DOI 10.1111/btp.12277; Lion MB, 2014, DIVERS DISTRIB, V20, P1245, DOI 10.1111/ddi.12228; Lovei GL, 2000, J INSECT CONSERV, V4, P239, DOI 10.1023/A:1011370806886; Lovejoy T.E., 1984, P295; Mac Nally R, 2001, OECOLOGIA, V128, P116, DOI 10.1007/s004420100632; Manu S, 2007, IBIS, V149, P287, DOI 10.1111/j.1474-919X.2006.00628.x; Marion ZH, 2017, ECOLOGY, V98, P933, DOI 10.1002/ecy.1753; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; May F, 2018, METHODS ECOL EVOL, V9, P1401, DOI 10.1111/2041-210X.12986; MCCOLLIN D, 1993, GLOBAL ECOL BIOGEOGR, V3, P48, DOI 10.2307/2997459; McGlinn DJ, 2019, METHODS ECOL EVOL, V10, P258, DOI [10.1111/2041-210X.13102, 10.1111/2041-210X.13102Citations:20]; MCINTYRE NE, 1995, LANDSCAPE ECOL, V10, P85, DOI 10.1007/BF00153826; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Nemesio A, 2007, NEOTROP ENTOMOL, V36, P186, DOI 10.1590/S1519-566X2007000200003; Nemesio A, 2010, NEOTROP ENTOMOL, V39, P555, DOI 10.1590/S1519-566X2010000400014; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Nogueira AD, 2016, J ARACHNOL, V44, P36, DOI 10.1636/P15-19.1; Nufio CR, 2009, INSECT CONSERV DIVER, V2, P295, DOI 10.1111/j.1752-4598.2009.00065.x; Nyeko P, 2009, BIOTROPICA, V41, P476, DOI 10.1111/j.1744-7429.2009.00499.x; Nyelele C, 2014, TROP ECOL, V55, P365; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Owen C.E.B., 2008, J STAT COMPUT SIMULA, V43, P217; Paciencia MLB, 2005, PLANT ECOL, V180, P87, DOI 10.1007/s11258-005-3025-x; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Silva MPP, 2009, BIODIVERS CONSERV, V18, P317, DOI 10.1007/s10531-008-9487-0; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Purvis Andy, 2018, Advances in Ecological Research, V58, P201; Raheem DC, 2009, J BIOGEOGR, V36, P1923, DOI 10.1111/j.1365-2699.2009.02136.x; Rocha R, 2017, LANDSCAPE ECOL, V32, P31, DOI 10.1007/s10980-016-0425-3; Sam K, 2014, J FIELD ORNITHOL, V85, P152, DOI 10.1111/jofo.12057; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Savilaakso S, 2009, DIVERS DISTRIB, V15, P356, DOI 10.1111/j.1472-4642.2008.00542.x; Schnitzler F. R., 2008, THESIS; Senior M. J. M, 2014, THESIS; Silva RJ, 2016, J INSECT CONSERV, V20, P549, DOI 10.1007/s10841-016-9885-7; Silveira GC, 2015, APIDOLOGIE, V46, P197, DOI 10.1007/s13592-014-0314-1; Slade EM, 2013, ECOLOGY, V94, P1519, DOI 10.1890/12-1366.1; Sridhar H, 2008, CURR SCI INDIA, V94, P748; Stireman JO, 2014, OECOLOGIA, V176, P207, DOI 10.1007/s00442-014-3014-7; Storck-Tonon D, 2017, BIOL CONSERV, V214, P270, DOI 10.1016/j.biocon.2017.07.018; Stouffer PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020543; Struebig MJ, 2009, BIOL CONSERV, V142, P2089, DOI 10.1016/j.biocon.2009.04.005; TELLERIA JL, 1995, BIOL CONSERV, V71, P61, DOI 10.1016/0006-3207(94)00021-H; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tilman D, 2017, NATURE, V546, P73, DOI 10.1038/nature22900; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; Uehara-Prado M, 2007, GLOBAL ECOL BIOGEOGR, V16, P43, DOI 10.1111/j.1466-8238.2006.00267.x; Ulrich W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163338; Usher MB, 1998, BIODIVERS CONSERV, V7, P725, DOI 10.1023/A:1008836302193; Vallan D, 2000, BIOL CONSERV, V96, P31, DOI 10.1016/S0006-3207(00)00041-0; Vasconcelos HL, 2006, J BIOGEOGR, V33, P1348, DOI 10.1111/j.1365-2699.2006.01516.x; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Vulinec K, 2008, TROP CONSERV SCI, V1, P111, DOI 10.1177/194008290800100204; Wang YP, 2012, CURR ZOOL, V58, P828, DOI 10.1093/czoolo/58.6.828; Williams MR, 2011, J INSECT CONSERV, V15, P37, DOI 10.1007/s10841-010-9307-1; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Zartman CE, 2003, ECOLOGY, V84, P948, DOI 10.1890/0012-9658(2003)084[0948:HFIOEB]2.0.CO;2; Ziter C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00135.1	165	105	106	65	305	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					238	+		10.1038/s41586-020-2531-2	http://dx.doi.org/10.1038/s41586-020-2531-2		JUL 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32728213				2022-12-28	WOS:000554511600002
J	Grosswendt, S; Kretzmer, H; Smith, ZD; Kumar, AS; Hetzel, S; Wittler, L; Klages, S; Timmermann, B; Mukherji, S; Meissner, A				Grosswendt, Stefanie; Kretzmer, Helene; Smith, Zachary D.; Kumar, Abhishek Sampath; Hetzel, Sara; Wittler, Lars; Klages, Sven; Timmermann, Bernd; Mukherji, Shankar; Meissner, Alexander			Epigenetic regulator function through mouse gastrulation	NATURE			English	Article							ALBINO-DELETION COMPLEX; GERM-CELL LINEAGE; STEM-CELLS; DNA METHYLATION; PLURIPOTENT; COMMITMENT; ALLOCATION; GENES; MICE; TRANSCRIPTION	During ontogeny, proliferating cells become restricted in their fate through the combined action of cell-type-specific transcription factors and ubiquitous epigenetic machinery, which recognizes universally available histone residues or nucleotides in a context-dependent manner(1,2). The molecular functions of these regulators are generally well understood, but assigning direct developmental roles to them is hampered by complex mutant phenotypes that often emerge after gastrulation(3,4). Single-cell RNA sequencing and analytical approaches have explored this highly conserved, dynamic period across numerous model organisms(5-8), including mouse(9-18). Here we advance these strategies using a combined zygotic perturbation and single-cell RNA-sequencing platform in which many mutant mouse embryos can be assayed simultaneously, recovering robust morphological and transcriptional information across a panel of ten essential regulators. Deeper analysis of central Polycomb repressive complex (PRC) 1 and 2 components indicates substantial cooperativity, but distinguishes a dominant role for PRC2 in restricting the germline. Moreover, PRC mutant phenotypes emerge after gross epigenetic and transcriptional changes within the initial conceptus prior to gastrulation. Our experimental framework may eventually lead to a fully quantitative view of how cellular diversity emerges using an identical genetic template and from a single totipotent cell. An experimental and analytical pipeline is used to assess, at the single-cell level, complex transcriptional and morphological mutant phenotypes that occur in mouse embryos during gastrulation.	[Grosswendt, Stefanie; Kretzmer, Helene; Kumar, Abhishek Sampath; Hetzel, Sara; Meissner, Alexander] Max Planck Inst Mol Genet, Dept Genome Regulat, Berlin, Germany; [Smith, Zachary D.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Smith, Zachary D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Klages, Sven; Timmermann, Bernd] Max Planck Inst Mol Genet, Sequencing Core Facil, Berlin, Germany; [Mukherji, Shankar] Washington Univ, Dept Phys, St Louis, MO 63130 USA	Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Max Planck Society; Max Planck Society; Washington University (WUSTL)	Meissner, A (corresponding author), Max Planck Inst Mol Genet, Dept Genome Regulat, Berlin, Germany.; Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	meissner@molgen.mpg.de	Sampath Kumar, Abhishek/ABF-1316-2021; Kretzmer, Helene/GSJ-2664-2022	Kretzmer, Helene/0000-0002-0723-4980; Sampath Kumar, Abhishek/0000-0001-7918-6706; Grosswendt, Stefanie/0000-0001-7722-2937	RIKEN BRC through the National Bio-Resource Project of the MEXT/AMED, Japan [CDB0461T]; National Institutes of Health (NIH) [1P50HG006193, P01GM099117, 1R01HD078679, 1DP3K111898]; Max Planck Society	RIKEN BRC through the National Bio-Resource Project of the MEXT/AMED, Japan; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank A. Bolondi, R. Weigert and other members of the Meissner laboratory, M. Chan and D. Hnisz for discussions and advice, S. Otto for experimental support characterizing the EED-knockout mES cell line, M. Walter for support with embryo isolations, T. Ahsendorf for help with initial efforts to optimize our genotyping pipeline, and D. Andergassen for discussions on SNP typing. We are also grateful to F. Koch and the transgenic facility, including M. Peetz, and C. Giesecke-Thiel of the Flow Cytometry Facility for their feedback and support. We thank M. Saitou for the mVenus Prdm14 promoter sperm that were provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT/AMED, Japan (Acc. No. CDB0461T). This work was funded by the National Institutes of Health (NIH; 1P50HG006193, P01GM099117, 1R01HD078679 and 1DP3K111898) and the Max Planck Society.	Andergassen D, 2017, ELIFE, V6, DOI 10.7554/eLife.25125; Argelaguet R, 2019, NATURE, V576, P487, DOI 10.1038/s41586-019-1825-8; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Boulard M, 2015, NAT GENET, V47, P479, DOI 10.1038/ng.3272; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chan MM, 2019, NATURE, V570, P77, DOI 10.1038/s41586-019-1184-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; FAUST C, 1995, DEVELOPMENT, V121, P273; Faust C, 1998, DEVELOPMENT, V125, P4495; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Ibarra-Soria X, 2018, NAT CELL BIOL, V20, P127, DOI 10.1038/s41556-017-0013-z; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Krueger Felix, 2016, F1000Res, V5, P1479, DOI 10.12688/f1000research.9037.2; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lei H, 1996, DEVELOPMENT, V122, P3195; Leitch HG, 2013, DEVELOPMENT, V140, P2495, DOI 10.1242/dev.091603; Li Y, 2018, GENOME BIOL, V19, P16; Magnusdottir E, 2014, DEVELOPMENT, V141, P245, DOI 10.1242/dev.098269; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mohammed H, 2017, CELL REP, V20, P1215, DOI 10.1016/j.celrep.2017.07.009; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nakagata N, 2011, METHODS MOL BIOL, V693, P57, DOI 10.1007/978-1-60761-974-1_4; Nashun B, 2015, MOL CELL, V60, P611, DOI 10.1016/j.molcel.2015.10.010; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Nicetto D, 2019, SCIENCE, V363, P294, DOI 10.1126/science.aau0583; NISWANDER L, 1989, DEVELOPMENT, V105, P175; NISWANDER L, 1988, DEVELOPMENT, V102, P45; Nowotschin S, 2019, NATURE, V569, P361, DOI 10.1038/s41586-019-1127-1; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peng GD, 2019, NATURE, V572, P528, DOI 10.1038/s41586-019-1469-8; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Plass M, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1723; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivera-Perez JA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015867; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Semrau S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01076-4; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Smith ZD, 2017, NATURE, V549, P543, DOI 10.1038/nature23891; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang CF, 2018, NAT CELL BIOL, V20, P620, DOI 10.1038/s41556-018-0093-4; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wymeersch FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.10042; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying QL, 2003, METHOD ENZYMOL, V365, P327; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zylicz JJ, 2019, CELL, V176, P182, DOI 10.1016/j.cell.2018.11.041	76	41	40	9	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					102	+		10.1038/s41586-020-2552-x	http://dx.doi.org/10.1038/s41586-020-2552-x		JUL 2020	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32728215	Green Accepted			2022-12-28	WOS:000553758900004
J	Zhao, Z; Zlokovic, BV				Zhao, Zhen; Zlokovic, Berislav V.			Therapeutic TVs for Crossing Barriers in the Brain	CELL			English	Editorial Material							ANTIBODY; DISEASE	Brain disorders are at the leading edge of global disease burden worldwide. Effective therapies are lagging behind because most drugs cannot reach their targets in the brain because of the blood-brain barrier (BBB). The new development of a BBB transport vehicle may bring us a step closer to solve this problem.	[Zhao, Zhen; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA	University of Southern California	Zhao, Z; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	zzhao@usc.edu; zlokovic@usc.edu	zhao, zhen/A-2080-2012	zhao, zhen/0000-0001-8967-5570	National Institutes of Health (NIH) [R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, 5P50AG005142]; Cure Alzheimer's Fund; Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease [16 CVD 05]; NIH [R01AG061288, R01NS110687, R03AG063287, R21AG066090]; BrightFocus Foundation;  [509279]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); 	The work of B.V.Z. is supported by the National Institutes of Health (NIH) grant nos. R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, and 5P50AG005142, in addition to the Alzheimer's Association strategic 509279 grant, Cure Alzheimer's Fund, and the Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease reference no. 16 CVD 05. The work of Z.Z. is supported by the NIH grant nos. R01AG061288, R01NS110687, R03AG063287, and R21AG066090 and BrightFocus Foundation.	FRIDEN PM, 1991, P NATL ACAD SCI USA, V88, P4771, DOI 10.1073/pnas.88.11.4771; Kariolis MS, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1359; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Ullman JC, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1163; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zhou QH, 2011, MOL PHARMACEUT, V8, P280, DOI 10.1021/mp1003515; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	12	3	3	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					267	269		10.1016/j.cell.2020.06.041	http://dx.doi.org/10.1016/j.cell.2020.06.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32707092	Green Accepted, Bronze			2022-12-28	WOS:000552745000003
J	Quinn, MS; Nauta, K; Jordan, MJT; Bowman, JM; Houston, PL; Kable, SH				Quinn, Mitchell S.; Nauta, Klaas; Jordan, Meredith J. T.; Bowman, Joel M.; Houston, Paul L.; Kable, Scott H.			Rotational resonances in the H2CO roaming reaction are revealed by detailed correlations	SCIENCE			English	Article							H PLUS MGH; FORMALDEHYDE; MECHANISM; ACETALDEHYDE; PRODUCTS; DYNAMICS; STATES; ATOMS; PATH	Since its discovery 16 years ago, roaming has become a ubiquitous mechanism in molecular photochemistry. Its general features are now understood, but little detail is known about how the potential energy surface (PES) determines reaction outcomes. We performed detailed experiments on formaldehyde (H2CO) photodissociation and determined fully correlated quantum state distributions of the molecular hydrogen and carbon monoxide products. These experiments reveal previously undetected bimodal carbon monoxide rotational distributions. Insights from classical trajectory calculations demonstrate that these features arise from resonances as the PES directs the reaction into cis and trans O-C-H center dot center dot center dot H critical geometries, which produce rebound and stripping mechanisms, respectively. These subtle and pervasive effects demonstrate additional complexity in this prototypical roaming reaction, which we expect to be general. They also provide detailed benchmarks for predictive theories of roaming.	[Quinn, Mitchell S.; Nauta, Klaas; Kable, Scott H.] Univ New South Wales, Sch Chem, Kensington, NSW 2052, Australia; [Jordan, Meredith J. T.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Bowman, Joel M.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Houston, Paul L.] Cornell Univ, Dept Chem & Biochem, Ithaca, NY USA	University of New South Wales Sydney; University of Sydney; Emory University; Cornell University	Kable, SH (corresponding author), Univ New South Wales, Sch Chem, Kensington, NSW 2052, Australia.	s.kable@unsw.edu.au	Houston, Paul/AAJ-1503-2021	Jordan, Meredith/0000-0002-9871-8605; Kable, Scott/0000-0002-0331-6137	Australian Research Council [DP190102013]; Australian postgraduate award; Army Research Office, DURIP grant [W911NF-14-1-0471]	Australian Research Council(Australian Research Council); Australian postgraduate award(Australian Government); Army Research Office, DURIP grant	The University of New South Wales and University of Sydney work was supported by the Australian Research Council (DP190102013). M.S.Q. was supported by an Australian postgraduate award. J.M.B. thanks the Army Research Office, DURIP grant (W911NF-14-1-0471), for funding a computer cluster where the trajectory calculations were performed.	Andrews DU, 2013, J PHYS CHEM A, V117, P7631, DOI 10.1021/jp405582z; Bailly D, 2010, MOL PHYS, V108, P827, DOI 10.1080/00268970903413350; Bowman JM, 2011, ANNU REV PHYS CHEM, V62, P531, DOI 10.1146/annurev-physchem-032210-103518; Cascarini FJJ, 2019, J PHYS CHEM A, V123, P2679, DOI 10.1021/acs.jpca.9b01370; CLOUTHIER DJ, 1983, ANNU REV PHYS CHEM, V34, P31, DOI 10.1146/annurev.pc.34.100183.000335; Conte R, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816277; Coutinho ND, 2015, J PHYS CHEM LETT, V6, P1553, DOI 10.1021/acs.jpclett.5b00384; Dickenson GD, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032502; Dribinski V, 2002, REV SCI INSTRUM, V73, P2634, DOI 10.1063/1.1482156; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Heazlewood BR, 2008, P NATL ACAD SCI USA, V105, P12719, DOI 10.1073/pnas.0802769105; Houston PL, 2006, P NATL ACAD SCI USA, V103, P16079, DOI 10.1073/pnas.0604441103; Houston PL, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4982823; Houston PL, 2016, J PHYS CHEM A, V120, P5103, DOI 10.1021/acs.jpca.6b00488; Kamarchik E, 2010, J PHYS CHEM LETT, V1, P3058, DOI 10.1021/jz1011884; Lahankar SA, 2008, CHEM PHYS, V347, P288, DOI 10.1016/j.chemphys.2007.11.007; Lee KLK, 2014, CHEM SCI, V5, P4633, DOI 10.1039/c4sc02266a; Li AY, 2013, J PHYS CHEM A, V117, P5052, DOI 10.1021/jp4049988; Lopez JG, 2007, J AM CHEM SOC, V129, P9976, DOI 10.1021/ja0717360; Maeda S, 2015, J AM CHEM SOC, V137, P3433, DOI 10.1021/ja512394y; Mauguiere FAL, 2017, ANNU REV PHYS CHEM, V68, P499, DOI 10.1146/annurev-physchem-052516-050613; Mauguiere FAL, 2016, J PHYS CHEM A, V120, P5145, DOI 10.1021/acs.jpca.6b00682; Mauguiere FAL, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4870060; Mauguiere FAL, 2014, CHEM PHYS LETT, V592, P282, DOI 10.1016/j.cplett.2013.12.051; Mereshchenko AS, 2015, NAT CHEM, V7, P562, DOI [10.1038/NCHEM.2278, 10.1038/nchem.2278]; Mikosch J, 2008, SCIENCE, V319, P183, DOI 10.1126/science.1150238; QUINN M, 2020, UNPRECEDENTED CORREL, DOI DOI 10.26190/5F0E4DB844041; QUINN M, 2020, UNPRECEDENTED CORREL; Quinn MS, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4983138; SCHINKE R, 1986, J CHEM PHYS, V84, P1487, DOI 10.1063/1.450494; Schinke R, 1993, PHOTODISSOCIATION DY; Schinke R., 1993, PHOTODISSOCIATION DY; Sivaramakrishnan R, 2011, J PHYS CHEM A, V115, P3366, DOI 10.1021/jp2006205; Suits AG, 2008, ACCOUNTS CHEM RES, V41, P873, DOI 10.1021/ar8000734; Suits AG, 2020, ANNU REV PHYS CHEM, V71, P77, DOI 10.1146/annurev-physchem-050317-020929; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; VANZEE RD, 1993, J CHEM PHYS, V99, P1664, DOI 10.1063/1.465335; Wang XH, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0194; Zhang JX, 2010, J PHYS CHEM LETT, V1, P2747, DOI 10.1021/jz1010658	40	16	16	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2020	369	6511					1592	+		10.1126/science.abc4088	http://dx.doi.org/10.1126/science.abc4088			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV9TD	32763914				2022-12-28	WOS:000574653300028
J	Chastain, DB; Osae, SP; Henao-Martinez, AF; Franco-Paredes, C; Chastain, JS; Young, HN				Chastain, Daniel B.; Osae, Sharmon P.; Henao-Martinez, Andres F.; Franco-Paredes, Carlos; Chastain, Joeanna S.; Young, Henry N.			Racial Disproportionality in Covid Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chastain, Daniel B.; Osae, Sharmon P.] Univ Georgia, Coll Pharm, Albany, GA 31701 USA; [Chastain, Joeanna S.] Phoebe Putney Mem Hosp, Albany, GA USA; [Young, Henry N.] Univ Georgia, Coll Pharm, Athens, GA 30602 USA; [Henao-Martinez, Andres F.; Franco-Paredes, Carlos] Univ Colorado, Div Infect Dis, Anschutz Med Campus, Aurora, CO USA; [Franco-Paredes, Carlos] Hosp Infantil Mexico Dr Federico Gomez, Federico Gomez, Mexico City, DF, Mexico	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Colorado System; University of Colorado Anschutz Medical Campus; Hospital Infantil de Mexico Federico Gomez	Chastain, DB (corresponding author), Univ Georgia, Coll Pharm, Albany, GA 31701 USA.		Franco-Paredes, Carlos Ernesto/GRR-3214-2022; Henao-Martínez, Andrés F./E-1488-2012; Chastain, Daniel/H-4846-2014	Franco-Paredes, Carlos Ernesto/0000-0001-8757-643X; Henao-Martínez, Andrés F./0000-0001-7363-8652; Chastain, Daniel/0000-0002-4018-0195				Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113	5	71	72	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2020	383	9								10.1056/NEJMp2021971	http://dx.doi.org/10.1056/NEJMp2021971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2NK	32780573	Bronze			2022-12-28	WOS:000563821400003
J	Ference, BA; Kastelein, JJP; Catapano, AL				Ference, Brian A.; Kastelein, John J. P.; Catapano, Alberico L.			Lipids and Lipoproteins in 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Insights Clinical Update reviews the central role of apolipoprotein B(100)molecule (apoB)-containing lipoproteins in the development of atherosclerotic cardiovascular disease (ASCVD), with implications for patient risk assessment and choice of lipid-lowering therapy.	[Ference, Brian A.] Univ Cambridge, Ctr Naturally Randomized Trials, 2Worts Causeway, Cambridge CB1 8RN, England; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Catapano, Alberico L.] Multimed IRCCS, Milan, Italy	University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan; IRCCS Multimedica	Ference, BA (corresponding author), Univ Cambridge, Ctr Naturally Randomized Trials, 2Worts Causeway, Cambridge CB1 8RN, England.	baf29@medschl.cam.ac.uk						Ference BA, 2017, JAMA-J AM MED ASSOC, V318, P947, DOI 10.1001/jama.2017.11467; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804	8	36	37	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					595	596		10.1001/jama.2020.5685	http://dx.doi.org/10.1001/jama.2020.5685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32717042				2022-12-28	WOS:000562845100022
J	Franz, AR; Engel, C; Bassler, D; Rudiger, M; Thome, UH; Maier, RF; Krageloh-Mann, I; Kron, M; Essers, J; Buhrer, C; Rellensmann, G; Rossi, R; Bittrich, HJ; Roll, C; Hohn, T; Ehrhardt, H; Avenarius, S; Korner, HT; Stein, A; Buxmann, H; Vochem, M; Poets, CF				Franz, Axel R.; Engel, Corinna; Bassler, Dirk; Ruediger, Mario; Thome, Ulrich H.; Maier, Rolf F.; Kraegeloh-Mann, Ingeborg; Kron, Martina; Essers, Jochen; Buehrer, Christoph; Rellensmann, Georg; Rossi, Rainer; Bittrich, Hans-Joerg; Roll, Claudia; Hoehn, Thomas; Ehrhardt, Harald; Avenarius, Stefan; Koerner, Hans Thorsten; Stein, Anja; Buxmann, Horst; Vochem, Matthias; Poets, Christian F.		Ettno Investigators	Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants The ETTNO Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-CELL TRANSFUSIONS; NECROTIZING ENTEROCOLITIS; RISK; RETINOPATHY; ASSOCIATIONS; DEATH	Importance Red blood cell transfusions are commonly administered to infants weighing less than 1000 g at birth. Evidence-based transfusion thresholds have not been established. Previous studies have suggested higher rates of cognitive impairment with restrictive transfusion thresholds. Objective To compare the effect of liberal vs restrictive red blood cell transfusion strategies on death or disability. Design, Setting, and Participants Randomized clinical trial conducted in 36 level III/IV neonatal intensive care units in Europe among 1013 infants with birth weights of 400 g to 999 g at less than 72 hours after birth; enrollment took place between July 14, 2011, and November 14, 2014, and follow-up was completed by January 15, 2018. Interventions Infants were randomly assigned to liberal (n = 492) or restrictive (n = 521) red blood cell transfusion thresholds based on infants' postnatal age and current health state. Main Outcome and Measures The primary outcome, measured at 24 months of corrected age, was death or disability, defined as any of cognitive deficit, cerebral palsy, or severe visual or hearing impairment. Secondary outcome measures included individual components of the primary outcome, complications of prematurity, and growth. Results Among 1013 patients randomized (median gestational age at birth, 26.3 [interquartile range {IQR}, 24.9-27.6] weeks; 509 [50.2%] females), 928 (91.6%) completed the trial. Among infants in the liberal vs restrictive transfusion thresholds groups, respectively, incidence of any transfusion was 400/492 (81.3%) vs 315/521 (60.5%); median volume transfused was 40 mL (IQR, 16-73 mL) vs 19 mL (IQR, 0-46 mL); and weekly mean hematocrit was 3 percentage points higher with liberal thresholds. Among infants in the liberal vs restrictive thresholds groups, the primary outcome occurred in 200/450 (44.4%) vs 205/478 (42.9%), respectively, for a difference of 1.6% (95% CI, -4.8% to 7.9%; P = .72). Death by 24 months occurred in 38/460 (8.3%) vs 44/491 (9.0%), for a difference of -0.7% (95% CI, -4.3% to 2.9%; P = .70), cognitive deficit was observed in 154/410 (37.6%) vs 148/430 (34.4%), for a difference of 3.2% (95% CI, -3.3% to 9.6%; P = .47), and cerebral palsy occurred in 18/419 (4.3%) vs 25/443 (5.6%), for a difference of -1.3% (95% CI, -4.2% to 1.5%; P = .37), in the liberal vs the restrictive thresholds groups, respectively. In the liberal vs restrictive thresholds groups, necrotizing enterocolitis requiring surgical intervention occurred in 20/492 (4.1%) vs 28/518 (5.4%); bronchopulmonary dysplasia occurred in 130/458 (28.4%) vs 126/485 (26.0%); and treatment for retinopathy of prematurity was required in 41/472 (8.7%) vs 38/492 (7.7%). Growth at follow-up was also not significantly different between groups. [GRAPHICS] Conclusions and Relevance Among infants with birth weights of less than 1000 g, a strategy of liberal blood transfusions compared with restrictive transfusions did not reduce the likelihood of death or disability at 24 months of corrected age.	[Franz, Axel R.; Engel, Corinna] Univ Childrens Hosp Tubingen, Ctr Pediat Clin Studies, Tubingen, Germany; [Franz, Axel R.; Poets, Christian F.] Univ Childrens Hosp, Neonatol, Tubingen, Germany; [Bassler, Dirk] Univ Zurich, Univ Zurich Hosp, Dept Neonatol, Zurich, Switzerland; [Ruediger, Mario] Tech Univ Dresden, Pediat Clin, Dept Neonatol & Pediat Intens Care Med, Fac Med, Dresden, Germany; [Thome, Ulrich H.] Univ Leipzig, Childrens Hosp, Div Neonatol, Dept ofWomen & Childrens Hlth, Leipzig, Germany; [Maier, Rolf F.] Philipps Univ Marburg, Univ Hosp, Childrens Hosp, Marburg, Germany; [Kraegeloh-Mann, Ingeborg] Univ Childrens Hosp Tubingen, Dept Paediat Neurol & Dev Med, Tubingen, Germany; [Kron, Martina] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Essers, Jochen] Univ Hosp Ulm, Ulm, Germany; [Buehrer, Christoph] Charite Univ Med Berlin, Berlin, Germany; [Rellensmann, Georg] Univ Hosp Munster, Pediat, Munster, Germany; [Rossi, Rainer] Vivantes Klinikum Neukolln, Berlin, Germany; [Bittrich, Hans-Joerg] Helios Klinikum Erfurt, Erfurt, Germany; [Roll, Claudia] Univ Witten Herdecke, Vest Kinder & Jugendklin Datteln, Datteln, Germany; [Hoehn, Thomas] Univ Hosp Dusseldorf, Neonatol & Pediat Intens Care, Dusseldorf, Germany; [Ehrhardt, Harald] Justus Liebig Univ Giessen, Dept Gen Pediat & Neonatol, Giessen, Germany; [Avenarius, Stefan] Univ Hosp Magdeburg, Pediat, Magdeburg, Germany; [Koerner, Hans Thorsten] Klinikum Links der Weser, Neonatol, Bremen, Germany; [Stein, Anja] Univ Duisburg Essen, Dept Paediat 1, Essen, Germany; [Buxmann, Horst] Univ Hosp Frankfurt, Frankfurt, Germany; [Vochem, Matthias] Olga Hosp, Klinikum Stuttgart, Stuttgart, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; Technische Universitat Dresden; Leipzig University; Philipps University Marburg; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Ulm University; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; VIivantes Klinikum Neukolln; Helios Kliniken; Witten Herdecke University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Justus Liebig University Giessen; University Hospital Magdeburg; University of Duisburg Essen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart	Franz, AR (corresponding author), Univ Childrens Hosp Tubingen, Ctr Pediat Clin Studies, Dept Neonatol, Calwerstr 7, D-72076 Tubingen, Germany.	axel.franz@med.uni-tuebingen.de	Ehrhardt, Harald/L-9007-2018; Franz, Axel/AAC-8067-2022; Greisen, Gorm/AAA-6463-2022; Schwarz, Christoph E./GQY-5743-2022	Ehrhardt, Harald/0000-0003-4587-1734; Greisen, Gorm/0000-0001-8042-3262; Schwarz, Christoph E./0000-0003-0975-1575; Stein, Anja/0000-0002-0497-4609	German Research Foundation (Deutsche Forschungsgemeinschaft) [Fr-1455/6-1, Fr-1455/6-2]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The trial was funded by German Research Foundation (Deutsche Forschungsgemeinschaft) grants Fr-1455/6-1 and Fr-1455/6-2.	Baer VL, 2011, TRANSFUSION, V51, P1170, DOI 10.1111/j.1537-2995.2010.02980.x; Bassler D, 2015, NEW ENGL J MED, V373, P1497, DOI 10.1056/NEJMoa1501917; Bell EF, 2008, ARCH DIS CHILD-FETAL, V93, P1469, DOI 10.1136/adc.2007.128819; Blau J, 2011, J PEDIATR-US, V158, P403, DOI 10.1016/j.jpeds.2010.09.015; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Cans C, 2007, DEV MED CHILD NEUROL, V49, P35, DOI 10.1111/j.1469-8749.2007.tb12626.x; Christensen RD, 2013, J MATERN-FETAL NEO M, V26, P60, DOI 10.3109/14767058.2013.830495; Di Fiore JM, 2010, J PEDIATR-US, V157, P69, DOI 10.1016/j.jpeds.2010.01.046; Ghirardello S, 2017, AM J PERINAT, V34, P88, DOI 10.1055/s-0036-1584300; Guillen U, 2012, SEMIN PERINATOL, V36, P244, DOI 10.1053/j.semperi.2012.04.004; Hay S, 2017, SEMIN PERINATOL, V41, P80, DOI 10.1053/j.semperi.2016.09.021; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Inder TE, 1997, J PEDIATR-US, V131, P541, DOI 10.1016/S0022-3476(97)70058-1; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Kirpalani H, 2011, J PEDIATR-US, V159, P359, DOI 10.1016/j.jpeds.2011.05.002; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Mohamed A, 2012, PEDIATRICS, V129, P529, DOI 10.1542/peds.2011-2872; dos Santos AMN, 2011, J PEDIATR-US, V159, P371, DOI 10.1016/j.jpeds.2011.02.040; Paul DA, 2011, PEDIATRICS, V127, P635, DOI 10.1542/peds.2010-3178; Poets CF, 2015, JAMA-J AM MED ASSOC, V314, P595, DOI 10.1001/jama.2015.8841; Silvers KM, 1998, ARCH DIS CHILD-FETAL, V78, pF214, DOI 10.1136/fn.78.3.F214; Slidsborg C, 2016, OPHTHALMOLOGY, V123, P796, DOI 10.1016/j.ophtha.2015.12.019; Stainsby D, 2008, BRIT J HAEMATOL, V141, P73, DOI 10.1111/j.1365-2141.2008.07022.x; Valieva OA, 2009, J PEDIATR-US, V155, P331, DOI 10.1016/j.jpeds.2009.02.026; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Whyte R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000512.pub2; Whyte RK, 2009, PEDIATRICS, V123, P207, DOI 10.1542/peds.2008-0338; Widness John A, 2008, Neoreviews, V9, pe520, DOI 10.1542/neo.9-11-e520	28	61	62	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					560	570		10.1001/jama.2020.10690	http://dx.doi.org/10.1001/jama.2020.10690			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780138	Bronze, Green Published			2022-12-28	WOS:000562845100018
J	Oratis, AT; Bush, JWM; Stone, HA; Bird, JC				Oratis, Alexandros T.; Bush, John W. M.; Stone, Howard A.; Bird, James C.			A new wrinkle on liquid sheets: Turning the mechanism of viscous bubble collapse upside down	SCIENCE			English	Article							MODEL	Viscous bubbles are prevalent in both natural and industrial settings. Their rupture and collapse may be accompanied by features typically associated with elastic sheets, including the development of radial wrinkles. Previous investigators concluded that the film weight is responsible for both the film collapse and wrinkling instability. Conversely, we show here experimentally that gravity plays a negligible role: The same collapse and wrinkling arise independently of the bubble's orientation. We found that surface tension drives the collapse and initiates a dynamic buckling instability. Because the film weight is irrelevant, our results suggest that wrinkling may likewise accompany the breakup of relatively small-scale, curved viscous and viscoelastic films, including those in the respiratory tract responsible for aerosol production from exhalation events.	[Oratis, Alexandros T.; Bird, James C.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Bush, John W. M.] MIT, Dept Appl Math, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Boston University; Massachusetts Institute of Technology (MIT); Princeton University	Bird, JC (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.	jbird@bu.edu		Bird, James/0000-0002-1405-9930; Stone, Howard/0000-0002-9670-0639	National Science Foundation [1004678, 1351466]; Office of Naval Research [N00014-16-1-3000]	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	This work was supported by National Science Foundation grant nos. 1004678 and 1351466 and Office of Naval Research grant no. N00014-16-1-3000.	Bhattacharya S, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4798825; Box F, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.198003; CULICK FEC, 1960, J APPL PHYS, V31, P1128, DOI 10.1063/1.1735765; da Silveira R, 2000, SCIENCE, V287, P1468, DOI 10.1126/science.287.5457.1468; Davidovitch B, 2011, P NATL ACAD SCI USA, V108, P18227, DOI 10.1073/pnas.1108553108; Debregeas G, 1998, SCIENCE, V279, P1704, DOI 10.1126/science.279.5357.1704; DEBREGEAS G, 1995, PHYS REV LETT, V75, P3886, DOI 10.1103/PhysRevLett.75.3886; Fluegel A, 2007, GLASS TECHNOL-PART A, V48, P13; Gladden JR, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.035503; Gonnermann HM, 2007, ANNU REV FLUID MECH, V39, P321, DOI 10.1146/annurev.fluid.39.050905.110207; Grotberg JB, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3517737; Hallett MB, 2007, TRENDS CELL BIOL, V17, P209, DOI 10.1016/j.tcb.2007.03.002; Holmes DP, 2019, CURR OPIN COLLOID IN, V40, P118, DOI 10.1016/j.cocis.2019.02.008; Howell P. D., 1996, EUR J APPL MATH, V7, P321, DOI DOI 10.1017/S0956792500002400; Huang J, 2007, SCIENCE, V317, P650, DOI 10.1126/science.1144616; Hure J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.054302; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Kadoura M, 2016, PROG ORG COAT, V99, P452, DOI 10.1016/j.porgcoat.2016.07.002; King H, 2012, P NATL ACAD SCI USA, V109, P9716, DOI 10.1073/pnas.1201201109; Kucken M, 2004, EUROPHYS LETT, V68, P141, DOI 10.1209/epl/i2004-10161-2; Kumar D, 2020, NAT MATER, V19, P690, DOI 10.1038/s41563-020-0640-9; Le Merrer M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.064502; Mahadevan L, 2010, TECTONICS, V29, DOI 10.1029/2010TC002720; Pietenpol WB, 1936, PHYSICS-J GEN APPL P, V7, P26, DOI 10.1063/1.1745341; Pokorny R, 2015, J AM CERAM SOC, V98, P3112, DOI 10.1111/jace.13775; Ribe NM, 2002, J FLUID MECH, V457, P255, DOI 10.1017/S0022112001007649; Savva N, 2009, J FLUID MECH, V626, P211, DOI 10.1017/S0022112009005795; Taylor, 1969, P 12 INT C APPL MECH, P382; Teichman J, 2003, J FLUID MECH, V478, P71, DOI 10.1017/S0022112002003038; Toba Y., 1959, J OCEANOGR SOC JAPAN, V15, P121, DOI [10.5928/KAIYOU1942.15.121, DOI 10.5928/KAIYOU1942.15.121]; Trouton FT, 1906, P R SOC LOND A-CONTA, V77, P426, DOI 10.1098/rspa.1906.0038; VANDEFLIERT BW, 1995, J FLUID MECH, V292, P359, DOI 10.1017/S002211209500156X; Vella D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.014301; Vella D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.174301; Vermorel R, 2007, P ROY SOC A-MATH PHY, V463, P641, DOI 10.1098/rspa.2006.1781; Vermorel R, 2009, P ROY SOC A-MATH PHY, V465, P823, DOI 10.1098/rspa.2008.0297	36	29	31	23	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					685	+		10.1126/science.aba0593	http://dx.doi.org/10.1126/science.aba0593			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32764069				2022-12-28	WOS:000559184400044
J	Wilcock, J; Etherington, C; Hawthorne, K; Brown, G				Wilcock, Jane; Etherington, Clare; Hawthorne, Kamila; Brown, Graham			Insect bites	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wilcock, Jane] Silverdale Med Practice, Salford M27 8HP, Lancs, England; [Etherington, Clare] Ridgeway Surg, Harrow, Middx, England; [Hawthorne, Kamila] Cynon Vale Med Practice, Mt Ash, Wales; [Brown, Graham] North Bristol NHS Trust, Bristol, Avon, England	North Bristol NHS Trust	Wilcock, J (corresponding author), Silverdale Med Practice, Salford M27 8HP, Lancs, England.	jane.wilcock@nhs.net	Wilcock, Jane/E-7237-2019	Wilcock, Jane/0000-0003-0086-4688				[Anonymous], 2012, Drug Ther Bull, V50, P45, DOI 10.1136/dtb.2012.04.0099; [Anonymous], 2020, BUG; Elliot AJ, 2006, FAM PRACT, V23, P490, DOI 10.1093/fampra/cml042; Francis NA, 2016, J ANTIMICROB CHEMOTH, V71, P2037, DOI 10.1093/jac/dkw084; Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x; Logan JG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-275; National Institute for Health and Care Excellence, 2016, CKS INS BIT STINGS M; National Institute for Health and Care Excellence, 2019, INS BIT STINGS ANT P; NHS, 2019, SYMPT INS BIT STINGS; Pali-Scholl I, 2019, ALLERGY, V74, P874, DOI 10.1111/all.13722; RCGP Overdiagnosis Group, 2019, BR J FAM MED; Scott JM, 2014, J AM MOSQUITO CONTR, V30, P136, DOI 10.2987/13-6368.1; UK Tetralogy Information Service uktis, 2018, US INS REP PREGN; WHO, 2020, VECT DIS	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2020	370								m2856	10.1136/bmj.m2856	http://dx.doi.org/10.1136/bmj.m2856			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7QQ	32769081				2022-12-28	WOS:000560709600011
J	Kar, P				Kar, Partha			Partha Kar: Our approach to tackling obesity needs rethinking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com						Alkharaiji Mohammed, 2019, Endocrinol Diabetes Metab, V2, pe00042, DOI 10.1002/edm2.42; Hall KD, 2018, MED CLIN N AM, V102, P183, DOI 10.1016/j.mcna.2017.08.012; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; National Institute for Health and Care Excellence, 2014, OB ID ASS MAN	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3034	10.1136/bmj.m3034	http://dx.doi.org/10.1136/bmj.m3034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32764031	Bronze			2022-12-28	WOS:000560719800009
J	Matute, JD; Duan, JZ; Blumberg, RS				Matute, Juan D.; Duan, Jinzhi; Blumberg, Richard S.			Microbial RNAs Pressure Piezo1 to Respond	CELL			English	Editorial Material								Serotonin production by enterochromaffin cells (ECs) is microbiota-dependent, but the mechanism of this is unknown. In this issue of Cell, Sugisawa et al. demonstrate that Piezo1 in ECs senses single-strand RNA (ssRNA) from intestinal microbiota to promote serotonin production. Deletion of Piezo1 in intestinal epithelium promotes bone formation, decreases peristalsis, and protects from colitis because of decreased serotonin.	[Matute, Juan D.; Duan, Jinzhi; Blumberg, Richard S.] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Dept Med, Boston, MA 02115 USA; [Matute, Juan D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Div Neonatol & Newborn Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Blumberg, RS (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Dept Med, Boston, MA 02115 USA.	rblumberg@bwh.harvard.edu		Matute, Juan/0000-0002-1703-8115	NIH [DK088199, DK51362, DK44319, DK53056]; CCF Research Fellowship Award [707702]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCF Research Fellowship Award	Supported by NIH grants DK088199, DK51362, DK44319, DK53056 (R.S.B.) and CCF Research Fellowship Award #707702 (J.D.M.).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Alcaino C, 2018, P NATL ACAD SCI USA, V115, pE7632, DOI 10.1073/pnas.1804938115; BERTACCINI G, 1960, J PHYSIOL-LONDON, V153, P239, DOI 10.1113/jphysiol.1960.sp006532; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Gehart H, 2019, CELL, V176, P1158, DOI 10.1016/j.cell.2018.12.029; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Spohn SN, 2017, NAT REV GASTRO HEPAT, V14, P412, DOI 10.1038/nrgastro.2017.51; Sugisawa E, 2020, CELL, V182, P609, DOI 10.1016/j.cell.2020.06.022; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047	11	3	4	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					542	544		10.1016/j.cell.2020.07.015	http://dx.doi.org/10.1016/j.cell.2020.07.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32763186	Green Accepted, Bronze			2022-12-28	WOS:000558649000004
J	Pennisi, E				Pennisi, Elizabeth			Lizard man	SCIENCE			English	Editorial Material																			0	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					496	499		10.1126/science.369.6503.496	http://dx.doi.org/10.1126/science.369.6503.496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732406				2022-12-28	WOS:000556568100021
J	Ahn, IE; Tian, X; Wiestner, A				Ahn, Inhye E.; Tian, Xin; Wiestner, Adrian			Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							CLL	Patients with chronic lymphocytic leukemia with chromosome 17 abnormalities have a worse prognosis than those without such alterations. In this phase 2 study, patients who received continuous ibrutinib had a durable response that continued after 6.5 years in some patients.	[Ahn, Inhye E.; Tian, Xin; Wiestner, Adrian] NHLBI, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wiestner, A (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.	wiestnea@nhlbi.nih.gov		Tian, Xin/0000-0003-1896-2462	National Heart, Lung, and Blood Institute; Pharmacyclics, an AbbVie company	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pharmacyclics, an AbbVie company(AbbVie)	Supported by the intramural program of the National Heart, Lung, and Blood Institute. Pharmacyclics, an AbbVie company, provided ibrutinib and research support for the investigator-initiated trial.	Ahn IE, 2018, BLOOD, V131, P2357, DOI 10.1182/blood-2017-12-820910; Fischer K, 2019, NEW ENGL J MED, V380, P2225, DOI 10.1056/NEJMoa1815281; O'Brien S, 2016, LANCET ONCOL, V17, P1409, DOI 10.1016/S1470-2045(16)30212-1; Shanafelt TD, 2019, NEW ENGL J MED, V381, P432, DOI 10.1056/NEJMoa1817073; Woyach JA, 2018, NEW ENGL J MED, V379, P2517, DOI 10.1056/NEJMoa1812836	5	48	49	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					498	500		10.1056/NEJMc2005943	http://dx.doi.org/10.1056/NEJMc2005943			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW2GI	32726539	Green Accepted, Bronze			2022-12-28	WOS:000556861800022
J	Paul, DW; Knight, KR; Campbell, A; Aronson, L				Paul, Dereck W., Jr.; Knight, Kelly R.; Campbell, Andre; Aronson, Louise			Beyond a Moment - Reckoning with Our History and Embracing Antiracism in Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Paul, Dereck W., Jr.; Knight, Kelly R.; Campbell, Andre; Aronson, Louise] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Paul, DW (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Paul, Dereck/0000-0001-6099-5933				Alexander M, 2010, NEW JIM CROW MASS IN; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Edwards F, 2019, P NATL ACAD SCI USA, V116, P16793, DOI 10.1073/pnas.1821204116; Netherland J, 2016, CULT MED PSYCHIAT, V40, P664, DOI 10.1007/s11013-016-9496-5	5	16	16	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2020	383	15					1404	1406		10.1056/NEJMp2021812	http://dx.doi.org/10.1056/NEJMp2021812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OD1NS	32722907	Bronze			2022-12-28	WOS:000579622800006
J	Schieker, M; Conaghan, PG; Mindeholm, L; Praestgaard, J; Solomon, DH; Scotti, C; Gram, H; Thuren, T; Roubenoff, R; Ridker, PM				Schieker, Matthias; Conaghan, Philip G.; Mindeholm, Linda; Praestgaard, Jens; Solomon, Daniel H.; Scotti, Celeste; Gram, Herman; Thuren, Tom; Roubenoff, Ronenn; Ridker, Paul M.			Effects of Interleukin-1 beta Inhibition on Incident Hip and Knee Replacement Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							OSTEOARTHRITIS; INFLAMMATION	Background: Osteoarthritis is a common inflammatory disorder with no disease-modifying therapies. Whether inhibition of interleukin-1 beta (IL-1 beta) can reduce the consequences of large joint osteoarthritis is unclear. Objective: To determine whether IL-1 beta inhibition with canakinumab reduces incident total hip or knee replacement (THR/TKR). Design: Exploratory analysis of a randomized trial. (Clinical Trials.gov: NCT01327846) Setting: 1091 clinical sites in 39 countries. Participants: 10 061 CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) participants. Intervention: Random allocation to placebo or canakinumab (50, 150, or 300 mg) subcutaneously once every 3 months. Measurements: The primary and secondary outcomes were time to first incident THR/TKR and time to first occurrence of an osteoarthritis-related adverse event (AE). Data were obtained through blinded ascertainment of trial clinical and safety databases. Results: Median follow-up was 3.7 years. For the individual canakinumab dose groups, compared with placebo, hazard ratios (HRs) for incident THR/TKR during follow-up were 0.60 (95% CI, 0.38 to 0.95) for the 50-mg group, 0.53 (CI, 0.33 to 0.84) for the 150-mg group, and 0.60 (CI, 0.38 to 0.93) for the 300-mg group. Thus, in the pooled canakinumab groups, compared with the placebo group, incidence rates for THR/TKR were 0.31 and 0.54 events per 100 person-years (HR, 0.58 [CI, 0.42 to 0.80]; P = 0.001), respectively. The HR for the secondary end point of osteoarthritis-related AEs was 0.73 (CI, 0.61 to 0.87). Similar findings were observed in analyses restricted to participants with a history of osteoarthritis. Limitation: Because the parent trial was not designed to examine the efficacy of IL-1 beta inhibitors in osteoarthritis, information on structural joint outcomes was not collected. Conclusion: Findings from this exploratory analysis of a randomized controlled trial support further investigation of IL-1 beta inhibition for treatment of large joint osteoarthritis.	[Schieker, Matthias; Mindeholm, Linda; Scotti, Celeste; Roubenoff, Ronenn] Novartis Inst Biomed Res, WSJ 386-10-48-07, CH-4002 Basel, Switzerland; [Conaghan, Philip G.] Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England; [Praestgaard, Jens] Novartis Inst Biomed Res, 220 Massachusetts Ave,2nd Floor, Cambridge, MA 02139 USA; [Solomon, Daniel H.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Gram, Herman] Novartis Pharma AG, Forum 1, CH-4002 Basel, Switzerland; [Thuren, Tom] Novartis Pharmaceut, One Hlth Plaza, E Hanover, NJ 07839 USA; [Ridker, Paul M.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA; [Ridker, Paul M.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Cardiovasc Dis, 900 Commonwealth Ave, Boston, MA 02215 USA	Novartis; Chapel Allerton Hospital; Novartis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Novartis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	pridker@bwh.harvard.edu	Schieker, Matthias/AGZ-2030-2022	Schieker, Matthias/0000-0002-1230-3653; Conaghan, Philip/0000-0002-3478-5665	Novartis Pharmaceuticals; National Institute for Health Research infrastructure at Leeds	Novartis Pharmaceuticals(Novartis); National Institute for Health Research infrastructure at Leeds	The CANTOS trial was supported by Novartis Pharmaceuticals. Dr. Conaghan is supported in part by the National Institute for Health Research infrastructure at Leeds.	Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096; Chevalier X, 2019, NAT REV RHEUMATOL, V15, P191, DOI 10.1038/s41584-019-0185-y; Cohen SB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3430; Eitner L, 2018, EUR J PAIN, V22, P1281, DOI 10.1002/ejp.1215; Fleischmann RM, 2019, ARTHRITIS RHEUMATOL, V71, P1056, DOI 10.1002/art.40840; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Lohmander LS, 2019, NAT REV RHEUMATOL, V15, P133, DOI 10.1038/s41584-019-0174-1; Malda J, 2016, NAT REV RHEUMATOL, V12, P243, DOI 10.1038/nrrheum.2015.170; Martel-Pelletier J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.72; Osteoarthritis Research Society International, 2019, OST SER DIS WHIT PAP; Park-Min KH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6418; Rahmati M, 2016, BONE, V85, P81, DOI 10.1016/j.bone.2016.01.019; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2018, EUR HEART J, V39, P3499, DOI 10.1093/eurheartj/ehy310; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Shen J, 2017, CONNECT TISSUE RES, V58, P49, DOI 10.1080/03008207.2016.1208655; Solomon DH, 2018, ANN INTERN MED, V169, P535, DOI 10.7326/M18-1167; Vallurupalli M, 2020, ANN INTERN MED, V172, P523, DOI 10.7326/M19-2945; Wang X, 2015, OSTEOARTHR CARTILAGE, V23, P22, DOI 10.1016/j.joca.2014.10.002; Wood MJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125325	24	39	40	4	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					509	+		10.7326/M20-0527	http://dx.doi.org/10.7326/M20-0527			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX4GS	32744862	Green Published, Green Accepted			2022-12-28	WOS:000575671400006
J	Parikh, S; O'Laughlin, K; Ehrlich, HY; Campbell, L; Harizaj, A; Durante, A; Leung, V				Parikh, Sunil; O'Laughlin, Kevin; Ehrlich, Hanna Y.; Campbell, Lauren; Harizaj, Adora; Durante, Amanda; Leung, Vivian			Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Parikh, Sunil; Ehrlich, Hanna Y.; Campbell, Lauren] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA; [O'Laughlin, Kevin] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Harizaj, Adora; Durante, Amanda; Leung, Vivian] Connecticut Dept Publ Hlth, Hartford, CT USA	Yale University; Centers for Disease Control & Prevention - USA	Parikh, S (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA.	sunil.parikh@yale.edu	Leung, Vivian H/GNW-5365-2022	Ehrlich, Hanna/0000-0002-7501-6424; Leung, Vivian/0000-0001-6086-5338	NCATS NIH HHS [UL1 TR001863] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bigelow BF, 2021, JAMA INTERN MED, V181, P127, DOI 10.1001/jamainternmed.2020.3738; Centers for Disease Control and Prevention, TESTING GUIDELINES N; Connecticut Department of Public Health, COVID 19 DAILY DPH R; Feaster M, 2020, EMERG INFECT DIS, V26, P2416, DOI 10.3201/eid2610.202694; Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775; Sanchez GV, 2020, MMWR-MORBID MORTAL W, V69, P882, DOI 10.15585/mmwr.mm6927e1	6	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2020	324	11					1101	1103		10.1001/jama.2020.14984	http://dx.doi.org/10.1001/jama.2020.14984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OF2XM	32790860	Bronze, Green Published			2022-12-28	WOS:000581077300024
J	Mulligan, MJ				Mulligan, Mark J.			An Inactivated Virus Candidate Vaccine to Prevent COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mulligan, Mark J.] NYU, Grossman Sch Med, Langone Vaccine Ctr, New York, NY USA	New York University	Mulligan, MJ (corresponding author), NYU, Grossman Sch Med, Alexandria Ctr Life Sci, West Tower,430 E 29th St,Room 304, New York, NY 10016 USA.	mark.mulligan@nyulangone.org						Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Food and Drug Administration, 2020, DEV LIC VACC PREV CO; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Jackson LA, 2020, N ENGL J MED; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Sahin U, 2020, CONCURRENT HUMAN ANT, DOI [10.1101/2020.07.17.20140533, DOI 10.1101/2020.07.17.20140533]; Xia SL, 2020, JAMA-J AM MED ASSOC, V324, P951, DOI 10.1001/jama.2020.15543; Zhou FJ, 2014, PEDIATRICS, V133, P577, DOI 10.1542/peds.2013-0698; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	13	7	8	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					943	945		10.1001/jama.2020.15539	http://dx.doi.org/10.1001/jama.2020.15539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32789500	Bronze			2022-12-28	WOS:000571867000015
J	Chan, KK; Dorosky, D; Sharma, P; Abbasi, SA; Dye, JM; Kranz, DM; Herbert, AS; Procko, E				Chan, Kui K.; Dorosky, Danielle; Sharma, Preeti; Abbasi, Shawn A.; Dye, John M.; Kranz, David M.; Herbert, Andrew S.; Procko, Erik			Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2	SCIENCE			English	Article							RESPIRATORY-SYNDROME CORONAVIRUS; ANGIOTENSIN-CONVERTING ENZYME-2; CELL ENTRY; RECEPTOR; DOMAIN	The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds angiotensin-converting enzyme 2 (ACE2) on host cells to initiate entry, and soluble ACE2 is a therapeutic candidate that neutralizes infection by acting as a decoy. By using deep mutagenesis, mutations in ACE2 that increase S binding are found across the interaction surface, in the asparagine 90-glycosylation motif and at buried sites. The mutational landscape provides a blueprint for understanding the specificity of the interaction between ACE2 and S and for engineering high-affinity decoy receptors. Combining mutations gives ACE2 variants with affinities that rival those of monoclonal antibodies. A stable dimeric variant shows potent SARS-CoV-2 and -1 neutralization in vitro. The engineered receptor is catalytically active, and its close similarity with the native receptor may limit the potential for viral escape.	[Chan, Kui K.] Orthogonal Biol, Champaign, IL 61821 USA; [Dorosky, Danielle; Abbasi, Shawn A.; Dye, John M.; Herbert, Andrew S.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Sharma, Preeti; Kranz, David M.; Procko, Erik] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Sharma, Preeti; Kranz, David M.; Procko, Erik] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA; [Herbert, Andrew S.] Geneva Fdn, Tacoma, WA 98402 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Procko, E (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Procko, E (corresponding author), Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.	procko@illinois.edu	Sharma, Preeti/P-1044-2019	Sharma, Preeti/0000-0002-8210-9004; Chan, Kui/0000-0002-6351-2885; Abbasi, Shawn/0000-0002-7516-5876; Procko, Erik/0000-0002-0028-490X	NIH [R01AI129719]; CARES Act with programmatic oversight from the Military Infectious Diseases Research Program-project [14066041]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CARES Act with programmatic oversight from the Military Infectious Diseases Research Program-project	The development of deep mutagenesis to study virus-receptor interactions was supported by NIH award R01AI129719 to E.P. Funding for USAMRIID was provided through the CARES Act with programmatic oversight from the Military Infectious Diseases Research Program-project 14066041.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Baum A., 2020, SCIENCE, DOI [10.1126/science.eabd0831, DOI 10.1126/SCIENCE.EABD0831]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, 2020, NAT MICROBIOL, V4, P3; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Haschke M, 2013, CLIN PHARMACOKINET, V52, P783, DOI 10.1007/s40262-013-0072-7; Heredia JD, 2019, J VIROL, V93, DOI 10.1128/JVI.00219-19; Heredia JD, 2018, J IMMUNOL, V200, P3825, DOI 10.4049/jimmunol.1800343; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2004, BIOCHEM BIOPH RES CO, V319, P1216, DOI 10.1016/j.bbrc.2004.05.114; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Jones SJ, 2020, ACE 2 CODING VARIANT, V2020, DOI [10.1101/2020.04.05.026633, DOI 10.1101/2020.04.05.026633]; Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x; Lei CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16048-4; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li Y, 2020, J ENERGY STORAGE; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Park J, 2019, J BIOL CHEM, V294, P4759, DOI 10.1074/jbc.RA118.006173; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Stawiski E.W., 2020, BIORXIV, DOI [10.1101/2020.04.07.024752, DOI 10.1101/2020.04.07.024752]; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Treml B, 2010, CRIT CARE MED, V38, P596, DOI 10.1097/CCM.0b013e3181c03009; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhang G., 2020, BIORXIV, DOI 10.1101/2020.03.19.999318; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	49	264	267	12	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2020	369	6508			SI		1261	+		10.1126/science.abc0870	http://dx.doi.org/10.1126/science.abc0870			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NL6LT	32753553	Green Published			2022-12-28	WOS:000567525400056
J	Gostin, LO; Cohen, IG; Koplan, JP				Gostin, Lawrence O.; Cohen, I. Glenn; Koplan, Jeffrey P.			Universal Masking in the United States The Role of Mandates, Health Education, and the CDC	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Cohen, I. Glenn] Harvard Law Sch, Cambridge, MA USA; [Koplan, Jeffrey P.] Emory Univ, Atlanta, GA 30322 USA	Georgetown University; Harvard University; Emory University	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@georgetown.edu						Brooks JT, 2020, JAMA-J AM MED ASSOC, V324, P635, DOI 10.1001/jama.2020.13107; Centers for Disease Control and Prevention, CONS WEAR MASKS; Flynn M, 2018, WASHINGTON POST; Institute of Medicine, 2007, FUT DRUG SAF PROM PR; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Wang XW, 2020, JAMA-J AM MED ASSOC, V324, P703, DOI 10.1001/jama.2020.12897	7	27	27	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2020	324	9					837	838		10.1001/jama.2020.15271	http://dx.doi.org/10.1001/jama.2020.15271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP3QW	32790823	Bronze			2022-12-28	WOS:000570094600009
J	Bressler, NM				Bressler, Neil M.			Reducing the Progression of Myopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE; ATROPINE		[Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University	Bressler, NM (corresponding author), Johns Hopkins Univ Hosp, Maumenee 752,600 N Wolfe St, Baltimore, MD 21287 USA.	nmboffice@jhmi.edu						Barathi VA, 2011, MOL VIS, V17, P680; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Chua WH, 2006, OPHTHALMOLOGY, V113, P2285, DOI 10.1016/j.ophtha.2006.05.062; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Outdoor learning: a national guide for early childhood educators, OUTD LEARN NAT GUID; Ruiz-Pomeda A, 2018, GRAEF ARCH CLIN EXP, V256, P1011, DOI 10.1007/s00417-018-3906-z; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Walline JJ, 2020, JAMA-J AM MED ASSOC, V324, P571, DOI 10.1001/jama.2020.10834; Williams KM, 2015, EUR J EPIDEMIOL, V30, P305, DOI 10.1007/s10654-015-0010-0; Wu PC, 2018, OPHTHALMOLOGY, V125, P1239, DOI 10.1016/j.ophtha.2017.12.011	11	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					558	559		10.1001/jama.2020.10953	http://dx.doi.org/10.1001/jama.2020.10953			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780128				2022-12-28	WOS:000562845100017
J	Livingston, EH				Livingston, Edward H.			Success of Antibiotic Therapy vs Laparoscopic Appendectomy for Uncomplicated Appendicitis in Children A Matter of Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Livingston, Edward H.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Livingston, EH (corresponding author), Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.	edward.livingston@jamanetwork.org						McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; Minneci PC, 2020, JAMA, DOI 10.1001/jama.2020.10888; Salminen P, 2018, JAMA-J AM MED ASSOC, V320, P1259, DOI 10.1001/jama.2018.13201; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154	4	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					594	594		10.1001/jama.2020.13381	http://dx.doi.org/10.1001/jama.2020.13381			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32730560	Bronze			2022-12-28	WOS:000562845100021
J	Barberia, LG; Gomez, EJ				Barberia, Lorena G.; Gomez, Eduardo J.			Political and institutional perils of Brazil's COVID-19 crisis	LANCET			English	Editorial Material									[Barberia, Lorena G.] Univ Sao Paulo, Dept Polit Sci, Sao Paulo, Brazil; [Gomez, Eduardo J.] Lehigh Univ, Coll Hlth, Bethlehem, PA 18015 USA	Universidade de Sao Paulo; Lehigh University	Gomez, EJ (corresponding author), Lehigh Univ, Coll Hlth, Bethlehem, PA 18015 USA.	edg219@lehigh.edu	Barberia, Lorena/F-3174-2010	Barberia, Lorena/0000-0001-6319-543X				Agencia Estado, 2020, DES CRIS MUIT PIOR C; [Anonymous], 2020, NEW YORK TIMES STATE, DOI 10.1016/S2468-2667(20)30117-1; Barberia L, 2020, ICU HOSP BED CAPACIT; Barreto ML, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001692; Cruz I, 2020, NEXO 0506; Datafolha, 2020, DATAFOLHA; Fonseca P, 2020, REUTERS 0328; Fox M, 2020, WORLD; Fraser B, 2020, SCI AM; Friedman U., 2020, ATLANTIC; Granato L., 2020, EXAME; Heuser C., 2020, INT POLITICS SOC; Hunter W, 2019, J DEMOCR, V30, P68, DOI 10.1353/jod.2019.0005; MacDonald SB, 2020, BOLSONAROS FIRST YEA; Machado CV, 2017, CAD SAUDE PUBLICA, V33, DOI 10.1590/0102-311X00129616; Massuda A, 2018, BMJ GLOB HLTH, V3, P1; Ministerio da Saude, 2020, FLUX MAN CLIN AT PRI; Supremo Tribunal Federal, 2020, MED CAUT AC DIR INC; Thomas G., 2019, CBN NEWS; UOL, 2020, UOL 0416; US Centers for Disease Control and Prevention, 2020, REC REG US CLOTH FAC	21	52	54	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					367	368		10.1016/S0140-6736(20)31681-0	http://dx.doi.org/10.1016/S0140-6736(20)31681-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0SW	32738938	Bronze, Green Published			2022-12-28	WOS:000561619100012
J	McGowan, ML; Norris, AH; Bessett, D				McGowan, Michelle L.; Norris, Alison H.; Bessett, Danielle			Care Churn - Why Keeping Clinic Doors Open Isn't Enough to Ensure Access to Abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McGowan, Michelle L.] Cincinnati Childrens Hosp Med Ctr, Eth Ctr, Cincinnati, OH 45229 USA; [McGowan, Michelle L.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [McGowan, Michelle L.] Univ Cincinnati, Dept Womens Gender & Sexual Studies, Cincinnati, OH 45221 USA; [Bessett, Danielle] Univ Cincinnati, Dept Sociol, Cincinnati, OH USA; [Norris, Alison H.] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Norris, Alison H.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	McGowan, ML (corresponding author), Cincinnati Childrens Hosp Med Ctr, Eth Ctr, Cincinnati, OH 45229 USA.; McGowan, ML (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA.; McGowan, ML (corresponding author), Univ Cincinnati, Dept Womens Gender & Sexual Studies, Cincinnati, OH 45221 USA.			Bessett, Danielle/0000-0002-8743-368X				Gerdts C, 2016, AM J PUBLIC HEALTH, V106, P857, DOI 10.2105/AJPH.2016.303134; Notris AH, 2020, AM J PUBLIC HEALTH, V110, P1228, DOI 10.2105/AJPH.2020.305706; Venator J, 2019, UNDUE BURDEN TEXAS A	3	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6					508	510		10.1056/NEJMp2013466	http://dx.doi.org/10.1056/NEJMp2013466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB3TI	32757520				2022-12-28	WOS:000560438400011
J	Rimmer, A				Rimmer, Abi			Covid-19: 700 000 patients could be left unable to see a GP face to face, charity warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Foundation, 2020, MIGHT COV 19 AFF NUM	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3146	10.1136/bmj.m3146	http://dx.doi.org/10.1136/bmj.m3146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7UK	32763907	Bronze			2022-12-28	WOS:000560719800013
J	Gibb, R; Redding, DW; Chin, KQ; Donnelly, CA; Blackburn, TM; Newbold, T; Jones, KE				Gibb, Rory; Redding, David W.; Chin, Kai Qing; Donnelly, Christl A.; Blackburn, Tim M.; Newbold, Tim; Jones, Kate E.			Zoonotic host diversity increases in human-dominated ecosystems	NATURE			English	Article							LAND-USE; INFECTIOUS-DISEASE; SPATIAL-PATTERNS; SPECIES RICHNESS; EXTINCTION RISK; BIODIVERSITY; TRAITS; TRANSMISSION; EMERGENCE; SPILLOVER	Wildlife communities in human-managed ecosystems contain proportionally more species that share human pathogens, and at a higher abundance, than undisturbed habitats, suggesting that landscape transformation creates increasing opportunities for contact between humans and potential hosts of human disease. Land use change-for example, the conversion of natural habitats to agricultural or urban ecosystems-is widely recognized to influence the risk and emergence of zoonotic disease in humans(1,2). However, whether such changes in risk are underpinned by predictable ecological changes remains unclear. It has been suggested that habitat disturbance might cause predictable changes in the local diversity and taxonomic composition of potential reservoir hosts, owing to systematic, trait-mediated differences in species resilience to human pressures(3,4). Here we analyse 6,801 ecological assemblages and 376 host species worldwide, controlling for research effort, and show that land use has global and systematic effects on local zoonotic host communities. Known wildlife hosts of human-shared pathogens and parasites overall comprise a greater proportion of local species richness (18-72% higher) and total abundance (21-144% higher) in sites under substantial human use (secondary, agricultural and urban ecosystems) compared with nearby undisturbed habitats. The magnitude of this effect varies taxonomically and is strongest for rodent, bat and passerine bird zoonotic host species, which may be one factor that underpins the global importance of these taxa as zoonotic reservoirs. We further show that mammal species that harbour more pathogens overall (either human-shared or non-human-shared) are more likely to occur in human-managed ecosystems, suggesting that these trends may be mediated by ecological or life-history traits that influence both host status and tolerance to human disturbance(5,6). Our results suggest that global changes in the mode and the intensity of land use are creating expanding hazardous interfaces between people, livestock and wildlife reservoirs of zoonotic disease.	[Gibb, Rory; Redding, David W.; Chin, Kai Qing; Blackburn, Tim M.; Newbold, Tim; Jones, Kate E.] UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, London, England; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England; [Donnelly, Christl A.] Imperial Coll London, Ctr Global Infect Dis Anal, Sch Publ Hlth, MRC, London, England; [Blackburn, Tim M.; Jones, Kate E.] Zool Soc London, Inst Zool, London, England	University of London; University College London; University of Oxford; Imperial College London; Zoological Society of London	Redding, DW; Jones, KE (corresponding author), UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, London, England.; Jones, KE (corresponding author), Zool Soc London, Inst Zool, London, England.	d.redding@ucr.ac.uk; kate.e.jones@ucl.ac.uk	Newbold, Tim/R-8958-2019; Newbold, Tim/D-1524-2012; Blackburn, Tim M/A-7685-2011; Jones, Kate/G-4768-2010	Newbold, Tim/0000-0001-7361-0051; Newbold, Tim/0000-0001-7361-0051; Redding, David/0000-0001-8615-1798; CHIN, KAI QING/0000-0002-2282-8023; Donnelly, Christl/0000-0002-0195-2463; Jones, Kate/0000-0001-5231-3293	University College London Graduate Research Scholarship; Ecosystem Services for Poverty Alleviation Programme; Dynamic Drivers of Disease in Africa Consortium; NERC [NE-J001570-1]; MRC UKRI/Rutherford Fellowship [MR/R02491X/1]; Wellcome Trust Institutional Strategic Support Fund [204841/Z/16/Z]; Royal Society University Research Fellowship; UK MRC; DFID [MR/R015600/1]; UK National Institute for Health Research Health Protection Research Unit in Modelling Methodology at Imperial College London; Public Health England [HPRU-2012-10080]; MRC [MR/R015600/1] Funding Source: UKRI; NERC [NE/J000507/2] Funding Source: UKRI	University College London Graduate Research Scholarship; Ecosystem Services for Poverty Alleviation Programme; Dynamic Drivers of Disease in Africa Consortium; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC UKRI/Rutherford Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Royal Society University Research Fellowship(Royal Society of London); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFID; UK National Institute for Health Research Health Protection Research Unit in Modelling Methodology at Imperial College London; Public Health England; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Enright, A. Etard, L. Franklinos, R. Freeman, R. Lowe and R. Pearson for discussion on previous versions of the manuscript. This research was supported by a University College London Graduate Research Scholarship (R.G.); the Ecosystem Services for Poverty Alleviation Programme, Dynamic Drivers of Disease in Africa Consortium, NERC project no. NE-J001570-1 (D.W.R. and K.E.J.); an MRC UKRI/Rutherford Fellowship (MR/R02491X/1) and Wellcome Trust Institutional Strategic Support Fund (204841/Z/16/Z) (both to D.W.R.); and a Royal Society University Research Fellowship (T.N.). C.A.D. thanks the UK MRC and DFID for Centre funding (MR/R015600/1), and the UK National Institute for Health Research Health Protection Research Unit in Modelling Methodology at Imperial College London in partnership with Public Health England for funding (grant HPRU-2012-10080).	Becker DJ, 2018, J ANIM ECOL, V87, P511, DOI 10.1111/1365-2656.12765; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V4, P33, DOI 10.1016/j.sste.2012.12.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Burkett-Cadena ND, 2018, BASIC APPL ECOL, V26, P101, DOI 10.1016/j.baae.2017.09.012; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112; Cooper N, 2012, ECOL LETT, V15, P1370, DOI 10.1111/j.1461-0248.2012.01858.x; Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190; Dallas TA, 2019, OIKOS, V128, P23, DOI 10.1111/oik.05602; Ducatez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089955; Faust CL, 2018, ECOL LETT, V21, P471, DOI 10.1111/ele.12904; Fornace KM, 2016, EMERG INFECT DIS, V22, P201, DOI 10.3201/eid2202.150656; Gonzalez-Suarez M, 2012, J ANIM ECOL, V81, P1211, DOI 10.1111/j.1365-2656.2012.01999.x; Gottdenker NL, 2014, ECOHEALTH, V11, P619, DOI 10.1007/s10393-014-0941-z; Gottdenker NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001884; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Harris NC, 2010, ECOL LETT, V13, P1411, DOI 10.1111/j.1461-0248.2010.01527.x; Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012; Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Hosseini PR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0129; Hudson LN, 2017, ECOL EVOL, V7, P145, DOI 10.1002/ece3.2579; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Joseph MB, 2013, ECOL LETT, V16, P1405, DOI 10.1111/ele.12180; Kamiya T, 2014, BIOL REV, V89, P123, DOI 10.1111/brv.12046; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Newbold T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006841; Newbold T, 2016, ECOGRAPHY, V39, P1151, DOI 10.1111/ecog.01932; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Plourde BT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180716; Popp A, 2017, GLOBAL ENVIRON CHANG, V42, P331, DOI 10.1016/j.gloenvcha.2016.10.002; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Rohr JR, 2020, NAT ECOL EVOL, V4, P24, DOI 10.1038/s41559-019-1060-6; Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577; Shah HA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12333-z; Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wardeh M, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.49; Wertheim HFL, 2012, ATLAS HUMAN INFECT D; Young H, 2013, ECOL LETT, V16, P656, DOI 10.1111/ele.12094; Young HS, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0116; Zuur AF, 2010, MIXED EFFECTS MODELS	55	257	262	31	239	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					398	+		10.1038/s41586-020-2562-8	http://dx.doi.org/10.1038/s41586-020-2562-8		AUG 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32759999	Green Submitted			2022-12-28	WOS:000556239400002
J	Nguyen, HCB; Adlanmerini, M; Hauck, AK; Lazar, MA				Nguyen, Hoang C. B.; Adlanmerini, Marine; Hauck, Amy K.; Lazar, Mitchell A.			Dichotomous engagement of HDAC3 activity governs inflammatory responses	NATURE			English	Article							HISTONE DEACETYLASE 3; SET ENRICHMENT ANALYSIS; IN-VIVO; TRANSCRIPTION; INHIBITORS; MACROPHAGE; EXPRESSION; ATF3; METABOLISM; ACTIVATION	During the activation of mouse macrophages by lipopolysaccharides, histone deacetylase 3 controls inflammatory responses by both repressing and activating gene transcription depending on its differential association with transcription factors. The histone deacetylases (HDACs) are a superfamily of chromatin-modifying enzymes that silence transcription through the modification of histones. Among them, HDAC3 is unique in that interaction with nuclear receptor corepressors 1 and 2 (NCoR1/2) is required to engage its catalytic activity(1-3). However, global loss of HDAC3 also results in the repression of transcription, the mechanism of which is currently unclear(4-8). Here we report that, during the activation of macrophages by lipopolysaccharides, HDAC3 is recruited to activating transcription factor 2 (ATF2)-bound sites without NCoR1/2 and activates the expression of inflammatory genes through a non-canonical mechanism. By contrast, the deacetylase activity of HDAC3 is selectively engaged at ATF3-bound sites that suppress Toll-like receptor signalling. Loss of HDAC3 in macrophages safeguards mice from lethal exposure to lipopolysaccharides, but this protection is not conferred upon genetic or pharmacological abolition of the catalytic activity of HDAC3. Our findings show that HDAC3 is a dichotomous transcriptional activator and repressor, with a non-canonical deacetylase-independent function that is vital for the innate immune system.	[Nguyen, Hoang C. B.; Adlanmerini, Marine; Hauck, Amy K.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Nguyen, Hoang C. B.; Adlanmerini, Marine; Hauck, Amy K.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@pennmedicine.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	ADLANMERINI, Marine/0000-0001-5230-2797; Bui Nguyen, Hoang/0000-0001-6975-3084	National Institutes of Health (NIH) [P30 19525]; NIH [R01 DK43806, T32 DK07314]; American Diabetes Association [1-18-PDF-126]; JPB Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); JPB Foundation	We thank D. Steger and H. Goodarzi for discussions, J. Marinis and J. DiSpirito for help with setting up the macrophage system, and the Functional Genomics Core of the Penn Diabetes Research Center (National Institutes of Health (NIH) P30 19525) for next-generation sequencing. This work was supported by NIH R01 DK43806 (M.A.L.), NIH T32 DK07314 (A.K.H.), American Diabetes Association 1-18-PDF-126 (M.A.) and the JPB Foundation.	Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen S, 2018, J NEUROINFLAMM, V15; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; De Souza C, 2015, RECENT PAT ANTI-CANC, V10, P145; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emmett MJ, 2017, NATURE, V546, P544, DOI 10.1038/nature22819; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fonseca GJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08236-0; Gasperini M, 2019, CELL, V176, P377, DOI 10.1016/j.cell.2018.11.029; Greer CB, 2015, CELL REP, V13, P1444, DOI 10.1016/j.celrep.2015.10.013; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Honore PM, 2019, ANN INTENSIVE CARE, V9; Hu QP, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0264-9; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Khuu CH, 2007, MOL IMMUNOL, V44, P1598, DOI 10.1016/j.molimm.2006.08.006; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kuang Z, 2019, SCIENCE, V365, P1428, DOI 10.1126/science.aaw3134; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee MS, 2013, MOL CELLS, V35, P498, DOI 10.1007/s10059-013-2349-y; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Lewandowski SL, 2015, J BIOL CHEM, V290, P27067, DOI 10.1074/jbc.M115.684753; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Luo H, 2015, J ATHEROSCLER THROMB, V22, P1214, DOI 10.5551/jat.28415; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marinelli C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0458-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Yan Q, 2012, P NATL ACAD SCI USA, V109, P14140, DOI 10.1073/pnas.1119842109; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	51	38	40	2	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					286	+		10.1038/s41586-020-2576-2	http://dx.doi.org/10.1038/s41586-020-2576-2		AUG 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32760002	Green Accepted			2022-12-28	WOS:000556239400006
J	Kracht, L; Borggrewe, M; Eskandar, S; Brouwer, N; Lopes, SMCD; Laman, JD; Scherjon, SA; Prins, JR; Kooistra, SM; Eggen, BJL				Kracht, L.; Borggrewe, M.; Eskandar, S.; Brouwer, N.; Lopes, S. M. Chuva de Sousa; Laman, J. D.; Scherjon, S. A.; Prins, J. R.; Kooistra, S. M.; Eggen, B. J. L.			Human fetal microglia acquire homeostatic immune-sensing properties early in development	SCIENCE			English	Article							READ ALIGNMENT; RNA-SEQ; DIFFERENTIATION; MYELINOGENESIS; TURNOVER; BINDING; CELLS; PU.1; AGE	Microglia, immune cells of the central nervous system (CNS), are important for tissue development and maintenance and are implicated in CNS disease, but we lack understanding of human fetal microglia development. Single-cell gene expression and bulk chromatin profiles of microglia at 9 to 18 gestational weeks (GWs) of human fetal development were generated. Microglia were heterogeneous at all studied GWs. Microglia start to mature during this developmental period and increasingly resemble adult microglia with CNS-surveilling properties. Chromatin accessibility increases during development with associated transcriptional networks reflective of adult microglia. Thus, during early fetal development, microglia progress toward a more mature, immune-sensing competent phenotype, and this might render the developing human CNS vulnerable to environmental perturbations during early pregnancy.	[Kracht, L.; Borggrewe, M.; Eskandar, S.; Brouwer, N.; Laman, J. D.; Kooistra, S. M.; Eggen, B. J. L.] Univ Groningen, Univ Med Ctr Groningen, Sect Mol Neurobiol, Dept Biomed Sci Cells & Syst, Groningen, Netherlands; [Eskandar, S.; Scherjon, S. A.; Prins, J. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Lopes, S. M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Lopes, S. M. Chuva de Sousa] Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Ghent University Hospital	Kooistra, SM; Eggen, BJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sect Mol Neurobiol, Dept Biomed Sci Cells & Syst, Groningen, Netherlands.	s.m.kooistra@umcg.nl; b.j.l.eggen@umcg.nl		Prins, Jelmer/0000-0002-3984-2163; Eggen, Bart/0000-0001-8941-0353; Kracht, Laura/0000-0001-7601-8336	Graduate School of Medical Sciences, University of Groningen; Dutch MS Research Foundation [13-833, 16-947]; University of Groningen; Zabawas Foundation (Den Haag, The Netherlands)	Graduate School of Medical Sciences, University of Groningen; Dutch MS Research Foundation; University of Groningen; Zabawas Foundation (Den Haag, The Netherlands)	L.K. is funded by a fellowship from the Graduate School of Medical Sciences, University of Groningen. M.B. and S.M.K. are supported by the Dutch MS Research Foundation (13-833, 16-947). S.E. holds a scholarship from the Junior Scientific Masterclass, University of Groningen. J.R.P. received a Mandema fellowship, University of Groningen. The Zabawas Foundation (Den Haag, The Netherlands) is thanked for financial support of sequencing.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Ayata P, 2018, NAT NEUROSCI, V21, P1049, DOI 10.1038/s41593-018-0192-3; Borggrewe M, 2018, GLIA, V66, P2645, DOI 10.1002/glia.23517; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Croen LA, 2019, AUTISM RES, V12, P1551, DOI 10.1002/aur.2175; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Galatro TF, 2017, METHODS MOL BIOL, V1559, P333, DOI 10.1007/978-1-4939-6786-5_23; Ghosh S, 2018, GLIA, V66, P1200, DOI 10.1002/glia.23271; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hornig M, 2018, MOL PSYCHIATR, V23, P759, DOI 10.1038/mp.2017.119; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kostovic I, 2019, J ANAT, V235, P481, DOI 10.1111/joa.12920; Kracht L., 2020, ZENODO, DOI [10.5281/zenodo.3835875., DOI 10.5281/ZENODO.3835875]; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Masuda T, 2020, CELL REP, V30, P1271, DOI 10.1016/j.celrep.2020.01.010; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mattei D, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.80; Menassa DA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01014; Monier A, 2007, J NEUROPATH EXP NEUR, V66, P372, DOI 10.1097/nen.0b013e3180517b46; Monier A, 2006, J COMP NEUROL, V499, P565, DOI 10.1002/cne.21123; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Parakalan R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-64; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tay TL, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00421; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; van der Poel M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08976-7; Venema WTU, 2019, GASTROENTEROLOGY, V156, P812, DOI 10.1053/j.gastro.2018.10.046; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980	57	55	55	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					530	+		10.1126/science.aba5906	http://dx.doi.org/10.1126/science.aba5906			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732419	Green Published			2022-12-28	WOS:000556568100038
J	Gorkin, DU; Barozzi, I; Zhao, Y; Zhang, YX; Huang, H; Lee, AY; Li, B; Chiou, J; Wildberg, A; Ding, B; Zhang, B; Wang, MC; Strattan, JS; Davidson, JM; Qiu, YJ; Afzal, V; Akiyama, JA; Plajzer-Frick, I; Novak, CS; Kato, M; Garvin, TH; Pham, QT; Harrington, AN; Mannion, BJ; Lee, EA; Fukuda-Yuzawa, Y; He, YP; Preissl, S; Chee, S; Han, JY; Williams, BA; Trout, D; Amrhein, H; Yang, HB; Cherry, JM; Wang, W; Gaulton, K; Ecker, JR; Shen, Y; Dickel, DE; Visel, A; Pennacchio, LA; Ren, B				Gorkin, David U.; Barozzi, Iros; Zhao, Yuan; Zhang, Yanxiao; Huang, Hui; Lee, Ah Young; Li, Bin; Chiou, Joshua; Wildberg, Andre; Ding, Bo; Zhang, Bo; Wang, Mengchi; Strattan, J. Seth; Davidson, Jean M.; Qiu, Yunjiang; Afzal, Veena; Akiyama, Jennifer A.; Plajzer-Frick, Ingrid; Novak, Catherine S.; Kato, Momoe; Garvin, Tyler H.; Pham, Quan T.; Harrington, Anne N.; Mannion, Brandon J.; Lee, Elizabeth A.; Fukuda-Yuzawa, Yoko; He, Yupeng; Preissl, Sebastian; Chee, Sora; Han, Jee Yun; Williams, Brian A.; Trout, Diane; Amrhein, Henry; Yang, Hongbo; Cherry, J. Michael; Wang, Wei; Gaulton, Kyle; Ecker, Joseph R.; Shen, Yin; Dickel, Diane E.; Visel, Axel; Pennacchio, Len A.; Ren, Bing			An atlas of dynamic chromatin landscapes in mouse fetal development	NATURE			English	Article							GENOME-WIDE; TRANSCRIPTION FACTOR; ACCESSIBLE CHROMATIN; SUPER-ENHANCERS; CELL IDENTITY; DOMAINS; STATE; GENE; EXPRESSION; ENCODE	Analysis of chromatin state and accessibility in mouse tissues from twelve sites and eight developmental stages provides a comprehensive view of chromatin dynamics. The Encyclopedia of DNA Elements (ENCODE) project has established a genomic resource for mammalian development, profiling a diverse panel of mouse tissues at 8 developmental stages from 10.5 days after conception until birth, including transcriptomes, methylomes and chromatin states. Here we systematically examined the state and accessibility of chromatin in the developing mouse fetus. In total we performed 1,128 chromatin immunoprecipitation with sequencing (ChIP-seq) assays for histone modifications and 132 assay for transposase-accessible chromatin using sequencing (ATAC-seq) assays for chromatin accessibility across 72 distinct tissue-stages. We used integrative analysis to develop a unified set of chromatin state annotations, infer the identities of dynamic enhancers and key transcriptional regulators, and characterize the relationship between chromatin state and accessibility during developmental gene regulation. We also leveraged these data to link enhancers to putative target genes and demonstrate tissue-specific enrichments of sequence variants associated with disease in humans. The mouse ENCODE data sets provide a compendium of resources for biomedical researchers and achieve, to our knowledge, the most comprehensive view of chromatin dynamics during mammalian fetal development to date.	[Gorkin, David U.; Zhao, Yuan; Zhang, Yanxiao; Huang, Hui; Lee, Ah Young; Li, Bin; Qiu, Yunjiang; Preissl, Sebastian; Chee, Sora; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Gorkin, David U.; Preissl, Sebastian; Han, Jee Yun; Ren, Bing] Univ Calif San Diego, Sch Med, Ctr Epigen, La Jolla, CA 92093 USA; [Barozzi, Iros; Afzal, Veena; Akiyama, Jennifer A.; Plajzer-Frick, Ingrid; Novak, Catherine S.; Kato, Momoe; Garvin, Tyler H.; Pham, Quan T.; Harrington, Anne N.; Mannion, Brandon J.; Lee, Elizabeth A.; Fukuda-Yuzawa, Yoko; Dickel, Diane E.; Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Barozzi, Iros] Imperial Coll London, Dept Surg & Canc, London, England; [Zhao, Yuan; Qiu, Yunjiang; He, Yupeng] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Huang, Hui; Chiou, Joshua] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Chiou, Joshua; Gaulton, Kyle] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Wildberg, Andre; Ding, Bo; Wang, Mengchi; Wang, Wei; Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhang, Bo; Yang, Hongbo] Penn State Sch Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Strattan, J. Seth; Davidson, Jean M.; Cherry, J. Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [He, Yupeng; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Williams, Brian A.; Trout, Diane; Amrhein, Henry] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Shen, Yin] Inst Human Genet, San Francisco, CA USA; [Shen, Yin] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Shen, Yin] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Visel, Axel; Pennacchio, Len A.] US DOE, Joint Genome Inst, Berkeley, CA 94704 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Imperial College London; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Stanford University; Salk Institute; California Institute of Technology; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint Genome Institute - JGI; University of California System; University of California Merced; University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ctr Epigen, La Jolla, CA 92093 USA.; Visel, A; Pennacchio, LA (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.; Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Visel, A; Pennacchio, LA (corresponding author), US DOE, Joint Genome Inst, Berkeley, CA 94704 USA.; Visel, A (corresponding author), Univ Calif, Sch Nat Sci, Merced, CA 95343 USA.; Pennacchio, LA (corresponding author), Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA.; Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA.	avisel@lbl.gov; lapennacchio@lbl.gov; biren@ucsd.edu	Barozzi, Iros/GLQ-8907-2022; Visel, Axel/A-9398-2009; Ecker, Joseph R/B-9144-2008	Barozzi, Iros/0000-0003-0690-3473; Visel, Axel/0000-0002-4130-7784; Ecker, Joseph R/0000-0001-5799-5895; Ren, Bing/0000-0002-5435-1127; Dickel, Diane/0000-0001-5497-6824; Chee, Sora/0000-0003-2687-7786; Cherry, J. Michael/0000-0001-9163-5180; Huang, Hui/0000-0002-4319-543X; Pennacchio, Len/0000-0002-8748-3732; Mannion, Brandon/0000-0002-1149-3790; Chiou, Joshua/0000-0002-4618-0647	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA014195] Funding Source: Medline; NHGRI NIH HHS [U24 HG009397, UM1 HG009421, U54 HG006997] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cao Q, 2017, NAT GENET, V49, P1428, DOI 10.1038/ng.3950; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DRESSLER GR, 1995, SEMIN NEPHROL, V15, P263; England J, 2013, CELL MOL LIFE SCI, V70, P1221, DOI 10.1007/s00018-012-1131-1; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ferrai C, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177754; Fishilevich S., 2017, DATABASE, V2017, P2017, DOI DOI 10.1093/DATABASE/BAX028; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Gillis JA, 2016, DEVELOPMENT, V143, P1313, DOI 10.1242/dev.133884; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; He YP, 2020, NATURE, V583, P752, DOI 10.1038/s41586-020-2119-x; He YP, 2017, P NATL ACAD SCI USA, V114, pE1633, DOI 10.1073/pnas.1618353114; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jayewickreme CD, 2015, DEV BIOL, V405, P21, DOI 10.1016/j.ydbio.2015.05.024; Kaucka M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600060; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore J., 2020, NATURE, DOI [10.1038/s41586-020-2493-4, DOI 10.1038/S41586-020-2493-4]; Ngo V, 2019, P NATL ACAD SCI USA, V116, P3668, DOI 10.1073/pnas.1813565116; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roy S, 2015, NUCLEIC ACIDS RES, V43, P8694, DOI 10.1093/nar/gkv865; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Sethi A, 2020, NAT METHODS, V17, P807, DOI 10.1038/s41592-020-0907-8; Sheaffer KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008284; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shimozaki Koji, 2014, World J Stem Cells, V6, P485, DOI 10.4252/wjsc.v6.i4.485; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sisu C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17157-w; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang YJ, 2018, P NATL ACAD SCI USA, V115, P2407, DOI 10.1073/pnas.1719474115; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhang K., 2019, SCI ADV, V5; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	95	97	98	4	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					744	+		10.1038/s41586-020-2093-3	http://dx.doi.org/10.1038/s41586-020-2093-3			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728240	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000554831500025
J	Slomski, A				Slomski, Anita			Rivaroxaban Reduces Complications of PAD Revascularization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					327	327		10.1001/jama.2020.12589	http://dx.doi.org/10.1001/jama.2020.12589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32721003				2022-12-28	WOS:000562851000011
J	Bhatia, M; Mahtani, KR; Rochman, R; Collins, SL				Bhatia, Meena; Mahtani, Kamal R.; Rochman, Ruby; Collins, Sally L.			Primary care assessment and management of common physical symptoms in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT-INFECTION; ACUTE FATTY LIVER; VENOUS THROMBOEMBOLISM; ABDOMINAL-PAIN; ASYMPTOMATIC BACTERIURIA; UNIQUE QUANTIFICATION; NAUSEA; DIAGNOSIS; DISEASE; ASSOCIATION		[Bhatia, Meena; Collins, Sally L.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Mahtani, Kamal R.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Collins, Sally L.] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Bhatia, M (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford, England.	meena.bhatia@ouh.nhs.uk						Allroggen H, 2000, POSTGRAD MED J, V76, P12, DOI 10.1136/pmj.76.891.12; Behrouzi R, 2018, CLIN MED, V18, P75, DOI 10.7861/clinmedicine.18-1-75; Blakely SB, 1933, J AMER MED ASSOC, V101, P970, DOI 10.1001/jama.1933.02740380006003; BPACNZ, 2011, MAN UR TRACT INF PRE; British Thoracic SocietyScottish Intercollegiate Guidelines Network, 2014, THORAX S1, V69, P1; CADTH, 2017, ROUT UR LOW RISK PRE; Coad F, 2018, BRIT J HOSP MED, V79, P571, DOI 10.12968/hmed.2018.79.10.571; Collins S, 2013, OXFORD HDB OBSTET GY, DOI [10.1093/med/9780199698400.001.0001, DOI 10.1093/MED/9780199698400.001.0001]; Cutner A, 1992, BRIT J OBSTET GYNAEC, V12, P75, DOI 10.3109/01443619209013599; Devarajan S, 2011, OBSTET GYNAECOL REPR, V21, P198, DOI [10.1016/j.ogrm.2011.04.001, DOI 10.1016/J.OGRM.2011.04.001]; Dixit A, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/697697; Ducarme G, 2014, J PERINATOL, V34, P87, DOI 10.1038/jp.2013.161; Ebrahimi N, 2009, J OBSTET GYNAECOL CA, V31, P803, DOI 10.1016/S1701-2163(16)34298-0; Einarson TR, 2013, J POPUL THER CLIN PH, V20, pE171; Flint J, 2016, RHEUMATOLOGY, V55, P1698, DOI 10.1093/rheumatology/kev405; Green LJ, 2020, OBSTET GYNECOL, V135, P653, DOI 10.1097/AOG.0000000000003721; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Jarvis S, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k80; JONES D, 2012, BMJ-BRIT MED J, V345, P77350, DOI DOI 10.1136/BMJ.E6818; Kalinderi K, 2018, J OBSTET GYNAECOL, V38, P448, DOI 10.1080/01443615.2017.1370579; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Koren G, 2002, AM J OBSTET GYNECOL, V186, pS228, DOI 10.1067/mob.2002.123054; Koves B, 2017, EUR UROL, V72, P865, DOI 10.1016/j.eururo.2017.07.014; Kurinczuk J.J., 2017, SAVING LIVES IMPROVI; Lee SY, 2017, TAIWAN J OBSTET GYNE, V56, P432, DOI 10.1016/j.tjog.2017.04.035; Legge A, 2014, CAN MED ASSOC J, V186, pE157, DOI 10.1503/cmaj.130499; Liang CC, 2012, ARCH GYNECOL OBSTET, V285, P1205, DOI 10.1007/s00404-011-2124-2; Liu J, 2017, AM J GASTROENTEROL, V112, P838, DOI 10.1038/ajg.2017.54; Lumbiganon P, 2009, OBSTET GYNECOL, V113, P339, DOI 10.1097/AOG.0b013e318195c2a2; Martin SR, 2005, CLIN OBSTET GYNECOL, V48, P2, DOI 10.1097/01.grf.0000153208.93620.39; Matuszkiewicz-Rowinska J, 2015, ARCH MED SCI, V11, P67, DOI 10.5114/aoms.2013.39202; Mayer IE, 1998, GASTROENTEROL CLIN N, V27, P1, DOI 10.1016/S0889-8553(05)70346-0; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; McParlin C, 2016, JAMA-J AM MED ASSOC, V316, P1392, DOI 10.1001/jama.2016.14337; Mehta N, 2015, BEST PRACT RES CL OB, V29, P598, DOI 10.1016/j.bpobgyn.2015.04.005; Melnick DM, 2004, AM J SURG, V187, P170, DOI 10.1016/j.amjsurg.2003.11.023; MILNE JA, 1978, BRIT J OBSTET GYNAEC, V85, P260, DOI 10.1111/j.1471-0528.1978.tb10497.x; Mitsikostas DD, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0596-y; Moher D., 2009, ANN INTERN MED, V6, DOI [DOI 10.18632/aging.103000, 10.1371/journal.pmed.100009]; MOORE LG, 1987, J APPL PHYSIOL, V62, P158, DOI 10.1152/jappl.1987.62.1.158; Morton A, 2018, OBSTET MED, V11, P126, DOI 10.1177/1753495X18759353; National Collaborating Centre for Women's and Children's Health (UK), 2011, ANT CAR ROUT CAR HLT; National Institute for Health and Care Excellence, HYPERTENSION PREGNAN; National Institute for Health and Care Excellence, 2018, UR TRACT INF LOW ANT; National Institute for Health and Care Excellence, 2017, REC SEPS REC DIAGN E; Negro A, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0816-0; Nelson-Piercy C., 2015, HDB OBSTET MED, DOI [10.1201/b18316, DOI 10.1201/B18316]; Niemeijer MN, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.012; Pearce CF, 2012, CLIN OBSTET GYNECOL, V55, P810, DOI 10.1097/GRF.0b013e31825d7b68; Public Health England, 2010, MAN INF GUID PRIM CA; Revell K, 2014, OBSTET GYNAECOL, V16, P179, DOI 10.1111/tog.12101; Robbins MS, 2015, NEUROLOGY, V85, P1024, DOI 10.1212/WNL.0000000000001954; Royal College College of Obstetricians and Gynaecologists, 2016, MAN NAUS VOM PREGN H; Royal College of Physicians, 2019, AC CAR TOOLK 15 MAN; Salick A, 2005, BIOMEDICA, V21, P22; Schatz M., 1997, ASTHMA IMMUNOLOGICAL; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Sultan AA, 2012, BRIT J HAEMATOL, V156, P366, DOI 10.1111/j.1365-2141.2011.08956.x; Treasure T, 2010, J ROY SOC MED, V103, P210, DOI 10.1258/jrsm.2010.100086; UK Department for Work and Pensions, 2018, FIT NOT; Weston P, 2015, OBSTET GYNAECOL, V17, P105, DOI 10.1111/tog.12188; Widmer M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000491.pub3; Woodfield CA, 2010, AM J ROENTGENOL, V194, pWS14, DOI 10.2214/AJR.07.7139	64	1	1	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2020	370								m2248	10.1136/bmj.m2248	http://dx.doi.org/10.1136/bmj.m2248			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS7LZ	32718941	Green Published			2022-12-28	WOS:000554458200012
J	Horton, R				Horton, Richard			Offline: Preparing for a vaccine against COVID-19	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					226	226						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32711784	Green Published, Bronze			2022-12-28	WOS:000567020100011
J	Malyszko, J; Tesarova, P; Capasso, G; Capasso, A				Malyszko, Jolanta; Tesarova, Petra; Capasso, Giovambattista; Capasso, Anna			The link between kidney disease and cancer: complications and treatment	LANCET			English	Review							GLOMERULAR-FILTRATION-RATE; RETROPERITONEAL FIBROSIS; ONCO-NEPHROLOGY; T-CELLS; NEPHROTOXICITY; INJURY; RISK; IMMUNOTHERAPY; RADIOTHERAPY; IFOSFAMIDE	Acute and chronic kidney disease encompasses a complex set of diseases that can both lead to, and result from, cancer. In particular, kidney disease can arise from the use of chemotherapeutic agents. Many of the current and newly developed cancer chemotherapeutic agents are nephrotoxic and can promote kidney dysfunction, which frequently manifests during the terminal stages of cancer. Given the link between kidney disease and cancer development and treatment, the aim of this Review is to highlight the importance of multidisciplinary collaboration between oncologists and nephrologists to predict and prevent chemotherapeutic-induced nephrotoxicity. As new therapies are introduced to treat cancer, new renal toxicities require proper diagnosis and management. We anticipate that multidisciplinary collaborations will lead to the development and implementation of guidelines for clinicians to improve the therapeutic management of patients with both cancer and renal impairment.	[Malyszko, Jolanta] Med Univ Warsaw, Dept Nephrol Dialysis & Internal Med, PL-02097 Warsaw, Poland; [Tesarova, Petra] Charles Univ Prague, Dept Oncol, Prague, Czech Republic; [Capasso, Giovambattista] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Naples, Italy; [Capasso, Giovambattista] Biogem Inst, Ariano Irpino, Italy; [Capasso, Anna] Univ Texas Austin, Dell Med Sch, Dept Oncol, Livestrong Canc Inst, Austin, TX 78712 USA	Medical University of Warsaw; Charles University Prague; Universita della Campania Vanvitelli; University of Texas System; University of Texas Austin	Malyszko, J (corresponding author), Med Univ Warsaw, Dept Nephrol Dialysis & Internal Med, PL-02097 Warsaw, Poland.	jolmal@poczta.onet.pl	Malyszko, Jolanta/GSM-7177-2022	Malyszko, Jolanta/0000-0001-8701-8171				Ahmed M, 1997, J AM SOC NEPHROL, V8, P848; Akce M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02166; Ando M, 2018, INTERNAL MED, V57, P1503, DOI 10.2169/internalmedicine.9838-17; Au E, 2018, NAT REV NEPHROL, V14, P508, DOI 10.1038/s41581-018-0022-6; Balko JM, 2018, CANCER DISCOV, V8, P143, DOI 10.1158/2159-8290.CD-17-1356; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Brehm MA, 2019, FASEB J, V33, P3137, DOI 10.1096/fj.201800636R; Bretagne M, 2017, CANCER CHEMOTH PHARM, V80, P45, DOI 10.1007/s00280-017-3326-5; Brock PR, 2018, NEW ENGL J MED, V378, P2376, DOI 10.1056/NEJMoa1801109; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Brosnan EM, 2014, CANCER-AM CANCER SOC, V120, P664, DOI 10.1002/cncr.28478; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Capasso A, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0518-z; Chanan-Khan A, 2016, LANCET ONCOL, V17, P200, DOI 10.1016/S1470-2045(15)00465-9; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chien CC, 2017, J CANCER, V8, P9, DOI 10.7150/jca.16550; Chinnadurai R, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1578-5; Daviet F, 2019, BRIT J CLIN PHARMACO, V85, P403, DOI 10.1111/bcp.13808; De Stefano A, 2011, CANCER CHEMOTH PHARM, V68, P1207, DOI 10.1007/s00280-011-1604-1; Deng JH, 2018, CANCER DISCOV, V8, P216, DOI 10.1158/2159-8290.CD-17-0915; Deutsch E, 2019, LANCET ONCOL, V20, pE452, DOI 10.1016/S1470-2045(19)30171-8; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Fermiano M, 2014, AM J HEALTH-SYST PH, V71, P793, DOI 10.2146/ajhp130483; Flombaum CD, 2011, CANC KIDNEY FRONTIER, P115; Gastaud L, 2013, LUNG CANCER, V82, P362, DOI 10.1016/j.lungcan.2013.08.007; Gupta S, 2020, AM J KIDNEY DIS, V76, P63, DOI 10.1053/j.ajkd.2019.10.011; Heaf JG, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0828-2; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Iwakura T, 2019, NEPHROL DIAL TRANSPL, V34, P1669, DOI 10.1093/ndt/gfy397; Izzedine H, 2015, NEPHROL DIAL TRANSPL, V30, P1979, DOI 10.1093/ndt/gfu387; Janowitz T, 2017, J CLIN ONCOL, V35, P2798, DOI 10.1200/JCO.2017.72.7578; Janus N, 2010, BRIT J CANCER, V103, P1815, DOI 10.1038/sj.bjc.6605979; Jenkins RW, 2018, CANCER DISCOV, V8, P196, DOI 10.1158/2159-8290.CD-17-0833; Jhaveri KD, 2018, CLIN J AM SOC NEPHRO, V13, P796, DOI 10.2215/CJN.12871117; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kala J., 2019, RAD NEPHROPATHY; Kitching AR, 2018, KIDNEY INT, V94, P4, DOI 10.1016/j.kint.2018.05.006; Krens SD, 2019, LANCET ONCOL, V20, pE200, DOI 10.1016/S1470-2045(19)30145-7; Krishnappa V, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0812-x; Lameire N, 2014, CLIN KIDNEY J, V7, P11, DOI 10.1093/ckj/sft135; Lanitis E, 2017, ANN ONCOL, V28, P18, DOI 10.1093/annonc/mdx238; Lapi F, 2013, JAMA-J AM MED ASSOC, V310, P289, DOI 10.1001/jama.2013.8638; Launay-Vacher V, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000091; Le RQ, 2018, ONCOLOGIST, V23, P943, DOI 10.1634/theoncologist.2018-0028; Lee YC, 2018, CANCER MED-US, V7, P485, DOI 10.1002/cam4.1289; Leppert JT, 2018, J AM SOC NEPHROL, V29, P207, DOI 10.1681/ASN.2017020136; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Malyszko J, 2020, KIDNEY INT, V97, P894, DOI 10.1016/j.kint.2019.12.023; Malyszko J, 2017, NEPHROL DIAL TRANSPL, V32, P924, DOI 10.1093/ndt/gfw338; Martins F, 2019, LANCET ONCOL, V20, pE54, DOI 10.1016/S1470-2045(18)30828-3; May J, 2014, LEUKEMIA LYMPHOMA, V55, P1345, DOI 10.3109/10428194.2013.840780; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Morigi M, 2018, J AM SOC NEPHROL, V29, P1799, DOI 10.1681/ASN.2017111218; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; MOUL JW, 1992, J UROLOGY, V147, P124, DOI 10.1016/S0022-5347(17)37155-0; Mulaomerovic A, 2007, CANCER LETT, V248, P192, DOI 10.1016/j.canlet.2006.07.004; Murakami N, 2017, CURR PROB CANCER, V41, P100, DOI 10.1016/j.currproblcancer.2016.12.004; Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021; Nissim I, 2006, CANCER RES, V66, P7824, DOI 10.1158/0008-5472.CAN-06-1043; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Oleas D, 2021, CLIN KIDNEY J, V14, P1364, DOI 10.1093/ckj/sfaa008; Perazella MA, 2018, J AM SOC NEPHROL, V29, P2039, DOI 10.1681/ASN.2018050488; Perazella MA, 2012, CLIN J AM SOC NEPHRO, V7, P1713, DOI 10.2215/CJN.02780312; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Perico L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00937-2; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Rizk DV, 2018, J AM SOC NEPHROL, V29, P1609, DOI 10.1681/ASN.2018020160; Rossi R, 1997, NEPHROL DIAL TRANSPL, V12, P1091, DOI 10.1093/ndt/12.6.1091; Ruggiero A, 2017, BRIT J CLIN PHARMACO, V83, P2605, DOI 10.1111/bcp.13388; Runowska Marta, 2016, Reumatologia (Warsaw), V54, P256, DOI 10.5114/reum.2016.63667; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Shah JJ, 2013, ONCOLOGY-NY, V27, P19; Sleilalty G, 2018, INTERN MED J, V48, P1382, DOI 10.1111/imj.13933; SRISKANDAN K, 1985, BRIT MED J, V290, P1590, DOI 10.1136/bmj.290.6481.1590-d; Stengel B, 2010, J NEPHROL, V23, P253; Sugiyama M, 2014, CLIN KIDNEY J, V7, P90, DOI 10.1093/ckj/sft154; The International Agency for Research on Cancer, 2018, LAT GLOB CANC DAT CA; Viggiano D, 2019, NEPHROL DIAL TRANSPL, V34, P1623, DOI 10.1093/ndt/gfz029; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Wang YC, 2019, JAMA ONCOL, V5, P1008, DOI 10.1001/jamaoncol.2019.0393; Zuber J, 2002, MEDICINE, V81, P321, DOI 10.1097/00005792-200207000-00008	83	41	42	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					277	287						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK8ZY	32711803				2022-12-28	WOS:000567020100018
J	Mello, MM; Greene, JA; Sharfstein, JM				Mello, Michelle M.; Greene, Jeremy A.; Sharfstein, Joshua M.			Attacks on Public Health Officials During COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mello, Michelle M.] Stanford Univ, Dept Med, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Dept Med, Sch Med, Stanford Hlth Policy, Stanford, CA 94305 USA; [Greene, Jeremy A.; Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St,Room W1033F, Baltimore, MD 21205 USA; [Greene, Jeremy A.] Johns Hopkins Sch Med, Dept Hist Med, Baltimore, MD USA	Stanford University; Stanford University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St,Room W1033F, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu		Mello, Michelle/0000-0003-2877-4270				Forgey Quint, 2020, POLITICO; Halpern SD, 2020, JAMA-J AM MED ASSOC, V324, P337, DOI 10.1001/jama.2020.11623; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609; Poland GA, 2019, JAMA-J AM MED ASSOC, V322, P209, DOI 10.1001/jama.2019.7445; Said C, 2020, SAN FRANCISCO CHRONI; San Mateo County Health, HLTH OFF UPD; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V324, P133, DOI 10.1001/jama.2020.10175	7	21	21	3	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2020	324	8					741	742		10.1001/jama.2020.14423	http://dx.doi.org/10.1001/jama.2020.14423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM6UD	32777019	Bronze			2022-12-28	WOS:000568230000016
J	Daniels, AM; Studdert, DM				Daniels, Alexandra M.; Studdert, David M.			Hepatitis C Treatment in Prisons - Incarcerated People's Uncertain Right to Direct-Acting Antiviral Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Access to highly effective direct-acting antiviral drugs has largely remained elusive for incarcerated people, who are disproportionately affected by hepatitis C. But the constitutional case for wider access to such drugs in prisons is compelling.	[Daniels, Alexandra M.; Studdert, David M.] Stanford Law Sch, Stanford, CA 94305 USA; [Studdert, David M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Daniels, AM (corresponding author), Stanford Law Sch, Stanford, CA 94305 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537				Beckman AL, 2018, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20180724.396136/full/, DOI 10.1377/HBL0G20180724.396136/FULL/]; Federal Bureau of Prisons, 2018, EVALUATION MANAGEMEN; Liu HH, 2019, SUBSCRIPTION MODELS; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Varan AK, 2014, PUBLIC HEALTH REP, V129, P187, DOI 10.1177/003335491412900213	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2020	383	7					611	613		10.1056/NEJMp2004438	http://dx.doi.org/10.1056/NEJMp2004438			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE7HD	32786186				2022-12-28	WOS:000562771200007
J	Muthusamy, T; Cordes, T; Handzlik, MK; You, L; Lim, EW; Gengatharan, J; Pinto, AFM; Badur, MG; Kolar, MJ; Wallace, M; Saghatelian, A; Metallo, CM				Muthusamy, Thangaselvam; Cordes, Thekla; Handzlik, Michal K.; You, Le; Lim, Esther W.; Gengatharan, Jivani; Pinto, Antonio F. M.; Badur, Mehmet G.; Kolar, Matthew J.; Wallace, Martina; Saghatelian, Alan; Metallo, Christian M.			Serine restriction alters sphingolipid diversity to constrain tumour growth	NATURE			English	Article							1-DEOXYSPHINGOLIPIDS; NEUROPATHY; DEOXYSPHINGOLIPIDS; IDENTIFICATION; ACCUMULATION; MITOCHONDRIA; METABOLISM; MODEL; FLUX	Serine, glycine and other nonessential amino acids are critical for tumour progression, and strategies to limit their availability are emerging as potential therapies for cancer(1-3). However, the molecular mechanisms driving this response remain unclear and the effects on lipid metabolism are relatively unexplored. Serine palmitoyltransferase (SPT) catalyses the de novo biosynthesis of sphingolipids but also produces noncanonical 1-deoxysphingolipids when using alanine as a substrate(4,5). Deoxysphingolipids accumulate in the context of mutations inSPTLC1orSPTLC2(6,7)-or in conditions of low serine availability(8,9)-to drive neuropathy, and deoxysphinganine has previously been investigated as an anti-cancer agent(10). Here we exploit amino acid metabolism and the promiscuity of SPT to modulate the endogenous synthesis of toxic deoxysphingolipids and slow tumour progression. Anchorage-independent growth reprogrammes a metabolic network involving serine, alanine and pyruvate that drives the endogenous synthesis and accumulation of deoxysphingolipids. Targeting the mitochondrial pyruvate carrier promotes alanine oxidation to mitigate deoxysphingolipid synthesis and improve spheroid growth, similar to phenotypes observed with the direct inhibition of SPT or ceramide synthesis. Restriction of dietary serine and glycine potently induces the accumulation of deoxysphingolipids while decreasing tumour growth in xenograft models in mice. Pharmacological inhibition of SPT rescues xenograft growth in mice fed diets restricted in serine and glycine, and the reduction of circulating serine by inhibition of phosphoglycerate dehydrogenase (PHGDH) leads to the accumulation of deoxysphingolipids and mitigates tumour growth. The promiscuity of SPT therefore links serine and mitochondrial alanine metabolism to membrane lipid diversity, which further sensitizes tumours to metabolic stress. In xenograft tumour models in mice, modulation of dietary serine, serine palmitoyltransferase or phosphoglycerate dehydrogenase activity enables control of the endogenous synthesis of deoxysphingolipids, sensitizing the tumours to metabolic stress and slowing their progression.	[Muthusamy, Thangaselvam; Cordes, Thekla; Handzlik, Michal K.; You, Le; Lim, Esther W.; Gengatharan, Jivani; Badur, Mehmet G.; Wallace, Martina; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Pinto, Antonio F. M.] Salk Inst Biol Studies, Mass Spectrometry Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Metallo, Christian M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; Salk Institute; University of California System; University of California San Diego	Metallo, CM (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Metallo, CM (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	cmetallo@ucsd.edu	Metallo, Christian/HCH-3476-2022	Metallo, Christian/0000-0003-2404-3040; Kolar, Matthew/0000-0001-8054-9121; Wallace, Martina/0000-0001-8272-5678; Cordes, Thekla/0000-0002-8097-191X; Handzlik, Michal/0000-0002-4653-1902; Pinto, Antonio/0000-0002-1573-8011	NIH [R01CA188652, R01CA234245, U54CA132379, P30CA014195, S10OD021815]; Camille and Henry Dreyfus Teacher-Scholar Award; National Science Foundation (NSF) Faculty Early Career Development (CAREER) Program [1454425]; Helmsley Center for Genomic Medicine; Ferring Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camille and Henry Dreyfus Teacher-Scholar Award; National Science Foundation (NSF) Faculty Early Career Development (CAREER) Program(National Science Foundation (NSF)); Helmsley Center for Genomic Medicine; Ferring Foundation(Ferring Pharmaceuticals)	We thank M. Gantner, M. Friedlander and all members of the laboratory of C.M.M. for support and helpful discussions; and N. Mainolfi, V. Suri, A. Friedman and M. Manfredi of Raze Therapeutics for providing PH-755. This work was supported by the NIH (R01CA188652 and R01CA234245 to C.M.M.; U54CA132379), a Camille and Henry Dreyfus Teacher-Scholar Award (to C.M.M.), the National Science Foundation (NSF) Faculty Early Career Development (CAREER) Program (1454425 to C.M.M.), the Helmsley Center for Genomic Medicine (to A.F.M.P) and funding from Ferring Foundation (to A.S.). This work was also supported by NIH grants to the Salk Institute Mass Spectrometry Core (P30CA014195, S10OD021815).	Alecu I, 2017, J LIPID RES, V58, P60, DOI 10.1194/jlr.M072421; Alecu I, 2017, J LIPID RES, V58, P42, DOI 10.1194/jlr.M068676; Baird RD, 2009, MOL CANCER THER, V8, P1430, DOI 10.1158/1535-7163.MCT-08-1167; BIELAWSKI J, 2009, METHODS MOL BIOL 1, V579, P443, DOI DOI 10.1007/978-1-60761-322-0_22; Cordes T, 2019, METHODS MOL BIOL, V1978, P219, DOI 10.1007/978-1-4939-9236-2_14; Duan JJ, 2015, J BIOL CHEM, V290, P15380, DOI 10.1074/jbc.R115.658823; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Esaki K, 2015, J BIOL CHEM, V290, P14595, DOI 10.1074/jbc.M114.603860; Gantner ML, 2019, NEW ENGL J MED, V381, P1422, DOI 10.1056/NEJMoa1815111; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; Guri Y, 2017, CANCER CELL, V32, P807, DOI 10.1016/j.ccell.2017.11.011; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Jeske L, 2019, NUCLEIC ACIDS RES, V47, pD542, DOI 10.1093/nar/gky1048; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Knott SRV, 2018, NATURE, V554, P378, DOI 10.1038/nature25465; LeBoeuf SE, 2020, CELL METAB, V31, P339, DOI 10.1016/j.cmet.2019.11.012; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lone MA, 2019, BBA-MOL CELL BIOL L, V1864, P512, DOI 10.1016/j.bbalip.2018.12.013; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Oswald MCW, 2015, HUM MOL GENET, V24, P6899, DOI 10.1093/hmg/ddv390; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Parker SJ, 2017, METAB ENG, V43, P208, DOI 10.1016/j.ymben.2016.12.010; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rodriguez AE, 2019, CELL METAB, V29, P1003, DOI 10.1016/j.cmet.2019.01.014; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Steiner R, 2016, J LIPID RES, V57, P1194, DOI 10.1194/jlr.M067033; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Wallace M, 2018, NAT CHEM BIOL, V14, P1021, DOI 10.1038/s41589-018-0132-2; Wu JM, 2015, J CHROMATOGR B, V1006, P167, DOI 10.1016/j.jchromb.2015.10.030; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	36	66	69	3	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 29	2020	586	7831					790	+		10.1038/s41586-020-2609-x	http://dx.doi.org/10.1038/s41586-020-2609-x		AUG 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP6RE	32788725	Green Submitted, Green Accepted			2022-12-28	WOS:000559369600005
J	Petkova, E; Antman, EM; Troxel, AB				Petkova, Eva; Antman, Elliott M.; Troxel, Andrea B.			Pooling Data From Individual Clinical Trials in the COVID-19 Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes principles and processes to allow pooling of individual patient data from clinical trials given decelerating participant recruitment at sites where the COVID-19 surge has been controlled and new cases are diminishing.	[Petkova, Eva] NYU, Dept Populat Hlth, Grossman Sch Med, New York, NY USA; [Petkova, Eva] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Antman, Elliott M.; Troxel, Andrea B.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	New York University; Nathan Kline Institute for Psychiatric Research; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Antman, EM (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu		Troxel, Andrea/0000-0002-1393-3075; Petkova, Eva/0000-0001-5129-9442				Agresti A, 2003, CATEGORICAL DATA ANA; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P2262, DOI 10.1001/jama.2020.8115; Gelman R, 2013, BAYESIAN DATA ANAL, DOI [10.1201/b16018, DOI 10.1201/B16018]; Lewis RJ, 2018, JAMA-J AM MED ASSOC, V320, P2208, DOI 10.1001/jama.2018.16916; Li L, 2020, JAMA; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; NYU Langone Medical Center, 2020, INT CONV PLASM COVID; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352; Tierney JF, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003019	9	44	44	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					543	545		10.1001/jama.2020.13042	http://dx.doi.org/10.1001/jama.2020.13042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32717043	Bronze			2022-12-28	WOS:000562845100010
J	Grewal, R				Grewal, Ruby			Surgery versus cast immobilisation for acute scaphoid fractures	LANCET			English	Editorial Material							WAIST FRACTURES; SCREW FIXATION		[Grewal, Ruby] Univ Western Ontario, Div Orthoped, Roth McFarlane Hand & Upper Limb Ctr, London, ON N6A 4V2, Canada	Western University (University of Western Ontario)	Grewal, R (corresponding author), Univ Western Ontario, Div Orthoped, Roth McFarlane Hand & Upper Limb Ctr, London, ON N6A 4V2, Canada.	rgrewa@uwo.ca						[Anonymous], 2005, J BONE JOINT SURG A; Bond CD, 2001, J BONE JOINT SURG AM, V83A, P483, DOI 10.2106/00004623-200104000-00001; CLAY NR, 1991, J BONE JOINT SURG BR, V73, P828, DOI 10.1302/0301-620X.73B5.1894676; Clementson M, 2015, J HAND SURG-AM, V40, P1341, DOI 10.1016/j.jhsa.2015.03.007; Dias JJ, 2020, LANCET, V396, P390, DOI 10.1016/S0140-6736(20)30931-4; Geoghegan JM, 2009, J HAND SURG-EUR VOL, V34E, P631, DOI 10.1177/1753193409105189; Grewal Ruby, 2016, Open Orthop J, V10, P431; Grewal R, 2013, J HAND SURG-AM, V38A, P872, DOI 10.1016/j.jhsa.2013.01.032; Li HY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013266; Saeden B, 2001, J BONE JOINT SURG BR, V83B, P230, DOI 10.1302/0301-620X.83B2.11197	10	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2020	396	10248					362	363						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0SW	32771092				2022-12-28	WOS:000561619100009
J	Hong, GS				Hong, Guosong			Seeing the sound	SCIENCE			English	Editorial Material							DEEP; EXCITATION		[Hong, Guosong] Stanford Univ, Dept Mat Sci & Engn, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA	Stanford University	Hong, GS (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.	guosongh@stanford.edu		Hong, Guosong/0000-0002-8858-4471	NIA NIH HHS [R00 AG056636] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Airan R, 2017, SCIENCE, V357, DOI 10.1126/science.aao1200; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Chen S, 2019, SCIENCE, V365, P456, DOI 10.1126/science.aay4350; Chen S, 2018, SCIENCE, V359, P679, DOI 10.1126/science.aaq1144; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Hong GS, 2019, NAT REV NEUROSCI, V20, P330, DOI 10.1038/s41583-019-0140-6; Hong GS, 2018, SCIENCE, V360, P1447, DOI 10.1126/science.aas9160; Hong GS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0010; Jeong SM, 2013, ADV MATER, V25, P6194, DOI 10.1002/adma.201301679; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu LS, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201800336; Marshel JH, 2019, SCIENCE, V365, P558, DOI 10.1126/science.aaw5202; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Qian X, 2018, ADV MATER, V30, DOI 10.1002/adma.201800291; Salatino JW, 2017, NAT BIOMED ENG, V1, P862, DOI 10.1038/s41551-017-0154-1; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wang JB, 2018, NEURON, V100, P728, DOI 10.1016/j.neuron.2018.10.042; Wang XD, 2015, ADV MATER, V27, P2324, DOI 10.1002/adma.201405826; Wu X, 2019, P NATL ACAD SCI USA, V116, P26332, DOI 10.1073/pnas.1914387116; Zagzebski JA, 1996, ESSENTIALS ULTRASOUN; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	24	12	12	4	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					638	+		10.1126/science.abd3636	http://dx.doi.org/10.1126/science.abd3636			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764064	Green Accepted			2022-12-28	WOS:000559184400035
J	Sekar, N; Shiller, D				Sekar, Nitin; Shiller, Derek			Engage with animal welfare in conservation	SCIENCE			English	Editorial Material							CONSCIOUSNESS		[Sekar, Nitin] WWF India, Wildlife & Habitats Div, New Delhi, India; [Shiller, Derek] Humane League, New York, NY USA	World Wildlife Fund	Sekar, N (corresponding author), WWF India, Wildlife & Habitats Div, New Delhi, India.	nitin.sekar@gmail.com		Shiller, Derek/0000-0003-3768-3012				Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Braithwaite VA, 2007, DIS AQUAT ORGAN, V75, P131, DOI 10.3354/dao075131; Butler AB, 2006, BIOL BULL-US, V211, P106, DOI 10.2307/4134586; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dubois S, 2017, CONSERV BIOL, V31, P753, DOI 10.1111/cobi.12896; Estes JA, 2018, EFFECTIVE CONSERVATION SCIENCE: DATA NOT DOGMA, P128, DOI 10.1093/oso/9780198808978.003.0020; Feinberg TE, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00667; Hampton JO, 2019, CONSERV BIOL, V33, P751, DOI 10.1111/cobi.13249; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Mashour GA, 2013, P NATL ACAD SCI USA, V110, P10357, DOI 10.1073/pnas.1301188110; Mellor D.J., 2015, CARING WILDLIFE WORL; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Ramp D, 2015, BIOSCIENCE, V65, P323, DOI 10.1093/biosci/biu223; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Wallach AD, 2018, CONSERV BIOL, V32, P1255, DOI 10.1111/cobi.13126	15	9	10	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					629	+		10.1126/science.aba7271	http://dx.doi.org/10.1126/science.aba7271			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MZ5SN	32764058				2022-12-28	WOS:000559184400027
J	Kumar, A; Bechhoefer, J				Kumar, Avinash; Bechhoefer, John			Exponentially faster cooling in a colloidal system	NATURE			English	Article							WATER FREEZE FASTER; HOT-WATER; NATURAL-CONVECTION; MPEMBA; EVAPORATION	As the temperature of a cooling object decreases as it relaxes to thermal equilibrium, it is intuitively assumed that a hot object should take longer to cool than a warm one. Yet, some 2,300 years ago, Aristotle observed that "to cool hot water quickly, begin by putting it in the sun"(1,2). In the 1960s, this counterintuitive phenomenon was rediscovered as the statement that "hot water can freeze faster than cold water" and has become known as the Mpemba effect(3); it has since been the subject of much experimental investigation(4-8) and some controversy(8,9). Although many specific mechanisms have been proposed(6,7,10-16), no general consensus exists as to the underlying cause. Here we demonstrate the Mpemba effect in a controlled setting-the thermal quench of a colloidal system immersed in water, which serves as a heat bath. Our results are reproducible and agree quantitatively with calculations based on a recently proposed theoretical framework(17). By carefully choosing parameters, we observe cooling that is exponentially faster than that observed using typical parameters, in accord with the recently predicted strong Mpemba effect(18). Our experiments outline the generic conditions needed to accelerate heat removal and relaxation to thermal equilibrium and support the idea that the Mpemba effect is not simply a scientific curiosity concerning how water freezes into ice-one of the many anomalous features of water(19)-but rather the prototype for a wide range of anomalous relaxation phenomena of broad technological importance.	[Kumar, Avinash; Bechhoefer, John] Simon Fraser Univ, Dept Phys, Burnaby, BC, Canada	Simon Fraser University	Bechhoefer, J (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC, Canada.	johnb@sfu.ca		Kumar, Avinash/0000-0001-6184-3069	National Sciences and Engineering Research Council of Canada (NSERC)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank O. Raz, Z. Lu, K. Proesmans, R. Chetrite, N. Forde, S. Dodge and T. K. Saha for suggestions; X. Su and especially L. Zhang, who contributed to preliminary versions of the experiment. This research work has been supported by Discovery and RTI Grants from the National Sciences and Engineering Research Council of Canada (NSERC). Author contributions J.B. conceived and designed the research; A.K. built the optical tweezers setup and performed the experiment; J.B. and A.K analysed the data and wrote the paper.	Ahn YH, 2016, KOREAN J CHEM ENG, V33, P1903, DOI 10.1007/s11814-016-0029-2; AUERBACH D, 1995, AM J PHYS, V63, P882, DOI 10.1119/1.18059; Baity-Jesi M, 2019, P NATL ACAD SCI USA, V116, P15350, DOI 10.1073/pnas.1819803116; Berut A, 2012, NATURE, V483, P187, DOI 10.1038/nature10872; Burridge HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37665; Chaddah P., 2010, OVERTAKING APPROACHI; Chupeau M, 2020, P NATL ACAD SCI USA, V117, P1383, DOI 10.1073/pnas.1910677116; Cohen AE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.118102; Debenedetti P. G., 1997, METASTABLE LIQUIDS C; Esposito S, 2008, PHYSICA A, V387, P757, DOI 10.1016/j.physa.2007.10.029; Gal A, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.060602; Gijon A, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.032103; Goldenfeld N., 2019, LECT PHASE TRANSITIO, DOI [https://doi.org/10.1201/9780429493492, DOI 10.1201/9780429493492]; Greaney PA, 2011, METALL MATER TRANS A, V42A, P3907, DOI 10.1007/s11661-011-0843-4; Hu CL, 2018, CRYST GROWTH DES, V18, P5757, DOI 10.1021/acs.cgd.8b01250; Jaynes E.T., 2003, PROBABILITY THEORY L; Jeng M, 2006, AM J PHYS, V74, P514, DOI 10.1119/1.2186331; Jin J, 2015, J PHYS CHEM C, V119, P2622, DOI 10.1021/jp511752n; Jun Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061106; Katz JI, 2009, AM J PHYS, V77, P27, DOI 10.1119/1.2996187; Katz J. I., 2017, REPLY BURRIDGE LINDE; Keller T, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aaa161; Klich I, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021060; Kumar A, 2018, PROC SPIE, V10723, DOI 10.1117/12.2323837; Kumar A, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5055580; Lasanta A, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.148001; LEBOWITZ JL, 1957, ANN PHYS-NEW YORK, V1, P1, DOI 10.1016/0003-4916(57)90002-7; Lu ZY, 2017, P NATL ACAD SCI USA, V114, P5083, DOI 10.1073/pnas.1701264114; Mirabedin SM, 2017, INT J REFRIG, V73, P219, DOI 10.1016/j.ijrefrig.2016.09.006; Moore AL, 2014, MATER TODAY, V17, P163, DOI 10.1016/j.mattod.2014.04.003; Mpemba E. B., 1969, PHYS ED, V4, P172; Nava A, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.125102; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Stone M., 2009, MATH PHYS GUIDED TOU; Sun CQ, 2016, ATTRIBUTE WATER SING; Tao YW, 2017, J CHEM THEORY COMPUT, V13, P55, DOI 10.1021/acs.jctc.6b00735; Torrente A, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.060901; Vynnycky M, 2015, INT J HEAT MASS TRAN, V80, P243, DOI 10.1016/j.ijheatmasstransfer.2014.09.015; Vynnycky M, 2012, INT J HEAT MASS TRAN, V55, P7297, DOI 10.1016/j.ijheatmasstransfer.2012.07.060; Vynnycky M, 2010, HEAT MASS TRANSFER, V46, P881, DOI 10.1007/s00231-010-0637-z; Webster E. W, 1923, ARISTOTLE METEROLOGI; WOJCIECHOWSKI B, 1988, CRYST RES TECHNOL, V23, P843, DOI 10.1002/crat.2170230702; Zhang L., 2019, THESIS; Zhang X, 2014, PHYS CHEM CHEM PHYS, V16, P22995, DOI 10.1039/c4cp03669g	45	37	37	18	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					64	+		10.1038/s41586-020-2560-x	http://dx.doi.org/10.1038/s41586-020-2560-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH2HW	32760048	Green Submitted			2022-12-28	WOS:000618099100001
J	Thornton, J				Thornton, Jacqui			How hierarchical communication "rules" hamper doctor training and patient care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacqui@jacquithornton.com						NHS Improvement, ACT AC SBAR COMM TOO; Royal College of Physicians, 2016, BEING JUN DOCT; Royal College of Radiologists, 2019, NHS DOES NOT HAV EN	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2020	370								m2999	10.1136/bmj.m2999	http://dx.doi.org/10.1136/bmj.m2999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RC	32759280				2022-12-28	WOS:000556139400014
J	Langan, SM; Irvine, AD; Weidinger, S				Langan, Sinead M.; Irvine, Alan D.; Weidinger, Stephan			Atopic dermatitis	LANCET			English	Review							QUALITY-OF-LIFE; THERAPEUTIC PATIENT EDUCATION; HARMONIZING OUTCOME MEASURES; GENOME-WIDE ASSOCIATION; HEALTH-CARE UTILIZATION; COPY-NUMBER VARIATION; EUROPEAN TASK-FORCE; SKIN-DISEASE; DOUBLE-BLIND; TOPICAL CORTICOSTEROIDS	Atopic dermatitis is a common inflammatory skin disorder characterised by recurrent eczematous lesions and intense itch. The disorder affects people of all ages and ethnicities, has a substantial psychosocial impact on patients and relatives, and is the leading cause of the global burden from skin disease. Atopic dermatitis is associated with increased risk of multiple comorbidities, including food allergy, asthma, allergic rhinitis, and mental health disorders. The pathophysiology is complex and involves a strong genetic predisposition, epidermal dysfunction, and T-cell driven inflammation. Although type-2 mechanisms are dominant, there is increasing evidence that the disorder involves multiple immune pathways. Currently, there is no cure, but increasing numbers of innovative and targeted therapies hold promise for achieving disease control, including in patients with recalcitrant disease. We summarise and discuss advances in our understanding of the disease and their implications for prevention, management, and future research.	[Langan, Sinead M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Langan, Sinead M.] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England; [Langan, Sinead M.] Hlth Data Res UK, London, England; [Irvine, Alan D.] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [Irvine, Alan D.] Childrens Hlth Ireland, Dermatol, Crumlin, Ireland; [Irvine, Alan D.] Natl Childrens Res Ctr, Dublin, Ireland; [Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Kiel, Germany	University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Trinity College Dublin; National Children's Research Centre (NCRC); Trinity College Dublin; University of Kiel; Schleswig Holstein University Hospital	Langan, SM (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	sinead.langan@lshtm.ac.uk	Irvine, Alan D/A-3982-2008	Irvine, Alan D/0000-0002-9048-2044; Langan, Sinead/0000-0002-7022-7441	European Union; Wellcome Senior Research Fellowship in Clinical Science [205039/Z/16/Z]; Health Data Research UK (LOND1); UK Medical Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation; Wellcome Trust; UK National Institute for Health Research [ISRCTN15837754]; UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR) [ISRCTN11210918]; Innovative Medicines Initiative 2 Joint Undertaking [821511]; Sanofi Deutschland; Leo Pharma; La Roche Posay; Sanofi Genzyme; Regeneron; AbbVie; Novartis; Galderma	European Union(European Commission); Wellcome Senior Research Fellowship in Clinical Science; Health Data Research UK (LOND1); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research(National Institute for Health Research (NIHR)); UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR); Innovative Medicines Initiative 2 Joint Undertaking; Sanofi Deutschland; Leo Pharma(LEO Pharma); La Roche Posay; Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Regeneron(Regeneron); AbbVie(AbbVie); Novartis(Novartis); Galderma	SML is a co-investigator in the European Union Horizon 2020-funded BIOMAP Consortium, and is supported by a Wellcome Senior Research Fellowship in Clinical Science (205039/Z/16/Z) and by a grant from Health Data Research UK (LOND1), which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation, and the Wellcome Trust. ADI is a co-investigator of the UK National Institute for Health Researchfunded TREAT (ISRCTN15837754) trial and the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR; ISRCTN11210918), a principal investigator in the European Union Horizon 2020-funded BIOMAP Consortium, and a co-principal investigator on the A-STAR Registry. ADI has received consulting fees from AbbVie, Genentech, Janssen, LEO Pharma, Novartis, Regeneron, Sanofi Genzyme, and Pfizer. SW is coordinator of the BIOMAP Consortium, a project funded by the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement number 821511, and a co-principal investigator of the German Atopic Eczema Registry (TREATgermany). SW has received institutional research grants from Sanofi Deutschland, Leo Pharma, and La Roche Posay, has received fees from Sanofi Genzyme, Regeneron, LEO Pharma, AbbVie, Pfizer, Eli Lilly, Kymab, and Novartis, lectured at educational events sponsored by Sanofi Genzyme, Regeneron, LEO Pharma, AbbVie, Novartis, and Galderma, and is involved in clinical trials with many pharmaceutical industries that manufacture drugs used for the treatment of psoriasis and atopic eczema. The conclusions in this Seminar are those of the authors and do not necessarily represent the views of the funders.	Abraham S, 2020, BRIT J DERMATOL, V183, P382, DOI 10.1111/bjd.18958; Abuabara K, 2018, ALLERGY, V73, P696, DOI 10.1111/all.13320; Abuabara K, 2019, J ALLERGY CLIN IMMUN, V144, P710, DOI 10.1016/j.jaci.2019.05.040; Abuabara K, 2018, J ALLERGY CLIN IMMUN, V141, P778, DOI 10.1016/j.jaci.2017.05.031; Ahmed A, 2018, BRIT J DERMATOL, V178, P659, DOI 10.1111/bjd.16046; Akerstrom U, 2015, ACTA DERM-VENEREOL, V95, P587, DOI 10.2340/00015555-2051; Akinlade B, 2019, BRIT J DERMATOL, V181, P459, DOI 10.1111/bjd.17869; Alexander H, 2020, BRIT J DERMATOL, V182, P1331, DOI 10.1111/bjd.18643; Andersen RM, 2016, J EUR ACAD DERMATOL, V30, P604, DOI 10.1111/jdv.13442; Apfelbacher CJ, 2011, ALLERGY, V66, P206, DOI 10.1111/j.1398-9995.2010.02464.x; Ariens LFM, 2020, ALLERGY, V75, P116, DOI 10.1111/all.14080; Ariens LFM, 2019, ACTA DERM-VENEREOL, V99, P762, DOI 10.2340/00015555-3212; Ascott A, 2019, J ALLERGY CLIN IMMUN, V143, P1821, DOI 10.1016/j.jaci.2018.11.030; Balieva FN, 2018, ACTA DERM-VENEREOL, V98, P563, DOI 10.2340/00015555-2918; Barbarot S, 2018, ALLERGY, V73, P1284, DOI 10.1111/all.13401; Barbarot S, 2014, BRIT J DERMATOL, V170, P44, DOI 10.1111/bjd.12932; Barnes L, 2015, DRUG SAFETY, V38, P493, DOI 10.1007/s40264-015-0287-7; Baurecht H, 2018, J ALLERGY CLIN IMMUN, V141, P1668, DOI 10.1016/j.jaci.2018.01.019; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Beattie PE, 2006, BRIT J DERMATOL, V155, P145, DOI 10.1111/j.1365-2133.2006.07185.x; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Belgrave DCM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001748; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Brandner JM, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974451; Brenninkmeijer EEA, 2008, BRIT J DERMATOL, V158, P754, DOI 10.1111/j.1365-2133.2007.08412.x; Brodska P, 2014, DERMATITIS, V25, P120, DOI 10.1097/DER.0000000000000040; Brown SJ, 2012, J INVEST DERMATOL, V132, P98, DOI 10.1038/jid.2011.342; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Brunner PM, 2017, ALLERGY, V72, P2017, DOI 10.1111/all.13223; Bylund S, 2020, ACTA DERM-VENEREOL, V100; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chalmers JR, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2031-3; Chen H, 2011, BRIT J DERMATOL, V165, P106, DOI 10.1111/j.1365-2133.2011.10331.x; Cochrane D, 2015, INT J INTEGR CARE, V15; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Coutinho SD, 2000, MED MYCOL, V38, P73, DOI 10.1080/714030882; de Bruin-Weller M, 2018, BRIT J DERMATOL, V178, P1083, DOI 10.1111/bjd.16156; Deckert S, 2014, ALLERGY, V69, P37, DOI 10.1111/all.12246; Deleuran M, 2020, J AM ACAD DERMATOL, V82, P377, DOI 10.1016/j.jaad.2019.07.074; Dizon MP, 2018, BRIT J DERMATOL, V178, P1280, DOI 10.1111/bjd.16340; Dorland W.A.N., 2012, DORLANDS ILLUSTRATED, V32nd Edn; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Eckert L, 2018, J AM ACAD DERMATOL, V78, P54, DOI 10.1016/j.jaad.2017.08.002; Eckert L, 2017, J AM ACAD DERMATOL, V77, P274, DOI 10.1016/j.jaad.2017.04.019; Eichenfield LF, 2017, J AM ACAD DERMATOL, V77, P641, DOI 10.1016/j.jaad.2017.06.010; Eichenfield LF, 2017, J ALLERGY CLIN IMMUN, V139, pS49, DOI 10.1016/j.jaci.2017.01.009; Elias MS, 2019, J ALLERGY CLIN IMMUN, V144, P470, DOI 10.1016/j.jaci.2019.05.024; Ersser SJ, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004054.PUB2; Faiz S, 2019, J AM ACAD DERMATOL, V81, P143, DOI 10.1016/j.jaad.2019.02.053; Feld M, 2016, J ALLERGY CLIN IMMUN, V138, P500, DOI 10.1016/j.jaci.2016.02.020; Fischer AH, 2017, J AM ACAD DERMATOL, V77, P1060, DOI 10.1016/j.jaad.2017.08.035; Fleckman P, 2019, ICHTHYOSIS VULGARIS; Flohr C, 2004, J ALLERGY CLIN IMMUN, V114, P150, DOI 10.1016/j.jaci.2004.04.027; Flohr C, 2009, BRIT J DERMATOL, V161, P846, DOI 10.1111/j.1365-2133.2009.09261.x; Flohr C, 2011, CURR PROBL DERMATOL, V41, P1, DOI 10.1159/000323290; Foisy Michelle, 2011, Evid Based Child Health, V6, P1322; Frankel HC, 2012, AM J CLIN DERMATOL, V13, P113, DOI 10.2165/11597780-000000000-00000; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gandhi NA, 2016, NAT REV DRUG DISCOV, V15, P35, DOI 10.1038/nrd4624; Garritsen FM, 2014, BRIT J DERMATOL, V170, P501, DOI 10.1111/bjd.12645; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Glatz M, 2015, ACTA DERM-VENEREOL, V95, P191, DOI 10.2340/00015555-1864; Gonzalez-Cervera J, 2017, ANN ALLERG ASTHMA IM, V118, P582, DOI 10.1016/j.anai.2017.02.006; Gonzalez-Lopez G, 2017, BRIT J DERMATOL, V177, P688, DOI 10.1111/bjd.15165; Green C, 2004, HEALTH TECHNOL ASSES, V8, P1; Grinich EE, 2018, BRIT J DERMATOL, V179, P540, DOI 10.1111/bjd.16732; Guan B, 2019, ACTA ENDOCRINOL-BUCH, V15, P158, DOI 10.4183/aeb.2019.158; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Halling-Overgaard AS, 2017, BRIT J DERMATOL, V177, P84, DOI 10.1111/bjd.15065; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Haufe E, 2018, HAUTARZT, V69, P815, DOI 10.1007/s00105-018-4261-z; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Heratizadeh A, 2017, J ALLERGY CLIN IMMUN, V140, P845, DOI 10.1016/j.jaci.2017.01.029; Herd RM, 1996, BRIT J DERMATOL, V135, P20; Hon K.L., 2018, DRUGS CONTEXT, V7; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Incyte, 2018, INC ANN POS DAT PHAS; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jeon C, 2017, DERMATOLOGY THER, V7, P349, DOI 10.1007/s13555-017-0192-3; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Jungersted JM, 2010, ALLERGY, V65, P911, DOI 10.1111/j.1398-9995.2010.02326.x; Kaffenberger BH, 2014, J AM ACAD DERMATOL, V71, P480, DOI 10.1016/j.jaad.2014.04.045; Kantor R, 2017, EXPERT REV CLIN IMMU, V13, P15, DOI 10.1080/1744666X.2016.1212660; Kapoor R, 2008, J AM ACAD DERMATOL, V58, P68, DOI 10.1016/j.jaad.2007.06.041; Karimkhani C, 2014, JAMA DERMATOL, V150, P945, DOI 10.1001/jamadermatol.2014.709; Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Khattri S, 2017, EXP DERMATOL, V26, P28, DOI 10.1111/exd.13112; Kim Y, 2019, J INVEST DERMATOL, V139, P827, DOI 10.1016/j.jid.2018.10.029; Koh BH, 2010, P NATL ACAD SCI USA, V107, P10614, DOI 10.1073/pnas.1005383107; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kono M, 2014, ALLERGY, V69, P537, DOI 10.1111/all.12369; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Langan SM, 2006, BRIT J DERMATOL, V155, P504, DOI 10.1111/j.1365-2133.2006.07381.x; Langan SM, 2009, BRIT J DERMATOL, V161, P640, DOI 10.1111/j.1365-2133.2009.09320.x; Langan SM, 2017, J INVEST DERMATOL, V137, P1375, DOI 10.1016/j.jid.2017.01.030; LeBovidge JS, 2016, J ALLERGY CLIN IMMUN, V138, P325, DOI 10.1016/j.jaci.2016.04.003; Levin E, 2014, J DERMATOL TREAT, V25, P501, DOI 10.3109/09546634.2013.844314; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Li K, 2016, BRIT J DERMATOL, V174, P1098, DOI 10.1111/bjd.14287; Li R, 2019, EXPERT OPIN BIOL TH, V19, P367, DOI 10.1080/14712598.2019.1573422; Liang Y, 2018, PEDIATR DERMATOL, V35, P70, DOI 10.1111/pde.13362; Lloyd-Lavery A, 2019, CLIN EXP DERMATOL, V44, P370, DOI 10.1111/ced.13853; Lowe KE, 2020, J ALLERGY CLIN IMMUN, V145, P563, DOI 10.1016/j.jaci.2019.09.015; Machado MLS, 2010, MED MYCOL, V48, P889, DOI 10.3109/13693780903532080; Mack MR, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1005; Mack MR, 2018, TRENDS IMMUNOL, V39, P980, DOI 10.1016/j.it.2018.10.001; Mansfield KE, 2020, JAMA DERMATOL, V156, P1086, DOI 10.1001/jamadermatol.2020.1948; Manz J, 2016, J INVEST DERMATOL, V136, P2380, DOI 10.1016/j.jid.2016.07.009; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Martin MJ, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040442; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; Mathyer ME, 2018, EXP DERMATOL, V27, P989, DOI 10.1111/exd.13691; Matterne U, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012167.pub2; McAleer MA, 2019, BRIT J DERMATOL, V180, P586, DOI 10.1111/bjd.17088; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Meggitt SJ, 2006, LANCET, V367, P839, DOI 10.1016/S0140-6736(06)68340-2; Meylan P, 2017, J INVEST DERMATOL, V137, P2497, DOI 10.1016/j.jid.2017.07.834; Misery L, 2007, DERMATOLOGY, V215, P123, DOI 10.1159/000104263; Mittermann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156077; Mohan GC, 2015, JAMA DERMATOL, V151, P1009, DOI 10.1001/jamadermatol.2015.0250; Nakagawa H, 2020, J AM ACAD DERMATOL, V82, P823, DOI 10.1016/j.jaad.2019.12.015; NANKERVIS H, 2015, COCHRANE DB SYST REV, V15, DOI DOI 10.1186/S12895-015-0024-Z; National Institute for Health and Care Excellence, 2013, AT ECZ 12S; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Oh BH, 2009, ANN DERMATOL, V21, P352, DOI 10.5021/ad.2009.21.4.352; Olsson M, 2020, BRIT J DERMATOL, V182, P1245, DOI 10.1111/bjd.18442; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2018, J ALLERGY CLIN IMMUN, V141, P964, DOI 10.1016/j.jaci.2017.09.044; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pigors M, 2018, J INVEST DERMATOL, V138, P2674, DOI 10.1016/j.jid.2018.05.013; Ramirez FD, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.0025; Rodenbeck DL, 2016, CLIN DERMATOL, V34, P607, DOI 10.1016/j.clindermatol.2016.05.011; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Roduit C, 2017, JAMA PEDIATR, V171, P655, DOI 10.1001/jamapediatrics.2017.0556; Roekevisch E, 2018, J ALLERGY CLIN IMMUN, V141, P825, DOI 10.1016/j.jaci.2017.09.033; Roekevisch E, 2014, J ALLERGY CLIN IMMUN, V133, P429, DOI 10.1016/j.jaci.2013.07.049; Roosta N, 2010, J CUTAN MED SURG, V14, P285, DOI 10.2310/7750.2010.09053; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Saeki H, 2017, BRIT J DERMATOL, V177, P419, DOI 10.1111/bjd.15493; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sandhu JK, 2019, JAMA DERMATOL, V155, P178, DOI 10.1001/jamadermatol.2018.4566; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Santer M, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22570; Saunders SP, 2016, J ALLERGY CLIN IMMUN, V137, P482, DOI 10.1016/j.jaci.2015.06.045; Savage J, 2016, J ALLER CL IMM-PRACT, V4, P196, DOI 10.1016/j.jaip.2015.11.024; Schmitt J, 2011, BRIT J DERMATOL, V164, P415, DOI 10.1111/j.1365-2133.2010.10030.x; Schmitt J, 2014, J ALLERGY CLIN IMMUN, V134, P800, DOI 10.1016/j.jaci.2014.07.043; Schmitt J, 2013, Z KINDER JUG-PSYCH, V41, P35, DOI 10.1024/1422-4917/a000208; Schmitt J, 2012, ALLERGY, V67, P1111, DOI 10.1111/j.1398-9995.2012.02874.x; Schneeweiss MC, 2021, J AM ACAD DERMATOL, V85, P321, DOI 10.1016/j.jaad.2019.05.073; Schonmann Y, 2020, J ALLER CL IMM-PRACT, V8, P248, DOI 10.1016/j.jaip.2019.08.030; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Schram ME, 2011, J ALLERGY CLIN IMMUN, V128, P353, DOI 10.1016/j.jaci.2011.03.024; Schwartz Daniella M, 2017, Nat Rev Drug Discov, V17, P78, DOI 10.1038/nrd.2017.267; Scott IC, 2018, DRUG SAFETY, V41, P645, DOI 10.1007/s40264-018-0651-5; Seger EW, 2019, J AM ACAD DERMATOL, V80, P411, DOI 10.1016/j.jaad.2018.09.053; Seidenari S, 1995, ACTA DERM-VENEREOL, V75, P429; Serrano L, 2019, J AM ACAD DERMATOL, V80, P904, DOI 10.1016/j.jaad.2018.11.028; Silverberg JI, 2020, JAMA DERMATOL, V156, P863, DOI 10.1001/jamadermatol.2020.1406; Silverberg JI, 2018, ANN ALLERG ASTHMA IM, V121, P340, DOI 10.1016/j.anai.2018.07.006; Silverberg JI, 2015, JAMA DERMATOL, V151, P743, DOI 10.1001/jamadermatol.2014.5432; Silverberg JI, 2015, J INVEST DERMATOL, V135, P56, DOI 10.1038/jid.2014.325; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Silverberg JI, 2013, PEDIAT ALLERG IMM-UK, V24, P476, DOI 10.1111/pai.12095; Silverberg JI, 2013, J INVEST DERMATOL, V133, P1752, DOI 10.1038/jid.2013.19; Silverwood RJ, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1786; Simpson EL, 2020, BRIT J DERMATOL, V183, P242, DOI 10.1111/bjd.18898; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson EL, 2020, LANCET, V396, P255, DOI 10.1016/S0140-6736(20)30732-7; Simpson EL, 2020, JAMA DERMATOL, V156, P44, DOI 10.1001/jamadermatol.2019.3336; Simpson EL, 2017, J AM ACAD DERMATOL, V77, P623, DOI 10.1016/j.jaad.2017.06.042; Simpson EL, 2016, J AM ACAD DERMATOL, V74, P491, DOI 10.1016/j.jaad.2015.10.043; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Simpson EL, 2010, J AM ACAD DERMATOL, V63, P587, DOI 10.1016/j.jaad.2009.11.011; Skjerven HO, 2020, LANCET, V395, P951, DOI 10.1016/S0140-6736(19)32983-6; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Solman L, 2019, CLIN EXP DERMATOL, V44, P363, DOI 10.1111/ced.13885; Sonesson A, 2013, ACTA DERM-VENEREOL, V93, P340, DOI 10.2340/00015555-1465; Spuls PI, 2017, BRIT J DERMATOL, V176, P979, DOI 10.1111/bjd.15179; Stefanovic N, 2020, ALLERGY, V75, P63, DOI 10.1111/all.13946; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Strina A, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-11; Strom MA, 2016, BRIT J DERMATOL, V175, P920, DOI 10.1111/bjd.14697; Thomsen SF, 2007, ALLERGY ASTHMA PROC, V28, P535, DOI 10.2500/aap2007.28.3041; Torrelo A, 2014, J EUR ACAD DERMATOL, V28, P2, DOI 10.1111/jdv.12480; Totte JEE, 2016, BRIT J DERMATOL, V175, P687, DOI 10.1111/bjd.14566; Tsakok T, 2019, BRIT J DERMATOL, V180, P464, DOI 10.1111/bjd.16934; Tsoi LC, 2020, J ALLERGY CLIN IMMUN, V145, P1406, DOI 10.1016/j.jaci.2019.11.047; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; van Zuuren EJ, 2017, BRIT J DERMATOL, V177, P1256, DOI 10.1111/bjd.15602; Vestergaard C, 2019, J EUR ACAD DERMATOL, V33, P1644, DOI 10.1111/jdv.15709; VIRTANEN T, 1995, J ALLERGY CLIN IMMUN, V96, P411, DOI 10.1016/S0091-6749(95)70061-7; von Kobyletzki LB, 2014, ACTA DERM-VENEREOL, V94, P179, DOI 10.2340/00015555-1681; Wan J, 2019, J INVEST DERMATOL, V139, P1906, DOI 10.1016/j.jid.2019.02.024; Wang L, 2020, JAMA DERMATOL, V156, P158, DOI 10.1001/jamadermatol.2019.3786; Weidinger S, 2017, BRIT J DERMATOL, V177, P999, DOI 10.1111/bjd.15827; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Werfel T, 2015, J ALLERGY CLIN IMMUN, V136, P96, DOI 10.1016/j.jaci.2015.04.015; Williams, 2000, ATOPIC DERMATITIS EP; Williams HC, 1996, LANCET, V348, P1391, DOI 10.1016/S0140-6736(05)65466-9; Williams HC, 1996, BRIT J DERMATOL, V135, P12; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wollenberg A, 2020, BRIT J DERMATOL, V182, P1120, DOI 10.1111/bjd.18434; Wollenberg A, 2008, ALLERGY, V63, P742, DOI 10.1111/j.1398-9995.2008.01683.x; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P850, DOI 10.1111/jdv.14888; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P657, DOI 10.1111/jdv.14891; Wu KK, 2021, J DERMATOL TREAT, V32, P455, DOI 10.1080/09546634.2019.1659480; Xie QW, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01773; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Yang EJ, 2019, PEDIATR DERMATOL, V36, P66, DOI 10.1111/pde.13727; Yang TLB, 2019, J ALLERGY CLIN IMMUN, V144, P353, DOI 10.1016/j.jaci.2019.06.016; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001; Yu SH, 2015, J INVEST DERMATOL, V135, P3183, DOI 10.1038/jid.2015.337; Zink A, 2019, ACTA DERM-VENEREOL, V99, P263, DOI 10.2340/00015555-3102; Zuberbier T, 2006, J ALLERGY CLIN IMMUN, V118, P226, DOI 10.1016/j.jaci.2006.02.031	227	361	377	59	146	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					345	360						16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0RO	32738956				2022-12-28	WOS:000561615700018
J	Hilger, D; Kumar, KK; Hu, HL; Pedersen, MF; O'Brien, ES; Giehm, L; Jennings, C; Eskici, G; Inoue, A; Lerch, M; Mathiesen, JM; Skiniotis, G; Kobilka, BK				Hilger, Daniel; Kumar, Kaavya Krishna; Hu, Hongli; Pedersen, Mie Fabricius; O'Brien, Evan S.; Giehm, Lise; Jennings, Christine; Eskici, Gozde; Inoue, Asuka; Lerch, Michael; Mathiesen, Jesper Mosoliff; Skiniotis, Georgios; Kobilka, Brian K.			Structural insights into differences inGprotein activation by family Aand family BGPCRs	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYO-EM STRUCTURE; GLUCAGON RECEPTOR; MOLECULAR-DYNAMICS; LIGAND EFFICACY; GLP-1 RECEPTOR; VISUALIZATION; PHARMACOLOGY; SOFTWARE; COMPLEX	Family B heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) play important roles in carbohydrate metabolism. Recent structures of family B GPCR-G(s) protein complexes reveal a disruption in the alpha-helix of transmembrane segment 6 (TM6) not observed in family A GPCRs. To investigate the functional impact of this structural difference, we compared the structure and function of the glucagon receptor (GCGR; family B) with the beta(2) adrenergic receptor (beta(2)AR; family A). We determined the structure of the GCGR-G, complex by means of cryo-electron microscopy at 3.1-angstrom resolution. This structure shows the distinct break in TM6. Guanosine triphosphate (GTP) turnover, guanosine diphosphate release, GTP binding, and G protein dissociation studies revealed much slower rates for G protein activation by the GCGR compared with the beta(2)AR. Fluorescence and double electron-electron resonance studies suggest that this difference is due to the inability of agonist alone to induce a detectable outward movement of the cytoplasmic end of TM6.	[Hilger, Daniel; Kumar, Kaavya Krishna; Hu, Hongli; O'Brien, Evan S.; Eskici, Gozde; Skiniotis, Georgios; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA; [Hu, Hongli; Eskici, Gozde; Skiniotis, Georgios] Stanford Univ, Sch Med, Dept Struct Biol, 279 Campus Dr, Stanford, CA 94305 USA; [Pedersen, Mie Fabricius; Giehm, Lise; Mathiesen, Jesper Mosoliff] Zealand Pharma AS, Sydmarken 11, DK-2860 Soborg, Denmark; [Jennings, Christine; Lerch, Michael] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Skiniotis, Georgios] Stanford Univ, Dept Photon Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Hilger, Daniel] Philipps Univ Marburg, Dept Pharmaceut Chem, Marbacher Weg 6, D-35037 Marburg, Germany; [Hu, Hongli] Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen 518172, Guangdong, Peoples R China	Stanford University; Stanford University; Zealand Pharma A/S; Medical College of Wisconsin; Tohoku University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Philipps University Marburg; Chinese University of Hong Kong, Shenzhen	Skiniotis, G; Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.; Skiniotis, G (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, 279 Campus Dr, Stanford, CA 94305 USA.; Mathiesen, JM (corresponding author), Zealand Pharma AS, Sydmarken 11, DK-2860 Soborg, Denmark.; Skiniotis, G (corresponding author), Stanford Univ, Dept Photon Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.	jmm@zealandpharma.com; yiorgo@stanford.edu; kobilka@stanford.edu	Hilger, Daniel/C-7297-2019; O'Brien, Evan/J-2098-2017	Hilger, Daniel/0000-0001-5179-1357; Kobilka, Brian/0000-0001-5958-3990; Hu, Hongli/0000-0003-3658-272X; Mathiesen, Jesper Mosolff/0000-0003-4251-4416; O'Brien, Evan/0000-0002-2260-7722; Skiniotis, Georgios/0000-0003-0238-7846; , Christine/0000-0003-0370-5375	German Academic Exchange Service (DAAD); American Diabetes Association (ADA); Japan Agency for Medical Research and Development (AMED) [PRIME18 g5910013]; Japan Society for the Promotion of Science (JSPS) KAKENHI [17K08264]; NIH [RO1GM083118, RO1NS028471]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); American Diabetes Association (ADA)(American Diabetes Association); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	D.H.wassupported by the German Academic Exchange Service (DAAD).K.K.K.was supported by the American Diabetes Association (ADA) Postdoctoral Fellowship. A. wasfunded by the PRIME18 g5910013 from the Japan Agency for Medical Research and Development (AMED)and the Japan Society for the Promotion of Science (JSPS) KAKENHI 17K08264. The work is supported by NIH grants RO1GM083118 and RO1NS02847t1o B.K.K.;B.K.K.is a Chan Zuckerberg Blohub investigator.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Dal Maso E, 2018, BIOCHEM PHARMACOL, V150, P212, DOI 10.1016/j.bcp.2018.02.005; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Graaf C, 2017, TRENDS BIOCHEM SCI, V42, P946, DOI 10.1016/j.tibs.2017.10.003; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Du Y, 2019, CELL, V177, P1232, DOI 10.1016/j.cell.2019.04.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EXTON JH, 1971, J BIOL CHEM, V246, P6166; Fay JF, 2017, METHOD ENZYMOL, V593, P343, DOI 10.1016/bs.mie.2017.06.026; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Glukhova A, 2018, ACS PHARMACOL TRANSL, V1, P73, DOI 10.1021/acsptsci.8b00026; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gregorio GG, 2017, NATURE, V547, P68, DOI 10.1038/nature22354; Gupte TM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12755-9; Heymann JB, 2018, PROTEIN SCI, V27, P159, DOI 10.1002/pro.3293; Hovelmann U, 2018, DIABETES CARE, V41, P531, DOI 10.2337/dc17-1402; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kimball CP, 1923, J BIOL CHEM, V58, P337; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Liu XY, 2019, CELL, V177, P1243, DOI 10.1016/j.cell.2019.04.021; Lorenzen E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2778; Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; MARTYNA GJ, 1994, PHYS REV E, V50, P3234, DOI 10.1103/PhysRevE.50.3234; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Muller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016; Okude J, 2015, ANGEW CHEM INT EDIT, V54, P15771, DOI 10.1002/anie.201508794; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; ROJAS FJ, 1985, J BIOL CHEM, V260, P7829; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Seifert R, 1999, MOL PHARMACOL, V56, P348, DOI 10.1124/mol.56.2.348; Serafin DS, 2020, TRENDS PHARMACOL SCI, V41, P249, DOI 10.1016/j.tips.2020.01.009; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Staus DP, 2018, P NATL ACAD SCI USA, V115, P3834, DOI 10.1073/pnas.1722336115; Susac L, 2018, P NATL ACAD SCI USA, V115, P12733, DOI 10.1073/pnas.1813649115; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; UNSON CG, 1991, J BIOL CHEM, V266, P2763; Unson CG, 2002, BIOPOLYMERS, V66, P218, DOI 10.1002/bip.10259; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wingler LM, 2019, CELL, V176, P468, DOI 10.1016/j.cell.2018.12.005; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668; Yin YT, 2017, J BIOL CHEM, V292, P9865, DOI 10.1074/jbc.M117.782987; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2019, SCIENCE, V364, P148, DOI 10.1126/science.aav7942; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	73	48	48	6	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					523	+	eaba3373	10.1126/science.aba3373	http://dx.doi.org/10.1126/science.aba3373			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32732395	Green Accepted, Green Submitted			2022-12-28	WOS:000556568100036
J	Lebon, G				Lebon, Guillaume			Fine-tuning receptor-G protein activation and signaling	SCIENCE			English	Editorial Material							GLUCAGON		[Lebon, Guillaume] Univ Montpellier, CNRS, INSERM, Inst Genom Fonct IGF, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Lebon, G (corresponding author), Univ Montpellier, CNRS, INSERM, Inst Genom Fonct IGF, Montpellier, France.	guillaume.lebon@igf.cnrs.fr	Lebon, Guillaume/AAZ-4486-2020	Guillaume, Lebon/0000-0003-1162-5148	University of Montpellier; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale	University of Montpellier; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the University of Montpellier, Centre National de la Recherche Scientifique, and Institut National de la Sante et de la Recherche Medicale.	Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; EXTON JH, 1971, J BIOL CHEM, V246, P6166; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Hilger D, 2020, SCIENCE, V369, P523, DOI 10.1126/science.aba3373; Liang YL, 2020, MOL CELL, V77, P656, DOI 10.1016/j.molcel.2020.01.012; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Qiao AN, 2020, SCIENCE, V367, P1346, DOI 10.1126/science.aaz5346; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049	8	1	1	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					507	508		10.1126/science.abc9291	http://dx.doi.org/10.1126/science.abc9291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732411	Green Submitted			2022-12-28	WOS:000556568100026
J	Madhi, SA; Polack, FP; Piedra, PA; Munoz, FM; Trenholme, AA; Simoes, EAF; Swamy, GK; Agrawal, S; Ahmed, K; August, A; Baqui, AH; Calvert, A; Chen, J; Cho, I; Cotton, MF; Cutland, CL; Englund, JA; Fix, A; Gonik, B; Hammitt, L; Heath, PT; de Jesus, JN; Jones, CE; Khalil, A; Kimberlin, DW; Libster, R; Llapur, CJ; Lucero, M; Marc, GP; Marshall, HS; Masenya, MS; Martinon-Torres, F; Meece, JK; Nolan, TM; Osman, A; Perrett, KP; Plested, JS; Richmond, PC; Snape, MD; Shakib, JH; Shinde, V; Stoney, T; Thomas, DN; Tita, AT; Varner, MW; Vatish, M; Vrbicky, K; Wen, J; Zaman, K; Zar, HJ; Glenn, GM; Fries, LF				Madhi, S. A.; Polack, F. P.; Piedra, P. A.; Munoz, F. M.; Trenholme, A. A.; Simoes, E. A. F.; Swamy, G. K.; Agrawal, S.; Ahmed, K.; August, A.; Baqui, A. H.; Calvert, A.; Chen, J.; Cho, I.; Cotton, M. F.; Cutland, C. L.; Englund, J. A.; Fix, A.; Gonik, B.; Hammitt, L.; Heath, P. T.; de Jesus, J. N.; Jones, C. E.; Khalil, A.; Kimberlin, D. W.; Libster, R.; Llapur, C. J.; Lucero, M.; Marc, G. Perez; Marshall, H. S.; Masenya, M. S.; Martinon-Torres, F.; Meece, J. K.; Nolan, T. M.; Osman, A.; Perrett, K. P.; Plested, J. S.; Richmond, P. C.; Snape, M. D.; Shakib, J. H.; Shinde, V.; Stoney, T.; Thomas, D. N.; Tita, A. T.; Varner, M. W.; Vatish, M.; Vrbicky, K.; Wen, J.; Zaman, K.; Zar, H. J.; Glenn, G. M.; Fries, L. F.		Prepare Study Grp	Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; BLIND	BackgroundRespiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory tract infection in infants, with the most severe cases concentrated among younger infants. MethodsHealthy pregnant women, at 28 weeks 0 days through 36 weeks 0 days of gestation, with an expected delivery date near the start of the RSV season, were randomly assigned in an overall ratio of approximately 2:1 to receive a single intramuscular dose of RSV fusion (F) protein nanoparticle vaccine or placebo. Infants were followed for 180 days to assess outcomes related to lower respiratory tract infection and for 364 days to assess safety. The primary end point was RSV-associated, medically significant lower respiratory tract infection up to 90 days of life, and the primary analysis of vaccine efficacy against the primary end point was performed in the per-protocol population of infants (prespecified criterion for success, lower bound of the 97.52% confidence interval [CI] of >= 30%). ResultsA total of 4636 women underwent randomization, and there were 4579 live births. During the first 90 days of life, the percentage of infants with RSV-associated, medically significant lower respiratory tract infection was 1.5% in the vaccine group and 2.4% in the placebo group (vaccine efficacy, 39.4%; 97.52% CI, -1.0 to 63.7; 95% CI, 5.3 to 61.2). The corresponding percentages for RSV-associated lower respiratory tract infection with severe hypoxemia were 0.5% and 1.0% (vaccine efficacy, 48.3%; 95% CI, -8.2 to 75.3), and the percentages for hospitalization for RSV-associated lower respiratory tract infection were 2.1% and 3.7% (vaccine efficacy, 44.4%; 95% CI, 19.6 to 61.5). Local injection-site reactions among the women were more common with vaccine than with placebo (40.7% vs. 9.9%), but the percentages of participants who had other adverse events were similar in the two groups. ConclusionsRSV F protein nanoparticle vaccination in pregnant women did not meet the prespecified success criterion for efficacy against RSV-associated, medically significant lower respiratory tract infection in infants up to 90 days of life. The suggestion of a possible benefit with respect to other end-point events involving RSV-associated respiratory disease in infants warrants further study. (Funded by Novavax and the Bill and Melinda Gates Foundation; ClinicalTrials.gov NCT02624947.) This randomized trial of RSV F protein nanoparticle vaccination during pregnancy did not show efficacy (according to the prespecified success criterion) against RSV-associated, medically significant lower respiratory tract infection but suggested possible benefits with respect to other RSV-related outcomes.	[Madhi, S. A.; Cutland, C. L.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, S. A.; Cutland, C. L.] Univ Witwatersrand, Vaccine Preventable Dis, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa; [Masenya, M. S.] Wits Reprod Hlth & HIV Inst, Shandukani Res Ctr, Johannesburg, South Africa; [Ahmed, K.; Osman, A.] Setshaba Res Ctr, Soshanguve, South Africa; [Cotton, M. F.] Stellenbosch Univ, Tygerberg Hosp, Family Ctr Res Ubuntu, Dept Paediat & Child Hlth, Cape Town, South Africa; [Zar, H. J.] Univ Cape Town, South African Med Res Council, Dept Paediat & Child Hlth, Red Cross War Mem Childrens Hosp,Unit Child & Ado, Cape Town, South Africa; [Polack, F. P.; Libster, R.] Fdn INFANT, Buenos Aires, DF, Argentina; [Marc, G. Perez] Hosp Mil Cent Dr Cosme Argerich, Buenos Aires, DF, Argentina; [Libster, R.] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Llapur, C. J.] Hosp Nino Jesus, Dept Pediat Pulmonol, San Miguel De Tucuman, Argentina; [Piedra, P. A.; Munoz, F. M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Piedra, P. A.; Munoz, F. M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Trenholme, A. A.] Univ Auckland, Middlemore Hosp, Auckland, New Zealand; [Simoes, E. A. F.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Simoes, E. A. F.] Childrens Hosp Colorado, Colorado Sch Publ Hlth, Ctr Global Hlth, Aurora, CO USA; [Swamy, G. K.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; [Agrawal, S.; August, A.; Chen, J.; Cho, I.; Fix, A.; Plested, J. S.; Shinde, V.; Thomas, D. N.; Wen, J.; Glenn, G. M.; Fries, L. F.] Novavax, 22 Firstfield Rd, Gaithersburg, MD 20878 USA; [Baqui, A. H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD USA; [Hammitt, L.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Dept Int Hlth, Baltimore, MD USA; [Calvert, A.; Heath, P. T.] St Georges Univ London, Vaccine Inst, London, England; [Khalil, A.] St Georges Univ London, Vasc Biol Res Ctr, Mol & Clin Sci Res Inst, London, England; [Jones, C. E.] Univ Southampton, Paediat Infect Dis Clin & Expt Sci, Southampton, Hants, England; [Jones, C. E.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Snape, M. D.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Snape, M. D.] Univ Oxford, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England; [Vatish, M.] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England; [Englund, J. A.] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Gonik, B.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [de Jesus, J. N.; Lucero, M.] Res Inst Trop Med, Muntinlupa, Philippines; [Kimberlin, D. W.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Tita, A. T.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Maternal Fetal Med, Birmingham, AL 35294 USA; [Tita, A. T.] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL USA; [Marshall, H. S.] Univ Adelaide, Womens & Childrens Hosp, Adelaide, SA, Australia; [Marshall, H. S.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Nolan, T. M.; Perrett, K. P.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia; [Nolan, T. M.; Perrett, K. P.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Richmond, P. C.; Stoney, T.] Univ Western Australia, Perth Childrens Hosp, Wesfarmers Ctr Vaccines & Infect Dis, Telethon Kids Inst,Div Paediat,Sch Med, Perth, WA, Australia; [Meece, J. K.] Marshfield Clin Res Inst, Marshfield, WI USA; [Martinon-Torres, F.] Univ Santiago de Compostela, Pediat Clin Infectol & Traslac, Hosp Clin, Santiago De Compostela, Spain; [Shakib, J. H.] Univ Utah, Sch Med, Dept Pediat, Div Gen Pediat,Hlth Sci Ctr, Salt Lake City, UT USA; [Varner, M. W.] Univ Utah, Dept Obstet & Gynecol, Hlth Sci Ctr, Salt Lake City, UT USA; [Vrbicky, K.] Meridian Clin Res, Norfolk, NE USA; [Zaman, K.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh	South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Stellenbosch University; Tygerberg Hospital; South African Medical Research Council; University of Cape Town; Baylor College of Medicine; Baylor College of Medicine; University of Auckland; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; St Georges University London; St Georges University London; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Wayne State University; Research Institute for Tropical Medicine - Philippines; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Adelaide; Womens & Childrens Hospital Australia; Robinson Research Institute; University of Adelaide; University of Melbourne; Murdoch Children's Research Institute; Telethon Kids Institute; University of Western Australia; Wesfarmers Limited; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; International Centre for Diarrhoeal Disease Research (ICDDR)	Fries, LF (corresponding author), Novavax, 22 Firstfield Rd, Gaithersburg, MD 20878 USA.	lfries@novavax.com	Zar, Heather/GZL-5350-2022; vatish, manu/AAY-8750-2020; Cutland, Clare L./GXE-9967-2022; Jones, Chrissie/GXG-4400-2022; Richmond, Peter C/G-3379-2012; Perrett, Kirsten/P-8813-2019; Mashiya, Nombeko Monica/AET-3950-2022; Martinon-Torres, Federico/E-4982-2016	Zar, Heather/0000-0002-9046-759X; vatish, manu/0000-0002-6012-2574; Cutland, Clare L./0000-0001-8250-8307; Richmond, Peter C/0000-0001-7562-7228; Jones, Christine/0000-0003-1523-2368; Madhi, Shabir/0000-0002-7629-0636; Heath, Paul/0000-0002-7540-7433; Perrett, Kirsten/0000-0002-5683-996X; ahmed, khatija/0000-0003-0309-1641; Mashiya, Nombeko Monica/0000-0003-0124-9118; Snape, Matthew/0000-0003-0531-5426; Martinon-Torres, Federico/0000-0002-9023-581X	Novavax; Bill and Melinda Gates Foundation	Novavax; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by Novavax and by a grant from the Bill and Melinda Gates Foundation.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P53; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P433; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; August A, 2017, VACCINE, V35, P3749, DOI 10.1016/j.vaccine.2017.05.045; Morris SK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-106; Munoz FM, 2019, J INFECT DIS, V220, P1802, DOI 10.1093/infdis/jiz390; Munoz FM, 2015, VACCINE, V33, P6441, DOI 10.1016/j.vaccine.2015.07.112; O'Brien KL, 2015, LANCET INFECT DIS, V15, P1398, DOI 10.1016/S1473-3099(15)00247-9; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; The World Bank, 2020, WORLD BANK GROUP; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	11	134	138	4	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2020	383	5					426	439		10.1056/NEJMoa1908380	http://dx.doi.org/10.1056/NEJMoa1908380			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW2GI	32726529	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000556861800010
J	Rubin, R				Rubin, Rita			Better HHS Planning Needed for National Disaster Medical System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					326	326		10.1001/jama.2020.11957	http://dx.doi.org/10.1001/jama.2020.11957			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32720990				2022-12-28	WOS:000562851000004
J	Ba, ZQ; Lou, JM; Ye, AY; Dai, HQ; Dring, EW; Lin, SG; Jain, S; Kyritsis, N; Kieffer-Kwon, KR; Casellas, R; Alt, FW				Ba, Zhaoqing; Lou, Jiangman; Ye, Adam Yongxin; Dai, Hai-Qiang; Dring, Edward W.; Lin, Sherry G.; Jain, Suvi; Kyritsis, Nia; Kieffer-Kwon, Kyong-Rim; Casellas, Rafael; Alt, Frederick W.			CTCF orchestrates long-range cohesin-driven V(D)J recombinational scanning	NATURE			English	Article							DOUBLE-STRANDED BREAKS; IGH LOCUS; MAMMALIAN GENOMES; CHROMATIN LOOPS; DNA; DOMAINS; TRANSCRIPTION; ELEMENTS; PAX5; REARRANGEMENT	Using an auxin-inducible approach, the authors show that downmodulation of CTCF activity promotes cohesin-driven RAG endonuclease scanning, and thus V(D)J recombination, across theIghlocus. The RAG endonuclease initiatesIghlocus V(D)J recombination in progenitor (pro)-B cells(1). Upon binding a recombination centre-based J(H), RAG scans upstream chromatin via loop extrusion, potentially mediated by cohesin, to locate Ds and assemble a DJ(H)-based recombination centre(2). CTCF looping factor-bound elements (CBEs) within IGCR1 upstream of Ds impede RAG scanning(3-5); however, their inactivation allows scanning to proximal V(H)s, where additional CBEs activate rearrangement and impede scanning any further upstream(5). Distal V(H)utilization is thought to involve diffusional access to the recombination centre following large-scaleIghlocus contraction(6-8). Here we test the potential of linear RAG scanning to mediate distal V(H)usage in G1-arrestedv-Ablpro-B cell lines(9), which undergo robust D-to-J(H)but little V-H-to-DJ(H)rearrangements, presumably owing to lack of locus contraction(2,5). Through an auxin-inducible approach(10), we degraded the cohesin component RAD21(10-12)or CTCF(12,13)in these G1-arrested lines. Degradation of RAD21 eliminated all V(D)J recombination and interactions associated with RAG scanning, except for reecombination centre-located DQ52-to-J(H)joining, in which synapsis occurs by diffusion(2). Remarkably, while degradation of CTCF suppressed most CBE-based chromatin interactions, it promoted robust recombination centre interactions with, and robust V-H-to-DJ(H)joining of, distal V(H)s, with patterns similar to those of 'locus-contracted' primary pro-B cells. Thus, downmodulation of CTCF-bound scanning-impediment activity promotes cohesin-driven RAG scanning across the 2.7-MbIghlocus.	[Ba, Zhaoqing; Lou, Jiangman; Ye, Adam Yongxin; Dai, Hai-Qiang; Dring, Edward W.; Lin, Sherry G.; Jain, Suvi; Kyritsis, Nia; Alt, Frederick W.] Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Ba, Zhaoqing; Lou, Jiangman; Ye, Adam Yongxin; Dai, Hai-Qiang; Dring, Edward W.; Lin, Sherry G.; Jain, Suvi; Kyritsis, Nia; Alt, Frederick W.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Kieffer-Kwon, Kyong-Rim; Casellas, Rafael] NIAMS, Lymphocyte Nucl Biol, NIH, Bethesda, MD 20892 USA; [Kieffer-Kwon, Kyong-Rim; Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ba, ZQ; Alt, FW (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA.; Ba, ZQ; Alt, FW (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Casellas, R (corresponding author), NIAMS, Lymphocyte Nucl Biol, NIH, Bethesda, MD 20892 USA.; Casellas, R (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zhaoqing.ba@childrens.harvard.edu; rafael.casellas@nih.gov; alt@enders.tch.harvard.edu		Dai, Hai-Qiang/0000-0003-4337-9770; Casellas, Rafael/0000-0001-9282-2287; Ye, Yongxin/0000-0002-1542-0740; Ba, Zhaoqing/0000-0002-8431-5469	NIH [R01 AI020047]; NIH Regulome Project	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Regulome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank lab members for stimulating discussions. This work was supported by NIH R01 AI020047 (to F.W.A.). R.C. is partially funded by the NIH Regulome Project. F.W.A. is an investigator of the Howard Hughes Medical Institute. Z.B. was and H.-Q.D. is a Cancer Research Institute Irvington fellow.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bolland DJ, 2016, CELL REP, V15, P2475, DOI 10.1016/j.celrep.2016.05.020; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Canzio D, 2019, CELL, V177, P639, DOI 10.1016/j.cell.2019.03.008; Choi NM, 2013, J IMMUNOL, V191, P2393, DOI 10.4049/jimmunol.1301279; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Ebert A, 2015, ADV IMMUNOL, V128, P93, DOI 10.1016/bs.ai.2015.07.006; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hansen AS, 2019, MOL CELL, V76, P395, DOI 10.1016/j.molcel.2019.07.039; Hansen AS, 2018, NUCLEUS-PHILA, V9, P20, DOI 10.1080/19491034.2017.1389365; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hsieh THS, 2020, MOL CELL, V78, P539, DOI 10.1016/j.molcel.2020.03.002; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Khoury A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13753-7; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Lee SH, 2019, NATURE, V570, P344, DOI 10.1038/s41586-019-1305-1; Li Y, 2020, NATURE, V578, P472, DOI 10.1038/s41586-019-1910-z; Lin SG, 2018, ADV IMMUNOL, V139, P93, DOI 10.1016/bs.ai.2018.07.001; Lin SG, 2016, P NATL ACAD SCI USA, V113, P7846, DOI 10.1073/pnas.1608649113; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Proudhon C, 2015, ADV IMMUNOL, V128, P123, DOI 10.1016/bs.ai.2015.07.003; Pugacheva EM, 2020, P NATL ACAD SCI USA, V117, P2020, DOI 10.1073/pnas.1911708117; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Saldana-Meyer R, 2019, MOL CELL, V76, P412, DOI 10.1016/j.molcel.2019.08.015; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Teng G, 2015, ADV IMMUNOL, V128, P1, DOI 10.1016/bs.ai.2015.07.002; Wutz G, 2020, ELIFE, V9, DOI 10.7554/eLife.52091; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Yatskevich S, 2019, ANNU REV GENET, V53, P445, DOI 10.1146/annurev-genet-112618-043633; Zhang Y, 2019, NATURE, V573, P600, DOI 10.1038/s41586-019-1547-y; Zhao LJ, 2016, J EXP MED, V213, P1921, DOI 10.1084/jem.20160670	59	40	40	0	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2020	586	7828					305	+		10.1038/s41586-020-2578-0	http://dx.doi.org/10.1038/s41586-020-2578-0		JUL 2020	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9PR	32717742	Green Accepted, Green Submitted			2022-12-28	WOS:000574145200001
J	Tau, N; Yahav, D; Shepshelovich, D				Tau, Noam; Yahav, Dafna; Shepshelovich, Daniel			Postmarketing Safety of Vaccines Approved by the US Food and Drug Administration A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; PREVENTABLE DISEASES	Background: Vaccines are one of the greatest achievements in public health. Prevalence and clinical significance of emerging postapproval, vaccine-related safety issues have not been systematically studied. Objective: To explore postmarketing safety modifications in U.S. Food and Drug Administration (FDA)-approved vaccine labels. Design: Retrospective cohort study. Setting: United States. Participants: Initial and subsequent labels of all vaccines that were FDA-approved between 1 January 1996 and 31 December 2015. Measurements: The primary aim was a descriptive analysis of the prevalence and characteristics of postapproval, safety-related label changes. The secondary aim was to describe the distribution of data sources triggering these modifications. Results: The study cohort comprised 57 FDA-approved vaccines. Initial approval for 53 (93%) of the vaccines was supported by randomized controlled trials, with a median cohort size of 4161 participants (interquartile range, 2204 to 8634 participants). There were 58 postapproval, safety-related label modifications associated with 25 vaccines (49 warnings and precautions, 8 contraindications, and 1 safety-related withdrawal). The initial approval trial characteristics were similar in vaccines with and without postmarketing, safety-related label modifications. The most common safety issue triggering label modifications was expansion of population restrictions (n = 21 [36%]), followed by allergies (n = 13 [22%]). The most common source of safety data was postmarketing surveillance (n = 28 of 58 [48%]). Limitation: The data source of the initial signal triggering safety-related label changes may not necessarily represent all safety data received and processed by the FDA. Conclusion: Over a 20-year period, vaccines were found to be remarkably safe. A large proportion of safety issues were identified through existing postmarketing surveillance programs and were of limited clinical significance. These findings confirm the robustness of the vaccine approval system and postmarketing surveillance.	[Tau, Noam] Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Yahav, Dafna] Rabin Med Ctr, Infect Dis Unit, 39 Jabotinski St, IL-49100 Petah Tiqwa, Israel; [Shepshelovich, Daniel] Tel Aviv Sourasky Med Ctr, Med T, 6 Weitzman St, IL-6423906 Tel Aviv, Israel	Chaim Sheba Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Shepshelovich, D (corresponding author), Tel Aviv Sourasky Med Ctr, Med T, 6 Weitzman St, IL-6423906 Tel Aviv, Israel.	shepshelovich@yahoo.com	Tau, Noam/AAK-6164-2020; Yahav, Dafna/AAX-9961-2020	Tau, Noam/0000-0003-0849-1708; Yahav, Dafna/0000-0003-3181-9791				Centers for Disease Control and Prevention, VACC SAF DAT VSD; Centers for Disease Control and Prevention, MEASL RUB MEAS CAS O; Centers for Disease Control and Prevention, PERT WHOOP COUGH PER; Centers for Disease Control and Prevention, CLIN IMM SAF ASS CIS; Centers for Disease Control and Prevention, 2016, MMWR-MORBID MORTAL W, V65; Centers for Disease Control and Prevention, VACC ADV EV REP SYST; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Hill HA, 2018, MMWR-MORBID MORTAL W, V67, P1123, DOI 10.15585/mmwr.mm6740a4; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Olive JK, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002578; Ozawa S, 2013, HUM VACC IMMUNOTHER, V9, P1774, DOI 10.4161/hv.24961; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Plotkin S.L., 2004, VACCINES-BASEL, V5, P1; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Schwartz JL, 2012, MILBANK Q, V90, P278, DOI 10.1111/j.1468-0009.2012.00664.x; Shepshelovich D, 2019, MAYO CLIN PROC, V94, P74, DOI 10.1016/j.mayocp.2018.07.027; Shepshelovich D, 2018, J CLIN ONCOL, V36, P1798, DOI 10.1200/JCO.2017.77.5593; Tau N, 2019, JAMA INTERN MED, V179, P1590, DOI 10.1001/jamainternmed.2019.3066; U.S. Food and Drug Administration, 2020, FDA ONL LAB REP; U.S. Food and Drug Administration, FREED INF; U.S. Food and Drug Administration, VAERS OV; U.S. Food and Drug Administration, BIOL APPR YEAR; U.S. Food & Drug Administration, VACC LIC US US; US National Library of Medicine, DAILYMED; Wise J, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3967; Zhou FJ, 2014, PEDIATRICS, V133, P577, DOI 10.1542/peds.2013-0698	27	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2020	173	6					445	+		10.7326/M20-2726	http://dx.doi.org/10.7326/M20-2726			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX3SZ	32716700				2022-12-28	WOS:000575633300017
J	Cramer, P				Cramer, Patrick			Rosalind Franklin and the Advent of Molecular Biology	CELL			English	Editorial Material							SODIUM THYMONUCLEATE FIBERS; DISCOVERY	Rosalind Franklin provided the key data for deriving the double helix structure of DNA. The English chemist also pioneered structural studies of colloids, viruses, and RNA. To celebrate the 100th anniversary of Franklin's birth, I summarize her work, which shaped the emerging discipline of molecular biology.	[Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de			Max Planck Society; Deutsche Forschungsgemeinschaft [SFB860, SPP1935, EXC 2067/1390729940]; Advanced Investigator Grant CHROMATRANS from the European Research Council [882357]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Advanced Investigator Grant CHROMATRANS from the European Research Council	I am grateful to Elena Conti, Elspeth Garman, Herbert Jackle, Tom Jovin, Mary Osborn, and Ernst-Ludwig Winnacker for insightful comments. I regret that, due to space limitations, many references had to be excluded. For readers interested in learning more, I recommend Rosalind Franklin and D.N.A. by Anne Sayre (W. W. Norton & Co, 1975), Rosalind Franklin: The Dark Lady of DNA by Barbara Maddox (Harper Collins, 2002), and Francis Crick Discoverer of the Genetic Code by Matt Ridley (Harper Perennial, 2006). I am supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SFB860, SPP1935, EXC 2067/1390729940), and the Advanced Investigator Grant CHROMATRANS from the European Research Council, grant agreement 882357.	Astbury W.T., 1938, NATURE, V141, P747, DOI [10.1038/141747b0, DOI 10.1038/141747B0]; FRANKLIN RE, 1953, NATURE, V172, P156, DOI 10.1038/172156a0; FRANKLIN RE, 1955, ACTA CRYSTALLOGR, V8, P151, DOI 10.1107/S0365110X55000595; FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P673, DOI 10.1107/S0365110X53001939; FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P678, DOI 10.1107/S0365110X53001940; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; FRANKLIN RE, 1955, NATURE, V175, P379, DOI 10.1038/175379a0; FRANKLIN RE, 1956, NATURE, V177, P929, DOI 10.1038/177928b0; KLUG A, 1974, NATURE, V248, P787, DOI 10.1038/248787a0; KLUG A, 1968, NATURE, V219, P808, DOI 10.1038/219808a0; Klug A, 2004, J MOL BIOL, V335, P3, DOI 10.1016/j.jmb.2003.11.015; PERUTZ MF, 1969, SCIENCE, V164, P1537, DOI 10.1126/science.164.3887.1537; Watson J.D., 1968, DOUBLE HELIX PERSONA; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0	15	2	2	14	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2020	182	4					787	789		10.1016/j.cell.2020.07.028	http://dx.doi.org/10.1016/j.cell.2020.07.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NC8UU	32730810	Bronze			2022-12-28	WOS:000561488500001
J	Friedman, JM; Jones, KL; Carey, JC				Friedman, Jan M.; Jones, Kenneth Lyons; Carey, John C.			Exome Sequencing and Clinical Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL GENETICS	This Viewpoint describes indications and proper clinical use and interpretation of exome sequencing, explaining that the testing is not diagnostic in itself but requires correlation with patients' history and presentation in the context of a comprehensive clinical evaluation.	[Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Jones, Kenneth Lyons] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Carey, John C.] Univ Utah Hlth, Dept Pediat, Salt Lake City, UT USA	University of British Columbia; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah	Friedman, JM (corresponding author), Childrens & Womens Hosp, Med Genet Res Unit, 4500 Oak St,POB 153, Vancouver, BC V6H 3N1, Canada.	jan.friedman@ubc.ca	Jones, Kenneth/GXF-4945-2022	Friedman, Jan/0000-0002-7482-9570				Baldridge D, 2017, GENET MED, V19, P1040, DOI 10.1038/gim.2016.224; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8; Croke JM, 2012, CURR ONCOL, V19, pE232, DOI 10.3747/co.19.944; Laver TW, 2016, DIABETES, V65, P3212, DOI 10.2337/db16-0628; Power Michael, 2013, Evid Based Med, V18, P5, DOI 10.1136/eb-2012-100645; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Salmon LB, 2019, GENET MED, V21, P1443, DOI 10.1038/s41436-018-0343-7; Scotet V, 2006, PEDIATRICS, V118, pE1523, DOI 10.1542/peds.2005-3161; Wright CF, 2019, AM J HUM GENET, V104, P275, DOI 10.1016/j.ajhg.2018.12.015	10	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2020	324	7					627	628		10.1001/jama.2020.11126	http://dx.doi.org/10.1001/jama.2020.11126			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NG9GI	32735311				2022-12-28	WOS:000564288700003
J	Mulligan, MJ; Lyke, KE; Kitchin, N; Absalon, J; Gurtman, A; Lockhart, S; Neuzil, K; Raabe, V; Bailey, R; Swanson, KA; Li, P; Koury, K; Kalina, W; Cooper, D; Fontes-Garfias, C; Shi, PY; Tureci, O; Tompkins, KR; Walsh, EE; Frenck, R; Falsey, AR; Dormitzer, PR; Gruber, WC; Sahin, U; Jansen, KU				Mulligan, Mark J.; Lyke, Kirsten E.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Neuzil, Kathleen; Raabe, Vanessa; Bailey, Ruth; Swanson, Kena A.; Li, Ping; Koury, Kenneth; Kalina, Warren; Cooper, David; Fontes-Garfias, Camila; Shi, Pei-Yong; Tuereci, Oezlem; Tompkins, Kristin R.; Walsh, Edward E.; Frenck, Robert; Falsey, Ann R.; Dormitzer, Philip R.; Gruber, William C.; Sahin, Ugur; Jansen, Kathrin U.			Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults	NATURE			English	Article							IMMUNOGENICITY; SAFETY; DOMAIN	In March 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1), a pandemic. With rapidly accumulating numbers of cases and deaths reported globally(2), a vaccine is urgently needed. Here we report the available safety, tolerability and immunogenicity data from an ongoing placebo-controlled, observer-blinded dose-escalation study (ClinicalTrials.gov identifier NCT04368728) among 45 healthy adults (18-55 years of age), who were randomized to receive 2 doses-separated by 21 days-of 10 mu g, 30 mu g or 100 mu g of BNT162b1. BNT162b1 is a lipid-nanoparticle-formulated, nucleoside-modified mRNA vaccine that encodes the trimerized receptor-binding domain (RBD) of the spike glycoprotein of SARS-CoV-2. Local reactions and systemic events were dose-dependent, generally mild to moderate, and transient. A second vaccination with 100 mu g was not administered because of the increased reactogenicity and a lack of meaningfully increased immunogenicity after a single dose compared with the 30-mu g dose. RBD-binding IgG concentrations and SARS-CoV-2 neutralizing titres in sera increased with dose level and after a second dose. Geometric mean neutralizing titres reached 1.9-4.6-fold that of a panel of COVID-19 convalescent human sera, which were obtained at least 14 days after a positive SARS-CoV-2 PCR. These results support further evaluation of this mRNA vaccine candidate. In a dose-escalation study of the COVID-19 RNA vaccine BNT162b1 in 45 healthy adults, RBD-binding IgG concentrations and SARS-CoV-2 neutralizing titres in sera increased with dose level and after a second vaccine dose.	[Mulligan, Mark J.; Raabe, Vanessa] NYU, Langone Vaccine Ctr, New York, NY USA; [Mulligan, Mark J.; Raabe, Vanessa] NYU, Grossman Sch Med, New York, NY USA; [Lyke, Kirsten E.; Neuzil, Kathleen] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Kitchin, Nicholas; Lockhart, Stephen; Bailey, Ruth] Pfizer Inc, Vaccine Res & Dev, Hurley, England; [Absalon, Judith; Gurtman, Alejandra; Swanson, Kena A.; Koury, Kenneth; Kalina, Warren; Cooper, David; Tompkins, Kristin R.; Dormitzer, Philip R.; Gruber, William C.; Jansen, Kathrin U.] Pfizer Inc, Vaccine Res & Dev, Pearl River, NY 10965 USA; [Li, Ping] Pfizer Inc, Vaccine Res & Dev, Collegeville, PA USA; [Fontes-Garfias, Camila; Shi, Pei-Yong] Univ Texas Med Branch, Galveston, TX 77555 USA; [Tuereci, Oezlem; Sahin, Ugur] BioNTech, Mainz, Germany; [Walsh, Edward E.; Falsey, Ann R.] Univ Rochester, Rochester, NY USA; [Walsh, Edward E.; Falsey, Ann R.] Rochester Gen Hosp, Rochester, NY 14621 USA; [Frenck, Robert] Cincinnati Childrens Hosp, Cincinnati, OH USA	New York University; New York University; University System of Maryland; University of Maryland Baltimore; Pfizer; Pfizer; Pfizer; University of Texas System; University of Texas Medical Branch Galveston; BioNTech SE; University of Rochester; Rochester General Hospital; Cincinnati Children's Hospital Medical Center	Absalon, J (corresponding author), Pfizer Inc, Vaccine Res & Dev, Pearl River, NY 10965 USA.	judith.absalon@pfizer.com	Tristan, Mario/ABA-6697-2020	Tristan, Mario/0000-0001-6732-3398; Lockhart, Stephen/0000-0002-0805-2193; Raabe, Vanessa/0000-0003-2579-1104; Fontes-Garfias, Camila/0000-0002-1912-8413	NYU CTSA grant from the National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001445]; BioNTech	NYU CTSA grant from the National Center for Advancing Translational Sciences, National Institutes of Health; BioNTech	We thank C. Monahan and D. Gantt for writing and editorial support; H. Ma, J. Trammel and K. Challagali for statistical analysis support in the generation of this manuscript; all of the participants who volunteered for this study; A. Kottkamp, R. Herati, R. Pellet Madan, M. Olson, M. Samanovic-Golden, E. Cohen, A. Cornelius, L. Frye, H. Youn, B. Fran, K. Ballani, N. Veling, J. Erb, M. Ali, L. Zhao, S. Rettig, H. Khan, H. Lambert, K. Hu, J. Hyde, M. McArthur, J. Ortiz, R. Rapaka, L. Wadsworth, G. Cummings, T. Robinson, N. Greenberg, L. Chrisley, W. Somrajit, J. Marron, C. Thomas, K. Brooks, L. Turek, P. Farley, S. Eddington, P. Komninou, M. Reymann, K. Strauss, B. Shrestha, S. Joshi, R. Barnes, R. Sukhavasi, M. Lee, A. Kwon, T. Sharp, E. Pierce, M. Criddle, A. Cline, S. Parker, M. Dickey, K. Buschle, A. Cawein, J. L. Perez, H. Seehra, D. Tresnan, R. Maroko, H. Smith, S. Tweedy, A. Jones, G. Adams, R. Malick, E. Worobetz, E. Weaver, L. Zhang, C. Devlin, D. Boyce, E. Harkins Tull, M. Boaz, M. Cruz, C. Rosenbaum, C. Miculka, A. Kuhn, F. Bates, P. Strecker, A. Kemmer-Bruck, and the Vaccines Clinical Assay Team and Vaccines Assay Development Team for their assistance during this study. Staffing services were supported in part by an NYU CTSA grant (UL1 TR001445) from the National Center for Advancing Translational Sciences, National Institutes of Health. BioNTech is the sponsor of the study. Pfizer was responsible for the design, data collection, data analysis, data interpretation and writing of the report. The corresponding authors had full access to all of the data in the study and had final responsibility for the decision to submit the data for publication. All study data were available to all authors.	Feldman RA, 2019, VACCINE, V37, P3326, DOI 10.1016/j.vaccine.2019.04.074; Alberer M, 2017, LANCET, V390, P1511, DOI 10.1016/S0140-6736(17)31665-3; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Foster GR, 2004, J IMMUNOL, V173, P1663, DOI 10.4049/jimmunol.173.3.1663; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Hopkins RJ, 2013, VACCINE, V31, P3051, DOI 10.1016/j.vaccine.2013.04.063; Johns Hopkins University & Medicine, 2020, KILLING REPUBLIC CIT; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Lai LL, 2015, JAMA-J AM MED ASSOC, V313, P1249, DOI 10.1001/jama.2015.1995; Muruato AE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17892-0; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Rauch S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01963; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216; Sahin U, 2020, CONCURRENT HUMAN ANT, DOI [10.1101/2020.07.17.20140533, DOI 10.1101/2020.07.17.20140533]; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Walsh Edward E, 2020, medRxiv, DOI 10.1101/2020.08.17.20176651; World Health Organization, 2020, WHO; World Health Organization, 2020, DIR GEN OP REM MED B; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	26	802	817	14	187	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2020	586	7830					589	+		10.1038/s41586-020-2639-4	http://dx.doi.org/10.1038/s41586-020-2639-4		AUG 2020	10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OE6NR	32785213	Bronze			2022-12-28	WOS:000576135500001
J	Lee, GM; Bell, BP; Romero, JR				Lee, Grace M.; Bell, Beth P.; Romero, Jose R.			The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the role of the Advisory Committee on Immunization Practices, a federal advisory committee that makes vaccine-related recommendations to the CDC and DHHS, in guiding the development and deployment of COVID-19 vaccines.	[Lee, Grace M.] Stanford Univ, Sch Med, 300 Pasteur Dr,H306-A, Stanford, CA 94305 USA; [Lee, Grace M.] Stanford Childrens Hlth, Stanford, CA USA; [Bell, Beth P.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Romero, Jose R.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Romero, Jose R.] Arkansas Dept Hlth, Little Rock, AR 72205 USA	Stanford University; University of Washington; University of Washington Seattle; University of Arkansas System; University of Arkansas Medical Sciences	Lee, GM (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr,H306-A, Stanford, CA 94305 USA.	gmlee@stanfordchildrens.org						[Anonymous], COVID 19 RAC ETHN MI; Food and Drug Administration; Center for Biologics Evaluation and Research, DEV LIC VACC PREV CO; Lee G, 2018, MMWR-MORBID MORTAL W, V67, P1271, DOI 10.15585/mmwr.mm6745a4; O'Callaghan KP, 2020, JAMA, DOI 10.1001/jama.2020.12190; Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711; Smith JC, 2009, ANN INTERN MED, V150, P45, DOI 10.7326/0003-4819-150-1-200901060-00009; WHO, DRAFT LANDSC COVID 1; Yoo BK, 2011, AM J PREV MED, V40, P1, DOI 10.1016/j.amepre.2010.09.028	8	9	9	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					546	547		10.1001/jama.2020.13167	http://dx.doi.org/10.1001/jama.2020.13167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32717075	Bronze			2022-12-28	WOS:000562845100011
J	Tanne, JH				Tanne, Janice Hopkins			Trump's call for essential drugs to be made in US threatens innovation, says trade group	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rowland C, 2020, WASHINGTON POST; White House, 2020, D TRUMP IS ENS ESS M	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2020	370								m3170	10.1136/bmj.m3170	http://dx.doi.org/10.1136/bmj.m3170			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB1XI	32784201				2022-12-28	WOS:000560307500002
J	Walline, JJ; Walker, MK; Mutti, DO; Jones-Jordan, LA; Sinnott, LT; Giannoni, AG; Bickle, KM; Schulle, KL; Nixon, A; Pierce, GE; Berntsen, DA				Walline, Jeffrey J.; Walker, Maria K.; Mutti, Donald O.; Jones-Jordan, Lisa A.; Sinnott, Loraine T.; Giannoni, Amber Gaume; Bickle, Katherine M.; Schulle, Krystal L.; Nixon, Alex; Pierce, Gilbert E.; Berntsen, David A.		Blink Study Grp	Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children The BLINK Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIPHERAL DEFOCUS; SOFT; PREVALENCE; HYPEROPIA; WEAR	Importance Slowing myopia progression could decrease the risk of sight-threatening complications. Objective To determine whether soft multifocal contact lenses slow myopia progression in children, and whether high add power (+2.50 D) slows myopia progression more than medium (+1.50 D) add power lenses. Design, Setting, and Participants A double-masked randomized clinical trial that took place at 2 optometry schools located in Columbus, Ohio, and Houston, Texas. A total of 294 consecutive eligible children aged 7 to 11 years with -0.75 D to -5.00 D of spherical component myopia and less than 1.00 D astigmatism were enrolled between September 22, 2014, and June 20, 2016. Follow-up was completed June 24, 2019. Interventions Participants were randomly assigned to wear high add power (n = 98), medium add power (n = 98), or single-vision (n = 98) contact lenses. Main Outcomes and Measures The primary outcome was the 3-year change in cycloplegic spherical equivalent autorefraction, as measured by the mean of 10 autorefraction readings. There were 11 secondary end points, 4 of which were analyzed for this study, including 3-year eye growth. Results Among 294 randomized participants, 292 (99%) were included in the analyses (mean [SD] age, 10.3 [1.2] years; 177 [60.2%] were female; mean [SD] spherical equivalent refractive error, -2.39 [1.00] D). Adjusted 3-year myopia progression was -0.60 D for high add power, -0.89 D for medium add power, and -1.05 D for single-vision contact lenses. The difference in progression was 0.46 D (95% CI, 0.29-0.63) for high add power vs single vision, 0.30 D (95% CI, 0.13-0.47) for high add vs medium add power, and 0.16 D (95% CI, -0.01 to 0.33) for medium add power vs single vision. Of the 4 secondary end points, there were no statistically significant differences between the groups for 3 of the end points. Adjusted mean eye growth was 0.42 mm for high add power, 0.58 mm for medium add power, and 0.66 mm for single vision. The difference in eye growth was -0.23 mm (95% CI, -0.30 to -0.17) for high add power vs single vision, -0.16 mm (95% CI, -0.23 to -0.09) for high add vs medium add power, and -0.07 mm (95% CI, -0.14 to -0.01) for medium add power vs single vision. Conclusions and Relevance Among children with myopia, treatment with high add power multifocal contact lenses significantly reduced the rate of myopia progression over 3 years compared with medium add power multifocal and single-vision contact lenses. However, further research is needed to understand the clinical importance of the observed differences.	[Walline, Jeffrey J.; Mutti, Donald O.; Jones-Jordan, Lisa A.; Sinnott, Loraine T.; Bickle, Katherine M.; Nixon, Alex; Pierce, Gilbert E.] Ohio State Univ, Coll Optometry, 338 West Tenth Ave, Columbus, OH 43210 USA; [Walker, Maria K.; Giannoni, Amber Gaume; Schulle, Krystal L.; Berntsen, David A.] Univ Houston, Coll Optometry, Houston, TX USA; [Nixon, Alex] Johnson & Johnson Vis Care Inc, Jacksonville, FL USA	University System of Ohio; Ohio State University; University of Houston System; University of Houston; Johnson & Johnson	Walline, JJ (corresponding author), Ohio State Univ, Coll Optometry, 338 West Tenth Ave, Columbus, OH 43210 USA.	walline.1@osu.edu	, Jeff/AAE-1426-2022	, Jeff/0000-0002-9503-6094	NIH [U10 EY023204, U10 023206, U10 023208, U10 023210, P30 EY007551, UL1 TR001070]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by grants from NIH granted to Drs Berntsen (U10 EY023204), Jordan (U10 023206), Walline (U10 023208), Mutti (U10 023210), Frishman (P30 EY007551), and Jackson (UL1 TR001070), and Bausch + Lomb provided contact lens solutions for the study.	Allen PM, 2013, OPHTHAL PHYSL OPT, V33, P267, DOI 10.1111/opo.12035; Aller TA, 2016, OPTOMETRY VISION SCI, V93, P344, DOI 10.1097/OPX.0000000000000808; [Anonymous], 2011, INVEST OPHTH VIS SCI, V52, P2749; Anstice NS, 2011, OPHTHALMOLOGY, V118, P1152, DOI 10.1016/j.ophtha.2010.10.035; Berntsen DA, 2013, OPTOMETRY VISION SCI, V90, P1215, DOI 10.1097/OPX.0000000000000066; Berntsen DA, 2013, INVEST OPHTH VIS SCI, V54, P5761, DOI 10.1167/iovs.13-11904; Chamberlain P, 2019, OPTOMETRY VISION SCI, V96, P556, DOI 10.1097/OPX.0000000000001410; Cheng X, 2016, OPTOMETRY VISION SCI, V93, P353, DOI 10.1097/OPX.0000000000000773; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; Fujikado T, 2014, CLIN OPHTHALMOL, V8, P1947, DOI 10.2147/OPTH.S66884; Glynn RJ, 2012, OPHTHAL EPIDEMIOL, V19, P159, DOI 10.3109/09286586.2012.674614; Gwiazda J, 2003, INVEST OPHTH VIS SCI, V44, P1492, DOI 10.1167/iovs.02-0816; Gwiazda J, 2002, INVEST OPHTH VIS SCI, V43, P314; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; HOLM S, 1979, SCAND J STAT, V6, P65; Hyman L, 2005, ARCH OPHTHALMOL-CHIC, V123, P977, DOI 10.1001/archopht.123.7.977; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Kang P, 2013, OPTOMETRY VISION SCI, V90, P658, DOI 10.1097/OPX.0b013e3182990878; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Paune J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/507572; Rosen R, 2012, OPHTHAL PHYSL OPT, V32, P527, DOI 10.1111/j.1475-1313.2012.00937.x; Ruiz-Pomeda A, 2018, GRAEF ARCH CLIN EXP, V256, P1011, DOI 10.1007/s00417-018-3906-z; Sankaridurg P, 2019, OPHTHAL PHYSL OPT, V39, P294, DOI 10.1111/opo.12621; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Thorn F, 2005, OPTOMETRY VISION SCI, V82, P286, DOI 10.1097/01.OPX.0000159370.66540.34; Ticak A, 2013, OPTOMETRY VISION SCI, V90, P3, DOI 10.1097/OPX.0b013e3182781868; Verkicharla PK, 2015, OPHTHAL PHYSL OPT, V35, P465, DOI 10.1111/opo.12238; Walline JJ, 2008, INVEST OPHTH VIS SCI, V49, P4702, DOI 10.1167/iovs.08-2067; Walline JJ, 2018, EYE CONTACT LENS, V44, P205, DOI 10.1097/ICL.0000000000000511; Walline JJ, 2017, OPTOMETRY VISION SCI, V94, P856, DOI 10.1097/OPX.0000000000001106; Walline JJ, 2013, OPTOMETRY VISION SCI, V90, P1207, DOI 10.1097/OPX.0000000000000036; Walline JJ, 2009, OPTOMETRY VISION SCI, V86, P222, DOI 10.1097/OPX.0b013e3181971985; Walline JJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1760, DOI 10.1001/archopht.122.12.1760; Wolffsohn JS, 2019, INVEST OPHTH VIS SCI, V60, pM132, DOI 10.1167/iovs.18-25955; Yam JC, 2019, OPHTHALMOLOGY, V126, P113, DOI 10.1016/j.ophtha.2018.05.029; ZADNIK K, 1993, OPTOMETRY VISION SCI, V70, P750, DOI 10.1097/00006324-199309000-00012	40	72	74	2	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					571	580		10.1001/jama.2020.10834	http://dx.doi.org/10.1001/jama.2020.10834			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780139	Bronze, Green Published			2022-12-28	WOS:000562845100019
J	Salice, C				Salice, Clara			Building a portfolio for specialty applications	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Salice, Clara] Whipps Cross Hosp & Chest Clin, London, England	University of London; Queen Mary University London	Salice, C (corresponding author), Whipps Cross Hosp & Chest Clin, London, England.	clara.salice@nhs.net						Health Education England, 2019, GUID PROD MED PORTF; Internal Medicine Training Recruitment NHS, 2020, APPL SCOR	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2020	370								m2481	10.1136/bmj.m2481	http://dx.doi.org/10.1136/bmj.m2481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB7QQ	32769076				2022-12-28	WOS:000560709600008
J	Jacox, MG; Alexander, MA; Bograd, SJ; Scott, JD				Jacox, Michael G.; Alexander, Michael A.; Bograd, Steven J.; Scott, James D.			Thermal displacement by marine heatwaves	NATURE			English	Article							SEA-SURFACE TEMPERATURE; RANGE SHIFTS; CLIMATE-CHANGE; NORTH PACIFIC; HEAT-WAVE; EL-NINO; OCEAN; SATELLITE; FISHERIES; ECOSYSTEM	Marine heatwaves (MHWs)-discrete but prolonged periods of anomalously warm ocean temperatures-can drastically alter ocean ecosystems, with profound ecological and socioeconomic impacts(1-8). Considerable effort has been directed at understanding the patterns, drivers and trends of MHWs globally(9-11). Typically, MHWs are characterized on the basis of their intensity and persistence at a given location-an approach that is particularly relevant for corals and other sessile organisms that must endure increased temperatures. However, many ecologically and commercially important marine species respond to environmental disruptions by relocating to favourable habitats, and dramatic range shifts of mobile marine species are among the conspicuous impacts of MHWs(1,4,12,13). Whereas spatial temperature shifts have been studied extensively in the context of long-term warming trends(14-18), they are unaccounted for in existing global MHW analyses. Here we introduce thermal displacement as a metric that characterizes MHWs by the spatial shifts of surface temperature contours, instead of by local temperature anomalies, and use an observation-based global sea surface temperature dataset to calculate thermal displacements for all MHWs from 1982 to 2019. We show that thermal displacements during MHWs vary from tens to thousands of kilometres across the world's oceans and do not correlate spatially with MHW intensity. Furthermore, short-term thermal displacements during MHWs are of comparable magnitude to century-scale shifts inferred from warming trends(18), although their global spatial patterns are very different. These results expand our understanding of MHWs and their potential impacts on marine species, revealing which regions are most susceptible to thermal displacement, and how such shifts may change under projected ocean warming. The findings also highlight the need for marine resource management to account for MHW-driven spatial shifts, which are of comparable scale to those associated with long-term climate change and are already happening. Ocean heatwaves displace surface isotherms by tens to thousands of kilometres-comparable to shifts associated with long-term warming trends-potentially driving rapid redistributions of marine species.	[Jacox, Michael G.; Bograd, Steven J.] NOAA, Southwest Fisheries Sci Ctr, Monterey, CA 93940 USA; [Jacox, Michael G.; Alexander, Michael A.; Scott, James D.] NOAA, Earth Syst Res Lab, Boulder, CO 80303 USA; [Jacox, Michael G.; Bograd, Steven J.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Scott, James D.] Univ Colorado, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Boulder	Jacox, MG (corresponding author), NOAA, Southwest Fisheries Sci Ctr, Monterey, CA 93940 USA.; Jacox, MG (corresponding author), NOAA, Earth Syst Res Lab, Boulder, CO 80303 USA.; Jacox, MG (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	michael.jacox@noaa.gov	Alexander, Michael A/A-7097-2013; Bograd, Steven/AAA-4824-2021	Alexander, Michael A/0000-0001-9646-6427; Jacox, Michael/0000-0003-3684-0717; Scott, James D/0000-0002-8709-8594				Alexander MA, 2018, ELEMENTA-SCI ANTHROP, V6, DOI 10.1525/elementa.191; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Babcock RC, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00558; Banzon V, 2016, EARTH SYST SCI DATA, V8, P165, DOI 10.5194/essd-8-165-2016; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Briscoe DK, 2017, DEEP-SEA RES PT II, V140, P182, DOI 10.1016/j.dsr2.2016.11.004; Brito-Morales I, 2018, TRENDS ECOL EVOL, V33, P441, DOI 10.1016/j.tree.2018.03.009; Brodeur RD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026614; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cavole LM, 2016, OCEANOGRAPHY, V29, P273, DOI 10.5670/oceanog.2016.32; Chen K, 2014, J GEOPHYS RES-OCEANS, V119, P218, DOI 10.1002/2013JC009393; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Diffenbaugh NS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043888; Doi T, 2019, J CLIMATE, V32, P957, DOI 10.1175/JCLI-D-18-0193.1; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Frolicher TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03163-6; Hobday AJ, 2018, OCEANOGRAPHY, V31, P162, DOI 10.5670/oceanog.2018.205; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Holbrook NJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10206-z; Hu ZZ, 2017, J CLIMATE, V30, P689, DOI [10.1175/jcli-d-16-0348.1, 10.1175/JCLI-D-16-0348.1]; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jacox MG, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00497; Jacox MG, 2019, NATURE, V571, P485, DOI 10.1038/d41586-019-02196-1; Lea RN, 2000, CAL COOP OCEAN FISH, V41, P117; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Niquen M, 2004, DEEP-SEA RES PT II, V51, P563, DOI 10.1016/j.dsr2.2004.03.001; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Oliver ECJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16101; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Pearcy WG, 2002, PROG OCEANOGR, V54, P399, DOI 10.1016/S0079-6611(02)00060-5; Perkins SE, 2013, J CLIMATE, V26, P4500, DOI 10.1175/JCLI-D-12-00383.1; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rogers LA, 2019, NAT CLIM CHANGE, V9, P512, DOI 10.1038/s41558-019-0503-z; Romanou A, 2006, J CLIMATE, V19, P3378, DOI 10.1175/JCLI3773.1; Scannell HA, 2016, GEOPHYS RES LETT, V43, P2069, DOI 10.1002/2015GL067308; Schwing FB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026911; Seager R, 2019, NAT CLIM CHANGE, V9, P517, DOI 10.1038/s41558-019-0505-x; Smale DA, 2019, NAT CLIM CHANGE, V9, P306, DOI 10.1038/s41558-019-0412-1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Thomson JA, 2015, GLOBAL CHANGE BIOL, V21, P1463, DOI 10.1111/gcb.12694; Walker HJ, 2020, ESTUAR COAST SHELF S, V236, DOI 10.1016/j.ecss.2020.106634	48	44	45	4	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					82	+		10.1038/s41586-020-2534-z	http://dx.doi.org/10.1038/s41586-020-2534-z			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32760046				2022-12-28	WOS:000560290400018
J	Scudellari, M				Scudellari, Megan			THE PANDEMIC'S FUTURE	NATURE			English	News Item						SARS-CoV-2; Epidemiology; Immunology		This coronavirus is here for the long haul - here's what scientists predict for the next months and years. This coronavirus is here for the long haul - here's what scientists predict for the next months and years.										Acuna-Zegarra MA, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108370; [Anonymous], 2020, COVID 19 CIDRAP VIEW; [Anonymous], 2020, ESTIMATING CASES COV; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Havers F. P., 2020, J AM MED ASS INT MED, DOI [10.1001/jamainternmed.2020.4130, DOI 10.1001/JAMAINTERNMED.2020.4130]; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Kennedy DM, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104440; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027; Ly H., 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107725; Moriyama M, 2020, ANNU REV VIROL, V7, P83, DOI 10.1146/annurev-virology-012420-022445; Nouvellet P., 2020, REPORT 26 REDUCTION; Rahmandad H., 2020, PREPRINT; Richard AN, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20224; Santana-Cibrian M., 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.07.23.20161026, DOI 10.1101/2020.07.23.20161026]; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	18	138	139	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					22	25		10.1038/d41586-020-02278-5	http://dx.doi.org/10.1038/d41586-020-02278-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB1QU	32760050				2022-12-28	WOS:000560290400006
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Mental health and economic problems are worse in US than in other rich nations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kelly J., 2020, FORBES; Williams II RD, 2020, AM FACE GREATER MENT	2	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2020	370								m3110	10.1136/bmj.m3110	http://dx.doi.org/10.1136/bmj.m3110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NB7UK	32764109	Bronze			2022-12-28	WOS:000560719800012
J	Gemmell, NJ; Rutherford, K; Prost, S; Tollis, M; Winter, D; Macey, JR; Adelson, DL; Suh, A; Bertozzi, T; Grau, JH; Organ, C; Gardner, PP; Muffato, M; Patricio, M; Billis, K; Martin, FJ; Flicek, P; Petersen, B; Kang, L; Michalak, P; Buckley, TR; Wilson, M; Cheng, YY; Miller, H; Schott, RK; Jordan, MD; Newcomb, RD; Arroyo, JI; Valenzuela, N; Hore, TA; Renart, J; Peona, V; Peart, CR; Warmuth, VM; Zeng, L; Kortschak, RD; Raison, JM; Zapata, VV; Wu, ZQ; Santesmasses, D; Mariotti, M; Guigo, R; Rupp, SM; Twort, VG; Dussex, N; Taylor, H; Abe, H; Bond, DM; Paterson, JM; Mulcahy, DG; Gonzalez, VL; Barbieri, CG; DeMeo, DP; Pabinger, S; Van Stijn, T; Clarke, S; Ryder, O; Edwards, SV; Salzberg, SL; Anderson, L; Nelson, N; Stone, C				Gemmell, Neil J.; Rutherford, Kim; Prost, Stefan; Tollis, Marc; Winter, David; Macey, J. Robert; Adelson, David L.; Suh, Alexander; Bertozzi, Terry; Grau, Jose H.; Organ, Chris; Gardner, Paul P.; Muffato, Matthieu; Patricio, Mateus; Billis, Konstantinos; Martin, Fergal J.; Flicek, Paul; Petersen, Bent; Kang, Lin; Michalak, Pawel; Buckley, Thomas R.; Wilson, Melissa; Cheng, Yuanyuan; Miller, Hilary; Schott, Ryan K.; Jordan, Melissa D.; Newcomb, Richard D.; Arroyo, Jose Ignacio; Valenzuela, Nicole; Hore, Tim A.; Renart, Jaime; Peona, Valentina; Peart, Claire R.; Warmuth, Vera M.; Zeng, Lu; Kortschak, R. Daniel; Raison, Joy M.; Zapata, Valeria Velasquez; Wu, Zhiqiang; Santesmasses, Didac; Mariotti, Marco; Guigo, Roderic; Rupp, Shawn M.; Twort, Victoria G.; Dussex, Nicolas; Taylor, Helen; Abe, Hideaki; Bond, Donna M.; Paterson, James M.; Mulcahy, Daniel G.; Gonzalez, Vanessa L.; Barbieri, Charles G.; DeMeo, Dustin P.; Pabinger, Stephan; Van Stijn, Tracey; Clarke, Shannon; Ryder, Oliver; Edwards, Scott, V; Salzberg, Steven L.; Anderson, Lindsay; Nelson, Nicola; Stone, Clive		Ngatiwai Trust Board	The tuatara genome reveals ancient features of amniote evolution	NATURE			English	Article							NEW-ZEALAND; SPHENODON; ELEMENTS	The tuatara (Sphenodon punctatus)-the only living member of the reptilian order Rhynchocephalia (Sphenodontia), once widespread across Gondwana(1,2)-is an iconic species that is endemic to New Zealand(2,3). A key link to the now-extinct stem reptiles (from which dinosaurs, modern reptiles, birds and mammals evolved), the tuatara provides key insights into the ancestral amniotes(2,4). Here we analyse the genome of the tuatara, which-at approximately 5 Gb-is among the largest of the vertebrate genomes yet assembled. Our analyses of this genome, along with comparisons with other vertebrate genomes, reinforce the uniqueness of the tuatara. Phylogenetic analyses indicate that the tuatara lineage diverged from that of snakes and lizards around 250 million years ago. This lineage also shows moderate rates of molecular evolution, with instances of punctuated evolution. Our genome sequence analysis identifies expansions of proteins, non-protein-coding RNA families and repeat elements, the latter of which show an amalgam of reptilian and mammalian features. The sequencing of the tuatara genome provides a valuable resource for deep comparative analyses of tetrapods, as well as for tuatara biology and conservation. Our study also provides important insights into both the technical challenges and the cultural obligations that are associated with genome sequencing. The approximately 5-Gb tuatara (Sphenodon punctatus) genome assembly provides a resource for analysing amniote evolution, and highlights the imperative for meaningful cultural engagement with Indigenous communities in genome-sequencing endeavours.	[Gemmell, Neil J.; Rutherford, Kim; Hore, Tim A.; Dussex, Nicolas; Taylor, Helen; Abe, Hideaki; Bond, Donna M.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Prost, Stefan] LOEWE Ctr Translat Biodivers Genom, Senckenberg Museum, Frankfurt, Germany; [Prost, Stefan] Natl Zool Garden, South African Natl Biodivers Inst, Pretoria, South Africa; [Tollis, Marc; Wilson, Melissa; Rupp, Shawn M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Tollis, Marc] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Winter, David] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand; [Macey, J. Robert; Barbieri, Charles G.; DeMeo, Dustin P.] Peralta Genom Inst, Oakland, CA USA; [Adelson, David L.; Bertozzi, Terry; Zeng, Lu; Kortschak, R. Daniel; Raison, Joy M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Suh, Alexander; Peona, Valentina; Peart, Claire R.; Warmuth, Vera M.] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr EBC, Evolutionary Biol, Uppsala, Sweden; [Suh, Alexander; Peona, Valentina] Uppsala Univ, Dept OrganismaL Biol, Evolutionary Biol Ctr EBC, Systemat Biol, Uppsala, Sweden; [Bertozzi, Terry] South Australian Museum, Evolutionary Biol Unit, Adelaide, SA, Australia; [Grau, Jose H.] Amedes Med Dienstleistungen, Amedes Genet, Berlin, Germany; [Grau, Jose H.] Humboldt Univ, Museum Nat Kunde Berlin, Leibniz Inst Evolut & Biodiversitatsforsch, Berlin, Germany; [Organ, Chris] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Gardner, Paul P.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Muffato, Matthieu; Patricio, Mateus; Billis, Konstantinos; Martin, Fergal J.; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Petersen, Bent] Univ Copenhagen, Fac Hearth & Med Sci, GLOBE Inst, Sect Evolutionary Genom, Copenhagen, Denmark; [Kang, Lin; Michalak, Pawel] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Michalak, Pawel] Virginia Maryland Coll Vet Med, Ctr One Hearth Res, Blacksburg, VA USA; [Michalak, Pawel] Univ Haifa, Inst Evolut, Haifa, Israel; [Buckley, Thomas R.; Twort, Victoria G.] Manaaki Whenua Landcare Res, Auckland, New Zealand; [Buckley, Thomas R.; Twort, Victoria G.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Cheng, Yuanyuan] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Miller, Hilary] Biomatters, Auckland, New Zealand; [Schott, Ryan K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Jordan, Melissa D.; Newcomb, Richard D.] New Zealand Inst Kant & Food Res, Auckland, New Zealand; [Arroyo, Jose Ignacio] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Valenzuela, Nicole; Zapata, Valeria Velasquez; Wu, Zhiqiang] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Renart, Jaime] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Peart, Claire R.; Warmuth, Vera M.] Ludwig Maximilian Univ Munich, Fac Biol, Div Evolutionary Biol, Planegg Martinsried, Germany; [Santesmasses, Didac; Mariotti, Marco; Guigo, Roderic] Univ Pompeu Fabra UPF, Ctr Genom Regulat CRG, Barcelona Inst Sci & Technol, Barcelona, Spain; [Paterson, James M.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Mulcahy, Daniel G.; Gonzalez, Vanessa L.] Natl Museum Nat Hist, Smithsonian Inst, Global Genome Initiat, Washington, DC 20560 USA; [Pabinger, Stephan] Ctr Hlth & Bioresources Mol Diagnost, Austrian Inst Technol AIT, Vienna, Austria; [Van Stijn, Tracey; Clarke, Shannon] AgResearch, Invermay Agr Ctr, Mosgiel, New Zealand; [Ryder, Oliver] San Diego Zoo Inst Conservat Res, Escondido, CA USA; [Edwards, Scott, V] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Edwards, Scott, V] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Anderson, Lindsay; Nelson, Nicola] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Stone, Clive] Ngatiwai Trust Board, Whangarei, New Zealand	University of Otago; Senckenberg Gesellschaft fur Naturforschung (SGN); South African National Biodiversity Institute; Arizona State University; Arizona State University-Tempe; Northern Arizona University; Massey University; University of Adelaide; Uppsala University; Uppsala University; South Australian Museum; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Montana State University System; Montana State University Bozeman; University of Otago; European Molecular Biology Laboratory (EMBL); University of Copenhagen; University of Haifa; Landcare Research - New Zealand; University of Auckland; University of Sydney; Smithsonian Institution; Smithsonian National Museum of Natural History; Pontificia Universidad Catolica de Chile; Iowa State University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Munich; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Canterbury; Smithsonian Institution; Smithsonian National Museum of Natural History; Austrian Institute of Technology (AIT); AgResearch - New Zealand; Zoological Society of San Diego; Harvard University; Harvard University; Johns Hopkins University; Victoria University Wellington	Gemmell, NJ (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	neil.gemmell@otago.ac.nz	Tollis, Marc/AAX-2332-2020; Twort, Victoria/AAL-9807-2021; Billis, Konstantinos/ABE-6046-2021; Rutherford, Kim/Y-7995-2018; Wu, Zhiqiang/CAG-6688-2022; Kang, Lin/AAA-2260-2019; Guigo, Roderic/D-1303-2010; Salzberg, Steven L/F-6162-2011; Zeng, Lu/AHC-5320-2022; Dussex, Nicolas/Q-9947-2017; Peona, Valentina/G-3482-2015; Bertozzi, Terry/E-2748-2013; Gemmell, Neil/C-6774-2009; Renart, Jaime/B-7661-2009; Adelson, David/E-5506-2011	Tollis, Marc/0000-0002-1917-2473; Twort, Victoria/0000-0002-5581-4154; Billis, Konstantinos/0000-0001-8568-4306; Rutherford, Kim/0000-0001-6277-726X; Wu, Zhiqiang/0000-0002-4238-7317; Kang, Lin/0000-0002-9186-9574; Guigo, Roderic/0000-0002-5738-4477; Salzberg, Steven L/0000-0002-8859-7432; Zeng, Lu/0000-0001-9381-7690; Dussex, Nicolas/0000-0002-9179-8593; Kortschak, Robert Daniel/0000-0001-8295-2301; Martin, Fergal/0000-0002-1672-050X; Peona, Valentina/0000-0001-5119-1837; Muffato, Matthieu/0000-0002-7860-3560; Valenzuela, Nicole/0000-0003-1148-631X; Gonzalez, Vanessa Liz/0000-0002-1593-4469; Petersen, Bent/0000-0002-2472-8317; Mulcahy, Daniel G./0000-0001-6614-2405; Velasquez-Zapata, Valeria/0000-0002-2756-2156; Bertozzi, Terry/0000-0001-6665-3395; Gemmell, Neil/0000-0003-0671-3637; Bond, Donna/0000-0001-7704-1263; Flicek, Paul/0000-0002-3897-7955; Santesmasses, Didac/0000-0003-3398-8943; Renart, Jaime/0000-0001-6620-3706; Adelson, David/0000-0003-2404-5636; Prost, Stefan/0000-0002-6229-3596; Barbieri, Charles/0000-0002-4198-956X	Ngatiwai iwi, Allan Wilson Centre, University of Otago; New Zealand Department of Conservation, New Zealand Genomics and Illumina; CONICYT [21130515]; NIH [R35 GM124827]; Wellcome Trust [WT108749/Z/15/Z]; European Molecular Biology Laboratory	Ngatiwai iwi, Allan Wilson Centre, University of Otago; New Zealand Department of Conservation, New Zealand Genomics and Illumina; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Laboratory	N.J.G. acknowledges the support of Ngatiwai iwi, Allan Wilson Centre, University of Otago, New Zealand Department of Conservation, New Zealand Genomics and Illumina. J.I.A. was supported by CONICYT National Doctoral Scholarship No. 21130515. M.W. was supported by NIH grant R35 GM124827. Ensembl annotation was supported by the Wellcome Trust (WT108749/Z/15/Z) and the European Molecular Biology Laboratory. We thank Ngati Koata, Te Atiawa o Te Waka-a-Maui, and Ngati Manuhiri iwi for granting permission to reuse tuatara samples obtained from Stephens Island (Takapourewa), North Brother Island and Little Barrier Island (Hauturu), respectively; all of the people involved in obtaining and curating the samples held in the Victoria University of Wellington tuatara collection; A. Zimin, D. Puiu, G. Marcais, J. Yorke and R. Crowhurst for help with and discussions about genome assembly; I. Fiddes, J. Armstrong and B. Paten for help with comparative genome alignments and annotation; the National eScience Infrastructure (NeSI) and Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) for computational support; R. McPhee for help with figures; and T. Braisher for manuscript coordination and editing.	Aiewsakun P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13954; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Capel B, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.60; COOPER A, 1995, P ROY SOC B-BIOL SCI, V261, P293, DOI 10.1098/rspb.1995.0150; Cree A., 2014, TUATARA BIOL CONSERV; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Gilbert N, 1999, P NATL ACAD SCI USA, V96, P2869, DOI 10.1073/pnas.96.6.2869; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Hay JM, 2010, CONSERV GENET, V11, P1063, DOI 10.1007/s10592-009-9952-7; Head JJ, 2015, PALAEONTOL ELECTRON, V18; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Jones MEH, 2009, P ROY SOC B-BIOL SCI, V276, P1385, DOI 10.1098/rspb.2008.1785; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Landis MJ, 2017, P NATL ACAD SCI USA, V114, P13224, DOI 10.1073/pnas.1710920114; MacAvoy ES, 2007, CONSERV GENET, V8, P305, DOI 10.1007/s10592-006-9170-5; Magallon S., 2009, TIMETREE LIFE, P133; Meyer-Rochow VB, 2005, MICRON, V36, P423, DOI 10.1016/j.micron.2005.03.009; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-439; Miller HC, 2009, TRENDS GENET, V25, P13, DOI 10.1016/j.tig.2008.09.007; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; O'Meally D, 2009, CYTOGENET GENOME RES, V127, P213, DOI 10.1159/000300099; Pasquesi GIM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05279-1; Radhakrishnan S, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0136-2; Rest JS, 2003, MOL PHYLOGENET EVOL, V29, P289, DOI 10.1016/S1055-7903(03)00108-8; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Schott RK, 2019, EVOLUTION, V73, P1958, DOI 10.1111/evo.13810; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sotero-Caio CG, 2017, GENOME BIOL EVOL, V9, P161, DOI 10.1093/gbe/evw264; Subramanian S, 2009, TRENDS GENET, V25, P16, DOI 10.1016/j.tig.2008.11.001; Suh A, 2015, GENOME BIOL EVOL, V7, P205, DOI 10.1093/gbe/evu256; Vandewege MW, 2016, GENOME BIOL EVOL, V8, P1327, DOI 10.1093/gbe/evw078; Wang J, 2015, P NATL ACAD SCI USA, V112, pE4428, DOI 10.1073/pnas.1507253112; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Webster AJ, 2003, SCIENCE, V301, P478, DOI 10.1126/science.1083202; Zeng L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193588	37	58	58	6	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					403	+		10.1038/s41586-020-2561-9	http://dx.doi.org/10.1038/s41586-020-2561-9		AUG 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32760000	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000556239400001
J	Labaki, WW; Rosenberg, SR				Labaki, Wassim W.; Rosenberg, Sharon R.			Chronic Obstructive Pulmonary Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PNEUMOCOCCAL POLYSACCHARIDE VACCINE; AMERICAN THORACIC SOCIETY; AIR-FLOW OBSTRUCTION; ALPHA-1-ANTITRYPSIN DEFICIENCY; UPDATED RECOMMENDATIONS; LUNG TRANSPLANTATION; ACUTE EXACERBATIONS; CHRONIC-BRONCHITIS; SMOKING-CESSATION; RANDOMIZED-TRIAL		[Labaki, Wassim W.] Univ Michigan, Ann Arbor, MI 48109 USA; [Rosenberg, Sharon R.] Northwestern Univ, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; Northwestern University	Labaki, WW (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Albert RK, 2016, NEW ENGL J MED, V375, P1617, DOI 10.1056/NEJMoa1604344; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; American Thoracic Society, ATS OFF DOC; [Anonymous], 1980, Ann Intern Med, V93, P391; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Bafadhel M, 2018, LANCET RESP MED, V6, P117, DOI 10.1016/S2213-2600(18)30006-7; Borro Jose M, 2016, World J Transplant, V6, P347, DOI 10.5500/wjt.v6.i2.347; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Centers for Disease Control and Prevention, 2018, DAT STAT COPD DEATH; Navarro JC, 2015, ARCH BRONCONEUMOL, V51, P109, DOI 10.1016/j.arbres.2014.06.012; Chapman KR, 2018, AM J RESP CRIT CARE, V198, P329, DOI 10.1164/rccm.201803-0405OC; Chapman KR, 2015, LANCET, V386, P360, DOI 10.1016/S0140-6736(15)60860-1; Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6; Cho-Reyes S, 2019, COPD-J COPD FDN, V6, P267, DOI 10.15326/jcopdf.6.3.2018.0168; Coleman JM, 2019, ANN AM THORAC SOC, V16, P1091, DOI 10.1513/AnnalsATS.201810-657CME; Criner GJ, 2019, AM J RESP CRIT CARE, V200, P1354, DOI 10.1164/rccm.201902-0383OC; Criner GJ, 2018, AM J RESP CRIT CARE, V198, P1151, DOI 10.1164/rccm.201803-0590OC; Fishman A, 2003, NEW ENGL J MED, V348, P2059; FLENLEY DC, 1981, LANCET, V1, P681; Jimenez-Ruiz CA, 2015, EUR RESPIR J, V46, P61, DOI 10.1183/09031936.00092614; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Leuppi JD, 2013, JAMA-J AM MED ASSOC, V309, P2223, DOI 10.1001/jama.2013.5023; Lipson DA, 2018, NEW ENGL J MED, V378, P1671, DOI 10.1056/NEJMoa1713901; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martinez FJ, 2017, AM J RESP CRIT CARE, V195, P748, DOI 10.1164/rccm.201603-0622OC; Martinez FJ, 2015, LANCET, V385, P857, DOI 10.1016/S0140-6736(14)62410-7; Matanock A, 2019, MMWR-MORBID MORTAL W, V68, P1069, DOI 10.15585/mmwr.mm6846a5; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; National Institute for Health and Care Excellence, 2018, CHRON OBSTR PULM DIS; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Oba Y, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012620.pub2; Perez-Padilla R, 2012, ARCH MED RES, V43, P159, DOI 10.1016/j.arcmed.2012.03.007; Poole PJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002733.pub2; Press VG, 2019, ANN AM THORAC SOC, V16, P161, DOI 10.1513/AnnalsATS.201811-755WS; Puhan MA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub4; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sandhaus RA, 2016, CHRON OBSTR PULM DIS, V3, P668, DOI 10.15326/jcopdf.3.3.2015.0182; Schaffer JM, 2015, JAMA-J AM MED ASSOC, V313, P936, DOI 10.1001/jama.2015.1175; Sethi S, 1999, J ANTIMICROB CHEMOTH, V43, P97, DOI 10.1093/jac/43.suppl_1.97; Siddiqui FM, 2018, CURR OPIN PULM MED, V24, P199, DOI 10.1097/MCP.0000000000000452; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P1372, DOI 10.1001/jama.2016.2638; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; US Department of Veterans Affairs US Department of Defense, 2014, VA DOD CLIN PRACT GU; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Walters JAE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001390.pub4; Walters JAE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub4; Wedzicha JA, 2017, EUR RESPIR J, V50; Wedzicha JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00791-2016; Weill D, 2015, J HEART LUNG TRANSPL, V34, P1, DOI 10.1016/j.healun.2014.06.014; Woodruff PG, 2017, AM J RESP CRIT CARE, V196, P375, DOI 10.1164/rccm.201705-0973WS; Yohannes AM, 2014, EUR RESPIR REV, V23, P345, DOI 10.1183/09059180.00007813	59	80	88	5	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2020	173	3					ITC17	ITC30		10.7326/AITC202008040	http://dx.doi.org/10.7326/AITC202008040			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW7BG	32745458				2022-12-28	WOS:000557186700002
J	Kamerow, D				Kamerow, Douglas			The leading cause of death in the US Even in the pandemic, don't forget tobacco	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.; Kamerow, D (corresponding author), Georgetown Univ, Family Med, Washington, DC 20057 USA.	dkamerow@aafp.org						Center for Disease Control and Prevention, 2020, SMOK TOB US FAST FAC; Centers for Disease Control and Prevention, 2020, COR DIS 2019 PEOPL C; Centers for Disease Control and Prevention, 2020, LEAD CAUS DEATH; Institute for Health Metrics and Evaluation, 2020, COVID 19 PROJ; Lancaster T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001292.pub3; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Schroeder SA, 2013, NEW ENGL J MED, V368, P389, DOI 10.1056/NEJMe1213751	8	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2020	370								m3079	10.1136/bmj.m3079	http://dx.doi.org/10.1136/bmj.m3079			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1QV	32747438				2022-12-28	WOS:000556138700006
J	Han, XD				Han, Xiaodong			Ductile van der Waals materials	SCIENCE			English	Editorial Material									[Han, Xiaodong] Beijing Univ Technol, Inst Microstruct & Property Adv Mat, Beijing 100124, Peoples R China	Beijing University of Technology	Han, XD (corresponding author), Beijing Univ Technol, Inst Microstruct & Property Adv Mat, Beijing 100124, Peoples R China.	xdhan@bjut.edu.cn	han, xiao/HDN-9782-2022		National Science Foundation of China [51988101, 91860202]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	X.H. thanks the National Science Foundation of China, program nos. 51988101 and 91860202, for support.	Bandurin DA, 2017, NAT NANOTECHNOL, V12, P223, DOI [10.1038/nnano.2016.242, 10.1038/NNANO.2016.242]; Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; CAMASSEL J, 1978, PHYS REV B, V17, P4718, DOI 10.1103/PhysRevB.17.4718; Chen H, 2019, SCIENCE, V365, P1036, DOI 10.1126/science.aax7864; He WK, 2019, SCIENCE, V365, P1418, DOI 10.1126/science.aax5123; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Peng J, 2019, SCIENCE, V366, P690, DOI 10.1126/science.aaz5704; Peng KL, 2016, ENERG ENVIRON SCI, V9, P454, DOI 10.1039/c5ee03366g; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; Shi X, 2018, NAT MATER, V17, P421, DOI 10.1038/s41563-018-0047-z; Wang C, 2019, ADV MATER, V31, DOI 10.1002/adma.201903491; Wei TR, 2020, SCIENCE, V369, P542, DOI 10.1126/science.aba9778	14	13	13	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					509	509		10.1126/science.abd4527	http://dx.doi.org/10.1126/science.abd4527			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732412				2022-12-28	WOS:000556568100027
J	Ma, LL				Ma, Lala			Mapping the clean air haves and have-nots	SCIENCE			English	Editorial Material							ENVIRONMENTAL JUSTICE; DISPARITIES; ECONOMICS; PLACE		[Ma, Lala] Univ Kentucky, Dept Econ, Lexington, KY 40506 USA	University of Kentucky	Ma, LL (corresponding author), Univ Kentucky, Dept Econ, Lexington, KY 40506 USA.	lala.ma@uky.edu	Ma, Lala/AAP-3540-2021					Anguelovski I, 2019, P NATL ACAD SCI USA, V116, P26139, DOI 10.1073/pnas.1920490117; Banzhaf HS, 2013, J URBAN ECON, V74, P83, DOI 10.1016/j.jue.2012.09.006; Banzhaf S, 2019, J ECON PERSPECT, V33, P185, DOI 10.1257/jep.33.1.185; Cole Luke, 2001, GROUND ENV RACISM RI; Colmer J, 2020, SCIENCE, V369, P575, DOI 10.1126/science.aaz9353; Commission for Racial Justice,United Church of Christ, 1987, TECHNICAL REPORT; Currie J, 2011, AM ECON REV, V101, P1, DOI 10.1257/aer.101.3.1; Cutter S.L.L., 2012, HAZARDS VULNERABILIT; Depro B, 2015, J ASSOC ENVIRON RESO, V2, P439, DOI 10.1086/682716; Meng J, 2019, ENVIRON SCI TECHNOL, V53, P5071, DOI 10.1021/acs.est.8b06875; Messer KD, 2006, ENVIRON RESOUR ECON, V33, P299, DOI 10.1007/s10640-005-3609-x; Mohai P, 2006, DEMOGRAPHY, V43, P383, DOI 10.1353/dem.2006.0017; Robinson LA, 2016, REV ENV ECON POLICY, V10, P308, DOI 10.1093/reep/rew011; U.S. Government Accountability Office (GAO), 1983, RCED83168 GAO	14	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					503	504		10.1126/science.abb0943	http://dx.doi.org/10.1126/science.abb0943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV7YK	32732408				2022-12-28	WOS:000556568100023
J	Kannan, B; Ruckriegel, MJ; Campbell, DL; Kockum, AF; Braumuller, J; Kim, DK; Kjaergaard, M; Krantz, P; Melville, A; Niedzielski, BM; Vepsalainen, A; Winik, R; Yoder, JL; Nori, F; Orlando, TP; Gustavsson, S; Oliver, WD				Kannan, Bharath; Ruckriegel, Max J.; Campbell, Daniel L.; Frisk Kockum, Anton; Braumuller, Jochen; Kim, David K.; Kjaergaard, Morten; Krantz, Philip; Melville, Alexander; Niedzielski, Bethany M.; Vepsalainen, Antti; Winik, Roni; Yoder, Jonilyn L.; Nori, Franco; Orlando, Terry P.; Gustavsson, Simon; Oliver, William D.			Waveguide quantum electrodynamics with superconducting artificial giant atoms	NATURE			English	Article								Models of light-matter interactions in quantum electrodynamics typically invoke the dipole approximation(1,2), in which atoms are treated as point-like objects when compared to the wavelength of the electromagnetic modes with which they interact. However, when the ratio between the size of the atom and the mode wavelength is increased, the dipole approximation no longer holds and the atom is referred to as a 'giant atom'(2,3). So far, experimental studies with solid-state devices in the giant-atom regime have been limited to superconducting qubits that couple to short-wavelength surface acoustic waves(4-10), probing the properties of the atom at only a single frequency. Here we use an alternative architecture that realizes a giant atom by coupling small atoms to a waveguide at multiple, but well separated, discrete locations. This system enables tunable atom-waveguide couplings with large on-off ratios(3)and a coupling spectrum that can be engineered by the design of the device. We also demonstrate decoherence-free interactions between multiple giant atoms that are mediated by the quasi-continuous spectrum of modes in the waveguide-an effect that is not achievable using small atoms(11). These features allow qubits in this architecture to switch between protected and emissive configurations in situ while retaining qubit-qubit interactions, opening up possibilities for high-fidelity quantum simulations and non-classical itinerant photon generation(12,13). Superconducting giant atoms are realized in a waveguide by coupling small atoms to the waveguide at multiple discrete locations, producing tunable atom-waveguide coupling and enabling decoherence-free interactions.	[Kannan, Bharath; Ruckriegel, Max J.; Campbell, Daniel L.; Braumuller, Jochen; Kjaergaard, Morten; Krantz, Philip; Vepsalainen, Antti; Winik, Roni; Orlando, Terry P.; Gustavsson, Simon; Oliver, William D.] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Kannan, Bharath; Orlando, Terry P.; Oliver, William D.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Frisk Kockum, Anton; Krantz, Philip] Chalmers Univ Technol, Dept Microtechnol & Nanosci, Wallenberg Ctr Quantum Technol, Gothenburg, Sweden; [Kim, David K.; Melville, Alexander; Niedzielski, Bethany M.; Yoder, Jonilyn L.; Oliver, William D.] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA; [Nori, Franco] RIKEN Cluster Pioneering Res, Theoret Quantum Phys Lab, Wako, Saitama, Japan; [Nori, Franco] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Oliver, William D.] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Chalmers University of Technology; Lincoln Laboratory; Massachusetts Institute of Technology (MIT); RIKEN; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Kannan, B; Oliver, WD (corresponding author), MIT, Res Lab Elect, Cambridge, MA 02139 USA.; Kannan, B; Oliver, WD (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Oliver, WD (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA.; Oliver, WD (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	bkannan@mit.edu; william.oliver@mit.edu	Gustavsson, Simon/B-5391-2012; Kockum, Anton Frisk/E-8255-2014; Krantz, Philip/Q-3701-2016	Gustavsson, Simon/0000-0002-7069-1025; Kockum, Anton Frisk/0000-0002-2534-3021; , Alexander Melville/0000-0003-1158-9036; Krantz, Philip/0000-0002-8553-3353; Ruckriegel, Max/0000-0002-4776-699X; Kannan, Bharath/0000-0001-8181-6746				Andersson G, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.240402; Andersson G, 2019, NAT PHYS, V15, P1123, DOI 10.1038/s41567-019-0605-6; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bolgar AN, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.223603; Campbell ET, 2018, NATURE, V559, pE6, DOI 10.1038/s41586-018-0116-0; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Forn-Diaz P, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.054015; Gonzalez-Tudela A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.163603; Gu X, 2017, PHYS REP, V718, P1, DOI 10.1016/j.physrep.2017.10.002; Gustafsson MV, 2014, SCIENCE, V346, P207, DOI 10.1126/science.1257219; Hoi IC, 2015, NAT PHYS, V11, P1045, DOI [10.1038/nphys3484, 10.1038/NPHYS3484]; Hoi IC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025011; Hoi IC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.073601; Kannan B., 2020, GENERATING SPATIALLY; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kjaergaard M, 2020, ANNU REV CONDEN MA P, V11, P369, DOI 10.1146/annurev-conmatphys-031119-050605; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kockum A. F., 2020, INT S MATH QUANT THE, DOI [10.1007/978-981-15-5191-8, DOI 10.1007/978-981-15-5191-8]; Kockum AF, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.140404; Kockum AF, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013837; Lalumiere K, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043806; Lamata L, 2018, ADV PHYS-X, V3, P1, DOI 10.1080/23746149.2018.1457981; Lu Y., 2019, CHARACTERIZING DECOH; Macklin C, 2015, SCIENCE, V350, P307, DOI 10.1126/science.aaa8525; Manenti R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01063-9; Mirhosseini M, 2019, NATURE, V569, P692, DOI 10.1038/s41586-019-1196-1; Moores BA, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.227701; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; Roy D, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.021001; Sletten LR, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021056; Vadiraj A. M., 2020, ENG LEVEL STRUCTURE; van Loo AF, 2013, SCIENCE, V342, P1494, DOI 10.1126/science.1244324; Walls D. F., 2008, J QUANTUM OPTICS; Wen PY, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.233602	38	71	71	14	128	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					775	+		10.1038/s41586-020-2529-9	http://dx.doi.org/10.1038/s41586-020-2529-9			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728243	Green Submitted			2022-12-28	WOS:000554831500030
J	Lei, YS; Chen, YM; Zhang, RQ; Li, YH; Yan, QZ; Lee, S; Yu, YG; Tsai, HH; Choi, W; Wang, KP; Luo, YQ; Gu, Y; Zheng, XR; Wang, CF; Wang, CH; Hu, HJ; Li, Y; Qi, BY; Lin, MY; Zhang, ZR; Dayeh, SA; Pharr, M; Fenning, DP; Lo, YH; Luo, J; Yang, KS; Yoo, J; Nie, WY; Xu, S				Lei, Yusheng; Chen, Yimu; Zhang, Ruiqi; Li, Yuheng; Yan, Qizhang; Lee, Seunghyun; Yu, Yugang; Tsai, Hsinhan; Choi, Woojin; Wang, Kaiping; Luo, Yanqi; Gu, Yue; Zheng, Xinran; Wang, Chunfeng; Wang, Chonghe; Hu, Hongjie; Li, Yang; Qi, Baiyan; Lin, Muyang; Zhang, Zhuorui; Dayeh, Shadi A.; Pharr, Matt; Fenning, David P.; Lo, Yu-Hwa; Luo, Jian; Yang, Kesong; Yoo, Jinkyoung; Nie, Wanyi; Xu, Sheng			A fabrication process for flexible single-crystal perovskite devices	NATURE			English	Article							SOLAR-CELLS; EFFICIENCY	A solution-based lithography-assisted epitaxial-growth-and-transfer method is used to fabricate single-crystal hybrid perovskites on any surface, with precise control of the thickness, area and chemical composition gradient. Organic-inorganic hybrid perovskites have electronic and optoelectronic properties that make them appealing in many device applications(1-4). Although many approaches focus on polycrystalline materials(5-7), single-crystal hybrid perovskites show improved carrier transport and enhanced stability over their polycrystalline counterparts, due to their orientation-dependent transport behaviour(8-10)and lower defect concentrations(11,12). However, the fabrication of single-crystal hybrid perovskites, and controlling their morphology and composition, are challenging(12). Here we report a solution-based lithography-assisted epitaxial-growth-and-transfer method for fabricating single-crystal hybrid perovskites on arbitrary substrates, with precise control of their thickness (from about 600 nanometres to about 100 micrometres), area (continuous thin films up to about 5.5 centimetres by 5.5 centimetres), and composition gradient in the thickness direction (for example, from methylammonium lead iodide, MAPbI(3), to MAPb(0.5)Sn(0.5)I(3)). The transferred single-crystal hybrid perovskites are of comparable quality to those directly grown on epitaxial substrates, and are mechanically flexible depending on the thickness. Lead-tin gradient alloying allows the formation of a graded electronic bandgap, which increases the carrier mobility and impedes carrier recombination. Devices based on these single-crystal hybrid perovskites show not only high stability against various degradation factors but also good performance (for example, solar cells based on lead-tin-gradient structures with an average efficiency of 18.77 per cent).	[Lei, Yusheng; Chen, Yimu; Zhang, Ruiqi; Li, Yuheng; Yan, Qizhang; Luo, Yanqi; Wang, Chonghe; Hu, Hongjie; Li, Yang; Lin, Muyang; Zhang, Zhuorui; Dayeh, Shadi A.; Fenning, David P.; Luo, Jian; Yang, Kesong; Xu, Sheng] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Lee, Seunghyun; Pharr, Matt] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Yu, Yugang; Wang, Kaiping; Gu, Yue; Qi, Baiyan; Dayeh, Shadi A.; Lo, Yu-Hwa; Luo, Jian; Xu, Sheng] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Tsai, Hsinhan; Yoo, Jinkyoung; Nie, Wanyi] Los Alamos Natl Lab, Los Alamos, NM USA; [Choi, Woojin; Dayeh, Shadi A.; Lo, Yu-Hwa; Xu, Sheng] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Zheng, Xinran] Tsinghua Univ, Dept Phys, Beijing, Peoples R China; [Wang, Chunfeng] Shenzhen Univ, Coll Phys & Optoelect Engn, Shenzhen, Guangdong, Peoples R China; [Xu, Sheng] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego; Tsinghua University; Shenzhen University; University of California System; University of California San Diego	Xu, S (corresponding author), Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.; Xu, S (corresponding author), Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA.; Xu, S (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.; Xu, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	shengxu@ucsd.edu	Wang, Chonghe/ABH-4984-2020; Li, Yang/GWM-7879-2022; wang, kaiping/AAU-7201-2021; Yan, Qizhang/AAC-5435-2022; Gu, Yue/AAY-5643-2021; Luo, jian/HGE-7331-2022; Yoo, Jinkyoung/B-5291-2008; Yang, Kesong/U-2240-2019; li, yong/HDN-3885-2022; Wang, Chonghe/ABG-4491-2021; Li, Yuheng/AAE-1241-2019; Li, Yuan/GXV-1310-2022; Luo, Jian/A-4777-2008; wang, kaiping/AGH-9889-2022; Pharr, Matt/G-3919-2010	Wang, Chonghe/0000-0002-1083-2666; Gu, Yue/0000-0003-0437-5339; Yoo, Jinkyoung/0000-0002-9578-6979; Yang, Kesong/0000-0002-9691-0636; Li, Yuheng/0000-0002-1865-1122; Luo, Jian/0000-0002-5424-0216; wang, kaiping/0000-0003-2524-8347; Pharr, Matt/0000-0001-8738-5393; Dayeh, Shadi/0000-0002-1756-1774; Yan, Qizhang/0000-0002-3798-642X				Ahn N, 2015, J AM CHEM SOC, V137, P8696, DOI 10.1021/jacs.5b04930; Bokdam M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28618; Chen M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07951-y; Chen YM, 2020, NATURE, V577, P209, DOI 10.1038/s41586-019-1868-x; Chen ZL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02039-5; Ciric L, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5023115; Domanski K, 2018, NAT ENERGY, V3, P61, DOI 10.1038/s41560-017-0060-5; Dullweber T, 2001, SOL ENERG MAT SOL C, V67, P145, DOI 10.1016/S0927-0248(00)00274-9; Feng JG, 2018, NAT ELECTRON, V1, P404, DOI 10.1038/s41928-018-0101-5; Gong XW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09538-7; HUTCHBY JA, 1976, J APPL PHYS, V47, P3140, DOI 10.1063/1.323108; Jiang Q, 2019, NAT PHOTONICS, V13, P500, DOI 10.1038/s41566-019-0462-y; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Ke WJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08918-3; Leblebici SY, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.93, 10.1038/nenergy.2016.93]; Lee L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15882; Lei YS, 2018, ADV MATER, V30, DOI 10.1002/adma.201705992; Lin KB, 2018, NATURE, V562, P245, DOI 10.1038/s41586-018-0575-3; Liu MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3278; Liu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06317-8; National Renewable Energy Laboratory, 2020, BEST RES CELL EFF CH; Noel NK, 2014, ENERG ENVIRON SCI, V7, P3061, DOI 10.1039/c4ee01076k; Ono LK, 2018, JOULE, V2, P1961, DOI 10.1016/j.joule.2018.07.007; Richter JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13941; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911; Tsai HH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04430-2; Tsai H, 2018, SCIENCE, V360, P67, DOI 10.1126/science.aap8671; Wang CF, 2018, ADV MATER, V30, DOI 10.1002/adma.201801368; Wang Q, 2014, ENERG ENVIRON SCI, V7, P2359, DOI 10.1039/c4ee00233d; Wang SH, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.195; Yang WS, 2017, SCIENCE, V356, P1376, DOI 10.1126/science.aan2301; Yun JS, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201705363; Zhang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10030; Zhao PJ, 2018, ADV MATER, V30, DOI 10.1002/adma.201802763; Zheng GHJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05076-w; Zou W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03049-7	36	168	170	111	692	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					790	+		10.1038/s41586-020-2526-z	http://dx.doi.org/10.1038/s41586-020-2526-z			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728239				2022-12-28	WOS:000554831500033
J	Moore, JE; Purcaro, MJ; Pratt, HE; Epstein, CB; Shoresh, N; Adrian, J; Kawli, T; Davis, CA; Dobin, A; Kaul, R; Halow, J; Van Nostrand, EL; Freese, P; Gorkin, DU; Shen, Y; He, YP; Mackiewicz, M; Pauli-Behn, F; Williams, BA; Mortazavi, A; Keller, CA; Zhang, XO; Elhajjajy, SI; Huey, J; Dickel, DE; Snetkova, V; Wei, XT; Wang, XF; Rivera-Mulia, JC; Rozowsky, J; Zhang, J; Chhetri, SB; Zhang, JL; Victorsen, A; White, KP; Visel, A; Yeo, GEW; Burge, CB; Lecuyer, E; Gilbert, DM; Dekker, J; Rinn, J; Mendenhall, EM; Ecker, JR; Kellis, M; Klein, RJ; Noble, WS; Kundaje, A; Guigo, R; Farnham, PJ; Cherry, JM; Myers, RM; Ren, B; Graveley, BR; Gerstein, MB; Pennacchio, LA; Snyder, MP; Bernstein, BE; Wold, B; Hardison, RC; Gingeras, TR; Stamatoyannopoulos, JA; Weng, ZP				Moore, Jill E.; Purcaro, Michael J.; Pratt, Henry E.; Epstein, Charles B.; Shoresh, Noam; Adrian, Jessika; Kawli, Trupti; Davis, Carrie A.; Dobin, Alexander; Kaul, Rajinder; Halow, Jessica; Van Nostrand, Eric L.; Freese, Peter; Gorkin, David U.; Shen, Yin; He, Yupeng; Mackiewicz, Mark; Pauli-Behn, Florencia; Williams, Brian A.; Mortazavi, Ali; Keller, Cheryl A.; Zhang, Xiao-Ou; Elhajjajy, Shaimae I.; Huey, Jack; Dickel, Diane E.; Snetkova, Valentina; Wei, Xintao; Wang, Xiaofeng; Rivera-Mulia, Juan Carlos; Rozowsky, Joel; Zhang, Jing; Chhetri, Surya B.; Zhang, Jialing; Victorsen, Alec; White, Kevin P.; Visel, Axel; Yeo, Gene W.; Burge, Christopher B.; Lecuyer, Eric; Gilbert, David M.; Dekker, Job; Rinn, John; Mendenhall, Eric M.; Ecker, Joseph R.; Kellis, Manolis; Klein, Robert J.; Noble, William S.; Kundaje, Anshul; Guigo, Roderic; Farnham, Peggy J.; Cherry, J. Michael; Myers, Richard M.; Ren, Bing; Graveley, Brenton R.; Gerstein, Mark B.; Pennacchio, Len A.; Snyder, Michael P.; Bernstein, Bradley E.; Wold, Barbara; Hardison, Ross C.; Gingeras, Thomas R.; Stamatoyannopoulos, John A.; Weng, Zhiping		ENCODE Project Consortium	Expanded encyclopaedias of DNA elements in the human and mouse genomes	NATURE			English	Article							CHROMATIN-STRUCTURE; GENE-EXPRESSION; TRANSCRIPTION; PRINCIPLES; LANDSCAPE; SEQUENCE; ENCODE; IDENTIFICATION; ENHANCERS; DYNAMICS	The authors summarize the data produced by phase III of the Encyclopedia of DNA Elements (ENCODE) project, a resource for better understanding of the human and mouse genomes. The human and mouse genomes contain instructions that specify RNAs and proteins and govern the timing, magnitude, and cellular context of their production. To better delineate these elements, phase III of the Encyclopedia of DNA Elements (ENCODE) Project has expanded analysis of the cell and tissue repertoires of RNA transcription, chromatin structure and modification, DNA methylation, chromatin looping, and occupancy by transcription factors and RNA-binding proteins. Here we summarize these efforts, which have produced 5,992 new experimental datasets, including systematic determinations across mouse fetal development. All data are available through the ENCODE data portal (), including phase II ENCODE(1)and Roadmap Epigenomics(2)data. We have developed a registry of 926,535 human and 339,815 mouse candidatecis-regulatory elements, covering 7.9 and 3.4% of their respective genomes, by integrating selected datatypes associated with gene regulation, and constructed a web-based server (SCREEN;) to provide flexible, user-defined access to this resource. Collectively, the ENCODE data and registry provide an expansive resource for the scientific community to build a better understanding of the organization and function of the human and mouse genomes.	[Moore, Jill E.; Purcaro, Michael J.; Pratt, Henry E.; Zhang, Xiao-Ou; Elhajjajy, Shaimae I.; Huey, Jack; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Epstein, Charles B.; Shoresh, Noam; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Adrian, Jessika; Kawli, Trupti; Kundaje, Anshul; Cherry, J. Michael; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; [Davis, Carrie A.; Dobin, Alexander; Gingeras, Thomas R.] Cold Spring Harbor Lab, Funct Genom, POB 100, Cold Spring Harbor, NY 11724 USA; [Kaul, Rajinder; Halow, Jessica; Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA 98121 USA; [Stamatoyannopoulos, John A.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Van Nostrand, Eric L.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, Sanford Consortium Regenerat Med, Dept Cellular & Mol Med,Stem Cell Program, La Jolla, CA 92093 USA; [Freese, Peter] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gorkin, David U.; Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, Ctr Epigen, La Jolla, CA 92093 USA; [Gorkin, David U.; Shen, Yin; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92103 USA; [Shen, Yin] Univ Calif San Francisco, Dept Neurol, Inst Human Genet, San Francisco, CA 94143 USA; [He, Yupeng; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Mackiewicz, Mark; Pauli-Behn, Florencia; Chhetri, Surya B.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Williams, Brian A.; Wold, Barbara] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Mortazavi, Ali] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Keller, Cheryl A.; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Dickel, Diane E.; Snetkova, Valentina; Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Wei, Xintao; Graveley, Brenton R.] UConn Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA; [Wang, Xiaofeng; Lecuyer, Eric] Univ Montreal, Dept Biochim & Med Mol, Montreal, PQ, Canada; [Wang, Xiaofeng; Lecuyer, Eric] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Wang, Xiaofeng; Lecuyer, Eric] Inst Rech Clin Montreal IRCM, Montreal, PQ, Canada; [Rivera-Mulia, Juan Carlos; Gilbert, David M.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Rivera-Mulia, Juan Carlos] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Rozowsky, Joel; Zhang, Jing; Gerstein, Mark B.] Yale Univ, New Haven, CT 06520 USA; [Chhetri, Surya B.; Mendenhall, Eric M.] Univ Alabama, Biol Sci, Huntsville, AL 35899 USA; [Zhang, Jialing] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Victorsen, Alec] Univ Chicago, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [White, Kevin P.] Tempus Labs, Chicago, IL USA; [Visel, Axel; Pennacchio, Len A.] US DOE, Joint Genome Inst, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA USA; [Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA USA; [Dekker, Job] Univ Massachusetts, Sch Med, HHMI, Worcester, MA USA; [Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA USA; [Rinn, John] Univ Colorado, Boulder, CO 80309 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Klein, Robert J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Noble, William S.] Univ Washington, Sch Med, Dept Genom Sci, Seattle, WA USA; [Guigo, Roderic] Barcelona Inst Sci & Technol, Bioinformat & Genom Program, Ctr Genom Regulat CRG, Barcelona, Spain; [Guigo, Roderic] Univ Pompeu Fabra, Barcelona, Spain; [Farnham, Peggy J.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA; [Snyder, Michael P.] Stanford Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Broad Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02115 USA; [Weng, Zhiping] Tongji Univ, Sch Life Sci & Technol, Dept Thorac Surg, Clin Translat Res Ctr,Shanghai Pulm Hosp, Shanghai, Peoples R China; [Weng, Zhiping] Boston Univ, Bioinformat Program, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Cold Spring Harbor Laboratory; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Francisco; Salk Institute; HudsonAlpha Institute for Biotechnology; California Institute of Technology; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Universite de Montreal; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; State University System of Florida; Florida State University; University of Minnesota System; University of Minnesota Twin Cities; Yale University; University of Alabama System; University of Alabama Huntsville; Yale University; University of Chicago; United States Department of Energy (DOE); Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California Merced; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; Salk Institute; Massachusetts Institute of Technology (MIT); Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Southern California; University of California System; University of California Berkeley; Stanford University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tongji University; Boston University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.; Cherry, JM; Snyder, MP (corresponding author), Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA.; Gingeras, TR (corresponding author), Cold Spring Harbor Lab, Funct Genom, POB 100, Cold Spring Harbor, NY 11724 USA.; Stamatoyannopoulos, JA (corresponding author), Altius Inst Biomed Sci, Seattle, WA 98121 USA.; Stamatoyannopoulos, JA (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.; Ren, B (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ctr Epigen, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92103 USA.; Myers, RM (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.; Wold, B (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Hardison, RC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Pennacchio, LA (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.; Graveley, BR (corresponding author), UConn Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA.; Gerstein, MB (corresponding author), Yale Univ, New Haven, CT 06520 USA.; Pennacchio, LA (corresponding author), US DOE, Joint Genome Inst, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.; Pennacchio, LA (corresponding author), Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA.; Snyder, MP (corresponding author), Stanford Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Broad Inst, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Weng, ZP (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Thorac Surg, Clin Translat Res Ctr,Shanghai Pulm Hosp, Shanghai, Peoples R China.; Weng, ZP (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	cherry@stanford.edu; rmyers@hudsonalpha.org; biren@ucsd.edu; graveley@uchc.edu; mark@gersteinlab.org; lapennacchio@lbl.gov; mpsnyder@stanford.edu; Bernstein.Bradley@mgh.harvard.edu; woldb@caltech.edu; rch8@psu.edu; gingeras@cshl.edu; jstam@altius.org; zhiping.weng@umassmed.edu	Barozzi, Iros/GLQ-8907-2022; Halow, Jessica/GQO-7562-2022; Kellis, Manolis/ABE-7385-2020; Uszczynska-Ratajczak, Barbara/G-9814-2015; Chen, Jia-Yu/J-6798-2013; Hardison, Ross C/G-1142-2010; Guigo, Roderic/D-1303-2010; He, Peng/AAT-3673-2021; Chen, Hao/AAN-4948-2021; Lagarde, Julien/AAI-1686-2020; Ecker, Joseph R/B-9144-2008; Savic, Daniel/N-5525-2018; Klein, Robert/ABI-7857-2020; Visel, Axel/A-9398-2009; Qin, Qian/AAI-7894-2020; Boyle, Alan/I-1848-2014; Yeo, Gene/AAE-7676-2019; Johnson, Rory/ABE-2503-2021; Rodriguez, Jose/AAS-4147-2021; Liu, Yaping/A-8601-2018; Zang, Chongzhi/D-1445-2011; Hubbard, Tim @timjph/C-2567-2008; Zhang, Xiao-Ou/J-6229-2014	Barozzi, Iros/0000-0003-0690-3473; Kellis, Manolis/0000-0001-7113-9630; Uszczynska-Ratajczak, Barbara/0000-0003-0150-3841; Chen, Jia-Yu/0000-0001-9449-9321; Hardison, Ross C/0000-0003-4084-7516; Guigo, Roderic/0000-0002-5738-4477; He, Peng/0000-0002-2457-3554; Lagarde, Julien/0000-0002-0290-7445; Ecker, Joseph R/0000-0001-5799-5895; Savic, Daniel/0000-0002-6693-0265; Klein, Robert/0000-0003-3539-5391; Visel, Axel/0000-0002-4130-7784; Qin, Qian/0000-0002-2119-6263; Boyle, Alan/0000-0002-2081-1105; Yeo, Gene/0000-0002-0799-6037; Johnson, Rory/0000-0003-4607-2782; Rodriguez, Jose/0000-0002-9948-5073; Schlaffner, Christoph/0000-0003-2717-3406; Ren, Bing/0000-0002-5435-1127; Liu, Yaping/0000-0003-4165-7693; Frankish, Adam/0000-0002-4333-628X; Cherry, J. Michael/0000-0001-9163-5180; Kundaje, Anshul/0000-0003-3084-2287; Purcaro, Michael/0000-0002-4735-4215; Izuogu, Osagie/0000-0003-3116-2558; Whitaker, John W./0000-0002-0585-9119; Tsuji, Junko/0000-0003-0139-3750; Barrell, Daniel/0000-0002-0977-0963; Victorsen, Alec/0000-0003-2326-0916; Dobin, Alexander/0000-0002-4115-9128; Zang, Chongzhi/0000-0003-4812-3627; Rivera-Mulia, Juan Carlos/0000-0002-7566-3875; Hubbard, Tim @timjph/0000-0002-1767-9318; Pagan, Michael/0000-0002-7638-531X; Chan, Esther/0000-0002-2406-2623; Tress, Michael/0000-0001-9046-6370; Chee, Sora/0000-0003-2687-7786; Mendenhall, Eric/0000-0002-7395-6295; Pratt, Henry/0000-0001-9413-834X; Beer, Michael A/0000-0001-9955-3809; Reimonn, Thomas/0000-0002-5129-7989; Yee, Brian/0000-0001-5615-8550; Nelson, Jemma/0000-0003-2846-2007; Shen, Quan/0000-0001-9041-8475; Pennacchio, Len/0000-0002-8748-3732; Sundararaman, Balaji/0000-0001-8559-1660; Liu, Jason/0000-0001-7197-7319; Bennett, Esther Ruth/0000-0002-9009-4607; Lee, Donghoon/0000-0003-0453-6059; Garcia Giron, Carlos/0000-0002-0935-7271; Epstein, Charles B./0000-0001-8358-8345; Zhang, Qi/0000-0001-6197-0973; Pan, Xinghua (Victor)/0000-0002-7421-8155; Snyder, Michael/0000-0003-0784-7987; Yu, Tianxiong/0000-0003-1151-4624; Martin, Fergal/0000-0002-1672-050X; Blue, Steven/0000-0003-0279-6690; Kaul, Rajinder/0000-0002-7895-9284; Zhang, Xiao-Ou/0000-0002-2027-1313; Zhou, Xiao-Qiao/0000-0002-0724-5153; Dickel, Diane/0000-0001-5497-6824; Sisu, Cristina/0000-0001-9371-0797; Moore, Jill/0000-0002-3023-0806; DANYKO, CASSIDY/0000-0001-7803-783X; Xiao, Rui/0000-0002-9477-1054	BBSRC [BB/I025360/1] Funding Source: UKRI; NCI NIH HHS [P30 CA045508, P30 CA008748, P30 CA014195] Funding Source: Medline; NHGRI NIH HHS [U54 HG006994, U01 HG007019, U54 HG006997, U54 HG007010, U41 HG007000, U24 HG009397, U54 HG006991, F32 HG006993, U01 HG007036, UM1 HG009390, T32 HG000044, U41 HG006992, U54 HG007002, U54 HG007005, U01 HG007037, R01 HG003143, U01 HG009431, U54 HG006996, U01 HG007033, U54 HG007004, U54 HG006998, UM1 HG009442, U24 HG009446] Funding Source: Medline; NIDDK NIH HHS [R24 DK106766, R01 DK068634, R37 DK050107] Funding Source: Medline; NIGMS NIH HHS [R01 GM083337, T32 GM087237] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Breeze C. E., 2020, BIORXIV, V2020, DOI [10.1101/2020.06.26.172718, DOI 10.1101/2020.06.26.172718]; Breschi A., GENOME RES; Breschi A, 2017, NAT REV GENET, V18, P425, DOI 10.1038/nrg.2017.19; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cai SF, 2015, MOL CELL, V60, P561, DOI 10.1016/j.molcel.2015.10.042; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2018, NAT GENET, V50, P1388, DOI 10.1038/s41588-018-0195-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gorkin DU, 2020, NATURE, V583, P744, DOI 10.1038/s41586-020-2093-3; Grubert F, 2020, NATURE, V583, P737, DOI 10.1038/s41586-020-2151-x; He P, 2020, NATURE, V583, P760, DOI 10.1038/s41586-020-2536-x; He YP, 2020, NATURE, V583, P752, DOI 10.1038/s41586-020-2119-x; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langdon WB, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-014-0034-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meuleman W, 2020, NATURE, V584, P244, DOI 10.1038/s41586-020-2559-3; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Partridge EC, 2020, NATURE, V583, P720, DOI 10.1038/s41586-020-2023-4; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rahmanian S, 2019, GENOME RES, V29, P1900, DOI 10.1101/gr.248997.119; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivera-Mulia JC, 2019, GENOME RES, V29, P1415, DOI 10.1101/gr.247049.118; Rivera-Mulia JC, 2016, CURR OPIN CELL BIOL, V40, P168, DOI 10.1016/j.ceb.2016.03.022; Rivera-Mulia JC, 2015, GENOME RES, V25, P1091, DOI 10.1101/gr.187989.114; Sethi A, 2020, NAT METHODS, V17, P807, DOI 10.1038/s41592-020-0907-8; Shendure J, 2019, CELL, V177, P45, DOI 10.1016/j.cell.2019.02.003; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Snyder MP, 2020, NATURE, V583, P693, DOI 10.1038/s41586-020-2449-8; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Arensbergen J, 2017, NAT BIOTECHNOL, V35, P145, DOI 10.1038/nbt.3754; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vierstra J, 2020, NATURE, V583, P729, DOI 10.1038/s41586-020-2528-x; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xiang GJ, 2020, GENOME RES, V30, P472, DOI 10.1101/gr.255760.119; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14743-w; Zhang XO, 2019, GENOME RES, V29, P1402, DOI 10.1101/gr.249789.119; Zhang Y, 2016, NUCLEIC ACIDS RES, V44, P6721, DOI 10.1093/nar/gkw278	69	435	438	32	76	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					699	+		10.1038/s41586-020-2493-4	http://dx.doi.org/10.1038/s41586-020-2493-4			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728249	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000554831500020
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Trump is criticised for again promoting unorthodox medical information	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Andrews TM, 2020, WASHINGTON POST; [Anonymous], CNN; [Anonymous], 2020, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.M2263; Basen R, 2020, EVIDENCE DOCTOR GROU; Tanne JH, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2989	5	2	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2020	370								370:m3046	10.1136/bmj.m3046	http://dx.doi.org/10.1136/bmj.m3046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV1RG	32732320	Bronze			2022-12-28	WOS:000556139900001
J	Vierstra, J; Lazar, J; Sandstrom, R; Halow, J; Lee, K; Bates, D; Diegel, M; Dunn, D; Neri, F; Haugen, E; Rynes, E; Reynolds, A; Nelson, J; Johnson, A; Frerker, M; Buckley, M; Kaul, R; Meuleman, W; Stamatoyannopoulos, JA				Vierstra, Jeff; Lazar, John; Sandstrom, Richard; Halow, Jessica; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Dunn, Douglas; Neri, Fidencio; Haugen, Eric; Rynes, Eric; Reynolds, Alex; Nelson, Jemma; Johnson, Audra; Frerker, Mark; Buckley, Michael; Kaul, Rajinder; Meuleman, Wouter; Stamatoyannopoulos, John A.			Global reference mapping of human transcription factor footprints	NATURE			English	Article							FACTOR-BINDING SITES; DNA SHAPE; SCALE; CONSERVATION; CIRCUITRY; DYNAMICS; REVEALS; REGIONS; REPAIR; MOUSE	A high-density DNase I cleavage map from 243 human cell and tissue types provides a genome-wide, nucleotide-resolution map of human transcription factor footprints. Combinatorial binding of transcription factors to regulatory DNA underpins gene regulation in all organisms. Genetic variation in regulatory regions has been connected with diseases and diverse phenotypic traits(1), but it remains challenging to distinguish variants that affect regulatory function(2). Genomic DNase I footprinting enables the quantitative, nucleotide-resolution delineation of sites of transcription factor occupancy within native chromatin(3-6). However, only a small fraction of such sites have been precisely resolved on the human genome sequence(6). Here, to enable comprehensive mapping of transcription factor footprints, we produced high-density DNase I cleavage maps from 243 human cell and tissue types and states and integrated these data to delineate about 4.5 million compact genomic elements that encode transcription factor occupancy at nucleotide resolution. We map the fine-scale structure within about 1.6 million DNase I-hypersensitive sites and show that the overwhelming majority are populated by well-spaced sites of single transcription factor-DNA interaction. Cell-context-dependentcis-regulation is chiefly executed by wholesale modulation of accessibility at regulatory DNA rather than by differential transcription factor occupancy within accessible elements. We also show that the enrichment of genetic variants associated with diseases or phenotypic traits in regulatory regions(1,7)is almost entirely attributable to variants within footprints, and that functional variants that affect transcription factor occupancy are nearly evenly partitioned between loss- and gain-of-function alleles. Unexpectedly, we find increased density of human genetic variation within transcription factor footprints, revealing an unappreciated driver ofcis-regulatory evolution. Our results provide a framework for both global and nucleotide-precision analyses of gene regulatory mechanisms and functional genetic variation.	[Vierstra, Jeff; Lazar, John; Sandstrom, Richard; Halow, Jessica; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Dunn, Douglas; Neri, Fidencio; Haugen, Eric; Rynes, Eric; Reynolds, Alex; Nelson, Jemma; Johnson, Audra; Frerker, Mark; Buckley, Michael; Kaul, Rajinder; Meuleman, Wouter; Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA 98121 USA; [Lazar, John; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Vierstra, J; Stamatoyannopoulos, JA (corresponding author), Altius Inst Biomed Sci, Seattle, WA 98121 USA.; Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA.	jvierstra@altius.org; jstam@altius.org	Halow, Jessica/GQO-7562-2022	Lazar, John/0000-0002-3142-1858; Vierstra, Jeff/0000-0001-6406-8563; Nelson, Jemma/0000-0003-2846-2007; Kaul, Rajinder/0000-0002-7895-9284	NHGRI NIH HHS [U54 HG007010, UM1 HG009444, R35 HG011317] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aggarwala V, 2016, NAT GENET, V48, P349, DOI 10.1038/ng.3511; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arnold R, 1996, NUCLEIC ACIDS RES, V24, P2640, DOI 10.1093/nar/24.14.2640; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Carlson J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05936-5; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; He XM, 2015, GENOME BIOL EVOL, V7, P3155, DOI 10.1093/gbe/evv205; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Lusk RW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000829; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meuleman W, 2020, NATURE, V584, P244, DOI 10.1038/s41586-020-2559-3; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Rastegar S, 2008, DEV BIOL, V318, P366, DOI 10.1016/j.ydbio.2008.03.034; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; SVAREN J, 1994, J BIOL CHEM, V269, P9335; Taliun D., 2019, PREPRINT, DOI [10.1101/563866v1, DOI 10.1101/563866V1]; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Vierstra J, 2016, NAT METHODS, V13, P213, DOI 10.1038/nmeth.3768; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yin ML, 2017, CELL RES, V27, P1365, DOI 10.1038/cr.2017.131; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	51	81	81	4	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					729	+		10.1038/s41586-020-2528-x	http://dx.doi.org/10.1038/s41586-020-2528-x			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32728250	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000554831500023
J	Saitz, R; Schwitzer, G				Saitz, Richard; Schwitzer, Gary			Communicating Science in the Time of a Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint uses the example of rapid changes to public reporting on the efficacy of hydroxychloroquine and remdesivir for COVID-19 to illustrate how misinformation damages the public's trust in science and medicine, and urges accuracy and circumspection in news reports of developments in the pandemic.	[Saitz, Richard] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, 801 Massachusetts Ave,Fourth Floor, Boston, MA 02118 USA; [Saitz, Richard] Boston Univ, Sch Med, Clin Addict Res & Educ Unit, Sect Gen Internal Med,Boston Med Ctr,Grayken Ctr, Boston, MA USA; [Schwitzer, Gary] HealthNewsRevieworg, Minneapolis, MN USA; [Schwitzer, Gary] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Boston University; Boston Medical Center; Boston University; University of Minnesota System; University of Minnesota Twin Cities	Saitz, R (corresponding author), Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, 801 Massachusetts Ave,Fourth Floor, Boston, MA 02118 USA.	Richard.Saitz@jamanetwork.org						[Anonymous], 2020, LOW COST DEXAMETHASO; [Anonymous], 2020, NIH CLIN TRIAL SHOWS; Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099; Beigel JH, 2020, N ENGL J MED; Boulware DR, 2020, N ENGL J MED; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; WHO, WHO WELCOMES PRELIMI	9	36	36	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					443	444		10.1001/jama.2020.12535	http://dx.doi.org/10.1001/jama.2020.12535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749498	Bronze			2022-12-28	WOS:000561261900009
J	Klompas, M; Baker, MA; Rhee, C				Klompas, Michael; Baker, Meghan A.; Rhee, Chanu			Airborne Transmission of SARS-CoV-2 Theoretical Considerations and Available Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses physical and epidemiological evidence supporting droplet vs aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and concludes on balance that aerosol transmission seems unlikely to be the dominant mode of coronavirus disease 2019 (COVID-19) spread.	[Klompas, Michael; Baker, Meghan A.; Rhee, Chanu] Harvard Med Sch, 401 Pk Dr,Ste 401, Boston, MA 02215 USA; [Klompas, Michael; Baker, Meghan A.; Rhee, Chanu] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 401 Pk Dr,Ste 401, Boston, MA 02215 USA; [Klompas, Michael; Baker, Meghan A.; Rhee, Chanu] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital	Klompas, M (corresponding author), Harvard Med Sch, 401 Pk Dr,Ste 401, Boston, MA 02215 USA.; Klompas, M (corresponding author), Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 401 Pk Dr,Ste 401, Boston, MA 02215 USA.	mklompas@bwh.harvard.edu	Rhee, Chanu/AAO-8368-2020					Bartoszko JJ, 2020, INFLUENZA OTHER RESP, V14, P365, DOI 10.1111/irv.12745; Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756; Chen YL, 2020, J APPL LAB MED, V5, P41, DOI 10.1373/jalm.2019.029397; Cheng LL, 2021, JAMA INTERN MED, V181, P71, DOI 10.1001/jamainternmed.2020.5503; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175; Reynolds KA, 2016, ARCH ENVIRON OCCUP H, V71, P157, DOI 10.1080/19338244.2015.1058234; Rosenberg ES, 2020, CLIN INFECT DIS, V71, P1953, DOI 10.1093/cid/ciaa549	10	228	234	5	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					441	442		10.1001/jama.2020.12458	http://dx.doi.org/10.1001/jama.2020.12458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32658248	Bronze			2022-12-28	WOS:000561261900008
J	Kakani, P; Chandra, A; Mullainathan, S; Obermeyer, Z				Kakani, Pragya; Chandra, Amitabh; Mullainathan, Sendhil; Obermeyer, Ziad			Allocation of COVID-19 Relief Funding to Disproportionately Black Counties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level Black population fraction accounting for county COVID-19 burden, comorbidity, and hospital financial health.	[Kakani, Pragya] Harvard Univ, Cambridge, MA 02138 USA; [Chandra, Amitabh] Harvard Sch Business, Harvard John Kennedy Sch Govt, Cambridge, MA USA; [Mullainathan, Sendhil] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Obermeyer, Ziad] Univ Calif Berkeley, Sch Publ Hlth, 2121 Berkeley Way, Berkeley, CA 94704 USA	Harvard University; Harvard University; University of Chicago; University of California System; University of California Berkeley	Obermeyer, Z (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 2121 Berkeley Way, Berkeley, CA 94704 USA.	zobermeyer@berkeley.edu			National Institute on Aging [P01-AG005842, T32-AG000186]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by the National Institute on Aging grants P01-AG005842 (all authors) and T32-AG000186 (Ms Kakani).	Dowling MK, 2020, JAMA-J AM MED ASSOC, V324, P229, DOI 10.1001/jama.2020.10531; Khullar D, 2020, JAMA-J AM MED ASSOC, V323, P2127, DOI 10.1001/jama.2020.6269; Lillie-Blanton M, 2005, HEALTH AFFAIR, V24, P398, DOI 10.1377/hlthaff.24.2.398; Schwartz K., 2020, DISTRIBUTION CARES A; Smedley B. D., 2003, UNEQUAL TREATMENT CO	5	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					1000	1003		10.1001/jama.2020.14978	http://dx.doi.org/10.1001/jama.2020.14978			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32766734	Bronze, Green Published			2022-12-28	WOS:000571867000025
J	Lurie, N; Sharfstein, JM; Goodman, JL				Lurie, Nicole; Sharfstein, Joshua M.; Goodman, Jesse L.			The Development of COVID-19 Vaccines Safeguards Needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint lists 4 safeguards policy makers should consider before release of a COVID-19 vaccine, including ensuring effectiveness through clinical trials, providing evidence of safety, requiring informed consent before vaccination, and establishing comprehensive adverse effects monitoring systems.	[Lurie, Nicole] Harvard Med Sch, Coalit Epidem Preparedness Innovat CEPI, Boston, MA 02115 USA; [Sharfstein, Joshua M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Goodman, Jesse L.] Georgetown Univ, Sch Med, Washington, DC USA	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Lurie, N (corresponding author), Coalit Epidem Preparedness Innovat CEPI, 1900 Penn Ave NW, Washington, DC 20006 USA.	nicole.lurie@cepi.net						[Anonymous], 2020, ASS PRESS; Emanuel EJ, 2020, NY TIMES; Goodman JL, 2020, JAMA-J AM MED ASSOC, V323, P1899, DOI 10.1001/jama.2020.6434; Ison MG, 2020, JAMA-J AM MED ASSOC, V323, P2365, DOI 10.1001/jama.2020.8863; Lambert PH, 2020, VACCINE, V38, P4783, DOI 10.1016/j.vaccine.2020.05.064; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; Weiland Noah, 2020, NEW YORK TIMES; Zhang S, 2020, ATLANTIC	9	37	38	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					439	440		10.1001/jama.2020.12461	http://dx.doi.org/10.1001/jama.2020.12461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32628262	Bronze			2022-12-28	WOS:000561261900007
J	Sommers, BD; Coburn, BE				Sommers, Benjamin D.; Coburn, Brett E.			Prescribing Paid Sick Leave-An Important Tool for Primary Care During the Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Sommers, Benjamin D.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Coburn, Brett E.] Alston & Bird LLP, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	bsommers@hsph.hdivard.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					324	325		10.1001/jama.2020.12209	http://dx.doi.org/10.1001/jama.2020.12209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32720994	Bronze			2022-12-28	WOS:000562851000003
J	Levitt, L				Levitt, Larry			COVID-19 and Massive Job Losses Will Test the US Health Insurance Safety Net	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Levitt, Larry] Henry J Kaiser Family Fdn, 185 Berry St,Ste 2000, San Francisco, CA 94107 USA		Levitt, L (corresponding author), Henry J Kaiser Family Fdn, 185 Berry St,Ste 2000, San Francisco, CA 94107 USA.	larryl@kff.org							0	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					431	432		10.1001/jama.2020.12248	http://dx.doi.org/10.1001/jama.2020.12248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749479	Bronze			2022-12-28	WOS:000561261900003
J	van Doremalen, N; Lambe, T; Spencer, A; Belij-Rammerstorfer, S; Purushotham, JN; Port, JR; Avanzato, VA; Bushmaker, T; Flaxman, A; Ulaszewska, M; Feldmann, F; Allen, ER; Sharpe, H; Schulz, J; Holbrook, M; Okumura, A; Meade-White, K; Perez-Perez, L; Edwards, NJ; Wright, D; Bissett, C; Gilbride, C; Williamson, BN; Rosenke, R; Long, D; Ishwarbhai, A; Kailath, R; Rose, L; Morris, S; Powers, C; Lovaglio, J; Hanley, PW; Scott, D; Saturday, G; de Wit, E; Gilbert, SC; Munster, VJ				van Doremalen, Neeltje; Lambe, Teresa; Spencer, Alexandra; Belij-Rammerstorfer, Sandra; Purushotham, Jyothi N.; Port, Julia R.; Avanzato, Victoria A.; Bushmaker, Trenton; Flaxman, Amy; Ulaszewska, Marta; Feldmann, Friederike; Allen, Elizabeth R.; Sharpe, Hannah; Schulz, Jonathan; Holbrook, Myndi; Okumura, Atsushi; Meade-White, Kimberly; Perez-Perez, Lizzette; Edwards, Nick J.; Wright, Daniel; Bissett, Cameron; Gilbride, Ciaran; Williamson, Brandi N.; Rosenke, Rebecca; Long, Dan; Ishwarbhai, Alka; Kailath, Reshma; Rose, Louisa; Morris, Susan; Powers, Claire; Lovaglio, Jamie; Hanley, Patrick W.; Scott, Dana; Saturday, Greg; de Wit, Emmie; Gilbert, Sarah C.; Munster, Vincent J.			ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; IMMUNIZATION; MICE	The ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 induces an immune response in rhesus macaques and leads to reduced SARS-CoV-2 viral loads in respiratory tissues and an absence of pneumonia, but not to a reduction in nasal virus shedding, compared with unvaccinated animals. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019(1,2)and is responsible for the coronavirus disease 2019 (COVID-19) pandemic(3). Vaccines are an essential countermeasure and are urgently needed to control the pandemic(4). Here we show that the adenovirus-vector-based vaccine ChAdOx1 nCoV-19, which encodes the spike protein of SARS-CoV-2, is immunogenic in mice and elicites a robust humoral and cell-mediated response. This response was predominantly mediated by type-1 T helper cells, as demonstrated by the profiling of the IgG subclass and the expression of cytokines. Vaccination with ChAdOx1 nCoV-19 (using either a prime-only or a prime-boost regimen) induced a balanced humoral and cellular immune response of type-1 and type-2 T helper cells in rhesus macaques. We observed a significantly reduced viral load in the bronchoalveolar lavage fluid and lower respiratory tract tissue of vaccinated rhesus macaques that were challenged with SARS-CoV-2 compared with control animals, and no pneumonia was observed in vaccinated SARS-CoV-2-infected animals. However, there was no difference in nasal shedding between vaccinated and control SARS-CoV-2-infected macaques. Notably, we found no evidence of immune-enhanced disease after viral challenge in vaccinated SARS-CoV-2-infected animals. The safety, immunogenicity and efficacy profiles of ChAdOx1 nCoV-19 against symptomatic PCR-positive COVID-19 disease will now be assessed in randomized controlled clinical trials in humans.	[van Doremalen, Neeltje; Purushotham, Jyothi N.; Port, Julia R.; Avanzato, Victoria A.; Bushmaker, Trenton; Schulz, Jonathan; Holbrook, Myndi; Okumura, Atsushi; Meade-White, Kimberly; Perez-Perez, Lizzette; Williamson, Brandi N.; de Wit, Emmie; Munster, Vincent J.] NIAID, Lab Virol, NIH, Hamilton, MT 59840 USA; [Lambe, Teresa; Spencer, Alexandra; Belij-Rammerstorfer, Sandra; Purushotham, Jyothi N.; Flaxman, Amy; Ulaszewska, Marta; Allen, Elizabeth R.; Sharpe, Hannah; Edwards, Nick J.; Wright, Daniel; Bissett, Cameron; Gilbride, Ciaran; Ishwarbhai, Alka; Kailath, Reshma; Rose, Louisa; Morris, Susan; Powers, Claire; Gilbert, Sarah C.] Univ Oxford, Jenner Inst, Oxford, England; [Feldmann, Friederike; Rosenke, Rebecca; Long, Dan; Lovaglio, Jamie; Hanley, Patrick W.; Scott, Dana; Saturday, Greg] NIAID, Rocky Mt Vet Branch, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Jenner Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Munster, VJ (corresponding author), NIAID, Lab Virol, NIH, Hamilton, MT 59840 USA.; Gilbert, SC (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	sarah.gilbert@ndm.ox.ac.uk; vincent.munster@nih.gov	van Doremalen, Neeltje/AAD-2315-2021; de Wit, Emmie/A-1549-2019; Lambe, Teresa/E-5733-2016; Okumura, Atsushi/E-8012-2015; Munster, Vincent/I-7607-2018	de Wit, Emmie/0000-0002-9763-7758; Lambe, Teresa/0000-0001-7711-897X; Okumura, Atsushi/0000-0002-7779-3059; Lovaglio, Jamie/0000-0002-7567-446X; Van Doremalen, Neeltje/0000-0003-4368-6359; Perez-Perez, Lizzette/0000-0001-5881-4363; Holbrook, Myndi/0000-0003-2376-2633; Spencer, Alexandra/0000-0001-7958-6961; Sharpe, Hannah/0000-0002-1194-2429; Munster, Vincent/0000-0002-2288-3196; Bissett, Cameron/0000-0003-3345-663X; Wright, Daniel/0000-0002-8114-1838; Allen, Elizabeth/0000-0002-6406-4834; Port, Julia Rebecca/0000-0002-0489-6591	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [1ZIAAI001179-01]; Department of Health and Social Care; EPSRC [EP/R013756/1] Funding Source: UKRI; MRC [MC_PC_19055] Funding Source: UKRI	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Department of Health and Social Care; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank O. Abiona, B. Bailes, A. Carmody, K. Corbett, K. Cordova, J. Faris, H. Feldmann, S. Gerber, B. Graham, E. Haddock, R. Kissinger, M. Jones, M. Marsh, K. Menk, A. Mora, S. Seifert, L. Shupert, B. Smith, N. Thornburg, A. Weidow, M. Woods and K. C. Yinda for their assistance during this study. This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (1ZIAAI001179-01) and the Department of Health and Social Care using UK Aid funding managed by the NIHR.	Bewig B, 2000, BIOTECHNIQUES, V28, P870, DOI 10.2144/00285bm08; Bliss CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21630-4; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dicks MDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040385; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; van Doremalen N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8399; Weingartl H, 2004, J VIROL, V78, P12672, DOI 10.1128/JVI.78.22.12672-12676.2004; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	20	510	523	4	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2020	586	7830					578	+		10.1038/s41586-020-2608-y	http://dx.doi.org/10.1038/s41586-020-2608-y		JUL 2020	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OE6NR	32511340	Bronze, Green Accepted			2022-12-28	WOS:000577298500001
J	Wolinetz, CD; Collins, FS				Wolinetz, Carrie D.; Collins, Francis S.			Recognition of Research Participants' Need for Autonomy Remembering the Legacy of Henrietta Lacks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wolinetz, Carrie D.; Collins, Francis S.] NIH, One Ctr Dr,Bldg 1,Room 126, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, One Ctr Dr,Bldg 1,Room 126, Bethesda, MD 20892 USA.	collinsf@od.nih.gov						Carnethon MR, 2020, JAMA-J AM MED ASSOC, V323, P211, DOI 10.1001/jama.2019.19329; Getz KA, 2020, THER INNOV REGUL SCI, V54, P1541, DOI 10.1007/s43441-020-00181-9; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Jamison P., 2020, WASHINGTON POST, DOI 10.1371/journal.pmed.1002632; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Skloot R., 2011, IMMORTAL LIFE HENRIE; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	8	19	19	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2020	324	11					1027	1028		10.1001/jama.2020.15936	http://dx.doi.org/10.1001/jama.2020.15936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OF2XM	32780115	Bronze			2022-12-28	WOS:000581077300009
J	Pearson, E; Frakt, A				Pearson, Elsa; Frakt, Austin			Health Care Cost Growth Benchmarks in 5 States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Pearson, Elsa; Frakt, Austin] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Frakt, Austin] Vet Hlth Adm, Partnered Evidence Based Policy Resource Ctr, John F Kennedy Fed Bldg,15 Sudbury St, Boston, MA 02203 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Frakt, A (corresponding author), Vet Hlth Adm, Partnered Evidence Based Policy Resource Ctr, John F Kennedy Fed Bldg,15 Sudbury St, Boston, MA 02203 USA.	frakt@bu.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					537	538		10.1001/jama.2020.12437	http://dx.doi.org/10.1001/jama.2020.12437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32780131	Bronze			2022-12-28	WOS:000562845100003
J	Yancy, CW				Yancy, Clyde W.			Academic Medicine and Black Lives Matter Time for Deep Listening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In the context of the Black Lives Matter movement, this Viewpoint considers the demand that academic medicine address its own structural racism, and concludes on the basis of its history, culture, role, and influence that the institution can, should, and must make racial justice a part of its work and mission.	[Yancy, Clyde W.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, 676 N St Clair,Ste 600, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Yancy, CW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, 676 N St Clair,Ste 600, Chicago, IL 60611 USA.	cyancy@nm.org						Carnethon MR, 2020, JAMA-J AM MED ASSOC, V323, P211, DOI 10.1001/jama.2019.19329; Cooper LA, 2019, JAMA INTERN MED, V179, P1686, DOI 10.1001/jamainternmed.2019.4100; Polite BN, 2019, JAMA-J AM MED ASSOC, V321, P1663, DOI 10.1001/jama.2019.4266; Thorp HH, 2020, SCIENCE, V368, P1161, DOI 10.1126/science.abd1896; Williams D. R., 2020, JAMA-J AM MED ASSOC, V323, P2478; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750	6	33	33	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					435	436		10.1001/jama.2020.12532	http://dx.doi.org/10.1001/jama.2020.12532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749497				2022-12-28	WOS:000561261900005
